PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wild, R; Gerasimaite, R; Jung, JY; Truffault, V; Pavlovic, I; Schmidt, A; Saiardi, A; Jessen, HJ; Poirier, Y; Hothorn, M; Mayer, A				Wild, Rebekka; Gerasimaite, Ruta; Jung, Ji-Yul; Truffault, Vincent; Pavlovic, Igor; Schmidt, Andrea; Saiardi, Adolfo; Jessen, Henning Jacob; Poirier, Yves; Hothorn, Michael; Mayer, Andreas			Control of eukaryotic phosphate homeostasis by inositol polyphosphate sensor domains	SCIENCE			English	Article							SPX DOMAIN; PYROPHOSPHATE SYNTHESIS; ARABIDOPSIS; INHIBITOR; IDENTIFICATION; ACCUMULATION; PHR2; XPR1	Phosphorus is a macronutrient taken up by cells as inorganic phosphate (Pi). How cells sense cellular Pi levels is poorly characterized. Here, we report that SPX domains-which are found in eukaryotic phosphate transporters, signaling proteins, and inorganic polyphosphate polymerases-provide a basic binding surface for inositol polyphosphate signaling molecules (InsPs), the concentrations of which change in response to Pi availability. Substitutions of critical binding surface residues impair InsP binding in vitro, inorganic polyphosphate synthesis in yeast, and Pi transport in Arabidopsis. In plants, InsPs trigger the association of SPX proteins with transcription factors to regulate Pi starvation responses. We propose that InsPs communicate cytosolic Pi levels to SPX domains and enable them to interact with a multitude of proteins to regulate Pi uptake, transport, and storage in fungi, plants, and animals.	[Wild, Rebekka; Hothorn, Michael] Univ Geneva, Dept Bot & Plant Biol, Struct Plant Biol Lab, Geneva, Switzerland; [Gerasimaite, Ruta; Schmidt, Andrea; Mayer, Andreas] Univ Lausanne, Dept Biochem, Lausanne, Switzerland; [Jung, Ji-Yul; Poirier, Yves] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland; [Truffault, Vincent] Max Planck Inst Dev Biol, Dept Biochem, Tubingen, Germany; [Pavlovic, Igor; Jessen, Henning Jacob] Univ Zurich, Dept Chem & Pharm, Zurich, Switzerland; [Saiardi, Adolfo] UCL, Med Res Council Lab Mol Cell Biol, London, England; [Jessen, Henning Jacob] Univ Freiburg, Inst Organ Chem, Hugstetter Str 55, D-79106 Freiburg, Germany	University of Geneva; University of Lausanne; University of Lausanne; Max Planck Society; University of Zurich; University of London; University College London; University of Freiburg	Hothorn, M (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Struct Plant Biol Lab, Geneva, Switzerland.; Mayer, A (corresponding author), Univ Lausanne, Dept Biochem, Lausanne, Switzerland.; Poirier, Y (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland.	yves.poirier@unil.ch; michael.hothorn@unige.ch; andrea.mayer@unil.ch	JUNG, JI-YUL/M-5643-2016; Gerasimaitė, Rūta/GLV-5402-2022; Jessen, Henning/F-5108-2014; Mayer, Andreas/AAE-4315-2020; Pavlovic, Igor/AAG-5295-2019; Jessen, Henning/O-1157-2019	Jessen, Henning/0000-0002-1025-9484; Mayer, Andreas/0000-0001-6131-313X; Jessen, Henning/0000-0002-1025-9484; Hothorn, Michael/0000-0002-3597-5698	European Research Council (ERC) under the European Union [310856]; European Molecular Biology Organisation (EMBO); Swiss National Fund (SNF) [31003A-138339, 31003A-159998]; SNF [PP00P2 157607, 144258]; ERC [233458]; MRC [MC_U122680443, MC_UU_12018/4] Funding Source: UKRI; Medical Research Council [MC_U122680443, MC_UU_12018/4] Funding Source: researchfish	European Research Council (ERC) under the European Union(European Research Council (ERC)); European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); Swiss National Fund (SNF)(Swiss National Science Foundation (SNSF)); SNF; ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank G. Braunlich for help with data analysis and J. Piehler for a sample of tris-NTA-Oregon Green488. Atomic coordinates and structure factors have been deposited with the Protein Data Bank with accession nos. 5IIG (SPX-TTM<SUP>ScVtc4</SUP> form A), 5IIQ (SPX-TTM<SUP>ScVtc4</SUP> form B), 5IIT (SPX<SUP>ScVtc4</SUP>-macro), 5IJH (SPX<SUP>HsXPR1</SUP> SO<INF>4</INF><SUP>2-</SUP>), 5IJJ (SPX<SUP>CtGde1</SUP> InsP<INF>6</INF>), and 5IJP (SPX<SUP>CtVtc4</SUP> InsP<INF>6</INF>). We thank S. Wege for assistance with confocal microscopy and P<INF>i</INF> export assays. This project was funded by grants from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant agreement 310856, the European Molecular Biology Organisation (EMBO) Young Investigator Programme (to M. H.), the Swiss National Fund (SNF) grants 31003A-138339 and 31003A-159998 (to Y. P.), an SNF Professorship PP00P2 157607 (to H. J. J.), and from ERC grant 233458 and SNF grant 144258 (to A. M.). Diffraction experiments were performed at beam lines PXII and PXIII of the Swiss Light Source, Paul Scherrer Institute, Villigen, and at beam-line ID29 of the European Synchrotron Radiation Facility, Grenoble, France. The supplementary materials contain additional data.	Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Desai M, 2014, PLANT J, V80, P642, DOI 10.1111/tpj.12669; Duan K, 2008, PLANT J, V54, P965, DOI 10.1111/j.1365-313X.2008.03460.x; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Hurlimann HC, 2009, EMBO REP, V10, P1003, DOI 10.1038/embor.2009.105; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Legati A, 2015, NAT GENET, V47, P579, DOI 10.1038/ng.3289; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Liu JL, 2015, P NATL ACAD SCI USA, V112, pE6571, DOI 10.1073/pnas.1514598112; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Lv QD, 2014, PLANT CELL, V26, P1586, DOI 10.1105/tpc.114.123208; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; OGAWA N, 1995, MOL CELL BIOL, V15, P997; Park BS, 2014, PLANT CELL, V26, P454, DOI 10.1105/tpc.113.120311; Pratt J, 2009, PLANT PHYSIOL, V151, P1646, DOI 10.1104/pp.109.144626; Puga MI, 2014, P NATL ACAD SCI USA, V111, P14947, DOI 10.1073/pnas.1404654111; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Secco D, 2012, NEW PHYTOL, V193, P842, DOI 10.1111/j.1469-8137.2011.04002.x; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shears Stephen B, 2015, Adv Biol Regul, V57, P203, DOI 10.1016/j.jbior.2014.09.015; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Wang ZY, 2014, P NATL ACAD SCI USA, V111, P14953, DOI 10.1073/pnas.1404680111; Wege S, 2016, PLANT PHYSIOL, V170, P385, DOI 10.1104/pp.15.00975; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022	29	280	303	5	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2016	352	6288			SI		986	990		10.1126/science.aad9858	http://dx.doi.org/10.1126/science.aad9858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM2AK	27080106	Green Accepted			2022-12-28	WOS:000376147800047
J	Larson, EB				Larson, Eric B.			Review: In older persons at vascular risk, statins do not prevent dementia or cognitive decline at 3.5 to 5 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DISEASE		[Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA		Larson, EB (corresponding author), Grp Hlth Res Inst, Seattle, WA USA.							Li G, 2007, NEUROLOGY, V69, P878, DOI 10.1212/01.wnl.0000277657.95487.1c; Li G, 2010, J AM GERIATR SOC, V58, P1311, DOI 10.1111/j.1532-5415.2010.02906.x; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					JC42	JC42		10.7326/ACPJC-2016-164-8-042	http://dx.doi.org/10.7326/ACPJC-2016-164-8-042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	27089091				2022-12-28	WOS:000374257900004
J	Klein, T; Siegwolf, RTW; Korner, C				Klein, Tamir; Siegwolf, Rolf T. W.; Koerner, Christian			Belowground carbon trade among tall trees in a temperate forest	SCIENCE			English	Article							ECTOMYCORRHIZAL FUNGI; ROOT GRAFTS; PLANTS; CANOPY; GROWTH; LIMITATION; SEEDLINGS; NETWORKS	Forest trees compete for light and soil resources, but photoassimilates, once produced in the foliage, are not considered to be exchanged between individuals. Applying stable carbon isotope labeling at the canopy scale, we show that carbon assimilated by 40-meter-tall spruce is traded over to neighboring beech, larch, and pine via overlapping root spheres. Isotope mixing signals indicate that the interspecific, bidirectional transfer, assisted by common ectomycorrhiza networks, accounted for 40% of the fine root carbon ( about 280 kilograms per hectare per year tree-to-tree transfer). Although competition for resources is commonly considered as the dominant tree-to-tree interaction in forests, trees may interact in more complex ways, including substantial carbon exchange.	[Klein, Tamir; Koerner, Christian] Univ Basel, Inst Bot, Schonbeinstr 6, CH-4056 Basel, Switzerland; [Siegwolf, Rolf T. W.] Paul Scherrer Inst, Lab Atmospher Chem, Ecosyst Fluxes Res Grp, CH-5323 Villigen, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Klein, T (corresponding author), Univ Basel, Inst Bot, Schonbeinstr 6, CH-4056 Basel, Switzerland.	tamir.klein@unibas.ch	Siegwolf, Rolf Theodor Walter/GLT-9297-2022; Siegwolf, Rolf TW/D-4121-2009; Körner, Christian/B-6592-2014	Siegwolf, Rolf Theodor Walter/0000-0002-0249-0651; Siegwolf, Rolf TW/0000-0002-0249-0651; Körner, Christian/0000-0001-7768-7638	Swiss National Fund project FORCARB [31003A_14753/1]; Plant Fellows program of the Zurich-Basel Plant Science Center (PSC) through the EU FP7 Marie Curie action	Swiss National Fund project FORCARB; Plant Fellows program of the Zurich-Basel Plant Science Center (PSC) through the EU FP7 Marie Curie action	Research at the Swiss canopy crane site was funded by the Swiss National Fund project FORCARB (31003A_14753/1 to C.K.). T.K. was cofunded by the Plant Fellows program of the Zurich-Basel Plant Science Center (PSC) through the EU FP7 Marie Curie action. We thank J. Grunzweig (Hebrew University of Jerusalem, Israel) and R. Milo (Weizmann Institute of Science, Israel) for providing comments on an earlier version of the paper; M. Saurer and L. Schmid at the Paul Scherrer Institute for stable isotope analyses; S. G. Keel, R. Keller, and M. Wilhelm for collection and taxonomic classification of mycorrhizal fungi; E. Amstutz and L. Rizzelli for crane operation; and G. Grun for electronics and CO<INF>2</INF> control. Data showing the experimental set-up, mycorrhiza species list, supplementary figs. S1 to S15, and materials and methods are available in the supplementary materials. The authors declare no conflict of interest and that there are no material transfer agreements or patent applications involved in the study.	Agerer R., 2004, DEEMY INFORM SYSTEM; Bent E, 2011, APPL ENVIRON MICROB, V77, P3351, DOI 10.1128/AEM.02575-10; Chevillat VS, 2005, BASIC APPL ECOL, V6, P519, DOI 10.1016/j.baae.2005.04.008; Fitter AH, 1998, FUNCT ECOL, V12, P406, DOI 10.1046/j.1365-2435.1998.00206.x; Ford CR, 2007, TREE PHYSIOL, V27, P375, DOI 10.1093/treephys/27.3.375; FRANCIS R, 1984, NATURE, V307, P53, DOI 10.1038/307053a0; Fraser EC, 2006, TREE PHYSIOL, V26, P1019, DOI 10.1093/treephys/26.8.1019; GRAHAM BF, 1960, ECOLOGY, V41, P56, DOI 10.2307/1931939; GRAHAM BF, 1966, BOT REV, V32, P255, DOI 10.1007/BF02858662; HIRREL MC, 1979, NEW PHYTOL, V83, P731, DOI 10.1111/j.1469-8137.1979.tb02303.x; Hogberg P, 2008, NEW PHYTOL, V177, P220, DOI 10.1111/j.1469-8137.2007.02238.x; Hynson NA, 2012, OECOLOGIA, V169, P307, DOI 10.1007/s00442-011-2198-3; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Lang C, 2011, MYCORRHIZA, V21, P297, DOI 10.1007/s00572-010-0338-y; Matarese D. M., 2011, THESIS PORTLAND STAT; Mildner M, 2015, BIOGEOCHEMISTRY, V124, P95, DOI 10.1007/s10533-015-0084-5; Mildner M, 2014, OECOLOGIA, V175, P747, DOI 10.1007/s00442-014-2935-5; Pepin S, 2002, OECOLOGIA, V133, P1, DOI 10.1007/s00442-002-1008-3; PERRY DA, 1992, ECOLOGY MIXED SPECIE, P151; Pillukat Angela, 1992, Zeitschrift fuer Mykologie, V58, P211; REID CPP, 1969, ECOLOGY, V50, P179, DOI 10.2307/1934844; Robinson D, 1999, J EXP BOT, V50, P9, DOI 10.1093/jexbot/50.330.9; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Vargas R, 2009, NEW PHYTOL, V182, P710, DOI 10.1111/j.1469-8137.2009.02789.x; Wallander H, 2011, FOREST ECOL MANAG, V262, P999, DOI 10.1016/j.foreco.2011.05.035; WOODS FW, 1964, ECOLOGY, V45, P886, DOI 10.2307/1934943	30	125	134	20	337	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					342	344		10.1126/science.aad6188	http://dx.doi.org/10.1126/science.aad6188			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081070				2022-12-28	WOS:000373990100040
J	Guarnerio, J; Bezzi, M; Jeong, JC; Paffenholz, SV; Berry, K; Naldini, MM; Lo-Coco, F; Tay, Y; Beck, AH; Pandolfi, PP				Guarnerio, Jlenia; Bezzi, Marco; Jeong, Jong Cheol; Paffenholz, Stella V.; Berry, Kelsey; Naldini, Matteo M.; Lo-Coco, Francesco; Tay, Yvonne; Beck, Andrew H.; Pandolfi, Pier Paolo			Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations	CELL			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; CIRCULAR RNAS; CELL-LINE; MICRORNA; TRANSCRIPTION; SEQUENCES; DIAGNOSIS; BIOMARKER; PROTEINS	Chromosomal translocations encode oncogenic fusion proteins that have been proven to be causally involved in tumorigenesis. Our understanding of whether such genomic alterations also affect non-coding RNAs is limited, and their impact on circular RNAs (circRNAs) has not been explored. Here, we show that well-established cancer-associated chromosomal translocations give rise to fusion circRNAs (f-circRNA) that are produced from transcribed exons of distinct genes affected by the translocations. F-circRNAs contribute to cellular transformation, promote cell viability and resistance upon therapy, and have tumor-promoting properties in in vivo models. Our work expands the current knowledge regarding molecular mechanisms involved in cancer onset and progression, with potential diagnostic and therapeutic implications.	[Guarnerio, Jlenia; Bezzi, Marco; Paffenholz, Stella V.; Berry, Kelsey; Naldini, Matteo M.; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Canc Res Inst,Dept Med,Med Sch, Boston, MA 02215 USA; [Guarnerio, Jlenia; Bezzi, Marco; Jeong, Jong Cheol; Paffenholz, Stella V.; Berry, Kelsey; Naldini, Matteo M.; Beck, Andrew H.; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Canc Res Inst,Dept Pathol,Med Sch, Boston, MA 02215 USA; [Lo-Coco, Francesco] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00173 Rome, Italy; [Lo-Coco, Francesco] Fdn Santa Lucia, I-00173 Rome, Italy; [Tay, Yvonne] Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst Singapore, Singapore 117597, Singapore; [Tay, Yvonne] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Rome Tor Vergata; IRCCS Santa Lucia; National University of Singapore; National University of Singapore	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Canc Res Inst,Dept Med,Med Sch, Boston, MA 02215 USA.; Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Canc Res Inst,Dept Pathol,Med Sch, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu		Naldini, Matteo Maria/0000-0002-9542-2884; Bezzi, Marco/0000-0001-9376-690X; Pandolfi, Pier Paolo/0000-0002-5352-5295; guarnerio, jlenia/0000-0001-7576-7095	American- Italian Cancer Foundation	American- Italian Cancer Foundation	We thank Lauren Southwood and Kaitlyn Doherty for insightful editing and all members of the Pandolfi lab for critical discussion. We thank Dr. Daniel Costa for providing H3122 cell line and Dr. Mireia Castillo Martin for providing SKNEP cell line. J.G. was supported by a fellowship from American- Italian Cancer Foundation during the execution of this work. S.V.P. has been granted leave of absence from the German Cancer Research Center DKFZ, Heidelberg.	Anderson JL, 2012, PEDIATR RES, V72, P112, DOI 10.1038/pr.2012.54; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bahn JH, 2015, CLIN CHEM, V61, P221, DOI 10.1373/clinchem.2014.230433; Bailey LC, 2008, LANCET ONCOL, V9, P873, DOI 10.1016/S1470-2045(08)70229-8; Barrett SP, 2015, ELIFE, V4, DOI 10.7554/eLife.07540; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dekking EHA, 2012, LEUKEMIA, V26, P1976, DOI 10.1038/leu.2012.125; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; dos Santos GA, 2013, J EXP MED, V210, P2793, DOI 10.1084/jem.20131121; Forman SJ, 2013, BLOOD, V121, P1077, DOI 10.1182/blood-2012-08-234492; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; HSU MT, 1979, NATURE, V280, P339, DOI 10.1038/280339a0; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LANOTTE M, 1991, BLOOD, V77, P1080; Lengfelder E, 2012, LEUKEMIA, V26, P433, DOI 10.1038/leu.2011.245; Li F, 2015, ONCOTARGET, V6, P6001, DOI 10.18632/oncotarget.3469; Li PF, 2015, CLIN CHIM ACTA, V444, P132, DOI 10.1016/j.cca.2015.02.018; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Lowenberg B, 2011, NEW ENGL J MED, V364, P1027, DOI 10.1056/NEJMoa1010222; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Smith MA, 2008, PEDIATR BLOOD CANCER, V50, P703, DOI 10.1002/pbc.21099; Somervaille TCP, 2010, INT J HEMATOL, V91, P735, DOI 10.1007/s12185-010-0579-8; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Wang Y, 2015, RNA, V21, P172, DOI 10.1261/rna.048272.114; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	50	412	447	6	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					289	302		10.1016/j.cell.2016.03.020	http://dx.doi.org/10.1016/j.cell.2016.03.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27040497	Bronze			2022-12-28	WOS:000374123000009
J	Jang, J; Wang, YD; Lalli, MA; Guzman, E; Godshalk, SE; Zhou, HJ; Kosik, KS				Jang, Jiwon; Wang, Yidi; Lalli, Matthew A.; Guzman, Elmer; Godshalk, Sirie E.; Zhou, Hongjun; Kosik, Kenneth S.			Primary Cilium-Autophagy-Nrf2 (PAN) Axis Activation Commits Human Embryonic Stem Cells to a Neuroectoderm Fate	CELL			English	Article							REPRESSIVE COMPLEX 2; LINEAGE SPECIFIERS; OXIDATIVE STRESS; PRIMARY CILIUM; SELF-RENEWAL; C-ELEGANS; MAINTAINS PLURIPOTENCY; SELECTIVE AUTOPHAGY; HUMAN ESCS; DIFFERENTIATION	Under defined differentiation conditions, human embryonic stem cells (hESCs) can be directed toward a mesendoderm (ME) or neuroectoderm (NE) fate, the first decision during hESC differentiation. Coupled with lineage-specific G1 lengthening, a divergent ciliation pattern emerged within the first 24 hr of induced lineage specification, and these changes heralded a neuroectoderm decision before any neural precursor markers were expressed. By day 2, increased ciliation in NE precursors induced autophagy that resulted in the inactivation of Nrf2 and thereby relieved transcriptional activation of OCT4 and NANOG. Nrf2 binds directly to upstream regions of these pluripotency genes to promote their expression and repress NE derivation. Nrf2 suppression was sufficient to rescue poorly neurogenic iPSC lines. Only after these events had been initiated did neural precursor markers get expressed at day 4. Thus, we have identified a primary cilium-autophagy-Nrf2 (PAN) control axis coupled to cell-cycle progression that directs hESCs toward NE.	[Jang, Jiwon; Wang, Yidi; Lalli, Matthew A.; Guzman, Elmer; Godshalk, Sirie E.; Zhou, Hongjun; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular Dev Biol, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu	Zhou, Hongjun/E-5322-2010	Zhou, Hongjun/0000-0002-8873-293X; Wang, Yidi/0000-0003-2384-3812; Lalli, Matthew/0000-0003-0419-1206; Jang, Jiwon/0000-0002-5884-5685	California Institute for Regenerative Medicine (CIRM) grant [CL1-00521]; Rainwater Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; CIRM [TG2-01151]	California Institute for Regenerative Medicine (CIRM) grant; Rainwater Charitable Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; CIRM(California Institute for Regenerative Medicine)	Thanks to the Gilad lab at University of Chicago and the Yerkes Primate Research Center for human and chimpanzee iPSC lines, Ana Maria Cuervo at Albert Einstein College of Medicine for insightful comments, and the Laboratory for Stem Cell Biology and Engineering at UC Santa Barbara, supported by the California Institute for Regenerative Medicine (CIRM) grant CL1-00521. Support came from the Rainwater Charitable Foundation, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. J.J. was supported by a fellowship from CIRM (TG2-01151).	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bangs FK, 2015, NAT CELL BIOL, V17, P113, DOI 10.1038/ncb3091; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Boles NC, 2014, CELL REP, V6, P724, DOI 10.1016/j.celrep.2014.01.026; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Fujie Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113052; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Hosogane M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003698; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jang JW, 2014, STEM CELLS, V32, P2616, DOI 10.1002/stem.1764; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Koyanagi-Aoi M, 2013, P NATL ACAD SCI USA, V110, P20569, DOI 10.1073/pnas.1319061110; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Plotnikova OV, 2009, METHOD CELL BIOL, V94, P137, DOI 10.1016/S0091-679X(08)94007-3; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Romero IG, 2015, ELIFE, V4, DOI 10.7554/eLife.07103; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; SAVATIER P, 1994, ONCOGENE, V9, P809; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Streichan SJ, 2014, P NATL ACAD SCI USA, V111, P5586, DOI 10.1073/pnas.1323016111; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; van de Leemput J, 2014, NEURON, V83, P51, DOI 10.1016/j.neuron.2014.05.013; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017	60	66	69	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					410	420		10.1016/j.cell.2016.02.014	http://dx.doi.org/10.1016/j.cell.2016.02.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27020754	Bronze			2022-12-28	WOS:000374123000019
J	Shum, EY; Jones, SH; Shao, A; Dumdie, J; Krause, MD; Chan, WK; Lou, CH; Espinoza, JL; Song, HW; Phan, MH; Ramaiah, M; Huang, LL; McCarrey, JR; Peterson, KJ; De Rooij, DG; Cook-Andersen, H; Wilkinson, MF				Shum, Eleen Y.; Jones, Samantha H.; Shao, Ada; Dumdie, Jennifer; Krause, Matthew D.; Chan, Wai-Kin; Lou, Chih-Hong; Espinoza, Josh L.; Song, Hye-Won; Phan, Mimi H.; Ramaiah, Madhuvanthi; Huang, Lulu; McCarrey, John R.; Peterson, Kevin J.; De Rooij, Dirk G.; Cook-Andersen, Heidi; Wilkinson, Miles F.			The Antagonistic Gene Paralogs Upf3a and Upf3b Govern Nonsense-Mediated RNA Decay	CELL			English	Article							MESSENGER-RNA; STRUCTURAL BASIS; GERM-CELLS; STEM-CELL; EXPRESSION; IDENTIFICATION; MACHINERY; EVOLUTION; INSIGHTS; PROTEIN	Gene duplication is a major evolutionary force driving adaptation and speciation, as it allows for the acquisition of new functions and can augment or diversify existing functions. Here, we report a gene duplication event that yielded another outcome-the generation of antagonistic functions. One product of this duplication event-UPF3B-is critical for the nonsense-mediated RNA decay (NMD) pathway, while its autosomal counterpart-UPF3A-encodes an enigmatic protein previously shown to have trace NMD activity. Using loss-of-function approaches in vitro and in vivo, we discovered that UPF3A acts primarily as a potent NMD inhibitor that stabilizes hundreds of transcripts. Evidence suggests that UPF3A acquired repressor activity through simple impairment of a critical domain, a rapid mechanism that may have been widely used in evolution. Mice conditionally lacking UPF3A exhibit "hyper'' NMD and display defects in embryogenesis and gametogenesis. Our results support a model in which UPF3A serves as a molecular rheostat that directs developmental events.	[Shum, Eleen Y.; Jones, Samantha H.; Shao, Ada; Dumdie, Jennifer; Krause, Matthew D.; Lou, Chih-Hong; Espinoza, Josh L.; Song, Hye-Won; Phan, Mimi H.; Ramaiah, Madhuvanthi; Huang, Lulu; Cook-Andersen, Heidi; Wilkinson, Miles F.] Univ Calif San Diego, Sch Med, Dept Reprod Med, La Jolla, CA 92103 USA; [Chan, Wai-Kin] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [McCarrey, John R.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78219 USA; [De Rooij, Dirk G.] Univ Utrecht, Fac Sci, Dept Biol, Reprod Biol Grp,Div Dev Biol, Padualaan 8, NL-3584 Utrecht, Netherlands; [Wilkinson, Miles F.] Univ Calif San Diego, Inst Genom Med, San Diego, CA 92103 USA; [Peterson, Kevin J.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA	University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas at San Antonio (UTSA); Utrecht University; University of California System; University of California San Diego; Dartmouth College	Wilkinson, MF (corresponding author), Univ Calif San Diego, Sch Med, Dept Reprod Med, La Jolla, CA 92103 USA.; Wilkinson, MF (corresponding author), Univ Calif San Diego, Inst Genom Med, San Diego, CA 92103 USA.	mfwilkinson@ucsd.edu	de Rooij, D.G./AAW-1195-2021; Chan, Waikin/AAI-4995-2020; Peterson, Kevin J/A-2188-2009; Chousal, Jennifer/AFN-7142-2022	Chousal, Jennifer/0000-0002-8725-6142; de Rooij, Dirk/0000-0003-3932-4419; Cook-Andersen, Heidi/0000-0003-3916-5120; Espinoza, Josh/0000-0003-3447-3845; Shum, Eleen Y./0000-0002-1541-1609	NIH [GM111838, HD001259, K12 HD001259]; Howard Hughes Medical Institute; Interfaces Scholar program, Reproductive Health Research grant [K12 HD001259]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007203, F30HD089579, K12HD001259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198, R01GM111838] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Interfaces Scholar program, Reproductive Health Research grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (GM111838, HD001259, and K12 HD001259), the Howard Hughes Medical Institute, and the Interfaces Scholar program, Reproductive Health Research grant (K12 HD001259). The authors thank Jens Lykke-Andersen (UCSD), Sebastien Durand (UCSD), and Mary Ann Handel (Jackson Laboratories) for their valuable scientific input, antibodies, and samples.	Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; Boelz S, 2006, BIOCHEM BIOPH RES CO, V349, P186, DOI 10.1016/j.bbrc.2006.08.017; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Buchwald G, 2010, P NATL ACAD SCI USA, V107, P10050, DOI 10.1073/pnas.1000993107; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chan WK, 2009, NAT STRUCT MOL BIOL, V16, P747, DOI 10.1038/nsmb.1612; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Huang LL, 2012, WIRES RNA, V3, P807, DOI 10.1002/wrna.1137; Huang LL, 2011, MOL CELL, V43, P950, DOI 10.1016/j.molcel.2011.06.031; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jolly LA, 2013, HUM MOL GENET, V22, P4673, DOI 10.1093/hmg/ddt315; Kadlec J, 2004, NAT STRUCT MOL BIOL, V11, P330, DOI 10.1038/nsmb741; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; Nguyen LS, 2014, NEUROSCI BIOBEHAV R, V46, P175, DOI 10.1016/j.neubiorev.2013.10.016; Lou CH, 2014, CELL REP, V6, P748, DOI 10.1016/j.celrep.2014.01.028; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Maderazo AB, 2003, MOL CELL BIOL, V23, P842, DOI 10.1128/MCB.23.3.842-851.2003; MCCARREY JR, 1992, NAT GENET, V2, P200, DOI 10.1038/ng1192-200; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nguyen LS, 2012, MOL PSYCHIATR, V17, P1103, DOI 10.1038/mp.2011.163; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Song HW, 2012, REPRODUCTION, V143, P611, DOI 10.1530/REP-11-0479; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Teshima KM, 2008, GENETICS, V178, P1385, DOI 10.1534/genetics.107.082933; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Zetoune AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-83; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018	39	87	90	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					382	395		10.1016/j.cell.2016.02.046	http://dx.doi.org/10.1016/j.cell.2016.02.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27040500	Green Accepted, Bronze			2022-12-28	WOS:000374123000017
J	Hua, XY; Carvalho, N; Tew, M; Huang, ES; Herman, WH; Clarke, P				Hua, Xinyang; Carvalho, Natalie; Tew, Michelle; Huang, Elbert S.; Herman, William H.; Clarke, Philip			Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							INSULIN		[Hua, Xinyang; Carvalho, Natalie; Tew, Michelle; Clarke, Philip] Univ Melbourne, Sch Populat & Global Hlth, Carlton, Vic 3053, Australia; [Huang, Elbert S.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Herman, William H.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Melbourne; University of Chicago; University of Michigan System; University of Michigan	Clarke, P (corresponding author), Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Level 4,207 Bouverie St, Carlton, Vic 3053, Australia.	philip.clarke@unimelb.edu.au	Carvalho, Natalie/AAD-4321-2022	TEW, MICHELLE/0000-0003-3009-8056; Hua, Xinyang/0000-0003-2102-5461; Carvalho, Natalie/0000-0002-5599-2209; Clarke, Philip/0000-0002-7555-5348	NIDDK NIH HHS [P30 DK092949, P30 DK020572, R01 DK090435, K24 DK105340, P30 DK089503, 5R01 DK090435-02, P30 DK092926] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949, R01DK090435, P30DK089503, K24DK105340, P30DK020572] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agency for Health Care Research and Quality, MEPS HC155 2012 FULL; Agency for Health Care Research and Quality, COMP RET DRUG PRIC M; Greene JA, 2015, NEW ENGL J MED, V372, P1171, DOI 10.1056/NEJMms1411398; Lipska KJ, 2014, JAMA-J AM MED ASSOC, V311, P2331, DOI 10.1001/jama.2014.6316; Luo J, 2015, JAMA INTERN MED, V175, P1681, DOI 10.1001/jamainternmed.2015.4338; Zhuo XH, 2015, DIABETES CARE, V38, P581, DOI 10.2337/dc14-1687	6	87	89	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1400	1402		10.1001/jama.2016.0126	http://dx.doi.org/10.1001/jama.2016.0126			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	27046369	Green Accepted, Bronze			2022-12-28	WOS:000373381500025
J	Watts, G				Watts, Geoff			Sam Adjei Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1270	1270		10.1016/S0140-6736(16)30028-9	http://dx.doi.org/10.1016/S0140-6736(16)30028-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27035019	Bronze			2022-12-28	WOS:000372697500015
J	Scher, HI				Scher, Howard I.			Defining new standards of care for men with prostate cancer	LANCET			English	Editorial Material							ANDROGEN-DEPRIVATION THERAPY; DOCETAXEL		[Scher, Howard I.] Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, Dept Med, Genitourinary Oncol Serv, New York, NY 10065 USA; [Scher, Howard I.] Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University	Scher, HI (corresponding author), Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, Dept Med, Genitourinary Oncol Serv, New York, NY 10065 USA.; Scher, HI (corresponding author), Weill Cornell Med Coll, New York, NY USA.	scherh@mskcc.org						Gravis G, 2016, EUR UROL, V70, P256, DOI 10.1016/j.eururo.2015.11.005; Gravis G, 2013, LANCET ONCOL, V14, P149, DOI 10.1016/S1470-2045(12)70560-0; Huggins C, 1942, ANN SURG, V115, P1192, DOI 10.1097/00000658-194206000-00030; James ND, 2016, LANCET, V387, P1163, DOI 10.1016/S0140-6736(15)01037-5; James ND, 2012, LANCET ONCOL, V13, P549, DOI 10.1016/S1470-2045(12)70088-8; Sweeney C, 2014, J CLIN ONCOL S, V32, P5; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Templeton AJ, 2013, ANN ONCOL, V24, P2972, DOI 10.1093/annonc/mdt397; Vale CL, 2016, LANCET ONCOL, V17, P243, DOI 10.1016/S1470-2045(15)00489-1; Warde P, 2011, LANCET, V378, P2104, DOI 10.1016/S0140-6736(11)61095-7; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2	11	1	2	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1135	1137		10.1016/S0140-6736(15)01235-0	http://dx.doi.org/10.1016/S0140-6736(15)01235-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	27025318	hybrid			2022-12-28	WOS:000372412000004
J	Schmidt, HR; Zheng, SD; Gurpinar, E; Koehl, A; Manglik, A; Kruse, AC				Schmidt, Hayden R.; Zheng, Sanduo; Gurpinar, Esin; Koehl, Antoine; Manglik, Aashish; Kruse, Andrew C.			Crystal structure of the human sigma 1 receptor	NATURE			English	Article							AMINO-ACID-RESIDUES; LIGAND; PHARMACOLOGY; PROTEINS; CONSERVATION; ACTIVATION; EXPRESSION; MUTATION; BINDING; DOMAIN	The human sigma 1 receptor is an enigmatic endoplasmic-reticulumresident transmembrane protein implicated in a variety of disorders including depression, drug addiction, and neuropathic pain(1). Recently, an additional connection to amyotrophic lateral sclerosis has emerged from studies of human genetics and mouse models(2). Unlike many transmembrane receptors that belong to large, extensively studied families such as G-protein- coupled receptors or ligand-gated ion channels, the sigma 1 receptor is an evolutionary isolate with no discernible similarity to any other human protein. Despite its increasingly clear importance in human physiology and disease, the molecular architecture of the s1 receptor and its regulation by drug-like compounds remain poorly defined. Here we report crystal structures of the human sigma 1 receptor in complex with two chemically divergent ligands, PD144418 and 4-IBP. The structures reveal a trimeric architecture with a single transmembrane domain in each protomer. The carboxy-terminal domain of the receptor shows an extensive flat, hydrophobic membrane-proximal surface, suggesting an intimate association with the cytosolic surface of the endoplasmic reticulum membrane in cells. This domain includes a cupin-like beta-barrel with the ligand-binding site buried at its centre. This large, hydrophobic ligand-binding cavity shows remarkable plasticity in ligand recognition, binding the two ligands in similar positions despite dissimilar chemical structures. Taken together, these results reveal the overall architecture, oligomerization state, and molecular basis for ligand recognition by this important but poorly understood protein.	[Schmidt, Hayden R.; Zheng, Sanduo; Gurpinar, Esin; Kruse, Andrew C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Koehl, Antoine; Manglik, Aashish] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA	Harvard University; Harvard Medical School; Stanford University	Kruse, AC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	andrew_kruse@hms.harvard.edu		Koehl, Antoine/0000-0003-2367-1096; Schmidt, Hayden/0000-0003-1886-6534	Merck Postdoctoral Fellowship in Biological Chemistry and Molecular Pharmacology; National Institutes of Health Cellular and Developmental Biology training grant at Harvard Medical School [T32GM007226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007226] Funding Source: NIH RePORTER	Merck Postdoctoral Fellowship in Biological Chemistry and Molecular Pharmacology; National Institutes of Health Cellular and Developmental Biology training grant at Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank beamline staff at the Advanced Photon Source for their technical assistance and support. We thank S. Blacklow and B. Zimmerman for discussions and input throughout the project, and K. Arnett for assistance with SEC-MALS experiments. Financial support for this work was provided by departmental startup funds. S.Z. is supported by a Merck Postdoctoral Fellowship in Biological Chemistry and Molecular Pharmacology, and H.R.S. is supported by the National Institutes of Health Cellular and Developmental Biology training grant at Harvard Medical School (T32GM007226).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Akunne HC, 1997, NEUROPHARMACOLOGY, V36, P51, DOI 10.1016/S0028-3908(96)00161-X; Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; [Anonymous], 2016, JJ; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bermack JE, 2005, SYNAPSE, V55, P37, DOI 10.1002/syn.20085; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BROWNSTEIN MJ, 1993, P NATL ACAD SCI USA, V90, P5391, DOI 10.1073/pnas.90.12.5391; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Dussossoy D, 1999, EUR J BIOCHEM, V263, P377, DOI 10.1046/j.1432-1327.1999.00500.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gromek KA, 2014, J BIOL CHEM, V289, P20333, DOI 10.1074/jbc.M113.537993; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JOHN CS, 1994, J MED CHEM, V37, P1737, DOI 10.1021/jm00038a002; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Kovacs KJ, 1998, EUR J PHARMACOL, V350, P47, DOI 10.1016/S0014-2999(98)00220-9; LARGENT BL, 1987, MOL PHARMACOL, V32, P772; Lever JR, 2014, J PHARMACOL EXP THER, V351, P153, DOI 10.1124/jpet.114.216671; Nguyen L, 2015, J PHARMACOL SCI, V127, P17, DOI 10.1016/j.jphs.2014.12.005; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mavlyutov TA, 2013, NEUROSCIENCE, V240, P129, DOI 10.1016/j.neuroscience.2013.02.035; Mavlyutov TA, 2015, J PHARMACOL SCI, V127, P10, DOI 10.1016/j.jphs.2014.12.013; Mei JF, 2002, J PHARMACOL EXP THER, V300, P1070, DOI 10.1124/jpet.300.3.1070; Mishra AK, 2015, BIOCHEM J, V466, P263, DOI 10.1042/BJ20141321; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reisinger V, 2006, PROTEOMICS, P6, DOI 10.1002/pmic.200600553; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Schrodinger LLC, 2010, PYMOL MOL GRAPHICS S, V1.3r1; Seth P, 2001, BBA-MOL CELL RES, V1540, P59, DOI 10.1016/S0167-4889(01)00117-3; Shin EJ, 2007, NEUROCHEM INT, V50, P791, DOI 10.1016/j.neuint.2007.01.008; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tagashira H, 2014, BBA-GEN SUBJECTS, V1840, P3320, DOI 10.1016/j.bbagen.2014.08.012; Wu ZP, 2008, J BIOL CHEM, V283, P28198, DOI 10.1074/jbc.M802099200; Yamamoto H, 1999, FEBS LETT, V445, P19, DOI 10.1016/S0014-5793(99)00084-8	44	301	305	6	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					527	+		10.1038/nature17391	http://dx.doi.org/10.1038/nature17391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27042935	Green Accepted, Green Submitted			2022-12-28	WOS:000374815900053
J	McCarthy, M				McCarthy, Mary			Too much scrutiny is bad for general practice The UK is almost alone in Europe with its micromanagement of primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Commonwealth Fund, 2015, 2015 COMM FUND INT S; Grimsgaand C, 2015, DAGENS MEDISIN  1117; Wachter RM, 2016, NY TIMES	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2016	353								i2151	10.1136/bmj.i2151	http://dx.doi.org/10.1136/bmj.i2151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZF	27094463				2022-12-28	WOS:000374999100003
J	Gensch, T; Glorius, F				Gensch, T.; Glorius, F.			SYNTHETIC CHEMISTRY The straight dope on the scope of chemical reactions	SCIENCE			English	Editorial Material							ROBUSTNESS SCREEN		[Gensch, T.; Glorius, F.] Univ Munster, Inst Organ Chem, Corrensstr 40, D-48149 Munster, Germany	University of Munster	Glorius, F (corresponding author), Univ Munster, Inst Organ Chem, Corrensstr 40, D-48149 Munster, Germany.	glorius@uni-muenster.de	Glorius, Frank/K-6385-2015	Glorius, Frank/0000-0002-0648-956X				Bess EN, 2014, P NATL ACAD SCI USA, V111, P14698, DOI 10.1073/pnas.1409522111; Collins KD, 2015, ACCOUNTS CHEM RES, V48, P619, DOI 10.1021/ar500434f; Collins KD, 2014, NAT PROTOC, V9, P1348, DOI 10.1038/nprot.2014.076; Collins KD, 2013, NAT CHEM, V5, P597, DOI [10.1038/NCHEM.1669, 10.1038/nchem.1669]; Kutchukian PS, 2016, CHEM SCI, V7, P2604, DOI 10.1039/c5sc04751j	5	35	35	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					294	295		10.1126/science.aaf3539	http://dx.doi.org/10.1126/science.aaf3539			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081056				2022-12-28	WOS:000373990100021
J	Contreras-Valdes, FM; Josephson, ME				Contreras-Valdes, Fernando M.; Josephson, Mark E.			"Frog Sign" in Atrioventricular Nodal Reentrant Tachycardia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Contreras-Valdes, Fernando M.; Josephson, Mark E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Contreras-Valdes, FM (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	fcontrer@bidmc.harvard.edu	Contreras, Fernando/F-8087-2017	Contreras, Fernando/0000-0002-7569-7012					0	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					E17	E17		10.1056/NEJMicm1501617	http://dx.doi.org/10.1056/NEJMicm1501617			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27074085				2022-12-28	WOS:000374128400001
J	McIlvennan, CK; Allen, LA				McIlvennan, Colleen K.; Allen, Larry A.			Palliative care in patients with heart failure	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; VENTRICULAR ASSIST DEVICES; SHARED DECISION-MAKING; QUALITY-OF-LIFE; LONG-TERM TRENDS; OLDER-ADULTS; CLINICIAN ATTITUDES; ADVANCE DIRECTIVES; EUROPEAN-SOCIETY; POLICY STATEMENT	Despite advances in cardiac therapy, heart failure (HF) remains a progressive, highly symptomatic, and deadly disease that places great demands on patients, caregivers, and healthcare systems. Palliative care is a multidisciplinary approach to care that focuses on communication, shared decision making, and advance care planning; provides relief from pain and other distressing symptoms; integrates psychological and spiritual aspects of care; and offers a support system to help families cope during illness and bereavement. Palliative care has applications across the stages of heart failure, including early in the course of illness, often in conjunction with other therapies that are intended to prolong life. However, the incorporation of palliative care into the management of heart failure has been suboptimal for several reasons: uncertainty in the disease trajectory, failure to reward communication between healthcare providers and patients, siloed care, lack of knowledge, overlay of comorbidity and frailty, life saving devices with complex trade-offs, and a limited evidence base. This review will summarize the current literature on the emerging role of palliative care in patients with heart failure and the challenges and opportunities for its integration into routine care. It will discuss current initiatives and future directions of the collaborative relationship between the palliative care and heart failure disciplines.	[McIlvennan, Colleen K.; Allen, Larry A.] Univ Colorado, Sch Med, Div Cardiol, Sect Adv Heart Failure & Transplantat, Aurora, CO 80045 USA; [McIlvennan, Colleen K.; Allen, Larry A.] Univ Colorado, Sch Med, Adult & Child Ctr Hlth Outcomes & Res & Delivery, Aurora, CO 80045 USA; [McIlvennan, Colleen K.; Allen, Larry A.] Colorado Cardiovasc Outcomes Res Consortium, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Allen, LA (corresponding author), Univ Colorado, Sch Med, B130, Aurora, CO 80045 USA.	larry.allen@ucdenver.edu	Allen, Larry/AAI-1323-2020		National Institutes of Health; Patient-Centered Outcomes Research Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI)	We have read and understood BMJ policy on declaration of interests and declare the following interests: LAA discloses institutional research grant support from National Institutes of Health and Patient-Centered Outcomes Research Institute; and consulting relationships with St Jude, Janssen, and Novartis.	Afilalo J, 2014, J AM COLL CARDIOL, V63, P747, DOI 10.1016/j.jacc.2013.09.070; Aiken LS, 2006, J PALLIAT MED, V9, P111, DOI 10.1089/jpm.2006.9.111; Allen LA, 2008, JAMA-J AM MED ASSOC, V299, P2533, DOI 10.1001/jama.299.21.2533; Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; American Board of Internal Medicine, HOSP PALL CAR POL; American Heart Association/American Stroke Assocation, PRINC PALL CAR; Apatira L, 2008, ANN INTERN MED, V149, P861, DOI 10.7326/0003-4819-149-12-200812160-00005; Austin CA, 2015, JAMA INTERN MED, V175, P1213, DOI 10.1001/jamainternmed.2015.1679; Bekelman DB, 2007, J CARD FAIL, V13, P643, DOI 10.1016/j.cardfail.2007.05.005; Bekelman DB, 2014, J PALLIAT MED, V17, P145, DOI 10.1089/jpm.2013.0143; Bekelman DB, 2011, J PALLIAT MED, V14, P815, DOI 10.1089/jpm.2010.0508; Bekelman DB, 2009, J GEN INTERN MED, V24, P592, DOI 10.1007/s11606-009-0931-y; Bloomfield GS, 2013, CURR CARDIOL REV, V9, P157, DOI 10.2174/1573403X11309020008; Bocchi EA, 2009, ARQ BRAS CARDIOL, V93, P1, DOI 10.1590/S0066-782X2009002000001; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Brush S, 2010, J HEART LUNG TRANSPL, V29, P1337, DOI 10.1016/j.healun.2010.07.001; Cacciatore F, 2005, EUR J CLIN INVEST, V35, P723, DOI 10.1111/j.1365-2362.2005.01572.x; Caldwell PH, 2007, CAN J CARDIOL, V23, P791, DOI 10.1016/S0828-282X(07)70829-2; Carson P, 2005, J AM COLL CARDIOL, V46, P2329, DOI 10.1016/j.jacc.2005.09.016; Center to Advance Palliative Care, GROWTH PALL CAR US H; Centers for Medicare and Medicaid Services, PROP POL PAYM QUAL P; Centers for Medicare and Medicaid Services, DEC MEM VENTR ASS DE; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Chaudhry SI, 2010, J AM COLL CARDIOL, V55, P309, DOI 10.1016/j.jacc.2009.07.066; Cheang MH, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000188; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; ClinicalTrials.gov, COLL CAR ALL SYMPT A; Daley A, 2006, PALLIATIVE MED, V20, P593, DOI 10.1177/0269216306071060; Dionne-Odom JN, 2014, J PALLIAT MED, V17, P995, DOI 10.1089/jpm.2013.0680; Dunlay SM, 2015, PALLIATIVE MED, V29, P260, DOI 10.1177/0269216314556565; Dunlay SM, 2012, CIRC-CARDIOVASC QUAL, V5, P283, DOI 10.1161/CIRCOUTCOMES.112.966036; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; Elwyn G, 2010, MED DECIS MAKING, V30, P701, DOI 10.1177/0272989X10386231; Evangelista LS, 2012, J PALLIAT MED, V15, P1316, DOI 10.1089/jpm.2012.0228; Faris R, 2002, EUR J HEART FAIL, V4, P541, DOI 10.1016/S1388-9842(02)00101-0; Feldman D, 2013, J HEART LUNG TRANSPL, V32, P157, DOI 10.1016/j.healun.2012.09.013; Fendler TJ, 2015, HEART FAIL CLIN, V11, P479, DOI 10.1016/j.hfc.2015.03.010; Freedland KE, 2015, JAMA INTERN MED, V175, P1773, DOI 10.1001/jamainternmed.2015.5220; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Frosch DL, 1999, AM J PREV MED, V17, P285, DOI 10.1016/S0749-3797(99)00097-5; Gadoud A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113188; Gohler A, 2006, J CARD FAIL, V12, P554, DOI 10.1016/j.cardfail.2006.03.003; Goldstein N, 2010, ANN INTERN MED, V152, P296, DOI 10.7326/0003-4819-152-5-201003020-00007; Golin CE, 2000, J AM GERIATR SOC, V48, pS52, DOI 10.1111/j.1532-5415.2000.tb03141.x; Goodman DC, TRENDS VARIATION END; Gozalo P, 2015, NEW ENGL J MED, V372, P1823, DOI 10.1056/NEJMsa1408705; Grady KL, 2000, CIRCULATION, V102, P2443, DOI 10.1161/01.CIR.102.19.2443; Greener DT, 2014, J PALLIAT MED, V17, P1115, DOI 10.1089/jpm.2013.0658; Gundersen Health System, RESP CHOIC ADV CAR P; Halpern SD, 2015, NEW ENGL J MED, V373, P2001, DOI 10.1056/NEJMp1509664; Halpern SD, 2015, ANN INTERN MED, V162, P224, DOI 10.7326/M14-2476; Hammes BJ, 2010, J AM GERIATR SOC, V58, P1249, DOI 10.1111/j.1532-5415.2010.02956.x; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Harding R, 2008, J PAIN SYMPTOM MANAG, V36, P149, DOI 10.1016/j.jpainsymman.2007.09.012; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Heo S, 2008, AM J CRIT CARE, V17, P124; Hickman SE, 2015, J AM GERIATR SOC, V63, P341, DOI 10.1111/jgs.13248; Hill L, 2015, EUR J CARDIOVASC NUR; Hill L, 2015, PALLIATIVE MED, V29, P310, DOI 10.1177/0269216314550374; Institute of Medicine, 2001, CROSSING QUALITY CHA; Iqbal J, 2010, EUR J HEART FAIL, V12, P1002, DOI 10.1093/eurjhf/hfq114; Jaarsma T, 2013, EUR J CARDIOVASC NUR, V12, P230, DOI [10.1177/1474515113476605, 10.1177/1474515112449539]; Jaarsma T, 2009, EUR J HEART FAIL, V11, P433, DOI 10.1093/eurjhf/hfp041; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Johnson MJ, 2002, EUR J HEART FAIL, V4, P753, DOI 10.1016/S1388-9842(02)00158-7; Joint Commission, 2015, COMPR CERT MAN DIS S; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Kavalieratos D, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000544; Kavalieratos D, 2014, J PALLIAT MED, V17, P475, DOI 10.1089/jpm.2013.0526; Kirkpatrick JN, 2012, AM J CARDIOL, V109, P91, DOI 10.1016/j.amjcard.2011.08.011; Koberich S, 2015, J PUBLIC HEALTH RES, V4, DOI 10.4081/jphr.2015.556; Kraynik SE, 2014, J PAIN SYMPTOM MANAG, V48, P471, DOI 10.1016/j.jpainsymman.2013.09.010; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P374, DOI 10.1161/CIRCOUTCOMES.111.962217; Krumholz HM, 1998, CIRCULATION, V98, P648, DOI 10.1161/01.CIR.98.7.648; Lanken PN, 2008, AM J RESP CRIT CARE, V177, P912, DOI 10.1164/rccm.200605-587ST; Laribi S, 2012, EUR J HEART FAIL, V14, P234, DOI 10.1093/eurjhf/hfr182; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lupu D, 2010, J PAIN SYMPTOM MANAG, V40, P899, DOI 10.1016/j.jpainsymman.2010.07.004; Matlock DD, 2011, PACE, V34, P1634, DOI 10.1111/j.1540-8159.2011.03237.x; Matlock DD, 2014, CIRC-CARDIOVASC QUAL, V7, P487, DOI 10.1161/CIRCOUTCOMES.113.000289; Matlock DD, 2012, PROG CARDIOVASC DIS, V55, P274, DOI 10.1016/j.pcad.2012.10.007; May P, 2014, J PALLIAT MED, V17, P1054, DOI 10.1089/jpm.2013.0594; McIlvennan CK, 2016, JAMA INTERN IN PRESS; McIlvennan CK, 2015, CIRC-CARDIOVASC QUAL, V8, P172, DOI 10.1161/CIRCOUTCOMES.114.001276; McIlvennan CK, 2014, CIRC-HEART FAIL, V7, P1003, DOI 10.1161/CIRCHEARTFAILURE.114.001391; McIlvennan CK, 2014, CIRC-CARDIOVASC QUAL, V7, P374, DOI 10.1161/CIRCOUTCOMES.113.000729; McMurray JJV, 1998, EUR HEART J, V19, pP9; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mentz RJ, 2014, AM HEART J, V168, P645, DOI 10.1016/j.ahj.2014.07.018; Meyer Theo E, 2014, Curr Heart Fail Rep, V11, P188, DOI 10.1007/s11897-014-0195-7; Morrison RS, 2011, HEALTH AFFAIR, V30, P454, DOI 10.1377/hlthaff.2010.0929; National Hospice and Palliative Care Organization, FACTS HOSP PALL CAR; Nazarian S, 2005, AM HEART J, V150, P955, DOI 10.1016/j.ahj.2005.01.012; Neumann T, 2009, DTSCH ARZTEBL INT, V106, P269, DOI 10.3238/arztebl.2009.0269; Nordgren Lena, 2003, Eur J Cardiovasc Nurs, V2, P213; O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068; Oxberry SG, 2011, EUR J HEART FAIL, V13, P1006, DOI 10.1093/eurjhf/hfr068; Pasalic D, 2015, AM J HOSP PALLIAT CA; Ponikowski P, 2014, ESC HEART FAIL, V1, P4, DOI 10.1002/ehf2.12005; ROGER VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI [DOI 10.1001/JAMA.292.3.344, 10.1001/jama.292.3.344]; Rumsfeld JS, 2013, CIRCULATION, V127, P2233, DOI 10.1161/CIR.0b013e3182949a2e; Sabatino CP, 2010, MILBANK Q, V88, P211, DOI 10.1111/j.1468-0009.2010.00596.x; Saczynski JS, 2013, J AM GERIATR SOC, V61, P26, DOI 10.1111/jgs.12062; Segal DI, 2005, INT J PALLIAT NURS, V11, P135, DOI 10.12968/ijpn.2005.11.3.18033; Setoguchi S, 2010, AM HEART J, V160, P139, DOI 10.1016/j.ahj.2010.03.038; Shore S, 2015, JACC-HEART FAIL, V3, P906, DOI 10.1016/j.jchf.2015.06.012; Smith S, 2014, PALLIATIVE MED, V28, P130, DOI 10.1177/0269216313493466; Smith Thomas J, 2003, J Palliat Med, V6, P699, DOI 10.1089/109662103322515202; Swetz KM, 2013, EUR J HEART FAIL, V15, P1262, DOI 10.1093/eurjhf/hft094; Swetz Keith M, 2011, Curr Heart Fail Rep, V8, P212, DOI 10.1007/s11897-011-0060-x; Swetz KM, 2011, MAYO CLIN PROC, V86, P493, DOI 10.4065/mcp.2010.0747; Tanvetyanon T, 2003, CRIT CARE MED, V31, P60, DOI 10.1097/00003246-200301000-00009; Taylor DH, 2007, SOC SCI MED, V65, P1466, DOI 10.1016/j.socscimed.2007.05.028; Thompson JS, 2015, JACC-HEART FAIL, V3, P965, DOI 10.1016/j.jchf.2015.09.007; Tse DMW, 2007, PALLIATIVE MED, V21, P425, DOI 10.1177/0269216307079825; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; University of Ottawa, 2010, OTT DEC SUPP FRAM; von Gunten CF, 2002, JAMA-J AM MED ASSOC, V287, P875, DOI 10.1001/jama.287.7.875; Wong CY, 2011, AM J MED, V124, P136, DOI 10.1016/j.amjmed.2010.08.017; World Health Organization, WHO DEF PALL CAR; Worldwide Palliative Care Alliance, GLOB ATL PALL CAR EN; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	123	89	90	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2016	353								i1010	10.1136/bmj.i1010	http://dx.doi.org/10.1136/bmj.i1010			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ7EU	27079896				2022-12-28	WOS:000374375500001
J	Peters, IR; Majumdar, S; Jaeger, HM				Peters, Ivo R.; Majumdar, Sayantan; Jaeger, Heinrich M.			Direct observation of dynamic shear jamming in dense suspensions	NATURE			English	Article							FRONTS	Liquid-like at rest, dense suspensions of hard particles can undergo striking transformations in behaviour when agitated or sheared(1). These phenomena include solidification during rapid impact(2,3), as well as strong shear thickening characterized by discontinuous, orders-of-magnitude increases in suspension viscosity(4-8). Much of this highly non-Newtonian behaviour has recently been interpreted within the framework of a jamming transition. However, although jamming indeed induces solid-like rigidity(9-11), even a strongly shear-thickened state still flows and thus cannot be fully jammed(12,13). Furthermore, although suspensions are incompressible, the onset of rigidity in the standard jamming scenario requires an increase in particle density(9,10,14). Finally, whereas shear thickening occurs in the steady state, impact-induced solidification is transient(2,15-17). As a result, it has remained unclear how these dense suspension phenomena are related and how they are connected to jamming. Here we resolve this by systematically exploring both the steady-state and transient regimes with the same experimental system. We demonstrate that a fully jammed, solid-like state can be reached without compression and instead purely with shear, as recently proposed for dry granular systems(18,19). This state is created by transient shear-jamming fronts, which we track directly. We also show that shear stress, rather than shear rate, is the key control parameter. From these findings we map out a state diagram with particle density and shear stress as variables. We identify discontinuous shear thickening with a marginally jammed regime just below the onset of full, solid-like jamming(20). This state diagram provides a unifying framework, compatible with prior experimental and simulation results on dense suspensions, that connects steady-state and transient behaviour in terms of a dynamic shear-jamming process.	[Peters, Ivo R.; Majumdar, Sayantan; Jaeger, Heinrich M.] Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Peters, Ivo R.] Univ Southampton, Engn & Environm, Southampton SO17 1BJ, Hants, England	University of Chicago; University of Southampton	Peters, IR (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	i.r.peters@soton.ac.uk	Peters, Ivo/L-8857-2016	Peters, Ivo/0000-0002-3549-3322	US Army Research Office [W911NF-12-1-0182]; Chicago Materials Research Science and Engineering Center; NSF [DMR-1420709]; Kadanoff-Rice fellowship	US Army Research Office; Chicago Materials Research Science and Engineering Center; NSF(National Science Foundation (NSF)); Kadanoff-Rice fellowship	We thank E. Brown, E. Han, N. James, S. Mukhopadhyay and Q. Xu for discussions. This work was supported by the US Army Research Office through grant W911NF-12-1-0182 and the Chicago Materials Research Science and Engineering Center, which is funded by the NSF through grant DMR-1420709. S.M. acknowledges support through a Kadanoff-Rice fellowship.	BARNES HA, 1989, J RHEOL, V33, P329, DOI 10.1122/1.550017; Bi DP, 2011, NATURE, V480, P355, DOI 10.1038/nature10667; Brown E, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/4/046602; Brown E, 2012, J RHEOL, V56, P875, DOI 10.1122/1.4709423; Brown E, 2010, NAT MATER, V9, P220, DOI [10.1038/NMAT2627, 10.1038/nmat2627]; Brown E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.086001; Cates ME, 1998, PHYS REV LETT, V81, P1841, DOI 10.1103/PhysRevLett.81.1841; Cheng X, 2011, SCIENCE, V333, P1276, DOI 10.1126/science.1207032; Fall A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.098301; Fall A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018301; Fernandez N, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.108301; Guy BM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.088304; HELLMAN NN, 1950, J AM CHEM SOC, V72, P5186, DOI 10.1021/ja01167a110; Keys AS, 2007, NAT PHYS, V3, P260, DOI 10.1038/nphys572; Kumar N., 2015, GRANULAR MA IN PRESS; Lin NYC, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.228304; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Liu B, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.188301; Mari R, 2014, J RHEOL, V58, P1693, DOI 10.1122/1.4890747; Petel OE, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4791785; Peters IR, 2014, SOFT MATTER, V10, P6564, DOI 10.1039/c4sm00864b; Sair L, 1944, IND ENG CHEM, V36, P205, DOI 10.1021/ie50411a004; Seto R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.218301; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Vitelli V, 2011, NATURE, V480, P325, DOI 10.1038/480325a; von Kann S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.060401; Wagner NJ, 2009, PHYS TODAY, V62, P27, DOI 10.1063/1.3248476; Waitukaitis SR, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/44001; Waitukaitis S. R., 2014, IMPACT ACTIVATED SOL, P51; Waitukaitis SR, 2012, NATURE, V487, P205, DOI 10.1038/nature11187; Wyart M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.098302	31	188	195	12	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					214	+		10.1038/nature17167	http://dx.doi.org/10.1038/nature17167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27042934	Green Accepted			2022-12-28	WOS:000374415100035
J	Shoubridge, EA				Shoubridge, Eric A.			Mitochondrial disease therapy from thin air?	SCIENCE			English	Editorial Material							HYPOXIA-INDUCIBLE FACTORS; ADAPTATION		[Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Dept Human Genet, Montreal, PQ, Canada	McGill University	Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Human Genet, Montreal, PQ, Canada.	eric@ericpc.mni.mcgill.ca						Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021	7	5	5	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					31	32		10.1126/science.aaf5248	http://dx.doi.org/10.1126/science.aaf5248			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034357				2022-12-28	WOS:000373039600018
J	Das, P				Das, Pamela			Soumya Swaminathan: re-energising tuberculosis research in India	LANCET			English	Biographical-Item																		SWAMINATHAN S, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1153	1153		10.1016/S0140-6736(16)30008-3	http://dx.doi.org/10.1016/S0140-6736(16)30008-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	27025325				2022-12-28	WOS:000372412000013
J	Norrie, J				Norrie, John			ICON-6: the danger of changing study design midstream	LANCET			English	Editorial Material							DOUBLE-BLIND; PHASE-III; COLORECTAL-CANCER; CEDIRANIB		[Norrie, John] Univ Aberdeen, Hlth Serv Res Unit, Ctr Healthcare Randomised Trials CHaRT, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Norrie, J (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Ctr Healthcare Randomised Trials CHaRT, Aberdeen AB25 2ZD, Scotland.	j.norrie@abdn.ac.uk						Batchelor TT, 2013, J CLIN ONCOL, V31, P3212, DOI 10.1200/JCO.2012.47.2464; [Center for Biologics Evaluation and Research (CBER) Center for Drug Evaluation and Research (CDER) Food and Drug Administration US Department of Health and Human Services], 2010, GUID IND AD DES CLIN; Hoff PM, 2012, J CLIN ONCOL, V30, P3596, DOI 10.1200/JCO.2012.42.6031; Jennison C., 2010, GROUP SEQUENTIAL ADA; Ledermann JA, 2013, EUR CANC C AMST NETH; Ledermann JA, 2016, LANCET, V387, P1066, DOI 10.1016/S0140-6736(15)01167-8; Schmoll HJ, 2012, J CLIN ONCOL, V30, P3588, DOI 10.1200/JCO.2012.42.5355; Spiegelhalter DJ, 2003, BAYESIAN APPROACHES; Symonds RP, 2015, LANCET ONCOL, V16, P1515, DOI 10.1016/S1470-2045(15)00220-X	9	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1031	1032		10.1016/S0140-6736(16)00658-9	http://dx.doi.org/10.1016/S0140-6736(16)00658-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	27025174	hybrid			2022-12-28	WOS:000371775000005
J	Baigent, C				Baigent, Colin			Aspirin for Disease Prevention: Public Policy or Personal Choice?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COLORECTAL-CANCER; TASK-FORCE; FOLLOW-UP; RISK		[Baigent, Colin] Univ Oxford, Oxford, England	University of Oxford	Baigent, C (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.	colin.baigent@ndph.ox.ac.uk			MRC [MC_U137686849] Funding Source: UKRI; Medical Research Council [MC_U137686849] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003	7	5	5	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					846	847		10.7326/M16-0576	http://dx.doi.org/10.7326/M16-0576			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27064970	Green Submitted			2022-12-28	WOS:000379343000018
J	Ludwig, DS				Ludwig, David S.			Lifespan Weighed Down by Diet	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, 300 Longwood Ave, Boston, MA 02115 USA; [Ludwig, David S.] Harvard Univ, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ludwig, DS (corresponding author), Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, 300 Longwood Ave, Boston, MA 02115 USA.; Ludwig, DS (corresponding author), Harvard Univ, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24 DK082730, K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2015, Q PROV EST CRUD AG A; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Ludwig DS, 2014, JAMA-J AM MED ASSOC, V311, P2167, DOI 10.1001/jama.2014.4133; Mozaffarian D, 2014, JAMA-J AM MED ASSOC, V312, P889, DOI 10.1001/jama.2014.8232; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; National Institutes of Health, EST FUND VAR RES CON; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; United States Department of Agriculture, 2015 2020 DIET GUID	10	39	39	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2269	2270		10.1001/jama.2016.3829	http://dx.doi.org/10.1001/jama.2016.3829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27043490				2022-12-28	WOS:000377183100010
J	van 't Hof, AWJ; Ottervanger, JP				van 't Hof, Arnoud W. J.; Ottervanger, Jan Paul			Primary angioplasty for STEMI: hard to improve upon	LANCET			English	Editorial Material							ELEVATION MYOCARDIAL-INFARCTION; CORONARY ANGIOPLASTY; THROMBOLYTIC THERAPY; REFLOW		[van 't Hof, Arnoud W. J.; Ottervanger, Jan Paul] Isala Heart Ctr, Dept Cardiol, NL-8025 AB Zwolle, Netherlands		van 't Hof, AWJ (corresponding author), Isala Heart Ctr, Dept Cardiol, NL-8025 AB Zwolle, Netherlands.	a.w.j.vant.hof@isala.nl						Carrick D, 2014, J AM COLL CARDIOL, V63, P2088, DOI 10.1016/j.jacc.2014.02.530; Ghatak A, 2015, J INTERV CARDIOL, V28, P503, DOI 10.1111/joic.12249; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kelbaek H, 2016, LANCET, V387, P2199, DOI 10.1016/S0140-6736(16)30072-1; Nallamothu BK, 2007, NEW ENGL J MED, V357, P1631, DOI 10.1056/NEJMra065985; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; Suryapranata H, 2005, HEART, V91, P641, DOI 10.1136/hrt.2004.056705; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002	13	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2166	2168		10.1016/S0140-6736(16)30123-4	http://dx.doi.org/10.1016/S0140-6736(16)30123-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27053443				2022-12-28	WOS:000376820800006
J	Rouse, B; Cipriani, A; Shi, QY; Coleman, AL; Dickersin, K; Li, TJ				Rouse, Benjamin; Cipriani, Andrea; Shi, Qiyuan; Coleman, Anne L.; Dickersin, Kay; Li, Tianjing			Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma	ANNALS OF INTERNAL MEDICINE			English	Article							PROSTAGLANDIN ANALOGS; OCULAR HYPERTENSION; EFFICACY; BRIMONIDINE; MANAGEMENT; TRIALS; UNOPROSTONE; FRAMEWORK; PRESSURE; TIMOLOL	Background: Network meta-analysis compares multiple treatment options for the same condition and may be useful for developing clinical practice guidelines. Purpose: To compare treatment recommendations for first-line medical therapy for primary open angle-glaucoma (POAG) from major updates of American Academy of Ophthalmology (AAO) guidelines with the evidence available at the time, using network meta-analysis. Data Sources: MEDLINE, Embase, and the Cochrane Library were searched on 11 March 2014 for randomized, controlled trials (RCTs) of glaucoma monotherapies compared with placebo, vehicle, or no treatment or other monotherapies. The AAO Web site was searched in August 2014 to identify AAO POAG guidelines. Study Selection: Eligible RCTs were selected by 2 independent reviewers, and guidelines were selected by 1 person. Data Extraction: One person abstracted recommendations from guidelines and a second person verified. Two people independently abstracted data from included RCTs. Data Synthesis: Guidelines were grouped together on the basis of literature search dates, and RCTs that existed at 1991, 1995, 1999, 2004, and 2009 were analyzed. The outcome of interest was intraocular pressure (IOP) at 3 months. Only the latest guideline made a specific recommendation: prostaglandins. Network meta-analyses showed that all treatments were superior to placebo in decreasing IOP at 3 months. The mean reductions (95% credible intervals [CrIs]) for the highest-ranking class compared with placebo were as follows: 1991: beta-blockers, 4.01 (CrI, 0.48 to 7.43); 1995: alpha(2)-adrenergic agonists, 5.64 (CrI, 1.73 to 9.50); 1999: prostaglandins, 5.43 (CrI, 3.38 to 7.38); 2004: prostaglandins, 4.75 (CrI, 3.11 to 6.44); 2009: prostaglandins, 4.58 (CrI, 2.94 to 6.24). Limitation: When comparisons are informed by a small number of studies, the treatment effects and rankings may not be stable. Conclusion: For timely recommendations when multiple treatment options are available, guidelines developers should consider network meta-analysis.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Univ Oxford, Oxford OX3 7JX, England; [Coleman, Anne L.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, 100 Stein Plaza,Box 957000, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Rouse, Benjamin; Dickersin, Kay; Li, Tianjing] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Clin Trials & Evidence Synth, 615 North Wolfe St,Room E6011, Baltimore, MD 21205 USA; [Cipriani, Andrea] Univ Oxford, Dept Psychiat, Warneford Lane, Oxford OX3 7JX, England; [Shi, Qiyuan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, 415 North Washington St,553, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Li, TJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Clin Trials & Evidence Synth, 615 North Wolfe St,Room E6011, Baltimore, MD 21205 USA.	tli19@jhu.edu	Cipriani, Andrea/P-6944-2015	Cipriani, Andrea/0000-0001-5179-8321; Li, Tianjing/0000-0001-5371-4558; Rouse, Benjamin/0000-0002-4052-5667	National Eye Institute, National Institutes of Health [1 RC1 EY020140, 1 U01 EY020522]; National Institute for Health Research Oxford Cognitive Health Clinical Research Facility; NATIONAL EYE INSTITUTE [RC1EY020140, U01EY020522] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute for Health Research Oxford Cognitive Health Clinical Research Facility; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	By grant 1 RC1 EY020140 and grant 1 U01 EY020522, National Eye Institute, National Institutes of Health (principal investigator: Dr. Kay Dickersin). Dr. Andrea Cipriani is supported by the National Institute for Health Research Oxford Cognitive Health Clinical Research Facility.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; American Academy of Ophthalmology Glaucoma Panel, 2005, PREF PRACT PATT GUID; American Academy of Ophthalmology Glaucoma Panel, 1996, PREF PRACT PATT GUID; American Academy of Ophthalmology Glaucoma Panel, 2000, PREF PRACT PATT GUID; American Academy of Ophthalmology Glaucoma Panel, 2006, PREF PRACT PATT GUID; American Academy of Ophthalmology Glaucoma Panel, 2010, PREF PRACT PATT GUID; American Academy of Ophthalmology Glaucoma Panel, 1989, PREF PRACT PATT GUID; American Academy of Ophthalmology Glaucoma Panel, 1992, PREF PRACT PATT GUID; American Academy of Ophthalmology Glaucoma Panel, 2003, PREF PRACT PATT GUID; American Academy of Ophthalmology Glaucoma Panel, 1990, PREF PRACT PATT GUID; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Aptel F, 2008, J GLAUCOMA, V17, P667, DOI 10.1097/IJG.0b013e3181666557; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Eddy DM, 2005, HEALTH AFFAIR, V24, P9, DOI 10.1377/hlthaff.24.1.9; Eden J, 2008, KNOWING WHAT WORKS H; Fung AT, 2007, BRIT J OPHTHALMOL, V91, P62, DOI 10.1136/bjo.2006.096693; Fung DS, 2014, CLIN OPHTHALMOL, V8, P543, DOI 10.2147/OPTH.S41562; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Gehr Bernhard T, 2006, BMC Med Res Methodol, V6, P25, DOI 10.1186/1471-2288-6-25; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Harms NV, 2013, EXPERT OPIN PHARMACO, V14, P105, DOI 10.1517/14656566.2013.748038; Hodge WG, 2008, BRIT J OPHTHALMOL, V92, P7, DOI 10.1136/bjo.2007.123737; Hommer A, 2009, EUROPEAN OPHTHALMIC, P19, DOI 10.17925/EOR.2009.03.01.19; Ip S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-15; Kendall T, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5673; Krupin T, 2011, AM J OPHTHALMOL, V151, P671, DOI 10.1016/j.ajo.2010.09.026; Li N, 2006, CLIN EXP OPHTHALMOL, V34, P755, DOI 10.1111/j.1442-9071.2006.01237.x; Li TJ, 2016, OPHTHALMOLOGY, V123, P129, DOI 10.1016/j.ophtha.2015.09.005; Li TJ, 2015, ANN INTERN MED, V162, P287, DOI 10.7326/M14-1603; Li TJ, 2013, OPHTHALMOLOGY, V120, P1113, DOI 10.1016/j.ophtha.2012.11.038; Li TJ, 2012, ANN INTERN MED, V156, P367, DOI 10.7326/0003-4819-156-5-201203060-00009; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Medeiros FA, 2015, BRIT J OPHTHALMOL, V99, P599, DOI 10.1136/bjophthalmol-2014-305550; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P1871, DOI 10.1210/jc.2011-3060; National Institute for Health and Care Excellence, 2009, GLAUC DIAGN MAN CHRO; National Institute for Health and Care Excellence. Neuropathic pain-pharmacological management, 2013, NEUR PAIN PHARM MAN, V173; Owen RK, 2015, VALUE HEALTH, V18, P116, DOI 10.1016/j.jval.2014.10.006; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sommer A, 1990, QRB Qual Rev Bull, V16, P65; Stewart WC, 2008, OPHTHALMOLOGY, V115, P1117, DOI 10.1016/j.ophtha.2007.10.004; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018; Trikalinos TA, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P241; Watts NB, 2012, J CLIN ENDOCR METAB, V97, P1802, DOI 10.1210/jc.2011-3045	52	30	30	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					674	+		10.7326/M15-2367	http://dx.doi.org/10.7326/M15-2367			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27088551	Green Accepted, Green Submitted			2022-12-28	WOS:000375878500015
J	Abeliovich, A; Rhinn, H				Abeliovich, Asa; Rhinn, Herve			PARKINSON'S DISEASE Guilt by genetic association	NATURE			English	Editorial Material									[Abeliovich, Asa; Rhinn, Herve] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Abeliovich, Asa; Rhinn, Herve] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Abeliovich, Asa; Rhinn, Herve] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Abeliovich, Asa; Rhinn, Herve] Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Abeliovich, A (corresponding author), Columbia Univ, Dept Pathol, New York, NY 10032 USA.; Abeliovich, A (corresponding author), Columbia Univ, Dept Cell Biol, New York, NY 10032 USA.; Abeliovich, A (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.; Abeliovich, A (corresponding author), Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, New York, NY 10032 USA.	aa900@columbia.edu						Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Rhinn H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2032; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939	8	5	6	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					40	41		10.1038/nature17891	http://dx.doi.org/10.1038/nature17891			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27096361				2022-12-28	WOS:000375473900032
J	Soldner, F; Stelzer, Y; Shivalila, CS; Abraham, BJ; Latourelle, JC; Barrasa, MI; Goldmann, J; Myers, RH; Young, RA; Jaenisch, R				Soldner, Frank; Stelzer, Yonatan; Shivalila, Chikdu S.; Abraham, Brian J.; Latourelle, Jeanne C.; Barrasa, M. Inmaculada; Goldmann, Johanna; Myers, Richard H.; Young, Richard A.; Jaenisch, Rudolf			Parkinson-associated risk variant in distal enhancer of alpha-synuclein modulates target gene expression	NATURE			English	Article							GENOME-WIDE ASSOCIATION; ADULT HUMAN BRAIN; STEM-CELLS; INTEGRATIVE ANALYSIS; GENOTYPE IMPUTATION; REGULATORY DNA; HUMAN-DISEASE; METAANALYSIS; LOCUS; IDENTIFICATION	Genome-wide association studies (GWAS) have identified numerous genetic variants associated with complex diseases, but mechanistic insights are impeded by a lack of understanding of how specific risk variants functionally contribute to the underlying pathogenesis(1). It has been proposed that cis-acting effects of non-coding risk variants on gene expression are a major factor for phenotypic variation of complex traits and disease susceptibility. Recent genome-scale epigenetic studies have highlighted the enrichment of GWAS-identified variants in regulatory DNA elements of disease-relevant cell types(2-6). Furthermore, single nucleotide polymorphism (SNP)specific changes in transcription factor binding are correlated with heritable alterations in chromatin state and considered a major mediator of sequence-dependent regulation of gene expression(7-10). Here we describe a novel strategy to functionally dissect the cis-acting effect of genetic risk variants in regulatory elements on gene expression by combining genome-wide epigenetic information with clustered regularly-interspaced short palindromic repeats (CRISPR)/Cas9 genome editing in human pluripotent stem cells. By generating a genetically precisely controlled experimental system, we identify a common Parkinson's disease associated risk variant in a non-coding distal enhancer element that regulates the expression of a-synuclein (SNCA), a key gene implicated in the pathogenesis of Parkinson's disease. Our data suggest that the transcriptional deregulation of SNCA is associated with sequence-dependent binding of the brain-specific transcription factors EMX2 and NKX6-1. This work establishes an experimental paradigm to functionally connect genetic variation with disease-relevant phenotypes.	[Soldner, Frank; Stelzer, Yonatan; Shivalila, Chikdu S.; Abraham, Brian J.; Barrasa, M. Inmaculada; Goldmann, Johanna; Young, Richard A.; Jaenisch, Rudolf] Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Shivalila, Chikdu S.; Young, Richard A.; Jaenisch, Rudolf] MIT, Dept Biol, 31 Ames St, Cambridge, MA 02139 USA; [Latourelle, Jeanne C.; Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Boston University	Jaenisch, R (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Jaenisch, R (corresponding author), MIT, Dept Biol, 31 Ames St, Cambridge, MA 02139 USA.	jaenisch@wi.mit.edu	Abraham, Brian/C-2230-2019; Young, Richard A/F-6495-2012	Abraham, Brian/0000-0001-8085-3027; Young, Richard A/0000-0001-8855-8647	NIH [1 R01 NS088538-01, 2R01MH104610-15]; Qatar National Research Fund [NPRP 5-531-1-094]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Research Fund(Qatar National Research Fund (QNRF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge the investigators of the original Parkinson's disease GWAS meta-analysis, PDGene and Menno Creyghton at the Hubrecht Institute for sharing data used for this study. We would like to thank B. Zaidi for helpful discussion in conceiving this work. We thank R. Alagappan, D. Fu and T. Lungjangwa for technical support and help in human ES cell culture and molecular biology and A. D'Alessio for helpful advice for performing ChIP-seq experiments. We would like to thank P. Wisniewski, M. Ly, C. Zollo and C. Araneo of the Whitehead Institute FACS facility for their help with cell sorting, T. Volkert, J. Love and S. Gupta at the Whitehead Genome Technologies Core for Solexa sequencing, W. Salmon and N. Watson from the W. M. Keck Biological Imaging Facility and T. DiCesare for help with the figure illustrations. We thank all the members of the Jaenisch laboratory for discussions and comments on the manuscript. R. J. was supported by NIH grants 1 R01 NS088538-01 and 2R01MH104610-15 and by Qatar National Research Fund grant number NPRP 5-531-1-094.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chiba-Falek O, 2005, AM J HUM GENET, V76, P478, DOI 10.1086/428655; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cronin KD, 2009, HUM MOL GENET, V18, P3274, DOI 10.1093/hmg/ddp265; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948; Dumitriu A, 2011, HUM MOL GENET, V20, P1478, DOI 10.1093/hmg/ddr026; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Ferrer I, 2011, J NEURAL TRANSM, V118, P821, DOI 10.1007/s00702-010-0482-8; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Kasowski M., 2013, SCIENCE; Kilpinen H., 2013, SCIENCE; Kim HJ, 2012, J MOL NEUROSCI, V47, P249, DOI 10.1007/s12031-012-9732-6; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim JH, 2003, METHOD ENZYMOL, V365, P303; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Ligon KL, 2003, DEVELOPMENT, V130, P2275, DOI 10.1242/dev.00421; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Mariani J, 2012, NUCLEIC ACIDS RES, V40, P6461, DOI 10.1093/nar/gks295; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McVicker G., 2013, SCIENCE; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Vermunt MW, 2014, CELL REP, V9, P767, DOI 10.1016/j.celrep.2014.09.023; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	58	350	366	7	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					95	+		10.1038/nature17939	http://dx.doi.org/10.1038/nature17939			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27096366	Green Submitted, Green Accepted			2022-12-28	WOS:000375473900046
J	Fonfara, I; Richter, H; Bratovic, M; Le Rhun, A; Charpentier, E				Fonfara, Ines; Richter, Hagen; Bratovic, Majda; Le Rhun, Anais; Charpentier, Emmanuelle			The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA	NATURE			English	Article							INTEGRATIVE GENOMICS VIEWER; CRYSTAL-STRUCTURE; CAS IMMUNITY; THERMUS-THERMOPHILUS; GUIDED ENDONUCLEASE; TARGET DNA; COMPLEX; RECOGNITION; SYSTEMS; PROTEIN	CRISPR-Cas systems that provide defence against mobile genetic elements in bacteria and archaea have evolved a variety of mechanisms to target and cleave RNA or DNA(1). The well-studied types I, II and III utilize a set of distinct CRISPR-associated ( Cas) proteins for production of mature CRISPR RNAs (crRNAs) and interference with invading nucleic acids. In types I and III, Cas6 or Cas5d cleaves precursor crRNA (pre-crRNA)(2-5) and the mature crRNAs then guide a complex of Cas proteins ( Cascade-Cas3, type I; Csm or Cmr, type III) to target and cleave invading DNA or RNA(6-12). In type II systems, RNase III cleaves pre-crRNA base-paired with trans-activating crRNA (tracrRNA) in the presence of Cas9 (refs 13, 14). The mature tracrRNA-crRNA duplex then guides Cas9 to cleave target DNA15. Here, we demonstrate a novel mechanism in CRISPR-Cas immunity. We show that type V-A Cpf1 from Francisella novicida is a dual-nuclease that is specific to crRNA biogenesis and target DNA interference. Cpf1 cleaves pre-crRNA upstream of a hairpin structure formed within the CRISPR repeats and thereby generates intermediate crRNAs that are processed further, leading to mature crRNAs. After recognition of a 5'-YTN- 3' protospacer adjacent motif on the non-target DNA strand and subsequent probing for an eight-nucleotide seed sequence, Cpf1, guided by the single mature repeat-spacer crRNA, introduces double-stranded breaks in the target DNA to generate a 5' overhang(16). The RNase and DNase activities of Cpf1 require sequence- and structure-specific binding to the hairpin of crRNA repeats. Cpf1 uses distinct active domains for both nuclease reactions and cleaves nucleic acids in the presence of magnesium or calcium. This study uncovers a new family of enzymes with specific dual endoribonuclease and endonuclease activities, and demonstrates that type V- A constitutes the most minimalistic of the CRISPR- Cas systems so far described.	[Fonfara, Ines; Le Rhun, Anais; Charpentier, Emmanuelle] Umea Univ, Dept Mol Biol, UCMR, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Fonfara, Ines; Richter, Hagen; Bratovic, Majda; Le Rhun, Anais; Charpentier, Emmanuelle] Helmholtz Ctr Infect Res, Dept Regulat Infect Biol, D-38124 Braunschweig, Germany; [Fonfara, Ines; Richter, Hagen; Bratovic, Majda; Le Rhun, Anais; Charpentier, Emmanuelle] Max Planck Inst Infect Biol, Dept Regulat Infect Biol, D-10117 Berlin, Germany; [Bratovic, Majda; Charpentier, Emmanuelle] Hannover Med Sch, D-30625 Hannover, Germany	Umea University; Helmholtz Association; Helmholtz-Center for Infection Research; Max Planck Society; Hannover Medical School	Charpentier, E (corresponding author), Umea Univ, Dept Mol Biol, UCMR, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.; Charpentier, E (corresponding author), Helmholtz Ctr Infect Res, Dept Regulat Infect Biol, D-38124 Braunschweig, Germany.; Charpentier, E (corresponding author), Max Planck Inst Infect Biol, Dept Regulat Infect Biol, D-10117 Berlin, Germany.; Charpentier, E (corresponding author), Hannover Med Sch, D-30625 Hannover, Germany.	charpentier@mpiib-berlin.mpg.de	Le Rhun, Anaïs/S-6019-2019; Fonfara, Ines/S-8369-2018	Le Rhun, Anaïs/0000-0003-2211-2153; Fonfara, Ines/0000-0003-4075-9217	Alexander von Humboldt Foundation (AvH Professorship); German Federal Ministry for Education and Research; Helmholtz Association; German Research Foundation; Max Planck Society; Goran Gustafsson Foundation (Goran Gustafsson Prize from the Royal Swedish Academy of Sciences); Swedish Research Council; Umea University; Helmholtz Postdoc Programme	Alexander von Humboldt Foundation (AvH Professorship)(Alexander von Humboldt Foundation); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); German Research Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Goran Gustafsson Foundation (Goran Gustafsson Prize from the Royal Swedish Academy of Sciences); Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University; Helmholtz Postdoc Programme	We thank K. Schmidt, F. Hille and A. Escalera Maurer for technical help. This work was funded by the Alexander von Humboldt Foundation (AvH Professorship), the German Federal Ministry for Education and Research, the Helmholtz Association, the German Research Foundation, the Max Planck Society, the Goran Gustafsson Foundation (Goran Gustafsson Prize from the Royal Swedish Academy of Sciences), the Swedish Research Council and Umea University (all to E.C.), and the Helmholtz Postdoc Programme (to H.R.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dong D., 2016, NATURE; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gruber A. R., 2008, NUCLEIC ACIDS RES, V36, P3429; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Herbert S, 2001, INFECT IMMUN, V69, P2996, DOI 10.1128/IAI.69.5.2996-3003.2001; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; MCCLELLAND M, 1988, NUCLEIC ACIDS RES, V16, P364, DOI 10.1093/nar/16.1.364; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nam KH, 2012, J BIOL CHEM, V287, P35943, DOI 10.1074/jbc.M112.382598; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Punetha A, 2014, NUCLEIC ACIDS RES, V42, P3846, DOI 10.1093/nar/gkt1335; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Schunder E, 2013, INT J MED MICROBIOL, V303, P51, DOI 10.1016/j.ijmm.2012.11.004; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vasu K, 2013, NUCLEIC ACIDS RES, V41, P9812, DOI 10.1093/nar/gkt734; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang W, 2008, NAT STRUCT MOL BIOL, V15, P1228, DOI 10.1038/nsmb.1502; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020	43	479	565	22	363	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					517	+		10.1038/nature17945	http://dx.doi.org/10.1038/nature17945			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27096362				2022-12-28	WOS:000374815900051
J	Leon, MB; Smith, CR; Mack, MJ; Makkar, RR; Svensson, LG; Kodali, SK; Thourani, VH; Tuzcu, EM; Miller, DC; Herrmann, HC; Doshi, D; Cohen, DJ; Pichard, AD; Kapadia, S; Dewey, T; Babaliaros, V; Szeto, WY; Williams, MR; Kereiakes, D; Zajarias, A; Greason, KL; Whisenant, BK; Hodson, RW; Moses, JW; Trento, A; Brown, DL; Fearon, WF; Pibarot, P; Hahn, RT; Jaber, WA; Anderson, WN; Alu, MC; Webb, JG				Leon, Martin B.; Smith, Craig R.; Mack, Michael J.; Makkar, Raj R.; Svensson, Lars G.; Kodali, Susheel K.; Thourani, Vinod H.; Tuzcu, E. Murat; Miller, D. Craig; Herrmann, Howard C.; Doshi, Darshan; Cohen, David J.; Pichard, Augusto D.; Kapadia, Samir; Dewey, Todd; Babaliaros, Vasilis; Szeto, Wilson Y.; Williams, Mathew R.; Kereiakes, Dean; Zajarias, Alan; Greason, Kevin L.; Whisenant, Brian K.; Hodson, Robert W.; Moses, Jeffrey W.; Trento, Alfredo; Brown, David L.; Fearon, William F.; Pibarot, Philippe; Hahn, Rebecca T.; Jaber, Wael A.; Anderson, William N.; Alu, Maria C.; Webb, John G.		PARTNER 2 Investigators	Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSFEMORAL TRANSCATHETER; CLINICAL-OUTCOMES; STENOSIS; IMPLANTATION; SOCIETY; COMPLICATIONS; INSIGHTS; TAVR	BACKGROUND Previous trials have shown that among high-risk patients with aortic stenosis, survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement. We evaluated the two procedures in a randomized trial involving intermediate-risk patients. METHODS We randomly assigned 2032 intermediate-risk patients with severe aortic stenosis, at 57 centers, to undergo either TAVR or surgical replacement. The primary end point was death from any cause or disabling stroke at 2 years. The primary hypothesis was that TAVR would not be inferior to surgical replacement. Before randomization, patients were entered into one of two cohorts on the basis of clinical and imaging findings; 76.3% of the patients were included in the transfemoral-access cohort and 23.7% in the transthoracic-access cohort. RESULTS The rate of death from any cause or disabling stroke was similar in the TAVR group and the surgery group (P = 0.001 for noninferiority). At 2 years, the Kaplan-Meier event rates were 19.3% in the TAVR group and 21.1% in the surgery group (hazard ratio in the TAVR group, 0.89; 95% confidence interval [CI], 0.73 to 1.09; P = 0.25). In the transfemoral-access cohort, TAVR resulted in a lower rate of death or disabling stroke than surgery (hazard ratio, 0.79; 95% CI, 0.62 to 1.00; P = 0.05), whereas in the transthoracic-access cohort, outcomes were similar in the two groups. TAVR resulted in larger aortic-valve areas than did surgery and also resulted in lower rates of acute kidney injury, severe bleeding, and new-onset atrial fibrillation; surgery resulted in fewer major vascular complications and less paravalvular aortic regurgitation. CONCLUSIONS In intermediate-risk patients, TAVR was similar to surgical aortic-valve replacement with respect to the primary end point of death or disabling stroke.	[Leon, Martin B.; Smith, Craig R.; Kodali, Susheel K.; Doshi, Darshan; Moses, Jeffrey W.; Hahn, Rebecca T.; Alu, Maria C.] Columbia Univ, Med Ctr, 161 Ft Washington Ave,6th Floor, New York, NY 10032 USA; [Williams, Mathew R.] NYU, Langone Med Ctr, New York, NY USA; [Mack, Michael J.; Brown, David L.] Baylor Scott & White Healthcare, Plano, TX USA; [Makkar, Raj R.; Trento, Alfredo] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Miller, D. Craig; Fearon, William F.] Stanford Univ, Stanford, CA 94305 USA; [Svensson, Lars G.; Tuzcu, E. Murat; Kapadia, Samir; Jaber, Wael A.] Cleveland Clin, Cleveland, OH USA; [Thourani, Vinod H.; Babaliaros, Vasilis] Emory Univ, Atlanta, GA 30322 USA; [Herrmann, Howard C.; Szeto, Wilson Y.] Univ Penn, Philadelphia, PA 19104 USA; [Cohen, David J.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Zajarias, Alan] Washington Univ, St Louis, MO USA; [Pichard, Augusto D.] Medstar Washington Hosp Ctr, Washington, DC USA; [Dewey, Todd] HCA Med City Dallas Hosp, Dallas, TX USA; [Kereiakes, Dean] Christ Hosp, Cincinnati, OH 45219 USA; [Greason, Kevin L.] Mayo Clin, Rochester, MN USA; [Whisenant, Brian K.] Intermt Med Ctr, Salt Lake City, UT USA; [Hodson, Robert W.] Providence St Vincent Hosp, Portland, OR USA; [Pibarot, Philippe] Univ Laval, Quebec City, PQ, Canada; [Webb, John G.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada	Columbia University; New York University; NYU Langone Medical Center; Baylor Health Care System; Cedars Sinai Medical Center; Stanford University; Cleveland Clinic Foundation; Emory University; University of Pennsylvania; Saint Luke's Mid America Heart Institute; Washington University (WUSTL); MedStar Washington Hospital Center; Medical City Dallas Hospital; Christ Hospital - Ohio; Mayo Clinic; Intermountain Healthcare; Intermountain Medical Center; Laval University; St. Paul's Hospital; University of Saskatchewan	Leon, MB (corresponding author), Columbia Univ, Med Ctr, 161 Ft Washington Ave,6th Floor, New York, NY 10032 USA.	mleon@crf.org	Jaber, Wael/Y-4713-2019; Hahn, Rebecca/ABE-6221-2020; Doğan, Ali/AAN-5331-2020; Cohen, David/AAF-1648-2019; thourani, vinod/AAP-5968-2020; Pibarot, Philippe/ABD-5300-2021; Asch, Federico/AAS-7653-2021	Asch, Federico/0000-0002-1744-5271; Williams, Mathew/0000-0003-2055-8741; Miller, D. Craig/0000-0001-7619-0080	Edwards Lifesciences	Edwards Lifesciences	Funded by Edwards Lifesciences;	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Athappan G, 2014, J AM COLL CARDIOL, V63, P2101, DOI 10.1016/j.jacc.2014.02.540; Binder RK, 2013, JACC-CARDIOVASC INTE, V6, P293, DOI 10.1016/j.jcin.2012.09.019; Blackstone EH, 2015, CIRCULATION, V131, P1989, DOI 10.1161/CIRCULATIONAHA.114.012525; Brennan JM, 2012, CIRCULATION, V126, P1621, DOI 10.1161/CIRCULATIONAHA.112.091371; D'Errigo P, 2013, INT J CARDIOL, V167, P1945, DOI 10.1016/j.ijcard.2012.05.028; Genereux P, 2014, J AM COLL CARDIOL, V63, P1100, DOI 10.1016/j.jacc.2013.10.058; Genereux P, 2012, J AM COLL CARDIOL, V60, P1043, DOI 10.1016/j.jacc.2012.07.003; Hamm CW, 2014, EUR HEART J, V35, P1588, DOI 10.1093/eurheartj/eht381; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Holzhey D, 2016, ANN THORAC SURG, V101, P658, DOI 10.1016/j.athoracsur.2015.07.090; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866; Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2; Kappetein AP, 2012, EUR HEART J, V33, P2403, DOI 10.1093/eurheartj/ehs255; Kodali S, 2016, EUR HEART J, V37, P2252, DOI 10.1093/eurheartj/ehw112; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Latib A, 2012, AM HEART J, V164, P910, DOI 10.1016/j.ahj.2012.09.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Makkar RR, 2015, NEW ENGL J MED, V373, P2015, DOI 10.1056/NEJMoa1509233; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Mohr FW, 2014, EUR J CARDIO-THORAC, V46, P808, DOI 10.1093/ejcts/ezu290; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Piazza N, 2013, JACC-CARDIOVASC INTE, V6, P443, DOI 10.1016/j.jcin.2013.01.136; Pibarot P, 2015, JACC-CARDIOVASC IMAG, V8, P340, DOI 10.1016/j.jcmg.2015.01.008; Pibarot P, 2014, J AM COLL CARDIOL, V64, P1323, DOI 10.1016/j.jacc.2014.06.1195; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Schymik G, 2015, CATHETER CARDIO INTE, V86, P738, DOI 10.1002/ccd.25866; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Siontis GCM, 2014, J AM COLL CARDIOL, V64, P129, DOI 10.1016/j.jacc.2014.04.033; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2015, J AM COLL CARDIOL, V66, P804, DOI 10.1016/j.jacc.2015.06.013; Thourani VH, 2015, ANN THORAC SURG, V99, P55, DOI 10.1016/j.athoracsur.2014.06.050; Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Webb JG, 2015, JACC-CARDIOVASC INTE, V8, P1797, DOI 10.1016/j.jcin.2015.08.017; Webb JG, 2009, J AM COLL CARDIOL, V53, P1855, DOI 10.1016/j.jacc.2008.07.075; Wenaweser P, 2013, EUR HEART J, V34, P1894, DOI 10.1093/eurheartj/eht086	40	2991	3066	13	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1609	1620		10.1056/NEJMoa1514616	http://dx.doi.org/10.1056/NEJMoa1514616			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK3UR	27040324	Bronze			2022-12-28	WOS:000374843400005
J	Parmigiani, A; Faroughi, S; Huber, C; Bachmann, O; Su, Y				Parmigiani, A.; Faroughi, S.; Huber, C.; Bachmann, O.; Su, Y.			Bubble accumulation and its role in the evolution of magma reservoirs in the upper crust	NATURE			English	Article							LATTICE-BOLTZMANN MODEL; TAUPO VOLCANIC ZONE; GAS; ERUPTION; PERSPECTIVES; PETROGENESIS; SUSPENSIONS; TIMESCALES; EMULSIONS; VOLATILES	Volcanic eruptions transfer huge amounts of gas to the atmosphere1,2. In particular, the sulfur released during large silicic explosive eruptions can induce global cooling3. A fundamental goal in volcanology, therefore, is to assess the potential for eruption of the large volumes of crystal-poor, silicic magma that are stored at shallow depths in the crust, and to obtain theoretical bounds for the amount of volatiles that can be released during these eruptions. It is puzzling that highly evolved, crystal-poor silicic magmas are more likely to generate volcanic rocks than plutonic rocks(4,5). This observation suggests that such magmas are more prone to erupting than are their crystal-rich counterparts. Moreover, well studied examples of largely crystal-poor eruptions (for example, Katmai(6), Taupo(7) and Minoan(8)) often exhibit a release of sulfur that is 10 to 20 times higher than the amount of sulfur estimated to be stored in the melt. Here we argue that these two observations rest on how the magmatic volatile phase (MVP) behaves as it rises buoyantly in zoned magma reservoirs. By investigating the fluid dynamics that controls the transport of the MVP in crystal-rich and crystal-poor magmas, we show how the interplay between capillary stresses and the viscosity contrast between the MVP and the host melt results in a counterintuitive dynamics, whereby the MVP tends to migrate efficiently in crystal-rich parts of a magma reservoir and accumulate in crystal-poor regions. The accumulation of low-density bubbles of MVP in crystal-poor magmas has implications for the eruptive potential of such magmas(9,10), and is the likely source of the excess sulfur released during explosive eruptions.	[Parmigiani, A.; Bachmann, O.] ETH, Inst Geochem & Petr, CH-8092 Zurich, Switzerland; [Parmigiani, A.; Faroughi, S.; Huber, C.; Su, Y.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Faroughi, S.; Huber, C.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Parmigiani, A (corresponding author), ETH, Inst Geochem & Petr, CH-8092 Zurich, Switzerland.; Parmigiani, A (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	andrea.parmigiani@erdw.ethz.ch	Su, Yanqing/F-6544-2011	Su, Yanqing/0000-0003-0790-5905; Faroughi, Salah Aldin/0000-0002-6543-1691; Bachmann, Olivier/0000-0003-2952-3465	Swiss National Science Foundation [154854, 200021-103441]; National Science Foundation [1454821]; Swiss National Supercomputing Centre (CSCS) [s479, s597]; Euler Supercomputer from ETHZ; Division Of Earth Sciences [1719480] Funding Source: National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); Swiss National Supercomputing Centre (CSCS); Euler Supercomputer from ETHZ; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Discussion of an early version of the paper with A. Burgisser, P. W. Lipman, O. Malaspinas, M. Lupi and W. Degruyter helped us to clarify some concepts. We also thank O. Malaspinas and the rest of the Palabos team, as well as M. L. Porter for discussing how to implement lattice Boltzmann algorithms. We thank J. Bourquin for help with redrafting several figures. A. P. and O. B. acknowledge support from the Swiss National Science Foundation (Ambizione grant no. 154854 to A. P., and project no. 200021-103441 to O. B.). S.F., C.H. and Y.S. acknowledge funding from a National Science Foundation CAREER grant (1454821; awarded to C.H.). This work was also supported by grants from the Swiss National Supercomputing Centre (CSCS) under projects s479 and s597, and the Euler Supercomputer from ETHZ.	Bachl CA, 2001, GEOL SOC AM BULL, V113, P1213, DOI 10.1130/0016-7606(2001)113<1213:COAPEF>2.0.CO;2; Bachmann O, 2004, J PETROL, V45, P1565, DOI 10.1093/petrology/egh019; Batchelor G.K., 2000, INTRO FLUID DYNAMICS; Beresnev IA, 2009, TRANSPORT POROUS MED, V80, P581, DOI 10.1007/s11242-009-9381-6; BLAKE S, 1984, J GEOPHYS RES, V89, P8237, DOI 10.1029/JB089iB10p08237; Christiansen RL., 2001, QUATERNARY PLIOCENE; Clift R., 1975, BUBBLES DROPS PARTIC; Coon ET, 2014, COMPUTAT GEOSCI, V18, P17, DOI 10.1007/s10596-013-9379-6; Cooper KM, 2014, NATURE, V506, P480, DOI 10.1038/nature12991; Costa F, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016402; d'Humieres D, 2002, PHILOS T ROY SOC A, V360, P437, DOI 10.1098/rsta.2001.0955; DEVINE JD, 1984, J GEOPHYS RES, V89, P6309, DOI 10.1029/JB089iB07p06309; Druitt TH, 2012, NATURE, V482, P77, DOI 10.1038/nature10706; Dufek J, 2010, GEOLOGY, V38, P687, DOI 10.1130/G30831.1; Faroughi SA, 2015, GEOPHYS RES LETT, V42, P53, DOI 10.1002/2014GL062570; Faroughi SA, 2015, RHEOL ACTA, V54, P85, DOI 10.1007/s00397-014-0825-8; GAUGLITZ PA, 1988, IND ENG CHEM RES, V27, P1282, DOI 10.1021/ie00079a032; Gerlach D, 2007, CHEM ENG SCI, V62, P2109, DOI 10.1016/j.ces.2006.12.061; Gerlach TM, 1996, FIRE AND MUD, P415; GERLACH TM, 1994, J VOLCANOL GEOTH RES, V62, P317, DOI 10.1016/0377-0273(94)90039-6; GRAHAM IJ, 1995, J VOLCANOL GEOTH RES, V68, P59, DOI 10.1016/0377-0273(95)00008-I; Guillot P, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016307; HALLIDAY AN, 1991, CHEM GEOL, V92, P107, DOI 10.1016/0009-2541(91)90051-R; He X, 1998, J COMPUT PHYS, V146, P282, DOI 10.1006/jcph.1998.6057; He XY, 1997, PHYS REV E, V55, pR6333, DOI 10.1103/PhysRevE.55.R6333; Heise W, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043110; Higuera FJ, 2005, J FLUID MECH, V530, P369, DOI 10.1017/S0022112005003770; Hildreth W, 2000, GEOL SOC AM BULL, V112, P1594, DOI 10.1130/0016-7606(2000)112<1594:KVCATG>2.0.CO;2; Hildreth W, 2004, J VOLCANOL GEOTH RES, V136, P169, DOI 10.1016/j.jvolgeores.2004.05.019; Hildreth W, 2007, US GEOLOGICAL SURVEY; Holtzman R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.264504; Huang H, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066701; Huber C, 2013, WATER RESOUR RES, V49, P6371, DOI 10.1002/wrcr.20514; Huber C, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004042; Huber C, 2009, EARTH PLANET SC LETT, V283, P38, DOI 10.1016/j.epsl.2009.03.029; Huppert HE, 2002, NATURE, V420, P493, DOI 10.1038/nature01211; Jain AK, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006002; LENORMAND R, 1988, J FLUID MECH, V189, P165, DOI 10.1017/S0022112088000953; Lipman PW, 2015, GEOSPHERE, V11, P705, DOI 10.1130/GES01091.1; MARTIN D, 1988, NATURE, V332, P534, DOI 10.1038/332534a0; Oppenheimer J, 2015, FRONT PHYS-LAUSANNE, V3, DOI 10.3389/fphy.2015.00060; Parmigiani A, 2011, J FLUID MECH, V686, P40, DOI 10.1017/jfm.2011.268; Philpotts AR, 1998, NATURE, V395, P343, DOI 10.1038/26404; Porter ML, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036701; Quan SP, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066303; Ruprecht P, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002022; Sbragaglia M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026702; Self S, 2006, PHILOS T R SOC A, V364, P2073, DOI 10.1098/rsta.2006.1814; Shan XW, 2006, J FLUID MECH, V550, P413, DOI 10.1017/S0022112005008153; SHAN XW, 1995, J STAT PHYS, V81, P379, DOI 10.1007/BF02179985; SHAN XW, 1993, PHYS REV E, V47, P1815, DOI 10.1103/PhysRevE.47.1815; Shinohara H, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000244; SIGURDSSON H, 1990, J VOLCANOL GEOTH RES, V41, P127, DOI 10.1016/0377-0273(90)90086-U; Sillitoe RH, 2010, ECON GEOL, V105, P3, DOI 10.2113/gsecongeo.105.1.3; SONSHINE RM, 1966, APPL SCI RES, V16, P273, DOI 10.1007/BF00384073; Walker BA, 2007, J VOLCANOL GEOTH RES, V167, P239, DOI 10.1016/j.jvolgeores.2006.12.008; Wallace PJ, 2005, J VOLCANOL GEOTH RES, V140, P217, DOI 10.1016/j.jvolgeores.2004.07.023; Wallace PJ, 2001, J VOLCANOL GEOTH RES, V108, P85, DOI 10.1016/S0377-0273(00)00279-1; WILSON CJN, 1984, J GEOPHYS RES, V89, P8463, DOI 10.1029/JB089iB10p08463	59	128	128	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					492	+		10.1038/nature17401	http://dx.doi.org/10.1038/nature17401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27074507				2022-12-28	WOS:000374815900045
J	Bartsch, E; Medcalf, KE; Park, AL; Ray, JG				Bartsch, Emily; Medcalf, Karyn E.; Park, Alison L.; Ray, Joel G.		High Risk Pre-eclampsia	Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; IN-VITRO FERTILIZATION; LOW-DOSE ASPIRIN; UTERINE ARTERY DOPPLER; ASSISTED REPRODUCTIVE TECHNOLOGY; ADVANCED MATERNAL AGE; INTRAUTERINE GROWTH RESTRICTION; LOW-BIRTH-WEIGHT; OBSTETRIC OUTCOMES; NULLIPAROUS WOMEN	OBJECTIVE To develop a practical evidence based list of clinical risk factors that can be assessed by a clinician at <= 16 weeks' gestation to estimate a woman's risk of pre-eclampsia. DESIGN Systematic review and meta-analysis of cohort studies. DATA SOURCES PubMed and Embase databases, 2000-15. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Cohort studies with >= 1000 participants that evaluated the risk of pre-eclampsia in relation to a common and generally accepted clinical risk factor assessed at <= 16 weeks' gestation. DATA EXTRACTION Two independent reviewers extracted data from included studies. A pooled event rate and pooled relative risk for pre-eclampsia were calculated for each of 14 risk factors. RESULTS There were 25 356 688 pregnancies among 92 studies. The pooled relative risk for each risk factor significantly exceeded 1.0, except for prior intrauterine growth restriction. Women with antiphospholipid antibody syndrome had the highest pooled rate of pre-eclampsia (17.3%, 95% confidence interval 6.8% to 31.4%). Those with prior pre-eclampsia had the greatest pooled relative risk (8.4, 7.1 to 9.9). Chronic hypertension ranked second, both in terms of its pooled rate (16.0%, 12.6% to 19.7%) and pooled relative risk (5.1, 4.0 to 6.5) of pre-eclampsia. Pregestational diabetes (pooled rate 11.0%, 8.4% to 13.8%; pooled relative risk 3.7, 3.1 to 4.3), prepregnancy body mass index (BMI) >30 (7.1%, 6.1% to 8.2%; 2.8, 2.6 to 3.1), and use of assisted reproductive technology (6.2%, 4.7% to 7.9%; 1.8, 1.6 to 2.1) were other prominent risk factors. CONCLUSIONS There are several practical clinical risk factors that, either alone or in combination, might identify women in early pregnancy who are at "high risk" of pre-eclampsia. These data can inform the generation of a clinical prediction model for pre-eclampsia and the use of aspirin prophylaxis in pregnancy.	[Bartsch, Emily; Medcalf, Karyn E.] Univ Toronto, Toronto, ON, Canada; [Park, Alison L.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON, Canada; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Obstet & Gynecol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Ray, JG (corresponding author), St Michaels Hosp, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	rayj@smh.ca	Kingdom, John/A-3247-2013	Berger, Howard/0000-0003-3842-213X; Lord, Sarah (Sally) J/0000-0003-2763-5949; Urquia, Marcelo/0000-0002-8289-8090	Knowledge Synthesis grant from the Canadian Institutes for Health Research	Knowledge Synthesis grant from the Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Knowledge Synthesis grant from the Canadian Institutes for Health Research. JGR holds a Canadian Institutes for Health Research Chair in Reproductive and Child Health Services and Policy Research.	Al-Mulhim AA, 2003, FETAL DIAGN THER, V18, P275, DOI 10.1159/000070809; Ananth CV, 2007, OBSTET GYNECOL, V110, P128, DOI 10.1097/01.AOG.0000266983.77458.71; Anderson NH, 2012, AUST NZ J OBSTET GYN, V52, P552, DOI 10.1111/j.1479-828X.2012.01475.x; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Bartsch E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116296; Basso O, 2004, INT J EPIDEMIOL, V33, P858, DOI 10.1093/ije/dyh116; Bautista-Castano I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080410; Berlac JF, 2014, ACTA OBSTET GYN SCAN, V93, P447, DOI 10.1111/aogs.12368; BEROYZ G, 1994, LANCET, V343, P619; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Black M, 2008, BJOG-INT J OBSTET GY, V115, P269, DOI 10.1111/j.1471-0528.2007.01562.x; Blomberg M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005840; Boghossian NS, 2014, ANN EPIDEMIOL, V24, P871, DOI 10.1016/j.annepidem.2014.10.003; Boyd HA, 2013, AM J EPIDEMIOL, V178, P1611, DOI 10.1093/aje/kwt189; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Brown MA, 2007, BJOG-INT J OBSTET GY, V114, P984, DOI 10.1111/j.1471-0528.2007.01376.x; Brunelli VB, 2015, BJOG-INT J OBSTET GY, V122, P904, DOI 10.1111/1471-0528.13334; Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; Carbone IF, 2011, HUM REPROD, V26, P1659, DOI 10.1093/humrep/der117; Catov JM, 2007, INT J EPIDEMIOL, V36, P412, DOI 10.1093/ije/dyl271; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chen XK, 2009, HYPERTENS PREGNANCY, V28, P1, DOI 10.1080/10641950802001859; Cnossen JS, 2009, ACTA OBSTET GYN SCAN, V88, P758, DOI 10.1080/00016340903008953; Croft ML, 2010, TWIN RES HUM GENET, V13, P595, DOI 10.1375/twin.13.6.595; Dayan N, 2015, OBESITY, V23, P200, DOI 10.1002/oby.20896; Di Lorenzo G, 2012, PLACENTA, V33, P495, DOI 10.1016/j.placenta.2012.03.003; Dokras A, 2006, OBSTET GYNECOL, V108, P61, DOI 10.1097/01.AOG.0000219768.08249.b6; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Dwyer T, 2001, J CLIN EPIDEMIOL, V54, P440, DOI 10.1016/S0895-4356(00)00313-9; El-Chaar D, 2013, J OBSTET GYNAECOL CA, V35, P224, DOI 10.1016/S1701-2163(15)30994-4; English FA, 2015, INTEGR BLOOD PRESS C, V8, P7, DOI 10.2147/IBPC.S50641; Eras JL, 2000, EPIDEMIOLOGY, V11, P36, DOI 10.1097/00001648-200001000-00009; Erez O, 2006, J MATERN-FETAL NEO M, V19, P141, DOI 10.1080/14767050500246045; Euser AM, 2009, NEPHRON CLIN PRACT, V113, pC214, DOI 10.1159/000235241; Fortner RT, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.021; Frederick IO, 2006, EPIDEMIOLOGY, V17, P428, DOI 10.1097/01.ede.0000221028.33245.0b; Gaillard R, 2011, AM J HYPERTENS, V24, P1046, DOI 10.1038/ajh.2011.95; Gaillard R, 2011, J HYPERTENS, V29, P937, DOI 10.1097/HJH.0b013e328345500c; Gaio DS, 2001, HYPERTENS PREGNANCY, V20, P269, DOI 10.1081/PRG-100107829; Gilbert WM, 2007, J REPROD MED, V52, P1046; Goetzinger KR, 2010, PRENATAL DIAG, V30, P1138, DOI 10.1002/pd.2627; Harb HM, 2013, BJOG-INT J OBSTET GY, V120, P1308, DOI 10.1111/1471-0528.12366; Hauger MS, 2008, ACTA OBSTET GYN SCAN, V87, P953, DOI 10.1080/00016340802303349; Henderson JT, 2014, ANN INTERN MED, V160, P695, DOI 10.7326/M13-2844; Hernandez-Diaz Sonia, 2009, BMJ, V338, pb2255, DOI 10.1136/bmj.b2255; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Johnston R, 2015, J BRAS REPROD ASSIST, V19, P16, DOI 10.5935/1518-0557.20150005; Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578; Kerrigan AM, 2010, MIDWIFERY, V26, P138, DOI 10.1016/j.midw.2008.12.005; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Kuivasaari-Pirinen Paula, 2012, ISRN Obstet Gynecol, V2012, P451915, DOI 10.5402/2012/451915; Lausman A, 2013, J OBSTET GYNAECOL CA, V35, P741, DOI 10.1016/S1701-2163(15)30865-3; Lee CJ, 2000, INT J GYNECOL OBSTET, V70, P327, DOI 10.1016/S0020-7292(00)00240-X; Lee S, 2014, MIDWIFERY, V30, P403, DOI 10.1016/j.midw.2013.04.010; Li DK, 2000, AM J EPIDEMIOL, V151, P57, DOI 10.1093/oxfordjournals.aje.a010122; Libby P, 2010, EUR HEART J, V31, P777, DOI 10.1093/eurheartj/ehq022; Liu SL, 2011, OBSTET GYNECOL, V118, P987, DOI 10.1097/AOG.0b013e31823311c1; Liu XM, 2011, ARCH GYNECOL OBSTET, V283, P65, DOI 10.1007/s00404-009-1288-5; Luke B, 2004, FERTIL STERIL, V81, P315, DOI 10.1016/j.fertnstert.2003.07.012; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Mahande MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079116; Martin CL, 2000, BRIT J OBSTET GYNAEC, V107, P745, DOI 10.1111/j.1471-0528.2000.tb13335.x; Mbah AK, 2010, BJOG-INT J OBSTET GY, V117, P997, DOI 10.1111/j.1471-0528.2010.02593.x; Melamed N, 2012, J MATERN-FETAL NEO M, V25, P2248, DOI 10.3109/14767058.2012.684174; Munkhaugen J, 2009, NEPHROL DIAL TRANSPL, V24, P3744, DOI 10.1093/ndt/gfp320; National Collaborating Centre for Women's and Children's Health (UK), 2010, HYPERTENSION IN PREG; Ness RB, 2008, AM J EPIDEMIOL, V168, P427, DOI 10.1093/aje/kwn140; Ngowa JDK, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.134.2315; Nili F, 2013, J Neonatal Perinatal Med, V6, P225, DOI 10.3233/NPM-1370113; Ohkuchi A, 2006, HYPERTENS RES, V29, P161, DOI 10.1291/hypres.29.161; Oken E, 2007, ANN EPIDEMIOL, V17, P663, DOI 10.1016/j.annepidem.2007.03.003; Ostlund I, 2004, EUR J OBSTET GYN R B, V113, P12, DOI 10.1016/j.ejogrb.2003.07.001; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Papageorghiou AT, 2005, BJOG-INT J OBSTET GY, V112, P703, DOI 10.1111/j.1471-0528.2005.00519.x; Pare E, 2014, OBSTET GYNECOL, V124, P763, DOI 10.1097/AOG.0000000000000451; Park JH, 2011, J OBSTET GYNAECOL RE, V37, P138, DOI 10.1111/j.1447-0756.2010.01332.x; Persson M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000601; Petersen I, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007390; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Plasencia W, 2007, ULTRASOUND OBST GYN, V30, P742, DOI 10.1002/uog.5157; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Ramos GA, 2005, AM J OBSTET GYNECOL, V193, P1089, DOI 10.1016/j.ajog.2005.06.040; Rasmussen S, 2000, OBSTET GYNECOL, V96, P696, DOI 10.1016/S0029-7844(00)01008-5; Rasmussen S., 2007, NORSK EPIDEMIOLOGI, V17, P191, DOI 10.5324/nje.v17i2.162; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Roberge S, 2013, ULTRASOUND OBST GYN, V41, P491, DOI 10.1002/uog.12421; Roberge S, 2012, FETAL DIAGN THER, V31, P141, DOI 10.1159/000336662; Rode L, 2005, OBSTET GYNECOL, V105, P537, DOI 10.1097/01.AOG.0000152304.39492.1c; Ruano Rodrigo, 2005, Clinics, V60, P407, DOI 10.1590/S1807-59322005000500010; Saereeporncharenkul Kasem, 2011, J Med Assoc Thai, V94 Suppl 2, pS52; Salihu HM, 2011, J MATERN-FETAL NEO M, V24, P1088, DOI 10.3109/14767058.2010.546451; Sandvik MK, 2010, NEPHROL DIAL TRANSPL, V25, P3600, DOI 10.1093/ndt/gfq275; Schneider S, 2011, J PERINAT MED, V39, P257, DOI [10.1515/JPM.2011.010, 10.1515/jpm.2011.010]; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; SCHROTH WS, 1994, ACAD MED, V69, pS54, DOI 10.1097/00001888-199410000-00041; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Shevell T, 2005, OBSTET GYNECOL, V106, P1039, DOI 10.1097/01.AOG.0000183593.24583.7c; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; SIBAI BM, 1995, AM J OBSTET GYNECOL, V172, P1553, DOI 10.1016/0002-9378(95)90495-6; Silberstein T, 2014, J MATERN-FETAL NEO M, V27, P1316, DOI 10.3109/14767058.2013.856415; Sinclair JC, 2001, J CLIN EPIDEMIOL, V54, P253, DOI 10.1016/S0895-4356(01)00347-X; Sohlberg S, 2012, AM J HYPERTENS, V25, P120, DOI 10.1038/ajh.2011.175; Steinfeld J D, 2000, J Matern Fetal Med, V9, P238; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stuart JJ, 2013, J WOMENS HEALTH, V22, P37, DOI 10.1089/jwh.2012.3740; Sun LM, 2009, OBSTET GYNECOL, V114, P818, DOI 10.1097/AOG.0b013e3181b76bd1; Suzuki S, 2009, ARCH GYNECOL OBSTET, V280, P389, DOI 10.1007/s00404-009-0932-4; Tandberg A, 2015, BJOG-INT J OBSTET GY, V122, P915, DOI 10.1111/1471-0528.13051; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Thomson F, 2005, BJOG-INT J OBSTET GY, V112, P632, DOI 10.1111/j.1471-0528.2004.00489.x; Tikkanen M, 2011, ACTA OBSTET GYN SCAN, V90, P140, DOI 10.1111/j.1600-0412.2010.01030.x; Urquia ML, 2012, J EPIDEMIOL COMMUN H, V66, P971, DOI 10.1136/jech-2011-200772; van Oostwaard MF, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.009; Verghese L, 2012, J OBSTET GYNAECOL, V32, P128, DOI 10.3109/01443615.2011.635224; Villar JSL, 2003, ECLAMPSIA AND PRE EC; Voigt M, 2008, Z Geburtshilfe Neonatol, V212, P201, DOI 10.1055/s-2008-1076995; Wahabi HA, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-47; Walker MC, 2004, BJOG-INT J OBSTET GY, V111, P1294, DOI 10.1111/j.1471-0528.2004.00345.x; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Wilson BJ, 2009, ANN INTERN MED, V151, P878, DOI [10.7326/0000605-200912150-00177, 10.7326/0003-4819-151-12-200912150-00177]; Wright D, 2012, FETAL DIAGN THER, V32, P171, DOI 10.1159/000338470; Xiong X, 1999, AM J OBSTET GYNECOL, V180, P207, DOI 10.1016/S0002-9378(99)70176-6; Xiong X, 2002, AM J OBSTET GYNECOL, V187, P1013, DOI 10.1067/mob.2002.126282; Xiong X, 2000, J REPROD MED, V45, P727; Yaniv SS, 2011, ARCH GYNECOL OBSTET, V283, P755, DOI 10.1007/s00404-010-1459-4; Yogev Y, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.039; Zetterstrom K, 2005, ACTA OBSTET GYN SCAN, V84, P419, DOI 10.1111/j.0001-6349.2005.00508.x; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang J, 2015, INT J REPROD BIOMED, V13, P169	132	399	418	2	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2016	353								i1753	10.1136/bmj.i1753	http://dx.doi.org/10.1136/bmj.i1753			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK5ZF	27094586	hybrid, Green Published			2022-12-28	WOS:000374999100001
J	Goldberg, A; Mychajliw, AM; Hadly, EA				Goldberg, Amy; Mychajliw, Alexis M.; Hadly, Elizabeth A.			Post-invasion demography of prehistoric humans in South America	NATURE			English	Article							HUMAN-POPULATION; RADIOCARBON-DATES; HISTORY; CLIMATE; NORTH; DISTRIBUTIONS; CALIBRATION; IMPACT; GROWTH	As the last habitable continent colonized by humans, the site of multiple domestication hotspots, and the location of the largest Pleistocene megafaunal extinction, South America is central to human prehistory(1-7). Yet remarkably little is known about human population dynamics during colonization, subsequent expansions, and domestication(2-5). Here we reconstruct the spatiotemporal patterns of human population growth in South America using a newly aggregated database of 1,147 archaeological sites and 5,464 calibrated radiocarbon dates spanning fourteen thousand to two thousand years ago (ka). We demonstrate that, rather than a steady exponential expansion, the demographic history of South Americans is characterized by two distinct phases. First, humans spread rapidly throughout the continent, but remained at low population sizes for 8,000 years, including a 4,000-year period of 'boom-and-bust' oscillations with no net growth. Supplementation of hunting with domesticated crops and animals(4,8) had a minimal impact on population carrying capacity. Only with widespread sedentism, beginning similar to 5 ka(4,8), did a second demographic phase begin, with evidence for exponential population growth in cultural hotspots, characteristic of the Neolithic transition worldwide(9). The unique extent of humanity's ability to modify its environment to markedly increase carrying capacity in South America is therefore an unexpectedly recent phenomenon.	[Goldberg, Amy; Mychajliw, Alexis M.; Hadly, Elizabeth A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hadly, Elizabeth A.] Stanford Univ, Woods Inst, Stanford, CA 94305 USA	Stanford University; Stanford University	Goldberg, A (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	agoldb@stanford.edu		Goldberg, Amy/0000-0001-9306-1539	NSF [EAR 1148181, BCS 1515127]; NSF Graduate Research fellowship; ARCS fellowship; Stanford Interdisciplinary Graduate Fellowship; Gabilan Fellowship; Direct For Social, Behav & Economic Scie [1515127] Funding Source: National Science Foundation; Directorate For Geosciences [1148181] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF Graduate Research fellowship(National Science Foundation (NSF)); ARCS fellowship; Stanford Interdisciplinary Graduate Fellowship; Gabilan Fellowship; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank A. Barnosky, J. Kang, N. Rosenberg, E. Lindsey, N. Villavicencio, L. Frishkoff, K. Solari, J. Hsu, and H. Frank for conversations and feedback on the paper, as well as E. Jewett and M. Edge for discussions of statistical methods. We also greatly appreciate assistance from the Stanford Geospatial Center. This work was stimulated by discussions of an NSF-funded group (EAR 1148181) comparing the timing of megafaunal extinctions with archeological and palaeoenvironmental data in South America. We acknowledge support from NSF grant BCS 1515127, as well as NSF Graduate Research and ARCS fellowships to A.G., a Stanford Interdisciplinary Graduate Fellowship to A. M. M, and a Gabilan Fellowship to E. A. H. Radiocarbon data and associated information are available in the Supplementary Information.	Anderson D.G., 2011, CLIMATE CHANGE CULTU; [Anonymous], 2015, MATLAB REL 2015A; [Anonymous], 2010, ARCGIS VERS 10; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barnosky AD, 2016, P NATL ACAD SCI USA, V113, P856, DOI 10.1073/pnas.1505295112; BocquetAppel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P1, DOI 10.1007/978-1-4020-8539-0; Boone JL, 2002, WORLD ARCHAEOL, V34, P6, DOI 10.1080/00438240220134232; Brown WA, 2015, J ARCHAEOL SCI, V53, P133, DOI 10.1016/j.jas.2014.10.013; Chaput MA, 2015, P NATL ACAD SCI USA, V112, P12127, DOI 10.1073/pnas.1505657112; Cohen J. E., 1995, MANY PEOPLE CAN EART; Contreras DA, 2014, J ARCHAEOL SCI, V52, P591, DOI 10.1016/j.jas.2014.05.030; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Downey SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105730; EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019; Gayo EM, 2015, QUATERN INT, V356, P4, DOI 10.1016/j.quaint.2014.09.076; Gazave E, 2014, P NATL ACAD SCI USA, V111, P757, DOI 10.1073/pnas.1310398110; HASSAN FA, 1981, DEMOGRAPHIC ARCHAEOL; Haub C, 1995, Popul Today, V23, P4; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Hinz M, 2012, J ARCHAEOL SCI, V39, P3331, DOI 10.1016/j.jas.2012.05.028; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kelly RL, 2013, P NATL ACAD SCI USA, V110, P443, DOI 10.1073/pnas.1201341110; KINGSLAND S, 1982, Q REV BIOL, V57, P29, DOI 10.1086/412574; Marquet PA, 2012, P NATL ACAD SCI USA, V109, P14754, DOI 10.1073/pnas.1116724109; Mellars P, 2011, SCIENCE, V333, P623, DOI 10.1126/science.1206930; Meltzer D. J., 2009, 1 PEOPLES NEW WORLD; Michczynska DJ, 2007, RADIOCARBON, V49, P799, DOI 10.1017/S0033822200042673; Michczynska DJ, 2004, RADIOCARBON, V46, P733, DOI 10.1017/S0033822200035773; Moore JD, 2014, PREHISTORY OF SOUTH AMERICA: ANCIENT CULTURAL DIVERSITY ON THE LEAST KNOWN CONTINENT, P1; Ogburn DE, 2012, RADIOCARBON, V54, P219, DOI 10.2458/azu_js_rc.v54i2.16014; Peros MC, 2010, J ARCHAEOL SCI, V37, P656, DOI 10.1016/j.jas.2009.10.029; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; RICK JW, 1987, AM ANTIQUITY, V52, P55, DOI 10.2307/281060; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Sandweiss DH, 2009, P NATL ACAD SCI USA, V106, P1359, DOI 10.1073/pnas.0812645106; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Shennan S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3486; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Silverman B., 1986, DENSITY ESTIMATION S, V175; Silverman H, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P3, DOI 10.1007/978-0-387-74907-5_1; Surovell TA, 2009, J ARCHAEOL SCI, V36, P1715, DOI 10.1016/j.jas.2009.03.029; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; Wand MP, 1994, KERNEL SMOOTHING; Williams AN, 2012, J ARCHAEOL SCI, V39, P578, DOI 10.1016/j.jas.2011.07.014; Woodbridge J, 2014, J ARCHAEOL SCI, V51, P216, DOI 10.1016/j.jas.2012.10.025	53	117	118	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					232	+		10.1038/nature17176	http://dx.doi.org/10.1038/nature17176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DJ7TJ	27049941				2022-12-28	WOS:000374415100039
J	Liddelow, SA; Barres, BA				Liddelow, Shane A.; Barres, Ben A.			REGENERATION Not everything is scary about a glial scar	NATURE			English	Editorial Material							REACTIVE ASTROCYTES; ABLATION; STAT3		[Liddelow, Shane A.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Liddelow, SA; Barres, BA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	liddelow@stanford.edu; barres@stanford.edu	Liddelow, Shane/ABE-6456-2020	Liddelow, Shane/0000-0002-0840-1437				Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	10	29	30	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					182	183		10.1038/nature17318	http://dx.doi.org/10.1038/nature17318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27027287				2022-12-28	WOS:000374415100026
J	Sorensen, JJWH; Pedersen, MK; Munch, M; Haikka, P; Jensen, JH; Planke, T; Andreasen, MG; Gajdacz, M; Molmer, K; Lieberoth, A; Sherson, JF				Sorensen, Jens Jakob W. H.; Pedersen, Mads Kock; Munch, Michael; Haikka, Pinja; Jensen, Jesper Halkjaer; Planke, Tilo; Andreasen, Morten Ginnerup; Gajdacz, Miroslav; Molmer, Klaus; Lieberoth, Andreas; Sherson, Jacob F.			Retracted: Exploring the quantum speed limit with computer games (Publication with Expression of Concern. See vol. 581, 2020) (Publication with Expression of Concern. See vol. 581, 2020)	NATURE			English	Article; Publication with Expression of Concern							NEUTRAL ATOMS; TRANSITION	Humans routinely solve problems of immense computational complexity by intuitively forming simple, low-dimensional heuristic strategies(1,2). Citizen science (or crowd sourcing) is a way of exploiting this ability by presenting scientific research problems to non-experts. 'Gamification'-the application of game elements in a non-game context-is an effective tool with which to enable citizen scientists to provide solutions to research problems. The citizen science games Foldit(3), EteRNA(4) and EyeWire(5) have been used successfully to study protein and RNA folding and neuron mapping, but so far gamification has not been applied to problems in quantum physics. Here we report on Quantum Moves, an online platform gamifying optimization problems in quantum physics. We show that human players are able to find solutions to difficult problems associated with the task of quantum computing(6). Players succeed where purely numerical optimization fails, and analyses of their solutions provide insights into the problem of optimization of a more profound and general nature. Using player strategies, we have thus developed a few-parameter heuristic optimization method that efficiently outperforms the most prominent established numerical methods. The numerical complexity associated with time-optimal solutions increases for shorter process durations. To understand this better, we produced a low-dimensional rendering of the optimization landscape. This rendering reveals why traditional optimization methods fail near the quantum speed limit (that is, the shortest process duration with perfect fidelity)(7-9). Combined analyses of optimization landscapes and heuristic solution strategies may benefit wider classes of optimization problems in quantum physics and beyond.	[Sorensen, Jens Jakob W. H.; Pedersen, Mads Kock; Munch, Michael; Haikka, Pinja; Jensen, Jesper Halkjaer; Planke, Tilo; Andreasen, Morten Ginnerup; Gajdacz, Miroslav; Molmer, Klaus; Lieberoth, Andreas; Sherson, Jacob F.] Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark	Aarhus University	Sherson, JF (corresponding author), Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark.	sherson@phys.au.dk	Lieberoth, Andreas/AAO-4518-2020	Lieberoth, Andreas/0000-0003-0214-5791; Gajdacz, Miroslav/0000-0003-1134-758X; Pedersen, Mads Kock/0000-0001-7210-1933; Munch, Michael/0000-0002-3692-4091	European Research Council; Lundbeck Foundation; Aarhus University Research Foundation; Templeton Foundation; Danish Council for Independent Research; Villum Foundation; Carlsberg Foundation; Villum Fonden [00007335] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Aarhus University Research Foundation; Templeton Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Villum Foundation(Villum Fonden); Carlsberg Foundation(Carlsberg Foundation); Villum Fonden(Villum Fonden)	We thank the Quantum Moves players, without whom this work would have been impossible. We thank J. Rafner for graphical support and J. Jarecki, O. Vuculescu and C. Bergenholtz for discussions. This work was supported by the European Research Council, the Lundbeck Foundation, the Aarhus University Research Foundation, the Templeton Foundation, the Danish Council for Independent Research, the Villum Foundation and the Carlsberg Foundation.	Anderlini M, 2007, NATURE, V448, P452, DOI 10.1038/nature06011; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bilalic M, 2010, J EXP PSYCHOL GEN, V139, P728, DOI 10.1037/a0020756; Calarco T, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.012306; Caneva T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.240501; Caneva T, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.022326; Caneva T, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012312; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; De Chiara G, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052333; Doria P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.190501; Gajdacz M, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.062106; Jager G, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.033628; Jorgensen NB, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.032306; Kaufman AM, 2015, NATURE, V527, P208, DOI 10.1038/nature16073; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Lee J, 2014, P NATL ACAD SCI USA, V111, P2122, DOI 10.1073/pnas.1313039111; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Lieberoth A., 2014, HUMAN COMPUT, V1, P221; Lintott C, 2011, MON NOT R ASTRON SOC, V410, P166, DOI 10.1111/j.1365-2966.2010.17432.x; Mandelstam L., 1945, J PHYS-USSR, V9, P249, DOI DOI 10.1007/978-3-642-74626-0_8; McLeod P, 1996, J EXP PSYCHOL HUMAN, V22, P531; Rabitz HA, 2004, SCIENCE, V303, P1998, DOI 10.1126/science.1093384; Roslund J, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.013408; Sauermann H, 2015, P NATL ACAD SCI USA, V112, P679, DOI 10.1073/pnas.1408907112; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Sklarz SE, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.053619; Todd P.M., 1999, SIMPLE HEURISTICS MA; Ugray Z, 2007, INFORMS J COMPUT, V19, P328, DOI 10.1287/ijoc.1060.0175; Vuculescu O, 2014, CREAT INNOV MANAG, V23, P121, DOI 10.1111/caim.12059; Weitenberg C, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.032322; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Zahedinejad E, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.032310	35	82	82	4	109	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					210	+		10.1038/nature17620	http://dx.doi.org/10.1038/nature17620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075097	Green Submitted			2022-12-28	WOS:000374415100034
J	Wang, ZJ; Alexandradinata, A; Cava, RJ; Bernevig, BA				Wang, Zhijun; Alexandradinata, A.; Cava, R. J.; Bernevig, B. Andrei			Hourglass fermions	NATURE			English	Article							TOPOLOGICAL CRYSTALLINE INSULATOR; ENERGY-BANDS; PHASE-TRANSITION; POLARIZATION; REALIZATION	Spatial symmetries in crystals may be distinguished by whether they preserve the spatial origin. Here we study spatial symmetries that translate the origin by a fraction of the lattice period, and find that these non-symmorphic symmetries protect an exotic surface fermion whose dispersion relation is shaped like an hourglass; surface bands connect one hourglass to the next in an unbreakable zigzag pattern. These 'hourglass' fermions are formed in the large-gap insulators, KHgX (X = As, Sb, Bi), which we propose as the first material class whose band topology relies on non-symmorphic symmetries. Besides the hourglass fermion, another surface of KHgX manifests a three-dimensional generalization of the quantum spin Hall effect, which has previously been observed only in two-dimensional crystals. To describe the bulk topology of non-symmorphic crystals, we propose a non-Abelian generalization of the geometric theory of polarization. Our non-trivial topology originates from an inversion of the rotational quantum numbers, which we propose as a criterion in the search for topological materials.	[Wang, Zhijun; Alexandradinata, A.; Bernevig, B. Andrei] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Alexandradinata, A.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08540 USA	Princeton University; Yale University; Princeton University	Bernevig, BA (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	bernevig@princeton.edu	Wang, Zhijun/O-8015-2014	Wang, Zhijun/0000-0003-2169-8068	NSF CAREER [DMR-095242, ONR-N00014-11-1-0635]; TI MURI [W911NF-12-1-0461]; NSF-MRSEC [DMR-1420541]; Packard Foundation; Keck grant; ONR [25812-G0001-10006242-101]; Schmidt fund [23800-E2359-FB625]; Yale Fellowship in Condensed Matter Physics	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); TI MURI; NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Packard Foundation(The David & Lucile Packard Foundation); Keck grant; ONR(Office of Naval Research); Schmidt fund; Yale Fellowship in Condensed Matter Physics	We thank C. Fang, D. P. Arovas, J. Li, L. Muechler and X. Dai for discussions. This work was supported by NSF CAREER DMR-095242, ONR-N00014-11-1-0635, TI MURI W911NF-12-1-0461, NSF-MRSEC DMR-1420541, Packard Foundation, Keck grant, "ONR Majorana Fermions" 25812-G0001-10006242-101, and Schmidt fund 23800-E2359-FB625. During the refereeing stages of this work, A. A. was supported by the Yale Fellowship in Condensed Matter Physics.	Alexandradinata A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.116403; Alexandradinata A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.155114; Alexandradinata A., 2014, PREPRINT; Bernevig B. A., PHYS REV X IN PRESS; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Dong XY, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.045429; Fang C, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.161105; Fang C, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.035119; Fidkowski L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.036601; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Fu L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045302; Fu LA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.106802; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hsieh TH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1969; Huang ZS, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.245109; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; KINGSMITH RD, 1993, PHYS REV B, V47, P1651, DOI 10.1103/PhysRevB.47.1651; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Lax M., 1974, SYMMETRY PRINCIPLES; Liu CX, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085304; Lu L., 2016, NATURE PHYS; Michel L, 1999, PHYS REV B, V59, P5998, DOI 10.1103/PhysRevB.59.5998; Michel L, 2000, EUROPHYS LETT, V50, P519, DOI 10.1209/epl/i2000-00300-9; Mong RSK, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245209; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Parameswaran S. A., 2015, PREPRINT; Parameswaran SA, 2013, NAT PHYS, V9, P299, DOI [10.1038/nphys2600, 10.1038/NPHYS2600]; Po H. C., 2015, PREPRINT; RESTA R, 1994, REV MOD PHYS, V66, P899, DOI 10.1103/RevModPhys.66.899; Roy R., 2012, PREPRINT; Roy R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195321; Shiozaki K, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.155120; Shiozaki K, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.165114; Taherinejad M, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.115102; Tanaka Y, 2012, NAT PHYS, V8, P800, DOI [10.1038/nphys2442, 10.1038/NPHYS2442]; Teo JCY, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045426; Tinkham M., 2003, GROUP THEORY QUANTUM, P279; VANDERBILT D, 1993, PHYS REV B, V48, P4442, DOI 10.1103/PhysRevB.48.4442; Varjas D, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.195116; VOGEL R, 1980, Z NATURFORSCH B, V35, P114, DOI 10.1515/znb-1980-0127; Watanabe H, 2015, P NATL ACAD SCI USA, V112, P14551, DOI 10.1073/pnas.1514665112; WILCZEK F, 1984, PHYS REV LETT, V52, P2111, DOI 10.1103/PhysRevLett.52.2111; Xu SY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2191; Yan BH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116406; ZAK J, 1989, PHYS REV LETT, V62, P2747, DOI 10.1103/PhysRevLett.62.2747; Zhang HJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156402	51	287	293	6	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					189	194		10.1038/nature17410	http://dx.doi.org/10.1038/nature17410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075096	Green Submitted			2022-12-28	WOS:000374415100030
J	Aragao, MDV; van der Linden, V; Brainer-Lima, AM; Coeli, RR; Rocha, MA; da Silva, PS; de Carvalho, MDCG; van der Linden, A; de Holanda, AC; Valenca, MM				Vasco Aragao, Maria de Fatima; van der Linden, Vanessa; Brainer-Lima, Alessandra Mertens; Coeli, Regina Ramos; Rocha, Maria Angela; da Silva, Paula Sobral; Costa Gomes de Carvalho, Maria Durce; van der Linden, Ana; de Holanda, Arthur Cesario; Valenca, Marcelo Moraes			Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ABNORMALITIES; OUTBREAK	OBJECTIVE To report radiological findings observed in computed tomography (CT) and magnetic resonance imaging (MRI) scans of the first cases of congenital infection and microcephaly presumably associated with the Zika virus in the current Brazilian epidemic. DESIGN Retrospective study with a case series. SETTING Association for Assistance of Disabled Children (AACD), Pernambuco state, Brazil. PARTICIPANTS 23 children with a diagnosis of congenital infection presumably associated with the Zika virus during the Brazilian microcephaly epidemic. MAIN OUTCOME MEASURES Types of abnormalities and the radiological pattern of lesions identified on CT and MRI brain scans. RESULTS Six of the 23 children tested positive for IgM antibodies to Zika virus in cerebrospinal fluid. The other 17 children met the protocol criteria for congenital infection presumably associated with the Zika virus, even without being tested for IgM antibodies to the virus-the test was not yet available on a routine basis. Of the 23 children, 15 underwent CT, seven underwent both CT and MRI, and one underwent MRI. Of the 22 children who underwent CT, all had calcifications in the junction between cortical and subcortical white matter, 21 (95%) had malformations of cortical development, 20 (91%) had a decreased brain volume, 19 (86%) had ventriculomegaly, and 11 (50%) had hypoplasia of the cerebellum or brainstem. Of the eight children who underwent MRI, all had calcifications in the junction between cortical and subcortical white matter, malformations of cortical development occurring predominantly in the frontal lobes, and ventriculomegaly. Seven of the eight (88%) children had enlarged cisterna magna, seven (88%) delayed myelination, and six each (75%) a moderate to severe decrease in brain volume, simplified gyral pattern, and abnormalities of the corpus callosum (38% hypogenesis and 38% hypoplasia). Malformations were symmetrical in 75% of the cases. CONCLUSION Severe cerebral damage was found on imaging in most of the children in this case series with congenital infection presumably associated with the Zika virus. The features most commonly found were brain calcifications in the junction between cortical and subcortical white matter associated with malformations of cortical development, often with a simplified gyral pattern and predominance of pachygyria or polymicrogyria in the frontal lobes. Additional findings were enlarged cisterna magna, abnormalities of corpus callosum (hypoplasia or hypogenesis), ventriculomegaly, delayed myelination, and hypoplasia of the cerebellum and the brainstem.	[Vasco Aragao, Maria de Fatima] Ctr Diagnost Multimagem, Rua Frei Matias Tevis 194, BR-52010450 Ilha Do Leite Recife, PE, Brazil; [Vasco Aragao, Maria de Fatima] Mauricio de Nassau Univ, Sch Med, Recife, PE, Brazil; [van der Linden, Vanessa] Associat Assistance Disabled Children, Recife, PE, Brazil; [van der Linden, Vanessa] Barao de Lucena Hosp, Recife, PE, Brazil; [Brainer-Lima, Alessandra Mertens] Univ Pernambuco, PROCAPE, Recife, PE, Brazil; [Coeli, Regina Ramos; Rocha, Maria Angela; da Silva, Paula Sobral; Costa Gomes de Carvalho, Maria Durce] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil; [van der Linden, Ana] Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil; [de Holanda, Arthur Cesario] Univ Fed Pernambuco, Sch Med, Recife, PE, Brazil; [Valenca, Marcelo Moraes] Univ Fed Pernambuco, Neurol & Neurosurg, Recife, PE, Brazil	Universidade de Pernambuco (UPE); Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Aragao, MDV (corresponding author), Ctr Diagnost Multimagem, Rua Frei Matias Tevis 194, BR-52010450 Ilha Do Leite Recife, PE, Brazil.; Aragao, MDV (corresponding author), Mauricio de Nassau Univ, Sch Med, Recife, PE, Brazil.	vascoaragao@gmail.com	Valenca, Marcelo/A-4302-2013; CESARIO, Alfredo/O-4215-2015	Valenca, Marcelo/0000-0003-0678-3782; CESARIO, Alfredo/0000-0003-4687-0709				Barkovich AJ, 2012, PEDIAT NEUROIMAGING; BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709; Besnard M, 2014, Euro Surveill, V19; Bosemani T, 2015, RADIOGRAPHICS, V35, P200, DOI 10.1148/rg.351140038; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Centre d'hygiene et de salubrite publique de la Direction de la sante, 2015, B TEL SIT SUIV RES O; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dogan Y, 2011, FETAL DIAGN THER, V30, P141, DOI 10.1159/000330636; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Hess C.P., 2013, IMAGING OF THE BRAIN, P45; Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Malinger G, 2003, AJNR AM J NEURORADIO, V24, P28; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC; Ministerio da Saude (Brazil), 2016, CENTR OP EM SAUSD PU; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712; Sze G, 1999, CRANIAL MRI CT, P453; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Tavernise S, 2016, NY TIMES	27	195	198	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2016	353								i1901	10.1136/bmj.i1901	http://dx.doi.org/10.1136/bmj.i1901			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7ET	27075009	hybrid, Green Published			2022-12-28	WOS:000374375400003
J	Ramsden, CE; Zamora, D; Majchrzak-Hong, S; Faurot, KR; Broste, SK; Frantz, RP; Davis, JM; Ringel, A; Suchindran, CM; Hibbeln, JR				Ramsden, Christopher E.; Zamora, Daisy; Majchrzak-Hong, Sharon; Faurot, Keturah R.; Broste, Steven K.; Frantz, Robert P.; Davis, John M.; Ringel, Amit; Suchindran, Chirayath M.; Hibbeln, Joseph R.			Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LINOLEIC-ACID METABOLITES; SERUM-CHOLESTEROL RESPONSE; N-6 FATTY-ACIDS; SECONDARY PREVENTION; REPLACEMENT THERAPY; DISEASE; RISK; METAANALYSIS; MORTALITY; LIPIDS	OBJECTIVE To examine the traditional diet-heart hypothesis through recovery and analysis of previously unpublished data from the Minnesota Coronary Experiment (MCE) and to put findings in the context of existing diet-heart randomized controlled trials through a systematic review and meta-analysis. DESIGN The MCE (1968-73) is a double blind randomized controlled trial designed to test whether replacement of saturated fat with vegetable oil rich in linoleic acid reduces coronary heart disease and death by lowering serum cholesterol. Recovered MCE unpublished documents and raw data were analyzed according to hypotheses prespecified by original investigators. Further, a systematic review and meta-analyses of randomized controlled trials that lowered serum cholesterol by providing vegetable oil rich in linoleic acid in place of saturated fat without confounding by concomitant interventions was conducted. SETTING One nursing home and six state mental hospitals in Minnesota, United States. PARTICIPANTS Unpublished documents with completed analyses for the randomized cohort of 9423 women and men aged 20-97; longitudinal data on serum cholesterol for the 2355 participants exposed to the study diets for a year or more; 149 completed autopsy files. INTERVENTIONS Serum cholesterol lowering diet that replaced saturated fat with linoleic acid (from corn oil and corn oil polyunsaturated margarine). Control diet was high in saturated fat from animal fats, common margarines, and shortenings. MAIN OUTCOME MEASURES Death from all causes; association between changes in serum cholesterol and death; and coronary atherosclerosis and myocardial infarcts detected at autopsy. RESULTS The intervention group had significant reduction in serum cholesterol compared with controls (mean change from baseline -13.8% v -1.0%; P<0.001). Kaplan Meier graphs showed no mortality benefit for the intervention group in the full randomized cohort or for any prespecified subgroup. There was a 22% higher risk of death for each 30 mg/dL (0.78 mmol/L) reduction in serum cholesterol in covariate adjusted Cox regression models (hazard ratio 1.22, 95% confidence interval 1.14 to 1.32; P<0.001). There was no evidence of benefit in the intervention group for coronary atherosclerosis or myocardial infarcts. Systematic review identified five randomized controlled trials for inclusion (n= 10 808). In meta-analyses, these cholesterol lowering interventions showed no evidence of benefit on mortality from coronary heart disease (1.13, 0.83 to 1.54) or all cause mortality (1.07, 0.90 to 1.27). CONCLUSIONS Available evidence from randomized controlled trials shows that replacement of saturated fat in the diet with linoleic acid effectively lowers serum cholesterol but does not support the hypothesis that this translates to a lower risk of death from coronary heart disease or all causes. Findings from the Minnesota Coronary Experiment add to growing evidence that incomplete publication has contributed to overestimation of the benefits of replacing saturated fat with vegetable oils rich in linoleic acid.	[Ramsden, Christopher E.; Majchrzak-Hong, Sharon; Ringel, Amit; Hibbeln, Joseph R.] NIAAA, Sect Nutr Neurosci, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA; [Ramsden, Christopher E.; Faurot, Keturah R.] Univ N Carolina, Dept Phys Med & Rehabil, Program Integrat Med, Chapel Hill, NC USA; [Zamora, Daisy; Davis, John M.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Broste, Steven K.] Medtronic, Minneapolis, MN USA; [Frantz, Robert P.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Davis, John M.] Univ Illinois, Inst Psychiat, Chicago, IL USA; [Suchindran, Chirayath M.] UNC Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Medtronic; Mayo Clinic; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill	Ramsden, CE (corresponding author), NIAAA, Sect Nutr Neurosci, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA.; Ramsden, CE (corresponding author), Univ N Carolina, Dept Phys Med & Rehabil, Program Integrat Med, Chapel Hill, NC USA.	Chris.Ramsden@nih.gov	Zamora, Daisy/ABG-5162-2021; Ramsden, Christopher/AAW-9516-2021	Ramsden, Christopher/0000-0002-4058-7630; Frantz, Robert/0000-0003-4128-3978; Zamora, Daisy/0000-0003-2114-5156; Faurot, Keturah/0000-0001-6122-7821	US Public Health Service; National Heart Institute through R01 mechanism [HE09686]; intramural program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health; University of North Carolina Program on Integrative Medicine (National Institutes of Health) [T-32 AT003378]; National Center for Complementary & Integrative Health [T32AT003378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000235, ZIAAA000115] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Heart Institute through R01 mechanism; intramural program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health; University of North Carolina Program on Integrative Medicine (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The MCE was funded by the US Public Health Service and the National Heart Institute through the R01 mechanism (grant HE09686). The intramural program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, and the University of North Carolina Program on Integrative Medicine (National Institutes of Health grant T-32 AT003378) supported data recovery and evaluation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the US Public Health Service.	ANDERSON JT, 1961, J NUTR, V75, P388, DOI 10.1093/jn/75.4.388; [Anonymous], 1974, DHEW PUBL NIH, V(NIH) 75-628; [Anonymous], 1977, DIET GOALS US; [Anonymous], 1984, NIH CONSENSUS STATE, V5, P1; [Anonymous], 2015, WHO STAT PUBL DISCL; ARMSTRONG ML, 1970, CIRC RES, V27, P59, DOI 10.1161/01.RES.27.1.59; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Blanchard H, 2013, PROSTAG LEUKOTR ESS, V88, P383, DOI 10.1016/j.plefa.2013.03.006; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Brewer ER, 1975, CIRCULATION S2, V51, P1; Broste SK, 1981, LIFETABLE ANAL MINNE; BUCHWALD H, 1990, NEW ENGL J MED, V323, P946, DOI 10.1056/NEJM199010043231404; CAMEJO G, 1976, ATHEROSCLEROSIS, V24, P341, DOI 10.1016/0021-9150(76)90126-X; CAPLAN AL, 1984, HUM PATHOL, V15, P1105, DOI 10.1016/S0046-8177(84)80304-4; Chemin J, 2014, PFLUG ARCH EUR J PHY, V466, P689, DOI 10.1007/s00424-014-1467-5; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; DAWSON EA, 1975, CIRCULATION, V52, P271; Diffenderfer MR, 2014, CURR OPIN LIPIDOL, V25, P221, DOI 10.1097/MOL.0000000000000067; ENIG MG, 1990, J AM COLL NUTR, V9, P471, DOI 10.1080/07315724.1990.10720404; Executive Committee on Diet and Heart Disease, 1968, NAT DIET HEART STUD; Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236; Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096; Ferreiro-Vera C, 2013, FOOD CHEM, V136, P576, DOI 10.1016/j.foodchem.2012.08.081; Frantz I., 1971, CHEM ANAL 3 WE UNPUB; FRANTZ ID, 1975, CIRCULATION, V52, P4; FRANTZ ID, 1989, ARTERIOSCLEROSIS, V9, P129, DOI 10.1161/01.ATV.9.1.129; Frantz Jr ID, 1967, RO1 HE 0986 02 SUPPL; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; GETZ GS, 1969, AM J MED, V46, P657, DOI 10.1016/0002-9343(69)90018-7; Godlee F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5641; Grodstein F, 1996, AM J EPIDEMIOL, V143, P979; Guesnet P, 2011, PROSTAG LEUKOTR ESS, V85, P353, DOI 10.1016/j.plefa.2011.08.003; He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128; JAMA, 1970, JAMA, V214, P1303, DOI DOI 10.1001/JAMA.1970.03180070069012; KEYS A, 1965, METABOLIS, V14, P747, DOI 10.1016/0026-0495(65)90001-6; KEYS A, 1965, METABOLIS, V14, P776, DOI 10.1016/0026-0495(65)90004-1; KEYS A, 1974, AM J CLIN NUTR, V27, P188, DOI 10.1093/ajcn/27.2.188; KEYS A, 1957, LANCET, V2, P959; Keys A., 1967, RO1 HE 0986 03 RES G; Kirpich IA, 2013, ALCOHOL, V47, P257, DOI 10.1016/j.alcohol.2013.01.005; Kristal AR, 2005, CANCER EPIDEM BIOMAR, V14, P2826, DOI 10.1158/1055-9965.EPI-12-ED1; Kuipers RS, 2010, BRIT J NUTR, V104, P1666, DOI 10.1017/S0007114510002679; Lehman R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8158; Liu HL, 2015, AM J PATHOL, V185, P43, DOI 10.1016/j.ajpath.2014.09.007; Maki KC, 2014, ADV NUTR, V5, P7, DOI 10.3945/an.113.004929; Marmesat S, 2012, FOOD CHEM, V135, P2333, DOI 10.1016/j.foodchem.2012.06.128; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Naci H, 2013, EUR J PREV CARDIOL, V20, P641, DOI 10.1177/2047487313480435; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Otto MCD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000506; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Ramasamy I, 2014, CLIN CHEM LAB MED, V52, P1695, DOI 10.1515/cclm-2013-0358; RAMSDEN CE, 2013, BMJ-BRIT MED J, V346, pe8707, DOI DOI 10.1136/BMJ.E8707; Ramsden CE, MOL PAIN IN PRESS; Ramsden CE, 2015, J PAIN, V16, P707, DOI 10.1016/j.jpain.2015.04.007; Ramsden CE, 2013, PAIN, V154, P2441, DOI 10.1016/j.pain.2013.07.028; Ramsden CE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8707; Ramsden CE, 2012, PROSTAG LEUKOTR ESS, V87, P135, DOI 10.1016/j.plefa.2012.08.004; Rockwood MRH, 2011, CAN GERIATR J, V14, P2; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; SHERWIN R, 1978, AM J EPIDEMIOL, V108, P92, DOI 10.1093/oxfordjournals.aje.a112607; SPADY DK, 1992, SEMIN LIVER DIS, V12, P373, DOI 10.1055/s-2008-1040407; SPIEKERMAN RE, 1962, CIRCULATION, V25, P57, DOI 10.1161/01.CIR.25.1.57; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; The Coronary Drug Project, 1972, JAMA-J AM MED ASSOC, V220, P996, DOI [10.1001/jama.1972.03200070084015, DOI 10.1001/JAMA.1972.03200070084015]; The Coronary Drug Project, 1973, JAMA-J AM MED ASSOC, V226, P652, DOI DOI 10.1001/JAMA.1973.03230060030009; THOMPSON LU, 1983, CAN I FOOD SC TECH J, V16, P246, DOI 10.1016/S0315-5463(83)72257-1; U. S. Department of Agriculture, 2010, USDA NAT NUTR DAT ST; US Department of Agriculture Agricultural Research Service, WHAT WE EAT AM; Van Assche K, 2015, KENNEDY INST ETHIC J, V25, P67, DOI 10.1353/ken.2015.0000; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P51, DOI 10.1177/2042018810375656; Willett WC, 2007, J CARDIOVASC MED, V8, pS42, DOI 10.2459/01.JCM.0000289275.72556.13; Wilson R, 2002, FREE RADICAL BIO MED, V32, P162, DOI 10.1016/S0891-5849(01)00780-8; Wu JHY, 2014, CIRCULATION, V130, P1245, DOI 10.1161/CIRCULATIONAHA.114.011590; Young SS, 2011, SIGNIFICANCE, V8, P116, DOI DOI 10.1111/J.1740-9713.2011.00506.X	78	220	226	1	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2016	353								i1246	10.1136/bmj.i1246	http://dx.doi.org/10.1136/bmj.i1246			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7ER	27071971	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000374375200001
J	Chan, JCN; Gregg, EW; Sargent, J; Horton, R				Chan, Juliana C. N.; Gregg, Edward W.; Sargent, Jennifer; Horton, Richard			Reducing global diabetes burden by implementing solutions and identifying gaps: a Lancet Commission	LANCET			English	Editorial Material							FOLLOW-UP; GLUCOSE; INTERVENTION; MORTALITY; DISEASE; RISK		[Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China; [Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Gregg, Edward W.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, Atlanta, GA USA; [Sargent, Jennifer; Horton, Richard] The Lancet, London, England	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Centers for Disease Control & Prevention - USA	Chan, JCN (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China.; Chan, JCN (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China.	jchan@cuhk.edu.hk	Chan, Juliana/B-7918-2016	Chan, Juliana/0000-0003-1325-1194; Gregg, Edward/0000-0003-2381-6822				[Anonymous], 2015, IDF DIAB; Beran D, 2016, LANCET DIABETES ENDO, V4, P275, DOI 10.1016/S2213-8587(15)00521-5; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Ma RCW, 2009, NAT REV ENDOCRINOL, V5, P529, DOI 10.1038/nrendo.2009.180; Miccoli R, 2011, DIABETES CARE, V34, pS231, DOI 10.2337/dc11-s235; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Upadhyay J, 2014, NEW ENGL J MED, V371, P285, DOI 10.1056/NEJMc1406009; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118	14	44	49	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1494	1495		10.1016/S0140-6736(16)30165-9	http://dx.doi.org/10.1016/S0140-6736(16)30165-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI8HH	27061676				2022-12-28	WOS:000373741600009
J	Collins, PY; Saxena, S				Collins, Pamela Y.; Saxena, Shekhar			Action on mental health needs global cooperation	NATURE			English	Editorial Material							DISORDERS; COUNTRIES		[Collins, Pamela Y.] US Natl Inst Mental Hlth, Off Res Dispar & Global Mental Hlth, Bethesda, MD USA; [Saxena, Shekhar] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); World Health Organization	Collins, PY (corresponding author), US Natl Inst Mental Hlth, Off Res Dispar & Global Mental Hlth, Bethesda, MD USA.; Saxena, S (corresponding author), WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland.	pamela.collins@nih.gov; saxenas@who.int	Collins, Pamela Y/AAD-9334-2022	Collins, Pamela Y./0000-0003-3956-448X	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Gilbert BJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001834; Hamdani SU, 2015, PEDIATRICS, V136, P1166, DOI 10.1542/peds.2015-0861; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7	7	29	30	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					25	27		10.1038/532025a	http://dx.doi.org/10.1038/532025a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI5RE	27078549	Bronze			2022-12-28	WOS:000373555500013
J	Illman, J				Illman, John			MEDICINE AND THE MEDIA Patients in the papers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												john@jicmedia.org						Illman J, 1989, WOMAN           1021	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2016	353								i1948	10.1136/bmj.i1948	http://dx.doi.org/10.1136/bmj.i1948			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LT	27056798				2022-12-28	WOS:000373895900009
J	Shen, H				Shen, Helen			THE ROBOTS THAT TAP INTO BRAIN CELLS	NATURE			English	Editorial Material							IN-VIVO											Desai NS, 2015, J NEUROPHYSIOL, V114, P1331, DOI 10.1152/jn.00025.2015; Kodandaramaiah SB, 2016, NAT PROTOC, V11, P634, DOI 10.1038/nprot.2016.007; Kodandaramaiah SB, 2012, NAT METHODS, V9, P585, DOI [10.1038/NMETH.1993, 10.1038/nmeth.1993]	3	2	2	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					135	136		10.1038/532135a	http://dx.doi.org/10.1038/532135a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27078570	Bronze			2022-12-28	WOS:000373555500049
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The great QOF experiment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2016	353								i1763	10.1136/bmj.i1763	http://dx.doi.org/10.1136/bmj.i1763			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LL	27044641	Bronze, Green Published			2022-12-28	WOS:000373894800001
J	Dorresteijn, JAN; Kaasenbrood, L; Cook, NR; van Kruijsdijk, RCM; van der Graaf, Y; Visseren, FLJ; Ridker, PM				Dorresteijn, Jannick A. N.; Kaasenbrood, Lotte; Cook, Nancy R.; van Kruijsdijk, Rob C. M.; van der Graaf, Yolanda; Visseren, Frank L. J.; Ridker, Paul M.			How to translate clinical trial results into gain in healthy life expectancy for individual patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; PREDICTION MODEL; RISK; VALIDATION; SURVIVAL	Treatment effects from randomised trials are typically expressed as numbers needed to treat to prevent one adverse disease event during a fixed time interval (eg, five or 10 years). In the actual patient, however, many diseases are chronically progressive, despite treatment. Examples are diabetic nephropathy, some types of malignancies, osteoporosis, and atherosclerosis. In these examples, the aim of treatment is not to prevent but to delay the occurrence of symptomatic disease. Thus the actual effect of treatment is gain in disease-free life expectancy	[Dorresteijn, Jannick A. N.; Kaasenbrood, Lotte; van Kruijsdijk, Rob C. M.; Visseren, Frank L. J.] Univ Med Ctr Utrecht, Dept Vasc Med, POB 85500, NL-3508 GA Utrecht, Netherlands; [Cook, Nancy R.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, MA Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Utrecht University; Utrecht University Medical Center	Dorresteijn, JAN (corresponding author), Univ Med Ctr Utrecht, Dept Vasc Med, POB 85500, NL-3508 GA Utrecht, Netherlands.	J.A.N.Dorresteijn2@umcutrecht.nl	van Kruijsdijk, Rob/AAW-5860-2020	Venkatasubramanian, Siddharth/0000-0002-5860-0768; Visseren, Frank/0000-0003-3951-5223				Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Briggs A, 2006, DECISION MODELLING H; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Dehmer SP, ANN INTERN MED; Dorresteijn JAN, 2011, EUR HEART J, V32, P2962, DOI 10.1093/eurheartj/ehr423; Dorresteijn JAN, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5888; Ferket BS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001361; Geskus RB, 2011, BIOMETRICS, V67, P39, DOI 10.1111/j.1541-0420.2010.01420.x; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; Kent DM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-30; Koller MT, 2012, ANN INTERN MED, V157, P389, DOI 10.7326/0003-4819-157-6-201209180-00002; Koller MT, 2012, STAT MED, V31, P1089, DOI 10.1002/sim.4384; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Wang SJ, 2008, J CLIN ONCOL, V26, P2112, DOI 10.1200/JCO.2007.14.7934; Wolkewitz M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5060	21	41	41	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2016	352								i1548	10.1136/bmj.i1548	http://dx.doi.org/10.1136/bmj.i1548			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TO	27029390	Bronze, Green Published			2022-12-28	WOS:000373492400004
J	Higham, CE; Johannsson, G; Shalet, SM				Higham, Claire E.; Johannsson, Gudmundur; Shalet, Stephen M.			Hypopituitarism	LANCET			English	Review							GROWTH-HORMONE GH; QUALITY-OF-LIFE; FRACTIONATED STEREOTACTIC RADIOTHERAPY; NONFUNCTIONING PITUITARY-ADENOMAS; IPILIMUMAB-INDUCED HYPOPHYSITIS; INSULIN-INDUCED HYPOGLYCEMIA; CARDIOVASCULAR RISK-FACTORS; REPLACEMENT THERAPY; DEFICIENT ADULTS; CENTRAL HYPOTHYROIDISM	Hypopituitarism refers to deficiency of one or more hormones produced by the anterior pituitary or released from the posterior pituitary. Hypopituitarism is associated with excess mortality, a key risk factor being cortisol deficiency due to adrenocorticotropic hormone (ACTH) deficiency. Onset can be acute or insidious, and the most common cause in adulthood is a pituitary adenoma, or treatment with pituitary surgery or radiotherapy. Hypopituitarism is diagnosed based on baseline blood sampling for thyroid stimulating hormone, gonadotropin, and prolactin deficiencies, whereas for ACTH, growth hormone, and antidiuretic hormone deficiency dynamic stimulation tests are usually needed. Repeated pituitary function assessment at regular intervals is needed for diagnosis of the predictable but slowly evolving forms of hypopituitarism. Replacement treatment exists in the form of thyroxine, hydrocortisone, sex steroids, growth hormone, and desmopressin. If onset is acute, cortisol deficiency should be replaced first. Modifications in replacement treatment are needed during the transition from paediatric to adult endocrine care, and during pregnancy.	[Higham, Claire E.; Shalet, Stephen M.] Christie Hosp NHS Fdn Trust, Dept Endocrinol, Manchester, Lancs, England; [Higham, Claire E.; Shalet, Stephen M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Endocrinol & Diabet, Inst Human Dev,Fac Med & Human Sci, Manchester, Lancs, England; [Johannsson, Gudmundur] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Johannsson, Gudmundur] Sahlgrens Univ Hosp, Dept Endocrinol, Gothenburg, Sweden	Christie NHS Foundation Trust; Christie Hospital; University of Manchester; University of Gothenburg; Sahlgrenska University Hospital	Shalet, SM (corresponding author), Christie Hosp NHS Fdn Trust, Endocrine Dept, Manchester M20 4BX, Lancs, England.	stephen.m.shalet@manchester.ac.uk	Higham, Claire/L-4136-2015	Higham, Claire/0000-0002-0917-9743; Johannsson, Gudmundur/0000-0003-3484-8440	Merck Serono; Novartis; Novo Nordisk; Otsuka; Pfizer; Shire; Ipsen; Sandoz; Merck; Eli Lilly; Novo Nordisk Fonden [NNF15OC0015922] Funding Source: researchfish	Merck Serono(Merck & Company); Novartis(Novartis); Novo Nordisk(Novo Nordisk); Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Shire; Ipsen(Ipsen); Sandoz(Novartis); Merck(Merck & Company); Eli Lilly(Eli Lilly); Novo Nordisk Fonden(Novo Nordisk Foundation)	GJ has served as a consultant to Viropharma/Shire and AstraZeneca and has received lecture fees from Merck Serono, Novartis, Novo Nordisk, Otsuka, Pfizer, and Shire. SMS has received fees for lecturing and ad-hoc advisory board consultancy from Pfizer, Novo Nordisk, Ipsen, Sandoz, Merck, and Eli Lilly. CEH declares no competing interests.	Agha A, 2004, CLIN ENDOCRINOL, V60, P688, DOI 10.1111/j.1365-2265.2004.02035.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Alatzoglou KS, 2014, ENDOCR REV, V35, P376, DOI 10.1210/er.2013-1067; Albarel F, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0845; Alexopoulou O, 2004, EUR J ENDOCRINOL, V150, P1, DOI 10.1530/eje.0.1500001; Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; ARAFAH BM, 1994, J CLIN ENDOCR METAB, V79, P348, DOI 10.1210/jc.79.2.348; Arafah BM, 2000, J CLIN ENDOCR METAB, V85, P1789, DOI 10.1210/jc.85.5.1789; ARAFAH PM, 1986, J CLIN ENDOCR METAB, V62, P1173, DOI 10.1210/jcem-62-6-1173; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Arwert LI, 2006, NEUROENDOCRINOLOGY, V83, P12, DOI 10.1159/000093337; Attanasio AF, 2011, J CLIN ENDOCR METAB, V96, P2255, DOI 10.1210/jc.2011-0448; Bancalari RE, 2012, ENDOCR DEV, V23, P1, DOI 10.1159/000341733; Barker FG, 2003, J CLIN ENDOCR METAB, V88, P4709, DOI 10.1210/jc.2003-030461; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; BESSER GM, 1976, BRIT MED J, V1, P448, DOI 10.1136/bmj.1.6007.448; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Bidlingmaier M, 2014, J CLIN ENDOCR METAB, V99, P1712, DOI 10.1210/jc.2013-3059; Bladowska J, 2012, PITUITARY ADENOMAS, P13; Briet C, 2015, ENDOCRIN METAB CLIN, V44, P199, DOI 10.1016/j.ecl.2014.10.016; Brooke AM, 2006, J CLIN ENDOCR METAB, V91, P3773, DOI 10.1210/jc.2006-0316; Brooke AM, 2006, CLIN ENDOCRINOL, V65, P673, DOI 10.1111/j.1365-2265.2006.02648.x; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Burman P, 2013, J CLIN ENDOCR METAB, V98, P1466, DOI 10.1210/jc.2012-4059; Capatina C, 2015, EUR J ENDOCRINOL, V172, pR179, DOI 10.1530/EJE-14-0794; Carrozza V, LEVOTHYROXINE REPLAC; Chemaitilly W, 2015, J CLIN ONCOL, V33, P492, DOI 10.1200/JCO.2014.56.7933; Child CJ, 2011, EUR J ENDOCRINOL, V165, P217, DOI 10.1530/EJE-11-0286; Chitale A, 2013, CLIN ENDOCRINOL, V79, P14, DOI 10.1111/j.1365-2265.2012.04478.x; CLAYTON PE, 1991, J PEDIATR-US, V118, P226, DOI 10.1016/S0022-3476(05)80487-1; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; Cohen-Inbar O, 2016, CLIN ENDOCRINOL, V84, P524, DOI 10.1111/cen.12938; Crowley RK, 2014, J CLIN ENDOCR METAB, V99, P4027, DOI 10.1210/jc.2014-2476; Cuesta M, 2016, QJM-INT J MED, V109, P303, DOI 10.1093/qjmed/hcv175; Curran AJ, 1998, EUR J ENDOCRINOL, V139, P54, DOI 10.1530/eje.0.1390054; Darzy Ken H., 2009, V15, P1, DOI 10.1159/000207607; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; Depenbusch M, 2002, EUR J ENDOCRINOL, V147, P617, DOI 10.1530/eje.0.1470617; Dichtel LE, 2014, J CLIN ENDOCR METAB, V99, P4712, DOI 10.1210/jc.2014-2830; Diri H, 2014, EUR J ENDOCRINOL, V171, P311, DOI 10.1530/EJE-14-0244; Drake WM, 2001, ENDOCR REV, V22, P425, DOI 10.1210/er.22.4.425; Drake WM, 1998, J CLIN ENDOCR METAB, V83, P3913, DOI 10.1210/jc.83.11.3913; Eisenberg Y, 2016, ENDOCR PRACT, V22, P76, DOI 10.4158/EP15940.RA; Faje AT, 2014, J CLIN ENDOCR METAB, V99, P4078, DOI 10.1210/jc.2014-2306; Fenske W, 2012, J CLIN ENDOCR METAB, V97, P3426, DOI 10.1210/jc.2012-1981; Fenske W, 2011, J CLIN ENDOCR METAB, V96, P1506, DOI 10.1210/jc.2010-2345; Fernandez-Rodriguez Eva, 2011, Front Endocrinol (Lausanne), V2, P25, DOI 10.3389/fendo.2011.00025; Ferretti E, 1999, J CLIN ENDOCR METAB, V84, P924, DOI 10.1210/jc.84.3.924; Filipsson H, 2006, J CLIN ENDOCR METAB, V91, P3954, DOI 10.1210/jc.2006-0524; Forss M, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-8; Gaillard RC, 2012, EUR J ENDOCRINOL, V166, P1069, DOI 10.1530/EJE-11-1028; Giavoli C, 2004, J CLIN ENDOCR METAB, V89, P5397, DOI 10.1210/jc.2004-1114; Goede SL, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/831275; Golay V, 2014, PITUITARY, V17, P125, DOI 10.1007/s11102-013-0477-1; Hahner S, 2015, J CLIN ENDOCR METAB, V100, P407, DOI 10.1210/jc.2014-3191; Handelsman DJ, 2013, J CLIN ENDOCR METAB, V98, P3971, DOI 10.1210/jc.2013-3375; Hannon MJ, 2015, CLIN ENDOCRINOL, V82, P115, DOI 10.1111/cen.12533; Hartman ML, 2013, J CLIN ENDOCR METAB, V98, P980, DOI 10.1210/jc.2012-2684; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Johannsson G, 2012, J CLIN ENDOCR METAB, V97, P473, DOI 10.1210/jc.2011-1926; Johannsson G, 1997, CLIN ENDOCRINOL, V47, P571, DOI 10.1046/j.1365-2265.1997.3271123.x; Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P1743, DOI 10.1210/jc.87.4.1743; JOHANSSON JO, 1995, METABOLISM, V44, P1126, DOI 10.1016/0026-0495(95)90004-7; JORGENSEN JOL, 1989, J CLIN ENDOCR METAB, V69, P1127, DOI 10.1210/jcem-69-6-1127; Jostel A, 2009, CLIN ENDOCRINOL, V71, P529, DOI 10.1111/j.1365-2265.2009.03534.x; Kalra Sanjay, 2011, Indian J Endocrinol Metab, V15 Suppl 3, pS151, DOI 10.4103/2230-8210.84845; Kaltsas GA, 2000, J CLIN ENDOCR METAB, V85, P1370, DOI 10.1210/jc.85.4.1370; Karaca Z, 2010, EUR J ENDOCRINOL, V162, P453, DOI 10.1530/EJE-09-0923; Khajeh L, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0205-0; Klose M, 2013, J CLIN ENDOCR METAB, V98, P3802, DOI 10.1210/jc.2013-1610; Koulouri O, 2011, CLIN ENDOCRINOL, V74, P744, DOI 10.1111/j.1365-2265.2011.03984.x; Kraan GPB, 1998, J CLIN ENDOCR METAB, V83, P1247, DOI 10.1210/jc.83.4.1247; Kronvall E, 2015, WORLD NEUROSURG, V83, P574, DOI 10.1016/j.wneu.2014.12.007; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Leung KC, 2004, ENDOCR REV, V25, P693, DOI 10.1210/er.2003-0035; Liu PY, 2009, J CLIN ENDOCR METAB, V94, P801, DOI 10.1210/jc.2008-1648; Luger A, 2012, DIABETES CARE, V35, P57, DOI 10.2337/dc11-0449; Maghnie M, 2005, EUR J ENDOCRINOL, V152, P735, DOI 10.1530/eje.1.01911; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Marek J, 2011, EUR J ENDOCRINOL, V164, P169, DOI 10.1530/EJE-10-0733; McCabe MJ, 2014, HAND CLINIC, V124, P3, DOI 10.1016/B978-0-444-59602-4.00001-0; Miller KK, 2001, J CLIN ENDOCR METAB, V86, P561, DOI 10.1210/jc.86.2.561; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Monaghan PJ, 2014, J CLIN ENDOCR METAB, V99, P4434, DOI 10.1210/jc.2014-2258; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Mukherjee A, 2006, J CLIN ENDOCR METAB, V91, P2520, DOI 10.1210/jc.2005-2491; Mukherjee A, 2003, CLIN ENDOCRINOL, V59, P743, DOI 10.1046/j.1365-2265.2003.01916.x; Mukherjee A, 2010, CLIN ENDOCRINOL, V73, P425, DOI 10.1111/j.1365-2265.2009.03751.x; Nieman L K, 2003, J Endocrinol Invest, V26, P74; Nilsson B, 2000, J CLIN ENDOCR METAB, V85, P1420, DOI 10.1210/jc.85.4.1420; Nomikos P, 2004, ACTA NEUROCHIR, V146, P27, DOI 10.1007/s00701-003-0174-3; Nystrom HF, 2012, PITUITARY, V15, P495, DOI 10.1007/s11102-011-0356-6; Oksnes M, 2014, J CLIN ENDOCR METAB, V99, P1665, DOI 10.1210/jc.2013-4253; Olsson DS, 2012, EUR J ENDOCRINOL, V166, P1061, DOI 10.1530/EJE-12-0077; Olsson DS, 2009, EUR J ENDOCRINOL, V161, P663, DOI 10.1530/EJE-09-0572; Olsson DS, 2015, J CLIN ENDOCR METAB, V100, P2651, DOI 10.1210/jc.2015-1475; Olsson DS, 2015, J CLIN ENDOCR METAB, V100, P467, DOI 10.1210/jc.2014-3525; Persani L, 2012, J CLIN ENDOCR METAB, V97, P3068, DOI 10.1210/jc.2012-1616; Plat L, 1999, J CLIN ENDOCR METAB, V84, P3082, DOI 10.1210/jc.84.9.3082; Raappana A, 2010, J CLIN ENDOCR METAB, V95, P4268, DOI 10.1210/jc.2010-0537; Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x; Ramiandrasoa C, 2013, EUR J ENDOCRINOL, V169, P431, DOI 10.1530/EJE-13-0279; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; ROBERTSON GL, 1973, J CLIN INVEST, V52, P2340, DOI 10.1172/JCI107423; Roug S, 2010, EUR J ENDOCRINOL, V162, P685, DOI 10.1530/EJE-09-1045; Schalin-Jantti C, 2010, CLIN ENDOCRINOL, V73, P72, DOI 10.1111/j.1365-2265.2009.03755.x; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Shalet SM, 2013, EUR J ENDOCRINOL, V169, pR81, DOI 10.1530/EJE-13-0418; Sherlock M, 2010, ENDOCR REV, V31, P301, DOI 10.1210/er.2009-0033; Shimon I, 2002, THYROID, V12, P823, DOI 10.1089/105072502760339406; Slawik M, 2007, J CLIN ENDOCR METAB, V92, P4115, DOI 10.1210/jc.2007-0297; Stochholm K, 2015, GROWTH HORM IGF RES, V25, P149, DOI 10.1016/j.ghir.2015.06.006; Swearingen B, 2012, J CLIN ENDOCR METAB, V97, P1073, DOI 10.1210/jc.2011-3237; Swords FM, 2003, CLIN ENDOCRINOL, V59, P613, DOI 10.1046/j.1365-2265.2003.01894.x; Tanriverdi F, 2014, ENDOCRINE, V47, P198, DOI 10.1007/s12020-013-0127-4; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Timper K, 2015, J CLIN ENDOCR METAB, V100, P2268, DOI 10.1210/jc.2014-4507; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; van Bunderen CC, 2011, J CLIN ENDOCR METAB, V96, P3151, DOI 10.1210/jc.2011-1215; Vila G, 2015, FERTIL STERIL, V104, P1210, DOI 10.1016/j.fertnstert.2015.07.1132; WEAVER JU, 1994, CLIN ENDOCRINOL, V41, P639, DOI 10.1111/j.1365-2265.1994.tb01830.x; Whitaker MJ, 2014, CLIN ENDOCRINOL, V80, P554, DOI 10.1111/cen.12316; Wieringa GE, 2014, CLIN CHIM ACTA, V432, P68, DOI 10.1016/j.cca.2014.01.014; Wilson V, 2014, QJM-INT J MED, V107, P21, DOI 10.1093/qjmed/hct193; Wiren L, 1998, CLIN ENDOCRINOL, V48, P613, DOI 10.1046/j.1365-2265.1998.00462.x; Wiren L, 2002, CLIN ENDOCRINOL, V57, P235, DOI 10.1046/j.1365-2265.2002.01572.x; Xu ZY, 2013, NEUROSURGERY, V72, P630, DOI 10.1227/NEU.0b013e3182846e44	130	105	112	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 12	2016	388	10058					2403	2415		10.1016/S0140-6736(16)30053-8	http://dx.doi.org/10.1016/S0140-6736(16)30053-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB5RB	27041067				2022-12-28	WOS:000387436900028
J	McWilliams, JM; Hatfield, LA; Chernew, ME; Landon, BE; Schwartz, AL				McWilliams, J. Michael; Hatfield, Laura A.; Chernew, Michael E.; Landon, Bruce E.; Schwartz, Aaron L.			Early Performance of Accountable Care Organizations in Medicare	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-CARE; VERTICAL INTEGRATION; PHYSICIAN PRACTICES; RISK ADJUSTMENT; ACOS; BENEFICIARIES; LEADERSHIP; OWNERSHIP; PATIENT; PAYMENT	BACKGROUND In the Medicare Shared Savings Program (MSSP), accountable care organizations (ACOs) have financial incentives to lower spending and improve quality. We used quasi-experimental methods to assess the early performance of MSSP ACOs, METHODS Using Medicare claims from 2009 through 2013 and a difference-in-differences design, we compared changes in spending and in performance on quality measures from before the start of AGO contracts to after the start of the contracts between beneficiaries served by the 220 ACOs entering the MSSP in mid-2012 (2012 ACO cohort) or January 2013 (2013 ACO cohort) and those served by non-ACO providers (control group), with adjustment for geographic area and beneficiary characteristics. We analyzed the 2012 and 2013 ACO cohorts separately because entry time could reflect the capacity of an ACO to achieve savings. We compared ACO savings according to organizational structure, baseline spending, and concurrent AGO contracting with commercial insurers. RESULTS Adjusted Medicare spending and spending trends were similar in the ACO cohorts and the control group during the precontract period. In 2013, the differential change (i.e., the between-group difference in the change from the precontract period) in total adjusted annual spending was -$144 per beneficiary in the 2012 ACO cohort as compared with the control group (P=0.02), consistent with a 1.4% savings, but only -$3 per beneficiary in the 2013 ACO cohort as compared with the control group (P=0.96). Estimated savings were consistently greater in independent primary care groups than in hospital-integrated groups among 2012 and 2013 MSSP entrants (P=0.005 for interaction). MSSP contracts were associated with improved performance on some quality measures and unchanged performance on others. CONCLUSIONS The first full year of MSSP contracts was associated with early reductions in Medicare spending among 2012 entrants but not among 2013 entrants. Savings were greater in independent primary care groups than in hospital-integrated groups.	[McWilliams, J. Michael; Hatfield, Laura A.; Chernew, Michael E.; Landon, Bruce E.; Schwartz, Aaron L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [McWilliams, J. Michael] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	McWilliams, JM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu	Hatfield, Laura A./I-6835-2019	Hatfield, Laura A./0000-0003-0366-3929	National Institute on Aging of the National Institutes of Health [P01 AG032952, AG044106-01A1]; Laura and John Arnold Foundation; NATIONAL INSTITUTE ON AGING [F30AG044106, P01AG032952] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Laura and John Arnold Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institute on Aging of the National Institutes of Health (P01 AG032952 and Flu AG044106-01A1) and from the Laura and John Arnold Foundation.	Agency for Healthcare Research and Quality, 2015, PREV QUAL IND TECHN; Anderson RE, 2014, J GEN INTERN MED, V29, P1296, DOI 10.1007/s11606-014-2900-3; [Anonymous], MED SHAR SAV PROGR A; Auerbach DI, 2013, HEALTH AFFAIR, V32, P1781, DOI 10.1377/hlthaff.2013.0372; Baker LC, 2014, HEALTH AFFAIR, V33, P756, DOI 10.1377/hlthaff.2013.1279; Burns LR, 2013, ADV HEALTH CARE MANA, V15, P39, DOI 10.1108/S1474-8231(2013)0000015009; Casalino LP, 2014, HEALTH AFFAIR, V33, P1680, DOI 10.1377/hlthaff.2014.0434; [Centers for Medicare and Medic-aid Services Department of Health and Human Services], 2015, FED REGISTER, V80, P32691; [Centers for Medicare and Medic-aid Services Department of Health and Human Services], 2016, FED REGISTER, V81, P5823; Centers for Medicare and Medicaid Services, 2015, MED ACOS PROV IMPR C; Centers for Medicare and Medicaid Services, 2015, FIN BEN ASS METH; Centers for Medicare and Medicaid Services, 2014, MED SHAR SAV PROGR S; Centers for Medicare & Medicaid Services, 2015, MED SHAR SAV PROGR Q; Colla CH, 2014, HEALTH AFFAIR, V33, P964, DOI 10.1377/hlthaff.2013.1463; [Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care Institute of Medicine Board on Health Care Services], 2013, VAR HLTH CAR SPEND T; Douven R, 2015, HEALTH AFFAIR, V34, P143, DOI 10.1377/hlthaff.2014.0444; Epstein AM, 2014, HEALTH AFFAIR, V33, P95, DOI 10.1377/hlthaff.2013.1063; Lewis VA, 2013, HEALTH SERV RES, V48, P1840, DOI 10.1111/1475-6773.12102; McWilliams, 2014, REFINING ACO PROGRAM; McWilliams JM, 2015, NEW ENGL J MED, V372, P1927, DOI 10.1056/NEJMsa1414929; McWilliams JM, 2014, JAMA INTERN MED, V174, P938, DOI 10.1001/jamainternmed.2014.1073; McWilliams JM, 2013, JAMA INTERN MED, V173, P1447, DOI 10.1001/jamainternmed.2013.6886; McWilliams JM, 2013, JAMA-J AM MED ASSOC, V310, P829, DOI 10.1001/jama.2013.276302; McWilliams JM, 2012, NEW ENGL J MED, V366, pE29, DOI 10.1056/NEJMp1202004; Mostashari F, 2014, JAMA-J AM MED ASSOC, V311, P1855, DOI 10.1001/jama.2014.4086; Neprash HT, 2015, JAMA INTERN MED, V175, P1932, DOI 10.1001/jamainternmed.2015.4610; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Robinson JC, 2014, JAMA-J AM MED ASSOC, V312, P1663, DOI 10.1001/jama.2014.14072; Rose S, 2016, HEALTH AFFAIR, V35, P440, DOI 10.1377/hlthaff.2015.1026; Schwartz AL, 2015, JAMA INTERN MED, V175, P1815, DOI 10.1001/jamainternmed.2015.4525; Schwartz AL, 2014, JAMA INTERN MED, V174, P1067, DOI 10.1001/jamainternmed.2014.1541; Song ZR, 2014, NEW ENGL J MED, V371, P1704, DOI 10.1056/NEJMsa1404026; U.S. Census Bureau, 2010, AM COMM SURV 5 YEAR; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Yun HF, 2010, HEALTH SERV OUTCOME, V10, P100, DOI 10.1007/s10742-010-0060-4; Zaslavsky AM, 2012, HEALTH SERV RES, V47, P1300, DOI 10.1111/j.1475-6773.2012.01411.x	36	274	274	1	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2357	2366		10.1056/NEJMsa1600142	http://dx.doi.org/10.1056/NEJMsa1600142			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO5WW	27075832	Green Accepted, Bronze			2022-12-28	WOS:000377854600009
J	Kirchhof, P; Fabritz, L				Kirchhof, Paulus; Fabritz, Larissa			Can biomarkers balance stroke and bleeding risk?	LANCET			English	Editorial Material							ATRIAL-FIBRILLATION; INFLAMMATION; MANAGEMENT; EVENTS		[Kirchhof, Paulus; Fabritz, Larissa] Univ Birmingham, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Kirchhof, Paulus; Fabritz, Larissa] Univ Hosp Muenster, Dept Cardiovasc Med, Munster, Germany; [Kirchhof, Paulus] Atrial Fibrillat NETwork, Munster, Germany; [Kirchhof, Paulus; Fabritz, Larissa] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Kirchhof, Paulus] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England	University of Birmingham; University of Munster; University of Birmingham	Kirchhof, P (corresponding author), Univ Birmingham, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England.; Kirchhof, P (corresponding author), Univ Hosp Muenster, Dept Cardiovasc Med, Munster, Germany.; Kirchhof, P (corresponding author), Atrial Fibrillat NETwork, Munster, Germany.; Kirchhof, P (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.; Kirchhof, P (corresponding author), Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England.	p.kirchhof@bham.ac.uk	Kirchhof, Paulus/AAT-7074-2021	Kirchhof, Paulus/0000-0002-1881-0197; Fabritz, Larissa/0000-0002-9241-1733	British Heart Foundation [FS/13/43/30324] Funding Source: researchfish	British Heart Foundation(British Heart Foundation)		Camm AJ, 2012, EUR HEART J, V33; Fabritz L, 2016, NAT REV CARDIOL, V13, P230, DOI 10.1038/nrcardio.2015.194; Hijazi Z, 2016, LANCET, V387, P2302, DOI 10.1016/S0140-6736(16)00741-8; Hijazi Z, 2016, EUR HEART J, V37, P1582, DOI 10.1093/eurheartj/ehw054; Hijazi Z, 2016, HEART, V102, P508, DOI 10.1136/heartjnl-2015-308887; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Kirchhof P, 2016, EUROPACE, V18, P37, DOI 10.1093/europace/euv304; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735; Wallentin L, 2014, CIRCULATION, V130, P1847, DOI 10.1161/CIRCULATIONAHA.114.011204	11	4	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2266	2268		10.1016/S0140-6736(16)30121-0	http://dx.doi.org/10.1016/S0140-6736(16)30121-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27056737				2022-12-28	WOS:000376969100005
J	De Poli, M; Zawodny, W; Quinonero, O; Lorch, M; Webb, SJ; Clayden, J				De Poli, Matteo; Zawodny, Wojciech; Quinonero, Ophelie; Lorch, Mark; Webb, Simon J.; Clayden, Jonathan			Conformational photoswitching of a synthetic peptide foldamer bound within a phospholipid bilayer	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SCREW-SENSE PREFERENCE; ORIENTATION; RESOLUTION; CHEMISTRY; DYNAMICS; ACID; F-19	The dynamic properties of foldamers, synthetic molecules that mimic folded biomolecules, have mainly been explored in free solution. We report on the design, synthesis, and conformational behavior of photoresponsive foldamers bound in a phospholipid bilayer akin to a biological membrane phase. These molecules contain a chromophore, which can be switched between two configurations by different wavelengths of light, attached to a helical synthetic peptide that both promotes membrane insertion and communicates conformational change along its length. Light-induced structural changes in the chromophore are translated into global conformational changes, which are detected by monitoring the solid-state F-19 nuclear magnetic resonance signals of a remote fluorine-containing residue located 1 to 2 nanometers away. The behavior of the foldamers in the membrane phase is similar to that of analogous compounds in organic solvents.	[De Poli, Matteo; Zawodny, Wojciech; Quinonero, Ophelie; Webb, Simon J.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Lorch, Mark] Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England; [Webb, Simon J.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Clayden, Jonathan] Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England	University of Manchester; University of Hull; University of Manchester; University of Bristol	Clayden, J (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	j.clayden@bristol.ac.uk		Clayden, Jonathan/0000-0001-5080-9535; Zawodny, Wojciech/0000-0001-8642-889X; Webb, Simon/0000-0001-9793-8748	European Research Council; UK Engineering and Physical Sciences Research Council [EP/K039547/1, EP/N009134/1]; EPSRC [EP/K039547/1, EP/N009134/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N009134/1, EP/K039547/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by the European Research Council (Advanced Investigator Grant ROCOCO) and UK Engineering and Physical Sciences Research Council grants EP/K039547/1 and EP/N009134/1. We thank B. Gore or assistance with ss-NMR experiments, R. Adams and G. Morris for helpful discussions on solution and solid-state NMR data, and S. Koehler and L. Natrajan for valuable suggestions for preliminary irradiation studies. Detailed experimental procedures and all data supporting this publication are presented in the supplementary materials. Metrical parameters for the structure of 2 are available free of charge from he Cambridge Crystallographic Data Centre under accession number CCDC 1415763. Author contributions: M.D.P., S.J.W., and J.C. conceived the project and designed the experiments; M.D.P. synthesized the compounds with assistance from W.Z. and O.Q.; M.D.P. and M.L. devised, and carried out the ss-NMR experiments; M.D.P., S.J.W., and J.C. analyzed the data and wrote the paper.	Aisenbrey C, 2012, ORG BIOMOL CHEM, V10, P1440, DOI 10.1039/c1ob06278f; Baker LA, 2014, CURR OPIN STRUC BIOL, V27, P48, DOI 10.1016/j.sbi.2014.03.009; Bandara HMD, 2012, CHEM SOC REV, V41, P1809, DOI 10.1039/c1cs15179g; Bouchard M, 1995, BIOPHYS J, V69, P1933, DOI 10.1016/S0006-3495(95)80063-9; Broichhagen J, 2014, CURR OPIN CHEM BIOL, V21, P121, DOI 10.1016/j.cbpa.2014.07.008; Brown RA, 2012, ANGEW CHEM INT EDIT, V51, P1395, DOI 10.1002/anie.201107583; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Davis JH, 1995, BIOPHYS J, V69, P1917, DOI 10.1016/S0006-3495(95)80062-7; De Poli M, 2014, J ORG CHEM, V79, P4659, DOI 10.1021/jo500714b; DEGRIP WJ, 2000, MOL MECH VISUAL TRAN, P1, DOI DOI 10.1016/S1383-8121(00)80004-4; Duer M.J., 2004, INTRO SOLID STATE NM; Feringa BL, 2011, MOLECULAR SWITCHES, VOL 1, 2ND EDITION, P1, DOI 10.1002/9783527634408; Filippov AV, 2015, ANNU REP NMR SPECTRO, V85, P27, DOI 10.1016/bs.arnmr.2014.12.001; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; GERSON F, 1960, HELV CHIM ACTA, V43, P1889, DOI 10.1002/hlca.19600430702; Gessmann R, 2003, J PEPT SCI, V9, P753, DOI 10.1002/psc.490; Gostl R, 2014, CHEM SOC REV, V43, P1982, DOI 10.1039/c3cs60383k; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hong M, 2012, ANNU REV PHYS CHEM, V63, P1, DOI 10.1146/annurev-physchem-032511-143731; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; HUMMEL RP, 1987, ANGEW CHEM INT EDIT, V26, P1150, DOI 10.1002/anie.198711501; Huster D, 2014, BBA-MOL CELL BIOL L, V1841, P1146, DOI 10.1016/j.bbalip.2013.12.002; Joh NH, 2014, SCIENCE, V346, P1520, DOI 10.1126/science.1261172; Koch K, 2012, TOP CURR CHEM, V306, P89, DOI 10.1007/128_2011_162; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Le Bailly BAF, 2016, ANGEW CHEM INT EDIT, V55, P2132, DOI 10.1002/anie.201510605; Le Bailly BAF, 2015, CHEM SCI, V6, P2313, DOI 10.1039/c4sc03944k; Mazeres S, 1996, BIOPHYS J, V71, P327, DOI 10.1016/S0006-3495(96)79228-7; Nagao T, 2015, BBA-BIOMEMBRANES, V1848, P2789, DOI 10.1016/j.bbamem.2015.07.019; NISHIMURA N, 1976, B CHEM SOC JPN, V49, P1381, DOI 10.1246/bcsj.49.1381; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Pike SJ, 2014, CHEM-EUR J, V20, P15981, DOI 10.1002/chem.201403626; Pike SJ, 2013, ORG BIOMOL CHEM, V11, P3168, DOI 10.1039/c3ob40463c; Poenova T, 2015, ANAL CHEM, V87, P5458, DOI 10.1021/ac504288u; Ramamoorthy A, 2013, J PHYS CHEM B, V117, P6693, DOI 10.1021/jp4034003; Shanmugam G, 2004, BIOPHYS J, V87, P622, DOI 10.1529/biophysj.104.040907; Strandberg E, 2004, CONCEPT MAGN RESON A, V23A, P89, DOI 10.1002/cmr.a.20024; Struts Andrey V, 2015, Methods Mol Biol, V1271, P133, DOI 10.1007/978-1-4939-2330-4_10; Su YC, 2010, J AM CHEM SOC, V132, P9197, DOI 10.1021/ja103658h; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; TONIOLO C, 1991, TRENDS BIOCHEM SCI, V16, P350; Toniolo C., 2009, PEPTAIBIOTICS; Wadhwani P., 2009, FLUORINE MED CHEM CH, P463; Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016; Watt ED, 2014, ANAL CHEM, V86, P58, DOI 10.1021/ac403956k; Williams JK, 2013, J AM CHEM SOC, V135, P9885, DOI 10.1021/ja4041412	46	113	114	5	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					575	580		10.1126/science.aad8352	http://dx.doi.org/10.1126/science.aad8352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27033546	Green Submitted, Green Accepted			2022-12-28	WOS:000374998600042
J	Ramanan, D; Bowcutt, R; Lee, SC; Tang, MS; Kurtz, ZD; Ding, Y; Honda, K; Gause, WC; Blaser, MJ; Bonneau, RA; Lim, YAL; Loke, P; Cadwell, K				Ramanan, Deepshika; Bowcutt, Rowann; Lee, Soo Ching; Tang, Mei San; Kurtz, Zachary D.; Ding, Yi; Honda, Kenya; Gause, William C.; Blaser, Martin J.; Bonneau, Richard A.; Lim, Yvonne A. L.; Loke, P'ng; Cadwell, Ken			Helminth infection promotes colonization resistance via type 2 immunity	SCIENCE			English	Article							CROHNS-DISEASE; T-CELLS; INFLAMMATION; MICROBIOTA; DIVERSITY; COLITIS	Increasing incidence of inflammatory bowel diseases, such as Crohn's disease, in developed nations is associated with changes to the microbial environment, such as decreased prevalence of helminth colonization and alterations to the gut microbiota. We find that helminth infection protects mice deficient in the Crohn's disease susceptibility gene Nod2 from intestinal abnormalities by inhibiting colonization by an inflammatory Bacteroides species. Resistance to Bacteroides colonization was dependent on type 2 immunity, which promoted the establishment of a protective microbiota enriched in Clostridiales. Additionally, we show that individuals from helminth-endemic regions harbor a similar protective microbiota and that deworming treatment reduced levels of Clostridiales and increased Bacteroidales. These results support a model of the hygiene hypothesis in which certain individuals are genetically susceptible to the consequences of a changing microbial environment.	[Ramanan, Deepshika; Cadwell, Ken] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Ramanan, Deepshika; Kurtz, Zachary D.] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY 10016 USA; [Bowcutt, Rowann; Tang, Mei San; Kurtz, Zachary D.; Blaser, Martin J.; Loke, P'ng; Cadwell, Ken] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Bowcutt, Rowann; Tang, Mei San; Kurtz, Zachary D.; Blaser, Martin J.; Loke, P'ng; Cadwell, Ken] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Lee, Soo Ching; Lim, Yvonne A. L.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Ding, Yi] NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Honda, Kenya] RIKEN Ctr Integrat Med Sci IMS, Yokohama, Kanagawa 2300045, Japan; [Honda, Kenya] Japan Agcy Med Res & Dev AMED, CREST, Tokyo 1000004, Japan; [Gause, William C.] Rutgers State Univ, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07101 USA; [Bonneau, Richard A.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Bonneau, Richard A.] NYU, Courant Inst Math Sci, 251 Mercer St, New York, NY 10012 USA; [Bonneau, Richard A.] Simons Fdn, Simons Ctr Data Anal, New York, NY 10011 USA	New York University; New York University; New York University; New York University; Universiti Malaya; New York University; NYU Langone Medical Center; RIKEN; Japan Science & Technology Agency (JST); Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University; New York University	Cadwell, K (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA.; Loke, P; Cadwell, K (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.; Loke, P; Cadwell, K (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.; Lim, YAL (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	limailian@um.edu.my; png.loke@nyumc.org; ken.cadwell@med.nyu.edu	Lee, Soo Ching/J-3159-2014; Bonneau, Richard/GZL-2900-2022; Loke, Png/X-2278-2019; LIM, YVONNE AL/B-5276-2010; Bonneau, Richard/ABD-6737-2021; LEE, SOO CHING/ABF-1409-2020	Lee, Soo Ching/0000-0002-5454-2265; LIM, YVONNE AL/0000-0003-4050-6332; LEE, SOO CHING/0000-0002-5454-2265; Cadwell, Ken/0000-0002-5860-0661	NIH [P30CA016087, UL1 TR00038, DK103788, DK093668, HL123340, AI093811, AI007180, DK090989, AI107588]; Broad Medical Research Program; Kevin and Marsha Keating Family Foundation; MCJ Amelior Foundation; NIH National Center for Advancing Translational Sciences [UL1 18000038]; University of Malaya-Ministry of Education HIR grant [UM.C/625/HIR/MOE/MED/23]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093811, R01AI107588, T32AI007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103788, R01DK093668, R01DK090989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Medical Research Program; Kevin and Marsha Keating Family Foundation; MCJ Amelior Foundation; NIH National Center for Advancing Translational Sciences; University of Malaya-Ministry of Education HIR grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Artis for seed stock of T muris, H. Silva for assistance with flow cytometry panels, B. Zeck and L. Chiriboga for assistance with immunohistochemistry, and New York University School of Medicine Flow Cytometry and Cell Sorting Center, Genomics Core, and Immunohistochemistry Core (supported in part by NIH grants P30CA016087 and UL1 TR00038). The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. RNA-seq data have been made publicly available and can be accessed using the Gene Expression Omnibus accession number GSE76504. Fastq files and corresponding mapping files for 16S sequencing data are available on request. Clostridia strains derived from human microbiota are available from K.H. under a material transfer agreement with RIKEN. K.H. is an inventor on patent applications (U.S. 14/362,097, PET/JP2012/007687) filed by the University of Tokyo, related to the human-derived Clostridia, and is a scientific adviser to Vedanta Biosciences. P.L., K.C., D.R., and R.B. are inventors on a patent application filed by New York University, related to the studies reporter here. This work was supported by NIH grants DK103788 (K.C. and P.L.), DK093668 (K.C.), HL123340 (K.C.), AI093811 (P.L.), AI007180 (Z.D.K. and M.J.B.), DK090989 (Z.D.K. and M.J.B.), and AI107588 (W.C.G.); the Broad Medical Research Program (P.L.); the Kevin and Marsha Keating Family Foundation (P.L.); The MCJ Amelior Foundation (W.C.G.); NIH National Center for Advancing Translational Sciences grant UL1 18000038 (K.C. and P.L.); a philanthropic contribution from B. Levine (K.C. and P.L.); and University of Malaya-Ministry of Education HIR grant UM.C/625/HIR/MOE/MED/23 (Y.A.L.L. and P.L.). K.C. is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Hang L, 2013, J IMMUNOL, V191, P1927, DOI 10.4049/jimmunol.1201457; Holm JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125495; Houlden A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125945; Hunter MM, 2010, GASTROENTEROLOGY, V138, P1395, DOI 10.1053/j.gastro.2009.12.041; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Klementowicz JE, 2012, SEMIN IMMUNOPATHOL, V34, P815, DOI 10.1007/s00281-012-0348-2; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Qualcomm, 2014, TECHNICAL REPORT; Ramanan D, 2014, IMMUNITY, V41, P311, DOI 10.1016/j.immuni.2014.06.015; Weinstock JV, 2009, INFLAMM BOWEL DIS, V15, P128, DOI 10.1002/ibd.20633; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012; Ziegler T, 2015, J IMMUNOL, V194, P1555, DOI 10.4049/jimmunol.1401217	22	239	252	8	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					608	612		10.1126/science.aaf3229	http://dx.doi.org/10.1126/science.aaf3229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27080105	Green Accepted			2022-12-28	WOS:000374998600050
J	Li, N; Daie, K; Svoboda, K; Druckmann, S				Li, Nuo; Daie, Kayvon; Svoboda, Karel; Druckmann, Shaul			Robust neuronal dynamics in premotor cortex during motor planning	NATURE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; NEURAL-NETWORKS; WORKING-MEMORY; CORTICAL ACTIVITY; DECISION-MAKING; MOVEMENT; CIRCUITS; SYSTEM; CHAOS	Neural activity maintains representations that bridge past and future events, often over many seconds. Network models can produce persistent and ramping activity, but the positive feedback that is critical for these slow dynamics can cause sensitivity to perturbations. Here we use electrophysiology and optogenetic perturbations in the mouse premotor cortex to probe the robustness of persistent neural representations during motor planning. We show that preparatory activity is remarkably robust to large-scale unilateral silencing: detailed neural dynamics that drive specific future movements were quickly and selectively restored by the network. Selectivity did not recover after bilateral silencing of the premotor cortex. Perturbations to one hemisphere are thus corrected by information from the other hemisphere. Corpus callosum bisections demonstrated that premotor cortex hemispheres can maintain preparatory activity independently. Redundancy across selectively coupled modules, as we observed in the premotor cortex, is a hallmark of robust control systems. Network models incorporating these principles show robustness that is consistent with data.	[Li, Nuo; Daie, Kayvon; Svoboda, Karel; Druckmann, Shaul] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K; Druckmann, S (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org; druckmanns@janelia.hhmi.org			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank B. DePasquale, A. Finkelstein, D. Gutnisky, A. Hantman, H. Inagaki, V. Jayaraman, J. Magee, S. Peron, S. Romani and N. Spruston for comments on the manuscript and discussion, T. Pluntke for animal training, A. Hu for histology, T. Harris and B. Barbarits for silicon probe recording system. This work was funded by Howard Hughes Medical Institute. N.L. and K.D. are Helen Hay Whitney Foundation postdoctoral fellows.	Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Barak O, 2013, PROG NEUROBIOL, V103, P214, DOI 10.1016/j.pneurobio.2013.02.002; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Cisek P, 2009, J NEUROSCI, V29, P11560, DOI 10.1523/JNEUROSCI.1844-09.2009; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Druckmann S, 2012, CURR BIOL, V22, P2095, DOI 10.1016/j.cub.2012.08.058; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Fisher D, 2013, NEURON, V79, P987, DOI 10.1016/j.neuron.2013.06.041; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Guo ZCV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088678; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Haykin S., 2002, ADAPTIVE FILTER THEO, V4th ed.; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hooks BM, 2015, J NEUROSCI, V35, P4418, DOI 10.1523/JNEUROSCI.3741-14.2015; Kaufman MT, 2014, NAT NEUROSCI, V17, P440, DOI 10.1038/nn.3643; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Kopec CD, 2015, NEURON, V88, P367, DOI 10.1016/j.neuron.2015.08.033; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; Li N, 2015, NATURE, V519, P51, DOI 10.1038/nature14178; Lim S, 2013, NAT NEUROSCI, V16, P1306, DOI 10.1038/nn.3492; Liu D, 2014, SCIENCE, V346, P458, DOI 10.1126/science.1256573; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Murakami M, 2015, CURR OPIN NEUROBIOL, V33, P40, DOI 10.1016/j.conb.2015.01.005; Murakami M, 2014, NAT NEUROSCI, V17, P1574, DOI 10.1038/nn.3826; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Sadtler PT, 2014, NATURE, V512, P423, DOI 10.1038/nature13665; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Sheffield MEJ, 2011, NAT NEUROSCI, V14, P200, DOI 10.1038/nn.2728; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tanaka M, 2007, J NEUROSCI, V27, P12109, DOI 10.1523/JNEUROSCI.1873-07.2007; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009	50	214	216	8	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					459	+		10.1038/nature17643	http://dx.doi.org/10.1038/nature17643			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27074502	Green Accepted			2022-12-28	WOS:000374815900038
J	Prochazka, AV				Prochazka, Allan V.			Varenicline increased smoking cessation at 24 weeks in patients hospitalized with ACS and motivated to quit	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Prochazka, Allan V.] Denver VA Med Ctr, Denver, CO USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Prochazka, AV (corresponding author), Denver VA Med Ctr, Denver, CO USA.							Grandi SM, 2013, CAN J CARDIOL, V29, P1704, DOI 10.1016/j.cjca.2013.09.014; Jang JS, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002226; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; WILHELMSSON C, 1975, LANCET, V1, P416	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					JC43	JC43		10.7326/ACPJC-2016-164-6-043	http://dx.doi.org/10.7326/ACPJC-2016-164-6-043			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	27089092				2022-12-28	WOS:000374257900005
J	Yeoman, TFM; Rust, PA				Yeoman, Thomas F. M.; Rust, Philippa A.			A rugby player's finger injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FLEXOR DIGITORUM PROFUNDUS; AVULSION INJURIES; TENDON; RUPTURES		[Yeoman, Thomas F. M.] Royal Infirm, Dept Orthopaed & Trauma, Edinburgh, Midlothian, Scotland; [Rust, Philippa A.] St Johns Hosp, Dept Plast Surg, Livingston, Scotland	Royal Infirmary of Edinburgh	Yeoman, TFM (corresponding author), Royal Infirm, Dept Orthopaed & Trauma, Edinburgh, Midlothian, Scotland.	tyeoman@nhs.net						BOYES JH, 1960, J BONE JOINT SURG AM, V42, P637, DOI 10.2106/00004623-196042040-00008; Bunnell S., 1944, SURG OF THE HAND; BYNUM DK, 1988, J HAND SURG-AM, V13A, P222, DOI 10.1016/S0363-5023(88)80053-4; Carroll R E, 1970, J Trauma, V10, P1109, DOI 10.1097/00005373-197012000-00002; CHANG WHJ, 1972, PLAST RECONSTR SURG, V50, P260, DOI 10.1097/00006534-197209000-00011; Concannon MJ, 1996, ANN PLAS SURG, V36, P84, DOI 10.1097/00000637-199601000-00017; Drape JL, 1998, SKELETAL RADIOL, V27, P617, DOI 10.1007/s002560050447; FOLMAR RC, 1972, J BONE JOINT SURG AM, VA 54, P579, DOI 10.2106/00004623-197254030-00011; Freilich AM, 2015, CLIN SPORT MED, V34, P151, DOI 10.1016/j.csm.2014.09.001; Goodson A, 2010, J HAND SURG-ASIAN-PA, V15, P103, DOI 10.1142/S0218810410004710; Gunter GS., 1960, AUST NZ J SURG, V30, P1, DOI [10.1111/j.1445-2197.1960.tb03078.x, DOI 10.1111/J.1445-2197.1960.TB03078.X]; HALLOCK GG, 1994, ANN PLAS SURG, V33, P211, DOI 10.1097/00000637-199408000-00016; Hohl Justin B, 2008, Am J Orthop (Belle Mead NJ), V37, P210; Kang N, 2003, J HAND SURG-BRIT EUR, V28B, P363, DOI 10.1016/S0266-7681(03)00100-1; Kumar BA, 2000, J HAND SURG-BRIT EUR, V25B, P95, DOI 10.1054/jhsb.1999.0306; Leddy J P, 1977, J Hand Surg Am, V2, P66; LUNN PG, 1984, J HAND SURG-BRIT EUR, V9B, P69, DOI 10.1016/0266-7681(84)90020-2; MANSKE PR, 1978, HAND, V10, P52, DOI 10.1016/S0072-968X(78)80025-4; Mcmaster PE, 1933, J BONE JOINT SURG, V15, P705; Reef T C, 1977, Am J Sports Med, V5, P281, DOI 10.1177/036354657700500617; SCOTT JR, 1995, J HAND SURG-BRIT EUR, V20B, P286, DOI 10.1016/S0266-7681(05)80079-8; SMALL JO, 1989, J HAND SURG-BRIT EUR, V14B, P383, DOI 10.1016/0266-7681(89)90152-6; SMITH JH, 1981, J HAND SURG-AM, V6, P600, DOI 10.1016/S0363-5023(81)80141-4; Stamos BD, 2000, HAND CLIN, V16, P359; Tripathi AK, 2009, J HAND SURG-EUR VOL, V34E, P85, DOI 10.1177/1753193408096764; Tuttle HG, 2006, CLIN ORTHOP RELAT R, P157, DOI 10.1097/01.blo.0000205903.51727.62; Von Zander, 1891, THESIS BERLIN; WENGER DR, 1973, ARCH SURG-CHICAGO, V106, P145	28	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2016	353								i1911	10.1136/bmj.i1911	http://dx.doi.org/10.1136/bmj.i1911			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7ET	27075336				2022-12-28	WOS:000374375400004
J	Mackenbach, JP; Kulhanova, I; Artnik, B; Bopp, M; Borrell, C; Clemens, T; Costa, G; Dibben, C; Kalediene, R; Lundberg, O; Martikainen, P; Menvielle, G; Ostergren, O; Prochorskas, R; Rodriguez-Sanz, M; Strand, BH; Looman, CWN; de Gelder, R				Mackenbach, Johan P.; Kulhanova, Ivana; Artnik, Barbara; Bopp, Matthias; Borrell, Carme; Clemens, Tom; Costa, Giuseppe; Dibben, Chris; Kalediene, Ramune; Lundberg, Olle; Martikainen, Pekka; Menvielle, Gwenn; Ostergren, Olof; Prochorskas, Remigijus; Rodriguez-Sanz, Maica; Strand, Bjorn Heine; Looman, Caspar W. N.; de Gelder, Rianne			Changes in mortality inequalities over two decades: register based study of European countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOCIOECONOMIC INEQUALITIES; EDUCATIONAL INEQUALITIES; LIFE EXPECTANCY; HEALTH INEQUALITIES; SOCIAL INEQUALITIES; SMOKING; TRENDS; MEN; INCOME; DEATH	OBJECTIVE To determine whether government efforts in reducing inequalities in health in European countries have actually made a difference to mortality inequalities by socioeconomic group. DESIGN Register based study. DATA SOURCE Mortality data by level of education and occupational class in the period 1990-2010, usually collected in a census linked longitudinal study design. We compared changes in mortality between the lowest and highest socioeconomic groups, and calculated their effect on absolute and relative inequalities in mortality (measured as rate differences and rate ratios, respectively). SETTING All European countries for which data on socioeconomic inequalities in mortality were available for the approximate period between years 1990 and 2010. These included Finland, Norway, Sweden, Scotland, England and Wales (data applied to both together), France, Switzerland, Spain (Barcelona), Italy (Turin), Slovenia, and Lithuania. RESULTS Substantial mortality declines occurred in lower socioeconomic groups in most European countries covered by this study. Relative inequalities in mortality widened almost universally, because percentage declines were usually smaller in lower socioeconomic groups. However, as absolute declines were often smaller in higher socioeconomic groups, absolute inequalities narrowed by up to 35%, particularly among men. Narrowing was partly driven by ischaemic heart disease, smoking related causes, and causes amenable to medical intervention. Progress in reducing absolute inequalities was greatest in Spain (Barcelona), Scotland, England and Wales, and Italy (Turin), and absent in Finland and Norway. More detailed studies preferably using individual level data are necessary to identify the causes of these variations. CONCLUSIONS Over the past two decades, trends in inequalities in mortality have been more favourable in most European countries than is commonly assumed. Absolute inequalities have decreased in several countries, probably more as a side effect of population wide behavioural changes and improvements in prevention and treatment, than as an effect of policies explicitly aimed at reducing health inequalities.	[Mackenbach, Johan P.; Kulhanova, Ivana; Looman, Caspar W. N.; de Gelder, Rianne] Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Artnik, Barbara] Fac Med, Dept Publ Hlth, Ljubljana, Slovenia; [Bopp, Matthias] Univ Zurich, Epidemiol Biostat & Prevent Inst, CH-8006 Zurich, Switzerland; [Borrell, Carme; Rodriguez-Sanz, Maica] Agencia Salut Publ Barcelona, Barcelona, Spain; [Clemens, Tom; Dibben, Chris] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Costa, Giuseppe] Univ Turin, Dept Clin Med & Biol, I-10124 Turin, Italy; [Kalediene, Ramune] Lithuanian Univ Hlth Sci, Kaunas, Lithuania; [Lundberg, Olle; Ostergren, Olof] Ctr Hlth Equ Studies, Stockholm, Sweden; [Lundberg, Olle] Mid Sweden Univ, Dept Hlth Sci, Ostersund, Sweden; [Martikainen, Pekka] Univ Helsinki, Dept Sociol, FIN-00014 Helsinki, Finland; [Menvielle, Gwenn] Univ Paris 04, INSERM, IPLESP, UMRS 1136, F-75230 Paris 05, France; [Strand, Bjorn Heine] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway	Erasmus University Rotterdam; Erasmus MC; University of Zurich; Public Health Agency of Barcelona; University of Edinburgh; University of Turin; Lithuanian University of Health Sciences; Mid-Sweden University; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Norwegian Institute of Public Health (NIPH)	Mackenbach, JP (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.mackenbach@erasmusmc.nl	Kulhánová, Ivana/B-9253-2019; Menvielle, Gwenn/E-7201-2017; costa, giuseppe/K-2526-2016; Strand, Bjørn/AAV-7948-2021	Kulhánová, Ivana/0000-0002-9688-1548; Strand, Bjørn/0000-0003-4385-8886; Ostergren, Olof/0000-0002-7156-3260; COSTA, Giuseppe/0000-0003-3187-4889; Martikainen, Pekka/0000-0001-9374-1438; Dibben, Chris/0000-0003-1769-3774; Clemens, Tom/0000-0002-6979-0026; Bopp, Matthias/0000-0003-0766-3723	European Commission Research and Innovation Directorate General [278511]; MRC [MR/K007017/1] Funding Source: UKRI; Medical Research Council [MR/K007017/1, MC_PC_13040] Funding Source: researchfish	European Commission Research and Innovation Directorate General; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a grant (FP7-CP-FP no 278511) from the European Commission Research and Innovation Directorate General, as part of the "Developing methodologies to reduce inequalities in the determinants of health" (DEMETRIQ) project. The sponsor had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Bauld L, 2008, INT J HEALTH SERV, V38, P439, DOI 10.2190/HS.38.3.d; Carey G, 2014, J EPIDEMIOL COMMUNIT; Department of Health, 2003, TACKL HLTH IN PROGR; Fair Society, 2010, HLTH LIV MARM REV; Gregoraci G, TOB CONTROL IN PRESS; Harper S, 2010, MILBANK Q, V88, P4, DOI 10.1111/j.1468-0009.2010.00587.x; Herttua K, 2008, AM J EPIDEMIOL, V168, P1110, DOI 10.1093/aje/kwn216; Hotchkiss JW, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1088; Inoue M., 2001, GPE DISCUSSION PAPER, V31; Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181; Kulik MC, 2014, NICOTINE TOB RES, V16, P507, DOI 10.1093/ntr/ntt175; Kunst AE, 1998, SOC SCI MED, V46, P1459, DOI 10.1016/S0277-9536(98)00041-0; Leinsalu M, 2009, INT J EPIDEMIOL, V38, P512, DOI 10.1093/ije/dyn248; Leyland AH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-172; Lozano R, 2001, MISCODING MISCLASSIF; Mackenbach JP, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001909; Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Mackenbach JP, 2011, J EPIDEMIOL COMMUN H, V65, P568, DOI 10.1136/jech.2010.128280; Mackenbach JP, 2003, INT J HEALTH SERV, V33, P523, DOI 10.2190/C12H-NBA4-7QWE-6K3T; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Marinacci C, 2013, EUR J PUBLIC HEALTH, V23, P582, DOI 10.1093/eurpub/cks184; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Martikainen P, 2014, EPIDEMIOLOGY, V25, P182, DOI 10.1097/EDE.0000000000000064; Martikainen P, 2013, J EPIDEMIOL COMMUN H, V67, P219, DOI 10.1136/jech-2012-201266; Norstrom T, 2002, ALCOHOL POSTWAR EURO; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Ostergren O, 2012, EURO GBD SE POTENTIA, P113; Plug I, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-346; Regidor E, 2012, EUR J PUBLIC HEALTH, V22, P80, DOI 10.1093/eurpub/ckr051; Schaap MM, 2008, TOB CONTROL, V17, P248, DOI 10.1136/tc.2007.024265; Shkolnikov VM, 2007, SOC SCI MED, V64, P1392, DOI 10.1016/j.socscimed.2006.11.014; Stirbu I, 2010, J EPIDEMIOL COMMUN H, V64, P913, DOI 10.1136/jech.2008.081737; Strand BH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1208; Tarkiainen L, 2012, J EPIDEMIOL COMMUN H, V66, P573, DOI 10.1136/jech.2010.123182; Whitehead M, 1998, MILBANK Q, V76, P469, DOI 10.1111/1468-0009.00099; Whitehead M, 2006, CONCEPTS PRINCIPLES; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; World Health Organisation [WHO], 1999, HEALTH21 HLTH ALL PO	41	161	163	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2016	353								i1732	10.1136/bmj.i1732	http://dx.doi.org/10.1136/bmj.i1732			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ7EQ	27067249	Green Published, hybrid			2022-12-28	WOS:000374375100001
J	Gerson-Gurwitz, A; Wang, SH; Sathe, S; Green, R; Yeo, GW; Oegema, K; Desai, A				Gerson-Gurwitz, Adina; Wang, Shaohe; Sathe, Shashank; Green, Rebecca; Yeo, Gene W.; Oegema, Karen; Desai, Arshad			A Small RNA-Catalytic Argonaute Pathway Tunes Germline Transcript Levels to Ensure Embryonic Divisions	CELL			English	Article							SMALL INTERFERING RNAS; C. ELEGANS GERMLINE; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; EPIGENETIC MEMORY; MOUSE OOCYTES; IN-VITRO; CSR-1; PIRNAS; FAMILY	Multiple division cycles without growth are a characteristic feature of early embryogenesis. The female germline loads proteins and RNAs into oocytes to support these divisions, which lack many quality control mechanisms operating in somatic cells undergoing growth. Here, we describe a small RNA-Argonaute pathway that ensures early embryonic divisions in C. elegans by employing catalytic slicing activity to broadly tune, instead of silence, germline gene expression. Misregulation of one target, a kinesin-13 microtubule depolymerase, underlies a major phenotype associated with pathway loss. Tuning of target transcript levels is guided by the density of homologous small RNAs, whose generation must ultimately be related to target sequence. Thus, the tuning action of a small RNA-catalytic Argonaute pathway generates oocytes capable of supporting embryogenesis. We speculate that the specialized nature of germline chromatin led to the emergence of small RNA-catalytic Argonaute pathways in the female germline as a post-transcriptional control layer to optimize oocyte composition.	[Gerson-Gurwitz, Adina; Wang, Shaohe; Green, Rebecca; Oegema, Karen; Desai, Arshad] Ludwig Inst Canc Res, San Diego, CA 92093 USA; [Gerson-Gurwitz, Adina; Wang, Shaohe; Sathe, Shashank; Green, Rebecca; Yeo, Gene W.; Oegema, Karen; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Wang, Shaohe; Yeo, Gene W.; Oegema, Karen; Desai, Arshad] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Sathe, Shashank; Yeo, Gene W.] UCSD Stem Cell Program, La Jolla, CA 92093 USA; [Sathe, Shashank; Yeo, Gene W.] Sanford Consortium Regenerat Med, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Desai, A (corresponding author), Ludwig Inst Canc Res, San Diego, CA 92093 USA.; Desai, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Desai, A (corresponding author), Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Wang, Shaohe/J-6456-2019; Yeo, Gene/AAE-7676-2019	Wang, Shaohe/0000-0001-9522-2359; Yeo, Gene/0000-0002-0799-6037; Green, Rebecca/0000-0002-4528-011X	EMBO Long-Term Fellowship [ALTF 251-2012]; NIH [HG004659, MH107369, NS075449, GM074215]; Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Amy Pasquinelli, Andreas Rechtsteiner, James Broughton, and the members of the A.D. and K.O. labs for helpful discussions and Kristen Jepsen and the UCSD Institute for Genomic Medicine Genomics Center for help with sequencing. This work was supported by an NIH grant (GM074215) (to A.D.). A.G.-G. was supported by an EMBO Long-Term Fellowship (ALTF 251-2012). G.W.Y. and S.S. are supported by grants from the NIH (HG004659, MH107369, and NS075449). A.D. and K.O. receive salary and other support from the Ludwig Institute for Cancer Research.	Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Avgousti DC, 2012, EMBO J, V31, P3821, DOI 10.1038/emboj.2012.216; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Billi A. C., 2014, WORMBOOK; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Campbell AC, 2015, DEVELOPMENT, V142, P1745, DOI 10.1242/dev.121434; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cecere G, 2014, NAT STRUCT MOL BIOL, V21, P358, DOI 10.1038/nsmb.2801; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Conine CC, 2013, CELL, V155, P1532, DOI 10.1016/j.cell.2013.11.032; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Decker M, 2011, CURR BIOL, V21, P1259, DOI 10.1016/j.cub.2011.06.002; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gassmann R, 2012, NATURE, V484, P534, DOI 10.1038/nature10973; Ghosh-Roy A, 2012, DEV CELL, V23, P716, DOI 10.1016/j.devcel.2012.08.010; Grishok A, 2013, ADV GENET, V83, P1, DOI 10.1016/B978-0-12-407675-4.00001-8; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Kuhn CD, 2013, TRENDS BIOCHEM SCI, V38, P263, DOI 10.1016/j.tibs.2013.02.008; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; LERNER K, 1988, CYTOBIOS, V55, P51; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Nonomura KI, 2007, PLANT CELL, V19, P2583, DOI 10.1105/tpc.107.053199; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Ortiz MA, 2014, G3-GENES GENOM GENET, V4, P1765, DOI 10.1534/g3.114.012351; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Stein P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005013; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Updike DL, 2009, GENETICS, V183, P1397, DOI 10.1534/genetics.109.110171; Wang SH, 2015, ELIFE, V4, DOI 10.7554/eLife.08649; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wedeles CJ, 2013, DEV CELL, V27, P664, DOI 10.1016/j.devcel.2013.11.016; Woodruff JB, 2015, SCIENCE, V348, P808, DOI 10.1126/science.aaa3923; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	45	50	51	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					396	409		10.1016/j.cell.2016.02.040	http://dx.doi.org/10.1016/j.cell.2016.02.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27020753	Bronze, Green Accepted			2022-12-28	WOS:000374123000018
J	Moyes, DL; Wilson, D; Richardson, JP; Mogavero, S; Tang, SX; Wernecke, J; Hofs, S; Gratacap, RL; Robbins, J; Runglall, M; Murciano, C; Blagojevic, M; Thavaraj, S; Forster, TM; Hebecker, B; Kasper, L; Vizcay, G; Iancu, SI; Kichik, N; Hader, A; Kurzai, O; Luo, T; Kruger, T; Kniemeyer, O; Cota, E; Bader, O; Wheeler, RT; Gutsmann, T; Hube, B; Naglik, JR				Moyes, David L.; Wilson, Duncan; Richardson, Jonathan P.; Mogavero, Selene; Tang, Shirley X.; Wernecke, Julia; Hoefs, Sarah; Gratacap, Remi L.; Robbins, Jon; Runglall, Manohursingh; Murciano, Celia; Blagojevic, Mariana; Thavaraj, Selvam; Foerster, Toni M.; Hebecker, Betty; Kasper, Lydia; Vizcay, Gema; Iancu, Simona I.; Kichik, Nessim; Haeder, Antje; Kurzai, Oliver; Luo, Ting; Krueger, Thomas; Kniemeyer, Olaf; Cota, Ernesto; Bader, Oliver; Wheeler, Robert T.; Gutsmann, Thomas; Hube, Bernhard; Naglik, Julian R.			Candidalysin is a fungal peptide toxin critical for mucosal infection	NATURE			English	Article							PROTEIN-KINASE HOMOLOG; SACCHAROMYCES-CEREVISIAE; HYPHAL DEVELOPMENT; EPITHELIAL-CELLS; OROPHARYNGEAL CANDIDIASIS; PATHOGENICITY MECHANISMS; TRANSCRIPTION FACTOR; BETA-MANNOSYLATION; FILAMENTOUS GROWTH; ALBICANS ENCODES	Cytolytic proteins and peptide toxins are classical virulence factors of several bacterial pathogens which disrupt epithelial barrier function, damage cells and activate or modulate host immune responses. Such toxins have not been identified previously in human pathogenic fungi. Here we identify the first, to our knowledge, fungal cytolytic peptide toxin in the opportunistic pathogen Candida albicans. This secreted toxin directly damages epithelial membranes, triggers a danger response signalling pathway and activates epithelial immunity. Membrane permeabilization is enhanced by a positive charge at the carboxy terminus of the peptide, which triggers an inward current concomitant with calcium influx. C. albicans strains lacking this toxin do not activate or damage epithelial cells and are avirulent in animal models of mucosal infection. We propose the name 'Candidalysin' for this cytolytic peptide toxin; a newly identified, critical molecular determinant of epithelial damage and host recognition of the clinically important fungus, C. albicans.	[Moyes, David L.; Richardson, Jonathan P.; Tang, Shirley X.; Runglall, Manohursingh; Murciano, Celia; Blagojevic, Mariana; Thavaraj, Selvam; Iancu, Simona I.; Kichik, Nessim; Naglik, Julian R.] Kings Coll London, Inst Dent, Mucosal & Salivary Biol Div, London SE1 1UL, England; [Wilson, Duncan; Mogavero, Selene; Hoefs, Sarah; Foerster, Toni M.; Hebecker, Betty; Kasper, Lydia; Hube, Bernhard] Hans Knoell Inst, Dept Microbial Pathogen Mech, D-07745 Jena, Germany; [Wernecke, Julia; Gutsmann, Thomas] Res Ctr Borstel, Div Biophys, D-23845 Borstel, Germany; [Wernecke, Julia] Deutsch Elektronen Synchrotron DESY, D-22607 Hamburg, Germany; [Gratacap, Remi L.; Wheeler, Robert T.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME 04469 USA; [Robbins, Jon] Kings Coll London, Wolfson CARD, Guys Campus, London SE1 1UL, England; [Hebecker, Betty] Hans Knoell Inst, Res Grp Microbial Immunol, D-07745 Jena, Germany; [Vizcay, Gema] Kings Coll London, Ctr Ultrastruct Imaging, London SE1 1UL, England; [Kichik, Nessim; Cota, Ernesto] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Haeder, Antje; Kurzai, Oliver] Hans Knoell Inst, Sept Res Ctr, D-07745 Jena, Germany; [Haeder, Antje; Kurzai, Oliver] Univ Jena, D-07745 Jena, Germany; [Luo, Ting; Krueger, Thomas; Kniemeyer, Olaf] Hans Knoell Inst, Dept Mol & Appl Microbiol, D-07745 Jena, Germany; [Bader, Oliver] Univ Med Ctr Gottingen, Inst Med Microbiol, D-37075 Gottingen, Germany; [Hube, Bernhard] Univ Jena, D-07737 Jena, Germany; [Hube, Bernhard] Integrated Res & Treatment Ctr, Ctr Sepsis Control & Care, D-07747 Jena, Germany; [Wilson, Duncan] Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen Fungal Grp, Aberdeen AB25 2ZD, Scotland; [Runglall, Manohursingh] Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London SE1 1UL, England; [Murciano, Celia] Univ Valencia, ERI Biotecmed & Microbiol & Ecol Dept, E-46100 Valencia, Spain	University of London; King's College London; Hans Knoll Institute (HKI); Forschungszentrum Borstel; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Maine System; University of Maine Orono; University of London; King's College London; Hans Knoll Institute (HKI); University of London; King's College London; Imperial College London; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); University of Gottingen; Friedrich Schiller University of Jena; University of Aberdeen; Guy's & St Thomas' NHS Foundation Trust; University of Valencia	Hube, B (corresponding author), Hans Knoell Inst, Dept Microbial Pathogen Mech, D-07745 Jena, Germany.; Hube, B (corresponding author), Univ Jena, D-07737 Jena, Germany.; Hube, B (corresponding author), Integrated Res & Treatment Ctr, Ctr Sepsis Control & Care, D-07747 Jena, Germany.	bernhard.hube@leibniz-hki.de	Kniemeyer, Olaf/K-1253-2013; Thavaraj, Selvam/AAO-9113-2020; Wheeler, Robert/H-3085-2019; Gutsmann, Thomas/E-6100-2011; Bader, Oliver/C-7650-2015; Murciano, Celia/K-8816-2014; Mogavero, Selene/L-8432-2017; Robbins, Jonathan/A-8661-2008	Kniemeyer, Olaf/0000-0002-9493-6402; Thavaraj, Selvam/0000-0001-5720-7422; Wheeler, Robert/0000-0003-3223-7021; Bader, Oliver/0000-0002-1534-440X; Murciano, Celia/0000-0003-0035-5306; Mogavero, Selene/0000-0003-0642-0068; Robbins, Jonathan/0000-0003-1907-0714; Wernecke, Julia/0000-0003-0152-9953; Moyes, David/0000-0002-1657-918X; Naglik, Julian/0000-0002-8072-7917; Kurzai, Oliver/0000-0002-7277-2646; Runglall, Manohursingh/0000-0002-0549-9029; Richardson, Jonathan/0000-0001-9638-2725; Kruger, Thomas/0000-0001-8984-3853; Hube, Bernhard/0000-0002-6028-0425; Wilson, Duncan/0000-0001-6617-0123; Kichik Rodriguez, Nessim/0000-0003-4315-2090	Medical Research Council [MR/J008303/1, MR/M011372/1]; Biotechnology & Biological Sciences Research Council [BB/J015261/1]; FP7-PEOPLE-Initial Training Network [606786]; Wellcome Trust [097377/Z/11/Z, 102549/Z/13/Z]; Royal Society [102549/Z/13/Z]; Deutsche Forschungsgemeinschaft [CRC/TR124, SPP 1580 (Hu 528/17-1)]; CSCC, German Federal Ministry of Education and Health (BMBF) [01E01002]; Cluster of Excellence 'Inflammation at interfaces' and Deutsche Forschungsgemeinschaft [SPP1580, GU 568/5-1]; National Institutes of Health [R15AI094406]; Burroughs Wellcome Fund; Biotechnology and Biological Sciences Research Council [BB/N014677/1, BB/K003887/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI094406] Funding Source: NIH RePORTER; BBSRC [BB/K003887/1, BB/N014677/1] Funding Source: UKRI; MRC [MR/M011372/1, MR/J008303/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology & Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FP7-PEOPLE-Initial Training Network; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CSCC, German Federal Ministry of Education and Health (BMBF)(Federal Ministry of Education & Research (BMBF)); Cluster of Excellence 'Inflammation at interfaces' and Deutsche Forschungsgemeinschaft; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Gaffen, B. Klein, C. Hertweck, A. Tucker, J. Green and S. Challacombe for comments on the manuscript. For experimental assistance, we thank S. Bevan and D. Andersson (calcium assays), D. Nayar (histology), D. Rahman and M. Mistry (murine model), M. Nilan (zebrafish model), S. Groth (FRET spectroscopy), N. Gebauer (Impedance experiments), D. Schulz (kex1 Delta/Delta strain) and our colleagues for supplying fungal mutant strains. This work was supported by grants from the Medical Research Council (MR/J008303/1, MR/M011372/1), Biotechnology & Biological Sciences Research Council (BB/J015261/1), FP7-PEOPLE-2013-Initial Training Network (606786) to J.R.N.; Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology (097377/Z/11/Z) to J.R.N. and D.W.; Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (102549/Z/13/Z) to D.W.; Deutsche Forschungsgemeinschaft CRC/TR124 FungiNet Project C1 and Z2, Deutsche Forschungsgemeinschaft SPP 1580 (Hu 528/17-1) and CSCC, German Federal Ministry of Education and Health (BMBF) 01E01002 to B. Hu.; Cluster of Excellence 'Inflammation at interfaces' and Deutsche Forschungsgemeinschaft SPP1580 project GU 568/5-1 to T.G.; National Institutes of Health (R15AI094406) and the Burroughs Wellcome Fund to R.T.W.	Bader O, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-116; Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Bechinger B, 2012, CHEM PHYS LIPIDS, V165, P282, DOI 10.1016/j.chemphyslip.2012.01.009; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 2000, GENETICS, V155, P57; Brothers KM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003634; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; CHEN GC, 1977, ANAL LETT, V10, P1195, DOI 10.1080/00032717708067855; Citiulo F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002777; Cranfield C, 2015, METHODS MOL BIOL, V1232, P45, DOI 10.1007/978-1-4939-1752-5_4; Cranfield CG, 2014, BIOPHYS J, V106, P182, DOI 10.1016/j.bpj.2013.11.1121; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; de Boer AD, 2010, YEAST, V27, P611, DOI 10.1002/yea.1790; Firon A, 2007, MOL MICROBIOL, V66, P1256, DOI 10.1111/j.1365-2958.2007.06011.x; FONZI WA, 1993, GENETICS, V134, P717; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Gratacap RL, 2013, DIS MODEL MECH, V6, P1260, DOI 10.1242/dmm.012039; Gutsmann T, 2015, NAT PROTOC, V10, P188, DOI 10.1038/nprot.2015.003; Hausauer DL, 2005, EUKARYOT CELL, V4, P1273, DOI 10.1128/EC.4.7.1273-1286.2005; Hebecker B, 2014, EXPERT REV ANTI-INFE, V12, P867, DOI 10.1586/14787210.2014.916210; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Hube B, 1997, INFECT IMMUN, V65, P3529, DOI 10.1128/IAI.65.9.3529-3538.1997; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; Kamai Y, 2001, ANTIMICROB AGENTS CH, V45, P3195, DOI 10.1128/AAC.45.11.3195-3197.2001; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Liu P, 2005, NATURE, V437, P159, DOI 10.1038/nature03926; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Los FCO, 2013, MICROBIOL MOL BIOL R, V77, P173, DOI 10.1128/MMBR.00052-12; Martin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058613; Mayer FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002592; Mille C, 2004, J BIOL CHEM, V279, P47952, DOI 10.1074/jbc.M405534200; Mille C, 2008, J BIOL CHEM, V283, P9724, DOI 10.1074/jbc.M708825200; Mille C, 2012, GLYCOBIOLOGY, V22, P1332, DOI 10.1093/glycob/cws097; Mio T, 1997, J BACTERIOL, V179, P2363, DOI 10.1128/jb.179.7.2363-2372.1997; Mio T, 1996, J BACTERIOL, V178, P2416, DOI 10.1128/jb.178.8.2416-2419.1996; Mio T, 1997, J BACTERIOL, V179, P4096, DOI 10.1128/jb.179.13.4096-4105.1997; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Moyes DL, 2015, VIRULENCE, V6, P338, DOI 10.1080/21505594.2015.1012981; Moyes DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026580; Moyes DL, 2012, MED MICROBIOL IMMUN, V201, P93, DOI 10.1007/s00430-011-0209-y; Moyes DL, 2011, CLIN DEV IMMUNOL, P1, DOI 10.1155/2011/346307; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Murciano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033362; Murciano C, 2011, INFECT IMMUN, V79, P4902, DOI 10.1128/IAI.05591-11; Naglik J R, 2011, Adv Dent Res, V23, P50, DOI 10.1177/0022034511399285; Naglik J. R., 2014, J SCI, V2014; Naglik JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004257; Naglik JR, 2011, MICROBES INFECT, V13, P963, DOI 10.1016/j.micinf.2011.06.009; NAVARROGARCIA F, 1995, MOL CELL BIOL, V15, P2197; Newport G, 1997, J BIOL CHEM, V272, P28954, DOI 10.1074/jbc.272.46.28954; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; Palmer GE, 2003, EUKARYOT CELL, V2, P411, DOI 10.1128/EC.2.3.411-421.2003; Pardini G, 2006, J BIOL CHEM, V281, P40399, DOI 10.1074/jbc.M606361200; Pieta P, 2012, P NATL ACAD SCI USA, V109, P21223, DOI 10.1073/pnas.1201559110; Rohm M, 2013, MOL MICROBIOL, V87, P132, DOI 10.1111/mmi.12087; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Sandini S, 2007, CELL MICROBIOL, V9, P1223, DOI 10.1111/j.1462-5822.2006.00862.x; SanJose C, 1996, J BACTERIOL, V178, P5850, DOI 10.1128/jb.178.19.5850-5852.1996; Schild L, 2011, EUKARYOT CELL, V10, P98, DOI 10.1128/EC.00210-10; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; Schromm AB, 1996, FEBS LETT, V399, P267, DOI 10.1016/S0014-5793(96)01338-5; Sentandreu M, 1998, J BACTERIOL, V180, P282, DOI 10.1128/JB.180.2.282-289.1998; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Sonneborn A, 2000, MOL MICROBIOL, V35, P386, DOI 10.1046/j.1365-2958.2000.01705.x; Southard SB, 1999, J BACTERIOL, V181, P7439, DOI 10.1128/JB.181.24.7439-7448.1999; Staab JF, 2003, TRENDS MICROBIOL, V11, P69, DOI 10.1016/S0966-842X(02)00029-X; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Taylor BN, 2005, INFECT IMMUN, V73, P7061, DOI 10.1128/IAI.73.10.7061-7063.2005; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; Trinh LA, 2011, GENE DEV, V25, P2306, DOI 10.1101/gad.174037.111; Wachtler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036952; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; White SJ, 2007, PLOS PATHOG, V3, P1866, DOI 10.1371/journal.ppat.0030184; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zhao X, 2005, MICROBIOL-SGM, V151, P1619, DOI 10.1099/mic.0.27763-0; Zhao XM, 2007, MICROBIOL-SGM, V153, P2342, DOI 10.1099/mic.0.2006/005017-0; Zhao X, 2007, MED MYCOL, V45, P429, DOI 10.1080/13693780701377162; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0	98	411	425	14	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					64	+		10.1038/nature17625	http://dx.doi.org/10.1038/nature17625			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27027296	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000373555500033
J	Okumura, R; Kurakawa, T; Nakano, T; Kayama, H; Kinoshita, M; Motooka, D; Gotoh, K; Kimura, T; Kamiyama, N; Kusu, T; Ueda, Y; Wu, H; Iijima, H; Barman, S; Osawa, H; Matsuno, H; Nishimura, J; Ohba, Y; Nakamura, S; Iida, T; Yamamoto, M; Umemoto, E; Sano, K; Takeda, K				Okumura, Ryu; Kurakawa, Takashi; Nakano, Takashi; Kayama, Hisako; Kinoshita, Makoto; Motooka, Daisuke; Gotoh, Kazuyoshi; Kimura, Taishi; Kamiyama, Naganori; Kusu, Takashi; Ueda, Yoshiyasu; Wu, Hong; Iijima, Hideki; Barman, Soumik; Osawa, Hideki; Matsuno, Hiroshi; Nishimura, Junichi; Ohba, Yusuke; Nakamura, Shota; Iida, Tetsuya; Yamamoto, Masahiro; Umemoto, Eiji; Sano, Koichi; Takeda, Kiyoshi			Lypd8 promotes the segregation of flagellated microbiota and colonic epithelia	NATURE			English	Article							MUCUS LAYERS; PANETH CELLS; GUT; BACTERIA; MUCIN; HOST; HOMEOSTASIS; MOLECULES; INTESTINE; LECTIN	Colonic epithelial cells are covered by thick inner and outer mucus layers(1,2). The inner mucus layer is free of commensal microbiota, which contributes to the maintenance of gut homeostasis(3-6). In the small intestine, molecules critical for prevention of bacterial invasion into epithelia such as Paneth-cell-derived anti-microbial peptides and regenerating islet-derived 3 (RegIII) family proteins have been identified(7-11). Although there are mucus layers providing physical barriers against the large number of microbiota present in the large intestine, the mechanisms that separate bacteria and colonic epithelia are not fully elucidated. Here we show that Ly6/PLAUR domain containing 8 (Lypd8) protein prevents flagellated microbiota invading the colonic epithelia in mice. Lypd8, selectively expressed in epithelial cells at the uppermost layer of the large intestinal gland, was secreted into the lumen and bound flagellated bacteria including Proteus mirabilis. In the absence of Lypd8, bacteria were present in the inner mucus layer and many flagellated bacteria invaded epithelia. Lypd8(-/-) mice were highly sensitive to intestinal inflammation induced by dextran sulfate sodium (DSS). Antibiotic elimination of Gram-negative flagellated bacteria restored the bacterial-free state of the inner mucus layer and ameliorated DSS-induced intestinal inflammation in Lypd8(-/-) mice. Lypd8 bound to flagella and suppressed motility of flagellated bacteria. Thus, Lypd8 mediates segregation of intestinal bacteria and epithelial cells in the colon to preserve intestinal homeostasis.	[Okumura, Ryu; Kurakawa, Takashi; Kayama, Hisako; Kinoshita, Makoto; Kimura, Taishi; Kamiyama, Naganori; Kusu, Takashi; Ueda, Yoshiyasu; Barman, Soumik; Umemoto, Eiji; Takeda, Kiyoshi] Osaka Univ, WPI Immunol Frontier Res Ctr, Grad Sch Med, Lab Immune Regulat,Dept Microbiol & Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Okumura, Ryu; Kayama, Hisako; Kinoshita, Makoto; Barman, Soumik; Umemoto, Eiji; Takeda, Kiyoshi] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Tokyo 1000004, Japan; [Nakano, Takashi; Wu, Hong; Sano, Koichi] Osaka Med Coll, Dept Microbiol & Infect Control, Takatsuki, Osaka 5698686, Japan; [Motooka, Daisuke; Gotoh, Kazuyoshi; Nakamura, Shota; Iida, Tetsuya] Osaka Univ, Microbial Dis Res Inst, Genome Informat Res Ctr, Dept Infect Metagenom, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Gotoh, Kazuyoshi] Okayama Univ, Grad Sch Med, Dept Bacteriol, Okayama 7008558, Japan; [Iijima, Hideki] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Osawa, Hideki; Matsuno, Hiroshi; Nishimura, Junichi] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Dept Cell Physiol, Sapporo, Hokkaido 0608638, Japan; [Iida, Tetsuya] Osaka Univ, Dept Bacterial Infect, Microbial Dis Res Inst, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Yamamoto, Masahiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Microbial Dis Res Inst, Lab Immunoparasitol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka Medical College; Osaka University; Okayama University; Osaka University; Osaka University; Hokkaido University; Osaka University; Osaka University	Takeda, K (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Grad Sch Med, Lab Immune Regulat,Dept Microbiol & Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Takeda, K (corresponding author), Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Tokyo 1000004, Japan.	ktakeda@ongene.med.osaka-u.ac.jp	Nakamura, Shota/E-3033-2010; Umemoto, Eiji/AAX-6562-2021; Barman, Soumik/AAT-3064-2021	Nakamura, Shota/0000-0003-2058-5942; Barman, Soumik/0000-0002-3641-2125; Takeda, Kiyoshi/0000-0002-1778-6332	Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [26293041] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Fujioka, T. Kondo and Y. Magota for technical assistance, T. Oida for generation of mAb, Y. Matsunaga and J. Takagi for the binding assay, S. Pareek for critical reading of the manuscript, and C. Hidaka for secretarial assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, the Japan Agency for Medical Research and Development.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Hansen R, 2011, FEMS IMMUNOL MED MIC, V61, P1, DOI 10.1111/j.1574-695X.2010.00744.x; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kong HK, 2012, BMB REP, V45, P595, DOI 10.5483/BMBRep.2012.45.11.210; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mukherjee S, 2014, NATURE, V505, P103, DOI 10.1038/nature12729; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Zhang YF, 2010, MOL BIOL REP, V37, P2055, DOI 10.1007/s11033-009-9663-7	21	106	110	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					117	+		10.1038/nature17406	http://dx.doi.org/10.1038/nature17406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27027293				2022-12-28	WOS:000373555500045
J	Middlemiss, RP; Samarelli, A; Paul, DJ; Hough, J; Rowan, S; Hammond, GD				Middlemiss, R. P.; Samarelli, A.; Paul, D. J.; Hough, J.; Rowan, S.; Hammond, G. D.			Measurement of the Earth tides with a MEMS gravimeter	NATURE			English	Article							GRAVITY; ERUPTION; VOLCANO; SILICON	The ability to measure tiny variations in the local gravitational acceleration allows, besides other applications, the detection of hidden hydrocarbon reserves, magma build-up before volcanic eruptions, and subterranean tunnels. Several technologies are available that achieve the sensitivities required for such applications (tens of microgal per hertz(1/2)): free-fall gravimeters(1), spring-based gravimeters(2,3), superconducting gravimeters(4), and atom interferometers(5). All of these devices can observe the Earth tides(6): the elastic deformation of the Earth's crust as a result of tidal forces. This is a universally predictable gravitational signal that requires both high sensitivity and high stability over timescales of several days to measure. All present gravimeters, however, have limitations of high cost (more than 100,000 US dollars) and high mass (more than 8 kilograms). Here we present a microelectromechanical system (MEMS) device with a sensitivity of 40 microgal per hertz(1/2) only a few cubic centimetres in size. We use it to measure the Earth tides, revealing the long-term stability of our instrument compared to any other MEMS device. MEMS accelerometers-found in most smart phones(7)-can be mass-produced remarkably cheaply, but none are stable enough to be called a gravimeter. Our device has thus made the transition from accelerometer to gravimeter. The small size and low cost of this MEMS gravimeter suggests many applications in gravity mapping. For example, it could be mounted on a drone instead of low-flying aircraft for distributed land surveying and exploration, deployed to monitor volcanoes, or built into multi-pixel density-contrast imaging arrays.	[Middlemiss, R. P.; Samarelli, A.; Hough, J.; Rowan, S.; Hammond, G. D.] Univ Glasgow, Sch Phys & Astron, SUPA, Kelvin Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland; [Middlemiss, R. P.; Paul, D. J.] Univ Glasgow, Sch Engn, Rankine Bldg,Oakfield Ave, Glasgow G12 8LT, Lanark, Scotland	University of Glasgow; University of Glasgow	Middlemiss, RP; Hammond, GD (corresponding author), Univ Glasgow, Sch Phys & Astron, SUPA, Kelvin Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	richard.middlemiss@glasgow.ac.uk; giles.hammond@glasgow.ac.uk	Middlemiss, Richard/R-1379-2017; Paul, Douglas J/F-7116-2014	Middlemiss, Richard/0000-0002-2095-6750; Paul, Douglas J/0000-0001-7402-8530; Hammond, Giles/0000-0002-1414-3622	Royal Society Paul Instrument Fund; STFC [ST/M000427/1]; Engineering and Physical Sciences Research Council [EP/M01326X/1, EP/N003225/1] Funding Source: researchfish; Science and Technology Facilities Council [Gravitational Waves, ST/M000427/1, ST/N005422/1] Funding Source: researchfish; EPSRC [EP/M01326X/1, EP/N003225/1] Funding Source: UKRI; STFC [Gravitational Waves, ST/N005422/1] Funding Source: UKRI	Royal Society Paul Instrument Fund(Royal Society of London); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The work was funded by the Royal Society Paul Instrument Fund and STFC grant number ST/M000427/1. We thank M. Pitkin for advice on completing statistical significance tests on the data, W. Cunningham for advice on finite element modelling, M. Perreur-Lloyd and R. Jones for their help in rendering three-dimensional images of the apparatus, and the staff and other users of the James Watt Nanofabrication Centre for help and support in undertaking the MEMS fabrication.	ALLAN DW, 1966, PR INST ELECTR ELECT, V54, P221, DOI 10.1109/PROC.1966.4634; Battaglia M, 2008, GEOPHYSICS, V73, pWA3, DOI 10.1190/1.2977792; Bauer-Gottwein P, 2011, IAHS-AISH P, V343, P187; Baxter PJ, 1997, J VOLCANOL GEOTH RES, V77, P325, DOI 10.1016/S0377-0273(96)00103-5; Bell CJ, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/6/065010; Bertolini A, 1999, NUCL INSTRUM METH A, V435, P475, DOI 10.1016/S0168-9002(99)00554-9; BUTLER DK, 1984, GEOPHYSICS, V49, P1084, DOI 10.1190/1.1441723; Carbone L, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/11/115005; Cella G, 2002, NUCL INSTRUM METH A, V487, P652, DOI 10.1016/S0168-9002(01)02193-3; Chin EJ, 2005, PHYS LETT A, V336, P97, DOI 10.1016/j.physleta.2005.01.013; Cho CH, 2009, CURR APPL PHYS, V9, P538, DOI 10.1016/j.cap.2008.03.024; D'Alessandro A, 2013, B SEISMOL SOC AM, V103, P2906, DOI 10.1785/0120120287; de Angelis M, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/2/022001; Essen HH, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002338; FARRELL WE, 1973, PHILOS T R SOC A, V274, P253, DOI 10.1098/rsta.1973.0050; Goodkind JM, 1999, REV SCI INSTRUM, V70, P4131, DOI 10.1063/1.1150092; Jiang Z, 2012, METROLOGIA, V49, P95, DOI 10.1088/0026-1394/49/1/014; Kirkendall B, 2007, IEEE T GEOSCI REMOTE, V45, P1786, DOI 10.1109/TGRS.2007.895427; Krishnamoorthy U, 2008, SENSOR ACTUAT A-PHYS, V145, P283, DOI 10.1016/j.sna.2008.03.017; Laermer Franz, 1996, Google Patents, US Patent, Patent No. [5,501,893, 5501893]; Laine J., 2014, LEAD EDGE, V33, P1234, DOI [10.1190/tle33111234.1, DOI 10.1190/TLE33111234.1]; Lederer M, 2009, ACTA GEODYN GEOMATER, V6, P383; PETERSON JR, 1993, 93322 US GEOL SURV; Pike W. T., 2014, IEEE Sensors 2014. Proceedings, P1599, DOI 10.1109/ICSENS.2014.6985324; Pike W. T., 2013, 2013 Transducers & Eurosensors XXVII: 17th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS & EUROSENSORS XXVII), P622, DOI 10.1109/Transducers.2013.6626843; Pike WT, 2004, MICROELECTRON ENG, V73-4, P340, DOI 10.1016/j.mee.2004.02.064; Poggi MA, 2005, ANAL CHEM, V77, P1192, DOI 10.1021/ac048828h; Riccardi U, 2011, METROLOGIA, V48, P28, DOI 10.1088/0026-1394/48/1/003; Rim H, 2015, GEOPHYSICS, V80, pG1, DOI 10.1190/GEO2013-0394.1; Romaides AJ, 2001, J PHYS D APPL PHYS, V34, P433, DOI 10.1088/0022-3727/34/3/331; Rymer H, 2000, GEOPHYS RES LETT, V27, P2389, DOI 10.1029/1999GL011293; Aparicio SSM, 2014, J GEOPHYS RES-SOL EA, V119, P5033, DOI 10.1002/2013JB010795; Van Camp M, 2005, COMPUT GEOSCI-UK, V31, P631, DOI 10.1016/j.cageo.2004.11.015; Van Camp M, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003497; Watanabe H, 2004, INT J THERMOPHYS, V25, P221, DOI 10.1023/B:IJOT.0000022336.83719.43	37	164	169	14	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					614	+		10.1038/nature17397	http://dx.doi.org/10.1038/nature17397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27029276	Green Accepted			2022-12-28	WOS:000373027400033
J	Barrett, PM; Topol, EJ				Barrett, Paddy M.; Topol, Eric J.			The art of medicine To truly look inside	LANCET			English	Editorial Material									[Barrett, Paddy M.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Scripps Hlth, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute	Topol, EJ (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	etopol@scripps.edu						Blaufox M. D., 2001, EAR CHEST ILLUSTRATE; Khan HA, 2014, AM J MED, V127, pe1; Marwick TH, 2014, JACC-CARDIOVASC IMAG, V7, P1069, DOI 10.1016/j.jcmg.2014.07.008; Mehat M, 2014, JACC-CARDIOVASC IMAG, V7, P983; Reisier SJ, 2009, TECHNOLOGICAL MED CH; The Chirurgeon's Apprentice, 2015, LAENN BAT SHORT HIST	6	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1268	1269		10.1016/S0140-6736(16)30027-7	http://dx.doi.org/10.1016/S0140-6736(16)30027-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27035018				2022-12-28	WOS:000372697500014
J	Whitlock, EP; Burda, BU; Williams, SB; Guirguis-Blake, JM; Evans, CV				Whitlock, Evelyn P.; Burda, Brittany U.; Williams, Selvi B.; Guirguis-Blake, Janelle M.; Evans, Corinne V.			Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							LOW-DOSE ASPIRIN; SEROTONIN REUPTAKE INHIBITORS; CARDIOVASCULAR EVENTS; ACETYLSALICYLIC-ACID; ANTIINFLAMMATORY DRUGS; GENERAL-POPULATION; RANDOMIZED-TRIAL; CANCER INCIDENCE; ALTERNATE-DAY; DISEASE	Background: The balance between potential aspirin-related risks and benefits is critical in primary prevention. Purpose: To evaluate the risk for serious bleeding with regular aspirin use in cardiovascular disease (CVD) primary prevention. Data Sources: PubMed, MEDLINE, Cochrane Central Register of Controlled Trials (2010 through 6 January 2015), and relevant references from other reviews. Study Selection: Randomized, controlled trials; cohort studies; and meta-analyses comparing aspirin with placebo or no treatment to prevent CVD or cancer in adults. Data Extraction: One investigator abstracted data, another checked for accuracy, and 2 assessed study quality. Data Synthesis: In CVD primary prevention studies, very-low-dose aspirin use (<= 100 mg daily or every other day) increased major gastrointestinal (GI) bleeding risk by 58% (odds ratio [OR], 1.58 [95% CI, 1.29 to 1.95]) and hemorrhagic stroke risk by 27% (OR, 1.27 [CI, 0.96 to 1.68]). Projected excess bleeding events with aspirin depend on baseline assumptions. Estimated excess major bleeding events were 1.39 (CI, 0.70 to 2.28) for GI bleeding and 0.32 (CI, -0.05 to 0.82) for hemorrhagic stroke per 1000 person-years of aspirin exposure using baseline bleeding rates from a community-based observational sample. Such events could be greater among older persons, men, and those with CVD risk factors that also increase bleeding risk. Limitations: Power to detect effects on hemorrhagic stroke was limited. Harms other than serious bleeding were not examined. Conclusion: Consideration of the safety of primary prevention with aspirin requires an individualized assessment of aspirin's effects on bleeding risks and expected benefits because absolute bleeding risk may vary considerably by patient.	[Whitlock, Evelyn P.] Kaiser Permanente Res Affiliates, Evidence Based Practice Ctr, Portland, OR USA; [Burda, Brittany U.; Williams, Selvi B.; Evans, Corinne V.] Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA; Univ Washington, Seattle, WA 98195 USA; [Whitlock, Evelyn P.] Patient Ctr Outcomes Res Inst, 1828 L St,Northwest,Suite 900, Washington, DC 20036 USA; [Guirguis-Blake, Janelle M.] Univ Washington, Dept Family Med, Tacoma Family Med Residency Program, 521 Martin Luther King Jr Way, Tacoma, WA 98405 USA	Kaiser Permanente; Kaiser Permanente; University of Washington; University of Washington Seattle; University of Washington; University of Washington Tacoma	Whitlock, EP (corresponding author), Kaiser Permanente Res Affiliates, Evidence Based Practice Ctr, Portland, OR USA.; Whitlock, EP (corresponding author), Patient Ctr Outcomes Res Inst, 1828 L St,Northwest,Suite 900, Washington, DC 20036 USA.				AHRQ [HHS-290-2012-00151-I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract HHS-290-2012-00151-I from AHRQ.	Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Brotons C, 2015, AM J CARDIOVASC DRUG, V15, P113, DOI 10.1007/s40256-014-0100-5; Chubak J, 2014, AHRQ PUBLICATION, V15-05228-EF-1; Chubak J, 2016, ANN INTERN MED, V164, P814, DOI 10.7326/M15-2117; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; de Abajo FJ, 2013, EUR J CLIN PHARMACOL, V69, P691, DOI 10.1007/s00228-012-1386-3; de Abajo FJ, 2011, DRUG AGING, V28, P345, DOI 10.2165/11589340-000000000-00000; De Berardis G, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-21; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; Dehmer SP, 2015, AHRQ PUBLICATION, V15-05229-EF-1; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Dumbleton JS, 2015, EBIOMEDICINE, V2, P1200, DOI 10.1016/j.ebiom.2015.07.012; Ekstrom N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002688; Elwood PC, 2013, CURR COLORECT CANC R, V9, P9, DOI 10.1007/s11888-012-0149-y; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Freedman JE, 2012, CIRCULATION, V125, pE548, DOI 10.1161/CIRCULATIONAHA.112.104224; Rodriguez LAG, 2011, CIRCULATION, V123, P1108, DOI 10.1161/CIRCULATIONAHA.110.973008; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Grimm RH, 2013, CONTEMP CLIN TRIALS, V36, P555, DOI 10.1016/j.cct.2013.09.014; Guirguis-Blake JM, 2016, ANN INTERN MED, V164, P804, DOI 10.7326/M15-2113; Guirguis-Blake JM, 2015, AHRQ PUBLICATION, V13-05195-EF-1; Halvorsen S, 2014, J AM COLL CARDIOL, V64, P319, DOI 10.1016/j.jacc.2014.03.049; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hedberg J, 2013, J INTERN MED, V274, P371, DOI 10.1111/joim.12103; Henderson N, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.300; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hernandez-Diaz S, 2002, J CLIN EPIDEMIOL, V55, P157, DOI 10.1016/S0895-4356(01)00461-9; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Hreinsson JP, 2013, SCAND J GASTROENTERO, V48, P439, DOI 10.3109/00365521.2012.763174; Huang ES, 2011, AM J MED, V124, P426, DOI 10.1016/j.amjmed.2010.12.022; Huang ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015721; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; Iso H, 1999, STROKE, V30, P1764, DOI 10.1161/01.STR.30.9.1764; Iwamoto J, 2013, WORLD J GASTROENTERO, V19, P1673, DOI 10.3748/wjg.v19.i11.1673; Kvasnovsky CL, 2014, COLORECTAL DIS, V16, pO189, DOI 10.1111/codi.12516; Lanas A, 2006, GUT, V55, P1731, DOI 10.1136/gut.2005.080754; Lanas A, 2013, ALIMENT PHARM THER, V37, P738, DOI 10.1111/apt.12240; Lanas A, 2011, CLIN GASTROENTEROL H, V9, P762, DOI 10.1016/j.cgh.2011.05.020; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Lin KJ, 2014, CIRC-CARDIOVASC QUAL, V7, P70, DOI 10.1161/CIRCOUTCOMES.113.000494; Meade TW, 1998, LANCET, V351, P233; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Patrono C, 2013, EUR HEART J, V34, P3403, DOI 10.1093/eurheartj/eht058; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Shah NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124653; Shiotani A, 2008, J GASTROENTEROL, V43, P581, DOI 10.1007/s00535-008-2206-5; Strate LL, 2005, GASTROENTEROL CLIN N, V34, P643, DOI 10.1016/j.gtc.2005.08.007; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Targownik LE, 2009, AM J GASTROENTEROL, V104, P1475, DOI 10.1038/ajg.2009.128; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Valkhoff VE, 2013, CAN J GASTROENTEROL, V27, P159, DOI 10.1155/2013/596015; van Kruijsdijk RCM, 2015, HEART, V101, P369, DOI 10.1136/heartjnl-2014-306342; Wells G., NEWCASTLE OTTAWA SCA; Whitlock EP, 2015, AHRQ PUBLICATION, V13-05193-EF-1; Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009	62	158	166	2	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					826	U92		10.7326/M15-2112	http://dx.doi.org/10.7326/M15-2112			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27064261				2022-12-28	WOS:000379343000016
J	Thompson, M; Walter, F				Thompson, Matthew; Walter, Fiona			Increases in general practice workload in England	LANCET			English	Editorial Material							POPULATION; BURNOUT; GPS		[Thompson, Matthew] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Walter, Fiona] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	University of Washington; University of Washington Seattle; University of Cambridge	Thompson, M (corresponding author), Univ Washington, Dept Family Med, Seattle, WA 98195 USA.	mjt@uw.edu	Walter, Fiona/F-3054-2014; Walter, Fiona/GYR-1347-2022	Walter, Fiona/0000-0002-7191-6476				Dale J, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0363-1; Doran N, 2016, BRIT J GEN PRACT, V66, pE128, DOI 10.3399/bjgp16X683425; Elnegaard S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2034-5; Everington S, 2016, BMJ-BRIT MED J, V352, P1942; Gibson J, 2015, EIGHT NATIONAL GP WO; Gill PJ, 2013, ARCH DIS CHILD, V98, P328, DOI 10.1136/archdischild-2012-302383; Hann M., 2013, 7 NATL GP WORKLIFE S; Hobbs FDR, 2016, LANCET, V387, P2323, DOI 10.1016/S0140-6736(16)00620-6; Mahony C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g126; NHS England, 2016, GEN PRACT WORKF ACT; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sinsky CA, 2013, ANN FAM MED, V11, P272, DOI 10.1370/afm.1531; Soler JK, 2008, FAM PRACT, V25, P245, DOI 10.1093/fampra/cmn038	13	25	25	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2270	2272		10.1016/S0140-6736(16)00743-1	http://dx.doi.org/10.1016/S0140-6736(16)00743-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN3NN	27059885	hybrid			2022-12-28	WOS:000376969100007
J	Thourani, VH; Kodali, S; Makkar, RR; Herrmann, HC; Williams, M; Babaliaros, V; Smalling, R; Lim, S; Malaisrie, SC; Kapadia, S; Szeto, WY; Greason, KL; Kereiakes, D; Ailawadi, G; Whisenant, BK; Devireddy, C; Leipsic, J; Hahn, RT; Pibarot, P; Weissman, NJ; Jaber, WA; Cohen, DJ; Suri, R; Tuzcu, EM; Svensson, LG; Webb, JG; Moses, JW; Mack, MJ; Miller, DC; Smith, CR; Alu, MC; Parvataneni, R; D'Agostino, RB; Leon, MB				Thourani, Vinod H.; Kodali, Susheel; Makkar, Raj R.; Herrmann, Howard C.; Williams, Mathew; Babaliaros, Vasilis; Smalling, Richard; Lim, Scott; Malaisrie, S. Chris; Kapadia, Samir; Szeto, Wilson Y.; Greason, Kevin L.; Kereiakes, Dean; Ailawadi, Gorav; Whisenant, Brian K.; Devireddy, Chandan; Leipsic, Jonathon; Hahn, Rebecca T.; Pibarot, Philippe; Weissman, Neil J.; Jaber, Wael A.; Cohen, David J.; Suri, Rakesh; Tuzcu, E. Murat; Svensson, Lars G.; Webb, John G.; Moses, Jeffrey W.; Mack, Michael J.; Miller, D. Craig; Smith, Craig R.; Alu, Maria C.; Parvataneni, Rupa; D'Agostino, Ralph B., Jr.; Leon, Martin B.			Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis	LANCET			English	Article							TRANSFEMORAL TRANSCATHETER; CLINICAL-OUTCOMES; STENOSIS; IMPLANTATION	Background Transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 valve demonstrates good 30 day clinical outcomes in patients with severe aortic stenosis who are at intermediate risk of surgical mortality. Here we report longer-term data in intermediate-risk patients given SAPIEN 3 TAVR and compare outcomes to those of intermediate-risk patients given surgical aortic valve replacement. Methods In the SAPIEN 3 observational study, 1077 intermediate-risk patients at 51 sites in the USA and Canada were assigned to receive TAVR with the SAPIEN 3 valve [952 [88%] via transfemoral access) between Feb 17, 2014, and Sept 3, 2014. In this population we assessed all-cause mortality and incidence of strokes, re-intervention, and aortic valve regurgitation at 1 year after implantation. Then we compared 1 year outcomes in this population with those for intermediate-risk patients treated with surgical valve replacement in the PARTNER 2A trial between Dec 23, 2011, and Nov 6, 2013, using a prespecified propensity score analysis to account for between-trial differences in baseline characteristics. The clinical events committee and echocardiographic core laboratory methods were the same for both studies. The primary endpoint was the composite of death from any cause, all strokes, and incidence of moderate or severe aortic regurgitation. We did non-inferiority (margin 7.5%) and superiority analyses in propensity score quintiles to calculate pooled weighted proportion differences for outcomes. Findings At 1 year follow-up of the SAPIEN 3 observational study, 79 of 1077 patients who initiated the TAVR procedure had died (all-cause mortality 7.4%; 6.5% in the transfemoral access subgroup), and disabling strokes had occurred in 24 (2%), aortic valve re-intervention in six (1%), and moderate or severe paravalvular regurgitation in 13 (2%). In the propensity-score analysis we included 963 patients treated with SAPIEN 3 TAVR and 747 with surgical valve replacement. For the primary composite endpoint of mortality, strokes, and moderate or severe aortic regurgitation, TAVR was both non-inferior (pooled weighted proportion difference of -9.2%; 90% CI -12.4 to -6; p<0.0001) and superior (-9.2%, 95% CI -13.0 to -5.4; p<0.0001) to surgical valve replacement. Interpretation TAVR with SAPIEN 3 in intermediate-risk patients with severe aortic stenosis is associated with low mortality, strokes, and regurgitation at 1 year. The propensity score analysis indicates a significant superiority for our composite outcome with TAVR compared with surgery, suggesting that TAVR might be the preferred treatment alternative in intermediate-risk patients.	[Thourani, Vinod H.; Babaliaros, Vasilis; Devireddy, Chandan] Emory Univ, Sch Med, Atlanta, GA USA; [Kodali, Susheel; Hahn, Rebecca T.; Moses, Jeffrey W.; Smith, Craig R.; Alu, Maria C.; Leon, Martin B.] Columbia Univ, Med Ctr, New York, NY USA; [Makkar, Raj R.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Herrmann, Howard C.; Szeto, Wilson Y.] Univ Penn, Philadelphia, PA 19104 USA; [Williams, Mathew] NYU Langone Med Ctr, New York, NY USA; [Smalling, Richard] Univ Texas Mem Hermann Heart & Vasc Inst, Houston, TX USA; [Lim, Scott; Ailawadi, Gorav] Univ Virginia, Charlottesville, VA USA; [Malaisrie, S. Chris] Northwestern Univ, Chicago, IL 60611 USA; [Kapadia, Samir; Jaber, Wael A.; Suri, Rakesh; Tuzcu, E. Murat; Svensson, Lars G.] Cleveland Clin, Cleveland, OH 44106 USA; [Greason, Kevin L.] Mayo Clin, Rochester, MN USA; [Kereiakes, Dean] Christ Hosp, Cincinnati, OH 45219 USA; [Whisenant, Brian K.] Intermt Med Ctr, Salt Lake City, UT USA; [Leipsic, Jonathon; Webb, John G.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Pibarot, Philippe] Univ Laval, Quebec City, PQ, Canada; [Weissman, Neil J.] Medstar Hlth Res Inst, Washington, DC USA; [Weissman, Neil J.] Georgetown Univ, Washington, DC USA; [Cohen, David J.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Mack, Michael J.] Baylor Scott & White Healthcare, Plano, TX USA; [Miller, D. Craig] Stanford Univ, Stanford, CA 94305 USA; [Parvataneni, Rupa] Cardiovasc Res Fdn, New York, NY USA; [D'Agostino, Ralph B., Jr.] Wake Forest Sch Med, Winston Salem, NC USA	Emory University; Columbia University; Cedars Sinai Medical Center; University of Pennsylvania; NYU Langone Medical Center; University of Virginia; Northwestern University; Cleveland Clinic Foundation; Mayo Clinic; Christ Hospital - Ohio; Intermountain Healthcare; Intermountain Medical Center; St. Paul's Hospital; University of Saskatchewan; Laval University; MedStar Health Research Institute; Georgetown University; Saint Luke's Mid America Heart Institute; Baylor Health Care System; Stanford University; Cardiovascular Research Foundation (CRF); Wake Forest University	Thourani, VH (corresponding author), Emory Hosp Midtown, Atlanta, GA 30308 USA.	vthoura@emory.edu	Cohen, David/AAF-1648-2019; Doğan, Ali/AAN-5331-2020; Hahn, Rebecca/ABE-6221-2020; Dagostino, Ralph/C-4060-2017; Pibarot, Philippe/ABD-5300-2021; Leipsic, Jonathon/ABE-6194-2020; thourani, vinod/AAP-5968-2020; Jaber, Wael/Y-4713-2019	Dagostino, Ralph/0000-0002-3550-8395; Williams, Mathew/0000-0003-2055-8741; Miller, D. Craig/0000-0001-7619-0080	Edwards Lifesciences; National Heart, Lung, and Blood Institute [R01 HL67025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067025] Funding Source: NIH RePORTER	Edwards Lifesciences; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Edwards Lifesciences sponsored the PARTNER 2A and SAPIEN 3 trials and, alongside the executive committee, collaboratively designed both studies. Edwards Lifesciences funded both studies, participated in the selection and management of sites, and monitored the data. Edwards Lifesciences was not directly involved in the drafting of this manuscript. DCM is supported by National Heart, Lung, and Blood Institute research grant R01 HL67025.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Athappan G, 2014, J AM COLL CARDIOL, V63, P2101, DOI 10.1016/j.jacc.2014.02.540; Blackstone EH, 2015, CIRCULATION, V131, P1989, DOI 10.1161/CIRCULATIONAHA.114.012525; D'Agostino RB, 2007, CIRCULATION, V115, P2340, DOI 10.1161/CIRCULATIONAHA.105.594952; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Holmes DR, 2015, J AM COLL CARDIOL, V66, P2813, DOI 10.1016/j.jacc.2015.10.021; Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2; Kappetein AP, 2012, EUR HEART J, V33, P2403, DOI 10.1093/eurheartj/ehs255; Kodali S, 2016, EUR HEART J, V37, P2252, DOI 10.1093/eurheartj/ehw112; Kodali S, 2015, EUR HEART J, V36, P449, DOI 10.1093/eurheartj/ehu384; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Latib A, 2012, AM HEART J, V164, P910, DOI 10.1016/j.ahj.2012.09.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Leon MB, 2016, AM COLL CARD ACC SCI; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Manoharan G, 2015, JACC-CARDIOVASC INTE, V8, P1359, DOI 10.1016/j.jcin.2015.05.015; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Mohr FW, 2014, EUR J CARDIO-THORAC, V46, P808, DOI 10.1093/ejcts/ezu290; Piazza N, 2013, JACC-CARDIOVASC INTE, V6, P443, DOI 10.1016/j.jcin.2013.01.136; Pibarot P, 2015, JACC-CARDIOVASC IMAG, V8, P340, DOI 10.1016/j.jcmg.2015.01.008; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2015, J AM COLL CARDIOL, V66, P804, DOI 10.1016/j.jacc.2015.06.013; Thourani VH, 2015, ANN THORAC SURG, V99, P55, DOI 10.1016/j.athoracsur.2014.06.050; Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Webb JG, 2015, JACC-CARDIOVASC INTE, V8, P1797, DOI 10.1016/j.jcin.2015.08.017; Wenaweser P, 2013, EUR HEART J, V34, P1894, DOI 10.1093/eurheartj/eht086	29	717	737	2	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2218	2225		10.1016/S0140-6736(16)30073-3	http://dx.doi.org/10.1016/S0140-6736(16)30073-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27053442				2022-12-28	WOS:000376820800031
J	Swedberg, K; Borer, JS; Pitt, B; Pocock, S; Rouleau, J				Swedberg, Karl; Borer, Jeffrey S.; Pitt, Bertram; Pocock, Stuart; Rouleau, Jean			Challenges to Data Monitoring Committees When Regulatory Authorities Intervene	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEART-FAILURE; TRIAL; ALISKIREN; CANDESARTAN; EXPERIENCE; MORTALITY; OUTCOMES		[Swedberg, Karl] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Swedberg, Karl] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Pocock, Stuart] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Borer, Jeffrey S.] Suny Downstate Med Ctr, Howard Gilman Inst Heart Valve Dis, Div Cardiovasc Med, New York, NY USA; [Borer, Jeffrey S.] Suny Downstate Med Ctr, Schiavone Inst Cardiovasc Translat Res, New York, NY USA; [Pitt, Bertram] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Rouleau, Jean] Univ Montreal, Inst Cardiol Montreal, Montreal, PQ, Canada	University of Gothenburg; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Michigan System; University of Michigan; Universite de Montreal; Institut de Cardiologie de Montreal	Swedberg, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden.; Swedberg, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England.		Swedberg, Karl/B-2475-2008					Borer JS, 2008, JAMA-J AM MED ASSOC, V299, P1710, DOI 10.1001/jama.299.14.1710; Canada H., 2003, GUID DOC CLIN TRIAL; DeMets David L, 2004, Clin Trials, V1, P525, DOI 10.1191/1740774504cn54oa; DeMets DL, 2006, CLIN TRIALS, V3, P142, DOI 10.1191/1740774506cn137oa; European Medicines Agency, 2005, GUID DAT MON COMM; Gheorghiade M, 2013, JAMA-J AM MED ASSOC, V309, P1125, DOI 10.1001/jama.2013.1954; Krum H, 2011, EUR J HEART FAIL, V13, P107, DOI 10.1093/eurjhf/hfq212; Maggioni AP, 2013, EUR HEART J, V34, P3117, DOI 10.1093/eurheartj/eht342; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2016, NEW ENGL J MED, V374, P1521, DOI 10.1056/NEJMoa1514859; National Institutes of Health, 2002, DRAFT GUID EST OP DA; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Pocock S, 2005, AM HEART J, V149, P939, DOI 10.1016/j.ahj.2004.10.038; Pocock S, 2004, EUR HEART J, V25, P1974, DOI 10.1016/j.ehj.2004.09.015; Salmonson T, 2016, NEW ENGL J MED, V374, P1585, DOI 10.1056/NEJMc1603514; Tougas G, 2016, NEW ENGL J MED, V374, P1586, DOI 10.1056/NEJMc1603515; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	17	10	10	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1580	1584		10.1056/NEJMsb1601674	http://dx.doi.org/10.1056/NEJMsb1601674			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ7IA	27043879	Green Published			2022-12-28	WOS:000374383900015
J	Swinstead, EE; Miranda, TB; Paakinaho, V; Baek, S; Goldstein, I; Hawkins, M; Karpova, TS; Ball, D; Mazza, D; Lavis, LD; Grimm, JB; Morisaki, T; Grontved, L; Presman, DM; Hager, GL				Swinstead, Erin E.; Miranda, Tina B.; Paakinaho, Ville; Baek, Songjoon; Goldstein, Ido; Hawkins, Mary; Karpova, Tatiana S.; Ball, David; Mazza, Davide; Lavis, Luke D.; Grimm, Jonathan B.; Morisaki, Tatsuya; Grontved, Lars; Presman, Diego M.; Hager, Gordon L.			Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions	CELL			English	Article							TRANSCRIPTION FACTOR; GLUCOCORTICOID-RECEPTOR; IN-VIVO; BINDING; ESTROGEN; REVEALS; CELL; ACCESSIBILITY; ALPHA; GENE	The estrogen receptor (ER), glucocorticoid receptor (GR), and forkhead box protein 1 (FoxA1) are significant factors in breast cancer progression. FoxA1 has been implicated in establishing ER-binding patterns though its unique ability to serve as a pioneer factor. However, the molecular interplay between ER, GR, and FoxA1 requires further investigation. Here we show that ER and GR both have the ability to alter the genomic distribution of the FoxA1 pioneer factor. Single-molecule tracking experiments in live cells reveal a highly dynamic interaction of FoxA1 with chromatin in vivo. Furthermore, the FoxA1 factor is not associated with detectable footprints at its binding sites throughout the genome. These findings support a model wherein interactions between transcription factors and pioneer factors are highly dynamic. Moreover, at a subset of genomic sites, the role of pioneer can be reversed, with the steroid receptors serving to enhance binding of FoxA1.	[Swinstead, Erin E.; Miranda, Tina B.; Paakinaho, Ville; Baek, Songjoon; Goldstein, Ido; Hawkins, Mary; Karpova, Tatiana S.; Ball, David; Morisaki, Tatsuya; Grontved, Lars; Presman, Diego M.; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bldg 41,41 Lib Dr, Bethesda, MD 20892 USA; [Mazza, Davide] Osped San Raffaele, Ist Sci, Ctr Imaging Sperimentale, I-20132 Milan, Italy; [Mazza, Davide] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Lavis, Luke D.; Grimm, Jonathan B.] Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA; [Morisaki, Tatsuya] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Grontved, Lars] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Howard Hughes Medical Institute; Colorado State University; University of Southern Denmark	Hager, GL (corresponding author), NCI, Lab Receptor Biol & Gene Express, NIH, Bldg 41,41 Lib Dr, Bethesda, MD 20892 USA.	hagerg@exchange.nih.gov	Goldstein, Ido/Y-6554-2019; Mazza, Davide/R-5340-2016; Presman, Diego Martín/Y-6750-2019	Goldstein, Ido/0000-0003-0139-1499; Mazza, Davide/0000-0003-2776-4142; Presman, Diego Martín/0000-0003-4515-8058; Karpova, Tatiana/0000-0001-6025-2128; Lavis, Luke/0000-0002-0789-6343; Paakinaho, Ville/0000-0003-4204-1436; Grontved, Lars/0000-0002-6735-8483; Morisaki, Tatsuya/0000-0001-7401-4673	NIH, NCI, Center for Cancer Research; Howard Hughes Medical Institute; Australian Postgraduate Award; National Institute of General Medical Sciences Pharmacological Research and Training Fellowship; Sigrid Juselius Foundation; Marie Curie International Incoming Fellowship [GA: 27432]; Japan Society for the Promotion of Science; Danish Research Council; SDU2020; NATIONAL CANCER INSTITUTE [ZICBC011571, ZIABC005450] Funding Source: NIH RePORTER; Lundbeck Foundation [R194-2015-1060] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0013333] Funding Source: researchfish; Villum Fonden [00007292] Funding Source: researchfish	NIH, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Australian Postgraduate Award(Australian Government); National Institute of General Medical Sciences Pharmacological Research and Training Fellowship; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Marie Curie International Incoming Fellowship(European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Danish Research Council(Det Frie Forskningsrad (DFF)); SDU2020; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); Villum Fonden(Villum Fonden)	The authors thank the National Cancer Institute Advanced Technology Program Sequencing Facility for sequencing services. The research was supported, in part, by the Intramural Research Program of the NIH, NCI, Center for Cancer Research and the Howard Hughes Medical Institute. E.E.S. was supported, in part, by an Australian Postgraduate Award. T.B.M. was supported, in part, by a National Institute of General Medical Sciences Pharmacological Research and Training Fellowship. V.P. was supported, in part, by the Sigrid Juselius Foundation. D.M. was supported, in part, by a Marie Curie International Incoming Fellowship (GA: 27432). T.M. was supported, in part, by the Japan Society for the Promotion of Science. L.G. was supported by the Danish Research Council and SDU2020. The authors declare the following competing financial interests: J.B.G. and L.D.L. have filed patent applications on the Janelia Fluor dyes, such as JF549, whose value may be affected by this publication.	Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Caizzi L, 2014, P NATL ACAD SCI USA, V111, P4892, DOI 10.1073/pnas.1315445111; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; CHURCH GM, 1985, NATURE, V313, P798, DOI 10.1038/313798a0; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Grontved L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8048; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; He HH, 2014, NAT METHODS, V11, P73, DOI [10.1038/NEMTH.2762, 10.1038/nmeth.2762]; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kassabov SR, 2002, MOL CELL BIOL, V22, P7524, DOI 10.1128/MCB.22.21.7524-7534.2002; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Li M, 2015, ELIFE, V4, DOI 10.7554/eLife.06249; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McKnight JN, 2011, MOL CELL BIOL, V31, P4746, DOI 10.1128/MCB.05735-11; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Miranda TB, 2013, CANCER RES, V73, P5130, DOI 10.1158/0008-5472.CAN-13-0742; Morisaki T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5456; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Siersbaek R, 2014, CELL REP, V7, P1434, DOI 10.1016/j.celrep.2014.04.043; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Yamaguchi N, 2008, BIOCHEM BIOPH RES CO, V365, P711, DOI 10.1016/j.bbrc.2007.11.064; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	47	184	186	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					593	605		10.1016/j.cell.2016.02.067	http://dx.doi.org/10.1016/j.cell.2016.02.067			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27062924	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000374636800018
J	Aronson, FR				Aronson, Frederick R.			Ibrutinib increased survival more than chlorambucil in older patients with untreated chronic lymphocytic leukemia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Aronson, Frederick R.] New England Canc Specialists, Scarborough, ME USA		Aronson, FR (corresponding author), New England Canc Specialists, Scarborough, ME USA.							Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Hillmen P, 2015, LANCET, V385, P1873, DOI 10.1016/S0140-6736(15)60027-7; Woyach JA, 2013, J CLIN ONCOL, V31, P440, DOI 10.1200/JCO.2011.41.5646	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					JC44	JC44		10.7326/ACPJC-2016-164-8-044	http://dx.doi.org/10.7326/ACPJC-2016-164-8-044			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	27089094				2022-12-28	WOS:000374257900006
J	Ghogawala, Z; Dziura, J; Butler, WE; Dai, F; Terrin, N; Magge, SN; Coumans, JVCE; Harrington, JF; Amin-Hanjani, S; Schwartz, JS; Sonntag, VKH; Barker, FG; Benzel, EC				Ghogawala, Zoher; Dziura, James; Butler, William E.; Dai, Feng; Terrin, Norma; Magge, Subu N.; Coumans, Jean-Valery C. E.; Harrington, J. Fred; Amin-Hanjani, Sepideh; Schwartz, J. Sanford; Sonntag, Volker K. H.; Barker, Fred G., II; Benzel, Edward C.			Laminectomy plus Fusion versus Laminectomy Alone for Lumbar Spondylolisthesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOMES RESEARCH TRIAL; LOW-BACK-PAIN; DEGENERATIVE SPONDYLOLISTHESIS; SPINAL STENOSIS; REOPERATION RATES; GUIDELINE UPDATE; COST-UTILITY; DECOMPRESSION; PERFORMANCE; RATIONALE	BACKGROUND The comparative effectiveness of performing instrumented (rigid pedicle screws affixed to titanium alloy rods) lumbar spinal fusion in addition to decompressive laminectomy in patients with symptomatic lumbar grade I degenerative spondylolisthesis with spinal stenosis is unknown. METHODS In this randomized, controlled trial, we assigned patients, 50 to 80 years of age, who had stable degenerative spondylolisthesis (degree of spondylolisthesis, 3 to 14 mm) and symptomatic lumbar spinal stenosis to undergo either decompressive laminectomy alone (decompression-alone group) or laminectomy with posterolateral instrumented fusion (fusion group). The primary outcome measure was the change in the physical-component summary score of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36; range, 0 to 100, with higher scores indicating better quality of life) 2 years after surgery. The secondary outcome measure was the score on the Oswestry Disability Index (range, 0 to 100, with higher scores indicating more disability related to back pain). Patients were followed for 4 years. RESULTS A total of 66 patients (mean age, 67 years; 80% women) underwent randomization. The rate of follow-up was 89% at 1 year, 86% at 2 years, and 68% at 4 years. The fusion group had a greater increase in SF-36 physical-component summary scores at 2 years after surgery than did the decompression-alone group (15.2 vs. 9.5, for a difference of 5.7; 95% confidence interval, 0.1 to 11.3; P = 0.046). The increases in the SF-36 physical-component summary scores in the fusion group remained greater than those in the decompression-alone group at 3 years and at 4 years (P = 0.02 for both years). With respect to reductions in disability related to back pain, the changes in the Oswestry Disability Index scores at 2 years after surgery did not differ significantly between the study groups (-17.9 in the decompression-alone group and -26.3 in the fusion group, P = 0.06). More blood loss and longer hospital stays occurred in the fusion group than in the decompression-alone group (P< 0.001 for both comparisons). The cumulative rate of reoperation was 14% in the fusion group and 34% in the decompression-alone group (P = 0.05). CONCLUSIONS Among patients with degenerative grade I spondylolisthesis, the addition of lumbar spinal fusion to laminectomy was associated with slightly greater but clinically meaningful improvement in overall physical health-related quality of life than laminectomy alone.	[Ghogawala, Zoher; Magge, Subu N.] Lahey Hosp & Med Ctr, Dept Neurosurg, Alan L & Jacqueline B Stuart Spine Res Ctr, Burlington, MA 01805 USA; [Butler, William E.; Coumans, Jean-Valery C. E.; Barker, Fred G., II] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Terrin, Norma] Tufts Univ, Sch Med, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Ghogawala, Zoher] Greenwich Hosp, Wallace Trials Ctr, Greenwich, CT USA; [Dziura, James; Dai, Feng] Yale Univ, Sch Publ Hlth, Yale Ctr Analyt Sci, New Haven, CT USA; [Harrington, J. Fred] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Amin-Hanjani, Sepideh] Univ Illinois, Dept Neurosurg, Chicago, IL USA; [Schwartz, J. Sanford] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Wharton Sch Business, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Leonard Davis Inst, Philadelphia, PA 19104 USA; [Sonntag, Volker K. H.] Barrow Neurol Inst, Barrow Neurosurg Associates, Phoenix, AZ 85013 USA; [Benzel, Edward C.] Cleveland Clin Fdn, Ctr Spine Hlth, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Benzel, Edward C.] Cleveland Clin Fdn, Dept Neurosurg, 9500 Euclid Ave, Cleveland, OH 44195 USA	Lahey Hospital & Medical Center; Harvard University; Massachusetts General Hospital; Tufts University; Yale University; University of New Mexico; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Barrow Neurological Institute; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ghogawala, Z (corresponding author), Lahey Hosp & Med Ctr, Dept Neurosurg, 41 Mall Rd, Burlington, MA 01805 USA.	zoher.ghogawala@lahey.org			Jean and David Wallace Foundation [GH 382]; Greenwich Lumbar Stenosis SLIP Study Fund [GH 384]; Stephanie and Lawrence Flinn, Jr. Charitable Trust	Jean and David Wallace Foundation; Greenwich Lumbar Stenosis SLIP Study Fund; Stephanie and Lawrence Flinn, Jr. Charitable Trust	Supported by research grants from the Jean and David Wallace Foundation (GH 382) and the Greenwich Lumbar Stenosis SLIP Study Fund (GH 384), which was established by Lucinda B. Watson with support from the Stephanie and Lawrence Flinn, Jr. Charitable Trust and James and Elizabeth Li, and by Alan and Jacqueline Stuart, who provided funds to create a Spine Outcomes Research Center at Lahey Hospital and Medical Center to complete the analysis of the SLIP trial results.	Abdu WA, 2009, SPINE, V34, P2351, DOI 10.1097/BRS.0b013e3181b8a829; Alimi M, 2015, J NEUROSURG-SPINE, V22, P339, DOI 10.3171/2014.11.SPINE13597; Blumenthal C, 2013, J NEUROSURG-SPINE, V18, P340, DOI 10.3171/2013.1.SPINE12537; Brodke DS, 2013, SPINE, V38, P2287; Chang HS, 2014, SPINE, V39, P400; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81; Fairbank JC, 1980, PHYSIOTHERAPY, V66, P271; Forsth P, 2016, NEW ENGL J MED, V374, P1413, DOI 10.1056/NEJMoa1513721; Ghogawala Z, 2004, J NEUROSURG-SPINE, V1, P267, DOI 10.3171/spi.2004.1.3.0267; Ghogawala Z, 2015, ANN SURG; Ghogawala Z, 2014, NEUROSURGERY, V75, P334, DOI 10.1227/NEU.0000000000000479; Ghogawala Z, 2014, J NEUROSURG-SPINE, V21, P7, DOI 10.3171/2014.4.SPINE14258; Hagg O, 2003, EUR SPINE J, V12, P12, DOI 10.1007/s00586-002-0464-0; HAMANISHI C, 1994, J SPINAL DISORD, V7, P388; Hedeker D., 2006, LONGITUDINAL DATA AN; HERKOWITZ HN, 1991, J BONE JOINT SURG AM, V73A, P802, DOI 10.2106/00004623-199173060-00002; Kelleher MO, 2010, SPINE, V35, pE981, DOI 10.1097/BRS.0b013e3181c46fb4; Kepler CK, 2014, SPINE, V39, P1584, DOI 10.1097/BRS.0000000000000486; Kim S, 2012, SPINE J, V12, P44, DOI 10.1016/j.spinee.2011.10.004; KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009; Martin BI, 2007, SPINE, V32, P382, DOI 10.1097/01.brs.0000254104.55716.46; Radcliff K, 2012, J BONE JOINT SURG AM, V94A, P1685, DOI 10.2106/JBJS.K.00952; Rampersaud YR, 2014, CAN J SURG, V57, pE126, DOI 10.1503/cjs.032213; Resnick DK, 2014, J NEUROSURG-SPINE, V21, P54, DOI 10.3171/2014.4.SPINE14274; Schroeder GD, 2015, SPINE, V40, pE1161, DOI 10.1097/BRS.0000000000001116; Soegaard R, 2007, SPINE, V32, P2405, DOI 10.1097/BRS.0b013e3181573b2d; The SAS Institute, 2013, SAS VERS 9 4; Ware JE, 2001, SF 36 PHYS MENTAL HL; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302	30	413	431	6	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1424	1434		10.1056/NEJMoa1508788	http://dx.doi.org/10.1056/NEJMoa1508788			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27074067	Bronze			2022-12-28	WOS:000374128400006
J	Mock, DW				Mock, Douglas W.			ANIMAL BEHAVIOUR Some begging is actually bragging	NATURE			English	Editorial Material							NEED		[Mock, Douglas W.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Mock, DW (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	dmock@ou.edu						Caro S. M., 2016, NATURE COMMUN; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Mock DW, 2011, BEHAV ECOL, V22, P909, DOI 10.1093/beheco/arr091; Price K, 1996, ANIM BEHAV, V51, P421, DOI 10.1006/anbe.1996.0039; Shizuka D, 2013, ECOL LETT, V16, P315, DOI 10.1111/ele.12040	7	6	6	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					180	181		10.1038/nature17317	http://dx.doi.org/10.1038/nature17317			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27027289				2022-12-28	WOS:000374415100024
J	Snow, R				Snow, Rosamund			Self harm and the emergency department	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rsnow@bmj.com						Hawton K, 2015, J AFFECT DISORDERS, V175, P147, DOI 10.1016/j.jad.2014.12.062; National Institute for Health and Care Excellence, 2013, QUAL STAND SELF HARM; Royal College of Psychiatrists, 2006, BATT SERV PEOPL WHO	3	7	7	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2016	353								i1150	10.1136/bmj.i1150	http://dx.doi.org/10.1136/bmj.i1150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7ET	27076483	Green Published, Bronze			2022-12-28	WOS:000374375400001
J	Sheron, N; Gilmore, I				Sheron, Nick; Gilmore, Ian			Effect of policy, economics, and the changing alcohol marketplace on alcohol related deaths in England and Wales	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIVER-DISEASE; GLOBAL BURDEN; CONSUMPTION; MORTALITY; DRINKING; TOBACCO; IMPACT; PRICE; UNIT; UK		[Sheron, Nick] Univ Southampton, Fac Med, Clin & Expt Sci Acad Unit, Southampton SO16 6YD, Hants, England; [Gilmore, Ian] Univ Liverpool, Liverpool, Merseyside, England	University of Southampton; University of Liverpool	Sheron, N (corresponding author), Univ Southampton, Fac Med, Clin & Expt Sci Acad Unit, Southampton SO16 6YD, Hants, England.	Nick.Sheron@soton.ac.uk		Sheron, Nick/0000-0002-6156-8367; Sheron, Nick/0000-0001-5232-8292				Academy of Medical Sciences, 2004, CALL TIM NAT DRINK M; Anderson K, 2004, WORLD'S WINE MARKETS, P1; Anderson K, 2001, GLOBAL WINE PRODUCTI; [Anonymous], 2015, IRELAND UNVEILS MINI; Black H, 2011, ADDICTION, V106, P729, DOI 10.1111/j.1360-0443.2010.03225.x; British Beer and Pub Association, 2009, STAT HDB BPPA; British Beer and Pub Association, 2008, STAT HDB BPPA; British Beer and Pub Association, 2013, STAT HDB BPPA; Bruun K., 1975, ALCOHOL CONTROL POLI; Chisholm D, 2006, DRUG ALCOHOL REV, V25, P553, DOI 10.1080/09595230600944487; Edwards G, 1997, ADDICTION, V92, pS73, DOI 10.1111/j.1360-0443.1997.tb03399.x; Ernst and Young, 2015, WIN SPIR TRAD ASS EC; Habel C, 2008, PARETO EFFECT 80 20; Hastings G, 2005, J PUBLIC HEALTH POL, V26, P296, DOI 10.1057/palgrave.jphp.3200039; Hastings G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1227; Hastings G, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1767; Health and Social Care Information Centre, 2015, SMOK DRINK DRUG US Y; Health and Social Care Information Centre, 2012, STAT ALC; HM Revenue and Customs, 2015, NUMB IND INC TAXP; HM Revenue and Customs, 2016, ALC DUT B; HMRC, 2015, ALC CLEAR DAT; Holmes J, 2014, DRUG ALCOHOL REV, V33, P515, DOI 10.1111/dar.12191; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; House of Commons Health Committee, 2010, ALC 1 REP SESS 2009; House of Commons Health Committee, ALC WRITT EV 2010; Huang CD, 2003, GOVT EC SERVICE WORK, V140, P1; International Monetary Fund, 2016, WORLD EC OUTL DAT; Jones L, 2013, UPDATING ENGLAND SPE; Jones L., 2008, ALCOHOL ATTRIBUTABLE; Kerr WC, 2000, ADDICTION, V95, P339, DOI 10.1046/j.1360-0443.2000.9533394.x; Meng Y, 2013, MODELLED INCOME GROU; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Moriaty G., 2014, IRISH TIMES     1203; Mosher JF, 2012, AM J PUBLIC HEALTH, V102, P56, DOI 10.2105/AJPH.2011.300387; National Centre for Social Research University College London Department of Epidemiology and Public Health, SN7260 U COLL LOND N; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; OECD, 2015, TACKLING HARMFUL ALC; Office for National Statistics, 2016, REF TABL; Office for National Statistics, 2018, DEATHS REGISTERED EN; Office for National Statistics, 2016, 20 CENT MORT FIL; Office for National Statistics, 2003, HLTH STAT Q, P17; ONS, 2006, DEF ALC REL DEATHS; Prime Minister's Strategy Unit, 2004, ALC HARM RED STRAT; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Sheron N, 2014, CLIN MED, V14, P396, DOI 10.7861/clinmedicine.14-4-396; Sheron N, 2011, LANCET, V377, P1297, DOI 10.1016/S0140-6736(11)60022-6; Siddle R., 2015, HARPERS         0211; Welsh Government, 2015, NEW PLANS MIN UN PRI; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139	51	16	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	2016	353								i1860	10.1136/bmj.i1860	http://dx.doi.org/10.1136/bmj.i1860			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ0LQ	27052417	Green Accepted			2022-12-28	WOS:000373895500006
J	Huarte, M				Huarte, Maite			A lncRNA links genomic variation with celiac disease	SCIENCE			English	Editorial Material							VARIANTS; MOTIF; RNAS		[Huarte, Maite] Univ Navarra, Ctr Appl Med Res CIMA, Dept Gene Therapy & Regulat Gene Express, E-31080 Pamplona, Spain; [Huarte, Maite] Inst Hlth Res Navarra, IdiSNA, Pamplona, Spain	University of Navarra	Huarte, M (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Dept Gene Therapy & Regulat Gene Express, E-31080 Pamplona, Spain.; Huarte, M (corresponding author), Inst Hlth Res Navarra, IdiSNA, Pamplona, Spain.	maitehuarte@unav.es	Huarte, Maite/J-6903-2014	Huarte, Maite/0000-0003-3753-6493				Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	6	9	12	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					43	44		10.1126/science.aaf6015	http://dx.doi.org/10.1126/science.aaf6015			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034364				2022-12-28	WOS:000373039600026
J	Page, B				Page, Ben			Junior doctors' dispute: a pollster's view	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Ben.Page@ipsos.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2016	352								i1717	10.1136/bmj.i1717	http://dx.doi.org/10.1136/bmj.i1717			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TW	27032652				2022-12-28	WOS:000373493300007
J	Patel, AN; Henry, TD; Quyyumi, AA; Schaer, GL; Anderson, RD; Toma, C; East, C; Remmers, AE; Goodrich, J; Desai, AS; Recker, D; DeMaria, A				Patel, Amit N.; Henry, Timothy D.; Quyyumi, Arshed A.; Schaer, Gary L.; Anderson, R. David; Toma, Catalin; East, Cara; Remmers, Ann E.; Goodrich, James; Desai, Akshay S.; Recker, David; DeMaria, Anthony		IxCELL-DCM Investigators	Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial	LANCET			English	Article							AUTOLOGOUS BONE-MARROW; MULTICELLULAR THERAPY; MONONUCLEAR-CELLS; PROGENITOR CELLS; STEM-CELLS; CARDIOMYOPATHY; MORTALITY; DELIVERY	Background Ixmyelocel-T is an expanded, multicellular therapy produced from a patient's own bone marrow by selectively expanding two key types of bone marrow mononuclear cells: CD90+ mesenchymal stem cells and CD45+ CD14+ auto-fluorescent+ activated macrophages. Early phase clinical trials suggest that intramyocardial delivery of ixmyelocel-T might improve clinical, functional, symptomatic, and quality-of-life outcomes in patients with heart failure due to ischaemic dilated cardiomyopathy. We aimed to assess the safety and efficacy of catheter-based transendocardial injection of ixmyelocel-T cell therapy in patients with heart failure and reduced ejection fractions. Methods In this randomised, double-blind, placebo-controlled phase 2B trial (ixCELL-DCM), patients from 31 sites in North America with New York Heart Association class III or IV symptomatic heart failure due to ischaemic dilated cardiomyopathy, who had left ventricular ejection fraction 35% or less, an automatic implantable cardioverter defibrillator, and who were ineligible for revascularisation procedures were randomly assigned (1: 1) to receive ixmyelocel-T or placebo at the time of bone marrow aspiration and followed for 12 months. Randomisation was done through an interactive (voice/web) response system. The pharmacist, treating physician, and coordinator at each site were unblinded, but the the follow-up team was completely blinded. The primary endpoint was a composite of all-cause death, cardiovascular admission to hospital, and unplanned clinic visits to treat acute decompensated heart failure based on the blinded adjudication of an independent clinical endpoint committee. Primary efficacy endpoint analyses and safety analyses were done by modified intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01670981. Findings Between April 2, 2013, and Jan 28, 2015, 126 participants were randomly assigned to receive either ixmyelocel-T (n=66) or placebo (n=60). 114 (90%) patients comprised the modified intention-to-treat population and 109 (87%) patients were included in the per-protocol primary efficacy analysis (58 in the ixmyelocel-T group and 51 in the placebo group). The primary efficacy endpoint was observed in 47 patients: 50 events in 25 (49%) of 51 patients in the placebo group and 38 events in 22 (38%) of 58 patients in the ixmyelocel-T group, which represents a 37% reduction in cardiac events compared with placebo (risk ratio 0.63 [95% CI 0.42-0.97]; p= 0.0344). 41 (75%) of 51 participants in the placebo group had serious adverse events versus 31 (53%) of 58 in the ixmyelocel-T group (p= 0.0197). Interpretation To the best of our knowledge, ixCELL-DCM is the largest cell therapy study done in patients with heart failure so far. The transendocardial delivery of ixmyelocel-T in patients with heart failure and reduced ejection fraction due to ischaemic dilated cardiomyopathy resulted in a significant reduction in adjudicated clinical cardiac events compared with placebo leading to improved patient outcomes.	[Patel, Amit N.] Univ Utah Hlth Care, Salt Lake City, UT USA; [Henry, Timothy D.] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Quyyumi, Arshed A.] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA; [Schaer, Gary L.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Anderson, R. David] Univ Florida, Gainesville, FL USA; [Toma, Catalin] Univ Pittsburgh, Pittsburgh, PA USA; [East, Cara] Baylor Univ, Med Ctr, Dallas, TX USA; [Remmers, Ann E.; Goodrich, James; Recker, David] Vericel Corp, Cambridge, MA USA; [Desai, Akshay S.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [DeMaria, Anthony] Univ Calif San Diego, San Diego, CA 92103 USA	Utah System of Higher Education; University of Utah; University of Utah Hospital; Cedars Sinai Medical Center; Emory University; Rush University; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor University; Baylor University Medical Center; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Diego	Henry, TD (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.; Patel, AN (corresponding author), Univ Utah, Sch Med, Dept Surg Cardiac, 3c127, Salt Lake City, UT 84132 USA.	Amit.Patel@hsc.utah.edu; henryt@cshs.org	Desai, Akshay/ABE-7250-2020	Anderson, R. David/0000-0003-3490-3286; Remmers, Ann/0000-0002-2465-7651	Vericel Corporation	Vericel Corporation	Vericel Corporation.	Agnetti G, 2015, BIOMED RES INT, V2015, P265; Assmus B, 2007, CIRC RES, V100, P1234, DOI 10.1161/01.RES.0000264508.47717.6b; Bartel RL, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt117; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Chiong M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.130; Finkelstein DM, 1999, STAT MED, V18, P1341, DOI 10.1002/(SICI)1097-0258(19990615)18:11&lt;1341::AID-SIM129&gt;3.0.CO;2-7; Fisher SA, 2016, CLIN PHARMACOL THER, V100, P88, DOI 10.1002/cpt.344; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Henry T. D., 2016, CELL TRANSPLANT; Henry TD, 2014, CIRC RES, V115, P730, DOI 10.1161/CIRCRESAHA.115.304554; Kilic A, 2015, J THORAC DIS, V7, P2158, DOI 10.3978/j.issn.2072-1439.2015.10.64; Kissel CK, 2007, J AM COLL CARDIOL, V49, P2341, DOI 10.1016/j.jacc.2007.01.095; Ledford KJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0007-3; Ledford KJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt345; Leistner DM, 2011, EUR HEART J, V32, P485, DOI 10.1093/eurheartj/ehq430; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; McLaren DP, 2016, CARDIOL J, V23, P155, DOI 10.5603/CJ.a2016.0005; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Patel AN, 2015, STEM CELL TRANSL MED, V4, P1021, DOI 10.5966/sctm.2015-0070; Patel AN, 2015, HEART FAIL CLIN, V11, P275, DOI 10.1016/j.hfc.2014.12.006; Perin EC, 2015, CIRC RES, V117, P576, DOI 10.1161/CIRCRESAHA.115.306332; Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418; Pocock SJ, 2012, EUR HEART J, V33, P176, DOI 10.1093/eurheartj/ehr352; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186	26	101	102	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2412	2421		10.1016/S0140-6736(16)30137-4	http://dx.doi.org/10.1016/S0140-6736(16)30137-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1ST	27059887				2022-12-28	WOS:000377560100034
J	Grundy, Q; Bero, LA; Malone, RE				Grundy, Quinn; Bero, Lisa A.; Malone, Ruth E.			Marketing and the Most Trusted Profession: The Invisible Interactions Between Registered Nurses and Industry	ANNALS OF INTERNAL MEDICINE			English	Article							ACADEMIC MEDICAL-CENTERS; CONFLICT-OF-INTEREST; PHARMACEUTICAL-INDUSTRY; PHYSICIAN; GIFTS; WILL	Background: The mainstay for addressing conflicts of interest in health care is disclosure of personal financial ties to industry. However, this approach fails to capture the complexity of industry interactions that are built into clinical practice. Further, the policy climate focuses on physicians and traditional pharmaceutical marketing. Objective: To describe industry activities targeted at registered nurses. Design: Qualitative, ethnographic study conducted from January 2012 to October 2014. Setting: Four acute care hospitals in a western U.S. city. Participants: A purposive sample of 72 participants with direct experience with industry, including staff nurses, administrators, and industry and supply chain professionals. Measurements: Fieldwork, including observations (102 hours), semistructured in-depth interviews (n = 51), focus groups (n = 4), and documents analysis. Results: Nurses' reported financial relationships with industry were similar to those reported by prescribers. However, nurses reported that their most significant interactions with industry occurred in daily practice. The current policy environment rendered these interactions invisible, leaving nurses with little guidance to ensure that the boundary between service and sales remained intact. Limitations: This study could not determine the frequency or prevalence of nurse-industry interactions. The sample is not representative. Conclusion: Nurse-industry interactions may be common and influential, but they remain invisible in the current policy climate. Although some aspects of these interactions may be beneficial, others may pose financial risks to hospitals or safety risks to patients. Disclosure strategies alone do not provide health professionals with adequate support to manage day-to-day interactions. Management of industry interactions must include guidance for nurses.	[Grundy, Quinn; Bero, Lisa A.] Univ Sydney, Charles Perkins Ctr, D17 Hub,6th Floor, Sydney, NSW 2006, Australia; [Malone, Ruth E.] Univ Calif San Francisco, 3333 Calif St, San Francisco, CA 94118 USA	University of Sydney; University of California System; University of California San Francisco	Grundy, Q (corresponding author), Univ Sydney, Charles Perkins Ctr, D17 Hub,6th Floor, Sydney, NSW 2006, Australia.	quinn.grundy@sydney.edu.au		Bero, Lisa/0000-0003-1893-6651	Canadian Institutes of Health Research Doctoral Research Award; Agency for Healthcare Research and Quality [R36HS022383]; Graduate Dean's Health Science Fellowship, the University of California, San Francisco; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R36HS022383] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Graduate Dean's Health Science Fellowship, the University of California, San Francisco; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was funded by the Canadian Institutes of Health Research Doctoral Research Award and grant R36HS022383 from the Agency for Healthcare Research and Quality. Dr. Grundy was supported by the Graduate Dean's Health Science Fellowship, the University of California, San Francisco.	American Nurses Association, 2015, COD ETH NURS; [Anonymous], EXPERTISE NURSING PR; Benner P.A., 1996, EXPERTISE NURSING PR, P351; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Campbell EG, 2010, ARCH INTERN MED, V170, P1820, DOI 10.1001/archinternmed.2010.383; Centers for Medicare & Medicaid Services, 2015, FACTS OPEN PAYM DAT; Centers for Medicare & Medicaid Services (CMS) HHS, 2013, Fed Regist, V78, P9457; Chan G. K., 2010, INTERPRETIVE PHENOME; Crigger NJ, 2009, NURS PHILOS, V10, P253, DOI 10.1111/j.1466-769X.2009.00412.x; Grundy Q, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001561; Hammersley M., 1983, ETHNOGRAPHY PRINCIPL; Institute of Medicine, 2009, CONFLICT INTEREST ME; Jutel A, 2008, PLOS MED, V5, P193, DOI 10.1371/journal.pmed.0050005; Jutel A, 2009, ANN PHARMACOTHER, V43, P1057, DOI 10.1345/aph.1M027; Kamberelis G., 2005, SAGE HDB QUALITATIVE, P887; Ladd EC, 2010, AM J MANAG CARE, V16, pE358; Lasater KB, 2014, NURS PHILOS, V15, P221, DOI 10.1111/nup.12040; Mackey TK, 2013, J AM BOARD FAM MED, V26, P327, DOI 10.3122/jabfm.2013.03.120264; McNeill PM, 2006, INTERN MED J, V36, P571, DOI 10.1111/j.1445-5994.2006.01151.x; Morain SR, 2014, ANN INTERN MED, V161, P915, DOI 10.7326/M14-1683; Mueller PS, 2011, J INTERV CARD ELECTR, V32, P253, DOI 10.1007/s10840-011-9607-8; Ornstein C, 2015, BILL WOULD NURSES PH; Riffkin R., 2014, AM RATE NURSES HIGHE; Rosenbaum L, 2015, NEW ENGL J MED, V372, P1959, DOI 10.1056/NEJMms1502497; Rothbauer P., 2008, SAGE ENCY QUALITATIV, P892, DOI DOI 10.4135/9781412963909.N468; Rothman DJ, 2010, JAMA-J AM MED ASSOC, V304, P2294, DOI 10.1001/jama.2010.1714; Santhakumar S, 2015, JAMA-J AM MED ASSOC, V313, P23, DOI 10.1001/jama.2014.15472; Sismondo S, 2013, J LAW MED ETHICS, V41, P635, DOI 10.1111/jlme.12073; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Welton John M, 2006, Policy Polit Nurs Pract, V7, P270, DOI 10.1177/1527154406297510	30	16	17	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2016	164	11					733	+		10.7326/M15-2522	http://dx.doi.org/10.7326/M15-2522			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO1AI	27043976	Green Submitted			2022-12-28	WOS:000377510100005
J	Goenka, S; Andersen, LB				Goenka, Shifalika; Andersen, Lars Bo			Our health is a function of where we live	LANCET			English	Editorial Material							PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; DISEASES		[Goenka, Shifalika] Indian Inst Publ Hlth, Publ Hlth Fdn India, Ctr Chron Condit & Injuries, Delhi, India; [Goenka, Shifalika] Ctr Chron Dis Control, Gurgaon 122002, Haryana, India; [Andersen, Lars Bo] Sogn Fjordane Univ Coll, Fac Teacher Educ & Sports, Sogndal, Norway	Public Health Foundation of India; Western Norway University of Applied Sciences	Goenka, S (corresponding author), Indian Inst Publ Hlth, Publ Hlth Fdn India, Ctr Chron Condit & Injuries, Delhi, India.; Goenka, S (corresponding author), Ctr Chron Dis Control, Gurgaon 122002, Haryana, India.	shifalika.goenka@phfi.org		Goenka, Shifalika/0000-0001-6993-2883				Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; [Anonymous], 2015, TIMES INDIA; Central Road Research Institute, 2016, EV BUS RAP TRANS BRT; Goenka S, 2007, POWERING INDIAS GROW; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Peer Nasheeta, 2015, Trop Dis Travel Med Vaccines, V1, P6, DOI 10.1186/s40794-015-0007-4; Perdue WC, 2003, AM J PUBLIC HEALTH, V93, P1390, DOI 10.2105/AJPH.93.9.1390; Remais JV, 2013, INT J EPIDEMIOL, V42, P221, DOI 10.1093/ije/dys135; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Sen J, 2009, FOOTFALLS OBSTACLE C; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	13	13	14	2	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2168	2170		10.1016/S0140-6736(16)00348-2	http://dx.doi.org/10.1016/S0140-6736(16)00348-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27045736				2022-12-28	WOS:000376820800007
J	Theriot, JC; Lim, CH; Yang, H; Ryan, MD; Musgrave, CB; Miyake, GM				Theriot, Jordan C.; Lim, Chern-Hooi; Yang, Haishen; Ryan, Matthew D.; Musgrave, Charles B.; Miyake, Garret M.			Organocatalyzed atom transfer radical polymerization driven by visible light	SCIENCE			English	Article							COMPLEXES; CATALYSTS; ANALOGS; DESIGN	Atom transfer radical polymerization (ATRP) has become one of the most implemented methods for polymer synthesis, owing to impressive control over polymer composition and associated properties. However, contamination of the polymer by the metal catalyst remains a major limitation. Organic ATRP photoredox catalysts have been sought to address this difficult challenge but have not achieved the precision performance of metal catalysts. Here, we introduce diaryl dihydrophenazines, identified through computationally directed discovery, as a class of strongly reducing photoredox catalysts. These catalysts achieve high initiator efficiencies through activation by visible light to synthesize polymers with tunable molecular weights and low dispersities.	[Theriot, Jordan C.; Lim, Chern-Hooi; Yang, Haishen; Ryan, Matthew D.; Musgrave, Charles B.; Miyake, Garret M.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Lim, Chern-Hooi; Musgrave, Charles B.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Musgrave, Charles B.; Miyake, Garret M.] Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Miyake, GM (corresponding author), Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA.; Miyake, GM (corresponding author), Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA.	garret.miyake@colorado.edu	MUSGRAVE, CHARLES B/Y-2966-2018	YANG, HAISHEN/0000-0002-0437-7388	University of Colorado Boulder; NSF [CHE-1214131]; Graduate Assistance in Areas of National Need fellowship; Advanced Research Projects Agency-Energy; Direct For Mathematical & Physical Scien [1214131] Funding Source: National Science Foundation	University of Colorado Boulder; NSF(National Science Foundation (NSF)); Graduate Assistance in Areas of National Need fellowship; Advanced Research Projects Agency-Energy; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	G.M.M. is grateful for financial support from the University of Colorado Boulder and Advanced Research Projects Agency-Energy. This work was supported in part by NSF grant CHE-1214131 (C.B.M. and C.-H.L.). J.C.T. is thankful for a NSF Graduate Research Fellowship Program fellowship. M.D.R. acknowledges support from a Graduate Assistance in Areas of National Need fellowship. We also gratefully acknowledge use of Extreme Science and Engineering Development Environment supercomputing resources (NSF ACI-1053575) and the Janus supercomputer, which is supported by NSF (CNS-0821794) and the University of Colorado Boulder. We thank L. Hansman, A. Lockwood, S. Fatur, and N. Damrauer for technical assistance and enlightening discussions. We have filed a provisional patent application on the work described here.	Aguirre-Soto A, 2014, J AM CHEM SOC, V136, P7418, DOI 10.1021/ja502441d; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Discekici EH, 2015, CHEM COMMUN, V51, P11705, DOI 10.1039/c5cc04677g; Fors Brett P, 2012, Angew Chem Int Ed Engl, V51, P8850, DOI 10.1002/anie.201203639; Goto A, 2007, J AM CHEM SOC, V129, P13347, DOI 10.1021/ja0755820; Goto A, 2013, J AM CHEM SOC, V135, P11131, DOI 10.1021/ja4036016; Hawker CJ, 2005, SCIENCE, V309, P1200, DOI 10.1126/science.1109778; Hiraoka S, 2004, J AM CHEM SOC, V126, P58, DOI 10.1021/ja0367748; Laursen JB, 2004, CHEM REV, V104, P1663, DOI 10.1021/cr020473j; Lim CH, 2014, J AM CHEM SOC, V136, P16081, DOI 10.1021/ja510131a; Magenau AJD, 2011, SCIENCE, V332, P81, DOI 10.1126/science.1202357; Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g; Matyjaszewski K, 2006, P NATL ACAD SCI USA, V103, P15309, DOI 10.1073/pnas.0602675103; Matyjaszewski K, 2015, ACS SYM SER, V1187, P1; Matyjaszewski K, 2014, J AM CHEM SOC, V136, P6513, DOI 10.1021/ja408069v; Matyjaszewski K, 2009, NAT CHEM, V1, P276, DOI [10.1038/NCHEM.257, 10.1038/nchem.257]; Miyake G. M., 2015, U. S. Patent, Patent No. [US 9,156,921 B2, 9156921]; Miyake G. M., 2013, U. S. Patent application, Patent No. [61,212, 61212]; Miyake GM, 2014, MACROMOLECULES, V47, P8255, DOI 10.1021/ma502044f; Ohtsuki A, 2015, J AM CHEM SOC, V137, P5610, DOI 10.1021/jacs.5b02617; Okamoto T, 2003, ORG LETT, V5, P373, DOI 10.1021/ol0274458; Ouchi M, 2009, CHEM REV, V109, P4963, DOI 10.1021/cr900234b; Pan XC, 2015, ACS MACRO LETT, V4, P192, DOI 10.1021/mz500834g; Patten TE, 1996, SCIENCE, V272, P866, DOI 10.1126/science.272.5263.866; Pintauer T, 2008, CHEM SOC REV, V37, P1087, DOI 10.1039/b714578k; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Terada E, 2005, J ORG CHEM, V70, P10073, DOI 10.1021/jo051791w; Treat NJ, 2014, J AM CHEM SOC, V136, P16096, DOI 10.1021/ja510389m; Treat NJ, 2014, ACS MACRO LETT, V3, P580, DOI 10.1021/mz500242a; Tsarevsky NV, 2007, CHEM REV, V107, P2270, DOI 10.1021/cr050947p; Zhang ZY, 2015, J AM CHEM SOC, V137, P8509, DOI 10.1021/jacs.5b03491; Zheng ZW, 2014, J MATER CHEM C, V2, P9858, DOI 10.1039/c4tc01965b	33	502	508	34	608	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1082	1086		10.1126/science.aaf3935	http://dx.doi.org/10.1126/science.aaf3935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27033549				2022-12-28	WOS:000376480800034
J	Lowy, DR; Collins, FS				Lowy, Douglas R.; Collins, Francis S.			Aiming High - Changing the Trajectory for Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lowy, Douglas R.] NCI, Bethesda, MD 20892 USA; [Collins, Francis S.] NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA	Lowy, DR (corresponding author), NCI, Bethesda, MD 20892 USA.				NATIONAL CANCER INSTITUTE [ZIABC010579] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2016, 1 M CANC MOONSH TASK; Bell JAH, 2015, SUPPORT CARE CANCER, V23, P1169, DOI 10.1007/s00520-014-2581-9; Biden J., 2016, INSPIRING NEW GENERA; [National Cancer Institute Vice Presidents Cancer Initiative National Institutes of Health], 2016, INV LAUNCH NEXT PHAS; Sprandio JD, 2012, J ONCOL PRACT, V8, p47S, DOI 10.1200/JOP.2012.000590	5	52	53	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1901	1904		10.1056/NEJMp1600894	http://dx.doi.org/10.1056/NEJMp1600894			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM1OX	27043262	Green Published, Bronze			2022-12-28	WOS:000376116600001
J	Bellon, JA; Conejo-Ceron, S; Moreno-Peral, P; King, M; Nazareth, I; Martin-Perez, C; Fernandez-Alonso, C; Rodriguez-Bayon, A; Fernandez, A; Aiarzaguena, JM; Monton-Franco, C; Ibanez-Casas, I; Rodriguez-Sanchez, E; Ballesta-Rodriguez, MI; Serrano-Blanco, A; Gomez, MC; LaFuente, P; Munoz-Garcia, MD; Minguez-Gonzalo, P; Araujo, L; Palao, D; Bully, P; Zubiaga, F; Navas-Campana, D; Mendive, J; Aranda-Regules, JM; Rodriguez-Morejon, A; Salvador-Carulla, L; Luna, JD				Angel Bellon, Juan; Conejo-Ceron, Sonia; Moreno-Peral, Patricia; King, Michael; Nazareth, Irwin; Martin-Perez, Carlos; Fernandez-Alonso, Carmen; Rodriguez-Bayon, Antonina; Fernandez, Anna; Maria Aiarzaguena, Jose; Monton-Franco, Carmen; Ibanez-Casas, Inmaculada; Rodriguez-Sanchez, Emiliano; Isabel Ballesta-Rodriguez, Maria; Serrano-Blanco, Antoni; Cruz Gomez, Maria; LaFuente, Pilar; del Mar Munoz-Garcia, Maria; Minguez-Gonzalo, Pilar; Araujo, Luz; Palao, Diego; Bully, Paola; Zubiaga, Fernando; Navas-Campana, Desiree; Mendive, Juan; Manuel Aranda-Regules, Jose; Rodriguez-Morejon, Alberto; Salvador-Carulla, Luis; de Dios Luna, Juan			Intervention to Prevent Major Depression in Primary Care A Cluster Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							GENERAL-PRACTICE ATTENDEES; INTERNATIONAL DIAGNOSTIC INTERVIEW; RISK PREDICTION ALGORITHM; MENTAL-DISORDERS; GLOBAL BURDEN; ONSET; VALIDATION; POPULATION; DISEASE; ANXIETY	Background: Not enough is known about universal prevention of depression in adults. Objective: To evaluate the effectiveness of an intervention to prevent major depression. Design: Multicenter, cluster randomized trial with sites randomly assigned to usual care or an intervention. (ClinicalTrials.gov:NCT01151982) Setting: 10 primary care centers in each of 7 cities in Spain. Participants: Two primary care physicians (PCPs) and 5236 nondepressed adult patients were randomly sampled from each center; 3326 patients consented and were eligible to participate. Intervention: For each patient, PCPs communicated individual risk for depression and personal predictors of risk and developed a psychosocial program tailored to prevent depression. Measurements: New cases of major depression, assessed every 6 months for 18 months. Results: At 18 months, 7.39% of patients in the intervention group (95% CI, 5.85% to 8.95%) developed major depression compared with 9.40% in the control (usual care) group (CI, 7.89% to 10.92%) (absolute difference, -2.01 percentage points [CI, -4.18 to 0.16 percentage points]; P = 0.070). Depression incidence was lower in the intervention centers in 5 cities and similar between intervention and control centers in 2 cities. Limitation: Potential self-selection bias due to nonconsenting patients. Conclusion: Compared with usual care, an intervention based on personal predictors of risk for depression implemented by PCPs provided a modest but nonsignificant reduction in the incidence of major depression. Additional study of this approach may be warranted.	Univ Malaga, Ctr Salud El Palo, Dist Atenc Primaria Malaga Guadalhorce, Inst Invest Biomed Malaga, E-29071 Malaga, Spain; Univ Malaga, Ctr Salud El Torcal, Dist Atenc Primaria Malaga Guadalhorce, Inst Invest Biomed Malaga, E-29071 Malaga, Spain; [King, Michael] UCL, Div Psychiat, Charles Bell House,67-73 Riding House St, London W1W 7EH, England; Univ Granada, Ctr Salud Marquesado, Area Nordeste Granada, Ctr Invest Biomed Salud Mental, Granada, Spain; Gerencia Reg Salud, Serv Programas Asistenciales, Unidad Invest Atenc Primaria, Valladolid, Spain; Serv Andaluz Salud, Ctr Salud San Jose Linares, Jaen, Spain; Serv Andaluz Salud, Ctr Federico Castillo Jaen, Jaen, Spain; Univ Sydney, Ctr Disabil Res & Policy, Sydney, NSW 2006, Australia; Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; Hosp Parc Tauli, Ctr Salud La Mina, Inst Catala Salut, Fundacio St Joan de Deu,Serv Salut Mental, Parc Sanitari St Joan de Deu, Barcelona, Spain; Osakidetza, Unidad Invest Atenc Primaria, Ctr Salud San Ignacio, Bilbao, Spain; Univ Zaragoza, Ctr Salud Casablanca Zaragoza, Unidad Invest Atenc Primaria, Inst Aragones Ciencias Salud,Inst Invest Sanitari, Zaragoza, Spain; Univ Zaragoza, Ctr Salud Arrabal Zaragoza, Unidad Invest Atenc Primaria, Inst Aragones Ciencias Salud,Inst Invest Sanitari, Zaragoza, Spain; Univ Zaragoza, Ctr Salud Andorra Teruel, Unidad Invest Atenc Primaria, Inst Aragones Ciencias Salud,Inst Invest Sanitari, Zaragoza, Spain; Ctr Salud Miguel Armijo, Salamanca, Spain; [Conejo-Ceron, Sonia; Moreno-Peral, Patricia; del Mar Munoz-Garcia, Maria; Araujo, Luz; Navas-Campana, Desiree] Unidad Invest, Dist Atenc Primaria Malaga Guadalhorce, C Sevilla,23,3a Planta, Malaga 29009, Spain; [Nazareth, Irwin] UCL, Dept Primary Care & Populat Hlth, Royal Free Site,Rowland Hill St, London NW3, England; [Martin-Perez, Carlos] Dist Sanitario Granada Nordeste, Ctr Salud Marquesado, Ave Mariana Pineda S-N, Granada 18500, Spain; [Fernandez-Alonso, Carmen] Gerencia Reg Salud Castilla & Leon, Paseo Zorrilla 1, Valladolid 47007, Spain; [Rodriguez-Bayon, Antonina] Ctr Salud San Jose, Plaza Juanfra Garrido Romera S-N, Jaen 23700, Spain; [Fernandez, Anna; Salvador-Carulla, Luis] Univ Sydney, Ctr Disabil Res & Policy, Brain & Mind Res Inst, Fac Hlth Sci, Cumberland Campus 75 East St, Lidcombe, NSW 2141, Australia; [Maria Aiarzaguena, Jose] Ctr Salud San Ignacio, Larrakotorre Kalea 9, Bilbao 48015, Bizkaia, Spain; [Monton-Franco, Carmen] Ctr Salud Casablanca, C Vinedo Viejo 10, Zaragoza 50009, Spain; [Ibanez-Casas, Inmaculada] Univ Granada, Ctr Invest Biomed Red Salud Mental, Fac Med, PTS Avda Invest, Granada 18016, Spain; [Rodriguez-Sanchez, Emiliano] Ctr Salud La Alamedilla, Unidad Invest, Ave Comuneros 27-31, Salamanca 37003, Spain; [Isabel Ballesta-Rodriguez, Maria] Ctr Salud Federico Castillo, C Ramo n Espantaleon S-N, Jaen 23005, Spain; [Serrano-Blanco, Antoni] Parc Sanitari Sant Joan de Deu, C Dr Antoni Pujadas 42, Barcelona 08830, Spain; [Cruz Gomez, Maria; Bully, Paola] Unidad Invest Atenc Primaria, C Luis Power 18-4, Bilbao 48014, Spain; [LaFuente, Pilar] Ctr Salud Andorra, C Huesca 0, Teruel 44500, Spain; [Minguez-Gonzalo, Pilar] Gerencia Reg Salud Castilla Leon, Unidad Invest, Paseo Zorrilla 1, Valladolid 47007, Spain; [Palao, Diego] Hosp Parc Tauli, Serv Salut Mental, Parc Tauli 1, Barcelona 08208, Spain; [Zubiaga, Fernando] Ctr Salud Arrabal, Unidad Invest Atenc Primaria, Andador Aragues Puerto 2-4, Zaragoza 50015, Spain; [Mendive, Juan] Ctr Salud La Mina, C Mar S-N, Barcelona 08930, Spain; [Manuel Aranda-Regules, Jose] Ctr San Andres Torcal, Malaga 29003, Spain; [Rodriguez-Morejon, Alberto] Univ Malaga, Dept Personalidad Evaluac & Tratamiento Psicol, Fac Psicol, Campus Teatinos S-N, Malaga 29590, Spain; [de Dios Luna, Juan] Univ Granada, Dept Bioestadist, Fac Med, Parque Tecnol Ciencias Salud,Avda Invest 11, Granada 18016, Spain	Universidad de Malaga; Universidad de Malaga; University of London; University College London; University of Granada; University of Sydney; University of Sydney; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; University of Zaragoza; University of Zaragoza; University of Zaragoza; University of London; University College London; University of Sydney; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Granada; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Universidad de Malaga; University of Granada	Bellon, JA (corresponding author), Unidad Invest, Dist Atenc Primaria Malaga Guadalhorce, C Sevilla,23,3a Planta, Malaga 29009, Spain.	jabellon@uma.es	Mendive, Juan/AAZ-9277-2021; Rodriguez-Morejón, Alberto/ABH-3079-2020; Conejo-CerÃn, Sonia/ABH-2992-2020; Moreno-Peral, Patricia/I-3594-2012; Serrano-Blanco, Antoni/H-4587-2012; Fernandez, Ana/H-4545-2012; Salvador-Carulla, Luis/K-6512-2013; PRISMA, Grupo/AAI-6753-2021; luna, juan de dios/N-9183-2016; Ibanez-Casas, Inmaculada/I-4659-2014; Rodriguez-Sanchez, Emiliano/N-5582-2014	Mendive, Juan/0000-0001-8095-7707; Rodriguez-Morejón, Alberto/0000-0003-1361-045X; Moreno-Peral, Patricia/0000-0003-4130-9090; Serrano-Blanco, Antoni/0000-0001-6123-0633; Fernandez, Ana/0000-0002-0333-1345; Salvador-Carulla, Luis/0000-0002-5742-9866; Bellon Saameno, Juan Angel/0000-0002-4268-4979; luna, juan de dios/0000-0002-1854-4968; Palao, Diego/0000-0002-3323-6568; Nazareth, Irwin/0000-0003-2146-9628; Conejo Ceron, Sonia/0000-0002-1357-2281; Ibanez-Casas, Inmaculada/0000-0002-1007-8966; Rodriguez-Sanchez, Emiliano/0000-0003-3667-7155	Spanish Ministry of Health; Institute of Health Carlos III; European Regional Development Fund [PS09/02272, PS09/02147, PS09/01095, PS09/00849, PS09/00461]; Andalusian Council of Health [PI-0569-2010]; Spanish Network of Primary Care Research [RD06/0018]; Aragon group [RD06/0018/0020]; Bizkaya group [RD06/0018/0018]; Castilla-Leon group [RD06/0018/0027]; Mental Health Barcelona Group [RD06/0018/0017]; Mental Health, Services and Primary Care Malaga group [RD06/0018/0039]; National Institute for Health Research [NF-SI-0611-10210, NF-SI-0515-10041] Funding Source: researchfish	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Institute of Health Carlos III(Instituto de Salud Carlos III); European Regional Development Fund(European Commission); Andalusian Council of Health; Spanish Network of Primary Care Research; Aragon group(Gobierno de Aragon); Bizkaya group; Castilla-Leon group; Mental Health Barcelona Group; Mental Health, Services and Primary Care Malaga group; National Institute for Health Research(National Institute for Health Research (NIHR))	By the Spanish Ministry of Health, the Institute of Health Carlos III, and the European Regional Development Fund (grants PS09/02272, PS09/02147, PS09/01095, PS09/00849, and PS09/00461); the Andalusian Council of Health (grant PI-0569-2010); the Spanish Network of Primary Care Research (grant RD06/0018); the Aragon group (grant RD06/0018/0020); the Bizkaya group (grant RD06/0018/0018); the Castilla-Leon group (grant RD06/0018/0027); the Mental Health Barcelona Group (grant RD06/0018/0017); and the Mental Health, Services and Primary Care Malaga group (grant RD06/0018/0039).	Bellon JA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-256; Baca E, 1999, ACTAS ESP PSIQUIATRI, V27, P375; Bell ML, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8668; Bellon JA, 2011, PSYCHOL MED, V41, P2075, DOI 10.1017/S0033291711000468; Bellon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092008; Bellon JA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-171; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Chisholm D, 2004, BRIT J PSYCHIAT, V184, P393, DOI 10.1192/bjp.184.5.393; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; Dowrick C, 1996, BRIT J GEN PRACT, V46, P105; Dowrick CF, 2000, BRIT J GEN PRACT, V50, P361; Eldridge SM, 2006, INT J EPIDEMIOL, V35, P1292, DOI 10.1093/ije/dyl129; Fernandez A, 2013, 10 INT C EUR NETW ME, P238; Frank E, 2002, GEN HOSP PSYCHIAT, V24, P12, DOI 10.1016/S0163-8343(01)00173-6; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hayes RJ, 2009, INTERD STAT, P3; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2013, ANN INTERN MED, V159, P560, DOI 10.7326/0003-4819-159-8-201310150-00709; King M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-6; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; King M, 2008, ARCH GEN PSYCHIAT, V65, P1368, DOI 10.1001/archpsyc.65.12.1368; Lee ML, 2002, MED CARE, V40, P761, DOI 10.1097/00005650-200209000-00006; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mennin DS, 2008, DEPRESS ANXIETY, V25, P289, DOI 10.1002/da.20493; Moreno-Peral P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106370; MUNOZ RF, 1995, AM J COMMUN PSYCHOL, V23, P199, DOI 10.1007/BF02506936; Munoz RF, 2010, ANNU REV CLIN PSYCHO, V6, P181, DOI 10.1146/annurev-clinpsy-033109-132040; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Raab GM, 2000, CONTROL CLIN TRIALS, V21, P330, DOI 10.1016/S0197-2456(00)00061-1; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Rubin DB, 1987, MULTIPLE IMPUTATIONS; Rubio-Valera M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089554; Saldivia S, 2014, REV MED CHILE, V142, P323, DOI 10.4067/S0034-98872014000300006; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tonelli M, 2011, CAN MED ASSOC J, V183, pE1189, DOI 10.1503/cmaj.101280; van Zoonen K, 2014, INT J EPIDEMIOL, V43, P318, DOI 10.1093/ije/dyt175; van't Veer-Tazelaar PJ, 2009, ARCH GEN PSYCHIAT, V66, P297, DOI 10.1001/archgenpsychiatry.2008.555; Wang JL, 2014, J EPIDEMIOL COMMUN H, V68, P418, DOI 10.1136/jech-2013-202845; Willemse GRWM, 2004, BRIT J PSYCHIAT, V185, P416, DOI 10.1192/bjp.185.5.416; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; Wright N, 2015, J CLIN EPIDEMIOL, V68, P603, DOI 10.1016/j.jclinepi.2014.12.006	44	20	20	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					656	+		10.7326/M14-2653	http://dx.doi.org/10.7326/M14-2653			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27019334				2022-12-28	WOS:000375878500013
J	Sirohi, D; Chen, ZG; Sun, L; Klose, T; Pierson, TC; Rossmann, MG; Kuhn, RJ				Sirohi, Devika; Chen, Zhenguo; Sun, Lei; Klose, Thomas; Pierson, Theodore C.; Rossmann, Michael G.; Kuhn, Richard J.			The 3.8 angstrom resolution cryo-EM structure of Zika virus	SCIENCE			English	Article							DENGUE VIRUS; TRANSMISSION; INFECTION; COMPLEX	The recent rapid spread of Zika virus and its unexpected linkage to birth defects and an autoimmune neurological syndrome have generated worldwide concern. Zika virus is a flavivirus like the dengue, yellow fever, and West Nile viruses. We present the 3.8 angstrom resolution structure of mature Zika virus, determined by cryo-electron microscopy (cryo-EM). The structure of Zika virus is similar to other known flavivirus structures, except for the similar to 10 amino acids that surround the Asn(154) glycosylation site in each of the 180 envelope glycoproteins that make up the icosahedral shell. The carbohydrate moiety associated with this residue, which is recognizable in the cryo-EM electron density, may function as an attachment site of the virus to host cells. This region varies not only among Zika virus strains but also in other flaviviruses, which suggests that differences in this region may influence virus transmission and disease.	[Sirohi, Devika; Chen, Zhenguo; Sun, Lei; Klose, Thomas; Rossmann, Michael G.; Kuhn, Richard J.] Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA; [Sirohi, Devika; Chen, Zhenguo; Sun, Lei; Klose, Thomas; Rossmann, Michael G.; Kuhn, Richard J.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA; [Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rossmann, MG; Kuhn, RJ (corresponding author), Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.; Rossmann, MG; Kuhn, RJ (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	mr@purdue.edu; kuhnr@purdue.edu	Sirohi, Devika/I-7136-2019; Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; Sirohi, Devika/0000-0001-8601-6211	National Institute of Allergy and Infectious Diseases of the NIH [R01AI073755, R01AI076331]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076331, R01AI073755, ZIAAI001209] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. de Lamballerie (Emergence des Pathologies Virales, Aix-Marseille Universite, Marseille, France) and the European Virus Archive Goes Global (EVAg) for consenting to the use of the H/PF/2013 ZIKV strain for this study under a material transfer agreement with EVAg's partner, Aix-Marseille Universite, and we thank M. S. Diamond (Washington University, St. Louis, MO, USA) for sending the virus. We acknowledge E. Frye for help with sequence alignments. We also acknowledge the use of the Purdue cryo-EM facility. We are grateful to W. Jiang for his jspr program, which was used to perform the anisotropic magnification corrections, and Y. Liu for providing help in submitting the Protein Data Bank (PDB) coordinates. The work presented in this report was funded by the National Institute of Allergy and Infectious Diseases of the NIH through grants R01AI073755 and R01AI076331 to M.G.R. and R.J.K. T.C.P was supported by the intramural program of the National Institute of Allergy and Infectious Diseases. Supporting information for this research is provided in the supplementary materials. The atomic coordinates and cryo-EM density maps for the mature ZIKV are available at the PDB and Electron Microscopy Data Bank under accession codes 5IRE and EMD-8116, respectively.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baronti C, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00500-14; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; European Centre for Disease Prevention and Control (ECDC), 2016, RAP RISK ASS ZIK VIR; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Guo F, 2014, METHODS MOL BIOL, V1117, P401, DOI 10.1007/978-1-62703-776-1_19; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lindenbach BD, 2013, FIELDS VIROLOGY, P712; Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060; Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; World Health Organization, 2016, ZIKA STRATEGIC RESPO; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	36	498	533	7	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					467	470		10.1126/science.aaf5316	http://dx.doi.org/10.1126/science.aaf5316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27033547	Green Accepted			2022-12-28	WOS:000374479700049
J	Petersen, LR; Jamieson, DJ; Powers, AM; Honein, MA				Petersen, Lyle R.; Jamieson, Denise J.; Powers, Ann M.; Honein, Margaret A.			Zika Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONGENITAL CYTOMEGALOVIRUS-INFECTION; TREATED HOUSE SCREENS; WEST-NILE; DENGUE VIRUSES; AEDES-AEGYPTI; TRANSMISSION; INSECTICIDE; VECTOR; CHIKUNGUNYA; OUTBREAK	IN 1947, A STUDY OF YELLOW FEVER YIELDED THE FIRST ISOLATION OF A NEW virus, from the blood of a sentinel rhesus macaque that had been placed in the Zika Forest of Uganda.(1) Zika virus remained in relative obscurity for nearly 70 years; then, within the span of just 1 year, Zika virus was introduced into Brazil from the Pacific Islands and spread rapidly throughout the Americas.(2) It became the first major infectious disease linked to human birth defects to be discovered in more than half a century and created such global alarm that the World Health Organization (WHO) would declare a Public Health Emergency of International Concern.(3) This review describes the current understanding of the epidemiology, transmission, clinical characteristics, and diagnosis of Zika virus infection, as well as the future outlook with regard to this disease.	[Petersen, Lyle R.; Powers, Ann M.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Ft Collins, CO USA; [Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA; [Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disorders, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Petersen, LR (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.	lxp2@cdc.gov		Jamieson, Denise/0000-0003-2597-1201				Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968; Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969; Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397; Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609; Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107; Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068; Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x; BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6; Besnard M, 2014, Euro Surveill, V19; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; BROMLEY B, 1995, J ULTRAS MED, V14, P303; Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813; de Paula Freitas Bruno, 2016, JAMA Ophthalmol, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267; Den Hollander NS, 2000, ULTRASOUND OBST GYN, V15, P282, DOI 10.1046/j.1469-0705.2000.00092.x; Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3; Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x; European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR; FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147; Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1; Foulon I, 2012, INT J PEDIATR OTORHI, V76, P712, DOI 10.1016/j.ijporl.2012.02.026; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gabis L, 1997, J PERINAT MED, V25, P213; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323; Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137; Johnston D, 2016, MMWR-MORBID MORTAL W, V65, P34, DOI 10.15585/mmwr.mm6502a4; Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5; Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]; Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2; Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107; Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683; Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029; Lanciott RS, 2016, EMERG INFEC IN PRESS; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188; Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801; Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; Mallet H-P, 2015, BILAN EPIDEMIE VIRUS; Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533; Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9; Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1; Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; MILLER E, 1982, LANCET, V2, P781; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Mohammed H, 2012, TRANSFUSION, V52, P1652, DOI 10.1111/j.1537-2995.2011.03492.x; Monaghan AJ., 2016, PLOS CURR-TREE LIFE, V8, DOI [10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76, DOI 10.1371/CURRENTS.OUTBREAKS.50DFC7F46798675FC63E7D7DA563DA76]; MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2; MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983; Morens DM, 2010, EMERG INFECT DIS, V16, P1023, DOI 10.3201/eid1606.100453; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; National Birth Defects Prevention Network, 2013, MAJ BIRTH DEF DAT PO; Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2; Oehler E, 2014, Euro Surveill, V19; OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0; Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020; Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015; PECKHAM CS, 1972, ARCH DIS CHILD, V47, P571, DOI 10.1136/adc.47.254.571; Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915; POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7; Rasmussen SA, 1990, DYSMORPHOL CLIN GENE, V4, P53; Reddy UM, 2014, AM J OBSTET GYNECOL, V210, P387, DOI 10.1016/j.ajog.2014.02.028; Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290; Reiter P, 2003, EMERG INFECT DIS, V9, P86; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; RORKE LB, 1973, ARCH OTOLARYNGOL, V98, P249; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9; SMITHBURN KC, 1954, J IMMUNOL, V72, P248; SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630; SMITHBURN KC, 1952, J IMMUNOL, V69, P223; SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9; Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685; Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960; Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2; Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920; Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; Webster WS, 1998, TERATOLOGY, V58, P13; WELLER TH, 1962, NEW ENGL J MED, V266, P1233, DOI 10.1056/NEJM196206142662401; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882; World Health Organization, 2016, ZIK VIR MICR GUILL B; Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	136	803	835	7	319	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1552	1563		10.1056/NEJMra1602113	http://dx.doi.org/10.1056/NEJMra1602113			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7IA	27028561	Bronze			2022-12-28	WOS:000374383900008
J	Hawkes, N				Hawkes, Nigel			Neurology team finalists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2016	353								i2085	10.1136/bmj.i2085	http://dx.doi.org/10.1136/bmj.i2085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EV	27084570				2022-12-28	WOS:000374375600003
J	Polman, A; Knight, M; Garnett, EC; Ehrler, B; Sinke, WC				Polman, Albert; Knight, Mark; Garnett, Erik C.; Ehrler, Bruno; Sinke, Wim C.			Photovoltaic materials: Present efficiencies and future challenges	SCIENCE			English	Review							SILICON SOLAR-CELLS; RADIATIVE EFFICIENCY; LIMIT	Recent developments in photovoltaic materials have led to continual improvements in their efficiency. We review the electrical characteristics of 16 widely studied geometries of photovoltaic materials with efficiencies of 10 to 29%. Comparison of these characteristics to the fundamental limits based on the Shockley-Queisser detailed-balance model provides a basis for identifying the key limiting factors, related to efficient light management and charge carrier collection, for these materials. Prospects for practical application and large-area fabrication are discussed for each material.	[Polman, Albert; Knight, Mark; Garnett, Erik C.; Ehrler, Bruno; Sinke, Wim C.] FOM Inst AMOLF, Ctr Nanophoton, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands; [Sinke, Wim C.] Energy Res Ctr Netherlands ECN, POB 1, Petten, Netherlands	AMOLF	Polman, A (corresponding author), FOM Inst AMOLF, Ctr Nanophoton, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	a.polman@amolf.nl	Ehrler, Bruno/L-5700-2016; Knight, Mark W/E-3089-2010; Polman, Albert/D-1490-2011; Garnett, Erik C/A-6847-2009	Ehrler, Bruno/0000-0002-5307-3241; Knight, Mark W/0000-0001-7625-403X; Polman, Albert/0000-0002-0685-3886; Garnett, Erik C/0000-0002-9158-8326	NanoNextNL, a nanotechnology program of the Dutch ministry of economic affairs; European Research Council; Global Climate and Energy Project	NanoNextNL, a nanotechnology program of the Dutch ministry of economic affairs; European Research Council(European Research Council (ERC)European Commission); Global Climate and Energy Project	This work is part of the research program of the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisation for Scientific Research (NWO). It is also supported by NanoNextNL, a nanotechnology program of the Dutch ministry of economic affairs, the European Research Council, and the Global Climate and Energy Project. The authors declare no competing financial interests. The data are archived in the laboratory of A.P. The data in table S1 will be continuously updated and made available on http://lmpv.amolf.nl/SQ.	Ahn S.-W., 2012, 37 PVSEC C FRANKF SE; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Brongersma ML, 2014, NAT MATER, V13, P451, DOI [10.1038/NMAT3921, 10.1038/nmat3921]; Chiu PT, 2014, 2014 IEEE 40TH PHOTOVOLTAIC SPECIALIST CONFERENCE (PVSC), P11, DOI 10.1109/PVSC.2014.6924957; Chuang CHM, 2014, NAT MATER, V13, P796, DOI [10.1038/nmat3984, 10.1038/NMAT3984]; Cousins P. J., 2010, P 35 IEEE PHOT SPEC, P275, DOI [10.1109/PVSC.2010.5615850, DOI 10.1109/PVSC.2010.5615850]; Feldman D., 2016, TECHNOLOGY ADV NEEDE; Geisz JF, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816837; Glunz S. W., 2015, 31st European Photovoltaic Solar Energy Conference 2015 (EUPVSEC), P259; Green MA, 2016, PROG PHOTOVOLTAICS, V24, P3, DOI 10.1002/pip.2728; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P1, DOI 10.1002/pip.2573; Hosoya M., 2014, GRAND REN EN C TOK J; International Energy Agency, 2015, KEY WORLD EN STAT; International Energy Agency, 2014, TECHN ROADM SOL PHOT, DOI 10.1049/PBRN009E; Jackson P, 2015, PHYS STATUS SOLIDI-R, V9, P28, DOI 10.1002/pssr.201409520; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Kayes B. M., 2011, 2011 37th IEEE Photovoltaic Specialists Conference (PVSC 2011), P000004, DOI 10.1109/PVSC.2011.6185831; KEAVNEY CJ, 1990, IEEE PHOT SPEC CONF, P141, DOI 10.1109/PVSC.1990.111606; Kirchartz T, 2009, J PHYS CHEM C, V113, P17958, DOI 10.1021/jp906292h; Komiya R., 2011, 21 INT PHOT SCI ENG, V2; Kosten ED, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.1; Matsui Takuya, 2013, 28th European Photovoltaic Solar Energy Conference and Exhibition (EU PVSEC 2013). Proceedings, P2213; Mishima T, 2011, SOL ENERG MAT SOL C, V95, P18, DOI 10.1016/j.solmat.2010.04.030; National Renewable Energy Laboratory, 2016, BEST RES CELL EFF; Ozawa H, 2014, CHEMPHYSCHEM, V15, P1201, DOI 10.1002/cphc.201301025; Polman A, 2012, NAT MATER, V11, P174, DOI 10.1038/nmat3263; Rau U, 2004, APPL PHYS LETT, V84, P3735, DOI 10.1063/1.1737071; Rau U, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.035211; Richter A, 2013, IEEE J PHOTOVOLT, V3, P1184, DOI 10.1109/JPHOTOV.2013.2270351; Sai H, 2014, IEEE J PHOTOVOLT, V4, P1349, DOI 10.1109/JPHOTOV.2014.2355037; Sai H, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.104101; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; SMITH DD, 2012, P 38 IEEE PHOT SPEC, P1594, DOI DOI 10.1109/PVSC.2012.6317899; SUGIMOTO H, 2014, P 40 IEEE PHOT SPEC, P2767, DOI DOI 10.1109/PVSC.2014.6925503; Swanson R., 2012, WORKSH CHALL PV SCI; Tanabe K, 2009, ENERGIES, V2, P504, DOI 10.3390/en20300504; Tanabe Nobuo, 2013, Fujikura Technical Review, P109; TIEDJE T, 1982, APPL PHYS LETT, V40, P627, DOI 10.1063/1.93168; Todorov TK, 2010, ADV MATER, V22, pE156, DOI 10.1002/adma.200904155; Topic M, 2015, IEEE J PHOTOVOLT, V5, P360, DOI 10.1109/JPHOTOV.2014.2359135; Verlinden P., 2014, 6 WORLD C PV EN CONV; Virtuani A., 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion, P4248; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Xing GC, 2014, NAT MATER, V13, P476, DOI [10.1038/NMAT3911, 10.1038/nmat3911]; Zhao J, 1998, APPL PHYS LETT, V73, P1838, DOI 10.1063/1.122299	45	1266	1279	73	1064	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283							aad4424	10.1126/science.aad4424	http://dx.doi.org/10.1126/science.aad4424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081076	Green Submitted			2022-12-28	WOS:000373990100030
J	Karpe, F; Lindgren, CM				Karpe, Fredrik; Lindgren, Cecilia M.			Obesity - On or Off?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRIM28		[Karpe, Fredrik] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Radcliffe Dept Med, Oxford, England; [Karpe, Fredrik] Univ Oxford, Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England; [Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Med, Oxford, England; [Lindgren, Cecilia M.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Karpe, F (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Radcliffe Dept Med, Oxford, England.; Karpe, F (corresponding author), Univ Oxford, Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England.			Lindgren, Cecilia/0000-0002-4903-9374	Wellcome Trust [086596] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Al Adhami H, 2015, GENOME RES, V25, P353, DOI 10.1101/gr.175919.114; Dalgaard K, 2016, CELL, V164, P353, DOI 10.1016/j.cell.2015.12.025; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Whitelaw NC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r111	4	4	4	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1486	1488		10.1056/NEJMcibr1601693	http://dx.doi.org/10.1056/NEJMcibr1601693			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27074072	Green Accepted			2022-12-28	WOS:000374128400014
J	Levine, A				Levine, Alaina			Privacy rules	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					273	274		10.1038/nj7598-273a	http://dx.doi.org/10.1038/nj7598-273a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ7TJ	27081683	Bronze			2022-12-28	WOS:000374415100051
J	Oberlander, J				Oberlander, Jonathan			The Virtues and Vices of Single-Payer Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Oberlander, Jonathan] Univ N Carolina, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC USA.							Cutler D, 2012, NEW ENGL J MED, V367, P1875, DOI 10.1056/NEJMp1209711; Maioni Antonia, 2015, HLTH CARE CANADA; Marmor TR., 2009, COMP STUDIES POLITIC; Starr P., 2011, REMEDY REACTION PECU; White J, 2013, HEALTH ECON POLICY L, V8, P289, DOI 10.1017/S1744133112000308	5	13	13	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1401	1403		10.1056/NEJMp1602009	http://dx.doi.org/10.1056/NEJMp1602009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27074063				2022-12-28	WOS:000374128400002
J	Ladher, N				Ladher, Navjoyt			MEDICINE AND THE MEDIA Nutrition science in the media: you are what you read	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRESS RELEASES		[Ladher, Navjoyt] BMJ, London, England		Ladher, N (corresponding author), BMJ, London, England.	nladher@bmj.com						Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Dunlop C., 2015, PROCESSED MEAT CANC; Goldacre B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7465; Hackman EM, 1999, J AM DIET ASSOC, V99, P1564, DOI 10.1016/S0002-8223(99)00384-3; Ioannidis JPA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6698; McCartney M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i355; Nestle M, 2016, JAMA INTERN MED, V176, P13, DOI 10.1001/jamainternmed.2015.6667; Schoenfeld JD, 2013, AM J CLIN NUTR, V97, P127, DOI 10.3945/ajcn.112.047142; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Sumner P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7015	11	4	4	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2016	353								i1879	10.1136/bmj.i1879	http://dx.doi.org/10.1136/bmj.i1879			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LT	27056136				2022-12-28	WOS:000373895900005
J	Hawkes, N				Hawkes, Nigel			THE BMJ AWARDS 2016 Anaesthesia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2016	353								i1841	10.1136/bmj.i1841	http://dx.doi.org/10.1136/bmj.i1841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LL	27044650				2022-12-28	WOS:000373894800002
J	Castellanos-Rubio, A; Fernandez-Jimenez, N; Kratchmarov, R; Luo, XB; Bhagat, G; Green, PHR; Schneider, R; Kiledjian, M; Bilbao, JR; Ghosh, S				Castellanos-Rubio, Ainara; Fernandez-Jimenez, Nora; Kratchmarov, Radomir; Luo, Xiaobing; Bhagat, Govind; Green, Peter H. R.; Schneider, Robert; Kiledjian, Megerditch; Bilbao, Jose Ramon; Ghosh, Sankar			A long noncoding RNA associated with susceptibility to celiac disease	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLE COMMON; REPRESSION; COMPLEXES; VARIANTS; CELL	Recent studies have implicated long noncoding RNAs (lncRNAs) as regulators of many important biological processes. Here we report on the identification and characterization of a lncRNA, lnc13, that harbors a celiac disease-associated haplotype block and represses expression of certain inflammatory genes under homeostatic conditions. Lnc13 regulates gene expression by binding to hnRNPD, a member of a family of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). Upon stimulation, lnc13 levels are reduced, thereby allowing increased expression of the repressed genes. Lnc13 levels are significantly decreased in small intestinal biopsy samples from patients with celiac disease, which suggests that down-regulation of lnc13 may contribute to the inflammation seen in this disease. Furthermore, the lnc13 disease-associated variant binds hnRNPD less efficiently than its wild-type counterpart, thus helping to explain how these single-nucleotide polymorphisms contribute to celiac disease.	[Castellanos-Rubio, Ainara; Kratchmarov, Radomir; Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Fernandez-Jimenez, Nora; Bilbao, Jose Ramon] Univ Basque Country UPV EHU, BioCruces Res Inst, Dept Genet Phys Anthropol & Anim Physiol, Leioa 48940, Basque Country, Spain; [Luo, Xiaobing; Kiledjian, Megerditch] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bhagat, Govind] Columbia Univ, Coll Phys & Surg, Dept Med, Ctr Celiac Dis, New York, NY 10032 USA; [Bhagat, Govind; Green, Peter H. R.] NYU, Sch Med, Alexandria Ctr Life Sci, New York, NY 10016 USA; [Schneider, Robert] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Columbia University; University of Basque Country; Columbia University; Columbia University; New York University; Rutgers State University New Brunswick	Ghosh, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA.	sg2715@columbia.edu	Fernandez-Jimenez, Nora/T-1535-2019; Bhagat, Govind/AAE-9493-2021; Castellanos-Rubio, Ainara/AAB-9700-2022; Bilbao, Jose Ramon/A-9177-2008	Bhagat, Govind/0000-0001-6250-048X; Bilbao, Jose Ramon/0000-0002-3176-501X; Kratchmarov, Radomir/0000-0002-6796-8564; Castellanos Rubio, Ainara/0000-0003-3192-9544; Schneider, Robert/0000-0001-5807-5564; Fernandez-Jimenez, Nora/0000-0001-6307-0880; Kiledjian, Megerditch/0000-0001-8099-0451	Basque government (Spain); Basque Department of Health [2011111034]; Spanish Instituto de Salud Carlos III [PI10/00310]; NIH [RO1-GM067005, R37-AI33443, RO1-AI093985, R01-DK102180]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033443, R37AI033443, R01AI093985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067005] Funding Source: NIH RePORTER	Basque government (Spain)(Basque Government); Basque Department of Health(Basque Government); Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Gurunathan for assistance with writing the paper and helpful discussions, B. Reizis and C. Schindler for reading the paper and providing helpful comments, and S. Zhang for the mass spectrometry analysis. The data presented here are tabulated in the main paper and the supplementary materials. The sequences reported in this paper have been deposited in the GenBank database (accession number KU712258). This work was supported by a research fellowship from the Basque government (Spain) to A. C.-R. and N.F.-J.; grants from the Basque Department of Health (2011111034) and the Spanish Instituto de Salud Carlos III (PI10/00310) to J. R. B.; NIH grant RO1-GM067005 to M. K.; and NIH grants R37-AI33443, RO1-AI093985, and R01-DK102180 to S.G.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Engreitz J, 2015, METHODS MOL BIOL, V1262, P183, DOI 10.1007/978-1-4939-2253-6_11; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fernandez-Jimenez N, 2014, HUM MOL GENET, V23, P1298, DOI 10.1093/hmg/ddt520; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jin GF, 2011, CARCINOGENESIS, V32, P1655, DOI 10.1093/carcin/bgr187; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lee C, 2008, CEREB CORTEX, V18, P2909, DOI 10.1093/cercor/bhn051; Li Y, 2008, MOL CELL BIOL, V28, P939, DOI 10.1128/MCB.01727-07; Li Y, 2011, RNA, V17, P419, DOI 10.1261/rna.2439811; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; Periolo N, 2014, CYTOKINE, V67, P44, DOI 10.1016/j.cyto.2014.01.004; Sadri N, 2009, J INVEST DERMATOL, V129, P657, DOI 10.1038/jid.2008.298; Salamov AA, 1998, BIOINFORMATICS, V14, P384, DOI 10.1093/bioinformatics/14.5.384; Skipper M, 2015, NATURE, V518, P313, DOI 10.1038/518313a; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010	30	155	162	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					91	95		10.1126/science.aad0467	http://dx.doi.org/10.1126/science.aad0467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034373	Green Accepted			2022-12-28	WOS:000373039600042
J	Balani, A; Marda, SS				Balani, Ankit; Marda, Sapna S.			Paget's Disease of Bone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Balani, Ankit; Marda, Sapna S.] Yashoda Hosp, Secunderabad, India		Balani, A (corresponding author), Yashoda Hosp, Secunderabad, India.	drankitbalani@gmail.com							0	1	2	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1264	1264		10.1056/NEJMicm1502815	http://dx.doi.org/10.1056/NEJMicm1502815			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8ZM	27028916				2022-12-28	WOS:000373085500009
J	Barrett, J				Barrett, James			PERSONAL VIEW Doctors are failing to help people with gender dysphoria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ESTROGEN PLUS PROGESTIN		[Barrett, James] Charing Cross Gender Ident Clin, 179-183 Fulham Palace Rd, London W6 8QZ, England		Barrett, J (corresponding author), Charing Cross Gender Ident Clin, 179-183 Fulham Palace Rd, London W6 8QZ, England.	James.Barrett@wlmht.nhs.uk						Barrett J, 2007, TRANSSEXUAL OTHER DI, P157; General Medical Council, GUID DOCT TREAT TRAN; Haraldsen IR, 2000, ACTA PSYCHIAT SCAND, V102, P276, DOI 10.1034/j.1600-0447.2000.102004276.x; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; NHS England, 2014, SSC1417 NHS ENGL; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Toorians AWFT, 2003, J CLIN ENDOCR METAB, V88, P5723, DOI 10.1210/jc.2003-030520; vanKesteren PJM, 1997, CLIN ENDOCRINOL, V47, P337, DOI 10.1046/j.1365-2265.1997.2601068.x	8	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2016	352								i1694	10.1136/bmj.i1694	http://dx.doi.org/10.1136/bmj.i1694			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TO	27030467				2022-12-28	WOS:000373492400007
J	Watts, G				Watts, Geoff			Paul Ichiro Terasaki Obituary	LANCET			English	Biographical-Item																		TERASAKI P, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1156	1156		10.1016/S0140-6736(16)30010-1	http://dx.doi.org/10.1016/S0140-6736(16)30010-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	27030848	Bronze			2022-12-28	WOS:000372412000015
J	Martin, SS; Hasan, RK				Martin, Seth S.; Hasan, Rani K.			Bioresorbable Vascular Scaffolds in Coronary Artery Disease: Weighing the Evidence and Next Steps	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ELUTING STENTS		[Martin, Seth S.; Hasan, Rani K.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA	Johns Hopkins University	Martin, SS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA.	smart100@jhmi.edu		Martin, Seth/0000-0002-7021-7622				Cassese S, 2016, LANCET, V387, P537, DOI 10.1016/S0140-6736(15)00979-4; Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038; Farooq V, 2014, EUROINTERVENTION, V10, P419, DOI 10.4244/EIJV10I4A73; Jeremias A, 2008, ANN INTERN MED, V148, P234, DOI 10.7326/0003-4819-148-3-200802050-00199; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Tamburino C, 2016, JACC-CARDIOVASC INTE, V9, P440, DOI 10.1016/j.jcin.2015.10.042; Zhang XL, 2016, ANN INTERN MED, V164, P752, DOI 10.7326/M16-0006	7	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2016	164	11					775	+		10.7326/M16-0754	http://dx.doi.org/10.7326/M16-0754			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1AI	27043657				2022-12-28	WOS:000377510100011
J	Kuratani, S; Hirasawa, T				Kuratani, Shigeru; Hirasawa, Tatsuya			Getting the measure of a monster	NATURE			English	Editorial Material							EVOLUTION		[Kuratani, Shigeru; Hirasawa, Tatsuya] RIKEN, Evolutionary Morphol Lab, Kobe, Hyogo 6500047, Japan	RIKEN	Kuratani, S; Hirasawa, T (corresponding author), RIKEN, Evolutionary Morphol Lab, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp; hirasawa@cdb.riken.jp	Kuratani, Shigeru/J-4146-2014; Hirasawa, Tatsuya/C-5347-2017	Kuratani, Shigeru/0000-0001-9717-7221; Hirasawa, Tatsuya/0000-0001-6868-3379				Clements T, 2016, NATURE, V532, P500, DOI 10.1038/nature17647; Janvier P., 1996, EARLY VERTEBRATES; JOHNSON R G, 1969, Fieldiana Geology, V12, P119; Kuraku S, 2006, ZOOL SCI, V23, P1053, DOI 10.2108/zsj.23.1053; McCoy VE, 2016, NATURE, V532, P496, DOI 10.1038/nature16992; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; RICHARDSON ES, 1966, SCIENCE, V151, P75, DOI 10.1126/science.151.3706.75-a; Traquair R. H., 1890, Annals of Natural History, V(6), P479	8	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					447	448		10.1038/nature17885	http://dx.doi.org/10.1038/nature17885			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27074506				2022-12-28	WOS:000374815900032
J	Paek, AL; Liu, JC; Loewer, A; Forrester, WC; Lahav, G				Paek, Andrew L.; Liu, Julia C.; Loewer, Alexander; Forrester, William C.; Lahav, Galit			Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing	CELL			English	Article							ALPHA-DEPENDENT APOPTOSIS; CANCER-CELLS; SINGLE CELLS; COLORECTAL-CANCER; GENOTOXIC STRESS; DRUG-RESISTANCE; GENE-EXPRESSION; TUMOR-CELLS; IAP; CHEMOTHERAPY	Many chemotherapeutic drugs kill only a fraction of cancer cells, limiting their efficacy. We used live-cell imaging to investigate the role of p53 dynamics in fractional killing of colon cancer cells in response to chemotherapy. We found that both surviving and dying cells reach similar levels of p53, indicating that cell death is not determined by a fixed p53 threshold. Instead, a cell's probability of death depends on the time and levels of p53. Cells must reach a threshold level of p53 to execute apoptosis, and this threshold increases with time. The increase in p53 apoptotic threshold is due to drug-dependent induction of anti-apoptotic genes, predominantly in the inhibitors of apoptosis (IAP) family. Our study underlines the importance of measuring the dynamics of key players in response to chemotherapy to determine mechanisms of resistance and optimize the timing of combination therapy.	[Paek, Andrew L.; Liu, Julia C.; Loewer, Alexander; Lahav, Galit] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Forrester, William C.] Novartis Inst Biomed Res, Dev & Mol Pathways, Cambridge, MA 02139 USA; [Loewer, Alexander] Tech Univ Darmstadt, Dept Biol, Petersenstr 30, D-64287 Darmstadt, Germany	Harvard University; Harvard Medical School; Novartis; Technical University of Darmstadt	Lahav, G (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	galit@hms.harvard.edu	Loewer, Alexander/AAL-6943-2021	Loewer, Alexander/0000-0002-8819-3040; Liu, Julia/0000-0002-8604-1633; Paek, Andrew/0000-0002-2835-8544	Novartis Institutes for Biomedical Research; NIH [GM083303]; American Cancer Society New England Division-Ellison Foundation Postdoctoral Fellowship; Molecular Biophysics Training Grant [NIH/NIGMS T32008313]; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083303] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society New England Division-Ellison Foundation Postdoctoral Fellowship; Molecular Biophysics Training Grant; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Wethank T. Weinert, U. Alon, and S. Gaudet for comments and discussions; G. Gaglia for the p21 promoter construct, S. Chen, J. Stewart-Ornstein, A. Iagovitina, and J. Reyes for advice on figures; J. Porter for support and encouragement; A. Kedves for help with initial cisplatin studies; the Nikon Imaging Center at Harvard Medical School for help with microscopy; and members of the Lahav lab for comments and discussion. This research was supported by Novartis Institutes for Biomedical Research and NIH grant GM083303. A.L.P. was supported by an American Cancer Society New England Division-Ellison Foundation Postdoctoral Fellowship. J.C.L. was supported by the Molecular Biophysics Training Grant (NIH/NIGMS T32008313) and the National Science Foundation Graduate Research Fellowship.	Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Altena R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115372; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Becker A, 2011, EUR J CANCER, V47, P2603, DOI 10.1016/j.ejca.2011.06.046; Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Flusberg DA, 2013, MOL BIOL CELL, V24, P2186, DOI 10.1091/mbc.E12-10-0737; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hussner J, 2012, MOL PHARMACOL, V81, P679, DOI 10.1124/mol.111.075994; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kuchina A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.88; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lee REC, 2014, MOL CELL, V53, P867, DOI 10.1016/j.molcel.2014.01.026; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Loewer A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-114; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Lopes RB, 2007, INT J CANCER, V120, P2344, DOI 10.1002/ijc.22554; Nakagawa Y, 2006, AM J HEMATOL, V81, P824, DOI 10.1002/ajh.20656; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rashi-Elkeles S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005032; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Roux J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145584; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tirro E, 2006, CANCER RES, V66, P4263, DOI 10.1158/0008-5472.CAN-05-3248; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhu Y, 2013, GENE DEV, V27, P1739, DOI 10.1101/gad.212258.112	58	151	154	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					631	642		10.1016/j.cell.2016.03.025	http://dx.doi.org/10.1016/j.cell.2016.03.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27062928	Green Accepted, Bronze			2022-12-28	WOS:000374636800021
J	Lerner, BH; Caplan, AL				Lerner, Barron H.; Caplan, Arthur L.			Judging the Past: How History Should Inform Bioethics	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TUSKEGEE; SYPHILIS; ETHICS	Bioethics has become a common course of study in medical schools, other health professional schools, and graduate and undergraduate programs. An analysis of past ethical scandals, as well as the bioethics apparatus that emerged in response to them, is often central to the discussion of bioethical questions. This historical perspective on bioethics is invaluable and demonstrates how, for example, the infamous Tuskegee syphilis study was inherently racist and how other experiments exploited mentally disabled and other disadvantaged persons. However, such instruction can resemble so-called Whig history, in which a supposedly more enlightened mindset is seen as having replaced the "bad old days" of physicians behaving immorally. Bioethical discourse-both in the classroom and in practice-should be accompanied by efforts to historicize but not minimize past ethical transgressions. That is, bioethics needs to emphasize why and how such events occurred rather than merely condemning them with an air of moral superiority. Such instruction can reveal the complicated historical circumstances that led physician-researchers ( some of whom were actually quite progressive in their thinking) to embark on projects that seem so unethical in hindsight. Such an approach is not meant to exonerate past transgressions but rather to explain them. In this manner, students and practitioners of bioethics can better appreciate how modern health professionals may be susceptible to the same types of pressures, misguided thinking, and conflicts of interest that sometimes led their predecessors astray.	[Lerner, Barron H.; Caplan, Arthur L.] NYU, Langone Sch Med, New York, NY 10016 USA; [Lerner, Barron H.; Caplan, Arthur L.] NYU, Langone Sch Med, Div Med Eth, 227 East 30th St,7th Floor, New York, NY 10016 USA; [Lerner, Barron H.] NYU, Langone Sch Med, Div Gen Internal Med, 227 East 30th St,7th Floor, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Lerner, BH (corresponding author), NYU, Langone Sch Med, Div Med Eth, 227 East 30th St,7th Floor, New York, NY 10016 USA.; Lerner, BH (corresponding author), NYU, Langone Sch Med, Div Gen Internal Med, 227 East 30th St,7th Floor, New York, NY 10016 USA.	barron.lerner@nyumc.org						Advisory Committee on Human Radiation Experiments, 1995, FIN REP; BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; Benedek TG, 1999, PERSPECT BIOL MED, V43, P1; Bernard C., 1957, INTRO LIT CORRES TON; BRANDT AM, 1978, HASTINGS CENT REP, V8, P21, DOI 10.2307/3561468; Brandt AM., 2007, CIGARETTE CENTURY RI; Braslow Joel, 1997, MENTAL ILLS BODILY C, DOI 10.1525/9780520917934; Cimons M, 1995, LOS ANGELES TIMES; El -Hai Jack, 2005, LOBOTOMIST MAVERICK; Greenberg D., 2015, GREAT RENAMING CRAZE; Howard S, 1931, ARROWSMITH; Jones JH., 1981, BAD BLOOD TUSKEGEE S; Lederer Susan, 1995, SUBJECTED SCI HUMAN; Lerner BH, 2004, NEW ENGL J MED, V351, P628, DOI 10.1056/NEJMp048108; LERNER BH, 1995, ANN INTERN MED, V122, P793, DOI 10.7326/0003-4819-122-10-199505150-00010; Lukianoff D, 2015, ATLANTIC; McNeil Jr D.G., 2010, NY TIMES; Muller-Hill Benno, 1992, MED WENT MAD BIOETHI; Ogren Kenneth, 2005, J Hist Neurosci, V14, P353, DOI 10.1080/096470490897692; Pernick MS, 2009, CAMBRIDGE WORLD HIST, P16; Pressman Jack, 1998, LAST RESORT PSYCHOSU; Proctor R.N., 2012, GOLDEN HOLOCAUST, DOI [10.1525/9780520950436, DOI 10.1525/9780520950436]; Reverby S., 2000, TUSKEGEES TRUTHS RET; Reverby SM, 2016, IMPACT EHICS; Reverby SM., 2013, EXAMINNIG TUSKEGEE I; Reverby SM, 2012, PUBLIC HEALTH REV, V34, DOI 10.1007/BF03391665; Reverby SM, 2014, B HIST MED, V88, P403, DOI 10.1353/bhm.2014.0062; Reynolds L, 2015, PLAZA PUBLICA; Rothman D., 1991, STRANGERS BEDSIDE HI, DOI DOI 10.4324/9781315130286; Rothman David J, 1996, JAMA, V276, P421, DOI 10.1001/jama.276.5.421; ROTHMAN DJ, 1982, HASTINGS CENT REP, V12, P5, DOI 10.2307/3561798; Welsome Eileen, 1999, PLUTONIUM FILES AM S; Wheeler Timothy B., 2014, BALTIMORE SUN	33	15	15	1	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					553	+		10.7326/M15-2642	http://dx.doi.org/10.7326/M15-2642			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	DJ5OH	27089070				2022-12-28	WOS:000374257900014
J	Yang, YT; Kozhimannil, KB; Snowden, JM				Yang, Y. Tony; Kozhimannil, Katy B.; Snowden, Jonathan M.			Pharmacist-Prescribed Birth Control in Oregon and Other States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Yang, Y. Tony] George Mason Univ, Dept Hlth Adm & Policy, MS 1J3,4400 Univ Dr, Fairfax, VA 22030 USA; [Kozhimannil, Katy B.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Snowden, Jonathan M.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA	George Mason University; University of Minnesota System; University of Minnesota Twin Cities; Oregon Health & Science University	Yang, YT (corresponding author), George Mason Univ, Dept Hlth Adm & Policy, MS 1J3,4400 Univ Dr, Fairfax, VA 22030 USA.	ytyang@gmu.edu						Belluck P, 2015, NY TIMES, pA14; Centers for Disease Control and Prevention, REPR HLTH DAT STAT REPR HLTH DAT STAT; Committee on Gynecologic Practice American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P1527, DOI 10.1097/01.AOG.0000423818.85283.bd; Dehlendorf C, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.037; Grindlay K, 2013, CONTRACEPTION, V88, P91, DOI 10.1016/j.contraception.2012.11.021; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Sonfield A., GUTTMACHER POLICY RE	7	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1567	1568		10.1001/jama.2016.2327	http://dx.doi.org/10.1001/jama.2016.2327			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	27019133				2022-12-28	WOS:000374289300012
J	Rutten, FH; Clark, AL; Hoes, AW				Rutten, Frans H.; Clark, Andrew L.; Hoes, Arno W.			How big a problem is heart failure with a normal ejection fraction?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EUROPEAN-SOCIETY; PREVALENCE; EPIDEMIOLOGY; DYSFUNCTION; DIAGNOSIS; PEOPLE		[Rutten, Frans H.; Hoes, Arno W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Clark, Andrew L.] Univ Hull, Castle Hill Hosp, Hull York Med Sch, Dept Cardiol, Cottingham, England	Utrecht University; Utrecht University Medical Center; University of Hull; University of York - UK	Rutten, FH (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	f.h.rutten@umcutrecht.nl						Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Boonman-de Winter LJM, 2015, INT J CARDIOL, V185, P162, DOI 10.1016/j.ijcard.2015.03.120; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Gerber Y, 2015, JAMA INTERN MED, V175, P996, DOI 10.1001/jamainternmed.2015.0924; Ingle L, 2008, HEART, V94, P748, DOI 10.1136/hrt.2007.131144; Lam CSP, 2014, EUR J HEART FAIL, V16, P1049, DOI 10.1002/ejhf.159; Maisel AS, 2015, J CARD FAIL; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Mureddu GF, 2012, EUR J HEART FAIL, V14, P718, DOI 10.1093/eurjhf/hfs052; National Institute Health and Clinical Excellence, 2010, CHRON HEART FAIL MAN; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pandey A, 2015, CIRC-HEART FAIL, V8, P33, DOI 10.1161/CIRCHEARTFAILURE.114.001615; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Rutten FH, 2005, BMJ-BRIT MED J, V331, P1379, DOI 10.1136/bmj.38664.661181.55; Senni M, 2014, EUR HEART J, V35, P2797, DOI 10.1093/eurheartj/ehu204; Taylor CJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005256; van Mourik Y, 2014, AGE AGEING, V43, P319, DOI 10.1093/ageing/afu001; van Riet EES, 2016, EUR J HEART FAIL, V18, P242, DOI 10.1002/ejhf.483; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	24	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2016	353								i1706	10.1136/bmj.i1706	http://dx.doi.org/10.1136/bmj.i1706			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZB	27091176	Green Published			2022-12-28	WOS:000374998700018
J	Lin, DH; Stuwe, T; Schilbach, S; Rundlet, EJ; Perriches, T; Mobbs, G; Fan, Y; Thierbach, K; Huber, FM; Collins, LN; Davenport, AM; Jeon, YE; Hoelz, A				Lin, Daniel H.; Stuwe, Tobias; Schilbach, Sandra; Rundlet, Emily J.; Perriches, Thibaud; Mobbs, George; Fan, Yanbin; Thierbach, Karsten; Huber, Ferdinand M.; Collins, Leslie N.; Davenport, Andrew M.; Jeon, Young E.; Hoelz, Andre			Architecture of the symmetric core of the nuclear pore	SCIENCE			English	Article							CRYSTAL-STRUCTURE; NUCLEOCYTOPLASMIC TRANSPORT; STRUCTURAL-ANALYSIS; FUNCTIONAL-ANALYSIS; REPEAT EXPANSION; INNER RING; COMPLEX; PROTEINS; REVEALS; DOMAIN	The nuclear pore complex (NPC) controls the transport of macromolecules between the nucleus and cytoplasm, but its molecular architecture has thus far remained poorly defined. We biochemically reconstituted NPC core protomers and elucidated the underlying protein-protein interaction network. Flexible linker sequences, rather than interactions between the structured core scaffold nucleoporins, mediate the assembly of the inner ring complex and its attachment to the NPC coat. X-ray crystallographic analysis of these scaffold nucleoporins revealed the molecular details of their interactions with the flexible linker sequences and enabled construction of full-length atomic structures. By docking these structures into the cryoelectron tomographic reconstruction of the intact human NPC and validating their placement with our nucleoporin interactome, we built a composite structure of the NPC symmetric core that contains similar to 320,000 residues and accounts for similar to 56 megadaltons of the NPC's structured mass. Our approach provides a paradigm for the structure determination of similarly complex macromolecular assemblies.	[Lin, Daniel H.; Stuwe, Tobias; Schilbach, Sandra; Rundlet, Emily J.; Perriches, Thibaud; Mobbs, George; Fan, Yanbin; Thierbach, Karsten; Huber, Ferdinand M.; Collins, Leslie N.; Davenport, Andrew M.; Jeon, Young E.; Hoelz, Andre] CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA	California Institute of Technology	Hoelz, A (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	hoelz@caltech.edu	Fan, Yanbin/AAM-5960-2020; Hoelz, Andre/AAB-6978-2021	Schilbach, Sandra/0000-0001-9071-8515	U. S. Department of Energy; National Institutes of Health (NIH); National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; NIH [5 T32 GM07616, R01-GM111461]; Amgen Graduate Fellowship through the Caltech-Amgen Research Collaboration; Deutsche Forschungsgemeinschaft; Boehringer Ingelheim Fonds; China Scholarship Council; Caltech startup funds; Albert Wyrick V Scholar Award from the V Foundation for Cancer Research; 54th Mallinckrodt Scholar Award from the Edward Mallinckrodt Jr. Foundation; Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research; Camille-Dreyfus Teacher Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616, R01GM111461, R01GM117360] Funding Source: NIH RePORTER	U. S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Graduate Fellowship through the Caltech-Amgen Research Collaboration(Amgen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); China Scholarship Council(China Scholarship Council); Caltech startup funds; Albert Wyrick V Scholar Award from the V Foundation for Cancer Research; 54th Mallinckrodt Scholar Award from the Edward Mallinckrodt Jr. Foundation; Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research; Camille-Dreyfus Teacher Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.-Y. Mock, S. Petrovic, and A. Patke for critical reading of the manuscript. We thank M. Beck for sharing the cryo-ET reconstruction of the intact human NPC before publication; E. Hurt for providing material and discussions; and C. Bayes, S. Butkovich, C. Frick, A. Koehl, H. Kuberczyk, R. Tran, and S. Zimmerman for experimental support. We also acknowledge J. Kaiser and the scientific staff of the SSRL beamline 12-2, the National Institute of General Medical Sciences and National Cancer Institute Structural Biology Facility (GM/CA) at the APS, and the ALS beamline 8.2.1 for their support with x-ray diffraction measurements. We acknowledge the Gordon and Betty Moore Foundation, the Beckman Institute, and the Sanofi-Aventis Bioengineering Research Program for their support of the Molecular Observatory at the California Institute of Technology (Caltech). The operations at the SSRL, ALS, and APS are supported by the U. S. Department of Energy and the National Institutes of Health (NIH). GM/CA has been funded in whole or in part with federal funds from the National Cancer Institute (grant ACB-12002) and the National Institute of General Medical Sciences (grant AGM-12006). D.H.L and A. M. D. were supported by a NIH Research Service Award (5 T32 GM07616). D.H.L. was also supported by an Amgen Graduate Fellowship through the Caltech-Amgen Research Collaboration. T.S. was supported by a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft. F.M.H. was supported by a doctoral fellowship from the Boehringer Ingelheim Fonds. Y. F. was supported by a visiting doctoral student scholarship from the China Scholarship Council. A. H. was supported by Caltech startup funds, the Albert Wyrick V Scholar Award from the V Foundation for Cancer Research, the 54th Mallinckrodt Scholar Award from the Edward Mallinckrodt Jr. Foundation, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research, a Camille-Dreyfus Teacher Scholar Award, and NIH grant R01-GM111461, and he is an inaugural Heritage Principal Investigator of the Heritage Medical Research Institute. The coordinates and structure factors have been deposited in the PDB with accession numbers 5HAX (Nup170<SUP>NTD</SUP>.Nup53<SUP>R3</SUP>), 5HAY (Nup170<SUP>CTD</SUP>), 5HAZ (Nup170<SUP>CTD</SUP>), 5HB0 (Nup170<SUP>CTD</SUP>.Nup145N<SUP>R3</SUP>), 5HB1 (Nup170<SUP>SOL</SUP>), 5HB2 (Nic96<SUP>SOL</SUP>), 5HB3 (Nic96<SUP>SOL</SUP>.Nup53<SUP>R2</SUP>), 5HB4 (Nup192<SUP>Delta HEAD</SUP>), 5HB5 (Nup145N<SUP>APD</SUP>), 5HB6 (Nup145N<SUP>APD</SUP>.Nup145C<SUP>N</SUP>), 5HB7 (Nup53<SUP>RRM</SUP>, space group P2<INF>1</INF>2<INF>1</INF>2<INF>1</INF>), and 5HB8 (Nup53<SUP>RRM</SUP>, space group P3<INF>1</INF>21). A PyMol session file containing the composite structure of the NPC symmetric core can be obtained from our webpage (http://ahweb.caltech.edu). The authors declare no financial conflicts of interest. This work is dedicated to the memory of Mandy Hoelz.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Andersen KR, 2013, ELIFE, V2, DOI 10.7554/eLife.00745; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Bilokapic S, 2012, P NATL ACAD SCI USA, V109, P15241, DOI 10.1073/pnas.1205151109; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Chug H, 2015, SCIENCE, V350, P106, DOI 10.1126/science.aac7420; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eibauer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8532; Eisenhardt N, 2014, J CELL SCI, V127, P908, DOI 10.1242/jcs.141739; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez DI, 2013, BIOPHYS J, V104, P1495, DOI 10.1016/j.bpj.2013.01.059; Fischer J, 2015, NAT STRUCT MOL BIOL, V22, P774, DOI 10.1038/nsmb.3084; Flemming D, 2012, J STRUCT BIOL, V177, P99, DOI 10.1016/j.jsb.2011.11.008; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Ibarra A, 2015, GENE DEV, V29, P337, DOI 10.1101/gad.256495.114; Jeudy S, 2007, J BIOL CHEM, V282, P34904, DOI 10.1074/jbc.M705479200; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545; Katta SS, 2014, TRENDS CELL BIOL, V24, P221, DOI 10.1016/j.tcb.2013.10.006; Kelley K, 2015, NAT STRUCT MOL BIOL, V22, P425, DOI 10.1038/nsmb.2998; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P2911, DOI 10.1074/mcp.M114.040915; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Le Sage V, 2013, VIRUSES-BASEL, V5, P2019, DOI 10.3390/v5082019; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Makio T, 2009, J CELL BIOL, V185, P459, DOI 10.1083/jcb.200810029; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Onischenko E, 2009, J CELL BIOL, V185, P475, DOI 10.1083/jcb.200810030; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Romier C, 2006, ACTA CRYSTALLOGR D, V62, P1232, DOI 10.1107/S0907444906031003; Sampathkumar P, 2013, STRUCTURE, V21, P560, DOI 10.1016/j.str.2013.02.005; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Seo HS, 2013, P NATL ACAD SCI USA, V110, P16450, DOI 10.1073/pnas.1316607110; Seo HS, 2009, P NATL ACAD SCI USA, V106, P14281, DOI 10.1073/pnas.0907453106; Stuwe T, 2015, SCIENCE, V350, P56, DOI 10.1126/science.aac9176; Stuwe T, 2015, SCIENCE, V347, P1148, DOI 10.1126/science.aaa4136; Stuwe T, 2014, P NATL ACAD SCI USA, V111, P2530, DOI 10.1073/pnas.1311081111; Teixeira MT, 1997, EMBO J, V16, P5086, DOI 10.1093/emboj/16.16.5086; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thierbach K, 2013, STRUCTURE, V21, P1672, DOI 10.1016/j.str.2013.07.004; Ungricht R, 2015, CURR OPIN CELL BIOL, V34, P135, DOI 10.1016/j.ceb.2015.04.005; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Whittle JRR, 2009, J BIOL CHEM, V284, P28442, DOI 10.1074/jbc.M109.023580; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wyatt PJ, 1997, INSTRUM SCI TECHNOL, V25, P1, DOI 10.1080/10739149709351443; Xu C, 2015, FEBS LETT, V589, P3247, DOI 10.1016/j.febslet.2015.09.008; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973	67	158	158	5	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283							aaf1015	10.1126/science.aaf1015	http://dx.doi.org/10.1126/science.aaf1015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081075	Green Accepted			2022-12-28	WOS:000373990100031
J	Thomas, AA; Denmark, SE				Thomas, Andy A.; Denmark, Scott E.			Pre-transmetalation intermediates in the Suzuki-Miyaura reaction revealed: The missing link	SCIENCE			English	Article							CROSS-COUPLING REACTIONS; RAPID-INJECTION NMR; DIRECT ARYLATION; ANIONIC BASES; ELECTROPHILES; ELIMINATION; COMPLEXES; MECHANISM; CATALYSIS; RHODIUM	Despite the widespread application of Suzuki-Miyaura cross-coupling to forge carbon-carbon bonds, the structure of the reactive intermediates underlying the key transmetalation step from the boron reagent to the palladium catalyst remains uncertain. Here we report the use of low-temperature rapid injection nuclear magnetic resonance spectroscopy and kinetic studies to generate, observe, and characterize these previously elusive complexes. Specifically, this work establishes the identity of three different species containing palladium-oxygen-boron linkages, a tricoordinate boronic acid complex, and two tetracoordinate boronate complexes with 2: 1 and 1: 1 stoichiometry with respect to palladium. All of these species transfer their boron-bearing aryl groups to a coordinatively unsaturated palladium center in the critical transmetalation event.	[Thomas, Andy A.; Denmark, Scott E.] Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Denmark, SE (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.	sdenmark@illinois.edu	Denmark, Scott E/A-8888-2008	Denmark, Scott E/0000-0002-1099-9765; Thomas, Andy/0000-0001-6336-5566	NSF [CHE-1012663, CHE-1151566]; University of Illinois; NIH [S10-RR028833]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028833] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); University of Illinois; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We are grateful for generous financial support from the NSF (CHE-1012663 and CHE-1151566). A.A.T. is grateful to the University of Illinois for graduate fellowships. We thank L. Zhu for helpful suggestions regarding NMR spectroscopy. Some of the data presented here were collected in the Core Facilities of the Carl R. Woese Institute for Genomic Biology on a 600-MHz NMR instrument (funded by NIH grant S10-RR028833) or at the Integrated Molecular Structure Education and Research Center at Northwestern University. Full experimental procedures, characterization and kinetic data, and copies of the <SUP>1</SUP>H, <SUP>13</SUP>C, <SUP>31</SUP>P, <SUP>19</SUP>F, <SUP>11</SUP>B, NOE, and exchange spectra can be found in the supplementary materials.	ALIPRANTIS AO, 1994, J AM CHEM SOC, V116, P6985, DOI 10.1021/ja00094a083; Amatore C, 2013, CHEM-EUR J, V19, P10082, DOI 10.1002/chem.201300177; Amatore C, 2012, CHEM-EUR J, V18, P6616, DOI 10.1002/chem.201200516; Amatore C, 2011, CHEM-EUR J, V17, P2492, DOI 10.1002/chem.201001911; BROWN HC, 1945, J AM CHEM SOC, V67, P374, DOI 10.1021/ja01219a007; Carrow BP, 2011, J AM CHEM SOC, V133, P2116, DOI 10.1021/ja1108326; Chang W.-T. T., 2011, ORGANIC REACTIONS, P213; Chemla F, 2014, METAL CATALYZED CROS, V1, P365; Denmark SE, 2010, J ORG CHEM, V75, P5558, DOI 10.1021/jo100837a; Driver MS, 1997, ORGANOMETALLICS, V16, P5706, DOI 10.1021/om970856l; Fu GC, 2008, ACCOUNTS CHEM RES, V41, P1555, DOI 10.1021/ar800148f; Grushin VV, 1996, ORGANOMETALLICS, V15, P5242, DOI 10.1021/om9605544; Lee J. C. H., 2014, METAL CATALYZED CROS, P65; Lennox AJJ, 2013, ANGEW CHEM INT EDIT, V52, P7362, DOI 10.1002/anie.201301737; Liu J., 2005, BORONIC ACIDS PREPAR, V2, P612; Magano J, 2011, CHEM REV, V111, P2177, DOI 10.1021/cr100346g; Martin-Matute B., 2014, METAL CATALYZED CROS, V1, P423; Matos K, 1998, J ORG CHEM, V63, P461, DOI 10.1021/jo971681s; Matthias B., 2013, TOPICS ORGANOMETALLI, V42; MCGARRITY JF, 1984, J ORG CHEM, V49, P4465, DOI 10.1021/jo00197a027; MIYAURA N, 1979, J CHEM SOC CHEM COMM, P866, DOI 10.1039/c39790000866; Nishihara Y, 2004, CHEM COMMUN, P192, DOI 10.1039/b308741g; Noth H., 1978, NUCL MAGNETIC RESONA, V14, P74; Pantcheva I, 2005, ORGANOMETALLICS, V24, P3815, DOI 10.1021/om049050t; PERKINS CW, 1980, J AM CHEM SOC, V102, P7753, DOI 10.1021/ja00546a019; Schmid R., 1982, MONOGRAPHS MODERN CH, V14; Schmidt AF, 2012, KINET CATAL+, V53, P714, DOI 10.1134/S0023158412060109; Schmidt AF, 2011, RUSS J GEN CHEM+, V81, P1573, DOI 10.1134/S1070363211070334; Sicre C, 2008, TETRAHEDRON, V64, P7437, DOI 10.1016/j.tet.2008.05.018; STEPHENS.TA, 1965, J CHEM SOC, P3632, DOI 10.1039/jr9650003632; Suzuki A, 1999, J ORGANOMET CHEM, V576, P147, DOI 10.1016/S0022-328X(98)01055-9; Suzuki A, 2011, ANGEW CHEM INT EDIT, V50, P6722, DOI 10.1002/anie.201101379; Tan YC, 2012, J AM CHEM SOC, V134, P3683, DOI 10.1021/ja2122156; Valente C., 2005, BORONIC ACIDS PREPAR, V2, P213; Wakioka M, 2012, ORGANOMETALLICS, V31, P4810, DOI 10.1021/om300367k; WEBER E, 1990, B CHEM SOC JPN, V63, P3670, DOI 10.1246/bcsj.63.3670; Wei CS, 2013, ANGEW CHEM INT EDIT, V52, P5822, DOI 10.1002/anie.201210252; Xu S., 2014, METAL CATALYZED CROS, V1, P133; Zhao PJ, 2007, J AM CHEM SOC, V129, P1876, DOI 10.1021/ja068587q	39	184	183	6	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					329	332		10.1126/science.aad6981	http://dx.doi.org/10.1126/science.aad6981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081068	Green Submitted			2022-12-28	WOS:000373990100037
J	Fantry, A				Fantry, Amanda			Say What You Mean, Mean What You Say	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fantry, Amanda] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Fantry, A (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	amanda.fantry@gmail.com							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1337	1338		10.1001/jama.2015.18910	http://dx.doi.org/10.1001/jama.2015.18910			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	27046362				2022-12-28	WOS:000373381500014
J	DeConto, RM; Pollard, D				DeConto, Robert M.; Pollard, David			Contribution of Antarctica to past and future sea-level rise	NATURE			English	Article							GREENLAND ICE-SHEET; WEST ANTARCTICA; OUTLET GLACIERS; ATMOSPHERIC CO2; PINE ISLAND; MODEL; COLLAPSE; OCEAN; DRIVEN; PLEISTOCENE	Polar temperatures over the last several million years have, at times, been slightly warmer than today, yet global mean sea level has been 6-9 metres higher as recently as the Last Interglacial (130,000 to 115,000 years ago) and possibly higher during the Pliocene epoch (about three million years ago). In both cases the Antarctic ice sheet has been implicated as the primary contributor, hinting at its future vulnerability. Here we use a model coupling ice sheet and climate dynamics-including previously underappreciated processes linking atmospheric warming with hydrofracturing of buttressing ice shelves and structural collapse of marine-terminating ice cliffs-that is calibrated against Pliocene and Last Interglacial sea-level estimates and applied to future greenhouse gas emission scenarios. Antarctica has the potential to contribute more than a metre of sea-level rise by 2100 and more than 15 metres by 2500, if emissions continue unabated. In this case atmospheric warming will soon become the dominant driver of ice loss, but prolonged ocean warming will delay its recovery for thousands of years.	[DeConto, Robert M.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Pollard, David] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	DeConto, RM (corresponding author), Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA.	deconto@geo.umass.edu			NSF [OCE 1202632 PLIOMAX, AGS 1203910/1203792]; Div Atmospheric & Geospace Sciences [1203910] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1443190, 1417886] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank C. Shields at NCAR for providing CCSM4 ocean model data. NCAR is sponsored by the NSF. We also thank R. Kopp for providing LIG sea-level data, and R. Alley, A. Dutton, and M. Raymo for discussions. This research was supported by the NSF under awards OCE 1202632 PLIOMAX project and AGS 1203910/1203792.	Alder JR, 2011, GEOSCI MODEL DEV, V4, P69, DOI 10.5194/gmd-4-69-2011; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Archer D, 2009, ANNU REV EARTH PL SC, V37, P117, DOI 10.1146/annurev.earth.031208.100206; Banwell AF, 2013, GEOPHYS RES LETT, V40, P5872, DOI 10.1002/2013GL057694; Bassis JN, 2013, NAT GEOSCI, V6, P833, DOI [10.1038/ngeo1887, 10.1038/NGEO1887]; Bassis JN, 2012, P ROY SOC A-MATH PHY, V468, P913, DOI 10.1098/rspa.2011.0422; Benn DI, 2007, EARTH-SCI REV, V82, P143, DOI 10.1016/j.earscirev.2007.02.002; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Capron E, 2014, QUATERNARY SCI REV, V103, P116, DOI 10.1016/j.quascirev.2014.08.018; Carlson AE, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000371; Cook CP, 2013, NAT GEOSCI, V6, P765, DOI [10.1038/ngeo1889, 10.1038/NGEO1889]; Dahl-Jensen D, 2013, NATURE, V493, P489, DOI 10.1038/nature11789; DeConto RM, 2012, GLOBAL PLANET CHANGE, V96-97, P181, DOI 10.1016/j.gloplacha.2012.05.018; Duplessy JC, 2007, SCIENCE, V316, P89, DOI 10.1126/science.1138582; Dutrieux P, 2014, SCIENCE, V343, P174, DOI 10.1126/science.1244341; Dutton A, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4019; Favier L., 2014, NATURE GEOSCI, V7, P874; Feldmann J, 2015, P NATL ACAD SCI USA, V112, P14191, DOI 10.1073/pnas.1512482112; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Fudge TJ, 2013, NATURE, V500, P440, DOI 10.1038/nature12376; Galaasen EV, 2014, SCIENCE, V343, P1129, DOI 10.1126/science.1248667; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Gomez N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9798; Hearty PJ, 2007, QUATERNARY SCI REV, V26, P2090, DOI 10.1016/j.quascirev.2007.06.019; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; Holden PB, 2010, CLIM PAST, V6, P431, DOI 10.5194/cp-6-431-2010; Holland PR, 2008, J CLIMATE, V21, P2558, DOI 10.1175/2007JCLI1909.1; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Huybrechts P., 1992, THESIS VRIJE U BRUSS; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Joughin I, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002110; Joughin I, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF001023; Kiehl JT, 1998, J CLIMATE, V11, P1131, DOI 10.1175/1520-0442(1998)011<1131:TNCFAR>2.0.CO;2; Koenig SJ, 2015, CLIM PAST, V11, P369, DOI 10.5194/cp-11-369-2015; Koenig SJ, 2014, GEOPHYS RES LETT, V41, P3933, DOI 10.1002/2014GL059770; Kopp RE, 2009, NATURE, V462, P863, DOI 10.1038/nature08686; Munneke PK, 2014, J GLACIOL, V60, P205, DOI 10.3189/2014JoG13J183; Le Brocq A. M., 2010, EARTH SYST SCI DATA, V2, P247, DOI [10.5194/essd-2-247-2010, DOI 10.5194/essd-2-247-2010, DOI 10.5194/ESSD-2-247-2010]; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Li C, 2013, CLIM DYNAM, V40, P1071, DOI 10.1007/s00382-012-1350-z; Locarnini R. A., 2013, WORLD OCEAN ATLAS 20, V1; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Martin MA, 2011, CRYOSPHERE, V5, P727, DOI 10.5194/tc-5-727-2011; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; McKay NP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048280; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Miller KG, 2012, GEOLOGY, V40, P407, DOI 10.1130/G32869.1; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Nick FM, 2010, J GLACIOL, V56, P781, DOI 10.3189/002214310794457344; Nick FM, 2013, NATURE, V497, P235, DOI 10.1038/nature12068; O'Leary MJ, 2013, NAT GEOSCI, V6, P796, DOI [10.1038/ngeo1890, 10.1038/NGEO1890]; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Pal JS, 2007, B AM METEOROL SOC, V88, P1395, DOI 10.1175/BAMS-88-9-1395; Phillips T, 2013, J GEOPHYS RES-EARTH, V118, P1241, DOI 10.1002/jgrf.20079; Phillips T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044397; Pollard D, 2012, GEOSCI MODEL DEV, V5, P1273, DOI 10.5194/gmd-5-1273-2012; Pollard D, 2012, CRYOSPHERE, V6, P953, DOI 10.5194/tc-6-953-2012; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Raymo ME, 2008, NATURE, V451, P284, DOI 10.1038/nature06589; Raymo ME, 2012, NATURE, V483, P453, DOI 10.1038/nature10891; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Ritz C, 2015, NATURE, V528, P115, DOI 10.1038/nature16147; Rovere A, 2014, EARTH PLANET SC LETT, V387, P27, DOI 10.1016/j.epsl.2013.10.030; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Schmidtko S, 2014, SCIENCE, V346, P1227, DOI 10.1126/science.1256117; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Slater DA, 2015, GEOPHYS RES LETT, V42, P2861, DOI 10.1002/2014GL062494; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; Stone EJ, 2013, CLIM PAST, V9, P621, DOI 10.5194/cp-9-621-2013; Tedesco M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039186; Thompson SL, 1997, J CLIMATE, V10, P871, DOI 10.1175/1520-0442(1997)010<0871:GAAMBF>2.0.CO;2; Trusel LD, 2015, NAT GEOSCI, V8, P927, DOI [10.1038/ngeo2563, 10.1038/NGEO2563]; Winkelmann R, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500589; Wouters B, 2015, SCIENCE, V348, P899, DOI 10.1126/science.aaa5727	80	1000	1015	32	657	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					591	597		10.1038/nature17145	http://dx.doi.org/10.1038/nature17145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27029274				2022-12-28	WOS:000373027400029
J	Hodis, HN; Mack, WJ; Henderson, VW; Shoupe, D; Budoff, MJ; Hwang-Levine, J; Li, YJ; Feng, M; Dustin, L; Kono, N; Stanczyk, FZ; Selzer, RH; Azen, SP				Hodis, Howard N.; Mack, Wendy J.; Henderson, Victor W.; Shoupe, Donna; Budoff, Matthew J.; Hwang-Levine, Juliana; Li, Yanjie; Feng, Mei; Dustin, Laurie; Kono, Naoko; Stanczyk, Frank Z.; Selzer, Robert H.; Azen, Stanley P.		Elite Res Grp	Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HORMONE REPLACEMENT THERAPY; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; CONJUGATED EQUINE ESTROGENS; TIMING HYPOTHESIS; OLDER WOMEN; ARTERY ATHEROSCLEROSIS; PRIMARY PREVENTION; RANDOMIZED-TRIAL; PARADIGM SHIFT	BACKGROUND Data suggest that estrogen-containing hormone therapy is associated with beneficial effects with regard to cardiovascular disease when the therapy is initiated temporally close to menopause but not when it is initiated later. However, the hypothesis that the cardiovascular effects of postmenopausal hormone therapy vary with the timing of therapy initiation (the hormone-timing hypothesis) has not been tested. METHODS A total of 643 healthy postmenopausal women were stratified according to time since menopause (<6 years [early postmenopause] or >= 10 years [late postmenopause]) and were randomly assigned to receive either oral 17 beta-estradiol (1 mg per day, plus progesterone [45 mg] vaginal gel administered sequentially [i.e., once daily for 10 days of each 30-day cycle] for women with a uterus) or placebo (plus sequential placebo vaginal gel for women with a uterus). The primary outcome was the rate of change in carotid-artery intima-media thickness (CIMT), which was measured every 6 months. Secondary outcomes included an assessment of coronary atherosclerosis by cardiac computed tomography (CT), which was performed when participants completed the randomly assigned regimen. RESULTS After a median of 5 years, the effect of estradiol, with or without progesterone, on CIMT progression differed between the early and late postmenopause strata (P = 0.007 for the interaction). Among women who were less than 6 years past menopause at the time of randomization, the mean CIMT increased by 0.0078 mm per year in the placebo group versus 0.0044 mm per year in the estradiol group (P = 0.008). Among women who were 10 or more years past menopause at the time of randomization, the rates of CIMT progression in the placebo and estradiol groups were similar (0.0088 and 0.0100 mm per year, respectively; P = 0.29). CT measures of coronary-artery calcium, total stenosis, and plaque did not differ significantly between the placebo group and the estradiol group in either postmenopause stratum. CONCLUSIONS Oral estradiol therapy was associated with less progression of subclinical atherosclerosis (measured as CIMT) than was placebo when therapy was initiated within 6 years after menopause but not when it was initiated 10 or more years after menopause. Estradiol had no significant effect on cardiac CT measures of atherosclerosis in either postmenopause stratum.	[Hodis, Howard N.; Mack, Wendy J.; Hwang-Levine, Juliana; Li, Yanjie; Feng, Mei; Dustin, Laurie; Kono, Naoko; Selzer, Robert H.; Azen, Stanley P.] Univ So Calif, Keck Sch Med, Atherosclerosis Res Unit, Los Angeles, CA 90033 USA; [Hodis, Howard N.] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Hodis, Howard N.; Mack, Wendy J.; Dustin, Laurie; Kono, Naoko; Stanczyk, Frank Z.; Azen, Stanley P.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Hodis, Howard N.; Hwang-Levine, Juliana] Univ So Calif, Keck Sch Med, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA; [Shoupe, Donna; Stanczyk, Frank Z.] Univ So Calif, Keck Sch Med, Dept Obstet & Gynaecol, Los Angeles, CA 90033 USA; [Henderson, Victor W.] Stanford Univ, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Henderson, Victor W.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Budoff, Matthew J.] Harbor Univ Calif, Los Angeles Biomed Res Inst, Los Angeles Med Ctr, Torrance, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Hodis, HN (corresponding author), Univ So Calif, Keck Sch Med, Div Cardiovasc Med, Atherosclerosis Res Unit, 2250 Alcazar St,CSC 132, Los Angeles, CA 90033 USA.	athero@usc.edu	Henderson, V/AAW-4744-2021; Budoff, Matthew/ABD-5175-2021	Budoff, Matthew/0000-0002-9616-1946; Stanczyk, Frank/0000-0002-3607-121X	National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [R01AG024154] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institute on Aging, National Institutes of Health	Boardman HMP, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002229.pub4; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Clarkson TB, 2007, MENOPAUSE, V14, P373, DOI 10.1097/GME.0b013e31803c764d; Harman SM, 2014, ANN INTERN MED, V161, P249, DOI 10.7326/M14-0353; Henderson VW, 2013, P NATL ACAD SCI USA, V110, P20290, DOI 10.1073/pnas.1312353110; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Herrington DM, 2001, ARTERIOSCL THROM VAS, V21, P1955, DOI 10.1161/hq1201.100241; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hodis HN, 2003, NEW ENGL J MED, V349, P535, DOI 10.1056/NEJMoa030830; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hodis HN, 2015, MENOPAUSE, V22, P391, DOI [10.1097/GME.0000000000000343, 10.1097/gme.0000000000000343]; Hodis HN, 2013, J AM GERIATR SOC, V61, P1011, DOI 10.1111/jgs.12281; Hodis HN, 2013, J AM GERIATR SOC, V61, P1005, DOI 10.1111/jgs.12140; HOLM S, 1979, SCAND J STAT, V6, P65; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Hwang J, 2006, ATHEROSCLEROSIS, V189, P76, DOI 10.1016/j.atherosclerosis.2005.11.026; LIEBERMAN EH, 1994, ANN INTERN MED, V121, P936, DOI 10.7326/0003-4819-121-12-199412150-00005; LOSORDO DW, 1994, CIRCULATION, V89, P1501, DOI 10.1161/01.CIR.89.4.1501; Mack WJ, 2000, ATHEROSCLEROSIS, V150, P371, DOI 10.1016/S0021-9150(99)00383-4; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Ostberg JE, 2007, CLIN ENDOCRINOL, V66, P557, DOI 10.1111/j.1365-2265.2007.02772.x; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Rosenfeld ME, 2002, ATHEROSCLEROSIS, V164, P251, DOI 10.1016/S0021-9150(02)00178-8; Salpeter SR, 2009, AM J MED, V122, P1016, DOI 10.1016/j.amjmed.2009.05.021; Salpeter SR, 2009, AM J MED, V122, P42, DOI 10.1016/j.amjmed.2008.07.026; Salpeter SR, 2006, J GEN INTERN MED, V21, P363, DOI 10.1111/j.1525-1497.2006.00389.x; Salpeter SR, 2004, J GEN INTERN MED, V19, P791, DOI 10.1111/j.1525-1497.2004.30281.x; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; SELZER RH, 1994, ATHEROSCLEROSIS, V111, P1, DOI 10.1016/0021-9150(94)90186-4; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Tarhouni K, 2014, ARTERIOSCL THROM VAS, V34, P1281, DOI 10.1161/ATVBAHA.114.303404; Vehkavaara S, 2000, CIRCULATION, V102, P2687, DOI 10.1161/01.CIR.102.22.2687; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432	37	369	386	4	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1221	1231		10.1056/NEJMoa1505241	http://dx.doi.org/10.1056/NEJMoa1505241			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8ZM	27028912	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000373085500005
J	Garrity, PS				Garrity, Philip S.			Bone of my bones	LANCET			English	Editorial Material									[Garrity, Philip S.] Harvard Univ, Sch Divin, Cambridge, MA 02138 USA	Harvard University	Garrity, PS (corresponding author), Harvard Univ, Sch Divin, Cambridge, MA 02138 USA.	philip_garrity@mail.harvard.edu		Garrity, Philip/0000-0003-4118-2739					0	0	0	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1154	1155		10.1016/S0140-6736(16)30009-5	http://dx.doi.org/10.1016/S0140-6736(16)30009-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	27030847				2022-12-28	WOS:000372412000014
J	Durand, CM; Segev, D; Sugarman, J				Durand, Christine M.; Segev, Dorry; Sugarman, Jeremy			Realizing HOPE: The Ethics of Organ Transplantation From HIV-Positive Donors	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STAGE RENAL-DISEASE; HEPATITIS-C; LIVER-TRANSPLANT; KIDNEY-TRANSPLANTATION; TROPIC VIRUS; PROGRESSION; SURVIVAL; OUTCOMES; RISK	The HIV Organ Policy Equity (HOPE) Act now allows transplantation of organs from HIV-positive living and deceased donors to HIV-positive individuals with end-stage organ disease in the United States. Although clinical experience with such transplants is limited to a small number of deceased-donor kidney transplants from HIV-positive to HIV-positive persons in South Africa, unprecedented HIV-positive-to-HIV-positive liver transplantations and living-donor kidney transplantations are also now on the horizon. Initially, all HIV-positive-to-HIV-positive transplantations will occur under research protocols with safeguards and criteria mandated by the National Institutes of Health. Nevertheless, this historic change brings ethical opportunities and challenges. For HIV-positive individuals needing an organ transplant, issues of access, risk, and consent must be considered. For potential HIV-positive donors, there are additional ethical challenges of privacy, fairness, and the right to donate. Careful consideration of the ethical issues involved is critical to the safe and appropriate evaluation of this novel approach to transplantation.	[Durand, Christine M.] Johns Hopkins Univ, Sch Med, 1830 East Monument St,Room 450D, Baltimore, MD 21205 USA; [Segev, Dorry] Johns Hopkins Univ, Sch Med, Dept Surg, 720 Rutland Ave,Ross 771B, Baltimore, MD 21205 USA; [Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Berman Inst Bioeth, 1809 Ashland Ave, Baltimore, MD 21205 USA; [Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Dept Med, 1809 Ashland Ave, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Durand, CM (corresponding author), Johns Hopkins Univ, Sch Med, 1830 East Monument St,Room 450D, Baltimore, MD 21205 USA.	christinedurand@jhmi.edu		Durand, Christine M./0000-0003-2605-9257; Sugarman, Jeremy/0000-0001-7022-8332	NIH [K23CA177321-01A1, 1K24DK101828-01]; Johns Hopkins University Center for AIDS Research [P30AI094189]; NATIONAL CANCER INSTITUTE [K23CA177321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK101828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Center for AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the NIH (grants K23CA177321-01A1 to C.M.D, 1K24DK101828-01 to D.S.) and the Johns Hopkins University Center for AIDS Research (P30AI094189).	Abraham AG, 2015, CLIN INFECT DIS, V60, P941, DOI 10.1093/cid/ciu919; [Anonymous], 2015, REV REC RED RISK HUM; Boyarsky BJ, 2011, AM J TRANSPLANT, V11, P1209, DOI 10.1111/j.1600-6143.2011.03506.x; Boyarsky BJ, 2016, ANN SURG, V263, P430, DOI 10.1097/SLA.0000000000001352; CANTOR ES, 1991, ARCH INTERN MED, V151, P125, DOI 10.1001/archinte.151.1.125; Fine DM, 2012, J AM SOC NEPHROL, V23, P343, DOI 10.1681/ASN.2011060562; Gottlieb GS, 2007, CLIN INFECT DIS, V45, P501, DOI 10.1086/520024; Health Resources and Services Administration (HRSA) Department of Health and Human Services (HHS), 2015, Fed Regist, V80, P26464; Health Resources and Services Administration (HRSA) Department of Health and Human Services (HHS), 2015, FED REGISTER, V80, P34912; Health Resources and Services Adminstration, 2016, OR PROC TRANSPL NETW; Ho YH, 2015, NEW ENGL J MED, V372, P2070, DOI 10.1056/NEJMc1503288; Ingelfinger JR, 2015, NEW ENGL J MED, V372, P663, DOI 10.1056/NEJMe1500221; Kucirka LM, 2010, AM J TRANSPLANT, V10, P1238, DOI 10.1111/j.1600-6143.2010.03091.x; Kucirka LM, 2012, AM J KIDNEY DIS, V60, P112, DOI 10.1053/j.ajkd.2012.03.015; Kucirka LM, 2011, JAMA-J AM MED ASSOC, V306, P620, DOI 10.1001/jama.2011.1127; Locke JE, 2016, TRANSPLANTATION, V100, P141, DOI 10.1097/TP.0000000000000829; Locke JE, 2015, J AM SOC NEPHROL, V26, P2222, DOI 10.1681/ASN.2014070726; Locke JE, 2014, TRANSPLANTATION, V97, P446, DOI 10.1097/01.TP.0000436905.54640.8c; Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617; Mgbako O, 2013, AM J TRANSPLANT, V13, P1636, DOI 10.1111/ajt.12311; Montenovo MI, 2015, ANN TRANSPL, V20, P44, DOI 10.12659/AOT.892530; Muller E, 2012, SAMJ S AFR MED J, V102, P497, DOI 10.7196/SAMJ.5754; Muller E, 2010, NEW ENGL J MED, V362, P2336, DOI 10.1056/NEJMc0900837; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Ragni MV, 2005, LIVER TRANSPLANT, V11, P1425, DOI 10.1002/lt.20534; Redd AD, 2013, LANCET INFECT DIS, V13, P622, DOI 10.1016/S1473-3099(13)70066-5; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Stock PG, 2010, NEW ENGL J MED, V363, P2004, DOI 10.1056/NEJMoa1001197; Subramanian A, 2010, GASTROENTEROLOGY, V138, P159, DOI 10.1053/j.gastro.2009.09.053; Terrault NA, 2012, LIVER TRANSPLANT, V18, P716, DOI 10.1002/lt.23411; Tricot L, 2009, AM J TRANSPLANT, V9, P1946, DOI 10.1111/j.1600-6143.2009.02684.x; Trullas JC, 2011, JAIDS-J ACQ IMM DEF, V57, P276, DOI 10.1097/QAI.0b013e318221fbda; United Network of Organ Sharing, 2016, ALL CALC; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	36	39	40	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					138	+		10.7326/M16-0560	http://dx.doi.org/10.7326/M16-0560			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2GY	27043422	Green Accepted			2022-12-28	WOS:000380583100021
J	[Anonymous]				[Anonymous]			Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendations From the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	1	1	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					776	776		10.7326/P16-9015	http://dx.doi.org/10.7326/P16-9015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27064765				2022-12-28	WOS:000379343000024
J	Jabbour, E; Kantarjian, H				Jabbour, Elias; Kantarjian, Hagop			Chemoimmunotherapy as a new standard of care for Burkitt leukaemia/lymphoma	LANCET			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; LYMPHOCYTIC-LEUKEMIA; RITUXIMAB; MULTICENTER; PHASE-2; TRIAL		[Jabbour, Elias; Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Jabbour, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	ejabbour@mdanderson.org			NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; DeAngel DJ, 2015, 20 C EUR HEM ASS VIE; Gokbuget N, 2015, AM SOC HAEM 57 ANN M; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hoelzer D, 2014, BLOOD, V124, P3870, DOI 10.1182/blood-2014-03-563627; Jabbour E, 2015, AM SOC HAEM 57 ANN M; Jabbour E, 2015, LANCET ONCOL, V16, P1547, DOI 10.1016/S1470-2045(15)00207-7; Jabbour E, 2015, BLOOD, V125, P4010, DOI 10.1182/blood-2014-08-596403; Kantarjian H, 2013, CANCER-AM CANCER SOC, V119, P2728, DOI 10.1002/cncr.28136; Maury S, 2015, AM SOC HAEM 57 ANN M; Ribrag V, 2016, LANCET; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2	12	5	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2360	2361		10.1016/S0140-6736(16)00164-1	http://dx.doi.org/10.1016/S0140-6736(16)00164-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1ST	27080497				2022-12-28	WOS:000377560100009
J	Su, XL; Ditlev, JA; Hui, EF; Xing, WM; Banjade, S; Okrut, J; King, DS; Taunton, J; Rosen, MK; Vale, RD				Su, Xiaolei; Ditlev, Jonathon A.; Hui, Enfu; Xing, Wenmin; Banjade, Sudeep; Okrut, Julia; King, David S.; Taunton, Jack; Rosen, Michael K.; Vale, Ronald D.			Phase separation of signaling molecules promotes T cell receptor signal transduction	SCIENCE			English	Article							ACTIN POLYMERIZATION; TYROSINE KINASE; ZETA-CHAIN; ACTIVATION; LAT; ASSEMBLIES; PARADIGM; PROTEINS; CLUSTERS; ZAP-70	Activation of various cell surface receptors triggers the reorganization of downstream signaling molecules into micrometer-or submicrometer-sized clusters. However, the functional consequences of such clustering have been unclear. We biochemically reconstituted a 12-component signaling pathway on model membranes, beginning with T cell receptor (TCR) activation and ending with actin assembly. When TCR phosphorylation was triggered, downstream signaling proteins spontaneously separated into liquid-like clusters that promoted signaling outputs both in vitro and in human Jurkat T cells. Reconstituted clusters were enriched in kinases but excluded phosphatases and enhanced actin filament assembly by recruiting and organizing actin regulators. These results demonstrate that protein phase separation can create a distinct physical and biochemical compartment that facilitates signaling.	[Su, Xiaolei; Ditlev, Jonathon A.; Hui, Enfu; Xing, Wenmin; Banjade, Sudeep; Okrut, Julia; Taunton, Jack; Rosen, Michael K.; Vale, Ronald D.] Howard Hughes Med Inst, Summer Inst, Marine Biol Lab, Woods Hole, MA 02543 USA; [Su, Xiaolei; Hui, Enfu; Okrut, Julia; Taunton, Jack; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Su, Xiaolei; Hui, Enfu; Okrut, Julia; Taunton, Jack; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Ditlev, Jonathon A.; Xing, Wenmin; Banjade, Sudeep; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Ditlev, Jonathon A.; Xing, Wenmin; Banjade, Sudeep; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [King, David S.] Univ Calif Berkeley, HHMI Mass Spectrometry Lab, Berkeley, CA 94720 USA; [King, David S.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Marine Biological Laboratory - Woods Hole; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rosen, MK; Vale, RD (corresponding author), Howard Hughes Med Inst, Summer Inst, Marine Biol Lab, Woods Hole, MA 02543 USA.; Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.; Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu; ron.vale@ucsf.edu			HHMI's Collaborative Innovation Awards; NIH [R01-GM56322]; Welch Foundation [I-1544]; Cancer Research Institute Irvington postdoctoral fellowship; National Research Service Award [F32 (5-F32-DK101188)]; Tobacco-Related Disease Research Program of the University of California [19FT-0090]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK101188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322] Funding Source: NIH RePORTER	HHMI's Collaborative Innovation Awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Research Institute Irvington postdoctoral fellowship; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program of the University of California(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Ross and L. Chang at Nikon Instruments for their loan of TIRF-capable microscopes, N. Stuurman for help with microscopy, A. Weiss for providing JCam2.5 cells, D. Liu for providing charged green fluorescent protein (GFP) constructs, C. Pak for providing charged GFP, J. Muller for providing intercellular adhesion molecule-1 protein, and L. Rice, X. Zeng, and members from the Vale Laboratory for comments on this manuscript. This work was supported by the HHMI's Collaborative Innovation Awards, NIH (R01-GM56322 to M.K.R.), and the Welch Foundation (I-1544 to M.K.R.). X.S. was supported by a Cancer Research Institute Irvington postdoctoral fellowship. J.A.D. was supported by National Research Service Award F32 (5-F32-DK101188). E.H. was supported as a fellow of the Leukemia and Lymphoma Society. J.O. was supported by funds from the Tobacco-Related Disease Research Program of the University of California (19FT-0090)	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Bienz M, 2014, TRENDS BIOCHEM SCI, V39, P487, DOI 10.1016/j.tibs.2014.08.006; Bilal MY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00141; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Ditlev JA, 2012, J CELL BIOL, V197, P643, DOI 10.1083/jcb.201111113; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Kumari S, 2015, ELIFE, V4, DOI 10.7554/eLife.04953; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Nag A, 2009, BIOPHYS J, V96, P2604, DOI 10.1016/j.bpj.2009.01.019; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Singleton KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000199; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325	26	548	556	20	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					595	599		10.1126/science.aad9964	http://dx.doi.org/10.1126/science.aad9964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27056844	Green Submitted, Green Accepted			2022-12-28	WOS:000374998600047
J	Robinson, A				Robinson, Ann			Sam Glover OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2016	353								i2155	10.1136/bmj.i2155	http://dx.doi.org/10.1136/bmj.i2155			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZB	27090983				2022-12-28	WOS:000374998700006
J	Rodrigues, FB; Neves, JB; Caldeira, D; Ferro, JM; Ferreira, JJ; Costa, J				Rodrigues, Filipe Brogueira; Neves, Joana Briosa; Caldeira, Daniel; Ferro, Jose M.; Ferreira, Joaquim J.; Costa, Joao			Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERVENTIONAL MANAGEMENT; RANDOMIZED-TRIAL; THERAPY; THROMBECTOMY; INTRAARTERIAL; THROMBOLYSIS; MULTICENTER; OCCLUSION; DEVICE; BIAS	OBJECTIVES To evaluate the efficacy and safety of endovascular treatment, particularly adjunctive intra-arterial mechanical thrombectomy, in patients with ischaemic stroke. DESIGN Systematic review and meta-analysis. DATA SOURCES Medline, Embase, Cochrane Central Register of Controlled Trials, Web of Science, SciELO, LILACS, and clinical trial registries from inception to December 2015. Reference lists were crosschecked. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised controlled trials in adults aged 18 or more with ischaemic stroke comparing endovascular treatment, including thrombectomy, with medical care alone, including intravenous recombinant tissue plasminogen activator (rt-PA). Trial endpoints were functional outcome (modified Rankin scale scores of <= 2) and mortality at 90 days after onset of symptoms. No language or time restrictions applied. RESULTS 10 randomised controlled trials (n=2925) were included. In pooled analysis endovascular treatment, including thrombectomy, was associated with a higher proportion of patients experiencing good (modified Rankin scale scores <= 2) and excellent (scores <= 1) outcomes 90 days after stroke, without differences in mortality or rates for symptomatic intracranial haemorrhage, compared with patients randomised to medical care alone, including intravenous rt-PA. Heterogeneity was high among studies. The more recent studies (seven randomised controlled trials, published or presented in 2015) proved better suited to evaluate the effect of adjunctive intra-arterial mechanical thrombectomy on its index disease owing to more accurate patient selection, intravenous rt-PA being administered at a higher rate and earlier, and the use of more efficient thrombectomy devices. In most of these studies, more than 86% of the patients were treated with stent retrievers, and rates of recanalisation were higher (>58%) than previously reported. Subgroup analysis of these seven studies yielded a risk ratio of 1.56 (95% confidence interval 1.38 to 1.75) for good functional outcomes and 0.86 (0.69 to 1.06) for mortality, without heterogeneity among the results of the studies. All trials were open label. Risk of bias was moderate across studies. The full results of two trials are yet to be published. CONCLUSIONS Moderate to high quality evidence suggests that compared with medical care alone in a selected group of patients endovascular thrombectomy as add-on to intravenous thrombolysis performed within six to eight hours after large vessel ischaemic stroke in the anterior circulation provides beneficial functional outcomes, without increased detrimental effects.	[Rodrigues, Filipe Brogueira; Caldeira, Daniel; Ferreira, Joaquim J.; Costa, Joao] Univ Lisbon, Fac Med, Lab Clin Pharmacol & Therapeut, Ave Prof Egas Moniz, P-1649035 Lisbon, Portugal; [Rodrigues, Filipe Brogueira; Caldeira, Daniel; Ferreira, Joaquim J.; Costa, Joao] Inst Mol Med, Clin Pharmacol Unit, Lisbon, Portugal; [Rodrigues, Filipe Brogueira; Neves, Joana Briosa] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Dept Med, Lisbon, Portugal; [Ferro, Jose M.; Ferreira, Joaquim J.] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Dept Neurosci Neurol, Lisbon, Portugal; [Costa, Joao] Univ Lisbon, Fac Med, Ctr Evidence Based Med, P-1649035 Lisbon, Portugal; [Costa, Joao] Univ Lisbon, Fac Med, Portuguese Collaborating Ctr IberoAmer Cochrane N, P-1649035 Lisbon, Portugal	Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Universidade de Lisboa	Rodrigues, FB (corresponding author), Univ Lisbon, Fac Med, Lab Clin Pharmacol & Therapeut, Ave Prof Egas Moniz, P-1649035 Lisbon, Portugal.; Rodrigues, FB (corresponding author), Inst Mol Med, Clin Pharmacol Unit, Lisbon, Portugal.; Rodrigues, FB (corresponding author), Ctr Hosp Lisboa Norte, Hosp Santa Maria, Dept Med, Lisbon, Portugal.	filipebrodrigues@gmail.com	Rodrigues, Filipe B./R-2679-2017; Caldeira, Daniel/AAJ-7974-2020; Ferro, José/ABA-1779-2021; Neves, Joana B/I-8705-2019	Rodrigues, Filipe B./0000-0002-5567-7938; Caldeira, Daniel/0000-0002-2520-5673; Neves, Joana B/0000-0002-8578-9893; Ferro, Jose/0000-0002-2343-9097				Badhiwala JH, 2015, JAMA-J AM MED ASSOC, V314, P1832, DOI 10.1001/jama.2015.13767; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bracard S, 2015, INT J STROKE, V10, P31; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BC, 2013, NEW ENGL J MED, V368, P2431, DOI [10.1056/NEJMc1304759, 10.1056/NEJMoa1213701]; Campbell BCV, 2014, INT J STROKE, V9, P126, DOI 10.1111/ijs.12206; Chen CJ, 2015, NEUROLOGY, V85, P1980, DOI 10.1212/WNL.0000000000002176; Ciccone A, 2014, LANCET NEUROL, V13, P865, DOI 10.1016/S1474-4422(14)70174-7; Ciccone A, 2011, INT J STROKE, V6, P259, DOI 10.1111/j.1747-4949.2011.00587.x; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Demchuk AM, 2015, INT J STROKE, V10, P429, DOI 10.1111/ijs.12424; Duncan PW, 2000, STROKE, V31, P1429, DOI 10.1161/01.STR.31.6.1429; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fargen KM, 2015, J NEUROINTERV SURG, V7, P84, DOI 10.1136/neurintsurg-2014-011543; Fiorella DJ, 2015, J NEUROINTERV SURG, V7, P314, DOI 10.1136/neurintsurg-2015-011707; Fransen PSS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-343; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2014, CIRCULATION, V130, P265, DOI 10.1161/CIRCULATIONAHA.113.007826; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Khatri P, 2008, INT J STROKE, V3, P130, DOI 10.1111/j.1747-4949.2008.00151.x; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kidwell CS, 2014, INT J STROKE, V9, P110, DOI 10.1111/j.1747-4949.2012.00894.x; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Korn EL, 2009, J CLIN ONCOL, V27, P1712, DOI 10.1200/JCO.2008.19.5339; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lang, 2013, BASIC STAT REPORTING; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077849; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mocco J, 2015, INT J STROKE, V10, P10; Molina CA, 2015, INT J STROKE, V10, P619, DOI 10.1111/ijs.12157; Mullen MT, 2012, STROKE, V43, P2350, DOI 10.1161/STROKEAHA.111.639211; Naci Huseyin, 2014, BMJ, V349, pg5741, DOI 10.1136/bmj.g5741; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Osanai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122806; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Saver JL, 2015, INT J STROKE, V10, P439, DOI 10.1111/ijs.12459; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Singh B, 2013, MAYO CLIN PROC, V88, P1056, DOI 10.1016/j.mayocp.2013.07.015; Thrift AG, 2014, INT J STROKE, V9, P6, DOI 10.1111/ijs.12245; Ueda T, 1999, STROKE, V30, P2360, DOI 10.1161/01.STR.30.11.2360; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Yarbrough CK, 2015, STROKE, V46, P3177, DOI 10.1161/STROKEAHA.115.009847	57	121	124	2	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2016	353								i1754	10.1136/bmj.i1754	http://dx.doi.org/10.1136/bmj.i1754			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZB	27091337	Green Published, hybrid			2022-12-28	WOS:000374998700001
J	Chen, HW; Zhang, PF; Zhang, LW; Iu, HLL; Jiang, Y; Zhang, DY; Han, ZW; Jiang, L				Chen, Huawei; Zhang, Pengfei; Zhang, Liwen; Iu, Hongliang L.; Jiang, Ying; Zhang, Deyuan; Han, Zhiwu; Jiang, Lei			Continuous directional water transport on the peristome surface of Nepenthes alata	NATURE			English	Article							COLLECTION; CAPILLARIES; CAPTURE; CORNERS; DROPS; RISE	Numerous natural systems contain surfaces or threads that enable directional water transport(1-7). This behaviour is usually ascribed to hierarchical structural features at the microscale and nanoscale, with gradients in surface energy(8),9 and gradients in Laplace pressure(10) thought to be the main driving forces. Here we study the prey-trapping pitcher organs of the carnivorous plant Nepenthes alata. We find that continuous, directional water transport occurs on the surface of the 'peristome'-the rim of the pitcher-because of its multiscale structure, which optimizes and enhances capillary rise(11,12) in the transport direction, and prevents backflow by pinning in place any water front that is moving in the reverse direction. This results not only in unidirectional flow despite the absence of any surface-energy gradient, but also in a transport speed that is much higher than previously thought. We anticipate that the basic 'design' principles underlying this behaviour could be used to develop artificial fluid-transport systems with practical applications.	[Chen, Huawei; Zhang, Pengfei; Zhang, Liwen; Zhang, Deyuan] Beihang Univ, Sch Mech Engn & Automat, Beijing 100191, Peoples R China; [Iu, Hongliang L.; Jiang, Lei] Chinese Acad Sci, Tech Inst Phys & Chem, Lab Bioinspired Smart Interface Sci, Beijing 100190, Peoples R China; [Jiang, Ying; Jiang, Lei] Beihang Univ, Sch Chem & Environm, Beijing 100191, Peoples R China; [Han, Zhiwu] Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun 130022, Peoples R China	Beihang University; Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS; Beihang University; Jilin University	Chen, HW; Zhang, DY (corresponding author), Beihang Univ, Sch Mech Engn & Automat, Beijing 100191, Peoples R China.; Jiang, L (corresponding author), Chinese Acad Sci, Tech Inst Phys & Chem, Lab Bioinspired Smart Interface Sci, Beijing 100190, Peoples R China.; Jiang, L (corresponding author), Beihang Univ, Sch Chem & Environm, Beijing 100191, Peoples R China.	chenhw75@buaa.edu.cn; zhangdy@buaa.edu.cn; jianglei@iccas.ac.cn	, 许永傲/AAC-2581-2019; Jiang, Lei/B-1066-2011; Zhang, Pengfei/ABI-5007-2020; JIANG, Ying/A-8684-2018	JIANG, Ying/0000-0002-6041-2272; Jiang, Ying/0000-0002-4556-9909; Zhang, Pengfei/0000-0002-9458-5067	National Natural Science Foundation of China [51290292, 51175020, 51475029, 21431009]; Beihang University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beihang University	We thank the National Natural Science Foundation of China (grant nos 51290292, 51175020, 51475029 and 21431009) and the Innovation Foundation of the Beijing University of Aeronautics and Astronautics (BUAA; now Beihang University) for PhD Graduates for providing financial support. We also thank G. Wang and Y. Lai from the National Natural Science Foundation of China, and S. Wang from Tianjin University, for support and discussions.	Bai H, 2010, ADV MATER, V22, P5521, DOI 10.1002/adma.201003169; Bauer U, 2008, P ROY SOC B-BIOL SCI, V275, P259, DOI 10.1098/rspb.2007.1402; Bauer U, 2009, PLANT SIGNAL BEHAV, V4, P1019, DOI 10.4161/psb.4.11.9664; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; Chu KH, 2010, NAT MATER, V9, P413, DOI [10.1038/nmat2726, 10.1038/NMAT2726]; CONCUS P, 1969, P NATL ACAD SCI USA, V63, P292, DOI 10.1073/pnas.63.2.292; Daniel S, 2001, SCIENCE, V291, P633, DOI 10.1126/science.291.5504.633; DERAMOS AL, 1994, CHEM ENG SCI, V49, P2395; Ellison AM, 2006, PLANT BIOLOGY, V8, P740, DOI 10.1055/s-2006-923956; Finn R, 1999, NOTICES AMS, V46, P770; Hauksbee F., 1712, PHILOS T R SOC LONDO, V27, P539; Higuera FJ, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.3000425; Ishii D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03024; Ju J, 2014, ACCOUNTS CHEM RES, V47, P2342, DOI 10.1021/ar5000693; Ju J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2253; Juniper BE., 1962, NEW SCI, V13, P75; Lafuma A, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/56001; Li K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3276; Lorenceau E, 2004, J FLUID MECH, V510, P29, DOI 10.1017/S0022112004009152; OLIVER JF, 1977, J COLLOID INTERF SCI, V59, P568, DOI 10.1016/0021-9797(77)90052-2; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Ponomarenko A, 2011, J FLUID MECH, V666, P146, DOI 10.1017/S0022112010005276; Sun MH, 2005, LANGMUIR, V21, P8978, DOI 10.1021/la050316q; Taylor B., 1712, PHILOS T ROY SOC LON, V27, P538, DOI DOI 10.1098/RSTL.1710.0070; Tian Y, 2013, NAT MATER, V12, P291, DOI 10.1038/nmat3610; Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Zheng YM, 2010, NATURE, V463, P640, DOI 10.1038/nature08729; Zhou JW, 2010, ELECTROPHORESIS, V31, P2, DOI 10.1002/elps.200900475	30	613	654	156	1841	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					85	+		10.1038/nature17189	http://dx.doi.org/10.1038/nature17189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27078568				2022-12-28	WOS:000373555500038
J	Xie, J; Hase, WL				Xie, Jing; Hase, William L.			Rethinking the SN2 reaction	SCIENCE			English	Editorial Material							CHEMICAL-DYNAMICS SIMULATIONS; MECHANISM		[Xie, Jing] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA; [Hase, William L.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79406 USA	University of Minnesota System; University of Minnesota Twin Cities; Texas Tech University System; Texas Tech University	Hase, WL (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79406 USA.	bill.hase@ttu.edu	Xie, Jing/ABA-1999-2021	Xie, Jing/0000-0001-9676-5734; Hase, William/0000-0002-0560-5100				Chabinyc ML, 1998, SCIENCE, V279, P1882, DOI 10.1126/science.279.5358.1882; Cowdrey WA, 1937, J CHEM SOC, P1252, DOI 10.1039/jr9370001252; HASE WL, 1994, SCIENCE, V266, P998, DOI 10.1126/science.266.5187.998; Ingold C.K., 1953, STRUCTURE MECH ORGAN; Ishida K., 1977, J CHEM PHYS, V66, P245; Laerdahl JK, 2002, INT J MASS SPECTROM, V214, P277, DOI 10.1016/S1387-3806(01)00575-9; Manikandan P, 2012, J PHYS CHEM A, V116, P3061, DOI 10.1021/jp211387c; MERKEL A, 1988, J AM CHEM SOC, V110, P8355, DOI 10.1021/ja00233a012; OLMSTEAD WN, 1977, J AM CHEM SOC, V99, P4219, DOI 10.1021/ja00455a002; Otto R, 2012, NAT CHEM, V4, P534, DOI [10.1038/NCHEM.1362, 10.1038/nchem.1362]; Stei M, 2016, NAT CHEM, V8, P151, DOI [10.1038/NCHEM.2400, 10.1038/nchem.2400]; Szabo I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6972; Xie J, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4922451; Xie J, 2014, ACCOUNTS CHEM RES, V47, P2960, DOI 10.1021/ar5001764	14	117	118	13	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					32	33		10.1126/science.aaf5172	http://dx.doi.org/10.1126/science.aaf5172			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034358				2022-12-28	WOS:000373039600019
J	Yeh, MW; Zhou, H; Adams, AL; Ituarte, PHG; Li, N; Liu, ILA; Haigh, PI				Yeh, Michael W.; Zhou, Hui; Adams, Annette L.; Ituarte, Philip H. G.; Li, Ning; Liu, In-Lu Amy; Haigh, Philip I.			The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; BONE-MINERAL DENSITY; MILD PRIMARY HYPERPARATHYROIDISM; MARGINAL STRUCTURAL MODELS; HIP FRACTURE; ORAL ALENDRONATE; ELDERLY-PATIENTS; SURGERY; GUIDELINES; MANAGEMENT	Background: The comparative effectiveness of surgical and medical treatments on fracture risk in primary hyperparathyroidism (PHPT) is unknown. Objective: To measure the relationship of parathyroidectomy and bisphosphonates with skeletal outcomes in patients with PHPT. Design: Retrospective cohort study. Setting: An integrated health care delivery system. Participants: All enrollees with biochemically confirmed PHPT from 1995 to 2010. Measurements: Bone mineral density (BMD) changes and fracture rate. Results: In 2013 patients with serial bone density examinations, total hip BMD increased transiently in women with parathyroidectomy (4.2% at <2 years) and bisphosphonates (3.6% at <2 years) and declined progressively in both women and men without these treatments (-6.6% and -7.6%, respectively, at >8 years). In 6272 patients followed for fracture, the absolute risk for hip fracture at 10 years was 20.4 events per 1000 patients who had parathyroidectomy and 85.5 events per 1000 patients treated with bisphosphonates compared with 55.9 events per 1000 patients without these treatments. The risk for any fracture at 10 years was 156.8 events per 1000 patients who had parathyroidectomy and 302.5 events per 1000 patients treated with bisphosphonates compared with 206.1 events per 1000 patients without these treatments. In analyses stratified by baseline BMD status, parathyroidectomy was associated with reduced fracture risk in both osteopenic and osteoporotic patients, whereas bisphosphonates were associated with increased fracture risk in these patients. Parathyroidectomy was associated with fracture risk reduction in patients regardless of whether they satisfied criteria from consensus guidelines for surgery. Limitation: Retrospective study design and nonrandom treatment assignment. Conclusion: Parathyroidectomy was associated with reduced fracture risk, and bisphosphonate treatment was not superior to observation.	Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA; Kaiser Permanente So Calif, Pasadena, CA 91101 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kaiser Permanente; Kaiser Permanente	Yeh, MW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Surg & Med, 10833 Le Conte Ave,72-228 CHS, Los Angeles, CA 90095 USA.; Yeh, MW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Sect Endocrine Surg, 10833 Le Conte Ave,72-228 CHS, Los Angeles, CA 90095 USA.	myeh@mednet.ucla.edu; hui.x.zhou@jp.org	Ituarte, Philip/ABG-5332-2021		National Institutes of Health/National Institute on Aging [RFA-AG-11-007]; Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research; American Geriatrics Society; Jahnigen Career Development Award	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research; American Geriatrics Society; Jahnigen Career Development Award	By the National Institutes of Health/National Institute on Aging RFA-AG-11-007, Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research, and its companion grant program, American Geriatrics Society, Jahnigen Career Development Award.	Ambrogini E, 2007, J CLIN ENDOCR METAB, V92, P3114, DOI 10.1210/jc.2007-0219; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Beaupre LA, 2012, J AM GERIATR SOC, V60, P1268, DOI 10.1111/j.1532-5415.2012.04033.x; Bilezikian JP, 2014, J CLIN ENDOCR METAB, V99, P3561, DOI 10.1210/jc.2014-1413; Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; Bilezikian JP, 2002, J CLIN ENDOCR METAB, V87, P5353, DOI 10.1210/jc.2002-021370; Bollerslev J, 2007, J CLIN ENDOCR METAB, V92, P1687, DOI 10.1210/jc.2006-1836; Carty SE, 2004, OTOLARYNG CLIN N AM, V37, P897, DOI 10.1016/j.otc.2004.02.020; Cauley JA, 2013, J GERONTOL A-BIOL, V68, P1243, DOI 10.1093/gerona/glt093; Cefalu CA, 2004, CURR MED RES OPIN, V20, P341, DOI 10.1185/030079903125003062; Chow CC, 2003, J CLIN ENDOCR METAB, V88, P581, DOI 10.1210/jc.2002-020890; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Haan MN, 1997, J AM GERIATR SOC, V45, P667, DOI 10.1111/j.1532-5415.1997.tb01468.x; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hirbe A, 2006, CLIN CANCER RES, V12, p6309S, DOI 10.1158/1078-0432.CCR-06-0652; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; JONES G, 1995, J RHEUMATOL, V22, P932; Khan AA, 2004, J CLIN ENDOCR METAB, V89, P3319, DOI 10.1210/jc.2003-030908; Khan AA, 2009, ENDOCR PRACT, V15, P705, DOI 10.4158/EP08178.ORR; Khosla S, 1999, J BONE MINER RES, V14, P1700, DOI 10.1359/jbmr.1999.14.10.1700; Lamberts M, 2014, ANN INTERN MED, V161, P690, DOI 10.7326/M13-1581; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Looker AC, 2009, OSTEOPOROSIS INT, V20, P1141, DOI 10.1007/s00198-008-0809-6; Lundstam K, 2015, J CLIN ENDOCR METAB, V100, P1359, DOI 10.1210/jc.2014-3441; Ma MKM, 2013, NEPHROLOGY, V18, P365, DOI 10.1111/nep.12056; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Rao DS, 2004, J CLIN ENDOCR METAB, V89, P5415, DOI 10.1210/jc.2004-0028; Reyes C, 2014, OSTEOPOROSIS INT, V25, P1751, DOI 10.1007/s00198-014-2682-9; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rossini M, 2001, J BONE MINER RES, V16, P113, DOI 10.1359/jbmr.2001.16.1.113; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210/jc.2007-1215; Sankaran S, 2010, J CLIN ENDOCR METAB, V95, P1653, DOI 10.1210/jc.2009-2384; Schneider DL, 2006, J CLIN DENSITOM, V9, P255, DOI 10.1016/j.jocd.2006.04.116; Silverberg SJ, 2014, J CLIN ENDOCR METAB, V99, P3580, DOI 10.1210/jc.2014-1415; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Udelsman R, 2009, J CLIN ENDOCR METAB, V94, P366, DOI 10.1210/jc.2008-1761; VanderWalde LH, 2006, ARCH SURG-CHICAGO, V141, P885, DOI 10.1001/archsurg.141.9.885; VanderWalde LH, 2009, WORLD J SURG, V33, P406, DOI 10.1007/s00268-008-9720-8; Vestergaard P, 2000, BRIT MED J, V321, P598, DOI 10.1136/bmj.321.7261.598; Wimmer NJ, 2013, J AM COLL CARDIOL, V62, P2147, DOI 10.1016/j.jacc.2013.07.036; Wu BA, 2010, J CLIN ENDOCR METAB, V95, P4324, DOI 10.1210/jc.2009-2819; Xu S, 2012, VALUE HEALTH, V15, P167, DOI 10.1016/j.jval.2011.07.010; Yang D, 2012, SAS GLOBAL FORUM, P1; Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022; Yeh MW, 2012, ANN SURG, V255, P1179, DOI 10.1097/SLA.0b013e31824dad7d; Yu N, 2011, CLIN ENDOCRINOL, V75, P169, DOI 10.1111/j.1365-2265.2010.03958.x	51	69	73	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2016	164	11					715	+		10.7326/M15-1232	http://dx.doi.org/10.7326/M15-1232			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1AI	27043778				2022-12-28	WOS:000377510100003
J	Weinreb, C; Riesselman, AJ; Ingraham, JB; Gross, T; Sander, C; Marks, DS				Weinreb, Caleb; Riesselman, Adam J.; Ingraham, John B.; Gross, Torsten; Sander, Chris; Marks, Debora S.			3D RNA and Functional Interactions from Evolutionary Couplings	CELL			English	Article							RESPONSE ELEMENT RRE; DE-NOVO PREDICTION; SECONDARY STRUCTURE; HIV-1 REV; GENE-EXPRESSION; RIBOSOMAL-RNA; BINDING-SITE; BASE-PAIRS; PROTEIN; RECOGNITION	Non-coding RNAs are ubiquitous, but the discovery of new RNA gene sequences far outpaces the research on the structure and functional interactions of these RNA gene sequences. We mine the evolutionary sequence record to derive precise information about the function and structure of RNAs and RNA-protein complexes. As in protein structure prediction, we use maximum entropy global probability models of sequence co-variation to infer evolutionarily constrained nucleotide-nucleotide interactions within RNA molecules and nucleotide-amino acid interactions in RNA-protein complexes. The predicted contacts allow all-atom blinded 3D structure prediction at good accuracy for several known RNA structures and RNA-protein complexes. For unknown structures, we predict contacts in 160 non-coding RNA families. Beyond 3D structure prediction, evolutionary couplings help identify important functional interactions-e.g., at switch points in riboswitches and at a complex nucleation site in HIV. Aided by increasing sequence accumulation, evolutionary coupling analysis can accelerate the discovery of functional interactions and 3D structures involving RNA.	[Weinreb, Caleb; Riesselman, Adam J.; Ingraham, John B.; Gross, Torsten; Marks, Debora S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Gross, Torsten] Charite, Inst Pathol, D-10117 Berlin, Germany; [Sander, Chris] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Riesselman, Adam J.] Harvard Univ, Sch Med, Program Biomed Informat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Marks, DS (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	debbie@hms.harvard.edu			DOE fellowship [DE-FG02-97ER25308]; NSF Graduate Research Fellowship; NIH grant [R01 GM106303]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106303] Funding Source: NIH RePORTER	DOE fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Marks lab for discussions and G. Park for help with figures. A.J.R. was supported by a DOE fellowship (DE-FG02-97ER25308). J.B.I. was supported by an NSF Graduate Research Fellowship. D.S.M., T.G., and C.S. were supported by an NIH grant (R01 GM106303).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Bai Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03656; BARTEL DP, 1991, CELL, V67, P529, DOI 10.1016/0092-8674(91)90527-6; BESAG J, 1975, J ROY STAT SOC D-STA, V24, P179, DOI 10.2307/2987782; Butcher SE, 2011, ACCOUNTS CHEM RES, V44, P1302, DOI 10.1021/ar200098t; Cao S, 2011, J PHYS CHEM B, V115, P4216, DOI 10.1021/jp112059y; Caserta E, 2015, J BIOL CHEM, V290, P23336, DOI 10.1074/jbc.M115.673236; Casu F, 2013, BIOPHYS J, V105, P1004, DOI 10.1016/j.bpj.2013.07.022; Charpentier B, 1997, J MOL BIOL, V266, P950, DOI 10.1006/jmbi.1996.0858; Cheng CY, 2015, ELIFE, V4, DOI 10.7554/eLife.07600; CROTHERS DM, 1972, P NATL ACAD SCI USA, V69, P3063, DOI 10.1073/pnas.69.10.3063; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Daugherty MD, 2010, P NATL ACAD SCI USA, V107, P12481, DOI 10.1073/pnas.1007022107; De Leonardis E, 2015, NUCLEIC ACIDS RES, V43, P10444, DOI 10.1093/nar/gkv932; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil JY, 2010, MOL BIOL EVOL, V27, P1868, DOI 10.1093/molbev/msq069; Eddy SR, 2014, ANNU REV BIOPHYS, V43, P433, DOI 10.1146/annurev-biophys-051013-022950; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Fernandes JD, 2012, RNA BIOL, V9, P6, DOI 10.4161/rna.9.1.18178; FOX GE, 1975, NATURE, V256, P505, DOI 10.1038/256505a0; Frellsen J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000406; Freyhult Eva, 2005, Appl Bioinformatics, V4, P53, DOI 10.2165/00822942-200504010-00006; Gallego J, 2001, ACCOUNTS CHEM RES, V34, P836, DOI 10.1021/ar000118k; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; Gopalan V, 2007, P NATL ACAD SCI USA, V104, P2031, DOI 10.1073/pnas.0611193104; Green NJ, 2010, FEBS LETT, V584, P318, DOI 10.1016/j.febslet.2009.11.056; Grigg JC, 2013, STRUCTURE, V21, P2025, DOI 10.1016/j.str.2013.09.001; GRUNDY FJ, 1994, J BACTERIOL, V176, P4518, DOI 10.1128/JB.176.15.4518-4526.1994; Grundy FJ, 2002, P NATL ACAD SCI USA, V99, P11121, DOI 10.1073/pnas.162366799; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P5785, DOI 10.1093/nar/20.21.5785; HEAPHY S, 1991, P NATL ACAD SCI USA, V88, P7366, DOI 10.1073/pnas.88.16.7366; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Hopf TA, 2015, ARXIV151004612; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Ippolito JA, 2000, J MOL BIOL, V295, P711, DOI 10.1006/jmbi.1999.3405; IWAI S, 1992, NUCLEIC ACIDS RES, V20, P6465, DOI 10.1093/nar/20.24.6465; Khanova E, 2012, RNA, V18, P720, DOI 10.1261/rna.030874.111; KJEMS J, 1992, EMBO J, V11, P1119, DOI 10.1002/j.1460-2075.1992.tb05152.x; Klingler T M, 1993, Proc Int Conf Intell Syst Mol Biol, V1, P225; Krasilnikov AS, 2004, SCIENCE, V306, P104, DOI 10.1126/science.1101489; Laing C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/28/283101; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; LEE CP, 1993, P NATL ACAD SCI USA, V90, P7149, DOI 10.1073/pnas.90.15.7149; Legiewicz M, 2008, P NATL ACAD SCI USA, V105, P14365, DOI 10.1073/pnas.0804461105; Lescoute A, 2005, NUCLEIC ACIDS RES, V33, P2395, DOI 10.1093/nar/gki535; LEVITT M, 1969, NATURE, V224, P759, DOI 10.1038/224759a0; Lu CR, 2010, J MOL BIOL, V404, P803, DOI 10.1016/j.jmb.2010.09.059; Luedtke NW, 2003, BIOPOLYMERS, V70, P103, DOI 10.1002/bip.10428; Magnus M, 2014, RNA BIOL, V11, P522, DOI 10.4161/rna.28826; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Miao ZC, 2015, RNA, V21, P1066, DOI 10.1261/rna.049502.114; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Mokdad A, 2008, J BIOMOL STRUCT DYN, V25, P467, DOI 10.1080/07391102.2008.10531239; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Novikova Irina V, 2012, Bioarchitecture, V2, P189, DOI 10.4161/bioa.22592; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; OLSEN HS, 1990, SCIENCE, V247, P845, DOI 10.1126/science.2406903; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Pang PS, 2005, J EXP ZOOL PART B, V304B, P50, DOI 10.1002/jez.b.21024; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Peterson RD, 1996, J MOL BIOL, V264, P863, DOI 10.1006/jmbi.1996.0683; Pollom E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003294; Quinodoz S, 2014, TRENDS CELL BIOL, V24, P651, DOI 10.1016/j.tcb.2014.08.009; Ramani V, 2015, NAT BIOTECHNOL, V33, P980, DOI 10.1038/nbt.3289; Rausch JW, 2015, VIRUSES-BASEL, V7, P3053, DOI 10.3390/v7062760; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Rutherford ST, 2015, P NATL ACAD SCI USA, V112, pE6038, DOI 10.1073/pnas.1518958112; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Serganov A, 2012, CURR OPIN STRUC BIOL, V22, P279, DOI 10.1016/j.sbi.2012.04.005; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Shang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039383; Sherpa C, 2015, NUCLEIC ACIDS RES, V43, P4676, DOI 10.1093/nar/gkv313; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Sreedhara A, 2001, J BIOL INORG CHEM, V6, P166, DOI 10.1007/s007750000187; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Zemmel RW, 1996, J MOL BIOL, V258, P763, DOI 10.1006/jmbi.1996.0285; Zhang JW, 2013, NATURE, V500, P363, DOI 10.1038/nature12440; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	98	98	100	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					963	975		10.1016/j.cell.2016.03.030	http://dx.doi.org/10.1016/j.cell.2016.03.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27087444	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000375800300022
J	Crowley, RA				Crowley, Ryan A.		Amer Coll Phys	Climate Change and Health: A Position Paper of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							GREENHOUSE-GAS EMISSIONS; PUBLIC-HEALTH; ATMOSPHERIC CO2; HEAT; ENVIRONMENT; MORTALITY; DISEASE; POLLEN; OPPORTUNITIES; ILLNESS	Climate change could have a devastating effect on human and environmental health. Potential effects of climate change on human health include higher rates of respiratory and heat-related illness, increased prevalence of vector-borne and waterborne diseases, food and water insecurity, and malnutrition. Persons who are elderly, sick, or poor are especially vulnerable to these potential consequences. Addressing climate change could have substantial benefits to human health. In this position paper, the American College of Physicians (ACP) recommends that physicians and the broader health care community throughout the world engage in environmentally sustainable practices that reduce carbon emissions; support efforts to mitigate and adapt to the effects of climate change; and educate the public, their colleagues, their community, and lawmakers about the health risks posed by climate change. Tackling climate change is an opportunity to dramatically improve human health and avert dire environmental outcomes, and ACP believes that physicians can play a role in achieving this goal.	[Crowley, Ryan A.] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA	American College of Physicians	Crowley, RA (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	RCrowley@mail.acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Afifi T., 2012, CLIMATE CHANGE VULNE; American Medical Association, H 135 938 GLOB CLIM; American Public Health Association, 2015, AD ACT GRANT SUCC ST; Anderegg WRL, 2010, P NATL ACAD SCI USA, V107, P12107, DOI 10.1073/pnas.1003187107; [Anonymous], SOURC GREENH GAS EM; [Anonymous], 2014, CLIM CHANG 2014 IMP; [Anonymous], 2005, JOINT SCI AC STAT GL; Banusiewicz JD, 2014, US DEP DEFENSE  1013; Barnes CS, 2013, J ALLER CL IMM-PRACT, V1, P137, DOI 10.1016/j.jaip.2012.07.002; Bergoglio JM., 2015, ENCYCLICAL LETT LAUT; Blum LN, 1998, JAMA-J AM MED ASSOC, V279, P1514, DOI 10.1001/jama.279.19.1514; Board on Atmospheric Sciences and Climate; Division on Earth and Life Studies, 2010, AM CLIM CHOIC PAN AD; Bollen J, 2009, EC DEP WORKING PAPER; Bowen A., 2015, LOOKING GREEN JOBS I; Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552; Carlowicz M., WORLD CHANGE GLOBAL; Centers for Disease Control and Prevention, 2012, DIS MENT HLTH PRIM K; Centers for Disease Control and Prevention, 2015, EXTR HEAT PREV GUID; Climate Policy Initiative, 2015, GLOB LANDSC CLIM FIN; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Council Environm Hlth, 2015, PEDIATRICS, V136, P992, DOI 10.1542/peds.2015-3232; D'Amato G, 2014, EUR RESPIR REV, V23, P161, DOI 10.1183/09059180.00001714; Dear K, 2015, LANCET, V386, P320, DOI 10.1016/S0140-6736(15)60897-2; Dugan A, 2014, AM MOST LIKELY SAY G; E. C. Course Developers, 2016, HLTH EFF OZ GEN POP; Environmental and Energy Study Institute, CLIM CHANG MIT RED G; Environmental Protection Agency, 2015, FACT SHEET OVERVIEW; Environmental Protection Agency (EPA) U. S, 2008, RED URB HEAT ISL COM; EPA, 2014, EPA452P14002; Ermert V, 2012, ENVIRON HEALTH PERSP, V120, P77, DOI 10.1289/ehp.1103681; Executive Office of the President of the United States, 2013, PRES CLIM ACT PLAN; Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Green Climate Fund, 2015, PLEDG TRACK; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Hansen G, 2011, IPCC SPECIAL REPORT; Health Care Without Harm, 2011, PROT PUBL HLTH CLIM; Health Care Without Harm Europe, CLIM EN CAS STUD; Health Care Without Harm Practice Greenhealth, 2015, ADDR CLIM CHANG HLTH; Health Care Without Harm US, 2015, CLIM AND HLTH; Healthier Hospitals Initiative, 2003, GUND HLTH SYST ACH E; Hood GA, 2015, DRINKING WATER GLOBA; Institute of Medicine, 2011, CLIM CHANG IND ENV H; Institute of Medicine (US) Committee on Damp Indoor Spaces and Health, 2004, DAMP IND SPAC HLTH; IPCC, 2015, CLIMATE CHANGE 2014, P151; Ipsos Global Trends, GLOB TRENDS 2014 ENV; Johnston FH, 2012, ENVIRON HEALTH PERSP, V120, P695, DOI 10.1289/ehp.1104422; Karl T. R., 2009, Global climate change impacts in the United States; Kelley CP, 2015, P NATL ACAD SCI USA, V112, P3241, DOI 10.1073/pnas.1421533112; Kim CS, 2011, AM J RESP CRIT CARE, V183, P1215, DOI 10.1164/rccm.201011-1813OC; Kinney PL, 2008, AM J PREV MED, V35, P459, DOI 10.1016/j.amepre.2008.08.025; Kirtman B., 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Knowlton K, 2011, HEALTH AFFAIR, V30, P2167, DOI 10.1377/hlthaff.2011.0229; Kovats RS, 2006, EUR J PUBLIC HEALTH, V16, P592, DOI 10.1093/eurpub/ckl049; Levin Kelly, 2013, WORLDS CARBON BUDGET; Luber, 2015, ASSESSING HLTH VULNE; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; Maibach E, 2011, CONV HUM IMPL CLIM C; Maizlish N, 2013, AM J PUBLIC HEALTH, V103, P703, DOI 10.2105/AJPH.2012.300939; McDonald Robert I, 2011, Proc Natl Acad Sci U S A, V108, P6312, DOI 10.1073/pnas.1011615108; McKie R, 2015, GUARDIAN; Meason B, 2014, HEALTH HUM RIGHTS, V16, P105; Motel, 2014, POLLS SHOW MOST AM B; National Aeronautics and Space Administration, VIT SIGNS LAND IC; National Institute of Environmental Health Sciences, 2015, MENT HLTH STRESS REL; National Institute of Environmental Health Sciences, CLIM CHANG HUM HLTH; National Research Council, 2012, AD IMP CLIM CHANG; Neira M., 2014, MEDIA CTR COMMENTARY; Neria Y, 2012, JAMA-J AM MED ASSOC, V308, P2571, DOI 10.1001/jama.2012.110700; OBrien LV, 2014, ENVIRON RES, V131, P181, DOI 10.1016/j.envres.2014.03.014; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Patz JA, 2008, AM J PREV MED, V35, P451, DOI 10.1016/j.amepre.2008.08.026; Patz JA, 2014, JAMA-J AM MED ASSOC, V312, P1565, DOI 10.1001/jama.2014.13186; Peregrin Tony, 2015, Bull Am Coll Surg, V100, P10; Permanente Kaiser, 2014, EXC GREEN HEALTHC HO; Physicians for Social Responsibility, 2011, CLIM CHANG HLTH; Portier Christopher J., 2010, HUMAN HLTH PERSPECTI; Ratard R., 2006, Morbidity and Mortality Weekly Report, V55, P41; Reid CE, 2009, ECOHEALTH, V6, P458, DOI 10.1007/s10393-009-0261-x; Rey G, 2007, INT ARCH OCC ENV HEA, V80, P615, DOI 10.1007/s00420-007-0173-4; Rice MB, 2015, ANN AM THORAC SOC, V12, P245, DOI 10.1513/AnnalsATS.201412-590ED; Rogers CA, 2006, ENVIRON HEALTH PERSP, V114, P865, DOI 10.1289/ehp.8549; Rygielski L, 2011, GOING GREEN WHIL IMP; Sarfaty M, 2016, J ALLER CL IMM-PRACT, V4, P333, DOI 10.1016/j.jaip.2015.09.018; Sarfaty M, 2015, ANN AM THORAC SOC, V12, P274, DOI 10.1513/AnnalsATS.201410-460BC; Sarfaty M, 2014, INT J ENV RES PUB HE, V11, P12473, DOI 10.3390/ijerph111212473; Schmidt CW, 2010, ENVIRON HEALTH PERSP, V118, pA536, DOI 10.1289/ehp.118-a536; Schwartz J, 2014, HLTH COBENEFITS CA 2; Seifert CA, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/024002; Shuman EK, 2010, NEW ENGL J MED, V362, P1061, DOI 10.1056/NEJMp0912931; Singer BD, 2005, FUNCT PLANT BIOL, V32, P667, DOI 10.1071/FP05039; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; South Florida Water Management District Interdepartmental Climate Change Group, 2009, CLIM CHANG WAT MAN S; Stanford Woods Institute for the Environment, 2015, CLIM CHANG IMP AGR I; Tamiotti Ludivine, 2009, TRADE CLIMATE CHANGE; The Partnership for Maternal Newborn & Child Health, 2012, PMNCH KNOWL SUMM 19; The White House, 2015, PROGR REP HIGHL FED; The White House, 2013, FED CLIM CHANG EXP R; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; U.S. Department of Energy, 2016, BETT BUILD ALL HEALT; U.S. Energy Information Administration, 2009, US COMM BUILD EN INT; U.S. Environmental Protection Agency, 2009, REV IMP CLIM VAR CHA; U.S. Environmental Protection Agency, 2014, CLIM CHANG IND US RA; U.S. Environmental Protection Agency, 2014, 430R14004 US EPA; U.S. Government Accountability Office, 2011, INT CLIM CHANG ASS F; U.S. Government Accountability Office, KEY ISS CLIM CHANG F; U. S. Government Accountability Office, 2015, CLIM CHANG HHS COULD; U.S. National Academy of Sciences; Royal Society, 2014, CLIM CHANG EV CAUS; U.S. National Aeronautics and Space Administration, CLIM CHANG DO WE KNO; UCSF Office of Sustainability, 2015, GREEN MED CTR UCSFMC; United States Environmental Protection Agency, 2015, CLIM CHANG US BEN GL; US Department of Health and Human Services, 2014, PRIM PROT ENH HLTH C; Verisk Maplecroft, 2014, CLIM CHANG LACK FOOD; Wan SQ, 2002, AM J BOT, V89, P1843, DOI 10.3732/ajb.89.11.1843; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2014, WHO C HLTH CLIM CHAN; World Health Organization, 2014, BURD DIS AMB AIR POL; World Health Organization, HLTH HOSP HLTH PLAN; Younger M, 2008, AM J PREV MED, V35, P517, DOI 10.1016/j.amepre.2008.08.017; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108	128	79	80	0	44	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					608	+		10.7326/M15-2766	http://dx.doi.org/10.7326/M15-2766			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27089232				2022-12-28	WOS:000375744000019
J	Banchereau, R; Hong, S; Cantarel, B; Baldwin, N; Baisch, J; Edens, M; Cepika, AM; Acs, P; Turner, J; Anguiano, E; Vinod, P; Kahn, S; Obermoser, G; Blankenship, D; Wakeland, E; Nassi, L; Gotte, A; Punaro, M; Liu, YJ; Banchereau, J; Rossello-Urgell, J; Wright, T; Pascual, V				Banchereau, Romain; Hong, Seunghee; Cantarel, Brandi; Baldwin, Nicole; Baisch, Jeanine; Edens, Michelle; Cepika, Alma-Martina; Acs, Peter; Turner, Jacob; Anguiano, Esperanza; Vinod, Parvathi; Kahn, Shaheen; Obermoser, Gerlinde; Blankenship, Derek; Wakeland, Edward; Nassi, Lorien; Gotte, Alisa; Punaro, Marilynn; Liu, Yong-Jun; Banchereau, Jacques; Rossello-Urgell, Jose; Wright, Tracey; Pascual, Virginia			Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients	CELL			English	Article							TRANSCRIPTIONAL REPERTOIRE ANALYSES; GENE-EXPRESSION; SET ANALYSIS; B-CELLS; ERYTHEMATOSUS; INTERFERON; DISEASE; BLOOD; SIGNATURE; AUTOIMMUNITY	Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of tolerance to nucleic acids and highly diverse clinical manifestations. To assess its molecular heterogeneity, we longitudinally profiled the blood transcriptome of 158 pediatric patients. Usingmixed models accounting for repeated measurements, demographics, treatment, disease activity (DA), and nephritis class, we confirmed a prevalent IFN signature and identified a plasmablast signature as the most robust biomarker of DA. We detected gradual enrichment of neutrophil transcripts during progression to active nephritis and distinct signatures in response to treatment in different nephritis subclasses. Importantly, personalized immunomonitoring uncovered individual correlates of disease activity that enabled patient stratification into seven groups, supported by patient genotypes. Our study uncovers the molecular heterogeneity of SLE and provides an explanation for the failure of clinical trials. This approach may improve trial design and implementation of tailored therapies in genetically and clinically complex autoimmune diseases.	[Banchereau, Romain; Hong, Seunghee; Cantarel, Brandi; Baldwin, Nicole; Baisch, Jeanine; Edens, Michelle; Cepika, Alma-Martina; Acs, Peter; Turner, Jacob; Anguiano, Esperanza; Vinod, Parvathi; Obermoser, Gerlinde; Blankenship, Derek; Liu, Yong-Jun; Rossello-Urgell, Jose; Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Kahn, Shaheen; Wakeland, Edward; Nassi, Lorien; Gotte, Alisa; Punaro, Marilynn; Wright, Tracey] UT Southwestern Med Ctr, Dallas, TX 75235 USA; [Nassi, Lorien; Gotte, Alisa; Punaro, Marilynn; Wright, Tracey; Pascual, Virginia] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Gotte, Alisa] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; [Liu, Yong-Jun] Medimmune Inc, Gaithersburg, MD 20878 USA; [Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT 06030 USA	Baylor Scott & White Health; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Scottish Rite Hospital for Children; Vanderbilt University; AstraZeneca; Medimmune; Jackson Laboratory	Pascual, V (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.; Pascual, V (corresponding author), Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA.	virginia.pascual@bswhealth.org	Pascual, Virginia/ABD-3099-2020; Cantarel, Brandi/ABF-5756-2020	Cantarel, Brandi/0000-0003-4126-4478; Cepika, Alma-Martina/0000-0003-2862-1901	National Institute of Arthritis and Musculoskeletal and Skin Diseases [P50 AR054083-01]; National Institute of Allergy and Infectious Diseases [U19 AI082715]; Alliance for Lupus Research; Baylor-Scott & White Health Care Research Foundation; BIIR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054083, P50AR070594] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Alliance for Lupus Research; Baylor-Scott & White Health Care Research Foundation; BIIR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50 AR054083-01), the National Institute of Allergy and Infectious Diseases (U19 AI082715), the Alliance for Lupus Research, and the Baylor-Scott & White Health Care Research Foundation and is dedicated to the memory of Dr. J. Donald Capra. We thank members of the sample, genomics, and flow cytometry cores at BIIR for research support. We thank Dr. Anna Lisa Lucido for her critical review of the manuscript and Drs. Katie Stewart, Julie Fuller, and Ashley Cooper for their clinical expertise. Jacques Banchereau is a member of the Board of Directors and the chairman of the Scientific Advisory Board of Neovacs, a French biotechnology company focused on the development of Kinoids, therapeutic vaccines for the treatment of autoimmune and inflammatory diseases (in particular SLE) and cancer. Yong-Jun Liu is an employee of Medimmune, which is involved in the development of drugs to treat SLE.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Cheng MH, 2012, ANNU REV IMMUNOL, V30, P393, DOI 10.1146/annurev-immunol-020711-074953; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Jonsson CA, 2003, INT IMMUNOPHARMACOL, V3, P31, DOI 10.1016/S1567-5769(02)00210-2; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Korbet SM, 2007, J AM SOC NEPHROL, V18, P244, DOI 10.1681/ASN.2006090992; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Petri M, 2009, LUPUS, V18, P980, DOI 10.1177/0961203309105529; Ritterhouse LL, 2011, ARTHRITIS RHEUM-US, V63, P3931, DOI 10.1002/art.30598; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Streicher K, 2014, ARTHRITIS RHEUMATOL, V66, P173, DOI 10.1002/art.38194; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Turner JA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0707-9; Ugarte-Gil MF, 2014, CLIN RHEUMATOL, V33, P441, DOI 10.1007/s10067-014-2531-4; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Yaari G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt660; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	35	329	341	3	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					551	565		10.1016/j.cell.2016.03.008	http://dx.doi.org/10.1016/j.cell.2016.03.008			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27040498	Green Accepted, Bronze			2022-12-28	WOS:000374636800015
J	Badylak, SF				Badylak, Stephen F.			TISSUE REGENERATION A scaffold immune microenvironment	SCIENCE			English	Editorial Material							STEM-CELLS; MACROPHAGES; INFLAMMATION; HOMEOSTASIS; RESOLUTION; PROLIFERATION		[Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Badylak, SF (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA.; Badylak, SF (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA.; Badylak, SF (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.	badylaks@upmc.edu		Badylak, Stephen/0000-0003-3555-0689				Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192; Bloom AB, 2014, PHYSIOL GENOMICS, V46, P309, DOI 10.1152/physiolgenomics.00170.2013; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Inman JL, 2015, DEVELOPMENT, V142, P1028, DOI 10.1242/dev.087643; Leid J, 2016, CIRC RES, V118, P1498, DOI 10.1161/CIRCRESAHA.115.308270; Little MC, 2014, J IMMUNOL, V193, P4684, DOI 10.4049/jimmunol.1400502; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035; Wang M, 2015, INT J BIOCHEM CELL B, V58, P53, DOI 10.1016/j.biocel.2014.11.003; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	15	23	23	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					298	298		10.1126/science.aaf7587	http://dx.doi.org/10.1126/science.aaf7587			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081059				2022-12-28	WOS:000373990100024
J	Malik, J				Malik, Jasmin			Marisa Eve Girawong Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2016	353								i2157	10.1136/bmj.i2157	http://dx.doi.org/10.1136/bmj.i2157			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EV	27083485				2022-12-28	WOS:000374375600005
J	Zhou, YH; Zheng, MH				Zhou, Yong-Hai; Zheng, Ming-Hua			A boy with a sac-like protrusion at the occipital region	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Zhou, Yong-Hai] Wenzhou Med Univ, Affiliated Hosp 2, Dept Paediat, Wenzhou 325000, Zhejiang, Peoples R China; [Zhou, Yong-Hai] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Zhejiang, Peoples R China; [Zheng, Ming-Hua] Wenzhou Med Univ, Liver Res Ctr, Dept Hepatol, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zheng, MH (corresponding author), Wenzhou Med Univ, Liver Res Ctr, Dept Hepatol, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China.	zhengmh@wmu.edu.cn	Zheng, Ming-Hua/H-5584-2019	Zheng, Ming-Hua/0000-0003-4984-2631				Bui CJ, 2007, J NEUROSURG, V107, P22, DOI 10.3171/PED-07/07/022; MEALEY J, 1970, J NEUROSURG, V32, P209, DOI 10.3171/jns.1970.32.2.0209; Sandler M A, 1986, Radiographics, V6, P1096; Thompson DNP, 2009, PRENATAL DIAG, V29, P412, DOI 10.1002/pd.2199	4	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2016	353								i2073	10.1136/bmj.i2073	http://dx.doi.org/10.1136/bmj.i2073			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EU	27079497				2022-12-28	WOS:000374375500005
J	Blanc, C				Blanc, Christophe			Colloidal crystal ordering in a liquid crystal	SCIENCE			English	Editorial Material									[Blanc, Christophe] Univ Montpellier, L2C, CNRS, UMR 5221, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Montpellier	Blanc, C (corresponding author), Univ Montpellier, L2C, CNRS, UMR 5221, F-34059 Montpellier, France.	christophe.blanc@umontpellier.fr	Blanc, Christophe/K-4677-2012	Blanc, Christophe/0000-0002-8470-478X				BROCHARD F, 1970, J PHYS-PARIS, V31, P691, DOI 10.1051/jphys:01970003107069100; Draper M, 2011, ADV FUNCT MATER, V21, P1260, DOI 10.1002/adfm.201001606; Gharbi MA, 2016, ACS NANO, V10, P3410, DOI 10.1021/acsnano.5b07379; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Mundoor H, 2016, SCIENCE, V352, P69, DOI 10.1126/science.aaf0801; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Nych A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2486; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Zhang Y, 2015, ACS NANO, V9, P3097, DOI 10.1021/nn5074644	10	11	11	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					40	41		10.1126/science.aaf4260	http://dx.doi.org/10.1126/science.aaf4260			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034362				2022-12-28	WOS:000373039600024
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Privacy is not secrecy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Matthews-King A., 2016, PULSE           0205; Pollock A., 2014, CARE DATA; Praities N., 2015, PULSE           0904	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2016	352								i1759	10.1136/bmj.i1759	http://dx.doi.org/10.1136/bmj.i1759			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TO	27029210	Green Published, Bronze			2022-12-28	WOS:000373492400011
J	Daniel, H				Daniel, Hilary		Hlth Public Policy Comm Amer Coll	Stemming the Escalating Cost of Prescription Drugs: A Position Paper of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							SPECIALTY DRUGS; UNITED-STATES; SPENDING TRENDS; CANCER DRUGS; PRICES; INNOVATION; MEDICATIONS; ADHERENCE; US; COVERAGE	This American College of Physicians position paper, initiated and written by its Health and Public Policy Committee and approved by the Board of Regents on 16 February 2016, reports policy recommendations from the American College of Physicians to address the escalating costs of prescription drugs in the United States. Prescription drugs play an important part in treating and preventing disease. However, the United States often pays more for some prescription drugs than other developed countries, and the high price and increasing costs associated with prescription medication is a major concern for patients, physicians, and payers. Pharmaceutical companies have considerable flexibility in how they price drugs, and the costs that payers and patients see are dependent on how payers are able to negotiate discounts or rebates. Beyond setting list prices are issues of regulatory approval, patents and intellectual property, assessment of value and cost-effectiveness, and health plan drug benefits. These issues are linked, and comprehensive efforts will be needed to affect how drugs are priced in the United States.	[Daniel, Hilary] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA	American College of Physicians	Daniel, H (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	hdaniel@mail.acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Abboud C, 2013, BLOOD, V121, P4439, DOI 10.1182/blood-2013-03-490003; Aitken M, 2009, HEALTH AFFAIR, V28, pW151, DOI 10.1377/hlthaff.28.1.w151; America's Health Insurance Plans, 2014, SPEC DRUGS ISS CHALL; American Diabetes Association, 2015, THE COST OF DIAB; Andrews M., 2014, KAISER HLTH NEW 0708; [Anonymous], 2015, BOTH PCSK9 INH INCL; [Anonymous], 2014, DRUGS            FEB; [Anonymous], 2015, FACTS GEN DRUGS; [Anonymous], CONTR HLTH CAR COSTS; [Anonymous], 2014, COMMUNICATION; [Anonymous], 2014 DRUG TREND REP; [Anonymous], 2013, HLTH AFF MILLWOOD; Anthem Blue Cross Blue Shield, 2011, GEN PREM 3 TIER PRES; Avorn J, 2015, NEW ENGL J MED, V372, P1877, DOI 10.1056/NEJMp1500848; Azoulay P, 2015, PUBLIC R D INVESTMEN; Bach PB, 2014, JAMA-J AM MED ASSOC, V312, P1629, DOI 10.1001/jama.2014.13235; Barlas Stephen, 2014, P T, V39, P833; Bhosle Monali J, 2007, Ther Clin Risk Manag, V3, P41; Blackstone EA, 2013, AM HEALTH DRUG BENEF, V6, P469; Bruen N, 2014, PAYING PRESCRIBED DR; Calmes Jackie, 2015, NY TIMES; Canary LA, 2015, ANN INTERN MED, V163, P226, DOI 10.7326/M15-0320; Centers for Medicare & Medicaid Services, NAT HLTH EXP PROJ 20; Centers for Medicare & Medicaid Services, 2013, 2013 CMS STAT; Chambers JD, 2014, HEALTH AFFAIR, V33, P1751, DOI 10.1377/hlthaff.2014.0574; Charles D, 2015, UNRESOLVED POLICY IS; Choudhry NK, 2016, ANN INTERN MED, V164, P41, DOI 10.7326/M14-2427; Coolidge A., 2014, CINCINNATI ENQUIRER; Crowley R, 2012, REFORMING MEDICARE A; DiJulio B, 2015, KAISER HLTH TRACKING; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Drahl C, 2012, CHEM ENG NEWS, V90, P13; Elsevier Clinical Solutions, 2015, GEN DRUG PRIC INCR C; Elsevier Clinical Solutions, 2015, CISC VIS NETW IND GL; Engelberg AB, 2009, NEW ENGL J MED, V361, P1917, DOI 10.1056/NEJMp0908496; Ermer DM, 2007, HLTH LAW POLICY, V1, P24; Everett BM, 2015, NEW ENGL J MED, V373, P1588, DOI 10.1056/NEJMp1508120; Express Scripts, 2015, WE HAV CHANG WE PAY; Fed. Trade CoMM'n, 2009, EMERGING HLTH CARE I; Federal Trade Commission, 2010, PAY FOR DEL DRUG CO; Friends of Cancer Research Website, BREAKTHR THER; Gagnon M, 2015, MIRROR MIRROR WALL M; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Gellad WF, 2008, J GEN INTERN MED, V23, P1435, DOI 10.1007/s11606-008-0689-7; Generic Pharmaceutical Association, 2016, ISS PAT SETTL; Generic Pharmaceutical Association, 2014, GEN DRUG SAV US 6 AN; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Gupta H, 2010, J PHARM BIOALLIED SC, V2, P2, DOI 10.4103/0975-7406.62694; Hartung DM, 2015, NEUROLOGY, V84, P2185, DOI 10.1212/WNL.0000000000001608; HMSA, 2014, SINGL SOURC GEN DRUG; Howard DH, 2015, J ECON PERSPECT, V29, P139, DOI 10.1257/jep.29.1.139; IMS Institute for Healthcare Informatics, 2015, MED US PEND SHIFTS R; IMS Institute for Healthcare Informatics, 2014, GLOB OUTL MED 2018; International Diabetes Federation, 2015, IDF DIABETES ATLAS; International Federation of Pharmaceutical Manufacturers and Associations, 2011, DAT EXCL ENC DEV NEW; Jacobson GA, 2007, CRS REP C; Kaiser Family Foundation, MED PART D PRESCR DR; Kaiser Permanente Institute for Health Policy, PHARM PRIC LESS ABR; Kanavos P, 2013, HEALTH AFFAIR, V32, P753, DOI 10.1377/hlthaff.2012.0920; Kantarjian H, 2013, CANCER-AM CANCER SOC, V119, P3903, DOI 10.1002/cncr.28330; Kirschner N, 2008, IMPROVED AVAILABILIT; Langreth R., 2014, BLOOMBERG       0508; Langreth R., 2015, BLOOMBERG       0506; Levinson DR, 2011, REBATES MEDICARE PAR; Lo C., 2015, PHARM TECHNOLOG 0107; Lotvin AM, 2014, HEALTH AFFAIR, V33, P1736, DOI 10.1377/hlthaff.2014.0511; Mailankody S, 2015, JAMA ONCOL, V1, P539, DOI 10.1001/jamaoncol.2015.0373; Midwest Business Group on Health, NAT EMPL IN SPEC PHA; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Mulcahy A.W., 2014, COST SAVINGS POTENTI; Mylan Pharmaceuticals Inc. et al. v. Warner Chilcott Public Limited Company et al, 2012, US DISTR COURT E DIS; National Center for Advancing Translational Sciences, 2015, DISC NEW THER US EX; National Center for Advancing Translational Sciences, 2015, NEW THER US; National Conference of State Legislatures, 2015, VAL BAS INS DES; National Institutes of Health, ACC MED PARTN; Neumann PJ, 2015, NEW ENGL J MED, V373, P2595, DOI 10.1056/NEJMp1512009; Neumann PJ, 2010, NEW ENGL J MED, V363, P1495, DOI 10.1056/NEJMp1007168; Office of Management and Budget, FISC YEAR 2016 BUDG; Office of the Inspector General U.S. Department of Health and Human Services, 2007, REV GEN DRUG PRIC IN; Office of the United States Trade Representative, 2016, TRANSP PARTN; Patient-Centered Outcomes Research Institute, 2014, US; Pearson CF., 2014, AVALERE ANAL MEDICAR; Pharmaceutical Research and Manufacturers of America, 2015, 2015 BIOPH RES IND P; Pharmaceutical Research and Manufacturers of America, 2013 BIOPH RES IND P; Philippidis A., 2015, GENETIC ENG BIOTECHN; Pollack A, 2015, NY TIMES, pB2; Prieto Luis, 2003, Health Qual Life Outcomes, V1, P80, DOI 10.1186/1477-7525-1-80; Pyenson B, 2015, MILLIMAN         SEP; Quon BS, 2005, ANN INTERN MED, V143, P397, DOI 10.7326/0003-4819-143-6-200509200-00004; Regnier S, 2013, HEALTH CARE MANAG SC, V16, P300, DOI 10.1007/s10729-013-9225-3; Rius Sanjuan J., 2015, COMMUNICATION; Roberts SA, 2011, HEALTH AFFAIR, V30, P1375, DOI 10.1377/hlthaff.2011.0231; Rocca WA, 2014, MAYO CLIN PROC, V89, P1336, DOI 10.1016/j.mayocp.2014.07.010; Roebuck MC, 2011, HEALTH AFFAIR, V30, P91, DOI 10.1377/hlthaff.2009.1087; Romley JA, 2012, HEALTH AFFAIR, V31, P683, DOI 10.1377/hlthaff.2011.1301; Rosenberg M., 2015, MARKET STRUCTURE NAL; Rosenberg ME, 2016, JAMA DERMATOL, V152, P158, DOI 10.1001/jamadermatol.2015.3897; Saadi E, 2014, AM HEALTH DRUG BENEF, V7, P373; Sampat BN, 2011, HEALTH AFFAIR, V30, P332, DOI 10.1377/hlthaff.2009.0917; Schondelmeyer SW, RX PRICE WATCH REPOR; Shapiro RJ, 2016, POTENTIAL AM MARKET; Spiro T., 2015, ENOUGH IS ENOUGH TIM; Stanton Dan, 2015, BIOPHARMA 0903; Starner CI, 2010, J MANAGE CARE PHARM, V16, P161; Staton T., 2015, FIERCEPHARMA    0827; The Advisory Board Company, 2015, CMS PREP ROLL OUT NE; The Congressional Budget Office, 2014, COMP COST MED PRESCR; Thomas J, 2014, FOLLOW ON BIOL LAW I; Trish E, 2014, HEALTH AFFAIR, V33, P2018, DOI 10.1377/hlthaff.2014.0538; Tu Ha T, 2007, Issue Brief Cent Stud Health Syst Change, P1; U. S. Food and Drug Administration, 2014, ACC APPR; U. S. Food and Drug Administration, 2016, NOV DRUGS 2015 JAN 2; U.S. Food and Drug Administration, 2014, FREQ ASK QUEST PAT E; US Food & Drug Administration, 2015, IMP DIR TO CONS ADV; Usdin S., 2011, BIOCENTURY      0509; Yazdany J, 2015, ARTHRITIS RHEUMATOL, V67, P1474, DOI 10.1002/art.39079; Zeng F, 2010, VALUE HEALTH, V13, P846, DOI 10.1111/j.1524-4733.2010.00730.x	117	23	23	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					50	+		10.7326/M15-2768	http://dx.doi.org/10.7326/M15-2768			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27018758				2022-12-28	WOS:000379215800007
J	Sessums, LL; McHugh, SJ; Rajkumar, R				Sessums, Laura L.; McHugh, Sarah J.; Rajkumar, Rahul			Medicare's Vision for Advanced Primary Care New Directions for Care Delivery and Payment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY		[Sessums, Laura L.; McHugh, Sarah J.; Rajkumar, Rahul] Ctr Medicare & Medicaid Serv, Mail Stop WB 06-05,7500 Security Blvd, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Sessums, LL (corresponding author), Ctr Medicare & Medicaid Serv, CMS, Seamless Care Models Grp, Mail Stop WB 06-05,7500 Security Blvd, Baltimore, MD 21244 USA.	laura.sessums@cms.hhs.gov						Berenson RA, 2015, HEALTH SERV RES, V50, P2155, DOI 10.1111/1475-6773.12413; Friedberg MW, 2015, JAMA INTERN MED, V175, P1362, DOI 10.1001/jamainternmed.2015.2047; Jones C, 2015, PROGR HUMAN GEOGRAPH, V0, P1; Press MJ, 2016, JAMA-J AM MED ASSOC, V315, P131, DOI 10.1001/jama.2015.18161; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	5	36	36	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2665	2666		10.1001/jama.2016.4472	http://dx.doi.org/10.1001/jama.2016.4472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27065435				2022-12-28	WOS:000378709300014
J	Evans, T; Pablos-Mendez, A				Evans, Tim; Pablos-Mendez, Ariel			Shaping of a new era for health financing	LANCET			English	Editorial Material									[Evans, Tim] World Bank Grp, Washington, DC 20433 USA; [Pablos-Mendez, Ariel] US Agcy Int Dev, Washington, DC 20523 USA	The World Bank; United States Agency for International Development (USAID)	Evans, T (corresponding author), World Bank Grp, Washington, DC 20433 USA.	tgevans@worldbank.org						[Anonymous], 2011, REV MOB DEV COUNTR; [Anonymous], 2015, GOING UNIVERSAL 24 D; Dieleman JL, 2016, LANCET, V387, P2521, DOI 10.1016/S0140-6736(16)30167-2; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Organization of African Unity, 2001, AFR SUMM HIV AIDS TU; Thomas V, 2011, EVIDENCE LESSONS LEA; United Nations, 2015, ADD AB ACT AG 3 INT; World Bank, 2015, GLOB FIN FAC SUPP EV; World Bank Group, 2015, GLOB EC PROSP SPILL; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	10	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2482	2484		10.1016/S0140-6736(16)30238-0	http://dx.doi.org/10.1016/S0140-6736(16)30238-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO7FG	27086171				2022-12-28	WOS:000377947200005
J	Gostin, LO; Hodge, JG				Gostin, Lawrence O.; Hodge, James G., Jr.			Is the United States Prepared for a Major Zika Virus Outbreak?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, Washington, DC 20001 USA; [Hodge, James G., Jr.] Arizona State Univ, Publ Hlth Law & Policy Program, Sandra Day OConnor Coll Law, Tempe, AZ USA	Georgetown University; Arizona State University; Arizona State University-Tempe	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2016, FED REG, V81, P10878; Boodman E, CHRISTIE CALLS QUARA; Kim M, MOSQUITOES SELF DEST; McNeil Jr DG, PUERTO RICO BRACES I; Pollack A, NEW WEAPON FIGHT ZIK; Sullivan P, GOP SKEPTICAL NEW FU; Tavernise S, CDC OFFERS GUIDELINE; The White House, FACT SHEET PREP RESP; World Health Organization, WHO DIR GEN BRIEFS M	9	5	6	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2016	315	22					2395	2396		10.1001/jama.2016.4919	http://dx.doi.org/10.1001/jama.2016.4919			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3CE	27074330	Green Published, Bronze			2022-12-28	WOS:000377656900012
J	Goroll, AH				Goroll, Allan H.			Eliminating the Term Primary Care "Provider" Consequences of Language for the Future of Primary Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Goroll, Allan H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Internal Med, 15 Parkman St,Ste 645, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Goroll, AH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Internal Med, 15 Parkman St,Ste 645, Boston, MA 02114 USA.	ahgoroll@partners.org						American Academy of Family Physicians (AAFP) American Academy of Pediatrics (AAP) American College of Physicians (ACP) American Osteopathic Association (AOA), 2007, JOINT PRINC PAT CTR; American College of Physicians (ACP), 2009, NURS PRACT PRIM CAR; Centers for Medicare & Medicaid Services (CMS), GLOSS PRIM CAR PROV; Hauer KE, 2008, JAMA-J AM MED ASSOC, V300, P1154, DOI 10.1001/jama.300.10.1154; Margolius D, 2010, HEALTH AFFAIR, V29, P779, DOI 10.1377/hlthaff.2010.0045; McGlynn EA, 2015, JAMA-J AM MED ASSOC, V314, P2501, DOI 10.1001/jama.2015.13453; National Resident Matching Program, 2015, RES DAT 2015 MAIN RE; Paydarfar D, 2011, JAMA-J AM MED ASSOC, V305, P2046, DOI 10.1001/jama.2011.702	8	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1833	1834		10.1001/jama.2016.2329	http://dx.doi.org/10.1001/jama.2016.2329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK9XF	27031172				2022-12-28	WOS:000375284400008
J	Jellinek, M				Jellinek, Michael			Trustees of Nonprofit Health Care Organizations Whom Do They Serve?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROFESSIONALISM		[Jellinek, Michael] Lahey Hlth Community Network, 41 Mall Rd, Burlington, MA 01805 USA	Lahey Hospital & Medical Center	Jellinek, M (corresponding author), Lahey Hlth Community Network, 41 Mall Rd, Burlington, MA 01805 USA.	michael.jellinek@lahey.org						Emanuel EJ, 2015, JAMA-J AM MED ASSOC, V313, P1799, DOI 10.1001/jama.2015.4336; Jennings B, ETHICS TRUSTEESHIP H; Margolis JD, 2015, JAMA-J AM MED ASSOC, V313, P1819, DOI 10.1001/jama.2015.4398; Martin AB, 2014, NATL HLTH EXPENDITUR	4	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1699	1700		10.1001/jama.2016.1778	http://dx.doi.org/10.1001/jama.2016.1778			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27055245				2022-12-28	WOS:000374759300012
J	Tehranchi, AK; Myrthil, M; Martin, T; Hie, BL; Golan, D; Fraser, HB				Tehranchi, Ashley K.; Myrthil, Marsha; Martin, Trevor; Hie, Brian L.; Golan, David; Fraser, Hunter B.			Pooled ChIP-Seq Links Variation in Transcription Factor Binding to Complex Disease Risk	CELL			English	Article							GENOME-WIDE ASSOCIATION; CYCLIN D1 EXPRESSION; GENETIC-VARIANTS; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; ATOPIC-DERMATITIS; CHROMATIN STATES; DNA METHYLATION; HUMANS; POPULATION	Cis-regulatory elements such as transcription factor (TF) binding sites can be identified genome-wide, but it remains far more challenging to pinpoint genetic variants affecting TF binding. Here, we introduce a pooling-based approach to mapping quantitative trait loci (QTLs) for molecular-level traits. Applying this to five TFs and a histone modification, we mapped thousands of cis-acting QTLs, with over 25-fold lower cost compared to standard QTL mapping. We found that single genetic variants frequently affect binding of multiple TFs, and CTCF can recruit all five TFs to its binding sites. These QTLs often affect local chromatin and transcription but can also influence long-range chromosomal contacts, demonstrating a role for natural genetic variation in chromosomal architecture. Thousands of these QTLs have been implicated in genome-wide association studies, providing candidate molecular mechanisms for many disease risk loci and suggesting that TF binding variation may underlie a large fraction of human phenotypic variation.	[Tehranchi, Ashley K.; Martin, Trevor; Fraser, Hunter B.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Myrthil, Marsha] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Hie, Brian L.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Golan, David] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Golan, David] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; University of Chicago; Stanford University; Stanford University; Stanford University	Fraser, HB (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	hbfraser@stanford.edu		Martin, Trevor/0000-0002-7302-1190; Hie, Brian/0000-0003-3224-8142	NIH [1DP2OD008456-01, T32GM007276]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank B. van de Geijn, Y. Gilad, T. Kawli, G. McVicker, J. Pritchard, M. Snyder, D. Spacek, R. Tewhey, and members of the H.B.F. lab for sharing data, protocols, cell lines, and advice. This work was supported by NIH grant 1DP2OD008456-01. A.K.T. is an NSF predoctoral fellow and was supported by NIH training grant T32GM007276.	Aittomaki S, 2004, INT IMMUNOL, V16, P265, DOI 10.1093/intimm/dxh037; Al Olama AA, 2015, HUM MOL GENET, V24, P5589, DOI 10.1093/hmg/ddv203; Ansel J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000049; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Bonhoure N, 2014, GENOME RES, V24, P1157, DOI 10.1101/gr.168260.113; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Ding ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004798; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dror I, 2015, GENOME RES, V25, P1268, DOI 10.1101/gr.184671.114; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Enard D, 2014, GENOME RES, V24, P885, DOI 10.1101/gr.164822.113; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fraser HB, 2013, GENOME RES, V23, P1089, DOI 10.1101/gr.152710.112; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Fraser HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008635; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Guo YF, 2015, BIOINFORMATICS, V31, P275, DOI 10.1093/bioinformatics/btu639; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Hulse AM, 2013, GENETICS, V193, P95, DOI 10.1534/genetics.112.146779; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaplow IM, 2015, GENOME RES, V25, P907, DOI 10.1101/gr.183749.114; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Levo M, 2015, GENOME RES, V25, P1018, DOI 10.1101/gr.185033.114; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin XH, 2013, J BIOL CHEM, V288, P14815, DOI 10.1074/jbc.M113.466565; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Rahmani M, 2001, ONCOGENE, V20, P5132, DOI 10.1038/sj.onc.1204678; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tewhey R., 2016, CELL; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Yamada Y, 2011, ATHEROSCLEROSIS, V215, P145, DOI 10.1016/j.atherosclerosis.2010.12.005	57	61	61	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					730	741		10.1016/j.cell.2016.03.041	http://dx.doi.org/10.1016/j.cell.2016.03.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27087447	Green Accepted, Bronze			2022-12-28	WOS:000374636800029
J	Markusse, IM; Akdemir, G; Dirven, L; Goekoop-Ruiterman, YPM; van Groenendael, JHLM; Han, KH; Molenaar, THE; Le Cessie, S; Lems, WF; van der Lubbe, PAHM; Kerstens, PJSM; Peeters, AJ; Ronday, HK; de Sonnaville, PBJ; Speyer, I; Stijnen, T; ten Wolde, S; Huizinga, TWJ; Allaart, CF				Markusse, Iris M.; Akdemir, Gulsah; Dirven, Linda; Goekoop-Ruiterman, Yvonne P. M.; van Groenendael, Johannes H. L. M.; Han, K. Huub; Molenaar, T. H. Esmeralda; Le Cessie, Saskia; Lems, Willem F.; van der Lubbe, Peter A. H. M.; Kerstens, Pit J. S. M.; Peeters, Andre J.; Ronday, H. Karel; de Sonnaville, Peter B. J.; Speyer, Irene; Stijnen, Theo; ten Wolde, Saskia; Huizinga, Tom W. J.; Allaart, Cornelia F.			Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment	ANNALS OF INTERNAL MEDICINE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; COLLEGE-OF-RHEUMATOLOGY; TREATMENT STRATEGIES; AMERICAN-COLLEGE; COMBINATION THERAPY; INCREASED MORTALITY; CLINICAL-PRACTICE; JOINT DAMAGE; DOUBLE-BLIND; OPEN-LABEL	Background: Treat-to-target therapy is effective for patients with rheumatoid arthritis (RA), but long-term results of continued targeted treatment are lacking. Objective: To evaluate long-term outcomes in patients with early RA after 10 years of targeted treatment in 4 treatment strategies. Design: Randomized trial. (Nederlands Trial Register: NTR262 and NTR265) Setting: The Netherlands. Patients: 508 patients with early active RA. Intervention: Sequential monotherapy (strategy 1), step-up combination therapy (strategy 2), or initial combination therapy with prednisone (strategy 3) or with infliximab (strategy 4), all followed by targeted treatment aiming at low disease activity. Measurements: Functional ability (Health Assessment Questionnaire [HAQ] score) and radiographic progression (Sharp-van der Heijde score) were primary end points. Survival in the study population was compared with the general population using the standardized mortality ratio. Results: 195 of 508 of patients (38%) dropped out of the study (28% in strategy 4 vs. 40% to 45% in strategies 1 to 3, respectively). At year 10, mean HAQ score (SD) was 0.57 (0.56); 53% and 14% of patients were in remission and drug-free remission, respectively, without differences among the strategies. Over 10 years, mean HAQ scores were 0.69, 0.72, 0.64, and 0.58 in strategies 1 to 4, respectively (differences not clinically relevant). Radiographic damage was limited for all strategies, with mean Sharp-van der Heijde estimates during follow-up of 11, 8, 8, and 6 in strategies 1 to 4, respectively (P = 0.15). Standardized mortality ratio was 1.16 (95% CI, 0.92 to 1.46) based on 72 observed and 62 expected deaths, with similar survival among the 4 strategies (P = 0.81). Limitation: Dropout rate varied by strategy. Conclusion: In patients with early RA, initial (temporary) combination therapy results in faster clinical improvement and targeted treatment determines long-term outcomes. Drug-free remission, with prevention of functional deterioration and clinically relevant radiographic damage, and normalized survival are realistic outcomes.	[Akdemir, Gulsah; Dirven, Linda; Huizinga, Tom W. J.; Allaart, Cornelia F.] Leiden Univ, Med Ctr, Dept Rheumatol, POB 9600, NL-2300 RC Leiden, Netherlands; [Goekoop-Ruiterman, Yvonne P. M.; Ronday, H. Karel] Haga Hosp, Dept Rheumatol, POB 40551, NL-2504 LP The Hague, Netherlands; [Speyer, Irene] Bronovo Hosp, Dept Rheumatol, POB 96900, NL-2509 JH The Hague, Netherlands; Fransiscus Hosp, Roosendaal, Netherlands; [Han, K. Huub] Maasstad Hosp, Dept Rheumatol, POB 9100, NL-3007 AC Rotterdam, Netherlands; [Molenaar, T. H. Esmeralda] Groene Hart Hosp, Dept Rheumatol, POB 1098, NL-2800 BB Gouda, Netherlands; [Lems, Willem F.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, POB 7057, NL-1007 MB Amsterdam, Netherlands; Reade, Amsterdam, Netherlands; [van der Lubbe, Peter A. H. M.] Vlietland Hosp, Dept Rheumatol, POB 215, NL-3100 AE Schiedam, Netherlands; [Peeters, Andre J.] Reinier de Graaf Hosp, Dept Rheumatol, POB 5011, NL-2625 AD Delft, Netherlands; Admiraal de Ruyter Hosp, Goes, Netherlands; [ten Wolde, Saskia] Kennemer Gasthuis, Dept Rheumatol, POB 417, NL-2000 AK Haarlem, Netherlands; [Markusse, Iris M.] van Riebeeckweg 212,PO 10016, NL-1201 DA Hilversum, Netherlands; [van Groenendael, Johannes H. L. M.] Bravis Hosp, Dept Rheumatol, POB 999, NL-4700 AZ Roosendaal, Netherlands; [Le Cessie, Saskia; Stijnen, Theo] Leiden Univ, Dept Med Stat, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands; [Kerstens, Pit J. S. M.] Westfriesgasthuis, Dept Rheumatol, POB 600, NL-1620 AR Hoorn, Netherlands; [de Sonnaville, Peter B. J.] Admiraal de Ruyter Hosp, Dept Rheumatol, POB 3200, NL-4380 DD Vlissingen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; Haaglanden Medical Center; Bronovo Hospital; Maasstad Hospital; Vrije Universiteit Amsterdam; Reinier de Graaf Hospital; Spaarne Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Markusse, IM (corresponding author), van Riebeeckweg 212,PO 10016, NL-1201 DA Hilversum, Netherlands.	I.M.Markusse@lumc.nl; c.f.allaart@lumc.nl	le+Cessie, Saskia/HGC-8966-2022	le Cessie, Saskia/0000-0003-2154-4923	Dutch College of Health Insurance Companies; Schering-Plough; Janssen	Dutch College of Health Insurance Companies; Schering-Plough(Merck & CompanySchering Plough Corporation); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Dutch College of Health Insurance Companies, Schering-Plough, and Janssen.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bakker MF, 2007, ANN RHEUM DIS, V66, P56, DOI 10.1136/ard.2007.078360; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; de Punder YMR, 2012, RHEUMATOLOGY, V51, P1610, DOI 10.1093/rheumatology/kes078; de Vries-Bouwstra JK, 2008, ARTHRITIS RHEUM-US, V58, P1293, DOI 10.1002/art.23439; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Goekoop-Ruiterman YPM, 2007, ANN INTERN MED, V146, P406, DOI 10.7326/0003-4819-146-6-200703200-00005; Gonzalez A, 2007, ARTHRITIS RHEUM, V56, P3583, DOI 10.1002/art.22979; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Heimans L, 2014, ANN RHEUM DIS, V73, P1356, DOI 10.1136/annrheumdis-2013-203243; Humphreys JH, 2014, ARTHRIT CARE RES, V66, P1296, DOI 10.1002/acr.22296; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P1039, DOI 10.1136/ard.2010.141234; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Landewe R, 2005, ANN RHEUM DIS, V64, P48, DOI 10.1136/ard.2005.042572; Leirisalo-Repo M, 2013, ANN RHEUM DIS, V72, P851, DOI 10.1136/annrheumdis-2012-201365; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Molenberghs G, 2007, MISSING DATA CLIN ST, P529; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; Pope JE, 2009, J RHEUMATOL, V36, P254, DOI 10.3899/jrheum.080479; Prevoo MLL, 1996, BRIT J RHEUMATOL, V35, P1101; Radovits BJ, 2010, ARTHRIT CARE RES, V62, P362, DOI 10.1002/acr.20105; RITCHIE DM, 1968, Q J MED, V37, P393; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P776; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; SIEGERT CEH, 1984, CLIN RHEUMATOL, V3, P305, DOI 10.1007/BF02032335; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; ter Wee MM, 2015, ANN RHEUM DIS, V74, P1233, DOI 10.1136/annrheumdis-2013-205143; van den Broek M, 2012, ANN RHEUM DIS, V71, P245, DOI 10.1136/annrheumdis-2011-200379; van den Hout WB, 2009, ARTHRIT RHEUM-ARTHR, V61, P291, DOI 10.1002/art.24169; van der Heijde D, 1999, J RHEUMATOL, V26, P743; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P49, DOI 10.1002/art.20775; van Nies JAB, 2010, RHEUMATOLOGY, V49, P2210, DOI 10.1093/rheumatology/keq250; VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092	40	73	74	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					523	+		10.7326/M15-0919	http://dx.doi.org/10.7326/M15-0919			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	27089068				2022-12-28	WOS:000374257900011
J	Ribas, A; Hamid, O; Daud, A; Hodi, FS; Wolchok, JD; Kefford, R; Joshua, AM; Patnaik, A; Hwu, WJ; Weber, JS; Gangadhar, TC; Hersey, P; Dronca, R; Joseph, RW; Zarour, H; Chmielowski, B; Lawrence, DP; Algazi, A; Rizvi, NA; Hoffner, B; Mateus, C; Gergich, K; Lindia, JA; Giannotti, M; Li, XN; Ebbinghaus, S; Kang, SP; Robert, C				Ribas, Antoni; Hamid, Omid; Daud, Adil; Hodi, F. Stephen; Wolchok, Jedd D.; Kefford, Richard; Joshua, Anthony M.; Patnaik, Amita; Hwu, Wen-Jen; Weber, Jeffrey S.; Gangadhar, Tara C.; Hersey, Peter; Dronca, Roxana; Joseph, Richard W.; Zarour, Hassane; Chmielowski, Bartosz; Lawrence, Donald P.; Algazi, Alain; Rizvi, Naiyer A.; Hoffner, Brianna; Mateus, Christine; Gergich, Kevin; Lindia, Jill A.; Giannotti, Maxine; Li, Xiaoyun Nicole; Ebbinghaus, Scot; Kang, S. Peter; Robert, Caroline			Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IPILIMUMAB; SAFETY	IMPORTANCE The programmed death 1 (PD-1) pathway limits immune responses to melanoma and can be blocked with the humanized anti-PD-1 monoclonal antibody pembrolizumab. OBJECTIVE To characterize the association of pembrolizumab with tumor response and overall survival among patients with advanced melanoma. DESIGN, SETTINGS, AND PARTICIPANTS Open-label, multicohort, phase 1b clinical trials (enrollment, December 2011-September 2013). Median duration of follow-up was 21 months. The study was performed in academic medical centers in Australia, Canada, France, and the United States. Eligible patients were aged 18 years and older and had advanced or metastatic melanoma. Data were pooled from 655 enrolled patients (135 from a nonrandomized cohort [n = 87 ipilimumab naive; n = 48 ipilimumab treated] and 520 from randomized cohorts [n = 226 ipilimumab naive; n = 294 ipilimumab treated]). Cutoff dates were April 18, 2014, for safety analyses and October 18, 2014, for efficacy analyses. EXPOSURES Pembrolizumab 10 mg/kg every 2 weeks, 10 mg/kg every 3 weeks, or 2 mg/kg every 3 weeks continued until disease progression, intolerable toxicity, or investigator decision. MAIN OUTCOMES AND MEASURES The primary end point was confirmed objective response rate (best overall response of complete response or partial response) in patients with measurable disease at baseline per independent central review. Secondary end points included toxicity, duration of response, progression-free survival, and overall survival. RESULTS Among the 655 patients (median [range] age, 61 [18-94] years; 405 [62%] men), 581 had measurable disease at baseline. An objective response was reported in 194 of 581 patients (33% [95% CI, 30%-37%]) and in 60 of 133 treatment-naive patients (45% [95% CI, 36% to 54%]). Overall, 74% (152/205) of responses were ongoing at the time of data cutoff; 44% (90/205) of patients had response duration for at least 1 year and 79% (162/205) had response duration for at least 6 months. Twelve-month progression-free survival rates were 35%(95% CI, 31%-39%) in the total population and 52% (95% CI, 43%-60%) among treatment-naive patients. Median overall survival in the total population was 23 months (95% CI, 20-29) with a 12-month survival rate of 66% (95% CI, 62%-69%) and a 24-month survival rate of 49% (95% CI, 44%-53%). In treatment-naive patients, median overall survival was 31 months (95% CI, 24 to not reached) with a 12-month survival rate of 73% (95% CI, 65%-79%) and a 24-month survival rate of 60% (95% CI, 51%-68%). Ninety-two of 655 patients (14%) experienced at least 1 treatment-related grade 3 or 4 adverse event (AE) and 27 of 655 (4%) patients discontinued treatment because of a treatment-related AE. Treatment-related serious AEs were reported in 59 patients (9%). There were no drug-related deaths. CONCLUSIONS AND RELEVANCE Among patients with advanced melanoma, pembrolizumab administration was associated with an overall objective response rate of 33%, 12-month progression-free survival rate of 35%, and median overall survival of 23 months; grade 3 or 4 treatment-related AEs occurred in 14%.	[Ribas, Antoni; Chmielowski, Bartosz] Univ Calif Los Angeles, Div Hematol & Oncol, 10833 Le Conte Ave,11-934 Factor Bldg, Los Angeles, CA 90095 USA; [Hamid, Omid; Hoffner, Brianna] Angeles Clin & Res Inst, Dept Hematol Oncol, Los Angeles, CA USA; [Daud, Adil; Algazi, Alain] Univ Calif San Francisco, Dept Hematol Oncol, San Francisco, CA 94143 USA; [Hodi, F. Stephen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wolchok, Jedd D.; Rizvi, Naiyer A.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Kefford, Richard] Westmead Hosp, Crown Princess Mary Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia; [Kefford, Richard] Melanoma Inst Australia, Sydney, NSW, Australia; [Kefford, Richard] Macquarie Univ, Dept Clin Med, Sydney, NSW 2109, Australia; [Joshua, Anthony M.] Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON, Canada; [Patnaik, Amita] South Texas Accelerated Res Therapeut, Dept Clin Res, San Antonio, TX USA; [Hwu, Wen-Jen] Univ Texas MD Anderson Canc Ctr, Dept Melanoma, Houston, TX 77030 USA; [Weber, Jeffrey S.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Cutaneous Oncol, Tampa, FL 33682 USA; [Gangadhar, Tara C.] Univ Penn, Abramson Canc Ctr, Div Hematol & Oncol, Philadelphia, PA 19104 USA; [Hersey, Peter] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Dronca, Roxana] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Joseph, Richard W.] Mayo Clin, Dept Hematol Oncol, Jacksonville, FL 32224 USA; [Zarour, Hassane] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Lawrence, Donald P.] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA USA; [Mateus, Christine; Robert, Caroline] Gustave Roussy Canc Campus, Dept Med Oncol, Villejuif Paris Sud, France; [Mateus, Christine; Robert, Caroline] Univ Paris Sud, Villejuif Paris Sud, France; [Gergich, Kevin; Lindia, Jill A.; Giannotti, Maxine; Ebbinghaus, Scot; Kang, S. Peter] Merck & Co Inc, Dept Clin Oncol, Kenilworth, NJ USA; [Li, Xiaoyun Nicole] Merck & Co Inc, BARDS, Kenilworth, NJ USA	University of California System; University of California Los Angeles; Angeles Clinic & Research Institute; University of California System; University of California San Francisco; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; University of Sydney; Melanoma Institute Australia; Macquarie University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; UTMD Anderson Cancer Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Pennsylvania; Pennsylvania Medicine; University of Sydney; Mayo Clinic; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; Universite Paris Saclay; Merck & Company; Merck & Company	Ribas, A (corresponding author), Univ Calif Los Angeles, Div Hematol & Oncol, 10833 Le Conte Ave,11-934 Factor Bldg, Los Angeles, CA 90095 USA.	aribas@mednet.ucla.edu	wang, edwin/G-5372-2010; Robert, Caroline/G-6157-2018; Daud, Adil/T-3079-2019	Robert, Caroline/0000-0002-9493-0238; Daud, Adil/0000-0002-6617-8421; Joseph, Richard/0000-0001-6102-4661; Joshua, Anthony/0000-0001-5159-4580; Weber, Jeffrey/0000-0002-4962-2957; Kefford, Richard/0000-0001-9251-9229	Merck Co, Inc.; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Merck Co, Inc.(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Merck & Co, Inc.	Ackerman A, 2014, CANCER-AM CANCER SOC, V120, P1695, DOI 10.1002/cncr.28620; Ascierto PA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-137; Ascierto PA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-61; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hamid A, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.3577; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Joseph RW, 2014, PIGM CELL MELANOMA R, V27, P1188; Kluger HM, 2014, PIGM CELL MELANOMA R, V27, P1203; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; National Institutes of Health, COMM TERM CRIT ADV E; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Robert C, 2014, EUR SOC MED ONC 2014; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Shreders A, 2015, J CLIN ONCOL, V33; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	24	687	725	6	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1600	1609		10.1001/jama.2016.4059	http://dx.doi.org/10.1001/jama.2016.4059			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	27092830	Bronze			2022-12-28	WOS:000374289300020
J	McDonnell, JJ				McDonnell, Jeffrey J.			Orchestrating a powerful group	SCIENCE			English	Editorial Material									[McDonnell, Jeffrey J.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada; [McDonnell, Jeffrey J.] Univ Aberdeen, Aberdeen AB9 1FX, Scotland	University of Saskatchewan; University of Aberdeen	McDonnell, JJ (corresponding author), Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada.; McDonnell, JJ (corresponding author), Univ Aberdeen, Aberdeen AB9 1FX, Scotland.		McDonnell, Jeffrey J/I-6400-2013	McDonnell, Jeffrey J/0000-0002-3880-3162					0	0	0	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					378	378		10.1126/science.352.6283.378	http://dx.doi.org/10.1126/science.352.6283.378			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ1UK	27081074				2022-12-28	WOS:000373990100047
J	Schwalm, EL; Grove, TL; Booker, SJ; Boal, AK				Schwalm, Erica L.; Grove, Tyler L.; Booker, Squire J.; Boal, Amie K.			Crystallographic capture of a radical S-adenosylmethionine enzyme in the act of modifying tRNA	SCIENCE			English	Article							PSEUDOURIDINE SYNTHASE RLUA; LARGE RIBOSOMAL-SUBUNIT; STRUCTURAL BASIS; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; RLMN METHYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; CONFERS RESISTANCE; NASCENT PEPTIDE; METHYL TRANSFER	RlmN is a dual-specificity RNA methylase that modifies C2 of adenosine 2503 (A2503) in 23S rRNA and C2 of adenosine 37 (A37) in several Escherichia coli transfer RNAs (tRNAs). A related methylase, Cfr, modifies C8 of A2503 via a similar mechanism, conferring resistance to multiple classes of antibiotics. Here, we report the x-ray structure of a key intermediate in the RlmN reaction, in which a Cys(118)-> Ala variant of the protein is cross-linked to a tRNAGlu substrate through the terminal methylene carbon of a formerly methylcysteinyl residue and C2 of A37. RlmN contacts the entire length of tRNAGlu, accessing A37 by using an induced-fit strategy that completely unfolds the tRNA anticodon stem-loop, which is likely critical for recognition of both tRNA and ribosomal RNA substrates.	[Schwalm, Erica L.; Grove, Tyler L.; Booker, Squire J.; Boal, Amie K.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Booker, Squire J.; Boal, Amie K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Booker, Squire J.] Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ; Boal, AK (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.; Booker, SJ; Boal, AK (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Booker, SJ (corresponding author), Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA.	squire@psu.edu; akb20@psu.edu			NIH [GM100011, GM101957]; Searle Scholars Program; Tobacco Settlement Funds [TSF13/14 SAP_4100062216]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM100011, R00GM100011, R01GM101957] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Tobacco Settlement Funds; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by NIH grants GM100011 (A.K.B.) and GM101957 (S.J.B.), the Searle Scholars Program (A.K.B.), and Tobacco Settlement Funds (TSF13/14 SAP_4100062216) to S.J.B. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). GM/CA-CAT has been funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession codes 5HR6 (C118A RlmN/tRNA in vivo cross-link) and 5HR7(C118A RlmN/tRNA in vitro cross-link).	Atkinson GC, 2013, ANTIMICROB AGENTS CH, V57, P4019, DOI 10.1128/AAC.00448-13; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Bauerle MR, 2015, J BIOL CHEM, V290, P3995, DOI 10.1074/jbc.R114.607044; Benitez-Paez A, 2012, RNA, V18, P1783, DOI 10.1261/rna.033266.112; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Chimnaronk S, 2009, BIOCHEMISTRY-US, V48, P5057, DOI 10.1021/bi900337d; de Farias ST, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00303; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2013, NAT CHEM BIOL, V9, P422, DOI [10.1038/NCHEMBIO.1251, 10.1038/nchembio.1251]; Grove TL, 2011, J AM CHEM SOC, V133, P19586, DOI 10.1021/ja207327v; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hoang C, 2006, MOL CELL, V24, P535, DOI 10.1016/j.molcel.2006.09.017; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ishitani R, 2008, CURR OPIN STRUC BIOL, V18, P330, DOI 10.1016/j.sbi.2008.05.003; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; McCusker KP, 2012, J AM CHEM SOC, V134, P18074, DOI 10.1021/ja307855d; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Raychaudhuri S, 1999, J BIOL CHEM, V274, P18880, DOI 10.1074/jbc.274.27.18880; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sekine S, 2001, NAT STRUCT BIOL, V8, P203, DOI 10.1038/84927; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Silakov A, 2014, J AM CHEM SOC, V136, P8221, DOI 10.1021/ja410560p; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; STEITZ TA, 1990, MOL BIOL REP, V14, P213, DOI 10.1007/BF00360479; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Wei YF, 2014, J AM CHEM SOC, V136, P9001, DOI 10.1021/ja5030194; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y	36	44	44	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					309	312		10.1126/science.aad5367	http://dx.doi.org/10.1126/science.aad5367			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081063	Green Submitted, Green Accepted			2022-12-28	WOS:000373990100032
J	Forsth, P; Olafsson, G; Carlsson, T; Frost, A; Borgstrom, F; Fritzell, P; Ohagen, P; Michaelsson, K; Sanden, B				Forsth, Peter; Olafsson, Gylfi; Carlsson, Thomas; Frost, Anders; Borgstrom, Fredrik; Fritzell, Peter; Ohagen, Patrik; Michaelsson, Karl; Sanden, Bengt			A Randomized, Controlled Trial of Fusion Surgery for Lumbar Spinal Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STUDY COMPARING DECOMPRESSION; DEGENERATIVE SPONDYLOLISTHESIS; SURGICAL-MANAGEMENT; SEGMENTAL MOTION; 6-MINUTE WALK; LAMINECTOMY; OUTCOMES; TRENDS; COMPLICATIONS; ARTHRODESIS	BACKGROUND The efficacy of fusion surgery in addition to decompression surgery in patients who have lumbar spinal stenosis, with or without degenerative spondylolisthesis, has not been substantiated in controlled trials. METHODS We randomly assigned 247 patients between 50 and 80 years of age who had lumbar spinal stenosis at one or two adjacent vertebral levels to undergo either decompression surgery plus fusion surgery (fusion group) or decompression surgery alone (decompression-alone group). Randomization was stratified according to the presence of preoperative degenerative spondylolisthesis (in 135 patients) or its absence. Outcomes were assessed with the use of patient-reported outcome measures, a 6-minute walk test, and a health economic evaluation. The primary outcome was the score on the Oswestry Disability Index (ODI; which ranges from 0 to 100, with higher scores indicating more severe disability) 2 years after surgery. The primary analysis, which was a per-protocol analysis, did not include the 14 patients who did not receive the assigned treatment and the 5 who were lost to follow-up. RESULTS There was no significant difference between the groups in the mean score on the ODI at 2 years (27 in the fusion group and 24 in the decompression-alone group, P = 0.24) or in the results of the 6-minute walk test (397 m in the fusion group and 405 m in the decompression- alone group, P = 0.72). Results were similar between patients with and those without spondylolisthesis. Among the patients who had 5 years of follow-up and were eligible for inclusion in the 5-year analysis, there were no significant differences between the groups in clinical outcomes at 5 years. The mean length of hospitalization was 7.4 days in the fusion group and 4.1 days in the decompression-alone group (P< 0.001). Operating time was longer, the amount of bleeding was greater, and surgical costs were higher in the fusion group than in the decompression-alone group. During a mean follow-up of 6.5 years, additional lumbar spine surgery was performed in 22% of the patients in the fusion group and in 21% of those in the decompression-alone group. CONCLUSIONS Among patients with lumbar spinal stenosis, with or without degenerative spondylolisthesis, decompression surgery plus fusion surgery did not result in better clinical outcomes at 2 years and 5 years than did decompression surgery alone.	[Forsth, Peter; Carlsson, Thomas; Fritzell, Peter; Michaelsson, Karl; Sanden, Bengt] Uppsala Univ, Dept Surg Sci, Div Orthoped, Uppsala, Sweden; [Ohagen, Patrik; Michaelsson, Karl] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Forsth, Peter; Frost, Anders] Karolinska Inst, Stockholm Spine Ctr, S-10401 Stockholm, Sweden; [Olafsson, Gylfi; Borgstrom, Fredrik] Karolinska Inst, Dept Learning Informat Management & Eth, S-10401 Stockholm, Sweden; [Olafsson, Gylfi; Borgstrom, Fredrik] Quantify Res, Stockholm, Sweden; [Fritzell, Peter] Futurum Acad Hlth & Care, Neuroorthoped Ctr, Ryhov, Sweden	Uppsala University; Uppsala University; Karolinska Institutet; Karolinska Institutet; Futurum	Forsth, P (corresponding author), Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden.	peter.forsth@surgsci.uu.se	Michaelsson, Karl/AAM-9094-2021; Försth, Peter/AAY-5195-2020	Michaelsson, Karl/0000-0003-2815-1217; Fritzell, Peter/0000-0002-2043-6376	Avtal om Lakarutbildning och Forskning (Agreement concerning Cooperation on Medical Education and Research) Uppsala University; Avtal om Lakarutbildning och Forskning (Agreement concerning Cooperation on Medical Education and Research) Uppsala County Council; Stockholm Spine Center; Johnson Johnson; Swedish Association of Local Authorities and Regions; Sweden municipality; Sweden county council; Medtronic	Avtal om Lakarutbildning och Forskning (Agreement concerning Cooperation on Medical Education and Research) Uppsala University; Avtal om Lakarutbildning och Forskning (Agreement concerning Cooperation on Medical Education and Research) Uppsala County Council; Stockholm Spine Center; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Swedish Association of Local Authorities and Regions; Sweden municipality; Sweden county council; Medtronic(Medtronic)	Supported by the Avtal om Lakarutbildning och Forskning (Agreement concerning Cooperation on Medical Education and Research) between Uppsala University and Uppsala County Council and by the Stockholm Spine Center. Johnson & Johnson provided financial support for the health economic analysis. The National Swedish Register for Spine Surgery (Swespine) is supported by the Swedish Association of Local Authorities and Regions; all of Sweden's municipalities, county councils, and regions are members of the association.; Mr. Olafsson reports receiving grant support from Medtronic. Dr. Borgstrom is an employee of and holds stock in Quantify Research. No other potential conflict of interest relevant to this article was reported.	Amundsen T, 2000, SPINE, V25, P1424, DOI 10.1097/00007632-200006010-00016; Bae HW, 2013, SPINE, V38, P916, DOI 10.1097/BRS.0b013e3182833e7c; BRIDWELL KH, 1993, J SPINAL DISORD, V6, P461, DOI 10.1097/00002517-199306060-00001; Briggs A, 2003, HEALTH ECON, V12, P377, DOI 10.1002/hec.766; Cabraja M, 2012, EUR SPINE J, V21, P256, DOI 10.1007/s00586-011-1870-y; Ciol MA, 1996, J AM GERIATR SOC, V44, P285, DOI 10.1111/j.1532-5415.1996.tb00915.x; Comer CM, 2011, SPINE, V36, P1969, DOI 10.1097/BRS.0b013e3181fc9daf; Deyo RA, 2013, SPINE, V38, P865; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Du Bois M, 2012, EUR SPINE J, V21, P2693, DOI 10.1007/s00586-012-2381-1; Forsth P, 2013, BONE JOINT J, V95B, P960, DOI 10.1302/0301-620X.95B7.30776; Fox MW, 1996, J NEUROSURG, V85, P793, DOI 10.3171/jns.1996.85.5.0793; Friedly JL, 2014, NEW ENGL J MED, V371, P11, DOI 10.1056/NEJMoa1313265; Frobin W, 1996, CLIN BIOMECH, V11, P457, DOI 10.1016/S0268-0033(96)00039-3; Ghogawala Z, 2016, NEW ENGL J MED, V374, P1424, DOI 10.1056/NEJMoa1508788; Hasegawa K, 2014, SPINE, V39, P2127; HERKOWITZ HN, 1991, J BONE JOINT SURG AM, V73A, P802, DOI 10.2106/00004623-199173060-00002; Jansson KA, 2003, EUR SPINE J, V12, P535, DOI 10.1007/s00586-003-0544-9; JOHNSSON KE, 1989, SPINE, V14, P591, DOI 10.1097/00007632-198906000-00008; Kepler CK, 2014, SPINE, V39, P1584; Kwok BC, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-23; LOMBARDI JS, 1985, SPINE, V10, P821, DOI 10.1097/00007632-198511000-00008; Mahant PR, 2001, NEUROL CLIN, V19, P553, DOI 10.1016/S0733-8619(05)70034-7; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; MARDJETKO SM, 1994, SPINE, V19, pS2256, DOI 10.1097/00007632-199410151-00002; Martin CR, 2007, SPINE, V32, P1791, DOI 10.1097/BRS.0b013e3180bc219e; MATSUNAGA S, 1990, SPINE, V15, P1204, DOI 10.1097/00007632-199011010-00021; Munting E, 2015, EUR SPINE J, V24, P358, DOI 10.1007/s00586-014-3349-0; Pearson A, 2010, SPINE, V35, P298, DOI 10.1097/BRS.0b013e3181bdafd1; Rampersaud YR, 2014, CAN J SURG, V57, pE126, DOI 10.1503/cjs.032213; Resnick DK, 2014, J NEUROSURG-SPINE, V21, P62, DOI 10.3171/2014.4.SPINE14275; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Sigmundsson FG, 2015, SPINE J, V15, P638, DOI 10.1016/j.spinee.2014.11.020; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; STOKES IAF, 1987, SPINE, V12, P688, DOI 10.1097/00007632-198709000-00009; Stromqvist B, 2013, EUR SPINE J, V22, P953, DOI 10.1007/s00586-013-2758-9; Stromqvist B, 2009, EUR SPINE J, V18, pS294, DOI 10.1007/s00586-009-1043-4; Vaccaro AR, 1997, SPINE, V22, P368, DOI 10.1097/00007632-199702150-00002; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136	41	428	450	9	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1413	1423		10.1056/NEJMoa1513721	http://dx.doi.org/10.1056/NEJMoa1513721			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27074066	Bronze			2022-12-28	WOS:000374128400005
J	McMahon, GT				McMahon, Graham T.			What Do I Need to Learn Today? - The Evolution of CME	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McMahon, Graham T.] Accreditat Council Continuing Med Educ, Chicago, IL USA		McMahon, GT (corresponding author), Accreditat Council Continuing Med Educ, Chicago, IL USA.		McMahon, Graham/D-3740-2009	McMahon, Graham/0000-0003-4288-6535				[Anonymous], 2015, ACCME ANN REP 2014; Cervero RM, 2015, J CONTIN EDUC HEALTH, V35, P131, DOI 10.1002/chp.21290; Combes JR, 2014, CONTINUING MED ED ST	3	35	36	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1403	1406		10.1056/NEJMp1515202	http://dx.doi.org/10.1056/NEJMp1515202			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27074064				2022-12-28	WOS:000374128400003
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: A mandate for mismanagement	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Bostock N, 2015, GP              0501; Buck D., 2015, KINGS FUND BLOG 0806; Campbell D, 2016, GUARDIAN; Conservative Party, STRONG LEAD CLEAR EC; Cooper C., 2015, INDEPENDENT; Garland J, 2015, 2015 GEN ELECTION VO; Helm T, 2015, GUARDIAN; Hughes D, 2016, BBC NEWS; King's Fund, 2016, 18 KINGS FUND; King's Fund, 2015, 1 100 DAYS SUMM SOC; Sellgren K., 2016, BBC NEWS; Stone J., 2016, INDEPENDENT; Timmins N, 2012, NEVER AGAIN STORY HL; Trust N. Health Foundation King's Fund., 2016, IMP 2015 SPEND REV H	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2016	353								i2012	10.1136/bmj.i2012	http://dx.doi.org/10.1136/bmj.i2012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LV	27059935	Bronze, Green Published			2022-12-28	WOS:000373896100005
J	Buckner, JC; Shaw, EG; Pugh, SL; Chakravarti, A; Gilbert, MR; Barger, GR; Coons, S; Ricci, P; Bullard, D; Brown, PD; Stelzer, K; Brachman, D; Suh, JH; Schultz, CJ; Bahary, JP; Fisher, BJ; Kim, H; Murtha, AD; Bell, EH; Won, M; Mehta, MP; Curran, WJ				Buckner, Jan C.; Shaw, Edward G.; Pugh, Stephanie L.; Chakravarti, Arnab; Gilbert, Mark R.; Barger, Geoffrey R.; Coons, Stephen; Ricci, Peter; Bullard, Dennis; Brown, Paul D.; Stelzer, Keith; Brachman, David; Suh, John H.; Schultz, Christopher J.; Bahary, Jean-Paul; Fisher, Barbara J.; Kim, Harold; Murtha, Albert D.; Bell, Erica H.; Won, Minhee; Mehta, Minesh P.; Curran, Walter J., Jr.			Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II TRIAL; TERM-FOLLOW-UP; ANAPLASTIC OLIGODENDROGLIOMA; RECURRENT GLIOMA; CHEMOTHERAPY; LOMUSTINE; RADIOTHERAPY; THERAPY; CANCER	BACKGROUND Grade 2 gliomas occur most commonly in young adults and cause progressive neurologic deterioration and premature death. Early results of this trial showed that treatment with procarbazine, lomustine (also called CCNU), and vincristine after radiation therapy at the time of initial diagnosis resulted in longer progression-free survival, but not overall survival, than radiation therapy alone. We now report the long-term results. METHODS We included patients with grade 2 astrocytoma, oligoastrocytoma, or oligodendroglioma who were younger than 40 years of age and had undergone subtotal resection or biopsy or who were 40 years of age or older and had undergone biopsy or resection of any of the tumor. Patients were stratified according to age, histologic findings, Karnofsky performance-status score, and presence or absence of contrast enhancement on pre-operative images. Patients were randomly assigned to radiation therapy alone or to radiation therapy followed by six cycles of combination chemotherapy. RESULTS A total of 251 eligible patients were enrolled from 1998 through 2002. The median follow-up was 11.9 years; 55% of the patients died. Patients who received radiation therapy plus chemotherapy had longer median overall survival than did those who received radiation therapy alone (13.3 vs. 7.8 years; hazard ratio for death, 0.59; P = 0.003). The rate of progression-free survival at 10 years was 51% in the group that received radiation therapy plus chemotherapy versus 21% in the group that received radiation therapy alone; the corresponding rates of overall survival at 10 years were 60% and 40%. A Cox model identified receipt of radiation therapy plus chemotherapy and histologic findings of oligodendroglioma as favorable prognostic variables for both progression-free and overall survival. CONCLUSIONS In a cohort of patients with grade 2 glioma who were younger than 40 years of age and had undergone subtotal tumor resection or who were 40 years of age or older, progression-free survival and overall survival were longer among those who received combination chemotherapy in addition to radiation therapy than among those who received radiation therapy alone. (Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT00003375.)	[Buckner, Jan C.] Mayo Clin, 200 First St SW, Rochester, MN 55905 USA; [Shaw, Edward G.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Bullard, Dennis] Triangle Neurosurg, Raleigh, NC USA; [Pugh, Stephanie L.; Won, Minhee] NRG Oncol Stat & Data Management Ctr, Philadelphia, PA USA; [Chakravarti, Arnab; Bell, Erica H.] Ohio State Univ, Columbus, OH 43210 USA; [Suh, John H.] Cleveland Clin, Cleveland, OH 44106 USA; [Gilbert, Mark R.; Brown, Paul D.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Barger, Geoffrey R.; Kim, Harold] Wayne State Univ, Detroit, MI USA; [Coons, Stephen] Barrow Neurol Inst, Phoenix, AZ USA; [Brachman, David] Arizona Oncol Serv Fdn, Phoenix, AZ USA; [Ricci, Peter] Radiol Imaging Associates, Englewood, CO USA; [Stelzer, Keith] Mid Columbia Med Ctr, The Dalles, OR USA; [Schultz, Christopher J.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Bahary, Jean-Paul] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Fisher, Barbara J.] London Reg Canc Program, London, ON, Canada; [Murtha, Albert D.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Mehta, Minesh P.] Univ Maryland, Baltimore, MD 21201 USA; [Curran, Walter J., Jr.] Emory Univ, Atlanta, GA 30322 USA	Mayo Clinic; Wake Forest University; Wake Forest Baptist Medical Center; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center; Wayne State University; Barrow Neurological Institute; Medical College of Wisconsin; Universite de Montreal; Western University (University of Western Ontario); University of Alberta; University System of Maryland; University of Maryland Baltimore; Emory University	Buckner, JC (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	buckner.jan@mayo.edu	Buckner, Jan/AAE-6388-2019; Gilbert, Mark R/J-7494-2016; Mehta, Minesh P./AAB-8915-2019	Gilbert, Mark R/0000-0003-2556-9722; Mehta, Minesh P./0000-0002-4812-5713	Radiation Therapy Oncology Group [U10 CA21661]; Community Clinical Oncology Program grant from the National Cancer Institute [U10 CA37422]; North Central Cancer Treatment Group [U10 CA25224]; Ohio State University Comprehensive Cancer Center [R01CA108633, 1RC2CA148190, 1R01CA169368]; Cancer Therapy Evaluation Program of the National Cancer Institute [NRG-BN-TS002]; NATIONAL CANCER INSTITUTE [U10CA180822, U10CA037422, U10CA180850, U10CA180835, R01CA108633, RC2CA148190, U10CA180868, R01CA188228, UG1CA189867, U10CA025224, R01CA169368, U10CA021661, R01CA140314, P30CA022453] Funding Source: NIH RePORTER	Radiation Therapy Oncology Group; Community Clinical Oncology Program grant from the National Cancer Institute; North Central Cancer Treatment Group; Ohio State University Comprehensive Cancer Center; Cancer Therapy Evaluation Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a Radiation Therapy Oncology Group grant (U10 CA21661) and a Community Clinical Oncology Program grant (U10 CA37422) from the National Cancer Institute, a grant (U10 CA25224) from the North Central Cancer Treatment Group, grants (R01CA108633, to Dr. Chakravarti; 1RC2CA148190, to Drs. Chakravarti and Curran; and 1R01CA169368, to Dr. Chakravarti) from the Ohio State University Comprehensive Cancer Center, and a grant (NRG-BN-TS002, to Drs. Bell and Chakravarti) from the Cancer Therapy Evaluation Program of the National Cancer Institute.	Biemond-ter Stege EM, 2005, CANCER-AM CANCER SOC, V103, P802, DOI 10.1002/cncr.20828; BUCKNER JC, 1995, J NEUROSURG, V82, P430, DOI 10.3171/jns.1995.82.3.0430; Buckner JC, 2003, J CLIN ONCOL, V21, P251, DOI 10.1200/JCO.2003.06.023; CAIRNCROSS G, 1994, J CLIN ONCOL, V12, P2013, DOI 10.1200/JCO.1994.12.10.2013; Cairncross JG, 2014, J CLIN ONCOL, V32, P783, DOI 10.1200/JCO.2013.49.3726; COX DR, 1972, J R STAT SOC B, V34, P187; FU KK, 1995, INT J RADIAT ONCOL, V32, P577, DOI 10.1016/0360-3016(95)00080-I; Galanis E, 1998, J CLIN ONCOL, V16, P2953, DOI 10.1200/JCO.1998.16.9.2953; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klein J. P., 2003, SURVIVAL ANAL TECHNI; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mason WP, 1996, NEUROLOGY, V46, P203, DOI 10.1212/WNL.46.1.203; Prabhu RS, 2014, J CLIN ONCOL, V32, P535, DOI 10.1200/JCO.2013.53.1830; Shaw EG, 2012, J CLIN ONCOL, V30, P3065, DOI 10.1200/JCO.2011.35.8598; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229	16	567	577	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					1344	1355		10.1056/NEJMoa1500925	http://dx.doi.org/10.1056/NEJMoa1500925			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3UW	27050206	Green Accepted, Bronze			2022-12-28	WOS:000373425000008
J	Farley, TA				Farley, Thomas A.			When Is It Ethical to Withhold Prevention?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COST-EFFECTIVENESS ANALYSIS		[Farley, Thomas A.] Philadelphia Dept Publ Hlth, Philadelphia, PA USA		Farley, TA (corresponding author), Philadelphia Dept Publ Hlth, Philadelphia, PA USA.							Chambers JD, 2015, HEALTH POLICY, V119, P156, DOI 10.1016/j.healthpol.2014.11.012; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Ong MK, 2005, AM J PUBLIC HEALTH, V95, P969, DOI 10.2105/AJPH.2004.040667; Xu X, 2015, AM J PREV MED, V48, P318, DOI 10.1016/j.amepre.2014.10.011	5	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					1303	1306		10.1056/NEJMp1516534	http://dx.doi.org/10.1056/NEJMp1516534			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI3UW	27050204				2022-12-28	WOS:000373425000003
J	Green, SH; Bayer, R; Fairchild, AL				Green, Sharon H.; Bayer, Ronald; Fairchild, Amy L.			Evidence, Policy, and E-Cigarettes - Will England Reframe the Debate?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Green, Sharon H.; Bayer, Ronald; Fairchild, Amy L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA	Columbia University	Green, SH (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA.		Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				Doward J., 2015, ACAD WAR E CIGARETTE; McNeill A., 2015, REPORT COMMISSIONED; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; Tobacco Advisory Group of the Royal College of Physicians, 2007, HARM RED NIC ADD HEL; Truth Initiative, 2015, WE STAND EL NIC DEL	5	64	65	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					1301	1303		10.1056/NEJMp1601154	http://dx.doi.org/10.1056/NEJMp1601154			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI3UW	27050203	Bronze			2022-12-28	WOS:000373425000002
J	Hirose, M; Cappellaro, P				Hirose, Masashi; Cappellaro, Paola			Coherent feedback control of a single qubit in diamond	NATURE			English	Article							NUCLEAR-SPIN; ENVELOPE MODULATION; QUANTUM FEEDBACK; SPECTROSCOPY; SILICON; SYSTEMS; STATES	Engineering desired operations on qubits subjected to the deleterious effects of their environment is a critical task in quantum information processing, quantum simulation and sensing. The most common approach relies on open-loop quantum control techniques, including optimal-control algorithms based on analytical(1) or numerical(2) solutions, Lyapunov design(3) and Hamiltonian engineering(4). An alternative strategy, inspired by the success of classical control, is feedback control(5). Because of the complications introduced by quantum measurement(6), closed-loop control is less pervasive in the quantum setting and, with exceptions(7,8), its experimental implementations have been mainly limited to quantum optics experiments. Here we implement a feedback-control algorithm using a solid-state spin qubit system associated with the nitrogen vacancy centre in diamond, using coherent feedback(9) to overcome the limitations of measurement-based feedback, and show that it can protect the qubit against intrinsic dephasing noise for milliseconds. In coherent feedback, the quantum system is connected to an auxiliary quantum controller (ancilla) that acquires information about the output state of the system (by an entangling operation) and performs an appropriate feedback action (by a conditional gate). In contrast to open-loop dynamical decoupling techniques(10), feedback control can protect the qubit even against Markovian noise and for an arbitrary period of time (limited only by the coherence time of the ancilla), while allowing gate operations. It is thus more closely related to quantum error-correction schemes(11-14), although these require larger and increasing qubit overheads. Increasing the number of fresh ancillas enables protection beyond their coherence time. We further evaluate the robustness of the feedback protocol, which could be applied to quantum computation and sensing, by exploring a trade-off between information gain and decoherence protection, as measurement of the ancilla-qubit correlation after the feedback algorithm voids the protection, even if the rest of the dynamics is unchanged.	[Hirose, Masashi; Cappellaro, Paola] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Hirose, Masashi; Cappellaro, Paola] MIT, Dept Nucl Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Cappellaro, P (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.; Cappellaro, P (corresponding author), MIT, Dept Nucl Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pcappell@mit.edu	Cappellaro, Paola/B-1413-2010	Cappellaro, Paola/0000-0003-3207-594X	US Air Force Office of Scientific Research [FA9550-12-1-0292]; US Office of Naval Research [N00014-14-1-0804]; Direct For Mathematical & Physical Scien [1125846, 1205923, 1521560] Funding Source: National Science Foundation; Division Of Physics [1205635] Funding Source: National Science Foundation	US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US Office of Naval Research(Office of Naval Research); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank L. Viola, F. Ticozzi, M. Lukin and F. Jelezko for discussions. This work was supported in part by the US Air Force Office of Scientific Research grant number FA9550-12-1-0292 and by the US Office of Naval Research grant number N00014-14-1-0804.	Arrad G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.150801; BLOCH F, 1957, PHYS REV, V105, P1206, DOI 10.1103/PhysRev.105.1206; Boscain U, 2006, J MATH PHYS, V47, DOI 10.1063/1.2203236; Chekhovich EA, 2013, NAT MATER, V12, P494, DOI [10.1038/NMAT3652, 10.1038/nmat3652]; Chen M, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.020101; Cramer J., 2015, PREPRINT; Doherty AC, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.062306; Griffiths RB, 1996, PHYS REV LETT, V76, P3228, DOI 10.1103/PhysRevLett.76.3228; Jacques V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.057403; Kalin M, 2001, J CHEM PHYS, V115, P10863, DOI 10.1063/1.1418742; Kessler EM, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.150802; Kim YH, 2000, PHYS REV LETT, V84, P1, DOI 10.1103/PhysRevLett.84.1; Laraoui A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2685; LINDBLAD G, 1976, COMMUN MATH PHYS, V48, P119, DOI 10.1007/BF01608499; Lloyd S, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.022108; Meriles CA, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3483676; MIMS WB, 1972, PHYS REV B-SOLID ST, V5, P2409, DOI 10.1103/PhysRevB.5.2409; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Neumann P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013017; Nielsen M. A., 2003, QUANTUM COMPUTATION; Pla JJ, 2013, NATURE, V496, P334, DOI 10.1038/nature12011; Ryan CA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.200402; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Steiner M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.035205; Taminiau TH, 2014, NAT NANOTECHNOL, V9, P171, DOI [10.1038/NNANO.2014.2, 10.1038/nnano.2014.2]; Ticozzi F, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.052328; Unden T., 2015, PREPRINT; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Viola L, 1999, PHYS REV LETT, V82, P2417, DOI 10.1103/PhysRevLett.82.2417; Waldherr G, 2014, NATURE, V506, P204, DOI 10.1038/nature12919; Wang XT, 2010, IEEE T AUTOMAT CONTR, V55, P2259, DOI 10.1109/TAC.2010.2043292; Widmann M, 2015, NAT MATER, V14, P164, DOI [10.1038/NMAT4145, 10.1038/nmat4145]; WISEMAN HM, 1993, PHYS REV LETT, V70, P548, DOI 10.1103/PhysRevLett.70.548; Wolfowicz G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.157601	37	63	63	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					77	+		10.1038/nature17404	http://dx.doi.org/10.1038/nature17404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27078567	Green Submitted			2022-12-28	WOS:000373555500036
J	Zhou, ZN; Tang, AT; Wong, WY; Bamezai, S; Goddard, LM; Shenkar, R; Zhou, S; Yang, JS; Wright, AC; Foley, M; Arthur, JSC; Whitehead, KJ; Awad, IA; Li, DY; Zheng, XJ; Kahn, ML				Zhou, Zinan; Tang, Alan T.; Wong, Weng-Yew; Bamezai, Sharika; Goddard, Lauren M.; Shenkar, Robert; Zhou, Su; Yang, Jisheng; Wright, Alexander C.; Foley, Matthew; Arthur, J. Simon C.; Whitehead, Kevin J.; Awad, Issam A.; Li, Dean Y.; Zheng, Xiangjian; Kahn, Mark L.			Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling	NATURE			English	Article							2-HIT MECHANISM; RHO KINASE; CCM1; ANGIOGENESIS; PROTEINS; MODEL	Cerebral cavernous malformations (CCMs) are common inherited and sporadic vascular malformations that cause strokes and seizures in younger individuals(1). CCMs arise from endothelial cell loss of KRIT1, CCM2 or PDCD10, non-homologous proteins that form an adaptor complex(2). How disruption of the CCM complex results in disease remains controversial, with numerous signalling pathways (including Rho(3,4), SMAD(5) and Wnt/beta-catenin(6)) and processes such as endothelial-mesenchymal transition (EndMT)(5) proposed to have causal roles. CCM2 binds to MEKK3 (refs 7-11), and we have recently shown that CCM complex regulation of MEKK3 is essential during vertebrate heart development(12). Here we investigate this mechanism in CCM disease pathogenesis. Using a neonatal mouse model of CCM disease, we show that expression of the MEKK3 target genes Klf2 and Klf4, as well as Rho and ADAMTS protease activity, are increased in the endothelial cells of early CCM lesions. By contrast, we find no evidence of EndMT or increased SMAD or Wnt signalling during early CCM formation. Endothelial-specific loss of Map3k3 (also known as Mekk3), Klf2 or Klf4 markedly prevents lesion formation, reverses the increase in Rho activity, and rescues lethality. Consistent with these findings in mice, we show that endothelial expression of KLF2 and KLF4 is increased in human familial and sporadic CCM lesions, and that a disease-causing human CCM2 mutation abrogates the MEKK3 interaction without affecting CCM complex formation. These studies identify gain of MEKK3 signalling and KLF2/4 function as causal mechanisms for CCM pathogenesis that may be targeted to develop new CCM therapeutics.	[Zhou, Zinan; Tang, Alan T.; Bamezai, Sharika; Goddard, Lauren M.; Zhou, Su; Yang, Jisheng; Kahn, Mark L.] Univ Penn, Dept Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Zhou, Zinan; Tang, Alan T.; Bamezai, Sharika; Goddard, Lauren M.; Zhou, Su; Yang, Jisheng; Kahn, Mark L.] Univ Penn, Cardiovasc Inst, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Wong, Weng-Yew; Zheng, Xiangjian] Centenary Inst, Lab Cardiovasc Signaling, Sydney, NSW 2050, Australia; [Shenkar, Robert; Awad, Issam A.] Univ Chicago, Dept Surg, Neurovasc Surg Program, Sect Neurosurg,Med & Biol Sci, Chicago, IL 60637 USA; [Wright, Alexander C.] Univ Penn, Med Ctr, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Foley, Matthew] Univ Sydney, Sydney Microscopy & Microanal, Sydney, NSW 2050, Australia; [Arthur, J. Simon C.] Univ Dundee, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland; [Whitehead, Kevin J.; Li, Dean Y.] Univ Utah, Div Cardiovasc Med, Salt Lake City, UT 84112 USA; [Whitehead, Kevin J.; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT 84112 USA; [Li, Dean Y.] Sichuan Acad Med Sci, Key Lab Human Dis Gene Study Sichuan Prov, Inst Lab Med, Chengdu 610072, Sichuan, Peoples R China; [Li, Dean Y.] Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China; [Zheng, Xiangjian] Univ Sydney, Sydney Med Sch, Fac Med, Sydney, NSW 2050, Australia	University of Pennsylvania; University of Pennsylvania; University of Sydney; Centenary Institute; University of Chicago; University of Pennsylvania; University of Sydney; University of Dundee; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; University of Sydney	Kahn, ML (corresponding author), Univ Penn, Dept Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Kahn, ML (corresponding author), Univ Penn, Cardiovasc Inst, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	markkahn@mail.med.upenn.edu	Shenkar, Robert/AAC-7065-2020	Bamezai, Sharika/0000-0002-2944-740X; Arthur, Simon/0000-0002-8135-1958; Foley, Matthew/0000-0003-4077-445X; Zheng, Xiangjian/0000-0001-6277-5168	National Institutes of Health (NIH) [R01HL094326, P01NS092521, VAMC 1IO1BX002976, RO1HL-084516, R01NS075168, T32HL07439]; Australian NHMRC project [161558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120846, R01HL084516, P01HL075215, T32HL007954, R01HL094326, K08HL079095, T32HL007439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS092521, R01NS075168, R01NS100949, R01NS080893] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002976] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian NHMRC project(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We thank the members of the Kahn laboratory for their comments during the course of this work. These studies were supported by National Institutes of Health (NIH) grants R01HL094326 (to M.L.K.), P01NS092521 (to I. A. A. and M.L.K.), VAMC 1IO1BX002976 (to D.Y.L.), RO1HL-084516 (to D.Y.L.), R01NS075168 (to K.J.W.), T32HL07439 (to A.T.T.), and Australian NHMRC project grant 161558 (to X.Z.).	Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; Bravi L, 2015, P NATL ACAD SCI USA, V112, P8421, DOI 10.1073/pnas.1501352112; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Cullere X., 2015, P NATL ACAD SCI US; Cuttano R, 2016, EMBO MOL MED, V8, P6, DOI 10.15252/emmm.201505433; Draheim KM, 2015, J CELL BIOL, V208, P987, DOI 10.1083/jcb.201407129; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Fisher OS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8937; Fisher OS, 2015, J BIOL CHEM, V290, P2842, DOI 10.1074/jbc.M114.616433; Gibson CC, 2015, CIRCULATION, V131, P289, DOI 10.1161/CIRCULATIONAHA.114.010403; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Marchi S, 2015, EMBO MOL MED, V7, P1403, DOI 10.15252/emmm.201505316; McDonald DA, 2012, STROKE, V43, P571, DOI 10.1161/STROKEAHA.111.625467; Mleynek TM, 2014, HUM MOL GENET, V23, P6223, DOI 10.1093/hmg/ddu342; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Plummer Nicholas W, 2005, Curr Neurol Neurosci Rep, V5, P391, DOI 10.1007/s11910-005-0063-7; Spiegler S, 2014, MOL GENET GENOM MED, V2, P176, DOI 10.1002/mgg3.60; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Wang XY, 2015, STRUCTURE, V23, P1087, DOI 10.1016/j.str.2015.04.003; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zheng XJ, 2012, DEV CELL, V23, P342, DOI 10.1016/j.devcel.2012.06.004; Zhou ZN, 2015, DEV CELL, V32, P168, DOI 10.1016/j.devcel.2014.12.009	34	167	169	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					122	+		10.1038/nature17178	http://dx.doi.org/10.1038/nature17178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27027284	Green Accepted			2022-12-28	WOS:000373555500046
J	Zhang, Y; Luo, Y; Zhang, Y; Yu, YJ; Kuang, YM; Zhang, L; Meng, QS; Luo, Y; Yang, JL; Dong, ZC; Hou, JG				Zhang, Yang; Luo, Yang; Zhang, Yao; Yu, Yun-Jie; Kuang, Yan-Min; Zhang, Li; Meng, Qiu-Shi; Luo, Yi; Yang, Jin-Long; Dong, Zhen-Chao; Hou, J. G.			Visualizing coherent intermolecular dipole-dipole coupling in real space	NATURE			English	Article							ENERGY-TRANSFER; FREE-BASE; RESOLUTION; PHOTON; FLUORESCENCE; SPECTROSCOPY; ABSORPTION; EMISSION	Many important energy-transfer and optical processes, in both biological and artificial systems, depend crucially on excitonic coupling that spans several chromophores(1-9). Such coupling can in principle be described in a straightforward manner by considering the coherent intermolecular dipole-dipole interactions involved(10,11). However, in practice, it is challenging to directly observe in real space the coherent dipole coupling and the related exciton delocalizations, owing to the diffraction limit in conventional optics. Here we demonstrate that the highly localized excitations that are produced by electrons tunnelling from the tip of a scanning tunnelling microscope, in conjunction with imaging of the resultant luminescence, can be used to map the spatial distribution of the excitonic coupling in well-defined arrangements of a few zinc-phthalocyanine molecules. The luminescence patterns obtained for excitons in a dimer, which are recorded for different energy states and found to resemble sigma and pi molecular orbitals, reveal the local optical response of the system and the dependence of the local optical response on the relative orientation and phase of the transition dipoles of the individual molecules in the dimer. We generate an in-line arrangement up to four zinc-phthalocyanine molecules, with a larger total transition dipole, and show that this results in enhanced 'single-molecule' superradiance from the oligomer upon site-selective excitation. These findings demonstrate that our experimental approach provides detailed spatial information about coherent dipole-dipole coupling in molecular systems, which should enable a greater understanding and rational engineering of light-harvesting structures and quantum light sources.	[Zhang, Yang; Luo, Yang; Zhang, Yao; Yu, Yun-Jie; Kuang, Yan-Min; Zhang, Li; Meng, Qiu-Shi; Luo, Yi; Yang, Jin-Long; Dong, Zhen-Chao; Hou, J. G.] Univ Sci & Technol China, Hefei Natl Lab Phys Sci, Microscale & Synerget Innovat Ctr Quantum Informa, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Dong, ZC; Hou, JG (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci, Microscale & Synerget Innovat Ctr Quantum Informa, Hefei 230026, Anhui, Peoples R China.	zcdong@ustc.edu.cn; jghou@ustc.edu.cn	Luo, Yang/ABA-5615-2021; Luo, Yi/B-1449-2009; Zhang, Yang/P-3785-2014; Dong, Z. C./HGD-0338-2022; Yang, Jinlong/D-3465-2009	Luo, Yi/0000-0003-0007-0394; Zhang, Yang/0000-0002-0118-8717; Luo, Yang/0000-0003-0887-934X; Zhang, Yao/0000-0002-6524-0289	National Basic Research Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences; Natural Science Foundation of China; Fundamental Research Funds for the Central Universities; Hefei Science Center of the Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hefei Science Center of the Chinese Academy of Sciences	We thank B. Wang for discussions. This work is supported by the National Basic Research Program of China, the Strategic Priority Research Program of the Chinese Academy of Sciences, the Natural Science Foundation of China, the Fundamental Research Funds for the Central Universities and Hefei Science Center of the Chinese Academy of Sciences.	Beenken WJD, 2004, J CHEM PHYS, V120, P2490, DOI 10.1063/1.1636460; BERNDT R, 1993, SCIENCE, V262, P1425, DOI 10.1126/science.262.5138.1425; Cavar E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196102; Chen C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.217402; Chen C, 2009, SCIENCE, V325, P981, DOI 10.1126/science.1174592; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Diehl FP, 2014, J PHYS CHEM LETT, V5, P262, DOI 10.1021/jz402512g; Dong ZC, 2010, NAT PHOTONICS, V4, P50, DOI 10.1038/NPHOTON.2009.257; Dong ZC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.086801; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Gouterman M., 1978, PORPHYRINS, V3; Halpin A, 2014, NAT CHEM, V6, P196, DOI [10.1038/NCHEM.1834, 10.1038/nchem.1834]; Hettich C, 2002, SCIENCE, V298, P385, DOI 10.1126/science.1075606; Hildner R, 2013, SCIENCE, V340, P1448, DOI 10.1126/science.1235820; Hoffmann G, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.212107; Kabakchiev A, 2010, CHEMPHYSCHEM, V11, P3412, DOI 10.1002/cphc.201000531; KASHA M, 1963, RADIAT RES, V20, P55, DOI 10.2307/3571331; Krishna V, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2227383; Lanzani G., 2012, PHOTOPHYSICS PHOTOVO; Le Moal E, 2009, SURF SCI, V603, P2434, DOI 10.1016/j.susc.2009.05.019; Le Ru E., 2008, PRINCIPLES SURFACE E; Lee J, 2014, ACS NANO, V8, P54, DOI 10.1021/nn405335h; Lippitz M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.103001; Lu XH, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.096802; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; Meng QS, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4927650; Merino P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9461; Minaev B, 2006, SPECTROCHIM ACTA A, V65, P308, DOI 10.1016/j.saa.2005.10.047; Murray C, 2011, PHYS CHEM CHEM PHYS, V13, P17543, DOI 10.1039/c1cp22039j; Ploigt HC, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.195404; Qiu XH, 2003, SCIENCE, V299, P542, DOI 10.1126/science.1078675; Rawls H.R., 1965, PURE APPL CHEM, V11, P371; Reecht G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.047403; Rossel F, 2010, SURF SCI REP, V65, P129, DOI 10.1016/j.surfrep.2010.06.001; Scholes GD, 2006, NAT MATER, V5, P683, DOI 10.1038/nmat1714; Scully MO, 2009, SCIENCE, V325, P1510, DOI 10.1126/science.1176695; Sun MT, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829407; Tretiak S, 1999, P NATL ACAD SCI USA, V96, P13003, DOI 10.1073/pnas.96.23.13003; Unold T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137404; Vlaming SM, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/30/305301; Wu SW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.236802; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Zhang C., 2015, JPN J APPL PHYS, V54; Zhao AD, 2005, SCIENCE, V309, P1542, DOI 10.1126/science.1113449; Zhou X, 2004, CAN J CHEM, V82, P19, DOI 10.1139/V03-175	45	216	218	21	482	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					623	+		10.1038/nature17428	http://dx.doi.org/10.1038/nature17428			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27029277				2022-12-28	WOS:000373027400035
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, Julia; Coupland, Carol			Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYCLO-OXYGENASE-2 INHIBITORS; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; GENERAL-PRACTICE; MISSING DATA; TYPE-2; OUTCOMES; PIOGLITAZONE; ROSIGLITAZONE	OBJECTIVE To assess the risks of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia in patients with type 2 diabetes associated with prescribed diabetes drugs, particularly newer agents including gliptins or glitazones (thiazolidinediones). DESIGN Open cohort study in primary care. SETTING 1243 practices contributing data to the QResearch database in England. PARTICIPANTS 469 688 patients with type 2 diabetes aged 25-84 years between 1 April 2007 and 31 January 2015. EXPOSURES Hypoglycaemic agents (glitazones, gliptins, metformin, sulphonylureas, insulin, and other) alone and in combination. MAIN OUTCOME MEASURES First recorded diagnoses of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia recorded on patients' primary care, mortality, or hospital records. Cox models estimated hazard ratios for diabetes treatments adjusting for potential confounders. RESULTS 21 308 (4.5%) and 32 533 (6.9%) patients received prescriptions for glitazones and gliptins during follow-up, respectively. Compared with non-use, glitazones were associated with a decreased risk of blindness (adjusted hazard ratio 0.71, 95% confidence interval 0.57 to 0.89; rate 14.4 per 10 000 person years of exposure) and an increased risk of hypoglycaemia (1.22, 1.10 to 1.37; 65.1); gliptins were associated with a decreased risk of hypoglycaemia (0.86, 0.77 to 0.96; 45.8). Although the numbers of patients prescribed gliptin monotherapy or glitazones monotherapy were relatively low, there were significantly increased risks of severe kidney failure compared with metformin monotherapy (adjusted hazard ratio 2.55, 95% confidence interval 1.13 to 5.74). We found significantly lower risks of hyperglycaemia among patients prescribed dual therapy involving metformin with either gliptins (0.78, 0.62 to 0.97) or glitazones (0.60, 0.45 to 0.80) compared with metformin monotherapy. Patients prescribed triple therapy with metformin, sulphonylureas, and either gliptins (adjusted hazard ratio 5.07, 95% confidence interval 4.28 to 6.00) or glitazones (6.32, 5.35 to 7.45) had significantly higher risks of hypoglycaemia than those prescribed metformin monotherapy, but these risks were similar to those involving dual therapy with metformin and sulphonylureas (6.03, 5.47 to 6.63). Patients prescribed triple therapy with metformin, sulphonylureas, and glitazones had a significantly reduced risk of blindness compared with metformin monotherapy (0.67, 0.48 to 0.94). CONCLUSIONS We have found lower risks of hyperglycaemia among patients prescribed dual therapy involving metformin with either gliptins or glitazones compared with metformin alone. Compared with metformin monotherapy, triple therapy with metformin, sulphonylureas, and either gliptins or glitazones was associated with an increased risk of hypoglycaemia, which was similar to the risk for dual therapy with metformin and sulphonylureas. Compared with metformin monotherapy, triple therapy with metformin, sulphonylureas, and glitazones was associated with a reduced risk of blindness. These results, while subject to residual confounding, could have implications for the prescribing of hypoglycaemic drugs.	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Univ Pk, Nottingham NG2 7RD, England	University of Nottingham	Hippisley-Cox, J (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	Julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Budde K, 2003, BRIT J CLIN PHARMACO, V55, P368, DOI 10.1046/j.1365-2125.2003.01785.x; [Center for Drug Evaluation and Research Department of Health and Human Services FaDA], 2008, GUID IND DIAB MELL E; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Coupland C, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h517, 10.1136/bmj.h517]; Davis TME, 2014, DIABETIC MED, V31, P200, DOI 10.1111/dme.12353; Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Eligar VS, 2013, DRUG DES DEV THER, V7, P893, DOI 10.2147/DDDT.S32331; Engel SS, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-3; Esposito K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005892; Eurich DT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2267; European Medicine Agency CfMPfHU, 2010, GUID CLIN INV MED PR; Hernandez AV, 2008, AM HEART J, V156, P23, DOI 10.1016/j.ahj.2008.03.002; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V331, P1310, DOI 10.1136/bmj.331.7528.1310; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Hippisley-Cox J, 2004, LANCET, V364, P423, DOI 10.1016/S0140-6736(04)16765-2; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox Julia, 2010, BMJ, V340, pc2197, DOI 10.1136/bmj.c2197; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Johnson ES, 2013, PHARMACOEPIDEM DR S, V22, P1, DOI 10.1002/pds.3334; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lee MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085479; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Majeed A, 2004, SOURCES USES STRENGT, V21; Majeed Azeem, 2004, Health Stat Q, P5; Meier CR, 1999, JAMA-J AM MED ASSOC, V281, P427, DOI 10.1001/jama.281.5.427; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; NATTRASS M, 1978, DIABETOLOGIA, V14, P71, DOI 10.1007/BF01263443; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; Parker C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4245; Pintilie M, 2007, STAT MED, V26, P1360, DOI 10.1002/sim.2655; Psaty BM, 2007, NEW ENGL J MED, V357, P67, DOI 10.1056/NEJMe078116; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tzoulaki I, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4731; VINOGRADOVA Y, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F114; Zanchi A, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13629	45	66	68	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2016	352								i1450	10.1136/bmj.i1450	http://dx.doi.org/10.1136/bmj.i1450			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TO	27029547	Green Published, hybrid			2022-12-28	WOS:000373492400001
J	Quon, BS; Rowe, SM				Quon, Bradley S.; Rowe, Steven M.			New and emerging targeted therapies for cystic fibrosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TRANSMEMBRANE CONDUCTANCE REGULATOR; INVESTIGATIONAL CFTR CORRECTOR; NONVIRAL GENE-TRANSFER; DRY POWDER MANNITOL; DOUBLE-BLIND; PSEUDOMONAS-AERUGINOSA; IN-VITRO; POTENTIATOR IVACAFTOR; NONSENSE MUTATIONS; CHLORIDE TRANSPORT	Cystic fibrosis (CF) is a monogenic autosomal recessive disorder that affects about 70 000 people worldwide. The clinical manifestations of the disease are caused by defects in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The discovery of the CFTR gene in 1989 has led to a sophisticated understanding of how thousands of mutations in the CFTR gene affect the structure and function of the CFTR protein. Much progress has been made over the past decade with the development of orally bioavailable small molecule drugs that target defective CFTR proteins caused by specific mutations. Furthermore, there is considerable optimism about the prospect of gene replacement or editing therapies to correct all mutations in cystic fibrosis. The recent approvals of ivacaftor and lumacaftor represent the genesis of a new era of precision medicine in the treatment of this condition. These drugs are having a positive impact on the lives of people with cystic fibrosis and are potentially disease modifying. This review provides an update on advances in our understanding of the structure and function of the CFTR, with a focus on state of the art targeted drugs that are in development.	[Quon, Bradley S.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC V6Z 1Y6, Canada; [Quon, Bradley S.] Univ British Columbia, Div Resp Med, Dept Med, Vancouver, BC V6Z 1Y6, Canada; [Rowe, Steven M.] Univ Alabama Birmingham, Dept Med Pediat & Cell Dev & Integrat Biol, Gregory Fleming James Cystic Fibrosis Res Ctr, Birmingham, AL USA	University of British Columbia; University of British Columbia; University of Alabama System; University of Alabama Birmingham	Quon, BS (corresponding author), Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC V6Z 1Y6, Canada.; Quon, BS (corresponding author), Univ British Columbia, Div Resp Med, Dept Med, Vancouver, BC V6Z 1Y6, Canada.	bradley.quon@hli.ubc.ca			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aitken ML, 2012, AM J RESP CRIT CARE, V185, P645, DOI 10.1164/rccm.201109-1666OC; Alton EWFW, 2014, GENE THER, V21, P89, DOI 10.1038/gt.2013.61; Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; Alton EWFW, 2013, BIOMATERIALS, V34, P10267, DOI 10.1016/j.biomaterials.2013.09.023; Alton EWFW, 1999, LANCET, V353, P947, DOI 10.1016/S0140-6736(98)06532-5; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; ANDERSEN D H, 1958, J Chronic Dis, V7, P58, DOI 10.1016/0021-9681(58)90185-1; Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015; Armstrong DK, 2014, ARCH DIS CHILD, V99, P465, DOI 10.1136/archdischild-2012-302158; Barry PJ, 2014, CHEST, V146, P152, DOI 10.1378/chest.13-2397; Barry PJ, 2014, THORAX, V69, P586, DOI 10.1136/thoraxjnl-2013-204532; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bellin MD, 2013, PEDIATR DIABETES, V14, P417, DOI 10.1111/pedi.12026; Bernarde C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124124; Bilton D, 2011, EUR RESPIR J, V38, P1071, DOI 10.1183/09031936.00187510; Bilton D, 2013, J CYST FIBROS, V12, P367, DOI 10.1016/j.jcf.2012.11.002; Birket SE, 2014, AM J RESP CRIT CARE, V190, P421, DOI 10.1164/rccm.201404-0670OC; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Boyle MP, 2013, LANCET RESP MED, V1, P158, DOI 10.1016/S2213-2600(12)70057-7; Broaddus VC, 2015, MURRAY NADELS TXB RE; Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Chang EH, 2015, INT FORUM ALLERGY RH, V5, P178, DOI 10.1002/alr.21440; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cystic Fibrosis Canada, 2013, ANN REPORT; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; Davies JC, 2016, LANCET RESP MED, VS2213-2600, P00545; Davies LA, 2014, HUM GENE THER CL DEV, V25, P97, DOI 10.1089/humc.2014.019; De Boeck K, 2014, J CYST FIBROS, V13, P674, DOI 10.1016/j.jcf.2014.09.005; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Durmowicz AG, 2013, CHEST, V143, P14, DOI 10.1378/chest.12-1430; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Ensign LM, 2012, ADV MATER, V24, P3887, DOI 10.1002/adma.201201800; Ferrari S, 2001, GENE THER, V8, P1380, DOI 10.1038/sj.gt.3301525; Flume PA, 2012, CHEST, V142, P718, DOI 10.1378/chest.11-2672; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Grasemann H, 2015, J CYST FIBROS, V14, P727, DOI 10.1016/j.jcf.2015.07.001; Griesenbach U, 2012, CURR PHARM DESIGN, V18, P642, DOI 10.2174/138161212799315993; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Harvey BG, 1999, J CLIN INVEST, V104, P1245, DOI 10.1172/JCI7935; Hayes D, 2015, J PEDIATR GASTR NUTR, V60, P578, DOI 10.1097/MPG.0000000000000765; Hayes D, 2014, RESPIRATION, V88, P345, DOI 10.1159/000365999; Hayes D, 2014, LUNG, V192, P823, DOI 10.1007/s00408-014-9629-y; Hayes D, 2014, AM J RESP CRIT CARE, V190, P590, DOI 10.1164/rccm.201405-0882LE; Hayes D, 2014, AM J RESP CRIT CARE, V190, P468, DOI 10.1164/rccm.201403-0595IM; Hebestreit H, 2013, J CYST FIBROS, V12, P599, DOI 10.1016/j.jcf.2013.05.006; Heltshe SL, 2015, CLIN INFECT DIS, V60, P703, DOI 10.1093/cid/ciu944; Hoare S, 2014, AM J RESP CRIT CARE, V189, P484, DOI 10.1164/rccm.201308-1433IM; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Howard M, 1996, NAT MED, V2, P467, DOI 10.1038/nm0496-467; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Hyde SC, 2000, GENE THER, V7, P1156, DOI 10.1038/sj.gt.3301212; Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; Kerem E, 2014, LANCET RESP MED, V2, P539, DOI 10.1016/S2213-2600(14)70100-6; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; Leier G, 2012, CELL PHYSIOL BIOCHEM, V29, P775, DOI 10.1159/000265129; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Liu XH, 2014, BIOCHEMISTRY-US, V53, P5613, DOI 10.1021/bi501007v; Lubamba B, 2011, EUR RESPIR J, V37, P72, DOI 10.1183/09031936.00013510; Lubamba B, 2008, AM J RESP CRIT CARE, V177, P506, DOI 10.1164/rccm.200703-344OC; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Macneill SJ, 2015, HODSON GEDDES CYSTIC; Marozkina NV, 2010, P NATL ACAD SCI USA, V107, P11393, DOI 10.1073/pnas.0909128107; Mastorakos P, 2015, P NATL ACAD SCI USA, V112, P8720, DOI 10.1073/pnas.1502281112; Mccoy KS, 2008, AM J RESP CRIT CARE, V178, P921, DOI 10.1164/rccm.200712-1804OC; McKone EF, 2014, LANCET RESP MED, V2, P902, DOI [10.1016/S2213-2600(14)70218-8, 10.1016/s2213-2600(14)70218-8]; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; McLachlan G, 2011, GENE THER, V18, P996, DOI 10.1038/gt.2011.55; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Mogayzel PJ, 2013, AM J RESP CRIT CARE, V187, P680, DOI 10.1164/rccm.201207-1160OE; Moss RB, 2004, CHEST, V125, P509, DOI 10.1378/chest.125.2.509; Moss RB, 2007, HUM GENE THER, V18, P726, DOI 10.1089/hum.2007.022; Moss RB, 2015, LANCET RESP MED, V3, P524, DOI 10.1016/S2213-2600(15)00201-5; Nick JA, 2014, PEDIATR PULM, V49, P188; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pilewski JM, 2014, PEDIATR PULM, V49, P157; Poschet JF, 2007, AM J PHYSIOL-LUNG C, V293, pL712, DOI 10.1152/ajplung.00314.2006; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robertson SM, 2015, J CLIN PHARMACOL, V55, P56, DOI 10.1002/jcph.377; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rowe SM, 2014, AM J RESP CRIT CARE, V190, P175, DOI 10.1164/rccm.201404-0703OC; Rowe SM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009761; Rowe SM, 2011, J MOL MED, V89, P1149, DOI 10.1007/s00109-011-0787-6; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Sanders NN, 2000, AM J RESP CRIT CARE, V162, P1905, DOI 10.1164/ajrccm.162.5.9909009; Sawicki GS, 2015, AM J RESP CRIT CARE, V192, P836, DOI 10.1164/rccm.201503-0578OC; Sawicki GS, 2013, J CYST FIBROS, V12, P461, DOI 10.1016/j.jcf.2012.12.009; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sermet-Gaudelus I, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-5; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Sheikh SI, 2015, CLIN OTOLARYNGOL, V40, P16, DOI 10.1111/coa.12310; Sheikh SI, 2015, J CYST FIBROS, V14, P84, DOI 10.1016/j.jcf.2014.06.011; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Sly PD, 2013, NEW ENGL J MED, V368, P1963, DOI 10.1056/NEJMoa1301725; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; Suk JS, 2014, J CONTROL RELEASE, V178, P8, DOI 10.1016/j.jconrel.2014.01.007; Taylor-Cousar J, 2016, J CYST FIBROS, V15, P116, DOI 10.1016/j.jcf.2015.01.008; Tsabari R, 2015, J CYST FIBROS, VS1569-1993, P00255; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Whiting P, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18180; WHO. Genomic Resource Centre, GEN HUM DIS; Wilschanski M, 2000, AM J RESP CRIT CARE, V161, P860, DOI 10.1164/ajrccm.161.3.9904116; Wilschanski M, 2011, EUR RESPIR J, V38, P59, DOI 10.1183/09031936.00120910; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC; Zabner J, 1996, J CLIN INVEST, V97, P1504, DOI 10.1172/JCI118573; Zaman K, 2014, BIOCHEM BIOPH RES CO, V443, P1257, DOI 10.1016/j.bbrc.2013.12.130; Zamecnik PC, 2004, P NATL ACAD SCI USA, V101, P8150, DOI 10.1073/pnas.0401933101; Zhang LQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000155; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021; Zucker DR, 2010, J CLIN EPIDEMIOL, V63, P1312, DOI 10.1016/j.jclinepi.2010.04.020	148	89	95	3	57	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2016	352								i859	10.1136/bmj.i859	http://dx.doi.org/10.1136/bmj.i859			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TO	27030675	Green Published			2022-12-28	WOS:000373492400024
J	Sternszus, R; Cruess, SR				Sternszus, Robert; Cruess, Sylvia R.			Learning from role modelling: making the implicit explicit	LANCET			English	Editorial Material							RESIDENTS		[Sternszus, Robert; Cruess, Sylvia R.] McGill Univ, Ctr Med Educ, Montreal, PQ H3A 1A3, Canada	McGill University	Cruess, SR (corresponding author), McGill Univ, Ctr Med Educ, Montreal, PQ H3A 1A3, Canada.	sylvia.cruess@mcgill.ca						Bandura A., 1986, SOCIAL FDN THOUGHT A; Cruess RL, 2014, ACAD MED, V89, P1446, DOI 10.1097/ACM.0000000000000427; Cruess SR, 2008, BRIT MED J, V336, P718, DOI 10.1136/bmj.39503.757847.BE; Eraut M, BR J ED PSYCHOL, V70, P113; Kenny NP, 2003, ACAD MED, V78, P1203, DOI 10.1097/00001888-200312000-00002; Passi V, 2016, MED TEACH, V38, P700, DOI 10.3109/0142159X.2015.1087482; SHUVAL JT, 1980, SOC SCI MED-MED SOC, V14, P5, DOI 10.1016/0160-7979(80)90003-X; Sternszus R, 2016, ACAD MED, V91, P427, DOI 10.1097/ACM.0000000000000996; Sternszus R, 2012, ACAD MED, V87, P1282, DOI 10.1097/ACM.0b013e3182624c53; TOSTESON DC, 1979, NEW ENGL J MED, V301, P690, DOI 10.1056/NEJM197909273011304; Wright S, 1996, ACAD MED, V71, P290, DOI 10.1097/00001888-199603000-00024; Wright SM, 2002, CAN MED ASSOC J, V167, P638	12	7	7	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1257	1258		10.1016/S0140-6736(16)00381-0	http://dx.doi.org/10.1016/S0140-6736(16)00381-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27025420				2022-12-28	WOS:000372697500006
J	Godfrey-Faussett, P; Ayles, H				Godfrey-Faussett, Peter; Ayles, Helen			Why are people living with HIV still dying of tuberculosis?	LANCET			English	Editorial Material							RANDOMIZED TRIAL; BURDEN; IMMUNODEFICIENCY; HOUSEHOLD; THERAPY; AFRICA; TB		[Godfrey-Faussett, Peter] UNAIDS, Off Deputy Execut Director, Geneva, Switzerland; [Ayles, Helen] ZAMBART, Lusaka, Zambia; [Godfrey-Faussett, Peter; Ayles, Helen] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England	UNAIDS; University of London; London School of Hygiene & Tropical Medicine	Godfrey-Faussett, P (corresponding author), UNAIDS, Off Deputy Execut Director, Geneva, Switzerland.; Godfrey-Faussett, P (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	faussettp@unaids.org		Ayles, Helen/0000-0003-4108-2842				Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Grant A, 2016, 2016 C RETR OPP INF, P155; Hosseinipour MC, 2016, LANCET, V387, P1198, DOI 10.1016/S0140-6736(16)00546-8; Jia ZW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-64; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P287; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Omar T, 2015, INT J TUBERC LUNG D, V19, P1320, DOI 10.5588/ijtld.15.0222; PITCHENIK AE, 1984, ANN INTERN MED, V101, P641, DOI 10.7326/0003-4819-101-5-641; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; World Health Organization, 2015, GLOB TUB REP 2015	13	4	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1141	1143		10.1016/S0140-6736(16)00699-1	http://dx.doi.org/10.1016/S0140-6736(16)00699-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG9OB	27025319	Green Submitted			2022-12-28	WOS:000372412000007
J	Michler, RE; Smith, PK; Parides, MK; Ailawadi, G; Thourani, V; Moskowitz, AJ; Acker, MA; Hung, JW; Chang, HL; Perrault, LP; Gillinov, AM; Argenziano, M; Bagiella, E; Overbey, JR; Moquete, EG; Gupta, LN; Miller, MA; Taddei-Peters, WC; Jeffries, N; Weisel, RD; Rose, EA; Gammie, JS; DeRose, JJ; Puskas, JD; Dagenais, F; Burks, SG; El-Hamamsy, I; Milano, CA; Atluri, P; Voisine, P; O'Gara, PT; Gelijns, AC				Michler, R. E.; Smith, P. K.; Parides, M. K.; Ailawadi, G.; Thourani, V.; Moskowitz, A. J.; Acker, M. A.; Hung, J. W.; Chang, H. L.; Perrault, L. P.; Gillinov, A. M.; Argenziano, M.; Bagiella, E.; Overbey, J. R.; Moquete, E. G.; Gupta, L. N.; Miller, M. A.; Taddei-Peters, W. C.; Jeffries, N.; Weisel, R. D.; Rose, E. A.; Gammie, J. S.; DeRose, J. J., Jr.; Puskas, J. D.; Dagenais, F.; Burks, S. G.; El-Hamamsy, I.; Milano, C. A.; Atluri, P.; Voisine, P.; O'Gara, P. T.; Gelijns, A. C.		CTSN	Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-FAILURE; MYOCARDIAL VIABILITY; PROGNOSTIC VALUE; SURVIVAL; DYSFUNCTION; SEVERITY; SURGERY; THERAPY	BACKGROUND In a trial comparing coronary-artery bypass grafting (CABG) alone with CABG plus mitral-valve repair in patients with moderate ischemic mitral regurgitation, we found no significant difference in the left ventricular end-systolic volume index (LVESVI) or survival after 1 year. Concomitant mitral-valve repair was associated with a reduced prevalence of moderate or severe mitral regurgitation, but patients had more adverse events. We now report 2-year outcomes. METHODS We randomly assigned 301 patients to undergo either CABG alone or the combined procedure. Patients were followed for 2 years for clinical and echocardiographic outcomes. RESULTS At 2 years, the mean (+/- SD) LVESVI was 41.2 +/- 20.0 ml per square meter of body-surface area in the CABG-alone group and 43.2 +/- 20.6 ml per square meter in the combined-procedure group (mean improvement over baseline, -14.1 ml per square meter and -14.6 ml per square meter, respectively). The rate of death was 10.6% in the CABG-alone group and 10.0% in the combined-procedure group (hazard ratio in the combined-procedure group, 0.90; 95% confidence interval, 0.45 to 1.83; P = 0.78). There was no significant between-group difference in the rank-based assessment of the LVESVI (including death) at 2 years (z score, 0.38; P = 0.71). The 2-year rate of moderate or severe residual mitral regurgitation was higher in the CABG-alone group than in the combined-procedure group (32.3% vs. 11.2%, P< 0.001). Overall rates of hospital readmission and serious adverse events were similar in the two groups, but neurologic events and supraventricular arrhythmias remained more frequent in the combined-procedure group. CONCLUSIONS In patients with moderate ischemic mitral regurgitation undergoing CABG, the addition of mitral-valve repair did not lead to significant differences in left ventricular reverse remodeling at 2 years. Mitral-valve repair provided a more durable correction of mitral regurgitation but did not significantly improve survival or reduce overall adverse events or readmissions and was associated with an early hazard of increased neurologic events and supraventricular arrhythmias. (Funded by the National Institutes of Health and Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00806988.)	[Michler, R. E.; DeRose, J. J., Jr.] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Cardiothorac & Vasc Surg, New York, NY USA; [Parides, M. K.; Moskowitz, A. J.; Chang, H. L.; Bagiella, E.; Overbey, J. R.; Moquete, E. G.; Gupta, L. N.; Gelijns, A. C.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Int Ctr Hlth Outcomes & Innovat Res InCHOIR, New York, NY 10029 USA; [Argenziano, M.] Columbia Univ, Coll Phys & Surg, Dept Surg, Div Cardiothorac Surg, New York, NY USA; [Rose, E. A.; Puskas, J. D.] Mt Sinai Hlth Syst, Dept Cardiac Surg, New York, NY USA; [Smith, P. K.; Milano, C. A.] Duke Univ, Med Ctr, Dept Surg, Div Cardiovasc & Thorac Surg, Durham, NC 27710 USA; [Ailawadi, G.; Burks, S. G.] Univ Virginia, Sch Med, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA; [Thourani, V.] Emory Univ, Sch Med, Div Cardiothorac Surg, Clin Res Unit, Atlanta, GA 30322 USA; [Acker, M. A.; Atluri, P.] Univ Penn, Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; [Hung, J. W.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [O'Gara, P. T.] Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA; [Perrault, L. P.; El-Hamamsy, I.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Weisel, R. D.] Univ Toronto, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Weisel, R. D.] Univ Toronto, Toronto Gen Hosp, Div Cardiovasc Surg, Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Weisel, R. D.] Univ Toronto, Div Cardiac Surg, Toronto, ON, Canada; [Dagenais, F.; Voisine, P.] Hop Laval, Inst Univ Cardiol Quebec, Quebec City, PQ, Canada; [Gillinov, A. M.] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA; [Miller, M. A.; Taddei-Peters, W. C.] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Jeffries, N.] NHLBI, Off Biostat Res, Bldg 10, Bethesda, MD 20892 USA; [Gammie, J. S.] Univ Maryland, Med Ctr, Dept Surg, Baltimore, MD 21201 USA	Montefiore Medical Center; Yeshiva University; Icahn School of Medicine at Mount Sinai; Columbia University; Icahn School of Medicine at Mount Sinai; Duke University; University of Virginia; Emory University; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Universite de Montreal; University of Toronto; Peter Munk Cardiac Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Laval University; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University System of Maryland; University of Maryland Baltimore	Gelijns, AC (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, 1Gustave L Levy Pl,Box 1077, New York, NY 10029 USA.	annetine.gelijns@mountsinai.org	Rose, Eric/AAJ-2281-2020; thourani, vinod/AAP-5968-2020; Parides, Michael/GON-8474-2022	Overbey, Jessica/0000-0001-7283-1661; Browndyke, Jeffrey/0000-0002-8573-7073; Douglas, Pamela/0000-0001-9876-4049; Moskowitz, Alan/0000-0002-4412-9450; Holubkov, Richard/0000-0003-0431-3381	National Institutes of Health; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL088953, UM1HL088925, UM1HL117924, UM1HL088939, U01HL088942, UM1HL088963, R01HL102121, UM1HL118007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Institutes of Health and Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00806988.	Bax JJ, 2001, CIRCULATION, V104, pI314; Bax JJ, 2004, CIRCULATION, V110; Bonow RO, 2015, JACC-CARDIOVASC IMAG, V8, P1121, DOI 10.1016/j.jcmg.2015.03.013; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Breithardt OA, 2003, J AM COLL CARDIOL, V41, P765, DOI 10.1016/S0735-1097(02)02937-6; Bursi F, 2005, CIRCULATION, V111, P295, DOI 10.1161/01.CIR.0000151097.30779.04; Capomolla S, 2000, AM HEART J, V139, P596, DOI 10.1016/S0002-8703(00)90036-X; Castleberry AW, 2014, CIRCULATION, V129, P2547, DOI 10.1161/CIRCULATIONAHA.113.005223; Chan KMJ, 2012, CIRCULATION, V126, P2502, DOI 10.1161/CIRCULATIONAHA.112.143818; DETRE KM, 1984, NEW ENGL J MED, V311, P1333; Fattouch K, 2009, J THORAC CARDIOV SUR, V138, P278, DOI 10.1016/j.jtcvs.2008.11.010; Goldstein D, 2016, NEW ENGL J MED, V374, P344, DOI 10.1056/NEJMoa1512913; Grigioni F, 2005, J AM COLL CARDIOL, V45, P260, DOI 10.1016/j.jacc.2004.10.030; Grodin JL, 2015, J CARD FAIL, V21, P44, DOI 10.1016/j.cardfail.2014.08.013; Meluzin J, 1998, J AM COLL CARDIOL, V32, P912, DOI 10.1016/S0735-1097(98)00324-6; Michler RE, 2013, J THORAC CARDIOV SUR, V146, P1139, DOI 10.1016/j.jtcvs.2012.09.007; Penicka M, 2009, CIRCULATION, V120, P1474, DOI 10.1161/CIRCULATIONAHA.108.842104; Perez de Isla L, 2007, EUR HEART J, V28, P2866, DOI 10.1093/eurheartj/ehm469; Roshanali F, 2006, ECHOCARDIOGR-J CARD, V23, P31, DOI 10.1111/j.1540-8175.2006.00163.x; Smith PK, 2014, NEW ENGL J MED, V371, P2178, DOI 10.1056/NEJMoa1410490; Smith PK, 2012, J THORAC CARDIOV SUR, V143, P111, DOI 10.1016/j.jtcvs.2011.05.006; Sundt TM, 2014, NEW ENGL J MED, V371, P2228, DOI 10.1056/NEJMe1412045; Suri RM, 2012, ANN THORAC SURG, V93, P761, DOI 10.1016/j.athoracsur.2011.11.062; Yiu SF, 2000, CIRCULATION, V102, P1400, DOI 10.1161/01.CIR.102.12.1400; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	25	322	338	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1932	1941		10.1056/NEJMoa1602003	http://dx.doi.org/10.1056/NEJMoa1602003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM1OX	27040451	Bronze, Green Accepted			2022-12-28	WOS:000376116600006
J	Bloch, JI; Woodruff, ED; Wood, AR; Rincon, AF; Harrington, AR; Morgan, GS; Foster, DA; Montes, C; Jaramillo, CA; Jud, NA; Jones, DS; MacFadden, BJ				Bloch, Jonathan I.; Woodruff, Emily D.; Wood, Aaron R.; Rincon, Aldo F.; Harrington, Arianna R.; Morgan, Gary S.; Foster, David A.; Montes, Camilo; Jaramillo, Carlos A.; Jud, Nathan A.; Jones, Douglas S.; MacFadden, Bruce J.			First North American fossil monkey and early Miocene tropical biotic interchange	NATURE			English	Article							MIDDLE EOCENE; ISTHMUS; PLATYRRHINES; BIOGEOGRAPHY; CALIBRATION; CHRONOLOGY; EMERGENCE; MAMMALIA; ORIGINS	New World monkeys (platyrrhines) are a diverse part of modern tropical ecosystems in North and South America, yet their early evolutionary history in the tropics is largely unknown. Molecular divergence estimates suggest that primates arrived in tropical Central America, the southern-most extent of the North American landmass, with several dispersals from South America starting with the emergence of the Isthmus of Panama 3-4 million years ago (Ma)(1). The complete absence of primate fossils from Central America has, however, limited our understanding of their history in the New World. Here we present the first description of a fossil monkey recovered from the North American landmass, the oldest known crown platyrrhine, from a precisely dated 20.9-Ma layer in the Las Cascadas Formation in the Panama Canal Basin, Panama. This discovery suggests that family-level diversification of extant New World monkeys occurred in the tropics, with new divergence estimates for Cebidae between 22 and 25 Ma, and provides the oldest fossil evidence for mammalian interchange between South and North America. The timing is consistent with recent tectonic reconstructions(2,3) of a relatively narrow Central American Seaway in the early Miocene epoch, coincident with over-water dispersals inferred for many other groups of animals and plants(4). Discovery of an early Miocene primate in Panama provides evidence for a circum-Caribbean tropical distribution of New World monkeys by this time, with ocean barriers not wholly restricting their northward movements, requiring a complex set of ecological factors to explain their absence in well-sampled similarly aged localities at higher latitudes of North America.	[Bloch, Jonathan I.; Woodruff, Emily D.; Wood, Aaron R.; Rincon, Aldo F.; Harrington, Arianna R.; Jud, Nathan A.; Jones, Douglas S.; MacFadden, Bruce J.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Woodruff, Emily D.; Harrington, Arianna R.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Wood, Aaron R.] Iowa State Univ, Dept Geol & Atmospher Sci, Ames, IA 50011 USA; [Rincon, Aldo F.; Foster, David A.] Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; [Harrington, Arianna R.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Morgan, Gary S.] New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; [Montes, Camilo] Univ Los Andes, Geociencias, Calle 1A 18A-10,Edificio IP, Bogota 111711, Colombia; [Jaramillo, Carlos A.] Smithsonian Trop Res Inst, Box 0843-03092, Balboa, Ancon, Panama	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Iowa State University; State University System of Florida; University of Florida; Duke University; Universidad de los Andes (Colombia); Smithsonian Institution; Smithsonian Tropical Research Institute	Bloch, JI (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	jbloch@flmnh.ufl.edu	Jud, Nathan/AAI-2384-2020; Rincon Burbano, Aldo Fernando/W-2740-2018	Jud, Nathan/0000-0001-6100-9779; Woodruff, Emily/0000-0001-5267-6094; Rincon Burbano, Aldo Fernando/0000-0002-4422-532X; Harrington, Arianna/0000-0002-2720-6098; jaramillo, carlos/0000-0002-2616-5079; Bloch, Jonathan/0000-0003-1484-6931; Foster, David/0000-0002-5603-9372; Montes, Camilo/0000-0002-3553-0787	National Science Foundation (NSF) [BCS 1304045, BCS 0851272]; Edward P. Bass Distinguished Visiting Environmental Scholar in the Yale Institute for Biospheric Studies (YIBS); NSF (PIRE project) [0966884]; Smithsonian Tropical Research Institute Paleobiology Fund; Florida Museum of Natural History; Div Of Biological Infrastructure [1203222] Funding Source: National Science Foundation; Office Of The Director [0966884] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Edward P. Bass Distinguished Visiting Environmental Scholar in the Yale Institute for Biospheric Studies (YIBS); NSF (PIRE project)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Smithsonian Tropical Research Institute Paleobiology Fund(Smithsonian InstitutionSmithsonian Tropical Research Institute); Florida Museum of Natural History; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank M. Silcox, D. Boyer, G. Gunnell, S. Chester, P. Morse, E. Sargis, D. Steadman, E. Kowalski, Z. Randall, A. Rosenberger, J. Krigbaum and D. Daegling for advice and discussion, R. Kay and L. Marivaux for reviews that significantly improved the quality of the manuscript, D. Byerley and G. Maccracken for finding primate fossils in Panama, M. Droulliard for assistance with geochronology laboratory and fieldwork, R. Kay, P. Holroyd and D. Reed for access to comparative specimens, J. Bourque for fossil preparation, D. Byerley for artwork associated with Fig. 3, D. Boyer for facilitating access to the Duke University SMIF microCT facility, and D. Boyer, G. Yapuncich and J. Thostenson for help acquiring and processing microCT scan data (funded in part by National Science Foundation (NSF) BCS 1304045 to D. Boyer and E. St Clair, and BCS 0851272 to R. Kay). We thank O. Moskalenko, M. Gitzendanner and D. Reed for assistance with the high-performance computing resources at the University of Florida. We thank the Autoridad del Canal de Panama (ACP) and the Ministerio de Comercio e Industria (MICI) for logistical support and access to the Panama Canal Zone. Part of this manuscript was written when J.I.B. was supported as an Edward P. Bass Distinguished Visiting Environmental Scholar in the Yale Institute for Biospheric Studies (YIBS). The NSF (PIRE project 0966884), Smithsonian Tropical Research Institute Paleobiology Fund, and the Florida Museum of Natural History funded this research. This is University of Florida Contribution to Paleobiology 782.	Albright LB, 2008, J GEOL, V116, P211, DOI 10.1086/587650; Bacon CD, 2015, P NATL ACAD SCI USA, V112, P6110, DOI 10.1073/pnas.1423853112; Black LP, 2003, CHEM GEOL, V200, P171, DOI 10.1016/S0009-2541(03)00166-9; Bond M, 2015, NATURE, V520, P538, DOI 10.1038/nature14120; Cooke SB, 2011, P NATL ACAD SCI USA, V108, P2699, DOI 10.1073/pnas.1009161108; Dunn RE, 2013, GEOL SOC AM BULL, V125, P539, DOI 10.1130/B30660.1; Farris DW, 2011, GEOLOGY, V39, P1007, DOI 10.1130/G32237.1; Houle A, 1999, AM J PHYS ANTHROPOL, V109, P541, DOI 10.1002/(SICI)1096-8644(199908)109:4<541::AID-AJPA9>3.0.CO;2-N; Jaramillo C.A., 2014, PALEOBOTANY BIOGEOGR, P134; Kay RF, 2015, SCIENCE, V347, P1068, DOI 10.1126/science.aaa9217; Kay RF, 2015, MOL PHYLOGENET EVOL, V82, P358, DOI 10.1016/j.ympev.2013.12.002; Kiesling NMJ, 2015, MOL PHYLOGENET EVOL, V82, P386, DOI 10.1016/j.ympev.2014.03.027; Kirby MX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002791; MacFadden BJ, 2006, TRENDS ECOL EVOL, V21, P157, DOI 10.1016/j.tree.2005.12.003; MACFADDEN BJ, 1990, J HUM EVOL, V19, P7, DOI 10.1016/0047-2484(90)90010-9; MacFadden BJ, 2014, J GEOL, V122, P113, DOI 10.1086/675244; MacPhee RDE, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)394<0001:DDZAEM>2.0.CO;2; Montes C, 2012, GEOL SOC AM BULL, V124, P780, DOI 10.1130/B30528.1; Montes C, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008959; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Rincon AF, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.970688; Rincon AF, 2013, J VERTEBR PALEONTOL, V33, P421, DOI 10.1080/02724634.2013.722573; Rincon AF, 2012, J VERTEBR PALEONTOL, V32, P456, DOI 10.1080/02724634.2012.635736; Rooney TO, 2011, CONTRIB MINERAL PETR, V161, P373, DOI 10.1007/s00410-010-0537-8; Rosenberger AL, 2010, J HUM EVOL, V59, P214, DOI 10.1016/j.jhevol.2010.03.003; Rosenberger Alfred L., 2009, P69, DOI 10.1007/978-0-387-78705-3_4; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Tedford Richard H., 2004, P169; Wood AR, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.923893; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8	30	49	51	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					243	+		10.1038/nature17415	http://dx.doi.org/10.1038/nature17415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27096364				2022-12-28	WOS:000376007200049
J	Wang, T; Naredla, RR; Thompson, SK; Hoye, TR				Wang, Teng; Naredla, Rajasekhar Reddy; Thompson, Severin K.; Hoye, Thomas R.			The pentadehydro-Diels-Alder reaction	NATURE			English	Article							STEPWISE MECHANISMS; THERMAL GENERATION; CYCLOAROMATIZATION; CYCLIZATION; SYSTEM; (Z)-1,2,4-HEPTATRIEN-6-YNE; ALPHA,3-DEHYDROTOLUENE; SUBSTITUENTS; NUCLEOPHILES; DIRADICALS	In the classic Diels-Alder [4 + 2] cycloaddition reaction(1), the overall degree of unsaturation (or oxidation state) of the 4 pi (diene) and 2 pi (dienophile) pairs of reactants dictates the oxidation state of the newly formed six-membered carbocycle. For example, in the classic Diels-Alder reaction, butadiene and ethylene combine to produce cyclohexene. More recent developments include variants in which the number of hydrogen atoms in the reactant pair and in the resulting product is reduced(2) by, for example, four in the tetradehydro-Diels-Alder (TDDA) and by six in the hexadehydro-Diels-Alder (HDDA)(3-7) reactions. Any oxidation state higher than tetradehydro (that is, lacking more than four hydrogens) leads to the production of a reactive intermediate that is more highly oxidized than benzene. This increases the power of the overall process substantially, because trapping of the reactive intermediate(8,9) can be used to increase the structural complexity of the final product in a controllable and versatile manner. Here we report an unprecedented overall 4 pi + 2 pi cycloaddition reaction that generates a different, highly reactive intermediate known as an alpha,3-dehydrotoluene. This species is in the same oxidation state as a benzyne. Like benzynes, alpha,3-dehydrotoluenes can be captured by various trapping agents to produce structurally diverse products that are complementary to those arising from the HDDA process. We call this new cycloisomerization process a pentadehydro-Diels-Alder (PDDA) reaction-a nomenclature chosen for chemical taxonomic reasons rather than mechanistic ones. In addition to alkynes, nitriles (RC equivalent to N), although non-participants in aza-HDDA reactions, readily function as the 2 pi component in PDDA cyclizations to produce, via trapping of the alpha,3-(5-aza) dehydrotoluene intermediates, pyridine-containing products.	[Wang, Teng; Naredla, Rajasekhar Reddy; Thompson, Severin K.; Hoye, Thomas R.] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hoye, TR (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	hoye@umn.edu		Thompson, Severin/0000-0001-8104-6120	National Institute of General Medical Sciences [GM65597]; National Cancer Institute of the US Department of Health and Human Services [CA76497]; NIH [S10OD011952]; NATIONAL CANCER INSTITUTE [R01CA076497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065597] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD011952] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute of the US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support from the National Institute of General Medical Sciences (GM65597) and the National Cancer Institute (CA76497) of the US Department of Health and Human Services is acknowledged. Portions of this work were performed using resources available through the University of Minnesota Supercomputing Institute (MSI). NMR spectra were recorded using instrumentation purchased with funds from the NIH Shared Instrumentation Grant programme (S10OD011952). We thank D. J. Marell for guidance in several aspects of the computations.	Ajaz A, 2011, J ORG CHEM, V76, P9320, DOI 10.1021/jo201567d; Beesley R.M., 1915, J AM CHEM SOC, V107, P1081; BERGMAN RG, 1973, ACCOUNTS CHEM RES, V6, P25, DOI 10.1021/ar50061a004; Bradley AZ, 1997, J AM CHEM SOC, V119, P9917, DOI 10.1021/ja972141f; Cremeens ME, 2005, J AM CHEM SOC, V127, P6652, DOI 10.1021/ja0445443; Diels O, 1928, LIEBIGS ANN CHEM, V460, P98; Grigg R, 1996, TETRAHEDRON, V52, P13441, DOI 10.1016/0040-4020(96)00801-0; Holden C, 2014, ANGEW CHEM INT EDIT, V53, P5746, DOI 10.1002/anie.201402405; Hoye TR, 2012, NATURE, V490, P208, DOI 10.1038/nature11518; Johnson RP, 2010, J PHYS ORG CHEM, V23, P283, DOI 10.1002/poc.1656; Karmakar R, 2015, ANGEW CHEM INT EDIT, V54, P6582, DOI 10.1002/anie.201412468; Karmakar R, 2014, ORG LETT, V16, P6, DOI 10.1021/ol403237z; Kimura H, 2008, CHEM LETT, V37, P662, DOI 10.1246/cl.2008.662; Liang Y, 2014, ORG LETT, V16, P5702, DOI 10.1021/ol502780w; LOGAN CF, 1994, J AM CHEM SOC, V116, P2137, DOI 10.1021/ja00084a061; Marell DJ, 2015, J ORG CHEM, V80, P11744, DOI 10.1021/acs.joc.5b01356; Miyawaki K, 1997, TETRAHEDRON LETT, V38, P3943, DOI 10.1016/S0040-4039(97)00785-5; Mohamed RK, 2013, CHEM REV, V113, P7089, DOI 10.1021/cr4000682; MYERS AG, 1992, J AM CHEM SOC, V114, P9369, DOI 10.1021/ja00050a017; MYERS AG, 1989, J AM CHEM SOC, V111, P8057, DOI 10.1021/ja00202a079; NAGATA R, 1989, TETRAHEDRON LETT, V30, P4995, DOI 10.1016/S0040-4039(01)80564-5; Niu D, 2014, NAT CHEM, V6, P34, DOI [10.1038/NCHEM.1797, 10.1038/nchem.1797]; Peterson PW, 2013, EUR J ORG CHEM, V2013, P2505, DOI 10.1002/ejoc.201201656; Sakai T, 2010, J AM CHEM SOC, V132, P13203, DOI 10.1021/ja106901u; Schmittel M, 1996, TETRAHEDRON LETT, V37, P999, DOI 10.1016/0040-4039(95)02369-0; Wang KP, 2013, CHEM SCI, V4, P3205, DOI 10.1039/c3sc50992c; Wessig P, 2008, CHEM REV, V108, P2051, DOI 10.1021/cr0783986; Willoughby PH, 2014, J AM CHEM SOC, V136, P13657, DOI 10.1021/ja502595m; Woods BP, 2014, ORG LETT, V16, P4578, DOI 10.1021/ol502131r; Yun SY, 2013, J AM CHEM SOC, V135, P4668, DOI 10.1021/ja400477r	30	34	34	7	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					484	488		10.1038/nature17429	http://dx.doi.org/10.1038/nature17429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27088605	Green Accepted			2022-12-28	WOS:000374815900043
J	Shah, T; Deswal, A				Shah, Tina; Deswal, Anita			Review: In HF with reduced ejection fraction, nurse-led titration of HF drugs reduces hospitalizations and mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Shah, Tina] Michael E DeBakey VA Med Ctr, Houston, TX USA; Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Shah, T (corresponding author), Michael E DeBakey VA Med Ctr, Houston, TX USA.							Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	1	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					JC41	JC41		10.7326/ACPJC-2016-164-8-041	http://dx.doi.org/10.7326/ACPJC-2016-164-8-041			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	27089090				2022-12-28	WOS:000374257900003
J	Peplow, M				Peplow, Mark			The 100 000 Genomes Project	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Genomics England, HIST 100000 GEN PROJ	1	43	43	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2016	353								i1757	10.1136/bmj.i1757	http://dx.doi.org/10.1136/bmj.i1757			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7ET	27075170				2022-12-28	WOS:000374375400002
J	Puram, RV; Kowalczyk, MS; de Boer, CG; Schneider, RK; Miller, PG; McConkey, M; Tothova, Z; Tejero, H; Heckl, D; Jaras, M; Chen, MC; Li, HB; Tamayo, A; Cowley, GS; Rozenblatt-Rosen, O; Al-Shahrour, F; Regev, A; Ebert, BL				Puram, Rishi V.; Kowalczyk, Monika S.; de Boer, Carl G.; Schneider, Rebekka K.; Miller, Peter G.; McConkey, Marie; Tothova, Zuzana; Tejero, Hector; Heckl, Dirk; Jaras, Marcus; Chen, Michelle C.; Li, Hubo; Tamayo, Alfred; Cowley, Glenn S.; Rozenblatt-Rosen, Orit; Al-Shahrour, Fatima; Regev, Aviv; Ebert, Benjamin L.			Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML	CELL			English	Article							HEMATOPOIETIC STEM; BONE-MARROW; COMMITTED PROGENITOR; THERAPEUTIC TARGET; MYELOID-LEUKEMIA; BMAL1; EXPRESSION; COMPONENT; TRANSFORMATION; RECEPTORS	Leukemia stem cells (LSCs) have the capacity to self-renew and propagate disease upon serial transplantation in animal models, and elimination of this cell population is required for curative therapies. Here, we describe a series of pooled, in vivo RNAi screens to identify essential transcription factors (TFs) in a murine model of acute myeloid leukemia (AML) with genetically and phenotypically defined LSCs. These screens reveal the heterodimeric, circadian rhythm TFs Clock and Bmal1 as genes required for the growth of AML cells in vitro and in vivo. Disruption of canonical circadian pathway components produces anti-leukemic effects, including impaired proliferation, enhanced myeloid differentiation, and depletion of LSCs. We find that both normal and malignant hematopoietic cells harbor an intact clock with robust circadian oscillations, and genetic knockout models reveal a leukemiaspecific dependence on the pathway. Our findings establish a role for the core circadian clock genes in AML.	[Puram, Rishi V.; Schneider, Rebekka K.; Miller, Peter G.; McConkey, Marie; Tothova, Zuzana; Heckl, Dirk; Jaras, Marcus; Chen, Michelle C.; Al-Shahrour, Fatima; Ebert, Benjamin L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA; [Puram, Rishi V.; Li, Hubo] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Puram, Rishi V.; Kowalczyk, Monika S.; de Boer, Carl G.; Tothova, Zuzana; Cowley, Glenn S.; Rozenblatt-Rosen, Orit; Regev, Aviv; Ebert, Benjamin L.] Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA; [Miller, Peter G.; Tothova, Zuzana; Li, Hubo; Ebert, Benjamin L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA; [Tejero, Hector; Al-Shahrour, Fatima] Spanish Natl Canc Res Ctr CNIO, Translat Bioinformat Unit, Madrid 28029, Spain; [Heckl, Dirk] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-30625 Hannover, NH, Germany; [Jaras, Marcus] Lund Univ, Dept Clin Genet, S-22184 Lund, Sweden; [Tamayo, Alfred] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Regev, Aviv] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Centro Nacional de Investigaciones Oncologicas (CNIO); Hannover Medical School; Lund University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Ebert, BL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA.; Ebert, BL (corresponding author), Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA.; Ebert, BL (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	bebert@partners.org	Heckl, Dirk/GMW-5407-2022; Rozenblatt-Rosen, Orit/HDN-4182-2022; Tejero, Hector/M-1045-2014	de Boer, Carl/0000-0001-8935-5921; Tamayo, Alfred/0000-0002-2321-0831; Jaras, Marcus/0000-0003-4080-7055; Tejero, Hector/0000-0002-4940-700X; Miller, Peter/0000-0002-6797-9335	Harvard Stem Cell Institute; NIH [P01 CA066996, R01 HL082945]; Klarman Family Foundation; Koch Institute Core Grant from National Cancer Institute [P30-CA14051]; Mildred-Scheel fellowship from German Cancer Foundation; Medical Scientist Training Program from National Institute of General Medical Sciences [T32GM007753]; NATIONAL CANCER INSTITUTE [K12CA087723, P30CA014051, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007901, R01HL082945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Family Foundation; Koch Institute Core Grant from National Cancer Institute; Mildred-Scheel fellowship from German Cancer Foundation; Medical Scientist Training Program from National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Charles Weitz, Scott Armstrong, George Daley, Itay Tirosh, R. Grant Rowe, and Samantha Morris for helpful scientific discussions. The germline Per2 mutant and Bmal1 knockout mice were generous gifts from Tyler Jacks and Thales Papagiannakopoulos. This work was funded by the Harvard Stem Cell Institute, the NIH (P01 CA066996 and R01 HL082945), the Klarman Family Foundation, and the Koch Institute Core Grant from the National Cancer Institute (P30-CA14051). D.H. was supported by a Mildred-Scheel fellowship from the German Cancer Foundation. R.V.P. was funded by the Medical Scientist Training Program grant T32GM007753 from the National Institute of General Medical Sciences.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Antoch MP, 2008, CELL CYCLE, V7, P1197, DOI 10.4161/cc.7.9.5886; Antoch MP, 2013, CELL CYCLE, V12, P3673, DOI 10.4161/cc.26614; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Burris TP, 2013, PHARMACOL REV, V65, P710, DOI 10.1124/pr.112.006833; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; CLARK RH, 1969, SCIENCE, V166, P236, DOI 10.1126/science.166.3902.236; Cui M, 2015, NEOPLASIA, V17, P79, DOI 10.1016/j.neo.2014.11.004; D'Hondt L, 2004, J CELL PHYSIOL, V200, P63, DOI 10.1002/jcp.20032; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Elshazley M, 2012, INT J CANCER, V131, P2820, DOI 10.1002/ijc.27598; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Hartwell KA, 2013, NAT CHEM BIOL, V9, P840, DOI [10.1038/nchembio.1367, 10.1038/NCHEMBIO.1367]; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heidel FH, 2012, CELL STEM CELL, V10, P412, DOI 10.1016/j.stem.2012.02.017; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Ieyasu A, 2014, J NEGAT RESULTS BIOM, V13, DOI 10.1186/1477-5751-13-4; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratov RV, 2009, AGING-US, V1, P979, DOI 10.18632/aging.100113; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krivtsov AV, 2009, ANN NY ACAD SCI, V1176, P144, DOI 10.1111/j.1749-6632.2009.04966.x; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li AH, 2013, FEBS LETT, V587, P2455, DOI 10.1016/j.febslet.2013.06.018; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Miller PG, 2013, CANCER CELL, V24, P45, DOI 10.1016/j.ccr.2013.05.004; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ozturk N, 2009, P NATL ACAD SCI USA, V106, P2841, DOI 10.1073/pnas.0813028106; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Rolls A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9516; Schepers K, 2015, CELL STEM CELL, V16, P254, DOI 10.1016/j.stem.2015.02.014; SMAALAND R, 1991, BLOOD, V77, P2603; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Thomas-Chollier M, 2012, NAT PROTOC, V7, P1551, DOI 10.1038/nprot.2012.088; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Xiao LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095878; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	76	130	136	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					303	316		10.1016/j.cell.2016.03.015	http://dx.doi.org/10.1016/j.cell.2016.03.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058663	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000374123000010
J	Burnham, AC				Burnham, A. C.			Compulsory Health Insurance (Reprinted from JAMA, vol 74, pg 412, 1920)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		BURNHAM AC, 1920, JAMA-J AM MED ASSOC, V74, P412	1	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1408	1408		10.1001/jama.2016.2728	http://dx.doi.org/10.1001/jama.2016.2728			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	27046381				2022-12-28	WOS:000373381500036
J	Descatha, A; Despreaux, T; Calfee, RP; Evanoff, B; Saint-Lary, O				Descatha, Alexis; Despreaux, Thomas; Calfee, Ryan P.; Evanoff, Bradley; Saint-Lary, Olivier			10-MINUTE CONSULTATION Progressive elbow pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EPICONDYLITIS		[Descatha, Alexis; Despreaux, Thomas] Univ Hosp Poincare Site, AP HP, EMS Samu92, Occupat Hlth Unit, Paris, France; [Descatha, Alexis; Despreaux, Thomas] Versailles St Quentin Univ, INSERM, UMS 011, UMR S 1168, Versailles, France; [Calfee, Ryan P.] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; [Evanoff, Bradley] Washington Univ, Sch Med, Inst Clin & Translat Sci, Div Gen Med Sci, St Louis, MO USA; [Saint-Lary, Olivier] Univ Versailles St Quentin En Yvelines, Fac Hlth Sci Simone Veil, Dept Family Med, F-78180 Montigny Le Bretonneux, France; [Saint-Lary, Olivier] Univ Paris 11, Univ Paris Saclay, UVSQ, CESP,INSERM U1018,Team Hlth Serv Res 1, F-94800 Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Washington University (WUSTL); Washington University (WUSTL); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Saint-Lary, O (corresponding author), Univ Versailles St Quentin En Yvelines, Fac Hlth Sci Simone Veil, Dept Family Med, F-78180 Montigny Le Bretonneux, France.; Saint-Lary, O (corresponding author), Univ Paris 11, Univ Paris Saclay, UVSQ, CESP,INSERM U1018,Team Hlth Serv Res 1, F-94800 Villejuif, France.	olivier.saint-lary@uvsq.fr		Evanoff, Bradley A./0000-0003-0085-333X				Bisset L, 2005, BRIT J SPORT MED, V39, P411, DOI 10.1136/bjsm.2004.016170; Bisset L., 2011, BMJ CLIN EVID, P1117; HAMILTON PG, 1986, J ROY COLL GEN PRACT, V36, P464; Hegmann KT, 2013, J OCCUP ENVIRON MED, V55, P1365, DOI 10.1097/JOM.0b013e3182a0d7ec; Kane SF, 2014, AM FAM PHYSICIAN, V89, P649; Pattanittum P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003686.pub2; Shiri R, 2011, BEST PRACT RES CL RH, V25, P43, DOI 10.1016/j.berh.2011.01.013; Tosti R, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.09.018	8	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2016	353								i1391	10.1136/bmj.i1391	http://dx.doi.org/10.1136/bmj.i1391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LO	27048479				2022-12-28	WOS:000373895300001
J	Guirguis-Blake, JM; Senger, CA; Webber, EM; Mularski, RA; Whitlock, EP				Guirguis-Blake, Janelle M.; Senger, Caitlyn A.; Webber, Elizabeth M.; Mularski, Richard A.; Whitlock, Evelyn P.			Screening for Chronic Obstructive Pulmonary Disease Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SMOKING-CESSATION INTERVENTIONS; LUNG-FUNCTION; PRIMARY-CARE; INHALED BUDESONIDE; GENERAL-PRACTICE; COST-EFFECTIVENESS; UNITED-STATES; COPD; QUESTIONNAIRE; VALIDATION	IMPORTANCE Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States. OBJECTIVE To systematically review literature on the accuracy of screening questionnaires and office-based screening pulmonary function testing and the efficacy and harms of treatment of screen-detected COPD. DATA SOURCES MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials for relevant English-language studies published through January 2015. STUDY SELECTION Two reviewers independently screened abstracts and studies. The search yielded 13 141 unique citations; 465 full-text articles were reviewed, and 33 studies met the inclusion criteria. DATA EXTRACTION AND SYNTHESIS Two reviewers rated the quality of each study using USPSTF criteria. MAIN OUTCOMES AND MEASURES Diagnostic accuracy (sensitivity, specificity, positive predictive value [PPV], and negative predictive value [NPV]; treatment efficacy (COPD exacerbations, all-cause mortality, quality of life, and dyspnea); and treatment harms. RESULTS All screening questionnaires were based on symptoms as well as risk factors such as age and smoking history. The COPD Diagnostic Questionnaire was the most extensively studied (5 studies, n = 3048), with moderate overall performance for COPD detection: area under the receiver operating characteristic curve (AUC), 0.65 to 0.72; sensitivity, 80% to 93%; and specificity, 24% to 49%, at a threshold of greater than 16.5. Positive predictive value and NPV ranged from 17% to 45% and 76% to 98%, respectively. For pulmonary function-based screening tools, FEV1/FEV6 was the best studied (3 studies, n = 1587), with AUC ranging from 0.84 to 0.85. Sensitivity ranged from 51% to 80%. Specificity (range, 90%-95%) and PPV (range, 63%-75%) appeared better than questionnaires. There was not strong evidence to support that screening and supplying smokers with spirometry results improves smoking cessation rates. Treatment trials were unavailable for screen-detected patients. Trials that reported outcomes in patients with mild to moderate COPD included 2 trials of long-acting beta-agonists (LABAs) (n = 3174), 1 RCT of LABAs and inhaled corticosteroids (ICS) (n = 1097), 5 RCTs of the long-acting muscarinic antagonist tiotropium (n = 4592), and 6 RCTs of ICS (n = 3983). They suggested no benefit in all-cause mortality, but a decrease in annual rates of exacerbations with pharmacologic treatments. Few trials reported harms for any individual drug class. Adverse effects were generally mild (eg, dry mouth and cough). CONCLUSIONS AND RELEVANCE There was no direct evidence available to determine the benefits and harms of screening asymptomatic adults for COPD using questionnaires or office-based screening pulmonary function testing or to determine the benefits of treatment in screen-detected populations. Indirect evidence suggests that the COPD Diagnostic Questionnaire has moderate overall performance for COPD detection. Among patients with mild to moderate COPD, the benefit of pharmacotherapy for reducing exacerbations was modest.	[Guirguis-Blake, Janelle M.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Guirguis-Blake, Janelle M.; Senger, Caitlyn A.; Webber, Elizabeth M.; Mularski, Richard A.; Whitlock, Evelyn P.] Kaiser Permanente, Res Affiliates Evidence Based Practice Ctr, Portland, OR USA; [Senger, Caitlyn A.; Webber, Elizabeth M.; Mularski, Richard A.; Whitlock, Evelyn P.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA	University of Washington; University of Washington Seattle; Kaiser Permanente; Kaiser Permanente	Guirguis-Blake, JM (corresponding author), Kaiser Permanente, Res Affiliates Evidence Based Practice Ctr, 521 Martin Luther King Jr Way, Tacoma, WA 98405 USA.; Guirguis-Blake, JM (corresponding author), Univ Washington, Dept Family Med, 521 Martin Luther King Jr Way, Tacoma, WA 98405 USA.	jguirgui@u.washington.edu			Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded by the Agency for Healthcare Research and Quality (AHRQ) under a contract to support the US Preventive Services Task Force (USPSTF).	Altose MD, 2000, NEW ENGL J MED, V343, P1902; American Lung Association, CHRON OBSTR PULM DIS; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Buffels J, 2004, CHEST, V125, P1394, DOI 10.1378/chest.125.4.1394; Calverley PMA, 2011, CHEST, V139, P505, DOI 10.1378/chest.09-2992; Calverley PMA, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-73; Centers for Disease Control and Prevention, COPD DAT STAT; Clark MA, 1999, ADDICT BEHAV, V24, P1, DOI 10.1016/S0306-4603(98)00030-6; Decramer M, 2013, RESP MED, V107, P223, DOI 10.1016/j.rmed.2012.10.022; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Dirven JAM, 2013, PRIM CARE RESP J, V22, P338, DOI 10.4104/pcrj.2013.00071; Enright P, 2006, CHEST, V129, P833, DOI 10.1378/chest.129.4.833; Enright P, 2014, AM J RESP CRIT CARE, V189, P229, DOI 10.1164/rccm.201306-1117LE; Enright P, 2011, PRIM CARE RESP J, V20, P6, DOI 10.4104/pcrj.2011.00004; Ford ES, 2013, CHEST, V144, P284, DOI 10.1378/chest.13-0809; Frith P, 2011, PRIM CARE RESP J, V20, P190, DOI 10.4104/pcrj.2011.00040; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Guirguis-Blake JM, 2016, AHRQ PUBLICATION; Hanania NA, 2010, RESP MED, V104, P1160, DOI 10.1016/j.rmed.2010.02.009; Hoogendoorn Martine, 2010, Int J Chron Obstruct Pulmon Dis, V5, P435, DOI 10.2147/COPD.S13826; Hoogendoorn M, 2010, THORAX, V65, P711, DOI 10.1136/thx.2009.131631; Hooper R, 2012, EUR RESPIR J, V39, P1343, DOI 10.1183/09031936.00002711; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Ruiz CAJ, 2012, NICOTINE TOB RES, V14, P1035, DOI 10.1093/ntr/nts001; Jimenez-Ruiz CA, 2001, CHEST, V119, P1365, DOI 10.1378/chest.119.5.1365; Jithoo A, 2013, EUR RESPIR J, V41, P548, DOI 10.1183/09031936.00132011; Jones R, 2011, PRIM CARE RESP J, V20, P222, DOI 10.4104/pcrj.2011.00048; Kaplan A, 2011, PRIM CARE RESP J, V20, P238, DOI 10.4104/pcrj.2011.00075; Kochanek Kenneth D, 2014, NCHS Data Brief, P1; Kotz D, 2008, EUR RESPIR J, V31, P298, DOI 10.1183/09031936.00074307; Kotz D, 2009, EUR RESPIR J, V33, P754, DOI 10.1183/09031936.00116308; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Lofdahl CG, 2007, EUR RESPIR J, V29, P1115, DOI 10.1183/09031936.00128806; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; Martinez FJ, 2008, COPD, V5, P85, DOI 10.1080/15412550801940721; McClure JB, 2009, AM J PREV MED, V37, P116, DOI 10.1016/j.amepre.2009.03.018; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mintz ML, 2011, MAYO CLIN PROC, V86, P375, DOI 10.4065/mcp.2010.0787; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; National Institute for Health and Clinical Excellence, 2006, GUID MAN; National Institute of Health and Care Excellence, CHRON OBSTR PULM DIS; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; Parkes G, 2008, BMJ-BRIT MED J, V336, P598, DOI 10.1136/bmj.39503.582396.25; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Perez-Padilla R, 2009, INT J TUBERC LUNG D, V13, P387; Price DB, 2006, CHEST, V129, P1531, DOI 10.1378/chest.129.6.1531; Price DB, 2006, RESPIRATION, V73, P285, DOI 10.1159/000090142; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; RISSER NL, 1990, J GEN INTERN MED, V5, P16, DOI 10.1007/BF02602303; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Sichletidis L, 2011, PRIM CARE RESP J, V20, P184, DOI 10.4104/pcrj.2011.00038; Sippel JM, 1999, J GEN INTERN MED, V14, P670, DOI 10.1046/j.1525-1497.1999.11088.x; Stanley AJ, 2014, PRIM CARE RESP J, V23, P92, DOI 10.4104/pcrj.2014.00015; Strassmann R, 2009, EUR RESPIR J, V34, P634, DOI 10.1183/09031936.00167708; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Thorn J, 2012, PRIM CARE RESP J, V21, P159, DOI 10.4104/pcrj.2011.00104; Tinkelman David G, 2007, Prim Care Respir J, V16, P41, DOI 10.3132/pcrj.2007.00009; Tonnel A-B, 2008, Int J Chron Obstruct Pulmon Dis, V3, P301; Troosters T, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.3; Tsukuya G, 2015, ALLERGOL INT, V64, P49, DOI 10.1016/j.alit.2014.06.002; US Preventive Serv Task Force, 2008, ANN INTERN MED, V148, P529, DOI 10.7326/0003-4819-148-7-200804010-00212; US Preventive Services Task Force, 2008, AHRQ PUBLICATION, V08-05124-EF-3; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Wagena EJ, 2004, RESP MED, V98, P805, DOI 10.1016/j.rmed.2004.06.001; Walters N, 2002, BRIT J GEN PRACT, V52, P132; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yawn BP, 2014, AM J PREV MED, V47, P563, DOI 10.1016/j.amepre.2014.07.030; Yawn Barbara P, 2010, Int J Chron Obstruct Pulmon Dis, V5, P1	70	93	98	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1378	1393		10.1001/jama.2016.2654	http://dx.doi.org/10.1001/jama.2016.2654			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	27046366	Bronze			2022-12-28	WOS:000373381500022
J	Morton, S				Morton, Sarah			10-MINUTE CONSULTATION Pain at the back of the heel	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACHILLES; TENDINOPATHY		[Morton, Sarah] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London W6 8RP, England	Imperial College London	Morton, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London W6 8RP, England.	sarah.morton@doctors.org.uk	Morton, Sarah/K-6050-2015	Morton, Sarah/0000-0002-9112-8821; Majeed, Azeem/0000-0002-2357-9858				Asplund CA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1262; Berner J, 2015, Rev Med Suisse, V11, P606; Berner J, 2015, REV MED SUISSE, V11, P610; Cook JL, 2002, MANUAL THER, V7, P121, DOI 10.1054/math.2002.0458; de Jonge S, 2011, BRIT J SPORT MED, V45, P1026, DOI 10.1136/bjsports-2011-090342; Holmes GB, 2006, FOOT ANKLE INT, V27, P952, DOI 10.1177/107110070602701115; Kaufman KR, 1999, AM J SPORT MED, V27, P585, DOI 10.1177/03635465990270050701; Kirchgesner T, 2014, JOINT BONE SPINE, V81, P485, DOI 10.1016/j.jbspin.2014.03.022; Malliaras P, 2013, SPORTS MED, V43, P267, DOI 10.1007/s40279-013-0019-z; NICE Clinical Knowledge Summaries, 2010, NICE CLIN KNOWLEDGE; Tu P, 2011, AM FAM PHYSICIAN, V84, P909	11	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2016	352								i1366	10.1136/bmj.i1366	http://dx.doi.org/10.1136/bmj.i1366			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TF	27026154	Green Published			2022-12-28	WOS:000373491500002
J	Bonow, RO; Leon, MB; Doshi, D; Moat, N				Bonow, Robert O.; Leon, Martin B.; Doshi, Darshan; Moat, Neil			Valvular heart disease 1 Management strategies and future challenges for aortic valve disease	LANCET			English	Article							END-POINT DEFINITIONS; LONG-TERM OUTCOMES; HIGH-RISK PATIENTS; TRANSCATHETER VALVE; NATRIURETIC PEPTIDE; INTERMEDIATE-RISK; ELDERLY-PATIENTS; REPLACEMENT; IMPLANTATION; STENOSIS	The management of aortic valve disease has been improved by accurate diagnosis and assessment of severity by echocardiography and advanced imaging techniques, efforts to elicit symptoms or objective markers of disease severity and progression, and consideration of optimum timing of aortic valve replacement, even in elderly patients. Prevalence of calcific aortic stenosis is growing in ageing populations. Conventional surgery remains the most appropriate option for most patients who require aortic valve replacement, but the transcatheter approach is established for high-risk patients or poor candidates for surgery. The rapid growth of transcatheter aortic valve replacement has been fuelled by improved technology, evidence-based clinical research, and setting up of multidisciplinary heart teams. Aortic regurgitation can be difficult to diagnose and quantify. Left ventricular dysfunction often precedes symptoms, needing active surveillance by echocardiography to determine the optimum time for aortic valve replacement. Development of transcatheter approaches for aortic regurgitation is challenging, owing to the absence of valvular calcification and distortion of aortic root anatomy in many patients.	[Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Leon, Martin B.; Doshi, Darshan] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Moat, Neil] Royal Brompton Hosp, London SW3 6LY, England	Northwestern University; Feinberg School of Medicine; Columbia University; Royal Brompton Hospital	Bonow, RO (corresponding author), 251 East Huron St,Galter 3-150, Chicago, IL 60611 USA.	r-bonow@northwestern.edu						Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Athappan G, 2014, J AM COLL CARDIOL, V63, P2101, DOI 10.1016/j.jacc.2014.02.540; Azevedo CF, 2010, J AM COLL CARDIOL, V56, P278, DOI 10.1016/j.jacc.2009.12.074; Bach DS, 2005, ANN THORAC SURG, V80, P480, DOI 10.1016/j.athoracsur.2005.03.027; Bapat VN, 2014, JACC-CARDIOVASC INTE, V7, P115, DOI 10.1016/j.jcin.2013.10.012; Barreto JA, 2013, JAMA-J AM MED ASSOC, V310, P2078, DOI 10.1001/jama.2013.282437; BONOW RO, 1988, CIRCULATION, V78, P1108, DOI 10.1161/01.CIR.78.5.1108; Bonow RO, 2013, J AM COLL CARDIOL, V61, P693, DOI 10.1016/j.jacc.2012.08.1025; Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; BURDON TA, 1992, J THORAC CARDIOV SUR, V103, P238; CHEITLIN MD, 1979, AM HEART J, V98, P689, DOI 10.1016/0002-8703(79)90465-4; Cheung DY, 2015, EXPERT OPIN BIOL TH, V15, P1155, DOI 10.1517/14712598.2015.1051527; Clavel MA, 2014, J AM COLL CARDIOL, V64, P1202, DOI 10.1016/j.jacc.2014.05.066; Clavel MA, 2014, J AM COLL CARDIOL, V63, P2016, DOI 10.1016/j.jacc.2014.02.581; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; CRIBIER A, 1986, LANCET, V1, P63; D'Errigo P, 2013, INT J CARDIOL, V167, P1945, DOI 10.1016/j.ijcard.2012.05.028; DAVIES SW, 1991, EUR HEART J, V12, P10, DOI 10.1093/oxfordjournals.eurheartj.a059815; Dujardin KS, 1999, CIRCULATION, V99, P1851, DOI 10.1161/01.CIR.99.14.1851; Duncan A, 2015, JACC-CARDIOVASC INTE, V8, P645, DOI 10.1016/j.jcin.2015.01.009; Dunning J, 2011, J THORAC CARDIOVASC, V142, p[776, e3]; Dvir D, 2014, JAMA-J AM MED ASSOC, V312, P162, DOI 10.1001/jama.2014.7246; Fairbairn TA, 2012, HEART, V98, P18, DOI 10.1136/heartjnl-2011-300065; Gehlot A, 1996, J THORAC CARDIOV SUR, V111, P1026, DOI 10.1016/S0022-5223(96)70379-3; Genereux P, 2012, J AM COLL CARDIOL, V60, P1043, DOI 10.1016/j.jacc.2012.07.003; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Hahn RT, 2015, JACC-CARDIOVASC IMAG, V8, P288, DOI 10.1016/j.jcmg.2014.12.013; Iung B, 2011, NAT REV CARDIOL, V8, P162, DOI 10.1038/nrcardio.2010.202; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866; Kaneko T, 2015, ANN THORAC SURG, V100, P1298, DOI 10.1016/j.athoracsur.2015.04.062; Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2; Kappetein AP, 2012, EUR HEART J, V33, P2403, DOI 10.1093/eurheartj/ehs255; Kodali S, EUR HEART J IN PRESS; Kodali S, 2015, EUR HEART J, V36, P449, DOI 10.1093/eurheartj/ehu384; Lafitte S, 2009, EUR J ECHOCARDIOGR, V10, P414, DOI 10.1093/ejechocard/jen299; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lansky AJ, 2015, EUR HEART J, V36, P2070, DOI 10.1093/eurheartj/ehv191; Latib A, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001779; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Lindman BR, 2014, JACC-CARDIOVASC INTE, V7, P707, DOI 10.1016/j.jcin.2014.01.167; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Linke A, 2014, EUR HEART J, V35, P2672, DOI 10.1093/eurheartj/ehu162; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Makkar RR, 2015, NEW ENGL J MED, V373, P2015, DOI 10.1056/NEJMoa1509233; MCKAY RG, 1991, J AM COLL CARDIOL, V17, P485, DOI 10.1016/S0735-1097(10)80120-2; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Mohr FW, 2014, EUR J CARDIO-THORAC, V46, P808, DOI 10.1093/ejcts/ezu290; Myerson SG, 2012, CIRCULATION, V126, P1452, DOI 10.1161/CIRCULATIONAHA.111.083600; Nashef SAM, 2002, EUR J CARDIO-THORAC, V22, P101, DOI 10.1016/S1010-7940(02)00208-7; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Osnabrugge RLJ, 2013, J AM COLL CARDIOL, V62, P1002, DOI 10.1016/j.jacc.2013.05.015; OTTO CM, 1994, CIRCULATION, V89, P642, DOI 10.1161/01.CIR.89.2.642; Palta S, 2000, CIRCULATION, V101, P2497, DOI 10.1161/01.CIR.101.21.2497; Pettersson GB, 2008, J AM COLL CARDIOL, V52, P40, DOI 10.1016/j.jacc.2008.01.073; Piazza N, 2013, JACC-CARDIOVASC INTE, V6, P443, DOI 10.1016/j.jcin.2013.01.136; Pibarot P, 2009, CIRCULATION, V119, P1034, DOI 10.1161/CIRCULATIONAHA.108.778886; Pizarro R, 2011, J AM COLL CARDIOL, V58, P1705, DOI 10.1016/j.jacc.2011.07.016; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Reardon MJ, 2015, J AM COLL CARDIOL, V66, P113, DOI 10.1016/j.jacc.2015.05.017; Rodes-Cabau J, 2014, JACC-CARDIOVASC INTE, V7, P1146, DOI 10.1016/j.jcin.2014.04.019; Rosenhek R, 2010, CIRCULATION, V121, P151, DOI 10.1161/CIRCULATIONAHA.109.894170; Ross J Jr, 1968, Circulation, V38, P61; Roy DA, 2013, J AM COLL CARDIOL, V61, P1577, DOI 10.1016/j.jacc.2013.01.018; Seiffert M, 2014, JACC-CARDIOVASC INTE, V7, P1168, DOI 10.1016/j.jcin.2014.05.014; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Tchetche D, 2012, AM HEART J, V164, P402, DOI 10.1016/j.ahj.2012.07.003; Thourani VH, 2015, ANN THORAC SURG, V99, P55, DOI 10.1016/j.athoracsur.2014.06.050; Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014; TORNOS MP, 1995, AM HEART J, V130, P333, DOI 10.1016/0002-8703(95)90450-6; TURINA J, 1987, EUR HEART J, V8, P471, DOI 10.1093/oxfordjournals.eurheartj.a062307; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Walther T, 2015, J AM COLL CARDIOL, V65, P2173, DOI 10.1016/j.jacc.2015.03.034; Webb JG, 2015, JACC-CARDIOVASC INTE, V8, P1850, DOI 10.1016/j.jcin.2015.10.004; Webb JG, 2010, CIRCULATION, V121, P1848, DOI 10.1161/CIRCULATIONAHA.109.924613	80	53	57	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1312	1323		10.1016/S0140-6736(16)00586-9	http://dx.doi.org/10.1016/S0140-6736(16)00586-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27025437				2022-12-28	WOS:000372697500030
J	Hasenfuss, G; Hayward, C; Burkhoff, D; Silvestry, FE; McKenzie, S; Gustafsson, F; Malek, F; Van der Heyden, J; Lang, I; Petrie, MC; Cleland, JGF; Leon, M; Kaye, DM				Hasenfuss, Gerd; Hayward, Chris; Burkhoff, Dan; Silvestry, Frank E.; McKenzie, Scott; Gustafsson, Finn; Malek, Filip; Van der Heyden, Jan; Lang, Irene; Petrie, Mark C.; Cleland, John G. F.; Leon, Martin; Kaye, David M.		REDUCE LAP-HF Study Investigators	A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial	LANCET			English	Article							LEFT ATRIAL PRESSURE; EXERCISE HEMODYNAMICS; PREVALENCE; MORTALITY; POPULATION; THERAPIES; DIAGNOSIS; CAPACITY; OUTCOMES; TRENDS	Background Heart failure with preserved ejection fraction (HFPEF) is a common, globally recognised, form of heart failure for which no treatment has yet been shown to improve symptoms or prognosis. The pathophysiology of HFPEF is complex but characterised by increased left atrial pressure, especially during exertion, which might be a key therapeutic target. The rationale for the present study was that a mechanical approach to reducing left atrial pressure might be effective in HFPEF. Methods The REDUCe Elevated Left Atrial Pressure in Patients with Heart Failure (REDUCE LAP-HF) study was an open-label, single-arm, phase 1 study designed to assess the performance and safety of a transcatheter interatrial shunt device (IASD, Corvia Medical, Tewkesbury, MA, USA) in patients older than 40 years of age with symptoms of HFPEF despite pharmacological therapy, left ventricular ejection fraction higher than 40%, and a raised pulmonary capillary wedge pressure at rest (>15 mm Hg) or during exercise (>25 mm Hg). The study was done at 21 centres (all departments of cardiology in the UK, Netherlands, Belgium, France, Germany, Austria, Denmark, Australia, and New Zealand). The co-primary endpoints were the safety and performance of the IASD at 6 months, together with measures of clinical efficacy, including functional capacity and clinical status, analysed per protocol. This study is registered with ClinicalTrials.gov,number NCT01913613. Findings Between Feb 8, 2014, and June 10, 2015, 68 eligible patients were entered into the study. IASD placement was successful in 64 patients and seemed to be safe and well tolerated; no patient had a peri-procedural or major adverse cardiac or cerebrovascular event or need for cardiac surgical intervention for device-related complications during 6 months of follow-up. At 6 months, 31 (52%) of 60 patients had a reduction in pulmonary capillary wedge pressure at rest, 34 (58%) of 59 had a lower pulmonary capillary wedge pressure during exertion, and 23 (39%) of 59 fulfilled both these criteria. Mean exercise pulmonary capillary wedge pressure was lower at 6 months than at baseline, both at 20 watts workload (mean 32 mm Hg [SD 8] at baseline vs 29 mm Hg [9] at 6 months, p=0.0124) and at peak exercise (34 mm Hg [8] vs 32 [8], p=0.0255), despite increased mean exercise duration (baseline vs 6 months: 7.3 min [SD 3.1] vs 8.2 min [3.4], p=0.03). Sustained device patency at 6 months was confirmed by left-to-right shunting (pulmonary/systemic flow ratio: 1.06 [SD 0.32] at baseline vs 1.27 [0.20] at 6 months, p=0.0004). Interpretation Implantation of an interatrial shunt device is feasible, seems to be safe, reduces left atrial pressure during exercise, and could be a new strategy for the management of HFPEF. The effectiveness of IASD compared with existing treatment for patients with HFPEF requires validation in a randomised controlled trial.	[Hasenfuss, Gerd] Univ Gottingen, Ctr Heart, D-37073 Gottingen, Germany; [Hayward, Chris] St Vincents Hosp, Sydney, NSW 2010, Australia; [Burkhoff, Dan] Columbia Univ, Dept Cardiol, New York, NY USA; [Silvestry, Frank E.] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA; [McKenzie, Scott] Prince Charles Hosp, Brisbane, Qld 4032, Australia; [Gustafsson, Finn] Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Malek, Filip] Na Homolce Hosp, Prague, Czech Republic; [Van der Heyden, Jan] St Antonius Hosp, Nieuwegein, Netherlands; [Lang, Irene] Univ Kliniken, Allgemeines Krankenhaus, Vienna, Austria; [Petrie, Mark C.] Golden Jubilee Natl Hosp, Glasgow, Lanark, Scotland; [Cleland, John G. F.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England; [Cleland, John G. F.] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Natl Heart & Lung Inst, London, England; [Leon, Martin] Columbia Univ, Med Ctr, New York, NY USA; [Kaye, David M.] Alfred Hosp, Melbourne, Vic 3004, Australia; [Kaye, David M.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; St Vincents Hospital Sydney; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Prince Charles Hospital; Rigshospitalet; University of Copenhagen; Na Homolce Hospital; St. Antonius Hospital Utrecht; Golden Jubilee Hospital; Imperial College London; Royal Brompton Hospital; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Columbia University; Florey Institute of Neuroscience & Mental Health; Baker Heart and Diabetes Institute	Kaye, DM (corresponding author), Alfred Hosp, Dept Cardiol, Commercial Rd, Melbourne, Vic 3004, Australia.	david.kaye@bakeridi.edu.au	Málek, Filip/ABI-1453-2020; Cleland, John G./AAZ-4185-2020; Kaye, David/AAF-1202-2021	Cleland, John G./0000-0002-1471-7016; Kaye, David/0000-0003-4058-0372; Gustafsson, Finn/0000-0003-2144-341X; Lang, Irene/0000-0003-0485-2692	Corvia Medical Inc.; National Institute for Health Research [NF-SI-0611-10227] Funding Source: researchfish	Corvia Medical Inc.; National Institute for Health Research(National Institute for Health Research (NIHR))	Corvia Medical Inc.	Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Borlaug BA, 2006, CIRCULATION, V114, P2138, DOI 10.1161/CIRCULATIONAHA.106.632745; Borlaug BA, 2015, J AM COLL CARDIOL, V66, P1672, DOI 10.1016/j.jacc.2015.07.067; Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701; Butler J, 2014, JACC-HEART FAIL, V2, P97, DOI 10.1016/j.jchf.2013.10.006; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Dorfs S, 2014, EUR HEART J, V35, P3103, DOI 10.1093/eurheartj/ehu315; Gori M, 2014, EUR HEART J, V35, P3442, DOI 10.1093/eurheartj/ehu254; Hamdani N, 2013, CIRC-HEART FAIL, V6, P1239, DOI 10.1161/CIRCHEARTFAILURE.113.000539; Hasenfuss G, 2015, J CARD FAIL, V21, P594, DOI 10.1016/j.cardfail.2015.05.008; Kaye D, 2014, J CARD FAIL, V20, P212, DOI 10.1016/j.cardfail.2014.01.005; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Lutembacher R., 1916, ARCH MAL COEUR VAISS, V9, P237; Maeder MT, 2010, J AM COLL CARDIOL, V56, P855, DOI 10.1016/j.jacc.2010.04.040; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Poole DC, 2012, AM J PHYSIOL-HEART C, V302, pH1050, DOI 10.1152/ajpheart.00943.2011; Redfield MM, 2015, NEW ENGL J MED, V373, P2314, DOI 10.1056/NEJMoa1510774; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Sondergaard L, 2014, EUR J HEART FAIL, V16, P796, DOI 10.1002/ejhf.111; Steinberg BA, 2012, CIRCULATION, V126, P65, DOI 10.1161/CIRCULATIONAHA.111.080770; Tan YT, 2009, J AM COLL CARDIOL, V54, P36, DOI 10.1016/j.jacc.2009.03.037; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	28	168	187	1	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1298	1304		10.1016/S0140-6736(16)00704-2	http://dx.doi.org/10.1016/S0140-6736(16)00704-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27025436	Green Accepted, Green Submitted			2022-12-28	WOS:000372697500028
J	Hosseinipour, MC; Bisson, GP; Miyahara, S; Sun, X; Moses, A; Riviere, C; Kirui, FK; Badal-Faesen, S; Lagat, D; Nyirenda, M; Naidoo, K; Hakim, J; Mugyenyi, P; Henostroza, G; Leger, PD; Lama, JR; Mohapi, L; Alave, J; Mave, V; Veloso, VG; Pillay, S; Kumarasamy, N; Bao, J; Hogg, E; Jones, L; Zolopa, A; Kumwenda, J; Gupta, A				Hosseinipour, Mina C.; Bisson, Gregory P.; Miyahara, Sachiko; Sun, Xin; Moses, Agnes; Riviere, Cynthia; Kirui, Fredrick K.; Badal-Faesen, Sharlaa; Lagat, David; Nyirenda, Mulinda; Naidoo, Kogieleum; Hakim, James; Mugyenyi, Peter; Henostroza, German; Leger, Paul D.; Lama, Javier R.; Mohapi, Lerato; Alave, Jorge; Mave, Vidya; Veloso, Valdilea G.; Pillay, Sandy; Kumarasamy, Nagalingeswaran; Bao, Jing; Hogg, Evelyn; Jones, Lynne; Zolopa, Andrew; Kumwenda, Johnstone; Gupta, Amita		AIDS Clinical Trials Grp A5274	Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial	LANCET			English	Article							PREVENTIVE THERAPY; INFECTED ADULTS; XPERT MTB/RIF; DOUBLE-BLIND; SETTINGS; AFRICA; INDIVIDUALS; MORTALITY; ACCURACY; INCOME	Background Mortality within the first 6 months after initiating antiretroviral therapy is common in resource-limited settings and is often due to tuberculosis in patients with advanced HIV disease. Isoniazid preventive therapy is recommended in HIV-positive adults, but subclinical tuberculosis can be difficult to diagnose. We aimed to assess whether empirical tuberculosis treatment would reduce early mortality compared with isoniazid preventive therapy in high-burden settings. Methods We did a multicountry open-label randomised clinical trial comparing empirical tuberculosis therapy with isoniazid preventive therapy in HIV-positive outpatients initiating antiretroviral therapy with CD4 cell counts of less than 50 cells per mu L. Participants were recruited from 18 outpatient research clinics in ten countries (Malawi, South Africa, Haiti, Kenya, Zambia, India, Brazil, Zimbabwe, Peru, and Uganda). Individuals were screened for tuberculosis using a symptom screen, locally available diagnostics, and the GeneXpert MTB/RIF assay when available before inclusion. Study candidates with confirmed or suspected tuberculosis were excluded. Inclusion criteria were liver function tests 2.5 times the upper limit of normal or less, a creatinine clearance of at least 30 mL/min, and a Karnofsky score of at least 30. Participants were randomly assigned (1:1) to either the empirical group (antiretroviral therapy and empirical tuberculosis therapy) or the isoniazid preventive therapy group (antiretroviral therapy and isoniazid preventive therapy). The primary endpoint was survival (death or unknown status) at 24 weeks after randomisation assessed in the intention-to-treat population. Kaplan-Meier estimates of the primary endpoint across groups were compared by the z-test. All participants were included in the safety analysis of antiretroviral therapy and tuberculosis treatment. This trial is registered with ClinicalTrials.gov, number NCT01380080. Findings Between Oct 31, 2011, and June 9, 2014, we enrolled 850 participants. Of these, we randomly assigned 424 to receive empirical tuberculosis therapy and 426 to the isoniazid preventive therapy group. The median CD4 cell count at baseline was 18 cells per mu L (IQR 9-32). At week 24, 22 (5%) participants from each group died or were of unknown status (95% CI 3.5-7.8) for empirical group and for isoniazid preventive therapy (95% CI 3.4-7.8); absolute risk difference of -0.06% (95% CI -3.05 to 2.94). Grade 3 or 4 signs or symptoms occurred in 50 (12%) participants in the empirical group and 46 (11%) participants in the isoniazid preventive therapy group. Grade 3 or 4 laboratory abnormalities occurred in 99 (23%) participants in the empirical group and 97 (23%) participants in the isoniazid preventive therapy group. Interpretation Empirical tuberculosis therapy did not reduce mortality at 24 weeks compared with isoniazid preventive therapy in outpatient adults with advanced HIV disease initiating antiretroviral therapy. The low mortality rate of the trial supports implementation of systematic tuberculosis screening and isoniazid preventive therapy in outpatients with advanced HIV disease.	[Hosseinipour, Mina C.; Moses, Agnes] UNC Project, Lilongwe, Malawi; [Hosseinipour, Mina C.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Bisson, Gregory P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Miyahara, Sachiko; Sun, Xin] Harvard Univ, Boston, MA 02115 USA; [Riviere, Cynthia; Leger, Paul D.] GHESKIO, Port Av Prince, Haiti; [Kirui, Fredrick K.] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Badal-Faesen, Sharlaa] Univ Witwatersrand, Dept Med, Clin HIV Res Unit, ZA-2001 Johannesburg, South Africa; [Mohapi, Lerato] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Lagat, David] Moi Univ, Sch Med, Eldoret, Kenya; [Nyirenda, Mulinda; Kumwenda, Johnstone] Johns Hopkins Project, Blantyre, Malawi; [Naidoo, Kogieleum] Ctr AIDS Programme Res South Africa, Durban, South Africa; [Hakim, James] Univ Zimbabwe, Harare, Zimbabwe; [Mugyenyi, Peter] Joint Clin Res Ctr, Kampala, Uganda; [Henostroza, German] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Lama, Javier R.; Alave, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Mave, Vidya] BJ Med Coll, Johns Hopkins Clin Trials Unit, Pune, Maharashtra, India; [Veloso, Valdilea G.] Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, BR-21045900 Rio De Janeiro, Brazil; [Pillay, Sandy] Durban Univ Technol, Durban Int CRS, Durban, South Africa; [Kumarasamy, Nagalingeswaran] VHS, YRGCARE Med Ctr, Madras, Tamil Nadu, India; [Bao, Jing] NIAID, HJF DAIDS, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hogg, Evelyn] Social & Sci Syst, Silver Spring, MD USA; [Jones, Lynne] Frontier Sci, Buffalo, NY USA; [Zolopa, Andrew] Stanford Univ, Palo Alto, CA 94304 USA; [Gupta, Amita] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Kenya Medical Research Institute; University of Witwatersrand; University of Witwatersrand; Moi University; University of Malawi; University of Zimbabwe; Joint Clinic Research Center - United Arab Emirates; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Fundacao Oswaldo Cruz; Durban University of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Social & Scientific Systems; Stanford University; Johns Hopkins University	Hosseinipour, MC (corresponding author), Tidziwe Ctr, UNC Project, Lilongwe, Malawi.	mina_hosseinipour@med.unc.edu	Kumarasasmy, Nagalingeswaran/AAB-7348-2021; Alave, Jorge/GSN-3726-2022	Alave, Jorge/0000-0002-1178-2445; Naidoo, Kogieleum/0000-0002-8874-6661; Matoga, Mitch/0000-0002-6542-8193; padayatchi, nesri/0000-0003-2543-9071; Nyirenda, Mulinda/0000-0003-2037-7449; Gupta, Amita/0000-0001-7036-2718; Wallis, Carole/0000-0001-8408-8772; MONTALBAN, ESMELDA/0000-0002-7613-2857	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [UM1 AI068634, UM1 AI068636, UM1 AI106701]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HH-SN272200800014C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069476, UM1AI069534, UM1AI106701, UM1AI069518, UM1AI069469, UM1AI108568, UM1AI069463, UM1AI068634, UM1AI069436, UM1AI069453, UM1AI068636] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Presented in part at the 8th IAS on HIV Pathogenesis Treatment and Prevention Conference, Vancouver Canada, July 18-22, 2015. Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers UM1 AI068634, UM1 AI068636, and UM1 AI106701. JB was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services (contract number HH-SN272200800014C). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Pharmaceutical support was provided by Gilead Sciences, but Gilead had no influence in the study design or the analysis of the data.	Akolo C., 2010, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD000171.PUB3); Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Charalambous S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000391010.02774.6f; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Cox HS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001760; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Fenner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077697; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055824; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Houben RMGJ, 2014, P NATL ACAD SCI USA, V111, P5325, DOI 10.1073/pnas.1317660111; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Koenig SP, 2009, CLIN INFECT DIS, V48, P829, DOI 10.1086/597098; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Singhal Sameer, 2011, Indian J Tuberc, V58, P108; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; UNAIDS, 2015, FACT SHEET; World Health Organization, 2016, CONS GUID US ANT DRU	30	52	54	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1198	1209		10.1016/S0140-6736(16)00546-8	http://dx.doi.org/10.1016/S0140-6736(16)00546-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	27025337	Green Accepted, Green Submitted			2022-12-28	WOS:000372412000031
J	Puchta, O; Cseke, B; Czaja, H; Tollervey, D; Sanguinetti, G; Kudla, G				Puchta, Olga; Cseke, Botond; Czaja, Hubert; Tollervey, David; Sanguinetti, Guido; Kudla, Grzegorz			Network of epistatic interactions within a yeast snoRNA	SCIENCE			English	Article							RNA-POLYMERASE-II; FITNESS LANDSCAPE; SACCHAROMYCES-CEREVISIAE; HIGH-RESOLUTION; EVOLUTION; SYSTEMS; GENE; PROTEINS	Epistatic interactions play a fundamental role in molecular evolution, but little is known about the spatial distribution of these interactions within genes. To systematically survey a model landscape of intragenic epistasis, we quantified the fitness of similar to 60,000 Saccharomyces cerevisiae strains expressing randomly mutated variants of the 333-nucleotide-long U3 small nucleolar RNA (snoRNA). The fitness effects of individual mutations were correlated with evolutionary conservation and structural stability. Many mutations had small individual effects but had large effects in the context of additional mutations, which indicated negative epistasis. Clusters of negative interactions were explained by local thermodynamic threshold effects, whereas positive interactions were enriched among large-effect sites and between base-paired nucleotides. We conclude that high-throughput mapping of intragenic epistasis can identify key structural and functional features of macromolecules.	[Puchta, Olga; Kudla, Grzegorz] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Cseke, Botond; Sanguinetti, Guido] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland; [Czaja, Hubert] Scott Tiger SA, Warsaw, Poland; [Tollervey, David; Sanguinetti, Guido] Univ Edinburgh, Ctr Synthet & Syst Biol, SynthSys, Edinburgh, Midlothian, Scotland; [Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Cseke, Botond] Microsoft Res Cambridge, Cambridge, England	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; Microsoft	Kudla, G (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	gkudla@gmail.com	Tollervey, David/AAR-6662-2020	Tollervey, David/0000-0003-2894-2772; Kudla, Grzegorz/0000-0002-7924-2744	Wellcome Trust [097383, 077248]; U.K. Medical Research Council; European Research Council [MLCS306999]; MRC [MC_UU_12018/23] Funding Source: UKRI; Medical Research Council [MC_UU_12018/23] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank B. Charlesworth, A. DeLuna, J. Plotkin, C. Schneider, and J. Zhang for discussions; E. Wacker and A. Gallacher for technical assistance; M. Bartosovic for computational help; and Edinburgh Genomics, Edinburgh Clinical Research Facility, and Institute of Genetics and Molecular Medicine technical support for next-generation sequencing. The sequencing and barcode count data were deposited in GEO (accession number GSE77709), and the data modeling pipeline can be found on https://github.com/terembura/EpistaticInteractionsYeastU3. G.K. and O.P. designed the project; O.P. performed experiments; O.P., B. C., H.C., D.T., G.S., and G.K. analyzed the data; B. C. and G.S. designed and B. C. implemented the data modeling pipeline; and G.K. wrote the manuscript with input from other coauthors. O.P. and G.K. were supported by Wellcome Trust grant 097383 and by the U.K. Medical Research Council, D.T. was supported by Wellcome Trust grant 077248, G.S. was supported by the European Research Council grant MLCS306999.	Bank C, 2015, MOL BIOL EVOL, V32, P229, DOI 10.1093/molbev/msu301; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Braberg H, 2013, CELL, V154, P775, DOI 10.1016/j.cell.2013.07.033; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Davis BH, 2009, P R SOC B, V276, P1823, DOI 10.1098/rspb.2008.1846; de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744; Dutca LM, 2011, NUCLEIC ACIDS RES, V39, P5164, DOI 10.1093/nar/gkr044; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Jimenez JI, 2013, P NATL ACAD SCI USA, V110, P14984, DOI 10.1073/pnas.1307604110; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Li C, 2016, SCIENCE, V352, P837, DOI 10.1126/science.aae0568; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Meer MV, 2010, NATURE, V464, P279, DOI 10.1038/nature08691; Otwinowski J, 2014, P NATL ACAD SCI USA, V111, pE2301, DOI 10.1073/pnas.1400849111; Otwinowski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061570; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Podgornaia AI, 2015, SCIENCE, V347, P673, DOI 10.1126/science.1257360; Samarsky DA, 1998, MOL CELL BIOL, V18, P3431, DOI 10.1128/MCB.18.6.3431; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97	23	63	64	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					840	844		10.1126/science.aaf0965	http://dx.doi.org/10.1126/science.aaf0965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27080103	Green Accepted			2022-12-28	WOS:000375663000045
J	Sutikna, T; Tocheri, MW; Morwood, MJ; Saptomo, EW; Jatmiko; Awe, RD; Wasisto, S; Westaway, KE; Aubert, M; Li, B; Zhao, JX; Storey, M; Alloway, BV; Morley, MW; Meijer, HJM; van den Bergh, GD; Grun, R; Dosseto, A; Brumm, A; Jungers, WL; Roberts, RG				Sutikna, Thomas; Tocheri, Matthew W.; Morwood, Michael J.; Saptomo, E. Wahyu; Jatmiko; Awe, Rokus Due; Wasisto, Sri; Westaway, Kira E.; Aubert, Maxime; Li, Bo; Zhao, Jian-xin; Storey, Michael; Alloway, Brent V.; Morley, Mike W.; Meijer, Hanneke J. M.; van den Bergh, Gerrit D.; Gruen, Rainer; Dosseto, Anthony; Brumm, Adam; Jungers, William L.; Roberts, Richard G.			Revised stratigraphy and chronology for Homo floresiensis at Liang Bua in Indonesia	NATURE			English	Article							LATE PLEISTOCENE; HUMAN OCCUPATION; NORTHERN AUSTRALIA; SOUTHEAST-ASIA; HOMININ; LUMINESCENCE; FELDSPAR; AGE; ARCHAEOLOGY; SITE		[Sutikna, Thomas; Morwood, Michael J.; Saptomo, E. Wahyu; Jatmiko; Awe, Rokus Due; Li, Bo; Alloway, Brent V.; Morley, Mike W.; van den Bergh, Gerrit D.; Roberts, Richard G.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Sutikna, Thomas; Saptomo, E. Wahyu; Jatmiko; Awe, Rokus Due; Wasisto, Sri] Pusat Penelitian Arkeol Nas, Jakarta 12510, Indonesia; [Tocheri, Matthew W.] Lakehead Univ, Dept Anthropol, Thunder Bay, ON P7B 5E1, Canada; [Tocheri, Matthew W.; Meijer, Hanneke J. M.] Smithsonian Inst, Dept Anthropol, Human Origins Program, Natl Museum Nat Hist, Washington, DC 20013 USA; [Westaway, Kira E.] Macquarie Univ, Dept Environm Sci, Traps MQ Luminescence Dating Facil, Sydney, NSW 2109, Australia; [Aubert, Maxime] Griffith Univ, Pl Evolut & Rock Art Heritage Unit, Res Ctr Human Evolut, Gold Coast, Qld 4222, Australia; [Aubert, Maxime; Brumm, Adam] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; [Zhao, Jian-xin] Univ Queensland, Sch Earth Sci, Brisbane, Qld 4072, Australia; [Storey, Michael] Nat Hist Museum Denmark, Sect Earth & Planetary Syst Sci, QUADLAB, DK-1350 Copenhagen, Denmark; [Alloway, Brent V.] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington 6012, New Zealand; [Meijer, Hanneke J. M.] Univ Bergen, Univ Museum Bergen, Dept Nat Hist, N-5007 Bergen, Norway; [Gruen, Rainer; Brumm, Adam] Griffith Univ, Environm Futures Res Inst, Res Ctr Human Evolut, Brisbane, Qld 4111, Australia; [Gruen, Rainer] Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia; [Dosseto, Anthony] Univ Wollongong, Sch Earth & Environm Sci, GeoQuEST Res Ctr, Wollongong, NSW 2522, Australia; [Jungers, William L.] SUNY Stony Brook, Med Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA; [Jungers, William L.] Assoc Vahatra, BP 3972, Antananarivo 101, Madagascar	University of Wollongong; Lakehead University; Smithsonian Institution; Smithsonian National Museum of Natural History; Macquarie University; Griffith University; University of Wollongong; University of Queensland; Victoria University Wellington; University of Bergen; Griffith University; Australian National University; University of Wollongong; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sutikna, T; Roberts, RG (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.; Sutikna, T (corresponding author), Pusat Penelitian Arkeol Nas, Jakarta 12510, Indonesia.; Tocheri, MW (corresponding author), Lakehead Univ, Dept Anthropol, Thunder Bay, ON P7B 5E1, Canada.; Tocheri, MW (corresponding author), Smithsonian Inst, Dept Anthropol, Human Origins Program, Natl Museum Nat Hist, Washington, DC 20013 USA.	thomasutikna@gmail.com; tocherim@gmail.com; rgrob@uow.edu.au	Roberts, Richard Graham/B-8245-2013; Dosseto, Anthony/A-2543-2008; Tocheri, Matthew/H-8851-2019; Grun, Rainer/A-1437-2012; Aubert, Maxime/AAT-6198-2020; Meijer, Hanneke J.M./A-1912-2013; Zhao, Jian-xin/A-5938-2008; van den Bergh, Gerrit D/I-7670-2016; Sutikna, Thomas/C-4709-2018; Li, Bo/B-8974-2016	Roberts, Richard Graham/0000-0002-0128-4119; Dosseto, Anthony/0000-0002-3575-0106; Tocheri, Matthew/0000-0001-7600-8998; Grun, Rainer/0000-0003-1366-3674; Aubert, Maxime/0000-0002-4189-531X; Meijer, Hanneke J.M./0000-0001-7066-6869; Zhao, Jian-xin/0000-0002-2413-6178; van den Bergh, Gerrit Dirk/0000-0003-1507-3336; Sutikna, Thomas/0000-0002-9742-4226; Westaway, Kira/0000-0001-5315-778X; Storey, Michael/0000-0002-3126-4637; Morley, Mike/0000-0001-7730-9637; Li, Bo/0000-0003-4186-4828	Australian Research Council (ARC) [DP0770234]; Waitt Foundation/National Geographic Society [2121-2]; Smithsonian Scholarly Studies Program; Peter Buck Fund for Human Origins Research; Smithsonian's Human Origins Program; University of Wollongong (UOW); ARC [DP1093049, DE140100254, DE130101560, FT14010038]; UOW postgraduate scholarship; Canada Research Chair; ARC Australian Laureate Fellowship [FL130100116]; Victoria University of Wellington Science Faculty Research Grant [201255]; Villum Foundation; Villum Fonden [00007408] Funding Source: researchfish	Australian Research Council (ARC)(Australian Research Council); Waitt Foundation/National Geographic Society; Smithsonian Scholarly Studies Program(Smithsonian Institution); Peter Buck Fund for Human Origins Research; Smithsonian's Human Origins Program; University of Wollongong (UOW); ARC(Australian Research Council); UOW postgraduate scholarship; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); ARC Australian Laureate Fellowship(Australian Research Council); Victoria University of Wellington Science Faculty Research Grant; Villum Foundation(Villum Fonden); Villum Fonden(Villum Fonden)	The 2007-2014 excavations at Liang Bua were supported by an Australian Research Council (ARC) Discovery Project grant to M.J.M. (DP0770234), a Waitt Foundation/National Geographic Society grant to M.W.T. and T.S. (No. 2121-2) and a Smithsonian Scholarly Studies Program award to M.W.T. Additional funding was provided by the Peter Buck Fund for Human Origins Research, the Smithsonian's Human Origins Program, the University of Wollongong (UOW) and the ARC (DP1093049 to K.E.W.). T.S. is supported by a UOW postgraduate scholarship, M.W.T. by a Canada Research Chair, M.A. and A.B. by ARC Discovery Early Career Researcher Awards (DE140100254 and DE130101560, respectively), B.L. by an ARC Future Fellowship (FT14010038), R.G.R. by an ARC Australian Laureate Fellowship (FL130100116) and B.V.A. by a Victoria University of Wellington Science Faculty Research Grant (201255). QUADLAB is funded by the Villum Foundation. Fieldwork was authorised by Pusat Penelitian Arkeologi Nasional (Jakarta, Indonesia) and Pemerintah Daerah Kabupaten Manggarai (Flores, Nusa Tenggara Timur). We also thank I Made Geria, V.N. Sene, R. Potts, P. Goldberg, K. Douka, G. Veatch, V. Rossi, A. Metallo, L. Kinsley, Y. Jafari, T. Lachlan, A. D. Nguyen, D. Yurnaldi, R. Setiawan, I Dewa Kompiang and the entire Liang Bua Team from Teras, Golo Manuk and Bere.	Aitken M.J., 1998, INTRO OPTICAL DATING; Alloway BV, 2004, EARTH PLANET SC LETT, V227, P121, DOI 10.1016/j.epsl.2004.08.014; Auclair M, 2003, RADIAT MEAS, V37, P487, DOI 10.1016/S1350-4487(03)00018-0; Bird MI, 1999, RADIOCARBON, V41, P127, DOI 10.1017/S0033822200019482; Botter-Jensen L, 2003, RADIAT MEAS, V37, P535, DOI 10.1016/S1350-4487(03)00020-9; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Clark TR, 2014, GEOCHIM COSMOCHIM AC, V138, P57, DOI 10.1016/j.gca.2014.04.022; Clarkson C, 2015, J HUM EVOL, V83, P46, DOI 10.1016/j.jhevol.2015.03.014; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Eggins SM, 2005, QUATERNARY SCI REV, V24, P2523, DOI 10.1016/j.quascirev.2005.07.006; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Franklin AD, 2000, RADIAT MEAS, V32, P633, DOI 10.1016/S1350-4487(00)00050-0; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Grun R, 2014, PALAEOGEOGR PALAEOCL, V416, P150, DOI 10.1016/j.palaeo.2014.07.023; Grun R, 1998, J HUM EVOL, V34, P555, DOI 10.1006/jhev.1997.0211; HEINRICH KFJ, 1991, ELECTRON PROBE QUANTITATION, P9; Hellstrom J, 2015, J ARCHAEOL SCI, V56, P32, DOI 10.1016/j.jas.2015.02.032; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Huntley D.J., 2001, ANCIENT TL, V19, P43; Huntley DJ, 2001, CAN J EARTH SCI, V38, P1093, DOI 10.1139/e01-013; Jacobs Z, 2015, J ARCHAEOL SCI, V63, P175, DOI 10.1016/j.jas.2015.01.023; Jochum KP, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001060; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; Kaifu Y, 2011, J HUM EVOL, V61, P644, DOI 10.1016/j.jhevol.2011.08.008; Larson SG, 2007, J HUM EVOL, V53, P718, DOI 10.1016/j.jhevol.2007.06.003; Lee JY, 2006, GEOCHIM COSMOCHIM AC, V70, P4507, DOI 10.1016/j.gca.2006.06.1563; Li B, 2014, GEOCHRONOMETRIA, V41, P178, DOI 10.2478/s13386-013-0160-3; Li B, 2013, QUAT GEOCHRONOL, V17, P1, DOI 10.1016/j.quageo.2013.03.006; Li B, 2011, QUAT GEOCHRONOL, V6, P468, DOI 10.1016/j.quageo.2011.05.001; Ludwig K.R., 2012, USERS MANUAL ISOPLOT; Meijer HJM, 2013, J VERTEBR PALEONTOL, V33, P877, DOI 10.1080/02724634.2013.746941; Moore MW, 2009, J HUM EVOL, V57, P503, DOI 10.1016/j.jhevol.2008.10.006; Morwood MJ, 2009, J HUM EVOL, V57, P437, DOI 10.1016/j.jhevol.2009.07.003; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Neudorf CM, 2012, RADIAT MEAS, V47, P696, DOI 10.1016/j.radmeas.2012.04.005; Orr CM, 2013, J HUM EVOL, V64, P109, DOI 10.1016/j.jhevol.2012.10.003; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rivera TA, 2013, CHEM GEOL, V345, P87, DOI 10.1016/j.chemgeo.2013.02.021; Roberts RG, 2009, J HUM EVOL, V57, P484, DOI 10.1016/j.jhevol.2009.01.003; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Roberts RG, 2015, J ARCHAEOL SCI, V56, P41, DOI 10.1016/j.jas.2015.02.028; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Sambridge M, 2012, QUAT GEOCHRONOL, V9, P42, DOI 10.1016/j.quageo.2012.02.010; Storey M, 2012, P NATL ACAD SCI USA, V109, P18684, DOI 10.1073/pnas.1208178109; Thiel C, 2011, QUATERN INT, V234, P23, DOI 10.1016/j.quaint.2010.05.018; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; van den Bergh GD, 2009, J HUM EVOL, V57, P527, DOI 10.1016/j.jhevol.2008.08.015; Van den Bergh GD, 2016, NATURE, V529, P208, DOI 10.1038/nature16448; Westaway KE, 2007, QUAT GEOCHRONOL, V2, P337, DOI 10.1016/j.quageo.2006.03.015; Westaway KE, 2009, QUATERNARY SCI REV, V28, P2897, DOI 10.1016/j.quascirev.2009.07.020; Westaway KE, 2009, RADIAT MEAS, V44, P462, DOI 10.1016/j.radmeas.2009.06.001; Westaway KE, 2006, QUATERNARY SCI REV, V25, P2513, DOI 10.1016/j.quascirev.2005.06.010; Wood R, 2015, J ARCHAEOL SCI, V56, P61, DOI 10.1016/j.jas.2015.02.019; Zhao JX, 2009, QUAT GEOCHRONOL, V4, P423, DOI 10.1016/j.quageo.2009.01.012; Zhou HY, 2011, J QUATERNARY SCI, V26, P781, DOI 10.1002/jqs.1506	63	139	145	6	141	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					366	+		10.1038/nature17179	http://dx.doi.org/10.1038/nature17179			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ7WU	27027286	Green Submitted			2022-12-28	WOS:000374424700031
J	Anderson, MA; Burda, JE; Ren, YL; Ao, Y; O'Shea, TM; Kawaguchi, R; Coppola, G; Khakh, BS; Deming, TJ; Sofroniew, MV				Anderson, Mark A.; Burda, Joshua E.; Ren, Yilong; Ao, Yan; O'Shea, Timothy M.; Kawaguchi, Riki; Coppola, Giovanni; Khakh, Baljit S.; Deming, Timothy J.; Sofroniew, Michael V.			Astrocyte scar formation aids central nervous system axon regeneration	NATURE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; CELL-ADHESION MOLECULES; SPINAL-CORD; NEURITE OUTGROWTH; REACTIVE ASTROCYTES; GUIDANCE MOLECULE; LOCAL-DELIVERY; MESSENGER-RNA; SENSORY AXONS; TENASCIN-C	Transected axons fail to regrow in the mature central nervous system. Astrocytic scars are widely regarded as causal in this failure. Here, using three genetically targeted loss-of-function manipulations in adult mice, we show that preventing astrocyte scar formation, attenuating scar-forming astrocytes, or ablating chronic astrocytic scars all failed to result in spontaneous regrowth of transected corticospinal, sensory or serotonergic axons through severe spinal cord injury (SCI) lesions. By contrast, sustained local delivery via hydrogel depots of required axon-specific growth factors not present in SCI lesions, plus growth-activating priming injuries, stimulated robust, laminin-dependent sensory axon regrowth past scar-forming astrocytes and inhibitory molecules in SCI lesions. Preventing astrocytic scar formation significantly reduced this stimulated axon regrowth. RNA sequencing revealed that astrocytes and non-astrocyte cells in SCI lesions express multiple axon-growth-supporting molecules. Our findings show that contrary to the prevailing dogma, astrocyte scar formation aids rather than prevents central nervous system axon regeneration.	[Anderson, Mark A.; Burda, Joshua E.; Ren, Yilong; Ao, Yan; O'Shea, Timothy M.; Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Kawaguchi, Riki; Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Kawaguchi, Riki; Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Deming, Timothy J.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Deming, Timothy J.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Anderson, Mark A.] Swiss Fed Inst Technol EPFL, Sch Life Sci, SV BMI UPCourtine, Stn 19, CH-1015 Lausanne, Switzerland; [Ren, Yilong] Tongji Univ, Sch Med, Tongji Hosp, Dept Spine Surg, Shanghai 200065, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Tongji University	Sofroniew, MV (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	sofroniew@mednet.ucla.edu	Kawaguchi, Riki/AAV-6090-2020; Sofroniew, Michael/ABE-8857-2020	Deming, Timothy/0000-0002-0594-5025	US National Institutes of Health [NS057624, NS084030, P30 NS062691, NS060677, MH099559A, MH104069]; Dr. Miriam and Sheldon G. Adelson Medical Foundation; Wings for Life; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH104069, R01MH099559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057624, R01NS060677, R01NS084030, P30NS062691] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Foundation; Wings for Life; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. W. Bergles for the NG2 antibody, and the Microscopy Core Resource of the UCLA Broad Stem Cell Research Center-CIRM Laboratory. This work was supported by the US National Institutes of Health (NS057624 and NS084030 to M.V.S.; P30 NS062691 to G.C. and NS060677, MH099559A, MH104069 to B.S.K.), and the Dr. Miriam and Sheldon G. Adelson Medical Foundation (M.V.S. and T.J.D.), and Wings for Life (M.V.S.).	Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; Becker CG, 2003, J NEUROSCI, V23, P6232; Blesch A, 1999, J NEUROSCI, V19, P3556; Blesch A, 2003, J COMP NEUROL, V467, P403, DOI 10.1002/cne.10934; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cajal RS., 1928, DEGENERATION REGENER; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edwards TJ, 2014, CELL REP, V8, P272, DOI 10.1016/j.celrep.2014.06.008; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Gotz B, 1996, J CELL BIOL, V132, P681, DOI 10.1083/jcb.132.4.681; Grill R, 1997, J NEUROSCI, V17, P5560; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hill JJ, 2012, P NATL ACAD SCI USA, V109, P9155, DOI 10.1073/pnas.1205697109; Horie H, 1999, J NEUROSCI, V19, P9964; Hossain-Ibrahim MK, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-80; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Hurtado A, 2008, BRAIN, V131, P2596, DOI 10.1093/brain/awn206; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Jiang R, 2014, JOVE-J VIS EXP, DOI 10.3791/51972; Kajiwara Y, 2009, BIOL PSYCHIAT, V66, P918, DOI 10.1016/j.biopsych.2009.05.033; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Lee JK, 2010, J NEUROSCI, V30, P10899, DOI 10.1523/JNEUROSCI.2269-10.2010; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Lu P, 2007, EXP NEUROL, V203, P8, DOI 10.1016/j.expneurol.2006.07.030; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malin D, 2009, J CELL SCI, V122, P995, DOI 10.1242/jcs.040378; MASON CA, 1988, J NEUROSCI, V8, P3124; Masuda T, 2008, J NEUROSCI, V28, P10380, DOI 10.1523/JNEUROSCI.1926-08.2008; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miller GM, 2015, EXP NEUROL, V274, P115, DOI 10.1016/j.expneurol.2015.08.015; Minor K, 2008, NEUROBIOL DIS, V32, P88, DOI 10.1016/j.nbd.2008.06.009; Mironova YA, 2013, TRENDS NEUROSCI, V36, P363, DOI 10.1016/j.tins.2013.04.003; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257; Nakanishi K, 2006, J BIOL CHEM, V281, P24970, DOI 10.1074/jbc.M601498200; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Omura T, 2015, NEURON, V86, P1215, DOI 10.1016/j.neuron.2015.05.005; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Qin JZ, 2014, J NEUROSCI, V34, P10311, DOI 10.1523/JNEUROSCI.5128-13.2014; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Sango K, 2003, EXP NEUROL, V182, P1, DOI 10.1016/S0014-4886(03)00090-6; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Shih CH, 2014, J NEUROSCI, V34, P2438, DOI 10.1523/JNEUROSCI.2947-13.2014; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; Takeda K, 1998, J IMMUNOL, V161, P4652; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tselnicker IF, 2014, BIOCHEM SOC T, V42, P1263, DOI 10.1042/BST20140166; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; White RE, 2008, EXP NEUROL, V214, P10, DOI 10.1016/j.expneurol.2008.06.012; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; WINDLE WF, 1956, PHYSIOL REV, V36, P427, DOI 10.1152/physrev.1956.36.4.427; WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang SS, 2015, ACS BIOMATER SCI ENG, V1, P705, DOI 10.1021/acsbiomaterials.5b00153; Zhang S, 2014, BIOMATERIALS, V35, P1989, DOI 10.1016/j.biomaterials.2013.11.005; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	103	1015	1052	19	529	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					195	+		10.1038/nature17623	http://dx.doi.org/10.1038/nature17623			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27027288	Green Accepted, Green Submitted			2022-12-28	WOS:000374415100031
J	Kamerow, D				Kamerow, Douglas			HPV vaccine: effective but underused in the US	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Robert Graham Ctr Policy Studies Primary Care, Washington, DC USA; [Kamerow, Douglas] Georgetown Univ, Washington, DC 20057 USA	Georgetown University	Kamerow, D (corresponding author), Robert Graham Ctr Policy Studies Primary Care, Washington, DC USA.; Kamerow, D (corresponding author), Georgetown Univ, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Markowitz LE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1968; MCCARTHY M, 2014, BMJ-BRIT MED J, V349, P69751, DOI DOI 10.1136/BMJ.G4877; Smith LM, 2015, CAN MED ASSOC J, V187, pE74, DOI 10.1503/cmaj.140900; Stokley S, 2014, MMWR-MORBID MORTAL W, V63, P620	4	1	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2016	353								i2060	10.1136/bmj.i2060	http://dx.doi.org/10.1136/bmj.i2060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EU	27081105				2022-12-28	WOS:000374375500004
J	Khurana, E				Khurana, Ekta			CANCER GENOMICS Hard-to-reach repairs	NATURE			English	Editorial Material							TERT PROMOTER MUTATIONS; MELANOMA		[Khurana, Ekta] Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY 10065 USA; [Khurana, Ekta] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	Cornell University; Cornell University	Khurana, E (corresponding author), Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY 10065 USA.; Khurana, E (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.	ekk2003@med.cornell.edu						Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173	11	3	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					181	182		10.1038/532181a	http://dx.doi.org/10.1038/532181a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075092				2022-12-28	WOS:000374415100025
J	Nandhagopal, R				Nandhagopal, R.			Fever with seizure and confusion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ENCEPHALITIS		[Nandhagopal, R.] SQU, Coll Med & Hlth Sci, Dept Med, Neurol Unit, POB 35, Muscat 123, Oman	Sultan Qaboos University	Nandhagopal, R (corresponding author), SQU, Coll Med & Hlth Sci, Dept Med, Neurol Unit, POB 35, Muscat 123, Oman.	rnandagopal@yahoo.com		Ramachandiran, Nandhagopal/0000-0002-2379-0055				Armangue T, 2014, ANN NEUROL, V75, P317, DOI 10.1002/ana.24083; AURELIUS E, 1991, LANCET, V337, P189, DOI 10.1016/0140-6736(91)92155-U; Bulakbasi N, 2008, NEUROIMAG CLIN N AM, V18, P53, DOI 10.1016/j.nic.2007.12.001; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747	4	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2016	353								i2023	10.1136/bmj.i2023	http://dx.doi.org/10.1136/bmj.i2023			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EU	27079203				2022-12-28	WOS:000374375500003
J	Ransohoff, RM				Ransohoff, Richard M.			NEUROINFLAMMATION Surprises from the sanitary engineers	NATURE			English	Editorial Material							TAM RECEPTORS; NEUROGENESIS; ROLES; BRAIN		[Ransohoff, Richard M.] Biogen Inc, Neuroimmunol Grp, 14 Cambridge Ctr, Cambridge, MA 02142 USA	Biogen	Ransohoff, RM (corresponding author), Biogen Inc, Neuroimmunol Grp, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	richard.ransohoff@biogen.com						Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Perdiguero EG, 2013, GLIA, V61, P112, DOI 10.1002/glia.22393; Sierra A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00240; Sierra A, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/610343; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; Verney C, 2010, J ANAT, V217, P436, DOI 10.1111/j.1469-7580.2010.01245.x	10	7	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					185	186		10.1038/nature17881	http://dx.doi.org/10.1038/nature17881			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27049948				2022-12-28	WOS:000374415100028
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Stop disciplining us for being ill	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2016, PULSE           0302; General Medical Council, 2014, DOCT WHO COMM SUIC G; General Medical Council, 2012, SUPP INF APPR REV; General Medical Council, YOUR HLTH MATT; Royal College of General Practitioners, 2014, PRINC GP APPR REV	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2016	353								i1925	10.1136/bmj.i1925	http://dx.doi.org/10.1136/bmj.i1925			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EQ	27067103	Bronze, Green Published			2022-12-28	WOS:000374375100002
J	Navari, RM; Aapro, M				Navari, Rudolph M.; Aapro, Matti			Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MODERATELY EMETOGENIC CHEMOTHERAPY; PLACEBO-CONTROLLED TRIAL; HIGH-DOSE METOCLOPRAMIDE; RANDOMIZED PHASE-III; DOUBLE-BLIND; INTRAVENOUS ONDANSETRON; ANTAGONIST APREPITANT; RECEPTOR ANTAGONIST; PLUS DEXAMETHASONE; DELAYED NAUSEA	CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CHEMOTHERAPY-induced emesis) is a common treatment-related side effect that has a detrimental effect on the quality of life of patients with cancer and may lead to dose reductions in or discontinuation of chemotherapy. The development of new antiemetic agents has dramatically changed the landscape of chemotherapy-induced emesis. In the 1970s, prolonged hospital stays for nausea after chemotherapy were common practice.(1) In 1979, a randomized trial involving patients with cancer showed that the overall incidence of chemotherapy-induced emesis was approximately 83%.(2) Two decades later, with newly available antiemetics, an observational study reported incidences of acute nausea and vomiting of 35% and 13%, respectively, among patients receiving highly and moderately emetogenic chemotherapy. 3 Currently, adherence to antiemetic guidelines provides effective relief from chemotherapy-induced emesis,(4-6) and patients rapidly return to normal daily activities after treatment.(7,8) As a result, the quality of life of patients with cancer has improved, and better control of chemotherapy-induced emesis may help avoid reductions in and discontinuation of chemotherapy. These major advances have been recognized in a worldwide online survey conducted by the American Society of Clinical Oncology (ASCO) in 2014, in which antiemetics were voted by physicians, patients, and the public as one of the "Top 5 Advances in 50 Years of Modern Oncology."(9) In this review, we provide background information and the history of the major landmarks in prophylaxis for chemotherapy-induced emesis in adult patients, describe current clinical practices and challenges, and discuss potential approaches to addressing the remaining gaps in the understanding and prevention of chemotherapy-induced emesis.	[Navari, Rudolph M.] Indiana Univ Sch Med, South Bend,202 Lincolnway E, Mishawaka, IN 46544 USA; [Navari, Rudolph M.] Harper Canc Res Inst, Indiana, PA USA; [Aapro, Matti] Clin Genolier, Multidisciplinary Oncol Inst, Genolier, Swaziland		Navari, RM (corresponding author), Indiana Univ Sch Med, South Bend,202 Lincolnway E, Mishawaka, IN 46544 USA.	rmnavari@gmail.com			Helsinn	Helsinn	We thank S. Bosnjak, R. Clark-Snow, P. Jahn, and M. DeFord for their thorough review of a previous version of the manuscript. Medical writing and editorial assistance was provided by Fishawack Communications and TRM Oncology, the Netherlands, with funding support provided by Helsinn.	Aapro M, 2014, ANN ONCOL, V25, P1328, DOI 10.1093/annonc/mdu101; Aapro M, 2012, ANN ONCOL, V23, P1986, DOI 10.1093/annonc/mds021; Aapro M, 2010, ANN ONCOL, V21, P1083, DOI 10.1093/annonc/mdp584; AAPRO MS, 1981, CANCER CHEMOTH PHARM, V7, P11; Affronti ML, 2014, SUPPORT CARE CANCER, V22, P1897, DOI 10.1007/s00520-014-2136-0; American Society of Clinical Oncology, 2014, ASCO 50 ANN POLL NAM; [Anonymous], 1997, Oncology (Williston Park), V11, P57; [Anonymous], 2013, MASCC ANTIEMETIC GUI; [Anonymous], 2015, VAR ROL PRESCR INF; Basurto C, 1995, ANN ONCOL, V6, P805; Bayo J, 2012, CLIN TRANSL ONCOL, V14, P413, DOI 10.1007/s12094-012-0818-y; Burmeister H, 2012, SUPPORT CARE CANCER, V20, P141, DOI 10.1007/s00520-010-1079-3; Cruz FM, 2012, SUPPORT CARE CANCER, V20, P601, DOI 10.1007/s00520-011-1138-4; Demulder PHM, 1990, ANN INTERN MED, V113, P834, DOI 10.7326/0003-4819-113-11-834; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; Di Maio M, 2015, J CLIN ONCOL, V33, P910, DOI 10.1200/JCO.2014.57.9334; Dranitsaris G, 2001, SUPPORT CARE CANCER, V9, P611, DOI 10.1007/s005200100273; Dranitsaris George, 2013, J Support Oncol, V11, P14; Eisenberg P, 2003, CANCER-AM CANCER SOC, V98, P2473, DOI 10.1002/cncr.11817; Foubert Jan, 2005, Eur J Oncol Nurs, V9, P21, DOI 10.1016/j.ejon.2004.03.006; FRYTAK S, 1981, P AM ASSOC CANC RES, V22, P421; Gralla R, 2003, ANN ONCOL, V14, P1570, DOI 10.1093/annonc/mdg417; Gralla RJ, 2014, ANN ONCOL, V25, P1333, DOI 10.1093/annonc/mdu096; GRALLA RJ, 1981, NEW ENGL J MED, V305, P905, DOI 10.1056/NEJM198110153051601; GRALLA RJ, 1983, DRUGS, V25, P63, DOI 10.2165/00003495-198300251-00007; Gralla RJ, 1999, J CLIN ONCOL, V17, P2971, DOI 10.1200/JCO.1999.17.9.2971; Gralla RJ, 1982, P AN M AM SOC CLIN, V1, P58; Grunberg SM, 2004, CANCER-AM CANCER SOC, V100, P2261, DOI 10.1002/cncr.20230; Grunberg S, 2011, J CLIN ONCOL, V29, P1495, DOI 10.1200/JCO.2010.31.7859; Haiderali A, 2011, SUPPORT CARE CANCER, V19, P843, DOI 10.1007/s00520-010-0915-9; HERRSTEDT J, 1993, NEW ENGL J MED, V328, P1076, DOI 10.1056/NEJM199304153281502; Herrstedt J, 2001, ANN ONCOL, V12, P1059; Hesketh P, 1996, J CLIN ONCOL, V14, P2242, DOI 10.1200/JCO.1996.14.8.2242; Hesketh PJ, 2014, ANN ONCOL, V25, P1340, DOI 10.1093/annonc/mdu110; Hesketh PJ, 2008, NEW ENGL J MED, V358, P2482, DOI 10.1056/NEJMra0706547; Hesketh PJ, 2016, J CLIN ONCOL, V34, P381, DOI 10.1200/JCO.2015.64.3635; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; HESKETH PJ, 1994, J CLIN ONCOL, V12, P596, DOI 10.1200/JCO.1994.12.3.596; Hesketh PJ, 1997, J CLIN ONCOL, V15, P103, DOI 10.1200/JCO.1997.15.1.103; Iihara H, 2012, J EVAL CLIN PRACT, V18, P753, DOI 10.1111/j.1365-2753.2011.01665.x; Janelsins MC, 2013, EXPERT OPIN PHARMACO, V14, P757, DOI 10.1517/14656566.2013.776541; Jordan K, 2007, SUPPORT CARE CANCER, V15, P1023, DOI 10.1007/s00520-006-0186-7; Jordan K, 2015, ANN ONCOL, V26, P1081, DOI 10.1093/annonc/mdv138; Jordan K, 1985, MASCC ISOO ANN M SUP; Jordan K, 2014, EUR J PHARMACOL, V722, P197, DOI 10.1016/j.ejphar.2013.09.073; JOSS RA, 1994, ANN ONCOL, V5, P253, DOI 10.1093/oxfordjournals.annonc.a058803; Kris Mark G, 2011, Clin Adv Hematol Oncol, V9, P1; KRIS MG, 1985, J CLIN ONCOL, V3, P1379, DOI 10.1200/JCO.1985.3.10.1379; Meiri E, 2007, CURR MED RES OPIN, V23, P533, DOI 10.1185/030079907X167525; Molassiotis A, 2014, J PAIN SYMPTOM MANAG, V47, P839, DOI 10.1016/j.jpainsymman.2013.06.012; MORRAN C, 1979, BMJ-BRIT MED J, V1, P1323, DOI 10.1136/bmj.1.6174.1323-a; Morrow GR, 1998, SUPPORT CARE CANCER, V6, P46; Morrow GR, 1996, AM J CLIN ONCOL-CANC, V19, P199, DOI 10.1097/00000421-199604000-00023; NAVARI R, 1995, J CLIN ONCOL, V13, P1242, DOI 10.1200/JCO.1995.13.5.1242; Navari RM, 2012, COMMUNITY ONCOL, V9, P20; Navari Rudolph M, 2003, J Support Oncol, V1, P89; Navari RM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/595894; Navari RM, 2014, DRUG DES DEV THER, V9, P155, DOI 10.2147/DDDT.S76158; Navari RM, 2014, EUR J PHARMACOL, V722, P180, DOI 10.1016/j.ejphar.2013.08.048; Navari RM, 2013, SUPPORT CARE CANCER, V21, P1655, DOI 10.1007/s00520-012-1710-6; Navari Rudolph M, 2011, J Support Oncol, V9, P188, DOI 10.1016/j.suponc.2011.05.002; NCCN, 2015, NCCN CLIN PRACTICE G; Poli-Bigelli S, 2003, CANCER-AM CANCER SOC, V97, P3090, DOI 10.1002/cncr.11433; Rapoport BL, 2015, LANCET ONCOL, V16, P1079, DOI 10.1016/S1470-2045(15)00035-2; Roila F, 2006, ANN ONCOL, V17, P20, DOI 10.1093/annonc/mdj078; Roila F, 1998, ANN ONCOL, V9, P811, DOI 10.1023/A:1008471812316; Roila F, 2004, SUPPORT CARE CANCER, V12, P446, DOI 10.1007/s00520-003-0553-6; ROILA F, 1992, LANCET, V340, P972, DOI 10.1016/0140-6736(92)92857-C; Rojas C, 2008, ANESTH ANALG, V107, P469, DOI 10.1213/ane.0b013e318172fa74; Rojas C, 2014, EUR J PHARMACOL, V722, P26, DOI 10.1016/j.ejphar.2013.08.049; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; Schwartzberg L, 2014, SUPPORT CARE CANCER, V22, P469, DOI 10.1007/s00520-013-1999-9; Schwartzberg LS, 2015, LANCET ONCOL, V16, P1071, DOI 10.1016/S1470-2045(15)00034-0; Viale Pamela Hallquist, 2012, Clin J Oncol Nurs, V16, pE133, DOI 10.1188/12.CJON.E133-E141; Vidall C, 2011, ECANCERMEDICALSCIENC, V5, DOI 10.3332/ecancer.2011.211; Ware Mark A, 2008, Ther Clin Risk Manag, V4, P99; WARR D, 1991, J NATL CANCER I, V83, P1169, DOI 10.1093/jnci/83.16.1169	77	212	224	6	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					1356	1367		10.1056/NEJMra1515442	http://dx.doi.org/10.1056/NEJMra1515442			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3UW	27050207				2022-12-28	WOS:000373425000009
J	Berende, A; ter Hofstede, HJM; Vos, FJ; van Middendorp, H; Vogelaar, ML; Tromp, M; van den Hoogen, FH; Donders, ART; Evers, AWM; Kullberg, BJ				Berende, Anneleen; ter Hofstede, Hadewych J. M.; Vos, Fidel J.; van Middendorp, Henriet; Vogelaar, Michiel L.; Tromp, Mirjam; van den Hoogen, Frank H.; Donders, A. Rogier T.; Evers, Andrea W. M.; Kullberg, Bart Jan			Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERSISTENT SYMPTOMS; ANTIBIOTIC-TREATMENT; GUIDELINES; MANAGEMENT	BACKGROUND The treatment of persistent symptoms attributed to Lyme disease remains controversial. We assessed whether longer-term antibiotic treatment of persistent symptoms attributed to Lyme disease leads to better outcomes than does shorter-term treatment. METHODS In a randomized, double-blind, placebo-controlled trial conducted in Europe, we assigned patients with persistent symptoms attributed to Lyme disease - either related temporally to proven Lyme disease or accompanied by a positive IgG or IgM immunoblot assay for Borrelia burgdorferi - to receive a 12-week oral course of doxycycline, clarithromycin plus hydroxychloroquine, or placebo. All study groups received open-label intravenous ceftriaxone for 2 weeks before initiating the randomized regimen. The primary outcome measure was health-related quality of life, as assessed by the physical-component summary score of the RAND-36 Health Status Inventory (RAND SF-36) (range, 15 to 61, with higher scores indicating better quality of life), at the end of the treatment period at week 14, after the 2-week course of ceftriaxone and the 12-week course of the randomized study drug or placebo had been completed. RESULTS Of the 281 patients who underwent randomization, 280 were included in the modified intention-to-treat analysis (86 patients in the doxycycline group, 96 in the clarithromycin-hydroxychloroquine group, and 98 in the placebo group). The SF-36 physical-component summary score did not differ significantly among the three study groups at the end of the treatment period, with mean scores of 35.0 (95% confidence interval [CI], 33.5 to 36.5) in the doxycycline group, 35.6 (95% CI, 34.2 to 37.1) in the clarithromycin-hydroxychloroquine group, and 34.8 (95% CI, 33.4 to 36.2) in the placebo group (P = 0.69; a difference of 0.2 [95% CI, -2.4 to 2.8] in the doxycycline group vs. the placebo group and a difference of 0.9 [95% CI, -1.6 to 3.3] in the clarithromycin-hydroxychloroquine group vs. the placebo group); the score also did not differ significantly among the groups at subsequent study visits (P = 0.35). In all study groups, the SF-36 physical-component summary score increased significantly from baseline to the end of the treatment period (P<0.001). The rates of adverse events were similar among the study groups. Four serious adverse events thought to be related to drug use occurred during the 2-week open-label ceftriaxone phase, and no serious drug-related adverse event occurred during the 12-week randomized phase. CONCLUSIONS In patients with persistent symptoms attributed to Lyme disease, longer-term antibiotic treatment did not have additional beneficial effects on health-related quality of life beyond those with shorter-term treatment.	[Berende, Anneleen; ter Hofstede, Hadewych J. M.; Vos, Fidel J.; Vogelaar, Michiel L.; Tromp, Mirjam; Kullberg, Bart Jan] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [van Middendorp, Henriet; Vogelaar, Michiel L.; Evers, Andrea W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands; [van den Hoogen, Frank H.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Donders, A. Rogier T.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Berende, Anneleen; ter Hofstede, Hadewych J. M.; Vos, Fidel J.; Vogelaar, Michiel L.; Tromp, Mirjam; Kullberg, Bart Jan] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Vos, Fidel J.; van den Hoogen, Frank H.] Sint Maartensklin, Nijmegen, Netherlands; [van Middendorp, Henriet; Evers, Andrea W. M.; Kullberg, Bart Jan] Leiden Univ, Inst Psychol, Hlth Med & Neuropsychol Unit, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Sint Maartens Clinic; Leiden University; Leiden University - Excl LUMC	Kullberg, BJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med 463, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Evers, A.W.M./L-4299-2015; Evers, Andrea/GWV-9705-2022; Evers, Andrea/U-8983-2019; Vos, Fidel J/E-9910-2018; van Middendorp, Henriet/B-8300-2013; van den Hoogen, Frank/I-7829-2018; Donders, A.R.T./L-4277-2015; A, Berende/G-3303-2016; Hofstede, Hadewych ter/AAD-1118-2019; Kullberg, BJ/C-8520-2013	Evers, Andrea/0000-0002-0090-5091; van den Hoogen, Frank/0000-0003-1044-015X; Donders, A.R.T./0000-0002-0484-1419; A, Berende/0000-0002-9079-9519; Kullberg, BJ/0000-0002-6813-8167; van Middendorp, Henriet/0000-0003-4575-0895	Netherlands Organization for Health Research and Development ZonMw	Netherlands Organization for Health Research and Development ZonMw(Netherlands Organization for Health Research and Development)	Funded by the Netherlands Organization for Health Research and Development ZonMw	ANGEL JH, 1984, BRIT J DIS CHEST, V78, P330; Berende A, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0543-y; Borm GF, 2007, J CLIN EPIDEMIOL, V60, P1234, DOI 10.1016/j.jclinepi.2007.02.006; Cairns V, 2005, INT J EPIDEMIOL, V34, P1340, DOI 10.1093/ije/dyi129; Cameron D, 2008, Minerva Med, V99, P489; Cameron DJ, 2014, EXPERT REV ANTI-INFE, V12, P1103, DOI 10.1586/14787210.2014.940900; Clarissou J, 2009, MED MALADIES INFECT, V39, P108, DOI 10.1016/j.medmal.2008.11.012; Cunningham WE, 2003, QUAL LIFE RES, V12, P1029, DOI 10.1023/A:1026191016380; DeLong AK, 2012, CONTEMP CLIN TRIALS, V33, P1132, DOI 10.1016/j.cct.2012.08.009; Donta Sam T, 2003, Med Sci Monit, V9, pPI136; Donta ST, 1997, CLIN INFECT DIS, V25, pS52, DOI 10.1086/516171; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Hays R.D., 1998, RAND 36 HLTH STATUS; Kaplan RF, 2003, NEUROLOGY, V60, P1916, DOI 10.1212/01.WNL.0000068030.26992.25; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Maruish ME., 2011, USERS MANUAL SF 36V2, V3rd ed.; Mygland A, 2010, EUR J NEUROL, V17, P8, DOI 10.1111/j.1468-1331.2009.02862.x; Raoult D, 1999, ARCH INTERN MED, V159, P167, DOI 10.1001/archinte.159.2.167; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; Stricker RB, 2011, INT J GEN MED, V4, P639, DOI 10.2147/IJGM.S23829; Urquhart J, 1997, CLIN PHARMACOKINET, V32, P345, DOI 10.2165/00003088-199732050-00001; van den Wijngaard CC, 2015, EUR J PUBLIC HEALTH, V25, P1071, DOI 10.1093/eurpub/ckv091; VANDAM AP, 1993, CLIN INFECT DIS, V17, P708, DOI 10.1093/clinids/17.4.708; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	26	139	142	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1209	1220		10.1056/NEJMoa1505425	http://dx.doi.org/10.1056/NEJMoa1505425			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8ZM	27028911	Bronze			2022-12-28	WOS:000373085500004
J	Lane, R				Lane, Richard			Eric Topol: innovator in cardiology and digital medicine	LANCET			English	Biographical-Item																			0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1267	1267		10.1016/S0140-6736(16)30026-5	http://dx.doi.org/10.1016/S0140-6736(16)30026-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27025425				2022-12-28	WOS:000372697500013
J	Remenyi, B; ElGuindy, A; Smith, SC; Yacoub, M; Holmes, DR				Remenyi, Boglarka; ElGuindy, Ahmed; Smith, Sidney C., Jr.; Yacoub, Magdi; Holmes, David R., Jr.			Valvular heart disease 3 Valvular aspects of rheumatic heart disease	LANCET			English	Article							MITRAL-VALVE REPAIR; LONG-TERM OUTCOMES; ATRIAL-FIBRILLATION; TRICUSPID-VALVE; BALLOON VALVULOPLASTY; CARDIAC-SURGERY; RADIOFREQUENCY ABLATION; DEVELOPING-COUNTRY; CLINICAL SPECTRUM; SYSTEMIC EMBOLISM	Acute rheumatic fever and rheumatic heart disease remain major global health problems. Although strategies for primary and secondary prevention are well established, their worldwide implementation is suboptimum. In patients with advanced valvular heart disease, mechanical approaches (both percutaneous and surgical) are well described and can, for selected patients, greatly improve outcomes; however, access to centres with experienced staff is very restricted in regions that have the highest prevalence of disease. Development of diagnostic strategies that can be locally and regionally provided and improve access to expert centres for more advanced disease are urgent and, as yet, unmet clinical needs. We outline current management strategies for valvular rheumatic heart disease on the basis of either strong evidence or expert consensus, and highlight areas needing future research and development.	[Remenyi, Boglarka] Menzies Sch Hlth Res, Darwin, NT, Australia; [ElGuindy, Ahmed] Aswan Heart Ctr, Dept Cardiol, Aswan, Egypt; [Smith, Sidney C., Jr.] Univ N Carolina, Heart & Vasc Ctr, Chapel Hill, NC USA; [Yacoub, Magdi] Univ London Imperial Coll Sci Technol & Med, Cardiothorac Surg, London, England; [Holmes, David R., Jr.] Mayo Clin, Dept Cardiol, Rochester, MN 55905 USA	Charles Darwin University; Menzies School of Health Research; Egyptian Knowledge Bank (EKB); Aswan University; University of North Carolina; University of North Carolina Chapel Hill; Imperial College London; Mayo Clinic	Holmes, DR (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	holmes.david@mayo.edu						ANTUNES MJ, 1990, EUR J CARDIO-THORAC, V4, P257, DOI 10.1016/1010-7940(90)90249-Y; Baskerville CA, 2012, HEART LUNG CIRC, V21, P36, DOI 10.1016/j.hlc.2011.08.010; Bernal JM, 2008, J THORAC CARDIOV SUR, V136, P476, DOI 10.1016/j.jtcvs.2008.02.065; Bilge M, 2014, ANATOL J CARDIOL, V14, P296, DOI 10.5152/akd.2014.5226; BLAND EF, 1951, CIRCULATION, V4, P836, DOI 10.1161/01.CIR.4.6.836; BLAND EF, 1987, CIRCULATION, V76, P1190, DOI 10.1161/01.CIR.76.6.1190; Bouleti C, 2014, CIRC-CARDIOVASC INTE, V7, P381, DOI 10.1161/CIRCINTERVENTIONS.113.000858; Campelo-Parada F, 2015, J AM COLL CARDIOL, V66, P2475, DOI 10.1016/j.jacc.2015.09.068; Carapetis JR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.84; Carapetis JR., 2012, ENTERPRISE SYSTEMS M, V2nd; Chauvaud Sylvain, 2001, Circulation, V104, pI, DOI 10.1161/hc37t1.094707; Chester Adrian H, 2014, Glob Cardiol Sci Pract, V2014, P52, DOI 10.5339/gcsp.2014.11; Chockalingam A, 2003, J HEART VALVE DIS, V12, P577; Chotivatanapong Taweesak, 2012, J Med Assoc Thai, V95 Suppl 8, pS51; Cilliers A, 2012, COCHRANE DB SYST REV, V6; Clark BC, 2015, J AM SOC ECHOCARDIOG, DOI [10.5830/CVJA-2013-0281016/j.echo.2015.11.013, DOI 10.5830/CVJA-2013-0281016/J.ECHO.2015.11.013]; Cohn AE, 1943, J AMER MED ASSOC, V121, P1; COULSHED N, 1970, BRIT HEART J, V32, P26; DARE AJ, 1993, HUM PATHOL, V24, P1330, DOI 10.1016/0046-8177(93)90267-K; Diao M, 2011, ARCH CARDIOVASC DIS, V104, P370, DOI 10.1016/j.acvd.2011.04.001; Ducrocq G, 2010, J THORAC CARDIOV SUR, V140, P930, DOI 10.1016/j.jtcvs.2010.02.003; DURAN CMG, 1991, CIRCULATION, V84, P125; Egbe AC, 2015, J AM COLL CARDIOL, V66, P2285, DOI 10.1016/j.jacc.2015.09.022; El-Hamamsy I, 2010, LANCET, V376, P524, DOI 10.1016/S0140-6736(10)60828-8; Finucane K, 2013, GLOB HEART, V8, P213, DOI 10.1016/j.gheart.2013.08.010; GALLOWAY A C, 1989, Annals of Thoracic Surgery, V47, P655; Gentles TL, 2015, ANN THORAC SURG, V100, P1383, DOI 10.1016/j.athoracsur.2015.06.009; Gewitz MH, 2015, CIRCULATION, V131, P1806, DOI 10.1161/CIR.0000000000000205; Godown J, 2015, PEDIATRICS, V135, pE939, DOI 10.1542/peds.2014-2774; Gometza B, 1996, J HEART VALVE DIS, V5, P294; GORDIS L, 1985, CIRCULATION, V72, P1155, DOI 10.1161/01.CIR.72.6.1155; GORDON SPF, 1992, J AM COLL CARDIOL, V19, P968, DOI 10.1016/0735-1097(92)90280-Z; Grossi EA, 1998, J THORAC CARDIOV SUR, V115, P389, DOI 10.1016/S0022-5223(98)70283-1; Gunther G, 2006, LANCET, V367, P391, DOI 10.1016/S0140-6736(06)68128-2; Harling L, 2011, EUR J CARDIO-THORAC, V40, P1087, DOI 10.1016/j.ejcts.2011.03.036; Iung B, 2014, CAN J CARDIOL, V30, P962, DOI 10.1016/j.cjca.2014.03.022; JAIYESIMI F, 1981, TROP GEOGR MED, V33, P8; JOSWIG BC, 1982, AM HEART J, V104, P1400, DOI 10.1016/0002-8703(82)90185-5; Kalangos A, 2008, ANN THORAC SURG, V86, P161, DOI 10.1016/j.athoracsur.2008.03.005; Kamblock J, 2005, J HEART VALVE DIS, V14, P440; Karthikeyan G, 2014, AM J CARDIOL, V114, P869, DOI 10.1016/j.amjcard.2014.06.016; Kim GS, 2014, J THORAC CARDIOV SUR, V147, P247, DOI 10.1016/j.jtcvs.2012.10.007; Kumar Arkalgud Sampath, 2006, Interact Cardiovasc Thorac Surg, V5, P356; Kumar AS, 2014, WORLD J PEDIATR CONG, V5, P80, DOI 10.1177/2150135113512333; Kumar Rajesh, 2002, Indian Heart J, V54, P54; Larrazabal LA, 2007, CIRCULATION, V116, P1882, DOI 10.1161/CIRCULATIONAHA.107.695403; Laule M, 2013, J AM COLL CARDIOL, V61, P1929, DOI 10.1016/j.jacc.2013.01.070; Lauten A, 2011, EUR HEART J, V32, P1027; Lawrence JG, 2013, CIRCULATION, V128, P492, DOI 10.1161/CIRCULATIONAHA.113.001477; Litmathe J, 2006, THORAC CARDIOV SURG, V54, P459, DOI 10.1055/s-2006-924247; Manyemba J., 2002, COCHRANE DB SYST REV, V2002, pCD002227, DOI [10.1002/14651858.CD002227, DOI 10.1002/14651858.CD002227, 10.1002/14651858.CD00222712137650]; MARCUS RH, 1994, ANN INTERN MED, V120, P177, DOI 10.7326/0003-4819-120-3-199402010-00001; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Marin F, 1999, AM J CARDIOL, V84, P862, DOI 10.1016/S0002-9149(99)00453-1; Michaud CRR, 1999, RHEUMATIC FEVER, P485; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Palacios IF, 2002, CIRCULATION, V105, P1465, DOI 10.1161/01.CIR.0000012143.27196.F4; Parnaby MG, 2010, J PAEDIATR CHILD H, V46, P527, DOI 10.1111/j.1440-1754.2010.01841.x; Peverill RE, 1996, CIRCULATION, V94, P331, DOI 10.1161/01.CIR.94.3.331; Pillai AA, 2015, CARDIOVASC INTERV TH, V30, P45, DOI 10.1007/s12928-014-0286-0; Pinho-Gomes AC, 2015, J CARDIAC SURG, V30, P117, DOI 10.1111/jocs.12452; Pourafkari Leili, 2015, Asian Cardiovasc Thorac Ann, V23, P17, DOI 10.1177/0218492314530134; Remenyi B, 2013, WORLD J PEDIATR CONG, V4, P155, DOI 10.1177/2150135112474024; Remenyi B, 2013, NAT REV CARDIOL, V10, P284, DOI 10.1038/nrcardio.2013.34; Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7; Remond M, 2015, INT J CARDIOL, V198, P117, DOI 10.1016/j.ijcard.2015.07.005; Rifaie O, 2010, EUROINTERVENTION, V6, P227, DOI 10.4244/; Roberts K, 2014, CIRCULATION, V129, P1953, DOI 10.1161/CIRCULATIONAHA.113.003495; Roberts KV, 2015, MED J AUSTRALIA, V203, DOI 10.5694/mja15.00139; Roberts KV, 2013, MED J AUSTRALIA, V199, P196, DOI 10.5694/mja13.10520; ROBERTS WC, 1978, CIRCULATION, V57, P803, DOI 10.1161/01.CIR.57.4.803; ROY SB, 1963, LANCET, V2, P1193, DOI 10.1016/S0140-6736(63)92922-2; Russell EA, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0094-1; Schofer J, 2015, JACC-CARDIOVASC INTE, V8, P1842, DOI 10.1016/j.jcin.2015.08.022; Schofer J, 2015, J AM COLL CARDIOL, V65, P1190, DOI 10.1016/j.jacc.2015.01.025; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Sharma Jugal, 2015, Asian Cardiovasc Thorac Ann, V23, P923, DOI 10.1177/0218492315598240; Sharma S, 2014, CARDIOVASC PATHOL, V23, P319, DOI 10.1016/j.carpath.2014.07.008; Singh SK, 2006, ANN THORAC SURG, V82, P1735, DOI 10.1016/j.athoracsur.2006.06.016; SKOULARIGIS J, 1994, CIRCULATION, V90, P167; Soma-Pillay P, 2008, SAMJ S AFR MED J, V98, P553; Song JK, 2010, J THORAC CARDIOV SUR, V139, P103, DOI 10.1016/j.jtcvs.2009.04.022; Sultan FAT, 2010, J HEART VALVE DIS, V19, P374; Tandon R, 2013, NAT REV CARDIOL, V10, P171, DOI 10.1038/nrcardio.2012.197; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; VIGNA C, 1993, CHEST, V103, P348, DOI 10.1378/chest.103.2.348; Wang B, 2013, EUR J CARDIO-THORAC, V43, P513, DOI 10.1093/ejcts/ezs213; Wang DR, 2013, CLIN NEUROL NEUROSUR, V115, P1575, DOI 10.1016/j.clineuro.2013.06.017; Wang X, 2014, INT J CARDIOL, V174, P497, DOI 10.1016/j.ijcard.2014.03.153; Watkins D, 2016, CARDIOVASC J AFR, V27, P184, DOI 10.5830/CVJA-2015-090; Webb RH, 2015, J AM SOC ECHOCARDIOG, V28, P981, DOI 10.1016/j.echo.2015.03.012; Wei L, 2015, JACC-CARDIOVASC INTE, V8, P1831, DOI 10.1016/j.jcin.2015.08.021; WILKINS GT, 1988, BRIT HEART J, V60, P299; Yacoub M, 2014, J CARDIOVASC TRANSL, V7, P797, DOI 10.1007/s12265-014-9598-9; Yacoub MH, 2007, CIRCULATION, V116, P1876, DOI 10.1161/CIRCULATIONAHA.107.726265; Yacoub MH, 2015, J AM COLL CARDIOL, V66, P889, DOI 10.1016/j.jacc.2015.07.007; Yacoub MH, 2014, LANCET, V384, P559, DOI 10.1016/S0140-6736(14)61090-4; Yakub MA, 2016, EUR J CARDIO-THORAC, V49, P553, DOI 10.1093/ejcts/ezv099; Yakub MA, 2013, EUR J CARDIO-THORAC, V44, P673, DOI 10.1093/ejcts/ezt093; Yanagawa B, 2016, CURR OPIN CARDIOL, V31, P162, DOI 10.1097/HCO.0000000000000269; Yuko-Jowi C, 2006, E AFR MED J, V82, P514; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449; Zuhlke LJ, 2013, GLOB HEART, V8, P189, DOI 10.1016/j.gheart.2013.08.008	105	66	78	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1335	1346		10.1016/S0140-6736(16)00547-X	http://dx.doi.org/10.1016/S0140-6736(16)00547-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27025439				2022-12-28	WOS:000372697500032
J	Delaney, M; Wendel, S; Bercovitz, RS; Cid, J; Cohn, C; Dunbar, NM; Apelseth, TO; Popovsky, M; Stanworth, SJ; Tinmouth, A; De Watering, LV; Waters, JH; Yazer, M; Ziman, A				Delaney, Meghan; Wendel, Silvano; Bercovitz, Rachel S.; Cid, Joan; Cohn, Claudia; Dunbar, Nancy M.; Apelseth, Torunn O.; Popovsky, Mark; Stanworth, Simon J.; Tinmouth, Alan; De Watering, Leo Van; Waters, Jonathan H.; Yazer, Mark; Ziman, Alyssa		Biomed Excellence Safer Transfusio	Transfusion reactions: prevention, diagnosis, and treatment	LANCET			English	Review							SICKLE-CELL-DISEASE; ACUTE LUNG INJURY; VERSUS-HOST-DISEASE; CONVERTING ENZYME-INHIBITORS; HYPERKALEMIC CARDIAC-ARREST; POSTTRANSFUSION PURPURA; CIRCULATORY OVERLOAD; MASSIVE TRANSFUSION; BLOOD-TRANSFUSION; NECROTIZING ENTEROCOLITIS	Blood transfusion is one of the most common procedures in patients in hospital so it is imperative that clinicians are knowledgeable about appropriate blood product administration, as well as the signs, symptoms, and management of transfusion reactions. In this Review, we, an international panel, provide a synopsis of the pathophysiology, treatment, and management of each diagnostic category of transfusion reaction using evidence-based recommendations whenever available.	[Delaney, Meghan] Bloodworks NW, Seattle, WA 98115 USA; [Delaney, Meghan] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wendel, Silvano] Hosp Sirio Libanes Blood Bank, Sao Paulo, Brazil; [Bercovitz, Rachel S.] BloodCtr Wisconsin, Milwaukee, WI USA; [Cid, Joan] UB, Dept Hemotherapy & Hemostasis, CDB, IDIBAPS, Barcelona, Spain; [Cohn, Claudia] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Dunbar, Nancy M.] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA; [Dunbar, Nancy M.] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA; [Apelseth, Torunn O.] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway; [Apelseth, Torunn O.] Haukeland Hosp, Dept Immunol & Transfus Med, Bergen, Norway; [Popovsky, Mark] Haemonetics Corp, Braintree, MA USA; [Stanworth, Simon J.] John Radcliffe Hosp, NHS Blood & Transplant Oxford Univ Hosp NHS Trust, Oxford, England; [Stanworth, Simon J.] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Tinmouth, Alan] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Tinmouth, Alan] Univ Ottawa, Dept Lab Med & Pathol, Ottawa, ON, Canada; [Tinmouth, Alan] Univ Ottawa, Ctr Transfus Res, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [De Watering, Leo Van] Sanquin, Ctr Clin Transfus Res, Amsterdam, Netherlands; [Waters, Jonathan H.] Univ Pittsburgh, Dept Anesthesiol & Bioengn, Pittsburgh, PA USA; [Waters, Jonathan H.] McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Yazer, Mark] Univ Pittsburgh, Dept Pathol, Div Transfus Med, Inst Transfus Med, Pittsburgh, PA USA; [Ziman, Alyssa] Univ Calif Los Angeles, David Geffen Sch Med, Div Transfus Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of Washington; University of Washington Seattle; Hospital Sirio Libanes; Versiti Blood Center of Wisconsin; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Minnesota System; University of Minnesota Twin Cities; Dartmouth College; Dartmouth College; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Institute for Transfusion Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Delaney, M (corresponding author), Bloodworks NW, Seattle, WA 98115 USA.	meghand@bloodworksnw.org	Dunbar, Nancy M/D-8883-2011; Selogie, Eileen A/L-3628-2016; Cid, Joan/F-7778-2016; Wendel, S/AAQ-9048-2020; Ziman, Alyssa/N-9598-2019	Cid, Joan/0000-0001-5445-4508; Bercovitz, Rachel/0000-0002-6399-1249; Ziman, Alyssa/0000-0002-1814-9319; Dunbar, Nancy M./0000-0001-8601-5438				Amsler L, 2015, HAEMOVIGILANCE ANN R; ANDERSON KC, 1990, NEW ENGL J MED, V323, P315; Andrzejewski C, 2013, TRANSFUSION, V53, P3037, DOI 10.1111/trf.12454; Andrzejewski C, 2012, TRANSFUSION, V52, P2310, DOI 10.1111/j.1537-2995.2012.03595.x; Arnold DM, 2004, TRANSFUSION, V44, P1361, DOI 10.1111/j.0041-1132.2004.04057.x; Bolton-Maggs PHB, 2014, TRANSFUSION MED, V24, P197, DOI 10.1111/tme.12142; Bolton-Maggs PHB, 2014, 2013 ANN SHOT REPORT; BOYAN CP, 1964, ANN SURG, V160, P282, DOI 10.1097/00000658-196408000-00016; Callum JL, 2014, TRANSFUSION, V54, P2344, DOI 10.1111/trf.12802; CDC, 2014, NHSN BIOV COMP HEM M; Chou ST, 2013, BLOOD, V122, P1062, DOI 10.1182/blood-2013-03-490623; Cohn CS, 2014, TRANSFUSION, V54, P1927, DOI 10.1111/trf.12597; Cyr M, 2001, TRANSFUSION, V41, P136, DOI 10.1046/j.1537-2995.2001.41010136.x; Darabi K, 2005, TRANSFUSION, V45, P1930, DOI 10.1111/j.1537-2995.2005.00608.x; de Montalembert M, 2011, HAEMATOL-HEMATOL J, V96, P801, DOI 10.3324/haematol.2010.038307; Delaney M, 2013, PEDIATR CRIT CARE ME, V14, pE263, DOI 10.1097/PCC.0b013e31828a70c5; Delaney M, 2013, TRANSFUSION, V53, P771, DOI 10.1111/j.1537-2995.2012.03789.x; DIAMOND WJ, 1980, ANN INTERN MED, V93, P231, DOI 10.7326/0003-4819-93-2-231; Doria C, 2008, LIVER TRANSPLANT, V14, P684, DOI 10.1002/lt.21425; Dzik W H, 1988, Transfus Med Rev, V2, P76, DOI 10.1016/S0887-7963(88)70035-8; Eder AF, 2011, TRANSFUSION, V51, P1662, DOI 10.1111/j.1537-2995.2011.03083.x; El-Dib M, 2011, J PERINATOL, V31, P183, DOI 10.1038/jp.2010.157; Elliott Malcolm, 2012, Br J Nurs, V21, P621; Ezidiegwu CN, 2004, ARCH PATHOL LAB MED, V128, P991; Figueroa PI, 2006, AM J CLIN PATHOL, V126, P422, DOI 10.1309/C6U7VP87GC030WMG; FREDLUND H, 1989, EUR J HAEMATOL, V43, P259; FRIEDLANDER M, 1989, CAN J ANAESTH, V36, P460, DOI 10.1007/BF03005348; Fung MK, 2014, TECHNICAL MANUAL, V18th; Funk MB, 2011, TRANSFUS MED HEMOTH, V38, P266, DOI 10.1159/000330372; Garratty G, 2012, TRANSFUSION MED, V22, P77, DOI 10.1111/j.1365-3148.2012.01151.x; Gonzalez Corina E, 2005, Curr Hematol Rep, V4, P154; Goodnough LT, 2009, TRANSFUSION, V49, P1321, DOI 10.1111/j.1537-2995.2009.02157.x; Gupta S, 2015, TRANSFUSION, V55, P623, DOI 10.1111/trf.12876; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Harm SK, 2014, AM J CLIN PATHOL, V141, P256, DOI 10.1309/AJCP47QAAXTOZEKJ; Harvey AR, 2015, TRANSFUSION, V55, P709, DOI 10.1111/trf.12918; Heddle N M, 1999, Curr Opin Hematol, V6, P420, DOI 10.1097/00062752-199911000-00012; Heddle NM, 2002, TRANSFUSION, V42, P556, DOI 10.1046/j.1537-2995.2002.00094.x; Hirayama F, 2013, BRIT J HAEMATOL, V160, P434, DOI 10.1111/bjh.12150; Inaba S, 2000, TRANSFUSION, V40, P1469, DOI 10.1046/j.1537-2995.2000.40121469.x; Jacobs MR, 2011, TRANSFUSION, V51, P2573, DOI 10.1111/j.1537-2995.2011.03308.x; KALISH RI, 1987, VOX SANG, V53, P169, DOI 10.1111/j.1423-0410.1987.tb04943.x; Kalra A, 2012, AM J THER, V19, pE90, DOI 10.1097/MJT.0b013e3181e4ddb2; Katus MC, 2014, VOX SANG, V107, P103, DOI 10.1111/vox.12146; Kennedy LD, 2008, TRANSFUSION, V48, P2285, DOI 10.1111/j.1537-2995.2008.01858.x; Kenton Alexander B, 2005, J Perinatol, V25, P173, DOI 10.1038/sj.jp.7211237; Kirpalani H, 2012, SEMIN PERINATOL, V36, P269, DOI 10.1053/j.semperi.2012.04.007; KOHAN AI, 1994, VOX SANG, V67, P195, DOI 10.1111/j.1423-0410.1994.tb01659.x; Koshy R, 2009, Immunohematology, V25, P44; Lafeuillade B, 2015, TRANSFUSION, V55, P636, DOI 10.1111/trf.12883; LaSalle-Williams M, 2011, TRANSFUSION, V51, P1732, DOI 10.1111/j.1537-2995.2010.03045.x; Lee AC, 2014, TRANSFUSION, V54, P244, DOI 10.1111/trf.12192; Leslie Kate, 2003, Best Pract Res Clin Anaesthesiol, V17, P485, DOI 10.1016/S1521-6896(03)00049-1; Lieberman L, 2013, TRANSFUS MED REV, V27, P206, DOI 10.1016/j.tmrv.2013.07.002; Lin L, 2004, TRANSFUSION, V44, P1496, DOI 10.1111/j.1537-2995.2004.04125.x; Lin RY, 2000, ANN EMERG MED, V36, P462, DOI 10.1067/mem.2000.109445; Marschner S, 2010, TRANSFUSION, V50, P2489, DOI 10.1111/j.1537-2995.2010.02714.x; Marti-Carvajal AJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007539.pub2; MCCULLOUGH J, 1972, ANESTH ANAL CURR RES, V51, P102; Meikle A, 2000, CAN J ANAESTH, V47, P792, DOI 10.1007/BF03019483; Menis M, 2015, TRANSFUSION, V55, P284, DOI 10.1111/trf.12782; Mohamed A, 2012, PEDIATRICS, V129, P529, DOI 10.1542/peds.2011-2872; Moola S, 2011, INT J EVID-BASED HEA, V9, P337, DOI 10.1111/j.1744-1609.2011.00227.x; Moreau ME, 2007, TRANSFUSION, V47, P410, DOI 10.1111/j.1537-2995.2007.01097.x; MUELLERECKHARDT C, 1988, BLUT, V57, P163, DOI 10.1007/BF00319544; Murphy WG, 2011, TRANSFUS APHER SCI, V45, P69, DOI 10.1016/j.transci.2011.06.005; Narick C, 2012, TRANSFUSION, V52, P160, DOI 10.1111/j.1537-2995.2011.03247.x; NESS PM, 1990, TRANSFUSION, V30, P688, DOI 10.1046/j.1537-2995.1990.30891020325.x; Noizat-Pirenne F, 2015, VOX SANG, V108, P262, DOI 10.1111/vox.12217; Noizat-Pirenne F, 2013, CR BIOL, V336, P152, DOI 10.1016/j.crvi.2012.09.011; OHTO H, 1992, TRANSFUSION, V32, P691, DOI 10.1046/j.1537-2995.1992.32792391051.x; OLINGER GN, 1976, J THORAC CARDIOV SUR, V72, P503; OWEN HG, 1994, TRANSFUSION, V34, P891, DOI 10.1046/j.1537-2995.1994.341095026976.x; Pagano MB, 2015, TRANSFUSION, V55, P1668, DOI 10.1111/trf.13047; Pfuntner A, 2011, FREQUENT PROCEDURES; Piccin A, 2015, TRANSFUSION, V55, P1223, DOI 10.1111/trf.12965; Pujani M, 2014, BLOOD TRANSFUS-ITALY, V12, pS100, DOI 10.2450/2012.0154-12; Riley W, 2012, TRANSFUSION, V52, P1957, DOI 10.1111/j.1537-2995.2011.03539.x; Robillard P, 2011, TRANSFUSION, V51, P1405, DOI 10.1111/j.1537-2995.2010.03001.x; ROSSE WF, 1990, BLOOD, V76, P1431; Ruhl H, 2009, TRANSFUS MED REV, V23, P62, DOI 10.1016/j.tmrv.2008.09.006; RUNGE JW, 1992, ANN EMERG MED, V21, P237, DOI 10.1016/S0196-0644(05)80881-9; Sanders RP, 2005, BRIT J HAEMATOL, V130, P781, DOI 10.1111/j.1365-2141.2005.05670.x; Sandler SG, 2015, TRANSFUSION, V55, P199, DOI 10.1111/trf.12796; Sayah DM, 2012, CRIT CARE CLIN, V28, P363, DOI 10.1016/j.ccc.2012.04.001; Schonewille H, 2000, TRANSFUSION, V40, P1127, DOI 10.1046/j.1537-2995.2000.40091127.x; Schwickerath V, 2010, TRANSFUSION, V50, P1465, DOI 10.1111/j.1537-2995.2010.02629.x; SEAGER OA, 1974, JAMA-J AM MED ASSOC, V229, P790, DOI 10.1001/jama.229.7.790; Sesok-Pizzini D, 2014, TRANSFUSION, V54, P4, DOI 10.1111/trf.12470; Shaz BH, 2014, BLOOD, V123, P3374, DOI 10.1182/blood-2014-04-565473; Sihler KC, 2010, CHEST, V137, P209, DOI 10.1378/chest.09-0252; Silliman CC, 2014, BLOOD, V123, P3488, DOI 10.1182/blood-2013-10-532424; Simons FER, 2011, J ALLERGY CLIN IMMUN, V127, P587, DOI 10.1016/j.jaci.2011.01.038; Strauss RG, 2010, TRANSFUSION, V50, P1862, DOI 10.1111/j.1537-2995.2010.02789.x; STRAUTZ RL, 1989, AM J EMERG MED, V7, P162, DOI 10.1016/0735-6757(89)90129-0; Sweeney JD, 1998, TRANSFUSION, V38, P410, DOI 10.1046/j.1537-2995.1998.38498257382.x; Takahashi TA, 1995, TRANSFUSION, V35, P967, DOI 10.1046/j.1537-2995.1995.351196110903.x; Talano JAM, 2003, PEDIATRICS, V111, pE661, DOI 10.1542/peds.111.6.e661; Tinegate H, 2012, BRIT J HAEMATOL, V159, P143, DOI 10.1111/bjh.12017; Tobian AAR, 2011, TRANSFUSION, V51, P1676, DOI 10.1111/j.1537-2995.2010.03008.x; Tormey CA, 2013, ARCH PATHOL LAB MED, V137, P861, DOI 10.5858/arpa.2012-0154-CR; Toy P, 2005, CRIT CARE MED, V33, P721, DOI 10.1097/01.CCM.0000159849.94750.51; Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932; Treleaven J, 2011, BRIT J HAEMATOL, V152, P35, DOI 10.1111/j.1365-2141.2010.08444.x; Uhlmann EJ, 2014, TRANSFUSION, V54, P384, DOI 10.1111/trf.12258; Unni N, 2014, TRANSFUSION, V54, P98, DOI 10.1111/trf.12251; VAMVAKAS EC, 1995, TRANSFUSION, V35, P26, DOI 10.1046/j.1537-2995.1995.35195090655.x; Van der Linden P, 2012, ACTA CLIN BELG, V67, P201, DOI 10.2143/ACB.67.3.2062656; Vichinsky EP, 2001, TRANSFUSION, V41, P1086, DOI 10.1046/j.1537-2995.2001.41091086.x; Vlaar APJ, 2013, LANCET, V382, P984, DOI 10.1016/S0140-6736(12)62197-7; Weinstock C, 2015, TRANSFUSION, V55, P605, DOI 10.1111/trf.12882; Weiskopf RB, 2005, TRANSFUSION, V45, P1295, DOI 10.1111/j.1537-2995.2005.00220.x; Whitaker BI, 2011, HHSP23320110008TC; Williamson LM, 2007, TRANSFUSION, V47, P1455, DOI 10.1111/j.1537-2995.2007.01281.x; WIN N, 1995, VOX SANG, V69, P138, DOI 10.1111/j.1423-0410.1995.tb01685.x; Win N, 2008, TRANSFUSION, V48, P1231, DOI 10.1111/j.1537-2995.2008.01693.x; Win N, 2010, TRANSFUS MED REV, V24, P64, DOI 10.1016/j.tmrv.2009.09.006; Winters JL, 2010, TRANSFUSION, V50, P1444, DOI 10.1111/j.1537-2995.2010.02609.x; Zavizion B, 2004, VOX SANG, V87, P143, DOI 10.1111/j.1423-0410.2004.00556.x	119	199	207	2	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2825	2836		10.1016/S0140-6736(15)01313-6	http://dx.doi.org/10.1016/S0140-6736(15)01313-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE5FB	27083327				2022-12-28	WOS:000389629800033
J	Komor, AC; Kim, YB; Packer, MS; Zuris, JA; Liu, DR				Komor, Alexis C.; Kim, Yongjoo B.; Packer, Michael S.; Zuris, John A.; Liu, David R.			Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage	NATURE			English	Article							CRISPR-CAS9 NUCLEASES; ENZYME APOBEC1; ENDONUCLEASE; PROTEINS	Current genome-editing technologies introduce double-stranded (ds) DNA breaks at a target locus as the first step to gene correction1,2. Although most genetic diseases arise from point mutations, current approaches to point mutation correction are inefficient and typically induce an abundance of random insertions and deletions (indels) at the target locus resulting from the cellular response to dsDNA breaks(1,2). Here we report the development of 'base editing', a new approach to genome editing that enables the direct, irreversible conversion of one target DNA base into another in a programmable manner, without requiring dsDNA backbone cleavage or a donor template. We engineered fusions of CRISPR/Cas9 and a cytidine deaminase enzyme that retain the ability to be programmed with a guide RNA, do not induce dsDNA breaks, and mediate the direct conversion of cytidine to uridine, thereby effecting a C -> T (or G -> A) substitution. The resulting 'base editors' convert cytidines within a window of approximately five nucleotides, and can efficiently correct a variety of point mutations relevant to human disease. In four transformed human and murine cell lines, second-and third-generation base editors that fuse uracil glycosylase inhibitor, and that use a Cas9 nickase targeting the non-edited strand, manipulate the cellular DNA repair response to favour desired base-editing outcomes, resulting in permanent correction of similar to 15-75% of total cellular DNA with minimal (typically <= 1%) indel formation. Base editing expands the scope and efficiency of genome editing of point mutations.	[Komor, Alexis C.; Kim, Yongjoo B.; Packer, Michael S.; Zuris, John A.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Komor, Alexis C.; Kim, Yongjoo B.; Packer, Michael S.; Zuris, John A.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Liu, DR (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022; Huang, ZhiXin/H-5123-2017	Huang, ZhiXin/0000-0003-0705-1970; Kim, Yongjoo Bill/0000-0002-2560-8931; Komor, Alexis/0000-0001-5043-0998	US National Institutes of Health (NIH) [R01 EB022376]; F-Prime Biomedical Research Initiative [A28161]; Howard Hughes Medical Institute; Ruth L. Kirchstein National Research Service [F32 GM 112366-2]; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship (NSERC PGS-D); Harvard Biophysics NIH training grant [T32 GM008313]; Ruth L. Kirschstein National Research Service Award Postdoctoral Fellow [F32 GM 106601-2]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106601, F32GM112366] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F-Prime Biomedical Research Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ruth L. Kirchstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship (NSERC PGS-D); Harvard Biophysics NIH training grant; Ruth L. Kirschstein National Research Service Award Postdoctoral Fellow; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) R01 EB022376 (formerly R01 GM065400), F-Prime Biomedical Research Initiative (A28161), and the Howard Hughes Medical Institute. A.C.K. is a Ruth L. Kirchstein National Research Service Awards Postdoctoral Fellow (F32 GM 112366-2). Y.B.K. holds a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship (NSERC PGS-D). M.S.P. is an NSF Graduate Research Fellow and was supported by the Harvard Biophysics NIH training grant T32 GM008313. J.A.Z. was a Ruth L. Kirschstein National Research Service Award Postdoctoral Fellow (F32 GM 106601-2). We thank B. Hyman and E. Hudry for providing immortalized mouse astrocytes containing APOE4.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hilton IB, 2015, GENOME RES, V25, P1442, DOI 10.1101/gr.190124.115; Jiang F., 2016, SCIENCE; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kunz C, 2009, CELL MOL LIFE SCI, V66, P1021, DOI 10.1007/s00018-009-8739-9; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Saraconi G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0417-z; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Seripa D, 2007, ANN HUM GENET, V71, P496, DOI 10.1111/j.1469-1809.2006.00344.x; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	33	2190	2480	104	1126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					420	+		10.1038/nature17946	http://dx.doi.org/10.1038/nature17946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27096365	Green Accepted, Green Submitted			2022-12-28	WOS:000376004300054
J	Kellum, JA; Ronco, C; Bellomo, R				Kellum, John A.; Ronco, Claudio; Bellomo, Rinaldo			Acute kidney disease and the community	LANCET			English	Editorial Material							CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE; INJURY; AKI		[Kellum, John A.] Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA 15261 USA; [Ronco, Claudio] San Bortolo Hosp, Int Renal Res Inst IRRIV, Dept Nephrol Dialysis & Transplantat, Vicenza, Italy; [Bellomo, Rinaldo] Austin Hosp, Dept Intens Care, Melbourne, Vic 3084, Australia; [Bellomo, Rinaldo] Austin Hosp, Dept Med, Melbourne, Vic 3084, Australia; [Bellomo, Rinaldo] Univ Melbourne, Melbourne, Vic, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Kellum, JA (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA 15261 USA.	kellumja@ccm.upmc.edu	Kellum, John/AAP-3072-2020; Kellum, John A/HCH-2944-2022	Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653; Ronco, Claudio/0000-0002-6697-4065; Bellomo, Rinaldo/0000-0002-1650-8939				Bihorac A, 2014, AM J RESP CRIT CARE, V189, P932, DOI 10.1164/rccm.201401-0077OC; Bouchard J, 2015, CLIN J AM SOC NEPHRO, V10, P1324, DOI 10.2215/CJN.04360514; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Kellum JA, 2016, AM J RESP CRIT CARE, V193, P281, DOI 10.1164/rccm.201505-0995OC; Kellum JA, 2012, JAMA-J AM MED ASSOC, V307, P2265, DOI 10.1001/jama.2012.4315; MacLeod A, 2009, LANCET, V374, P1405, DOI 10.1016/S0140-6736(09)61843-2; Mehta RL, 2016, LANCET, V387, P2017, DOI 10.1016/S0140-6736(16)30240-9; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Ronco C, 2014, BLOOD PURIFICAT, V38, pI; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wilson FP, 2015, LANCET, V385, P1966, DOI 10.1016/S0140-6736(15)60266-5	13	10	13	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					1974	1976		10.1016/S0140-6736(16)30239-2	http://dx.doi.org/10.1016/S0140-6736(16)30239-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL8HJ	27086172				2022-12-28	WOS:000375881500006
J	Bhogaraju, S; Dikic, I				Bhogaraju, Sagar; Dikic, Ivan			CELL BIOLOGY Ubiquitination without E1 and E2 enzymes	NATURE			English	Editorial Material							LEGIONELLA-PNEUMOPHILA; SYSTEM		[Bhogaraju, Sagar; Dikic, Ivan] Goethe Univ Frankfurt, Inst Biochem 2, Sch Med, D-60590 Frankfurt, Germany; [Bhogaraju, Sagar; Dikic, Ivan] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ Frankfurt, Inst Biochem 2, Sch Med, D-60590 Frankfurt, Germany.; Dikic, I (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511; Bhogaraju, Sagar/0000-0001-9998-5927				Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Barkauskaite E, 2015, MOL CELL, V58, P935, DOI 10.1016/j.molcel.2015.05.007; Glowacki G, 2002, PROTEIN SCI, V11, P1657, DOI 10.1110/ps.0200602; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Joazeiro CAP, 2000, SCIENCE, V289, P2061, DOI 10.1126/science.289.5487.2061; Maculins T, 2016, CELL RES, V26, P499, DOI 10.1038/cr.2016.30; Qiu JZ, 2016, NATURE, V533, P120, DOI 10.1038/nature17657; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Xu L, 2013, MICROBES INFECT, V15, P157, DOI 10.1016/j.micinf.2012.11.001	11	17	18	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					43	44		10.1038/nature17888	http://dx.doi.org/10.1038/nature17888			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27096359				2022-12-28	WOS:000375473900034
J	Clements, T; Dolocan, A; Martin, P; Purnell, MA; Vinther, J; Gabbott, SE				Clements, Thomas; Dolocan, Andrei; Martin, Peter; Purnell, Mark A.; Vinther, Jakob; Gabbott, Sarah E.			The eyes of Tullimonstrum reveal a vertebrate affinity	NATURE			English	Article							FOSSIL; ILLINOIS; PIGMENT; RECORD; CHARACTERS; COMPONENTS; EVOLUTION; FEATHERS; LAMPREY; HAGFISH	Tullimonstrum gregarium is an iconic soft-bodied fossil from the Carboniferous Mazon Creek Lagerstatte ( Illinois, USA)(1). Despite a large number of specimens and distinct anatomy, various analyses over the past five decades have failed to determine the phylogenetic affinities of the 'Tully monster', and although it has been allied to such disparate phyla as the Mollusca(2), Annelida(3),(4) or Chordata(5), it remains enigmatic(1-5). The nature and phylogenetic affinities of Tullimonstrum have defied confident systematic placement because none of its preserved anatomy provides unequivocal evidence of homology, without which comparative analysis fails. Here we show that the eyes of Tullimonstrum possess ultrastructural details indicating homology with vertebrate eyes. Anatomical analysis using scanning electron microscopy reveals that the eyes of Tullimonstrum preserve a retina defined by a thick sheet comprising distinct layers of spheroidal and cylindrical melanosomes. Time-offlight secondary ion mass spectrometry and multivariate statistics provide further evidence that these microbodies are melanosomes. A range of animals have melanin in their eyes, but the possession of melanosomes of two distinct morphologies arranged in layers, forming retinal pigment epithelium, is a synapomorphy of vertebrates. Our analysis indicates that in addition to evidence of colour patterning(6), ecology(7) and thermoregulation(8), fossil melanosomes can also carry a phylogenetic signal. Identification in Tullimonstrum of spheroidal and cylindrical melanosomes forming the remains of retinal pigment epithelium indicates that it is a vertebrate; considering its body parts in this new light suggests	[Clements, Thomas; Purnell, Mark A.; Gabbott, Sarah E.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Dolocan, Andrei] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA; [Martin, Peter; Vinther, Jakob] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Martin, Peter] Univ Bristol, HH Wills Phys Lab, Interface Anal Ctr, Bristol BS8 1TQ, Avon, England; [Vinther, Jakob] Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England	University of Leicester; University of Texas System; University of Texas Austin; University of Bristol; University of Bristol; University of Bristol	Gabbott, SE (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.; Vinther, J (corresponding author), Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England.; Vinther, J (corresponding author), Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England.	jakob.vinther@bristol.ac.uk; sg21@le.ac.uk	Vinther, Jakob/GZG-4679-2022; Purnell, Mark/A-2336-2010	Martin, Peter/0000-0003-3395-8656; Clements, Thomas/0000-0002-6563-4720; Purnell, Mark/0000-0002-1777-9220; Vinther, Jakob/0000-0002-3584-9616	Natural Environment Research Council [P14DF19, NE/K004557/1]; National Science Foundation [DMR-0923096]; Engineering and Physical Sciences Research Council [EP/K035746/1] Funding Source: researchfish; Natural Environment Research Council [1357873, NE/E015336/1] Funding Source: researchfish; EPSRC [EP/K035746/1] Funding Source: UKRI; NERC [NE/E015336/1, NE/K004557/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	W. Simpson, P. Mayer, S. Williams, D. Rudkin and K. Seymour are thanked for specimen access and loans. Funding was through a Natural Environment Research Council studentship P14DF19 (to T.C.) and grant NE/K004557/1 (to M.A.P. and S.E.G.). We also acknowledge the National Science Foundation grant DMR-0923096 used to purchase the TOF-SIMS instrument at Texas Materials Institute, UTA. D. Murdock, C. Nedza, S. Wentges and A. Clements are thanked for proofreading. S. Furzeland is thanked for scanning electron microscope optimization. P. Smith is thanked for Adobe Illustrator tutorials.	BARDACK D, 1977, Fieldiana Geology, V33, P489; BARDACK D, 1991, SCIENCE, V254, P701, DOI 10.1126/science.254.5032.701; BARDACK D, 1968, SCIENCE, V162, P1265, DOI 10.1126/science.162.3859.1265; Beall B.S., 1991, P271; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; Colleary C, 2015, P NATL ACAD SCI USA, V112, P12592, DOI 10.1073/pnas.1509831112; Donoghue PCJ, 2009, BIOESSAYS, V31, P178, DOI 10.1002/bies.200800128; Fein A., 1982, PHOTORECEPTORS THEIR, V5; Foster M.W., 1979, P269; Haacke C, 2001, J MORPHOL, V248, P41, DOI 10.1002/jmor.1019; Hase S, 2006, PIGM CELL RES, V19, P248, DOI 10.1111/j.1600-0749.2006.00306.x; JOHNSON R G, 1969, Fieldiana Geology, V12, P119; Kluessendorf J, 2000, PALAEONTOLOGY, V43, P919, DOI 10.1111/1475-4983.00155; Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105; Lindgren J, 2014, NATURE, V506, P484, DOI 10.1038/nature12899; Liu Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P510, DOI 10.1562/2004-10-19-RA-345.1; RICHARDSON ES, 1966, SCIENCE, V151, P75, DOI 10.1126/science.151.3706.75-a; Rieppel O, 2002, BIOL J LINN SOC, V75, P59, DOI 10.1046/j.1095-8312.2002.00006.x; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; Sallan LC, 2014, J VERTEBR PALEONTOL, V34, P22, DOI 10.1080/02724634.2013.782875; Sansom RS, 2013, PALAEONTOLOGY, V56, P457, DOI 10.1111/pala.12037; Sansom RS, 2011, P ROY SOC B-BIOL SCI, V278, P1150, DOI 10.1098/rspb.2010.1641; Sato S, 2001, PIGM CELL RES, V14, P428, DOI 10.1034/j.1600-0749.2001.140602.x; Schram F.R., 1991, P35; Shabica C.W., 1997, RICHARDSONS GUIDE FO; Speiser DI, 2014, J NAT HIST, V48, P2899, DOI 10.1080/00222933.2014.959572; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Vopalensky P, 2009, PHILOS T R SOC B, V364, P2819, DOI 10.1098/rstb.2009.0079; Wagner MS, 2004, SURF SCI, V570, P78, DOI 10.1016/j.susc.2004.06.184; WEIHS D, 1981, B MAR SCI, V31, P31	30	34	34	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					500	+		10.1038/nature17647	http://dx.doi.org/10.1038/nature17647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27074512	Green Submitted			2022-12-28	WOS:000374815900047
J	Pfeifer, GP				Pfeifer, Gerd P.			An elusive DNA base in mammals	NATURE			English	Editorial Material							ADENINE METHYLATION; N-6-ADENINE; ROLES		[Pfeifer, Gerd P.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA	Van Andel Institute	Pfeifer, GP (corresponding author), Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA.	gerd.pfeifer@vai.org						Bestor TH, 2015, P NATL ACAD SCI USA, V112, P6796, DOI 10.1073/pnas.1415301111; Dunwell TL, 2013, CELL CYCLE, V12, P3357, DOI 10.4161/cc.26540; Fedeles BI, 2015, J BIOL CHEM, V290, P20734, DOI 10.1074/jbc.R115.656462; Fu Y, 2015, CELL, V161, P879, DOI 10.1016/j.cell.2015.04.010; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Iyer LM, 2016, BIOESSAYS, V38, P27, DOI 10.1002/bies.201500104; Koziol MJ, 2016, NAT STRUCT MOL BIOL, V23, P24, DOI 10.1038/nsmb.3145; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Ratel D, 2006, BIOESSAYS, V28, P309, DOI 10.1002/bies.20342; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Wu TP, 2016, NATURE, V532, P329, DOI 10.1038/nature17640; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	15	5	8	0	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					319	320		10.1038/nature17315	http://dx.doi.org/10.1038/nature17315			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27027294				2022-12-28	WOS:000374424700021
J	Khajetoorians, AA; Heinrich, AJ				Khajetoorians, Alexander Ako; Heinrich, Andreas J.			PHYSICS Toward single-atom memory	SCIENCE			English	Editorial Material							MAGNETIC-ANISOTROPY		[Khajetoorians, Alexander Ako] Radboud Univ Nijmegen, NL-6525 AJ Nijmegen, Netherlands; [Heinrich, Andreas J.] IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA	Radboud University Nijmegen; International Business Machines (IBM)	Khajetoorians, AA (corresponding author), Radboud Univ Nijmegen, NL-6525 AJ Nijmegen, Netherlands.	a.khajetoorians@science.ru.nl	Khajetoorians, Alexander A/F-9698-2015					Baumann S, 2015, SCIENCE, V350, P417, DOI 10.1126/science.aac8703; Donati F, 2016, SCIENCE, V352, P318, DOI 10.1126/science.aad9898; Donati F, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.237201; Gambardella P, 2003, SCIENCE, V300, P1130, DOI 10.1126/science.1082857; Hubner C, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155134; Khajetoorians AA, 2013, SCIENCE, V339, P55, DOI 10.1126/science.1228519; Khajetoorians AA, 2011, SCIENCE, V332, P1062, DOI 10.1126/science.1201725; Loth S, 2012, SCIENCE, V335, P196, DOI 10.1126/science.1214131; Meier F, 2008, SCIENCE, V320, P82, DOI 10.1126/science.1154415; Meihaus KR, 2013, J AM CHEM SOC, V135, P17952, DOI 10.1021/ja4094814; Miyamachi T, 2013, NATURE, V503, P242, DOI 10.1038/nature12759; Rau IG, 2014, SCIENCE, V344, P988, DOI 10.1126/science.1252841; Steinbrecher M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10454	13	22	22	4	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					296	297		10.1126/science.aaf2481	http://dx.doi.org/10.1126/science.aaf2481			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081058				2022-12-28	WOS:000373990100023
J	Breitschwerdt, D; Feige, J; Schulreich, MM; de Avillez, MA; Dettbarn, C; Fuchs, B				Breitschwerdt, D.; Feige, J.; Schulreich, M. M.; de Avillez, M. A.; Dettbarn, C.; Fuchs, B.			The locations of recent supernovae near the Sun from modelling Fe-60 transport	NATURE			English	Article							INITIAL MASS FUNCTION; M-CIRCLE-DOT; GALACTIC DISK; STARS; NUCLEOSYNTHESIS; EARTH; HYDRODYNAMICS; ASSOCIATIONS; EXPLOSION; EVOLUTION	The signature of Fe-60 in deep-sea crusts indicates that one or more supernovae exploded in the solar neighbourhood about 2.2 million years ago(1-4). Recent isotopic analysis is consistent with a core-collapse or electron-capture supernova that occurred 60 to 130 parsecs from the Sun(5). Moreover, peculiarities in the cosmic ray spectrum point to a nearby supernova about two million years ago(6). The Local Bubble of hot, diffuse plasma, in which the Solar System is embedded, originated from 14 to 20 supernovae within a moving group, whose surviving members are now in the Scorpius-Centaurus stellar association(7,8). Here we report calculations of the most probable trajectories and masses of the supernova progenitors, and hence their explosion times and sites. The Fe-60 signal arises from two supernovae at distances between 90 and 100 parsecs. The closest occurred 2.3 million years ago at present-day galactic coordinates l = 327 degrees, b = 11 degrees, and the second-closest exploded about 1.5 million years ago at l = 343 degrees, b = 25 degrees, with masses of 9.2 and 8.8 times the solar mass, respectively. The remaining supernovae, which formed the Local Bubble, contribute to a smaller extent because they happened at larger distances and longer ago (Fe-60 has a half-life of 2.6 million years(9,10)). There are uncertainties relating to the nucleosynthesis yields and the loss of Fe-60 during transport, but they do not influence the relative distribution of Fe-60 in the crust layers, and therefore our model reproduces the measured relative abundances very well.	[Breitschwerdt, D.; Feige, J.; Schulreich, M. M.; de Avillez, M. A.] Berlin Inst Technol, Dept Astron & Astrophys, Hardenbergstr 36, D-10623 Berlin, Germany; [de Avillez, M. A.] Univ Evora, Dept Math, Rua Romao Ramalho 59, P-7000 Evora, Portugal; [Dettbarn, C.; Fuchs, B.] Heidelberg Univ, Zentrum Astron, Astron Rech Inst, Monchhofstr 12-14, D-69120 Heidelberg, Germany	Technical University of Berlin; University of Evora; Ruprecht Karls University Heidelberg	Breitschwerdt, D (corresponding author), Berlin Inst Technol, Dept Astron & Astrophys, Hardenbergstr 36, D-10623 Berlin, Germany.	breitschwerdt@astro.physik.tu-berlin.de		Schulreich, Michael/0000-0001-7761-9766; Feige, Jenny/0000-0002-3187-7898	DFG [1573]	DFG(German Research Foundation (DFG))	D.B., M.A.de.A. and M.M.S. acknowledge funding by the DFG priority program 1573 "Physics of the Interstellar Medium". We thank U. Bolick for help during the preparation of the manuscript and R. Teyssier for discussions on details of the RAMSES code.	Apellaniz JM, 2005, ASTROPHYS J, V629, P873, DOI 10.1086/431458; Athanassiadou T, 2011, NEW ASTRON, V16, P229, DOI 10.1016/j.newast.2010.09.007; Benitez N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.081101; Berghofer TW, 2002, ASTRON ASTROPHYS, V390, P299, DOI 10.1051/0004-6361:20020627; Bishop S., 2013, AM PHYS SOC APR M 20, V58; BLAAUW A, 1964, ANNU REV ASTRON ASTR, V2, P213, DOI 10.1146/annurev.aa.02.090164.001241; Boldyrev S, 2002, ASTROPHYS J, V569, P841, DOI 10.1086/339403; Breitschwerdt D, 2006, ASTRON ASTROPHYS, V452, pL1, DOI 10.1051/0004-6361:20064989; Davidson P. A., 2004, TURBULENCE INTRO SCI, P234; de Avillez MA, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201117172; de Avillez MA, 2002, ASTROPHYS J, V581, P1047, DOI 10.1086/344256; de Avillez MA, 2004, ASTRON ASTROPHYS, V425, P899, DOI 10.1051/0004-6361:200400025; De Avillez MA, 2007, ASTROPHYS J, V665, pL35, DOI 10.1086/521222; de Avillez MA, 2009, ASTROPHYS J LETT, V697, pL158, DOI 10.1088/0004-637X/697/2/L158; EGGER RJ, 1995, ASTRON ASTROPHYS, V294, pL25; Erlykin AD, 2015, J PHYS G NUCL PARTIC, V42, DOI 10.1088/0954-3899/42/11/115202; European Space Agency, 1997, ESA SPEC PUBL SP, VSP-1200; Feige J, 2013, EPJ WEB CONF, V63, DOI 10.1051/epjconf/20136303003; Feige J., 2014, THESIS U VIENNA; Ferland GJ, 1998, PUBL ASTRON SOC PAC, V110, P761, DOI 10.1086/316190; Ferriere K, 1998, ASTROPHYS J, V497, P759, DOI 10.1086/305469; Fields BD, 2005, ASTROPHYS J, V621, P902, DOI 10.1086/427797; Firestone RB, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/29; Fitoussi C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.121101; Fleck RC, 1996, ASTROPHYS J, V458, P739, DOI 10.1086/176853; Fry BJ, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/71; Fuchs B, 2006, MON NOT R ASTRON SOC, V373, P993, DOI 10.1111/j.1365-2966.2006.11044.x; Kachelriess M, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.181103; Kahn F. D., 1998, LECT NOTE PHYS, V506, P483; Knie K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.171103; Knie K, 1999, PHYS REV LETT, V83, P18, DOI 10.1103/PhysRevLett.83.18; KUIJKEN K, 1989, MON NOT R ASTRON SOC, V239, P605, DOI 10.1093/mnras/239.2.605; KUIJKEN K, 1989, MON NOT R ASTRON SOC, V239, P571, DOI 10.1093/mnras/239.2.571; Limongi M, 2006, ASTROPHYS J, V647, P483, DOI 10.1086/505164; Lindblad B., 1959, HDB PHYS, V11, P21; MASSEY P, 1995, ASTROPHYS J, V454, P151, DOI 10.1086/176474; MCCRAY R, 1987, ASTROPHYS J, V317, P190, DOI 10.1086/165267; Melott A. L., 2015, PREPRINT; Melott AL, 2015, INT J ASTROBIOL, V14, P375, DOI 10.1017/S1473550414000512; Poutivtsev M., 2007, THESIS TU MUNCHEN; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; Robitaille TP, 2010, ASTROPHYS J LETT, V710, pL11, DOI 10.1088/2041-8205/710/1/L11; Rugel G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.072502; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Savage BD, 2006, ASTROPHYS J SUPPL S, V162, P134, DOI 10.1086/497915; SCHALLER G, 1992, ASTRON ASTROPHYS SUP, V96, P269; Sedov L. I., 1993, SIMILARITY DIMENSION, P242; SHARMA P, 1987, NUCL INSTRUM METH B, V29, P335, DOI 10.1016/0168-583X(87)90261-8; TAYLOR G, 1950, PROC R SOC LON SER-A, V201, P175, DOI 10.1098/rspa.1950.0050; Teyssier R, 2002, ASTRON ASTROPHYS, V385, P337, DOI 10.1051/0004-6361:20011817; Wallner A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.041101; Wanajo S, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/1/L6; Wang L, 1996, GEOCHIM COSMOCHIM AC, V60, P109, DOI 10.1016/0016-7037(95)00379-7; Wasserburg GJ, 1998, ASTROPHYS J, V500, pL189, DOI 10.1086/311414; WEAVER R, 1977, ASTROPHYS J, V218, P377, DOI 10.1086/155692; Wielen R., 1982, LANDOLTBORNSTEIN NUM, V2, P225; Woosley SE, 2007, PHYS REP, V442, P269, DOI 10.1016/j.physrep.2007.02.009; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237	58	73	73	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					73	+		10.1038/nature17424	http://dx.doi.org/10.1038/nature17424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27078566				2022-12-28	WOS:000373555500035
J	Rahi, SJ; Pecani, K; Ondracka, A; Oikonomou, C; Cross, FR				Rahi, Sahand Jamal; Pecani, Kresti; Ondracka, Andrej; Oikonomou, Catherine; Cross, Frederick R.			The CDK-APC/C Oscillator Predominantly Entrains Periodic Cell-Cycle Transcription	CELL			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; G1 CYCLINS; POSITIVE FEEDBACK; MITOTIC EXIT; REGULATED GENES; INHIBITOR SIC1; BUDDING YEAST; S-PHASE; PHOSPHORYLATION; PROTEOLYSIS	Throughout cell-cycle progression, the expression of multiple transcripts oscillate, and whether these are under the centralized control of the CDK-APC/C proteins or can be driven by a de-centralized transcription factor (TF) cascade is a fundamental question for understanding cell-cycle regulation. In budding yeast, we find that the transcription of nearly all genes, as assessed by RNA-seq or fluorescence microscopy in single cells, is dictated by CDK-APC/C. Three exceptional genes are transcribed in a pulsatile pattern in a variety of CDK-APC/C arrests. Pursuing one of these transcripts, the SIC1 inhibitor of B-type cyclins, we use a combination of mathematical modeling and experimentation to provide evidence that, counter-intuitively, Sic1 provides a failsafe mechanism promoting nuclear division when levels of mitotic cyclins are low.	[Rahi, Sahand Jamal; Pecani, Kresti; Ondracka, Andrej; Oikonomou, Catherine; Cross, Frederick R.] Rockefeller Univ, Lab Cell Cycle Genet, 1230 York Ave, New York, NY 10065 USA; [Rahi, Sahand Jamal; Cross, Frederick R.] Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10065 USA; [Oikonomou, Catherine] CALTECH, 1200 E Calif Blvd, Pasadena, CA 91107 USA	Rockefeller University; Rockefeller University; California Institute of Technology	Rahi, SJ (corresponding author), Rockefeller Univ, Lab Cell Cycle Genet, 1230 York Ave, New York, NY 10065 USA.; Rahi, SJ (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10065 USA.	sjrahi@rockefeller.edu	Pecani, Kresti/N-1484-2017	Pecani, Kresti/0000-0002-1254-7025; Ondracka, Andrej/0000-0003-4193-6027; Oikonomou, Catherine/0000-0003-2312-4746	NIH grant [5RO1-GM078153-07]; NRSA Training Grant [CA009673-36A1]; Merck and Simons Foundation Postdoctoral Fellowships; NATIONAL CANCER INSTITUTE [T32CA009673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078153] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA Training Grant; Merck and Simons Foundation Postdoctoral Fellowships; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.J.R. thanks Nahal Mansouri for insightful discussions and Aleeza Kazmi for help with image processing. The work was supported by NIH grant 5RO1-GM078153-07 to F.R.C., NRSA Training Grant CA009673-36A1, and Merck and Simons Foundation Postdoctoral Fellowships to S.J.R.	AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Bristow SL, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0446-7; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; DIRICK L, 1991, NATURE, V351, P754, DOI 10.1038/351754a0; Drapkin BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.78; Haase SB, 2014, GENETICS, V196, P65, DOI 10.1534/genetics.113.152595; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; Oikonomou C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020788; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Procko A.G., 2011, THESIS ROCKEFELLER U; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Sbia M, 2008, J BIOL CHEM, V283, P11135, DOI 10.1074/jbc.M800196200; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Simmons Kovacs L.A., 2012, MOL CELL, V45, P669; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Toyn JH, 1997, GENETICS, V145, P85; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856	37	30	30	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					475	487		10.1016/j.cell.2016.02.060	http://dx.doi.org/10.1016/j.cell.2016.02.060			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058667	Green Accepted, Bronze			2022-12-28	WOS:000374123000024
J	Ghahramani, GK; Seline, AE; Wanat, KA				Ghahramani, Grant K.; Seline, Alison E.; Wanat, Karolyn A.			Postprocedural Blue Toes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHOLESTEROL CRYSTAL EMBOLIZATION; DISEASE		[Ghahramani, Grant K.; Seline, Alison E.; Wanat, Karolyn A.] Univ Iowa Hosp & Clin, Dept Dermatol, 200 Hawkins Dr, Iowa City, IA 52242 USA; [Wanat, Karolyn A.] Univ Iowa Hosp & Clin, Dept Dermatol & Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Wanat, KA (corresponding author), Univ Iowa Hosp & Clin, Dept Dermatol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	karolyn-wanat@uiowa.edu		Seline, Alison/0000-0003-3961-9428				Belenfant X, 1999, AM J KIDNEY DIS, V33, P840, DOI 10.1016/S0272-6386(99)70415-4; DAHLBERG PJ, 1989, SURGERY, V105, P737; Donohue KG, 2003, J EUR ACAD DERMATOL, V17, P504, DOI 10.1046/j.1468-3083.2003.00710.x; FINE MJ, 1987, ANGIOLOGY, V38, P769, DOI 10.1177/000331978703801007; Mayo RR, 1996, AM J MED, V100, P524, DOI 10.1016/S0002-9343(95)00059-3; Quinones A, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0315-y; Saric M, 2011, CURR OPIN CARDIOL, V26, P472, DOI 10.1097/HCO.0b013e32834b7fdd; Scolari F, 2007, CIRCULATION, V116, P298, DOI 10.1161/CIRCULATIONAHA.106.680991; SKLAR JL, 1993, INT J DERMATOL, V32, P607; THADHANI RI, 1995, MEDICINE, V74, P350, DOI 10.1097/00005792-199511000-00005	10	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1396	1397		10.1001/jama.2016.1810	http://dx.doi.org/10.1001/jama.2016.1810			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	27046368				2022-12-28	WOS:000373381500024
J	Desban, L; Wyart, C				Desban, Laura; Wyart, Claire			A brain conditioned for social defeat	SCIENCE			English	Editorial Material							ZEBRAFISH; HABENULA; FEAR; BEHAVIOR		[Desban, Laura; Wyart, Claire] GH Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Wyart, C (corresponding author), GH Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, F-75013 Paris, France.	claire.wyart@icm-institute.org	Wyart, Claire/AAB-4603-2020; Wyart, Claire/H-3783-2016	Wyart, Claire/0000-0002-1668-4975; Wyart, Claire/0000-0002-1668-4975; Desban, Laura/0000-0002-7624-9203				Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Chase ID, 2011, ADV GENET, V75, P51, DOI 10.1016/B978-0-12-380858-5.00001-0; Chou MY, 2016, SCIENCE, V352, P87, DOI 10.1126/science.aac9508; deCarvalho TN, 2014, GENESIS, V52, P636, DOI 10.1002/dvg.22785; Dreosti E, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00039; Dreosti E, 2014, CURR BIOL, V24, P440, DOI 10.1016/j.cub.2014.01.016; Fernald RD, 2014, COLD SH Q B, V79, P229, DOI 10.1101/sqb.2014.79.024752; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Misslin R, 2003, NEUROPHYSIOL CLIN, V33, P55, DOI 10.1016/S0987-7053(03)00009-1; Oliveira RF, 2016, P NATL ACAD SCI USA, V113, pE654, DOI 10.1073/pnas.1514292113; Oliveira RF, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00131; Oliveira RF, 2011, ZEBRAFISH, V8, P73, DOI 10.1089/zeb.2011.0690; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Yamaguchi T, 2013, NEURON, V78, P537, DOI 10.1016/j.neuron.2013.02.035	15	1	1	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					42	43		10.1126/science.aaf6016	http://dx.doi.org/10.1126/science.aaf6016			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034363				2022-12-28	WOS:000373039600025
J	Galeotti, S; DeConto, R; Naish, T; Stocchi, P; Florindo, F; Pagani, M; Barrett, P; Bohaty, SM; Lanci, L; Pollard, D; Sandroni, S; Talarico, FM; Zachos, JC				Galeotti, Simone; DeConto, Robert; Naish, Timothy; Stocchi, Paolo; Florindo, Fabio; Pagani, Mark; Barrett, Peter; Bohaty, Steven M.; Lanci, Luca; Pollard, David; Sandroni, Sonia; Talarico, Franco M.; Zachos, James C.			Antarctic Ice Sheet variability across the Eocene-Oligocene boundary climate transition	SCIENCE			English	Article							SEA-LEVEL; VICTORIA LAND; GLACIATION; RECORDS	About 34 million years ago, Earth's climate cooled and an ice sheet formed on Antarctica as atmospheric carbon dioxide (CO2) fell below similar to 750 parts per million (ppm). Sedimentary cycles from a drill core in the western Ross Sea provide direct evidence of orbitally controlled glacial cycles between 34 million and 31 million years ago. Initially, under atmospheric CO2 levels of >= 600 ppm, a smaller Antarctic Ice Sheet (AIS), restricted to the terrestrial continent, was highly responsive to local insolation forcing. A more stable, continental-scale ice sheet calving at the coastline did not form until similar to 32.8 million years ago, coincident with the earliest time that atmospheric CO2 levels fell below similar to 600 ppm. Our results provide insight into the potential of the AIS for threshold behavior and have implications for its sensitivity to atmospheric CO2 concentrations above present-day levels.	[Galeotti, Simone; Lanci, Luca] Univ Urbino Carlo Bo, Dipartimento Sci Pure & Appl, I-61029 Urbino, Italy; [DeConto, Robert] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Naish, Timothy; Barrett, Peter] Victoria Univ Wellington, Antarctic Res Ctr, Wellington, New Zealand; [Naish, Timothy] GNS Sci, POB 30368, Lower Hutt, New Zealand; [Stocchi, Paolo] NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, NL-1790 AB Den Burg, Texel, Netherlands; [Stocchi, Paolo] Univ Utrecht, NL-1790 AB Den Burg, Texel, Netherlands; [Florindo, Fabio] Ist Nazl Geofis & Vulcanol, I-00143 Rome, Italy; [Pagani, Mark] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Bohaty, Steven M.] Univ Southampton, Natl Oceanog Ctr, Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Pollard, David] Penn State Univ, Earth Syst Sci Ctr, State Coll, PA USA; [Sandroni, Sonia; Talarico, Franco M.] Univ Siena, Museo Nazl Antartide, Via Laterina 8, I-53100 Siena, Italy; [Talarico, Franco M.] Univ Siena, Dipartimento Sci Fis Terra & Ambiente, Via Laterina 8, I-53100 Siena, Italy; [Zachos, James C.] Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	University of Urbino; University of Massachusetts System; University of Massachusetts Amherst; Victoria University Wellington; GNS Science - New Zealand; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Istituto Nazionale Geofisica e Vulcanologia (INGV); Yale University; NERC National Oceanography Centre; University of Southampton; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Siena; University of Siena; University of California System; University of California Santa Cruz	Galeotti, S (corresponding author), Univ Urbino Carlo Bo, Dipartimento Sci Pure & Appl, I-61029 Urbino, Italy.	simone.galeotti@uniurb.it	Zachos, James C/A-7674-2008; Florindo, Fabio/M-1459-2019; Sandroni, Sonia/C-7188-2008; Florindo, Fabio/F-4119-2010; Florindo, Fabio/AAU-2548-2021; Lanci, Luca/J-8823-2015; talarico, franco/G-9472-2012	Zachos, James C/0000-0001-8439-1886; Florindo, Fabio/0000-0002-6058-9748; Sandroni, Sonia/0000-0002-7941-7145; Florindo, Fabio/0000-0002-6058-9748; Lanci, Luca/0000-0002-3389-6371; Galeotti, Simone/0000-0001-9636-9344; Stocchi, Paolo/0000-0002-1377-3817; talarico, franco/0000-0002-7254-4301; Naish, Tim/0000-0002-1185-9932	Programma Nazionale di Ricerche in Antartide (Italy) [PNRA 2004/4.09]; NSF [ANT-0424589, 1043018, OCE-1202632]; New Zealand Ministry of Business Innovation and Employment [C05X1001]; Natural Environment Research Council [NE/L007452/1] Funding Source: researchfish; Div Atmospheric & Geospace Sciences [1203910] Funding Source: National Science Foundation; NERC [NE/L007452/1] Funding Source: UKRI	Programma Nazionale di Ricerche in Antartide (Italy); NSF(National Science Foundation (NSF)); New Zealand Ministry of Business Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research is an outcome of a 2-year project (PNRA 2004/4.09) partly funded by Programma Nazionale di Ricerche in Antartide (Italy). Also supported by NSF grants ANT-0424589, 1043018, and OCE-1202632 and by New Zealand Ministry of Business Innovation and Employment contract C05X1001(TN). Data are available from www.pangaea.de/.	Billups K, 2003, EARTH PLANET SC LETT, V209, P181, DOI 10.1016/S0012-821X(03)00067-0; Bohaty SM, 2012, EARTH PLANET SC LETT, V317, P251, DOI 10.1016/j.epsl.2011.11.037; Coxall HK, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002021; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Ehrmann W, 2005, PALAEOGEOGR PALAEOCL, V229, P187, DOI 10.1016/j.palaeo.2005.06.022; FIELDING, 2001, TERR ANTARCT, V0008; Florindo F, 2005, GLOBAL PLANET CHANGE, V45, P207, DOI 10.1016/j.gloplacha.2004.09.009; Foster GL, 2013, P NATL ACAD SCI USA, V110, P1209, DOI 10.1073/pnas.1216073110; Galeotti S, 2012, PALAEOGEOGR PALAEOCL, V335, P84, DOI 10.1016/j.palaeo.2011.08.011; Gasson E., 2014, CLIM PAST DISCUSS, V9, P5701; Katz ME, 2008, NAT GEOSCI, V1, P329, DOI 10.1038/ngeo179; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Liu ZF, 2004, CHINESE SCI BULL, V49, P2190, DOI 10.1360/04wd0228; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Miller KG, 2008, GEOL SOC AM BULL, V120, P34, DOI 10.1130/B26105.1; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Naish TR, 2001, NATURE, V413, P719, DOI 10.1038/35099534; Olivetti V, 2013, TECTONOPHYSICS, V594, P80, DOI 10.1016/j.tecto.2013.03.017; Palike H, 2006, SCIENCE, V314, P1894, DOI 10.1126/science.1133822; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Patterson MO, 2014, NAT GEOSCI, V7, P841, DOI 10.1038/NGEO2273; Pearson PN, 2009, NATURE, V461, P1110, DOI 10.1038/nature08447; Pollard D, 2005, GLOBAL PLANET CHANGE, V45, P9, DOI 10.1016/j.gloplacha.2004.09.011; SANDRONI S, 2001, TERRA ANTARTICA, V0008; Wilson DS, 2013, GEOPHYS RES LETT, V40, P4305, DOI 10.1002/grl.50797; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	30	80	85	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					76	80		10.1126/science.aab0669	http://dx.doi.org/10.1126/science.aab0669			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034370	Green Accepted, Green Submitted			2022-12-28	WOS:000373039600038
J	Docherty, AB; O'Donnell, R; Brunskill, S; Trivella, M; Doree, C; Holst, L; Parker, M; Gregersen, M; de Almeida, JP; Walsh, TS; Stanworth, SJ				Docherty, Annemarie B.; O'Donnell, Rob; Brunskill, Susan; Trivella, Marialena; Doree, Carolyn; Holst, Lars; Parker, Martyn; Gregersen, Merete; de Almeida, Juliano Pinheiro; Walsh, Timothy S.; Stanworth, Simon J.			Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BLOOD-CELL TRANSFUSION; RANDOMIZED CONTROLLED-TRIAL; HIP FRACTURE; MYOCARDIAL-INFARCTION; ELDERLY-PATIENTS; ANEMIA; THRESHOLD; REQUIREMENTS; FEASIBILITY; MULTICENTER	OBJECTIVE To compare patient outcomes of restrictive versus liberal blood transfusion strategies in patients with cardiovascular disease not undergoing cardiac surgery. DESIGN Systematic review and meta-analysis. DATA SOURCES Randomised controlled trials involving a threshold for red blood cell transfusion in hospital. We searched (to 2 November 2015) CENTRAL, Medline, Embase, CINAHL, PubMed, LILACS, NHSBT Transfusion Evidence Library, ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, ISRCTN Register, and EU Clinical Trials Register. Authors were contacted for data whenever possible. TRIAL SELECTION Published and unpublished randomised controlled trials comparing a restrictive with liberal transfusion threshold and that included patients with cardiovascular disease. DATA EXTRACTION AND SYNTHESIS Data extraction was completed in duplicate. Risk of bias was assessed using Cochrane methods. Relative risk ratios with 95% confidence intervals were presented in all meta-analyses. Mantel-Haenszel random effects models were used to pool risk ratios. MAIN OUTCOME MEASURES 30 day mortality, and cardiovascular events. RESULTS 41 trials were identified; of these, seven included data on patients with cardiovascular disease. Data from a further four trials enrolling patients with cardiovascular disease were obtained from the authors. In total, 11 trials enrolling patients with cardiovascular disease (n= 3033) were included for meta-analysis (restrictive transfusion, n= 1514 patients; liberal transfusion, n= 1519). The pooled risk ratio for the association between transfusion thresholds and 30 day mortality was 1.15 (95% confidence interval 0.88 to 1.50, P= 0.50), with little heterogeneity (I-2= 14%). The risk of acute coronary syndrome in patients managed with restrictive compared with liberal transfusion was increased (nine trials; risk ratio 1.78, 95% confidence interval 1.18 to 2.70, P= 0.01, I-2= 0%). CONCLUSIONS The results show that it may not be safe to use a restrictive transfusion threshold of less than 80 g/L in patients with ongoing acute coronary syndrome or chronic cardiovascular disease. Effects on mortality and other outcomes are uncertain. These data support the use of a more liberal transfusion threshold (> 80 g/L) for patients with both acute and chronic cardiovascular disease until adequately powered high quality randomised trials have been undertaken in patients with cardiovascular disease.	[Docherty, Annemarie B.; Walsh, Timothy S.] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Docherty, Annemarie B.; O'Donnell, Rob; Walsh, Timothy S.] Royal Infirm Edinburgh NHS Trust, Crit Care Dept, Edinburgh, Midlothian, Scotland; [Brunskill, Susan; Trivella, Marialena; Stanworth, Simon J.] John Radcliffe Hosp, NHS Blood & Transplant, Systemat Review Initiat, Oxford OX3 9DU, England; [Doree, Carolyn] Univ Oxford, Ctr Stat Med, Oxford, England; [Holst, Lars] Copenhagen Univ Hosp, Rigshosp, Dept Intens Care, Copenhagen, Denmark; [Parker, Martyn] Peterborough & Stamford Hosp NHS Trust, Dept Orthopaed, Peterborough, Cambs, England; [Gregersen, Merete] Aarhus Univ, Dept Geriatr, Aarhus, Denmark; [de Almeida, Juliano Pinheiro] Univ Sao Paulo, Hosp Clin, Fac Med, Inst Canc,Surg Intens Care Unit, Sao Paulo, Brazil; [de Almeida, Juliano Pinheiro] Univ Sao Paulo, Hosp Clin, Fac Med, Inst Canc,Dept Anesthesiol, Sao Paulo, Brazil; [Stanworth, Simon J.] NHS Blood & Transplant Oxford Univ Hosp NHS Trust, Dept Haematol, Oxford, England	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Oxford; University of Oxford; Rigshospitalet; University of Copenhagen; Aarhus University; Universidade de Sao Paulo; Universidade de Sao Paulo; Oxford University Hospitals NHS Foundation Trust	Docherty, AB (corresponding author), Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.; Docherty, AB (corresponding author), Royal Infirm Edinburgh NHS Trust, Crit Care Dept, Edinburgh, Midlothian, Scotland.	annemarie.docherty@ed.ac.uk		O'Donnell, Rob/0000-0002-7708-3700; Gregersen, Merete/0000-0002-5365-7335; Docherty, Annemarie/0000-0001-8277-420X; Trivella, Marialena/0000-0003-4492-1760	Cancer Research UK [16895] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Association of Anaesthetists of Great Britain and Ireland, 2008, BLOOD TRANSF AN RED, V2; BERGAMIN F, 2014, CRIT CARE, V18, P112; BLAIR SD, 1986, BRIT J SURG, V73, P783, DOI 10.1002/bjs.1800731007; Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113; British Heart Foundation, 2015, CARD DIS STAT 2015; Brunskill SJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009699.pub2; Bush RL, 1997, AM J SURG, V174, P143, DOI 10.1016/S0002-9610(97)00073-1; Carson Jeffrey L, 2012, Cochrane Database Syst Rev, pCD002042, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Carson JL, 1998, TRANSFUSION, V38, P522, DOI 10.1046/j.1537-2995.1998.38698326331.x; Colomo A, 2008, HEPATOLOGY, V48, p413A; Cooper HA, 2011, AM J CARDIOL, V108, P1108, DOI 10.1016/j.amjcard.2011.06.014; de Almeida JP, 2015, ANESTHESIOLOGY, V122, P29, DOI 10.1097/ALN.0000000000000511; Deans KJ, 2007, CRIT CARE MED, V35, P1509, DOI 10.1097/01.CCM.0000266584.40715.A6; Docherty A, 2014, TRANSFUSION THRESHOL; Fan YX, 2014, ARCH GERONTOL GERIAT, V59, P181, DOI 10.1016/j.archger.2014.03.009; Fominskiy E, 2015, BRIT J ANAESTH, V115, P511, DOI 10.1093/bja/aev317; FORTUNE JB, 1987, J TRAUMA, V27, P243, DOI 10.1097/00005373-198703000-00003; Foss NB, 2009, TRANSFUSION, V49, P227, DOI 10.1111/j.1537-2995.2008.01967.x; Gregersen M, 2015, EUR J ORTHOP SURG TR; Gregersen M, 2015, ACTA ORTHOP, V86, P363, DOI 10.3109/17453674.2015.1006980; Grover M, 2006, VOX SANG, V90, P105, DOI 10.1111/j.1423-0410.2006.00730.x; Haberkern CM, 1997, BLOOD, V89, P1533; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HEBERT PC, 1995, JAMA-J AM MED ASSOC, V273, P1439, DOI 10.1001/jama.273.18.1439; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hochain P, 1996, GUT, V38, P154, DOI 10.1136/gut.38.1.154; Holst LB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1354; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Jairath V, 2015, LANCET, V386, P137, DOI 10.1016/S0140-6736(14)61999-1; KOSHY M, 1988, NEW ENGL J MED, V319, P1447, DOI 10.1056/NEJM198812013192204; Liu DX, 2015, CHINESE MED J-PEKING, V128, P1801, DOI 10.4103/0366-6999.159357; Lotke PA, 1999, J ARTHROPLASTY, V14, P647, DOI 10.1016/S0883-5403(99)90216-4; Mazza Bruno Franco, 2015, Rev. bras. ter. intensiva, V27, P36, DOI 10.5935/0103-507X.20150007; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Nagele P, 2013, AM HEART J, V166, P325, DOI 10.1016/j.ahj.2013.04.018; National Institute for Health and Clinical Excellence, 2015, TRANSF NICE GUID NG2; Nielsen K, 2012, TRANSFUSION MED, V22, P418, DOI 10.1111/j.1365-3148.2012.01196.x; Nielsen K, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-89; Nordic Cochrane Centre, 2014, REV MAN REVMAN COMP; Norfolk D., 2013, HDB TRANSFUSION MED; Ostermann M, 2014, CRIT CARE, V18, DOI 10.1186/cc13818; Palmer J, 1998, TRANSFUSION MED, V8, P52; Park SH, 2008, CANCER CHEMOTH PHARM, V62, P1, DOI 10.1007/s00280-007-0561-1; Parker MJ, 2013, INJURY, V44, P1916, DOI 10.1016/j.injury.2013.04.033; Patel NN, 2015, LANCET HAEMATOL, V2, pE543, DOI 10.1016/S2352-3026(15)00198-2; Prick BW, 2014, BJOG-INT J OBSTET GY, V121, P1005, DOI 10.1111/1471-0528.12531; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Shunemann H, 2011, COCHRANE COLLABORATI; So-Osman C, 2010, VOX SANG, V98, P56, DOI 10.1111/j.1423-0410.2009.01225.x; So-Osman C., 2004, VOX SANGUINIS S3, V87, P52; Tay J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-207; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Villarejo F., 1999, Acta Gastroenterologica Latinoamericana, V29, P261; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Walsh TS, 2013, CRIT CARE MED, V41, P2354, DOI 10.1097/CCM.0b013e318291cce4; Walsh TS, 2005, BRIT J ANAESTH, V94, P445, DOI 10.1093/bja/aei073; Webert KE, 2008, TRANSFUSION, V48, P81, DOI 10.1111/j.1537-2995.2007.01485.x; WEISS GB, 1982, LANCET, V1, P105; Wilkinson KL, 2011, TRANSFUS MED REV, V25, P145, DOI 10.1016/j.tmrv.2010.11.006; Wu Q., CLIN RES RESTRICTIVE; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; Zheng H, 2013, EXP THER MED, V5, P511, DOI 10.3892/etm.2012.834; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	72	139	143	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2016	352								i1351	10.1136/bmj.i1351	http://dx.doi.org/10.1136/bmj.i1351			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TF	27026510	Green Published, hybrid			2022-12-28	WOS:000373491500001
J	Del Trigo, M; Bergeron, S; Bernier, M; Amat-Santos, IJ; Puri, R; Campelo-Parada, F; Altisent, OAJ; Regueiro, A; Eigler, N; Rozenfeld, E; Pibarot, P; Abraham, WT; Rodes-Cabau, J				Del Trigo, Maria; Bergeron, Sebastien; Bernier, Mathieu; Amat-Santos, Ignacio J.; Puri, Rishi; Campelo-Parada, Francisco; Altisent, Omar Abdul-Jawad; Regueiro, Ander; Eigler, Neal; Rozenfeld, Erez; Pibarot, Philippe; Abraham, William T.; Rodes-Cabau, Josep			Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study	LANCET			English	Article							ATRIAL SEPTAL-DEFECTS; 6-MINUTE WALK TEST; TRANSCATHETER TREATMENT; NATRIURETIC PEPTIDES; ELDERLY-PATIENTS; DECOMPRESSION; MORBIDITY; MORTALITY; THERAPY	Background In patients with heart failure, interventions to reduce elevated left atrial pressure improve symptoms and reduce the risk of hospital admission. We aimed to assess the safety and potential efficacy of therapeutic left-to-right interatrial shunting in patients with heart failure with reduced ejection fraction. Methods We did this proof-of-principle cohort study at one centre in Canada. Patients (aged >= 18 years) with New York Heart Association (NYHA) class III chronic heart failure with reduced ejection fraction were enrolled under the Canadian special access programme. Shunt implants were done after transseptal catheterisation with transoesophageal echocardiographic guidance under general anaesthesia. Patients had clinical and echocardiography evaluations at baseline and months 1 and 3 after shunt implantation. Findings Between Oct 10, 2013, and March 27, 2015, we enrolled ten patients. The device was successfully implanted in all patients; no device-related or procedural adverse events occurred during follow-up. Transoesophageal echocardiography at 1 month showed that all shunts were patent, with no thrombosis or migration. From baseline to 3 month follow-up, we recorded improvements in NYHA classification (from class III to class II in seven [78%] of nine patients, from class III to class I in one [11%] patient, and no change in one [11%] patient; p=0.0004); quality of life, as assessed by the Duke Activity Status Index (from a mean score of 13 [SD 6.2] to 24.8 [12.9]; p=0.016) and the Kansas City Cardiomyopathy Questionnaire (from a mean score of 44.3 [SD 9.8] to 79.1 [13.0]; p=00001); and 6 min walk test distance (from a mean of 244 m [SD 112] to 318 m [134]; p=0016). Pulmonary capillary wedge pressure was reduced from a mean of 23 mm Hg (SD 5) at baseline to 17 mm Hg (8) at 3 months (p=0.035), with no changes in right atrial pressure, pulmonary arterial pressure, or pulmonary resistance. No patient was admitted to hospital for worsening heart failure. One (10%) patient was admitted to hospital with gastrointestinal bleeding at month 1; one (10%) patient died after incessant ventricular tachycardia storm, which led to terminal heart failure 2 months post-procedure. Interpretation This first-in-man experience with an implanted left-to-right interatrial shunt demonstrates initial safety and early beneficial clinical and haemodynamic outcomes in patients with heart failure with reduced ejection fraction. Further large-scale randomised studies are warranted.	[Del Trigo, Maria; Bergeron, Sebastien; Bernier, Mathieu; Amat-Santos, Ignacio J.; Puri, Rishi; Campelo-Parada, Francisco; Altisent, Omar Abdul-Jawad; Regueiro, Ander; Pibarot, Philippe; Rodes-Cabau, Josep] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ G1V 4G5, Canada; [Eigler, Neal; Rozenfeld, Erez] V Wave, Caesarea, Israel; [Abraham, William T.] Ohio State Univ, Columbus, OH 43210 USA	Laval University; Quebec Heart & Lung Institute; University System of Ohio; Ohio State University	Rodes-Cabau, J (corresponding author), Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ G1V 4G5, Canada.	josep.rodes@criucpq.ulaval.ca	Pibarot, Philippe/ABD-5300-2021; DEl Trigo, Maria/AAY-7532-2021; Altisent, Omar Abdul-Jawad/AAK-8164-2021; Amat-Santos, Ignacio J/AAG-8163-2021	Campelo-Parada, Francisco/0000-0003-1821-0658	V-Wave; V-Wave, Caesarea, Israel	V-Wave; V-Wave, Caesarea, Israel	V-Wave.; This study was partly funded by V-Wave, Caesarea, Israel.	Abraham WT, 2011, LANCET, V377, P658, DOI 10.1016/S0140-6736(11)60101-3; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Amat-Santos IJ, 2015, EUROINTERVENTION, V10, P1127, DOI 10.4244/EIJY14M05_07; BITTNER V, 1993, JAMA-J AM MED ASSOC, V270, P1702, DOI 10.1001/jama.270.14.1702; Cahalin LP, 1996, CHEST, V110, P325, DOI 10.1378/chest.110.2.325; del Rio CL, 2013, CIRCULATION, V128; Del Trigo M, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001943; Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI DOI 10.1016/S0735-1097(02)01862-4; Ewert P, 2001, CATHETER CARDIO INTE, V52, P177, DOI 10.1002/1522-726X(200102)52:2<177::AID-CCD1043>3.0.CO;2-G; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Januzzi JL, 2011, J AM COLL CARDIOL, V58, P1881, DOI 10.1016/j.jacc.2011.03.072; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Malek F, 2015, INT J CARDIOL, V187, P227, DOI 10.1016/j.ijcard.2015.03.198; Masson S, 2008, J AM COLL CARDIOL, V52, P997, DOI 10.1016/j.jacc.2008.04.069; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Richards M, 2013, JACC-HEART FAIL, V1, P192, DOI 10.1016/j.jchf.2013.02.004; Ritzema J, 2010, CIRCULATION, V121, P1086, DOI 10.1161/CIRCULATIONAHA.108.800490; Roberts E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h910; Seib PM, 1999, CATHETER CARDIO INTE, V46, P179, DOI 10.1002/(SICI)1522-726X(199902)46:2<179::AID-CCD13>3.3.CO;2-N; Sondergaard L, 2014, EUR J HEART FAIL, V16, P796, DOI 10.1002/ejhf.111; Spertus J, 2005, AM HEART J, V150, P707, DOI 10.1016/j.ahj.2004.12.010; Webb G, 2006, CIRCULATION, V114, P1645, DOI 10.1161/CIRCULATIONAHA.105.592055	23	75	87	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1290	1297		10.1016/S0140-6736(16)00585-7	http://dx.doi.org/10.1016/S0140-6736(16)00585-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27025435				2022-12-28	WOS:000372697500027
J	Sallis, JF; Cerin, E; Conway, TL; Adams, MA; Frank, LD; Pratt, M; Salvo, D; Schipperijn, J; Smith, G; Cain, KL; Davey, R; Kerr, J; Lai, PC; Mitas, J; Reis, R; Sarmiento, OL; Schofield, G; Troelsen, J; Van Dyck, D; De Bourdeaudhuij, I; Owen, N				Sallis, James F.; Cerin, Ester; Conway, Terry L.; Adams, Marc A.; Frank, Lawrence D.; Pratt, Michael; Salvo, Deborah; Schipperijn, Jasper; Smith, Graham; Cain, Kelli L.; Davey, Rachel; Kerr, Jacqueline; Lai, Poh-Chin; Mitas, Josef; Reis, Rodrigo; Sarmiento, Olga L.; Schofield, Grant; Troelsen, Jens; Van Dyck, Delfien; De Bourdeaudhuij, Ilse; Owen, Neville			Physical activity in relation to urban environments in 14 cities worldwide: a cross-sectional study	LANCET			English	Article							PUBLIC-HEALTH; IPEN ADULT; ACCELEROMETER; COMMUNITIES; INACTIVITY; SCIENCE; DISEASE; LIFE	Background Physical inactivity is a global pandemic responsible for over 5 million deaths annually through its effects on multiple non-communicable diseases. We aimed to document how objectively measured attributes of the urban environment are related to objectively measured physical activity, in an international sample of adults. Methods We based our analyses on the International Physical activity and Environment Network (IPEN) adult study, which was a coordinated, international, cross-sectional study. Participants were sampled from neighbourhoods with varied levels of walkability and socioeconomic status. The present analyses of data from the IPEN adult study included 6822 adults aged 18-66 years from 14 cities in ten countries on five continents. Indicators of walkability, public transport access, and park access were assessed in 1.0 km and 0.5 km street network buffers around each participant's residential address with geographic information systems. Mean daily minutes of moderate-to-vigorous-intensity physical activity were measured with 4-7 days of accelerometer monitoring. Associations between environmental attributes and physical activity were estimated using generalised additive mixed models with gamma variance and logarithmic link functions. Results Four of six environmental attributes were significantly, positively, and linearly related to physical activity in the single variable models: net residential density (exp[b] 1.006 [95% CI 1.003-1.009]; p=0.001), intersection density (1.069 [1.011-1.130]; p=0.019), public transport density (1.037 [1.018-1.056]; p=0.0007), and number of parks (1.146 [1.033-1.272]; p=0.010). Mixed land use and distance to nearest public transport point were not related to physical activity. The difference in physical activity between participants living in the most and least activity-friendly neighbourhoods ranged from 68 min/week to 89 min/week, which represents 45-59% of the 150 min/week recommended by guidelines. Interpretation Design of urban environments has the potential to contribute substantially to physical activity. Similarity of findings across cities suggests the promise of engaging urban planning, transportation, and parks sectors in efforts to reduce the health burden of the global physical inactivity pandemic.	[Sallis, James F.; Conway, Terry L.; Cain, Kelli L.; Kerr, Jacqueline] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Cerin, Ester] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Cerin, Ester] Australian Catholic Univ, Inst Hlth & Ageing, Melbourne, Vic, Australia; [Adams, Marc A.] Arizona State Univ, Sch Nutr & Hlth Promot, Tempe, AZ USA; [Adams, Marc A.] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Frank, Lawrence D.] Univ British Columbia, Sch Populat & Publ Hlth, Hlth & Community Design Lab, Vancouver, BC V5Z 1M9, Canada; [Frank, Lawrence D.] Univ British Columbia, Sch Community & Reg Planning, Hlth & Community Design Lab, Vancouver, BC V5Z 1M9, Canada; [Pratt, Michael] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Salvo, Deborah] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Michael & Susan Dell Ctr Hlth Living, Austin Reg Campus, Austin, TX USA; [Salvo, Deborah] Natl Inst Publ Hlth Mexico, Ctr Nutr & Hlth Res, Cuernavaca, Morelos, Mexico; [Schipperijn, Jasper; Troelsen, Jens] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Smith, Graham] Staffordshire Univ, Inst Environm Sustainabil & Regenerat, Stoke On Trent ST4 2DE, Staffs, England; [Davey, Rachel] Univ Canberra, Ctr Res & Act Publ Hlth, Bruce, ACT, Australia; [Lai, Poh-Chin] Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China; [Mitas, Josef] Palacky Univ, Fac Phys Culture, Inst Act Lifestyle, CR-77147 Olomouc, Czech Republic; [Reis, Rodrigo] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil; [Reis, Rodrigo] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil; [Sarmiento, Olga L.] Univ Los Andes, Sch Med, Bogota, Colombia; [Schofield, Grant] Auckland Univ Technol, Auckland, New Zealand; [Van Dyck, Delfien; De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Owen, Neville] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of California System; University of California San Diego; University of Hong Kong; Australian Catholic University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of British Columbia; University of British Columbia; Emory University; Rollins School Public Health; University of Texas System; University of Texas Health Science Center Houston; Instituto Nacional de Salud Publica; University of Southern Denmark; Staffordshire University; University of Canberra; University of Hong Kong; Palacky University Olomouc; Pontificia Universidade Catolica do Parana; Universidade Federal do Parana; Universidad de los Andes (Colombia); Auckland University of Technology; Ghent University; Baker Heart and Diabetes Institute	Sallis, JF (corresponding author), Univ Calif San Diego, San Diego, CA 92103 USA.	jsallis@ucsd.edu	Cerin, Ester/L-1271-2015; De+Bourdeaudhuij, Ilse/AAC-5528-2019; Mitáš, Josef/K-1760-2015; Adams, Marc/C-3513-2013; Cerin, Ester/Z-2011-2019; Reis, Rodrigo/F-7447-2012; Schipperijn, Jasper/AAF-5426-2020; Sarmiento, Olga L/AAS-4165-2020; Sallis, James F/D-3001-2014; Cain, Kelli/J-8283-2019; Van Dyck, Delfien/AAO-8981-2020	Cerin, Ester/0000-0002-7599-165X; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Mitáš, Josef/0000-0001-7219-931X; Adams, Marc/0000-0001-6310-1472; Cerin, Ester/0000-0002-7599-165X; Reis, Rodrigo/0000-0002-9872-9865; Schipperijn, Jasper/0000-0002-6558-7610; Sarmiento, Olga L/0000-0002-9190-3568; Sallis, James F/0000-0003-2555-9452; Lai, PC/0000-0003-2458-5405; Van Dyck, Delfien/0000-0003-1783-9075; Troelsen, Jens/0000-0001-8105-0349; Cain, Kelli/0000-0002-7934-9680; Salvo, Deborah/0000-0002-9726-0882	National Cancer Institute of National Institutes of Health [CA127296]; NATIONAL CANCER INSTITUTE [R01CA127296] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067350] Funding Source: NIH RePORTER	National Cancer Institute of National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for coordination of the IPEN adult study, including the present analysis, was provided by the National Cancer Institute of National Institutes of Health (CA127296) with studies in each country funded by different sources.	Adams MA, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-43; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Cain K., 2013, ACCELEROMETER SCORIN; Cao XY, 2009, TRANSPORT REV, V29, P359, DOI 10.1080/01441640802539195; Cerin E, 2014, MED SCI SPORT EXER, V46, P2253, DOI 10.1249/MSS.0000000000000367; Ding D, 2012, HEALTH PLACE, V18, P100, DOI 10.1016/j.healthplace.2011.08.021; Ewing R., 2008, GROWING COOLER EVIDE; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Frank LD, 2000, J PLAN EDUC RES, V20, P6, DOI 10.1177/073945600128992564; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Freedson PS, 2000, RES Q EXERCISE SPORT, V71, pS21, DOI 10.1080/02701367.2000.11082782; Gebel K, 2007, AM J PREV MED, V32, P361, DOI 10.1016/j.amepre.2007.01.020; Heath Gregory W, 2006, J Phys Act Health, V3, pS55, DOI 10.1123/jpah.3.s1.s55; Kerr J, 2013, J PHYS ACT HEALTH, V10, P581, DOI 10.1123/jpah.10.4.581; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Sallis JF, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0188-2; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Shoham DA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1435-9; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; WELK GJ, 2002, PHYS ACTIVITY ASSESS, P125; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Winkler EA, 2009, MED SCI SPORTS EXERC, V41, P171; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; World Health Organization, 2013, 66 WORLD HLTH ASS MA; World Health Organization, 2004, GLOB STRAT DIET PHYS	29	602	626	41	451	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2207	2217		10.1016/S0140-6736(15)01284-2	http://dx.doi.org/10.1016/S0140-6736(15)01284-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN1IZ	27045735	Green Submitted			2022-12-28	WOS:000376820800030
J	Lezaic, M				Lezaic, Marjana			MATERIALS SCIENCE Clockwork at the atomic scale	NATURE			English	Editorial Material									[Lezaic, Marjana] Forschungszentrum Julich, Quantum Theory Mat, Peter Grunberg Inst 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Lezaic, M (corresponding author), Forschungszentrum Julich, Quantum Theory Mat, Peter Grunberg Inst 1, D-52425 Julich, Germany.	m.lezaic@fz-juelich.de	Lezaic, Marjana/H-8510-2013	Lezaic, Marjana/0000-0002-7318-9444				ANDERSON PW, 1965, PHYS REV LETT, V14, P217, DOI 10.1103/PhysRevLett.14.217; Benedek NA, 2013, J PHYS CHEM C, V117, P13339, DOI 10.1021/jp402046t; Kim TH, 2016, NATURE, V533, P68, DOI 10.1038/nature17628; Puggioni D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4432; Shi YG, 2013, NAT MATER, V12, P1024, DOI [10.1038/nmat3754, 10.1038/NMAT3754]; VAUGHEY JT, 1991, CHEM MATER, V3, P935, DOI 10.1021/cm00017a032	6	5	5	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					38	39		10.1038/nature17890	http://dx.doi.org/10.1038/nature17890			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27096367				2022-12-28	WOS:000375473900030
J	McMurray, JJV; Krum, H; Abraham, WT; Dickstein, K; Kober, LV; Desai, AS; Solomon, SD; Greenlaw, N; Ali, MA; Chiang, YT; Shao, Q; Tarnesby, G; Massie, BM				McMurray, John J. V.; Krum, Henry; Abraham, William T.; Dickstein, Kenneth; Kober, Lars V.; Desai, Akshay S.; Solomon, Scott D.; Greenlaw, Nicola; Ali, M. Atif; Chiang, Yanntong; Shao, Qing; Tarnesby, Georgia; Massie, Barry M.		ATMOSPHERE Comm Investigator	Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME INHIBITORS; RANDOMIZED-TRIAL; MINIMIZE OUTCOMES; RENIN INHIBITOR; ATMOSPHERE; VALSARTAN; MORTALITY; SURVIVAL; CANDESARTAN	BACKGROUND Among patients with chronic heart failure, angiotensin-converting-enzyme (ACE) inhibitors reduce mortality and hospitalization, but the role of a renin inhibitor in such patients is unknown. We compared the ACE inhibitor enalapril with the renin inhibitor aliskiren (to test superiority or at least noninferiority) and with the combination of the two treatments (to test superiority) in patients with heart failure and a reduced ejection fraction. METHODS After a single-blind run-in period, we assigned patients, in a double-blind fashion, to one of three groups: 2336 patients were assigned to receive enalapril at a dose of 5 or 10 mg twice daily, 2340 to receive aliskiren at a dose of 300 mg once daily, and 2340 to receive both treatments (combination therapy). The primary composite outcome was death from cardiovascular causes or hospitalization for heart failure. RESULTS After a median follow-up of 36.6 months, the primary outcome occurred in 770 patients (32.9%) in the combination-therapy group and in 808 (34.6%) in the enalapril group (hazard ratio, 0.93; 95% confidence interval [ CI], 0.85 to 1.03). The primary outcome occurred in 791 patients (33.8%) in the aliskiren group (hazard ratio vs. enalapril, 0.99; 95% CI, 0.90 to 1.10); the prespecified test for noninferiority was not met. There was a higher risk of hypotensive symptoms in the combination-therapy group than in the enalapril group (13.8% vs. 11.0%, P = 0.005), as well as higher risks of an elevated serum creatinine level (4.1% vs. 2.7%, P = 0.009) and an elevated potassium level (17.1% vs. 12.5%, P<0.001). CONCLUSIONS In patients with chronic heart failure, the addition of aliskiren to enalapril led to more adverse events without an increase in benefit. Noninferiority was not shown for aliskiren as compared with enalapril.	[McMurray, John J. V.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Greenlaw, Nicola] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Krum, Henry] Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Abraham, William T.] Ohio State Univ, Davis Heart & Lung Res Inst, Div Cardiovasc Med, Columbus, OH 43210 USA; [Dickstein, Kenneth] Stavanger Univ Hosp, Stavanger, Norway; [Dickstein, Kenneth] Univ Bergen, Inst Internal Med, Bergen, Norway; [Kober, Lars V.] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark; [Desai, Akshay S.; Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA; [Ali, M. Atif; Chiang, Yanntong; Shao, Qing; Tarnesby, Georgia] Novartis Pharmaceut, Basel, Switzerland; [Massie, Barry M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Glasgow; University of Glasgow; Monash University; University System of Ohio; Ohio State University; Stavanger University Hospital; University of Bergen; Rigshospitalet; University of Copenhagen; Harvard University; Brigham & Women's Hospital; Novartis; University of California System; University of California San Francisco	McMurray, JJV (corresponding author), Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland.	john.mcmurray@glasgow.ac.uk	Urina-Triana, Miguel A/H-2605-2016; mcmurray, John/B-2467-2013; YILMAZ, Mehmet Birhan/Y-1372-2019; Bardaji, Alfredo/V-7985-2019; Murohara, Toyoaki/M-4958-2014; Juillière, Yves/AAG-1038-2020; Skibitsky, Vitaliy/O-9627-2017; Gislason, Gunnar/B-7561-2009; Kinugawa, Shintaro/E-1268-2012; Khokhlov, Alexander L./E-2765-2017; De Caterina, Raffaele/K-3857-2016; Nielsen, Olav Wendelboe/S-4390-2016; SOLOVEV, OLEG/Y-6307-2018; Bello, Natalie/J-1001-2019; Jhund, Pardeep/GLS-9508-2022; Desai, Akshay/ABE-7250-2020; Strongin, Leonid/ABD-1913-2020; Nedogoda, Sergey V/O-4656-2014; Senni, Michele/J-9380-2018; Khromtsova, Oksana M./F-4530-2018; sharma, kamal/AAG-7271-2019; Widimsky, Jiri/H-8647-2017; Gapon, Lyudmila I./S-6520-2016; Lowes, Brian/M-9020-2017; Mareev, Vyacheslav Yurievich/Q-1375-2017	Urina-Triana, Miguel A/0000-0001-6003-4622; mcmurray, John/0000-0002-6317-3975; YILMAZ, Mehmet Birhan/0000-0002-8169-8628; Bardaji, Alfredo/0000-0003-1900-6974; Juillière, Yves/0000-0002-6101-7530; Skibitsky, Vitaliy/0000-0002-4855-418X; Gislason, Gunnar/0000-0002-0548-402X; Khokhlov, Alexander L./0000-0002-0032-0341; De Caterina, Raffaele/0000-0003-1637-574X; Nielsen, Olav Wendelboe/0000-0003-3532-9431; SOLOVEV, OLEG/0000-0002-2590-9283; Bello, Natalie/0000-0003-3257-3623; Jhund, Pardeep/0000-0003-4306-5317; Strongin, Leonid/0000-0003-2645-2729; Nedogoda, Sergey V/0000-0001-5981-1754; Senni, Michele/0000-0001-5502-7882; Khromtsova, Oksana M./0000-0003-0763-0542; sharma, kamal/0000-0001-5866-2566; Widimsky, Jiri/0000-0001-8242-9705; Gapon, Lyudmila I./0000-0002-3620-0659; Isnard, Richard/0000-0002-3439-8104; Diaz Molina, Beatriz/0000-0002-7773-8121; Joho, Shuji/0000-0002-4443-1457; Romanens, Michel/0000-0002-2426-1542; Burkard, Thilo/0000-0001-6373-9820; Golba, Krzysztof/0000-0001-5722-7976; Lowes, Brian/0000-0002-5919-2540; Costa Duarte Barbosa, Eduardo/0000-0002-4361-936X; Mahon, Niall/0000-0002-2872-2297; Jaramillo, Monica/0000-0003-0100-5682; Kober, Lars/0000-0002-6635-1466; Orismar Sampaio, Roney/0000-0002-7566-2426; McDonald, Kenneth/0000-0001-8011-3301; URAL, DILEK/0000-0003-0224-1433; Guevara, Lempira/0000-0003-1871-5787; Lupon, Josep/0000-0002-5601-9611; Mareev, Vyacheslav Yurievich/0000-0002-7285-2048; Bozkurt, Biykem/0000-0002-6362-0253; Vazir, Ali/0000-0002-6706-7862; Joseph, Jacob/0000-0002-7279-4896; Gomez-Bueno, Manuel/0000-0002-9764-7518; Wachter, Rolf/0000-0003-2231-2200	Novartis	Novartis(Novartis)	Funded by Novartis; ATMOSPHERE ClinicalTrials.gov number, NCT00853658.	Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Gheorghiade M, 2013, JAMA-J AM MED ASSOC, V309, P1125, DOI 10.1001/jama.2013.1954; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Krum H, 2015, EUR J HEART FAIL, V17, P1075, DOI 10.1002/ejhf.408; Krum H, 2013, EUR J HEART FAIL, V15, P1205, DOI 10.1093/eurjhf/hft133; Krum H, 2011, EUR J HEART FAIL, V13, P107, DOI 10.1093/eurjhf/hfq212; Maggioni AP, 2013, EUR HEART J, V34, P3117, DOI 10.1093/eurheartj/eht342; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2008, CIRC-HEART FAIL, V1, P17, DOI 10.1161/CIRCHEARTFAILURE.107.740704; McMurray JJV, 2014, NEW ENGL J MED, V371, P2336, DOI 10.1056/NEJMc1412654; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; McMurray JJV, 2012, EUR J HEART FAIL, V14, P341, DOI 10.1093/eurjhf/hfs033; Oparil S, 2007, LANCET, V370, P221, DOI 10.1016/S0140-6736(07)61124-6; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Seed A, 2007, EUR J HEART FAIL, V9, P1120, DOI 10.1016/j.ejheart.2007.09.002; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Swedberg K, 2016, NEW ENGL J MED, V374, P1580, DOI 10.1056/NEJMsb1601674; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	22	153	157	0	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1521	1532		10.1056/NEJMoa1514859	http://dx.doi.org/10.1056/NEJMoa1514859			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7IA	27043774	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000374383900005
J	Walden, J				Walden, Jeffrey			Sins of the Fathers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TORTURE		[Walden, Jeffrey] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Walden, J (corresponding author), Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA.	jeffrey.walden@conehealth.com						Fassin D, 2005, AM ANTHROPOL, V107, P597, DOI 10.1525/aa.2005.107.4.597; Moreno A, 2008, J LEGAL MED, V29, P443, DOI 10.1080/01947640802494820; Nazario Sonia, 2006, ENRIQUES JOURNEY; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; Transactional Records Access Clearinghouse, 2014, TRAC IMM REPR UN CHI; Transactional Records Access Clearinghouse, 2015, IMM DEP P	6	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1569	1570		10.1001/jama.2016.0024	http://dx.doi.org/10.1001/jama.2016.0024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	27092828				2022-12-28	WOS:000374289300013
J	Kermode-Scott, B				Kermode-Scott, Barbara			Maurice Wood OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												kermodeb@gmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2016	353								i2129	10.1136/bmj.i2129	http://dx.doi.org/10.1136/bmj.i2129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EU	27081104				2022-12-28	WOS:000374375500008
J	Cousins, S				Cousins, Sophie			MATERNAL AND CHILD HEALTH Assam: India's state with the highest maternal mortality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophcousins@gmail.com						Mahanta TG, 2014, INDAN J COMMUNITY HE, V26, P301; National Health Mission, 2013, ASS STAT WIS INF; Reddy Hanimi, 2012, WHO South East Asia J Public Health, V1, P279, DOI 10.4103/2224-3151.207024; Sarma G., 2013, THE ECHO; WHO UNICEF UNFPA World Bank Group and United Nations Population Division Maternal Mortality Estimation Inter-Agency Group, 2015, MAT MORT 1990 2015; Zaman S, 2014, J OBSTET GYNAECOL BA, V1	6	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2016	353								i1908	10.1136/bmj.i1908	http://dx.doi.org/10.1136/bmj.i1908			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LO	27048471				2022-12-28	WOS:000373895300012
J	Csete, J; Kamarulzaman, A; Kazatchkine, M; Altice, F; Balicki, M; Buxton, J; Cepeda, J; Comfort, M; Goosby, E; Goulao, J; Hart, C; Kerr, T; Lajous, AM; Lewis, S; Martin, N; Mejia, D; Camacho, A; Mathieson, D; Obot, I; Ogunrombi, A; Sherman, S; Stone, J; Vallath, N; Vickerman, P; Zabransky, T; Beyrer, C				Csete, Joanne; Kamarulzaman, Adeeba; Kazatchkine, Michel; Altice, Frederick; Balicki, Marek; Buxton, Julia; Cepeda, Javier; Comfort, Megan; Goosby, Eric; Goulao, Joao; Hart, Carl; Kerr, Thomas; Lajous, Alejandro Madrazo; Lewis, Stephen; Martin, Natasha; Mejia, Daniel; Camacho, Adriana; Mathieson, David; Obot, Isidore; Ogunrombi, Adeolu; Sherman, Susan; Stone, Jack; Vallath, Nandini; Vickerman, Peter; Zabransky, Tomas; Beyrer, Chris			Public health and international drug policy	LANCET			English	Review							HEPATITIS-C-VIRUS; METHADONE-MAINTENANCE THERAPY; HEROIN-ASSISTED TREATMENT; SAFER INJECTION FACILITY; OPIATE SUBSTITUTION THERAPY; HIV ANTIRETROVIRAL THERAPY; DAR-ES-SALAAM; HUMAN-IMMUNODEFICIENCY-VIRUS; SUBSTANCE-ABUSE TREATMENT; MALE LIFE EXPECTANCY		[Csete, Joanne; Hart, Carl] Columbia Univ, New York, NY USA; [Kamarulzaman, Adeeba] Univ Malaya, Kuala Lumpur, Malaysia; [Kazatchkine, Michel] UN Special Envoy HIV Eastern Europe & Cent Asia, Geneva, Switzerland; [Altice, Frederick] Yale Univ, New Haven, CT USA; [Buxton, Julia] Cent European Univ, Budapest, Hungary; [Cepeda, Javier; Sherman, Susan; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA; [Comfort, Megan] RTI Int, Washington, DC USA; [Goosby, Eric] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Goulao, Joao] Minist Hlth, Lisbon, Portugal; [Kerr, Thomas] Univ British Columbia, Ctr Excellence HIV AIDS, Vancouver, BC V5Z 1M9, Canada; [Lajous, Alejandro Madrazo] Ctr Invest & Docencia Econ, Mexico City, DF, Mexico; [Lewis, Stephen] AIDS Free World, Toronto, ON, Canada; [Martin, Natasha] Univ Calif San Diego, San Diego, CA 92103 USA; [Mejia, Daniel; Camacho, Adriana] Univ Los Andes, Bogota, Colombia; [Mathieson, David] Human Rights Watch, Yangon, Myanmar; [Obot, Isidore] Univ Uyo, Uyo, Nigeria; [Ogunrombi, Adeolu] Youth Rise Nigeria, Lagos, Nigeria; [Stone, Jack; Vickerman, Peter] Univ Bristol, Bristol, Avon, England; [Vallath, Nandini] Trivandrum Inst Palliat Sci, Trivandrum, Kerala, India; [Zabransky, Tomas] Charles Univ Prague, Prague, Czech Republic	Columbia University; Universiti Malaya; Yale University; Central European University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Research Triangle Institute; University of California System; University of California San Francisco; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Centro de Investigacion y Docencia Economicas A.C. (CIDE); University of California System; University of California San Diego; Universidad de los Andes (Colombia); University of Uyo; University of Bristol; Charles University Prague	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St,E 7152, Baltimore, MD 21205 USA.	cbeyrer@jhu.edu	Adebiyi, Adeolu/AFT-1123-2022; Zabransky, Tomas W/M-1860-2016; Stone, Jack/L-9149-2019; Stone, Jack/AAS-5455-2021; stone, jack/H-9549-2016; Obot, Isidore/AAZ-8477-2020; Goulão, João A C B/L-2417-2018; KAMARULZAMAN, ADEEBA/B-5216-2010	Adebiyi, Adeolu/0000-0002-0385-0639; Stone, Jack/0000-0002-4584-0068; stone, jack/0000-0002-4584-0068; Martin, Natasha/0000-0001-8344-1810; camacho, adriana/0000-0001-8325-9015; Vickerman, Peter/0000-0002-8291-5890; Obot, Isidore/0000-0002-7207-0652; Zabransky, Tomas/0000-0002-2601-6508; Altice, Frederick/0000-0002-7860-693X	Open Society Foundation; Johns Hopkins University Center for AIDS Research; US National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID) [1P30AI094189]; Johns Hopkins Training Program in HIV Epidemiology and Prevention Science of the NIH/NIAID [1T32AI102623-01A1]; International AIDS Society, Geneva, Switzerland; University of Malaya High Impact Research Grant [HIRGA E000001-20001]; US National Institute on Drug Abuse [R01 DA037773-01A1]; Bill & Melinda Gates Foundation; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol, UK; UK Engineering and Physical Sciences Research Council (ESPRC); Engineering and Physical Sciences Research Council [1414884] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-049] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, T32AI102623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037773, R01DA029910] Funding Source: NIH RePORTER	Open Society Foundation; Johns Hopkins University Center for AIDS Research; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins Training Program in HIV Epidemiology and Prevention Science of the NIH/NIAID; International AIDS Society, Geneva, Switzerland; University of Malaya High Impact Research Grant; US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol, UK; UK Engineering and Physical Sciences Research Council (ESPRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Center for Public Health and Human Rights at Johns Hopkins served as the secretariat for the Johns Hopkins-Lancet Commission on Drug Policy and Health. The work of the Commission was partly supported by a grant to the Johns Hopkins Center for Public Health and Human Rights from the Open Society Foundation; the Johns Hopkins University Center for AIDS Research, a programme funded by the US National Institutes of Health (NIH) and National Institute of Allergy and Infectious Diseases (NIAID; 1P30AI094189) that supported CB and SGS; the Johns Hopkins Training Program in HIV Epidemiology and Prevention Science (1T32AI102623-01A1) of the NIH/NIAID, which supported JCe; and the International AIDS Society, Geneva, Switzerland. AK received funding from the University of Malaya High Impact Research Grant (HIRGA E000001-20001). NM and PV received funding from the US National Institute on Drug Abuse (R01 DA037773-01A1). PV was funded by the Bill & Melinda Gates Foundation-funded HIV modelling consortium and the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol, UK. JS acknowledges funding from the UK Engineering and Physical Sciences Research Council (ESPRC). The views expressed in this Commission are those of the authors and not necessarily those of the US NIH or the UK NHS, NIHR, or Department of Health. We acknowledge the contribution of people who contributed material for text boxes, including Daniel Wolfe, Howard Zucker, Anthony Annucci, Sharon Stancliff e, Malik Burnett, and Holly Catania, and the contribution of unpublished data from Romania by Christina Oprea.	Abrahams R, OPEN LETT REGARDING; Adimora AA, 2003, JAIDS-J ACQ IMM DEF, V34, P423, DOI 10.1097/00126334-200312010-00010; Oliveira MDA, 2009, J CLIN VIROL, V44, P200, DOI 10.1016/j.jcv.2008.12.008; Ahmed T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1404-3; Al-Darraji HAA, 2014, J SUBST ABUSE TREAT, V46, P144, DOI 10.1016/j.jsat.2013.08.023; Alexander L, 2014, DRUG ALCOHOL DEPEN, V138, P1, DOI 10.1016/j.drugalcdep.2014.02.006; Allen EJ, 2012, INT J DRUG POLICY, V23, P346, DOI 10.1016/j.drugpo.2012.07.006; Alpert M, 2013, INT J PRISON HEALTH, V9, P40, DOI 10.1108/17449201311310797; American Pharmacists Association, CVS PHARM EXP NAL AC; Amon JJ, 2014, INT J DRUG POLICY, V25, P13, DOI 10.1016/j.drugpo.2013.05.019; Andrews C, 2015, HEALTH AFFAIR, V34, P828, DOI 10.1377/hlthaff.2014.1330; [Anonymous], 2015, AIDS CHANG EV; [Anonymous], ECONOMIST; [Anonymous], 2011, GUID INT TUB CAS FIN; [Anonymous], 2006, IARC MON EV CARC RIS; [Anonymous], WORLD REPORT VIOLENC; Arroyo-Cobo JM, 2010, PUBLIC HEALTH, V124, P629, DOI 10.1016/j.puhe.2010.08.007; Aspinall EJ, 2014, INT J EPIDEMIOL, V43, P235, DOI 10.1093/ije/dyt243; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Atuesta Becerra L., 2014, ENDING DRUG WARS REP, P49; Atun R, 2010, INT J DRUG POLICY, V21, P103, DOI 10.1016/j.drugpo.2010.01.002; Bach P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1255-7; Bachhuber MA, 2014, JAMA INTERN MED, V174, P1668, DOI 10.1001/jamainternmed.2014.4005; Bachireddy C, 2014, DRUG ALCOHOL DEPEN, V134, P106, DOI 10.1016/j.drugalcdep.2013.09.020; Bandewar Sunita Vs, 2015, Indian J Med Ethics, V12, P77; Basu A, 2008, HEALTH ECON, V17, P927, DOI 10.1002/hec.1305; Bayoumi AM, 2008, CAN MED ASSOC J, V179, P1143, DOI 10.1503/cmaj.080808; Bazazi AR, 2015, INT J DRUG POLICY, V26, P675, DOI 10.1016/j.drugpo.2014.11.010; Beletsky L, 2014, INT J DRUG POLICY, V25, P105, DOI 10.1016/j.drugpo.2013.06.005; Biadglegne F, 2015, EPIDEMIOL INFECT, V143, P887, DOI 10.1017/S095026881400288X; Bird SM, 2015, DRUG-EDUC PREV POLIC, V22, P66, DOI 10.3109/09687637.2014.981509; Bocai A, 2010, HIV HBV HCV BEHAV SU; Bohnert ASB, 2011, DRUG ALCOHOL DEPEN, V113, P62, DOI 10.1016/j.drugalcdep.2010.07.008; Botescu A, 2012, HIV AIDS INJECTING D; Bozicevic I, 2013, CLIN MICROBIOL INFEC, V19, P917, DOI 10.1111/1469-0691.12313; Bretana NA, 2015, EMERG INFECT DIS, V21, P765, DOI 10.3201/eid2105.141832; Bridge J, 2016, INT J DRUG POLICY, V27, P132, DOI 10.1016/j.drugpo.2015.08.001; Brooner R, 1998, Public Health Rep, V113 Suppl 1, P129; Buavirat A, 2003, BRIT MED J, V326, P308, DOI 10.1136/bmj.326.7384.308; Burns K., 2009, WOMEN HARM REDUCTION; Burris S, 2011, PUBLIC HEALTH REP, V126, P22, DOI 10.1177/00333549111260S305; Butler T, 2007, AUST NZ J PUBL HEAL, V31, P44, DOI 10.1111/j.1753-6405.2007.00009.x; Buxton J., GLOBAL DRUG POLICY O; Camacho Adriana, 2015, 408 CTR GLOB DEV; Canadian HIV/ AIDS, DRUG POL OV PREV RES; Canadian HIV/AIDS Legal Network, 2006, LEG HLTH HUM RIGHTS; Cantor DJ, 2014, REFUG SURV Q, V33, P34, DOI 10.1093/rsq/hdu008; Canudas-Romo V, 2015, J EPIDEMIOL COMMUN H, V69, P28, DOI 10.1136/jech-2014-204237; Carpentier C., 2012, HOWARD J CRIM JUST, V51, P37, DOI [DOI 10.1111/J.1468-2311.2011.00677.X, 10.1111/j.1468-2311.2011.00677.x]; Carson A. E., 2015, PRISONERS IN 2014; Carson Ann, 2014, PRISONERS IN 2013; Carter CI, 2013, OPIOID OVERDOSE PREV; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Cassidy TA, 2014, PAIN MED, V15, P440, DOI 10.1111/pme.12295; Caulkins J.P., 2014, ENDING DRUG WARS REP, P16; Center for Gender and Refugee Studies, 2014, TREACH JOURN CHILD M; Cepeda JA, 2015, DRUG ALCOHOL DEPEN, V147, P196, DOI 10.1016/j.drugalcdep.2014.11.021; Chakrapani V, 2013, INT J PRISON HEALTH, V9, P82, DOI 10.1108/17449201311326952; Cherny NI, 2010, ANN ONCOL, V21, P615, DOI 10.1093/annonc/mdp581; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Chouvy PA, 2014, INT J DRUG POLICY, V25, P416, DOI 10.1016/j.drugpo.2014.01.001; Christian J., 2005, J CONTEMP CRIM JUST, V21, P31; Codd H., 2013, SHADOW PRISON FAMILI; Coffin PO, 2015, CURR HIV-AIDS REP, V12, P145, DOI 10.1007/s11904-014-0248-2; Coffin Phillip O, 2013, J Med Econ, V16, P1051, DOI 10.3111/13696998.2013.811080; Cole C, 2011, DRUG TEST ANAL, V3, P89, DOI 10.1002/dta.220; Collins J., 2014, ENDING DRUG WARS REP, P8; Comfort M., ANN AM ACAD IN PRESS; Comfort M, 2007, ANNU REV LAW SOC SCI, V3, P271, DOI 10.1146/annurev.lawsocsci.3.081806.112829; Comfort Megan, 2009, DOING TIME TOGETHER; Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443; Cook C, 2014, FUNDING CRISIS HARM; Csete J., 2011, BALANCING ACT POLICY; Csete J, 2014, ENDING DRUG WARS REP, P70; Csete J., 2010, MOUNTAINTOPS WHAT WO; Csete J, 2012, INT J DRUG POLICY, V23, P82, DOI 10.1016/j.drugpo.2011.07.011; Culbert GJ, 2016, AIDS BEHAV, V20, P1026, DOI 10.1007/s10461-015-1198-4; Culbert GJ, 2015, DRUG ALCOHOL DEPEN, V149, P71, DOI 10.1016/j.drugalcdep.2015.01.018; Dara M, 2015, INT J INFECT DIS, V32, P111, DOI 10.1016/j.ijid.2014.12.029; Daskalopoulou M, 2014, LANCET HIV, V1, pE22, DOI 10.1016/S2352-3018(14)70001-3; Davis CS, 2015, AM J PUBLIC HEALTH, V105, P1530, DOI 10.2105/AJPH.2015.302638; De Bortoli L, 2014, CHILD FAM SOC WORK, V19, P136, DOI 10.1111/cfs.12002; DeBeck K, 2009, ADDICTION, V104, P69, DOI 10.1111/j.1360-0443.2008.02387.x; Degenhardt L, 2007, REFERENCE GROUP THEM; Degenhardt L, 2015, ADDICTION, V110, P226, DOI 10.1111/add.12746; Degenhardt L, 2014, INT J DRUG POLICY, V25, P53, DOI 10.1016/j.drugpo.2013.08.004; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Degenhardt L, 2010, INT J DRUG POLICY, V21, P347, DOI 10.1016/j.drugpo.2009.11.007; Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126; Delcher C, 2015, DRUG ALCOHOL DEPEN, V150, P63, DOI 10.1016/j.drugalcdep.2015.02.010; Dennis BB, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-105; Desa U, 2016, TRANSF OUR WORLD 203; Deshpande A, 2015, CAN FAM PHYSICIAN, V61, pE372; Dolan K, 2015, INT J DRUG POLICY, V26, pS12, DOI 10.1016/j.drugpo.2014.10.012; Dolan K, 2010, EUR J EPIDEMIOL, V25, P143, DOI 10.1007/s10654-009-9421-0; Doltu S., PRESENTATION UNAIDS; Domoslawski A, 2011, DRUG POLICY PORTUGAL; Donny EC, 2005, ADDICTION, V100, P1496, DOI 10.1111/j.1360-0443.2005.01232.x; Drug Policy Alliance, 2015, FED LAWM INTR NAL PR; Dursteler KM, 2015, SUBST ABUSE REHABIL, V6, P61, DOI 10.2147/SAR.S50807; Espinosa V, 2015, AM STAT, V69, P17, DOI 10.1080/00031305.2014.965796; Eurasian Harm Reduction Network, AL ANN SERB IS LOS H; European Centre for Disease Prevention and Control, 2013, THEM REP PRIS MON IM; European Monitoring Centre for Drugs and Drug Abuse, 2015, PERSP DRUGS PREV OV; European Monitoring Centre for Drugs and Drug Addiction, 2011, GUID TREAT DRUG DEP; European Monitoring Centre for Drugs and Drug Addiction, 2015, EUR DRUG REP 2015 TR; European Monitoring Centre for Drugs and Drug Addiction, 2012, PRIS DRUGS EUR PROBL; European Monitoring Centre for Drugs and Drug Addiction, 2015, ALT PUN DRUG US OFF; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2011, STAT B; European Monitoring Centre on Drugs and Drug Addiction, HARM RED OV GREECE; Faggiano F., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002208; Fareed A, 2010, J ADDICT DIS, V29, P1, DOI 10.1080/10550880903436010; Fareed A, 2009, J ADDICT DIS, V28, P399, DOI 10.1080/10550880903183042; Farrell M, 2008, ADDICTION, V103, P251, DOI 10.1111/j.1360-0443.2007.02081.x; Farrell M, 2015, BRIT J PSYCHIAT, V207, P3, DOI 10.1192/bjp.bp.114.160986; Fawthrop T., 2015, DRUG FREE ASEAN 2015; Fischer B, 2007, J URBAN HEALTH, V84, P552, DOI 10.1007/s11524-007-9198-y; Fischer B, 2016, INT J DRUG POLICY, V27, P23, DOI 10.1016/j.drugpo.2015.08.007; Fishstein P., 2014, DESPAIR HOPE RURAL L; Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227; Fox E., DRUG TRADE FUELS FEM; Gallahue P., 2012, DEATH PENALTY DRUG O; Gallahue P., 2015, DRUGS DEATH PENALTY; Gallant J., DRUG ADDICTION ONTAR; German Federal Ministry for Economic Cooperation and Development, 2013, RETH APPR ALT DEV PR; Getahun H, 2013, B WORLD HEALTH ORGAN, V91, P154, DOI 10.2471/BLT.13.117267; Getahun H, 2012, CURR OPIN HIV AIDS, V7, P345, DOI 10.1097/COH.0b013e328354bd44; Ghani MA, 2015, INT J DRUG POLICY, V26, P175, DOI 10.1016/j.drugpo.2014.10.002; Giacomello Corina, 2014, NACLA REPORT AM, V42, P38; Girshick LoriB., 1996, SOLEDAD WOMEN WIVES; Global Commission on Drug Policy, 2015, NEG IMP DRUG CONTR P; Global Commission on Drug Policy, 2011, WAR ON DRUGS; Global Commission on HIV and the Law, 2012, HIV LAW RISKS RIGHTS; Government of Australia National Centre in HIV Epidemiology and Clinical Research, 2009, RET INV 2 EV COST EF; Government of the Russian Federation, HIV INF RUSS FED; Grau LE, 2011, AIDS BEHAV, V15, P45, DOI 10.1007/s10461-010-9775-z; Grebely J, 2015, J HEPATOL, V63, P779, DOI 10.1016/j.jhep.2015.06.014; Green KM, 2006, J MARRIAGE FAM, V68, P430, DOI 10.1111/j.1741-3737.2006.00262.x; Grillo I., LEGALIZATION MARIJUA; Guise A, 2014, CLIN INFECT DIS, V59, P743, DOI 10.1093/cid/ciu387; Gupta A, 2014, INT J TUBERC LUNG D, V18, P793, DOI 10.5588/ijtld.13.0208; Guttinger F, 2003, EUR ADDICT RES, V9, P73, DOI 10.1159/000068811; Guyton KZ, 2015, LANCET ONCOL, V16, P490, DOI 10.1016/S1470-2045(15)70134-8; Hagan H, 2003, AIDS, V17, P911, DOI 10.1097/00002030-200304110-00017; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Hall W, 2015, CLIN PHARMACOL THER, V97, P607, DOI 10.1002/cpt.110; Hall W, 2015, LANCET PSYCHIAT, V2, P292, DOI 10.1016/S2215-0366(15)00083-8; HAMMERSLEY R, 1995, ADDICTION, V90, P959, DOI 10.1046/j.1360-0443.1995.9079598.x; Hammett TM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-261; Harm Reduction International, 2015, 10 20 CALL RED RES W; Harm Reduction International, 2014, GLOB STAT HARM RED; Hayashi K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-733; Hayashi K, 2010, INT J DRUG POLICY, V21, P418, DOI 10.1016/j.drugpo.2010.03.002; Heinle Kimberly, 2015, DRUG VIOLENCE MEXICO; Hickman M, 2007, J VIRAL HEPATITIS, V14, P645, DOI 10.1111/j.1365-2893.2007.00855.x; Hoover J, 2009, HARM REDUCTION PRISO; Hope VD, 2011, J VIRAL HEPATITIS, V18, P262, DOI 10.1111/j.1365-2893.2010.01297.x; Horwitz S., JUSTICE DEP SET FREE; Hughes CE, 2012, DRUG ALCOHOL REV, V31, P101, DOI 10.1111/j.1465-3362.2011.00383.x; Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; Human Rights Watch, 2012, DEATH SENT AB PERS M; Human Rights Watch, 2012, TORT NAM TREATM HUM; Human Rights Watch, 2014, WORLD REP 2014 IND C; Hurt H, 2009, NEUROTOXICOL TERATOL, V31, P334, DOI 10.1016/j.ntt.2009.08.002; Iakobishvili E., 2012, CAUSE ALARM INCARCER; Ingold J., DENVER POST; International Labour Organization UNDP UNAIDS, 2012, JOINT STAT COMP DRUG; International Narcotics Control Board, 2014, ANN REP 2014; Iroh PA, 2015, AM J PUBLIC HEALTH, V105, pE5, DOI 10.2105/AJPH.2015.302635; Jeffries S, 2014, CAN J CRIMINOL CRIM, V56, P447, DOI 10.3138/cjccj.2014.S03; Johnson RC, 2009, J LAW ECON, V52, P251, DOI 10.1086/597102; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Gonzalez-Perez GJ, 2012, REV PANAM SALUD PUBL, V32, P335, DOI 10.1590/S1020-49892012001100003; Jurgens R., 2007, EVIDENCE ACTION SERI; Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0; Kalina K, 2007, J DRUG ISSUES, V37, P181, DOI 10.1177/002204260703700109; Kamarulzaman A, 2015, INT J DRUG POLICY, V26, pS33, DOI 10.1016/j.drugpo.2014.11.011; Keller J., JUDGE GRANTS INJUNCT; Kenny KS, 2015, INT J DRUG POLICY, V26, P1158, DOI 10.1016/j.drugpo.2015.05.024; Kerr T, 2006, BRIT MED J, V332, P220, DOI 10.1136/bmj.332.7535.220; Kerr T, 2005, LANCET, V366, P316, DOI 10.1016/S0140-6736(05)66475-6; Kerr T, 2005, INT J DRUG POLICY, V16, P210, DOI 10.1016/j.drugpo.2005.04.005; Kerr T, 2007, AM J PUBLIC HEALTH, V97, P1228, DOI 10.2105/AJPH.2006.086256; Kerr T, 2012, DRUG ALCOHOL DEPEN, V124, P108, DOI 10.1016/j.drugalcdep.2011.12.019; Kerr T, 2010, AM J PUBLIC HEALTH, V100, P1449, DOI 10.2105/AJPH.2009.178467; Keshavjee S, 2014, PARTNERS HLTH REPORT, V1, P4; Kheirandish P, 2009, J URBAN HEALTH, V86, P902, DOI 10.1007/s11524-009-9393-0; Ki-moon B., 2015, COMMUNICATION; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; King NB, 2014, AM J PUBLIC HEALTH, V104, pE32, DOI 10.2105/AJPH.2014.301966; Kopak AM, 2015, INT J PRISON HEALTH, V11, P4, DOI 10.1108/IJPH-07-2014-0023; Lambdin BH, 2014, CLIN INFECT DIS, V59, P735, DOI 10.1093/cid/ciu382; Lappalainen L, 2015, ADDICTION, V110, P1330, DOI 10.1111/add.12970; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Latin American Commission on Drugs and Democracy, 2010, DRUGS DEM PAR SHIFT; Latypov A, 2014, INT J DRUG POLICY, V25, P1155, DOI 10.1016/j.drugpo.2014.09.015; Laudet AB, 2010, J SUBST ABUSE TREAT, V38, P51, DOI 10.1016/j.jsat.2009.06.003; Ledebur K, 2013, STABILITY, V2, DOI 10.5334/sta.aw; Lee D, 2012, J INFECT DIS, V205, pS274, DOI 10.1093/infdis/jis042; Lee H, 2014, AM J PUBLIC HEALTH, V104, P421, DOI 10.2105/AJPH.2013.301504; Leece P, 2015, CAN MED ASSOC J, V187, P717, DOI 10.1503/cmaj.150329; Levine H., 2015, NEW YORK CITY POLICE, P117; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106899; Lin CQ, 2014, INT J DRUG POLICY, V25, P1066, DOI 10.1016/j.drugpo.2014.04.021; Lines R, DEATH PENALTY DRUG O; Luciani F, 2014, ADDICTION, V109, P1695, DOI 10.1111/add.12643; Lunze K, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19043; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; MacArthur GJ, 2014, INT J DRUG POLICY, V25, P34, DOI 10.1016/j.drugpo.2013.07.001; Madras B., 2015, 37 SESS WHO EXP COMM; Madrazo Lajous A., 2014, ENDING WAR DRUGS REP, P55; Maher L, 2001, CURRENT ISSUES CRIMI, V13, P5, DOI DOI 10.1080/10345329.2001.12036213; Mannelli P, 2013, INDIAN J MED RES, V137, P636; Mansfield D., 2011, ASSESSING SUPPLY SID; Mansfield D., 2005, ALTERNATIVE LIVELIHO; Mares A., 2011, RISE FEMICIDE WOMEN; Mari JD, 2013, DRUGS, V73, P1549, DOI 10.1007/s40265-013-0113-4; Marshall BDL, 2011, LANCET, V377, P1429, DOI 10.1016/S0140-6736(10)62353-7; Martin NK, 2016, HEPATOLOGY, V63, P1796, DOI 10.1002/hep.28497; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Matusow H, 2013, J SUBST ABUSE TREAT, V44, P473, DOI 10.1016/j.jsat.2012.10.004; MAYES LC, 1992, JAMA-J AM MED ASSOC, V267, P406, DOI 10.1001/jama.267.3.406; McAllister WB, 2012, LSE IDEAS, P10; McCollister KE, 2003, ADDICTION, V98, P1647, DOI 10.1111/j.1360-0443.2003.00541.x; McSweeney K, 2014, SCIENCE, V343, P489, DOI 10.1126/science.1244082; Mejia D, 2014, EFFECTS ENFORCEMENT; Mejia D, 2014, ENDING DRUG WARS, P26; Mejia D, 2013, 53 CEDE U LOS AND; Mejia Daniel, 2015, PLAN COLOMBIA ANAL E; Melendez-Torres GJ, 2016, CURR OPIN INFECT DIS, V29, P58, DOI 10.1097/QCO.0000000000000234; Menendez A, 2015, ECUADOR COLOMBIA SET; Metz VE, 2014, SUBST ABUS, V35, P309, DOI 10.1080/08897077.2014.909377; Mexican National Institute of Statistics and Geography, ADM REG DEATH; Milloy MJ, 2011, J INFECT DIS, V203, P1215, DOI 10.1093/infdis/jir032; Milloy MJ, 2009, ADDICTION, V104, P620, DOI 10.1111/j.1360-0443.2009.02541.x; Milloy MJ, 2008, DRUG ALCOHOL REV, V27, P693, DOI 10.1080/09595230801956157; Milloy MJS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-156; Minority Rights Group International, 2014, WORLD DIR MIN IND PE; Mitruka K, 2015, MMWR-MORBID MORTAL W, V64, P753, DOI 10.15585/mmwr.mm6428a2; Mohapatra S, 2015, ASIAN J PSYCHIATR, V14, P80, DOI 10.1016/j.ajp.2015.03.001; Momenghalibaf A., 2013, HEPATITIS C TREATMEN; Mounteney J, 2015, INT J DRUG POLICY, V26, P626, DOI 10.1016/j.drugpo.2015.04.003; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naning H., 2014, RETURN INVESTMENT CO; Network for Public Health Law, 2015, LEG INT RED OV MORT; Ni MJJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-572; Niculescu I, 2015, AIDS RES HUM RETROV, V31, P488, DOI 10.1089/aid.2014.0189; Nolan S, 2014, ADDICTION, V109, P2053, DOI 10.1111/add.12682; Nordt C, 2006, LANCET, V367, P1830, DOI 10.1016/S0140-6736(06)68804-1; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; O'Hara M., INT DRUG CRIME MEASU; O'Neill KL, 2014, SOC TEXT, V32, P11, DOI 10.1215/01642472-2703833; Open Society Foundations, 2013, PROT SERV POL SEX WO; Open Society Foundations, 2013, STOPP OV PEER BAS DI; Organization of American States, 2013, DRUG PROBL AM; Organization of American States Inter-American Commission of Women, 2014, WOM DRUGS AM POL WOR; Osorio J, 2015, J CONFLICT RESOLUT, V59, P1403, DOI 10.1177/0022002715587048; Pacula RL, 2015, J POLICY ANAL MANAG, V34, P7, DOI 10.1002/pam.21804; Pain & Policy Studies Group, 2014, ACH BAL STAT PAIN PO; Palmateer NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104515; Pan American Health Organization, 2011, IMPR ACC KEY POP COM; Panitchpakdi P., 2006, GLOB FUND OBS, V65, P4; Paone D, 2015, DRUG ALCOHOL DEPEN, V155, P298, DOI 10.1016/j.drugalcdep.2015.08.007; Paraskevis D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078941; Pardo B, 2014, INT J DRUG POLICY, V25, P727, DOI 10.1016/j.drugpo.2014.05.010; Penal Reform International, 2015, GLOB PRIS TRENDS 201; Perez Correa C, 2012, RESULTADOS PRIMERA E; Phipps C., WHO WERE 8 PEOPLE EX; Pinkerton SD, 2011, INT J DRUG POLICY, V22, P179, DOI 10.1016/j.drugpo.2011.03.003; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Polomeni P, 2014, INT J GEN MED, V7, P143, DOI 10.2147/IJGM.S53170; Prellwitz IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069033; Reddon H, 2014, AIDS BEHAV, V18, P740, DOI 10.1007/s10461-013-0584-z; Rehm J, 2005, DRUG ALCOHOL DEPEN, V79, P137, DOI 10.1016/j.drugalcdep.2005.01.005; Reinarman C, 2004, AM J PUBLIC HEALTH, V94, P836, DOI 10.2105/AJPH.94.5.836; Republic of Ecuador, 2008, APPL INST P UNPUB; Richie Beth., 2002, INVISIBLE PUNISHMENT, P136; Rihs-Middel M, 2005, HEROIN ASSISTED TREA; Rincon-Ruiz A, 2013, GEOFORUM, V46, P60, DOI 10.1016/j.geoforum.2012.12.009; Roberts A., 2010, WOMEN WHO INJECT DRU; Rosmarin A., 2012, DRUGS LAW HUM RIGHTS; Rozen L., HOLBROOKE IVE CHANGE; Salisbury DS, 2013, GEOJOURNAL, V78, P41, DOI 10.1007/s10708-011-9430-x; Sarafis P, 2014, LANCET INFECT DIS, V14, P180, DOI 10.1016/S1473-3099(14)70017-9; Sarang A, 2013, HEALTH POLICY PLANN, V28, P681, DOI 10.1093/heapol/czs107; Saucier R, 2014, PRIVATIZING CRUELTY, P123; Schluger NW, 2013, DRUG ALCOHOL DEPEN, V132, pS32, DOI 10.1016/j.drugalcdep.2013.07.012; Seelye KQ, HEROIN CRISIS WHITE; Sentencing Project, FACTS PRIS PEOPL PRI; Sentencing Project, TRENDS US CORR; Shalihu N, 2014, AIDS CARE, V26, P968, DOI 10.1080/09540121.2014.880398; Shen H, 2014, NATURE, V507, P407, DOI 10.1038/507407a; Shoptaw S, 2007, ADDICTION, V102, P130, DOI 10.1111/j.1360-0443.2006.01775.x; Small W, 2009, AIDS CARE, V21, P708, DOI 10.1080/09540120802511869; Snyder HN, 2014, ARRESTS US 1980 2012; SNYDER HOWARD N., 2012, ARRESTS US 1990 2010; Solomon KR, 2005, PREPARED INTERAMERIC; Statistics Canada, PRIS STAT 2013 14; Stover HJ, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-18; Stolberg Victor B, 2011, J Ethn Subst Abuse, V10, P126, DOI 10.1080/15332640.2011.573310; Strang J, 2015, BRIT J PSYCHIAT, V207, P5, DOI 10.1192/bjp.bp.114.149195; Strathdee SA, 1997, AIDS, V11, pF59, DOI 10.1097/00002030-199708000-00001; Strathdee SA, 2015, NEW ENGL J MED, V373, P397, DOI 10.1056/NEJMp1507252; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Stuckler D, 2008, P NATL ACAD SCI USA, V105, P13280, DOI 10.1073/pnas.0801200105; Sun HM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005997; Tanguay P, 2015, CHAMPION IDU INNOVAT; Taylor A, 2013, ADDICTION, V108, P1296, DOI 10.1111/add.12107; Nguyen TV, 2016, AIDS BEHAV, V20, P2357, DOI 10.1007/s10461-015-1265-x; Ti LP, 2015, PREV SCI, V16, P313, DOI 10.1007/s11121-014-0477-z; Todrys KW, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-8; Tran OC, 2015, JAIDS-J ACQ IMM DEF, V69, pE43, DOI 10.1097/QAI.0000000000000582; Hoang TV, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0075-9; Treloar C, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0045-2; Tsui JI, 2014, JAMA INTERN MED, V174, P1974, DOI 10.1001/jamainternmed.2014.5416; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; Turney K, 2014, J HEALTH SOC BEHAV, V55, P302, DOI 10.1177/0022146514544173; Tyndall MW, 2003, AIDS, V17, P887, DOI 10.1097/00002030-200304110-00014; UK Home Office, 2014, INT COMP; UN Commission on Narcotic Drugs, 2014, JOINT MIN STAT 2014; UN General Assembly, 1998, POL DECL UN GEN ASS; UN High Commissioner for Human Rights, 2015, HUM RIGHTS COUNC 30; UN International Drug Control Programme, 1998, KEY STAT ILL DRUG PR; UN Offi ce on Drugs and Crime, 2015, WORLD DRUG REP; UN Office on Drugs and Crime, 2015, UN WOM WHO INT NETW; UN Office on Drugs and Crime, 2015, EST PLUR BOL MON CUL; UN Office on Drugs and Crime, 2014, SE AS OP SURV 2014 L; UN Office on Drugs and Crime, 2008, MAK DRUG CONTR FIT P; UN Office on Drugs and Crime, BOL REACC UN DRUG CO; UN Office on Drugs and Crime, DRUG US TRAFF SEN ST; UN Office on Drugs and Crime, 2014, 23 SESS COMM CRIM PR; UN Office on Drugs and Crime Government of Colombia, 2015, COL COC CULT SURV 20; UN Office on Drugs and Crime Government of Colombia, 2014, COL COC CULT SURV 20; UN Office on Drugs and Crime National Drug Commission of Peru, 2015, PER MON CULT COC 201; UN Office on Drugs and Crime Regional Centre for East Asia and the Pacific, 2008, DRUG FREE ASEAN 2015; UN Office on Drugs and Crime UNAIDS World Bank, 2007, HIV PRIS SUB SAH AFR; UN Office on Drugs and WHO UNAIDS UNDP International Labour Organization, 2013, POL BRIEF HIV PREV T; UN Women, 2014, GEND PERSP IMP DRUG; UNAIDS, ALT ACT COMP DET INN; UNAIDS, COUNTR REP UKR; UNAIDS, 2014, THE GAP REP; UNDP, 2015, ADDR DEV DIM DRUG PO; UNDP, REQ PROP NAT SURV DR; Ungar L., FUNDING BAN NEEDLE E; United Nations Economic and Social Council, 2010, UN RUL TREATM WOM PR; United Nations Office on Drugs and Crime, 2008, WORLD DRUG REP; United Nations Office on Drugs and Crime, 2004, SUBST AB TREATM CAR; United Nations Office on Drugs and Crime, 2009, COERC COH TREAT DRUG; University of New South Wales, INJ DRUG US REF GROU; UNODC, 2012, TRANSN ORG CRIM CENT; Uprimny R, 2013, ADDICTED PUNISHMENT; Urban Health Research Initiative, 2009, DRUG SIT VANC; US Centers for Disease Control and Prevention, CDC VIT AIGNS TOD HE; Vagenas P, 2013, DRUG ALCOHOL DEPEN, V132, pS25, DOI 10.1016/j.drugalcdep.2013.07.010; van Amsterdam Jan, 2015, Curr Drug Abuse Rev, V8, P3; van Amsterdam J, 2015, J PSYCHOPHARMACOL, V29, P655, DOI 10.1177/0269881115581980; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vanichseni S, 2015, AM J PUBLIC HEALTH, V105, P1136, DOI 10.2105/AJPH.2014.302473; Vickerman P, 2014, INT J DRUG POLICY, V25, P1163, DOI 10.1016/j.drugpo.2014.09.013; Vickerman P, 2013, DRUG ALCOHOL DEPEN, V132, P172, DOI 10.1016/j.drugalcdep.2013.01.020; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; VOCAL-NY Users Union, 2015, METH IMPR HLTH EMP P; Vu MQ, 2011, ADDICTION, V106, P583, DOI 10.1111/j.1360-0443.2010.03175.x; Wakefield S, 2013, CHILDREN PRISON BOOM; Wakeman Sarah E., 2010, HIV Therapy, V4, P505, DOI 10.2217/HIV.10.35; Walmsley R, 2018, WORLD PRISON POPULAT; Watt G, 2014, SERVICE EVALUATION S; Werb D, 2013, AIDS BEHAV, V17, P68, DOI 10.1007/s10461-012-0136-y; West African Commission on Drugs, 2014, NOT JUST TRANS DRUGS; Westergaard RP, 2013, CURR OPIN INFECT DIS, V26, P10, DOI 10.1097/QCO.0b013e32835c1dd0; Westergaard RP, 2011, CLIN INFECT DIS, V53, P725, DOI 10.1093/cid/cir491; White B, 2014, MED J AUSTRALIA, V201, P326, DOI 10.5694/mja13.00153; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2012, DRUG RES TUB FREQ AS; WHO, 2015, POL GUID INT COLL TB; WHO, 2014, COMM MAN OP OV; WHO, 2014, GUID SCREEN CAR TREA; WHO, 2014, CONS GUID HIV PREV D; WHO/ Europe UN Office on Drugs and Crime, 2013, GOOD GOV PRIS HLTH 2; WHO Expert Committee on Drug Dependence, 2015, 37 EXP COMM DRUG DEP; WHO Regional Office for the Western Pacific, 2009, CLIN GUID WITHDR MAN; WHO UN Office on Drugs and Crime, 2004, UN JOINT PROGR HIV A; WHO UN Office on Drugs and Crime UN Joint Programme on HIV/ AIDS, 2008, POL GUID COLL TB HIV; WHO UN Office on Drugs and Crime UN Population Fund, 2015, HIV YOUNG MEN WHO HA; WHO Western Pacific Regional Office, 2009, ASS COMP TREATM PEOP; Widman L, 2014, INT J STD AIDS, V25, P348, DOI 10.1177/0956462413505999; Wildeman C., 2013, REV BLACK POLITICAL, V40, P39, DOI DOI 10.1007/S12114-011-9112-4; Wildeman C, 2013, WOMEN HEALTH ISS, V23, pE335, DOI 10.1016/j.whi.2013.07.006; Wildeman C, 2012, ANNU REV LAW SOC SCI, V8, P11, DOI 10.1146/annurev-lawsocsci-102510-105459; Wildeman C, 2012, AM SOCIOL REV, V77, P216, DOI 10.1177/0003122411436234; Wilson D, 2007, PLOS MED, V4, P988, DOI 10.1371/journal.pmed.0040204; Wilson DP, 2015, INT J DRUG POLICY, V26, pS5, DOI 10.1016/j.drugpo.2014.11.007; Withnall A., SWITZERLAND CHANGES; WODAK A, 2004, EFFECTIVENESS STERIL; Wolfe D, 2015, INT J DRUG POLICY, V26, P1072, DOI 10.1016/j.drugpo.2015.05.007; Wolfe D., 2012, DEATH DRUG TREATMENT; Wolfe D, 2007, INT J DRUG POLICY, V18, P246, DOI 10.1016/j.drugpo.2007.01.012; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2006, INT J DRUG POLICY, V17, P55, DOI 10.1016/j.drugpo.2005.12.007; Wood E, 2005, PUBLIC HEALTH, V119, P1111, DOI 10.1016/j.puhe.2005.05.006; Wood E, 2005, PUBLIC HEALTH REP, V120, P150, DOI 10.1177/003335490512000208; Wood E, 2003, JAIDS-J ACQ IMM DEF, V34, P116, DOI 10.1097/00126334-200309010-00019; Wood E, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-13; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; World Health Organization, 2011, ENS BAL NAT POL CONT; World Health Organization, 2014, GLOB TUB REP; World Health Organization United Nations Office on Drugs and Crime United Nations Programme on HIV/AIDS, 2012, TECHN GUID COUNTR SE; Xing Y, 2012, AIDS CARE, V24, P756, DOI 10.1080/09540121.2011.630359; Zabransky T, 2004, J DRUG ISSUES, V34, P661, DOI 10.1177/002204260403400309; Zezima K., COMMUNICATION	417	292	301	5	107	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1427	1480		10.1016/S0140-6736(16)00619-X	http://dx.doi.org/10.1016/S0140-6736(16)00619-X			54	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI0WH	27021149	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000373217500035
J	Martin, RE				Martin, Rainer E.			Going with the flow	SCIENCE			English	Editorial Material							MULTISTEP SYNTHESIS; CHEMISTRY		[Martin, Rainer E.] F Hoffmann La Roche Ltd, Med Chem, Roche Pharmaceut Res & Early Dev PRED, Roche Innovat Ctr Basel, Grenzacherstr 124, CH-4070 Basel, Switzerland	Roche Holding	Martin, RE (corresponding author), F Hoffmann La Roche Ltd, Med Chem, Roche Pharmaceut Res & Early Dev PRED, Roche Innovat Ctr Basel, Grenzacherstr 124, CH-4070 Basel, Switzerland.	rainer_e.martin@roche.com	Martin, Rainer E./AAB-4525-2020	Martin, Rainer E./0000-0001-7895-497X				Adamo A, 2016, SCIENCE, V352, P61, DOI 10.1126/science.aaf1337; Anastas P.T., 1998, GREEN CHEM THEORY PR; Baxendale IR, 2006, CHEM COMMUN, P2566, DOI 10.1039/b600382f; Hessel V, 2013, CHEMSUSCHEM, V6, P746, DOI 10.1002/cssc.201200766; Hopkin MD, 2010, CHEM COMMUN, V46, P2450, DOI 10.1039/c001550d; Kobayashi S, 2016, CHEM-ASIAN J, V11, P425, DOI 10.1002/asia.201500916; Levesque F, 2012, ANGEW CHEM INT EDIT, V51, P1706, DOI 10.1002/anie.201107446; Malet-Sanz L, 2012, J MED CHEM, V55, P4062, DOI 10.1021/jm2006029; McQuade DT, 2013, J ORG CHEM, V78, P6384, DOI 10.1021/jo400583m; Newton S, 2014, ANGEW CHEM INT EDIT, V53, P4915, DOI 10.1002/anie.201402056; Webb D, 2010, CHEM SCI, V1, P675, DOI 10.1039/c0sc00381f; Wegner J, 2011, CHEM COMMUN, V47, P4583, DOI 10.1039/c0cc05060a; Werner M, 2014, ANGEW CHEM INT EDIT, V53, P1704, DOI 10.1002/anie.201309301; Wiles C, 2009, FUTURE MED CHEM, V1, P1593, DOI 10.4155/FMC.09.132	14	4	4	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					44	45		10.1126/science.aaf3065	http://dx.doi.org/10.1126/science.aaf3065			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034365				2022-12-28	WOS:000373039600027
J	Ruben, A				Ruben, Adam			Of mice and mics	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					110	110		10.1126/science.352.6281.110	http://dx.doi.org/10.1126/science.352.6281.110			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034375				2022-12-28	WOS:000373039600045
J	Aslam, AM; Patel, AN				Aslam, Arif M.; Patel, Anand N.			Facial cutaneous squamous cell carcinoma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MOHS MICROGRAPHIC SURGERY; SKIN-CANCER; MALIGNANT-TRANSFORMATION; TRANSPLANT RECIPIENTS; ACTINIC KERATOSIS; RISK-FACTORS; METASTASIS; EXPERIENCE; MANAGEMENT; THERAPY		[Aslam, Arif M.; Patel, Anand N.] Nottingham NHS Treatment Ctr, Queens Med Ctr Campus, Nottingham NG7 2FT, England		Aslam, AM (corresponding author), Nottingham NHS Treatment Ctr, Queens Med Ctr Campus, Nottingham NG7 2FT, England.	a.aslam@doctors.org.uk						Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Anforth R, 2015, J AM ACAD DERMATOL, V72, P809, DOI 10.1016/j.jaad.2015.01.018; Brougham NDLS, 2012, J SURG ONCOL, V106, P811, DOI 10.1002/jso.23155; Criscione VD, 2009, CANCER-AM CANCER SOC, V115, P2523, DOI 10.1002/cncr.24284; de Berker D, 2007, BRIT J DERMATOL, V156, P222, DOI 10.1111/j.1365-2133.2006.07692.x; Diffey BL, 2005, BRIT J DERMATOL, V153, P679, DOI 10.1111/j.1365-2133.2005.06799.x; Edge SB, 2010, AJCC CANC STAGING MA, P301; English DR, 1998, INT J CANCER, V76, P628, DOI 10.1002/(SICI)1097-0215(19980529)76:5<628::AID-IJC3>3.0.CO;2-S; Fuchs A, 2007, DERMATOL SURG, V33, P1099, DOI 10.1111/j.1524-4725.2007.33224.x; Green A, 1996, AM J EPIDEMIOL, V144, P1034, DOI 10.1093/oxfordjournals.aje.a008875; HACKER SM, 1993, POSTGRAD MED, V93, P115; Hacker SM, 1993, POSTGRAD MED, V93, P125; Jennings Lorraine, 2010, J Clin Aesthet Dermatol, V3, P39; Lansbury Louise, 2013, BMJ, V347, pf6153, DOI 10.1136/bmj.f6153; Lehmann AR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-70; Leibovitch I, 2005, J AM ACAD DERMATOL, V53, P261, DOI 10.1016/j.jaad.2005.03.048; Leibovitch I, 2005, J AM ACAD DERMATOL, V53, P253, DOI 10.1016/j.jaad.2005.02.059; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Marcil I, 2000, ARCH DERMATOL, V136, P1524, DOI 10.1001/archderm.136.12.1524; MARKS R, 1988, LANCET, V1, P795, DOI 10.1016/s0140-6736(88)91658-3; Marks Robin, 1995, Journal of Dermatology (Tokyo), V22, P853, DOI 10.1111/j.1346-8138.1995.tb03935.x; Mehrany K, 2005, J AM ACAD DERMATOL, V53, P1067, DOI 10.1016/j.jaad.2005.08.055; Mohs FE, 1978, CHEMOSURGERY MICROSC; Moloney FJ, 2004, DERMATOL SURG, V30, P674, DOI 10.1111/j.1524-4725.2004.00155.x; Motley RJ, 2009, MULTIPROFESSIONAL GU; National Comprehensive Cancer Network, 2012, NCCN GUID VERS 01 20; National Institute for Health and Care Excellence, 2006, GUID CANC SERV IMPR; Otley CC, 2001, ARCH DERMATOL, V137, P459; Quaedvlieg PJF, 2006, EUR J DERMATOL, V16, P335; ROBINS P, 1981, J DERMATOL SURG ONC, V7, P800, DOI 10.1111/j.1524-4725.1981.tb00168.x; Robsahm TE, 2015, CANCER MED-US, V4, P472, DOI 10.1002/cam4.404; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; Scottish Intercollegiate Guidelines Network, 2014, MAN PRIM CUT SQUAM C; Singer JP, 2012, J HEART LUNG TRANSPL, V31, P694, DOI 10.1016/j.healun.2012.02.033; Zwald FO, 2011, J AM ACAD DERMATOL, V65, P253, DOI 10.1016/j.jaad.2010.11.062	35	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2016	352								i1513	10.1136/bmj.i1513	http://dx.doi.org/10.1136/bmj.i1513			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TW	27032668				2022-12-28	WOS:000373493300001
J	Lee, JD; Friedmann, PD; Kinlock, TW; Nunes, EV; Boney, TY; Hoskinson, RA; Wilson, D; McDonald, R; Rotrosen, J; Gourevitch, MN; Gordon, M; Fishman, M; Chen, DT; Bonnie, RJ; Cornish, JW; Murphy, SM; O'Brien, CP				Lee, Joshua D.; Friedmann, Peter D.; Kinlock, Timothy W.; Nunes, Edward V.; Boney, Tamara Y.; Hoskinson, Randall A., Jr.; Wilson, Donna; McDonald, Ryan; Rotrosen, John; Gourevitch, Marc N.; Gordon, Michael; Fishman, Marc; Chen, Donna T.; Bonnie, Richard J.; Cornish, James W.; Murphy, Sean M.; O'Brien, Charles P.			Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METHADONE-MAINTENANCE; BUPRENORPHINE; DEPENDENCE; ADDICTION; SEVERITY; OUTCOMES; TRIAL; JAIL	BACKGROUND Extended-release naltrexone, a sustained-release monthly injectable formulation of the full mu-opioid receptor antagonist, is effective for the prevention of relapse to opioid dependence. Data supporting its effectiveness in U.S. criminal justice populations are limited. METHODS In this five-site, open-label, randomized trial, we compared a 24-week course of extended-release naltrexone (Vivitrol) with usual treatment, consisting of brief counseling and referrals for community treatment programs, for the prevention of opioid relapse among adult criminal justice offenders (i.e., persons involved in the U.S. criminal justice system) who had a history of opioid dependence and a preference for opioid-free rather than opioid maintenance treatments and who were abstinent from opioids at the time of randomization. The primary outcome was the time to an opioid-relapse event, which was defined as 10 or more days of opioid use in a 28-day period as assessed by self-report or by testing of urine samples obtained every 2 weeks; a positive or missing sample was computed as 5 days of opioid use. Post-treatment follow-up occurred at weeks 27, 52, and 78. RESULTS A total of 153 participants were assigned to extended-release naltrexone and 155 to usual treatment. During the 24-week treatment phase, participants assigned to extended-release naltrexone had a longer median time to relapse than did those assigned to usual treatment (10.5 vs. 5.0 weeks, P<0.001; hazard ratio, 0.49; 95% confidence interval [CI], 0.36 to 0.68), a lower rate of relapse (43% vs. 64% of participants, P<0.001; odds ratio, 0.43; 95% CI, 0.28 to 0.65), and a higher rate of opioid-negative urine samples (74% vs. 56%, P<0.001; odds ratio, 2.30; 95% CI, 1.48 to 3.54). At week 78 (approximately 1 year after the end of the treatment phase), rates of opioid-negative urine samples were equal (46% in each group, P = 0.91). The rates of other prespecified secondary outcome measures - self-reported cocaine, alcohol, and intravenous drug use, unsafe sex, and reincarceration - were not significantly lower with extended-release naltrexone than with usual treatment. Over the total 78 weeks observed, there were no overdose events in the extended-release naltrexone group and seven in the usual-treatment group (P = 0.02). CONCLUSIONS In this trial involving criminal justice offenders, extended-release naltrexone was associated with a rate of opioid relapse that was lower than that with usual treatment. Opioid-use prevention effects waned after treatment discontinuation.	[Lee, Joshua D.; McDonald, Ryan; Gourevitch, Marc N.] NYU, Dept Populat Hlth, 227 E 30th St, New York, NY 10016 USA; [Lee, Joshua D.] NYU, Dept Med, Div Gen Internal Med & Clin Innovat, New York, NY USA; [Rotrosen, John] NYU, Dept Psychiat, New York, NY USA; [Nunes, Edward V.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, New York, NY USA; [Friedmann, Peter D.; Hoskinson, Randall A., Jr.; Wilson, Donna] Rhode Isl Hosp, Div Gen Internal Med, Dept Med, Providence, RI USA; [Friedmann, Peter D.; Hoskinson, Randall A., Jr.; Wilson, Donna] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Kinlock, Timothy W.; Gordon, Michael; Fishman, Marc] Univ Baltimore, Sch Criminal Justice, Friends Res Inst, Baltimore, MD 21201 USA; [Fishman, Marc] Maryland Treatment Ctr, Baltimore, MD USA; [Boney, Tamara Y.; Cornish, James W.; O'Brien, Charles P.] Univ Penn, Philadelphia, PA 19104 USA; [Cornish, James W.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Chen, Donna T.] Univ Virginia, Ctr Biomed Eth & Humanities, Sch Med, Charlottesville, VA USA; [Bonnie, Richard J.] Univ Virginia, Sch Law, Charlottesville, VA USA; [Murphy, Sean M.] Washington State Univ, Spokane, WA USA	New York University; New York University; New York University; Columbia University; New York State Psychiatry Institute; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; University System of Maryland; University of Baltimore; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Virginia; University of Virginia; Washington State University	Lee, JD (corresponding author), NYU, Dept Populat Hlth, 227 E 30th St, New York, NY 10016 USA.	joshua.lee@nyumc.org		Bonnie, Richard/0000-0003-2945-7699; Gourevitch, Marc/0000-0001-6865-2126; Lee, Joshua/0000-0003-3161-2950	National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024549, K24DA022412, R01DA024553, R01DA024555, P30DA040500, R01DA024550, R01DA024554] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by the National Institute on Drug Abuse	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bigelow GE, 2012, DRUG ALCOHOL DEPEN, V123, P57, DOI 10.1016/j.drugalcdep.2011.10.018; Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; Comer SD, 2002, PSYCHOPHARMACOLOGY, V159, P351, DOI 10.1007/s002130100909; Coviello DM, 2012, SUBST ABUS, V33, P48, DOI 10.1080/08897077.2011.609438; Gordon MS, 2008, ADDICTION, V103, P1333, DOI 10.1111/j.1360-0443.2008.002238.x; Gordon MS, 2015, SUBST ABUS, V36, P217, DOI 10.1080/08897077.2014.902787; Gordon MS, 2014, DRUG ALCOHOL DEPEN, V142, P33, DOI 10.1016/j.drugalcdep.2014.05.011; Kjome KL, 2011, SUBST ABUS-RES TREAT, V5, P1, DOI 10.4137/SART.S5452; Krupitsky E, 2011, LANCET, V377, P1506, DOI 10.1016/S0140-6736(11)60358-9; Lee JD, 2015, ADDICTION, V110, P1008, DOI 10.1111/add.12894; Lee JD, 2015, CONTEMP CLIN TRIALS, V41, P110, DOI 10.1016/j.cct.2015.01.005; Lee JD, 2012, SUBST ABUS, V33, P1, DOI 10.1080/08897077.2011.616797; Lee JD, 2010, J SUBST ABUSE TREAT, V39, P14, DOI 10.1016/j.jsat.2010.03.005; Magura S, 2009, DRUG ALCOHOL DEPEN, V99, P222, DOI 10.1016/j.drugalcdep.2008.08.006; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Nunn A, 2009, DRUG ALCOHOL DEPEN, V105, P83, DOI 10.1016/j.drugalcdep.2009.06.015; NURCO DN, 1993, J RES CRIME DELINQ, V30, P293, DOI 10.1177/0022427893030003003; Sobell L. C., 1995, ALCOHOL TIMELINE FOL; STOUT RL, 1994, J STUD ALCOHOL, P70, DOI 10.15288/jsas.1994.s12.70; WATKINS KE, 1992, AM J DRUG ALCOHOL AB, V18, P389, DOI 10.3109/00952999209051037	24	203	204	4	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1232	1242		10.1056/NEJMoa1505409	http://dx.doi.org/10.1056/NEJMoa1505409			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DH8ZM	27028913	Green Accepted, Bronze			2022-12-28	WOS:000373085500006
J	Chung, BC; Mashalidis, EH; Tanino, T; Kim, M; Matsuda, A; Hong, J; Ichikawa, S; Lee, SY				Chung, Ben C.; Mashalidis, Ellene H.; Tanino, Tetsuya; Kim, Mijung; Matsuda, Akira; Hong, Jiyong; Ichikawa, Satoshi; Lee, Seok-Yong			Structural insights into inhibition of lipid I production in bacterial cell wall synthesis	NATURE			English	Article							PENTAPEPTIDE TRANSLOCASE; MURAYMYCIN ANALOGS; ESCHERICHIA-COLI; HIGH-THROUGHPUT; MRAY; BIOSYNTHESIS; TOOLS; MODEL; STEP; SITE	Antibiotic-resistant bacterial infection is a serious threat to public health. Peptidoglycan biosynthesis is a well-established target for antibiotic development. MraY (phospho-MurNAc-pentapeptide translocase) catalyses the first and an essential membrane step of peptidoglycan biosynthesis. It is considered a very promising target for the development of new antibiotics, as many naturally occurring nucleoside inhibitors with antibacterial activity target this enzyme(1-4). However, antibiotics targeting MraY have not been developed for clinical use, mainly owing to a lack of structural insight into inhibition of this enzyme. Here we present the crystal structure of MraY from Aquifex aeolicus (MraY(AA)) in complex with its naturally occurring inhibitor, muraymycin D2 (MD2). We show that after binding MD2, MraY(AA) undergoes remarkably large conformational rearrangements near the active site, which lead to the formation of a nucleoside-binding pocket and a peptide-binding site. MD2 binds the nucleoside-binding pocket like a two-pronged plug inserting into a socket. Further interactions it makes in the adjacent peptide-binding site anchor MD2 to and enhance its affinity for MraY(AA). Surprisingly, MD2 does not interact with three acidic residues or the Mg2+ cofactor required for catalysis, suggesting that MD2 binds to MraY(AA) in a manner that overlaps with, but is distinct from, its natural substrate, UDP-MurNAc-pentapeptide. We have determined the principles of MD2 binding to MraY(AA), including how it avoids the need for pyrophosphate and sugar moieties, which are essential features for substrate binding. The conformational plasticity of MraY could be the reason that it is the target of many structurally distinct inhibitors. These findings can inform the design of new inhibitors targeting MraY as well as its paralogues, WecA and TarO.	[Chung, Ben C.; Mashalidis, Ellene H.; Lee, Seok-Yong] Duke Univ, Dept Biochem, Med Ctr, 303 Res Dr, Durham, NC 27710 USA; [Tanino, Tetsuya; Matsuda, Akira; Ichikawa, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nihi 6, Sapporo, Hokkaido 0600812, Japan; [Kim, Mijung; Hong, Jiyong] Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Hokkaido University; Duke University	Lee, SY (corresponding author), Duke Univ, Dept Biochem, Med Ctr, 303 Res Dr, Durham, NC 27710 USA.	seok-yong.lee@duke.edu	Ichikawa, Satoshi S/F-6915-2012		NIH [R01 GM100984]; Duke startup funds; JSPS [24102502, 25293026]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100984] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke startup funds; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data for this study were collected at beamlines NE-CAT 24-ID-C and SER-CAT 22-ID-D and at the Advanced Photon Source. We thank K. Yokoyama for advice and guidance throughout the project and Z. Johnson for manuscript reading. Initial X-ray screening of crystals was performed at the Duke macromolecular crystallography facility. This work was supported by NIH R01 GM100984 (S.-Y.L.) and Duke startup funds (S.-Y.L.). This work was also supported by the JSPS Grant-in-Aid for Scientific Research on Innovative Areas 'Chemical Biology of Natural Products' (S.I., grant number 24102502) and Scientific Research (B) (S.I., grant number 25293026).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Dabbagh B, 2008, BIOCHEMISTRY-US, V47, P8919, DOI 10.1021/bi8006274; Bernhardt TG, 2001, J BIOL CHEM, V276, P6093, DOI 10.1074/jbc.M007638200; Bogatcheva E, 2011, J ANTIMICROB CHEMOTH, V66, P578, DOI 10.1093/jac/dkq495; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Brandish PE, 1996, ANTIMICROB AGENTS CH, V40, P1640, DOI 10.1128/AAC.40.7.1640; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; Clarke TB, 2009, BIOCHEMISTRY-US, V48, P2675, DOI 10.1021/bi801993x; Dini C, 2002, BIOORG MED CHEM LETT, V12, P1209, DOI 10.1016/S0960-894X(02)00109-9; Dini C, 2000, BIOORG MED CHEM LETT, V10, P1839, DOI 10.1016/S0960-894X(00)00349-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gloster TM, 2012, NAT CHEM BIOL, V8, P683, DOI [10.1038/nchembio.1029, 10.1038/NCHEMBIO.1029]; Hirano S, 2005, ANGEW CHEM INT EDIT, V44, P1854, DOI 10.1002/anie.200462439; Ii K, 2010, J MED CHEM, V53, P3793, DOI 10.1021/jm100243n; Izumi M, 2009, CURR TOP MED CHEM, V9, P87, DOI 10.2174/156802609787354351; Koga T, 2004, J ANTIMICROB CHEMOTH, V54, P755, DOI 10.1093/jac/dkh417; Lecercle D, 2010, BIOORGAN MED CHEM, V18, P4560, DOI 10.1016/j.bmc.2010.04.023; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonald LA, 2002, J AM CHEM SOC, V124, P10260, DOI 10.1021/ja017748h; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; Nikonenko BV, 2009, ANTIMICROB AGENTS CH, V53, P3138, DOI 10.1128/AAC.00366-09; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; Rodolis MT, 2014, CHEM COMMUN, V50, P13023, DOI 10.1039/c4cc06516f; Shapiro AB, 2012, J BIOMOL SCREEN, V17, P662, DOI 10.1177/1087057112436885; Takeoka Y, 2014, ACS MED CHEM LETT, V5, P556, DOI 10.1021/ml5000096; Tanino T, 2011, J MED CHEM, V54, P8421, DOI 10.1021/jm200906r; Tanino T, 2011, ORG LETT, V13, P4028, DOI 10.1021/ol201527k; Tanino T, 2010, ACS MED CHEM LETT, V1, P258, DOI 10.1021/ml100057z; Tanino T, 2010, J ORG CHEM, V75, P1366, DOI 10.1021/jo9027193; Walsh CT, 2011, ACS CHEM BIOL, V6, P1000, DOI 10.1021/cb200284p; Wang R, 1997, BIOORGAN MED CHEM, V5, P661, DOI 10.1016/S0968-0896(97)00005-9; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h; Yamashita A, 2003, BIOORG MED CHEM LETT, V13, P3345, DOI 10.1016/S0960-894X(03)00671-1	36	75	76	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					557	+		10.1038/nature17636	http://dx.doi.org/10.1038/nature17636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27088606	Green Accepted			2022-12-28	WOS:000376443100046
J	Corley, DA; Haas, JS; Kobrin, S				Corley, Douglas A.; Haas, Jennifer S.; Kobrin, Sarah			Reducing Variation in the "Standard of Care" for Cancer Screening Recommendations From the PROSPR Consortium	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Corley, Douglas A.] Kaiser Permanente No Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA; [Haas, Jennifer S.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Kobrin, Sarah] NCI, Hlth Syst & Intervent Res Branch, Bethesda, MD 20892 USA	Kaiser Permanente; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Corley, DA (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	douglas.corley@kp.org		HAAS, JENNIFER/0000-0001-7227-851X	NCI NIH HHS [U54CA163261, 3U54CA163262-04S1, U54 CA163262, 3U54CA163308-04S1, U54CA163303, U54CA164336, U54CA163262, U01CA163304, 3U54CA163261-04S1, U54CA163313, U54CA163307, U54CA163308] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA163308, U54CA164336, U54CA163303, U54CA163307, U54CA163261, U54CA163262, U01CA163304, U54CA163313] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Centers for Disease Control and Prevention, NAT BREAST CERV CANC; Centers for Disease Control and Prevention, COL CANC CONTR PROGR; Centers for Medicare and Medicaid Services, DEC MEM SCREEN LUNG; Centers for Medicare and Medicaid Services, YOUR GUID MED PREV S YOUR GUID MED PREV S; Chubak J, 2016, CANCER EPIDEM BIOMAR, V25, P344, DOI 10.1158/1055-9965.EPI-15-0470; National Cancer Institute, SEER MED CANC TEST C; National Cancer Institute, 2011, POP BAS RES OPT SCRE	7	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2067	2068		10.1001/jama.2016.3067	http://dx.doi.org/10.1001/jama.2016.3067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27089237	Green Submitted, Green Accepted			2022-12-28	WOS:000375975300012
J	Joy, EA; Horne, BD; Bergstrom, S				Joy, Elizabeth A.; Horne, Benjamin D.; Bergstrom, Steven			Addressing Air Quality and Health as a Strategy to Combat Climate Change	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							POLLUTION; EXPOSURE		[Joy, Elizabeth A.] Intermt Healthcare, Community Hlth, 36 South State St, Salt Lake City, UT 84111 USA; [Horne, Benjamin D.] Intermt Heart Inst, 5121 South Cottonwood St, Salt Lake City, UT 84107 USA; [Bergstrom, Steven] Intermt Healthcare, 7302 South Bingham Junction Blvd, Midvale, UT 84047 USA	Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center	Joy, EA (corresponding author), Intermt Healthcare, Community Hlth, 36 South State St, Salt Lake City, UT 84111 USA.	liz.joy@imail.org	Horne, Benjamin/GQP-7851-2022					[Anonymous], 2013, REV EV HLTH ASP AIR; Centers for Disease Control and Prevention, 2014, AIR QUAL; Crowley RA, 2016, ANN INTERN MED, V164, P608, DOI 10.7326/M15-2766; Intermountain Healthcare, 2015, INT HEALTHC SUST ANN; Pope CA, 2008, AM J CARDIOL, V102, P1230, DOI 10.1016/j.amjcard.2008.06.044; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Pope CA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002506	7	5	6	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					626	+		10.7326/M16-0507	http://dx.doi.org/10.7326/M16-0507			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27089453				2022-12-28	WOS:000375744000027
J	Yu, BM				Yu, Byron M.			Fault tolerance in the brain	NATURE			English	Editorial Material							MECHANISMS		[Yu, Byron M.] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA; [Yu, Byron M.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Yu, BM (corresponding author), Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA.; Yu, BM (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	byronyu@cmu.edu						Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; KOLB B, 1989, PROG NEUROBIOL, V32, P235, DOI 10.1016/0301-0082(89)90023-3; Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643	5	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					449	450		10.1038/nature17886	http://dx.doi.org/10.1038/nature17886			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27074510				2022-12-28	WOS:000374815900034
J	Xu, QP; Shoji, M; Shibata, S; Naito, M; Sato, K; Elsliger, MA; Grant, JC; Axelrod, HL; Chiu, HJ; Farr, CL; Jaroszewski, L; Knuth, MW; Deacon, AM; Godzik, A; Lesley, SA; Curtis, MA; Nakayama, K; Wilson, IA				Xu, Qingping; Shoji, Mikio; Shibata, Satoshi; Naito, Mariko; Sato, Keiko; Elsliger, Marc-Andre; Grant, Joanna C.; Axelrod, Herbert L.; Chiu, Hsiu-Ju; Farr, Carol L.; Jaroszewski, Lukasz; Knuth, Mark W.; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Curtis, Michael A.; Nakayama, Koji; Wilson, Ian A.			A Distinct Type of Pilus from the Human Microbiome	CELL			English	Article							GINGIVALIS MFA1 FIMBRIAE; PORPHYROMONAS-GINGIVALIS; ESCHERICHIA-COLI; BACTEROIDES-GINGIVALIS; ARG-GINGIPAIN; PROTEIN; DISEASE; COMPONENTS; PERIODONTITIS; PURIFICATION	Pili are proteinaceous polymers of linked pilins that protrude from the cell surface of many bacteria and often mediate adherence and virulence. We investigated a set of 20 Bacteroidia pilins from the human microbiome whose structures and mechanism of assembly were unknown. Crystal structures and biochemical data revealed a diverse protein superfamily with a common Greek-key b sandwich fold with two transthyretin-like repeats that polymerize into a pilus through a strand-exchange mechanism. The assembly mechanism of the central, structural pilins involves proteinase-assisted removal of their N-terminal beta strand, creating an extended hydrophobic groove that binds the C-terminal donor strands of the incoming pilin. Accessory pilins at the tip and base have unique structural features specific to their location, allowing initiation or termination of the assembly. The Bacteroidia pilus, therefore, has a biogenesis mechanism that is distinct from other known pili and likely represents a different type of bacterial pilus.	[Xu, Qingping; Elsliger, Marc-Andre; Grant, Joanna C.; Axelrod, Herbert L.; Chiu, Hsiu-Ju; Farr, Carol L.; Jaroszewski, Lukasz; Knuth, Mark W.; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.] Joint Ctr Struct Genom, San Diego, CA 92121 USA; [Xu, Qingping; Axelrod, Herbert L.; Chiu, Hsiu-Ju; Deacon, Ashley M.] Stanford Synchrotron Radiat Lightsource, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Shoji, Mikio; Shibata, Satoshi; Naito, Mariko; Sato, Keiko; Nakayama, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Div Microbiol & Oral Infect, Dept Mol Microbiol & Immunol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan; [Elsliger, Marc-Andre; Lesley, Scott A.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Grant, Joanna C.; Farr, Carol L.; Knuth, Mark W.; Lesley, Scott A.] Novartis Res Fdn, Genom Inst, Prot Sci Dept, San Diego, CA 92121 USA; [Jaroszewski, Lukasz; Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Jaroszewski, Lukasz; Godzik, Adam] Sanford Burnham Prebys Med Discovery Inst, Program Bioinformat & Syst Biol, La Jolla, CA 92037 USA; [Curtis, Michael A.] Queen Mary Univ London, CIID, Blizard Inst, Barts & London Sch Med & Dent, 4 Newark St, London E1 2AT, England	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Nagasaki University; Scripps Research Institute; Novartis; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of London; Queen Mary University London	Wilson, IA (corresponding author), Joint Ctr Struct Genom, San Diego, CA 92121 USA.; Nakayama, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Div Microbiol & Oral Infect, Dept Mol Microbiol & Immunol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.; Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	knak@nagasaki-u.ac.jp; wilson@scripps.edu	Shoji, Mikio/J-8283-2018; Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Shoji, Mikio/0000-0002-7605-4721; Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Elsliger, Marc Andre/0000-0002-1989-7626; NAITO, Mariko/0000-0003-0769-7747; Curtis, Mike A/0000-0002-1563-9953	NIH NIGMS Protein Structure Initiative [U54 GM094586]; JSPS KAKENHI [24117006, 25293375]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIH, National Institute of General Medical Sciences [P41GM103393]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Grants-in-Aid for Scientific Research [16H05504] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, U54GM094586] Funding Source: NIH RePORTER	NIH NIGMS Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the other members of the Joint Center for Structural Genomics (JCSG) for their contribution to this work. This work was supported by the NIH NIGMS Protein Structure Initiative (U54 GM094586 to I.A.W.) and the JSPS KAKENHI (24117006 and 25293375 to K.N.). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and the NIH, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231.	Allen WJ, 2012, CURR OPIN STRUC BIOL, V22, P500, DOI 10.1016/j.sbi.2012.02.001; Amano A, 2003, J PERIODONTOL, V74, P90, DOI 10.1902/jop.2003.74.1.90; Amano A, 2010, PERIODONTOL 2000, V52, P12, DOI 10.1111/j.1600-0757.2009.00307.x; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Ellrott K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000798; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hajishengallis G, 2007, INT J PEPT RES THER, V13, P533, DOI 10.1007/s10989-007-9084-1; Hajishengallis G, 2007, J IMMUNOL, V179, P2359, DOI 10.4049/jimmunol.179.4.2359; Hamada N, 1996, INFECT IMMUN, V64, P4788, DOI 10.1128/IAI.64.11.4788-4794.1996; Hasegawa Y, 2013, MOL ORAL MICROBIOL, V28, P467, DOI 10.1111/omi.12040; Hasegawa Y, 2009, MICROBIOL-SGM, V155, P3333, DOI 10.1099/mic.0.028928-0; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Kadowaki T, 1998, J BIOL CHEM, V273, P29072, DOI 10.1074/jbc.273.44.29072; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; Nagano K, 2015, J DENT RES, V94, P1143, DOI 10.1177/0022034515588275; Nagano K, 2010, J DENT RES, V89, P903, DOI 10.1177/0022034510370089; Nakayama K, 1996, J BACTERIOL, V178, P2818, DOI 10.1128/jb.178.10.2818-2824.1996; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; Shoji M, 2010, CAN J MICROBIOL, V56, P959, DOI [10.1139/W10-084, 10.1139/w10-084]; Shoji M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-152; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; SOJAR HT, 1991, BIOCHEM BIOPH RES CO, V175, P713, DOI 10.1016/0006-291X(91)91624-L; VANDOORN J, 1987, MICROB PATHOGENESIS, V3, P87, DOI 10.1016/0882-4010(87)90067-2; VANDOORN J, 1992, MICROB PATHOGENESIS, V13, P75, DOI 10.1016/0882-4010(92)90033-K; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1281, DOI 10.1107/S1744309110006548; YOSHIMURA F, 1984, J BACTERIOL, V160, P949, DOI 10.1128/JB.160.3.949-957.1984; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	38	47	56	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					690	703		10.1016/j.cell.2016.03.016	http://dx.doi.org/10.1016/j.cell.2016.03.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27062925	Bronze, Green Accepted			2022-12-28	WOS:000374636800026
J	Roth, AE				Roth, Alvin E.			Lloyd Shapley (1923-2016) A founding father of game theory	NATURE			English	Biographical-Item									[Roth, Alvin E.] Stanford Univ, Econ, Stanford, CA 94305 USA	Stanford University	Roth, AE (corresponding author), Stanford Univ, Econ, Stanford, CA 94305 USA.	alroth@stanford.edu		Roth, Alvin/0000-0002-8834-6481				SHAPLEY LS, PUBLICATION LIST	1	1	1	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					178	178		10.1038/532178a	http://dx.doi.org/10.1038/532178a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075091	Bronze			2022-12-28	WOS:000374415100023
J	Watts, J; Sheehan, O; Atkinson, QD; Bulbulia, J; Gray, RD				Watts, Joseph; Sheehan, Oliver; Atkinson, Quentin D.; Bulbulia, Joseph; Gray, Russell D.			Ritual human sacrifice promoted and sustained the evolution of stratified societies	NATURE			English	Article							CHARACTERS; LANGUAGE	Evidence for human sacrifice is found throughout the archaeological record of early civilizations(1), the ethnographic records of indigenous world cultures(2-5), and the texts of the most prolific contemporary religions(6). According to the social control hypothesis(2,7,8), human sacrifice legitimizes political authority and social class systems, functioning to stabilize such social stratification. Support for the social control hypothesis is largely limited to historical anecdotes of human sacrifice(2,8), where the causal claims have not been subject to rigorous quantitative cross-cultural tests. Here we test the social control hypothesis by applying Bayesian phylogenetic methods to a geographically and socially diverse sample of 93 traditional Austronesian cultures. We find strong support for models in which human sacrifice stabilizes social stratification once stratification has arisen, and promotes a shift to strictly inherited class systems. Whilst evolutionary theories of religion have focused on the functionality of prosocial and moral beliefs(9,10), our results reveal a darker link between religion and the evolution of modern hierarchical societies(11,12).	[Watts, Joseph; Sheehan, Oliver; Atkinson, Quentin D.; Gray, Russell D.] Univ Auckland, Sch Psychol, Auckland 1142, New Zealand; [Sheehan, Oliver; Atkinson, Quentin D.; Gray, Russell D.] Max Planck Inst Sci Human Hist, D-07743 Jena, Germany; [Bulbulia, Joseph] Victoria Univ Wellington, Sch Art Hist Class & Religious Studies, Wellington 6014, New Zealand; [Gray, Russell D.] Australian Natl Univ, Res Sch Social Sci, GPO Box 4, Canberra, ACT 2601, Australia; [Gray, Russell D.] Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North 4442, New Zealand	University of Auckland; Victoria University Wellington; Australian National University; Massey University	Watts, J (corresponding author), Univ Auckland, Sch Psychol, Auckland 1142, New Zealand.	me@josephwatts.org	Watts, Joseph/A-5280-2014	Watts, Joseph/0000-0002-7737-273X; Bulbulia, Joseph/0000-0002-5861-2056; Atkinson, Quentin/0000-0002-8499-7535	John Templeton Foundation [28745]; Templeton World Charity Foundation [0077]; Rutherford Discovery Fellowship [RDF-OUA1101]; University of Auckland; Marsden Fund [UOA1104, VUW1321]	John Templeton Foundation; Templeton World Charity Foundation(Templeton World Charity Foundation); Rutherford Discovery Fellowship; University of Auckland; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	We would like to thank K. Sterelny for feedback on an earlier version of the manuscript as well as M. Pagel and A. Meade for assistance with BayesTraits. We would also like to thank The John Templeton Foundation (28745), Templeton World Charity Foundation (0077), a Rutherford Discovery Fellowship (RDF-OUA1101), a PhD scholarship from the University of Auckland, and the Marsden Fund (UOA1104, VUW1321) for funding.	Beatty A, 1992, SOC EXCHANGE NIAS; Bellah R.N., 2011, RELIG HUMAN EVOLUTIO; Bremmer J., 2007, STRANGE WORLD HUMAN; Burkert W., 1998, CREATION SACRED TRAC; Burt B, 1994, TRADITION CHRISTIANI; Carrasco D, 1999, CITY OF SACRIFICE; Coulanges F., 1877, ANCIENT CITY STUDY R; CRONK L, 1994, ZYGON, V29, P81, DOI 10.1111/j.1467-9744.1994.tb00651.x; Diaz del Castillo Bernal, 2008, HIST CONQUEST NEW SP; Dow MM, 2008, CROSS-CULT RES, V42, P148, DOI 10.1177/1069397107311186; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Flannery K., 2012, CREATION INEQUALITY; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Goodenough W., 1957, J POLYNESIAN SOC, V66, P146; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Harner M., 1977, AM ETHNOL, V4, P117, DOI DOI 10.1525/AE.1977.4.1.02A00070; Johnson Todd M., 2013, WORLDS RELIG FIGURES, P133; Kamakau S. M., 1968, KA POE KAHIKO PEOPLE; Ko AMS, 2014, AM J HUM GENET, V94, P426, DOI 10.1016/j.ajhg.2014.02.003; Lammers J, 2008, PSYCHOL SCI, V19, P558, DOI 10.1111/j.1467-9280.2008.02123.x; Mace R, 2005, TRENDS ECOL EVOL, V20, P116, DOI 10.1016/j.tree.2004.12.002; MACE R, 1994, CURR ANTHROPOL, V35, P549, DOI 10.1086/204317; Maddison WP, 2015, SYST BIOL, V64, P127, DOI 10.1093/sysbio/syu070; Marx K., 1975, K MARX F ENGELS COLL; Norenzayan A., 2014, BEHAV BRAIN SCI, V39; Orme D., 2018, R PACKAGE VERSION, V5, P1; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price B. J., 1978, AM ETHNOL, V5, P98; RAFTERY AE, 1996, MARKOV CHAIN MONTE C, P163; Ronay R, 2012, PSYCHOL SCI, V23, P669, DOI 10.1177/0956797611433876; SAHLINS MD, 1958, SOCIAL STRATIFICATIO; Smith Jonathan Z., 1987, VIOLENT ORIGINS WALT, P199; Team R core, 2015, R LANG ENV STAT COMP; Turner C.G., 1999, MAN CORN CANNIBALISM; Watts J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136783; Watts J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2556; Wheatley P., 1971, PIVOT 4 QUARTERS; Wilson EO., 1978, HUM NATURE-INT BIOS; Winkelman M, 2014, ANTHROPOL FORUM, V24, P47, DOI 10.1080/00664677.2014.860888; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085	42	79	82	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					228	+		10.1038/nature17159	http://dx.doi.org/10.1038/nature17159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DJ7TJ	27042932				2022-12-28	WOS:000374415100038
J	Krug, EG				Krug, Etienne G.			Trends in diabetes: sounding the alarm	LANCET			English	Editorial Material							PREVENTION		[Krug, Etienne G.] WHO, Management Noncommunicable Dis Disabil Violence &, CH-1211 Geneva, Switzerland	World Health Organization	Krug, EG (corresponding author), WHO, Management Noncommunicable Dis Disabil Violence &, CH-1211 Geneva, Switzerland.	kruge@who.int						Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Global Burden of Disease Study C, 2015, LANCET, V386, P743, DOI [10.1016/S0140-6736(15)60692-4, DOI 10.1016/S0140-6736(15)60692-4, 10.1016/s0140-6736(15)60692-4]; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Merlotti C, 2014, DIABETES OBES METAB, V16, P719, DOI 10.1111/dom.12270; Orozco LJ, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003054.PUB3; Smith-Spangler CM, 2012, DIABETES CARE, V35, P319, DOI 10.2337/dc11-1770; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; WHO, 2010, PACKAGE OF ESSENTIAL; WHO, 2016, GLOB REP ON DIAB; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	11	68	73	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1485	1486		10.1016/S0140-6736(16)30163-5	http://dx.doi.org/10.1016/S0140-6736(16)30163-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	27061675	hybrid			2022-12-28	WOS:000373741600004
J	Koch, M; Guttman, M; Dekker, J; Lomvardas, S				Koch, Marta; Guttman, Mitchell; Dekker, Job; Lomvardas, Stavros			A Guide to Packing Your DNA	CELL			English	Editorial Material									[Dekker, Job] Univ Massachusetts, Amherst, MA 01003 USA; [Guttman, Mitchell] CALTECH, Pasadena, CA 91125 USA; [Lomvardas, Stavros] Columbia Univ, New York, NY 10027 USA	University of Massachusetts System; University of Massachusetts Amherst; California Institute of Technology; Columbia University				Lomvardas, Stavros/0000-0002-7668-3026					0	1	1	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					259	261						3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058655	Bronze			2022-12-28	WOS:000374123000002
J	Weigelt, P; Steinbauer, MJ; Cabral, JS; Kreft, H				Weigelt, Patrick; Steinbauer, Manuel Jonas; Cabral, Juliano Sarmento; Kreft, Holger			Late Quaternary climate change shapes island biodiversity	NATURE			English	Article							SPECIES-AREA RELATIONSHIP; SPATIAL AUTOCORRELATION; INSULAR BIOGEOGRAPHY; DISTRIBUTION MODELS; GLOBAL PATTERNS; VEGETATION; RICHNESS; ECOLOGY; DRIVEN; SCALE	Island biogeographical models consider islands either as geologically static with biodiversity resulting from ecologically neutral immigration-extinction dynamics(1), or as geologically dynamic with biodiversity resulting from immigration-speciation-extinction dynamics influenced by changes in island characteristics over millions of years(2). Present climate and spatial arrangement of islands, however, are rather exceptional compared to most of the Late Quaternary, which is characterized by recurrent cooler and drier glacial periods. These climatic oscillations over short geological timescales strongly affected sea levels(3,4) and caused massive changes in island area, isolation and connectivity(5), orders of magnitude faster than the geological processes of island formation, subsidence and erosion considered in island theory(2,6). Consequences of these oscillations for present biodiversity remain unassessed(5,7). Here we analyse the effects of present and Last Glacial Maximum (LGM) island area, isolation, elevation and climate on key components of angiosperm diversity on islands worldwide. We find that post-LGM changes in island characteristics, especially in area, have left a strong imprint on present diversity of endemic species. Specifically, the number and proportion of endemic species today is significantly higher on islands that were larger during the LGM. Native species richness, in turn, is mostly determined by present island characteristics. We conclude that an appreciation of Late Quaternary environmental change is essential to understand patterns of island endemism and its underlying evolutionary dynamics.	[Weigelt, Patrick; Cabral, Juliano Sarmento; Kreft, Holger] Univ Gottingen, Biodivers Macroecol & Conservat Biogeog Grp, D-37077 Gottingen, Germany; [Weigelt, Patrick] Univ Gottingen, Syst Conservat Biol, D-37073 Gottingen, Germany; [Steinbauer, Manuel Jonas] Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, DK-8000 Aarhus, Denmark; [Steinbauer, Manuel Jonas] Univ Bayreuth, BayCEER, Dept Biogeog, POB 101251, D-95440 Bayreuth, Germany; [Cabral, Juliano Sarmento] German Ctr Integrat Biodivers Res iDiv, Synth Ctr, D-04103 Leipzig, Germany	University of Gottingen; University of Gottingen; Aarhus University; University of Bayreuth	Weigelt, P; Kreft, H (corresponding author), Univ Gottingen, Biodivers Macroecol & Conservat Biogeog Grp, D-37077 Gottingen, Germany.; Weigelt, P (corresponding author), Univ Gottingen, Syst Conservat Biol, D-37073 Gottingen, Germany.	pweigel@uni-goettingen.de; hkreft@uni-goettingen.de	Weigelt, Patrick/E-2122-2014; Kreft, Holger/A-4736-2008; Sarmento Cabral, Juliano/K-3973-2012; Kreft, Holger/AAY-7573-2020	Weigelt, Patrick/0000-0002-2485-3708; Kreft, Holger/0000-0003-4471-8236; Sarmento Cabral, Juliano/0000-0002-0116-220X; Kreft, Holger/0000-0003-4471-8236; Steinbauer, Manuel/0000-0002-7142-9272	German Research Council (DFG) Free Floater Program in the Excellence Initiative at the University of Gottingen; BEFmate project from the Ministry of Science and Culture of Lower Saxony; Danish Carlsbergfondet [CF14-0148]	German Research Council (DFG) Free Floater Program in the Excellence Initiative at the University of Gottingen; BEFmate project from the Ministry of Science and Culture of Lower Saxony; Danish Carlsbergfondet	P.W., J.S.C. and H.K. acknowledge funding by the German Research Council (DFG) Free Floater Program in the Excellence Initiative at the University of Gottingen. P.W. and H.K. additionally acknowledge funding by the BEFmate project from the Ministry of Science and Culture of Lower Saxony. M.J.S. was supported by the Danish Carlsbergfondet (CF14-0148). We are grateful to S. L. Chown, J. Gerlach, Y. Kisel, J. P. Price and J. D. Shaw for providing species lists. We thank R. J. Whittaker for helpful discussions and J.-C. Svenning for comments on a previous version of the manuscript.	Abe T, 2006, ANN BOT-LONDON, V98, P317, DOI 10.1093/aob/mcl117; Acevedo-Rodriguez P., CATALOGUE SEED PLANT; Ali JR, 2014, J BIOGEOGR, V41, P1227, DOI 10.1111/jbi.12313; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Arechavaleta M., 2009, LISTA ESPECIES SILVE; Arechavaleta M., 2005, LISTA PRELIMINAR ESP; Ashmole P., 2000, ST HELENA ASCENSION; Assing V, 2010, LIST TERRESTRIAL MAR; Athens JS, 2007, PAC SCI, V61, P17, DOI 10.1353/psc.2007.0001; Baker M. L., 2011, CENSUS VASCULAR PLAN; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; BIVAND R., 2014, SPDEP SPATIAL DEPEND; Borges P.A.V., 2008, LISTAGEM FUNGOS FLOR; Borregaard M. K., 2016, BIOL REV CAMB PHILOS; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Brofas G., 2001, Willdenowia, V31, P51, DOI 10.3372/wi.31.31104; Broughton DA, 2005, J TORREY BOT SOC, V132, P115, DOI 10.3159/1095-5674(2005)132[115:ACOTNV]2.0.CO;2; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Burton F.J., 2007, RED LIST ASSESSMENT; Cabral JS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3246; Caribbean Research and Management of Biodiversity Foundation, DUTCH CAR BIOD EXPL; Case T.J., 2002, NEW ISLAND BIOGEOGRA, DOI DOI 10.1093/OSO/9780195133462.001.0001; Charters M., FLORA BERMUDA; Christmas Island National Park, 2002, 3 CHRISTM ISL NAT PA; CLARK R., 1997, CHECKLIST VASCULAR P; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; CRONK QCB, 1989, J BIOGEOGR, V16, P47, DOI 10.2307/2845310; DArcy W. G., 1971, ATOLL RES BULL; De Lange P. J., 2011, CHECKLIST VASCULAR P; de Miranda Freitas A. M., 2007, FLORA FANEROGAMICA A; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Du Puy D. J., CHRISTMAS ISLAND SPE; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; EFRON B, 1978, J AM STAT ASSOC, V73, P113, DOI 10.2307/2286531; Exell AW, 1944, CATALOGUE VASCULAR P; Fernandez-Palacios J. M., 2015, GLOB ECOL BIOGEOGR; Florence J., BASE DONNEES BOT NAD; Fosberg F., 1987, ATOLL RES B, V294, P1; Fosberg F.R, 1980, FLORA ALDABRA NEIGHB; Gerlach Justin, 2003, Phelsuma, V11, P1; Gillespie RG, 2014, NATURE, V509, P297, DOI 10.1038/509297a; Green P. S., LORD HOWE ISLAND SPE; Greene SW, 1975, POLAR REC, V17, P473, DOI [10.1017/S0032247400032459, DOI 10.1098/rstb.2015.0338]; Guezou A., CDF CHECKLIST GALAPA; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harter DEV, 2015, PERSPECT PLANT ECOL, V17, P160, DOI 10.1016/j.ppees.2015.01.003; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill M, 2002, BIODIVERSITY SURVEYS; Hnatiuk R. J., SUBANTARCTIC ISLANDS; Imada C. T., 2012, BISHOP MUSEM TECHNIC, V60; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; JOHNSON P N, 1975, New Zealand Journal of Botany, V13, P665; Johnston I. M, 1931, P CALIF ACAD SCI, V20, P9; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kingston N, 2003, J BIOGEOGR, V30, P1311, DOI 10.1046/j.1365-2699.2003.00959.x; Kirchner F., 2010, FLORE VASCULAIRE REU; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Kreft H, 2008, ECOL LETT, V11, P116, DOI 10.1111/j.1461-0248.2007.01129.x; Levin G. A., 1989, SAN DIEGO SOC NATURA, V16, P1; Lorence D. H., FLORA HAWAIIAN ISLAN; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; MAC ARTHUR ROBERT H., 1967; Marticorena Clodomiro, 1998, Gayana Botanica, V55, P187; Mcfadden D., 1974, FRONTIERS EC; Miller A.G., 2004, ETHNOFLORA SOQOTRA A; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Moran R, 1996, FLORA GUADALUPE ISLA; Nogue S, 2013, J ECOL, V101, P368, DOI 10.1111/1365-2745.12051; Price JP, 2011, AM J BOT, V98, P449, DOI 10.3732/ajb.1000388; Price JP, 2002, P ROY SOC B-BIOL SCI, V269, P2429, DOI 10.1098/rspb.2002.2175; RENVOIZE S A, 1975, Kew Bulletin, V30, P133, DOI 10.2307/4102881; Ricklefs RE, 2001, SCIENCE, V294, P1522, DOI 10.1126/science.1065005; Rijsdijk KF, 2014, J BIOGEOGR, V41, P1242, DOI 10.1111/jbi.12336; Saez L., 2001, LLIBRE VERMELL FLORA; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Shaw JD, 2010, J BIOGEOGR, V37, P217, DOI 10.1111/j.1365-2699.2009.02204.x; St John H., 1988, CENSUS FLORA GAMBIER, V43; Steinbauer MJ, 2013, ACTA OECOL, V47, P52, DOI 10.1016/j.actao.2012.11.004; Stohigren TJ, 2008, ECOL LETT, V11, P313, DOI 10.1111/j.1461-0248.2008.01153.x; Strahm WA., 1993, CONSERVATION RESTORA; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-8238.2006.00280.x; Sykes W. R., 1970, BULLETIN, V200; Takahashi H., 1999, J PHYTOGEOGRAPHY TAX, V47, P131; Taylor R., 2006, STRAIGHT LONDON ANTI; Triantis KA, 2008, ECOGRAPHY, V31, P401, DOI 10.1111/j.0906-7590.2007.05323.x; Universitat de les Illes Balears, HERB VIRT MED OCC; University of Kent, COOK ISL BIOD ETHN D; WACE NM, 1965, PHILOS T ROY SOC B, V249, P273; WACE NM, 1961, ECOL MONOGR, V31, P337, DOI 10.2307/1950757; Wagner W.L., FLORA MARQUESAS ISLA; Warren BH, 2015, ECOL LETT, V18, P200, DOI 10.1111/ele.12398; Weigelt P., 2015, FRONTIERS BIOGEOGRAP, V7, P119; Weigelt P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12213; Weigelt P, 2013, P NATL ACAD SCI USA, V110, P15307, DOI 10.1073/pnas.1306309110; Weigelt P, 2013, ECOGRAPHY, V36, P417, DOI 10.1111/j.1600-0587.2012.07669.x; Whistler WA, 1998, STUDY RARE PLANTS AM; WHITEHEAD DR, 1969, EVOLUTION, V23, P171, DOI 10.1111/j.1558-5646.1969.tb03503.x; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x	101	152	155	8	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					99	+		10.1038/nature17443	http://dx.doi.org/10.1038/nature17443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27027291				2022-12-28	WOS:000373555500041
J	Bradley, SM; Liu, WH; Chan, PS; Nallamothu, BK; Grunwald, GK; Self, A; Sasson, C; Varosy, PD; Anderson, ML; Schneider, PM; Ho, PM				Bradley, Steven M.; Liu, Wenhui; Chan, Paul S.; Nallamothu, Brahmajee K.; Grunwald, Gary K.; Self, Alyssa; Sasson, Comilla; Varosy, Paul D.; Anderson, Monique L.; Schneider, Preston M.; Ho, P. Michael		Amer Heart Assoc Get Guidelines-Re	Defibrillation time intervals and outcomes of cardiac arrest in hospital: retrospective cohort study from Get With The Guidelines-Resuscitation registry	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-ASSOCIATION GUIDELINES; BIPHASIC WAVE-FORM; CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; CHEST COMPRESSIONS; COUNCIL GUIDELINES; CONTROLLED-TRIAL; SURVIVAL; IMPEDANCE; PROTOCOL	OBJECTIVE To describe temporal trends in the time interval between first and second attempts at defibrillation and the association between this time interval and outcomes in patients with persistent ventricular tachycardia or ventricular fibrillation (VT/VF) arrest in hospital. DESIGN Retrospective cohort study. SETTING 172 hospitals in the United States participating in the Get With The Guidelines-Resuscitation registry, 2004-12. PARTICIPANTS Adults who received a second defibrillation attempt for persistent VT/VF arrest within three minutes of a first attempt. INTERVENTIONS Second defibrillation attempts categorized as early (time interval of up to and including one minute between first and second defibrillation attempts) or deferred (time interval of more than one minute between first and second defibrillation attempts). MAIN OUTCOME MEASURE Survival to hospital discharge. RESULTS Among 2733 patients with persistent VT/VF after the first defibrillation attempt, 1121 (41%) received a deferred second attempt. Deferred second defibrillation for persistent VT/VF increased from 26% in 2004 to 57% in 2012 (P<0.001 for trend). Compared with early second defibrillation, unadjusted patient outcomes were significantly worse with deferred second defibrillation (57.4% v 62.5% for return of spontaneous circulation, 38.4% v 43.6% for survival to 24 hours, and 24.7% v 30.8% for survival to hospital discharge; P<0.01 for all comparisons). After risk adjustment, deferred second defibrillation was not associated with survival to hospital discharge (propensity weighting adjusted risk ratio 0.89, 95% confidence interval 0.78 to 1.01; P=0.08; hierarchical regression adjusted 0.92, 0.83 to 1.02; P=0.1). CONCLUSIONS Since 2004, the use of deferred second defibrillation for persistent VT/VF in hospital has doubled. Deferred second defibrillation was not associated with improved survival.	[Bradley, Steven M.; Liu, Wenhui; Grunwald, Gary K.; Varosy, Paul D.; Ho, P. Michael] VA Eastern Colorado Hlth Care Syst, 1055 Clermont St 111B, Denver, CO 80220 USA; [Bradley, Steven M.; Self, Alyssa; Varosy, Paul D.; Schneider, Preston M.; Ho, P. Michael] Univ Colorado, Sch Med, Aurora, CO USA; [Bradley, Steven M.; Varosy, Paul D.; Schneider, Preston M.; Ho, P. Michael] Colorado Cardiovasc Outcomes Res Consortium, Denver, CO USA; [Liu, Wenhui; Grunwald, Gary K.] Univ Colorado, Sch Publ Hlth, Aurora, CO USA; [Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Chan, Paul S.] Univ Missouri, Kansas City, MO 64110 USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Sasson, Comilla] Amer Heart Assoc, Dallas, TX USA; [Anderson, Monique L.] Duke Clin Res Inst, Durham, NC USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of Michigan System; University of Michigan; Duke University	Bradley, SM (corresponding author), VA Eastern Colorado Hlth Care Syst, Dept Vet Affairs, 1055 Clermont St 111B, Denver, CO 80220 USA.	Steven.Bradley@va.gov	Bradley, Steven/AID-7839-2022		VA Health Services Research and Development [HSRD-CDA2 10-199]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123980] Funding Source: NIH RePORTER	VA Health Services Research and Development(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research received no specific grant from any funding agency in the public, commercial, or not for profit sectors. SMB is supported by a career development award (HSR&D-CDA2 10-199) from VA Health Services Research and Development. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US government.	[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; [Anonymous], 2000, CIRCULATION S, V102, pI90; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Bobrow BJ, 2008, JAMA-J AM MED ASSOC, V299, P1158, DOI 10.1001/jama.299.10.1158; Cammarata G, 2006, RESUSCITATION, V69, P23, DOI 10.1016/j.resuscitation.2005.09.022; Chan PS, 2013, J AM COLL CARDIOL, V62, P601, DOI 10.1016/j.jacc.2013.05.051; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Eftestol T, 2002, CIRCULATION, V105, P2270, DOI 10.1161/01.CIR.0000016362.42586.FE; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Hinchey PR, 2010, ANN EMERG MED, V56, P348, DOI 10.1016/j.annemergmed.2010.01.036; Jost D, 2010, CIRCULATION, V121, P1614, DOI 10.1161/CIRCULATIONAHA.109.878389; Kern KB, 2002, CIRCULATION, V105, P645, DOI 10.1161/hc0502.102963; Larkin GL, 2010, RESUSCITATION, V81, P302, DOI 10.1016/j.resuscitation.2009.11.021; Li F, 2013, STAT MED, V32, P3373, DOI 10.1002/sim.5786; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; Link MS, 2010, CIRCULATION, V122, pS706, DOI 10.1161/CIRCULATIONAHA.110.970954; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Mittal S, 1999, J AM COLL CARDIOL, V34, P1595, DOI 10.1016/S0735-1097(99)00363-0; Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038; Morrison LJ, 2013, RESUSCITATION, V84, P1480, DOI 10.1016/j.resuscitation.2013.07.008; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Poole JE, 1997, J CARDIOVASC ELECTR, V8, P1373, DOI 10.1111/j.1540-8167.1997.tb01034.x; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; Schneider T, 2000, CIRCULATION, V102, P1780; Tang WC, 2006, CIRCULATION, V113, P2683, DOI 10.1161/CIRCULATIONAHA.105.592121; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; White RD, 2005, RESUSCITATION, V64, P63, DOI 10.1016/j.resuscitation.2004.06.021; Yu T, 2002, CIRCULATION, V106, P368, DOI 10.1161/01.CIR.0000021429.22005.2E; Zou GY, 2013, STAT METHODS MED RES, V22, P661, DOI 10.1177/0962280211427759	33	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	2016	353								i1653	10.1136/bmj.i1653	http://dx.doi.org/10.1136/bmj.i1653			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LQ	27052620	hybrid, Green Published			2022-12-28	WOS:000373895500003
J	Lebwohl, M				Lebwohl, Mark			Actinic Keratosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FLUOROURACIL CREAM; 5-PERCENT; EFFICACY		[Lebwohl, Mark] Icahn Sch Med Mt Sinai, Kimberly & Eric J Waldman Dept Dermatol, One Gustave L Levy Pl,Box 1048, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Lebwohl, M (corresponding author), Icahn Sch Med Mt Sinai, Kimberly & Eric J Waldman Dept Dermatol, One Gustave L Levy Pl,Box 1048, New York, NY 10029 USA.	lebwohl@aol.com						Dinehart SM, 1997, CANCER, V79, P920, DOI 10.1002/(SICI)1097-0142(19970301)79:5<920::AID-CNCR8>3.0.CO;2-F; Kanellou P, 2008, CANCER LETT, V264, P145, DOI 10.1016/j.canlet.2008.01.042; Lebwohl M, 2004, J AM ACAD DERMATOL, V50, P714, DOI 10.1016/j.jaad.2003.12.010; Lebwohl M, 2013, JAMA DERMATOL, V149, P666, DOI 10.1001/jamadermatol.2013.2766; Loven K, 2002, CLIN THER, V24, P990, DOI 10.1016/S0149-2918(02)80012-1; Mittelbronn MA, 1998, INT J DERMATOL, V37, P677, DOI 10.1046/j.1365-4362.1998.00467.x; Pomerantz H, 2015, JAMA DERMATOL, V151, P952, DOI 10.1001/jamadermatol.2015.0502; Smith Stacy R, 2006, J Drugs Dermatol, V5, P156	8	5	5	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1394	1395		10.1001/jama.2016.3065	http://dx.doi.org/10.1001/jama.2016.3065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	27046367				2022-12-28	WOS:000373381500023
J	Chan, PY; Silva, EAC; De Kouchkovsky, D; Joannas, LD; Hao, LM; Hu, DL; Huntsman, S; Eng, C; Licona-Limon, P; Weinstein, JS; Herbert, DR; Craft, JE; Flavell, RA; Repetto, S; Correale, J; Burchard, EG; Torgerson, DG; Ghosh, S; Rothlin, CV				Chan, Pamela Y.; Carrera Silva, Eugenio A.; De Kouchkovsky, Dimitri; Joannas, Leonel D.; Hao, Liming; Hu, Donglei; Huntsman, Scott; Eng, Celeste; Licona-Limon, Paula; Weinstein, Jason S.; Herbert, De'Broski R.; Craft, Joseph E.; Flavell, Richard A.; Repetto, Silvia; Correale, Jorge; Burchard, Esteban G.; Torgerson, Dara G.; Ghosh, Sourav; Rothlin, Carla V.			The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity	SCIENCE			English	Article							DENDRITIC CELLS; ASTHMA; AXL; INFECTION; INDUCTION; DEPLETION; RESPONSES; BLOCKADE	Host responses against metazoan parasites or an array of environmental substances elicit type 2 immunity. Despite its protective function, type 2 immunity also drives allergic diseases. The mechanisms that regulate the magnitude of the type 2 response remain largely unknown. Here, we show that genetic ablation of a receptor tyrosine kinase encoded by Tyro3 in mice or the functional neutralization of its ortholog in human dendritic cells resulted in enhanced type 2 immunity. Furthermore, the TYRO3 agonist PROS1 was induced in T cells by the quintessential type 2 cytokine, interleukin-4. T cell-specific Pros1 knockouts phenocopied the loss of Tyro3. Thus, a PROS1-mediated feedback from adaptive immunity engages a rheostat, TYRO3, on innate immune cells to limit the intensity of type 2 responses.	[Chan, Pamela Y.; Carrera Silva, Eugenio A.; De Kouchkovsky, Dimitri; Joannas, Leonel D.; Licona-Limon, Paula; Weinstein, Jason S.; Craft, Joseph E.; Flavell, Richard A.; Rothlin, Carla V.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Carrera Silva, Eugenio A.] Consejo Nacl Invest Cient & Tecn, Inst Med Expt, Lab Trombosis Expt, Acad Nacl Med, RA-1425 Buenos Aires, DF, Argentina; [Hao, Liming] Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA; [Hu, Donglei; Huntsman, Scott; Eng, Celeste; Burchard, Esteban G.; Torgerson, Dara G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Herbert, De'Broski R.] Univ Calif San Francisco, Dept Expt Med, San Francisco, CA 94158 USA; [Craft, Joseph E.] Yale Univ, Sch Med, Dept Internal Med Rheumatol, 333 Cedar St, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA; [Repetto, Silvia] Univ Buenos Aires, CONICET, Inst Invest Microbiol & Parasitol Med, RA-1121 Buenos Aires, DF, Argentina; [Repetto, Silvia] Univ Buenos Aires, Hosp Clin Jose de San Martin, RA-1120 Buenos Aires, DF, Argentina; [Correale, Jorge] Raul Carrea Inst Neurol Res FLENI, Ctr Res Neuroimmunol Dis, RA-1428 Buenos Aires, DF, Argentina; [Burchard, Esteban G.] Univ Calif San Francisco, Sch Pharm, Dept Bioengn, San Francisco, CA 94158 USA; [Ghosh, Sourav] Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA; [Licona-Limon, Paula] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City, DF, Mexico	Yale University; Buenos Aires National Academy of Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; Howard Hughes Medical Institute; Yale University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of California System; University of California San Francisco; Yale University; Universidad Nacional Autonoma de Mexico	Rothlin, CV (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	carla.rothlin@yale.edu	Herbert, DeBroski/AAD-3035-2019; Correale, Jorge/AAG-4245-2020	Herbert, DeBroski/0000-0002-2449-5365; Ghosh, Sourav/0000-0001-5990-8708; de Kouchkovsky, Dimitri/0000-0002-9609-3226; Carrera Silva, Eugenio Antonio/0000-0003-4428-8213	American Asthma Foundation; NIH [R01 AI089824, T32 AI007019, T32 GM007205, HL088133, HL078885, HL004464, HL104608, HL117004]; National Institute on Minority Health and Health Disparities [MD006902]; Kolltan Pharmaceuticals; Yale University Gershon-Trudeau Fellowship; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078885, R01HL088133, R01HL117004, K23HL004464, R01HL104608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089824, T32AI007019, R01AI095289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, R01GM083204] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD006902] Funding Source: NIH RePORTER	American Asthma Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Kolltan Pharmaceuticals; Yale University Gershon-Trudeau Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank G. Tokmulina for cell sorting and A. Iwasaki, R. Medzhitov, J. Nussbaum, and R. Locksley for scientific discussion. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. C. V. R. is a shareholder of Kolltan Pharmaceuticals. This research was supported by grants from the American Asthma Foundation (C. V. R. and E. G. B.), NIH (R01 AI089824 to C. V. R., T32 AI007019 to P. Y. C., T32 GM007205 to D. D. K., and HL088133, HL078885, HL004464, HL104608, and HL117004 to E. G. B), the National Institute on Minority Health and Health Disparities (MD006902 to E. G. B.), Kolltan Pharmaceuticals (C. V. R.) and the Yale University Gershon-Trudeau Fellowship (P.Y.C.).	Bosurgi L, 2013, P NATL ACAD SCI USA, V110, P13091, DOI 10.1073/pnas.1302507110; Fujimori T, 2015, MUCOSAL IMMUNOL, V8, P1021, DOI 10.1038/mi.2014.129; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Murakami R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073270; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perros F, 2009, ALLERGY, V64, P995, DOI 10.1111/j.1398-9995.2009.02095.x; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Portelli M, 2012, EXPERT REV RESP MED, V6, P223, DOI [10.1586/ERS.12.9, 10.1586/ers.12.9]; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Shibata T, 2014, J IMMUNOL, V192, P3569, DOI 10.4049/jimmunol.1302766; Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010; Smith KA, 2012, INFECT IMMUN, V80, P3481, DOI 10.1128/IAI.00436-12; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986	20	51	54	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					99	103		10.1126/science.aaf1358	http://dx.doi.org/10.1126/science.aaf1358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034374	Green Accepted, Green Published			2022-12-28	WOS:000373039600044
J	Kepler, SO; Koester, D; Ourique, G				Kepler, S. O.; Koester, Detlev; Ourique, Gustavo			A white dwarf with an oxygen atmosphere	SCIENCE			English	Article							MASSIVE AGB STARS; IA SUPERNOVAE; NUCLEOSYNTHESIS; DEPENDENCE; SKY; PROGENITORS; PARAMETERS; EVOLUTION; SPECTRA	Stars born with masses below around 10 solar masses end their lives as white dwarf stars. Their atmospheres are dominated by the lightest elements because gravitational diffusion brings the lightest element to the surface. We report the discovery of a white dwarf with an atmosphere completely dominated by oxygen, SDSS J124043.01+671034.68. After oxygen, the next most abundant elements in its atmosphere are neon and magnesium, but these are lower by a factor of >= 25 by number. The fact that no hydrogen or helium are observed is surprising. Oxygen, neon, and magnesium are the products of carbon burning, which occurs in stars at the high-mass end of pre-white dwarf formation. This star, a possible oxygen-neon white dwarf, will provide a rare observational test of the evolutionary paths toward white dwarfs.	[Kepler, S. O.; Ourique, Gustavo] Univ Fed Rio Grande do Sul, Inst Fis, BR-91501900 Porto Alegre, RS, Brazil; [Koester, Detlev] Univ Kiel, Inst Theoret Phys & Astrophys, Olshaussenstr 40, D-24098 Kiel, Germany	Universidade Federal do Rio Grande do Sul; University of Kiel	Kepler, SO (corresponding author), Univ Fed Rio Grande do Sul, Inst Fis, BR-91501900 Porto Alegre, RS, Brazil.	kepler@if.ufrgs.br	Kepler, S. O./H-5901-2012	Kepler, S. O./0000-0002-7470-5703	Science without Borders; Ministerio de Ciencia Tecnologia e Inovacao/Ministerio da Educacao-Brazil; Alfred P. Sloan Foundation; National Science Foundation; U.S. Department of Energy Office of Science; University of Arizona; Brazilian Participation Group; Brookhaven National Laboratory; Carnegie Mellon University; University of Florida; French Participation Group; German Participation Group; Harvard University; Instituto de Astrofisica de Canarias; Michigan State/Notre Dame/Joint Institute for Nuclear Astrophysics Participation Group; Johns Hopkins University; Lawrence Berkeley National Laboratory; Max Planck Institute for Astrophysics; Max Planck Institute for Extraterrestrial Physics; New Mexico State University; New York University; Ohio State University; Pennsylvania State University; University of Portsmouth; Princeton University; Spanish Participation Group; University of Tokyo; University of Utah; Vanderbilt University; University of Virginia; University of Washington; Yale University	Science without Borders; Ministerio de Ciencia Tecnologia e Inovacao/Ministerio da Educacao-Brazil; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy Office of Science(United States Department of Energy (DOE)); University of Arizona; Brazilian Participation Group; Brookhaven National Laboratory(United States Department of Energy (DOE)); Carnegie Mellon University; University of Florida(University of Florida); French Participation Group; German Participation Group; Harvard University; Instituto de Astrofisica de Canarias; Michigan State/Notre Dame/Joint Institute for Nuclear Astrophysics Participation Group; Johns Hopkins University(Johns Hopkins University); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Max Planck Institute for Astrophysics; Max Planck Institute for Extraterrestrial Physics; New Mexico State University; New York University; Ohio State University(Ohio State University); Pennsylvania State University; University of Portsmouth; Princeton University(Princeton University); Spanish Participation Group; University of Tokyo; University of Utah; Vanderbilt University; University of Virginia; University of Washington(University of Washington); Yale University	D.K. is supported by Science without Borders, Ministerio de Ciencia Tecnologia e Inovacao/Ministerio da Educacao-Brazil. Funding for SDSS-III has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the National Science Foundation, and the U.S. Department of Energy Office of Science. The SDSS-III web site is www.sdss3.org. SDSS-III is managed by the Astrophysical Research Consortium for the Participating Institutions of the SDSS-III Collaboration, including the University of Arizona, the Brazilian Participation Group, Brookhaven National Laboratory, Carnegie Mellon University, University of Florida, the French Participation Group, the German Participation Group, Harvard University, the Instituto de Astrofisica de Canarias, the Michigan State/Notre Dame/Joint Institute for Nuclear Astrophysics Participation Group, Johns Hopkins University, Lawrence Berkeley National Laboratory, Max Planck Institute for Astrophysics, Max Planck Institute for Extraterrestrial Physics, New Mexico State University, New York University, Ohio State University, Pennsylvania State University, University of Portsmouth, Princeton University, the Spanish Participation Group, University of Tokyo, University of Utah, Vanderbilt University, University of Virginia, University of Washington, and Yale University. The spectrum can be downloaded at http://dr12.sdss3.org/sas/dr12/sdss/spectro/redux/v5_7_0/spectra/7120/spec-7120-56720-0894.fits and the SDSS photometry from http://skyserver.sdss.org/dr7/en/tools/explore/obj.asp?ra=12%2040%2043.01&dec=+67%2010%2034.68.	Alam S, 2015, ASTROPHYS J SUPPL S, V219, DOI 10.1088/0067-0049/219/1/12; Althaus LG, 2009, ASTROPHYS J, V704, P1605, DOI 10.1088/0004-637X/704/2/1605; Barron-Palos L, 2006, NUCL PHYS A, V779, P318, DOI 10.1016/j.nuclphysa.2006.09.004; Bianchi L, 2014, ADV SPACE RES, V53, P900, DOI 10.1016/j.asr.2013.07.045; Chen MC, 2014, MON NOT R ASTRON SOC, V440, P1274, DOI 10.1093/mnras/stu108; Cummings J. D., 2016, 2 MASSIVE WHITE DWAR; Dan M, 2012, MON NOT R ASTRON SOC, V422, P2417, DOI 10.1111/j.1365-2966.2012.20794.x; Denissenkov PA, 2015, MON NOT R ASTRON SOC, V447, P2696, DOI 10.1093/mnras/stu2589; Doherty CL, 2014, MON NOT R ASTRON SOC, V441, P582, DOI 10.1093/mnras/stu571; Dufour P, 2008, ASTROPHYS J, V683, P978, DOI 10.1086/589855; Dufour P, 2011, WHITE DWARF ATMOSPHERES AND CIRCUMSTELLAR ENVIRONMENTS, P53; Dunlap BH, 2015, ASTR SOC P, V493, P547; Fryer CL, 2010, ASTROPHYS J, V725, P296, DOI 10.1088/0004-637X/725/1/296; Gansicke BT, 2010, SCIENCE, V327, P188, DOI 10.1126/science.1180228; GARCIABERRO E, 1994, ASTROPHYS J, V434, P306, DOI 10.1086/174729; Herwig F, 1999, ASTRON ASTROPHYS, V349, pL5; Kepler SO, 2016, MON NOT R ASTRON SOC, V455, P3413, DOI 10.1093/mnras/stv2526; Kepler SO, 2015, MON NOT R ASTRON SOC, V446, P4078, DOI 10.1093/mnras/stu2388; Koester D, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201424231; Liebert J, 2003, ASTRON J, V126, P2521, DOI 10.1086/378911; Meng X, 2008, ASTRON ASTROPHYS, V487, P625, DOI 10.1051/0004-6361:20078841; Nomoto K., 2014, P INT ASTRONOMICAL U, V296, P27; Nomoto K, 2013, ANNU REV ASTRON ASTR, V51, P457, DOI 10.1146/annurev-astro-082812-140956; Pakmor R, 2010, NATURE, V463, P61, DOI 10.1038/nature08642; Romero AD, 2015, MON NOT R ASTRON SOC, V450, P3708, DOI 10.1093/mnras/stv848; SCHATZMAN E, 1948, NATURE, V161, P61, DOI 10.1038/161061b0; Shen KJ, 2010, ASTROPHYS J, V715, P767, DOI 10.1088/0004-637X/715/2/767; Werner K, 2015, ASTRON ASTROPHYS, V582, DOI 10.1051/0004-6361/201526842	29	31	32	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					67	69		10.1126/science.aad6705	http://dx.doi.org/10.1126/science.aad6705			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034367				2022-12-28	WOS:000373039600035
J	Genovese, MC; Kremer, J; Zamani, O; Ludivico, C; Krogulec, M; Xie, L; Beattie, SD; Koch, AE; Cardillo, TE; Rooney, TP; Macias, WL; de Bono, S; Schlichting, DE; Smolen, JS				Genovese, Mark C.; Kremer, Joel; Zamani, Omid; Ludivico, Charles; Krogulec, Marek; Xie, Li; Beattie, Scott D.; Koch, Alisa E.; Cardillo, Tracy E.; Rooney, Terence P.; Macias, William L.; de Bono, Stephanie; Schlichting, Douglas E.; Smolen, Josef S.			Baricitinib in Patients with Refractory Rheumatoid Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE-ACTIVITY INDEX; INADEQUATE RESPONSE; DOUBLE-BLIND; EFFICACY; SAFETY; METHOTREXATE; MULTICENTER; VALIDATION; OUTCOMES; THERAPY	BACKGROUND In phase 2 studies, baricitinib, an oral Janus kinase 1 and 2 inhibitor, reduced disease activity in patients with rheumatoid arthritis who had not previously received treatment with biologic disease-modifying antirheumatic drugs (DMARDs). METHODS In this phase 3 study involving 527 patients with an inadequate response to or unacceptable side effects associated with one or more tumor necrosis factor inhibitors, other biologic DMARDs, or both, we randomly assigned the patients in a 1: 1: 1 ratio to baricitinib at a dose of 2 or 4 mg daily or placebo for 24 weeks. End points, tested hierarchically at week 12 to control type 1 error, were the American College of Rheumatology 20% (ACR20) response (primary end point), the Health Assessment Questionnaire-Disability Index (HAQ-DI) score, the 28-joint Disease Activity Score based on C-reactive protein level (DAS28-CRP), and a Simplified Disease Activity Index (SDAI) score of 3.3 or less (on a scale of 0.1 to 86.0, with a score of 3.3 or less indicating remission). Comparisons with placebo were made first with the 4-mg dose of baricitinib and then with the 2-mg dose. RESULTS Significantly more patients receiving baricitinib at the 4-mg dose than those receiving placebo had an ACR20 response at week 12 (55% vs. 27%, P<0.001). Differences between the higher-dose baricitinib group and the placebo group were also significant for the HAQ-DI score and the DAS28-CRP but not for an SDAI score of 3.3 or less. Adverse-event rates through 24 weeks were higher for patients receiving the 2-mg dose of baricitinib and those receiving the 4-mg dose than for patients receiving placebo (71% and 77%, respectively, vs. 64%), including infections (44% and 40%, vs. 31%). The rates of serious adverse events were 4%, 10%, and 7% in the three groups, respectively. Two nonmelanoma skin cancers and two major adverse cardiovascular events, including a fatal stroke, occurred in the higher-dose group. Baricitinib was associated with a small reduction in neutrophil levels and increases in serum creatinine and low-density lipoprotein cholesterol levels. CONCLUSIONS In patients with rheumatoid arthritis and an inadequate response to biologic DMARDs, baricitinib at a daily dose of 4 mg was associated with clinical improvement at 12 weeks.	[Genovese, Mark C.] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA; [Kremer, Joel] Albany Med Coll, Albany, NY 12208 USA; [Zamani, Omid] Rheumazentrum Favoriten, Vienna, Austria; [Smolen, Josef S.] Med Univ Vienna, Vienna, Austria; [Ludivico, Charles] East Penn Rheumatol, Bethlehem, PA USA; [Krogulec, Marek] MAK MED, Rheumatol Clin, Nadarzyn, Poland; [Xie, Li; Beattie, Scott D.; Koch, Alisa E.; Cardillo, Tracy E.; Rooney, Terence P.; Macias, William L.; de Bono, Stephanie; Schlichting, Douglas E.] Eli Lilly & Co, Indianapolis, IN 46285 USA	Stanford University; Albany Medical College; Medical University of Vienna; Eli Lilly	Genovese, MC (corresponding author), Stanford Univ, Sch Med, Div Immunol & Rheumatol, 1000 Welch Rd,Suite 203, Palo Alto, CA 94304 USA.			Beattie, Scott/0000-0003-2710-1234	Eli Lilly; Incyte	Eli Lilly(Eli Lilly); Incyte	Funded by Eli Lilly and Incyte	Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; [Anonymous], DIS ACT SCOR RHEUM A; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; FRIES JF, 1982, J RHEUMATOL, V9, P789; Genovese MC, 2008, ANN RHEUM DIS, V67, P547, DOI 10.1136/ard.2007.074773; Keystone EC, 2015, ANN RHEUM DIS, V74, P333, DOI 10.1136/annrheumdis-2014-206478; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; O'Shea JJ, 2013, ANN RHEUM DIS, V72, P111, DOI 10.1136/annrheumdis-2012-202576; O'Shea JJ, 2014, CELL, V157, P227, DOI 10.1016/j.cell.2014.03.010; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolen JS, 2015, NAT REV RHEUMATOL, V11, P276, DOI 10.1038/nrrheum.2015.8; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Tanaka Y, 2016, J RHEUMATOL, V43, P504, DOI 10.3899/jrheum.150613	20	380	400	2	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1243	1252		10.1056/NEJMoa1507247	http://dx.doi.org/10.1056/NEJMoa1507247			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8ZM	27028914	Bronze			2022-12-28	WOS:000373085500007
J	Li, Q; Chen, L; Gadinski, MR; Zhang, SH; Zhang, GZ; Li, HU; Iagodkine, E; Haque, A; Chen, LQ; Jackson, TN; Wang, Q				Li, Qi; Chen, Lei; Gadinski, Matthew R.; Zhang, Shihai; Zhang, Guangzu; Li, Haoyu U.; Iagodkine, Elissei; Haque, Aman; Chen, Long-Qing; Jackson, Thomas N.; Wang, Qing			Flexible high-temperature dielectric materials from polymer nanocomposites (vol 528, pg 576, 2015)	NATURE			English	Correction									[Li, Qi; Chen, Lei; Gadinski, Matthew R.; Zhang, Shihai; Zhang, Guangzu; Li, Haoyu U.; Iagodkine, Elissei; Haque, Aman; Chen, Long-Qing; Jackson, Thomas N.; Wang, Qing] Dow Chem Co USA, 455 Forest St, Marlborough, MA 01752 USA	Dow Chemical Company	Li, Q (corresponding author), Dow Chem Co USA, 455 Forest St, Marlborough, MA 01752 USA.		Chen, LongQing/I-7536-2012	Chen, LongQing/0000-0003-3359-3781				Li Q, 2015, NATURE, V523, P576, DOI 10.1038/nature14647	1	25	25	38	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					112	112		10.1038/nature17673	http://dx.doi.org/10.1038/nature17673			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UF	27074516	Bronze			2022-12-28	WOS:000452218600001
J	Twig, G; Yaniv, G; Levine, H; Leiba, A; Goldberger, N; Derazne, E; Shor, DB; Tzur, D; Afek, A; Shamiss, A; Haklai, Z; Kark, JD				Twig, Gilad; Yaniv, Gal; Levine, Hagai; Leiba, Adi; Goldberger, Nehama; Derazne, Estela; Shor, Dana Ben-Ami; Tzur, Dorit; Afek, Arnon; Shamiss, Ari; Haklai, Ziona; Kark, Jeremy D.			Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; FOLLOW-UP; YOUNG-ADULTS; HISTORICAL COHORT; CHILDHOOD OBESITY; PREMATURE DEATH; MID-ADULTHOOD; UNITED-STATES; RISK-FACTORS; MORTALITY	BACKGROUND In light of the worldwide increase in childhood obesity, we examined the association between body-mass index (BMI) in late adolescence and death from cardiovascular causes in adulthood. METHODS We grouped data on BMI, as measured from 1967 through 2010 in 2.3 million Israeli adolescents (mean age, 17.3 +/- 0.4 years), according to age-and sex-specific percentiles from the U.S. Centers for Disease Control and Prevention. Primary outcomes were the number of deaths attributed to coronary heart disease, stroke, sudden death from an unknown cause, or a combination of all three categories (total cardiovascular causes) by mid-2011. Cox proportional-hazards models were used. RESULTS During 42,297,007 person-years of follow-up, 2918 of 32,127 deaths (9.1%) were from cardiovascular causes, including 1497 from coronary heart disease, 528 from stroke, and 893 from sudden death. On multivariable analysis, there was a graded increase in the risk of death from cardiovascular causes and all causes that started among participants in the group that was in the 50th to 74th percentiles of BMI (i.e., within the accepted normal range). Hazard ratios in the obese group (>= 95th percentile for BMI), as compared with the reference group in the 5th to 24th percentiles, were 4.9 (95% confidence interval [CI], 3.9 to 6.1) for death from coronary heart disease, 2.6 (95% CI, 1.7 to 4.1) for death from stroke, 2.1 (95% CI, 1.5 to 2.9) for sudden death, and 3.5 (95% CI, 2.9 to 4.1) for death from total cardiovascular causes, after adjustment for sex, age, birth year, sociodemographic characteristics, and height. Hazard ratios for death from cardiovascular causes in the same percentile groups increased from 2.0 (95% CI, 1.1 to 3.9) during follow-up for 0 to 10 years to 4.1 (95% CI, 3.1 to 5.4) during follow-up for 30 to 40 years; during both periods, hazard ratios were consistently high for death from coronary heart disease. Findings persisted in extensive sensitivity analyses. CONCLUSIONS A BMI in the 50th to 74th percentiles, within the accepted normal range, during adolescence was associated with increased cardiovascular and all-cause mortality during 40 years of follow-up. Overweight and obesity were strongly associated with increased cardiovascular mortality in adulthood.	[Twig, Gilad; Leiba, Adi; Shor, Dana Ben-Ami; Shamiss, Ari] Chaim Sheba Med Ctr, Dept Med, IL-52621 Tel Hashomer, Israel; [Twig, Gilad; Yaniv, Gal] Chaim Sheba Med Ctr, Dr Pinchas Bornstein Talpiot Med Leadership Progr, IL-52621 Tel Hashomer, Israel; [Twig, Gilad; Yaniv, Gal; Leiba, Adi; Derazne, Estela; Tzur, Dorit] Israel Def Forces Med Corps, Tel Aviv, Israel; [Twig, Gilad; Leiba, Adi; Derazne, Estela; Shor, Dana Ben-Ami; Afek, Arnon; Shamiss, Ari] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Levine, Hagai; Kark, Jeremy D.] Hebrew Univ Jerusalem, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Goldberger, Nehama; Afek, Arnon; Haklai, Ziona] Israel Minist Hlth, Jerusalem, Israel; [Leiba, Adi] Harvard Univ, Dept Med, Mt Auburn Hosp, Cambridge, MA 02138 USA	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Harvard University; Mount Auburn Hospital	Twig, G (corresponding author), Chaim Sheba Med Ctr, Dept Med B, IL-52621 Ramat Gan, Israel.	gilad.twig@gmail.com	Goldberger, Nehama F/G-7714-2017; Twig, Gilad/C-4373-2018; Levine, Hagai/B-4329-2012	Goldberger, Nehama F/0000-0002-9537-9142; Twig, Gilad/0000-0003-2829-3645; Levine, Hagai/0000-0002-5597-4916	Environment and Health Fund	Environment and Health Fund	Funded by the Environment and Health Fund.	Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; DIPIETRO L, 1994, INT J OBESITY, V18, P585; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gray L, 2011, ARCH INTERN MED, V171, P1768, DOI 10.1001/archinternmed.2011.486; Guven Ayla, 2010, J Clin Res Pediatr Endocrinol, V2, P21, DOI 10.4274/jcrpe.v2i1.21; Hagg S, 2015, INT J EPIDEMIOL, V44, P578, DOI 10.1093/ije/dyv094; Jeffreys M, 2003, INT J OBESITY, V27, P1391, DOI 10.1038/sj.ijo.0802414; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Keith SW, 2011, INT J OBESITY, V35, P401, DOI 10.1038/ijo.2010.148; Kuczmarski RJ, 2002, VITAL HLTH STAT, V11, P1; Kvaavik E, 2003, ARCH PEDIAT ADOL MED, V157, P1212, DOI 10.1001/archpedi.157.12.1212; Lawlor DA, 2006, AM J CLIN NUTR, V83, P767, DOI 10.1093/ajcn/83.4.767; Mangner N, 2014, JACC-CARDIOVASC IMAG, V7, P1198, DOI 10.1016/j.jcmg.2014.08.006; McGill HC, 2000, AM J CLIN NUTR, V72, p1307S, DOI 10.1093/ajcn/72.5.1307s; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; O'Flaherty M, 2012, INT J CARDIOL, V158, P193, DOI 10.1016/j.ijcard.2011.01.016; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Shah RV, 2016, JAMA INTERN MED, V176, P87, DOI 10.1001/jamainternmed.2015.6309; Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Twig G, 2014, J CLIN ENDOCR METAB, V99, P2095, DOI 10.1210/jc.2014-1213; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006; Wurtz P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001765	29	486	501	5	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2016	374	25					2430	2440		10.1056/NEJMoa1503840	http://dx.doi.org/10.1056/NEJMoa1503840			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP1TG	27074389	Bronze			2022-12-28	WOS:000378271700007
J	Bibbins-Domingo, K				Bibbins-Domingo, Kirsten		US Preventive Serv Task Force	Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-DOSE ASPIRIN; HEART-ASSOCIATION; AMERICAN-COLLEGE; RANDOMIZED-TRIAL; FOLLOW-UP; RISK; EVENTS	Description: Update of the 2009 USPSTF recommendation on aspirin use to prevent cardiovascular disease (CVD) events and the 2007 recommendation on aspirin and nonsteroidal anti-inflammatory drug use to prevent colorectal cancer (CRC). Methods: The USPSTF reviewed 5 additional studies of aspirin for the primary prevention of CVD and several additional analyses of CRC follow-up data. The USPSTF also relied on commissioned systematic reviews of all-cause mortality and total cancer incidence and mortality and a comprehensive review of harms. The USPSTF then used a microsimulation model to systematically estimate the balance of benefits and harms. Population: This recommendation applies to adults aged 40 years or older without known CVD and without increased bleeding risk. Recommendations: The USPSTF recommends initiating low-dose aspirin use for the primary prevention of CVD and CRC in adults aged 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years. (B recommendation) The decision to initiate low-dose aspirin use for the primary prevention of CVD and CRC in adults aged 60 to 69 years who have a 10% or greater 10-year CVD risk should be an individual one. Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. Persons who place a higher value on the potential benefits than the potential harms may choose to initiate low-dose aspirin. (C recommendation) The current evidence is insufficient to assess the balance of benefits and harms of initiating aspirin use for the primary prevention of CVD and CRC in adults younger than 50 years. (I statement) The current evidence is insufficient to assess the balance of benefits and harms of initiating aspirin use for the primary prevention of CVD and CRC in adults aged 70 years or older. (I statement)	[Bibbins-Domingo, Kirsten; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Bibbins-Domingo, K (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.		Harper, Diane M./I-2180-2014; Phillips, William R./V-1065-2017; Epling, John W/J-1097-2019	Harper, Diane M./0000-0001-7648-883X; Phillips, William R./0000-0003-2802-4349; Epling, John W/0000-0001-9445-8669; Kemper, Alex/0000-0001-5491-3997; Davidson, Karina/0000-0002-9162-477X	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Academy of Family Physicians, 2009, CLIN PREV SERV REC C; [Anonymous], [No title captured]; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Chubak J, 2016, ANN INTERN MED, V164, P814, DOI 10.7326/M15-2117; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; Dehmer SP, 2015, AHRQ PUBLICATION, V15-05229-EF-1; Dehmer SP, 2016, ANN INTERN MED, V164, P777, DOI 10.7326/M15-2129; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Guirguis-Blake JM, 2016, ANN INTERN MED, V164, P804, DOI 10.7326/M15-2113; Guirguis-Blake JM, 2015, AHRQ PUBLICATION, V13-05195-EF-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Heron Melonie, 2015, Natl Vital Stat Rep, V64, P1; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Mainous AG, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000989; Meade TW, 1998, LANCET, V351, P233; Nemerovski CW, 2012, PHARMACOTHERAPY, V32, P1020, DOI 10.1002/phar.1127; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pignone M, 2010, DIABETES CARE, V33, P1395, DOI 10.2337/dc10-0555; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Vandvik O, 2012, CHEST, V141, pE637S, DOI 10.1378/chest.11-2306; Walker Jay, 2007, Interact Cardiovasc Thorac Surg, V6, P519, DOI 10.1510/icvts.2007.155788; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Whitlock EP, 2015, AHRQ PUBLICATION, V13-05193-EF-1; Whitlock EP, 2016, ANN INTERN MED, V164, P826, DOI 10.7326/M15-2112	37	598	633	4	72	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					836	U103		10.7326/M16-0577	http://dx.doi.org/10.7326/M16-0577			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27064677				2022-12-28	WOS:000379343000017
J	Povsic, TJ; Zeiher, AM				Povsic, Thomas J.; Zeiher, Andreas M.			IxCELL-DCM: rejuvenation for cardiac regenerative therapy?	LANCET			English	Editorial Material							LEFT-VENTRICULAR FUNCTION; REFRACTORY ANGINA; HEART-FAILURE; CELL THERAPY; METAANALYSIS; TRIALS; DESIGN		[Povsic, Thomas J.] Duke Med, DCRI, Durham, NC 27708 USA; [Zeiher, Andreas M.] Goethe Univ Frankfurt, Dept Internal Med, D-60054 Frankfurt, Germany	Duke University; Goethe University Frankfurt	Povsic, TJ (corresponding author), Duke Med, DCRI, Durham, NC 27708 USA.	Thomas.povsic@duke.edu						Bartunek J, 2016, EUR J HEART FAIL, V18, P160, DOI 10.1002/ejhf.434; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Delewi R, 2013, HEART, V99, P225, DOI 10.1136/heartjnl-2012-302230; Felker GM, 2008, J CARD FAIL, V14, P368, DOI 10.1016/j.cardfail.2008.01.009; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Patel AN, 2016, LANCET; Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418; Povsic TJ, 2013, AM HEART J, V165, P854, DOI 10.1016/j.ahj.2013.03.003	10	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2362	2363		10.1016/S0140-6736(16)30138-6	http://dx.doi.org/10.1016/S0140-6736(16)30138-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1ST	27059889				2022-12-28	WOS:000377560100010
J	Trinquart, L; Attiche, N; Bafeta, A; Porcher, R; Ravaud, P				Trinquart, Ludovic; Attiche, Nassima; Bafeta, Aida; Porcher, Raphael; Ravaud, Philippe			Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials	ANNALS OF INTERNAL MEDICINE			English	Article							MIXED-TREATMENT COMPARISONS; MULTIPLE-TREATMENTS METAANALYSIS; PELVIC PAIN SYNDROME; CHRONIC HEPATITIS-B; ATRIAL-FIBRILLATION; SYSTEMATIC REVIEWS; BETAMETHASONE DIPROPIONATE; PHARMACOLOGICAL-TREATMENTS; STROKE PREVENTION; GLYCEMIC CONTROL	Background: Ranking of interventions is one of the most appealing elements of network meta-analysis. There is, however, little evidence about the reliability of these rankings. Purpose: To empirically evaluate the extent of uncertainty in intervention rankings from network meta-analysis. Data Sources: Two previous systematic reviews that involved searches of the Cochrane Library, MEDLINE, and Embase up to July 2012 for articles that included networks of at least 3 interventions. Study Selection: 58 network meta-analyses involving 1308 randomized trials and 404 interventions with available aggregated outcome data. Data Analysis: Each network was analyzed with a Bayesian approach. For each intervention, the surface under the cumulative ranking curve (SUCRA) and its 95% credible interval (95% CrI) were estimated. Through use of the SUCRA values, the interventions were then rank-ordered between 0% (worst) and 100% (best). Data Synthesis: The median width of the 95% CrIs of the SUCRA was 65% (first to third quartile, 38% to 80%). In 28% of networks, there was a 50% or greater probability that the best-ranked treatment was actually not the best. No evidence showed a difference between the best-ranked intervention and the second and third best-ranked interventions in 90% and 71% of comparisons, respectively. In 39 networks with 6 or more interventions, the median probability that 1 of the top 2 interventions was among the bottom 2 was 35% (first to third quartile, 14% to 59%). Limitation: This analysis did not consider such factors as the risk of bias within trials or small-study effects that may affect the reliability of rankings. Conclusion: Treatment rankings derived from network metaanalyses have a substantial degree of imprecision. Authors and readers should interpret such rankings with great caution.	Univ Paris 05, Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin,INSERM U1153,Sorbonne Paris Ci, Paris, France; Cochrane France, Paris, France; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Trinquart, Ludovic; Attiche, Nassima; Bafeta, Aida; Porcher, Raphael; Ravaud, Philippe] Hop Hotel Dieu, Ctr Epidemiol Clin, 1 Pl Parvis Notre Dame, F-75181 Paris 04, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Columbia University	Trinquart, L (corresponding author), Hop Hotel Dieu, Ctr Epidemiol Clin, 1 Pl Parvis Notre Dame, F-75181 Paris 04, France.	ludovic.trinquart@aphp.fr	ravaud, philippe/C-1694-2009; aida, bafeta/T-5582-2019; Trinquart, Ludovic/H-4961-2019	aida, bafeta/0000-0001-8947-7881; Trinquart, Ludovic/0000-0002-3028-4900; Ravaud, Philippe/0000-0001-8264-9206; Porcher, Raphael/0000-0002-5277-4679	Cochrane France	Cochrane France	Drs. Trinquart, Attiche, and Bafeta were supported by Cochrane France.	Ades AE, 2010, VALUE HEALTH, V13, P976, DOI 10.1111/j.1524-4733.2010.00784.x; Anothaisintawee T, 2011, JAMA-J AM MED ASSOC, V305, P78, DOI 10.1001/jama.2010.1913; Bafeta A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1741; Bafeta A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3675; Baker WL, 2009, PHARMACOTHERAPY, V29, P891, DOI 10.1592/phco.29.8.891; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Bash LD, 2012, CARDIOVASC DRUG THER, V26, P167, DOI 10.1007/s10557-012-6374-4; Bergman GJD, 2010, SEMIN ARTHRITIS RHEU, V39, P425, DOI 10.1016/j.semarthrit.2009.12.002; Bottomley JM, 2011, CURR MED RES OPIN, V27, P251, DOI 10.1185/03007995.2010.541022; Chang KV, 2012, ARCH PHYS MED REHAB, V93, P1259, DOI 10.1016/j.apmr.2012.02.023; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Coleman CI, 2008, J HYPERTENS, V26, P622, DOI 10.1097/HJH.0b013e3282f3ef5e; Sanches ACC, 2011, DIABETES RES CLIN PR, V94, P333, DOI 10.1016/j.diabres.2011.09.001; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; da Costa BR, 2014, EUR HEART J, V35, P3336, DOI 10.1093/eurheartj/ehu424; Dakin H, 2010, VALUE HEALTH, V13, P934, DOI 10.1111/j.1524-4733.2010.00777.x; Daniels JP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2564; Del Santo F, 2012, EUR J CLIN PHARMACOL, V68, P441, DOI 10.1007/s00228-011-1141-1; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Dunkley AJ, 2012, DIABETES OBES METAB, V14, P616, DOI 10.1111/j.1463-1326.2012.01571.x; Edwards SJ, 2009, ALIMENT PHARM THER, V30, P547, DOI 10.1111/j.1365-2036.2009.04077.x; Edwards SJ, 2009, CURR MED RES OPIN, V25, P251, DOI [10.1185/03007990802633160, 10.1185/03007990802633160 ]; Efthimiou O, 2015, BIOSTATISTICS, V16, P84, DOI 10.1093/biostatistics/kxu030; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; Govan L, 2010, STAT MED, V29, P1340, DOI 10.1002/sim.3869; Gross JL, 2011, ANN INTERN MED, V154, P672, DOI 10.7326/0003-4819-154-10-201105170-00007; Gurusamy KS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009052.pub2; Guyot P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3537; Hong H, 2013, AHRQ PUBLICATION, V13-EHC004-EF; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Imamura M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14400; Jalota L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1110; Jansen JP, 2006, CURR MED RES OPIN, V22, P671, DOI 10.1185/030079906X96308; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jansen JP, 2011, SEMIN ARTHRITIS RHEU, V40, P275, DOI 10.1016/j.semarthrit.2010.06.001; Jansen JP, 2009, CURR MED RES OPIN, V25, P1861, DOI 10.1185/03007990903035281; Jonas DE, 2013, AHRQ PUBLICATION; Jones LJ, 2011, ARCH DIS CHILD-FETAL, V96, pF45, DOI 10.1136/adc.2009.168682; Kibret T, 2014, CLIN EPIDEMIOL, V6, P451, DOI 10.2147/CLEP.S69660; Lam SKH, 2007, BMJ-BRIT MED J, V335, P925, DOI 10.1136/bmj.39343.511389.BE; Launois R, 2011, J RHEUMATOL, V38, P835, DOI 10.3899/jrheum.100665; Littlewood KJ, 2012, J CYST FIBROS, V11, P419, DOI 10.1016/j.jcf.2012.03.010; Liu SC, 2012, DIABETES OBES METAB, V14, P810, DOI 10.1111/j.1463-1326.2012.01606.x; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu G, 2007, STAT MED, V26, P3681, DOI 10.1002/sim.2831; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lu GB, 2009, BIOSTATISTICS, V10, P792, DOI 10.1093/biostatistics/kxp032; Marshall EC, 1998, BMJ-BRIT MED J, V316, P1705, DOI DOI 10.1136/BMJ.316.7146.1701; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; Mavridis D, 2016, J CLIN EPIDEMIOL, V69, P161, DOI 10.1016/j.jclinepi.2015.05.027; Meader N, 2010, DRUG ALCOHOL DEPEN, V108, P110, DOI 10.1016/j.drugalcdep.2009.12.008; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Mills EJ, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5195; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Nikolakopoulou A, 2016, STAT MED, V35, P978, DOI 10.1002/sim.6608; Norton EC, 2012, VALUE HEALTH, V15, P1137, DOI 10.1016/j.jval.2012.06.001; Numthavaj P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-1; Owen A, 2010, INT J CARDIOL, V142, P218, DOI 10.1016/j.ijcard.2009.11.045; Phung OJ, 2011, DIABETIC MED, V28, P948, DOI 10.1111/j.1464-5491.2011.03303.x; Phung OJ, 2011, CHEST, V140, P374, DOI 10.1378/chest.10-3084; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Reich K, 2012, BRIT J DERMATOL, V166, P179, DOI 10.1111/j.1365-2133.2011.10583.x; Roskell NS, 2012, CURR MED RES OPIN, V28, P767, DOI 10.1185/03007995.2012.681637; Roskell NS, 2011, PAIN PRACT, V11, P516, DOI 10.1111/j.1533-2500.2010.00441.x; Roskell NS, 2010, THROMB HAEMOSTASIS, V104, P1106, DOI 10.1160/TH10-10-0642; Rucker G, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0060-8; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sciarretta S, 2011, ARCH INTERN MED, V171, P384, DOI 10.1001/archinternmed.2010.427; Siregar S, 2012, CIRC-CARDIOVASC QUAL, V5, P403, DOI 10.1161/CIRCOUTCOMES.111.964460; Sullivan SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113277; Tan SH, 2014, J CLIN EPIDEMIOL, V67, P672, DOI 10.1016/j.jclinepi.2013.11.006; Thakkinstian A, 2012, BJU INT, V110, P1014, DOI 10.1111/j.1464-410X.2012.11088.x; Thijs V, 2008, EUR HEART J, V29, P1086, DOI 10.1093/eurheartj/ehn106; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Trinquart L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035219; Uthman OA, 2010, CURR MED RES OPIN, V26, P53, DOI 10.1185/03007990903416853; van de Kerkhof P, 2011, CURR MED RES OPIN, V27, P225, DOI 10.1185/03007995.2010.541005; Van den Bruel A, 2011, BRIT J OPHTHALMOL, V95, P5, DOI 10.1136/bjo.2009.158360; van Valkenhoef G, 2012, RES SYNTH METHODS, V3, P285, DOI 10.1002/jrsm.1054; van Valkenhoef G, 2013, VALUE HEALTH, V16, P449, DOI 10.1016/j.jval.2012.11.012; van Valkenhoef G, 2012, STAT COMPUT, V22, P1099, DOI 10.1007/s11222-011-9281-9; Vejakama P, 2012, DIABETOLOGIA, V55, P566, DOI 10.1007/s00125-011-2398-8; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Vieira MC, 2011, HIV CLIN TRIALS, V12, P175, DOI [10.1310/hct1204-175, 10.1310/HCT1204-175]; Virgili G, 2011, CURR DRUG TARGETS, V12, P212, DOI 10.2174/138945011794182665; Wang H, 2010, J HOSP INFECT, V76, P1, DOI 10.1016/j.jhin.2010.04.025; Wilhelmus KR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002898.pub4; Woo G, 2010, GASTROENTEROLOGY, V139, P1218, DOI 10.1053/j.gastro.2010.06.042; Yu CH, 2006, CAN J ANAESTH, V53, P906, DOI 10.1007/BF03022834	99	88	91	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					666	+		10.7326/M15-2521	http://dx.doi.org/10.7326/M15-2521			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27089537				2022-12-28	WOS:000375878500014
J	Garcez, PP; Loiola, EC; Da Costa, RM; Higa, LM; Trindade, P; Delvecchio, R; Nascimento, JM; Brindeiro, R; Tanuri, A; Rehen, SK				Garcez, Patricia P.; Loiola, Erick Correia; da Costa, Rodrigo Madeiro; Higa, Luiza M.; Trindade, Pablo; Delvecchio, Rodrigo; Nascimento, Juliana Minardi; Brindeiro, Rodrigo; Tanuri, Amilcar; Rehen, Stevens K.			Zika virus impairs growth in human neurospheres and brain organoids	SCIENCE			English	Article							CEREBRAL ORGANOIDS; TRANSMISSION; INFECTION; GENERATION	Since the emergence of Zika virus (ZIKV), reports of microcephaly have increased considerably in Brazil; however, causality between the viral epidemic and malformations in fetal brains needs further confirmation. We examined the effects of ZIKV infection in human neural stem cells growing as neurospheres and brain organoids. Using immunocytochemistry and electron microscopy, we showed that ZIKV targets human brain cells, reducing their viability and growth as neurospheres and brain organoids. These results suggest that ZIKV abrogates neurogenesis during human brain development.	[Garcez, Patricia P.; Loiola, Erick Correia; da Costa, Rodrigo Madeiro; Trindade, Pablo; Nascimento, Juliana Minardi; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil; [Garcez, Patricia P.; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Higa, Luiza M.; Delvecchio, Rodrigo; Brindeiro, Rodrigo; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Nascimento, Juliana Minardi] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil	IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Estadual de Campinas	Garcez, PP; Rehen, SK (corresponding author), DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.; Garcez, PP; Rehen, SK (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.	ppgarcez@icb.ufrj.br; srehen@lance-ufrj.org	Nascimento, Juliana M/B-8764-2009; Loiola, Erick/I-4106-2016; Trindade, Pablo/D-8913-2016; Madeiro, Rodrigo/M-6433-2017; Higa, Luiza/W-2698-2019; Rehen, Stevens/J-5874-2012; Garcez, Patricia/F-8026-2012; Tanuri, Amilcar/AAM-8601-2021	Nascimento, Juliana M/0000-0003-3126-4984; Loiola, Erick/0000-0002-7926-795X; Trindade, Pablo/0000-0001-5953-7054; Madeiro, Rodrigo/0000-0001-5646-8858; Rehen, Stevens/0000-0003-4216-9501; Garcez, Patricia/0000-0002-9107-1335; 	Brazilian Development Bank; Funding Authority for Studies and Projects; National Council of Scientific and Technological Development; Foundation for Research Support in the State of Rio de Janeiro; Sao Paulo Research Foundation [2014/21035-0]; Coordination for the Improvement of Higher Education Personnel; MRC [MC_PC_15102] Funding Source: UKRI; Medical Research Council [MC_PC_15102] Funding Source: researchfish	Brazilian Development Bank; Funding Authority for Studies and Projects; National Council of Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support in the State of Rio de Janeiro; Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the laboratory crew members M. Costa, I. Gomes, G. Vitoria, J. Sochacki, R. Maciel, and M. Alloati for providing technical support and cultures of human iPS cells and brain organoids. We acknowledge O. M. Barth for comments on the electron micrographs. We also thank F. Pamplona for assistance with the Mind the Graph science infographic maker and Centro Nacional de Biologia Estrutural e Bioimagem for the use of their electron microscopy facility. Funds (not specifically for Zika virus studies) were provided by the Brazilian Development Bank; the Funding Authority for Studies and Projects; the National Council of Scientific and Technological Development; the Foundation for Research Support in the State of Rio de Janeiro; and fellowships from the Sao Paulo Research Foundation (grant 2014/21035-0) and Coordination for the Improvement of Higher Education Personnel. All protocols and procedures were approved by the institutional research ethics committee of Hospital Copa D'Or under approved protocol no. 727.269. The authors declare no competing financial interests.	BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; Grief C, 1997, ARCH VIROL, V142, P2347, DOI 10.1007/s007050050247; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408; Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199, DOI 10.1016/j.ophtha.2009.04.042; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	24	738	768	4	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					816	818		10.1126/science.aaf6116	http://dx.doi.org/10.1126/science.aaf6116			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27064148				2022-12-28	WOS:000375663000038
J	Li, C; Qian, WF; Maclean, CJ; Zhang, JZ				Li, Chuan; Qian, Wenfeng; Maclean, Calum J.; Zhang, Jianzhi			The fitness landscape of a tRNA gene	SCIENCE			English	Article							EPISTASIS; EVOLUTION; PROTEIN; ROBUSTNESS; SYSTEMS; DOMAIN; YEAST	Fitness landscapes describe the genotype-fitness relationship and represent major determinants of evolutionary trajectories. However, the vast genotype space, coupled with the difficulty of measuring fitness, has hindered the empirical determination of fitness landscapes. Combining precise gene replacement and next-generation sequencing, we quantified Darwinian fitness under a high-temperature challenge for more than 65,000 yeast strains, each carrying a unique variant of the single-copy tRNA(CCU)(Arg) gene at its native genomic location. Approximately 1% of single point mutations in the gene were beneficial and 42% were deleterious. Almost half of all mutation pairs exhibited statistically significant epistasis, which had a strong negative bias, except when the mutations occurred at Watson-Crick paired sites. Fitness was broadly correlated with the predicted fraction of correctly folded transfer RNA (tRNA) molecules, thereby revealing a biophysical basis of the fitness landscape.	[Li, Chuan; Qian, Wenfeng; Maclean, Calum J.; Zhang, Jianzhi] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Qian, Wenfeng] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Genet Network Biol, Beijing, Peoples R China	University of Michigan System; University of Michigan; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhang, JZ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	jianzhi@umich.edu		Qian, Wenfeng/0000-0001-6875-0842	NSF DDIG grant [DEB-1501788]; NIH [R01GM103232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103232] Funding Source: NIH RePORTER; Direct For Biological Sciences [1501788] Funding Source: National Science Foundation	NSF DDIG grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank S. Cho, W.-C. Ho, G. Kudla, and J.-R. Yang for valuable comments. Supported by NSF DDIG grant DEB-1501788 (J.Z. and C.L.) and NIH grant R01GM103232 (J.Z.). The NCBI accession number for the sequencing data is PRJNA311172.	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Bank C, 2015, MOL BIOL EVOL, V32, P229, DOI 10.1093/molbev/msu301; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom-Ackermann Z, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004084; de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Guy MP, 2014, GENE DEV, V28, P1721, DOI 10.1101/gad.245936.114; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Hiraga SI, 2012, MOL BIOL CELL, V23, P2741, DOI 10.1091/mbc.E11-04-0365; Lind PA, 2010, SCIENCE, V330, P825, DOI 10.1126/science.1194617; Meer MV, 2010, NATURE, V464, P279, DOI 10.1038/nature08691; Melamed D, 2013, RNA, V19, P1537, DOI 10.1261/rna.040709.113; Melnikov A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku511; Olson CA, 2014, CURR BIOL, V24, P2643, DOI 10.1016/j.cub.2014.09.072; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Qian WF, 2012, CELL REP, V2, P1399, DOI 10.1016/j.celrep.2012.09.017; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	21	92	92	4	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					837	840		10.1126/science.aae0568	http://dx.doi.org/10.1126/science.aae0568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27080104	Green Accepted			2022-12-28	WOS:000375663000044
J	Jha, A; Pronovost, P				Jha, Ashish; Pronovost, Peter			Toward a Safer Health Care System The Critical Need to Improve Measurement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT HARMS		[Jha, Ashish] Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Pronovost, Peter] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Jha, A (corresponding author), 42 Church St, Cambridge, MA 02138 USA.	ajha@hsph.harvard.edu						Adler-Milstein J, 2014, HEALTH AFFAIR, V33, P1664, DOI 10.1377/hlthaff.2014.0453; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Jha AK, 1998, J AM MED INFORM ASSN, V5, P305, DOI 10.1136/jamia.1998.0050305; McGlynn EA, 2015, JAMA-J AM MED ASSOC, V314, P2501, DOI 10.1001/jama.2015.13453; Pronovost P, 2014, NEW ENGL J MED, V371, P691, DOI 10.1056/NEJMp1405800; Pronovost PJ, 2012, JAMA-J AM MED ASSOC, V308, P769, DOI 10.1001/jama.2012.9537	7	24	26	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1831	1832		10.1001/jama.2016.3448	http://dx.doi.org/10.1001/jama.2016.3448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK9XF	27077647				2022-12-28	WOS:000375284400007
J	Feeney, KA; Hansen, LL; Putker, M; Olivares-Yanez, C; Day, J; Eades, LJ; Larrondo, LF; Hoyle, NP; O'Neill, JS; van Ooijen, G				Feeney, Kevin A.; Hansen, Louise L.; Putker, Marrit; Olivares-Yanez, Consuelo; Day, Jason; Eades, Lorna J.; Larrondo, Luis F.; Hoyle, Nathaniel P.; O'Neill, John S.; van Ooijen, Gerben			Daily magnesium fluxes regulate cellular timekeeping and energy balance	NATURE			English	Article							CIRCADIAN-RHYTHMS; PICOEUKARYOTE OSTREOCOCCUS; CLOCKS; MODEL; TRANSCRIPTION; EXCHANGER; REVEALS; PHOSPHORYLATION; TRANSLATION; ANNOTATION	Circadian clocks are fundamental to the biology of most eukaryotes, coordinating behaviour and physiology to resonate with the environmental cycle of day and night through complex networks of clock-controlled genes(1-3). A fundamental knowledge gap exists, however, between circadian gene expression cycles and the biochemical mechanisms that ultimately facilitate circadian regulation of cell biology(4,5). Here we report circadian rhythms in the intracellular concentration of magnesium ions, [Mg2+]i, which act as a cell-autonomous timekeeping component to determine key clock properties both in a human cell line and in a unicellular alga that diverged from each other more than 1 billion years ago(6). Given the essential role of Mg2+ as a cofactor for ATP, a functional consequence of [Mg2+] i oscillations is dynamic regulation of cellular energy expenditure over the daily cycle. Mechanistically, we find that these rhythms provide bilateral feedback linking rhythmic metabolism to clock-controlled gene expression. The global regulation of nucleotide triphosphate turnover by intracellular Mg2+ availability has potential to impact upon many of the cell's more than 600 MgATP-dependent enzymes(7) and every cellular system where MgNTP hydrolysis becomes rate limiting. Indeed, we find that circadian control of translation by mTOR(8) is regulated through [Mg2+] i oscillations. It will now be important to identify which additional biological processes are subject to this form of regulation in tissues of multicellular organisms such as plants and humans, in the context of health and disease.	[Feeney, Kevin A.; Putker, Marrit; Hoyle, Nathaniel P.; O'Neill, John S.] MRC Lab Mol Biol, Francis Crick Ave,Biomed Campus, Cambridge CB2 0QH, England; [Hansen, Louise L.; van Ooijen, Gerben] Univ Edinburgh, Sch Biol Sci, Max Born Crescent, Edinburgh EH9 3BF, Midlothian, Scotland; [Olivares-Yanez, Consuelo; Larrondo, Luis F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Genet Mol & Microbiol, Millennium Nucleus Fungal Integrat & Synthet Biol, Casilla 114-D, Santiago, Chile; [Day, Jason] Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England; [Eades, Lorna J.] Univ Edinburgh, Sch Chem, David Brewster Rd, Edinburgh EH9 3FJ, Midlothian, Scotland	MRC Laboratory Molecular Biology; University of Edinburgh; Pontificia Universidad Catolica de Chile; University of Cambridge; University of Edinburgh	O'Neill, JS (corresponding author), MRC Lab Mol Biol, Francis Crick Ave,Biomed Campus, Cambridge CB2 0QH, England.; van Ooijen, G (corresponding author), Univ Edinburgh, Sch Biol Sci, Max Born Crescent, Edinburgh EH9 3BF, Midlothian, Scotland.	oneillj@mrc-lmb.cam.ac.uk; Gerben.vanOoijen@ed.ac.uk	van Ooijen, Gerben/E-9371-2013; Larrondo, Luis/J-1086-2016	van Ooijen, Gerben/0000-0001-7967-0637; Larrondo, Luis/0000-0002-8832-7109	Royal Society University Research Fellowship [UF110173]; Medical Research Council [MC_UP_1201/4]; Wellcome Trust [093734/Z/10/Z]; KWF BUIT [2014-6637]; Millennium Nucleus for Fungal Integrative and Synthetic Biology [NC120043]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1131030];  [RS120372];  [RS140275]; MRC [MC_UP_1201/4] Funding Source: UKRI	Royal Society University Research Fellowship(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); KWF BUIT; Millennium Nucleus for Fungal Integrative and Synthetic Biology; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	G.v.O. is supported by a Royal Society University Research Fellowship (UF110173) and research grants (RS120372 and RS140275). J.S.O. is supported by the Medical Research Council (MC_UP_1201/4) and the Wellcome Trust (093734/Z/10/Z). M.P. is funded by KWF BUIT 2014-6637. L.F.L. and C.O.Y. are supported by Millennium Nucleus for Fungal Integrative and Synthetic Biology (NC120043), and Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1131030). S. K. Hodge is acknowledged for managing imaging facilities for algal experiments. At the MRC LMB, we are grateful to the Biomedical Services Group for animal care; M. Hastings and J. Chesham for supplying mouse tissue; P. Margiotta for assistance with figures. We also thank D. E. Salt, M. Knight, E. Grunewald, P. Crosby, L. Hewitt and B. Cross for criticism. The anti-puromycin ascites was a gift from M. Hegde.	Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Blanc-Mathieu R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1103; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Danku John M C, 2013, Methods Mol Biol, V953, P255, DOI 10.1007/978-1-62703-152-3_17; Danku JMC, 2009, J ANAL ATOM SPECTROM, V24, P103, DOI 10.1039/b803529f; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Endo M, 2014, NATURE, V515, P419, DOI 10.1038/nature13919; Fisher NI, 1995, STAT ANAL CIRCULAR D; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Jammalamadaka S. R., 2001, TOPICS CIRCULAR STAT, P1; Ko GYP, 2009, J NEUROCHEM, V110, P1150, DOI 10.1111/j.1471-4159.2009.06223.x; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; Kolisek M, 2012, AM J PHYSIOL-CELL PH, V302, pC318, DOI 10.1152/ajpcell.00289.2011; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Le Bihan T, 2015, PROTEOMICS, V15, P4135, DOI 10.1002/pmic.201500086; Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; Nishinaga H, 2009, BIOMED RES-TOKYO, V30, P87, DOI 10.2220/biomedres.30.87; Nitabach MN, 2005, METHOD ENZYMOL, V393, P682, DOI 10.1016/S0076-6879(05)93036-X; NJUS D, 1974, NATURE, V248, P116, DOI 10.1038/248116a0; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Olmedo M, 2012, P NATL ACAD SCI USA, V109, P20479, DOI 10.1073/pnas.1211705109; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Rubin H, 2007, ARCH BIOCHEM BIOPHYS, V458, P16, DOI 10.1016/j.abb.2006.03.026; Sterck L, 2012, NAT METHODS, V9, P1041, DOI 10.1038/nmeth.2242; Valekunja UK, 2013, P NATL ACAD SCI USA, V110, P1554, DOI 10.1073/pnas.1214168110; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van Ooijen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070021; van Ooijen G, 2012, TRENDS BIOCHEM SCI, V37, P484, DOI 10.1016/j.tibs.2012.07.006; van Ooijen G, 2011, CURR BIOL, V21, P869, DOI 10.1016/j.cub.2011.03.060; Wang YC, 2015, J NEUROPHYSIOL, V113, P2114, DOI 10.1152/jn.00404.2014; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	47	143	146	4	108	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					375	+		10.1038/nature17407	http://dx.doi.org/10.1038/nature17407			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27074515	Green Accepted			2022-12-28	WOS:000374424700033
J	Itkin, T; Gur-Cohen, S; Spencer, JA; Schajnovitz, A; Ramasamy, SK; Kusumbe, AP; Ledergor, G; Jung, Y; Milo, I; Poulos, MG; Kalinkovich, A; Ludin, A; Kollet, O; Shakhar, G; Butler, JM; Rafii, S; Adams, RH; Scadden, DT; Lin, CP; Lapidot, T				Itkin, Tomer; Gur-Cohen, Shiri; Spencer, Joel A.; Schajnovitz, Amir; Ramasamy, Saravana K.; Kusumbe, Anjali P.; Ledergor, Guy; Jung, Yookyung; Milo, Idan; Poulos, Michael G.; Kalinkovich, Alexander; Ludin, Aya; Kollet, Orit; Shakhar, Guy; Butler, Jason M.; Rafii, Shahin; Adams, Ralf H.; Scadden, David T.; Lin, Charles P.; Lapidot, Tsvee			Distinct bone marrow blood vessels differentially regulate haematopoiesis	NATURE			English	Article							STEM-CELL QUIESCENCE; PROGENITOR CELLS; RAPID MOBILIZATION; NICHE; MEGAKARYOCYTES; MURINE; ANGIOGENESIS; REGENERATION; MAINTENANCE; RECRUITMENT	Bone marrow endothelial cells (BMECs) form a network of blood vessels that regulate both leukocyte trafficking and haematopoietic stem and progenitor cell (HSPC) maintenance. However, it is not clear how BMECs balance these dual roles, and whether these events occur at the same vascular site. We found that mammalian bone marrow stem cell maintenance and leukocyte trafficking are regulated by distinct blood vessel types with different permeability properties. Less permeable arterial blood vessels maintain haematopoietic stem cells in a low reactive oxygen species (ROS) state, whereas the more permeable sinusoids promote HSPC activation and are the exclusive site for immature and mature leukocyte trafficking to and from the bone marrow. A functional consequence of high permeability of blood vessels is that exposure to blood plasma increases bone marrow HSPC ROS levels, augmenting their migration and differentiation, while compromising their long-term repopulation and survival. These findings may have relevance for clinical haematopoietic stem cell transplantation and mobilization protocols.	[Itkin, Tomer; Gur-Cohen, Shiri; Ledergor, Guy; Milo, Idan; Kalinkovich, Alexander; Ludin, Aya; Kollet, Orit; Shakhar, Guy; Lapidot, Tsvee] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Spencer, Joel A.; Jung, Yookyung; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; [Spencer, Joel A.; Jung, Yookyung; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02114 USA; [Schajnovitz, Amir; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Schajnovitz, Amir; Scadden, David T.] Harvard Stem Cell Inst, Boston, MA 02114 USA; [Schajnovitz, Amir; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Schajnovitz, Amir; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Ramasamy, Saravana K.; Kusumbe, Anjali P.; Adams, Ralf H.] Univ Munster, Dept Tissue Morphogenesis, Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Ramasamy, Saravana K.; Kusumbe, Anjali P.; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Ledergor, Guy] Tel Aviv Sourasky Med Ctr, Dept Internal Med, IL-64239 Tel Aviv, Israel; [Poulos, Michael G.; Butler, Jason M.; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA	Weizmann Institute of Science; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Max Planck Society; University of Munster; University of Munster; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Cornell University	Lapidot, T (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.; Lin, CP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA.; Lin, CP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02114 USA.	charles_lin@hms.harvard.edu; tsvee.lapidot@weizmann.ac.il	Adams, Ralf H/AAE-9274-2019; Spencer, Joel/GLT-9687-2022; KUMARI, ANJU/ABH-8502-2020	Spencer, Joel/0000-0002-4013-8763; Gur-Cohen, Shiri/0000-0002-6372-2284; Ledergor, Guy/0000-0003-0443-6066; Ramasamy, Saravana/0000-0003-2658-2945; Jung, Yookyung/0000-0003-2790-6016; KUMARI, ANJU/0000-0001-5130-4774	Ministry of Science, Technology Space, Israel; DKFZ, Germany; Israel Science Foundation [851/13]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; EU [261387]; European Research Council [339409]; NIH [EB017274, HL100402]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017274] Funding Source: NIH RePORTER	Ministry of Science, Technology Space, Israel(Ministry of Science, Technology and Space (MOST), Israel); DKFZ, Germany; Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; EU(European Commission); European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank G. Karsenty and M. A. Lichtman for fruitful discussions and for critically reviewing the manuscript. We thank S. Mendez-Ferrer and M. Argueta Hernandez for assistance in studies involving MSPCs and nervous system elements. We thank Z. Porat for technical assistance with ImageStream analysis and R. Rotkopf for assistance with statistical data analysis. This study was partially supported by the Ministry of Science, Technology & Space, Israel and the DKFZ, Germany, grants from the Israel Science Foundation (851/13), the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine and EU FP7-HEALTH-2010 (CELL-PID #261387) (T.L.). Confocal studies were supported by the European Research Council Advanced Grant 339409, 'AngioBone' (R.H.A.). Intravital multiphoton studies were supported by NIH grants EB017274 and HL100402 (C.P.L. & D.T.S.).	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bear MD, 2015, J CELL PHYSL; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; De Smet F, 2014, CHEM BIOL, V21, P1310, DOI 10.1016/j.chembiol.2014.07.018; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; Golan K, 2012, BLOOD, V119, P2478, DOI 10.1182/blood-2011-06-358614; Gur-Cohen S, 2015, NAT MED, V21, P1307, DOI 10.1038/nm.3960; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Houlihan DD, 2012, NAT PROTOC, V7, P2103, DOI 10.1038/nprot.2012.125; Hu LP, 2014, BLOOD, V124, pE45, DOI 10.1182/blood-2014-03-559369; Isern J, 2014, ELIFE, V3, DOI 10.7554/eLife.03696; Itkin T, 2012, BLOOD, V120, P1843, DOI 10.1182/blood-2011-11-394692; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kobayashi K, 2014, ARTERIOSCL THROM VAS, V34, P1716, DOI 10.1161/ATVBAHA.114.303890; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Nakamura-Ishizu A, 2014, BIOCHEM BIOPH RES CO, V454, P353, DOI 10.1016/j.bbrc.2014.10.095; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Ono N, 2014, DEV CELL, V29, P330, DOI 10.1016/j.devcel.2014.03.014; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Shen HM, 2012, BLOOD, V119, P3629, DOI 10.1182/blood-2011-08-373621; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Tesio M, 2011, BLOOD, V117, P419, DOI 10.1182/blood-2009-06-230359; Vandekeere S, 2015, MICROCIRCULATION, V22, P509, DOI 10.1111/micc.12229; Wei JW, 2015, CELL, V161, P1576, DOI 10.1016/j.cell.2015.05.029; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706; Zhao M, 2012, BLOOD, V120, P1831, DOI 10.1182/blood-2011-11-393991	50	405	415	6	142	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					323	+		10.1038/nature17624	http://dx.doi.org/10.1038/nature17624			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27074509	Green Accepted, Green Submitted			2022-12-28	WOS:000374424700024
J	Lee, WCA; Bonin, V; Reed, M; Graham, BJ; Hood, G; Glattfelder, K; Reid, RC				Lee, Wei-Chung Allen; Bonin, Vincent; Reed, Michael; Graham, Brett J.; Hood, Greg; Glattfelder, Katie; Reid, R. Clay			Anatomy and function of an excitatory network in the visual cortex	NATURE			English	Article							SERIAL ELECTRON-MICROSCOPY; ACTION-POTENTIALS; RECEPTIVE-FIELDS; DENDRITIC SPINES; NEURONS; AMPA; SPECIALIZATION; CONNECTIVITY; ORGANIZATION; EXPRESSION	Circuits in the cerebral cortex consist of thousands of neurons connected by millions of synapses. A precise understanding of these local networks requires relating circuit activity with the underlying network structure. For pyramidal cells in superficial mouse visual cortex (V1), a consensus is emerging that neurons with similar visual response properties excite each other(1-5), but the anatomical basis of this recurrent synaptic network is unknown. Here we combined physiological imaging and large-scale electron microscopy to study an excitatory network in V1. We found that layer 2/3 neurons organized into subnetworks defined by anatomical connectivity, with more connections within than between groups. More specifically, we found that pyramidal neurons with similar orientation selectivity preferentially formed synapses with each other, despite the fact that axons and dendrites of all orientation selectivities pass near (<5 mu m) each other with roughly equal probability. Therefore, we predict that mechanisms of functionally specific connectivity take place at the length scale of spines. Neurons with similar orientation tuning formed larger synapses, potentially enhancing the net effect of synaptic specificity. With the ability to study thousands of connections in a single circuit, functional connectomics is proving a powerful method to uncover the organizational logic of cortical networks.	[Lee, Wei-Chung Allen; Bonin, Vincent; Reed, Michael; Graham, Brett J.; Reid, R. Clay] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bonin, Vincent] VIB, Neuroelect Res Flanders, B-3001 Louvain, Belgium; [Bonin, Vincent] KU, B-3001 Louvain, Belgium; [Hood, Greg] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Biomed Applicat Grp, Pittsburgh, PA 15213 USA; [Glattfelder, Katie; Reid, R. Clay] Allen Inst Brain Sci, Seattle, WA 98103 USA	Harvard University; Harvard Medical School; Flanders Institute for Biotechnology (VIB); KU Leuven; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Allen Institute for Brain Science	Lee, WCA; Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.; Reid, RC (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	wei-chung_lee@hms.harvard.edu; clayr@alleninstitute.org	Bonin, Vincent/AAQ-3833-2020	Lee, Wei-Chung/0000-0002-4618-295X; Bonin, Vincent/0000-0002-9437-8092	NIH [R01 EY10115, R01 NS075436, R21 NS085320]; HMS Vision Core Grant [P30 EY12196]; AIBS; Bertarelli Program in Translational Neuroscience and Neuroengineering; Edward R. and Anne G. Lefler Center; Stanley and Theodora Feldberg Fund; Neuro-Electronics Research Flanders; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196, R01EY010115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085320, R01NS075436] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HMS Vision Core Grant; AIBS; Bertarelli Program in Translational Neuroscience and Neuroengineering; Edward R. and Anne G. Lefler Center; Stanley and Theodora Feldberg Fund; Neuro-Electronics Research Flanders; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Arora, E. Ashbolt, L. Bailey, L. Beaton, P. Chopra, A. Coda, M. Driesbach, R. Fang, M. Fisher, A. Giuliano, H. Godtfredsen, A. Henry, E. Holtzman, P. Hughes, K. Joines, J. Larson, S. Maillet, K. Moody, E. Nguyen, A. Orban, V. Osuiji, K. Robertson, D. Sandman, S. Schwartz, E. Sczerzenie, N. Thatra, L. Thomas, B. Titus, R. Torres for tracing and reconstruction; E. Raviola for discussions and advice; H. Kim for technical support at the beginning of the study; A. Wetzel for help with alignment and stitching; A. Cardona and S. Saalfeld for the CATMAID project being openly available; and N. da Costa for launching the EM annotation program at the Allen Institute for Brain Science, with help and support from B. Youngstrom, R. Young, C. Dang and J. Phillips. We also thank D. Brittain, W. Gray Roncal, L. Thomas, S. Yurgenson, H. Elliot, and the HMS Image and Data Analysis Core for programming; E. Benecchi and the HMS EM Core Facility for technical support; P. J. Manavalan, K. Lillaney, and R. Burns, for helping make the data freely available; and S. Druckmann, Y. Park, C. Priebe, and J. Vogelstein for discussions on statistical analyses. We are indebted to M. Andermann, S. Chatterjee, N. da Costa, L. Glickfeld, C. Harwell, D. Hildebrand, M. Histed, S. Mihalas, L. Ostroff, E. Raviola, and J. T. Vogelstein for critical reading of various versions of the manuscript. This work was supported by NIH grants to RCR (R01 EY10115 and R01 NS075436); through resources provided by the NRBSC (P41 RR06009) and MMBioS (P41 GM103712); the HMS Vision Core Grant (P30 EY12196); and the AIBS. We thank the Allen Institute founders, P. G. Allen and J. Allen, for their vision, encouragement, and support. WCL was also supported by the Bertarelli Program in Translational Neuroscience and Neuroengineering, Edward R. and Anne G. Lefler Center, and Stanley and Theodora Feldberg Fund, and the NIH (R21 NS085320). VB was also supported by Neuro-Electronics Research Flanders. The project described was partially supported by the NIH by the above named awards. Its content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Andermann ML, 2013, NEURON, V80, P900, DOI 10.1016/j.neuron.2013.07.052; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Bartol TM, 2015, ELIFE, V4, DOI 10.7554/eLife.10778; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Bopp R, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001932; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; FERRER I, 1986, J ANAT, V145, P217; Glickfeld LL, 2013, NAT NEUROSCI, V16, P219, DOI 10.1038/nn.3300; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1988, J NEUROSCI, V8, P4455; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; LARKMAN A, 1990, J NEUROSCI, V10, P1407; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PETERS A, 1985, J COMP NEUROL, V234, P218, DOI 10.1002/cne.902340208; Peters A., 1991, FINE STRUCTURE NERVO; Reid RC, 2012, NEURON, V75, P209, DOI 10.1016/j.neuron.2012.06.031; Reimann MW, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00120; Reinhold K, 2015, NAT NEUROSCI, V18, P1789, DOI 10.1038/nn.4153; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Saalfeld S, 2009, BIOINFORMATICS, V25, P1984, DOI 10.1093/bioinformatics/btp266; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wertz A, 2015, SCIENCE, V349, P70, DOI 10.1126/science.aab1687; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	47	236	239	5	84	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					370	+		10.1038/nature17192	http://dx.doi.org/10.1038/nature17192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27018655	Green Submitted, Green Accepted			2022-12-28	WOS:000374424700032
J	Burke, M; Craxton, M; Kolstad, CD; Onda, C; Allcott, H; Baker, E; Barrage, L; Carson, R; Gillingham, K; Graf-Zivin, J; Greenstone, M; Hallegatte, S; Hanemann, WM; Heal, G; Hsiang, S; Jones, B; Kelly, DL; Kopp, R; Kotchen, M; Mendelsohn, R; Meng, K; Metcalf, G; Moreno-Cruz, J; Pindyck, R; Rose, S; Rudik, I; Stock, J; Tol, RSJ				Burke, M.; Craxton, M.; Kolstad, C. D.; Onda, C.; Allcott, H.; Baker, E.; Barrage, L.; Carson, R.; Gillingham, K.; Graf-Zivin, J.; Greenstone, M.; Hallegatte, S.; Hanemann, W. M.; Heal, G.; Hsiang, S.; Jones, B.; Kelly, D. L.; Kopp, R.; Kotchen, M.; Mendelsohn, R.; Meng, K.; Metcalf, G.; Moreno-Cruz, J.; Pindyck, R.; Rose, S.; Rudik, I.; Stock, J.; Tol, R. S. J.			CLIMATE ECONOMICS Opportunities for advances in climate change economics	SCIENCE			English	Editorial Material							SOCIAL COST; GROWTH; POLICY; CARBON; US		[Burke, M.; Craxton, M.; Kolstad, C. D.; Onda, C.] Stanford Univ, Stanford, CA 94305 USA; [Allcott, H.] NYU, New York, NY USA; [Baker, E.] Univ Massachusetts, Amherst, MA 01003 USA; [Barrage, L.] Brown Univ, Providence, RI 02912 USA; [Carson, R.; Graf-Zivin, J.] Univ Calif San Diego, San Diego, CA 92103 USA; [Gillingham, K.; Kotchen, M.; Mendelsohn, R.] Yale Univ, New Haven, CT USA; [Greenstone, M.] Univ Chicago, Chicago, IL 60637 USA; [Hallegatte, S.] World Bank, 1818 H St NW, Washington, DC 20433 USA; [Hanemann, W. M.] Arizona State Univ, Tempe, AZ USA; [Heal, G.] Columbia Univ, New York, NY USA; [Hsiang, S.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Jones, B.] Northwestern Univ, Evanston, IL USA; [Kelly, D. L.] Univ Miami, Coral Gables, FL 33124 USA; [Kopp, R.] Resources Future Inc, 1616 P St NW, Washington, DC 20036 USA; [Meng, K.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Metcalf, G.] Tufts Univ, Medford, MA 02155 USA; [Moreno-Cruz, J.] Georgia Inst Technol, Atlanta, GA 30332 USA; [Pindyck, R.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rose, S.] Elect Power Res Inst, Palo Alto, CA USA; [Rudik, I.] Iowa State Univ, Ames, IA USA; [Stock, J.] Harvard Univ, Cambridge, MA 02138 USA; [Tol, R. S. J.] Univ Sussex, Falmer, England; [Tol, R. S. J.] Vrije Univ Amsterdam, Amsterdam, Netherlands	Stanford University; New York University; University of Massachusetts System; University of Massachusetts Amherst; Brown University; University of California System; University of California San Diego; Yale University; University of Chicago; The World Bank; Arizona State University; Arizona State University-Tempe; Columbia University; University of California System; University of California Berkeley; Northwestern University; University of Miami; Resources for the Future; University of California System; University of California Santa Barbara; Tufts University; University System of Georgia; Georgia Institute of Technology; Massachusetts Institute of Technology (MIT); Electric Power Research Institute (EPRI); Iowa State University; Harvard University; University of Sussex; Vrije Universiteit Amsterdam	Kolstad, CD (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	ckolstad@stanford.edu	Baker, Erin/R-7481-2019; Mendelsohn, Robert/GZA-9112-2022; Tol, Richard S. J./D-5245-2011	Baker, Erin/0000-0002-4139-9930; Tol, Richard S. J./0000-0002-8012-3988; Rudik, Ivan/0000-0003-4194-7279; Burke, Marshall/0000-0003-4288-5858				[Anonymous], 2010, HIDD COSTS EN UNPR C; Benjamin DJ, 2012, AM ECON REV, V102, P2083, DOI 10.1257/aer.102.5.2083; Borenstein S, 2012, J ECON PERSPECT, V26, P67, DOI 10.1257/jep.26.1.67; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Cisternino, 2009, NEW PERSPECTIVES REG; Committee on Assessing Approaches to Updating the Social Cost of Carbon, 2016, ASS APPR UPD SOC COS; Committee on Extreme Weather Events and Climate Change Attribution, 2016, ATT EXTR WEATH EV CO; Dell M, 2014, J ECON LIT, V52, P740, DOI 10.1257/jel.52.3.740; Gillingham K, 2014, REV ENV ECON POLICY, V8, P18, DOI 10.1093/reep/ret021; Greenstone M, 2013, REV ENV ECON POLICY, V7, P23, DOI 10.1093/reep/res015; Henderson JV, 2012, AM ECON REV, V102, P994, DOI 10.1257/aer.102.2.994; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Kelly DL, 1999, J ECON DYN CONTROL, V23, P491, DOI 10.1016/S0165-1889(98)00034-7; Liu AA, 2013, J ENVIRON ECON MANAG, V66, P656, DOI 10.1016/j.jeem.2013.06.004; Pindyck RS, 2013, J ECON LIT, V51, P860, DOI 10.1257/jel.51.3.860; Popp D, 2010, HBK ECON, V2, P873, DOI 10.1016/S0169-7218(10)02005-8; Rose S., 2014, 3002004657 EL POW RE	19	77	76	7	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					292	293		10.1126/science.aad9634	http://dx.doi.org/10.1126/science.aad9634			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ1UK	27081055	Green Submitted			2022-12-28	WOS:000373990100020
J	Blendon, RJ; Gorski, MT; Benson, JM				Blendon, Robert J.; Gorski, Mary T.; Benson, John M.			The Public and the Gene-Editing Revolution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blendon, Robert J.; Benson, John M.] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA; [Gorski, Mary T.] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Lanie Angela D, 2004, J Genet Couns, V13, P305, DOI 10.1023/B:JOGC.0000035524.66944.6d; National Academies of Sciences Engineering and Medicine, 2015, HUM GEN ED INT SUMM	2	44	44	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1406	1411		10.1056/NEJMp1602010	http://dx.doi.org/10.1056/NEJMp1602010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27074065				2022-12-28	WOS:000374128400004
J	Kang, JS; Hu, JX; Karra, R; Dickson, AL; Tornini, VA; Nachtrab, G; Gemberling, M; Goldman, JA; Black, BL; Poss, KD				Kang, Junsu; Hu, Jianxin; Karra, Ravi; Dickson, Amy L.; Tornini, Valerie A.; Nachtrab, Gregory; Gemberling, Matthew; Goldman, Joseph A.; Black, Brian L.; Poss, Kenneth D.			Modulation of tissue repair by regeneration enhancer elements	NATURE			English	Article							GENE-EXPRESSION; HEART REGENERATION; LIMB REGENERATION; ZEBRAFISH; CELL; GROWTH; MECHANISMS; EVOLUTION; CAPACITY	How tissue regeneration programs are triggered by injury has received limited research attention. Here we investigate the existence of enhancer regulatory elements that are activated in regenerating tissue. Transcriptomic analyses reveal that leptin b (lepb) is highly induced in regenerating hearts and fins of zebrafish. Epigenetic profiling identified a short DNA sequence element upstream and distal to lepb that acquires open chromatin marks during regeneration and enables injury-dependent expression from minimal promoters. This element could activate expression in injured neonatal mouse tissues and was divisible into tissue-specific modules sufficient for expression in regenerating zebrafish fins or hearts. Simple enhancer-effector transgenes employing lepb-linked sequences upstream of pro-or anti-regenerative factors controlled the efficacy of regeneration in zebrafish. Our findings provide evidence for 'tissue regeneration enhancer elements' (TREEs) that trigger gene expression in injury sites and can be engineered to modulate the regenerative potential of vertebrate organs.	[Kang, Junsu; Dickson, Amy L.; Tornini, Valerie A.; Nachtrab, Gregory; Gemberling, Matthew; Goldman, Joseph A.; Poss, Kenneth D.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Hu, Jianxin; Black, Brian L.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Karra, Ravi] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; University of California System; University of California San Francisco; Duke University	Poss, KD (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	kenneth.poss@duke.edu		Poss, Kenneth/0000-0002-6743-5709; Tornini, Valerie/0000-0003-2877-6057	AHA [12POST11920060]; NIH Clinical Investigator Award [K08 HL116485]; NSF Graduate Research Fellowship [1106401]; NIH [F32 HL120494, R01 HL089707, R01 HL064658, R01 GM074057, R01 HL081674]; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081674, R01HL064658, F32HL120494, K08HL116485, P01HL089707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074057] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH Clinical Investigator Award; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Burris, N. Lee, and T. Thoren for zebrafish care; A. Knecht, and J. Savage for technical advice or assistance; and M. Bagnat, C. Chen, F. Conlon, D. Fox, and M. Mokalled for comments on the manuscript. J.H. was supported by an AHA postdoctoral fellowship (12POST11920060), R.K. by an NIH Clinical Investigator Award (K08 HL116485), V.A.T. by an NSF Graduate Research Fellowship (1106401), and J.A.G. by an NIH postdoctoral fellowship (F32 HL120494). This work was supported by NIH grants to B.L.B. (R01 HL089707 and R01 HL064658) and K.D.P. (R01 GM074057 and R01 HL081674), who acknowledges support from HHMI.	AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Gemberling M, 2015, ELIFE, V4, DOI 10.7554/eLife.05871; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Giorgio E, 2015, HUM MOL GENET, V24, P3143, DOI 10.1093/hmg/ddv065; Guenther CA, 2015, BONE, V77, P31, DOI 10.1016/j.bone.2015.04.010; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Indjeian VB, 2016, CELL, V164, P45, DOI 10.1016/j.cell.2015.12.007; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lee Y, 2009, DEV BIOL, V331, P270, DOI 10.1016/j.ydbio.2009.05.545; Lonfat N, 2014, SCIENCE, V346, P1004, DOI 10.1126/science.1257493; Mahmoud AI, 2014, NAT PROTOC, V9, P305, DOI 10.1038/nprot.2014.021; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Nacu E, 2011, ANNU REV CELL DEV BI, V27, P409, DOI 10.1146/annurev-cellbio-092910-154115; Nawa H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/697935; Park C, 2013, CIRC RES, V112, P1380, DOI 10.1161/CIRCRESAHA.113.301078; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Simkin J, 2013, METHODS MOL BIOL, V1037, P419, DOI 10.1007/978-1-62703-505-7_24; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van den Heuvel A, 2015, BLOOD, V125, P1521, DOI 10.1182/blood-2014-11-567925; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Wehner D, 2015, TRENDS GENET, V31, P336, DOI 10.1016/j.tig.2015.03.012; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	53	153	155	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					201	+		10.1038/nature17644	http://dx.doi.org/10.1038/nature17644			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27049946	Green Accepted			2022-12-28	WOS:000374415100032
J	Kaur, A; Webster, MR; Marchbank, K; Behera, R; Ndoye, A; Kugel, CH; Dang, VM; Appleton, J; O'Connell, MP; Cheng, P; Valiga, AA; Morissette, R; McDonnell, NB; Ferrucci, L; Kossenkov, AV; Meeth, K; Tang, HY; Yin, XF; Wood, WH; Lehrmann, E; Becker, KG; Flaherty, KT; Frederick, DT; Wargo, JA; Cooper, ZA; Tetzlaff, MT; Hudgens, C; Aird, KM; Zhang, RG; Xu, XW; Liu, Q; Bartlett, E; Karakousis, G; Eroglu, Z; Lo, RS; Chan, M; Menzies, AM; Long, GV; Johnson, DB; Sosman, J; Schilling, B; Schadendorf, D; Speicher, DW; Bosenberg, M; Ribas, A; Weeraratna, AT				Kaur, Amanpreet; Webster, Marie R.; Marchbank, Katie; Behera, Reeti; Ndoye, Abibatou; Kugel, Curtis H., III; Dang, Vanessa M.; Appleton, Jessica; O'Connell, Michael P.; Cheng, Phil; Valiga, Alexander A.; Morissette, Rachel; McDonnell, Nazli B.; Ferrucci, Luigi; Kossenkov, Andrew V.; Meeth, Katrina; Tang, Hsin-Yao; Yin, Xiangfan; Wood, William H., III; Lehrmann, Elin; Becker, Kevin G.; Flaherty, Keith T.; Frederick, Dennie T.; Wargo, Jennifer A.; Cooper, Zachary A.; Tetzlaff, Michael T.; Hudgens, Courtney; Aird, Katherine M.; Zhang, Rugang; Xu, Xiaowei; Liu, Qin; Bartlett, Edmund; Karakousis, Giorgos; Eroglu, Zeynep; Lo, Roger S.; Chan, Matthew; Menzies, Alexander M.; Long, Georgina V.; Johnson, Douglas B.; Sosman, Jeffrey; Schilling, Bastian; Schadendorf, Dirk; Speicher, David W.; Bosenberg, Marcus; Ribas, Antoni; Weeraratna, Ashani T.			sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance	NATURE			English	Article							BETA-CATENIN; OXIDATIVE STRESS; CELLS; TUMOR; GROWTH; BRAF(V600E); PROGRESSION; PHENOTYPE; MITF	Cancer is a disease of ageing. Clinically, aged cancer patients tend to have a poorer prognosis than young. This may be due to accumulated cellular damage, decreases in adaptive immunity, and chronic inflammation. However, the effects of the aged microenvironment on tumour progression have been largely unexplored. Since dermal fibroblasts can have profound impacts on melanoma progression(1-4), we examined whether age-related changes in dermal fibroblasts could drive melanoma metastasis and response to targeted therapy. Here we find that aged fibroblasts secrete a Wnt antagonist, sFRP2, which activates a multi-step signalling cascade in melanoma cells that results in a decrease in beta-catenin and microphthalmia-associated transcription factor (MITF), and ultimately the loss of a key redox effector, APE1. Loss of APE1 attenuates the response of melanoma cells to DNA damage induced by reactive oxygen species, rendering the cells more resistant to targeted therapy (vemurafenib). Age-related increases in sFRP2 also augment both angiogenesis and metastasis of melanoma cells. These data provide an integrated view of how fibroblasts in the aged microenvironment contribute to tumour progression, offering new possibilities for the design of therapy for the elderly.	[Kaur, Amanpreet; Webster, Marie R.; Marchbank, Katie; Behera, Reeti; Ndoye, Abibatou; Kugel, Curtis H., III; Dang, Vanessa M.; Appleton, Jessica; O'Connell, Michael P.; Valiga, Alexander A.; Kossenkov, Andrew V.; Tang, Hsin-Yao; Yin, Xiangfan; Aird, Katherine M.; Zhang, Rugang; Liu, Qin; Speicher, David W.; Weeraratna, Ashani T.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Kaur, Amanpreet] Univ Sci, Philadelphia, PA 19104 USA; [Cheng, Phil] Univ Zurich, Dept Dermatol, CH-8006 Zurich, Switzerland; [Morissette, Rachel; McDonnell, Nazli B.; Ferrucci, Luigi; Wood, William H., III; Lehrmann, Elin; Becker, Kevin G.] NIA, NIH, Baltimore, MD 21224 USA; [Meeth, Katrina; Bosenberg, Marcus] Yale Univ, Dept Dermatol & Pathol, New Haven, CT 06511 USA; [Flaherty, Keith T.; Frederick, Dennie T.] Massachusetts Gen Hosp, Ctr Canc, Dev Therapeut, Boston, MA 02114 USA; [Wargo, Jennifer A.; Cooper, Zachary A.; Tetzlaff, Michael T.; Hudgens, Courtney] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Xu, Xiaowei; Bartlett, Edmund; Karakousis, Giorgos] Univ Penn, Dept Surg, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Xu, Xiaowei; Bartlett, Edmund; Karakousis, Giorgos] Univ Penn, Dept Pathol, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Eroglu, Zeynep] City Hope Med Ctr, Dept Med Oncol, Duarte, CA 91010 USA; [Lo, Roger S.; Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Chan, Matthew] Westmead Hosp, Crown Princess Mary Canc Ctr, Westmead, NSW 2145, Australia; [Menzies, Alexander M.; Long, Georgina V.] Melanoma Inst Australia, Sydney, NSW 2000, Australia; [Menzies, Alexander M.; Long, Georgina V.] Univ Sydney, Sydney, NSW 2000, Australia; [Johnson, Douglas B.; Sosman, Jeffrey] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Schilling, Bastian; Schadendorf, Dirk] Univ Duesburg Essen, Dept Dermatol, Univ Hosp, West German Canc Ctr, Essen, Germany; [Schilling, Bastian; Schadendorf, Dirk] German Canc Consortium DKTK, D-45127 Heidelberg, Germany	The Wistar Institute; University of Zurich; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Yale University; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; City of Hope; University of California System; University of California Los Angeles; University of Sydney; Melanoma Institute Australia; University of Sydney; Vanderbilt University; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Weeraratna, AT (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	aweeraratna@wistar.org	, Amanpreet/J-5344-2019; Long, Georgina V/C-1771-2013; Schilling, Bastian/AAY-8646-2020; O'Connell, Michael/F-9236-2017; Schadendorf, Dirk/AAE-8206-2019; Cheng, Phil/AAN-8567-2021; Aird, Katherine/AAY-3300-2020	, Amanpreet/0000-0002-4228-2742; Long, Georgina V/0000-0001-8894-3545; Schilling, Bastian/0000-0001-8859-4103; Cheng, Phil/0000-0003-2940-006X; O'Connell, Michael/0000-0002-8615-7660; Webster, Marie/0000-0001-7633-7150; Menzies, Alexander Maxwell/0000-0001-5183-7562; Lehrmann, Elin/0000-0002-9869-9475; Cooper, Zachary/0000-0003-1059-0940; Tang, Hsin-Yao/0000-0003-1838-018X; Bartlett, Edmund/0000-0002-0923-153X	National Institute on Aging, Baltimore, Maryland; Harry J. Lloyd Foundation; ACS-IRG; Melanoma Research Foundation; Cancer Center Support Grant [P30 CA010815];  [P01 CA 114046-06];  [T32 CA 9171-36];  [RO1 CA174746-01]; NATIONAL CANCER INSTITUTE [P01CA114046, T32CA009171, P30CA010815, P30CA016672, R01CA160331, R01CA174746, R50CA211199, K99CA208012, P50CA093372, P50CA174523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	National Institute on Aging, Baltimore, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Harry J. Lloyd Foundation; ACS-IRG(American Cancer Society); Melanoma Research Foundation; Cancer Center Support Grant; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Altieri, R. Marais, Z. Ronai, M. McMahon, and B. Vogelstein for comments on the manuscript. We thank R. Somasundaram for advice on immune analyses, M. Herlyn for the WM cell lines, and G. Bollag for PLX4720. We also thank R. Delgiacco, D. Gourevitch, F. Keeney, and D. Schultz. We thank A. Dias-Wanigasekera, E. Gaddy, and M. Ha for technical assistance, and R. Locke for editing the manuscript. This work was supported in part by funds from the Intramural Program of the National Institute on Aging, Baltimore, Maryland (N.M., K.G.B., R. M., W.H.W., L.F.), The Harry J. Lloyd Foundation (K.M., A.T.W.), P01 CA 114046-06 (A.T.W., Q.L.), T32 CA 9171-36 (M.R.W., C.H.K.), an ACS-IRG award (A.T.W.), the Melanoma Research Foundation (A.T.W.), and RO1 CA174746-01 (A.T.W., A.K.). Core facilities at the Wistar are supported by Cancer Center Support Grant P30 CA010815.	Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Bogenrieder T, 2002, CRIT REV ONCOL HEMAT, V44, P1, DOI 10.1016/S1040-8428(01)00196-2; Bouchlaka MN, 2013, J EXP MED, V210, P2223, DOI 10.1084/jem.20131219; Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Corazao-Rozas P, 2013, ONCOTARGET, V4, P1986, DOI 10.18632/oncotarget.1420; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Flach EH, 2011, MOL PHARMACEUT, V8, P2039, DOI 10.1021/mp200421k; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2011, PIGM CELL MELANOMA R, V24, P262, DOI 10.1111/j.1755-148X.2010.00809.x; Hsu MY, 2002, DIFFERENTIATION, V70, P522, DOI 10.1046/j.1432-0436.2002.700906.x; Issa JP, 2014, J CLIN INVEST, V124, P24, DOI 10.1172/JCI69735; Issa JP, 2000, CURR TOP MICROBIOL, V249, P101; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Lento W, 2014, GENE DEV, V28, P995, DOI 10.1101/gad.231944.113; Li G, 2002, CRIT REV ORAL BIOL M, V13, P62, DOI 10.1177/154411130201300107; Liu F, 2009, J INVEST DERMATOL, V129, P422, DOI 10.1038/jid.2008.255; O'Connell MP, 2013, CANCER DISCOV, V3, P1378, DOI 10.1158/2159-8290.CD-13-0005; Park HW, 2013, J HIST MED ALL SCI, V68, P49, DOI 10.1093/jhmas/jrr048; Ruiter D, 2002, LANCET ONCOL, V3, P35, DOI 10.1016/S1470-2045(01)00620-9; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Viros A, 2014, NATURE, V511, P478, DOI 10.1038/nature13298; Webster MR, 2015, BBA-REV CANCER, V1856, P244, DOI 10.1016/j.bbcan.2015.10.002; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Yu L., 2014, INTEGR BIOL, V350, P1391; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004	29	205	211	6	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					250	+		10.1038/nature17392	http://dx.doi.org/10.1038/nature17392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27042933	Green Accepted, Green Submitted			2022-12-28	WOS:000374415100043
J	Baranello, L; Wojtowicz, D; Cui, KR; Devaiah, BN; Chung, HJ; Chan-Salis, KY; Guha, R; Wilson, K; Zhang, XH; Zhang, HL; Piotrowski, J; Thomas, CJ; Singer, DS; Pugh, BF; Pommier, Y; Przytycka, TM; Kouzine, F; Lewis, BA; Zhao, KJ; Levens, D				Baranello, Laura; Wojtowicz, Damian; Cui, Kairong; Devaiah, Ballachanda N.; Chung, Hye-Jung; Chan-Salis, Ka Yim; Guha, Rajarshi; Wilson, Kelli; Zhang, Xiaohu; Zhang, Hongliang; Piotrowski, Jason; Thomas, Craig J.; Singer, Dinah S.; Pugh, B. Franklin; Pommier, Yves; Przytycka, Teresa M.; Kouzine, Fedor; Lewis, Brian A.; Zhao, Keji; Levens, David			RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription	CELL			English	Article							BROMODOMAIN PROTEIN BRD4; CARBOXY-TERMINAL DOMAIN; P-TEFB; IN-VIVO; DEPENDENT TRANSCRIPTION; SELECTIVE-INHIBITION; CLEAVAGE COMPLEXES; PAUSE RELEASE; GENOME-WIDE; CTD CODE	We report a mechanism through which the transcription machinery directly controls topoisomerase 1 (TOP1) activity to adjust DNA topology throughout the transcription cycle. By comparing TOP1 occupancy using chromatin immunoprecipitation sequencing (ChIP-seq) versus TOP1 activity using topoisomerase 1 sequencing (TOP1-seq), a method reported here to map catalytically engaged TOP1, TOP1 bound at promoters was discovered to become fully active only after pause-release. This transition coupled the phosphorylation of the carboxyl-terminal-domain (CTD) of RNA polymerase II (RNAPII) with stimulation of TOP1 above its basal rate, enhancing its processivity. TOP1 stimulation is strongly dependent on the kinase activity of BRD4, a protein that phosphorylates Ser2-CTD and regulates RNAPII pause-release. Thus the coordinated action of BRD4 and TOP1 overcame the torsional stress opposing transcription as RNAPII commenced elongation but preserved negative supercoiling that assists promotermelting at start sites. This nexus between transcription and DNA topology promises to elicit new strategies to intercept pathological gene expression.	[Baranello, Laura; Chung, Hye-Jung; Kouzine, Fedor; Levens, David] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Wojtowicz, Damian; Przytycka, Teresa M.] NCBI, Computat Biol Branch, NIH, Bethesda, MD 20892 USA; [Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Devaiah, Ballachanda N.; Singer, Dinah S.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Chan-Salis, Ka Yim; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Guha, Rajarshi; Wilson, Kelli; Zhang, Xiaohu; Thomas, Craig J.] NCATS, Div Preclin Innovat, NIH, Rockville, MD 20850 USA; [Zhang, Hongliang; Pommier, Yves] NCI, Dev Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Zhang, Hongliang; Pommier, Yves] NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; [Piotrowski, Jason; Lewis, Brian A.] NCI, Lymphoid Malignancies Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Levens, D (corresponding author), NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA.; Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov; levens@helix.nih.gov	Wojtowicz, Damian/AFG-8518-2022; Levens, David/C-9216-2009; Wojtowicz, Damian/AAF-2007-2022	Wojtowicz, Damian/0000-0002-4274-6383; Levens, David/0000-0002-7616-922X; Wojtowicz, Damian/0000-0002-4274-6383; Baranello, Laura/0000-0001-6039-1849; Thomas, Craig/0000-0001-9386-9001; Wilson, Kelli/0000-0003-2636-2766; Lewis, Brian/0000-0002-8321-0665; Przytycka, Teresa/0000-0002-6261-277X	Intramural Research Program of the US NIH; Center for Cancer Research of the National Cancer Institute; National Heart, Lung and Blood Institute; National Library of Medicine; NATIONAL CANCER INSTITUTE [ZIABC011381, ZIABC011011, ZIASC009144] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059055] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200887] Funding Source: NIH RePORTER	Intramural Research Program of the US NIH; Center for Cancer Research of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Our research is supported by the Intramural Research Program of the US NIH, Center for Cancer Research of the National Cancer Institute, the National Heart, Lung and Blood Institute, and the National Library of Medicine. The ChIP-seq and RNA-seq libraries were sequenced by the NHLBI DNA Sequencing and Genomics Core Facility.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Amente S, 2009, CELL CYCLE, V8, P1249, DOI 10.4161/cc.8.8.8286; Baranello L, 2014, INT J MOL SCI, V15, P13111, DOI 10.3390/ijms150713111; Baranello L, 2012, BBA-GENE REGUL MECH, V1819, P632, DOI 10.1016/j.bbagrm.2011.12.007; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bowen C, 2007, CANCER RES, V67, P455, DOI 10.1158/0008-5472.CAN-06-1591; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; Carty SM, 2002, MOL CELL PROTEOMICS, V1, P598, DOI 10.1074/mcp.M200029-MCP200; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Chong SS, 2014, CELL, V158, P314, DOI 10.1016/j.cell.2014.05.038; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; DUNAWAY M, 1993, NATURE, V361, P746, DOI 10.1038/361746a0; Durand-Dubief M, 2010, EMBO J, V29, P2126, DOI 10.1038/emboj.2010.109; DYNAN WS, 1981, J BIOL CHEM, V256, P5860; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Fedier A, 2003, INT J ONCOL, V22, P1169; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Joshi RS, 2010, EMBO J, V29, P740, DOI 10.1038/emboj.2009.391; Kanno T, 2014, NAT STRUCT MOL BIOL, V21, P1047, DOI 10.1038/nsmb.2912; Khobta A, 2006, J MOL BIOL, V357, P127, DOI 10.1016/j.jmb.2005.12.069; KIM WY, 1988, J BIOL CHEM, V263, P18880; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; KRETZSCHMAR M, 1993, P NATL ACAD SCI USA, V90, P11508, DOI 10.1073/pnas.90.24.11508; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Laco GS, 2008, BIOCHEM J, V411, P523, DOI 10.1042/BJ20071436; Laine JP, 2003, CANCER RES, V63, P7136; LI CJ, 1993, J BIOL CHEM, V268, P22463; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Patel MC, 2013, MOL CELL BIOL, V33, P2497, DOI 10.1128/MCB.01180-12; Pedersen JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003128; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Puc J, 2015, CELL, V160, P367, DOI 10.1016/j.cell.2014.12.023; Ramanathan Y, 2001, J BIOL CHEM, V276, P10913, DOI 10.1074/jbc.M010975200; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Roca J, 2011, TRANSCR-AUSTIN, V2, P82, DOI 10.4161/trns.2.2.14807; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Shykind BM, 1997, GENE DEV, V11, P397, DOI 10.1101/gad.11.3.397; Simmons DT, 1998, J BIOL CHEM, V273, P20390, DOI 10.1074/jbc.273.32.20390; Sordet O, 2008, J MOL BIOL, V381, P540, DOI 10.1016/j.jmb.2008.06.028; Spangler L, 2001, P NATL ACAD SCI USA, V98, P5544, DOI 10.1073/pnas.101004498; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wu J, 2010, BIOCHEM BIOPH RES CO, V397, P117, DOI 10.1016/j.bbrc.2010.05.081; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; ZHELKOVSKY AM, 1994, PROTEIN EXPRES PURIF, V5, P364, DOI 10.1006/prep.1994.1053; Zobeck KL, 2010, MOL CELL, V40, P965, DOI 10.1016/j.molcel.2010.11.022	74	134	136	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					357	371		10.1016/j.cell.2016.02.036	http://dx.doi.org/10.1016/j.cell.2016.02.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058666	Green Accepted, Bronze			2022-12-28	WOS:000374123000014
J	Chauhan, C				Chauhan, Cynthia			PERSONAL VIEW Patients' views can improve clinical trials for participants	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chauhan, Cynthia] Mayo Clin, Rochester, MN USA	Mayo Clinic	Chauhan, C (corresponding author), Mayo Clin, Rochester, MN USA.	cynthiachauhan@aol.com						ClinicalTrials.gov, 2016, PRAGM RAND TRIAL PRO; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0	2	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2016	353								i1922	10.1136/bmj.i1922	http://dx.doi.org/10.1136/bmj.i1922			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LT	27055740				2022-12-28	WOS:000373895900007
J	Kutyavin, VI; Chawla, A				Kutyavin, Vassily I.; Chawla, Ajay			Insulin Signaling in a Bit of a Jam	CELL			English	Editorial Material							INFLAMMATION; HOMEOSTASIS; RESISTANCE	In this issue of Cell, Okin and Medzhitov report that sustained inflammation promotes hyperglycemia by targeting the mevalonate pathway. This represents an important step forward in understanding the mechanisms underlying the association between chronic low-grade inflammation and disruption of normal tissue functions in metabolic diseases.	[Kutyavin, Vassily I.; Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.; Chawla, A (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.; Chawla, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418, R01DK101064] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER; NIAMS NIH HHS [DP1 AR064158] Funding Source: Medline; NIDDK NIH HHS [R01 DK101064, T32 DK007418] Funding Source: Medline; NIH HHS [DP1 OD006415] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Okin D, 2016, CELL, V165, P343, DOI 10.1016/j.cell.2016.02.023; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846	9	0	0	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					264	U138		10.1016/j.cell.2016.03.012	http://dx.doi.org/10.1016/j.cell.2016.03.012			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058657	Bronze			2022-12-28	WOS:000374123000015
J	Lin, ZH; Luo, XL; Yu, HT				Lin, Zhonghui; Luo, Xuelian; Yu, Hongtao			Structural basis of cohesin cleavage by separase	NATURE			English	Article							SISTER-CHROMATID SEPARATION; PROTEIN PHOSPHATASE 2A; INHIBITION; ANAPHASE; SECURIN; PHOSPHORYLATION; LOCALIZATION; ACTIVATION; SUBSTRATE; BINDING	Accurate chromosome segregation requires timely dissolution of chromosome cohesion after chromosomes are properly attached to the mitotic spindle. Separase is absolutely essential for cohesion dissolution in organisms from yeast to man(1,2). It cleaves the kleisin subunit of cohesin and opens the cohesin ring to allow chromosome segregation. Cohesin cleavage is spatiotemporally controlled by separase-associated regulatory proteins, including the inhibitory chaperone securin(3-6), and by phosphorylation of both the enzyme and substrates(7-12). Dysregulation of this process causes chromosome missegregation and aneuploidy, contributing to cancer and birth defects. Despite its essential functions, atomic structures of separase have not been determined. Here we report crystal structures of the separase protease domain from the thermophilic fungus Chaetomium thermophilum, alone or covalently bound to unphosphorylated and phosphorylated inhibitory peptides derived from a cohesin cleavage site. These structures reveal how separase recognizes cohesin and how cohesin phosphorylation by polo-like kinase 1 ( Plk1) enhances cleavage. Consistent with a previous cellular study(13), mutating two securin residues in a conserved motif that partly matches the separase cleavage consensus converts securin from a separase inhibitor to a substrate. Our study establishes atomic mechanisms of substrate cleavage by separase and suggests competitive inhibition by securin.	[Lin, Zhonghui; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Lin, Zhonghui; Luo, Xuelian; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA; [Luo, Xuelian] Univ Texas SW Med Ctr Dallas, Dept Biophys, 6001 Forest Pk Rd, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, HT (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, 6001 Forest Pk Rd, Dallas, TX 75390 USA.; Yu, HT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu			Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Cancer Prevention and Research Institute of Texas [RP110465-P3]; National Institutes of Health [GM107415]; Welch Foundation [I-1441]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107415] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Rosenbaum for the C. thermophilum complementary DNA, H. Ball for peptide synthesis, and D. Tomchick and Z. Chen for assistance with data collection. Diffraction data of the selenomethionine separase were collected at the Advanced Light Source at Lawrence Berkeley National Laboratory with the help of its staff. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract number DE-AC02-05CH11231. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This work is supported by the Cancer Prevention and Research Institute of Texas (RP110465-P3 to H.Y.), the National Institutes of Health (GM107415 to X.L.), and the Welch Foundation (I-1441 to H.Y.). H.Y. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gligoris TG, 2014, SCIENCE, V346, P963, DOI 10.1126/science.1256917; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hellmuth S, 2015, MOL CELL, V58, P495, DOI 10.1016/j.molcel.2015.03.025; Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3; in 't Veld PJH, 2014, SCIENCE, V346, P968, DOI 10.1126/science.1256904; Ishiguro T, 2010, NAT CELL BIOL, V12, P500, DOI 10.1038/ncb2052; Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Liu H, 2013, NAT CELL BIOL, V15, P40, DOI 10.1038/ncb2637; Matsuo K, 2012, CURR BIOL, V22, P915, DOI 10.1016/j.cub.2012.03.048; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nagao K, 2006, GENES CELLS, V11, P247, DOI 10.1111/j.1365-2443.2006.00941.x; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sullivan M, 2004, J BIOL CHEM, V279, P1191, DOI 10.1074/jbc.M309761200; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Viadiu H, 2005, NAT STRUCT MOL BIOL, V12, P552, DOI 10.1038/nsmb935; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Zhang NG, 2008, P NATL ACAD SCI USA, V105, P13033, DOI 10.1073/pnas.0801610105; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	36	46	46	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					131	+		10.1038/nature17402	http://dx.doi.org/10.1038/nature17402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27027290	Green Accepted, Green Submitted			2022-12-28	WOS:000373555500048
J	Ma, DL; Vano-Galvan, S				Ma, Dong-Lai; Vano-Galvan, Sergio			Creeping Eruption - Cutaneous Larva Migrans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ma, Dong-Lai] Peking Union Med Coll, Beijing 100021, Peoples R China; [Vano-Galvan, Sergio] Hosp Ramon & Cajal, E-28034 Madrid, Spain	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Hospital Universitario Ramon y Cajal	Ma, DL (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	mdonglai@sohu.com		Vano-Galvan, Sergio/0000-0003-2773-7494					0	9	9	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					E16	E16		10.1056/NEJMicm1509325	http://dx.doi.org/10.1056/NEJMicm1509325			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI3UW	27050235				2022-12-28	WOS:000373425000001
J	Oesterreich, FC; Herzel, L; Straube, K; Hujer, K; Howard, J; Neugebauer, KM				Oesterreich, Fernando Carrillo; Herzel, Lydia; Straube, Korinna; Hujer, Katja; Howard, Jonathon; Neugebauer, Karla M.			Splicing of Nascent RNA Coincides with Intron Exit from RNA Polymerase II	CELL			English	Article							IN-SITU TRANSCRIPTION; HIGH-RESOLUTION; SPLICEOSOME; ELONGATION; REVEALS; KINETICS; REQUIRES; GENOME	Protein-coding genes in eukaryotes are transcribed by RNA polymerase II (Pol II) and introns are removed from pre-mRNA by the spliceosome. Understanding the time lag between Pol II progression and splicing could provide mechanistic insights into the regulation of gene expression. Here, we present two single-molecule nascent RNA sequencing methods that directly determine the progress of splicing catalysis as a function of Pol II position. Endogenous genes were analyzed on a global scale in budding yeast. We show that splicing is 50% complete when Pol II is only 45 nt downstream of introns, with the first spliced products observed as introns emerge from Pol II. Perturbations that slow the rate of spliceosome assembly or speed up the rate of transcription caused splicing delays, showing that regulation of both processes determines in vivo splicing profiles. We propose that matched rates streamline the gene expression pathway, while allowing regulation through kinetic competition.	[Oesterreich, Fernando Carrillo; Herzel, Lydia; Straube, Korinna; Howard, Jonathon; Neugebauer, Karla M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Herzel, Lydia; Hujer, Katja] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany	Yale University; Max Planck Society	Neugebauer, KM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	karla.neugebauer@yale.edu	Herzel, Lydia/AAF-4474-2021; Howard, Jonathon/J-7492-2016	Howard, Jonathon/0000-0003-0086-1196	Max Planck Institute of Molecular Cell Biology and Genetics; NIH from National Institute of General Medical Sciences (NIGMS) [R01GM112766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112766] Funding Source: NIH RePORTER	Max Planck Institute of Molecular Cell Biology and Genetics; NIH from National Institute of General Medical Sciences (NIGMS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our laboratory, Karen Adelman, Samie Jaffrey, Dieter Soll, Joan Steitz, and Charles Query for discussions and critical comments on the manuscript. We are grateful to Craig Kaplan for the gift of strains, as well as Guilin Wang and the Yale Center for Genome Analysis for excellent technical assistance and advice. The presented work was supported by funding from the Max Planck Institute of Molecular Cell Biology and Genetics (to K.M.N.) and by NIH R01GM112766 from the National Institute of General Medical Sciences (NIGMS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Note that the co-first authors are listed alphabetically, reflecting their equal contributions.	Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bieberstein NI, 2012, CELL REP, V2, P62, DOI 10.1016/j.celrep.2012.05.019; Braberg H, 2013, CELL, V154, P775, DOI 10.1016/j.cell.2013.07.033; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; Brugiolo Mattia, 2013, F1000Prime Rep, V5, P9, DOI 10.12703/P5-9; Churchman L.S., 2012, CURR PROTOC MOL BIOL, V98, P4; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Coulon A, 2014, ELIFE, V3, DOI 10.7554/eLife.03939; Davis-Turak JC, 2015, NUCLEIC ACIDS RES, V43, P699, DOI 10.1093/nar/gku1338; Dujardin G, 2014, MOL CELL, V54, P683, DOI 10.1016/j.molcel.2014.03.044; Eser P, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156526; Fong N, 2014, GENE DEV, V28, P2663, DOI 10.1101/gad.252106.114; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Gahura O, 2011, NUCLEIC ACIDS RES, V39, P9759, DOI 10.1093/nar/gkr662; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Herzel L, 2015, METHODS, V85, P36, DOI 10.1016/j.ymeth.2015.04.024; Hoskins AA, 2011, SCIENCE, V331, P1289, DOI 10.1126/science.1198830; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Huranova M, 2010, J CELL BIOL, V191, P75, DOI 10.1083/jcb.201004030; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kaplan CD, 2012, PLOS GENET, V8, P172, DOI 10.1371/journal.pgen.1002627; Lacadie SA, 2005, MOL CELL, V19, P65, DOI 10.1016/j.molcel.2005.05.006; Lacadie SA, 2006, GENE DEV, V20, P2055, DOI 10.1101/gad.1434706; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Martin RM, 2013, CELL REP, V4, P1144, DOI 10.1016/j.celrep.2013.08.013; Martinez-Rucobo FW, 2015, MOL CELL, V58, P1079, DOI 10.1016/j.molcel.2015.04.004; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Meyer M, 2011, MOL CELL, V43, P1033, DOI 10.1016/j.molcel.2011.07.030; Moehle EA, 2014, RNA BIOL, V11, P313, DOI 10.4161/rna.28646; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; OSHEIM YN, 1985, CELL, V43, P143, DOI 10.1016/0092-8674(85)90019-4; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Preker PJ, 2006, RNA, V12, P994, DOI 10.1261/rna.6706; Rabani M, 2014, CELL, V159, P1698, DOI 10.1016/j.cell.2014.11.015; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Schmidt U, 2011, J CELL BIOL, V193, P819, DOI 10.1083/jcb.201009012; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; Shcherbakova I, 2013, CELL REP, V5, P151, DOI 10.1016/j.celrep.2013.08.026; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Tardiff DF, 2006, RNA, V12, P968, DOI 10.1261/rna.50506; Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; Wetterberg I, 2001, EMBO J, V20, P2564, DOI 10.1093/emboj/20.10.2564; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629	53	118	118	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					372	381		10.1016/j.cell.2016.02.045	http://dx.doi.org/10.1016/j.cell.2016.02.045			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27020755	Bronze, Green Accepted			2022-12-28	WOS:000374123000016
J	Vecchione, L; Gambino, V; Raaijmakers, J; Schlicker, A; Fumagalli, A; Russo, M; Villanueva, A; Beerling, E; Bartolini, A; Mollevi, DG; El-Murr, N; Chiron, M; Calvet, L; Nicolazzi, C; Combeau, C; Henry, C; Simon, IM; Tian, S; in't Veld, S; D'ario, G; Mainardi, S; Beijersbergen, RL; Lieftink, C; Linn, S; Rumpf-Kienzl, C; Delorenzi, M; Wessels, L; Salazar, R; Di Nicolantonio, F; Bardelli, A; van Rheenen, J; Medema, RH; Tejpar, S; Bernards, R				Vecchione, Loredana; Gambino, Valentina; Raaijmakers, Jonne; Schlicker, Andreas; Fumagalli, Arianna; Russo, Mariangela; Villanueva, Alberto; Beerling, Evelyne; Bartolini, Alice; Mollevi, David G.; El-Murr, Nizar; Chiron, Marielle; Calvet, Loreley; Nicolazzi, Celine; Combeau, Cecile; Henry, Christophe; Simon, Iris M.; Tian, Sun; in't Veld, Sjors; D'ario, Giovanni; Mainardi, Sara; Beijersbergen, Roderick L.; Lieftink, Cor; Linn, Sabine; Rumpf-Kienzl, Cornelia; Delorenzi, Mauro; Wessels, Lodewyk; Salazar, Ramon; Di Nicolantonio, Federica; Bardelli, Alberto; van Rheenen, Jacco; Medema, Rene H.; Tejpar, Sabine; Bernards, Rene			A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility	CELL			English	Article							METASTATIC COLORECTAL-CANCER; SYNTHETIC LETHAL INTERACTIONS; 1ST-LINE TREATMENT; BRAF MUTATION; TGF-BETA; IDENTIFICATION; KRAS; KINETOCHORES; VINORELBINE; POPULATION	BRAF(V600E) mutant colon cancers (CCs) have a characteristic gene expression signature that is also found in some tumors lacking this mutation. Collectively, they are referred to as "BRAF-like'' tumors and represent some 20% of CCs. We used a shRNA-based genetic screen focused on genes upregulated in BRAF(V600E) CCs to identify vulnerabilities of this tumor subtype that might be exploited therapeutically. Here, we identify RANBP2 (also known as NUP358) as essential for survival of BRAF-like, but not for non-BRAF-like, CC cells. Suppression of RANBP2 results in mitotic defects only in BRAF-like CC cells, leading to cell death. Mechanistically, RANBP2 silencing reduces microtubule outgrowth from the kinetochores, thereby inducing spindle perturbations, providing an explanation for the observed mitotic defects. We find that BRAF-like CCs display far greater sensitivity to the microtubule poison vinorelbine both in vitro and in vivo, suggesting that vinorelbine is a potential tailored treatment for BRAF-like CCs.	[Vecchione, Loredana; Gambino, Valentina; Schlicker, Andreas; Mainardi, Sara; Beijersbergen, Roderick L.; Lieftink, Cor; Wessels, Lodewyk; Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Vecchione, Loredana; Gambino, Valentina; Schlicker, Andreas; Mainardi, Sara; Beijersbergen, Roderick L.; Lieftink, Cor; Wessels, Lodewyk; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr Netherlands, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Raaijmakers, Jonne; Rumpf-Kienzl, Cornelia; Medema, Rene H.] Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Fumagalli, Arianna; Beerling, Evelyne; van Rheenen, Jacco] Hubrecht Inst KNAW, Canc Genom Netherlands, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Fumagalli, Arianna; Beerling, Evelyne; van Rheenen, Jacco] Univ Med Ctr Utrecht, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Russo, Mariangela; Di Nicolantonio, Federica; Bardelli, Alberto] Univ Turin, Dept Oncol, SP 142,Km 3-95, I-10060 Turin, Italy; [Russo, Mariangela; Bartolini, Alice; Di Nicolantonio, Federica; Bardelli, Alberto] IRCCS, Candiolo Canc Inst FPO, SP142,Km 3-95, I-10060 Turin, Italy; [Russo, Mariangela] FIRC Inst Mol Oncol IFOM, I-20139 Milan, Italy; [Villanueva, Alberto; Mollevi, David G.] Catalan Inst Oncol ICO, Chemoresistance & Predict Factors Grp, Program Canc Therapeut Resistance ProCURE, Barcelona 08908, Spain; [Villanueva, Alberto; Mollevi, David G.] Bellvitge Inst Biomed Res IDIBELL, Barcelona 08908, Spain; [El-Murr, Nizar; Chiron, Marielle; Calvet, Loreley; Nicolazzi, Celine; Combeau, Cecile; Henry, Christophe] Sanofi Oncol, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France; [Simon, Iris M.; Tian, Sun; in't Veld, Sjors] Agendia, Sci Pk 406, NL-1098 XH Amsterdam, Netherlands; [D'ario, Giovanni; Delorenzi, Mauro] SIB Swiss Inst Bioinformat, Bioinformat Core Facil, Quartier Sorge Batiment Genopode, CH-1015 Lausanne, Switzerland; [Linn, Sabine] Netherlands Canc Inst, Div Mol Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Delorenzi, Mauro] Univ Lausanne, Dept Oncol, Rue Bugnon 21, CH-1011 Lausanne, Switzerland; [Delorenzi, Mauro] Univ Lausanne, Ludwig Ctr Canc Res, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland; [Salazar, Ramon] Bellvitge Biomed Res Inst, IDIBELL, Catalan Inst Oncol, Med Oncol Dept, Lhospitalet De Llobregat 08908, Catalonia, Spain; [Tejpar, Sabine] Univ Hosp Leuven, Mol Digest Oncol, Herestr 49, B-3000 Leuven, Belgium; [Tejpar, Sabine] Katholieke Univ Leuven, Herestr 49, B-3000 Leuven, Belgium	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; IFOM - FIRC Institute of Molecular Oncology; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Agendia; Swiss Institute of Bioinformatics; Netherlands Cancer Institute; University of Lausanne; University of Lausanne; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); KU Leuven; University Hospital Leuven; KU Leuven	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; Bernards, R (corresponding author), Netherlands Canc Inst, Canc Genom Ctr Netherlands, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Gambino, Valentina/AAR-8814-2020; Russo, Mariangela/K-1900-2018; Di Nicolantonio, Federica/A-2503-2011; BARTOLINI, ALICE/K-2534-2018; BARDELLI, Alberto/J-9721-2018	Russo, Mariangela/0000-0003-4625-1449; Di Nicolantonio, Federica/0000-0001-9618-2010; Schlicker, Andreas/0000-0002-6588-7883; BARTOLINI, ALICE/0000-0003-3492-0772; BARDELLI, Alberto/0000-0003-1647-5070; In ' t Veld, Sjors/0000-0002-3680-8437; Beijersbergen, Roderick/0000-0003-0116-4130; Raaijmakers, Jonne/0000-0003-1759-8347; vecchione, loredana/0000-0003-3942-5498; Medema, Rene/0000-0002-6754-0381; Tian, Sun/0000-0002-0133-4454; Mollevi, David G./0000-0001-9110-518X; El-Murr, Nizar/0000-0001-7793-9436; Fumagalli, Arianna/0000-0002-3483-8026; Bernards, Rene/0000-0001-8677-3423	ESMO for Translational Research; EU FP7 program grant COLTHERES; NWO grant CSBC; Dutch Cancer Society (KWF); Fondo de Investigaciones Sanitarias [PI13-01339]; Generalitat de Catalunya [2005SGR00727]; AIRC IG [12812, 17707]; Fondazione Piemontese per la Ricerca sul Cancro-ONLUS; Fondo per la Ricerca Locale; Universita di Torino	ESMO for Translational Research; EU FP7 program grant COLTHERES; NWO grant CSBC; Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); AIRC IG(Fondazione AIRC per la ricerca sul cancro); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS; Fondo per la Ricerca Locale; Universita di Torino	We thank the members of the NKI Genomics Core Facility, the Pathology Department, Lauren Oomen, and Lenny Brocks from the NKI Digital Microscopy Facility for technical support. We thank the members of the IDIBELL animal core facility for the mouse care. We are grateful to Astrid Bosma, Paul van der Valk, Jan Schellens, Michiel Boekhout, Erik Voets, Roy van Heesbeen, Magali Michaut, and Rob Wolthuis for discussions and Lydia Blot, Sukhvinder Sidhu, and Veronique Blanc at Sanofi for their support. We would also like to thank John Lambert and Immunogen's colleagues for their contribution to the CC PDX work. This work was supported by grants from ESMO for Translational Research (to L.V.), an EU FP7 program grant COLTHERES (to R.B., F.D., A. Bardelli, S. Tejpar, I.M.S., S. Tian, G.D., and M.D.), an NWO grant CSBC (to R.L.B., R.B., L.W., and C.L.), the Dutch Cancer Society (KWF) (to R.B.), the Fondo de Investigaciones Sanitarias PI13-01339) and Generalitat de Catalunya (2005SGR00727) (to A.V.), AIRC IG (n. 12812) (to A. Bardelli), AIRC IG (n. 17707) (to F.N.), Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per mille 2010 e 2011 Ministero della Salute (to A. Bardelli and F.N.), Fondo per la Ricerca Locale (ex 60%), and Universita di Torino, 2014 (to F.N.). N.E.-M., M.C., L.C., C.N., C.C., and C.H. are employees of Sanofi Oncology. I.M.S. and S. Tian were employees of Agendia at the time of the study.	Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263; Arnaoutov A, 2003, DEV CELL, V5, P99, DOI 10.1016/S1534-5807(03)00194-1; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; Brunen D, 2013, CELL CYCLE, V12, P2960, DOI 10.4161/cc.26034; Clarke PR, 2005, NAT CELL BIOL, V7, P551, DOI 10.1038/ncb0605-551; Dienstmann R., 2014, ASCO M, V32, P3511, DOI DOI 10.1200/jco.2014.32.15_suppl.3511; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gebbia V, 1996, ONCOL REP, V3, P563; Gluck S, 2013, BREAST CANCER RES TR, V139, P759, DOI 10.1007/s10549-013-2572-4; Hashizume C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.370; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; IAFFAIOLI RV, 1995, ONCOL REP, V2, P513; Janssen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064029; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; LINN SC, 1994, LANCET, V343, P1648, DOI 10.1016/S0140-6736(94)93107-0; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Popovici V, 2012, J CLIN ONCOL, V30, P1288, DOI 10.1200/JCO.2011.39.5814; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Prota AE, 2014, P NATL ACAD SCI USA, V111, P13817, DOI 10.1073/pnas.1408124111; Raaijmakers JA, 2009, J CELL SCI, V122, P2436, DOI 10.1242/jcs.051912; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ritsma L, 2013, NAT PROTOC, V8, P583, DOI 10.1038/nprot.2013.026; Ritsma L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004394; Roepman P, 2014, INT J CANCER, V134, P552, DOI 10.1002/ijc.28387; Sargent DJ, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.3507; Sebio A, 2015, CURR COLORECT CANC R, V11, P118, DOI 10.1007/s11888-015-0267-4; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Tanenbaum ME, 2010, CHROMOSOMA, V119, P415, DOI 10.1007/s00412-010-0267-8; Tian S, 2013, GUT, V62, P540, DOI 10.1136/gutjnl-2012-302423; Tie J, 2011, INT J CANCER, V128, P2075, DOI 10.1002/ijc.25555; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Torosantucci L, 2008, MOL BIOL CELL, V19, P1873, DOI 10.1091/mbc.E07-10-1050; Cidon EU, 2010, CLIN MED INSIGHTS-ON, V4, P55, DOI 10.4137/CMO.S5214; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Vollebergh MA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3655; Yuan ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065995	41	62	62	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					317	330		10.1016/j.cell.2016.02.059	http://dx.doi.org/10.1016/j.cell.2016.02.059			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058664	Bronze			2022-12-28	WOS:000374123000011
J	Wallner, A; Feige, J; Kinoshita, N; Paul, M; Fifield, LK; Golser, R; Honda, M; Linnemann, U; Matsuzaki, H; Merchel, S; Rugel, G; Tims, SG; Steier, P; Yamagata, T; Winkler, SR				Wallner, A.; Feige, J.; Kinoshita, N.; Paul, M.; Fifield, L. K.; Golser, R.; Honda, M.; Linnemann, U.; Matsuzaki, H.; Merchel, S.; Rugel, G.; Tims, S. G.; Steier, P.; Yamagata, T.; Winkler, S. R.			Recent near-Earth supernovae probed by global deposition of interstellar radioactive Fe-60	NATURE			English	Article							MASSIVE STARS; NUCLEOSYNTHESIS; EXPLOSION; AL-26; DUST	The rate of supernovae in our local Galactic neighbourhood within a distance of about 100 parsecs from Earth is estimated to be one every 2-4 million years, based on the total rate in the Milky Way (2.0 +/- 0.7 per century(1,2)). Recent massive-star and supernova activity in Earth's vicinity may be traced by radionuclides with half-lives of up to 100 million years(3-6), if trapped in interstellar dust grains that penetrate the Solar System. One such radionuclide is Fe-60 (with a half-life of 2.6 million years)(7,8), which is ejected in supernova explosions and winds from massive stars(1,2,9). Here we report that the Fe-60 signal observed previously in deep-sea crusts(10,11) is global, extended in time and of interstellar origin from multiple events. We analysed deep-sea archives from all major oceans for Fe-60 deposition via the accretion of interstellar dust particles. Our results reveal Fe-60 interstellar influxes onto Earth at 1.5-3.2 million years ago and at 6.5-8.7 million years ago. The signal measured implies that a few per cent of fresh Fe-60 was captured in dust and deposited on Earth. Our findings indicate multiple supernova and massive-star events during the last ten million years at distances of up to 100 parsecs.	[Wallner, A.; Fifield, L. K.; Tims, S. G.] Australian Natl Univ, Res Sch Phys & Engn, Dept Nucl Phys, GPO Box 4, Canberra, ACT 2601, Australia; [Feige, J.; Golser, R.; Steier, P.; Winkler, S. R.] Univ Vienna, Fac Phys Isotope Res, VERA Lab, Wahringer Str 17, A-1090 Vienna, Austria; [Kinoshita, N.] Shimizu Corp, Inst Technol, Tokyo 1358530, Japan; [Paul, M.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Honda, M.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Linnemann, U.] Senckenberg Collect Nat Hist Dresden, GeoPlasmaLab, Konigsbrucker Landstr 159, D-01109 Dresden, Germany; [Matsuzaki, H.] Univ Tokyo, Univ Museum, MALT Micro Anal Lab, Tandem Accelerator, Tokyo 1130032, Japan; [Merchel, S.; Rugel, G.] Helmholtz Inst Resource Technol, HZDR, D-01328 Dresden, Germany; [Yamagata, T.] Nihon Univ, Grad Sch Integrated Basic Sci, Tokyo 1568550, Japan; [Feige, J.] Berlin Inst Technol, Dept Astron & Astrophys, Hardenbergstr 36, D-10623 Berlin, Germany	Australian National University; University of Vienna; Shimizu Corporation; Hebrew University of Jerusalem; University of Tsukuba; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Tokyo; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Nihon University; Technical University of Berlin	Wallner, A (corresponding author), Australian Natl Univ, Res Sch Phys & Engn, Dept Nucl Phys, GPO Box 4, Canberra, ACT 2601, Australia.	anton.wallner@anu.edu.au	Steier, Peter/AAZ-6043-2020; Wallner, Anton/G-1480-2011; Tims, Stephen G/P-6505-2015; Golser, Robin/D-7908-2019	Wallner, Anton/0000-0003-2804-3670; Tims, Stephen G/0000-0001-6014-0126; Golser, Robin/0000-0002-4934-6278; Winkler, Stephan/0000-0001-8348-3260; Rugel, Georg/0000-0002-0176-8842; Honda, Maki/0000-0002-9548-1745; Merchel, Silke/0000-0002-8755-3980; Feige, Jenny/0000-0002-3187-7898; Kinoshita, Norikazu/0000-0001-9135-483X; Fifield, Leslie/0000-0003-2866-4944	Austrian Science Fund (FWF) [I428-N16]; ESF Eurogenesis programme; Australian Research Council (ARC) [DP14100136]; Japan Society for the Promotion of Science (JSPS) KAKENHI [26800161]; University of Vienna; Grants-in-Aid for Scientific Research [26800161] Funding Source: KAKEN	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ESF Eurogenesis programme; Australian Research Council (ARC)(Australian Research Council); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); University of Vienna; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by (1) the Austrian Science Fund (FWF), project number I428-N16 and within the ESF Eurogenesis programme; (2) the Australian Research Council (ARC), project number DP14100136; and (3) the Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 26800161. J.F. acknowledges a stipend (Abschlussstipendium) from the University of Vienna. We thank the Antarctic Marine Geology Research Facility, Florida State University, USA (C. Sjunneskog) for providing the sediment cores, P. DeDeckker (ANU) for help in selecting the cores; JOGMEC, Japan for supplying the crust; and P. Martinez Arbizu and M. Turkay for providing the nodules. Stable isotope measurements were performed by A. Ritter and S. Gurlit (HZDR) and V. Guillouat (CEREGE, France). We appreciate the support of M. Frohlich, S. Akhmadaliev, S. Pavetich, R. Ziegenrucker and P. Collon. We thank M. Lugaro and A. Karakas for information on (super) asymptotic-giant-branch stars and D. Bourles on dating methods in deep-sea sediments. We thank D. Schumann for providing <SUP>60</SUP>Fe standard material.	Basu S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.141103; Beech M, 2011, ASTROPHYS SPACE SCI, V336, P287, DOI 10.1007/s10509-011-0873-9; Benitez N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.081101; Bishop S., 2013, AM PHYS SOC APR M, V58; Breitschwerdt D, 2006, ASTRON ASTROPHYS, V452, pL1, DOI 10.1051/0004-6361:20064989; Ellis J, 1996, ASTROPHYS J, V470, P1227, DOI 10.1086/177945; Faestermann T., 2014, LPSC, V45, P1778; Farley KA, 2006, NATURE, V439, P295, DOI 10.1038/nature04391; Feige J, 2013, EPJ WEB CONF, V63, DOI 10.1051/epjconf/20136303003; Fitoussi C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.121101; Frisch PC, 2009, SPACE SCI REV, V146, P235, DOI 10.1007/s11214-009-9502-0; Fry BJ, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/71; Knie K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.171103; Knie K, 1999, PHYS REV LETT, V83, P18, DOI 10.1103/PhysRevLett.83.18; Korschinek G., 1996, RADIOCARBON, V38, P68; Limongi M, 2006, ASTROPHYS J, V647, P483, DOI 10.1086/505164; Ludwig P., 2015, THESIS TU MUNICH; Maiz-Apellaniz J, 2001, ASTROPHYS J, V560, pL83, DOI 10.1086/324016; Mann I, 2010, ANNU REV ASTRON ASTR, V48, P173, DOI 10.1146/annurev-astro-081309-130846; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; RUDERMAN MA, 1974, SCIENCE, V184, P1079, DOI 10.1126/science.184.4141.1079; Rugel G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.072502; Stuart FM, 2012, CHEM GEOL, V322, P209, DOI 10.1016/j.chemgeo.2012.07.002; Timmes FX, 1997, ASTROPHYS J, V481, pL81, DOI 10.1086/310662; Wallner A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6956; Wallner A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.041101; Wanajo S, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/1/L6; Wang W, 2007, ASTRON ASTROPHYS, V469, P1005, DOI 10.1051/0004-6361:20066982; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237	31	118	118	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					69	72		10.1038/nature17196	http://dx.doi.org/10.1038/nature17196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27078565	Green Accepted			2022-12-28	WOS:000373555500034
J	King, WC; Chen, JY; Belle, SH; Courcoulas, AP; Dakin, GF; Elder, KA; Flum, DR; Hinojosa, MW; Mitchell, JE; Pories, WJ; Wolfe, BM; Yanovski, SZ				King, Wendy C.; Chen, Jia-Yuh; Belle, Steven H.; Courcoulas, Anita P.; Dakin, Gregory F.; Elder, Katherine A.; Flum, David R.; Hinojosa, Marcelo W.; Mitchell, James E.; Pories, Walter J.; Wolfe, Bruce M.; Yanovski, Susan Z.			Change in Pain and Physical Function Following Bariatric Surgery for Severe Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; WESTERN-ONTARIO-UNIVERSITY; LONGITUDINAL ASSESSMENT; MUSCULOSKELETAL PAIN; GASTRIC BYPASS; WEIGHT-LOSS; MOBILITY LIMITATION; OLDER-ADULTS; WALK TEST; HEALTH	IMPORTANCE The variability and durability of improvements in pain and physical function following Roux-en-Y gastric bypass (RYGB) or laparoscopic adjustable gastric banding (LAGB) are not well described. OBJECTIVES To report changes in pain and physical function in the first 3 years following bariatric surgery, and to identify factors associated with improvement. DESIGN, SETTING, AND PARTICIPANTS The Longitudinal Assessment of Bariatric Surgery-2 is an observational cohort study at 10 US hospitals. Adults with severe obesity undergoing bariatric surgery were recruited between February 2005 and February 2009. Research assessments were conducted prior to surgery and annually thereafter. Three-year follow-up through October 2012 is reported. EXPOSURES Bariatric surgery as clinical care. MAIN OUTCOMES AND MEASURES Primary outcomes were clinically meaningful presurgery to postsurgery improvements in pain and function using scores from the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) (ie, improvement of >= 5 points on the norm-based score [range, 0-100]) and 400-meter walk time (ie, improvement of >= 24 seconds) using established thresholds. The secondary outcome was clinically meaningful improvement using the Western Ontario McMaster Osteoarthritis Index (ie, improvement of >= 9.7 pain points and >= 9.3 function points on the transformed score [range, 0-100]). RESULTS Of 2458 participants, 2221 completed baseline and follow-up assessments (1743 [78.5%] were women; median age was 47 years; median body mass index [BMI] was 45.9; 70.4% underwent RYGB; 25.0% underwent LAGB). At year 1, clinically meaningful improvements were shown in 57.6%(95% CI, 55.3%-59.9%) of participants for bodily pain, 76.5%(95% CI, 74.6%-78.5%) for physical function, and 59.5%(95% CI, 56.4%-62.7%) for walk time. Additionally, among participants with severe knee or disability (633), or hip pain or disability (500) at baseline, approximately three-fourths experienced joint-specific improvements in knee pain (77.1%[95% CI, 73.5%-80.7%]) and in hip function (79.2%[95% CI, 75.3%-83.1%]). Between year 1 and year 3, rates of improvement significantly decreased to 48.6%(95% CI, 46.0%-51.1%) for bodily pain and to 70.2%(95% CI, 67.8%-72.5%) for physical function, but improvement rates for walk time, knee and hip pain, and knee and hip function did not (P for all >=.05). Younger age, male sex, higher income, lower BMI, and fewer depressive symptoms presurgery; no diabetes and no venous edema with ulcerations postsurgery (either no history or remission); and presurgery-to-postsurgery reductions in weight and depressive symptoms were associated with presurgery-to-postsurgery improvements in multiple outcomes at years 1, 2, and 3. CONCLUSIONS AND RELEVANCE Among a cohort of participants with severe obesity undergoing bariatric surgery, a large percentage experienced improvement, compared with baseline, in pain, physical function, and walk time over 3 years, but the percentage with improvement in pain and physical function decreased between year 1 and year 3.	[King, Wendy C.; Chen, Jia-Yuh; Belle, Steven H.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Courcoulas, Anita P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15261 USA; [Dakin, Gregory F.] Weill Cornell Med Ctr, New York, NY USA; [Elder, Katherine A.; Wolfe, Bruce M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Elder, Katherine A.] Univ Pacific, Forest Grove, OR USA; [Flum, David R.; Hinojosa, Marcelo W.] Univ Washington, Seattle, WA 98195 USA; [Mitchell, James E.] Neuropsychiat Res Inst, Fargo, ND USA; [Pories, Walter J.] E Carolina Univ, Brody Sch Med, Greenville, NC USA; [Yanovski, Susan Z.] NIDDK, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cornell University; Oregon Health & Science University; University of the Pacific; University of Washington; University of Washington Seattle; Neuropsychiatric Research Institute; University of North Carolina; East Carolina University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	King, WC (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Epidemiol Data Ctr, Room 105,130 DeSoto St, Pittsburgh, PA 15261 USA.	kingw@edc.pitt.edu	Flum, David/GPX-7976-2022; King, Wendy C/AAC-5122-2022	King, Wendy C/0000-0002-0740-0029	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Columbia University Medical Center [U01-DK66667]; Cornell University Medical Center CTRC [UL1-RR024996]; University of Washington [U01-DK66568]; CTRC [M01RR-00037, UL1-RR024153]; Neuropsychiatric Research Institute [U01-DK66471]; East Carolina University [U01-DK66526]; University of Pittsburgh Medical Center [U01-DK66585]; Oregon Health & Science University [U01-DK66555];  [U01 DK066557]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153, UL1RR024996, M01RR000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066568, U01DK066471, U01DK066526, U01DK066667, U01DK066555, U01DK066585, U01DK066557] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Columbia University Medical Center; Cornell University Medical Center CTRC; University of Washington(University of Washington); CTRC; Neuropsychiatric Research Institute; East Carolina University; University of Pittsburgh Medical Center; Oregon Health & Science University; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	LABS-2 was a cooperative agreement funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Grant numbers: Data Coordinating Center-U01 DK066557; Columbia University Medical Center-U01-DK66667 (in collaboration with Cornell University Medical Center CTRC, grant UL1-RR024996); University of Washington-U01-DK66568 (in collaboration with CTRC, grant M01RR-00037); Neuropsychiatric Research Institute-U01-DK66471; East Carolina University-U01-DK66526; University of Pittsburgh Medical Center-U01-DK66585 (in collaboration with CTRC, grant UL1-RR024153); Oregon Health & Science University-U01-DK66555.	BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bellamy N, 2005, CLIN EXP RHEUMATOL, V23, pS148; Belle SH, 2007, SURG OBES RELAT DIS, V3, P116, DOI 10.1016/j.soard.2007.01.006; Belle SH, 2013, SURG OBES RELAT DIS, V9, P926, DOI 10.1016/j.soard.2013.01.023; Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928; de Souza SAF, 2005, OBES SURG, V15, P1238, DOI 10.1381/096089205774512627; Edwards C, 2012, ARTHRITIS, DOI 10.1155/2012/504189; EDWARDS D, 1987, BIOMETRICS, V43, P913, DOI 10.2307/2531545; Ehrich EW, 2000, J RHEUMATOL, V27, P2635; de Souza SAF, 2009, SURG OBES RELAT DIS, V5, P540, DOI 10.1016/j.soard.2009.05.003; Frendl DM, 2014, MED CARE, V52, P439, DOI 10.1097/MLR.000000000000010311; Garver MJ, 2014, ARTHRITIS, DOI 10.1155/2014/375909; Gill RS, 2011, OBES REV, V12, P1083, DOI 10.1111/j.1467-789X.2011.00926.x; Hergenroeder AL, 2011, PHYS THER, V91, P1223, DOI 10.2522/ptj.20100214; Hills A P, 2002, Obes Rev, V3, P35, DOI 10.1046/j.1467-789X.2002.00054.x; Hooper MM, 2007, INT J OBESITY, V31, P114, DOI 10.1038/sj.ijo.0803349; Hulens M, 2001, SCAND J MED SCI SPOR, V11, P305, DOI 10.1034/j.1600-0838.2001.110509.x; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Josbeno DA, 2010, SURG OBES RELAT DIS, V6, P361, DOI 10.1016/j.soard.2008.08.003; King WC, 2013, EXERC SPORT SCI REV, V41, P26, DOI 10.1097/JES.0b013e31826444e0; Korenkov M, 2007, OBES SURG, V17, P679, DOI 10.1007/s11695-007-9118-y; Lange-Maia BS, 2015, AGING CLIN EXP RES, V27, P309, DOI 10.1007/s40520-014-0287-y; Maniscalco M, 2006, OBES SURG, V16, P836, DOI 10.1381/096089206777822331; McConnell S, 2001, ARTHRIT RHEUM-ARTHR, V45, P453, DOI 10.1002/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W; Mitchell JE, 2014, OBESITY, V22, P1799, DOI 10.1002/oby.20738; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Peltonen M, 2003, PAIN, V104, P549, DOI 10.1016/S0304-3959(03)00091-5; Perera S, 2014, J GERONTOL A-BIOL, V69, P1260, DOI 10.1093/gerona/glu033; Raoof M, 2015, OBES SURG, V25, P1119, DOI 10.1007/s11695-014-1513-6; Richette P, 2011, ANN RHEUM DIS, V70, P139, DOI 10.1136/ard.2010.134015; Rolland YM, 2004, J AM GERIATR SOC, V52, P972, DOI 10.1111/j.1532-5415.2004.52267.x; Sanchez-Santos R, 2006, OBES SURG, V16, P580, DOI 10.1381/096089206776945084; Simonsick EM, 2008, J GERONTOL A-BIOL, V63, P841, DOI 10.1093/gerona/63.8.841; Speck RM, 2014, SURG OBES RELAT DIS, V10, P161, DOI 10.1016/j.soard.2013.08.001; Steele T, 2015, OBES REV, V16, P248, DOI 10.1111/obr.12247; Tompkins J, 2008, PHYS THER, V88, P928, DOI 10.2522/ptj.20070296; Vincent HK, 2012, PM&R, V4, pS59, DOI 10.1016/j.pmrj.2012.01.005; Vincent HK, 2012, SURG OBES RELAT DIS, V8, P346, DOI 10.1016/j.soard.2011.11.020; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; Zdziarski LA, 2015, J PAIN RES, V8, P63, DOI 10.2147/JPR.S55360	40	92	92	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1362	1371		10.1001/jama.2016.3010	http://dx.doi.org/10.1001/jama.2016.3010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI3EP	27046364	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000373381500020
J	Shipley, WC				Shipley, W. C.			E Pluribus Unum Forever (Reprinted from JAMA, vol 67, pg 696, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Shipley WC, 1916, J AMER MED ASSOC, V67, P696	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1408	1408		10.1001/jama.2015.17080	http://dx.doi.org/10.1001/jama.2015.17080			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	27046380				2022-12-28	WOS:000373381500035
J	Watkins, SJ				Watkins, Stephen J.			PERSONAL VIEW The law is not equipped to consider scientific dispute	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sjande.watkins@gmail.com						Watkins SJ, 2000, BRIT MED J, V320, P2, DOI 10.1136/bmj.320.7226.2	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2016	352								i1768	10.1136/bmj.i1768	http://dx.doi.org/10.1136/bmj.i1768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TW	27032412				2022-12-28	WOS:000373493300015
J	Woodward, A; Blakely, T				Woodward, Alistair; Blakely, Tony			Nobody on the face of the globe lived longer	LANCET			English	Editorial Material									[Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat, Auckland 1050, New Zealand; [Blakely, Tony] Univ Otago Wellington, Dept Publ Hlth, Wellington, New Zealand	University of Auckland; University of Otago	Woodward, A (corresponding author), Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat, Auckland 1050, New Zealand.	a.woodward@auckland.ac.nz		Woodward, Alistair/0000-0001-5425-6018; Blakely, Tony/0000-0002-6995-4369					0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1049	1050		10.1016/S0140-6736(16)00667-X	http://dx.doi.org/10.1016/S0140-6736(16)00667-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG0SD	27030840				2022-12-28	WOS:000371775000016
J	Driggers, RW; Ho, CY; Korhonen, EM; Kuivanen, S; Jaaskelainen, AJ; Smura, T; Rosenberg, A; Hill, DA; DeBiasi, RL; Vezina, G; Timofeev, J; Rodriguez, FJ; Levanov, L; Razak, J; Iyengar, P; Hennenfent, A; Kennedy, R; Lanciotti, R; du Plessis, A; Vapalahti, O				Driggers, R. W.; Ho, C. -Y.; Korhonen, E. M.; Kuivanen, S.; Jaaskelainen, A. J.; Smura, T.; Rosenberg, A.; Hill, D. A.; DeBiasi, R. L.; Vezina, G.; Timofeev, J.; Rodriguez, F. J.; Levanov, L.; Razak, J.; Iyengar, P.; Hennenfent, A.; Kennedy, R.; Lanciotti, R.; du Plessis, A.; Vapalahti, O.			Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSION	The current outbreak of Zika virus (ZIKV) infection has been associated with an apparent increased risk of congenital microcephaly. We describe a case of a pregnant woman and her fetus infected with ZIKV during the 11th gestational week. The fetal head circumference decreased from the 47th percentile to the 24th percentile between 16 and 20 weeks of gestation. ZIKV RNA was identified in maternal serum at 16 and 21 weeks of gestation. At 19 and 20 weeks of gestation, substantial brain abnormalities were detected on ultrasonography and magnetic resonance imaging (MRI) without the presence of microcephaly or intracranial calcifications. On postmortem analysis of the fetal brain, diffuse cerebral cortical thinning, high ZIKV RNA loads, and viral particles were detected, and ZIKV was subsequently isolated.	[Driggers, R. W.; Timofeev, J.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Baltimore, MD 21205 USA; [Rodriguez, F. J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Driggers, R. W.; Timofeev, J.; Razak, J.] Childrens Natl Hlth Syst, Sibley Mem Hosp, Div Maternal Fetal Med, Washington, DC 20010 USA; [Ho, C. -Y.; Rosenberg, A.; Hill, D. A.] Childrens Natl Hlth Syst, Div Pathol, Washington, DC USA; [Ho, C. -Y.; Rosenberg, A.; Hill, D. A.] Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC USA; [DeBiasi, R. L.] Childrens Natl Hlth Syst, Div Pediat Infect Dis, Washington, DC USA; [Vezina, G.] Childrens Natl Hlth Syst, Dept Diagnost Radiol & Imaging, Washington, DC USA; [du Plessis, A.] Childrens Natl Hlth Syst, Div Fetal & Transit Med, Fetal Med Inst, Washington, DC 20010 USA; [Ho, C. -Y.; Hill, D. A.] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20052 USA; [DeBiasi, R. L.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat & Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Vezina, G.] George Washington Univ, Sch Med & Hlth Sci, Dept Radiol & Pediat, Washington, DC 20052 USA; [Iyengar, P.] Ctr Dis Control & Prevent CDC, Ctr Policy Planning & Evaluat, Washington, DC USA; [Hennenfent, A.] Dist Columbia Dept Hlth, Council State & Territorial Epidemiologists CST A, Washington, DC USA; [Kennedy, R.] One Med Grp, Washington, DC USA; [Korhonen, E. M.; Kuivanen, S.; Smura, T.; Levanov, L.; Vapalahti, O.] Univ Helsinki, Dept Virol, Helsinki, Finland; [Korhonen, E. M.; Vapalahti, O.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Jaaskelainen, A. J.; Vapalahti, O.] Univ Helsinki, Dept Virol & Immunol, Helsinki, Finland; [Jaaskelainen, A. J.; Vapalahti, O.] Helsinki Univ Hosp, Helsinki, Finland; [Lanciotti, R.] CDC, Arboviral Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging Zoonot Infect Dis, Atlanta, GA 30333 USA	Johns Hopkins University; Johns Hopkins University; Children's National Health System; Children's National Health System; Children's National Health System; Children's National Health System; Children's National Health System; Children's National Health System; George Washington University; George Washington University; George Washington University; Centers for Disease Control & Prevention - USA; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Centers for Disease Control & Prevention - USA	Driggers, RW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Baltimore, MD 21205 USA.; Driggers, RW (corresponding author), Childrens Natl Hlth Syst, Sibley Mem Hosp, Div Maternal Fetal Med, Washington, DC 20010 USA.; du Plessis, A (corresponding author), Childrens Natl Hlth Syst, Div Fetal & Transit Med, Fetal Med Inst, Washington, DC 20010 USA.; Vapalahti, O (corresponding author), Univ Helsinki, Dept Virol, Helsinki, Finland.; Vapalahti, O (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.; Vapalahti, O (corresponding author), Univ Helsinki, Dept Virol & Immunol, Helsinki, Finland.; Vapalahti, O (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	rdrigge1@jhmi.edu; adupless@childrensnational.org; olli.vapalahti@helsinki.fi	Hennenfent, Andrew/K-6548-2019; Pinto, Marcelo/G-7503-2012; Korhonen, Essi Marjaana/CAF-5553-2022; Ho, Cheng-Ying/AAA-5098-2019; Smura, Teemu P/C-4063-2016; Smura, Teemu/K-6421-2012	Pinto, Marcelo/0000-0003-3462-7277; Vapalahti, Olli/0000-0003-2270-6824; Smura, Teemu/0000-0002-9187-3151; Rosenberg, Avi/0000-0003-2356-950X; Korhonen, Essi/0000-0003-4730-7715				[Anonymous], 2016, Wkly Epidemiol Rec, V91, P73; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609; [Anonymous], 2016, MMWR MORB MORTAL WKL; Besnard M, 2014, EURO SURVEILL, V19; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Centers for Disease Control and Prevention, 2016, ZIK TRAV INF; Centers for Disease Control and Prevention, ZIK VIR CLIN EV DIS; Centers for Disease Control and Prevention, 2016, CDC HLTH ADV REC MAN; Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR DIS; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gilbert-Barness E, 2005, HDB PEDIAT AUTOPSY, P54; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Harreld JH, 2011, AM J NEURORADIOL, V32, P490, DOI 10.3174/ajnr.A2310; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Kline-Fath B, 2015, FUNDAMENTAL ADV FETA, P860; Korhonen EM, 2016, EURO SURVEILL, V21; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2015, EMERG INFEC IN PRESS; McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1; Tang H., 2016, CELL STEM CELL; Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148	30	573	588	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2016	374	22					2142	2151		10.1056/NEJMoa1601824	http://dx.doi.org/10.1056/NEJMoa1601824			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB2RP	27028667	Bronze			2022-12-28	WOS:000387209900007
J	Schofer, J				Schofer, Joachim			All over for valve surgery for intermediate-risk patients?	LANCET			English	Editorial Material							TRANSCATHETER; REPLACEMENT; OUTCOMES; STENOSIS		[Schofer, Joachim] Albertinen Heart Ctr, Med Care Ctr, D-22457 Hamburg, Germany; [Schofer, Joachim] Albertinen Heart Ctr, Dept Percutaeous Treatment Valvular Heart Dis, D-22457 Hamburg, Germany	University of Hamburg; University of Hamburg	Schofer, J (corresponding author), Albertinen Heart Ctr, Med Care Ctr, D-22457 Hamburg, Germany.; Schofer, J (corresponding author), Albertinen Heart Ctr, Dept Percutaeous Treatment Valvular Heart Dis, D-22457 Hamburg, Germany.	schofer@herz-hh.de						Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Latib A, 2012, AM HEART J, V164, P910, DOI 10.1016/j.ahj.2012.09.005; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Piazza N, 2013, JACC-CARDIOVASC INTE, V6, P443, DOI 10.1016/j.jcin.2013.01.136; Tamburino C, 2015, J AM COLL CARDIOL, V66, P804, DOI 10.1016/j.jacc.2015.06.013; Thourani VH, 2016, LANCET; Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109	11	6	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2170	2171		10.1016/S0140-6736(16)30122-2	http://dx.doi.org/10.1016/S0140-6736(16)30122-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27053441				2022-12-28	WOS:000376820800008
J	Lien, S; Koop, BF; Sandve, SR; Miller, JR; Kent, MP; Nome, T; Hvidsten, TR; Leong, JS; Minkley, DR; Zimin, A; Grammes, F; Grove, H; Gjuvsland, A; Walenz, B; Hermansen, RA; von Schalburg, K; Rondeau, EB; Di Genova, A; Samy, JKA; Vik, JO; Vigeland, MD; Caler, L; Grimholt, U; Jentoft, S; Vage, DI; de Jong, P; Moen, T; Baranski, M; Palti, Y; Smith, DR; Yorke, JA; Nederbragt, AJ; Tooming-Klunderud, A; Jakobsen, KS; Jiang, XT; Fan, DD; Liberles, DA; Vidal, R; Iturra, P; Jones, SJM; Jonassen, I; Maass, A; Omholt, SW; Davidson, WS				Lien, Sigbjorn; Koop, Ben F.; Sandve, Simen R.; Miller, Jason R.; Kent, Matthew P.; Nome, Torfinn; Hvidsten, Torgeir R.; Leong, Jong S.; Minkley, David R.; Zimin, Aleksey; Grammes, Fabian; Grove, Harald; Gjuvsland, Arne; Walenz, Brian; Hermansen, Russell A.; von Schalburg, Kris; Rondeau, Eric B.; Di Genova, Alex; Samy, Jeevan K. A.; Vik, Jon Olav; Vigeland, Magnus D.; Caler, Lis; Grimholt, Unni; Jentoft, Sissel; Vage, Dag Inge; de Jong, Pieter; Moen, Thomas; Baranski, Matthew; Palti, Yniv; Smith, Douglas R.; Yorke, James A.; Nederbragt, Alexander J.; Tooming-Klunderud, Ave; Jakobsen, Kjetill S.; Jiang, Xuanting; Fan, Dingding; Liberles, David A.; Vidal, Rodrigo; Iturra, Patricia; Jones, Steven J. M.; Jonassen, Inge; Maass, Alejandro; Omholt, Stig W.; Davidson, William S.			The Atlantic salmon genome provides insights into rediploidization	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DUPLICATE GENE RETENTION; TRANSPOSABLE ELEMENTS; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; LINKAGE MAP; EVOLUTION; FISHES; SALAR; SOFTWARE	The whole-genome duplication 80 million years ago of the common ancestor of salmonids (salmonid-specific fourth vertebrate whole-genome duplication, Ss4R) provides unique opportunities to learn about the evolutionary fate of a duplicated vertebrate genome in 70 extant lineages. Here we present a high-quality genome assembly for Atlantic salmon (Salmo salar), and show that large genomic reorganizations, coinciding with bursts of transposon-mediated repeat expansions, were crucial for the post-Ss4R rediploidization process. Comparisons of duplicate gene expression patterns across a wide range of tissues with orthologous genes from a pre-Ss4R outgroup unexpectedly demonstrate far more instances of neofunctionalization than subfunctionalization. Surprisingly, we find that genes that were retained as duplicates after the teleost-specific whole-genome duplication 320 million years ago were not more likely to be retained after the Ss4R, and that the duplicate retention was not influenced to a great extent by the nature of the predicted protein interactions of the gene products. Finally, we demonstrate that the Atlantic salmon assembly can serve as a reference sequence for the study of other salmonids for a range of purposes.	[Lien, Sigbjorn; Sandve, Simen R.; Kent, Matthew P.; Nome, Torfinn; Grammes, Fabian; Grove, Harald; Gjuvsland, Arne; Samy, Jeevan K. A.; Vik, Jon Olav; Vage, Dag Inge] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, NO-1432 As, Norway; [Koop, Ben F.; Leong, Jong S.; Minkley, David R.; von Schalburg, Kris] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada; [Miller, Jason R.; Walenz, Brian; Rondeau, Eric B.; Caler, Lis] J Craig Venter Inst, 9704 Med Ctr Dr, Rockville, MD 20850 USA; [Hvidsten, Torgeir R.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, NO-1432 As, Norway; [Hvidsten, Torgeir R.] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Zimin, Aleksey; Yorke, James A.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Hermansen, Russell A.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Hermansen, Russell A.; Liberles, David A.] Temple Univ, Ctr Computat Genet & Genom, Philadelphia, PA 19122 USA; [Hermansen, Russell A.; Liberles, David A.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Di Genova, Alex; Maass, Alejandro] Univ Chile, Ctr Math Modeling, Santiago 8370456, Chile; [Di Genova, Alex; Maass, Alejandro] Univ Chile, Ctr Genome Regulat, Santiago 8370415, Chile; [Vigeland, Magnus D.] Oslo Univ Hosp, Med Genet, NO-0424 Oslo, Norway; [Vigeland, Magnus D.] Univ Oslo, NO-0424 Oslo, Norway; [Grimholt, Unni] Norwegian Vet Inst, Dept Virol, NO-0454 Oslo, Norway; [Jentoft, Sissel; Nederbragt, Alexander J.; Tooming-Klunderud, Ave; Jakobsen, Kjetill S.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth CEES, NO-0316 Oslo, Norway; [de Jong, Pieter] CHORI, Oakland, CA 94609 USA; [Moen, Thomas] AquaGen, NO-7462 Trondheim, Norway; [Baranski, Matthew] Nofima, NO-9291 Tromso, Norway; [Palti, Yniv] ARS, Natl Ctr Cool & Cold Water Aquaculture, USDA, Kearneysville, WV 25430 USA; [Smith, Douglas R.] Beckman Genom, Danvers, MA 01923 USA; [Smith, Douglas R.] Courtagen Life Sci, Woburn, MA 01801 USA; [Jiang, Xuanting; Fan, Dingding] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Vidal, Rodrigo] Univ Santiago, Dept Biol, Lab Mol Ecol Genom & Evolutionary Studies, Santiago 9170022, Chile; [Iturra, Patricia] Univ Chile, Fac Med, Santiago 8380453, Chile; [Jones, Steven J. M.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Jones, Steven J. M.; Davidson, William S.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Jonassen, Inge] Univ Bergen, Dept Informat, NO-6020 Bergen, Norway; [Omholt, Stig W.] NTNU Norwegian Univ Sci & Technol, Dept Biol, Ctr Biodivers Dynam, NO-7491 Trondheim, Norway	Norwegian University of Life Sciences; University of Victoria; J. Craig Venter Institute; Norwegian University of Life Sciences; Umea University; University System of Maryland; University of Maryland College Park; University of Wyoming; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Universidad de Chile; Universidad de Chile; University of Oslo; University of Oslo; Norwegian Veterinary Institute; University of Oslo; Children's Hospital Oakland Research Institute; Nofima; United States Department of Agriculture (USDA); Beijing Genomics Institute (BGI); Universidad de Santiago de Chile; Universidad de Chile; British Columbia Cancer Agency; Simon Fraser University; University of Bergen; Norwegian University of Science & Technology (NTNU)			Koop, Ben F./A-8151-2008; Davidson, Willie/M-1992-2019; Samy, Jeevan Karloss Antony/S-1060-2019; Maass, Alejandro E/D-5848-2012; Hvidsten, Torgeir R./A-3409-2009; Jonassen, Inge/AAC-7035-2020; Jones, Steven J/C-3621-2009; Våge, Dag Inge/AAD-5178-2020; Vik, Jon Olav/B-9350-2008; Nome, Torfinn/E-5475-2015; Baranski, Matthew/I-7839-2018	Koop, Ben F./0000-0003-0045-5200; Maass, Alejandro E/0000-0002-7038-4527; Hvidsten, Torgeir R./0000-0001-6097-2539; Jones, Steven J/0000-0003-3394-2208; Våge, Dag Inge/0000-0003-2568-1554; Vigeland, Magnus Dehli/0000-0002-9134-4962; Miller, Jason/0000-0002-6912-2925; Jentoft, Sissel/0000-0001-8707-531X; Vik, Jon Olav/0000-0002-7778-4515; Nome, Torfinn/0000-0003-1659-132X; Dingding, Fan/0000-0002-8201-3846; Di Genova, Alex/0000-0002-3120-9283; Grammes, Fabian/0000-0002-9551-9280; Nederbragt, Lex/0000-0001-5539-0999; Baranski, Matthew/0000-0002-9138-071X; Jonassen, Inge/0000-0003-4110-0748; Gjuvsland, Arne/0000-0002-4391-3411; Leong, Jong/0000-0001-6521-9239; Grimholt, Unni/0000-0002-0202-8061	Research Council of Norway (NFR); Norwegian Seafood Research Fund; Genome BC; Chilean Economic Development Agency - CORFO and InnovaChile Committee; Marine Harvest; AquaGen; Cermaq; Salmobreed; NFR [208481/F50, 226266, 225181, 221734/030]; Natural Sciences and Engineering Research Council (NSERC), Canada; University of Victoria; ARS [ARS-0427931] Funding Source: Federal RePORTER	Research Council of Norway (NFR)(Research Council of Norway); Norwegian Seafood Research Fund; Genome BC; Chilean Economic Development Agency - CORFO and InnovaChile Committee; Marine Harvest; AquaGen; Cermaq; Salmobreed; NFR(Research Council of Norway); Natural Sciences and Engineering Research Council (NSERC), Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Victoria; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The International Cooperation to Sequence the Atlantic Salmon Genome (ICSASG) was funded by the following organizations: Research Council of Norway (NFR: http://www.rcn.no), Norwegian Seafood Research Fund (http://www.fhf.no/hot-topics/about-fhf), Genome BC (http://www.genomebc.ca), The Chilean Economic Development Agency - CORFO and InnovaChile Committee (http://www.english.corfo.cl), Marine Harvest (http://www.marineharvest.no), AquaGen (http://www.aquagen.no), Cermaq (http://www.cermaq.com) and Salmobreed (http://www.salmobreedno). Additional funding for bioinformatics and statistical support at CIGENE-NMBU was provided by NFR grants 208481/F50, 226266, 225181 and 221734/030. Funding for RNA-seq and most of the repeat analysis was provided by Natural Sciences and Engineering Research Council (NSERC), Canada. NSERC also provided funding for the analyses and assemblies generated at University of Victoria throughout the project. We acknowledge the help of S. Karoliussen, M. Arnyasi, R. Martinsen Anestad and I. Johansson Schneider at CIGENE-NMBU for generating salmon and rainbow trout genotypes, and G. Gao, National Center for Cool and Cold Water Aquaculture, ARS-USDA for generating rainbow trout genotypes We also acknowledge K. Beeson and H. Baden-Tilson at the J. Craig Venter Institute for library construction and Illumina sequencing. Bioinformatic analyses were performed using resources at the Orion Computing Cluster at CIGENE-NMBU, the Norwegian metacenter for computational science (under project nn4653k), computing resources at University of Victoria partly provided by Compute Canada, and NLHPC-Chile.	Adzhubei AA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-209; Agresti A, 2003, CATEGORICAL DATA ANA; Allendorf F.W., 1984, P1; Allendorf FW, 2015, J HERED, V106, P217, DOI 10.1093/jhered/esv015; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], [No title captured]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Berglund-Sonnhammer AC, 2006, J MOL EVOL, V63, P240, DOI 10.1007/s00239-005-0096-1; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Daron J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0546-4; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Force A, 1999, GENETICS, V151, P1531; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Green P, 1990, DOCUMENTATION CRI MA; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Guillen Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-53; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hardie DC, 2003, GENOME, V46, P683, DOI 10.1139/G03-040; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hubley R., 2013, REPEATMASKER OPEN 40; Hughes T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-213; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang N., 2013, REPEAT LIB CONSTRUCT; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kodama M, 2014, G3-GENES GENOM GENET, V4, P1717, DOI 10.1534/g3.114.012294; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langham RJ, 2004, GENETICS, V166, P935, DOI 10.1534/genetics.166.2.935; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Mank JE, 2006, GENETICA, V127, P321, DOI 10.1007/s10709-005-5248-0; Matveev V, 2009, GENE, V434, P16, DOI 10.1016/j.gene.2008.04.022; Mayfield-Jones D, 2013, SEMIN CELL DEV BIOL, V24, P320, DOI 10.1016/j.semcdb.2013.02.002; McCluskey BM, 2015, MOL BIOL EVOL, V32, P635, DOI 10.1093/molbev/msu325; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Pace JK, 2008, P NATL ACAD SCI USA, V105, P17023, DOI 10.1073/pnas.0806548105; Paradis E., 2004, BIOINFORMATICS; Phillips RB, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-46; R Core Team, 2020, R LANG ENV STAT COMP; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Rondeau EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102089; Sato Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-127; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schnable JC, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00002; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smit A.F., 2008, REPEATMODELER OPEN 1; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; WRIGHT JE, 1983, ISOZYMES-CURR T BIOL, V10, P239; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	74	581	602	10	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					200	+		10.1038/nature17164	http://dx.doi.org/10.1038/nature17164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27088604	Green Published, hybrid			2022-12-28	WOS:000376007200040
J	Verbist, KC; Guy, CS; Milasta, S; Liedmann, S; Kaminski, MM; Wang, RN; Green, DR				Verbist, Katherine C.; Guy, Cliff S.; Milasta, Sandra; Liedmann, Swantje; Kaminski, Marcin M.; Wang, Ruoning; Green, Douglas R.			Metabolic maintenance of cell asymmetry following division in activated T lymphocytes	NATURE			English	Article							C-MYC; EXPRESSION; EFFECTOR	Asymmetric cell division, the partitioning of cellular components in response to polarizing cues during mitosis, has roles in differentiation and development(1). It is important for the selfrenewal of fertilized zygotes in Caenorhabditis elegans and neuroblasts in Drosophila, and in the development of mammalian nervous and digestive systems(1). T lymphocytes, upon activation by antigen-presenting cells (APCs), can undergo asymmetric cell division, wherein the daughter cell proximal to the APC is more likely to differentiate into an effector-like T cell and the distal daughter is more likely to differentiate into a memory-like T cell(2). Upon activation and before cell division, expression of the transcription factor c-Myc drives metabolic reprogramming, necessary for the subsequent proliferative burst(3). Here we find that during the first division of an activated T cell in mice, c-Myc can sort asymmetrically. Asymmetric distribution of amino acid transporters, amino acid content, and activity of mammalian target of rapamycin complex 1 (mTORC1) is correlated with c-Myc expression, and both amino acids and mTORC1 activity sustain the differences in c-Myc expression in one daughter cell compared to the other. Asymmetric c-Myc levels in daughter T cells affect proliferation, metabolism, and differentiation, and these effects are altered by experimental manipulation of mTORC1 activity or c-Myc expression. Therefore, metabolic signalling pathways cooperate with transcription programs to maintain differential cell fates following asymmetric T-cell division.	[Verbist, Katherine C.; Guy, Cliff S.; Milasta, Sandra; Liedmann, Swantje; Kaminski, Marcin M.; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Wang, Ruoning] Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis, Columbus, OH 43205 USA	St Jude Children's Research Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	douglas.green@stjude.org	Kaminski, Marcin/L-6974-2015; Green, Douglas R/N-8083-2018	Kaminski, Marcin/0000-0002-9026-0185; Green, Douglas R/0000-0002-7332-1417; Verbist, Katherine/0000-0002-3511-5639; Liedmann, Swantje/0000-0002-3945-9148	ALSAC; US National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114581, R01AI123322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735, R01GM096208] Funding Source: NIH RePORTER	ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Cross, G. Lennon, and P. Ingle for cell sorting, P. Thomas for assistance with influenza infections, H. Chi for help with Listeria infections, and I. Pawlikowska for help with statistical analyses. This work was supported by ALSAC and grants from the US National Institutes of Health.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Colombetti S, 2006, J IMMUNOL, V176, P2730, DOI 10.4049/jimmunol.176.5.2730; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Marelli-Berg FM, 2012, IMMUNOLOGY, V136, P363, DOI 10.1111/j.1365-2567.2012.03583.x; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Peck B, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00096; Rohr JC, 2014, TRENDS IMMUNOL, V35, P170, DOI 10.1016/j.it.2014.02.006; Russell S. M., 2014, FRONT IMMUNOL, V5; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068	30	163	167	3	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					389	+		10.1038/nature17442	http://dx.doi.org/10.1038/nature17442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27064903	Green Accepted			2022-12-28	WOS:000374424700036
J	Krager, SC; Prochazka, AV				Krager, Steven C.; Prochazka, Allan V.			Review: In women 50 to 69 y of age at average risk, mammography screening reduces breast cancer mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FORCE RECOMMENDATION STATEMENT; TRIAL		[Krager, Steven C.; Prochazka, Allan V.] Denver VA Med Ctr, Denver, CO USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Krager, SC (corresponding author), Denver VA Med Ctr, Denver, CO USA.							American College of Obstetricians and Gynecologists, ACOG STAT REV AM CAN; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Hersch J, 2015, LANCET, V385, P1642, DOI 10.1016/S0140-6736(15)60123-4; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886	7	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					JC38	JC39		10.7326/ACPJC-2016-164-8-038	http://dx.doi.org/10.7326/ACPJC-2016-164-8-038			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	27089086				2022-12-28	WOS:000374257900001
J	Altobelli, N; Postberg, F; Fiege, K; Trieloff, M; Kimura, H; Sterken, VJ; Hsu, HW; Hillier, J; Khawaja, N; Moragas-Klostermeyer, G; Blum, J; Burton, M; Srama, R; Kempf, S; Gruen, E				Altobelli, N.; Postberg, F.; Fiege, K.; Trieloff, M.; Kimura, H.; Sterken, V. J.; Hsu, H. -W.; Hillier, J.; Khawaja, N.; Moragas-Klostermeyer, G.; Blum, J.; Burton, M.; Srama, R.; Kempf, S.; Gruen, E.			Flux and composition of interstellar dust at Saturn from Cassini's Cosmic Dust Analyzer	SCIENCE			English	Article							IN-SITU MEASUREMENTS; SOLAR-SYSTEM; PRESOLAR GRAINS; HELIOSPHERE; STARDUST; MICROPARTICLES; NEIGHBORHOOD; SPACECRAFT; ORIGINS; CLOUD	Interstellar dust (ISD) is the condensed phase of the interstellar medium. In situ data from the Cosmic Dust Analyzer on board the Cassini spacecraft reveal that the Saturnian system is passed by ISD grains from our immediate interstellar neighborhood, the local interstellar cloud. We determine the mass distribution of 36 interstellar grains, their elemental composition, and a lower limit for the ISD flux at Saturn. Mass spectra and grain dynamics suggest the presence of magnesium-rich grains of silicate and oxide composition, partly with iron inclusions. Major rock-forming elements (magnesium, silicon, iron, and calcium) are present in cosmic abundances, with only small grain-to-grain variations, but sulfur and carbon are depleted. The ISD grains in the solar neighborhood appear to be homogenized, likely by repeated processing in the interstellar medium.	[Altobelli, N.] European Space Agcy, European Space Astron Ctr, Madrid, Spain; [Postberg, F.; Fiege, K.; Trieloff, M.; Gruen, E.] Heidelberg Univ, Inst Geowissensch, Heidelberg, Germany; [Postberg, F.; Khawaja, N.; Moragas-Klostermeyer, G.; Srama, R.; Gruen, E.] Univ Stuttgart, Inst Raumfahrtsyst, D-70174 Stuttgart, Germany; [Fiege, K.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Trieloff, M.] Heidelberg Univ, Klaus Tschira Labor Kosmochem, Heidelberg, Germany; [Kimura, H.] Kobe Univ, Kobe, Hyogo 657, Japan; [Sterken, V. J.] Int Space Sci Inst, Bern, Switzerland; [Hsu, H. -W.; Kempf, S.] Univ Boulder, Boulder, CO USA; [Hillier, J.] Univ Kent, Canterbury CT2 7NZ, Kent, England; [Blum, J.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [Burton, M.] Jet Prop Lab, Pasadena, CA USA	European Space Agency; Ruprecht Karls University Heidelberg; University of Stuttgart; University System of Georgia; Georgia Institute of Technology; Ruprecht Karls University Heidelberg; Kobe University; University of Colorado System; University of Colorado Boulder; University of Kent; Braunschweig University of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Altobelli, N (corresponding author), European Space Agcy, European Space Astron Ctr, Madrid, Spain.	nicolas.altobelli@sciops.esa.int	Postberg, Frank/AAE-6295-2019; Hsu, Hsiang-Wen/V-4791-2018; Hsu, Hsiang-Wen/K-3018-2019	Postberg, Frank/0000-0002-5862-4276; Hsu, Hsiang-Wen/0000-0002-5478-4168; KEMPF, SASCHA/0000-0001-5236-3004; Kimura, Hiroshi/0000-0001-9093-2933; Khawaja, Nozair/0000-0001-8237-1523	European Space Agency; Deutsche Forschungsgemeinschaft (DFG) [1385, BL 298/20-2, TR333/14, SR77/1]; European Union [622856]; Deutsches Zentrum fur Luft- und Raumfahrt (DLR), Germany; International Space Science Institute; DFG; Klaus Tschira Foundation	European Space Agency(European Space AgencyEuropean Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission); Deutsches Zentrum fur Luft- und Raumfahrt (DLR), Germany; International Space Science Institute; DFG(German Research Foundation (DFG)); Klaus Tschira Foundation	N.A. and F.P. acknowledge European Space Agency faculty funding for travels and meetings that were necessary for the completion of this work. Funding through Deutsche Forschungsgemeinschaft (DFG) within the priority program 1385 "The First 10 Million Years of the Solar System - A Planetary Materials Approach" is acknowledged by K.F., J.B. (grant BL 298/20-2), and R.S., M.T., E.G., J.H., and F.P. (grants TR333/14 and SR77/1). J.H. has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 2013 under Reemployment and Eligibility Assessment (REA) grant agreement number 622856. R.S. and F.P. acknowledge funding through Deutsches Zentrum fur Luft- und Raumfahrt (DLR), Germany. V.J.S. acknowledges funding through the International Space Science Institute. N.K. acknowledges funding through the DFG. M.T. acknowledges funding by the Klaus Tschira Foundation. We thank J. Leitner, A. Westphal, R. Stroud, L. Nittler, P. Hoppe, H. Ishii, and H.-P. Gail for helpful discussions. We thank three anonymous reviewers for their thorough review of this paper. All CDA data used for this analysis are archived on the Small Bodies Node of the Planetary Data System (PDS-SBN), at http://sbn.psi.edu/archive/cocda.	Altobelli N, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010772; Altobelli N, 2006, ASTRON ASTROPHYS, V448, P243, DOI 10.1051/0004-6361:20053909; Altobelli N, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009874; Bose M, 2012, GEOCHIM COSMOCHIM AC, V93, P77, DOI 10.1016/j.gca.2012.06.027; Bose M, 2010, ASTROPHYS J, V714, P1624, DOI 10.1088/0004-637X/714/2/1624; Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; Fiege K, 2014, ICARUS, V241, P336, DOI 10.1016/j.icarus.2014.07.015; Floss C, 2012, METEORIT PLANET SCI, V47, P992, DOI 10.1111/j.1945-5100.2012.01366.x; Floss C, 2009, GEOCHIM COSMOCHIM AC, V73, P2415, DOI 10.1016/j.gca.2009.01.033; Frisch PC, 1999, ASTROPHYS J, V525, P492, DOI 10.1086/307869; Frisch PC, 2013, EARTH PLANETS SPACE, V65, P175, DOI 10.5047/eps.2012.05.001; GREENBERG JM, 1990, ASTROPHYS J, V361, P260, DOI 10.1086/169191; GRUN E, 1993, NATURE, V362, P428, DOI 10.1038/362428a0; Hillier JK, 2014, PLANET SPACE SCI, V97, P9, DOI 10.1016/j.pss.2014.04.008; Keller LP, 2011, GEOCHIM COSMOCHIM AC, V75, P5336, DOI 10.1016/j.gca.2011.06.040; Kimura H, 2003, ASTROPHYS J, V583, P314, DOI 10.1086/345102; Kimura H, 2001, ESA SPEC PUBL, V495, P633; Kimura H, 2015, MON NOT R ASTRON SOC, V449, P2250, DOI 10.1093/mnras/stv427; Kruger H, 2007, SPACE SCI REV, V130, P401, DOI 10.1007/s11214-007-9181-7; Landgraf M, 2002, ASTRON J, V123, P2857, DOI 10.1086/339704; Landgraf M, 2000, J GEOPHYS RES-SPACE, V105, P10303, DOI 10.1029/1999JA900243; Landgraf M, 2000, J GEOPHYS RES-SPACE, V105, P10343, DOI 10.1029/1999JA900359; Leitner J, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/38; Mann I, 2010, ANNU REV ASTRON ASTR, V48, P173, DOI 10.1146/annurev-astro-081309-130846; Nguyen AN, 2010, ASTROPHYS J, V719, P166, DOI 10.1088/0004-637X/719/1/166; Postberg F, 2009, PLANET SPACE SCI, V57, P1359, DOI 10.1016/j.pss.2009.06.027; Slavin J., 2010, 38 COSPAR SCI ASS PL, P1618; Slavin JD, 2008, ASTRON ASTROPHYS, V491, P53, DOI 10.1051/0004-6361:20078101; Slavin JD, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/46; Spahn F, 2006, PLANET SPACE SCI, V54, P1024, DOI 10.1016/j.pss.2006.05.022; Srama R, 2004, SPACE SCI REV, V114, P465, DOI 10.1007/s11214-004-1435-z; Sterken VJ, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201219609; Sterken VJ, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117119; Sterken VJ, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/2/141; Stroud RM, 2014, METEORIT PLANET SCI, V49, P1698, DOI 10.1111/maps.12136; Vollmer C, 2009, GEOCHIM COSMOCHIM AC, V73, P7127, DOI 10.1016/j.gca.2009.08.015; Westphal AJ, 2014, METEORIT PLANET SCI, V49, P1720, DOI 10.1111/maps.12221; Westphal AJ, 2014, SCIENCE, V345, P786, DOI 10.1126/science.1252496; Zhao XC, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/49; Zhukovska S, 2008, ASTRON ASTROPHYS, V479, P453, DOI 10.1051/0004-6361:20077789; Zinner E, 2007, GEOCHIM COSMOCHIM AC, V71, P4786, DOI 10.1016/j.gca.2007.07.012	42	68	69	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					312	318		10.1126/science.aac6397	http://dx.doi.org/10.1126/science.aac6397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081064				2022-12-28	WOS:000373990100033
J	Anders, AM				Anders, Alison M.			GEOCHEMISTRY How rain affects rock and rivers	NATURE			English	Editorial Material							MOUNTAIN-RANGES; CLIMATE; EROSION; UPLIFT; RATES		[Anders, Alison M.] Univ Illinois, Dept Geol, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign	Anders, AM (corresponding author), Univ Illinois, Dept Geol, Champaign, IL 61820 USA.	amanders@illinois.edu						Berner RA, 2003, NATURE, V426, P323, DOI 10.1038/nature02131; Dixon JL, 2009, EARTH SURF PROC LAND, V34, P1507, DOI 10.1002/esp.1836; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Herman F, 2013, NATURE, V504, P423, DOI 10.1038/nature12877; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Murphy BP, 2016, NATURE, V532, P223, DOI 10.1038/nature17449; Sheldon ND, 2006, J GEOL, V114, P367, DOI 10.1086/500993; Whipple KX, 2014, SCIENCE, V346, P918, DOI 10.1126/science.aaa0887; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Willenbring JK, 2016, TERRA NOVA, V28, P11, DOI 10.1111/ter.12185	10	1	1	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					186	187		10.1038/532186a	http://dx.doi.org/10.1038/532186a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075095				2022-12-28	WOS:000374415100029
J	Schwartz, KR; El Saleeby, CM; Nimkin, K; Friedmann, AM; Moon, A; Zukerberg, LR				Schwartz, Kevin R.; El Saleeby, Chadi M.; Nimkin, Katherine; Friedmann, Alison M.; Moon, Aeri; Zukerberg, Lawrence R.			Case 11-2016: A 12-Year-Old Boy with Malaise, Fevers, Abdominal Pain, and Pallor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HODGKIN LYMPHOMA; CHILDREN; DISEASE; CHEMOTHERAPY; ADOLESCENTS; RISK		[Schwartz, Kevin R.; El Saleeby, Chadi M.; Friedmann, Alison M.; Moon, Aeri] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Nimkin, Katherine] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Schwartz, Kevin R.; El Saleeby, Chadi M.; Friedmann, Alison M.; Moon, Aeri] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Nimkin, Katherine] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Zukerberg, Lawrence R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Schwartz, KR (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.; Schwartz, KR (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.							Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; Chow A, 2011, WORLD J PEDIATR, V7, P5, DOI 10.1007/s12519-011-0240-5; Elfstrom P, 2011, JNCI-J NATL CANCER I, V103, P436, DOI 10.1093/jnci/djq564; Farrace MG, 2001, CELL DEATH DIFFER, V8, P767, DOI 10.1038/sj.cdd.4400880; Friedman DL, 2014, J CLIN ONCOL, V32, P3651, DOI 10.1200/JCO.2013.52.5410; Gandhi JS, 2010, J CANCER RES THER, V6, P342, DOI 10.4103/0973-1482.73354; Jones K, 2007, AUSTRALAS RADIOL, V51, P489, DOI 10.1111/j.1440-1673.2007.01701.x; KADIN ME, 1971, CANCER-AM CANCER SOC, V27, P1277, DOI 10.1002/1097-0142(197106)27:6<1277::AID-CNCR2820270602>3.0.CO;2-T; Kakar S, 2003, AM J GASTROENTEROL, V98, P2027, DOI 10.1016/S0002-9270(03)00542-2; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Kluge R, 2013, PEDIATR RADIOL, V43, P406, DOI 10.1007/s00247-012-2559-z; Lanzkowsky L, 2011, MANUAL PEDIAT HEMATO; Massini G, 2009, MEDITERR J HEMATOL I, V1, DOI 10.4084/MJHID.2009.013; Mauz-Korholz C, 2010, J CLIN ONCOL, V28, P3680, DOI 10.1200/JCO.2009.26.9381; Singh A, 2013, GASTROINTEST ENDOSC, V77, P761, DOI 10.1016/j.gie.2012.11.041; Toma P, 2007, RADIOGRAPHICS, V27, DOI 10.1148/rg.275065157; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wilson ME, 2015, FEVER RETURNED TRAVE; Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410	19	0	0	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1466	1476		10.1056/NEJMcpc1512458	http://dx.doi.org/10.1056/NEJMcpc1512458			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27074070				2022-12-28	WOS:000374128400011
J	Hawkes, N				Hawkes, Nigel			Cardiology team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2016	353								i1992	10.1136/bmj.i1992	http://dx.doi.org/10.1136/bmj.i1992			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EQ	27067386				2022-12-28	WOS:000374375100003
J	Edwards, A; Nalla, P; Premawardhana, LD				Edwards, Alison; Nalla, Preethi; Premawardhana, L. D.			CASE REVIEW A man with a short history of lower back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURVIVAL BENEFIT; MYELOMA; THERAPY; THALIDOMIDE; BORTEZOMIB; DISEASE		[Edwards, Alison; Nalla, Preethi; Premawardhana, L. D.] Ysbyty Ystrad Fawr, Endocrinol Sect, Ystrad Fawr Way, Ystrad Mynach CF82 7EP, Caerphilly, Wales		Edwards, A (corresponding author), Ysbyty Ystrad Fawr, Endocrinol Sect, Ystrad Fawr Way, Ystrad Mynach CF82 7EP, Caerphilly, Wales.	Alison.Edwards6@wales.nhs.uk	Premawardhana, Lakdasa/L-4031-2019	Premawardhana, Lakdasa/0000-0003-0931-3700				Bird JM, 2014, GUIDELINES DIAGNOSIS; Cancer Research UK, 2014, STAT CANC TYP; Cavo M, 2009, BLOOD, V114; Colombo R, 2014, CL LYMPH MYELOM LEUK, V14, P441, DOI 10.1016/j.clml.2014.05.003; Dispenzieri A., 2015, WHAT IS IMMUNOGLOBUL; International Myeloma Working Group, 2015, IMWG CRIT DIAGN MYEL; International Myeloma Working Group, 2010, GUID SER FREE LIGHT; International Myeloma Working Group, 2010, GUID IM TECHN DIAGN; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lorenz EC, 2010, NEPHROL DIAL TRANSPL, V25, P1340, DOI 10.1093/ndt/gfp735; Ludwig H, 2009, BLOOD, V113, P3435, DOI 10.1182/blood-2008-07-169565; Mehta A, 2010, HAEMATOLOGY GLANCE; Moreau P, 2015, BLOOD, V125, P3076, DOI 10.1182/blood-2014-09-568915; Morgan GJ, 2011, BLOOD, V118, P1231, DOI 10.1182/blood-2011-02-338665; Myeloma UK, INFORMATION; National Cancer Intelligence Network, 2012, ROUT DIAGN STUD 2006, P62; National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF; National Institute for Health and Care Excellence, 2015, BACK PAIN LOW RAD CL; NICE, 2014, BORT IND THER MULT M; Office of National Statistics, 2014, CANC SURV ENGL AD DI; Palumbo A, 2009, ASH ANN M, V114, P613; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Rawstron AC, 2015, BLOOD, V125, P1932, DOI 10.1182/blood-2014-07-590166; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Rios-Tamayo R, 2015, J LEUK, V3, P184; Rosinol L, 2009, BLOOD, P114; San Miguel JF, 2013, J CLIN ONCOL, V31, P448, DOI 10.1200/JCO.2012.41.6180; Snowden JA, 2011, BRIT J HAEMATOL, V154, P76, DOI 10.1111/j.1365-2141.2011.08574.x; Walker RE, 2014, BRIT MED BULL, V111, P117, DOI 10.1093/bmb/ldu016	29	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2016	353								i1722	10.1136/bmj.i1722	http://dx.doi.org/10.1136/bmj.i1722			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LT	27055744				2022-12-28	WOS:000373895900001
J	Kirby, ME				Kirby, Matthew E.			CLIMATE SCIENCE Water's past revisited to predict its future	NATURE			English	Editorial Material									[Kirby, Matthew E.] Calif State Univ Fullerton, Dept Geol Sci, Fullerton, CA 92834 USA	California State University System; California State University Fullerton	Kirby, ME (corresponding author), Calif State Univ Fullerton, Dept Geol Sci, Fullerton, CA 92834 USA.	mkirby@fullerton.edu						Ault TR, 2014, J CLIMATE, V27, P7529, DOI 10.1175/JCLI-D-12-00282.1; Conway D, 2015, NAT CLIM CHANGE, V5, P837, DOI [10.1038/nclimate2735, 10.1038/NCLIMATE2735]; Cook BI, 2014, CLIM DYNAM, V43, P2607, DOI 10.1007/s00382-014-2075-y; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Ljungqvist FC, 2016, NATURE, V532, P94, DOI 10.1038/nature17418; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Prein AF, 2016, GEOPHYS RES LETT, V43, P1272, DOI 10.1002/2015GL066727; Schmidt GA, 2010, J QUATERNARY SCI, V25, P79, DOI 10.1002/jqs.1314; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Wise EK, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042193	11	3	3	1	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					44	45		10.1038/532044a	http://dx.doi.org/10.1038/532044a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27078563				2022-12-28	WOS:000373555500028
J	Ljungqvist, FC; Krusic, PJ; Sundqvist, HS; Zorita, E; Brattstrom, G; Frank, D				Ljungqvist, Fredrik Charpentier; Krusic, Paul J.; Sundqvist, Hanna S.; Zorita, Eduardo; Brattstrom, Gudrun; Frank, David			Northern Hemisphere hydroclimate variability over the past twelve centuries	NATURE			English	Article							CLIMATE FORCING RECONSTRUCTIONS; EARTH SYSTEM MODEL; PMIP SIMULATIONS; PRECIPITATION; DROUGHT; CMIP5; DYNAMICS; AMPLIFICATION; UNCERTAINTY; PATTERNS	Accurate modelling and prediction of the local to continental-scale hydroclimate response to global warming is essential given the strong impact of hydroclimate on ecosystem functioning, crop yields, water resources, and economic security(1-4). However, uncertainty in hydroclimate projections remains large(5-7), in part due to the short length of instrumental measurements available with which to assess climate models. Here we present a spatial reconstruction of hydroclimate variability over the past twelve centuries across the Northern Hemisphere derived from a network of 196 at least millennium-long proxy records. We use this reconstruction to place recent hydrological changes(8,9) and future precipitation scenarios(7,10,11) in a long-term context of spatially resolved and temporally persistent hydroclimate patterns. We find a larger percentage of land area with relatively wetter conditions in the ninth to eleventh and the twentieth centuries, whereas drier conditions are more widespread between the twelfth and nineteenth centuries. Our reconstruction reveals that prominent seesaw patterns of alternating moisture regimes observed in instrumental data(12-14) across the Mediterranean, western USA, and China have operated consistently over the past twelve centuries. Using an updated compilation of 128 temperature proxy records(15), we assess the relationship between the reconstructed centennial-scale Northern Hemisphere hydroclimate and temperature variability. Even though dry and wet conditions occurred over extensive areas under both warm and cold climate regimes, a statistically significant co-variability of hydroclimate and temperature is evident for particular regions. We compare the reconstructed hydroclimate anomalies with coupled atmosphere-ocean general circulation model simulations and find reasonable agreement during pre-industrial times. However, the intensification of the twentieth-century-mean hydroclimate anomalies in the simulations, as compared to previous centuries, is not supported by our new multi-proxy reconstruction. This finding suggests that much work remains before we can model hydroclimate variability accurately, and highlights the importance of using palaeoclimate data to place recent and predicted hydroclimate changes in a millennium-long context(16,17).	[Ljungqvist, Fredrik Charpentier] Stockholm Univ, Dept Hist, SE-10691 Stockholm, Sweden; [Ljungqvist, Fredrik Charpentier] Stockholm Univ, Ctr Medieval Studies, SE-10691 Stockholm, Sweden; [Ljungqvist, Fredrik Charpentier; Sundqvist, Hanna S.; Brattstrom, Gudrun] Stockholm Univ, Bolin Ctr Climate Res, SE-10691 Stockholm, Sweden; [Krusic, Paul J.] Navarino Environm Observ, GR-24001 Messinia, Greece; [Krusic, Paul J.; Sundqvist, Hanna S.] Stockholm Univ, Dept Phys Geog, SE-10691 Stockholm, Sweden; [Zorita, Eduardo] Helmholtz Zentrum Geesthacht, Inst Coastal Res, DE-21502 Geesthacht, Germany; [Brattstrom, Gudrun] Stockholm Univ, Dept Math, SE-10691 Stockholm, Sweden; [Frank, David] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland	Stockholm University; Stockholm University; Stockholm University; Stockholm University; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Stockholm University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Ljungqvist, FC (corresponding author), Stockholm Univ, Dept Hist, SE-10691 Stockholm, Sweden.; Ljungqvist, FC (corresponding author), Stockholm Univ, Ctr Medieval Studies, SE-10691 Stockholm, Sweden.; Ljungqvist, FC (corresponding author), Stockholm Univ, Bolin Ctr Climate Res, SE-10691 Stockholm, Sweden.	fredrik.c.l@historia.su.se	Charpentier Ljungqvist, Fredrik/I-5770-2012; Frank, David/C-7764-2013	Charpentier Ljungqvist, Fredrik/0000-0003-0220-3947; Frank, David/0000-0001-5463-5640	Swedish Research Council [C0592401]; Navarino Environmental Observatory (NEO) [1946322]; German Cluster of Excellence CLISAP [EXC177]; Bolin Centre for Climate Research, Stockholm University; Department of Physical Geography, Stockholm University; Division Of Earth Sciences [1440015] Funding Source: National Science Foundation; ICER [1450657] Funding Source: National Science Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Navarino Environmental Observatory (NEO); German Cluster of Excellence CLISAP; Bolin Centre for Climate Research, Stockholm University; Department of Physical Geography, Stockholm University; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this work was provided in part by the Swedish Research Council (grant number C0592401), and the Navarino Environmental Observatory (NEO) (project number 1946322). E.Z.'s contribution is part of the German Cluster of Excellence CLISAP (grant number EXC177). The publication cost was covered by the Bolin Centre for Climate Research, Stockholm University, and the Department of Physical Geography, Stockholm University. This is a contribution to the Past Global Changes (PAGES) 2k Network. We thank U. Buntgen at the Swiss Federal Research Institute WSL, and H. Grudd at the Swedish Polar Research Secretariat, for comments on the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Braconnot P, 2012, NAT CLIM CHANGE, V2, P417, DOI 10.1038/NCLIMATE1456; Bradley R. S., 1999, PALEOCLIMATOLOGY REC; Broecker WS, 2013, P NATL ACAD SCI USA, V110, P16710, DOI 10.1073/pnas.1301855110; Buntgen U, 2015, J CLIMATE, V28, P5272, DOI 10.1175/JCLI-D-14-00673.1; Chen JH, 2015, QUATERNARY SCI REV, V107, P98, DOI 10.1016/j.quascirev.2014.10.012; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Cook BI, 2014, CLIM DYNAM, V43, P2607, DOI 10.1007/s00382-014-2075-y; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; D'Odorico P, 2012, PHILOS T R SOC B, V367, P3145, DOI 10.1098/rstb.2012.0016; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Datta S, 2003, J APPL METEOROL, V42, P598, DOI 10.1175/1520-0450(2003)042&lt;0598:SVOSRA&gt;2.0.CO;2; DeAngelis AM, 2015, NATURE, V528, P249, DOI 10.1038/nature15770; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Esper J, 2003, TREE-RING RES, V59, P81; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Esper J, 2015, DENDROCHRONOLOGIA, V35, P62, DOI 10.1016/j.dendro.2015.07.001; Evans MN, 2014, GEOPHYS RES LETT, V41, P9127, DOI 10.1002/2014GL062063; Field C. B., 2013, CLIMATE CHANGE 201 A; Fisher RA, 1914, BIOMETRIKA, V10, P507; Franke J, 2013, NAT CLIM CHANGE, V3, P360, DOI [10.1038/nclimate1816, 10.1038/NCLIMATE1816]; Gao RS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009358; Giorgetta MA, 2013, J ADV MODEL EARTH SY, V5, P572, DOI 10.1002/jame.20038; Gonzalez-Rouco JF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024693; Greve P, 2014, NAT GEOSCI, V7, P716, DOI [10.1038/ngeo2247, 10.1038/NGEO2247]; GUIOT J, 1985, J CLIMATOL, V5, P325, DOI 10.1002/joc.3370050308; Huybers P, 2006, NATURE, V441, P329, DOI 10.1038/nature04745; Jones PD, 1997, J CLIMATE, V10, P2548, DOI 10.1175/1520-0442(1997)010<2548:ESEILS>2.0.CO;2; Lamb H. H., 1972, CLIMATE PRESENT FUTU, V2; Lamb H.H., 1972, CLIMATE PRESENT FUTU; Landrum L, 2013, J CLIMATE, V26, P1085, DOI 10.1175/JCLI-D-11-00326.1; Ljungqvist FC, 2012, CLIM PAST, V8, P227, DOI 10.5194/cp-8-227-2012; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; Mauritsen T, 2013, CLIM DYNAM, V41, P2539, DOI 10.1007/s00382-013-1808-7; Meko D. M., 1981, THESIS U ARIZONA; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; O'Gorman PA, 2009, P NATL ACAD SCI USA, V106, P14773, DOI 10.1073/pnas.0907610106; Orlowsky B, 2013, HYDROL EARTH SYST SC, V17, P1765, DOI 10.5194/hess-17-1765-2013; Osborn T. J., 2000, Dendrochronologia, V18, P9; Palmer W. C., 1965, 45 US DEP COMM RES; Pearson K., 1895, P R SOC LOND, V58, P240, DOI [10.1098/rspl.1895.0041, DOI 10.1098/RSPL.1895.0041]; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Polson D, 2013, GEOPHYS RES LETT, V40, P4783, DOI 10.1002/grl.50923; Schewe J, 2014, P NATL ACAD SCI USA, V111, P3245, DOI 10.1073/pnas.1222460110; Schmidt GA, 2012, GEOSCI MODEL DEV, V5, P185, DOI 10.5194/gmd-5-185-2012; Schmidt GA, 2011, GEOSCI MODEL DEV, V4, P33, DOI 10.5194/gmd-4-33-2011; Schmidt GA, 2014, J ADV MODEL EARTH SY, V6, P141, DOI 10.1002/2013MS000265; Schneider T, 2014, NATURE, V513, P45, DOI 10.1038/nature13636; Schulz M, 1997, COMPUT GEOSCI, V23, P929, DOI 10.1016/S0098-3004(97)00087-3; Schurer AP, 2013, J CLIMATE, V26, P6954, DOI 10.1175/JCLI-D-12-00826.1; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Steinhilber F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040142; Steinman BA, 2014, GEOPHYS RES LETT, V41, P2553, DOI 10.1002/2014GL059499; Stephens GL, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014532; Sueyoshi T, 2013, GEOSCI MODEL DEV, V6, P819, DOI 10.5194/gmd-6-819-2013; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Wan H, 2013, J GEOPHYS RES-ATMOS, V118, P534, DOI 10.1002/jgrd.50118; Wessel P., 1998, EOS T AM GEOPHYS UN, V79, P579, DOI [10.1029/98EO00426, DOI 10.1029/98EO00426, DOI 10.1029/98E000426]; Wilks DS, 1997, J CLIMATE, V10, P65, DOI 10.1175/1520-0442(1997)010<0065:RHTFAF>2.0.CO;2; Xin XG, 2013, ADV CLIM CHANG RES, V4, P41, DOI 10.3724/SP.J.1248.2013.00041; Xoplaki E, 2004, CLIM DYNAM, V23, P63, DOI 10.1007/s00382-004-0422-0; Zhang H, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/084020; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025	68	129	134	4	230	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					94	+		10.1038/nature17418	http://dx.doi.org/10.1038/nature17418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27078569				2022-12-28	WOS:000373555500040
J	Paustian, K; Lehmann, J; Ogle, S; Reay, D; Robertson, GP; Smith, P				Paustian, Keith; Lehmann, Johannes; Ogle, Stephen; Reay, David; Robertson, G. Philip; Smith, Pete			Climate-smart soils	NATURE			English	Article							GREENHOUSE-GAS MITIGATION; LAND-USE CHANGE; ORGANIC-MATTER; CARBON SEQUESTRATION; AGRICULTURAL SOILS; N2O EMISSIONS; C SEQUESTRATION; COVER CROPS; CO2; MANAGEMENT	Soils are integral to the function of all terrestrial ecosystems and to food and fibre production. An overlooked aspect of soils is their potential to mitigate greenhouse gas emissions. Although proven practices exist, the implementation of soil-based greenhouse gas mitigation activities are at an early stage and accurately quantifying emissions and reductions remains a substantial challenge. Emerging research and information technology developments provide the potential for a broader inclusion of soils in greenhouse gas policies. Here we highlight 'state of the art' soil greenhouse gas research, summarize mitigation practices and potentials, identify gaps in data and understanding and suggest ways to close such gaps through new research, technology and collaboration.	[Paustian, Keith] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA; [Paustian, Keith; Ogle, Stephen] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Lehmann, Johannes] Cornell Univ, Dept Soil & Crop Sci, Atkinson Ctr Sustainable Future, Ithaca, NY USA; [Ogle, Stephen] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA; [Reay, David] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Robertson, G. Philip] Michigan State Univ, WK Kellogg Biol Stn, E Lansing, MI 48824 USA; [Robertson, G. Philip] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Smith, Pete] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	Colorado State University; Colorado State University; Cornell University; Colorado State University; University of Edinburgh; Michigan State University; Michigan State University; University of Aberdeen	Paustian, K (corresponding author), Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA.; Paustian, K (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	keith.paustian@colostate.edu	Lehmann, Johannes/H-2682-2014; Smith, Pete/G-1041-2010; Robertson, G Philip/H-3885-2011; Reay, David/F-4054-2010; Paustian, Keith H/L-7593-2016	Lehmann, Johannes/0000-0002-4701-2936; Smith, Pete/0000-0002-3784-1124; Robertson, G Philip/0000-0001-9771-9895; Ogle, Stephen/0000-0003-1899-7446; Reay, Dave/0000-0001-5829-9007	USDA/NIFA [2011-67003-30205]; USDA/NRCS [CESU-68-7482-15-507]; NSF [DEB 1027253]; US DOE [DE-FCO2-07ER64494]; NERC [NE/M016900/1]; Belmont Forum/FACCE-JPI [NE/M021327/1]; Direct For Biological Sciences [1027253] Funding Source: National Science Foundation; Natural Environment Research Council [NE/M021327/1, NE/M016900/1] Funding Source: researchfish; NERC [NE/M021327/1] Funding Source: UKRI	USDA/NIFA(United States Department of Agriculture (USDA)); USDA/NRCS(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); US DOE(United States Department of Energy (DOE)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Belmont Forum/FACCE-JPI; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank A. Swan for figure design. We thank the following organisations for support: USDA/NIFA (grant number 2011-67003-30205 to K.P. and S.O.); USDA/NRCS (grant number CESU-68-7482-15-507 to K.P.); the NSF (grant number DEB 1027253 to G.P.R.); the US DOE (grant number DE-FCO2-07ER64494 to G.P.R.); NERC (grant number NE/M016900/1 to P.S.); and the Belmont Forum/FACCE-JPI (grant number NE/M021327/1 to P.S.).	Aguilera E, 2013, AGR ECOSYST ENVIRON, V164, P32, DOI 10.1016/j.agee.2012.09.006; Akiyama H, 2010, GLOBAL CHANGE BIOL, V16, P1837, DOI 10.1111/j.1365-2486.2009.02031.x; Alexander P, 2015, SOIL-GERMANY, V1, P331, DOI 10.5194/soil-1-331-2015; Awana MI, 2015, LAND USE POLICY, V42, P517, DOI 10.1016/j.landusepol.2014.09.006; Basu S, 2013, ATMOS CHEM PHYS, V13, P8695, DOI 10.5194/acp-13-8695-2013; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Bellassen V, 2015, NAT CLIM CHANGE, V5, P319, DOI 10.1038/nclimate2544; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; Burney JA, 2010, P NATL ACAD SCI USA, V107, P12052, DOI 10.1073/pnas.0914216107; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Conant RT, 2011, FRONT ECOL ENVIRON, V9, P169, DOI 10.1890/090153; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; Cooley D, 2013, ENVIRON ECOL STAT, V20, P129, DOI 10.1007/s10651-012-0211-6; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; DAVIDSON EA, 1993, BIOGEOCHEMISTRY, V20, P161, DOI 10.1007/BF00000786; DeLonge MS, 2013, ECOSYSTEMS, V16, P962, DOI 10.1007/s10021-013-9660-5; Dhawale NM, 2015, EUR J SOIL SCI, V66, P661, DOI 10.1111/ejss.12265; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Grandy AS, 2008, SCI TOTAL ENVIRON, V404, P297, DOI 10.1016/j.scitotenv.2007.11.013; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hillier J, 2011, ENVIRON MODELL SOFTW, V26, P1070, DOI 10.1016/j.envsoft.2011.03.014; Horowitz JK, 2013, J ENVIRON ECON MANAG, V66, P105, DOI 10.1016/j.jeem.2013.04.002; IPCC, 2006, INT PAN CLIM CHANG G, V4; Kadygrov N, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011597; Kahiluoto H, 2014, NAT CLIM CHANGE, V4, P309, DOI 10.1038/nclimate2209; Kell DB, 2012, PHILOS T R SOC B, V367, P1589, DOI 10.1098/rstb.2011.0244; Knox SH, 2015, GLOBAL CHANGE BIOL, V21, P750, DOI 10.1111/gcb.12745; Kravchenko AN, 2011, SOIL SCI SOC AM J, V75, P235, DOI 10.2136/sssaj2010.0076; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lauvaux T, 2012, ATMOS CHEM PHYS, V12, P337, DOI 10.5194/acp-12-337-2012; Lavallee S, 2004, INT J LIFE CYCLE ASS, V9, P349, DOI 10.1007/BF02979076; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lehmann J, 2015, BIOCHAR ENV MANAGEME, P235, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Lemke RL, 2010, AGR ECOSYST ENVIRON, V135, P42, DOI 10.1016/j.agee.2009.08.010; Levine UY, 2011, ISME J, V5, P1683, DOI 10.1038/ismej.2011.40; Linquist BA, 2015, GLOBAL CHANGE BIOL, V21, P407, DOI 10.1111/gcb.12701; Liu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056562, 10.1371/journal.pone.0055853]; Louwagie G, 2011, LAND DEGRAD DEV, V22, P5, DOI 10.1002/ldr.1028; Lynch JP, 2015, J EXP BOT, V66, P2199, DOI 10.1093/jxb/eru508; Mcsherry ME, 2013, GLOBAL CHANGE BIOL, V19, P1347, DOI 10.1111/gcb.12144; Miles NL, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001781; Millar N, 2010, MITIG ADAPT STRAT GL, V15, P185, DOI 10.1007/s11027-010-9212-7; Nadeu E, 2015, GLOBAL CHANGE BIOL, V21, P3181, DOI 10.1111/gcb.12889; Ogle SM, 2005, BIOGEOCHEMISTRY, V72, P87, DOI 10.1007/s10533-004-0360-2; Ogle SM, 2007, ECOL MODEL, V205, P453, DOI 10.1016/j.ecolmodel.2007.03.007; Ogle SM, 2010, GLOBAL CHANGE BIOL, V16, P810, DOI 10.1111/j.1365-2486.2009.01951.x; Organisation for Economic Co- operation and Development (OECD)- Food and Agriculture Organization (FAO) of the United Nations, AGR OUTL; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pacala S., 2010, VER GREENH GAS EM ME, P1; Paustian K, 1997, SOIL USE MANAGE, V13, P230, DOI 10.1111/j.1475-2743.1997.tb00594.x; Paustian K., 2011, HDB CLIMATE CHANGE A, P307; Paustian K, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/021001; Paustian K, 2012, MANAGING AGRICULTURAL GREENHOUSE GASES: COORDINATED AGRICULTURAL RESEARCH THROUGH GRACENET TO ADDRESS OUR CHANGING CLIMATE, P251, DOI 10.1016/B978-0-12-386897-8.00015-2; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Poeplau C, 2015, AGR ECOSYST ENVIRON, V200, P33, DOI 10.1016/j.agee.2014.10.024; Powlson DS, 2014, NAT CLIM CHANGE, V4, P678, DOI 10.1038/NCLIMATE2292; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Roberts KG, 2010, ENVIRON SCI TECHNOL, V44, P827, DOI 10.1021/es902266r; Robertson GP, 2013, BIOGEOCHEMISTRY, V114, P41, DOI 10.1007/s10533-012-9802-4; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Ryals R, 2015, ECOL APPL, V25, P531, DOI 10.1890/13-2126.1; Sanchez PA, 2009, SCIENCE, V325, P680, DOI 10.1126/science.1175084; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Scholes MC, 2013, SCIENCE, V342, P565, DOI 10.1126/science.1244579; Schuh AE, 2013, GLOBAL CHANGE BIOL, V19, P1424, DOI 10.1111/gcb.12141; Segers R, 1998, BIOGEOCHEMISTRY, V41, P23, DOI 10.1023/A:1005929032764; Shcherbak I, 2014, P NATL ACAD SCI USA, V111, P9199, DOI 10.1073/pnas.1322434111; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Smith P, 2007, AGR ECOSYST ENVIRON, V118, P6, DOI 10.1016/j.agee.2006.06.006; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Smith P, 2012, CURR OPIN ENV SUST, V4, P539, DOI 10.1016/j.cosust.2012.06.005; Smith P, 2012, GLOBAL CHANGE BIOL, V18, P2089, DOI 10.1111/j.1365-2486.2012.02689.x; Smith S, 2012, PHILOS T R SOC B, V367, P1441, DOI 10.1098/rstb.2011.0234; Stewart CE, 2008, SOIL SCI SOC AM J, V72, P379, DOI 10.2136/sssaj2007.0104; Su J, 2015, NATURE, V523, P602, DOI 10.1038/nature14673; Suwanwaree P, 2005, SOIL SCI SOC AM J, V69, P1722, DOI 10.2136/sssaj2004.0223; Swallow BM, 2013, LAND USE POLICY, V31, P81, DOI 10.1016/j.landusepol.2012.02.002; Tonitto C, 2006, AGR ECOSYST ENVIRON, V112, P58, DOI 10.1016/j.agee.2005.07.003; Tubiello FN, 2015, GLOBAL CHANGE BIOL, V21, P2655, DOI 10.1111/gcb.12865; van Groenigen KJ, 2013, NAT CLIM CHANGE, V3, P288, DOI [10.1038/NCLIMATE1712, 10.1038/nclimate1712]; van Kessel C, 2013, GLOBAL CHANGE BIOL, V19, P33, DOI 10.1111/j.1365-2486.2012.02779.x; van Wesemael B, 2011, PLANT SOIL, V338, P247, DOI 10.1007/s11104-010-0567-z; West TO, 2007, CLIMATIC CHANGE, V80, P25, DOI [10.1007/s10584-006-9173-8, 10.1007/s105S4-006-9173-8]; Whitman T, 2014, ENVIRON SCI TECHNOL, V48, P13727, DOI 10.1021/es503331y; Whitman T, 2011, ENVIRON SCI TECHNOL, V45, P3687, DOI 10.1021/es103301k; Wilhelm WW, 2004, AGRON J, V96, P1, DOI 10.2134/agronj2004.0001; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053; Yeluripati JB, 2015, COMPUT ELECTRON AGR, V111, P112, DOI 10.1016/j.compag.2014.11.016; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	94	917	942	76	1090	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					49	57		10.1038/nature17174	http://dx.doi.org/10.1038/nature17174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27078564	Green Submitted, Green Accepted			2022-12-28	WOS:000373555500031
J	McGuire, H; Longson, D; Adler, A; Farmer, A; Lewin, I				McGuire, Hugh; Longson, Damien; Adler, Amanda; Farmer, Andrew; Lewin, Ian		Guideline Dev Grp	GUIDELINES Management of type 2 diabetes in adults: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McGuire, Hugh] Natl Inst Hlth & Care Excellence, London, England; [Longson, Damien] Manchester Mental Hlth & Social Care Trust, Manchester M21 9UN, Lancs, England; [Adler, Amanda] Univ Cambridge, Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Farmer, Andrew] Univ Oxford, Oxford, England; [Lewin, Ian] Northern Devon Healthcare NHS Trust, Barnstaple EX31 4JB, Devon, England	National Institute for Health & Care Excellence; Open University - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford	McGuire, H (corresponding author), Natl Inst Hlth & Care Excellence, London, England.	Hugh.McGuire@nice.org.uk			National Institute for Health Research [NF-SI-0512-10077] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Gatineau M., 2014, ADULT OBESITY TYPE 2; National Institute for Health and Care Excellence, 2015, TYP 2 DIAB AD MAN	2	64	65	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	2016	353								i1575	10.1136/bmj.i1575	http://dx.doi.org/10.1136/bmj.i1575			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LQ	27052837				2022-12-28	WOS:000373895500001
J	Gordon, D; Huddleston, J; Chaisson, MJP; Hill, CM; Kronenberg, ZN; Munson, KM; Malig, M; Raja, A; Fiddes, I; Hillier, LW; Dunn, C; Baker, C; Armstrong, J; Diekhans, M; Paten, B; Shendure, J; Wilson, RK; Haussler, D; Chin, CS; Eichler, EE				Gordon, David; Huddleston, John; Chaisson, Mark J. P.; Hill, Christopher M.; Kronenberg, Zev N.; Munson, Katherine M.; Malig, Maika; Raja, Archana; Fiddes, Ian; Hillier, LaDeana W.; Dunn, Christopher; Baker, Carl; Armstrong, Joel; Diekhans, Mark; Paten, Benedict; Shendure, Jay; Wilson, Richard K.; Haussler, David; Chin, Chen-Shan; Eichler, Evan E.			Long-read sequence assembly of the gorilla genome	SCIENCE			English	Article							EVOLUTION; DIVERSITY; PATTERNS	Accurate sequence and assembly of genomes is a critical first step for studies of genetic variation. We generated a high-quality assembly of the gorilla genome using single-molecule, real-time sequence technology and a string graph de novo assembly algorithm. The new assembly improves contiguity by two to three orders of magnitude with respect to previously released assemblies, recovering 87% of missing reference exons and incomplete gene models. Although regions of large, high-identity segmental duplications remain largely unresolved, this comprehensive assembly provides new biological insight into genetic diversity, structural variation, gene loss, and representation of repeat structures within the gorilla genome. The approach provides a path forward for the routine assembly of mammalian genomes at a level approaching that of the current quality of the human genome.	[Gordon, David; Huddleston, John; Chaisson, Mark J. P.; Hill, Christopher M.; Kronenberg, Zev N.; Munson, Katherine M.; Malig, Maika; Raja, Archana; Baker, Carl; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Gordon, David; Huddleston, John; Raja, Archana; Shendure, Jay; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Fiddes, Ian; Armstrong, Joel; Diekhans, Mark; Paten, Benedict; Haussler, David] Univ Calif Santa Cruz, Genom Inst, Santa Cruz, CA 95064 USA; [Fiddes, Ian; Armstrong, Joel; Diekhans, Mark; Paten, Benedict; Haussler, David] Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Hillier, LaDeana W.; Wilson, Richard K.] Washington Univ, Sch Med, McDonnell Genome Inst, Dept Med,Dept Genet, St Louis, MO 63108 USA; [Dunn, Christopher; Chin, Chen-Shan] Pacific Biosci Calif, Menlo Pk, CA 94025 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; Washington University (WUSTL)	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.; Eichler, EE (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	eee@gs.washington.edu	Shendure, Jay/AAU-3684-2021; Wilson, Richard K./AAF-4139-2019; Munson, Katherine M/P-2462-2015	Wilson, Richard K./0000-0002-1992-1358; Munson, Katherine M/0000-0001-8413-6498; Dunn, Christopher/0000-0002-0601-3254	U.S. National Institutes of Health (NIH) [HG002385, HG007635, HG003079, HG007990, HG007234]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007990, U41HG007635, R01HG002385, U54HG003079, U41HG007234, R01HG006283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104390] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Scally and Z. Ning for early access to the upgraded Kamilah gorilla assembly (gorGor4) and for discussion regarding its assembly. We thank M. Duyzend, L. Harshman, and C. Lee for technical assistance and quality control in generating sequencing data and H. Li for helpful suggestions for the PSMC analysis. The authors thank M. Heget, K. Gillespie, and M. Shender from the Lincoln Park Zoo for providing gorilla peripheral blood and T. Brown for assistance in editing this manuscript. This work was supported, in part, by grants from the U.S. National Institutes of Health (NIH grant HG002385 to E.E.E. and HG007635 to R.K.W. and E.E.E.; HG003079 to R.K.W.; HG007990 to D.H. and B.P.; and HG007234 to B.P.). E. E. E., J.S., and D.H. are investigators of the Howard Hughes Medical Institute. E. E. E. is on the scientific advisory board (SAB) of DNAnexus and was a SAB member of Pacific Biosciences. (2009-2013); E. E. E. is a consultant for Kunming University of Science and Technology (KUST) as part of the 1000 China Talent Program. M.J.P.C. is a former employee of (2009-2012) and owns shares in Pacific Biosciences. On 24 February 2011, Pacific Biosciences filed a patent entitled "Sequence assembly and consensus sequence determination" (U.S. patent no. US20120330566, issued 27 December 2012); M.J.P.C. is identified as inventor of this patent. Pacific Biosciences has filed two patents related to the Falcon assembler algorithm entitled "String graph assembly for polyploid genomes" (U.S. patent no. US2015/0169823 A1 filed 18 December 2014, and U.S. patent no. US2015/0286775 A1 filed 18 June 2015); C. C. is identified as inventor for both patents. The Susie3 assembly, PacBio and Illumina sequencing data for Susie, and clone sequences have been deposited in the European Nucleotide Archive under the project accession PRJEB10880. E. E. E., D.G., J.H., M.J.P.C., C. M. H., and Z.N.K. designed experiments; K. M. M., M. M., and C.B. prepared libraries and generated sequencing data; D.G., J.H., M.J.P.C., C. M. H., Z.N.K., L.W.H., and A.R. performed bioinformatics analyses; I.F., J.A., M.D., B.P., R.K.W., and D.H. analyzed gene accuracy. J.S. helped in the evaluation of Hi-C data. C.D. and C.-S.C. aided in Falcon assembler modifications. J.H. deposited SMRT sequencing data into SRA. E. E. E., D.G., J.H., M.J.P.C., C. M. H., and Z.N.K. wrote the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Carbone L, 2014, NATURE, V513, P195, DOI 10.1038/nature13679; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chaisson MJP, 2015, NAT REV GENET, V16, P627, DOI 10.1038/nrg3933; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Little A M, 1999, Rev Immunogenet, V1, P105; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Myers G, 2014, LECT N BIOINFORMAT, V8701, P52, DOI 10.1007/978-3-662-44753-6_5; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pevzner PA, 2004, GENOME RES, V14, P1786, DOI 10.1101/gr.2395204; Polavarapu N, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r51; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; ROYLE NJ, 1994, NAT GENET, V6, P52, DOI 10.1038/ng0194-52; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Siepel A, 2007, GENOME RES, V17, P1763, DOI 10.1101/gr.7128207; Smit A, 1996, REPEATMASKER OPEN 30; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Sudmant PH, 2013, GENOME RES, V23, P1373, DOI 10.1101/gr.158543.113; Ventura M, 2011, GENOME RES, V21, P1640, DOI 10.1101/gr.124461.111; Xue YL, 2015, SCIENCE, V348, P242, DOI 10.1126/science.aaa3952; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110; Zhu JC, 2007, PLOS COMPUT BIOL, V3, P2498, DOI 10.1371/journal.pcbi.0030247	31	215	220	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281							aae0344	10.1126/science.aae0344	http://dx.doi.org/10.1126/science.aae0344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034376	Green Accepted			2022-12-28	WOS:000373039600031
J	Mundoor, H; Senyuk, B; Smalyukh, II				Mundoor, Haridas; Senyuk, Bohdan; Smalyukh, Ivan I.			Triclinic nematic colloidal crystals from competing elastic and electrostatic interactions	SCIENCE			English	Article							LIQUID-CRYSTALS; PARTICLES; FORCES; PHASE; DIPOLAR	The self-assembly of nanoparticles can enable the generation of composites with predesigned properties, but reproducing the structural diversity of atomic and molecular crystals remains a challenge. We combined anisotropic elastic and weakly screened electrostatic interactions to guide both orientational and triclinic positional self-ordering of inorganic nanocrystals in a nematic fluid host. The lattice periodicity of these low-symmetry colloidal crystals is more than an order of magnitude larger than the nanoparticle size. The orientations of the nanocrystals, as well as the crystallographic axes of the ensuing triclinic colloidal crystals, are coupled to the uniform alignment direction of the nematic host, which can be readily controlled on large scales. We examine colloidal pair and many-body interactions and show how triclinic crystals with orientational ordering of the semiconductor nanorods emerge from competing long-range elastic and electrostatic forces.	[Mundoor, Haridas; Senyuk, Bohdan; Smalyukh, Ivan I.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Mundoor, Haridas; Senyuk, Bohdan; Smalyukh, Ivan I.] Univ Colorado, Soft Mat Res Ctr, Boulder, CO 80309 USA; [Smalyukh, Ivan I.] Univ Colorado, Dept Elect Comp & Energy Engn, Mat Sci & Engn Program, Boulder, CO 80309 USA; [Smalyukh, Ivan I.] Natl Renewable Energy Lab, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA; [Smalyukh, Ivan I.] Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Smalyukh, II (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.; Smalyukh, II (corresponding author), Univ Colorado, Soft Mat Res Ctr, Boulder, CO 80309 USA.; Smalyukh, II (corresponding author), Univ Colorado, Dept Elect Comp & Energy Engn, Mat Sci & Engn Program, Boulder, CO 80309 USA.; Smalyukh, II (corresponding author), Natl Renewable Energy Lab, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA.; Smalyukh, II (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	ivan.smalyukh@colorado.edu	Smalyukh, Ivan I/C-2955-2011; Liu, Qing/GWC-9222-2022; Smalyukh, Ivan/AAC-9232-2020; Senyuk, Bohdan/M-3185-2014; Mundoor, Haridas/L-9948-2016	Smalyukh, Ivan I/0000-0003-3444-1966; Smalyukh, Ivan/0000-0003-3444-1966; Senyuk, Bohdan/0000-0002-0004-3161; Mundoor, Haridas/0000-0001-6589-6475	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [ER46921]; University of Colorado-Boulder [DE-SC0010305]	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); University of Colorado-Boulder	This research was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under award ER46921, contract DE-SC0010305 with the University of Colorado-Boulder. We acknowledge the use of electron microscopy facility at the National Institute of Standards and Technology, Boulder, and thank A. Sanders for the help with imaging. We thank P. Ackerman, Q. Liu, T. Lee, and T. Lubensky for discussions.	[Anonymous], 2007, PRINCIPLES CONDENSED; Batista CAS, 2015, SCIENCE, V350, P138, DOI 10.1126/science.1242477; Bogdan N, 2011, NANO LETT, V11, P835, DOI 10.1021/nl1041929; Cahn RW, 2001, NATURE, V413, P582, DOI 10.1038/35098169; Conkey DB, 2011, OPT EXPRESS, V19, P3835, DOI 10.1364/OE.19.003835; Damasceno PF, 2012, SCIENCE, V337, P453, DOI 10.1126/science.1220869; Hayward RC, 2000, NATURE, V404, P56, DOI 10.1038/35003530; Hsu MF, 2005, LANGMUIR, V21, P4881, DOI 10.1021/la046751m; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Lapointe CP, 2009, SCIENCE, V326, P1083, DOI 10.1126/science.1176587; Liu B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4092; Liu QK, 2014, NANO LETT, V14, P4071, DOI 10.1021/nl501581y; Loudet JC, 2000, NATURE, V407, P611, DOI 10.1038/35036539; Lubensky TC, 1998, PHYS REV E, V57, P610, DOI 10.1103/PhysRevE.57.610; Manoharan VN, 2015, SCIENCE, V349, DOI 10.1126/science.1253751; Mundoor H, 2015, SMALL, V11, P5572, DOI 10.1002/smll.201501788; Nych A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2486; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Ramaswamy S, 1996, MOL CRYST LIQ CRYS A, V288, P175, DOI 10.1080/10587259608034594; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Sainis SK, 2008, LANGMUIR, V24, P13334, DOI 10.1021/la8024606; Sands D.E., 2012, INTRO CRYSTALLOGRAPH; Senyuk B, 2013, NATURE, V493, P200, DOI 10.1038/nature11710; Smalyukh II, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.085503; Tuinier R., 2011, COLLOIDS DEPLETION I; Nguyen VD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2597; Wang F, 2010, NATURE, V463, P1061, DOI 10.1038/nature08777; Yethiraj A, 2003, NATURE, V421, P513, DOI 10.1038/nature01328	29	73	73	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					69	73		10.1126/science.aaf0801	http://dx.doi.org/10.1126/science.aaf0801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034368	Green Submitted			2022-12-28	WOS:000373039600036
J	Buckley, GJ; Strom, BL				Buckley, Gillian J.; Strom, Brian L.			What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERINATAL TRANSMISSION; SOFOSBUVIR; INFECTION; VIRUS; VELPATASVIR		Acad Sci Engn & Med, Div Hlth & Med, Board Populat Hlth & Publ Hlth Practice, Washington, DC USA; [Strom, Brian L.] State Univ New Jersey, Rutgers Univ, Rutgers Biomed & Hlth Sci, 65 Bergen St,Suite 1535, Newark, NJ 07103 USA; [Buckley, Gillian J.] Natl Acad Sci Engn & Med, 500 Fifth St NW, Washington, DC 20001 USA	National Academies of Sciences, Engineering & Medicine; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Academies of Sciences, Engineering & Medicine	Buckley, GJ (corresponding author), Natl Acad Sci Engn & Med, 500 Fifth St NW, Washington, DC 20001 USA.	GBuckley@nas.edu						Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Centers for Disease Control and Prevention, 2013, VIR HEP SURV US 2013; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; GBD, 2022, GBD COMPARE; Greenup AJ, 2014, J HEPATOL, V61, P502, DOI 10.1016/j.jhep.2014.04.038; National Academies of Sciences Engineering and Medicine, 2016, EL PUBL HLTH PROBL H; U.S. Department of Health and Human Services, 2015, VIR HEP PREV SURV 20; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x; World Health Organization, 2016, CAS INV EL IN PRESS	10	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					284	+		10.7326/M16-0772	http://dx.doi.org/10.7326/M16-0772			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27064885				2022-12-28	WOS:000381267200018
J	Merli, GJ; Weitz, HH				Merli, G. J.; Weitz, H. H.			The Consult Guys-A Real Headache: Anticoagulation and a Subdural Hematoma (vol 164, pg CG1, 2016)	ANNALS OF INTERNAL MEDICINE			English	Correction																		Merli GJ, 2016, ANN INTERN MED, V164, P852, DOI [10.7326/W16-0004, 10.7326/M16-1228]	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					852	852		10.7326/M16-1228	http://dx.doi.org/10.7326/M16-1228			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27089084				2022-12-28	WOS:000379343000023
J	Wherry, LR; Miller, S				Wherry, Laura R.; Miller, Sarah			Early Coverage, Access, Utilization, and Health Effects Associated With the Affordable Care Act Medicaid Expansions A Quasi-experimental Study	ANNALS OF INTERNAL MEDICINE			English	Article							INSURANCE EXPERIMENT	Background: In 2014, only 26 states and the District of Columbia chose to implement the Patient Protection and Affordable Care Act (ACA) Medicaid expansions for low-income adults. Objective: To evaluate whether the state Medicaid expansions were associated with changes in insurance coverage, access to and utilization of health care, and self-reported health. Design: Comparison of outcomes before and after the expansions in states that did and did not expand Medicaid. Setting: United States. Participants: Citizens aged 19 to 64 years with family incomes below 138% of the federal poverty level in the 2010 to 2014 National Health Interview Surveys. Measurements: Health insurance coverage (private, Medicaid, or none); improvements in coverage over the previous year; visits to physicians in general practice and specialists; hospitalizations and emergency department visits; skipped or delayed medical care; usual source of care; diagnoses of diabetes, high cholesterol, and hypertension; self-reported health; and depression. Results: In the second half of 2014, adults in expansion states experienced increased health insurance (7.4 percentage points [95% CI, 3.4 to 11.3 percentage points]) and Medicaid (10.5 percentage points[CI, 6.5 to 14.5 percentage points]) coverage and better coverage than 1 year before (7.1 percentage points[CI, 2.7 to 11.5 percentage points]) compared with adults in nonexpansion states. Medicaid expansions were associated with increased visits to physicians in general practice (6.6 percentage points[CI, 1.3 to 12.0 percentage points]), overnight hospital stays (2.4 percentage points[CI, 0.7 to 4.2 percentage points]), and rates of diagnosis of diabetes (5.2 percentage points[CI, 2.4 to 8.1 percentage points]) and high cholesterol (5.7 percentage points[CI, 2.0 to 9.4 percentage points]). Changes in other outcomes were not statistically significant. Limitation: Observational study may be susceptible to unmeasured confounders; reliance on self-reported data; limited post-ACA time frame provided information on short-term changes only. Conclusion: The ACA Medicaid expansions were associated with higher rates of insurance coverage, improved quality of coverage, increased utilization of some types of health care, and higher rates of diagnosis of chronic health conditions for low-income adults.	Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Michigan, Stephen M Ross Sch Business, Ann Arbor, MI 48109 USA; [Wherry, Laura R.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, 911 Broxton Ave,Room 226, Los Angeles, CA 90024 USA; [Miller, Sarah] Univ Michigan, Stephen M Ross Sch Business R4416, Business Econ & Publ Policy, 701 Tappan Ave, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan	Wherry, LR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, 911 Broxton Ave,Room 226, Los Angeles, CA 90024 USA.	lwherry@mednet.ucla.edu			NICHD NIH HHS [P2C HD041022, R24 HD041022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041022, R24HD041022] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Black L.I., 2015, Insurance Status by state Medicaid Expansion Status: Early Release of Estimates from the National Health Interview Survey, 2013 -September 2014; Cameron A., 2007, MICROECONOMETRICS ME; Center for Medicaid and CHIP Services, 2014, EL NONC MED CHIP; Centers for Medicare & Medicaid Services, 2014, MED CHIP OCT 2014 MO; Dorn S, 2014, WHAT IS RESULTS STAT; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Gunja M., 2015, HLTH INSURANCE COVER; Hogan DR, 2015, HEALTH AFFAIR, V34, P1554, DOI 10.1377/hlthaff.2014.1435; Kaufman HW, 2015, DIABETES CARE, V38, P833, DOI 10.2337/dc14-2334; Korhonen PE, 2011, J HYPERTENS, V29, P2070, DOI 10.1097/HJH.0b013e32834bbca7; Long JS, 1997, REGRESSION MODELS CA; Long SK, 2015, POLICY BRIEF; National Center for Health Statistics, 2015, VAR EST GUID NHIS 20; National Center for Health Statistics, 2015, MULT IMP FAM INC PER; National Center for Health Statistics. Survey Description, 2014, SURV DESCR 2014 NAT; Smith JaMC, 2015, CURRENT POPULATION R; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183; The Henry J. Kaiser Family Foundation, 2016, CURR STAT STAT MED E; Venkataraman K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113802	24	303	303	3	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					795	U49		10.7326/M15-2234	http://dx.doi.org/10.7326/M15-2234			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ6VG	27088438	Green Accepted			2022-12-28	WOS:000379343000013
J	Mehta, RL; Burdmann, EA; Cerda, J; Feehally, J; Finkelstein, F; Garcia-Garcia, G; Godin, M; Jha, V; Lameire, NH; Levin, NW; Lewington, A; Lombardi, R; Macedo, E; Rocco, M; Aronoff-Spencer, E; Tonelli, M; Zhang, J; Remuzzi, G				Mehta, Ravindra L.; Burdmann, Emmanuel A.; Cerda, Jorge; Feehally, John; Finkelstein, Fredric; Garcia-Garcia, Guillermo; Godin, Melanie; Jha, Vivekanand; Lameire, Norbert H.; Levin, Nathan W.; Lewington, Andrew; Lombardi, Raul; Macedo, Etienne; Rocco, Michael; Aronoff-Spencer, Eliah; Tonelli, Marcello; Zhang, Jing; Remuzzi, Giuseppe			Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study	LANCET			English	Article							RENAL REPLACEMENT THERAPY; CRITICALLY-ILL PATIENTS; VOLUME PERITONEAL-DIALYSIS; INTENSIVE-CARE; EPIDEMIOLOGY; FAILURE; AKI; HEMODIALYSIS; OUTCOMES	Background Epidemiological data for acute kidney injury are scarce, especially in low-income countries (LICs) and lower-middle-income countries (LMICs). We aimed to assess regional differences in acute kidney injury recognition, management, and outcomes. Methods In this multinational cross-sectional study, 322 physicians from 289 centres in 72 countries collected prospective data for paediatric and adult patients with confirmed acute kidney injury in hospital and non-hospital settings who met criteria for acute kidney injury. Signs and symptoms at presentation, comorbidities, risk factors for acute kidney injury, and process-of-care data were obtained at the start of acute kidney injury, and need for dialysis, renal recovery, and mortality recorded at 7 days, and at hospital discharge or death, whichever came earlier. We classified countries into high-income countries (HICs), upper-middle-income countries (UMICs), and combined LICs and LMICs (LLMICs) according to their 2014 gross national income per person. Findings Between Sept 29 and Dec 7, 2014, data were collected from 4018 patients. 2337 (58%) patients developed community-acquired acute kidney injury, with 889 (80%) of 1118 patients in LLMICs, 815 (51%) of 1594 in UMICs, and 663 (51%) of 1241 in HICs (for HICs vs UMICs p = 0.33; p < 0.0001 for all other comparisons). Hypotension (1615 [40%] patients) and dehydration (1536 [38%] patients) were the most common causes of acute kidney injury. Dehydration was the most frequent cause of acute kidney injury in LLMICs (526 [46%] of 1153 vs 518 [32%] of 1605 in UMICs vs 492 [39%] of 1260 in HICs) and hypotension in HICs (564 [45%] of 1260 vs 611 [38%%] of 1605 in UMICs vs 440 [38%] of 1153 LLMICs). Mortality at 7 days was 423 (11%) of 3855, and was higher in LLMICs (129 [12%] of 1076) than in HICs (125 [10%] of 1230) and UMICs (169 [11%] of 1549). Interpretation We identified common aetiological factors across all countries, which might be amenable to a standardised approach for early recognition and treatment of acute kidney injury. Study limitations include a small number of patients from outpatient settings and LICs, potentially under-representing the true burden of acute kidney injury in these areas. Additional strategies are needed to raise awareness of acute kidney injury in community healthcare settings, especially in LICs.	[Mehta, Ravindra L.; Aronoff-Spencer, Eliah; Zhang, Jing] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Burdmann, Emmanuel A.; Macedo, Etienne] Univ Sao Paulo, Sch Med, Div Nephrol, LIM 12, Sao Paulo, Brazil; [Cerda, Jorge] Albany Med Coll, Dept Med, Div Nephrol, Albany, NY 12208 USA; [Feehally, John] Univ Leicester, Renal Med, Leicester, Leics, England; [Finkelstein, Fredric] Yale Univ, New Haven, CT USA; [Garcia-Garcia, Guillermo] Univ Guadalajara, Hlth Sci Ctr, Hosp Civil Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Godin, Melanie] Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada; [Jha, Vivekanand] Univ Oxford, George Inst Global Hlth India, Oxford, England; [Lameire, Norbert H.] Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium; [Levin, Nathan W.] Mt Sinai Sch Med, Renal Res Inst, New York, NY USA; [Lewington, Andrew] Leeds Teaching Hosp, Dept Nephrol, Leeds, W Yorkshire, England; [Lombardi, Raul] Serv Med Integral, Dept Crit Care Med, Montevideo, Uruguay; [Rocco, Michael] Wake Forest Sch Med, Nephrol Sect, Dept Internal Med, Winston Salem, NC USA; [Tonelli, Marcello] Univ Calgary, Calgary, AB, Canada; [Remuzzi, Giuseppe] IRCCS Ist Ric Farmacol Mario Negri, Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Dept Med, Unit Nephrol Dialysis & Transplantat, Bergamo, Italy; [Remuzzi, Giuseppe] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy	University of California System; University of California San Diego; Universidade de Sao Paulo; Albany Medical College; University of Leicester; Yale University; Universidad de Guadalajara; University of Sherbrooke; University of Oxford; Ghent University; Ghent University Hospital; Icahn School of Medicine at Mount Sinai; Renal Research Institute; University of Leeds; Wake Forest University; University of Calgary; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII; University of Milan	Mehta, RL (corresponding author), Univ Calif San Diego, Dept Med, Med Ctr 8342, San Diego, CA 92103 USA.	rmehta@ucsd.edu	Mehta, Ravindra/ACD-4769-2022; Burdmann, Emmanuel/AAY-1966-2020; Burdmann, Emmanuel/B-7023-2009; Tonelli, Marcello/B-3028-2009; Macedo, Etienne/D-4659-2012; Remuzzi, Giuseppe/V-9766-2017	Mehta, Ravindra/0000-0002-0908-2968; Burdmann, Emmanuel/0000-0002-7644-8579; Tonelli, Marcello/0000-0002-0846-3187; Macedo, Etienne/0000-0002-3669-6519; Garcia Garcia, Guillermo/0000-0003-0558-0035; Remuzzi, Giuseppe/0000-0002-6194-3446; Jha, Vivekanand/0000-0002-8015-9470	International Society of Nephrology (ISN); Astute Medical (San Diego, CA, USA); Danone Nutricia Research (Palaiseau, France); Bellco (Mirandola, Italy); UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research [NIH P30-DK079337]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER	International Society of Nephrology (ISN); Astute Medical (San Diego, CA, USA); Danone Nutricia Research (Palaiseau, France); Bellco (Mirandola, Italy); UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The International Society of Nephrology (ISN) provided funding through unrestricted grants to the study, gave logistic support for this study, and holds all copyrights on the data obtained through this study. Further support has been provided through unrestricted grants from Astute Medical (San Diego, CA, USA), Danone Nutricia Research (Palaiseau, France) and Bellco (Mirandola, Italy). We thank all the providers for their involvement in data acquisition and International Society for Nephrology staff Luisa Strani, Louise Fox, and Luca Segantini, and the coordinating centre personnel Marcela Zhou-Huang, Susan Calleran, Wes Vetter, and Sean Patno for their support. Participating providers and centres are listed in the appendix. We acknowledge support from the UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research (NIH P30-DK079337) for this project.	Aitken E, 2013, QJM-INT J MED, V106, P323, DOI 10.1093/qjmed/hcs237; Bank W, 2015, GNI CAP ALT METH CUR; Basso F, 2010, BLOOD PURIFICAT, V30, P213, DOI 10.1159/000320126; Bouchard J, 2015, CLIN J AM SOC NEPHRO, V10, P1324, DOI 10.2215/CJN.04360514; Burdmann EA, 2011, SEMIN DIALYSIS, V24, P149, DOI 10.1111/j.1525-139X.2011.00868.x; Cerda J, 2015, CLIN J AM SOC NEPHRO, V10, P1859, DOI 10.2215/CJN.01170215; Chionh CY, 2013, CLIN J AM SOC NEPHRO, V8, P1649, DOI 10.2215/CJN.01540213; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Godin M, 2014, WORLD C NEPHR CAP TO; Horton R, 2015, LANCET, V385, P2551, DOI 10.1016/S0140-6736(15)60269-0; Horton R, 2015, LANCET, V385, P1058, DOI 10.1016/S0140-6736(15)60572-4; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Jamal JA, 2014, NEPHROLOGY, V19, P507, DOI 10.1111/nep.12276; Jha V, 2013, NAT REV NEPHROL, V9, P278, DOI 10.1038/nrneph.2013.36; Kilonzo KG, 2012, PERITON DIALYSIS INT, V32, P261, DOI 10.3747/pdi.2012.00083; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Lombardi R, 2014, NEPHROL DIAL TRANSPL, V29, P1369, DOI 10.1093/ndt/gfu078; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Obiagwu PN, 2015, TROP MED INT HEALTH, V20, P2, DOI 10.1111/tmi.12409; Overberger P, 2007, CLIN J AM SOC NEPHRO, V2, P623, DOI 10.2215/CJN.00780207; Ponce D, 2013, INT UROL NEPHROL, V45, P869, DOI 10.1007/s11255-012-0301-2; Ponce D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126436; Ponce D, 2012, CLIN J AM SOC NEPHRO, V7, P887, DOI 10.2215/CJN.11131111; Remuzzi G, 2013, LANCET, V382, P2041, DOI 10.1016/S0140-6736(13)62193-5; Talabani B, 2014, NEPHROLOGY, V19, P282, DOI 10.1111/nep.12221; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Van Berendoncks AM, 2010, CLIN J AM SOC NEPHRO, V5, P1755, DOI 10.2215/CJN.00770110; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wonnacott A, 2014, CLIN J AM SOC NEPHRO, V9, P1007, DOI 10.2215/CJN.07920713	30	215	221	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					2017	2025		10.1016/S0140-6736(16)30240-9	http://dx.doi.org/10.1016/S0140-6736(16)30240-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	27086173				2022-12-28	WOS:000375881500030
J	Chu, DM; Aagaard, KM				Chu, Derrick M.; Aagaard, Kjersti M.			Eating for trillions	NATURE			English	Editorial Material							GROWTH; DIET; UNDERNUTRITION; MICROBIOME; ALTERS		[Chu, Derrick M.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Aagaard, KM (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	aagaardt@bcm.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD082969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090964, P30DK020593, R01DK089201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014792] Funding Source: NIH RePORTER; NICHD NIH HHS [F32 HD082969] Funding Source: Medline; NIDDK NIH HHS [R01 DK089201, R24 DK090964, P30 DK020593] Funding Source: Medline; NINR NIH HHS [R01 NR014792] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Dewey KG, 2001, J NUTR, V131, P1879, DOI 10.1093/jn/131.7.1879; Ma J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4889; Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000	10	4	4	3	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					316	317		10.1038/nature17887	http://dx.doi.org/10.1038/nature17887			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27074514	Green Accepted			2022-12-28	WOS:000374424700019
J	McMahon, AC; Rahman, R; Jin, H; Shen, JL; Fieldsend, A; Luo, WF; Rosbash, M				McMahon, Aoife C.; Rahman, Reazur; Jin, Hua; Shen, James L.; Fieldsend, Allegra; Luo, Weifei; Rosbash, Michael			TRIBE: Hijacking an RNA-Editing Enzyme to Identify Cell-Specific Targets of RNA-Binding Proteins	CELL			English	Article							DOUBLE-STRANDED-RNA; FRAGILE-X-SYNDROME; NUCLEOTIDE-RESOLUTION; GENOME-WIDE; GENE-EXPRESSION; LIVING CELLS; FMRP TARGETS; STEM-CELLS; HITS-CLIP; IN-VIVO	RNA transcripts are bound and regulated by RNA-binding proteins (RBPs). Current methods for identifying in vivo targets of an RBP are imperfect and not amenable to examining small numbers of cells. To address these issues, we developed TRIBE (targets of RNA-binding proteins identified by editing), a technique that couples an RBP to the catalytic domain of the Drosophila RNA-editing enzyme ADAR and expresses the fusion protein in vivo. RBP targets are marked with novel RNA editing events and identified by sequencing RNA. We have used TRIBE to identify the targets of three RBPs (Hrp48, dFMR1, and NonA). TRIBE compares favorably to other methods, including CLIP, and we have identified RBP targets from as little as 150 specific fly neurons. TRIBE can be performed without an antibody and in small numbers of specific cells.	[McMahon, Aoife C.; Rahman, Reazur; Jin, Hua; Shen, James L.; Fieldsend, Allegra; Luo, Weifei; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Woods Hole, MA 02543 USA; [McMahon, Aoife C.; Rahman, Reazur; Jin, Hua; Shen, James L.; Fieldsend, Allegra; Luo, Weifei; Rosbash, Michael] Brandeis Univ, Natl Ctr Behav Genom, Woods Hole, MA 02543 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Woods Hole, MA 02543 USA.; Rosbash, M (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Woods Hole, MA 02543 USA.	rosbash@brandeis.edu	Jin, Hua/AAS-9079-2020	Jin, Hua/0000-0001-9829-0306; Shen, James/0000-0002-3178-0615; McMahon, Aoife/0000-0003-0978-0309	Howard Hughes Medical Institute; NIH EUREKA R01 grant [DA037721]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037721] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH EUREKA R01 grant; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Jin Billy Li, Donald Rio, Roy Parker, Robert Singer, and the members of the M.R. lab, especially Katherine Abruzzi, for helpful comments on the manuscript. We are grateful to Robert Reenan, Tom Jongens, Maureen Hanson, Bora Baysal, Shraddha Sharma, and Donald Rio for the gift of plasmids and reagents. This work was initially supported by the Howard Hughes Medical Institute and then an NIH EUREKA R01 grant (DA037721).	Abruzzi K, 2015, METHOD ENZYMOL, V551, P369, DOI 10.1016/bs.mie.2014.10.025; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bashirullah A, 1999, EMBO J, V18, P2610, DOI 10.1093/emboj/18.9.2610; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Blanchette M, 2009, MOL CELL, V33, P438, DOI 10.1016/j.molcel.2009.01.022; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Bruckert H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136610; Buratti E, 2013, MOL CELL NEUROSCI, V56, P465, DOI 10.1016/j.mcn.2013.03.001; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Contractor A, 2015, NEURON, V87, P699, DOI 10.1016/j.neuron.2015.06.017; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Eifler T, 2013, BIOCHEMISTRY-US, V52, P7857, DOI 10.1021/bi4006539; Fecko CJ, 2007, PHOTOCHEM PHOTOBIOL, V83, P1394, DOI 10.1111/j.1751-1097.2007.00179.x; Gupta A, 2012, RNA BIOL, V9, DOI [10.4161/rna.18386, 10.4161/rna.9.2.18386]; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Hilgers V, 2011, P NATL ACAD SCI USA, V108, P15864, DOI 10.1073/pnas.1112672108; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kang H, 2013, INT J MOL SCI, V14, P17204, DOI 10.3390/ijms140817204; Keegan LP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-209; Khodor YL, 2011, GENE DEV, V25, P2502, DOI 10.1101/gad.178962.111; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Kozlova N, 2006, EXP CELL RES, V312, P2619, DOI 10.1016/j.yexcr.2006.04.013; Kuttan A, 2012, P NATL ACAD SCI USA, V109, pE3295, DOI 10.1073/pnas.1212548109; Kwok CK, 2015, TRENDS BIOCHEM SCI, V40, P221, DOI 10.1016/j.tibs.2015.02.005; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lapointe CP, 2015, NAT METHODS, V12, P1163, DOI 10.1038/nmeth.3651; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Montiel-Gonzalez MF, 2013, P NATL ACAD SCI USA, V110, P18285, DOI 10.1073/pnas.1306243110; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Nelson MR, 2007, J BIOL CHEM, V282, P34031, DOI 10.1074/jbc.M706363200; Nussbacher JK, 2015, TRENDS NEUROSCI, V38, P226, DOI 10.1016/j.tins.2015.02.003; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Ouwenga RL, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0008-1; Pennington KL, 2013, P NATL ACAD SCI USA, V110, P7678, DOI 10.1073/pnas.1221712110; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Phelps KJ, 2015, NUCLEIC ACIDS RES, V43, P1123, DOI 10.1093/nar/gku1345; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Rodriguez J, 2012, MOL CELL, V47, P27, DOI 10.1016/j.molcel.2012.05.002; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Southall TD, 2013, DEV CELL, V26, P101, DOI 10.1016/j.devcel.2013.05.020; Sugimoto Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r67; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; Vogel P, 2014, CHEMMEDCHEM, V9, P2021, DOI 10.1002/cmdc.201402139; Vogel P, 2014, ANGEW CHEM INT EDIT, V53, P6267, DOI 10.1002/anie.201402634; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Yao AY, 2011, HUM MOL GENET, V20, P51, DOI 10.1093/hmg/ddq431; Yi-Brunozzi HY, 2001, J BIOL CHEM, V276, P37827; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	66	103	106	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					742	753		10.1016/j.cell.2016.03.007	http://dx.doi.org/10.1016/j.cell.2016.03.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27040499	Green Accepted, Bronze			2022-12-28	WOS:000374636800030
J	Howlett, DC; Sinnott, JD				Howlett, David C.; Sinnott, Joseph Dalby			Mild cough and decreased breath sounds in an 82 year old woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Howlett, David C.] East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, England; [Sinnott, Joseph Dalby] East Sussex Hosp NHS Trust, Eastbourne, England		Sinnott, JD (corresponding author), East Sussex Hosp NHS Trust, Eastbourne, England.	j.d.sinnott@gmail.com							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2016	353								i2080	10.1136/bmj.i2080	http://dx.doi.org/10.1136/bmj.i2080			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EV	27084262				2022-12-28	WOS:000374375600002
J	Fernandez-Palacios, JM				Maria Fernandez-Palacios, Jose			ISLAND BIOGEOGRAPHY Shaped by sea-level shifts	NATURE			English	Editorial Material							IMMIGRATION; RATES; AREA		[Maria Fernandez-Palacios, Jose] ULL, Isl Ecol & Biogeog Grp, Inst Univ Enfermedades Trop & Salud Publ Canarias, Tenerife 38200, Canary Islands, Spain	Universidad de la Laguna	Fernandez-Palacios, JM (corresponding author), ULL, Isl Ecol & Biogeog Grp, Inst Univ Enfermedades Trop & Salud Publ Canarias, Tenerife 38200, Canary Islands, Spain.	jmferpal@ull.es	Fernández-Palacios, José María/H-2054-2015	Fernández-Palacios, José María/0000-0001-9741-6878				Ali JR, 2014, J BIOGEOGR, V41, P1227, DOI 10.1111/jbi.12313; Bellemain E, 2008, TRENDS ECOL EVOL, V23, P461, DOI 10.1016/j.tree.2008.05.001; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P1, DOI 10.1046/j.1365-2699.2000.00185.x; LOMOLINO MV, 1990, OIKOS, V57, P297, DOI 10.2307/3565957; MAC ARTHUR ROBERT H., 1967; Fernandez-Palacios JM, 2016, GLOBAL ECOL BIOGEOGR, V25, P817, DOI 10.1111/geb.12320; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Rijsdijk KF, 2014, J BIOGEOGR, V41, P1242, DOI 10.1111/jbi.12336; Warren BH, 2010, CLADISTICS, V26, P526, DOI 10.1111/j.1096-0031.2009.00300.x; Weigelt P, 2016, NATURE, V532, P99, DOI 10.1038/nature17443; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x	15	22	22	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					42	43		10.1038/nature17880	http://dx.doi.org/10.1038/nature17880			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27027292				2022-12-28	WOS:000373555500027
J	Merrill, AL				Merrill, Andrea L.			A Man Who Needs Complex Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Merrill, Andrea/AAL-7568-2020	Merrill, Andrea/0000-0001-8805-8634					0	24	24	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					1380	1380		10.1056/NEJMclde1513948	http://dx.doi.org/10.1056/NEJMclde1513948			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3UW	27050211				2022-12-28	WOS:000373425000014
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: The best health system	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Appleby J, 2014, NHS PRODUCTIVITY CHA; Commonwealth Fund, 2014, MIRR MIRR WALL PERF; Cylus J, 2016, BMJ BLOGS       0209; Economist Intelligence Unit, 2015, NHS DOES IT COMP; HC Powerhouse, 2016, EUR CONS IND 2015; HM Treasury, 2015, COUNTR LIV ITS MEANS; King's Fund, 2016, HEALTHC SPEND COMP O; Niemietz K., 2014, ENVY WORLD CLOSER LO; Organisation for Economic Cooperation and Development, 2015, OECD HLTH STAT 2015; Riley A., 2015, BLOOMBERG	10	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2016	353								i1848	10.1136/bmj.i1848	http://dx.doi.org/10.1136/bmj.i1848			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LL	27044632	Green Published, Bronze			2022-12-28	WOS:000373894800003
J	Bock, RW; Paulus, RA				Bock, Richard W.; Paulus, Ronald A.			Immersion Day - Transforming Governance and Policy by Putting on Scrubs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bock, Richard W.; Paulus, Ronald A.] Mission Hlth, Asheville, NC USA		Bock, RW (corresponding author), Mission Hlth, Asheville, NC USA.							Lee T. H., 2016, EPIDEMIC EMPATHY HEA; Ostendorff J, 2016, CITIZEN TIMES; Shulkin DJ, 2008, NEW ENGL J MED, V358, P2091, DOI 10.1056/NEJMp0707144; Turner B, 2015, CITIZEN TIMES   1113	4	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1201	1203		10.1056/NEJMp1600068	http://dx.doi.org/10.1056/NEJMp1600068			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DH8ZM	27028908				2022-12-28	WOS:000373085500001
J	Cavadini, S; Fischer, ES; Bunker, RD; Potenza, A; Lingaraju, GM; Goldie, KN; Mohamed, WI; Faty, M; Petzold, G; Beckwith, REJ; Tichkule, RB; Hassiepen, U; Abdulrahman, W; Pantelic, RS; Matsumoto, S; Sugasawa, K; Stahlberg, H; Thoma, NH				Cavadini, Simone; Fischer, Eric S.; Bunker, Richard D.; Potenza, Alessandro; Lingaraju, Gondichatnahalli M.; Goldie, Kenneth N.; Mohamed, Weaam I.; Faty, Mahamadou; Petzold, Georg; Beckwith, Rohan E. J.; Tichkule, Ritesh B.; Hassiepen, Ulrich; Abdulrahman, Wassim; Pantelic, Radosav S.; Matsumoto, Syota; Sugasawa, Kaoru; Stahlberg, Henning; Thomae, Nicolas H.			Cullin-RING ubiquitin E3 ligase regulation by the COP9 signalosome	NATURE			English	Article							PIGMENTOSUM GROUP-E; GROWTH-FACTOR RECEPTOR; DNA-BINDING PROTEIN; DAMAGED DNA; C-CBL; STRUCTURAL BASIS; COMPLEX; SCF; LENALIDOMIDE; ARCHITECTURE	The cullin-RING ubiquitin E3 ligase (CRL) family comprises over 200 members in humans. The COP9 signalosome complex (CSN) regulates CRLs by removing their ubiquitin-like activator NEDD8. The CUL4A-RBX1-DDB1-DDB2 complex (CRL4A(DDB2)) monitors the genome for ultraviolet-light-induced DNA damage. CRL4A(DBB2) is inactive in the absence of damaged DNA and requires CSN to regulate the repair process. The structural basis of CSN binding to CRL4A(DDB2) and the principles of CSN activation are poorly understood. Here we present cryo-electron microscopy structures for CSN in complex with neddylated CRL4A ligases to 6.4 angstrom resolution. The CSN conformers defined by cryo-electron microscopy and a novel apo-CSN crystal structure indicate an induced-fit mechanism that drives CSN activation by neddylated CRLs. We find that CSN and a substrate cannot bind simultaneously to CRL4A, favouring a deneddylated, inactive state for substrate-free CRL4 complexes. These architectural and regulatory principles appear conserved across CRL families, allowing global regulation by CSN.	[Cavadini, Simone; Fischer, Eric S.; Bunker, Richard D.; Potenza, Alessandro; Lingaraju, Gondichatnahalli M.; Mohamed, Weaam I.; Faty, Mahamadou; Petzold, Georg; Abdulrahman, Wassim; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland; [Cavadini, Simone; Fischer, Eric S.; Bunker, Richard D.; Potenza, Alessandro; Lingaraju, Gondichatnahalli M.; Mohamed, Weaam I.; Faty, Mahamadou; Petzold, Georg; Abdulrahman, Wassim; Thomae, Nicolas H.] Univ Basel, Peterspl 10, CH-4003 Basel, Switzerland; [Fischer, Eric S.] Dana Farber Canc Inst, Dept Canc Biol, LC-4312,360 Longwood Ave, Boston, MA 02215 USA; [Fischer, Eric S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Goldie, Kenneth N.; Pantelic, Radosav S.; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, CH-4058 Basel, Switzerland; [Beckwith, Rohan E. J.; Tichkule, Ritesh B.] Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA; [Hassiepen, Ulrich] Novartis Pharma AG, Inst Biomed Res, Novartis Campus, CH-4056 Basel, Switzerland; [Pantelic, Radosav S.] Gatan R&D, 5974 W Las Positas Blvd, Pleasanton, CA 94588 USA; [Matsumoto, Syota; Sugasawa, Kaoru] Kobe Univ, Org Adv Sci & Technol, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Matsumoto, Syota; Sugasawa, Kaoru] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan	Friedrich Miescher Institute for Biomedical Research; University of Basel; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Basel; Novartis; Novartis; Universita della Svizzera Italiana; Kobe University; Kobe University	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.; Thoma, NH (corresponding author), Univ Basel, Peterspl 10, CH-4003 Basel, Switzerland.	nicolas.thoma@fmi.ch	Matsumoto, Syota/GOE-6847-2022; Stahlberg, Henning/H-1868-2011	Stahlberg, Henning/0000-0002-1185-4592; Thoma, Nicolas/0000-0003-2685-906X; Matsumoto, Syota/0000-0002-8776-2096; Petzold, Georg/0000-0001-5649-1716; Bunker, Richard/0000-0001-8866-5290; Fischer, Eric S./0000-0001-7337-6306	Novartis Research Foundation; European Research Council [ERC-2014-ADG 666068 CSNCRL]; Swiss initiative for Systems Biology (SystemsX.ch grant 'C-CINA'); European Molecular Biology Organization (EMBO) [ALTF-1350-2013]; Human Frontier Science Program (HFSP) [LT000210/2014]; Boehringer Ingelheim Fonds	Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); Swiss initiative for Systems Biology (SystemsX.ch grant 'C-CINA'); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank K. Bohm for technical assistance in protein expression and purification, D. Hess and J. Seebacher for mass spectrometry analysis, and M. Jones, B. Martoglio, R. Assenberg, C. Logel, I. Bechtold and M. Renatus for help developing the TR-FRET and PT22 CSN assays. We thank B. Anderson and A. Fecteau-Lefebvre ('C-CINA') for technical support and TEM maintenance. We are grateful to T. Walz and D. Barford for help and discussions. Part of this work was performed at beamline X10SA of the Swiss Light Source. This work was supported by the Novartis Research Foundation and grants to N.H.T. from the European Research Council (ERC-2014-ADG 666068 CSNCRL) and to H.S. from the Swiss initiative for Systems Biology (SystemsX.ch grant 'C-CINA'). G.P. was supported by long-term fellowships of the European Molecular Biology Organization (EMBO; ALTF-1350-2013) and the Human Frontier Science Program (HFSP; LT000210/2014). W.I.M. was supported by the Boehringer Ingelheim Fonds.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dubiel W, 2009, MOL CELL, V35, P547, DOI 10.1016/j.molcel.2009.08.011; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Rockel B, 2014, BIOCHEM BIOPH RES CO, V450, P991, DOI 10.1016/j.bbrc.2014.06.093; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Scrima A., 2011, FEBS LETT; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Takedachi A, 2010, MOL CELL BIOL, V30, P2708, DOI 10.1128/MCB.01460-09; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	47	123	124	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					598	+		10.1038/nature17416	http://dx.doi.org/10.1038/nature17416			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27029275				2022-12-28	WOS:000373027400030
J	Nishimura, RA; Vahanian, A; Eleid, MF; Mack, MJ				Nishimura, Rick A.; Vahanian, Alec; Eleid, Mackram F.; Mack, Michael J.			Valvular heart disease 2 Mitral valve disease-current management and future challenges	LANCET			English	Article							TO-EDGE REPAIR; ANNULAR CALCIFICATION; EARLY SURGERY; TRANSAPICAL IMPLANTATION; EXTENSIVE CALCIFICATION; PROCEDURAL VOLUME; FLAIL LEAFLETS; TASK-FORCE; FOLLOW-UP; REGURGITATION	The field of mitral valve disease diagnosis and management is rapidly changing. New understanding of disease pathology and progression, with improvements in and increased use of sophisticated imaging modalities, have led to early diagnosis and complex treatment. In primary mitral regurgitation, surgical repair is the standard of care. Treatment of asymptomatic patients with severe mitral regurgitation in valve reference centres, in which successful repair is more than 95% and surgical mortality is less than 1%, should be the expectation for the next 5 years. Transcatheter mitral valve repair with a MitraClip device is also producing good outcomes in patients with primary mitral regurgitation who are at high surgical risk. Findings from clinical trials of MitraClip versus surgery in patients of intermediate surgical risk are expected to be initiated in the next few years. In patients with secondary mitral regurgitation, mainly a disease of the left ventricle, the vision for the next 5 years is not nearly as clear. Outcomes from ongoing clinical trials will greatly inform this field. Use of transcatheter techniques, both repair and replacement, is expected to substantially expand. Mitral annular calcification is an increasing problem in elderly people, causing both mitral stenosis and regurgitation which are difficult to treat. There is anecdotal experience with use of transcatheter valves by either a catheter-based approach or as a hybrid technique with open surgery, which is being studied in early feasibility trials.	[Nishimura, Rick A.; Eleid, Mackram F.] Mayo Clin, Rochester, MN USA; [Vahanian, Alec] Hosp Bichat, Paris, France; [Mack, Michael J.] Baylor Scott & White Hlth, Plano, TX 75093 USA	Mayo Clinic; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Baylor Health Care System	Mack, MJ (corresponding author), Baylor Scott & White Hlth, Plano, TX 75093 USA.	michael.mack@baylorhealth.edu			Edwards Life Sciences; Abbott Vascular; Valtech	Edwards Life Sciences; Abbott Vascular(Abbott Laboratories); Valtech	AV reports personal fees from Edwards Life Sciences and Abbott Vascular and grants from Valtech, during the conduct of the study; and reports personal fees from Medtonic, outside the submitted work. RAN, MFE, and MJM declare no competing interests.	Abramowitz Y, 2015, J AM COLL CARDIOL, V66, P1934, DOI 10.1016/j.jacc.2015.08.872; Acker MA, 2014, NEW ENGL J MED, V370, P23, DOI 10.1056/NEJMoa1312808; Adams DH, 2006, HEART FAIL REV, V11, P241, DOI 10.1007/s10741-006-0103-7; Adams DH, 2010, EUR HEART J, V31, P1958, DOI 10.1093/eurheartj/ehq222; Adler Y, 2001, ATHEROSCLEROSIS, V155, P1, DOI 10.1016/S0021-9150(00)00737-1; Akram MR, 2009, EUR J ECHOCARDIOGR, V10, P103, DOI 10.1093/ejechocard/jen179; Allison MA, 2006, CIRCULATION, V113, P861, DOI 10.1161/CIRCULATIONAHA.105.552844; Badhwar V, 2016, ANN THORAC SURG, V101, P2265, DOI 10.1016/j.athoracsur.2015.11.049; Barasch E, 2006, AM HEART J, V151, P39, DOI 10.1016/j.ahj.2005.03.052; Beaudoin J, 2013, J AM COLL CARDIOL, V61, P1809, DOI 10.1016/j.jacc.2013.01.064; Bolling SF, 1998, J THORAC CARDIOV SUR, V115, P381, DOI 10.1016/S0022-5223(98)70282-X; Bolling SF, 2010, ANN THORAC SURG, V90, P1904, DOI 10.1016/j.athoracsur.2010.07.062; Bridgewater B, 2006, HEART, V92, P939, DOI 10.1136/hrt.2005.076109; Carabello BA, 1988, MOD CONCEPTS CARDIOV, V57, P53; Carpentier AF, 1996, J THORAC CARDIOV SUR, V111, P718, DOI 10.1016/S0022-5223(96)70332-X; Castillo JG, 2012, J THORAC CARDIOV SUR, V144, P308, DOI 10.1016/j.jtcvs.2011.12.054; Colli A, 2014, JACC-CARDIOVASC IMAG, V7, P322, DOI 10.1016/j.jcmg.2014.01.003; Conradi L, 2015, CATHETER CARDIO INTE, V86, P1114, DOI 10.1002/ccd.25962; Davierwala PM, 2013, ANN CARDIOTHORAC SUR, V2, P744, DOI 10.3978/j.issn.2225-319X.2013.10.14; Eggebrecht H, 2015, CATHETER CARDIO INTE, V86, P728, DOI 10.1002/ccd.25838; Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451; Enriquez-Sarano M, 2002, HEART, V88, P1; ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022, DOI 10.1161/01.CIR.91.4.1022; EnriquezSarano M, 1997, CIRCULATION, V96, P4121; EnriquezSarano M, 1997, MAYO CLIN PROC, V72, P1034, DOI 10.4065/72.11.1034; Feindel CM, 2003, J THORAC CARDIOV SUR, V126, P777, DOI 10.1016/S0022-5223(03)00081-3; Feldman T, 2015, J AM COLL CARDIOL, V66, P2844, DOI 10.1016/j.jacc.2015.10.018; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Fox CS, 2003, CIRCULATION, V107, P1492, DOI 10.1161/01.CIR.0000058168.26163.BC; GAASCH WH, 1995, CHEST, V108, P842, DOI 10.1378/chest.108.3.842; Gammie JS, 2007, CIRCULATION, V115, P881, DOI 10.1161/CIRCULATIONAHA.106.634436; Goldstein D, 2016, NEW ENGL J MED, V374, P344, DOI 10.1056/NEJMoa1512913; Goldstone AB, 2015, ANN THORAC SURG, V99, P1983, DOI 10.1016/j.athoracsur.2014.12.076; Grigioni F, 1999, J AM COLL CARDIOL, V34, P2078, DOI 10.1016/S0735-1097(99)00474-X; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; Guerrero M, 2015, TRANSCATHETER VALVE; Guerrero M, 2014, CATHETER CARDIO INTE, V83, pE287, DOI 10.1002/ccd.25441; Hamirani YS, 2011, AM J CARDIOL, V107, P1291, DOI 10.1016/j.amjcard.2011.01.005; Hasan R, 2013, CIRCULATION, V128, pE74, DOI 10.1161/CIRCULATIONAHA.113.001466; Himbert D, 2014, J AM COLL CARDIOL, V64, P2557, DOI 10.1016/j.jacc.2014.09.047; Johnston DR, 2010, ANN THORAC SURG, V89, P1385, DOI 10.1016/j.athoracsur.2009.12.070; Jokinen JJ, 2007, ANN THORAC SURG, V84, P451, DOI 10.1016/j.athoracsur.2007.03.058; Kang DH, 2009, CIRCULATION, V119, P797, DOI 10.1161/CIRCULATIONAHA.108.802314; Kanjanauthai S, 2010, ATHEROSCLEROSIS, V213, P558, DOI 10.1016/j.atherosclerosis.2010.08.072; KORN D, 1962, NEW ENGL J MED, V267, P900, DOI 10.1056/NEJM196211012671802; Kron IL, 2015, J THORAC CARDIOVASC, V149; Lee R, 2016, J THORAC CARDIOV SUR, V151, pE47, DOI 10.1016/j.jtcvs.2015.10.040; Ling LH, 1997, CIRCULATION, V96, P1819, DOI 10.1161/01.CIR.96.6.1819; Machler H, 2011, EUR J CARDIO-THORAC, V40, P1547, DOI 10.1016/j.ejcts.2011.05.005; Magne J, 2009, CIRCULATION, V120, pS104, DOI 10.1161/CIRCULATIONAHA.108.843995; Maisano F, 2016, EUR HEART J, V37, P817, DOI 10.1093/eurheartj/ehv603; Maisano F, 2015, EUROINTERVENTION, V11, pW58, DOI 10.4244/EIJV11SWA15; Maisano F, 2015, EUR HEART J, V36, P1651, DOI 10.1093/eurheartj/ehv123; Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mihaljevic T., 2011, J THORAC CARDIOVASC, V141, pe1; Mihaljevic T, 2011, J THORAC CARDIOV SUR, V141, P72, DOI 10.1016/j.jtcvs.2010.09.008; Mihos CG, 2014, J HEART VALVE DIS, V23, P91; Mirabel M, 2007, EUR HEART J, V28, P1358, DOI 10.1093/eurheartj/ehm001; Moss RR, 2003, CIRCULATION, V108, P90, DOI 10.1161/01.cir.0000089182.44963.bb; Muddassir SM, 2007, INT J CARDIOL, V123, P58, DOI 10.1016/j.ijcard.2006.11.142; NESTICO PF, 1984, AM HEART J, V107, P989, DOI 10.1016/0002-8703(84)90840-8; Nickenig G, 2014, J AM COLL CARDIOL, V64, P875, DOI 10.1016/j.jacc.2014.06.1166; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Nishimura RA, 2012, CIRCULATION, V125, P2138, DOI 10.1161/CIRCULATIONAHA.111.060319; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Obadia JF, 2015, EUROINTERVENTION, V10, P1354, DOI 10.4244/EIJV10I11A232; OLSON LJ, 1987, MAYO CLIN PROC, V62, P22, DOI 10.1016/S0025-6196(12)61522-5; Remenyi B, 2016, LANCET, V387, P1335, DOI 10.1016/S0140-6736(16)00547-X; Ribeiro HB, 2014, JACC-CARDIOVASC INTE, V7, pE137, DOI 10.1016/j.jcin.2014.02.024; ROBERTS WC, 1986, AM J CARDIOL, V58, P572, DOI 10.1016/0002-9149(86)90045-7; Rosenhek R, 2006, CIRCULATION, V113, P2238, DOI 10.1161/CIRCULATIONAHA.105.599175; Schillinger W, 2013, EUROINTERVENTION, V9, P84, DOI 10.4244/EIJV9I1A13; Seeburger J, 2014, J AM COLL CARDIOL, V63, P914, DOI 10.1016/j.jacc.2013.07.090; Seeburger J, 2009, EUR J CARDIO-THORAC, V36, P532, DOI 10.1016/j.ejcts.2009.03.058; Seeburger J, 2009, ANN THORAC SURG, V87, P1715, DOI 10.1016/j.athoracsur.2009.03.003; Silbiger JJ, 2012, AM HEART J, V164, P163, DOI 10.1016/j.ahj.2012.05.014; Siminiak T, 2012, EUR J HEART FAIL, V14, P931, DOI 10.1093/eurjhf/hfs076; Sinning JM, 2013, EUR HEART J, V34, P2609, DOI 10.1093/eurheartj/eht254; Suri RM, 2016, J AM COLL CARDIOL, V67, P488, DOI 10.1016/j.jacc.2015.10.098; Suri RM, 2013, JAMA-J AM MED ASSOC, V310, P609, DOI 10.1001/jama.2013.8643; Tribouilloy C, 2009, J AM COLL CARDIOL, V54, P1961, DOI 10.1016/j.jacc.2009.06.047; Uchimuro T, 2016, ANN THORAC SURG, V101, P889, DOI 10.1016/j.athoracsur.2015.08.071; Umakanthan R, 2008, ANN THORAC SURG, V85, P1544, DOI 10.1016/j.athoracsur.2008.01.099; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Van den Branden BJL, 2012, JACC-CARDIOVASC INTE, V5, P105, DOI 10.1016/j.jcin.2011.09.013; Vassileva CM, 2012, J HEART VALVE DIS, V21, P41; Velazquez EJ, 2015, AM HEART J, V170, P1050, DOI 10.1016/j.ahj.2015.08.004; WISENBAUGH T, 1988, CIRCULATION, V77, P515, DOI 10.1161/01.CIR.77.3.515; Wunderlich NC, 2013, EUR HEART J-CARD IMG, V14, P935, DOI 10.1093/ehjci/jet060; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	91	149	157	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1324	1334		10.1016/S0140-6736(16)00558-4	http://dx.doi.org/10.1016/S0140-6736(16)00558-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27025438				2022-12-28	WOS:000372697500031
J	Rossignol, P; Zannad, F				Rossignol, Patrick; Zannad, Faiez			Left-to-right atrial shunting: new hope for heart failure?	LANCET			English	Editorial Material							PRESERVED EJECTION FRACTION; TRANSCATHETER TREATMENT; EXERCISE HEMODYNAMICS; PRESSURE; IMPLANT; TRIALS		[Rossignol, Patrick; Zannad, Faiez] Ctr Invest Clin Plurithemat 1433, INSERM, F-54000 Nancy, France; [Rossignol, Patrick; Zannad, Faiez] INSERM, U1116, F-54000 Nancy, France; [Rossignol, Patrick; Zannad, Faiez] CHU Nancy, Inst Lorrain Coeur & Vaisseaux, Dept Cardiol, Vandoeuvre Les Nancy, France; [Rossignol, Patrick; Zannad, Faiez] Univ Lorraine, Nancy, France; [Rossignol, Patrick; Zannad, Faiez] French Clin Res Infrastruct Network F CRIN, INI CRCT Cardiovasc & Renal Clin Trialists, Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine	Rossignol, P (corresponding author), Ctr Invest Clin Plurithemat 1433, INSERM, F-54000 Nancy, France.; Rossignol, P (corresponding author), INSERM, U1116, F-54000 Nancy, France.; Rossignol, P (corresponding author), CHU Nancy, Inst Lorrain Coeur & Vaisseaux, Dept Cardiol, Vandoeuvre Les Nancy, France.; Rossignol, P (corresponding author), Univ Lorraine, Nancy, France.; Rossignol, P (corresponding author), French Clin Res Infrastruct Network F CRIN, INI CRCT Cardiovasc & Renal Clin Trialists, Nancy, France.	p.rossignol@chru-nancy.fr	Zannad, Faiez/K-4649-2019					Borlaug BA, 2015, J AM COLL CARDIOL, V66, P1672, DOI 10.1016/j.jacc.2015.07.067; del Rio CL, 2013, CIRCULATION, V128; Del Trigo M, 2016, LANCET, V387, P1290, DOI 10.1016/S0140-6736(16)00585-7; Dorfs S, 2014, EUR HEART J, V35, P3103, DOI 10.1093/eurheartj/ehu315; Hasenfuss G, 2016, LANCET, V387, P1298, DOI 10.1016/S0140-6736(16)00704-2; Kaye D, 2014, J CARD FAIL, V20, P212, DOI 10.1016/j.cardfail.2014.01.005; Malek F, 2015, INT J CARDIOL, V187, P227, DOI 10.1016/j.ijcard.2015.03.198; Rossignol P, 2015, LANCET, V386, P1588, DOI 10.1016/S0140-6736(15)00418-3; Rossignol P, 2015, CIRCULATION, V131, P7, DOI 10.1161/CIRCULATIONAHA.114.013637; Seib PM, 1999, CATHETER CARDIO INTE, V46, P179, DOI 10.1002/(SICI)1522-726X(199902)46:2<179::AID-CCD13>3.3.CO;2-N; Sondergaard L, 2014, EUR J HEART FAIL, V16, P796, DOI 10.1002/ejhf.111; US Food and Drug Administration, 2015, APPR DE NOV MED DEV; Zannad F, 2014, INT J CARDIOL, V175, P30, DOI 10.1016/j.ijcard.2014.05.021	13	3	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1253	1255		10.1016/S0140-6736(16)30055-1	http://dx.doi.org/10.1016/S0140-6736(16)30055-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27025419				2022-12-28	WOS:000372697500004
J	Maione, V; Stinco, G; Errichetti, E				Maione, Vincenzo; Stinco, Giuseppe; Errichetti, Enzo			Multiple enchondromas and skin angiomas: Maffucci syndrome	LANCET			English	Editorial Material									[Maione, Vincenzo; Stinco, Giuseppe; Errichetti, Enzo] Univ Udine, Inst Dermatol, Dept Expt & Clin Med, Udine, Italy	University of Udine	Maione, V (corresponding author), Univ Udine, Inst Dermatol, I-33100 Udine, Italy.	maionevincenzo@gmail.com	Maione, Vincenzo/E-2627-2015	Maione, Vincenzo/0000-0002-0420-5009					0	4	5	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					905	905		10.1016/S0140-6736(16)00088-X	http://dx.doi.org/10.1016/S0140-6736(16)00088-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU0RI	27037214				2022-12-28	WOS:000381911800029
J	Nghiem, PT; Bhatia, S; Lipson, EJ; Kudchadkar, RR; Miller, NJ; Annamalai, L; Berry, S; Chartash, EK; Daud, A; Fling, SP; Friedlander, PA; Kluger, HM; Kohrt, HE; Lundgren, L; Margolin, K; Mitchell, A; Olencki, T; Pardoll, DM; Reddy, SA; Shantha, EM; Sharfman, WH; Sharon, E; Shemanski, LR; Shinohara, MM; Sunshine, JC; Taube, JM; Thompson, JA; Townson, SM; Yearley, JH; Topalian, SL; Cheever, MA				Nghiem, Paul T.; Bhatia, Shailender; Lipson, Evan J.; Kudchadkar, Ragini R.; Miller, Natalie J.; Annamalai, Lakshmanan; Berry, Sneha; Chartash, Elliot K.; Daud, Adil; Fling, Steven P.; Friedlander, Philip A.; Kluger, Harriet M.; Kohrt, Holbrook E.; Lundgren, Lisa; Margolin, Kim; Mitchell, Alan; Olencki, Thomas; Pardoll, Drew M.; Reddy, Sunil A.; Shantha, Erica M.; Sharfman, William H.; Sharon, Elad; Shemanski, Lynn R.; Shinohara, Michi M.; Sunshine, Joel C.; Taube, Janis M.; Thompson, John A.; Townson, Steven M.; Yearley, Jennifer H.; Topalian, Suzanne L.; Cheever, Martin A.			PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYOMAVIRUS; NIVOLUMAB; RESPONSES; EXPRESSION; CANCER; CHEMOTHERAPY; ANTI-PD-1; CRITERIA; SAFETY; TUMORS	BACKGROUND Merkel-cell carcinoma is an aggressive skin cancer that is linked to exposure to ultraviolet light and the Merkel-cell polyomavirus (MCPyV). Advanced Merkel-cell carcinoma often responds to chemotherapy, but responses are transient. Blocking the programmed death 1 (PD-1) immune inhibitory pathway is of interest, because these tumors often express PD-L1, and MCPyV-specific T cells express PD-1. METHODS In this multicenter, phase 2, noncontrolled study, we assigned adults with advanced Merkel-cell carcinoma who had received no previous systemic therapy to receive pembrolizumab (anti-PD-1) at a dose of 2 mg per kilogram of body weight every 3 weeks. The primary end point was the objective response rate according to Response Evaluation Criteria in Solid Tumors, version 1.1. Efficacy was correlated with tumor viral status, as assessed by serologic and immunohistochemical testing. RESULTS A total of 26 patients received at least one dose of pembrolizumab. The objective response rate among the 25 patients with at least one evaluation during treatment was 56% (95% confidence interval [CI], 35 to 76); 4 patients had a complete response, and 10 had a partial response. With a median follow-up of 33 weeks (range, 7 to 53), relapses occurred in 2 of the 14 patients who had had a response (14%). The response duration ranged from at least 2.2 months to at least 9.7 months. The rate of progression-free survival at 6 months was 67% (95% CI, 49 to 86). A total of 17 of the 26 patients (65%) had virus-positive tumors. The response rate was 62% among patients with MCPyV-positive tumors (10 of 16 patients) and 44% among those with virus-negative tumors (4 of 9 patients). Drug-related grade 3 or 4 adverse events occurred in 15% of the patients. CONCLUSIONS In this study, first-line therapy with pembrolizumab in patients with advanced Merkel-cell carcinoma was associated with an objective response rate of 56%. Responses were observed in patients with virus-positive tumors and those with virus-negative tumors.	[Nghiem, Paul T.; Bhatia, Shailender; Miller, Natalie J.; Shantha, Erica M.; Shinohara, Michi M.; Thompson, John A.; Cheever, Martin A.] Univ Washington, Med Ctr, 850 Republican St,Brotman Rm 240, Seattle, WA 98109 USA; [Nghiem, Paul T.; Bhatia, Shailender; Fling, Steven P.; Lundgren, Lisa; Thompson, John A.; Cheever, Martin A.] Univ Washington, Fred Hutchinson Canc Res Ctr, 850 Republican St,Brotman Rm 240, Seattle, WA 98109 USA; [Fling, Steven P.; Lundgren, Lisa; Cheever, Martin A.] Univ Washington, Canc Immunotherapy Trials Network, 850 Republican St,Brotman Rm 240, Seattle, WA 98109 USA; [Mitchell, Alan; Shemanski, Lynn R.] Univ Washington, Canc Res & BioStat, 850 Republican St,Brotman Rm 240, Seattle, WA 98109 USA; [Lipson, Evan J.; Berry, Sneha; Pardoll, Drew M.; Sharfman, William H.; Sunshine, Joel C.; Taube, Janis M.; Topalian, Suzanne L.] Johns Hopkins Univ, Sch Med, 1550 Orleans St,CBR2,Rm 508, Baltimore, MD 21287 USA; [Lipson, Evan J.; Berry, Sneha; Pardoll, Drew M.; Sharfman, William H.; Sunshine, Joel C.; Taube, Janis M.; Topalian, Suzanne L.] Johns Hopkins Univ, Kimmel Canc Ctr, 1550 Orleans St,CBR2,Rm 508, Baltimore, MD 21287 USA; [Sharon, Elad] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Kudchadkar, Ragini R.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Annamalai, Lakshmanan; Chartash, Elliot K.; Townson, Steven M.; Yearley, Jennifer H.] Merck Res Labs, Kenilworth, NJ USA; [Daud, Adil] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kohrt, Holbrook E.; Margolin, Kim; Reddy, Sunil A.] Stanford Univ, Stanford, CA 94305 USA; [Friedlander, Philip A.] Mt Sinai Med Ctr, New York, NY 10029 USA; [Kluger, Harriet M.] Yale Univ, New Haven, CT USA; [Olencki, Thomas] Ohio State Univ, Columbus, OH 43210 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cancer Research & Biostatistics; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; Merck & Company; University of California System; University of California San Francisco; Stanford University; Icahn School of Medicine at Mount Sinai; Yale University; University System of Ohio; Ohio State University	Topalian, SL (corresponding author), Johns Hopkins Univ, Sch Med, 1550 Orleans St,CBR2,Rm 508, Baltimore, MD 21287 USA.; Nghiem, PT (corresponding author), Univ Washington, Dermatol Med, 850 Republican St,Brotman Rm 240, Seattle, WA 98109 USA.	pnghiem@uw.edu; stopali1@jhmi.edu	Nghiem, Paul T/A-9210-2011; Berry, Sneha/ABB-5974-2020; Thompson, John A/T-7985-2019; Daud, Adil/T-3079-2019	Nghiem, Paul T/0000-0003-2784-963X; Berry, Sneha/0000-0002-4887-8969; Thompson, John A/0000-0002-0872-7306; Daud, Adil/0000-0002-6617-8421; Sunshine, Joel/0000-0001-9987-6712; Shinohara, Michi/0000-0003-1388-5330; Margolin, Kim/0000-0002-5248-4356	National Cancer Institute; Merck; NATIONAL CANCER INSTITUTE [K24CA139052, R01CA162522, R01CA142779, UM1CA154967, U01CA154967, P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Merck(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the National Cancer Institute and Merck; ClinicalTrials.gov number, NCT02267603.	Afanasiev OK, 2013, CLIN CANCER RES, V19, P5351, DOI 10.1158/1078-0432.CCR-13-0035; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Behr DS, 2014, INT J CLIN EXP PATHO, V7, P7610; Berger RL, 1996, AM STAT, V50, P314, DOI 10.2307/2684927; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Doumani R, 2015, J INVEST DERMATOL, V135, pS44; Dowlatshahi M, 2013, J INVEST DERMATOL, V133, P1879, DOI 10.1038/jid.2013.75; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Goh G, 2016, ONCOTARGET, V7, P3393, DOI 10.18632/oncotarget.6494; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Harms PW, 2015, CANCER RES, V75, P3720, DOI 10.1158/0008-5472.CAN-15-0702; Iyer J, 2014, J CLIN ONCOL S52, V32, P52; Iyer JG, 2011, CLIN CANCER RES, V17, P6671, DOI 10.1158/1078-0432.CCR-11-1513; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lipson EJ, 2013, CANCER IMMUNOL RES, V1, P54, DOI 10.1158/2326-6066.CIR-13-0034; Lyford-Pike S, 2013, CANCER RES, V73, P1733, DOI 10.1158/0008-5472.CAN-12-2384; Lyngaa R, 2014, CLIN CANCER RES, V20, P1768, DOI 10.1158/1078-0432.CCR-13-2697; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; NIH, 2009, COMM TERM CRIT ADV E; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Paulson KG, 2013, J INVEST DERMATOL, V133, P642, DOI 10.1038/jid.2012.388; Paulson KG, 2011, J CLIN ONCOL, V29, P1539, DOI 10.1200/JCO.2010.30.6308; Paulson KG, 2010, CANCER RES, V70, P8388, DOI 10.1158/0008-5472.CAN-10-2128; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Seiwert TY, 2015, J CLIN ONCOL, V33; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Tai PTH, 2000, J CLIN ONCOL, V18, P2493, DOI 10.1200/JCO.2000.18.12.2493; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Voog E, 1999, CANCER, V85, P2589, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2589::AID-CNCR15>3.0.CO;2-F; Wong SQ, 2015, CANCER RES, V75, P5228, DOI 10.1158/0008-5472.CAN-15-1877	40	813	842	3	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2016	374	26					2542	2552		10.1056/NEJMoa1603702	http://dx.doi.org/10.1056/NEJMoa1603702			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP8DD	27093365	Green Accepted, Bronze			2022-12-28	WOS:000378727200006
J	Kostyuchenko, VA; Lim, EXY; Zhang, SJ; Fibriansah, G; Ng, TS; Ooi, JSG; Shi, J; Lok, SM				Kostyuchenko, Victor A.; Lim, Elisa X. Y.; Zhang, Shuijun; Fibriansah, Guntur; Ng, Thiam-Seng; Ooi, Justin S. G.; Shi, Jian; Lok, Shee-Mei			Structure of the thermally stable Zika virus	NATURE			English	Article							DENGUE VIRUS; ENVELOPE GLYCOPROTEIN; ENCEPHALITIS-VIRUS; CRYSTAL-STRUCTURE; MATURATION; INFECTION	Zika virus (ZIKV), formerly a neglected pathogen, has recently been associated with microcephaly in fetuses(1), and with Guillian-Barre syndrome in adults(2). Here we present the 3.7 angstrom resolution cryoelectron microscopy structure of ZIKV, and show that the overall architecture of the virus is similar to that of other flaviviruses. Sequence and structural comparisons of the ZIKV envelope (E) protein with other flaviviruses show that parts of the E protein closely resemble the neurovirulent West Nile and Japanese encephalitis viruses, while others are similar to dengue virus (DENV). However, the contribution of the E protein to flavivirus pathobiology is currently not understood. The virus particle was observed to be structurally stable even when incubated at 40 degrees C, in sharp contrast to the less thermally stable DENV3. This is also reflected in the infectivity of ZIKV compared to DENV serotypes 2 and 4 (DENV2 and DENV4) at different temperatures. The cryoelectron microscopy structure shows a virus with a more compact surface. This structural stability of the virus may help it to survive in the harsh conditions of semen(4), saliva(5) and urine(6). Antibodies or drugs that destabilize the structure may help to reduce the disease outcome or limit the spread of the virus.	[Kostyuchenko, Victor A.; Lim, Elisa X. Y.; Zhang, Shuijun; Fibriansah, Guntur; Ng, Thiam-Seng; Ooi, Justin S. G.; Lok, Shee-Mei] Duke Natl Univ Singapore, Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore; [Kostyuchenko, Victor A.; Lim, Elisa X. Y.; Zhang, Shuijun; Fibriansah, Guntur; Ng, Thiam-Seng; Ooi, Justin S. G.; Shi, Jian; Lok, Shee-Mei] Natl Univ Singapore, Dept Biol Sci, Ctr BioImaging Sci, Singapore 117557, Singapore; [Shi, Jian] Natl Univ Singapore, Dept Biol Sci, CryoEM Unit, Singapore 117557, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Lok, SM (corresponding author), Duke Natl Univ Singapore, Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore.; Lok, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Ctr BioImaging Sci, Singapore 117557, Singapore.	sheemei.lok@duke-nus.edu.sg	Fibriansah, Guntur/P-1201-2015; Geap, Justin Ooi Seng/AAS-3483-2021	Fibriansah, Guntur/0000-0002-9990-3335; Geap, Justin Ooi Seng/0000-0003-4899-8255; Lok, Shee-Mei/0000-0003-4631-8041	Singapore Ministry of Education Tier 3 grant [MOE2012-T3-1-008]; National Research Foundation [NRF-NRFI2016-01]; Duke-NUS Signature Research Programme - Ministry of Health, Singapore	Singapore Ministry of Education Tier 3 grant(Ministry of Education, Singapore); National Research Foundation; Duke-NUS Signature Research Programme - Ministry of Health, Singapore(Ministry of Health-SingaporeNational University of Singapore)	We thank the European Virus Archive for providing us with the ZIKV H/PF/2013 strain. We thank S. Lambert for helping to edit the paper. The work is supported by Singapore Ministry of Education Tier 3 grant (MOE2012-T3-1-008), National Research Foundation Investigatorship award (NRF-NRFI2016-01) awarded to S.-M.L. and the Duke-NUS Signature Research Programme funded by the Ministry of Health, Singapore.	Baronti C, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00500-14; Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651; Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13; Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu XG, 2007, J STRUCT BIOL, V160, P11, DOI 10.1016/j.jsb.2007.06.009; Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11; Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9; McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110	29	332	353	1	135	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					425	+		10.1038/nature17994	http://dx.doi.org/10.1038/nature17994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27093288	Bronze			2022-12-28	WOS:000376004300055
J	Liu, W; Li, H; Lu, QB; Cui, N; Yang, ZD; Hu, JG; Fan, YD; Guo, CT; Li, XK; Wang, YW; Liu, K; Zhang, XA; Yuan, L; Zhao, PY; Qin, SL; Cao, WC				Liu, Wei; Li, Hao; Lu, Qing-Bin; Cui, Ning; Yang, Zhen-Dong; Hu, Jian-Gong; Fan, Ya-Di; Guo, Chen-Tao; Li, Xiao-Kun; Wang, Ya-Wei; Liu, Kun; Zhang, Xiao-Ai; Yuan, Lan; Zhao, Pu-Yu; Qin, Shu-Li; Cao, Wu-Chun			Candidatus Rickettsia tarasevichiae Infection in Eastern Central China A Case Series	ANNALS OF INTERNAL MEDICINE			English	Article							TICK-BORNE RICKETTSIOSES; BRAZILIAN SPOTTED-FEVER; THROMBOCYTOPENIA SYNDROME; IXODES-PERSULCATUS; BACTERIAL DISEASES; CLINICAL-FEATURES; IDENTIFICATION; EHRLICHIA; CONORII; LESIONS	Background: Human infection with Candidatus Rickettsia tarasevichiae (CRT) was first reported in northeastern China in 2012. Objective: To describe the clinical spectrum and laboratory findings of patients infected with CRT in eastern central China. Design: Case series. Setting: A sentinel hospital for severe fever with thrombocytopenia syndrome (SFTS) in eastern central China in 2014. Participants: Hospitalized patients with SFTS-like illness. Measurements: Molecular and serologic tests were performed to diagnose CRT infection. Data about clinical manifestations and laboratory findings were retrieved from medical records. Results: 56 of 733 assessed patients had CRT based on polymerase chain reaction and sequencing. All patients presented with nonspecific manifestations, including fever (96%), malaise (88%), myalgia (57%), cough (25%), and dizziness (14%). Only 2 patients had rash. Further, 16% had eschar, 29% had lymphadenopathy, 100% had gastrointestinal symptoms, 34% had neuro-logic symptoms, 43% had hemorrhagic manifestations, and 23% had signs of plasma leakage. Thrombocytopenia was observed in 70%, leukopenia in 59%; lymphopenia in 45%; and elevated levels of lactate dehydrogenase in 82%, aspartate aminotransferase in 70%, alanine aminotransferase in 54%, and creatinine kinase in 46%. Co-infection with SFTS virus was documented in 66% patients, and 8 of the 56 patients died. Limitations: Patients with CRT were not treated for infection because they were retrospectively identified. This was not a population-based study, and the results cannot be generalized to all patients with CRT. Conclusion: Candidatus R tarasevichiae infection should be considered in the differential diagnosis of febrile patients with SFTS-like illness in endemic areas.	[Liu, Wei; Li, Hao; Hu, Jian-Gong; Fan, Ya-Di; Guo, Chen-Tao; Li, Xiao-Kun; Wang, Ya-Wei; Liu, Kun; Zhang, Xiao-Ai; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dong Da St, Beijing 100071, Peoples R China; Peking Univ, Beijing 100191, Peoples R China; [Cui, Ning; Yang, Zhen-Dong; Yuan, Lan; Zhao, Pu-Yu; Qin, Shu-Li] 154 Hosp, Peoples Liberat Army, 104 Nan Hu Rd, Xinyang 464000, Peoples R China; Anhui Med Univ, Hefei, Peoples R China; [Lu, Qing-Bin] Peking Univ, Sch Publ Hlth, 38 Xue Yuan Rd, Beijing 100191, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Peking University; Anhui Medical University; Peking University	Liu, W; Cao, WC (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dong Da St, Beijing 100071, Peoples R China.	lwbime@163.com; caowc@bmi.ac.cn		Liu, Wei/0000-0002-9302-8170	National Natural Science Foundation of China [81222037, 81290344, 81130086]; China Mega-Project for Infectious Diseases [2013ZX10004-202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Mega-Project for Infectious Diseases	By the National Natural Science Foundation of China (grants 81222037, 81290344, and 81130086) and the China Mega-Project for Infectious Diseases (grant 2013ZX10004-202).	Angerami RN, 2006, ANN NY ACAD SCI, V1078, P252, DOI 10.1196/annals.1374.044; Botelho-Nevers E, 2012, EXPERT REV ANTI-INFE, V10, P1425, DOI [10.1586/ERI.12.139, 10.1586/eri.12.139]; Bratton RL, 2005, AM FAM PHYSICIAN, V71, P2323; Brouqui P, 2004, CLIN MICROBIOL INFEC, V10, P1108, DOI 10.1111/j.1469-0691.2004.01019.x; Chen Z, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-237; Cunha BA, 2008, LANCET INFECT DIS, V8, P143, DOI 10.1016/S1473-3099(08)70022-7; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; de Almeida DN, 2010, TICKS TICK-BORNE DIS, V1, P149, DOI 10.1016/j.ttbdis.2010.05.002; Duque V, 2012, J INFECT CHEMOTHER, V18, P105, DOI 10.1007/s10156-011-0295-1; Fang LQ, 2015, LANCET INFECT DIS, V15, P1467, DOI 10.1016/S1473-3099(15)00177-2; Fournier PE, 2004, J CLIN MICROBIOL, V42, P816, DOI 10.1128/JCM.42.2.816-818.2004; Germanakis A, 2006, ANN NY ACAD SCI, V1078, P263, DOI 10.1196/annals.1374.049; Inokuma H, 2007, J VET MED SCI, V69, P661, DOI 10.1292/jvms.69.661; Jia N, 2014, EMERG INFECT DIS, V20, P866, DOI 10.3201/eid2005.130995; Jia N, 2013, NEW ENGL J MED, V369, P1178, DOI 10.1056/NEJMc1303004; Jiang JF, 2015, LANCET INFECT DIS, V15, P196, DOI 10.1016/S1473-3099(14)71046-1; Katargina O, 2015, TICKS TICK-BORNE DIS, V6, P689, DOI 10.1016/j.ttbdis.2015.06.001; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Levy C., 2004, Morbidity and Mortality Weekly Report, V53, P407; Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09679; Liu W, 2013, CLIN INFECT DIS, V57, P1292, DOI 10.1093/cid/cit530; Maleyev VV, 2009, TERAPEVT ARKH, V81, P32; Marzi A, 2015, EMERG INFECT DIS, V21, P305, DOI 10.3201/eid2102.141649; Masters EJ, 2003, ARCH INTERN MED, V163, P769, DOI 10.1001/archinte.163.7.769; Miediannikov O, 2006, ANN NY ACAD SCI, V1078, P80, DOI 10.1196/annals.1374.010; MITTERMAYER T, 1980, FOLIA PARASIT, V27, P373; National Health and Family Planning Commission of the People's Republic of China, 2007, MAN ETH REV BIOM RES; Ni XB, 2014, CLIN MICROBIOL INFEC, V20, P808, DOI 10.1111/1469-0691.12532; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; RANDALL MB, 1984, ARCH PATHOL LAB MED, V108, P963; Raoult D, 2002, CLIN INFECT DIS, V34, P1331, DOI 10.1086/340100; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Romer Y, 2011, EMERG INFECT DIS, V17, P1169, DOI 10.3201/eid1707.101857; Shpynov S, 2003, ANN NY ACAD SCI, V990, P162, DOI 10.1111/j.1749-6632.2003.tb07358.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Walker DH, 2007, CLIN INFECT DIS, V45, pS39, DOI 10.1086/518145; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; WALKER DH, 1985, AM J TROP MED HYG, V34, P361, DOI 10.4269/ajtmh.1985.34.361; Wen BH, 2002, J CLIN MICROBIOL, V40, P3286, DOI 10.1128/JCM.40.9.3286-3290.2002; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	43	25	31	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					641	+		10.7326/M15-2572	http://dx.doi.org/10.7326/M15-2572			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	27019406				2022-12-28	WOS:000375878500011
J	Beura, LK; Hamilton, SE; Bi, K; Schenkel, JM; Odumade, OA; Casey, KA; Thompson, EA; Fraser, KA; Rosato, PC; Filali-Mouhim, A; Sekaly, RP; Jenkins, MK; Vezys, V; Haining, WN; Jameson, SC; Masopust, D				Beura, Lalit K.; Hamilton, Sara E.; Bi, Kevin; Schenkel, Jason M.; Odumade, Oludare A.; Casey, Kerry A.; Thompson, Emily A.; Fraser, Kathryn A.; Rosato, Pamela C.; Filali-Mouhim, Ali; Sekaly, Rafick P.; Jenkins, Marc K.; Vezys, Vaiva; Haining, W. Nicholas; Jameson, Stephen C.; Masopust, David			Normalizing the environment recapitulates adult human immune traits in laboratory mice	NATURE			English	Article							CD8(+) T-CELLS; BARR-VIRUS INFECTION; MEMORY; MOUSE; TRANSLATION; EXPRESSION; GENERATION; MODELS; LOST; GUT	Our current understanding of immunology was largely defined in laboratory mice, partly because they are inbred and genetically homogeneous, can be genetically manipulated, allow kinetic tissue analyses to be carried out from the onset of disease, and permit the use of tractable disease models. Comparably reductionist experiments are neither technically nor ethically possible in humans. However, there is growing concern that laboratory mice do not reflect relevant aspects of the human immune system, which may account for failures to translate disease treatments from bench to bedside(1-8). Laboratory mice live in abnormally hygienic specific pathogen free (SPF) barrier facilities. Here we show that standard laboratory mouse husbandry has profound effects on the immune system and that environmental changes produce mice with immune systems closer to those of adult humans. Laboratory mice-like newborn, but not adult, humans-lack effector-differentiated and mucosally distributed memory T cells. These cell populations were present in free-living barn populations of feral mice and pet store mice with diverse microbial experience, and were induced in laboratory mice after co-housing with pet store mice, suggesting that the environment is involved in the induction of these cells. Altering the living conditions of mice profoundly affected the cellular composition of the innate and adaptive immune systems, resulted in global changes in blood cell gene expression to patterns that more closely reflected the immune signatures of adult humans rather than neonates, altered resistance to infection, and influenced T-cell differentiation in response to a de novo viral infection. These data highlight the effects of environment on the basal immune state and response to infection and suggest that restoring physiological microbial exposure in laboratory mice could provide a relevant tool for modelling immunological events in free- living organisms, including humans.	[Beura, Lalit K.; Schenkel, Jason M.; Casey, Kerry A.; Thompson, Emily A.; Fraser, Kathryn A.; Rosato, Pamela C.; Jenkins, Marc K.; Vezys, Vaiva; Masopust, David] Univ Minnesota, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55414 USA; [Hamilton, Sara E.; Odumade, Oludare A.; Jameson, Stephen C.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55414 USA; [Bi, Kevin; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Bi, Kevin; Haining, W. Nicholas] Childrens Hosp, Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA; [Filali-Mouhim, Ali; Sekaly, Rafick P.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Odumade, Oludare A.] Univ Calif San Diego, Rady Childrens Hosp, Dept Pediat, San Diego, CA 92123 USA; [Casey, Kerry A.] MedImmune LLC, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD 20878 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Case Western Reserve University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; AstraZeneca; Medimmune	Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55414 USA.; Jameson, SC (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55414 USA.	james024@umn.edu; masopust@umn.edu	Casey, Kerry A/B-5274-2011; Jameson, Stephen C/D-9892-2013; Jenkins, Marc K/G-1063-2012; Beura, Lalit/W-6281-2019; Casey, Kerry A/N-1456-2019; masopust, david/B-5027-2008; Schenkel, Jason/AAV-8184-2020; Vezys, Vaiva/N-3144-2013	Casey, Kerry A/0000-0001-7194-8585; Jameson, Stephen C/0000-0001-9137-1146; Jenkins, Marc K/0000-0001-8009-7655; Schenkel, Jason/0000-0003-4641-6872; 	National Institutes of Health [1R01AI111671, R01AI084913, R01AI116678, R01AI075168]; University of Minnesota; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111671, R01AI075168, R01AI116678, P01AI035296, R01AI084913, T32AI007313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grants 1R01AI111671, R01AI084913 (to D.M.), R01AI116678, R01AI075168 (to S.C.J.) and a BSL-3 suite rental waiver grant from the University of Minnesota. We thank R. Ahmed for providing reagents for pilot studies, P. Southern and D. McKenna for tissue samples or cord blood, and all members of the BSL-3 mouse team (University of Minnesota).	Adams AB, 2003, IMMUNOL REV, V196, P147, DOI 10.1046/j.1600-065X.2003.00082.x; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Beura LK, 2015, J LEUKOCYTE BIOL, V97, P217, DOI 10.1189/jlb.1HI0314-154R; Cadwell K, 2015, IMMUNITY, V42, P805, DOI 10.1016/j.immuni.2015.05.003; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Gordon EB, 2015, MBIO, V6, DOI 10.1128/mBio.00725-15; Hamilton SE, 2010, J IMMUNOL, V185, P6584, DOI 10.4049/jimmunol.1001215; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; MACHADO CSM, 1994, ACTA PAEDIATR, V83, P1264, DOI 10.1111/j.1651-2227.1994.tb13011.x; Maizels RM, 2013, NAT IMMUNOL, V14, P879, DOI 10.1038/ni.2643; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Odumade OA, 2012, J EXP MED, V209, P471, DOI 10.1084/jem.20112401; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Payne KJ, 2007, IMMUNITY, V26, P674, DOI 10.1016/j.immuni.2007.05.011; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JC, 2014, EMBO J, V33, P1295, DOI 10.1002/embj.201387651; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Thome J. J. C., 2016, NATURE MED; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; von Herrath MG, 2005, J EXP MED, V202, P1159, DOI 10.1084/jem.20051224; Votavova H, 2011, PLACENTA, V32, P763, DOI 10.1016/j.placenta.2011.06.022; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	42	601	611	8	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					512	+		10.1038/nature17655	http://dx.doi.org/10.1038/nature17655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27096360	Green Accepted			2022-12-28	WOS:000374815900050
J	Coleman, JA; Green, EM; Gouaux, E				Coleman, Jonathan A.; Green, Evan M.; Gouaux, Eric			X-ray structures and mechanism of the human serotonin transporter	NATURE			English	Article							HIGH-AFFINITY RECOGNITION; N-LINKED GLYCOSYLATION; BINDING-SITE; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; NOREPINEPHRINE TRANSPORTERS; SELECTIVE RECOGNITION; ALLOSTERIC BINDING; BACTERIAL HOMOLOG; MEMBRANE-PROTEINS	The serotonin transporter (SERT) terminates serotonergic signalling through the sodium-and chloride-dependent reuptake of neurotransmitter into presynaptic neurons. SERT is a target for antidepressant and psychostimulant drugs, which block reuptake and prolong neurotransmitter signalling. Here we report X-ray crystallographic structures of human SERT at 3.15 A resolution bound to the antidepressants (S)-citalopram or paroxetine. Antidepressants lock SERT in an outward-open conformation by lodging in the central binding site, located between transmembrane helices 1, 3, 6, 8 and 10, directly blocking serotonin binding. We further identify the location of an allosteric site in the complex as residing at the periphery of the extracellular vestibule, interposed between extracellular loops 4 and 6 and transmembrane helices 1, 6, 10 and 11. Occupancy of the allosteric site sterically hinders ligand unbinding from the central site, providing an explanation for the action of (S)-citalopram as an allosteric ligand. These structures define the mechanism of antidepressant action in SERT, and provide blueprints for future drug design.	[Coleman, Jonathan A.; Green, Evan M.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA; [Green, Evan M.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; University of California System; University of California San Francisco	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Coleman, Jonathan/0000-0003-0001-6195	Banting postdoctoral fellowship from the Canadian Institutes of Health Research; National Institutes of Health (NIH) [5R37MH070039]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	Banting postdoctoral fellowship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Cawley for generating monoclonal antibodies and Lundbeck for Br-citalopram. We thank A. Penmatsa and K. Wang for assistance with initial crystal screening, K. Durr and W. Lu for help with Fab crystallization and structure refinement, respectively, L. Vaskalis for assistance with figures, H. Owen for help with manuscript preparation and other Gouaux laboratory members for discussions. We acknowledge the staff of the Berkeley Center for Structural Biology at the Advanced Light Source and the Northeastern Collaborative Access Team at the Advanced Photon Source for assistance with data collection. J.A.C. has support from a Banting postdoctoral fellowship from the Canadian Institutes of Health Research. We are particularly grateful to Bernie and Jennifer LaCroute for their generous support, as well as for funding from the National Institutes of Health (NIH) (5R37MH070039). E.G. is an Investigator with the Howard Hughes Medical Institute.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen J, 2011, P NATL ACAD SCI USA, V108, P12137, DOI 10.1073/pnas.1103060108; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; BLACKBURN K. J., 1967, LIFE SCI, V6, P1653, DOI 10.1016/0024-3205(67)90176-2; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Carlsson A, 1968, J Pharm Pharmacol, V20, P150; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; GALFRE G, 1977, NATURE, V266, P550, DOI 10.1038/266550a0; GLOWINSKI J, 1964, NATURE, V204, P1318, DOI 10.1038/2041318a0; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Green EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145688; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HUMPHREYS CJ, 1994, BIOCHEMISTRY-US, V33, P9118, DOI 10.1021/bi00197a014; Jacobsen JPR, 2014, PSYCHOPHARMACOLOGY, V231, P4527, DOI 10.1007/s00213-014-3595-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Owens MJ, 2001, BIOL PSYCHIAT, V50, P345, DOI 10.1016/S0006-3223(01)01145-3; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; RAPPORT MM, 1948, J BIOL CHEM, V176, P1243; Rasmussen TN, 2009, NEUROPHARMACOLOGY, V57, P287, DOI 10.1016/j.neuropharm.2009.05.009; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2015, METHOD ENZYMOL, V557, P167, DOI 10.1016/bs.mie.2015.01.002; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sorensen L, 2012, J BIOL CHEM, V287, P43694, DOI 10.1074/jbc.M112.342212; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; TATE CG, 1994, J BIOL CHEM, V269, P26303; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; WENNOGLE LP, 1982, EUR J PHARMACOL, V86, P303, DOI 10.1016/0014-2999(82)90333-8; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006; Zhong HL, 2009, NEUROSCI LETT, V462, P207, DOI 10.1016/j.neulet.2009.07.030; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	59	358	363	13	159	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					334	+		10.1038/nature17629	http://dx.doi.org/10.1038/nature17629			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27049939	Green Accepted, Green Submitted			2022-12-28	WOS:000374424700026
J	Lee, BH; Lu, Y; Prado, MA; Shi, Y; Tian, G; Sun, SW; Elsasser, S; Gygi, SP; King, RW; Finley, D				Lee, Byung-Hoon; Lu, Ying; Prado, Miguel A.; Shi, Yuan; Tian, Geng; Sun, Shuangwu; Elsasser, Suzanne; Gygi, Steven P.; King, Randall W.; Finley, Daniel			USP14 deubiquitinates proteasome-bound substrates that are ubiquitinated at multiple sites	NATURE			English	Article							26S PROTEASOME; CYCLIN B1; DEGRADATION; UBP6; PROTEIN; PHOSPHORYLATION; SUFFICIENT; MECHANISMS; EXPRESSION; PROVIDES	USP14 is a major regulator of the proteasome and one of three proteasome-associated deubiquitinating enzymes(1-9). Its effects on protein turnover are substrate-specific, for unknown reasons. We report that USP14 shows a marked preference for ubiquitin-cyclin B conjugates that carry more than one ubiquitin modification or chain. This specificity is conserved from yeast to humans and is independent of chain linkage type. USP14 has been thought to cleave single ubiquitin groups from the distal tip of a chain, but we find that it removes chains from cyclin B en bloc, proceeding until a single chain remains. The suppression of degradation by USP14's catalytic activity reflects its capacity to act on a millisecond time scale, before the proteasome can initiate degradation of the substrate. In addition, single-molecule studies showed that the dwell time of ubiquitin conjugates at the proteasome was reduced by USP14-dependent deubiquitination. In summary, the specificity of the proteasome can be regulated by rapid ubiquitin chain removal, which resolves substrates based on a novel aspect of ubiquitin conjugate architecture.	[Lee, Byung-Hoon; Prado, Miguel A.; Shi, Yuan; Tian, Geng; Sun, Shuangwu; Elsasser, Suzanne; Gygi, Steven P.; King, Randall W.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Lu, Ying] Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA; [Sun, Shuangwu] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Shi, Yuan] Univ Calif Los Angeles, Dept Mol & Clin Pharmacol, Factor 10-638,650 Charles E Young Dr South, Los Angeles, CA 90095 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Zhejiang University; University of California System; University of California Los Angeles	Lee, BH; King, RW; Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	byung-hoon_lee@hms.harvard.edu; randy_king@hms.harvard.edu; daniel_finley@hms.harvard.edu	Prado, Miguel A/P-3922-2017	Prado, Miguel A/0000-0002-4914-1619; Lee, Byung-Hoon/0000-0002-7101-0471	NIH [R01GM5660052, R37-GM043601, R01GM66492-9, 5R01GM039023-26]; Rainwater Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601, R01GM039023, R01GM043601, R01GM066492, R01GM026875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rainwater Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to J. Paulo for expert assistance with mass spectrometry. We thank J. Hanna and Y. Ye for comments on the manuscript, N. Dimova for NCB1 constructs, Y. Ye for USP21 protein, Y. Saeki for PY-Sic1 clones, J. Yuan for USP14 plasmids, and R.P. Fisher and E. Winter for full-length cyclin B1 baculoviruses. This study was supported by NIH grant R01GM5660052 (to D.F.), NIH grant R37-GM043601 (to D.F.), NIH grant R01GM66492-9 (to R.W.K.), NIH grant 5R01GM039023-26 (to M.W. Kirschner), and a grant from the Rainwater Foundation to D.F.	Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Cox CJ, 2002, FEBS LETT, V527, P303, DOI 10.1016/S0014-5793(02)03246-5; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Homma T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11028; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kravtsova-Ivantsiv Y, 2011, ADV EXP MED BIOL, V691, P95, DOI 10.1007/978-1-4419-6612-4_10; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Mansour W, 2015, J BIOL CHEM, V290, P4688, DOI 10.1074/jbc.M114.568295; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Paulo JK, 2015, J PROTEOME RES, V14, P4246, DOI 10.1021/acs.jproteome.5b00398; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Vaden JH, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-3; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Xu D, 2015, ELIFE, V4, DOI 10.7554/eLife.10510; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	29	123	127	5	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					398	+		10.1038/nature17433	http://dx.doi.org/10.1038/nature17433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27074503	Green Accepted, Green Submitted			2022-12-28	WOS:000374424700037
J	Barrett, J; Brown, M				Barrett, Jessica; Brown, Mike			Travellers' diarrhoea	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ESCHERICHIA-COLI; DOUBLE-BLIND; INFECTION; PREVENTION; ETIOLOGY; EFFICACY; SUSCEPTIBILITY; METAANALYSIS; ANTIBIOTICS; LOPERAMIDE		[Barrett, Jessica; Brown, Mike] Univ Coll London Hosp NHS Trust, Hosp Trop Dis, London WC1E 6AU, England; [Brown, Mike] London Sch Hyg & Trop Med, Clin Res Dept, London WC1, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; University of London; London School of Hygiene & Tropical Medicine	Barrett, J (corresponding author), Univ Coll London Hosp NHS Trust, Hosp Trop Dis, London WC1E 6AU, England.	jessica.barrett@gstt.nhs.uk						Alajbegovic S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-39; ARTHUR JD, 1990, AM J TROP MED HYG, V43, P608, DOI 10.4269/ajtmh.1990.43.608; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Behrens RH, 2014, LANCET INFECT DIS, V14, P197, DOI 10.1016/S1473-3099(13)70297-4; Bourgeois AL, 2016, VACCINE; Clasen TF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub3; Dalhoff Axel, 2012, Interdiscip Perspect Infect Dis, V2012, P976273, DOI 10.1155/2012/976273; De Bruyn G, 2000, COCHRANE DB SYST REV, DOI 10.1002/; DuPont AW, 2008, CLIN INFECT DIS, V46, P594, DOI 10.1086/526774; Dupont HL, 2008, ALIMENT PHARM THER, V27, P741, DOI 10.1111/j.1365-2036.2008.03647.x; DuPont HL, 2009, J TRAVEL MED, V16, P149, DOI 10.1111/j.1708-8305.2008.00299.x; Ejemot-Nwadiaro RI, 2015, COCHRANE DB SYST REV, V9; Flores J, 2009, CURR OPIN INFECT DIS, V22, P471, DOI 10.1097/QCO.0b013e3283304eb6; Freeland AL, 2016, MMWR-MORBID MORTAL W, V65, DOI 10.15585/mmwr.mm6501a1; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Greenwood Z, 2008, J TRAVEL MED, V15, P221, DOI 10.1111/j.1708-8305.2008.00203.x; Halland M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1622; Health Protection Agency, 2010, FOR TRAV ASS ILLN FO; Heather CS, 2015, BMJ CLIN EVID, V2015; Henriey D, 2014, TRAVEL MED INFECT DI, V12, P494, DOI 10.1016/j.tmaid.2014.07.002; Hu YM, 2012, J TRAVEL MED, V19, P352, DOI 10.1111/j.1708-8305.2012.00650.x; Kantele A, 2015, TRAVEL MED INFECT DI, V13, P213, DOI 10.1016/j.tmaid.2015.05.005; McGregor A, 2007, J TRAVEL MED, V14, P61, DOI 10.1111/j.1708-8305.2006.00096.x; McGregor AC, 2012, T ROY SOC TROP MED H, V106, P549, DOI 10.1016/j.trstmh.2012.04.008; Nabarro LEB, 2015, CLIN MICROBIOL INFEC, V21, P791, DOI 10.1016/j.cmi.2015.04.019; Nichols Gordon L, 2015, Euro Surveill, V20, DOI 10.2807/1560-7917.ES.2015.20.43.30048; Orekoya O, 2015, CLIN MED, V15, P252, DOI 10.7861/clinmedicine.15-3-252; Pasupuleti V, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002733; Pitzurra R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-231; Public Health England, 2014, INV FAEC SPEC ENT PA, V30; Riddle MS, 2008, CLIN INFECT DIS, V47, P1007, DOI 10.1086/591703; Schindler V M, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.03.005; Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X; Schwille-Kiuntke J, 2015, ALIMENT PHARM THER, V41, P1029, DOI 10.1111/apt.13199; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Sommet J, 2013, ARCH DIS CHILD, V98, P533, DOI 10.1136/archdischild-2012-302500; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; Steffen R, 2015, JAMA-J AM MED ASSOC, V313, P71, DOI 10.1001/jama.2014.17006; Swaminathan A, 2009, J INFECTION, V59, P19, DOI 10.1016/j.jinf.2009.05.008; Ternhag A, 2007, CLIN INFECT DIS, V44, P696, DOI 10.1086/509924; Tham J, 2010, SCAND J INFECT DIS, V42, P275, DOI 10.3109/00365540903493715; von Sonnenburg F, 2000, LANCET, V356, P133, DOI 10.1016/S0140-6736(00)02451-X	42	13	14	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2016	353								i1937	10.1136/bmj.i1937	http://dx.doi.org/10.1136/bmj.i1937			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZF	27094342	Green Published			2022-12-28	WOS:000374999100002
J	Butt, CA				Butt, Carrie A.			Your Golden Hair, Margarete	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1546	1547		10.1001/jama.2015.14216	http://dx.doi.org/10.1001/jama.2015.14216			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	27092820				2022-12-28	WOS:000374289300001
J	DeLoughery, T				DeLoughery, Thomas			F-18-fluorodeoxyglucose PET/CT added to screening after unprovoked VTE did not increase cancer detection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[DeLoughery, Thomas] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	DeLoughery, T (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623; Ihaddadene R, 2016, BLOOD	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					JC45	JC45		10.7326/ACPJC-2016-164-8-045	http://dx.doi.org/10.7326/ACPJC-2016-164-8-045			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	27089095				2022-12-28	WOS:000374257900007
J	Donati, F; Rusponi, S; Stepanow, S; Wackerlin, C; Singha, A; Persichetti, L; Baltic, R; Diller, K; Patthey, F; Fernandes, E; Dreiser, J; Sljivancanin, Z; Kummer, K; Nistor, C; Gambardella, P; Brune, H				Donati, F.; Rusponi, S.; Stepanow, S.; Waeckerlin, C.; Singha, A.; Persichetti, L.; Baltic, R.; Diller, K.; Patthey, F.; Fernandes, E.; Dreiser, J.; Sljivancanin, Z.; Kummer, K.; Nistor, C.; Gambardella, P.; Brune, H.			Magnetic remanence in single atoms	SCIENCE			English	Article							INDIVIDUAL ATOMS; MOLECULE MAGNET; ANISOTROPY; BISTABILITY; SYMMETRY; BLOCKING; SURFACE; COMPLEX	A permanent magnet retains a substantial fraction of its saturation magnetization in the absence of an external magnetic field. Realizing magnetic remanence in a single atom allows for storing and processing information in the smallest unit of matter. We show that individual holmium (Ho) atoms adsorbed on ultrathin MgO(100) layers on Ag(100) exhibit magnetic remanence up to a temperature of 30 kelvin and a relaxation time of 1500 seconds at 10 kelvin. This extraordinary stability is achieved by the realization of a symmetry-protected magnetic ground state and by decoupling the Ho spin from the underlying metal by a tunnel barrier.	[Donati, F.; Rusponi, S.; Waeckerlin, C.; Singha, A.; Baltic, R.; Diller, K.; Patthey, F.; Fernandes, E.; Dreiser, J.; Brune, H.] Ecole Polytech Fed Lausanne, Inst Phys, Stn 3, CH-1015 Lausanne, Switzerland; [Stepanow, S.; Persichetti, L.; Nistor, C.; Gambardella, P.] ETH, Dept Mat, Honggerbergring 64, CH-8093 Zurich, Switzerland; [Dreiser, J.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Sljivancanin, Z.] Vinca Inst Nucl Sci 020, POB 522, Belgrade 11001, Serbia; [Sljivancanin, Z.] Texas A&M Univ Qatar, Doha, Qatar; [Kummer, K.] ESRF, F-38043 Grenoble, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Belgrade; Qatar Foundation (QF); Texas A&M University Qatar; European Synchrotron Radiation Facility (ESRF)	Brune, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Phys, Stn 3, CH-1015 Lausanne, Switzerland.; Gambardella, P (corresponding author), ETH, Dept Mat, Honggerbergring 64, CH-8093 Zurich, Switzerland.	pietro.gambardella@mat.ethz.ch; harald.brune@epfl.ch	Sljivancanin, Zeljko/C-5436-2018; Wäckerlin, Christian/AAC-9097-2021; Wäckerlin, Christian/C-7612-2018; Singha, Aparajita/AAN-8356-2021; Gambardella, Pietro/B-1880-2009; Donati, Fabio/M-9306-2016; Dreiser, Jan/W-6261-2018; Donati, Fabio/AAV-9856-2021; Brune, Harald/E-7284-2017	Sljivancanin, Zeljko/0000-0001-8575-2575; Wäckerlin, Christian/0000-0001-6587-1235; Wäckerlin, Christian/0000-0001-6587-1235; Singha, Aparajita/0000-0001-6301-0394; Gambardella, Pietro/0000-0003-0031-9217; Donati, Fabio/0000-0002-3932-2889; Dreiser, Jan/0000-0001-7480-1271; Donati, Fabio/0000-0002-3932-2889; Brune, Harald/0000-0003-4459-3111; Persichetti, Luca/0000-0001-6578-254X; Cador, Olivier/0000-0003-2064-6223; Stepanow, Sebastian/0000-0002-4090-6574; Rusponi, Stefano/0000-0002-8494-5532; Diller, Katharina/0000-0002-6917-7336	Swiss National Science Foundation [200021-153404, 200020-157081, 200021-146715, PZ00P2 142474, IZ73Z0-152406]; Swiss Competence Centre for Materials Science and Technology (CCMX); ETH Postdoctoral Fellowship [FEL-42 13-2]; "EPFL Fellows" fellowship program - Marie Curie, FP7 grant [291771]; Serbian Ministry of Education and Science [ON171033, ON171017]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Competence Centre for Materials Science and Technology (CCMX); ETH Postdoctoral Fellowship; "EPFL Fellows" fellowship program - Marie Curie, FP7 grant; Serbian Ministry of Education and Science(Ministry of Education, Science & Technological Development, Serbia)	Funding from the Swiss National Science Foundation (grants 200021-153404, 200020-157081, 200021-146715, PZ00P2 142474, and IZ73Z0-152406) and the Swiss Competence Centre for Materials Science and Technology (CCMX) is gratefully acknowledged. L.P. was supported by an ETH Postdoctoral Fellowship (FEL-42 13-2). K.D. acknowledges support from the "EPFL Fellows" fellowship program cofunded by Marie Curie, FP7 grant agreement no. 291771. Z.S. was supported by the Serbian Ministry of Education and Science under grants ON171033 and ON171017. The DFT calculations were performed at the PARADOX-IV supercomputer at the Scientific Computing Laboratory (SCL) of the Institute of Physics Belgrade. The XMCD experiments were performed at the EPFL-PSI X-Treme beamline of the Swiss Light Source (SLS) and the ID32 beamline of the European Synchrotron Radiation Facility (ESRF). The authors declare that they have no competing financial interests.	Baumann S, 2015, SCIENCE, V350, P417, DOI 10.1126/science.aac8703; Blaha P., 2001, WIEN2K; Brune H, 2009, SURF SCI, V603, P1812, DOI 10.1016/j.susc.2008.11.055; Coffey D, 2015, SCI REP-UK, V5, DOI 10.1038/srep13709; Donati F, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.237201; Donati F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.236801; Dreiser J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4891485; Gambardella P, 2003, SCIENCE, V300, P1130, DOI 10.1126/science.1082857; Ganzhorn M, 2013, NAT NANOTECHNOL, V8, P165, DOI [10.1038/nnano.2012.258, 10.1038/NNANO.2012.258]; Giraud R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.057203; Hirjibehedin CF, 2007, SCIENCE, V317, P1199, DOI 10.1126/science.1146110; Hubner C, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155134; Ishikawa N, 2005, J AM CHEM SOC, V127, P3650, DOI 10.1021/ja0428661; Ishikawa N, 2003, J AM CHEM SOC, V125, P8694, DOI 10.1021/ja029629n; Khajetoorians AA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.037205; Khajetoorians AA, 2013, SCIENCE, V339, P55, DOI 10.1126/science.1228519; Loth S, 2012, SCIENCE, V335, P196, DOI 10.1126/science.1214131; Mannini M, 2010, NATURE, V468, P417, DOI 10.1038/nature09478; Meier F, 2008, SCIENCE, V320, P82, DOI 10.1126/science.1154415; Miyamachi T, 2013, NATURE, V503, P242, DOI 10.1038/nature12759; Rau IG, 2014, SCIENCE, V344, P988, DOI 10.1126/science.1252841; Rinehart JD, 2011, J AM CHEM SOC, V133, P14236, DOI 10.1021/ja206286h; SESSOLI R, 1993, NATURE, V365, P141, DOI 10.1038/365141a0; Steinbrecher M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10454; Ungur L, 2014, ANGEW CHEM INT EDIT, V53, P4413, DOI 10.1002/anie.201310451; Yan S, 2015, NAT NANOTECHNOL, V10, P40, DOI [10.1038/NNANO.2014.281, 10.1038/nnano.2014.281]; Zadrozny JM, 2013, NAT CHEM, V5, P577, DOI [10.1038/NCHEM.1630, 10.1038/nchem.1630]	27	202	204	4	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					318	321		10.1126/science.aad9898	http://dx.doi.org/10.1126/science.aad9898			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081065	Green Submitted			2022-12-28	WOS:000373990100034
J	Hawkes, N				Hawkes, Nigel			Education team finalists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2016	353								i2057	10.1136/bmj.i2057	http://dx.doi.org/10.1136/bmj.i2057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EV	27084409				2022-12-28	WOS:000374375600001
J	Stephens, PA; Mason, LR; Green, RE; Gregory, RD; Sauer, JR; Alison, J; Aunins, A; Brotons, L; Butchart, SHM; Campedelli, T; Chodkiewicz, T; Chylarecki, P; Crowe, O; Elts, J; Escandell, V; Foppen, RPB; Heldbjerg, H; Herrando, S; Husby, M; Jiguet, F; Lehikoinen, A; Lindstrom, A; Noble, DG; Paquet, JY; Reif, J; Sattler, T; Szep, T; Teufelbauer, N; Trautmann, S; van Strien, AJ; van Turnhout, CAM; Vorisek, P; Willis, SG				Stephens, Philip A.; Mason, Lucy R.; Green, Rhys E.; Gregory, Richard D.; Sauer, John R.; Alison, Jamie; Aunins, Ainars; Brotons, Lluis; Butchart, Stuart H. M.; Campedelli, Tommaso; Chodkiewicz, Tomasz; Chylarecki, Przemyslaw; Crowe, Olivia; Elts, Jaanus; Escandell, Virginia; Foppen, Ruud P. B.; Heldbjerg, Henning; Herrando, Sergi; Husby, Magne; Jiguet, Frederic; Lehikoinen, Aleksi; Lindstrom, Ake; Noble, David G.; Paquet, Jean-Yves; Reif, Jiri; Sattler, Thomas; Szep, Tibor; Teufelbauer, Norbert; Trautmann, Sven; van Strien, Arco J.; van Turnhout, Chris A. M.; Vorisek, Petr; Willis, Stephen G.			Consistent response of bird populations to climate change on two continents	SCIENCE			English	Article							BODY-SIZE; DYNAMICS; IMPACTS	Global climate change is a major threat to biodiversity. Large-scale analyses have generally focused on the impacts of climate change on the geographic ranges of species and on phenology, the timing of ecological phenomena. We used long-term monitoring of the abundance of breeding birds across Europe and the United States to produce, for both regions, composite population indices for two groups of species: those for which climate suitability has been either improving or declining since 1980. The ratio of these composite indices, the climate impact indicator (CII), reflects the divergent fates of species favored or disadvantaged by climate change. The trend in CII is positive and similar in the two regions. On both continents, interspecific and spatial variation in population abundance trends are well predicted by climate suitability trends.	[Stephens, Philip A.; Willis, Stephen G.] Univ Durham, Sch Biol & Biomed Sci, Conservat Ecol Grp, South Rd, Durham DH1 3LE, England; [Mason, Lucy R.; Green, Rhys E.; Gregory, Richard D.] Royal Soc Protect Birds, Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Green, Rhys E.; Butchart, Stuart H. M.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Downing St, Cambridge CB2 3EJ, England; [Sauer, John R.] US Geol Survey, Patuxent Wildlife Res Ctr, 12100 Beech Forest Rd, Laurel, MD 20708 USA; [Alison, Jamie] Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 3BX, Merseyside, England; [Aunins, Ainars] Univ Latvia, Fac Biol, Jelgavas Iela 1, LV-1004 Riga, Latvia; [Brotons, Lluis] InForest JRU, Ctr Tecnol Forestal Catalunya, Ctr Mediterranean Forest Res, Solsona 25280, Spain; [Brotons, Lluis] REAF, Catalonia 08193, Spain; [Brotons, Lluis] CSIC, Catalonia 08193, Spain; [Butchart, Stuart H. M.] BirdLife Int, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England; [Campedelli, Tommaso] MITO2000 Natl Committee, Via Garibaldi 3, I-52015 Arezzo, Italy; [Chodkiewicz, Tomasz] Ogolnopolskie Towarzystwo Ochrony Ptakow, PL-05270 Odrowaza, Markl, Poland; [Chylarecki, Przemyslaw] Polish Acad Sci, Museum & Inst Zool, Wilcza 64, PL-00679 Warsaw, Poland; [Crowe, Olivia] BirdWatch Ireland, Unit 20 Block D Bullford Business Campus, Wicklow, Kilcoole County, Ireland; [Elts, Jaanus] Univ Tartu, Inst Ecol & Earth Sci, Vanemuise St 46, EE-51014 Tartu, Estonia; [Elts, Jaanus] Estonian Ornithol Soc, Veski 4, EE-51005 Tartu, Estonia; [Escandell, Virginia] Soc Espanola Ornitol, BirdLife Melquiad Biencinto 34, Madrid 28053, Spain; [Foppen, Ruud P. B.] European Bird Census Council, POB 6521, NL-6503 GA Nijmegen, Netherlands; [Foppen, Ruud P. B.; van Turnhout, Chris A. M.] Sovon Dutch Ctr Field Ornithol, POB 6521, NL-6503 GA Nijmegen, Netherlands; [Foppen, Ruud P. B.; van Turnhout, Chris A. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, POB 9010, NL-6500 GL Nijmegen, Netherlands; [Heldbjerg, Henning] Dansk Ornitologisk Forening BirdLife Denmark, Vesterbrogade 140, DK-1620 Copenhagen V, Denmark; [Heldbjerg, Henning] Univ Aarhus, Vesterbrogade 140, DK-1620 Copenhagen V, Denmark; [Herrando, Sergi] Nat Hist Museum Barcelona, Catalan Ornithol Inst, European Bird Census Council, Pl Leonardo da Vinci 4-5, Barcelona 08019, Catalonia, Spain; [Husby, Magne] Nord Univ, Sect Sci, N-7600 Levanger, Norway; [Jiguet, Frederic] Univ Paris 06, CESCO, CRBPO, UMR7204,Sorbonne Univ MNHN CNRS, CP 135,43 Rue Buffon, F-75005 Paris, France; [Lehikoinen, Aleksi] Univ Helsinki, Finnish Museum Nat Hist, Helsinki Lab Ornithol, POB 17, FIN-00014 Helsinki, Finland; [Lindstrom, Ake] Lund Univ, Dept Biol, Biodivers Unit, Ecol Bldg, S-22362 Lund, Sweden; [Noble, David G.] British Trust Ornithol, Norfolk IP24 2PU, England; [Paquet, Jean-Yves] Dept Etudes, Rue Nanon 98, B-5000 Namur, Belgium; [Reif, Jiri] Charles Univ Prague, Fac Sci, Inst Environm Studies, Prague, Czech Republic; [Reif, Jiri] Palacky Univ, Fac Sci, Dept Zool, 17 Listopadu 50, Olomouc 77143, Czech Republic; [Reif, Jiri; Vorisek, Petr] Palacky Univ, Fac Sci, Ornithol Lab, 17 Listopadu 50, Olomouc 77143, Czech Republic; [Sattler, Thomas] Swiss Ornithol Inst, Seerose 1, CH-6204 Sempach, Switzerland; [Szep, Tibor] Univ Nyiregyhaza, Inst Environm Sci, Sostoi Ut 31-B, H-4400 Nyiregyhaza, Hungary; [Teufelbauer, Norbert] BirdLife Austria, Museumspl 1-10-8, A-1070 Vienna, Austria; [Trautmann, Sven] Dachverband Deutsch Avifaunisten eV, Federat German Avifaunists, Speichern 6, D-48157 Munster, Germany; [van Strien, Arco J.] Stat Netherlands, POB 24500, NL-2490 HA The Hague, Netherlands; [Vorisek, Petr] Czech Soc Ornithol, Pan European Common Bird Monitoring Scheme, Na Belidle 252-34, CZ-15000 Prague 5, Czech Republic	Durham University; Royal Society for Protection of Birds; University of Cambridge; United States Department of the Interior; United States Geological Survey; University of Liverpool; University of Latvia; Centre Tecnologic Forestal de Catalunya (CTFC); Consejo Superior de Investigaciones Cientificas (CSIC); BirdLife International; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Radboud University Nijmegen; Aarhus University; Nord University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Helsinki; Lund University; British Trust for Ornithology; Charles University Prague; Palacky University Olomouc; Palacky University Olomouc; Swiss Ornithological Institute	Willis, SG (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Conservat Ecol Grp, South Rd, Durham DH1 3LE, England.	s.g.willis@durham.ac.uk	Elts, Jaanus/W-3205-2019; van Strien, Arco/AAG-1843-2020; Aunins, Ainars/H-4927-2011; Chodkiewicz, Tomasz/AAC-4975-2019; Butchart, Stuart/AAJ-1852-2021; Chylarecki, Przemysław/B-7696-2013; Alison, Jamie/F-2393-2019; Vorisek, Petr/E-3336-2012; Stephens, Philip/B-8397-2008; Lehikoinen, Aleksi/O-5444-2016; Reif, Jiri/I-9168-2017; Butchart, Stuart HM/Y-2711-2018; Mason, Lucy/I-2499-2019; Willis, Stephen G/F-8503-2015; Brotons, Lluís/D-1570-2009; Heldbjerg, Henning/GRF-3351-2022	Aunins, Ainars/0000-0002-6051-1879; Butchart, Stuart/0000-0002-1140-4049; Chylarecki, Przemysław/0000-0001-6863-4294; Alison, Jamie/0000-0002-6787-6192; Stephens, Philip/0000-0001-5849-788X; Reif, Jiri/0000-0003-2553-7333; Mason, Lucy/0000-0001-9567-6262; Willis, Stephen G/0000-0002-8656-5808; Brotons, Lluís/0000-0002-4826-4457; Chodkiewicz, Tomasz/0000-0002-9342-2370; Sattler, Thomas/0000-0001-5359-6387; Heldbjerg, Henning/0000-0003-4268-2671; Herrando, Sergi/0000-0002-5153-7970; Elts, Jaanus/0000-0002-2672-4918; Lehikoinen, Aleksi/0000-0002-1989-277X; Gregory, Richard/0000-0002-7419-5053; Paquet, Jean-Yves/0000-0002-2068-7976	Royal Society for the Protection of Birds; European Environment Agency; European Commission; Durham University's Grevillea Trust	Royal Society for the Protection of Birds; European Environment Agency; European Commission(European CommissionEuropean Commission Joint Research Centre); Durham University's Grevillea Trust	The climate suitability and population trend data for individual species at the country/state level are provided as supplementary material ( table S6) ( 20). Climate data are available from www.worldclim.org/. This work has been part-funded by the Royal Society for the Protection of Birds, the European Environment Agency, the European Commission, and Durham University's Grevillea Trust. We thank A. Teller and K. Biala for support; M. Flade, J. Schwarz, and C. Gruneberg for data provision; and M. Clement (U.S. Geological Survey) and two anonymous referees for comments on an earlier draft.	[Anonymous], 2014, AICHI TARGETS PASSPO; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; BirdLife International, 2004, BIRDS EUR POP EST TR; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Illan JG, 2014, GLOBAL CHANGE BIOL, V20, P3351, DOI 10.1111/gcb.12642; IPCC, 2018, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Jiguet F, 2010, P ROY SOC B-BIOL SCI, V277, P3601, DOI 10.1098/rspb.2010.0796; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; van de Pol M, 2010, ECOLOGY, V91, P1192, DOI 10.1890/09-0410.1; World Wildlife Fund, 2014, LIV PLAN REP 2014 SP	23	165	175	13	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					84	87		10.1126/science.aac4858	http://dx.doi.org/10.1126/science.aac4858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034371	Green Accepted			2022-12-28	WOS:000373039600040
J	Briggs, A				Briggs, Adam			Sugar tax could sweeten a market failure	NATURE			English	Editorial Material									[Briggs, Adam] Univ Oxford, Oxford OX1 2JD, England	University of Oxford	Briggs, A (corresponding author), Univ Oxford, Oxford OX1 2JD, England.	adam.briggs@dph.ox.ac.uk		Briggs, Adam/0000-0002-2314-1039				Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704	1	8	8	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					551	551		10.1038/531551a	http://dx.doi.org/10.1038/531551a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH8EX	27029244	Bronze			2022-12-28	WOS:000373027400004
J	De Leo, S; Lee, SY; Braverman, LE				De Leo, Simone; Lee, Sun Y.; Braverman, Lewis E.			Hyperthyroidism	LANCET			English	Review							AMERICAN THYROID ASSOCIATION; ANTITHYROID DRUG-TREATMENT; CLINICAL ENDOCRINOLOGISTS GUIDELINES; GRAVES-DISEASE; RADIOIODINE THERAPY; THYROTROPIN-RECEPTOR; SENSITIVE THYROTROPIN; PAINLESS THYROIDITIS; SUBACUTE THYROIDITIS; CONSENSUS STATEMENT	Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the clinical syndrome of excess circulating thyroid hormones, irrespective of the source. The most common cause of hyperthyroidism is Graves' disease, followed by toxic nodular goitre. Other important causes of thyrotoxicosis include thyroiditis, iodine-induced and drug-induced thyroid dysfunction, and factitious ingestion of excess thyroid hormones. Treatment options for Graves' disease include antithyroid drugs, radioactive iodine therapy, and surgery, whereas antithyroid drugs are not generally used long term in toxic nodular goitre, because of the high relapse rate of thyrotoxicosis after discontinuation. beta blockers are used in symptomatic thyrotoxicosis, and might be the only treatment needed for thyrotoxicosis not caused by excessive production and release of the thyroid hormones. Thyroid storm and hyperthyroidism in pregnancy and during the post-partum period are special circumstances that need careful assessment and treatment.	[De Leo, Simone] Fdn IRCCS Ca Granda, Endocrine Unit, Milan, Italy; [De Leo, Simone] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [De Leo, Simone; Lee, Sun Y.; Braverman, Lewis E.] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, 88 East Newton St,Evans 201, Boston, MA 02118 USA	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Boston University	Braverman, LE (corresponding author), Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, 88 East Newton St,Evans 201, Boston, MA 02118 USA.	lewis.braverman@bmc.org	de leo, simone/D-5947-2015	de leo, simone/0000-0002-1534-8216; Lee, Sun Young/0000-0002-6928-7471	National Institutes of Health [NIH T32DK007201-37]; National Italian American Foundation; Fondazione Bracco; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Italian American Foundation; Fondazione Bracco; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This Seminar was supported in part by the National Institutes of Health (NIH T32DK007201-37 to SYL) and the National Italian American Foundation and Fondazione Bracco (to SDL).	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Abraham P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003420.pub4; Abraham-Nordling M, 2011, EUR J ENDOCRINOL, V165, P899, DOI 10.1530/EJE-11-0548; Acharya SH, 2008, CLIN ENDOCRINOL, V69, P943, DOI 10.1111/j.1365-2265.2008.03279.x; Akamizu T, 2012, THYROID, V22, P661, DOI 10.1089/thy.2011.0334; Alexander EK, 2002, J CLIN ENDOCR METAB, V87, P1073, DOI 10.1210/jc.87.3.1073; ALLANNIC H, 1990, J CLIN ENDOCR METAB, V70, P675, DOI 10.1210/jcem-70-3-675; Anagnostis P, 2013, ENDOCRINE, V44, P448, DOI 10.1007/s12020-013-9895-0; Andersen SL, 2015, J CLIN ENDOCR METAB, V100, P1164, DOI 10.1210/jc.2014-3588; Andersen SL, 2013, J CLIN ENDOCR METAB, V98, P4373, DOI 10.1210/jc.2013-2831; Andrade VA, 2001, J CLIN ENDOCR METAB, V86, P3488, DOI 10.1210/jc.86.8.3488; Angell TE, 2015, J CLIN ENDOCR METAB, V100, P451, DOI 10.1210/jc.2014-2850; Antonelli A, 2013, THYROID, V23, P1461, DOI 10.1089/thy.2012.0485; Azizi F, 2006, EXPERT OPIN DRUG SAF, V5, P107, DOI 10.1517/14740338.5.1.107; Bahn R, 2008, THYROID, V18, P281, DOI 10.1089/thy.2008.0034; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Bahn Rebecca S, 2009, Thyroid, V19, P673, DOI 10.1089/thy.2009.0169; Barbesino G, 2013, J CLIN ENDOCR METAB, V98, P2247, DOI 10.1210/jc.2012-4309; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; Bartalena L, 2008, THYROID, V18, P333, DOI 10.1089/thy.2007.0315; Bartalena L, 2014, J ENDOCRINOL INVEST, V37, P691, DOI 10.1007/s40618-014-0097-2; Bartalena L, 2013, NAT REV ENDOCRINOL, V9, P724, DOI 10.1038/nrendo.2013.193; Beck-Peccoz P, 2013, WERNER INGBARS THYRO, P393; Benker G, 1998, CLIN ENDOCRINOL, V49, P451, DOI 10.1046/j.1365-2265.1998.00554.x; Biondi B, 2010, NAT REV ENDOCRINOL, V6, P431, DOI 10.1038/nrendo.2010.105; Boelaert K, 2010, J CLIN ENDOCR METAB, V95, P2715, DOI 10.1210/jc.2009-2495; Boelaert K, 2009, CLIN ENDOCRINOL, V70, P129, DOI 10.1111/j.1365-2265.2008.03291.x; Bojic T, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0023-3; Bonnema SJ, 2012, ENDOCR REV, V33, P920, DOI 10.1210/er.2012-1030; Bowman P, 2011, J THROID RES, V2011, DOI 10.4061/2011/235130; Brix TH, 2012, CLIN ENDOCRINOL, V76, P457, DOI 10.1111/j.1365-2265.2011.04318.x; BURCH HB, 1993, ENDOCRIN METAB CLIN, V22, P263, DOI 10.1016/S0889-8529(18)30165-8; Burch HB, 2001, J CLIN ENDOCR METAB, V86, P3016, DOI 10.1210/jc.86.7.3016; Burch HB, 2012, J CLIN ENDOCR METAB, V97, P4549, DOI 10.1210/jc.2012-2802; Cappelli C, 2008, EUR J RADIOL, V65, P99, DOI 10.1016/j.ejrad.2007.03.015; Carella C, 2006, THYROID, V16, P295, DOI 10.1089/thy.2006.16.295; Ceccarelli C, 2006, CLIN ENDOCRINOL, V65, P446, DOI 10.1111/j.1365-2265.2006.02613.x; Chen DY, 2014, EXP CLIN ENDOCR DIAB, V122, P1, DOI 10.1055/s-0033-1358484; Chen QX, 2014, CARDIOLOGY, V127, P176, DOI 10.1159/000356954; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; de Rooij A, 2009, EUR J ENDOCRINOL, V161, P771, DOI 10.1530/EJE-09-0286; DELOSSANTOS ET, 1989, ARCH INTERN MED, V149, P526, DOI 10.1001/archinte.149.3.526; Devereaux D, 2014, EMERG MED CLIN N AM, V32, P277, DOI 10.1016/j.emc.2013.12.001; Eckstein AK, 2006, J CLIN ENDOCR METAB, V91, P3464, DOI 10.1210/jc.2005-2813; Erbil Y, 2007, J CLIN ENDOCR METAB, V92, P2182, DOI 10.1210/jc.2007-0229; Eskes SA, 2012, J CLIN ENDOCR METAB, V97, P499, DOI 10.1210/jc.2011-2390; Fatourechi V, 2012, BEST PRACT RES CL EN, V26, P551, DOI [10.1016/j.beem.2011.10.001, 10.1016/j.beem.2012.07.002]; Fatourechi V, 2003, J CLIN ENDOCR METAB, V88, P2100, DOI 10.1210/jc.2002-021799; Fatourechi V, 2002, J CLIN ENDOCR METAB, V87, P5435, DOI 10.1210/jc.2002-020746; Madariaga AG, 2014, J CLIN ENDOCR METAB, V99, P923, DOI 10.1210/jc.2013-2409; Genovese BM, 2013, ANN SURG ONCOL, V20, P660, DOI 10.1245/s10434-012-2606-x; Gianetti E, 2015, J ENDOCRINOL INVEST, V38, P977, DOI 10.1007/s40618-015-0281-z; Goichot B, 2015, CLIN ENDOCRINOL OXF; Hauch A, 2014, ANN SURG ONCOL, V21, P3844, DOI 10.1245/s10434-014-3846-8; HEDBERG CW, 1987, NEW ENGL J MED, V316, P993, DOI 10.1056/NEJM198704163161605; Hershman JM, 2013, WERNER INGBARS THYRO, P409; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Ide A, 2014, THYROID, V24, P1027, DOI 10.1089/thy.2013.0585; Isozaki O, 2016, CLIN ENDOCRINOL, V84, P912, DOI 10.1111/cen.12949; Kahaly GJ, 2011, THYROID, V21, P585, DOI 10.1089/thy.2011.2106.ed3; Kandil E, 2013, SURGERY, V154, P1346, DOI 10.1016/j.surg.2013.04.068; Kaykhaei MA, 2008, ENDOCRINE, V34, P52, DOI 10.1007/s12020-008-9107-5; Kim HJ, 2001, AM J GASTROENTEROL, V96, P165; Klubo-Gwiezdzinska J, 2012, MED CLIN N AM, V96, P385, DOI 10.1016/j.mcna.2012.01.015; Koenig RJ, 2005, THYROID, V15, P835, DOI 10.1089/thy.2005.15.835; Korelitz JJ, 2013, THYROID, V23, P758, DOI 10.1089/thy.2012.0488; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Krohn K, 2001, J CLIN ENDOCR METAB, V86, P3336, DOI 10.1210/jc.86.7.3336; Kubota S, 2013, THYROID, V23, P269, DOI 10.1089/thy.2012.0459; la Cour JL, 2015, EUR J ENDOCRINOL, V172, P771, DOI 10.1530/EJE-14-1105; Laurberg P, 2014, CURR OPIN ENDOCRINOL, V21, P415, DOI 10.1097/MED.0000000000000088; Laurberg P, 2010, BEST PRACT RES CL EN, V24, P13, DOI 10.1016/j.beem.2009.08.013; Lee RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.042; Liu XM, 2015, EUR J ENDOCRINOL, V172, P321, DOI 10.1530/EJE-14-0704; Maia AL, 2013, ARQ BRAS ENDOCRINOL, V57, P205, DOI 10.1590/S0004-27302013000300006; Marino M, 2015, J ENDOCRINOL INVEST, V38, P283, DOI 10.1007/s40618-014-0214-2; McLeod DSA, 2012, ENDOCRINE, V42, P252, DOI 10.1007/s12020-012-9703-2; Meikle AW, 2004, THYROID, V14, pS17; Menconi F, 2014, AUTOIMMUN REV, V13, P398, DOI 10.1016/j.autrev.2014.01.013; MILNER MR, 1990, PHARMACOTHERAPY, V10, P100; Mohlin E, 2014, EUR J ENDOCRINOL, V170, P419, DOI 10.1530/EJE-13-0811; Moon JH, 2013, ENDOCRINOL METAB, V28, P275, DOI 10.3803/EnM.2013.28.4.275; Nakamura H, 2007, J CLIN ENDOCR METAB, V92, P2157, DOI 10.1210/jc.2006-2135; Nakamura H, 2013, J CLIN ENDOCR METAB, V98, P4776, DOI 10.1210/jc.2013-2569; Noh JY, 2009, J CLIN ENDOCR METAB, V94, P2806, DOI 10.1210/jc.2008-2700; Nystrom HF, 2013, CLIN ENDOCRINOL, V78, P768, DOI 10.1111/cen.12060; OKAMURA K, 1987, J CLIN ENDOCR METAB, V65, P719, DOI 10.1210/jcem-65-4-719; Ota H, 2007, CLIN ENDOCRINOL, V67, P41, DOI 10.1111/j.1365-2265.2007.02832.x; Otsuka F, 2012, CLIN ENDOCRINOL, V77, P310, DOI 10.1111/j.1365-2265.2012.04365.x; Palit TK, 2000, J SURG RES, V90, P161, DOI 10.1006/jsre.2000.5875; Paschke R, 1997, NEW ENGL J MED, V337, P1675, DOI 10.1056/NEJM199712043372307; Pearce EN, 2015, BEST PRACT RES CL OB, V29, P700, DOI 10.1016/j.bpobgyn.2015.04.007; Pearce EN, 2011, THYROID, V21, P573, DOI 10.1089/thy.2011.0104; Pearce EN, 2003, NEW ENGL J MED, V348, P2646, DOI 10.1056/NEJMra021194; Pradeep PV, 2007, WORLD J SURG, V31, P306, DOI 10.1007/s00268-006-0572-9; Quadbeck B, 2005, THYROID, V15, P1047, DOI 10.1089/thy.2005.15.1047; Razvi S, 2006, EUR J ENDOCRINOL, V154, P783, DOI 10.1530/eje.1.02169; Rivkees SA, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/132041; Rivkees SA, 2010, J CLIN ENDOCR METAB, V95, P3260, DOI 10.1210/jc.2009-2546; Robinson J, 2014, EUR THYROID J, V3, P245, DOI 10.1159/000367990; Rokni H, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.14424; Ross DS, 2011, NEW ENGL J MED, V364, P542, DOI 10.1056/NEJMct1007101; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Ryodi E, 2015, J CLIN ENDOCR METAB, V100, P3710, DOI 10.1210/jc.2015-1874; Santos RB, 2004, THYROID, V14, P525, DOI 10.1089/1050725041517093; Sato S, 2015, THYROID, V25, P43, DOI 10.1089/thy.2014.0084; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Schott M, 2004, HORM METAB RES, V36, P92, DOI 10.1055/s-2004-814217; Schwartz F, 2013, SCAND J CLIN LAB INV, V73, P240, DOI 10.3109/00365513.2013.769623; Schwartz KM, 2002, J CLIN ENDOCR METAB, V87, P438, DOI 10.1210/jc.87.2.438; Selmer C, 2014, J CLIN ENDOCR METAB, V99, P2372, DOI 10.1210/jc.2013-4184; Shiber S, 2014, THYROID, V24, P1515, DOI 10.1089/thy.2014.0218; Shinall MC, 2013, ANN SURG ONCOL, V20, P2964, DOI 10.1245/s10434-013-3126-z; Siu CW, 2007, HEART, V93, P483, DOI 10.1136/hrt.2006.100628; Stagnaro-Green A, 2012, J CLIN ENDOCR METAB, V97, P334, DOI 10.1210/jc.2011-2576; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Stan MN, 2013, THYROID, V23, P620, DOI 10.1089/thy.2012.0258; Swee DS, 2015, ENDOCR PRACT, V21, P182, DOI 10.4158/EP14023.OR; Takata K, 2010, CLIN ENDOCRINOL, V72, P845, DOI 10.1111/j.1365-2265.2009.03745.x; TALLSTEDT L, 1992, NEW ENGL J MED, V326, P1733, DOI 10.1056/NEJM199206253262603; Tozzoli R, 2012, AUTOIMMUN REV, V12, P107, DOI 10.1016/j.autrev.2012.07.003; Traisk F, 2009, J CLIN ENDOCR METAB, V94, P3700, DOI 10.1210/jc.2009-0747; Traube E, 2011, TEX HEART I J, V38, P225; Tsatsoulis A, 2000, EUR J ENDOCRINOL, V142, P231, DOI 10.1530/eje.0.1420231; Vaidya B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5128; VANSOESTBERGEN MJM, 1992, J ENDOCRINOL INVEST, V15, P797, DOI 10.1007/BF03348807; Vejbjerg P, 2009, CLIN ENDOCRINOL, V71, P440, DOI 10.1111/j.1365-2265.2008.03493.x; Vijayakumar A, 2014, J THROID RES, V2014, DOI 10.1155/2014/649502; Walter MA, 2006, EUR J NUCL MED MOL I, V33, P730, DOI 10.1007/s00259-006-0092-8; Walter MA, 2007, BRIT MED J, V334, P514, DOI 10.1136/bmj.39114.670150.BE; Wang MT, 2014, BRIT J CLIN PHARMACO, V78, P619, DOI 10.1111/bcp.12336; Watanabe N, 2015, J CLIN ENDOCR METAB, V100, P2700, DOI 10.1210/jc.2014-4542; Watanabe N, 2012, J CLIN ENDOCR METAB, V97, pE49, DOI 10.1210/jc.2011-2221; Werga-Kjellman P, 2001, THYROID, V11, P187, DOI 10.1089/105072501300042947; Wiersinga WM, 2006, EUR J ENDOCRINOL, V155, P387, DOI 10.1530/eje.1.02230; Wiersinga WM, 2013, CLIN ENDOCRINOL, V79, P145, DOI 10.1111/cen.12222; WINSA B, 1991, LANCET, V338, P1475, DOI 10.1016/0140-6736(91)92298-G; Yamashita S, 2011, THYROID, V21, P577, DOI 10.1089/thy.2011.2106.ed1; Yoshihara A, 2012, J CLIN ENDOCR METAB, V97, P2396, DOI 10.1210/jc.2011-2860	141	334	353	13	185	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					906	918		10.1016/S0140-6736(16)00278-6	http://dx.doi.org/10.1016/S0140-6736(16)00278-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU0RI	27038492	Green Accepted			2022-12-28	WOS:000381911800030
J	Kullgren, JT				Kullgren, Jeffrey T.			Injecting Facts Into the Heated Debates Over Medicaid Expansion	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AFFORDABLE CARE ACT; HEALTH; COVERAGE; ACCESS; STATES		[Kullgren, Jeffrey T.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Kullgren, Jeffrey T.] Univ Michigan, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Kullgren, JT (corresponding author), VA Ann Arbor Healthcare Syst, VA Ctr Clin Management Res, POB 130170, Ann Arbor, MI 48113 USA.	jkullgre@med.umich.edu						Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Claxton G, 2015, HEALTH AFFAIR, V34, P1779, DOI 10.1377/hlthaff.2015.0885; Clemans-Cope L, 2013, INQUIRY-J HEALTH CAR, V50, P135, DOI 10.1177/0046958013513675; Kaufman HW, 2015, DIABETES CARE, V38, P833, DOI 10.2337/dc14-2334; Kullgren JT, 2010, ARCH INTERN MED, V170, P1918, DOI 10.1001/archinternmed.2010.428; Rudowitz R., 2015, ACA MEDICAID EXPANSI; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; Sommers BD, 2014, HEALTH AFFAIR, V33, P700, DOI 10.1377/hlthaff.2013.1023; The Henry J Kaiser Family Foundation, STAT STAT ACT MED EX; Wherry LR, 2016, ANN INTERN MED, V164, P795, DOI 10.7326/M15-2234	10	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					848	849		10.7326/M16-0776	http://dx.doi.org/10.7326/M16-0776			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27088778				2022-12-28	WOS:000379343000019
J	Ribrag, V; Koscielny, S; Bosq, J; Leguay, T; Casasnovas, O; Fornecker, LM; Recher, C; Ghesquieres, H; Morschhauser, F; Girault, S; Le Gouill, S; Ojeda-Uribe, M; Mariette, C; Cornillon, J; Cartron, G; Verge, V; Chassagne-Clement, C; Dombret, H; Coiffier, B; Lamy, T; Tilly, H; Salles, G				Ribrag, Vincent; Koscielny, Serge; Bosq, Jacques; Leguay, Thibaut; Casasnovas, Olivier; Fornecker, Luc-Mathieu; Recher, Christian; Ghesquieres, Herve; Morschhauser, Franck; Girault, Stephane; Le Gouill, Steven; Ojeda-Uribe, Mario; Mariette, Clara; Cornillon, Jerome; Cartron, Guillaume; Verge, Veronique; Chassagne-Clement, Catherine; Dombret, Herve; Coiffier, Bertrand; Lamy, Thierry; Tilly, Herve; Salles, Gilles			Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial	LANCET			English	Article							CLEAVED-CELL LYMPHOMA; NON-HODGKIN-LYMPHOMA; CODOX-M/IVAC; MULTIAGENT CHEMOTHERAPY; PLUS RITUXIMAB; SURVIVAL RATE; CHILDREN; LEUKEMIA; ADOLESCENTS; THERAPY	Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm studies suggest that addition of rituximab to these regimens could improve patient outcomes. Our objective was to test this possibility in a randomised trial. Methods In this randomised, controlled, open-label, phase 3 trial, we recruited patients older than 18 years with untreated HIV-negative Burkitt's lymphoma (including Burkitt's leukaemia) from 45 haematological centres in France. Exclusion criteria were contraindications to any drug included in the chemotherapy regimens, any serious comorbidity, poor renal (creatinine concentration >150 mu mol/L) or hepatic (cirrhosis or previous hepatitis B or C) function, pregnancy, and any history of cancer except for non-melanoma skin tumours or stage 0 (in situ) cervical carcinoma. Patients were stratified into two groups based on disease extension (absence [group B] or presence [group C] of bone marrow or central nervous system involvement). Patients were further stratified in group C according to age (<40 years, 40-60 years, and >60 years) and central nervous system involvement. Participants were randomly assigned in each group to either intravenous rituximab injections and chemotherapy (lymphome malin B [LMB]) or chemotherapy alone by the Groupe d'Etude des Lymphomes de l'Adulte datacentre. Randomisation was stratified by treatment group and centre using computer-assisted permuted-block randomisation (block size of four; allocation ratio 1: 1). We gave rituximab (375 mg/m(2)) on day 1 and day 6 during the first two courses of chemotherapy (total of four infusions). The primary endpoint is 3 year event-free survival (EFS). We analysed all patients who had data available according to their originally assigned group. This trial is registered with ClinicalTrials.gov, number NCT00180882. Results Between Oct 14, 2004, and Sept 7, 2010, we randomly allocated 260 patients to rituximab or no rituximab (group B 124 patients [64 no rituximab; 60 rituximab]; group C 136 patients [66 no rituximab; 70 rituximab]). With a median follow-up of 38 months (IQR 24-59), patients in the rituximab group achieved better 3 year EFS (75% [95% CI 66-82]) than did those in the no rituximab group (62% [53-70]; log-rank p stratified by treatment group= 0.024). The hazard ratio estimated with a Cox model stratified by treatment group, assuming proportionality, was 0.59 for EFS (95% CI 0.38-0.94; p= 0.025). Adverse events did not differ between the two treatment groups. The most common adverse events were infectious (grade 3-4 in 137 [17%] treatment cycles in the rituximab group vs 115 [15%] in the no rituximab group) and haematological (mean duration of grade 4 neutropenia of 3.31 days per cycle [95% CI 3.01-3.61] vs 3.38 days per cycle [3.05-3.70]) events. Interpretation Addition of rituximab to a short intensive chemotherapy programme improves EFS in adults with Burkitt's leukaemia or lymphoma.	[Ribrag, Vincent] Univ Paris Saclay, Dept Med, Gustave Roussy, F-94805 Villejuif, France; [Koscielny, Serge] Univ Paris Saclay, Biostat & Epidemiol Unit, Gustave Roussy, F-94805 Villejuif, France; [Bosq, Jacques] Univ Paris Saclay, Dept Biopathol, Morphol Unit, Gustave Roussy, F-94805 Villejuif, France; [Verge, Veronique] Univ Paris Saclay, Haematol Unit, Gustave Roussy, F-94805 Villejuif, France; [Koscielny, Serge] Univ Paris 11, Inst Natl Sante & Rech Med, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Leguay, Thibaut] Ctr Hosp Univ Bordeaux, Serv Hematol Clin & Therapie Cellulaire, Bordeaux, France; [Casasnovas, Olivier] Ctr Hosp Univ Dijon, Serv Hematol Clin, Dijon, France; [Fornecker, Luc-Mathieu] Univ Strasbourg, Hop Hautepierre, Dept Hematol & Oncol, Strasbourg, France; [Recher, Christian] Univ Canc Toulouse Oncopole, Serv Hematol, Toulouse, France; [Ghesquieres, Herve] Univ Lyon 1, Ctr Leon Berard, Oncohematol, F-69365 Lyon, France; [Morschhauser, Franck] Univ Lille, Unite Grp Rech Formes Injectables & Technol Assoc, Serv Malad Sang, Lille, France; [Girault, Stephane] Ctr Hosp Univ Limoges, Hematol Clin & Therapie Cellulaire, Limoges, France; [Le Gouill, Steven] Nantes Univ Hosp, Nantes Inst Natl Sante & Rech Med, Ctr Invest Clin 004,Equipe 10, Inst Natl Sante & Rech Med,Dept Hematol,Unite Mix, Nantes, France; [Ojeda-Uribe, Mario] Hop Emile Muller, Dept Hematol, Ctr Competences Thrombot Microangiopathies, Mulhouse, France; [Ojeda-Uribe, Mario] Hop Emile Muller, Cellular Therapy Unit, Ctr Competences Thrombot Microangiopathies, Mulhouse, France; [Mariette, Clara] Grenoble Univ Hosp, Dept Haematol, Grenoble, France; [Cornillon, Jerome] Inst Canc Lucien Neuwirth, Dept Hematol, Saint Priest En Jarez, France; [Cartron, Guillaume] Ctr Hosp Univ Montpellier, Dept Hematol, Ctr Natl Rech Sci, Unite Mixte Rech 5235, Montpellier, France; [Chassagne-Clement, Catherine] Ctr Leon Berard, Dept Biopathol, F-69373 Lyon, France; [Dombret, Herve] Ctr Hosp Univ Paris, Serv Hematol Clin, Grp Hosp St Louis, Lariboisiere, Fernand Widal, France; [Dombret, Herve] Hop St Louis, Paris, France; [Coiffier, Bertrand] Hosp Civils Lyon, Hematol Clin, Ctr Hosp Lyon Sud, Pierre Benite, France; [Lamy, Thierry] Rennes Univ Hosp, Dept Clin Hematol, Rennes, France; [Lamy, Thierry] Univ Rennes 1, Inst Natl Sante & Rech, Unite Mixte Rech 917, Rennes Dept Clin Invest,Rennes Univ Hosp,Fac Med, Rennes, France; [Tilly, Herve] Univ Rouen, Ctr Henri Becquerel, Rouen, France; [Salles, Gilles] Univ Lyon 1, Hosp Civils Lyon, Pierre Benite, France	UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Bordeaux; CHU Dijon Bourgogne; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Universite de Lille - ISITE; Universite de Lille; CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Cancerologie de la Loire; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; CHU de Montpellier; UNICANCER; Centre Leon Berard; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; CHU Rennes; Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UNICANCER; Centre Henri Becquerel; Universite de Rouen Normandie; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Ribrag, V (corresponding author), Univ Paris Saclay, Dept Med, Gustave Roussy, F-94805 Villejuif, France.	vincent.ribrag@gustaveroussy.fr	Salles, Gilles/Z-2336-2019	Salles, Gilles/0000-0002-9541-8666; le gouill, steven/0000-0001-9840-2128; Casasnovas, Rene-Olivier/0000-0002-1156-8983; Cartron, Guillaume/0000-0003-0659-9635; Ojeda-Uribe, Mario/0000-0001-6881-6055	Roche	Roche(Roche Holding)	HT, OC, SLG, GS, and FM have received personal fees from Roche, and OC, GS, and HD have received grants from Roche. All other authors declare no competing interests.	Barnes JA, 2011, ANN ONCOL, V22, P1859, DOI 10.1093/annonc/mdq677; Bishop PC, 2000, CANCER INVEST, V18, P574, DOI 10.3109/07357900009012197; Cairo MS, 2007, BLOOD, V109, P2736, DOI 10.1182/blood-2006-07-036665; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Corazzelli G, 2012, BRIT J HAEMATOL, V156, P234, DOI 10.1111/j.1365-2141.2011.08947.x; Divine M, 2005, ANN ONCOL, V16, P1928, DOI 10.1093/annonc/mdi403; Divine M, 1996, J CLIN ONCOL, V14, P240, DOI 10.1200/JCO.1996.14.1.240; Dunleavy K, 2013, NEW ENGL J MED, V369, P1915, DOI 10.1056/NEJMoa1308392; Goldman S, 2014, BRIT J HAEMATOL, V167, P394, DOI 10.1111/bjh.13040; Hoelzer D, 2014, BLOOD, V124, P3870, DOI 10.1182/blood-2014-03-563627; Intermesoli T, 2013, HAEMATOLOGICA, V98, P1718, DOI 10.3324/haematol.2013.086827; JOST LM, 1995, ANN ONCOL, V6, P445, DOI 10.1093/oxfordjournals.annonc.a059214; Lee EJ, 2001, J CLIN ONCOL, V19, P4014, DOI 10.1200/JCO.2001.19.20.4014; LONGO DL, 1994, J CLIN ONCOL, V12, P2153, DOI 10.1200/JCO.1994.12.10.2153; Machin D, 1997, SAMPLE SIZE TABLES C, P251; Magrath I, 1996, J CLIN ONCOL, V14, P925, DOI 10.1200/JCO.1996.14.3.925; Mead GM, 2002, ANN ONCOL, V13, P1264, DOI 10.1093/annonc/mdf253; Mead GM, 2008, BLOOD, V112, P2248, DOI 10.1182/blood-2008-03-145128; MURPHY SB, 1980, SEMIN ONCOL, V7, P332; PATTE C, 1991, J CLIN ONCOL, V9, P123, DOI 10.1200/JCO.1991.9.1.123; PATTE C, 1986, J CLIN ONCOL, V4, P1219, DOI 10.1200/JCO.1986.4.8.1219; Patte C, 2001, BLOOD, V97, P3370, DOI 10.1182/blood.V97.11.3370; Patte C, 2007, BLOOD, V109, P2773, DOI 10.1182/blood-2006-07-036673; Rizzieri DA, 2014, BRIT J HAEMATOL, V165, P102, DOI 10.1111/bjh.12736; Swerdlow SH, 2008, WHO CLASSIFICATION T; Thomas DA, 2006, CANCER-AM CANCER SOC, V106, P1569, DOI 10.1002/cncr.21776; Thomas DA, 1999, J CLIN ONCOL, V17, P2461, DOI 10.1200/JCO.1999.17.8.2461; Todeschini G, 2012, AM J HEMATOL, V87, P22, DOI 10.1002/ajh.22189; Wasterlid T, 2013, ANN ONCOL, V24, P1879, DOI 10.1093/annonc/mdt058	31	117	122	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					2402	2411		10.1016/S0140-6736(15)01317-3	http://dx.doi.org/10.1016/S0140-6736(15)01317-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1ST	27080498				2022-12-28	WOS:000377560100033
J	Ulrich, CM; Grady, C				Ulrich, Connie M.; Grady, Christine			Nurses and Industry: Conflict or Collaboration?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EDUCATION		[Ulrich, Connie M.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Ulrich, Connie M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grady, Christine] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Grady, Christine] NIH, Bldg 10,Room 1C118, Bethesda, MD 20892 USA	University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA	Ulrich, CM (corresponding author), Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA.; Ulrich, CM (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	culrich@nursing.upenn.edu						American Nurses Association, 2015, COD ETH NURS; Grady C, 2008, AM J BIOETHICS, V8, P4, DOI 10.1080/15265160802166017; Grundy Q, 2016, ANN INTERN MED, V164, P733, DOI 10.7326/M15-2522; Hall P, 2001, MED EDUC, V35, P867, DOI 10.1046/j.1365-2923.2001.00919.x; Jutel A, 2008, PLOS MED, V5, P193, DOI 10.1371/journal.pmed.0050005; Meslin EM, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0077-y; Rosenbaum L, 2015, NEW ENGL J MED, V372, P1860, DOI 10.1056/NEJMms1502493; Steinbrook R, 2009, NEW ENGL J MED, V360, P557, DOI 10.1056/NEJMp0900143	8	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2016	164	11					773	+		10.7326/M16-0707	http://dx.doi.org/10.7326/M16-0707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1AI	27042939				2022-12-28	WOS:000377510100010
J	Barouch, DH; Ghneim, K; Bosche, WJ; Li, Y; Berkemeier, B; Hull, M; Bhattacharyya, S; Cameron, M; Liu, JY; Smith, K; Borducchi, E; Cabral, C; Peter, L; Brinkman, A; Shetty, M; Li, HL; Gittens, C; Baker, C; Wagner, W; Lewis, MG; Colantonio, A; Kang, HJ; Li, WJ; Lifson, JD; Piatak, M; Sekaly, RP				Barouch, Dan H.; Ghneim, Khader; Bosche, William J.; Li, Yuan; Berkemeier, Brian; Hull, Michael; Bhattacharyya, Sanghamitra; Cameron, Mark; Liu, Jinyan; Smith, Kaitlin; Borducchi, Erica; Cabral, Crystal; Peter, Lauren; Brinkman, Amanda; Shetty, Mayuri; Li, Hualin; Gittens, Courtney; Baker, Chantelle; Wagner, Wendeline; Lewis, Mark G.; Colantonio, Arnaud; Kang, Hyung-Joo; Li, Wenjun; Lifson, Jeffrey D.; Piatak, Michael, Jr.; Sekaly, Rafick-Pierre			Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus Monkeys	CELL			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; PREDICTING GENE-FUNCTION; RESPONSES; TRANSMISSION; DISEASE; NLRX1; HIV; REPLICATION; PROPAGATION	The earliest events following mucosal HIV-1 infection, prior to measurable viremia, remain poorly understood. Here, by detailed necropsy studies, we show that the virus can rapidly disseminate following mucosal SIV infection of rhesus monkeys and trigger components of the inflammasome, both at the site of inoculation and at early sites of distal virus spread. By 24 hr following inoculation, a proinflammatory signature that lacked antiviral restriction factors was observed in viral RNA-positive tissues. The early innate response included expression of NLRX1, which inhibits antiviral responses, and activation of the TGF-beta pathway, which negatively regulates adaptive immune responses. These data suggest a model in which the virus triggers specific host mechanisms that suppress the generation of antiviral innate and adaptive immune responses in the first few days of infection, thus facilitating its own replication. These findings have important implications for the development of vaccines and other strategies to prevent infection.	[Barouch, Dan H.; Liu, Jinyan; Smith, Kaitlin; Borducchi, Erica; Cabral, Crystal; Peter, Lauren; Brinkman, Amanda; Shetty, Mayuri; Li, Hualin] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Ghneim, Khader; Bhattacharyya, Sanghamitra; Cameron, Mark; Sekaly, Rafick-Pierre] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Bosche, William J.; Li, Yuan; Berkemeier, Brian; Hull, Michael; Lifson, Jeffrey D.; Piatak, Michael, Jr.] Frederick Natl Lab, AIDS & Canc Virus Program, Leidos Biomed Res, Frederick, MD 21702 USA; [Gittens, Courtney; Baker, Chantelle; Wagner, Wendeline; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Colantonio, Arnaud] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Kang, Hyung-Joo; Li, Wenjun] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); BIOQUAL Inc.; University of Massachusetts System; University of Massachusetts Worcester	Barouch, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu	Cameron, Mark/O-6775-2019; Li, Wenjun/F-5634-2015; Barouch, Dan/Y-3918-2019	Cameron, Mark/0000-0003-4768-4094; Li, Wenjun/0000-0001-5335-7386; Peter, Lauren/0000-0002-2105-7503; Brinkman, Amanda/0000-0002-2845-6494	NIH [AI060354, AI078526, AI084794, AI095985, AI096040, AI100645, HHSN261200800001E]; Ragon Institute of MGH, MIT, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, U19AI096040, R01AI084794, U19AI095985, U19AI078526, UM1AI100645, P30AI036219, P30AI060354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH, MIT, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Schultz, Q. Dang, J. Warren, L. Picker, P. Johnson, A. Haase, B. Keele, J. Bess, R. Fast, K. Oswald, R. Shoemaker, T. Hooper, C. Shaver, J. Yalley-Ogunro, I. Koralnik, L. Parenteau, S. Blackmore, E. Balandya, J. Jimenez, K. Stanley, S. Mathews, J. Smith, A. McNally, and F. Stephens for their generous advice, assistance, and reagents. The SIVmac239 peptides were obtained from the NIH AIDS Research and Reference Reagent Program. We acknowledge support from the NIH (AI060354, AI078526, AI084794, AI095985, AI096040, AI100645, and HHSN261200800001E) and the Ragon Institute of MGH, MIT, and Harvard. We dedicate this paper to Dr. Michael Piatak, Jr. in honor of his contributions to this study and so many others.	Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Baden LR, 2015, J INFECT DIS, V211, P518, DOI 10.1093/infdis/jiu485; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo H., 2016, CELL HOST MICROBE, V19; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hirao LA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004311; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Jakobsen MR, 2015, CURR OPIN HIV AIDS, V10, P96, DOI 10.1097/COH.0000000000000129; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Li HL, 2011, J VIROL, V85, P11007, DOI 10.1128/JVI.05346-11; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Lukens JR, 2015, IMMUNITY, V42, P654, DOI 10.1016/j.immuni.2015.03.006; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mostafavi S, 2010, BIOINFORMATICS, V26, P1759, DOI 10.1093/bioinformatics/btq262; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Parvatiyar K, 2011, IMMUNITY, V34, P821, DOI 10.1016/j.immuni.2011.06.006; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thaiss CA, 2015, IMMUNITY, V42, P595, DOI 10.1016/j.immuni.2015.03.010; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	39	94	97	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					656	667		10.1016/j.cell.2016.03.021	http://dx.doi.org/10.1016/j.cell.2016.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27085913	Green Accepted, Bronze			2022-12-28	WOS:000374636800023
J	Krause, S; Bon, V; Senkovska, I; Stoeck, U; Wallacher, D; Tobbens, DM; Zander, S; Pillai, RS; Maurin, G; Coudert, FX; Kaskel, S				Krause, Simon; Bon, Volodymyr; Senkovska, Irena; Stoeck, Ulrich; Wallacher, Dirk; Toebbens, Daniel M.; Zander, Stefan; Pillai, Renjith S.; Maurin, Guillaume; Coudert, Francois-Xavier; Kaskel, Stefan			A pressure-amplifying framework material with negative gas adsorption transitions	NATURE			English	Article							METAL-ORGANIC FRAMEWORK; POROUS COORDINATION POLYMERS; CO2; SORPTION; FLEXIBILITY; SELECTIVITY; SEPARATION; MEMBRANES	Adsorption-based phenomena are important in gas separations(1,2), such as the treatment of greenhouse-gas(3) and toxic-gas(4) pollutants, and in water-adsorption-based heat pumps(5) for solar cooling systems. The ability to tune the pore size, shape and functionality of crystalline porous coordination polymers-or metal-organic frameworks (MOFs)-has made them attractive materials for such adsorption-based applications(3,6-8). The flexibility and guest-molecule-dependent response(9,10) of MOFs give rise to unexpected and often desirable adsorption phenomena(11-14). Common to all isothermal gas adsorption phenomena, however, is increased gas uptake with increased pressure. Here we report adsorption transitions in the isotherms of a MOF (DUT-49) that exhibits a negative gas adsorption; that is, spontaneous desorption of gas (methane and n-butane) occurs during pressure increase in a defined temperature and pressure range. A combination of in situ powder X-ray diffraction, gas adsorption experiments and simulations shows that this adsorption behaviour is controlled by a sudden hysteretic structural deformation and pore contraction of the MOF, which releases guest molecules. These findings may enable technologies using frameworks capable of negative gas adsorption for pressure amplification in micro-and macroscopic system engineering. Negative gas adsorption extends the series of counterintuitive phenomena such as negative thermal expansion(15,16) and negative refractive indices(17) and may be interpreted as an adsorptive analogue of force-amplifying negative compressibility transitions proposed for metamaterials(18).	[Krause, Simon; Bon, Volodymyr; Senkovska, Irena; Stoeck, Ulrich; Kaskel, Stefan] Tech Univ Dresden, Dept Inorgan Chem, Bergstr 66, D-01062 Dresden, Germany; [Wallacher, Dirk] Helmholtz Zentrum Berlin Mat & Energie, Dept Sample Environm, Hahn Meitner Pl 1, D-14109 Berlin, Germany; [Toebbens, Daniel M.; Zander, Stefan] Helmholtz Zentrum Berlin Mat & Energie, Dept Struct & Dynam Energy Mat, Hahn Meitner Pl 1, D-14109 Berlin, Germany; [Pillai, Renjith S.; Maurin, Guillaume] Univ Montpellier, Inst Charles Gerhardt Montpellier UMR CNRS UM ENS, F-34095 Montpellier 05, France; [Coudert, Francois-Xavier] PSL Res Univ, Chim ParisTech, CNRS, Inst Rech Chim Paris, F-75005 Paris, France; [Stoeck, Ulrich] Leibniz Inst Solid State & Mat Res IFW Dresden, Inst Complex Mat, Helmholtzstr 20, D-01069 Dresden, Germany	Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech; Leibniz Institute for Solid State & Materials Research Dresden	Kaskel, S (corresponding author), Tech Univ Dresden, Dept Inorgan Chem, Bergstr 66, D-01062 Dresden, Germany.	stefan.kaskel@chemie.tu-dresden.de	Kaskel, Stefan/T-8393-2017; Bon, Volodymyr/N-6875-2018; MAURIN, Guillaume GM/G-7435-2015; Pillai, Renjith S./B-9682-2008; Krause, Simon/AAU-8501-2020; Coudert, François-Xavier/C-1374-2008	Kaskel, Stefan/0000-0003-4572-0303; Bon, Volodymyr/0000-0002-9851-5031; MAURIN, Guillaume GM/0000-0002-2096-0450; Pillai, Renjith S./0000-0003-0165-3305; Krause, Simon/0000-0001-9504-8514; Coudert, François-Xavier/0000-0001-5318-3910; Senkovska, Irena/0000-0001-7052-1029; Wallacher, Dirk/0000-0002-3391-7048	German Federal Ministry for education and research (project BMBF) [05K13OD3]; Helmholtz-Zentrum Berlin; GENCI [x2015087069]	German Federal Ministry for education and research (project BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz-Zentrum Berlin; GENCI	V.B. thanks the German Federal Ministry for education and research (project BMBF number 05K13OD3). S. Krause, V.B., I.S. and S. Kaskel thank the Helmholtz-Zentrum Berlin for financial support and allocation of synchrotron radiation beam time at the KMC-2 beamline. F.-X.C. thanks GENCI (grant number x2015087069) for access to High-Performance Computing resources. G.M. thanks Institut Universitaire de France for its support. We thank U. Koch for scanning electron microscope images, as well as L. Sarkisov and A. Fuchs for discussions.	Barea E, 2014, CHEM SOC REV, V43, P5419, DOI 10.1039/c3cs60475f; Bon V, 2014, MICROPOR MESOPOR MAT, V188, P190, DOI 10.1016/j.micromeso.2013.12.024; de Vos RM, 1998, SCIENCE, V279, P1710, DOI 10.1126/science.279.5357.1710; Fairen-Jimenez D, 2011, J AM CHEM SOC, V133, P8900, DOI 10.1021/ja202154j; Ferey G, 2009, CHEM SOC REV, V38, P1380, DOI 10.1039/b804302g; Furukawa H, 2014, J AM CHEM SOC, V136, P4369, DOI 10.1021/ja500330a; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/NCHEM.444, 10.1038/nchem.444]; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kondo A, 2006, NANO LETT, V6, P2581, DOI 10.1021/nl062032b; Matsuda R, 2014, NATURE, V509, P434, DOI 10.1038/509434a; McDonald TM, 2015, NATURE, V519, P303, DOI 10.1038/nature14327; Neimark AV, 2010, J PHYS CHEM LETT, V1, P445, DOI 10.1021/jz9003087; Nenoff TM, 2015, NAT CHEM, V7, P377, DOI 10.1038/nchem.2218; Nicolaou ZG, 2012, NAT MATER, V11, P608, DOI [10.1038/NMAT3331, 10.1038/nmat3331]; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; RIEKERT L, 1969, J PHYS CHEM-US, V73, P4384, DOI 10.1021/j100846a066; Salles F, 2010, J AM CHEM SOC, V132, P13782, DOI 10.1021/ja104357r; Sato H, 2014, SCIENCE, V343, P167, DOI 10.1126/science.1246423; Schneemann A, 2014, CHEM SOC REV, V43, P6062, DOI 10.1039/c4cs00101j; Serre C, 2007, ADV MATER, V19, P2246, DOI 10.1002/adma.200602645; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Stoeck U, 2012, CHEM COMMUN, V48, P10841, DOI 10.1039/c2cc34840c; Takashima Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1170; Takenaka K, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/1/013001; Tan JC, 2011, CHEM SOC REV, V40, P1059, DOI 10.1039/c0cs00163e; Thommes M, 2015, PURE APPL CHEM, V87, P1051, DOI 10.1515/pac-2014-1117; Traa Y., 2008, HDB POROUS SOLIDS, P1015; Yang SH, 2012, NAT MATER, V11, P710, DOI [10.1038/NMAT3343, 10.1038/nmat3343]	30	367	370	44	796	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					348	352		10.1038/nature17430	http://dx.doi.org/10.1038/nature17430			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27049950	Green Submitted			2022-12-28	WOS:000374424700028
J	Nissen, SE; Stroes, E; Dent-Acosta, RE; Rosenson, RS; Lehman, SJ; Sattar, N; Preiss, D; Bruckert, E; Ceska, R; Lepor, N; Ballantyne, CM; Gouni-Berthold, I; Elliott, M; Brennan, DM; Wasserman, SM; Somaratne, R; Scott, R; Stein, EA				Nissen, Steven E.; Stroes, Erik; Dent-Acosta, Ricardo E.; Rosenson, Robert S.; Lehman, Sam J.; Sattar, Naveed; Preiss, David; Bruckert, Eric; Ceska, Richard; Lepor, Norman; Ballantyne, Christie M.; Gouni-Berthold, Ioanna; Elliott, Mary; Brennan, Danielle M.; Wasserman, Scott M.; Somaratne, Ransi; Scott, Rob; Stein, Evan A.		GAUSS-3 Investigators	Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance The GAUSS-3 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MONOCLONAL-ANTIBODY; COMBINATION; CHOLESTEROL; ALIROCUMAB; SAFETY; PCSK9; MG	IMPORTANCE Muscle-related statin intolerance is reported by 5% to 20% of patients. OBJECTIVE To identify patients with muscle symptoms confirmed by statin rechallenge and compare lipid-lowering efficacy for 2 nonstatin therapies, ezetimibe and evolocumab. DESIGN, SETTING, AND PARTICIPANTS Two-stage randomized clinical trial including 511 adult patients with uncontrolled low-density lipoprotein cholesterol (LDL-C) levels and history of intolerance to 2 or more statins enrolled in 2013 and 2014 globally. Phase A used a 24-week crossover procedure with atorvastatin or placebo to identify patients having symptoms only with atorvastatin but not placebo. In phase B, after a 2-week washout, patients were randomized to ezetimibe or evolocumab for 24 weeks. INTERVENTIONS Phase A: atorvastatin (20 mg) vs placebo. Phase B: randomization 2: 1 to subcutaneous evolocumab (420 mg monthly) or oral ezetimibe (10 mg daily). MAIN OUTCOME AND MEASURES Coprimary end points were the mean percent change in LDL-C level from baseline to the mean of weeks 22 and 24 levels and from baseline to week 24 levels. RESULTS Of the 491 patients who entered phase A (mean age, 60.7 [SD, 10.2] years; 246 women [50.1%]; 170 with coronary heart disease [34.6%]; entry mean LDL-C level, 212.3 [SD, 67.9] mg/dL), muscle symptoms occurred in 209 of 491 (42.6%) while taking atorvastatin but not while taking placebo. Of these, 199 entered phase B, along with 19 who proceeded directly to phase B for elevated creatine kinase (N = 218, with 73 randomized to ezetimibe and 145 to evolocumab; entry mean LDL-C level, 219.9 [SD, 72] mg/dL). For the mean of weeks 22 and 24, LDL-C level with ezetimibe was 183.0 mg/dL; mean percent LDL-C change, -16.7%(95% CI, -20.5% to -12.9%), absolute change, -31.0mg/dL and with evolocumab was 103.6 mg/dL; mean percent change, -54.5%(95% CI, -57.2% to -51.8%); absolute change, -106.8 mg/dL (P<.001). LDL-C level at week 24 with ezetimibe was 181.5mg/dL; mean percent change, -16.7%(95% CI, -20.8% to -12.5%); absolute change, -31.2 mg/dL and with evolocumab was 104.1 mg/dL; mean percent change, -52.8%(95% CI, -55.8% to -49.8%); absolute change, -102.9 mg/dL (P<.001). For the mean of weeks 22 and 24, between-group difference in LDL-C was -37.8%; absolute difference, -75.8 mg/dL. Forweek 24, between-group difference in LDL-C was -36.1%; absolute difference, -71.7 mg/dL. Muscle symptoms were reported in 28.8% of ezetimibe-treated patients and 20.7% of evolocumab-treated patients (log-rank P=.17). Active study drug was stopped for muscle symptoms in 5 of 73 ezetimibe-treated patients (6.8%) and 1 of 145 evolocumab-treated patients (0.7%). CONCLUSIONS AND RELEVANCE Among patients with statin intolerance related to muscle-related adverse effects, the use of evolocumab compared with ezetimibe resulted in a significantly greater reduction in LDL-C levels after 24 weeks. Further studies are needed to assess long-term efficacy and safety.	[Nissen, Steven E.; Brennan, Danielle M.] Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Stroes, Erik] Univ Amsterdam, Fac Med, Amsterdam, Netherlands; [Dent-Acosta, Ricardo E.; Elliott, Mary; Wasserman, Scott M.; Somaratne, Ransi; Scott, Rob] Amgen Inc, Thousand Oaks, CA 91320 USA; [Rosenson, Robert S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Lehman, Sam J.] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia; [Sattar, Naveed] Univ Glasgow, Glasgow, Lanark, Scotland; [Preiss, David] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Preiss, David] Univ Oxford, Epidemiol Serv Unit, Oxford, England; [Bruckert, Eric] Univ Hosp Paris 6, Paris, France; [Ceska, Richard] Charles Univ Prague, Prague, Czech Republic; [Ceska, Richard] Gen Univ Hosp Prague, Prague, Czech Republic; [Lepor, Norman] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Gouni-Berthold, Ioanna] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, D-50931 Cologne, Germany; [Stein, Evan A.] Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA	Cleveland Clinic Foundation; University of Amsterdam; Amgen; Icahn School of Medicine at Mount Sinai; Flinders University South Australia; University of Glasgow; University of Oxford; University of Oxford; UDICE-French Research Universities; Sorbonne Universite; Charles University Prague; General University Hospital Prague; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baylor College of Medicine; University of Cologne	Nissen, SE (corresponding author), Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org	Ballantyne, Christie/A-6599-2008; Pintus, Paolo/AAQ-7789-2021; Lepor, Norman/AAP-2488-2021; Ceska, Richard/A-1840-2017; Scott, Russell/ABC-8328-2020; Kjaerulf Jensen, Henrik/A-7980-2018; Vigna, Giovanni/H-2826-2015; Blaha, Vladimir/C-1151-2016	Pintus, Paolo/0000-0002-8666-8399; Ceska, Richard/0000-0002-2541-5179; Scott, Russell/0000-0002-2107-6480; Blom, Dirk/0000-0003-3965-5912; Kjaerulf Jensen, Henrik/0000-0003-1802-4302; Vigna, Giovanni/0000-0001-8640-7052; Blaha, Vladimir/0000-0001-8088-9919; Preiss, David/0000-0003-3139-1836; Don-Wauchope, Andrew/0000-0003-2116-2423; Ballantyne, Christie/0000-0002-6432-1730; Krempf, Michel/0000-0002-4353-9511	Amgen Inc.	Amgen Inc.(Amgen)	This study was funded by Amgen Inc.	Athyros VG, 2008, AM J CARDIOL, V101, P483, DOI 10.1016/j.amjcard.2007.09.096; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Mampuya WM, 2013, AM HEART J, V166, P597, DOI 10.1016/j.ahj.2013.06.004; Moriarty PM, 2015, J CLIN LIPIDOL, V9, P758, DOI 10.1016/j.jacl.2015.08.006; Nissen SE, 2016, CLIN CARDIOL, V39, P137, DOI 10.1002/clc.22518; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Schwartz GG, 2014, AM HEART J, V168, P682, DOI 10.1016/j.ahj.2014.07.028; Stein EA, 2008, AM J CARDIOL, V101, P490, DOI 10.1016/j.amjcard.2007.09.099; Stiles S., 2016, FDA SAYS NO EZETIMIB; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790; Taylor BA, 2015, ATHEROSCLEROSIS, V238, P329, DOI 10.1016/j.atherosclerosis.2014.12.016; Tobert JA, 2016, EUR J PREV CARDIOL, V23, P891, DOI 10.1177/2047487315602861; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	17	329	342	4	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1580	1590		10.1001/jama.2016.3608	http://dx.doi.org/10.1001/jama.2016.3608			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	27039291	Bronze			2022-12-28	WOS:000374289300018
J	Wyer, P				Wyer, Peter			Review: Mechanical and manual CPR do not differ for survival or neurologic outcome in out-of-hospital cardiac arrest	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Wyer, Peter] Columbia Univ, Med Ctr, New York, NY USA	Columbia University	Wyer, P (corresponding author), Columbia Univ, Med Ctr, New York, NY USA.							Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011; Ewy GA, 2005, CIRCULATION, V111, P2134, DOI 10.1161/01.CIR.0000162503.57657.FA; Lewis RJ, 2006, JAMA-J AM MED ASSOC, V295, P2661, DOI 10.1001/jama.295.22.2661; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729	4	0	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					JC46	JC46		10.7326/ACPJC-2016-164-8-046	http://dx.doi.org/10.7326/ACPJC-2016-164-8-046			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	27089096				2022-12-28	WOS:000374257900008
J	Ainsworth, TD; Heron, SF; Ortiz, JC; Mumby, PJ; Grech, A; Ogawa, D; Eakin, CM; Leggat, W				Ainsworth, Tracy D.; Heron, Scott F.; Ortiz, Juan Carlos; Mumby, Peter J.; Grech, Alana; Ogawa, Daisie; Eakin, C. Mark; Leggat, William			Climate change disables coral bleaching protection on the Great Barrier Reef	SCIENCE			English	Article							PROJECTIONS; RESISTANCE; RESPONSES; STRESS	Coral bleaching events threaten the sustainability of the Great Barrier Reef (GBR). Here we show that bleaching events of the past three decades have been mitigated by induced thermal tolerance of reef-building corals, and this protective mechanism is likely to be lost under near-future climate change scenarios. We show that 75% of past thermal stress events have been characterized by a temperature trajectory that subjects corals to a protective, sub-bleaching stress, before reaching temperatures that cause bleaching. Such conditions confer thermal tolerance, decreasing coral cell mortality and symbiont loss during bleaching by over 50%. We find that near-future increases in local temperature of as little as 0.5 degrees C result in this protective mechanism being lost, which may increase the rate of degradation of the GBR.	[Ainsworth, Tracy D.; Ogawa, Daisie; Leggat, William] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4810, Australia; [Heron, Scott F.; Eakin, C. Mark] NOAA, Coral Reef Watch, College Pk, MD 20740 USA; [Heron, Scott F.] James Cook Univ, Coll Sci Technol & Engn, Marine Geophys Lab, Townsville, Qld 4811, Australia; [Ortiz, Juan Carlos; Mumby, Peter J.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, Brisbane, Qld 4072, Australia; [Ortiz, Juan Carlos; Mumby, Peter J.] Univ Queensland, Australian Res Council Ctr Excellence Coral Reef, Brisbane, Qld 4072, Australia; [Grech, Alana] Macquarie Univ, Dept Environm Sci, Sydney, NSW 2109, Australia; [Ogawa, Daisie; Leggat, William] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4810, Australia	James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; University of Queensland; University of Queensland; Macquarie University; James Cook University	Ainsworth, TD (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4810, Australia.	tracy.ainsworth@jcu.edu.au	Ainsworth, Tracy D/L-7309-2016; Leggat, Bill/AAJ-8929-2020; Grech, Alana/U-7776-2019; Heron, Scott F/E-7928-2011; Ortiz Cuellar, Juan carlos/GQZ-3899-2022; Mumby, Peter/F-9914-2010; Eakin, C. Mark/F-5585-2010	Ainsworth, Tracy D/0000-0001-6476-9263; Leggat, Bill/0000-0003-4148-2555; Grech, Alana/0000-0003-4117-3779; Mumby, Peter/0000-0002-6297-9053; Heron, Scott/0000-0001-5262-6978; Eakin, C. Mark/0000-0002-5987-0858	Australian Research Council Discovery Program [DP130101421]; Australian Research Council Super Science Program [FS110200046]; Australian Research Council Centre of Excellence for Coral Reef Studies [CE0561435]; Great Barrier Reef Foundation (Coral Health Grant); NOAA National Environmental Satellite, Data, and Information Service; NOAA Coral Reef Conservation Program; FigShare project [12040]	Australian Research Council Discovery Program(Australian Research Council); Australian Research Council Super Science Program(Australian Research Council); Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Great Barrier Reef Foundation (Coral Health Grant); NOAA National Environmental Satellite, Data, and Information Service; NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); FigShare project	The authors thank the following funding bodies: Australian Research Council Discovery Program grant DP130101421 (awarded to W.L. and T.D.A.); Australian Research Council Super Science Program grant FS110200046 (awarded to Terry P. Hughes, Director, Australian Research Council Centre of Excellence for Coral Reef Studies); Australian Research Council Centre of Excellence for Coral Reef Studies grant CE0561435; the Great Barrier Reef Foundation (Coral Health Grant); the NOAA National Environmental Satellite, Data, and Information Service; and the NOAA Coral Reef Conservation Program. The authors thank N. Wolff for providing SST projections and help in analysis of ecosystem model components and M. De Freitas Prazeres for cell counts. The contents in this manuscript are solely the opinions of the authors and do not constitute a statement of policy, decision, or position on behalf of NOAA or the U.S. government. T.D.A., S.F.H., J.C.O., and W.L. designed the study. T.D.A., D.O., and W.L. conducted experimental procedures and physiological analyses. S.F.H. and C.M.E. conducted SST and oceanographic analyses. J.C.O. and P.J.M. conducted predictive modeling and model validation. T.D.A., S.F.H., J.C.O., P.J.M., A.G., C.M.E., and W.L. wrote and finalized the manuscript. Code for the analysis of SST data is available through contact and collaboration with S. Heron (scott.heron@noaa.gov). Code for the ecosystem model is available through contact and collaboration with J.-C. Ortiz (j.ortiz@uq.edu.au). The NOAA data and code are available from a dedicated web page: http://coralreefwatch.noaa.gov/publications/AinsworthEtAl_2016.php. All data and code are available at FigShare project number 12040: Ecosystems model code and scripts (DOI 10.6084/m9.figshare.3081127); Bleaching on the GBR data release (DOI 10.6084/m9.figshare.3081127); Physiology and gene expression data (DOI 10.6084/m9.figshare.3081064). D.O. is currently employed by Boehringer Ingelheim, Fremont, CA. The authors declare no competing financial interests.	Ainsworth TD, 2011, SCI REP-UK, V1, DOI 10.1038/srep00160; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bellantuono AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050685; Bellantuono AJ, 2012, P ROY SOC B-BIOL SCI, V279, P1100, DOI 10.1098/rspb.2011.1780; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Game ET, 2008, ECOL APPL, V18, P670, DOI 10.1890/07-1027.1; Hartmann DL, 2013, PHYS SCI BASIS CONTR; Kwiatkowski L, 2014, CLIM DYNAM, V43, P1483, DOI 10.1007/s00382-013-1967-6; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Lough JM, 2008, J ENVIRON MONITOR, V10, P21, DOI [10.1039/b714627m, 10.1039/B714627M]; Mumby PJ, 2014, CURR BIOL, V24, pR413, DOI 10.1016/j.cub.2014.04.029; Munday PL, 2013, ECOL LETT, V16, P1488, DOI 10.1111/ele.12185; Ortiz JC, 2014, NAT CLIM CHANGE, V4, P1090, DOI 10.1038/NCLIMATE2439; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Riegl BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024802; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; van Hooidonk R, 2013, NAT CLIM CHANGE, V3, P508, DOI [10.1038/NCLIMATE1829, 10.1038/nclimate1829]; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Voolstra CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020392	23	263	268	35	738	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					338	342		10.1126/science.aac7125	http://dx.doi.org/10.1126/science.aac7125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081069				2022-12-28	WOS:000373990100039
J	Guo, J; Lu, JT; Feng, YX; Chen, J; Peng, JB; Lin, ZR; Meng, XZ; Wang, ZC; Li, XZ; Wang, EG; Jiang, Y				Guo, Jing; Lu, Jing-Tao; Feng, Yexin; Chen, Ji; Peng, Jinbo; Lin, Zeren; Meng, Xiangzhi; Wang, Zhichang; Li, Xin-Zheng; Wang, En-Ge; Jiang, Ying			Nuclear quantum effects of hydrogen bonds probed by tip-enhanced inelastic electron tunneling	SCIENCE			English	Article							MOLECULE VIBRATIONAL SPECTROSCOPY; SOLID-STATE; WATER; JUNCTIONS; MICROSCOPY; RESOLUTION; PROTON	We report the quantitative assessment of nuclear quantum effects on the strength of a single hydrogen bond formed at a water-salt interface, using tip-enhanced inelastic electron tunneling spectroscopy based on a scanning tunneling microscope. The inelastic scattering cross section was resonantly enhanced by "gating" the frontier orbitals of water via a chlorine-terminated tip, so the hydrogen-bonding strength can be determined with high accuracy from the red shift in the oxygen-hydrogen stretching frequency of water. Isotopic substitution experiments combined with quantum simulations reveal that the anharmonic quantum fluctuations of hydrogen nuclei weaken the weak hydrogen bonds and strengthen the relatively strong ones. However, this trend can be completely reversed when a hydrogen bond is strongly coupled to the polar atomic sites of the surface.	[Guo, Jing; Feng, Yexin; Chen, Ji; Peng, Jinbo; Lin, Zeren; Meng, Xiangzhi; Wang, Zhichang; Wang, En-Ge; Jiang, Ying] Peking Univ, Sch Phys, Int Ctr Quantum Mat, Beijing 100871, Peoples R China; [Lu, Jing-Tao] Huazhong Univ Sci & Technol, Sch Phys, Wuhan 430074, Peoples R China; [Feng, Yexin] Hunan Univ, Sch Phys & Elect, Changsha 410082, Hunan, Peoples R China; [Li, Xin-Zheng] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Li, Xin-Zheng; Wang, En-Ge; Jiang, Ying] Collaborat Innovat Ctr Quantum Matter, Beijing 100871, Peoples R China	Peking University; Huazhong University of Science & Technology; Hunan University; Peking University	Li, XZ; Wang, EG; Jiang, Y (corresponding author), Peking Univ, Sch Phys, Int Ctr Quantum Mat, Beijing 100871, Peoples R China.; Li, XZ (corresponding author), Peking Univ, Sch Phys, Beijing 100871, Peoples R China.; Li, XZ; Wang, EG; Jiang, Y (corresponding author), Collaborat Innovat Ctr Quantum Matter, Beijing 100871, Peoples R China.	xzli@pku.edu.cn; egwang@pku.edu.cn; yjiang@pku.edu.cn	Lü, Jing-Tao/V-9059-2019; Jiang, Ying/D-3626-2014; Lu, Jing Tao/D-2189-2009	Jiang, Ying/0000-0002-6887-5503; Lu, Jing Tao/0000-0001-8518-2816; Meng, Xiangzhi/0000-0001-7887-4240; Chen, Ji/0000-0003-1603-1963	National Basic Research Programs of China [2012CB921303]; National Natural Science Foundation of China [91321309, 11290162/A040106, 11304107, 61371015, 11422431, 11275008, 11274002, 91021007]; National Program for Support of Top-Notch Young Professionals	National Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Support of Top-Notch Young Professionals	This work was supported by the National Basic Research Programs of China under grant 2012CB921303 and the National Natural Science Foundation of China under grants 91321309, 11290162/A040106, 11304107, 61371015, 11422431, 11275008, 11274002, and 91021007. Y.J. acknowledges support from the National Program for Support of Top-Notch Young Professionals. We are grateful for the computational resources provided by the supercomputer TianHe-1A in Tianjin, China.	Andreani C, 2005, ADV PHYS, V54, P377, DOI 10.1080/00018730500403136; Benoit M, 1998, NATURE, V392, P258, DOI 10.1038/32609; Brougham DF, 1999, NATURE, V397, P241, DOI 10.1038/16672; Chiang CL, 2014, SCIENCE, V344, P885, DOI 10.1126/science.1253405; Galperin M, 2004, J CHEM PHYS, V121, P11965, DOI 10.1063/1.1814076; Galperin M, 2008, SCIENCE, V319, P1056, DOI 10.1126/science.1146556; Gawronski H, 2008, SCIENCE, V319, P930, DOI 10.1126/science.1152473; Greenwood N.N., 1997, CHEM ELEMENTS; Guo J, 2014, NAT MATER, V13, P184, DOI [10.1038/nmat3848, 10.1038/NMAT3848]; Harada Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.193001; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; Hodgson A, 2009, SURF SCI REP, V64, P381, DOI 10.1016/j.surfrep.2009.07.001; Iogansen AV, 1999, SPECTROCHIM ACTA A, V55, P1585, DOI 10.1016/S1386-1425(98)00348-5; Kim Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.126104; Li XZ, 2011, P NATL ACAD SCI USA, V108, P6369, DOI 10.1073/pnas.1016653108; Li YJ, 2016, NANO LETT, V16, P1104, DOI 10.1021/acs.nanolett.5b04340; Lorente N, 2000, PHYS REV LETT, V85, P2997, DOI 10.1103/PhysRevLett.85.2997; Lorente N, 2001, PHYS REV LETT, V86, P2593, DOI 10.1103/PhysRevLett.86.2593; Morgenstern K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.066102; Morrone JA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.017801; Nagata Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.226101; Ohara M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136104; Paesani F, 2009, J PHYS CHEM B, V113, P5702, DOI 10.1021/jp810590c; PERSSON BNJ, 1987, PHYS REV LETT, V59, P339, DOI 10.1103/PhysRevLett.59.339; Pietropaolo A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.127802; Rozenberg M, 2000, PHYS CHEM CHEM PHYS, V2, P2699, DOI 10.1039/b002216k; Song H, 2009, NATURE, V462, P1039, DOI 10.1038/nature08639; Soper AK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.065502; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; Stiopkin IV, 2011, NATURE, V474, P192, DOI 10.1038/nature10173; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Tuckerman ME, 1997, SCIENCE, V275, P817, DOI 10.1126/science.275.5301.817; VOTH GA, 1989, J CHEM PHYS, V91, P7749, DOI 10.1063/1.457242	33	94	105	15	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					321	325		10.1126/science.aaf2042	http://dx.doi.org/10.1126/science.aaf2042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081066				2022-12-28	WOS:000373990100035
J	Murphy, JJ; Bastida, D; Paria, S; Fagnoni, M; Melchiorre, P				Murphy, John J.; Bastida, David; Paria, Suva; Fagnoni, Maurizio; Melchiorre, Paolo			Asymmetric catalytic formation of quaternary carbons by iminium ion trapping of radicals	NATURE			English	Article							LEWIS-ACID CATALYSIS; CONJUGATE ADDITIONS; ENANTIOSELECTIVE SYNTHESIS; STEREOCENTERS; CENTERS; CONSTRUCTION; PHOTOREDOX; REAGENTS; ALKENES; ADVENT	An important goal of modern organic chemistry is to develop new catalytic strategies for enantioselective carbon-carbon bond formation that can be used to generate quaternary stereogenic centres. Whereas considerable advances have been achieved by exploiting polar reactivity(1), radical transformations have been far less successful(2). This is despite the fact that open-shell intermediates are intrinsically primed for connecting structurally congested carbons, as their reactivity is only marginally affected by steric factors(3). Here we show how the combination of photoredox(4) and asymmetric organic catalysis(5) enables enantioselective radical conjugate additions to beta,beta-disubstituted cyclic enones to obtain quaternary carbon stereocentres with high fidelity. Critical to our success was the design of a chiral organic catalyst, containing a redox-active carbazole moiety, that drives the formation of iminium ions and the stereoselective trapping of photochemically generated carbon-centred radicals by means of an electron-relay mechanism. We demonstrate the generality of this organocatalytic radical-trapping strategy with two sets of open-shell intermediates, formed through unrelated light-triggered pathways from readily available substrates and photoredox catalysts-this method represents the application of iminium ion activation(6) (a successful catalytic strategy for enantioselective polar chemistry) within the realm of radical reactivity.	[Murphy, John J.; Bastida, David; Paria, Suva; Melchiorre, Paolo] Barcelona Inst Sci & Technol, Inst Chem Res Catalonia ICIQ, Avda Paisos Catalans 16, Tarragona 43007, Spain; [Fagnoni, Maurizio] Univ Pavia, Dept Chem, Photogreen Lab, Viale Taramelli 12, I-27100 Pavia, Italy; [Melchiorre, Paolo] Catalan Inst Res & Adv Studies ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Universitat Rovira i Virgili; Institute of Chemical Research of Catalonia; University of Pavia; ICREA	Melchiorre, P (corresponding author), Barcelona Inst Sci & Technol, Inst Chem Res Catalonia ICIQ, Avda Paisos Catalans 16, Tarragona 43007, Spain.; Melchiorre, P (corresponding author), Catalan Inst Res & Adv Studies ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain.	pmelchiorre@iciq.es	Melchiorre, Paolo/K-9301-2014	Melchiorre, Paolo/0000-0001-8722-4602; Murphy, John/0000-0001-8411-9540	ICIQ Foundation; MINECO [CTQ2013-45938-P]; MINECO (Severo Ochoa Excellence Accreditation) [SEV-2013-0319]; AGAUR [2014 SGR 1059]; European Research Council (ORGA-NAUT) [ERC 278541]; Marie Curie COFUND [291787-ICIQ-IPMP]; CELLEX Foundation; ICREA Funding Source: Custom	ICIQ Foundation(Foundation CELLEX); MINECO(Spanish Government); MINECO (Severo Ochoa Excellence Accreditation)(Spanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Research Council (ORGA-NAUT); Marie Curie COFUND; CELLEX Foundation(Foundation CELLEX); ICREA(ICREA)	Financial support was provided by the ICIQ Foundation, MINECO (project CTQ2013-45938-P and Severo Ochoa Excellence Accreditation 2014-2018, SEV-2013-0319), AGAUR (2014 SGR 1059), and the European Research Council (ERC 278541, ORGA-NAUT). J.J.M. and S.P. thank the Marie Curie COFUND (291787-ICIQ-IPMP) and the CELLEX Foundation, respectively, for postdoctoral fellowships. We thank M. Minozzi, M. Nappi and E. Raluy for preliminary investigations, D. Merli and D. Dondi for assistance with EPR experiments, and D. Ravelli for discussions.	Bertrand S, 2000, EUR J ORG CHEM, V2000, P2227; Blouin N, 2008, ACCOUNTS CHEM RES, V41, P1110, DOI 10.1021/ar800057k; DAMM W, 1992, J AM CHEM SOC, V114, P4067, DOI 10.1021/ja00037a007; Espelt LR, 2015, J AM CHEM SOC, V137, P2452, DOI 10.1021/ja512746q; Fischer H, 2001, ANGEW CHEM INT EDIT, V40, P1340, DOI 10.1002/1521-3773(20010417)40:8<1340::AID-ANIE1340>3.0.CO;2-#; Gansauer A, 1999, ANGEW CHEM INT EDIT, V38, P2909, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2909::AID-ANIE2909>3.0.CO;2-Y; Gu XD, 2015, ORG LETT, V17, P1505, DOI 10.1021/acs.orglett.5b00387; Hafelinger G., 1994, CHEM ENAMINES, P1; Hawner C, 2010, CHEM COMMUN, V46, P7295, DOI 10.1039/c0cc02309d; Hird AW, 2005, J AM CHEM SOC, V127, P14988, DOI 10.1021/ja0553811; JAKOBSEN HJ, 1966, J CHEM SOC B, P940, DOI 10.1039/j29660000940; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; Liu YY, 2015, ACCOUNTS CHEM RES, V48, P740, DOI 10.1021/ar5004658; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; Murakata M, 1997, J AM CHEM SOC, V119, P11713, DOI 10.1021/ja972065g; Okada Y, 2011, J ORG CHEM, V76, P3470, DOI 10.1021/jo200490q; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Poniatowski A. J., 2010, CARBON CTR FREE RADI, P43; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Prudhomme DR, 1997, J ORG CHEM, V62, P8257, DOI 10.1021/jo971332y; Quasdorf KW, 2014, NATURE, V516, P181, DOI 10.1038/nature14007; Ravelli D, 2011, CHEM-EUR J, V17, P572, DOI 10.1002/chem.201002546; Schnermann MJ, 2012, ANGEW CHEM INT EDIT, V51, P9576, DOI 10.1002/anie.201204977; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Shintani R, 2009, J AM CHEM SOC, V131, P13588, DOI 10.1021/ja905432x; Sibi MP, 1996, J AM CHEM SOC, V118, P9200, DOI 10.1021/ja9623929; Sidera M, 2013, ANGEW CHEM INT EDIT, V52, P7995, DOI 10.1002/anie.201303202; Srikanth GSC, 2005, TETRAHEDRON, V61, P10377, DOI 10.1016/j.tet.2005.07.077; Tzirakis MD, 2009, CHEM SOC REV, V38, P2609, DOI 10.1039/b812100c; YAMASE T, 1984, J CHEM SOC DALTON, P793, DOI 10.1039/dt9840000793	30	254	252	9	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					218	222		10.1038/nature17438	http://dx.doi.org/10.1038/nature17438			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075098	Green Accepted			2022-12-28	WOS:000374415100036
J	Bajgoric, S; Boyd-Carson, W; Day, C; Rajagopalan, S				Bajgoric, Sanjin; Boyd-Carson, William; Day, Christopher; Rajagopalan, Sriram			CASE REVIEW An often forgotten cause of chest pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE AORTIC DISSECTION; PENETRATING ATHEROSCLEROTIC ULCER; INTRAMURAL HEMATOMA; INTERNATIONAL REGISTRY; ENDOVASCULAR REPAIR; CT; PATHOGENESIS; FEATURES; DISEASE		[Bajgoric, Sanjin] Royal Stoke Univ Hosp, Emergency Dept, Stoke On Trent ST4 6QG, Staffs, England; [Boyd-Carson, William] Royal Stoke Univ Hosp, Dept Med, Stoke On Trent ST4 6QG, Staffs, England; [Day, Christopher] Royal Stoke Univ Hosp, Dept Radiol, Stoke On Trent ST4 6QG, Staffs, England; [Rajagopalan, Sriram] Royal Stoke Univ Hosp, Dept Vasc Surg, Stoke On Trent ST4 6QG, Staffs, England	Royal Stoke University Hospital; Royal Stoke University Hospital; Royal Stoke University Hospital; Royal Stoke University Hospital	Bajgoric, S (corresponding author), Royal Stoke Univ Hosp, Emergency Dept, Stoke On Trent ST4 6QG, Staffs, England.	sanjinbajgoric@gmail.com	Day, Christopher/Z-3305-2019					BICKERSTAFF LK, 1982, SURGERY, V92, P1103; Brunkwall J, 2014, EUR J VASC ENDOVASC, V48, P285, DOI 10.1016/j.ejvs.2014.05.012; Castaner E, 2003, RADIOGRAPHICS, V23, pS93, DOI 10.1148/rg.23si035507; Chiu KWH, 2013, CLIN RADIOL, V68, P741, DOI 10.1016/j.crad.2013.03.001; Clouse WD, 2004, MAYO CLIN PROC, V79, P176, DOI 10.4065/79.2.176; Eggebrecht H, 2009, EUR J VASC ENDOVASC, V38, P659, DOI 10.1016/j.ejvs.2009.09.001; Erbel Raimund, 2014, Kardiol Pol, V72, P1169, DOI 10.5603/KP.2014.0225; Evangelista A, 2003, CIRCULATION, V108, P583, DOI 10.1161/01.CIR.0000081776.49923.5A; Fattori R, 2013, JACC-CARDIOVASC INTE, V6, P876, DOI 10.1016/j.jcin.2013.05.003; Ganaha F, 2002, CIRCULATION, V106, P342, DOI 10.1161/01.CIR.0000022164.26075.5A; Golledge J, 2008, LANCET, V372, P55, DOI 10.1016/S0140-6736(08)60994-0; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hatzaras I, 2007, CARDIOLOGY, V107, P103, DOI 10.1159/000094530; Hoey ETD, 2012, POSTGRAD MED J, V88, P661, DOI 10.1136/postgradmedj-2011-130677; Januzzi JL, 2002, AM J CARDIOL, V89, P623, DOI 10.1016/S0002-9149(01)02312-8; Lansman SL, 2010, J THORAC CARDIOV SUR, V140, pS92, DOI 10.1016/j.jtcvs.2010.07.062; LARSON EW, 1984, AM J CARDIOL, V53, P849, DOI 10.1016/0002-9149(84)90418-1; Litmanovich D, 2009, AM J ROENTGENOL, V193, P928, DOI 10.2214/AJR.08.2166; Macura KJ, 2003, AM J ROENTGENOL, V181, P309, DOI 10.2214/ajr.181.2.1810309; Mestres G, 2012, REV ESP CARDIOL, V65, P54, DOI [10.1016/j.rec.2011.07.019, 10.1016/j.recesp.2011.07.020]; Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; Nallamothu BK, 2002, AM J MED, V113, P468, DOI 10.1016/S0002-9343(02)01254-8; Nienaber CA, 2013, EUR HEART J-CARD IMG, V14, P15, DOI 10.1093/ehjci/jes215; Nienaber CA, 2012, EUR HEART J, V33, P26, DOI 10.1093/eurheartj/ehr186; Nienaber CA, 2009, CIRCULATION, V120, P2519, DOI 10.1161/CIRCULATIONAHA.109.886408; Patel Pawan D, 2008, Ther Adv Cardiovasc Dis, V2, P439, DOI 10.1177/1753944708090830; Pauls S, 2007, EUR J VASC ENDOVASC, V34, P66, DOI 10.1016/j.ejvs.2006.12.029; Ramanath VS, 2009, MAYO CLIN PROC, V84, P465, DOI 10.1016/S0025-6196(11)60566-1; Subramaniam K, 2010, ANESTHESIA PERIOPERA; Tsai TT, 2005, CIRCULATION, V112, P3802, DOI 10.1161/CIRCULATIONAHA.105.534198; Williams MA, 2007, CIRCULATION, V116, P572, DOI 10.1161/CIRCULATIONAHA.107.185214; YAMADA T, 1988, RADIOLOGY, V168, P347, DOI 10.1148/radiology.168.2.3393653	33	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2016	353								i1846	10.1136/bmj.i1846	http://dx.doi.org/10.1136/bmj.i1846			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LV	27059800				2022-12-28	WOS:000373896100001
J	Doshi, P				Doshi, Peter			INFECTIOUS DISEASES Convicting Zika	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Doshi, Peter] BMJ, London, England		Doshi, P (corresponding author), BMJ, London, England.	pdoshi@bmj.com						[Anonymous], 2016, CBC NEWS; [Anonymous], 2016, WHO DIRECTOR GEN ADD; Boadle A, 2016, REUTERS; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708; Butler D, 2016, NATURE, V531; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Regis CT, 2016, B WORLD HEALTH ORGAN, P4, DOI [DOI 10.2471/BLT.16.170639, 10.2471/BLT.16.170639]; WHO, 2016, ZIK VIR GUILL BARR S; WHO, 2016, MICR FACTSH; World Health Organization, 2016, ZIK SIT REP NEUR SYN	14	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2016	353								i1847	10.1136/bmj.i1847	http://dx.doi.org/10.1136/bmj.i1847			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LT	27056643	Bronze, Green Published			2022-12-28	WOS:000373895900003
J	Mitchell, AP				Mitchell, Aaron P.			MICROBIOLOGY Fungus produces a toxic surprise	NATURE			English	Editorial Material							PATHOGEN CANDIDA-ALBICANS		[Mitchell, Aaron P.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Mitchell, AP (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	apm1@cmu.edu		Mitchell, Aaron/0000-0002-0868-4000				BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Filler SG, 2013, TRENDS MICROBIOL, V21, P389, DOI 10.1016/j.tim.2013.05.006; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Moyes DL, 2016, NATURE, V532, P64, DOI 10.1038/nature17625; Naglik JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004257; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535	9	6	11	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					41	42		10.1038/nature17319	http://dx.doi.org/10.1038/nature17319			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27027285				2022-12-28	WOS:000373555500026
J	Cole, TB				Cole, Thomas B.			Into Bondage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1318	1319		10.1001/jama.2015.14190	http://dx.doi.org/10.1001/jama.2015.14190			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	27046354				2022-12-28	WOS:000373381500001
J	Gansicke, B				Gaensicke, Boris			An odd one out	SCIENCE			English	Editorial Material							STARS		[Gaensicke, Boris] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Warwick	Gansicke, B (corresponding author), Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.	boris.gaensicke@warwick.ac.uk	Gaensicke, Boris T/A-9421-2012	Gaensicke, Boris T/0000-0002-2761-3005				Doherty CL, 2015, MON NOT R ASTRON SOC, V446, P2599, DOI 10.1093/mnras/stu2180; Foley RJ, 2009, ASTRON J, V138, P376, DOI 10.1088/0004-6256/138/2/376; Iben I, 1997, ASTROPHYS J, V489, P772, DOI 10.1086/304822; Kepler SO, 2016, SCIENCE, V352, P67, DOI 10.1126/science.aad6705; Schatzman E., 1945, ANN DASTROPHYSIQUE, V8, P143; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513	6	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					37	37		10.1126/science.aaf3768	http://dx.doi.org/10.1126/science.aaf3768			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034360				2022-12-28	WOS:000373039600022
J	Wallach, D; Kang, TB; Dillon, CP; Green, DR				Wallach, David; Kang, Tae-Bong; Dillon, Christopher P.; Green, Douglas R.			Programmed necrosis in inflammation: Toward identification of the effector molecules	SCIENCE			English	Review							MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; PYROPTOTIC CELL-DEATH; NLRP3 INFLAMMASOME; RIP1 KINASE; GASDERMIN D; NECROPTOSIS; APOPTOSIS; ACTIVATION; MLKL	Until recently, programmed cell death was conceived of as a single set of molecular pathways. We now know of several distinct sets of death-inducing mechanisms that lead to differing cell-death processes. In one of them-apoptosis-the dying cell affects others minimally. In contrast, programmed necrotic cell death causes release of immunostimulatory intracellular components after cell-membrane rupture. Defining the in vivo relevance of necrotic death is hampered because the molecules initiating it [such as receptor-interacting protein kinase-1 (RIPK1), RIPK3, or caspase-1] also serve other functions. Proteins that participate in late events in two forms of programmed necrosis [mixed lineage kinase domain-like protein (MLKL) in necroptosis and gasdermin-D in pyroptosis] were recently discovered, bringing us closer to identifying molecules that strictly serve in death mediation, thereby providing probes for better assessing its role in inflammation.	[Wallach, David] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Kang, Tae-Bong] Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju 380701, South Korea; [Dillon, Christopher P.; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	Weizmann Institute of Science; Konkuk University; St Jude Children's Research Hospital	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.; Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	d.wallach@weizmann.ac.il; douglas.green@stjude.org	kang, Tae-bong/AAD-7950-2022; Green, Douglas R/N-8083-2018	kang, Tae-bong/0000-0003-1441-9470; Green, Douglas R/0000-0002-7332-1417				ADERKA D, 1985, CELL IMMUNOL, V92, P218, DOI 10.1016/0008-8749(85)90003-6; Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Crawford ED, 2012, CELL DEATH DIFFER, V19, P2040, DOI 10.1038/cdd.2012.99; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Giodini A, 2010, CURR OPIN IMMUNOL, V22, P94, DOI 10.1016/j.coi.2010.01.023; GRANGER GA, 1968, J IMMUNOL, V101, P111; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; JOKLIK WK, 1966, P NATL ACAD SCI USA, V56, P558, DOI 10.1073/pnas.56.2.558; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Labbe K, 2011, PROG INFLAMM RES SER, P17, DOI 10.1007/978-3-0348-0148-5_2; LASTER SM, 1988, J IMMUNOL, V141, P2629; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Marshall KD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00323; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mocarski ES, 2015, VIROLOGY, V479, P160, DOI 10.1016/j.virol.2015.03.016; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Py BF, 2014, CELL REP, V6, P1122, DOI 10.1016/j.celrep.2014.02.015; RUDDLE NH, 1968, J EXP MED, V128, P1267, DOI 10.1084/jem.128.6.1267; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wallach D, 2008, CELL DEATH DIFFER, V15, P1533, DOI 10.1038/cdd.2008.41; Wallach D, 2014, CYTOKINE GROWTH F R, V25, P157, DOI 10.1016/j.cytogfr.2013.12.001; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wang X, 2014, P NATL ACAD SCI USA, V111, P15438, DOI 10.1073/pnas.1412767111; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Weinlich R, 2014, MOL CELL, V56, P469, DOI 10.1016/j.molcel.2014.11.001; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Yoon S, 2016, CELL DEATH DIFFER, V23, P253, DOI 10.1038/cdd.2015.92; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang T, 2016, NAT MED, V22, P175, DOI 10.1038/nm.4017; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	69	353	368	10	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281							aaf2154	10.1126/science.aaf2154	http://dx.doi.org/10.1126/science.aaf2154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034377				2022-12-28	WOS:000373039600030
J	Prowell, TM; Theoret, MR; Pazdur, R				Prowell, Tatiana M.; Theoret, Marc R.; Pazdur, Richard			Seamless Oncology-Drug Development	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Prowell, Tatiana M.; Theoret, Marc R.; Pazdur, Richard] Food & Drug Adm, Ctr Drug Evaluat & Res, Off Hematol & Oncol Prod, Silver Spring, MD USA; [Prowell, Tatiana M.] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Breast Canc Program, Baltimore, MD USA	US Food & Drug Administration (FDA); Johns Hopkins University; Johns Hopkins Medicine	Prowell, TM (corresponding author), Food & Drug Adm, Ctr Drug Evaluat & Res, Off Hematol & Oncol Prod, Silver Spring, MD USA.; Prowell, TM (corresponding author), Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Breast Canc Program, Baltimore, MD USA.							American Association for Cancer Research, 2015, ACC ANT AG DEV VAL W; [Anonymous], 2015, 2015 FRIENDS BROOK C; [Anonymous], 2016, SESS DET AM ASS CANC; Food and Drug Administration, 2014, GUID IND EXP PROGR S	4	79	80	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2001	2003		10.1056/NEJMp1603747	http://dx.doi.org/10.1056/NEJMp1603747			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27074059				2022-12-28	WOS:000376443500001
J	Gillinov, AM; Bagiella, E; Moskowitz, AJ; Raiten, JM; Groh, MA; Bowdish, ME; Ailawadi, G; Kirkwood, KA; Perrault, LP; Parides, MK; Smith, RL; Kern, JA; Dussault, G; Hackmann, AE; Jeffries, NO; Miller, MA; Taddei-Peters, WC; Rose, EA; Weisel, RD; Williams, DL; Mangusan, RF; Argenziano, M; Moquete, EG; O'Sullivan, KL; Pellerin, M; Shah, KJ; Gammie, JS; Mayer, ML; Voisine, P; Gelijns, AC; O'Gara, PT; Mack, MJ				Gillinov, A. M.; Bagiella, E.; Moskowitz, A. J.; Raiten, J. M.; Groh, M. A.; Bowdish, M. E.; Ailawadi, G.; Kirkwood, K. A.; Perrault, L. P.; Parides, M. K.; Smith, R. L., II; Kern, J. A.; Dussault, G.; Hackmann, A. E.; Jeffries, N. O.; Miller, M. A.; Taddei-Peters, W. C.; Rose, E. A.; Weisel, R. D.; Williams, D. L.; Mangusan, R. F.; Argenziano, M.; Moquete, E. G.; O'Sullivan, K. L.; Pellerin, M.; Shah, K. J.; Gammie, J. S.; Mayer, M. L.; Voisine, P.; Gelijns, A. C.; O'Gara, P. T.; Mack, M. J.		CTSN	Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACC/AHA/ESC 2006 GUIDELINES; MANAGEMENT; MULTICENTER; PREVENTION; PREDICTORS	BACKGROUND Atrial fibrillation after cardiac surgery is associated with increased rates of death, complications, and hospitalizations. In patients with postoperative atrial fibrillation who are in stable condition, the best initial treatment strategy - heart-rate control or rhythm control - remains controversial. METHODS Patients with new-onset postoperative atrial fibrillation were randomly assigned to undergo either rate control or rhythm control. The primary end point was the total number of days of hospitalization within 60 days after randomization, as assessed by the Wilcoxon rank-sum test. RESULTS Postoperative atrial fibrillation occurred in 695 of the 2109 patients (33.0%) who were enrolled preoperatively; of these patients, 523 underwent randomization. The total numbers of hospital days in the rate-control group and the rhythm-control group were similar (median, 5.1 days and 5.0 days, respectively; P = 0.76). There were no significant between-group differences in the rates of death (P = 0.64) or overall serious adverse events (24.8 per 100 patient-months in the rate-control group and 26.4 per 100 patient-months in the rhythm-control group, P = 0.61), including thromboembolic and bleeding events. About 25% of the patients in each group deviated from the assigned therapy, mainly because of drug ineffectiveness (in the rate-control group) or amiodarone side effects or adverse drug reactions (in the rhythm-control group). At 60 days, 93.8% of the patients in the rate-control group and 97.9% of those in the rhythm-control group had had a stable heart rhythm without atrial fibrillation for the previous 30 days (P = 0.02), and 84.2% and 86.9%, respectively, had been free from atrial fibrillation from discharge to 60 days (P = 0.41). CONCLUSIONS Strategies for rate control and rhythm control to treat postoperative atrial fibrillation were associated with equal numbers of days of hospitalization, similar complication rates, and similarly low rates of persistent atrial fibrillation 60 days after onset. Neither treatment strategy showed a net clinical advantage over the other. (Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT02132767.)	[Gillinov, A. M.] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH USA; [Bagiella, E.; Moskowitz, A. J.; Kirkwood, K. A.; Parides, M. K.; Williams, D. L.; Moquete, E. G.; O'Sullivan, K. L.; Shah, K. J.; Gelijns, A. C.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Int Ctr Hlth Outcomes & Innovat Res, New York, NY 10029 USA; [Rose, E. A.] Mt Sinai Hlth Syst, Dept Cardiac Surg, New York, NY USA; [Argenziano, M.] Columbia Univ, Coll Phys & Surg, Dept Surg, Div Cardiothorac Surg, New York, NY USA; [Raiten, J. M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Mayer, M. L.] Univ Penn, Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; [Groh, M. A.; Mangusan, R. F.] Mission Hlth & Hosp, Cardiovasc & Thorac Surg, Asheville, NC USA; [Bowdish, M. E.; Hackmann, A. E.] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Ailawadi, G.; Kern, J. A.] Univ Virginia, Sch Med, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA; [Perrault, L. P.; Pellerin, M.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Dussault, G.; Voisine, P.] Hop Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Weisel, R. D.] Univ Toronto, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Weisel, R. D.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Div Cardiovasc Surg, Toronto, ON M5G 1L7, Canada; [Weisel, R. D.] Univ Toronto, Div Cardiac Surg, Toronto, ON, Canada; [Smith, R. L., II; Mack, M. J.] Baylor Hlth Care Syst, Heart Hosp Baylor Plano, Dept Cardiovasc Surg, Plano, TX USA; [Jeffries, N. O.] NHLBI, Off Biostat Res, Bldg 10, Bethesda, MD 20892 USA; [Miller, M. A.; Taddei-Peters, W. C.] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Gammie, J. S.] Univ Maryland, Med Ctr, Dept Surg, Baltimore, MD 21201 USA; [O'Gara, P. T.] Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA	Cleveland Clinic Foundation; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; University of Pennsylvania; University of Pennsylvania; University of Southern California; University of Virginia; Universite de Montreal; Laval University; University of Toronto; Peter Munk Cardiac Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Baylor Health Care System; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University System of Maryland; University of Maryland Baltimore; Harvard University; Brigham & Women's Hospital	Gelijns, AC (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, 1 Gustave L Levy Pl,Box 1077, New York, NY 10029 USA.	annetine.gelijns@mountsinai.org	Parides, Michael/GON-8474-2022; Rose, Eric/AAJ-2281-2020	Cresse, Stephen/0000-0003-3044-2873; Moskowitz, Alan/0000-0002-4412-9450; Holubkov, Richard/0000-0003-0431-3381; Browndyke, Jeffrey/0000-0002-8573-7073; Mangusan, Ralph/0000-0003-4775-8655	National Institutes of Health; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL088942, U01HL088953, UM1HL088925, UM1HL088963, UM1HL088953, UM1HL117922, UM1HL088939, UM1HL118007, UM1HL117924, R01HL102121, UM1HL088955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials. gov number, NCT02132767.	Al-Khatib SM, 2009, AM HEART J, V158, P792, DOI 10.1016/j.ahj.2009.09.003; Aranki SF, 1996, CIRCULATION, V94, P390, DOI 10.1161/01.CIR.94.3.390; Chelazzi C, 2011, ISRN Cardiol, V2011, P203179, DOI 10.5402/2011/203179; Echahidi N, 2008, J AM COLL CARDIOL, V51, P793, DOI 10.1016/j.jacc.2007.10.043; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Gelijns AC, 2014, J AM COLL CARDIOL, V64, P372, DOI 10.1016/j.jacc.2014.04.052; Imazio M, 2013, AM HEART J, V166, P13, DOI 10.1016/j.ahj.2013.03.025; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Jongnarangsin K, 2009, CARDIOL CLIN, V27, P69, DOI 10.1016/j.ccl.2008.09.011; Lee JK, 2000, AM HEART J, V140, P871, DOI 10.1067/mhj.2000.111104; Lee John K, 2003, Card Electrophysiol Rev, V7, P178, DOI 10.1023/A:1027428003609; Mathew JP, 1996, JAMA-J AM MED ASSOC, V276, P300, DOI 10.1001/jama.276.4.300; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; Mayson Sarah E, 2007, Cardiol Rev, V15, P231, DOI 10.1097/CRD.0b013e31813e62bb; Mitchell LB, 2005, CAN J CARDIOL, V21, p45B; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nair SG, 2010, ANN CARD ANAESTH, V13, P196, DOI 10.4103/0971-9784.69047; Ozaydin M, 2013, EUR HEART J, V34, P597, DOI 10.1093/eurheartj/ehs423; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	20	188	204	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1911	1921		10.1056/NEJMoa1602002	http://dx.doi.org/10.1056/NEJMoa1602002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM1OX	27043047	Bronze, Green Accepted			2022-12-28	WOS:000376116600004
J	Bertulani, CA; Zelevinsky, V				Bertulani, Carlos A.; Zelevinsky, Vladimir			Four neutrons together momentarily	NATURE			English	Editorial Material									[Bertulani, Carlos A.] Texas A&M Univ, Dept Phys & Astron, Commerce, TX 75429 USA; [Zelevinsky, Vladimir] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA	Texas A&M University System; Michigan State University	Bertulani, CA (corresponding author), Texas A&M Univ, Dept Phys & Astron, Commerce, TX 75429 USA.; Zelevinsky, V (corresponding author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.	carlos.bertulani@tamuc.edu; zelevinsky@nscl.msu.edu	Zelevinsky, Vladimir G/P-2571-2015; Bertulani, Carlos A/AAU-6814-2021	Bertulani, Carlos A/0000-0002-4065-6237	Direct For Mathematical & Physical Scien [1415656] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Bertulani CA, 2003, J PHYS G NUCL PARTIC, V29, P2431, DOI 10.1088/0954-3899/29/10/309; Kisamori K, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.052501; Marques FM, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.044006; MIGDAL AB, 1973, SOV J NUCL PHYS+, V16, P238; Pieper SC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.252501; Shapiro S.L., 1983, BLACK HOLES WHITE DW	6	9	9	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					448	449		10.1038/nature17884	http://dx.doi.org/10.1038/nature17884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27049938	Bronze			2022-12-28	WOS:000374815900033
J	Caron, MG; Gether, U				Caron, Marc G.; Gether, Ulrik			Antidepressants at work	NATURE			English	Editorial Material							SEROTONIN TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; ESCITALOPRAM; DISORDERS; MECHANISM; BINDING		[Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Gether, Ulrik] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark	Duke University; Duke University; Duke University; University of Copenhagen	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.; Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.; Gether, U (corresponding author), Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark.	marc.caron@duke.edu; gether@sund.ku.dk		Gether, Ulrik/0000-0002-0020-3807				Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Conn PJ, 2014, NAT REV DRUG DISCOV, V13, P692, DOI 10.1038/nrd4308; Jacobsen JPR, 2014, PSYCHOPHARMACOLOGY, V231, P4527, DOI 10.1007/s00213-014-3595-1; Kang HJ, 2013, INT J BIOCHEM CELL B, V45, P636, DOI 10.1016/j.biocel.2012.12.018; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Ng J, 2015, NAT REV NEUROL, V11, P567, DOI 10.1038/nrneurol.2015.172; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; PLENGE P, 1985, EUR J PHARMACOL, V119, P1, DOI 10.1016/0014-2999(85)90314-0; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhong HL, 2012, PSYCHOPHARMACOLOGY, V219, P1, DOI 10.1007/s00213-011-2463-5	12	3	3	2	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					320	321		10.1038/nature17883	http://dx.doi.org/10.1038/nature17883			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27049942				2022-12-28	WOS:000374424700022
J	Yapici, N; Cohn, R; Schusterreiter, C; Ruta, V; Vosshall, LB				Yapici, Nilay; Cohn, Raphael; Schusterreiter, Christian; Ruta, Vanessa; Vosshall, Leslie B.			A Taste Circuit that Regulates Ingestion by Integrating Food and Hunger Signals	CELL			English	Article							DROSOPHILA-MELANOGASTER; HYPOTHALAMIC CONTROL; TARGETED EXPRESSION; FEEDING-BEHAVIOR; NUTRIENT SENSOR; MAMMALIAN SWEET; NEURAL CIRCUIT; BITTER TASTE; IN-VIVO; NEURONS	Ingestion is a highly regulated behavior that integrates taste and hunger cues to balance food intake with metabolic needs. To study the dynamics of ingestion in the vinegar fly Drosophila melanogaster, we developed Expresso, an automated feeding assay that measures individual meal-bouts with high temporal resolution at nanoliter scale. Flies showed discrete, temporally precise ingestion that was regulated by hunger state and sucrose concentration. We identify 12 cholinergic local interneurons (IN1, for "ingestion neurons'') necessary for this behavior. Sucrose ingestion caused a rapid and persistent increase in IN1 interneuron activity in fasted flies that decreased proportionally in response to subsequent feeding bouts. Sucrose responses of IN1 interneurons in fed flies were significantly smaller and lacked persistent activity. We propose that IN1 neurons monitor ingestion by connecting sugar-sensitive taste neurons in the pharynx to neural circuits that control the drive to ingest. Similar mechanisms for monitoring and regulating ingestion may exist in vertebrates.	[Yapici, Nilay; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Cohn, Raphael; Ruta, Vanessa] Rockefeller Univ, Lab Neurophysiol & Behav, New York, NY 10065 USA; [Schusterreiter, Christian] Univ Oxford, Dept Comp Sci, Oxford OX1 3QD, England; [Schusterreiter, Christian] Ticomo Res GmbH, CH-6300 Zug, Switzerland; [Ruta, Vanessa; Vosshall, Leslie B.] Kavli Neural Syst Inst, New York, NY 10065 USA; [Vosshall, Leslie B.] Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Rockefeller University; University of Oxford; Howard Hughes Medical Institute	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA.; Vosshall, LB (corresponding author), Kavli Neural Syst Inst, New York, NY 10065 USA.; Vosshall, LB (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	leslie.vosshall@rockefeller.edu		Vosshall, Leslie/0000-0002-6060-8099; Ruta, Vanessa/0000-0002-4963-2768	Human Frontier Science Program Long-Term Postdoctoral Fellowship; Klarman Family Foundation Grants Program in Eating Disorders Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP2NS087942] Funding Source: NIH RePORTER	Human Frontier Science Program Long-Term Postdoctoral Fellowship(Human Frontier Science Program); Klarman Family Foundation Grants Program in Eating Disorders Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Eleanor Clowney, Monica Dus, Gaby Maimon, Kevin Lee, and members of the L.B.V. lab for comments on the manuscript; Isabel Gutierrez for expert technical assistance; Kunal Shah of the Rockefeller Precision Fabrication Facility for building the LED photo activation system; IO Rodeo, Inc., for developing the hardware for Expresso; and Larry Zipursky for sharing reagents prior to publication. N.Y. was supported by a Human Frontier Science Program Long-Term Postdoctoral Fellowship. This study was supported in part by a grant from Klarman Family Foundation Grants Program in Eating Disorders Research. Fly stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) and antibodies from the Developmental Studies Hybridoma Bank at the University of Iowa (NICHD) were used in this study. L.B.V. is an investigator of the Howard Hughes Medical Institute. C.S. is a founder of Ticomo Research GmbH. V.R. is a New York Stem Cell Foundation - Robertson Investigator.	Albin SD, 2015, CURR BIOL, V25, P2435, DOI 10.1016/j.cub.2015.08.005; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Barretto RPJ, 2015, NATURE, V517, P373, DOI 10.1038/nature13873; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brobeck J R, 1943, Yale J Biol Med, V15, P831; BURTON MJ, 1976, EXP NEUROL, V51, P668, DOI 10.1016/0014-4886(76)90189-8; Bussell JJ, 2014, CURR BIOL, V24, P1584, DOI 10.1016/j.cub.2014.06.011; Carleton A, 2010, TRENDS NEUROSCI, V33, P326, DOI 10.1016/j.tins.2010.04.002; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Chen Y, 2014, NEURON, V81, P280, DOI 10.1016/j.neuron.2013.12.021; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Cohn R, 2015, CELL, V163, P1742, DOI 10.1016/j.cell.2015.11.019; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; DAVIS WJ, 1979, TRENDS NEUROSCI, V2, P5, DOI 10.1016/0166-2236(79)90003-1; de Araujo IE, 2009, INT J OBESITY, V33, pS34, DOI 10.1038/ijo.2009.70; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; DETHIER VG, 1956, BIOL BULL, V111, P204, DOI 10.2307/1539012; Dus M, 2015, NEURON, V87, P139, DOI 10.1016/j.neuron.2015.05.032; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Flood TF, 2013, NATURE, V499, P83, DOI 10.1038/nature12208; FRANK ME, 1991, J NEUROPHYSIOL, V65, P1452, DOI 10.1152/jn.1991.65.6.1452; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; HANAMORI T, 1988, J NEUROPHYSIOL, V60, P478, DOI 10.1152/jn.1988.60.2.478; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Inagaki HK, 2014, NEURON, V84, P806, DOI 10.1016/j.neuron.2014.09.032; Inagaki HK, 2014, NAT METHODS, V11, P325, DOI [10.1038/NMETH.2765, 10.1038/nmeth.2765]; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Ishimaru Y, 2005, MECH DEVELOP, V122, P1310, DOI 10.1016/j.mod.2005.07.005; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Itskov PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5560; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kain P, 2015, NEURON, V85, P819, DOI 10.1016/j.neuron.2015.01.005; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Ledue EE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7667; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Manzo A, 2012, P NATL ACAD SCI USA, V109, P6307, DOI 10.1073/pnas.1120305109; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; MAYER J, 1953, NEW ENGL J MED, V249, P13, DOI 10.1056/NEJM195307022490104; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Miyazaki T, 2015, J NEUROGENET, V29, P144, DOI 10.3109/01677063.2015.1054993; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Navawongse R., 2015, DROSOPHILA LEARN EFF; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ostlund SB, 2013, PSYCHOPHARMACOLOGY, V229, P105, DOI 10.1007/s00213-013-3077-x; Pool AH, 2014, NEURON, V83, P164, DOI 10.1016/j.neuron.2014.05.006; Qi W, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0179-x; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; READ N, 1994, NUTR REV, V52, P1, DOI 10.1111/j.1753-4887.1994.tb01347.x; Ro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101107; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Shiraiwa Takashi, 2007, J Vis Exp, P193, DOI 10.3791/193; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; Spector AC, 1998, BEHAV NEUROSCI, V112, P678, DOI 10.1037/0735-7044.112.3.678; Stafford JW, 2012, J NEUROSCI, V32, P14767, DOI 10.1523/JNEUROSCI.1887-12.2012; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tinbergen N, 1951, STUDY INSTINCT; TRAVERS SP, 1990, ANAT REC, V227, P373, DOI 10.1002/ar.1092270313; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zukerman S, 2011, AM J PHYSIOL-REG I, V301, pR1635, DOI 10.1152/ajpregu.00425.2011	88	74	74	6	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					715	729		10.1016/j.cell.2016.02.061	http://dx.doi.org/10.1016/j.cell.2016.02.061			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27040496	Green Accepted, Bronze			2022-12-28	WOS:000374636800028
J	Woodstrover, A; Wood, W				Woodstrover, Allister; Wood, William			Charles Roger Wood OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2016	353								i2131	10.1136/bmj.i2131	http://dx.doi.org/10.1136/bmj.i2131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZB	27090857				2022-12-28	WOS:000374998700003
J	Ronagel, J; Dawkins, ST; Tolazzi, KN; Abah, O; Lutz, E; Schmidt-Kaler, F; Singer, K				Ronagel, Johannes; Dawkins, Samuel T.; Tolazzi, Karl N.; Abah, Obinna; Lutz, Eric; Schmidt-Kaler, Ferdinand; Singer, Kilian			A single-atom heat engine	SCIENCE			English	Article							QUANTUM	Heat engines convert thermal energy into mechanical work and generally involve a large number of particles. We report the experimental realization of a single-atom heat engine. An ion is confined in a linear Paul trap with tapered geometry and driven thermally by coupling it alternately to hot and cold reservoirs. The output power of the engine is used to drive a harmonic oscillation. From direct measurements of the ion dynamics, we were able to determine the thermodynamic cycles for various temperature differences of the reservoirs. We then used these cycles to evaluate the power P and efficiency h of the engine, obtaining values up to P = 3.4 x 10(-22) joules per second and eta = 0.28%, consistent with analytical estimations. Our results demonstrate that thermal machines can be reduced to the limit of single atoms.	[Ronagel, Johannes; Dawkins, Samuel T.; Schmidt-Kaler, Ferdinand; Singer, Kilian] Johannes Gutenberg Univ Mainz, Inst Phys, QUANTUM, D-55128 Mainz, Germany; [Tolazzi, Karl N.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Abah, Obinna; Lutz, Eric] Univ Erlangen Nurnberg, Dept Phys, D-91058 Erlangen, Germany; [Singer, Kilian] Univ Kassel, Expt Phys 1, D-34132 Kassel, Germany	Johannes Gutenberg University of Mainz; Max Planck Society; University of Erlangen Nuremberg; Universitat Kassel	Ronagel, J; Singer, K (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys, QUANTUM, D-55128 Mainz, Germany.; Singer, K (corresponding author), Univ Kassel, Expt Phys 1, D-34132 Kassel, Germany.	j.rossnagel@uni-mainz.de; ks@uni-kassel.de	Schmidt-Kaler, Ferdinand/E-2151-2017; Abah, Obinna C/D-2971-2014; Lutz, Eric/C-2713-2008	Abah, Obinna/0000-0003-0193-4860; Tolazzi, Karl Nicolas/0000-0001-5042-5400; Schmidt-Kaler, Ferdinand/0000-0002-5697-2568	German Research Foundation; Volkswagen Foundation; European Union (EU) COST action [MP1209]; EU Collaborative Project TherMiQ [618074]	German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); European Union (EU) COST action; EU Collaborative Project TherMiQ	We thank Princeton Instruments for the loan of the ICCD camera and S. Deffner for fruitful discussions. Supported by the German Research Foundation (grant "Einzelionenwarmekraftmaschine"), the Volkswagen Foundation (grant "Atomic Nano-Assembler"), European Union (EU) COST action MP1209, and the EU Collaborative Project TherMiQ (grant agreement 618074). The data presented in this report are available upon request to K.S.	Abah O, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.203006; Agarwal GS, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012130; An SM, 2015, NAT PHYS, V11, P193, DOI 10.1038/NPHYS3197; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Blickle V, 2012, NAT PHYS, V8, P143, DOI [10.1038/nphys2163, 10.1038/NPHYS2163]; Brandao FGSL, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.250404; Brandner K, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031019; Brantut JP, 2013, SCIENCE, V342, P713, DOI 10.1126/science.1242308; Cengel Y, 2014, THERMODYNAMICS ENG A; CIRAC JI, 1992, PHYS REV A, V46, P2668, DOI 10.1103/PhysRevA.46.2668; CIRAC JI, 1994, PHYS REV LETT, V72, P2977, DOI 10.1103/PhysRevLett.72.2977; CURZON FL, 1975, AM J PHYS, V43, P22, DOI 10.1119/1.10023; Dillenschneider R, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/50003; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; Horodecki M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3059; Hugel T, 2002, SCIENCE, V296, P1103, DOI 10.1126/science.1069856; Knunz S, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.023427; Kosloff R, 2014, ANNU REV PHYS CHEM, V65, P365, DOI 10.1146/annurev-physchem-040513-103724; Landau L.D, 2013, STAT PHYS; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Lin BH, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056117; Lin BH, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.046105; Linden N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.130401; Martinez IA, 2016, NAT PHYS, V12, P67, DOI [10.1038/NPHYS3518, 10.1038/nphys3518]; Metcalf HJ., 1999, LASER COOLING TRAPPI; Nagerl HC, 1998, OPT EXPRESS, V3, P89, DOI 10.1364/OE.3.000089; Peters T, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.063416; Poyatos JF, 1996, PHYS REV LETT, V77, P4728, DOI 10.1103/PhysRevLett.77.4728; Rossnagel J, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/4/045004; Rossnagel J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.030602; Scully MO, 2003, SCIENCE, V299, P862, DOI 10.1126/science.1078955; Steeneken PG, 2011, NAT PHYS, V7, P354, DOI 10.1038/NPHYS1871; Taylor J. R., 2005, CLASSICAL MECH; Whalen S, 2003, SENSOR ACTUAT A-PHYS, V104, P290, DOI 10.1016/S0924-4247(03)00032-3	35	419	420	10	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					325	329		10.1126/science.aad6320	http://dx.doi.org/10.1126/science.aad6320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081067	Green Accepted, Green Submitted			2022-12-28	WOS:000373990100036
J	Joesch, M; Meister, M				Joesch, Maximilian; Meister, Markus			A neuronal circuit for colour vision based on rod-cone opponency	NATURE			English	Article							MOUSE RETINA; HORIZONTAL CELLS; GANGLION-CELLS; MAMMALIAN RETINA; MICE; PHOTORECEPTORS; LIGHT; SENSITIVITY; RESPONSES	In bright light, cone-photoreceptors are active and colour vision derives from a comparison of signals in cones with different visual pigments. This comparison begins in the retina, where certain retinal ganglion cells have 'colour-opponent' visual responses-excited by light of one colour and suppressed by another colour(1). In dim light, rod-photoreceptors are active, but colour vision is impossible because they all use the same visual pigment. Instead, the rod signals are thought to splice into retinal circuits at various points, in synergy with the cone signals(2). Here we report a new circuit for colour vision that challenges these expectations. A genetically identified type of mouse retinal ganglion cell called JAMB (J-RGC)(3), was found to have colour-opponent responses, OFF to ultraviolet (UV) light and ON to green light. Although the mouse retina contains a green-sensitive cone, the ON response instead originates in rods. Rods and cones both contribute to the response over several decades of light intensity. Remarkably, the rod signal in this circuit is antagonistic to that from cones. For rodents, this UV-green channel may play a role in social communication, as suggested by spectral measurements from the environment. In the human retina, all of the components for this circuit exist as well, and its function can explain certain experiences of colour in dim lights, such as a 'blue shift' in twilight. The discovery of this genetically defined pathway will enable new targeted studies of colour processing in the brain.	[Joesch, Maximilian] Harvard Univ, 52 Oxford St, Cambridge, MA 02138 USA; [Meister, Markus] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Harvard University; California Institute of Technology	Joesch, M (corresponding author), Harvard Univ, 52 Oxford St, Cambridge, MA 02138 USA.; Meister, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	joeschkrotki@fas.harvard.edu; meister@caltech.edu		Joesch, Maximilian/0000-0002-3937-1330; Meister, Markus/0000-0003-2136-6506	NIH; International Human Frontier Science Program Organization; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Soucy and J. Greenwood for technical support, J. Cauceglia for providing the urine post samples, J. R. Sanes and E. Soucy for comments on the manuscript. This work was supported by grants to M. M. from the NIH and to M. J. from The International Human Frontier Science Program Organization.	AHNELT P, 1994, J COMP NEUROL, V343, P406, DOI 10.1002/cne.903430306; Baden T, 2013, NEURON, V80, P1206, DOI 10.1016/j.neuron.2013.09.030; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Chang L, 2013, NEURON, V77, P559, DOI 10.1016/j.neuron.2012.12.012; Daan S, 2011, J BIOL RHYTHM, V26, P118, DOI 10.1177/0748730410397645; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Henriksson JT, 2010, EXP EYE RES, V90, P382, DOI 10.1016/j.exer.2009.11.004; Hirasawa H, 2003, J GEN PHYSIOL, V122, P657, DOI 10.1085/jgp.200308863; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Jacobs GH, 2007, SCIENCE, V318, DOI 10.1126/science.1146519; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; MACKINTOSH JH, 1973, ANIM BEHAV, V21, P464, DOI 10.1016/S0003-3472(73)80006-5; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Nathan J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1489, DOI 10.1562/2006-02-27-RA-818; NELSON R, 1975, SCIENCE, V189, P137, DOI 10.1126/science.1138370; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; REITNER A, 1991, NATURE, V352, P798, DOI 10.1038/352798a0; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; STABELL U, 1994, VISION RES, V34, P1019, DOI 10.1016/0042-6989(94)90006-X; Sterratt DC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002921; Szikra T, 2014, NAT NEUROSCI, V17, P1728, DOI 10.1038/nn.3852; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X; Trumpler J, 2008, J NEUROSCI, V28, P6818, DOI 10.1523/JNEUROSCI.1564-08.2008; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wang YV, 2011, J NEUROSCI, V31, P7670, DOI 10.1523/JNEUROSCI.0629-11.2011; WELCH JF, 1953, J MAMMAL, V34, P502, DOI 10.1093/jmammal/34.4.502; Williams GA, 2005, VISUAL NEUROSCI, V22, P807, DOI 10.1017/S095252380522610X	36	78	81	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					236	+		10.1038/nature17158	http://dx.doi.org/10.1038/nature17158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27049951				2022-12-28	WOS:000374415100040
J	Hafez, D; Saint, S; Griauzde, MPHJ; Mody, R; Meddings, J				Hafez, Dina; Saint, Sanjay; Griauzde, M. P. H. Julius; Mody, Rajen; Meddings, Jennifer			A Deficient Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADULT SCURVY		[Hafez, Dina; Saint, Sanjay; Meddings, Jennifer] Univ Michigan, Dept Internal Med, 2800 Plymouth Rd,Bldg 16,Rm 427W, Ann Arbor, MI 48109 USA; [Hafez, Dina; Mody, Rajen; Meddings, Jennifer] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Griauzde, M. P. H. Julius] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Hafez, Dina] Univ Michigan, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA; [Hafez, Dina; Saint, Sanjay; Meddings, Jennifer] Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Meddings, J (corresponding author), Univ Michigan, Dept Internal Med, 2800 Plymouth Rd,Bldg 16,Rm 427W, Ann Arbor, MI 48109 USA.	meddings@umich.edu	Saint, Sanjay/AAF-5126-2019	Hafez Griauzde, Dina/0000-0002-2260-0299; Meddings, Jennifer/0000-0001-9503-0293	Doximity; Jvion; QuantiaMD	Doximity; Jvion; QuantiaMD	Dr. Saint reports receiving fees for serving on advisory boards for Doximity and Jvion; and Dr. Meddings, receiving a lecture fee from QuantiaMD. No potential conflict of interest relevant to this article was reported.	ALLEN JI, 1982, ANN EMERG MED, V11, P446, DOI 10.1016/S0196-0644(82)80047-4; [Anonymous], 2007, N ENGL J MED, V357, P392; Dunn PM, 1997, ARCH DIS CHILD-FETAL, V76, pF64, DOI 10.1136/fn.76.1.F64; Gulko E, 2015, SKELETAL RADIOL, V44, P291, DOI 10.1007/s00256-014-1962-y; Hirschmann JV, 1999, J AM ACAD DERMATOL, V41, P895, DOI 10.1016/S0190-9622(99)70244-6; Marcdante K., 2014, NELSON ESSENTIALS PE; MCKENNA KE, 1993, CLIN EXP DERMATOL, V18, P75, DOI 10.1111/j.1365-2230.1993.tb00976.x; Noble JM, 2007, PEDIATRICS, V119, pE783, DOI 10.1542/peds.2006-1071; Pimentel L, 2003, AM J EMERG MED, V21, P328, DOI 10.1016/S0735-6757(03)00083-4; Rajakumar K, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e76; REULER JB, 1985, JAMA-J AM MED ASSOC, V253, P805, DOI 10.1001/jama.253.6.805; Segel George B, 2002, Pediatr Rev, V23, P75, DOI 10.1542/pir.23-3-75; Sharp WG, 2013, J AUTISM DEV DISORD, V43, P2159, DOI 10.1007/s10803-013-1771-5; Weinstein M, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e55; WILSON CWM, 1975, ANN NY ACAD SCI, V258, P355, DOI 10.1111/j.1749-6632.1975.tb29295.x	15	13	13	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					1369	1374		10.1056/NEJMcps1407520	http://dx.doi.org/10.1056/NEJMcps1407520			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3UW	27050209				2022-12-28	WOS:000373425000011
J	Webster, A				Webster, Andrew			Recognize the value of social science	NATURE			English	Editorial Material									[Webster, Andrew] Univ York, SATSU, York YO10 5DD, N Yorkshire, England	University of York - UK	Webster, A (corresponding author), Univ York, SATSU, York YO10 5DD, N Yorkshire, England.	andrew.webster@york.ac.uk							0	4	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					7	7		10.1038/532007a	http://dx.doi.org/10.1038/532007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI5RE	27078528	Bronze			2022-12-28	WOS:000373555500004
J	Kassirer, JP				Kassirer, Jerome P.			Editorial independence: painful lessons	LANCET			English	Editorial Material									[Kassirer, Jerome P.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	Kassirer, JP (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	jpkassirer@gmail.com						Canadian Medical Association, 2016, CMA BOARD DIR ANN RE; Kassirer JP, 2006, CMAJ, V174, P845; Kelsall D, 2016, CAN MED ASSOC J, V188, pE113, DOI 10.1503/cmaj.160283; Weeks C., 2016, GLOBE MAIL	4	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1358	1359		10.1016/S0140-6736(16)30089-7	http://dx.doi.org/10.1016/S0140-6736(16)30089-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI0WH	27037213				2022-12-28	WOS:000373217500012
J	Adamo, A; Beingessner, RL; Behnam, M; Chen, J; Jamison, TF; Jensen, KF; Monbaliu, JCM; Myerson, AS; Revalor, EM; Snead, DR; Stelzer, T; Weeranoppanant, N; Wong, SY; Zhang, P				Adamo, Andrea; Beingessner, Rachel L.; Behnam, Mohsen; Chen, Jie; Jamison, Timothy F.; Jensen, Klavs F.; Monbaliu, Jean-Christophe M.; Myerson, Allan S.; Revalor, Eve M.; Snead, David R.; Stelzer, Torsten; Weeranoppanant, Nopphon; Wong, Shin Yee; Zhang, Ping			On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system	SCIENCE			English	Article							CONTINUOUS MANUFACTURING SYMPOSIUM; FINAL DOSAGE FORMATION; WORK-UP; INGREDIENTS; CHEMISTRY; BATCH; TOOL	Pharmaceutical manufacturing typically uses batch processing at multiple locations. Disadvantages of this approach include long production times and the potential for supply chain disruptions. As a preliminary demonstration of an alternative approach, we report here the continuous-flow synthesis and formulation of active pharmaceutical ingredients in a compact, reconfigurable manufacturing platform. Continuous end-to-end synthesis in the refrigerator-sized [1.0 meter (width) x 0.7 meter (length) x 1.8 meter (height)] system produces sufficient quantities per day to supply hundreds to thousands of oral or topical liquid doses of diphenhydramine hydrochloride, lidocaine hydrochloride, diazepam, and fluoxetine hydrochloride that meet U.S. Pharmacopeia standards. Underlying this flexible plug-and-play approach are substantial enabling advances in continuous-flow synthesis, complex multistep sequence telescoping, reaction engineering equipment, and real-time formulation.	[Adamo, Andrea; Behnam, Mohsen; Chen, Jie; Jensen, Klavs F.; Monbaliu, Jean-Christophe M.; Myerson, Allan S.; Revalor, Eve M.; Stelzer, Torsten; Weeranoppanant, Nopphon; Wong, Shin Yee] MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Beingessner, Rachel L.; Jamison, Timothy F.; Snead, David R.; Zhang, Ping] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Monbaliu, Jean-Christophe M.] Univ Liege, Dept Chem, Allee Six Aout 13, B-4000 Liege, Sart Tilman, Belgium; [Revalor, Eve M.] Univ Melbourne, Dept Chem & Biomol Engn, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia; [Snead, David R.] Georgia Pacific Chem, 2883 Miller Rd, Decatur, GA 30312 USA; [Stelzer, Torsten] Univ Puerto Rico, Dept Pharmaceut Sci, Med Sci Campus, San Juan, PR 00936 USA; [Wong, Shin Yee] Singapore Inst Technol, Chem Engn & Food Technol Cluster, 10 Dover Dr, Singapore 138683, Singapore; [Zhang, Ping] Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Liege; University of Melbourne; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Singapore Institute of Technology; Novartis	Jensen, KF; Myerson, AS (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Jamison, TF (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tfj@mit.edu; kfjensen@mit.edu; myerson@mit.edu	Jensen, Klavs F/F-2462-2012; Weeranoppanant, Nopphon/AAE-6770-2021	Jensen, Klavs F/0000-0001-7192-580X; Weeranoppanant, Nopphon/0000-0002-5379-4954; Snead, David/0000-0003-1239-533X; Monbaliu, Jean-Christophe/0000-0001-6916-8846	Defense Advanced Research Project Agency (DARPA); Space and Naval Warfare Systems Center Pacific (SSC Pacific) [N66001-II-C-4147]	Defense Advanced Research Project Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Space and Naval Warfare Systems Center Pacific (SSC Pacific)	Authors are listed in alphabetical order. We thank A. Clayton for elements of the system design, S. H. Harrison for the LabVIEW programming downstream, and A. T. Carlson for assistance with the design of the downstream units. We also thank L. M. Heckman and J. M. Noss for assistance with development of chemistry. This work was supported by the Defense Advanced Research Project Agency (DARPA) and Space and Naval Warfare Systems Center Pacific (SSC Pacific) under Contract no. N66001-II-C-4147. We thank E. Choi, D. T. McQuade, J. Lewin, and G. Ling for their advice and support. The data reported in this paper are available in the article or in the supplementary materials. A. A. is founder of Zaiput Flow Technologies. T.F.J. is a cofounder of Snapdragon Chemistry, Inc., and a scientific adviser for Zaiput Flow Technologies, Continuus Pharmaceuticals, Paraza Pharmaceuticals, and Asymchem. K.F.J. is a scientific adviser for Snapdragon Chemistry, Inc. A.S.M. is a scientific adviser to GenSyn Technologies, Blues Spark Technologies, Continuus Pharmaceuticals, and Goddard Laboratories. MIT has filed a patent on behalf of A. A., M.B., T.F.J., K.F.J., J.C., A.S.M., J.-C.M.M., E.M.R., D.R.S., T.S., N.W., S.Y.W., and P.Z.	Adamo A, 2013, IND ENG CHEM RES, V52, P10802, DOI 10.1021/ie401180t; Ahmed-Omer B, 2011, ORG BIOMOL CHEM, V9, P3854, DOI 10.1039/c0ob00906g; Badman C, 2015, J PHARM SCI-US, V104, P779, DOI 10.1002/jps.24246; Baumann M, 2015, BEILSTEIN J ORG CHEM, V11, P1194, DOI 10.3762/bjoc.11.134; Baxendale IR, 2015, J PHARM SCI-US, V104, P781, DOI 10.1002/jps.24252; Byrn S, 2015, J PHARM SCI-US, V104, P792, DOI 10.1002/jps.24247; Carter CF, 2010, ORG PROCESS RES DEV, V14, P393, DOI 10.1021/op900305v; Correia CA, 2015, ANGEW CHEM INT EDIT, V54, P4945, DOI 10.1002/anie.201411728; Ende D. J. am, 2011, CHEM ENG PHARM IND; Food and Drug Administration, 2013, FDA PERSP CONT MAN; Food and Drug Administration, 2013, STRAT PLAN PREV MIT; Ghislieri D, 2015, ANGEW CHEM INT EDIT, V54, P678, DOI 10.1002/anie.201409765; Gutmann B, 2015, ANGEW CHEM INT EDIT, V54, P6688, DOI 10.1002/anie.201409318; Hartman RL, 2011, ANGEW CHEM INT EDIT, V50, P7502, DOI 10.1002/anie.201004637; Hartman RL, 2010, ORG PROCESS RES DEV, V14, P1347, DOI 10.1021/op100154d; Heider PL, 2014, ORG PROCESS RES DEV, V18, P402, DOI 10.1021/op400294z; Hessel V, 2009, CHEM ENG TECHNOL, V32, P1655, DOI 10.1002/ceat.200900474; Hopkin MD, 2013, ORG BIOMOL CHEM, V11, P1822, DOI 10.1039/c2ob27002a; Ingham RJ, 2015, ANGEW CHEM INT EDIT, V54, P144, DOI 10.1002/anie.201409356; Lee SL, 2015, J PHARM INNOV, V10, P191, DOI 10.1007/s12247-015-9215-8; Levesque F, 2012, ANGEW CHEM INT EDIT, V51, P1706, DOI 10.1002/anie.201107446; Loefgren N. M., 1948, U. S. Patent, Patent No. [2,441,498, 244149811]; Malet-Sanz L, 2012, J MED CHEM, V55, P4062, DOI 10.1021/jm2006029; Mascia S, 2013, ANGEW CHEM INT EDIT, V52, P12359, DOI 10.1002/anie.201305429; Murray PRD, 2013, ORG PROCESS RES DEV, V17, P1192, DOI 10.1021/op4001548; Reilly TJ, 1999, J CHEM EDUC, V76, P1557, DOI 10.1021/ed076p1557; Rieveschl G., 1947, US Pat., Patent No. [2,421,714A, 2421714, 2 421 714]; Schaber SD, 2011, IND ENG CHEM RES, V50, P10083, DOI 10.1021/ie2006752; Service RF, 2015, SCIENCE, V347, P1190, DOI 10.1126/science.347.6227.1190; SUGASAWA T, 1979, J HETEROCYCLIC CHEM, V16, P445, DOI 10.1002/jhet.5570160306; USP (U. S. Pharmacopeia), 2014, USP MONOGRAPH, V34, P2597; USP (U. S. Pharmacopeia), 2014, USP MONOGRAPH, V37, P3035; USP (U. S. Pharmacopeia), 2014, USP MONOGRAPH, V37, P2580; USP (U. S. Pharmacopeia), 2014, USP MONOGRAPH, V37, P3552; Viviano M, 2011, ORG PROCESS RES DEV, V15, P858, DOI 10.1021/op2001047; Webb D, 2010, CHEM SCI, V1, P675, DOI 10.1039/c0sc00381f; Wong SY, 2013, ORG PROCESS RES DEV, V17, P684, DOI 10.1021/op400011s; Zhang P, 2014, ORG PROCESS RES DEV, V18, P1567, DOI 10.1021/op500166n	38	575	599	39	521	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					61	67		10.1126/science.aaf1337	http://dx.doi.org/10.1126/science.aaf1337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034366				2022-12-28	WOS:000373039600034
J	Joffe, S; Magnus, DC				Joffe, Steven; Magnus, David C.			A Flawed Revision of the Common Rule	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Joffe, Steven] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,BH1413, Philadelphia, PA 19104 USA; [Magnus, David C.] Stanford Univ, Stanford Ctr Biomed Eth, 1215 Welch Rd,Modular A, Stanford, CA 94305 USA	University of Pennsylvania; Pennsylvania Medicine; Stanford University	Joffe, S (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,BH1413, Philadelphia, PA 19104 USA.	joffes@upenn.edu	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384				American Society of Investigative Pathology, 2015, COMM LETT NOT PROP R; Dana Verrill, 2015, DEC CHARTS HELP YOU; Emanuel EJ, 2015, NEW ENGL J MED, V373, P2296, DOI 10.1056/NEJMp1512463; Hudson KL, 2015, NEW ENGL J MED, V373, P2293, DOI 10.1056/NEJMp1512205; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; Platt R, 2014, JAMA-J AM MED ASSOC, V311, P1497, DOI 10.1001/jama.2014.2144; Presidential Commission for the Study of Bioethical Issues, 2011, MOR SCI PROT PART HU; Secretarys Advisory Committee on Human Research Protections, 2012, DRAFT RECOMMENDATION; U.S. Department of Health and Human Services, 2015, FED REGISTER, V80, P53931	9	5	5	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					143	+		10.7326/M16-0119	http://dx.doi.org/10.7326/M16-0119			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2GY	27043302				2022-12-28	WOS:000380583100022
J	Dieleman, JL; Schneider, MT; Haakenstad, A; Singh, L; Sadat, NS; Birger, M; Reynolds, A; Templin, T; Hamavid, H; Chapin, A; Murray, CJL				Dieleman, Joseph L.; Schneider, Matthew T.; Haakenstad, Annie; Singh, Lavanya; Sadat, Nafi S.; Birger, Maxwell; Reynolds, Alex; Templin, Tara; Hamavid, Hannah; Chapin, Abigail; Murray, Christopher J. L.			Development assistance for health: past trends, associations, and the future of international financial flows for health	LANCET			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; DISEASE; MORTALITY; HIV	Background Disbursements of development assistance for health (DAH) have risen substantially during the past several decades. More recently, the international community's attention has turned to other international challenges, introducing uncertainty about the future of disbursements for DAH. Methods We collected audited budget statements, annual reports, and project-level records from the main international agencies that disbursed DAH from 1990 to the end of 2015. We standardised and combined records to provide a comprehensive set of annual disbursements. We tracked each dollar of DAH back to the source and forward to the recipient. We removed transfers between agencies to avoid double-counting and adjusted for inflation. We classified assistance into nine primary health focus areas: HIV/AIDS, tuberculosis, malaria, maternal health, newborn and child health, other infectious diseases, non-communicable diseases, Ebola, and sector-wide approaches and health system strengthening. For our statistical analysis, we grouped these health focus areas into two categories: MDG-related focus areas (HIV/AIDS, tuberculosis, malaria, child and newborn health, and maternal health) and non-MDG-related focus areas (other infectious diseases, non-communicable diseases, sector-wide approaches, and other). We used linear regression to test for structural shifts in disbursement patterns at the onset of the Millennium Development Goals (MDGs; ie, from 2000) and the global financial crisis (impact estimated to occur in 2010). We built on past trends and associations with an ensemble model to estimate DAH through the end of 2040. Findings In 2015, US$36.4 billion of DAH was disbursed, marking the fifth consecutive year of little change in the amount of resources provided by global health development partners. Between 2000 and 2009, DAH increased at 11.3% per year, whereas between 2010 and 2015, annual growth was just 1.2%. In 2015, 29.7% of DAH was for HIV/AIDS, 17.9% was for child and newborn health, and 9.8% was for maternal health. Linear regression identifies three distinct periods of growth in DAH. Between 2000 and 2009, MDG-related DAH increased by $290.4 million (95% uncertainty interval [UI] 174.3 million to 406.5 million) per year. These increases were significantly greater than were increases in non-MDG DAH during the same period (p=0.009), and were also signifi cantly greater than increases in the previous period (p<0.0001). Between 2000 and 2009, growth in DAH was highest for HIV/AIDS, malaria, and tuberculosis. Since 2010, DAH for maternal health and newborn and child health has continued to climb, although DAH for HIV/AIDS and most other health focus areas has remained flat or decreased. Our estimates of future DAH based on past trends and associations present a wide range of potential futures, although our mean estimate of $64.1 billion (95% UI $30.4 billion to $161.8 billion) shows an increase between now and 2040, although with a large uncertainty interval. Interpretation Our results provide evidence of two substantial shifts in DAH growth during the past 26 years. DAH disbursements increased faster in the first decade of the 2000s than in the 1990s, but DAH associated with the MDGs increased the most out of all focus areas. Since 2010, limited growth has characterised DAH and we expect this pattern to persist. Despite the fact that DAH is still growing, albeit minimally, DAH is shifting among the major health focus areas, with relatively little growth for HIV/AIDS, malaria, and tuberculosis. These changes in the growth and focus of DAH will have critical effects on health services in some low-income countries. Coordination and collaboration between donors and domestic governments is more important than ever because they have a great opportunity and responsibility to ensure robust health systems and service provision for those most in need.	[Dieleman, Joseph L.; Schneider, Matthew T.; Singh, Lavanya; Sadat, Nafi S.; Birger, Maxwell; Reynolds, Alex; Templin, Tara; Hamavid, Hannah; Chapin, Abigail; Murray, Christopher J. L.] Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Haakenstad, Annie] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Institute for Health Metrics & Evaluation; Harvard University; Harvard T.H. Chan School of Public Health	Dieleman, JL (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	dieleman@uw.edu			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill & Melinda Gates Foundation provided financial support for the study. We thank all the past members of Institute for Health Metrics and Evaluation's Financial Resources for Health research team, in particular Elizabeth Johnson and Casey Graves, whose foundation we are building upon. We also thank the remainder of the Institute for Health Metrics and Evaluation's Financial Resources for Health research team, including Cody Horst, Jonathan Joseph, and Liya Lomsadze.	[Anonymous], 2000, ROLE UN 21 CENTURY; Bollyky TJ, 2015, HEALTH AFFAIR, V34, P1464, DOI 10.1377/hlthaff.2015.0343; Daniels Jr ME, 2015, EMERGING GLOBAL HLTH; de Lay Paul, 2007, BMJ, V334, P345, DOI 10.1136/bmj.39113.539595.94; Dieleman JL, 2015, JAMA-J AM MED ASSOC, V313, P2359, DOI 10.1001/jama.2015.5825; Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Grepin KA, 2012, HEALTH POLICY PLANN, V27, P527, DOI 10.1093/heapol/czr076; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; IHME, 2016, FIN GLOB HLTH 2015 D; IHME, 2015, FIN GLOB HLTH 2014 S; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Leach-Kemon K, 2012, HEALTH AFFAIR, V31, P228, DOI 10.1377/hlthaff.2011.1154; Lordan G, 2011, SOC SCI MED, V73, P351, DOI 10.1016/j.socscimed.2011.05.045; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; UNAIDS, 2015, AIDS NUMB 2015; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO, WHO GLOB HLTH OBS DA	18	133	135	1	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2536	2544		10.1016/S0140-6736(16)30168-4	http://dx.doi.org/10.1016/S0140-6736(16)30168-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO7FG	27086170				2022-12-28	WOS:000377947200030
J	Kuck, KH; Brugada, J; Furnkranz, A; Metzner, A; Ouyang, FF; Chun, KRJ; Elvan, A; Arentz, T; Bestehorn, K; Pocock, SJ; Albenque, JP; Tondo, C				Kuck, Karl-Heinz; Brugada, Josep; Fuernkranz, Alexander; Metzner, Andreas; Ouyang, Feifan; Chun, K. R. Julian; Elvan, Arif; Arentz, Thomas; Bestehorn, Kurt; Pocock, Stuart J.; Albenque, Jean-Paul; Tondo, Claudio		FIRE AND ICE Investigators	Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY VEIN ISOLATION; OPEN-IRRIGATED RADIOFREQUENCY; CATHETER ABLATION; 2ND-GENERATION CRYOBALLOON	BACKGROUND Current guidelines recommend pulmonary-vein isolation by means of catheter ablation as treatment for drug-refractory paroxysmal atrial fibrillation. Radiofrequency ablation is the most common method, and cryoballoon ablation is the second most frequently used technology. METHODS We conducted a multicenter, randomized trial to determine whether cryoballoon ablation was noninferior to radiofrequency ablation in symptomatic patients with drug-refractory paroxysmal atrial fibrillation. The primary efficacy end point in a time-to-event analysis was the first documented clinical failure (recurrence of atrial fibrillation, occurrence of atrial flutter or atrial tachycardia, use of antiarrhythmic drugs, or repeat ablation) following a 90-day period after the index ablation. The noninferiority margin was prespecified as a hazard ratio of 1.43. The primary safety end point was a composite of death, cerebrovascular events, or serious treatment-related adverse events. RESULTS A total of 762 patients underwent randomization (378 assigned to cryoballoon ablation and 384 assigned to radiofrequency ablation). The mean duration of follow-up was 1.5 years. The primary efficacy end point occurred in 138 patients in the cryoballoon group and in 143 in the radiofrequency group (1-year Kaplan-Meier event rate estimates, 34.6% and 35.9%, respectively; hazard ratio, 0.96; 95% confidence interval [CI], 0.76 to 1.22; P < 0.001 for noninferiority). The primary safety end point occurred in 40 patients in the cryoballoon group and in 51 patients in the radiofrequency group (1-year Kaplan-Meier event rate estimates, 10.2% and 12.8%, respectively; hazard ratio, 0.78; 95% CI, 0.52 to 1.18; P = 0.24). CONCLUSIONS In this randomized trial, cryoballoon ablation was noninferior to radiofrequency ablation with respect to efficacy for the treatment of patients with drug-refractory paroxysmal atrial fibrillation, and there was no significant difference between the two methods with regard to overall safety. (Funded by Medtronic; FIRE AND ICE ClinicalTrials.gov number, NCT01490814.)	[Kuck, Karl-Heinz; Metzner, Andreas; Ouyang, Feifan] Asklepios Klin St Georg, Dept Cardiol, Lohmuhlenstr 5, D-20099 Hamburg, Germany; [Fuernkranz, Alexander; Chun, K. R. Julian] Markus Krankenhaus, Med Dept 3, Cardioangiol Ctr Bethanien, Frankfurt, Germany; [Arentz, Thomas] Herz Zentrum, Bad Krozingen, Germany; [Bestehorn, Kurt] Tech Univ Dresden, D-01062 Dresden, Germany; [Brugada, Josep] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Elvan, Arif] Isala Klin, Zwolle, Netherlands; [Pocock, Stuart J.] London Sch Hyg & Trop Med, London WC1, England; [Albenque, Jean-Paul] Clin Pasteur, Toulouse, France; [Tondo, Claudio] Univ Milan, Ctr Cardiol Monzino, Milan, Italy	Asklepios Klinik St. Georg; Technische Universitat Dresden; University of Barcelona; Hospital Clinic de Barcelona; Isala Clinics; University of London; London School of Hygiene & Tropical Medicine; IRCCS Centro Cardiologico Monzino; University of Milan	Kuck, KH (corresponding author), Asklepios Klin St Georg, Dept Cardiol, Lohmuhlenstr 5, D-20099 Hamburg, Germany.	k.kuck@asklepios.com	Tondo, Claudio/S-4671-2019; Jadidi, Amir/AAY-1683-2021; Kühne, Michael/AAB-5202-2022; Sticherling, Christian/AAY-4435-2021	Kühne, Michael/0000-0002-2937-3711; Sticherling, Christian/0000-0001-8428-7050; Tondo, Claudio/0000-0002-8500-8313	Medtronic	Medtronic(Medtronic)	Funded by Medtronic; FIRE AND ICE ClinicalTrials.gov number, NCT01490814.	Aryana A, 2015, J CARDIOVASC ELECTR, V26, P832, DOI 10.1111/jce.12695; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Furnkranz A, 2014, J CARDIOVASC ELECTR, V25, P1314, DOI 10.1111/jce.12529; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hunter RJ, 2015, J CARDIOVASC ELECTR, V26, P1307, DOI 10.1111/jce.12846; Jourda F, 2015, EUROPACE, V17, P225, DOI 10.1093/europace/euu215; Jung SH, 2005, J BIOPHARM STAT, V15, P969, DOI 10.1080/10543400500265736; Kautzner J, 2015, EUROPACE, V17, P1229, DOI 10.1093/europace/euv057; Kenigsberg DN, 2015, HEART RHYTHM, V12, P283, DOI 10.1016/j.hrthm.2014.11.012; Kuck KH, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003337; Luik A, 2015, CIRCULATION, V132, P1311, DOI 10.1161/CIRCULATIONAHA.115.016871; Natale A, 2014, J AM COLL CARDIOL, V64, P647, DOI 10.1016/j.jacc.2014.04.072; Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064; Reddy VY, 2015, J CARDIOVASC ELECTR, V26, P493, DOI 10.1111/jce.12626; Squara F, 2015, EUROPACE, V17, P718, DOI 10.1093/europace/euv060; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Wasserlauf J, 2015, PACE, V38, P483, DOI 10.1111/pace.12582; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Yorgun H, 2014, EUROPACE, V16, P645, DOI 10.1093/europace/eut240	19	984	1006	2	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2016	374	23					2235	2245		10.1056/NEJMoa1602014	http://dx.doi.org/10.1056/NEJMoa1602014			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO6VB	27042964	Green Accepted, Bronze			2022-12-28	WOS:000377920500007
J	Yusuf, S; Bosch, J; Dagenais, G; Zhu, J; Xavier, D; Liu, L; Pais, P; Lopez-Jaramillo, P; Leiter, LA; Dans, A; Avezum, A; Piegas, LS; Parkhomenko, A; Keltai, K; Keltai, M; Sliwa, K; Peters, RJG; Held, C; Chazova, I; Yusoff, K; Lewis, BS; Jansky, P; Khunti, K; Toff, WD; Reid, CM; Varigos, J; Sanchez-Vallejo, G; McKelvie, R; Pogue, J; Jung, H; Gao, P; Diaz, R; Lonn, E				Yusuf, S.; Bosch, J.; Dagenais, G.; Zhu, J.; Xavier, D.; Liu, L.; Pais, P.; Lopez-Jaramillo, P.; Leiter, L. A.; Dans, A.; Avezum, A.; Piegas, L. S.; Parkhomenko, A.; Keltai, K.; Keltai, M.; Sliwa, K.; Peters, R. J. G.; Held, C.; Chazova, I.; Yusoff, K.; Lewis, B. S.; Jansky, P.; Khunti, K.; Toff, W. D.; Reid, C. M.; Varigos, J.; Sanchez-Vallejo, G.; McKelvie, R.; Pogue, J.; Jung, H.; Gao, P.; Diaz, R.; Lonn, E.		HOPE-3 Investigators	Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; 52 COUNTRIES; INTERHEART; PREVENTION; CATARACT	BACKGROUND Previous trials have shown that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons without cardiovascular disease. Those trials have involved persons with elevated lipid levels or inflammatory markers and involved mainly white persons. It is unclear whether the benefits of statins can be extended to an intermediate-risk, ethnically diverse population without cardiovascular disease. METHODS In one comparison from a 2-by-2 factorial trial, we randomly assigned 12,705 participants in 21 countries who did not have cardiovascular disease and were at intermediate risk to receive rosuvastatin at a dose of 10 mg per day or placebo. The first coprimary outcome was the composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, and the second coprimary outcome additionally included revascularization, heart failure, and resuscitated cardiac arrest. The median follow-up was 5.6 years. RESULTS The overall mean low-density lipoprotein cholesterol level was 26.5% lower in the rosuvastatin group than in the placebo group. The first coprimary outcome occurred in 235 participants (3.7%) in the rosuvastatin group and in 304 participants (4.8%) in the placebo group (hazard ratio, 0.76; 95% confidence interval [CI], 0.64 to 0.91; P=0.002). The results for the second coprimary outcome were consistent with the results for the first (occurring in 277 participants [4.4%] in the rosuvastatin group and in 363 participants [5.7%] in the placebo group; hazard ratio, 0.75; 95% CI, 0.64 to 0.88; P<0.001). The results were also consistent in subgroups defined according to cardiovascular risk at baseline, lipid level, C-reactive protein level, blood pressure, and race or ethnic group. In the rosuvastatin group, there was no excess of diabetes or cancers, but there was an excess of cataract surgery (in 3.8% of the participants, vs. 3.1% in the placebo group; P=0.02) and muscle symptoms (in 5.8% of the participants, vs. 4.7% in the placebo group; P=0.005). CONCLUSIONS Treatment with rosuvastatin at a dose of 10 mg per day resulted in a significantly lower risk of cardiovascular events than placebo in an intermediate-risk, ethnically diverse population without cardiovascular disease. (Funded by the Canadian Institutes of Health Research and AstraZeneca; HOPE-3 ClinicalTrials. gov number, NCT00468923.)	[Chazova, I.] Plex, Moscow, Russia; [Yusoff, K.] Univ Teknol Majlis Amansh Rakyat, Selayang, Malaysia; [Yusoff, K.] Univ Coll Sedaya Int Univ, Kuala Lumpur, Malaysia; [Lewis, B. S.] Technion Israel Inst Technol, Lady Davis Carmel Med Ctr, Ruth & Bruce Rappaport Sch Med, Haifa, Israel; [Jansky, P.] Univ Hosp Motol, Prague, Czech Republic; [Khunti, K.] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Toff, W. D.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Toff, W. D.] Glenfield Hosp, Leicester Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, Leicester, Leics, England; [Reid, C. M.] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Reid, C. M.] Monash Ctr Cardiovasc Res & Educ Therapeut, Primary Care Diabet & Vasc Med, Melbourne, Vic, Australia; [Varigos, J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Diaz, R.] Inst Cardiovasc Rosario, Rosario, Argentina	Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Motol University Hospital; University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Curtin University; Monash University	Yusuf, S (corresponding author), Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Petrella, Robert J/G-6557-2018; Keltai, Katalin/V-4350-2019; Bosch, Jacqueline/AAP-6910-2021; Held, Claes/AAA-3973-2021; Cífková, Renata/O-5731-2017; Reid, Christopher M/AAP-8135-2021; Avezum, Alvaro/AAP-7687-2020; Vasilyeva, Larisa/AAZ-3708-2021; Leiter, Lawrence/AAG-4059-2020; Aroca, Gustavo/P-9173-2016; Urina-Triana, Miguel A/H-2605-2016; Nedogoda, Sergey V/O-4656-2014; Chazova, Irina/AAK-6581-2021; Avezum, Alvaro AA/K-6137-2016; Chazova, Irina/B-8688-2017; Söderberg, Stefan/AAG-3881-2019; Yusoff, Khalid/I-7029-2019; /ABC-9527-2021; Valle, Adriana/F-9897-2014	Keltai, Katalin/0000-0002-8294-9062; Bosch, Jacqueline/0000-0001-6292-4207; Held, Claes/0000-0001-9402-7404; Cífková, Renata/0000-0003-2765-3821; Vasilyeva, Larisa/0000-0003-0889-7898; Aroca, Gustavo/0000-0002-9222-3257; Urina-Triana, Miguel A/0000-0001-6003-4622; Nedogoda, Sergey V/0000-0001-5981-1754; Chazova, Irina/0000-0002-9822-4357; Avezum, Alvaro AA/0000-0002-3073-6890; Chazova, Irina/0000-0002-9822-4357; Söderberg, Stefan/0000-0001-9225-1306; Yusoff, Khalid/0000-0001-5669-5188; Yusuf, Salim/0000-0003-4776-5601; Valle, Adriana/0000-0002-0090-8524; Abhayaratna, Walter/0000-0002-4908-0641; Md Aris, Mohd Aznan/0000-0002-9967-1327; Varigos, John/0000-0001-6722-3135; Chazova, Irina E./0000-0002-1576-4877; da Silva Franco, Roberto Jorge/0000-0001-9787-4393	Canadian Institutes of Health Research; AstraZeneca; Canadian Institutes of Health Research; AstraZeneca	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca(AstraZeneca); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca(AstraZeneca)	Funded by the Canadian Institutes of Health Research and AstraZeneca	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bang CN, 2015, AM J CARDIOL, V116, P1840, DOI 10.1016/j.amjcard.2015.09.026; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Khatib R, 2016, LANCET, V387, P61, DOI 10.1016/S0140-6736(15)00469-9; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Lonn E, 2016, CAN J CARDIOL, V32, P311, DOI 10.1016/j.cjca.2015.07.001; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sackett DL, 2000, CAN MED ASSOC J, V162, P1311; Wise SJ, 2014, CAN J CARDIOL, V30, P1613, DOI 10.1016/j.cjca.2014.08.020; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177	18	404	431	1	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2021	2031		10.1056/NEJMoa1600176	http://dx.doi.org/10.1056/NEJMoa1600176			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27040132	Bronze, Green Published			2022-12-28	WOS:000376443500005
J	Martinez, J; Cunha, LD; Park, S; Yang, M; Lu, Q; Orchard, R; Li, QZ; Yan, M; Janke, L; Guy, C; Linkermann, A; Virgin, HW; Green, DR				Martinez, Jennifer; Cunha, Larissa D.; Park, Sunmin; Yang, Mao; Lu, Qun; Orchard, Robert; Li, Quan-Zhen; Yan, Mei; Janke, Laura; Guy, Cliff; Linkermann, Andreas; Virgin, Herbert W.; Green, Douglas R.			Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells	NATURE			English	Article							AUTOIMMUNE-DISEASE; ERYTHEMATOSUS; PHAGOCYTOSIS; CLEARANCE; IL-10; MICE; SUSCEPTIBILITY; ASSOCIATION; MACROPHAGES; PROTEINS	Defects in clearance of dying cells have been proposed to underlie the pathogenesis of systemic lupus erythematosus (SLE)(1). Mice lacking molecules associated with dying cell clearance develop SLE-like disease(2), and phagocytes from patients with SLE often display defective clearance and increased inflammatory cytokine production when exposed to dying cells in vitro. Previously, we(3-6) and others(7) described a form of noncanonical autophagy known as LC3-associated phagocytosis (LAP), in which phagosomes containing engulfed particles, including dying cells(3,4,7), recruit elements of the autophagy pathway to facilitate maturation of phagosomes and digestion of their contents. Genome-wide association studies have identified polymorphisms in the Atg5 (ref. 8) and possibly Atg7 (ref. 9) genes, involved in both canonical autophagy and LAP(3-7), as markers of a predisposition for SLE. Here we describe the consequences of defective LAP in vivo. Mice lacking any of several components of the LAP pathway show increased serum levels of inflammatory cytokines and autoantibodies, glomerular immune complex deposition, and evidence of kidney damage. When dying cells are injected into LAP-deficient mice, they are engulfed but not efficiently degraded and trigger acute elevation of pro-inflammatory cytokines but not anti-inflammatory interleukin (IL)-10. Repeated injection of dying cells into LAP-deficient, but not LAP-sufficient, mice accelerated the development of SLE-like disease, including increased serum levels of autoantibodies. By contrast, mice deficient in genes required for canonical autophagy but not LAP do not display defective dying cell clearance, inflammatory cytokine production, or SLE-like disease, and, like wild-type mice, produce IL-10 in response to dying cells. Therefore, defects in LAP, rather than canonical autophagy, can cause SLE-like phenomena, and may contribute to the pathogenesis of SLE.	[Martinez, Jennifer; Cunha, Larissa D.; Yang, Mao; Janke, Laura; Guy, Cliff; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Martinez, Jennifer] NIEHS, Immun Inflammat & Dis Lab, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA; [Park, Sunmin; Lu, Qun; Orchard, Robert; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Li, Quan-Zhen; Yan, Mei] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Linkermann, Andreas] Univ Kiel, Div Nephrol & Hypertens, D-24105 Kiel, Germany	St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Kiel	Martinez, J; Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Martinez, J (corresponding author), NIEHS, Immun Inflammat & Dis Lab, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	jennifer.martinez3@nih.gov; douglas.green@stjude.org	Janke, Laura/N-8121-2018; Martinez, Jennifer/C-3740-2019; Lu, Qun/O-2978-2018; Linkermann, Andreas/H-3551-2012; Linkermann, Andreas/AAB-8308-2020; Green, Douglas R/N-8083-2018	Janke, Laura/0000-0002-9871-6239; Martinez, Jennifer/0000-0002-3060-2518; Linkermann, Andreas/0000-0001-6287-9725; Linkermann, Andreas/0000-0001-6287-9725; Green, Douglas R/0000-0002-7332-1417; Virgin, Herbert/0000-0001-8580-7628	Intramural Research Program of the National Institutes of Health, NIEHS [1ZIAES10328601]; US National Institutes of Health [RO1 AI40646, U19 AI109725]; Lupus Research Institute; German Research Foundation [EXC306]; ALSAC; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646, T32AI007163, U19AI109725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES103286] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIEHS; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; German Research Foundation(German Research Foundation (DFG)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank T. Brewer, P. Fitzgerald, M. Henderson, J. Kolb and T. Oguin for technical assistance. We also thank K. Gerrish and R. Fannin for their work and analysis of the Nanostring data. This work was supported by the Intramural Research Program of the National Institutes of Health, NIEHS (1ZIAES10328601), as well as grants from the US National Institutes of Health (RO1 AI40646, U19 AI109725), the Lupus Research Institute, the German Research Foundation (EXC306), and ALSAC.	Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Campbell AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004801; Clarke AJ, 2015, ANN RHEUM DIS, V74, P912, DOI 10.1136/annrheumdis-2013-204343; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Lopez P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078756; Ma L, 2005, EUR J IMMUNOL, V35, P3364, DOI 10.1002/eji.200535192; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Teichmann LL, 2012, J IMMUNOL, V188, P678, DOI 10.4049/jimmunol.1102456; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	29	283	297	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					115	+		10.1038/nature17950	http://dx.doi.org/10.1038/nature17950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27096368	Green Accepted			2022-12-28	WOS:000375473900050
J	Dong, D; Ren, K; Qiu, XL; Zheng, JL; Guo, MH; Guan, XY; Liu, HN; Li, NN; Zhang, BL; Yang, DJ; Ma, C; Wang, S; Wu, D; Ma, YF; Fan, SL; Wang, JW; Gao, N; Huang, ZW				Dong, De; Ren, Kuan; Qiu, Xiaolin; Zheng, Jianlin; Guo, Minghui; Guan, Xiaoyu; Liu, Hongnan; Li, Ningning; Zhang, Bailing; Yang, Daijun; Ma, Chuang; Wang, Shuo; Wu, Dan; Ma, Yunfeng; Fan, Shilong; Wang, Jiawei; Gao, Ning; Huang, Zhiwei			The crystal structure of Cpf1 in complex with CRISPR RNA	NATURE			English	Article							TARGET DNA RECOGNITION; BACTERIAL IMMUNITY; ADAPTIVE IMMUNITY; CAS SYSTEMS; PROKARYOTES; ENDONUCLEASE; ARCHAEA; BACTERIOPHAGE; TOOLS	The CRISPR-Cas systems, as exemplified by CRISPR-Cas9, are RNA-guided adaptive immune systems used by bacteria and archaea to defend against viral infection(1-7). The CRISPR-Cpf1 system, a new class 2 CRISPR-Cas system, mediates robust DNA interference in human cells(1,8-10). Although functionally conserved, Cpf1 and Cas9 differ in many aspects including their guide RNAs and substrate specificity. Here we report the 2.38 A crystal structure of the CRISPR RNA (crRNA)-bound Lachnospiraceae bacterium ND2006 Cpf1 (LbCpf1). LbCpf1 has a triangle-shaped architecture with a large positively charged channel at the centre. Recognized by the oligonucleotide-binding domain of LbCpf1, the crRNA adopts a highly distorted conformation stabilized by extensive intramolecular interactions and the (Mg(H2O)(6))(2+) ion. The oligonucleotide-binding domain also harbours a looped-out helical domain that is important for LbCpf1 substrate binding. Binding of crRNA or crRNA lacking the guide sequence induces marked conformational changes but no oligomerization of LbCpf1. Our study reveals the crRNA recognition mechanism and provides insight into crRNA-guided substrate binding of LbCpf1, establishing a framework for engineering LbCpf1 to improve its efficiency and specificity for genome editing.	[Dong, De; Ren, Kuan; Qiu, Xiaolin; Zheng, Jianlin; Guo, Minghui; Guan, Xiaoyu; Liu, Hongnan; Zhang, Bailing; Yang, Daijun; Ma, Chuang; Wang, Shuo; Wu, Dan; Ma, Yunfeng; Huang, Zhiwei] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China; [Li, Ningning; Fan, Shilong; Wang, Jiawei; Gao, Ning] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China	Harbin Institute of Technology; Tsinghua University	Huang, ZW (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China.	huangzhiwei@hit.edu.cn	zhang, bailing/GZA-6966-2022; Wang, Jiawei/D-1144-2010; Gao, Ning/AAK-2214-2020; Gao, Ning/J-9623-2012; Huang, Zhiwei/AAF-6846-2019	Wang, Jiawei/0000-0001-9893-8539; Gao, Ning/0000-0003-3067-9993; Gao, Ning/0000-0003-3067-9993; Fan, Shilong/0000-0001-9272-2438; Li, Ningning/0000-0001-8601-5171	National Natural Science Foundation of China [31422014, 31450001, 31300605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank F. Yu and J. He at Shanghai Synchrotron Radiation Facility for help with data collection. We thank J. Chai for critical reading of the manuscript. We acknowledge the Tsinghua University Branch of China National Center for Protein Sciences Beijing for providing the facility support. This research was funded by the National Natural Science Foundation of China grant numbers 31422014, 31450001 and 31300605 to Z.H.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Draper DE, 1999, NUCLEIC ACIDS RES, V27, P381, DOI 10.1093/nar/27.2.381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fonfara I., 2016, NATURE; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kamadurai HB, 2008, ACTA CRYSTALLOGR F, V64, P470, DOI 10.1107/S174430910801381X; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schunder E, 2013, INT J MED MICROBIOL, V303, P51, DOI 10.1016/j.ijmm.2012.11.004; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	36	193	233	17	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					522	+		10.1038/nature17944	http://dx.doi.org/10.1038/nature17944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27096363				2022-12-28	WOS:000374815900052
J	Chetty, R; Stepner, M; Abraham, S; Lin, S; Scuderi, B; Turner, N; Bergeron, A; Cutler, D				Chetty, Raj; Stepner, Michael; Abraham, Sarah; Lin, Shelby; Scuderi, Benjamin; Turner, Nicholas; Bergeron, Augustin; Cutler, David			The Association Between Income and Life Expectancy in the United States, 2001-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SOCIAL-SECURITY; RELIGIOUS INVOLVEMENT; REGIONAL-VARIATIONS; POPULATION HEALTH; AIR-POLLUTION; CARE EVIDENCE; US COUNTIES; MORTALITY; INEQUALITY; DISPARITIES	IMPORTANCE The relationship between income and life expectancy is well established but remains poorly understood. OBJECTIVES To measure the level, time trend, and geographic variability in the association between income and life expectancy and to identify factors related to small area variation. DESIGN AND SETTING Income data for the US population were obtained from 1.4 billion deidentified tax records between 1999 and 2014. Mortality data were obtained from Social Security Administration death records. These data were used to estimate race-and ethnicity-adjusted life expectancy at 40 years of age by household income percentile, sex, and geographic area, and to evaluate factors associated with differences in life expectancy. EXPOSURE Pretax household earnings as a measure of income. MAIN OUTCOMES AND MEASURES Relationship between income and life expectancy; trends in life expectancy by income group; geographic variation in life expectancy levels and trends by income group; and factors associated with differences in life expectancy across areas. RESULTS The sample consisted of 1408 287 218 person-year observations for individuals aged 40 to 76 years (mean age, 53.0 years; median household earnings among working individuals, $61175 per year). There were 4114 38 0 deaths among men (mortality rate, 596.3 per 100 00 0) and 2 694 808 deaths among women (mortality rate, 375.1 per 10 0 00 0). The analysis yielded 4 results. First, higher income was associated with greater longevity throughout the income distribution. The gap in life expectancy between the richest 1% and poorest 1% of individuals was 14.6 years (95% CI, 14.4 to 143 years) for men and 10.1 years (95% CI, 9.9 to103 years) for women. Second, inequality in life expectancy increased over time. Between 2001 and 2014, life expectancy increased by 2.34 years for men and 2.91 years for women in the top 5% of the income distribution, but by only 0.32 years for men and 0.04 years for women in the bottom 5% (P<.001 for the differences for both sexes). Third, life expectancy for low-income individuals varied substantially across local areas. In the bottom income quartile, life expectancy differed by approximately 4.5 years between areas with the highest and lowest longevity. Changes in life expectancy between 2001 and 2014 ranged from gains of more than 4 years to losses of more than 2 years across areas. Fourth, geographic differences in life expectancy for individuals in the lowest income quartile were significantly correlated with health behaviors such as smoking (r=-0.69, P<.001), but were not significantly correlated with access to medical care, physical environmental factors, income inequality, or labor market conditions. Life expectancy for low-income individuals was positively correlated with the local area fraction of immigrants (r=0.72, P<.001), fraction of college graduates (r=0.42, P<.001), and government expenditures (r=0.57, P<.001). CONCLUSIONS AND RELEVANCE In the United States between 2001 and 2014, higher income was associated with greater longevity, and differences in life expectancy across income groups increased over time. However, the association between life expectancy and income varied substantially across areas; differences in longevity across income groups decreased in some areas and increased in others. The differences in life expectancy were correlated with health behaviors and local area characteristics.	[Chetty, Raj] Stanford Univ, Dept Econ, 579 Serra Mall, Stanford, CA 94305 USA; [Stepner, Michael; Abraham, Sarah] MIT, Dept Econ, Cambridge, MA 02139 USA; [Lin, Shelby] McKinsey & Co Inc, New York, NY USA; [Scuderi, Benjamin; Bergeron, Augustin; Cutler, David] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Turner, Nicholas] US Treasury, Off Tax Anal, Washington, DC USA	Stanford University; Massachusetts Institute of Technology (MIT); Harvard University; United States Department of the Treasury	Chetty, R (corresponding author), Stanford Univ, Dept Econ, 579 Serra Mall, Stanford, CA 94305 USA.	chetty@stanford.edu	Abraham, Sarah/GSM-7513-2022	Cutler, David/0000-0002-4949-8917	US Social Security Administration (SSA) as part of the SSA Retirement Research Consortium [RRC08098400-07]; National Institutes of Health [P01AG005842]; Social Sciences and Humanities Research Council of Canada; Smith Richardson Foundation; Laura and John Arnold Foundation; NATIONAL INSTITUTE ON AGING [P01AG005842] Funding Source: NIH RePORTER	US Social Security Administration (SSA) as part of the SSA Retirement Research Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Smith Richardson Foundation; Laura and John Arnold Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the US Social Security Administration (SSA) through grant RRC08098400-07 to the National Bureau of Economic Research as part of the SSA Retirement Research Consortium, and through funding from the National Institutes of Health (grant P01AG005842), the Social Sciences and Humanities Research Council of Canada, the Smith Richardson Foundation, and the Laura and John Arnold Foundation.	Almond D, 2010, Q J ECON, V125, P591, DOI 10.1162/qjec.2010.125.2.591; Arias Elizabeth, 2013, Natl Vital Stat Rep, V61, P1; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Berkman LF., 2014, SOCIAL EPIDEMIOLOGY, V2nd ed.; Bosworth B., 2016, LATER RETIREMENT INE; Bound J., 2014, IMPLICATIONS DIFFERE; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Caiazzo F, 2013, ATMOS ENVIRON, V79, P208; Card D, 2009, Q J ECON, V124, P597, DOI 10.1162/qjec.2009.124.2.597; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Cesarini D, 2016, Q J ECON, V131, P687, DOI 10.1093/qje/qjw001; CHEADLE A, 1991, PREV MED, V20, P250, DOI 10.1016/0091-7435(91)90024-X; Chetty R, 2014, Q J ECON, V129, P1553, DOI 10.1093/qje/qju022; Choi M, 2014, INT J EPIDEMIOL, V43, P1895, DOI 10.1093/ije/dyu212; Cilke J., PROFILE NONFILERS; Cobb LK, 2015, OBESITY, V23, P1331, DOI 10.1002/oby.21118; Coile C, 2004, NBER CONF R, P691; Cristia J. P., 2007, EMPIRICAL RELATIONSH; Currie J, 2005, Q J ECON, V120, P1003, DOI 10.1093/qje/120.3.1003; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; Deaton A, 2003, SOC SCI MED, V56, P1139, DOI 10.1016/S0277-9536(02)00115-6; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Doyle JJ, 2015, J POLIT ECON, V123, P170, DOI 10.1086/677756; Doyle JJ, 2011, AM ECON J-APPL ECON, V3, P221, DOI 10.1257/app.3.3.221; Duggan JE, 2008, IMF STAFF PAPERS, V55, P566, DOI 10.1057/imfsp.2008.21; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Finkelstein A, 2008, J PUBLIC ECON, V92, P1644, DOI 10.1016/j.jpubeco.2007.10.005; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fuchs V., 1974, WHO SHALL LIVE; Gavrilov LA, 2011, N AM ACTUAR J, V15, P432, DOI 10.1080/10920277.2011.10597629; Gelman A, 2016, P NATL ACAD SCI USA, V113, pE816, DOI 10.1073/pnas.1523465113; Gompertz B., 1825, PHILOS T R SOC LOND, V115, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Gravelle H, 1998, BMJ-BRIT MED J, V316, P382, DOI 10.1136/bmj.316.7128.382; Hummer RA, 1999, DEMOGRAPHY, V36, P273, DOI 10.2307/2648114; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Joynt KE, 2014, JAMA-J AM MED ASSOC, V312, P1644, DOI 10.1001/jama.2014.13336; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kindig DA, 2013, HEALTH AFFAIR, V32, P451, DOI 10.1377/hlthaff.2011.0892; Kitagawa EM, 1973, DIFFERENTIAL MORTALI; Kulkarni SC, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-16; Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025; Lochner K, 2001, AM J PUBLIC HEALTH, V91, P385, DOI 10.2105/AJPH.91.3.385; Lochner KA, 2003, SOC SCI MED, V56, P1797, DOI 10.1016/S0277-9536(02)00177-6; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; McCullough ME, 2000, HEALTH PSYCHOL, V19, P211, DOI 10.1037//0278-6133.19.3.211; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; National Academies of Sciences Engineering and Medicine, 2015, GROWING GAP LIFE EXP, DOI [10.17226/19015, DOI 10.17226/19015]; National Commission on Fiscal Responsibility and Reform, THE MOM OF TRUTH; Noble DJ, 2013, JAMA-J AM MED ASSOC, V309, P1119, DOI 10.1001/jama.2013.592; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Olshansky SJ, 1997, DEMOGRAPHY, V34, P1, DOI 10.2307/2061656; Olshansky SJ, 1998, POPUL DEV REV, V24, P381, DOI 10.2307/2807981; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Preston S, 2000, DEMOGRAPHY MEASURING; Putnam RD., 2000, BOWLING ALONE COLLAP; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Skinner J, 2012, HBK ECON, P45, DOI 10.1016/B978-0-444-53592-4.00002-5; Subramanian SV, 2003, HEALTH SERV RES, V38, P153, DOI 10.1111/1475-6773.00110; Sullivan D, 2009, Q J ECON, V124, P1265, DOI 10.1162/qjec.2009.124.3.1265; *US DEP HHS, HLTH PEOPL 2010; US. Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL 2020; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; Waldron Hilary, 2013, Soc Secur Bull, V73, P1; Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013; Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Woolf SH, 2011, HEALTH AFFAIR, V30, P1852, DOI 10.1377/hlthaff.2011.0685; World Health Organization, GLOB HLTH OBS DAT RE	74	1064	1078	24	322	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1750	1766		10.1001/jama.2016.4226	http://dx.doi.org/10.1001/jama.2016.4226			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK2QK	27063997	Green Accepted			2022-12-28	WOS:000374759300022
J	Blaha, M				Blaha, Michael			In primary prevention, the ACC/AHA risk-based approach predicted ASCVD better than trial-based or hybrid approaches	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR-DISEASE		[Blaha, Michael] Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Blaha, M (corresponding author), Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA.							Blaha MJ, 2016, CIRCULATION, V133, P849, DOI 10.1161/CIRCULATIONAHA.115.018524; Martin SS, 2015, J AM COLL CARDIOL, V65, P1361, DOI 10.1016/j.jacc.2015.01.043; Stone NJ, 2014, ANN INTERN MED, V160, P339, DOI 10.7326/M14-0126	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					JC47	JC47		10.7326/ACPJC-2016-164-8-047	http://dx.doi.org/10.7326/ACPJC-2016-164-8-047			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	27089097				2022-12-28	WOS:000374257900009
J	Viele, K; McGlothlin, A; Broglio, K				Viele, Kert; McGlothlin, Anna; Broglio, Kristine			Interpretation of Clinical Trials That Stopped Early	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SIZE		[Viele, Kert; McGlothlin, Anna; Broglio, Kristine] Berry Consultants LLC, 4301 Westbank Dr,Bldg B,Ste 140, Austin, TX 78746 USA		Viele, K (corresponding author), Berry Consultants LLC, 4301 Westbank Dr,Bldg B,Ste 140, Austin, TX 78746 USA.	kert@berryconsultants.com		McGlothlin, Anna/0000-0002-9079-6166				Broglio KR, 2014, J BIOPHARM STAT, V24, P685, DOI 10.1080/10543406.2014.888569; Jennison C, 2000, GROUP SEQUENTIAL MET; Saville BR, 2014, CLIN TRIALS, V11, P485, DOI 10.1177/1740774514531352; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Zhang JJ, 2012, CLIN CANCER RES, V18, P4872, DOI 10.1158/1078-0432.CCR-11-3118	5	20	20	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1646	1647		10.1001/jama.2016.2628	http://dx.doi.org/10.1001/jama.2016.2628			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	27092832				2022-12-28	WOS:000374289300023
J	Hinton, L				Hinton, Lisa			The intensive care unit was so noisy I couldn't sleep	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ENVIRONMENTAL NOISE; DISRUPTION		[Hinton, Lisa] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX1 2JD, England	University of Oxford	Hinton, L (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX1 2JD, England.	lisa.hinton@phc.ox.ac.uk	Hinton, Lisa/AAA-2266-2019	Hinton, Lisa/0000-0002-6082-3151				Aaron JN, 1996, SLEEP, V19, P707, DOI 10.1093/sleep/19.9.707; Cooper AB, 2001, SEM RESP CRIT CARE M, V22, P153, DOI 10.1055/s-2001-13829; Darbyshire JL, 2013, CRIT CARE, V17, DOI 10.1186/cc12870; Freedman NS, 2001, AM J RESP CRIT CARE, V163, P451, DOI 10.1164/ajrccm.163.2.9912128; Healthtalk, INT CAR PAT EXP; Healthtalk, TRIGG FILMS SERV IMP; Johansson Lotta, 2012, Open Nurs J, V6, P108, DOI 10.2174/1874434601206010108; Kamdar Biren B, 2012, J Intensive Care Med, V27, P97, DOI 10.1177/0885066610394322; Locock L, 2014, TESTING ACCELERATED; Nuffield Department of Clinical Neurosciences, 2014, RES AIM HELP PAT SLE; Salluh JI, 2010, CRIT CARE, V14, DOI 10.1186/cc9333	11	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2016	353								i2150	10.1136/bmj.i2150	http://dx.doi.org/10.1136/bmj.i2150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZB	27091908				2022-12-28	WOS:000374998700005
J	Hudson-Edwards, K				Hudson-Edwards, Karen			ENVIRONMENT Tackling mine wastes	SCIENCE			English	Editorial Material							RIO TINTO; GEOCHEMISTRY		[Hudson-Edwards, Karen] Univ London, Dept Earth & Planetary Sci, Birkbeck, London WC1E 7HX, England	University of London	Hudson-Edwards, K (corresponding author), Univ London, Dept Earth & Planetary Sci, Birkbeck, London WC1E 7HX, England.	k.hudson-edwards@bbk.ac.uk						Amils Ricardo, 2014, Life-Basel, V4, P511, DOI 10.3390/life4030511; Balaban SI, 2015, ENVIRON EARTH SCI, V74, P4685, DOI 10.1007/s12665-015-4440-5; Braungardt CB, 2003, APPL GEOCHEM, V18, P1757, DOI 10.1016/S0883-2927(03)00079-9; Brewer P. A., 2003, P INT S MAJ CHALL TA, P46; Cooke CA, 2011, AMBIO, V40, P18, DOI 10.1007/s13280-010-0086-4; Jones A, 2013, ENVIRON SCI POLLUT R, V20, P7570, DOI 10.1007/s11356-013-1513-4; Lottermoser B.G., 2010, MINE WASTES; Morton-Bermea O, 2015, ENVIRON EARTH SCI, V74, P1161, DOI 10.1007/s12665-015-4102-7; Nordstrom DK, 2015, APPL GEOCHEM, V57, P3, DOI 10.1016/j.apgeochem.2015.02.008; de la Campa AMS, 2011, ENVIRON RES, V111, P1018, DOI 10.1016/j.envres.2011.07.001; U.S. Environmental Protection Agency, 2015, EM RESP AUG 2015 REL	11	87	91	6	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					288	290		10.1126/science.aaf3354	http://dx.doi.org/10.1126/science.aaf3354			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081053				2022-12-28	WOS:000373990100018
J	Pirandola, S; Braunstein, SL				Pirandola, Stefano; Braunstein, Samuel L.			Unite to build a quantum internet	NATURE			English	Editorial Material							TELEPORTATION		[Pirandola, Stefano; Braunstein, Samuel L.] Univ York, Dept Comp Sci, York YO10 5DD, N Yorkshire, England	University of York - UK	Pirandola, S; Braunstein, SL (corresponding author), Univ York, Dept Comp Sci, York YO10 5DD, N Yorkshire, England.	stefano.pirandola@york.ac.uk; sam.braunstein@york.ac.uk	Braunstein, Samuel L/A-5501-2009; Pirandola, Stefano/AAI-5796-2020	Pirandola, Stefano/0000-0001-6165-5615; Braunstein, Samuel Leon/0000-0003-4790-136X	EPSRC [EP/M013472/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M013472/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Andrews RW, 2014, NAT PHYS, V10, P321, DOI [10.1038/nphys2911, 10.1038/NPHYS2911]; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; Pirandola S, 2015, NAT PHOTONICS, V9, P641, DOI [10.1038/NPHOTON.2015.154, 10.1038/nphoton.2015.154]; Pirandola S, 2015, NAT PHOTONICS, V9, P397, DOI [10.1038/nphoton.2015.83, 10.1038/NPHOTON.2015.83]; Takeda S, 2013, NATURE, V500, P315, DOI 10.1038/nature12366; Weedbrook C, 2012, REV MOD PHYS, V84, P621, DOI 10.1103/RevModPhys.84.621; Yokoyama S, 2013, NAT PHOTONICS, V7, P982, DOI [10.1038/NPHOTON.2013.287, 10.1038/nphoton.2013.287]	10	104	104	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					169	171		10.1038/532169a	http://dx.doi.org/10.1038/532169a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075080	Bronze, Green Accepted			2022-12-28	WOS:000374415100013
J	Hawkes, N				Hawkes, Nigel			THE BMJ AWARDS 2016 Palliative care team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2016	353								i1991	10.1136/bmj.i1991	http://dx.doi.org/10.1136/bmj.i1991			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LV	27059532				2022-12-28	WOS:000373896100004
J	Du, HD; Li, LM; Bennett, D; Guo, Y; Key, TJ; Bian, Z; Sherliker, P; Gao, HY; Chen, YP; Yang, L; Chen, JS; Wang, SQ; Du, RR; Su, H; Collins, R; Peto, R; Chen, ZM				Du, Huaidong; Li, Liming; Bennett, Derrick; Guo, Yu; Key, Timothy J.; Bian, Zheng; Sherliker, Paul; Gao, Haiyan; Chen, Yiping; Yang, Ling; Chen, Junshi; Wang, Shanqing; Du, Ranran; Su, Hua; Collins, Rory; Peto, Richard; Chen, Zhengming		China Kadoorie Biobank Study	Fresh Fruit Consumption and Major Cardiovascular Disease in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; VEGETABLE CONSUMPTION; OUTDOOR TEMPERATURE; REGRESSION DILUTION; PROSPECTIVE COHORT; BLOOD-PRESSURE; GLOBAL BURDEN; REDUCED RISK; METAANALYSIS; MORTALITY	BACKGROUND In Western populations, a higher level of fruit consumption has been associated with a lower risk of cardiovascular disease, but little is known about such associations in China, where the consumption level is low and rates of stroke are high. METHODS Between 2004 and 2008, we recruited 512,891 adults, 30 to 79 years of age, from 10 diverse localities in China. During 3.2 million person-years of follow-up, 5173 deaths from cardiovascular disease, 2551 incident major coronary events (fatal or nonfatal), 14,579 ischemic strokes, and 3523 intracerebral hemorrhages were recorded among the 451,665 participants who did not have a history of cardiovascular disease or antihypertensive treatments at baseline. Cox regression yielded adjusted hazard ratios relating fresh fruit consumption to disease rates. RESULTS Overall, 18.0% of participants reported consuming fresh fruit daily. As compared with participants who never or rarely consumed fresh fruit (the "nonconsumption" category), those who ate fresh fruit daily had lower systolic blood pressure (by 4.0 mm Hg) and blood glucose levels (by 0.5 mmol per liter [9.0 mg per deciliter]) (P<0.001 for trend for both comparisons). The adjusted hazard ratios for daily consumption versus nonconsumption were 0.60 (95% confidence interval [CI], 0.54 to 0.67) for cardiovascular death, and 0.66 (95% CI, 0.58 to 0.75), 0.75 (95% CI, 0.72 to 0.79), and 0.64 (95% CI, 0.56 to 0.74), respectively, for incident major coronary events, ischemic stroke, and hemorrhagic stroke. There was a strong log-linear dose-response relationship between the incidence of each outcome and the amount of fresh fruit consumed. These associations were similar across the 10 study regions and in subgroups of participants defined by baseline characteristics. CONCLUSIONS Among Chinese adults, a higher level of fruit consumption was associated with lower blood pressure and blood glucose levels and, largely independent of these and other dietary and nondietary factors, with significantly lower risks of major cardiovascular diseases. (Funded by the Wellcome Trust and others.)	[Du, Huaidong; Bennett, Derrick; Sherliker, Paul; Gao, Haiyan; Chen, Yiping; Yang, Ling; Collins, Rory; Peto, Richard; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Old Rd Campus, Oxford OX3 7LF, England; [Du, Huaidong; Bennett, Derrick; Sherliker, Paul; Gao, Haiyan; Chen, Yiping; Yang, Ling; Collins, Rory; Peto, Richard; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Old Rd Campus, Oxford OX3 7LF, England; [Key, Timothy J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Old Rd Campus, Oxford OX3 7LF, England; [Li, Liming] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China; [Li, Liming; Guo, Yu; Bian, Zheng] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Chen, Junshi] China Natl Ctr Food Safety Risk Assessment, Beijing 100730, Peoples R China; [Wang, Shanqing] Hainan Ctr Dis Control CDC, Haikou, Peoples R China; [Du, Ranran] Qingdao CDC, Qingdao, Peoples R China; [Su, Hua] Heilongjiang CDC, Harbin, Peoples R China	University of Oxford; University of Oxford; University of Oxford; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College	Du, HD (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Old Rd Campus, Oxford OX3 7LF, England.; Du, HD (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Old Rd Campus, Oxford OX3 7LF, England.; Li, LM (corresponding author), Peking Univ, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China.	huaidong.du@ctsu.ox.ac.uk; lmlee@vip.163.com	Bennett, Derrick/AFL-9254-2022; Bennett, Derrick/AAH-1220-2022; Collins, Rory/ABA-8487-2020; , Bennett/O-7998-2019	Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Du, Huaidong/0000-0002-9814-0049	Wellcome Trust; Kadoorie Charitable Foundation; Chinese National Natural Science Foundation [81390541]; British Heart Foundation; Medical Research Council; Cancer Research UK; Epidemiological Studies Unit, University of Oxford; MRC [MC_U137686851, MC_UU_12026/2] Funding Source: UKRI; Cancer Research UK [16491] Funding Source: researchfish; Medical Research Council [MC_UU_12026/2, MC_U137686851] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Kadoorie Charitable Foundation; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Epidemiological Studies Unit, University of Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Wellcome Trust, the Kadoorie Charitable Foundation, and the Chinese National Natural Science Foundation (81390541), with core funding provided by the British Heart Foundation, the Medical Research Council, and Cancer Research UK to the Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Bazzano Lydia A, 2003, Curr Atheroscler Rep, V5, P492, DOI 10.1007/s11883-003-0040-z; Bhupathiraju SN, 2013, AM J CLIN NUTR, V98, P1514, DOI 10.3945/ajcn.113.066381; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Crowe FL, 2011, EUR HEART J, V32, P1235, DOI 10.1093/eurheartj/ehq465; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Hartley L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009874.pub2; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; Hu D, 2014, STROKE, V45, P1613, DOI 10.1161/STROKEAHA.114.004836; Hu S, 2015, NATL CTR CARDIOVASCU; Larsson SC, 2013, ATHEROSCLEROSIS, V227, P147, DOI 10.1016/j.atherosclerosis.2012.12.022; Lewington S, 2003, J CARDIOVASC RISK, V10, P143, DOI 10.1097/00043798-200304000-00010; Lewington S, 2012, J HYPERTENS, V30, P1383, DOI 10.1097/HJH.0b013e32835465b5; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Micha R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008705; Oude Griep LM, 2011, EUR J CLIN NUTR, V65, P791, DOI 10.1038/ejcn.2011.36; Oyebode O, 2014, J EPIDEMIOL COMMUN H, V68, P856, DOI 10.1136/jech-2013-203500; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Rautiainen S, 2015, EUR J HEART FAIL, V17, P20, DOI 10.1002/ejhf.191; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rosengren A, 2009, HEART, V95, P2014, DOI 10.1136/hrt.2009.182436; Su DT, 2014, INT J EPIDEMIOL, V43, P1835, DOI 10.1093/ije/dyu158; Tuohy KM, 2012, J AGR FOOD CHEM, V60, P8776, DOI 10.1021/jf2053959; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu ZS, 2001, CIRCULATION, V103, P462; Xiao Yingting, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P232; Yang G H, 1997, Biomed Environ Sci, V10, P1; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yu DX, 2014, BRIT J NUTR, V111, P353, DOI 10.1017/S0007114513002328; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang XL, 2011, AM J CLIN NUTR, V94, P240, DOI 10.3945/ajcn.110.009340	36	176	208	4	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					1332	1343		10.1056/NEJMoa1501451	http://dx.doi.org/10.1056/NEJMoa1501451			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3UW	27050205	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000373425000007
J	Hawkes, N				Hawkes, Nigel			THE BMJ AWARDS 2016 Primary care team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2016	353								i1842	10.1136/bmj.i1842	http://dx.doi.org/10.1136/bmj.i1842			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LT	27055931				2022-12-28	WOS:000373895900002
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: A sexist contract for junior doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Department of Health, 2016, FAM TEST NEW CONTR D; Department of Health, 2016, EQ AN NEW CONTR DOCT	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2016	353								i1943	10.1136/bmj.i1943	http://dx.doi.org/10.1136/bmj.i1943			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LO	27048516	Bronze, Green Published			2022-12-28	WOS:000373895300018
J	Casarett, D				Casarett, David			The Science of Choosing Wisely - Overcoming the Therapeutic Illusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Casarett, David] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Casarett, D (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.							CHERKIN DC, 1995, SPINE, V20, P1, DOI 10.1097/00007632-199501000-00001; JENKINS HM, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093874; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; Schroen AT, 2000, CHEST, V118, P129, DOI 10.1378/chest.118.1.129; THOMAS KB, 1978, BRIT MED J, V1, P1327, DOI 10.1136/bmj.1.6123.1327	5	81	82	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1203	1205		10.1056/NEJMp1516803	http://dx.doi.org/10.1056/NEJMp1516803			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DH8ZM	27028909				2022-12-28	WOS:000373085500002
J	Rymer, H				Rymer, Hazel			Gravity measurements on chips	NATURE			English	Editorial Material									[Rymer, Hazel] Open Univ, Dept Earth Environm & Ecosyst Sci, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Rymer, H (corresponding author), Open Univ, Dept Earth Environm & Ecosyst Sci, Milton Keynes MK7 6AA, Bucks, England.	hazel.rymer@open.ac.uk		Rymer, Hazel/0000-0003-3949-1129				Hsiao KH, 2009, J ADV MECH DES SYST, V3, P179, DOI 10.1299/jamdsm.3.179; LaCoste L. J. B., 1988, LEADING EDGE, V7, P20, DOI DOI 10.1190/1.1439525; Middlemiss RP, 2016, NATURE, V531, P614, DOI 10.1038/nature17397	3	4	5	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					585	586		10.1038/531585a	http://dx.doi.org/10.1038/531585a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27029272				2022-12-28	WOS:000373027400025
J	Hong, S; Beja-Glasser, VF; Nfonoyim, BM; Frouin, A; Li, SM; Ramakrishnan, S; Merry, KM; Shi, QQ; Rosenthal, A; Barres, BA; Lemere, CA; Selkoe, DJ; Stevens, B				Hong, Soyon; Beja-Glasser, Victoria F.; Nfonoyim, Bianca M.; Frouin, Arnaud; Li, Shaomin; Ramakrishnan, Saranya; Merry, Katherine M.; Shi, Qiaoqiao; Rosenthal, Arnon; Barres, Ben A.; Lemere, Cynthia A.; Selkoe, Dennis J.; Stevens, Beth			Complement and microglia mediate early synapse loss in Alzheimer mouse models	SCIENCE			English	Article							MILD COGNITIVE IMPAIRMENT; PLAQUE-FORMATION; IN-VIVO; A-BETA; DISEASE; PROTEIN; MICE; ELIMINATION; REFINEMENT; EXPRESSION	Synapse loss in Alzheimer's disease (AD) correlates with cognitive decline. Involvement of microglia and complement in AD has been attributed to neuroinflammation, prominent late in disease. Here we show in mouse models that complement and microglia mediate synaptic loss early in AD. C1q, the initiating protein of the classical complement cascade, is increased and associated with synapses before overt plaque deposition. Inhibition of C1q, C3, or the microglial complement receptor CR3 reduces the number of phagocytic microglia, as well as the extent of early synapse loss. C1q is necessary for the toxic effects of soluble beta-amyloid (A beta) oligomers on synapses and hippocampal long-term potentiation. Finally, microglia in adult brains engulf synaptic material in a CR3-dependent process when exposed to soluble A beta oligomers. Together, these findings suggest that the complement-dependent pathway and microglia that prune excess synapses in development are inappropriately activated and mediate synapse loss in AD.	[Hong, Soyon; Beja-Glasser, Victoria F.; Nfonoyim, Bianca M.; Frouin, Arnaud; Ramakrishnan, Saranya; Merry, Katherine M.; Stevens, Beth] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Hong, Soyon; Beja-Glasser, Victoria F.; Nfonoyim, Bianca M.; Frouin, Arnaud; Ramakrishnan, Saranya; Merry, Katherine M.; Stevens, Beth] Harvard Univ, Med Sch HMS, Boston, MA 02115 USA; [Li, Shaomin; Shi, Qiaoqiao; Lemere, Cynthia A.; Selkoe, Dennis J.] Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Li, Shaomin; Shi, Qiaoqiao; Lemere, Cynthia A.; Selkoe, Dennis J.] HMS, Boston, MA 02115 USA; [Rosenthal, Arnon] Alector Inc, 953 Indiana St, San Francisco, CA 94107 USA; [Rosenthal, Arnon] Annexon Biosci, 280 Utah Ave Suite 110, San Francisco, CA 94080 USA; [Rosenthal, Arnon] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Palo Alto, CA 94305 USA; [Selkoe, Dennis J.] Prothena Biosci, Dublin, Ireland; [Stevens, Beth] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Stevens, B (corresponding author), Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.; Stevens, B (corresponding author), Harvard Univ, Med Sch HMS, Boston, MA 02115 USA.	beth.stevens@childrens.harvard.edu	Hong, Soyon/AAE-9662-2021	Hong, Soyon/0000-0002-5744-4871; Ramakrishnan, Saranya/0000-0003-3542-413X	Edward R. and Anne G. Lefler Fellowship; Coins for Alzheimer's Research Trust; Fidelity Biosciences Research Initiative (F-Prime); JPB Foundation; National Institutes of Health [AG000222]; National Institute of Neurological Disorders and Stroke-NIH [R01NS083845]; National Institute on Aging-NIH [1RF1AG051496A]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083845, RF1NS083845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015379, T32AG000222, RF1AG051496, R01AG006173] Funding Source: NIH RePORTER	Edward R. and Anne G. Lefler Fellowship; Coins for Alzheimer's Research Trust; Fidelity Biosciences Research Initiative (F-Prime); JPB Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Sabatini (HMS), T. Bartels (BWH), and members of the Stevens laboratory for critical reading of the manuscript; L. Dissing-Olesen (BCH) for help with the conceptual figure (fig. S12), M. Ericsson [HMS electron microscopy (EM) facility] for EM imaging, K. Kapur (BCH) for advice on statistics, D. M. Walsh (BWH) for A beta oligomers (S26C), S. Okabe (University of Tokyo) for homer-GFP mice, and M. Leviten and T. Yednock (Annexon Biosciences) for characterization and advice on the ANX-M1 anti-C1q antibody; D. Richardson (Harvard Center for Biological Imaging), A. Hill BCH Intellectual and Developmental Disabilities Research Center Cellular Imaging Core NIH-P30-HD-18655, and H. Elliot and T. Xie (HMS Image and Data Analysis Core) for assistance with imaging and data analysis; and S. Kim (BWH), K. Colodner (BCH), and S. Matousek (BWH) for assistance with mice. The J20 mice, C1qa KO mice, P2RY12 antibody, and the ANX-M1 C1q function-blocking antibody are available from L. Mucke, M. Botto, O. Butovsky, and A. Rosenthal under material transfer agreements with UCSF Gladstone, Imperial College London, BWH, and Annexon Biosciences, respectively. A.R. is a cofounder, consultant, and chairman of the board of directors; B. A. B. is a cofounder and chairman of the scientific advisory board; and B. S. serves on the scientific advisory board of Annexon LLC. A.R., B. A. B., and B. S. are minor shareholders of Annexon LLC. All other authors declare no competing financial interests related to this project. The following patents related to this project have been granted or applied for: PCT/2015/010288 (S. H. and B. S.), US14/988387 and EP14822330 (S. H., A.R., and B. S.), and US8148330, US9149444, US20150368324, US20150368325, US20150368326, and US20120328601 (B. S. and B. A. B.). This work was funded by an Edward R. and Anne G. Lefler Fellowship (S. H.), Coins for Alzheimer's Research Trust (B. S.), Fidelity Biosciences Research Initiative (F-Prime) (B. S. and C.A.L.), JPB Foundation (B. A. B.), the National Institutes of Health AG000222 (S. H.), National Institute of Neurological Disorders and Stroke-NIH R01NS083845 (D.J.S.), National Institute on Aging-NIH 1RF1AG051496A (B. S.). Supplementary materials contain additional data, including materials and methods. S. H. and B. S. designed the study and wrote the manuscript, with help from all authors. S. H. performed most experiments and data analysis; V.F.B.-G. and B.M.N. performed microglial activation and engulfment experiments along with immunohistochemistry; S. R. and K. M. M. performed C1q immunohistochemistry; A.F. performed FISH; S. L. performed electrophysiology; Q.S. and C.A.L. assisted with design and collection of APP/PS1 tissue; A. R. and B. A. B. designed and characterized the ANX-M1 anti-C1q antibody; and D.J.S. contributed in the discussions and experimental design.	Benoit ME, 2013, J BIOL CHEM, V288, P654, DOI 10.1074/jbc.M112.400168; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Ebihara T, 2003, J NEUROSCI, V23, P2170; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Hong S., METHODS MOL BIOL SYN; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Schafer Dorothy P, 2014, J Vis Exp, DOI 10.3791/51482; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346	30	1411	1452	19	391	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					712	716		10.1126/science.aad8373	http://dx.doi.org/10.1126/science.aad8373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27033548	Green Accepted			2022-12-28	WOS:000375417100039
J	Kusumbe, AP; Ramasamy, SK; Itkin, T; Mae, MA; Langen, UH; Betsholtz, C; Lapidot, T; Adams, RH				Kusumbe, Anjali P.; Ramasamy, Saravana K.; Itkin, Tomer; Mae, Maarja Andaloussi; Langen, Urs H.; Betsholtz, Christer; Lapidot, Tsvee; Adams, Ralf H.			Age-dependent modulation of vascular niches for haematopoietic stem cells	NATURE			English	Article							TRANSCRIPTION FACTOR; PROGENITOR CELLS; ANGIOGENESIS; NOTCH; PROTEIN; MORPHOGENESIS; OSTEOGENESIS; ACTIVATION; RECEPTORS; PERICYTES	Blood vessels define local microenvironments in the skeletal system, play crucial roles in osteogenesis and provide niches for haematopoietic stem cells(1-6). The properties of nicheforming vessels and their changes in the ageing organism remain incompletely understood. Here we show that Notch signalling in endothelial cells leads to the expansion of haematopoietic stem cell niches in bone, which involves increases in CD31-positive capillaries and platelet-derived growth factor receptor-beta (PDGFR beta)-positive perivascular cells, arteriole formation and elevated levels of cellular stem cell factor. Although endothelial hypoxia-inducible factor signalling promotes some of these changes, it fails to enhance vascular niche function because of a lack of arterialization and expansion of PDGFR beta-positive cells. In ageing mice, niche-forming vessels in the skeletal system are strongly reduced but can be restored by activation of endothelial Notch signalling. These findings indicate that vascular niches for haematopoietic stem cells are part of complex, age-dependent microenvironments involving multiple cell populations and vessel subtypes.	[Kusumbe, Anjali P.; Ramasamy, Saravana K.; Langen, Urs H.; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Kusumbe, Anjali P.; Ramasamy, Saravana K.; Langen, Urs H.; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Itkin, Tomer; Lapidot, Tsvee] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Mae, Maarja Andaloussi; Betsholtz, Christer] Uppsala Univ, Dept Immunol Genet & Pathol, Vasc Biol Program, SE-75185 Uppsala, Sweden; [Betsholtz, Christer] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden	Max Planck Society; University of Munster; Weizmann Institute of Science; Uppsala University; Karolinska Institutet	Kusumbe, AP; Adams, RH (corresponding author), Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany.; Kusumbe, AP (corresponding author), Univ Munster, Fac Med, D-48149 Munster, Germany.	anjali.kusumbe@mpi-muenster.mpg.de; ralf.adams@mpi-muenster.mpg.de	Andaloussi Mäe, Maarja/AAA-9215-2022; Adams, Ralf H/AAE-9274-2019	Ramasamy, Saravana/0000-0003-2658-2945	Max Planck Society; University of Munster; DFG cluster of excellence 'Cells in Motion'; European Research Council [AdG 339409]; Ministry of Science, Technology Space, Israel; DKFZ Germany; ERC [AdG 294556]; Knut and Alice Wallenberg Foundation; Swedish Cancer Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Munster; DFG cluster of excellence 'Cells in Motion'; European Research Council(European Research Council (ERC)European Commission); Ministry of Science, Technology Space, Israel(Ministry of Science, Technology and Space (MOST), Israel); DKFZ Germany; ERC(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Foundation	We thank M. Schiller for technical assistance, A. Starsichova for help with bone sample processing, M. Stehling for fluorescence-activated cell sorting (FACS), S. Volkery for microscopy, and M. Vanlandewijck and K. Nahar for help with Pdgfb<SUP>iOE-EC</SUP> bones. Funding was provided by the Max Planck Society, the University of Munster, the DFG cluster of excellence 'Cells in Motion', and the European Research Council (AdG 339409 'AngioBone'). This research was partly supported by a joint grant from the Ministry of Science, Technology & Space, Israel, DKFZ Germany, ERC AdG 294556 'BBBarrier', the Knut and Alice Wallenberg Foundation and the Swedish Cancer Foundation.	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Corada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3609; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Eaves C. J., 2008, CURR PROTOC IMMUNOL, V22; Gomez CR, 2012, BIOGERONTOLOGY, V13, P287, DOI 10.1007/s10522-012-9373-8; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Itkin T, 2012, BLOOD, V120, P1843, DOI 10.1182/blood-2011-11-394692; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KINASHI T, 1994, BLOOD, V83, P1033; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MIYAZAWA K, 1995, BLOOD, V85, P641, DOI 10.1182/blood.V85.3.641.bloodjournal853641; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Prisby RD, 2007, J BONE MINER RES, V22, P1280, DOI 10.1359/JBMR.070415; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Vooijs M, 2007, DEVELOPMENT, V134, P535, DOI 10.1242/dev.02733; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Xu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6758; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	42	268	285	2	86	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					380	+		10.1038/nature17638	http://dx.doi.org/10.1038/nature17638			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27074508	Green Accepted			2022-12-28	WOS:000374424700034
J	Penn, BH; Cox, JS				Penn, Bennett H.; Cox, Jeffery S.			Organelle stress triggers inflammation	NATURE			English	Editorial Material							UNFOLDED PROTEIN RESPONSE; ER STRESS		[Penn, Bennett H.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Cox, Jeffery S.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Penn, BH (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.; Cox, JS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	bennett.penn@ucsf.edu; jeff.cox@berkeley.edu			NIAID NIH HHS [K08 AI104766] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI104766] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011; de Jong MF, 2013, MBIO, V4, DOI 10.1128/mBio.00418-12; Fontana MF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001289; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Grimes CL, 2012, J AM CHEM SOC, V134, P13535, DOI 10.1021/ja303883c; Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kagan JC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016253; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Kustermans G, 2008, BIOCHEM PHARMACOL, V76, P1214, DOI 10.1016/j.bcp.2008.08.017; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156	17	4	4	1	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					321	322		10.1038/nature17882	http://dx.doi.org/10.1038/nature17882			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27049940				2022-12-28	WOS:000374424700023
J	Ramachandran, S; Henikoff, S				Ramachandran, Srinivas; Henikoff, Steven			Transcriptional Regulators Compete with Nucleosomes Post-replication	CELL			English	Article							RNA-POLYMERASE-II; DNA-REPLICATION; GENOME-WIDE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; CELL-CYCLE; CHROMATIN; FORK; RESOLUTION	Every nucleosome across the genome must be disrupted and reformed when the replication fork passes, but how chromatin organization is re-established following replication is unknown. To address this problem, we have developed Mapping In vivo Nascent Chromatin with EdU and sequencing (MINCE-seq) to characterize the genome-wide location of nucleosomes and other chromatin proteins behind replication forks at high temporal and spatial resolution. We find that the characteristic chromatin landscape at Drosophila promoters and enhancers is lost upon replication. The most conspicuous changes are at promoters that have high levels of RNA polymerase II (RNAPII) stalling and DNA accessibility and show specific enrichment for the BRM remodeler. Enhancer chromatin is also disrupted during replication, suggesting a role for transcription factor (TF) competition in nucleosome re-establishment. Thus, the characteristic nucleosome landscape emerges from a uniformly packaged genome by the action of TFs, RNAPII, and remodelers minutes after replication fork passage.	[Ramachandran, Srinivas; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Ramachandran, Srinivas; Henikoff, Steven] Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.; Henikoff, S (corresponding author), Howard Hughes Med Inst, Seattle, WA 98109 USA.	steveh@fhcrc.org		Ramachandran, Srinivas/0000-0003-2929-1377; Henikoff, Steven/0000-0002-7621-8685	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alabert C, 2015, GENE DEV, V29, P585, DOI 10.1101/gad.256354.114; Anderson AE, 2011, DEVELOPMENT, V138, P1957, DOI 10.1242/dev.058461; Annunziato AT, 2015, GENES-BASEL, V6, P353, DOI 10.3390/genes6020353; Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Asano M, 1999, EMBO J, V18, P2435, DOI 10.1093/emboj/18.9.2435; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BLUMENTH.AB, 1973, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/SQB.1974.038.01.024; Carone BR, 2014, DEV CELL, V30, P11, DOI 10.1016/j.devcel.2014.05.024; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Clemente-Ruiz M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002376; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Gunesdogan U, 2014, ELIFE, V3, DOI 10.7554/eLife.02443; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kaykov A, 2015, GENOME RES, V25, P391, DOI 10.1101/gr.180372.114; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Klapholz B, 2009, CHROMOSOMA, V118, P235, DOI 10.1007/s00412-008-0192-2; Leung KHT, 2013, BIOTECHNIQUES, V55, P204, DOI 10.2144/000114089; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Lubelsky Y, 2014, GENOME RES, V24, P1102, DOI 10.1101/gr.160010.113; Lucchini R, 2001, EMBO J, V20, P7294, DOI 10.1093/emboj/20.24.7294; MacAlpine DM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010207; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; Moshkin YM, 2002, GENE DEV, V16, P2621, DOI 10.1101/gad.231202; Moshkin YM, 2012, MOL CELL BIOL, V32, P675, DOI 10.1128/MCB.06365-11; Nakano S, 2011, CELL, V147, P1525, DOI 10.1016/j.cell.2011.11.053; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Orsi GA, 2014, GENOME RES, V24, P809, DOI 10.1101/gr.163642.113; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Ramachandran S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500587; RIZZINO A, 1978, IN VITRO CELL DEV B, V14, P437; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Skene PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09225; Teves SS, 2011, GENE DEV, V25, P2387, DOI [10.1101/gad.177675.111, 10.1101/gad.178079.111]; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; Weber CM, 2010, NAT STRUCT MOL BIOL, V17, P1500, DOI 10.1038/nsmb.1926; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Whitehouse I, 2013, CURR OPIN GENET DEV, V23, P140, DOI 10.1016/j.gde.2012.12.007; Yanez-Cuna JO, 2014, GENOME RES, V24, P1147, DOI 10.1101/gr.169243.113; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	50	88	89	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					580	592		10.1016/j.cell.2016.02.062	http://dx.doi.org/10.1016/j.cell.2016.02.062			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27062929	Green Accepted, Bronze			2022-12-28	WOS:000374636800017
J	Shi, SL; Wong, ZL; Buchwald, SL				Shi, Shi-Liang; Wong, Zackary L.; Buchwald, Stephen L.			Copper-catalysed enantioselective stereodivergent synthesis of amino alcohols	NATURE			English	Article							ASYMMETRIC HYDROAMINATION; DIASTEREOSELECTIVITY; ALDEHYDES; ALKENES; OLEFINS; KETONES	The chirality, or 'handedness', of a biologically active molecule can alter its physiological properties. Thus it is routine procedure in the drug discovery and development process to prepare and fully characterize all possible stereoisomers of a drug candidate for biological evaluation(1,2). Despite many advances in asymmetric synthesis, developing general and practical strategies for obtaining all possible stereoisomers of an organic compound that has multiple contiguous stereocentres remains a challenge(3). Here, we report a stereodivergent copper-based approach for the expeditious construction of amino alcohols with high levels of chemo-, regio-, diastereo- and enantioselectivity. Specifically, we synthesized these amino-alcohol products using sequential, copper-hydride-catalysed hydrosilylation and hydroamination of readily available enals and enones. This strategy provides a route to all possible stereoisomers of the amino-alcohol products, which contain up to three contiguous stereocentres. We leveraged catalyst control and stereospecificity simultaneously to attain exceptional control of the product stereochemistry. Beyond the immediate utility of this protocol, our strategy could inspire the development of methods that provide complete sets of stereoisomers for other valuable synthetic targets.	[Shi, Shi-Liang; Wong, Zackary L.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Buchwald, SL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	sbuchwal@mit.edu		Shi, Shi-Liang/0000-0002-0624-6824	National Institutes of Health [GM-58160]; National Science Foundation [CHE-0946721]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institutes of Health (grant GM-58160 to S.L.B.). The content of this paper is solely our responsibility and does not necessarily represent the official views of the National Institutes of Health. We thank Y.-M. Wang and M. T. Pirnot for help preparing the manuscript. The departmental X-ray diffraction instrumentation was purchased with the help of funding from the National Science Foundation (CHE-0946721). We thank P. Muller for X-ray crystallographic analysis of compound 5a.	Bandar JS, 2015, J AM CHEM SOC, V137, P14812, DOI 10.1021/jacs.5b10219; Barker TJ, 2011, SYNTHESIS-STUTTGART, P3954, DOI 10.1055/s-0031-1289581; Chen JX, 2000, TETRAHEDRON, V56, P2153, DOI 10.1016/S0040-4020(99)01098-4; Deutsch C, 2008, CHEM REV, V108, P2916, DOI 10.1021/cr0684321; Hannedouche J, 2013, CHEM-EUR J, V19, P4972, DOI 10.1002/chem.201203956; Huang Y, 2005, J AM CHEM SOC, V127, P15051, DOI 10.1021/ja055545d; Huber JD, 2007, J AM CHEM SOC, V129, P14552, DOI 10.1021/ja076035h; Jacobsen E. N., 1999, COMPREHENSIVE ASY S1, VI; Krautwald S, 2013, SCIENCE, V340, P1065, DOI 10.1126/science.1237068; Lee EC, 2005, J AM CHEM SOC, V127, P11586, DOI 10.1021/ja052058p; Lipshutz BH, 2003, J AM CHEM SOC, V125, P8779, DOI 10.1021/ja021391f; Lu G, 2011, ANGEW CHEM INT EDIT, V50, P4382, DOI 10.1002/anie.201101034; Luparia M, 2011, ANGEW CHEM INT EDIT, V50, P12631, DOI 10.1002/anie.201106321; McInturff EL, 2012, J AM CHEM SOC, V134, P20628, DOI 10.1021/ja311208a; Mechler M, 2015, ANGEW CHEM INT EDIT, V54, P10303, DOI 10.1002/anie.201502930; Miki Y, 2013, ANGEW CHEM INT EDIT, V52, P10830, DOI 10.1002/anie.201304365; Moser R, 2010, J AM CHEM SOC, V132, P7852, DOI 10.1021/ja102689e; Niu DW, 2015, J AM CHEM SOC, V137, P9716, DOI 10.1021/jacs.5b05446; Royer J., 2010, CHIRAL AMINE SYNTHES, DOI 10.1002/anie.201005721; Schindler CS, 2013, SCIENCE, V340, P1052, DOI 10.1126/science.1238769; Shi SL, 2015, NAT CHEM, V7, P38, DOI [10.1038/nchem.2131, 10.1038/NCHEM.2131]; Simmons B, 2009, ANGEW CHEM INT EDIT, V48, P4349, DOI 10.1002/anie.200900220; Tian X, 2011, J AM CHEM SOC, V133, P17934, DOI 10.1021/ja207847p; Wainer I. W., 2012, DRUG STEREOCHEMISTRY, V3rd; Wang BM, 2007, J AM CHEM SOC, V129, P768, DOI 10.1021/ja0670409; Wermuth CG, 2008, PRACTICE OF MEDICINAL CHEMISTRY, 3RD EDITION, P1; Yan XX, 2008, J AM CHEM SOC, V130, P14362, DOI 10.1021/ja804527r; Yang Y, 2015, SCIENCE, V349, P62, DOI 10.1126/science.aab3753; Zhu SL, 2014, J AM CHEM SOC, V136, P15913, DOI 10.1021/ja509786v; Zhu SL, 2013, J AM CHEM SOC, V135, P15746, DOI 10.1021/ja4092819	30	176	176	4	207	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					353	356		10.1038/nature17191	http://dx.doi.org/10.1038/nature17191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27018656	Green Accepted, Green Submitted			2022-12-28	WOS:000374424700029
J	Velazquez, EJ; Lee, KL; Jones, RH; Al-Khalidi, HR; Hill, JA; Panza, JA; Michler, RE; Bonow, RO; Doenst, T; Petrie, MC; Oh, JK; She, LL; Moore, VL; Desvigne-Nickens, P; Sopko, G; Rouleau, JL				Velazquez, Eric J.; Lee, Kerry L.; Jones, Robert H.; Al-Khalidi, Hussein R.; Hill, James A.; Panza, Julio A.; Michler, Robert E.; Bonow, Robert O.; Doenst, Torsten; Petrie, Mark C.; Oh, Jae K.; She, Lilin; Moore, Vanessa L.; Desvigne-Nickens, Patrice; Sopko, George; Rouleau, Jean L.		STICHES Investigators	Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; LOW EJECTION FRACTION; FAILURE STICH TRIAL; HEART-FAILURE; RANDOMIZED-TRIAL; FOLLOW-UP; SURGICAL-TREATMENT; GRAFT-SURGERY; SURVIVAL-DATA; DISEASE	BACKGROUND The survival benefit of a strategy of coronary-artery bypass grafting (CABG) added to guideline-directed medical therapy, as compared with medical therapy alone, in patients with coronary artery disease, heart failure, and severe left ventricular systolic dysfunction remains unclear. METHODS From July 2002 to May 2007, a total of 1212 patients with an ejection fraction of 35% or less and coronary artery disease amenable to CABG were randomly assigned to undergo CABG plus medical therapy (CABG group, 610 patients) or medical therapy alone (medical-therapy group, 602 patients). The primary outcome was death from any cause. Major secondary outcomes included death from cardiovascular causes and death from any cause or hospitalization for cardiovascular causes. The median duration of follow-up, including the current extended-follow-up study, was 9.8 years. RESULTS A primary outcome event occurred in 359 patients (58.9%) in the CABG group and in 398 patients (66.1%) in the medical-therapy group (hazard ratio with CABG vs. medical therapy, 0.84; 95% confidence interval [CI], 0.73 to 0.97; P = 0.02 by log-rank test). A total of 247 patients (40.5%) in the CABG group and 297 patients (49.3%) in the medical-therapy group died from cardiovascular causes (hazard ratio, 0.79; 95% CI, 0.66 to 0.93; P = 0.006 by log-rank test). Death from any cause or hospitalization for cardiovascular causes occurred in 467 patients (76.6%) in the CABG group and in 524 patients (87.0%) in the medical-therapy group (hazard ratio, 0.72; 95% CI, 0.64 to 0.82; P<0.001 by log-rank test). CONCLUSIONS In a cohort of patients with ischemic cardiomyopathy, the rates of death from any cause, death from cardiovascular causes, and death from any cause or hospitalization for cardiovascular causes were significantly lower over 10 years among patients who underwent CABG in addition to receiving medical therapy than among those who received medical therapy alone.	[Velazquez, Eric J.] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; [Lee, Kerry L.; Al-Khalidi, Hussein R.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Jones, Robert H.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [She, Lilin; Moore, Vanessa L.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Hill, James A.] Univ Florida, Gainesville, FL USA; [Panza, Julio A.] Westchester Med Ctr, Valhalla, NY USA; [Panza, Julio A.] New York Med Coll, Valhalla, NY 10595 USA; [Michler, Robert E.] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Cardiothorac & Vasc Surg, New York, NY USA; [Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Doenst, Torsten] Univ Jena, Univ Hosp Jena, Dept Cardiothorac Surg, Jena, Germany; [Petrie, Mark C.] Univ Glasgow, Glasgow, Lanark, Scotland; [Petrie, Mark C.] Golden Jubilee Natl Hosp, Glasgow, Lanark, Scotland; [Oh, Jae K.] Mayo Clin, Rochester, MN USA; [Desvigne-Nickens, Patrice; Sopko, George] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Rouleau, Jean L.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada	Duke University; Duke University; Duke University; Duke University; State University System of Florida; University of Florida; Westchester Medical Center; New York Medical College; Montefiore Medical Center; Yeshiva University; Northwestern University; Feinberg School of Medicine; Friedrich Schiller University of Jena; University of Glasgow; Golden Jubilee Hospital; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Universite de Montreal	Velazquez, EJ (corresponding author), Duke Clin Res Inst, Rm 0311 Terrace Level,2400 Pratt St, Durham, NC 27705 USA.	eric.velazquez@duke.edu	menicanti, lorenzo/K-5649-2018; Senni, Michele/J-9380-2018; Nicolau, Jose C/E-1487-2012; Romanov, Alexander/L-7898-2014; Siepe, Matthias/AAF-9846-2019	menicanti, lorenzo/0000-0001-8530-6284; Senni, Michele/0000-0001-5502-7882; Nicolau, Jose C/0000-0002-9680-3689; Romanov, Alexander/0000-0002-6958-6690; Siepe, Matthias/0000-0003-3305-9343; Plicner, Dariusz/0000-0002-3687-512X; Knosalla, Christoph/0000-0002-8127-5019; Jasinski, Marek/0000-0002-9989-7748; Bochenek, Andrzej/0000-0002-3046-3001; Varga-Szemes, Akos/0000-0002-2781-7462; Karason, Kristjan/0000-0002-2802-1191; Horowitz, John/0000-0001-6883-0703; Maurer, Gerald/0000-0002-9043-7657; Petrie, Mark/0000-0002-6333-9496; Zembala-John, Joanna/0000-0001-5787-3820; Kukulski, Tomasz/0000-0003-1911-8159	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Institutes of Health; STICH [and STICHES] ClinicalTrials.gov number, NCT00023595.	Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; Campeau L, 1997, NEW ENGL J MED, V336, P153; COX DR, 1972, J R STAT SOC B, V34, P187; DEMARCO T, 1988, AM HEART J, V115, P809; DETRE KM, 1984, NEW ENGL J MED, V311, P1333; Doenst T, 2013, CIRC-HEART FAIL, V6, P443, DOI 10.1161/CIRCHEARTFAILURE.112.000130; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; FISHER L, 1983, CIRCULATION, V68, P939, DOI 10.1161/01.CIR.68.5.939; Jones RH, 2010, J AM COLL CARDIOL, V56, P490, DOI 10.1016/j.jacc.2009.11.102; Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559; Jong P, 2003, LANCET, V361, P1843, DOI 10.1016/S0140-6736(03)13501-5; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kulik A, 2011, ANN THORAC SURG, V92, P1284, DOI 10.1016/j.athoracsur.2011.04.107; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; MUHLBAIER LH, 1992, CIRCULATION, V86, P198; Panza JA, 2014, J AM COLL CARDIOL, V64, P553, DOI 10.1016/j.jacc.2014.04.064; PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603; Qiu PH, 2008, J R STAT SOC B, V70, P191; Swedberg K, 1999, EUR HEART J, V20, P136, DOI 10.1053/euhj.1998.1098; Topkara VK, 2005, CIRCULATION, V112, pI344, DOI 10.1161/CIRCULATIONAHA.104.526277; VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603; Velazquez EJ, 2007, J THORAC CARDIOV SUR, V134, P1540, DOI 10.1016/j.jtcvs.2007.05.069; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; WHITE M, 1991, J AM COLL CARDIOL, V18, P1631, DOI 10.1016/0735-1097(91)90495-U; Wrobel K, 2015, CIRCULATION, V132, P720, DOI 10.1161/CIRCULATIONAHA.114.014932; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang S, 2005, BIOMETRIKA, V92, P1, DOI 10.1093/biomet/92.1.1; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	28	499	521	1	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1511	1520		10.1056/NEJMoa1602001	http://dx.doi.org/10.1056/NEJMoa1602001			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7IA	27040723	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000374383900004
J	Robertson, S				Robertson, Sandy			Ethel Mary Reddie OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2016	353								i2135	10.1136/bmj.i2135	http://dx.doi.org/10.1136/bmj.i2135			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZB	27091883				2022-12-28	WOS:000374998700004
J	Oliver, D				Oliver, David			David Oliver: Collectivism and selfishness in NHS users	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2016, BRIT PUBL STAT NHS F; [Anonymous], 2015, NHS DOES COMP; Baxter S., 2016, SUNDAY TIMES; Dore L, 2016, INDEPENDENT; Gibbons K, 2016, TIMES; Helm T, 2014, GUARDIAN; Owen C., 1989, Thatcheria, V24, P1; Lovejoy B, 1998, WHY COUNCILS CANT BE; Oliver D, 2015, BMJ BLOG        0507; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6119; Parris M., 2012, TIMES; Young T., 2016, TELEGRAPH	12	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2016	353								i2127	10.1136/bmj.i2127	http://dx.doi.org/10.1136/bmj.i2127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7EV	27084729	Bronze			2022-12-28	WOS:000374375600004
J	Sadtler, K; Estrellas, K; Allen, BW; Wolf, MT; Fan, HN; Tam, AJ; Patel, CH; Luber, BS; Wang, H; Wagner, KR; Powell, JD; Housseau, F; Pardoll, DM; Elisseeff, JH				Sadtler, Kaitlyn; Estrellas, Kenneth; Allen, Brian W.; Wolf, Matthew T.; Fan, Hongni; Tam, Ada J.; Patel, Chirag H.; Luber, Brandon S.; Wang, Hao; Wagner, Kathryn R.; Powell, Jonathan D.; Housseau, Franck; Pardoll, Drew M.; Elisseeff, Jennifer H.			Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells	SCIENCE			English	Article							SKELETAL-MUSCLE; IMMUNE-RESPONSE; EXPRESSION; INNATE; IGF-1; ACTIVATION	Immune-mediated tissue regeneration driven by a biomaterial scaffold is emerging as an innovative regenerative strategy to repair damaged tissues. We investigated how biomaterial scaffolds shape the immune microenvironment in traumatic muscle wounds to improve tissue regeneration. The scaffolds induced a pro-regenerative response, characterized by an mTOR/Rictor-dependent T helper 2 pathway that guides interleukin-4-dependent macrophage polarization, which is critical for functional muscle recovery. Manipulating the adaptive immune system using biomaterials engineering may support the development of therapies that promote both systemic and local pro-regenerative immune responses, ultimately stimulating tissue repair.	[Sadtler, Kaitlyn; Estrellas, Kenneth; Allen, Brian W.; Wolf, Matthew T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Translat Tissue Engn Ctr, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Sadtler, Kaitlyn; Estrellas, Kenneth; Allen, Brian W.; Wolf, Matthew T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA; [Fan, Hongni; Tam, Ada J.; Patel, Chirag H.; Powell, Jonathan D.; Housseau, Franck; Pardoll, Drew M.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21231 USA; [Luber, Brandon S.; Wang, Hao] Johns Hopkins Univ, Div Biostat & Bioinformat, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21231 USA; [Wagner, Kathryn R.] Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD 21205 USA; [Wagner, Kathryn R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Wagner, Kathryn R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Sadtler, Kaitlyn; Estrellas, Kenneth; Allen, Brian W.; Wolf, Matthew T.; Fan, Hongni; Tam, Ada J.; Patel, Chirag H.; Luber, Brandon S.; Wang, Hao; Powell, Jonathan D.; Housseau, Franck; Pardoll, Drew M.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Elisseeff, JH (corresponding author), Johns Hopkins Univ, Translat Tissue Engn Ctr, Wilmer Eye Inst, Baltimore, MD 21287 USA.; Elisseeff, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA.	jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010	Elisseeff, Jennifer/0000-0002-5066-1996; Wolf, Matthew/0000-0002-0328-2475	Maryland Stem Cell Research Fund (MSCRF) [113345]; Armed Forces Institute for Regenerative Medicine; U.S. Department of Defense [W81XWH-11-2-0022]; Jules Stein Professorship from the Research to Prevent Blindness Foundation; Hartwell Foundation; Cancer Center Core grant [P30CA006973]; National Institutes of Health [R01AI077610]; Bloomberg-Kimmel Institute for Cancer Immunotherapy; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079123] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077610, T32AI007247] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund (MSCRF); Armed Forces Institute for Regenerative Medicine; U.S. Department of Defense(United States Department of Defense); Jules Stein Professorship from the Research to Prevent Blindness Foundation; Hartwell Foundation; Cancer Center Core grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bloomberg-Kimmel Institute for Cancer Immunotherapy; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge the Sidney Kimmel Comprehensive Cancer Center Flow Cytometry Research Core and L. Blosser for their help on flow cytometric studies; A. Anderson for assistance with adipogenesis studies; S. Sommerfeld and X. Wang for assistance with the clinical product testing; A. Rittenbach for assistance with computed tomography imaging; M. de Palma for generous donation of the iBMM macrophage cell line; M. Swartz and the Swartz lab for assistance in the pilot studies and J.H.E. sabbatical hosting; A. Ewald for helpful discussions; and J. Schneck for critical review. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. K.S., F.H., D.P., and J.H.E. are inventors on provisional patent application no. 48317-502P01US, filed by Johns Hopkins University (JHU) related to regenerative immunology. J.H.E. holds equity in Aegeria Soft Tissue, a company that has licensed JHU intellectual property not directly related to the materials used in this study but similar enough that it may benefit from the results. The conflict is being managed by the Johns Hopkins Office of Policy Coordination. This work was funded by the Maryland Stem Cell Research Fund (MSCRF), grant 113345; the Armed Forces Institute for Regenerative Medicine; and U.S. Department of Defense grant W81XWH-11-2-0022 (awarded to J.H.E.) and the Jules Stein Professorship from the Research to Prevent Blindness Foundation. M.T.W. was supported by a postdoctoral fellowship from the Hartwell Foundation. D.M.P., J.D.P., B.S.L. and H.W. were supported by Cancer Center Core grant P30CA006973. J.D.P. was supported by a grant from the National Institutes of Health, R01AI077610. J.D.P, J.H.E., and D.M.P acknowledge support from the Bloomberg-Kimmel Institute for Cancer Immunotherapy.	Ali OA, 2014, CANCER RES, V74, P1670, DOI 10.1158/0008-5472.CAN-13-0777; Ali OA, 2013, ADV FUNCT MATER, V23, P4621, DOI 10.1002/adfm.201203859; Allman AJ, 2002, TISSUE ENG, V8, P53, DOI 10.1089/107632702753503054; Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024; Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Beachley VZ, 2015, NAT METHODS, V12, P1197, DOI 10.1038/nmeth.3619; Blackwell J, 2015, J PHYSIOL SCI, V65, P145, DOI 10.1007/s12576-014-0350-7; Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031; Davis ME, 2013, J APPL PHYSIOL, V115, P884, DOI 10.1152/japplphysiol.00137.2013; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Kim J, 2011, NANO TODAY, V6, P466, DOI 10.1016/j.nantod.2011.08.005; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Salmon-Ehr V, 2000, LAB INVEST, V80, P1337, DOI 10.1038/labinvest.3780141; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Sicari BM, 2012, TISSUE ENG PT A, V18, P1941, DOI [10.1089/ten.tea.2012.0475, 10.1089/ten.TEA.2012.0475]; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	33	326	333	12	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					366	370		10.1126/science.aad9272	http://dx.doi.org/10.1126/science.aad9272			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081073	Green Accepted			2022-12-28	WOS:000373990100046
J	Vinik, AI				Vinik, Aaron I.			Diabetic Sensory and Motor Neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALPHA-LIPOIC ACID; QUALITY-OF-LIFE; PERIPHERAL NEUROPATHY; RANDOMIZED-WITHDRAWAL; EXTENDED-RELEASE; PAIN; PLACEBO; DULOXETINE; MANAGEMENT; EFFICACY	A 65-year-old woman with a 5-year history of type 2 diabetes (a recent hemoglobin A(1C) level was 9.5%) reports the recent onset of burning, tingling, and stabbing pain in her feet that is worse at night and interferes with sleep and activities of daily living. Her medications include 500 mg of metformin and 2 mg of glimepiride, each taken twice daily. On physical examination, the patient is alert and oriented to person, place, and time. Her blood pressure is 140/90 mm Hg. She has reduced sensation to pinpricks in the knees, reduced ability to detect vibration from a 128-Hz tuning fork, and a loss of proprioception and of sensation to a 1-g monofilament (but not to a 10-g monofilament) in her toes. Strength in the lower legs is 5 out of 5 (normal) proximally and 4 out of 5 distally, and there is slightly weak dorsiflexion of both big toes, with no indication of entrapment. Her ankle reflexes are absent. She has no foot ulcers, and her pulses are easily palpable. How should her case be further evaluated and managed?	[Vinik, Aaron I.] Eastern Virginia Med Sch, Strelitz Diabet Ctr, 855 W Brambleton Ave, Norfolk, VA 23510 USA	Eastern Virginia Medical School	Vinik, AI (corresponding author), Eastern Virginia Med Sch, Strelitz Diabet Ctr, 855 W Brambleton Ave, Norfolk, VA 23510 USA.	vinikai@evms.edu			Merck; NeuroMetrix; Ipsen; Astellas; IONIS Pharmaceuticals; Pfizer; Daiichi Sankyo; Santarus; Nestle Health Science-Pamlab; Medikinetics; Janssen; Bayer; Alnylam; Cline Davis Mann; System Analytic; Tercica; ViroMed; Intarcia; Impeto Medical; Vero-Science; Novo Nordisk	Merck(Merck & Company); NeuroMetrix; Ipsen(Ipsen); Astellas(Astellas Pharmaceuticals); IONIS Pharmaceuticals; Pfizer(Pfizer); Daiichi Sankyo(Daiichi Sankyo Company Limited); Santarus; Nestle Health Science-Pamlab(Nestle SA); Medikinetics; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bayer(Bayer AG); Alnylam; Cline Davis Mann; System Analytic; Tercica; ViroMed; Intarcia; Impeto Medical; Vero-Science; Novo Nordisk(Novo Nordisk)	Dr. Vinik reports receiving fees for serving on advisory boards from Merck, NeuroMetrix, Ipsen, and Astellas, consulting fees from Merck, IONIS Pharmaceuticals, Pfizer, Daiichi Sankyo, NeuroMetrix, Santarus, Nestle Health Science-Pamlab, Medikinetics, Ipsen, Janssen, Bayer, Astellas, Alnylam, Cline Davis Mann, and System Analytic, lecture fees from Merck and Nestle Health Science-Pamlab, grant support from Pfizer, Daiichi Sankyo, Tercica, ViroMed, Intarcia, Impeto Medical, Vero-Science, and Novo Nordisk, and royalties for the use of the Norfolk QOLDN tool, a quality-of-life instrument owned by his medical school, which he codeveloped for use in clinical trials involving patients with diabetic neuropathy. He also reports being the inventor of a dietary supplement that includes a mixture of alpha lipoic acid, methylcobalamin, benfotiamine, dihomo-gamma-linoleic acid, cholecalciferol, and ascorbic acid, the rights to which were assigned to his medical school. Dr. Vinik reports that he, his laboratory, and his department have not received and will not receive any income that might derive from this product. No other potential conflict of interest relevant to this article was reported.	Albers JW, 1995, ANN NEUROL, V38, P869, DOI 10.1002/ana.410380607; Balducci S, 2006, J DIABETES COMPLICAT, V20, P216, DOI 10.1016/j.jdiacomp.2005.07.005; Boyd AL, 2010, DIABET METAB SYND OB, V3, P431, DOI [10.2147/DMSO.S13699, 10.2147/DMSOTT.S13699]; Bril V, 2011, NEUROLOGY, V76, P1758, DOI 10.1212/WNL.0b013e3182166ebe; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Fonseca VA, 2013, AM J MED, V126, P141, DOI 10.1016/j.amjmed.2012.06.022; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gibbons CH, 2015, BRAIN, V138, P43, DOI 10.1093/brain/awu307; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; Goldstein DJ, 2004, PSYCHOSOMATICS, V45, P17, DOI 10.1176/appi.psy.45.1.17; Handelsman Y, 2015, ENDOCR PRACT, V21, P1, DOI [10.4158/EP15672.GLSUPPL, 10.4158/EP15672.GL]; Handelsman Y, 2011, ENDOCR PRACT, V17, P287, DOI 10.4158/EP.17.2.287; Harati Y, 2000, J DIABETES COMPLICAT, V14, P65, DOI 10.1016/S1056-8727(00)00060-X; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Leishear K, 2012, J AM GERIATR SOC, V60, P1057, DOI 10.1111/j.1532-5415.2012.03998.x; MAX MB, 1987, NEUROLOGY, V37, P589, DOI 10.1212/WNL.37.4.589; Morrison S, 2014, J DIABETES COMPLICAT, V28, P715, DOI 10.1016/j.jdiacomp.2014.04.007; Mou J, 2014, CLIN J PAIN, V30, P286, DOI 10.1097/AJP.0b013e31829a4ced; Oyibo SO, 2002, DIABETIC MED, V19, P870, DOI 10.1046/j.1464-5491.2002.00801.x; Pittenger GL, 2004, DIABETES CARE, V27, P1974, DOI 10.2337/diacare.27.8.1974; Pop-Busui R, 2013, DIABETES CARE, V36, P3208, DOI 10.2337/dc13-0012; Raskin P, 2004, NEUROLOGY, V63, P865, DOI 10.1212/01.WNL.0000137341.89781.14; Rowbotham MC, 2004, PAIN, V110, P697, DOI 10.1016/j.pain.2004.05.010; Schwartz S, 2011, CURR MED RES OPIN, V27, P151, DOI 10.1185/03007995.2010.537589; Smith AG, 2006, DIABETES CARE, V29, P1294, DOI 10.2337/dc06-0224; Tesfaye S, 2005, NEW ENGL J MED, V352, P341, DOI 10.1056/NEJMoa032782; Tesfaye S, 2011, DIABETES-METAB RES, V27, P629, DOI 10.1002/dmrr.1225; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Veresiu AI, 2015, J DIABETES COMPLICAT, V29, P644, DOI 10.1016/j.jdiacomp.2015.04.001; Vinik A. I., 2012, PATHYS PRINC PRACT G, V1, P751, DOI [10.1002/9781119952930.ch65, DOI 10.1002/9781119952930.CH65]; Vinik A, 2014, PAIN MED, V15, P661, DOI 10.1111/pme.12310; Vinik A, 2013, CLIN THER, V35, P612, DOI 10.1016/j.clinthera.2013.03.008; Vinik A, 2010, J CLIN ENDOCR METAB, V95, P4802, DOI 10.1210/jc.2010-0892; Vinik AI, 2014, DIABETES CARE, V37, P2302, DOI 10.2337/dc13-2291; Vinik AI, 2013, ENDOCRIN METAB CLIN, V42, P747, DOI 10.1016/j.ecl.2013.06.001; Vinik AI, 2013, DIABETES METAB SYNDR, V6, P57, DOI 10.2147/DMSO.S24825; Vinik AI, 2015, 51 ANN M EUR ASS STU; Vinik E, 2003, DIABETES, V52, pA198; Wernicke JF, 2006, NEUROLOGY, V67, P1411, DOI 10.1212/01.wnl.0000240225.04000.1a; Ziegler D, 2016, J DIABETES COMPLICAT, V30, P350, DOI 10.1016/j.jdiacomp.2015.10.018; Ziegler Dan, 2014, Handb Clin Neurol, V126, P3, DOI 10.1016/B978-0-444-53480-4.00001-1; Ziegler D, 2011, DIABETES CARE, V34, P2054, DOI 10.2337/dc11-0503; Ziegler D, 2009, EUR J PAIN, V13, P582, DOI 10.1016/j.ejpain.2008.07.007	46	52	60	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1455	1464		10.1056/NEJMcp1503948	http://dx.doi.org/10.1056/NEJMcp1503948			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27074068				2022-12-28	WOS:000374128400009
J	Chawla, DS				Chawla, Dalmeet Singh			Web widget nudges scientists to share their data	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					136	136		10.1038/532136a	http://dx.doi.org/10.1038/532136a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI5RE	27078571				2022-12-28	WOS:000373555500050
J	Errea, I; Calandra, M; Pickard, CJ; Nelson, JR; Needs, RJ; Li, YW; Liu, HY; Zhang, YW; Ma, YM; Mauri, F				Errea, Ion; Calandra, Matteo; Pickard, Chris J.; Nelson, Joseph R.; Needs, Richard J.; Li, Yinwei; Liu, Hanyu; Zhang, Yunwei; Ma, Yanming; Mauri, Francesco			Quantum hydrogen-bond symmetrization in the superconducting hydrogen sulfide system	NATURE			English	Article							BILBAO CRYSTALLOGRAPHIC SERVER; AB-INITIO; ICE; APPROXIMATION; PHASES	The quantum nature of the proton can crucially affect the structural and physical properties of hydrogen compounds. For example, in the high-pressure phases(1,2) of H2O, quantum proton fluctuations lead to symmetrization of the hydrogen bond and reduce the boundary between asymmetric and symmetric structures in the phase diagram by 30 gigapascals (ref. 3). Here we show that an analogous quantum symmetrization occurs in the recently discovered(4) sulfur hydride superconductor with a superconducting transition temperature T-c of 203 kelvin at 155 gigapascals-the highest T-c reported for any superconductor so far. Superconductivity occurs via the formation of a compound with chemical formula H3S (sulfur trihydride) with sulfur atoms arranged on a body-centred cubic lattice(5-9). If the hydrogen atoms are treated as classical particles, then for pressures greater than about 175 gigapascals they are predicted to sit exactly halfway between two sulfur atoms in a structure with Im (3) over barm symmetry. At lower pressures, the hydrogen atoms move to an off-centre position, forming a short H-S covalent bond and a longer H center dot center dot center dot S hydrogen bond in a structure with R3m symmetry(5-9). X-ray diffraction experiments confirm the H3S stoichiometry and the sulfur lattice sites, but were unable to discriminate between the two phases(10). Ab initio density-functional-theory calculations show that quantum nuclear motion lowers the symmetrization pressure by 72 gigapascals for H3S and by 60 gigapascals for D3S. Consequently, we predict that the Im (3) over barm phase dominates the pressure range within which the high T-c was measured. The observed pressure dependence of T-c is accurately reproduced in our calculations for the Im (3) over barm phase, but not for the R3m phase. Therefore, the quantum nature of the proton fundamentally changes the superconducting phase diagram of H3S.	[Errea, Ion] Univ Basque Country UPV EHU, EUITI Bilbao, Fis Aplikatua Saila 1, Rafael Moreno Pitxitxi Pasealekua 3, Bilbao 48013, Spain; [Errea, Ion] DIPC, Manuel Lardizabal Pasealekua 4, Donostia San Sebastian 20018, Spain; [Calandra, Matteo; Mauri, Francesco] Univ Paris 06, Sorbonne Univ, CNRS, IMPMC,UMR 7590,MNHN,IRD, 4 Pl Jussieu, F-75005 Paris, France; [Pickard, Chris J.] Univ Cambridge, Dept Mat Sci & Met, 27 Charles Babbage Rd, Cambridge CB3 0FS, England; [Nelson, Joseph R.; Needs, Richard J.] Univ Cambridge, Cavendish Lab, Theory Condensed Matter Grp, JJ Thomson Ave, Cambridge CB3 0HE, England; [Li, Yinwei] Jiangsu Normal Univ, Sch Phys & Elect Engn, Xuzhou 221116, Peoples R China; [Liu, Hanyu] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Zhang, Yunwei; Ma, Yanming] Jilin Univ, State Key Lab Superhard Mat, Changchun 130012, Peoples R China; [Mauri, Francesco] Univ Roma La Sapienza, Dipartimento Fis, Piazzale Aldo Moro 5, I-00185 Rome, Italy	University of Basque Country; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); University of Cambridge; University of Cambridge; Jiangsu Normal University; Carnegie Institution for Science; Jilin University; Sapienza University Rome	Errea, I (corresponding author), Univ Basque Country UPV EHU, EUITI Bilbao, Fis Aplikatua Saila 1, Rafael Moreno Pitxitxi Pasealekua 3, Bilbao 48013, Spain.; Errea, I (corresponding author), DIPC, Manuel Lardizabal Pasealekua 4, Donostia San Sebastian 20018, Spain.; Calandra, M; Mauri, F (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, IMPMC,UMR 7590,MNHN,IRD, 4 Pl Jussieu, F-75005 Paris, France.; Mauri, F (corresponding author), Univ Roma La Sapienza, Dipartimento Fis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	ion.errea@ehu.eus; matteo.calandra@impmc.upmc.fr; francesco.mauri@uniroma1.it	Ma, Yanming/ABE-8450-2020; Zhang, Yunwei/AAW-8460-2020; Errea, Ion/J-4237-2014; Li, Yinwei/K-6388-2012; Calandra, Matteo/B-6161-2014; Calandra, Matteo/O-4636-2019; Ma, Yanming/A-7297-2008; Mauri, Francesco/K-5726-2012; Liu, Hanyu/E-9985-2012	Zhang, Yunwei/0000-0001-7856-9190; Errea, Ion/0000-0002-5719-6580; Calandra, Matteo/0000-0003-1505-2535; Ma, Yanming/0000-0003-3711-0011; Mauri, Francesco/0000-0002-6666-4710; Liu, Hanyu/0000-0003-2394-5421; Nelson, Joseph R./0000-0002-5653-092X	Spanish Ministry of Economy and Competitiveness [FIS2013-48286-C2-2-P]; EPSRC (UK) [EP/J017639/1, EP/K014560/1]; Cambridge Commonwealth Trust; National Natural Science Foundation of China [11204111, 11404148, 11274136, 11534003]; Changjiang Scholars Program of China; Natural Science Foundation of Jiangsu province [BK20130223]; Royal Society through Wolfson Research Merit award; EFree, an Energy Frontier Research Center - DOE, Office of Science, Basic Energy Sciences [DE-SC-0001057]; EPSRC [EP/K014560/1, EP/J017639/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K014560/1, EP/J017639/1] Funding Source: researchfish	Spanish Ministry of Economy and Competitiveness(Spanish Government); EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cambridge Commonwealth Trust; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changjiang Scholars Program of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Royal Society through Wolfson Research Merit award; EFree, an Energy Frontier Research Center - DOE, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge financial support from the Spanish Ministry of Economy and Competitiveness (FIS2013-48286-C2-2-P), the EPSRC (UK) (grant numbers EP/J017639/1 and EP/K014560/1), the Cambridge Commonwealth Trust, the National Natural Science Foundation of China (grant numbers 11204111, 11404148, 11274136 and 11534003), the 2012 Changjiang Scholars Program of China, and the Natural Science Foundation of Jiangsu province (grant number BK20130223). C.J.P. acknowledges support from the Royal Society through a Wolfson Research Merit award. Work at Carnegie was supported by EFree, an Energy Frontier Research Center funded by the DOE, Office of Science, Basic Energy Sciences under award number DE-SC-0001057. Computer facilities were provided by PRACE and the Donostia International Physics Center (DIPC).	Akashi R, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.224513; Aroyo MI, 2006, ACTA CRYSTALLOGR A, V62, P115, DOI 10.1107/S0108767305040286; Aroyo MI, 2006, Z KRISTALLOGR, V221, P15, DOI 10.1524/zkri.2006.221.1.15; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Benoit M, 1998, NATURE, V392, P258, DOI 10.1038/32609; Bernstein N, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.060511; Bianconi A, 2015, EPL-EUROPHYS LETT, V112, DOI 10.1209/0295-5075/112/37001; Bronstein Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.214101; Calandra M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165111; Cao W, 2004, BRIT CERAM T, V103, P71, DOI 10.1179/096797804225012774; Caracas R, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.085502; Drozdov AP, 2015, NATURE, V525, P73, DOI 10.1038/nature14964; Duan DF, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.180502; Duan DF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06968; Einaga M., 2015, PREPRINT; Errea I, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.157004; Errea I, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.064302; Errea I, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.177002; Flores-Livas J. A., 2015, PREPRINT; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Goncharov AF, 1996, SCIENCE, V273, P218, DOI 10.1126/science.273.5272.218; Goncharov AF, 1999, PHYS REV LETT, V83, P1998, DOI 10.1103/PhysRevLett.83.1998; Hirsch JE, 2015, PHYSICA C, V511, P45, DOI 10.1016/j.physc.2015.01.008; Landau L.D., 1980, COURSE THEORETICAL P, V5; LEE C, 1992, PHYS REV LETT, V69, P462, DOI 10.1103/PhysRevLett.69.462; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LEE CY, 1993, PHYS REV B, V47, P4863, DOI 10.1103/PhysRevB.47.4863; Li YW, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.020103; Li YW, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4874158; Loubeyre P, 1999, NATURE, V397, P503, DOI 10.1038/17300; Marques M, 2009, HIGH PRESSURE RES, V29, P208, DOI 10.1080/08957950802564031; MCMAHON MI, 1990, NATURE, V348, P317, DOI 10.1038/348317a0; Nicol EJ, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.220507; Papaconstantopoulos DA, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.184511; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Song M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.014106; Stroppa A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063020; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892	40	174	179	16	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					81	+		10.1038/nature17175	http://dx.doi.org/10.1038/nature17175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27018657	Green Accepted, Green Submitted			2022-12-28	WOS:000373555500037
J	Minn, AJ; Wherry, EJ				Minn, Andy J.; Wherry, E. John			Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling	CELL			English	Review							PERSISTENT LCMV INFECTION; IMMUNOGENIC TUMORS; ANTITUMOR IMMUNITY; DNA METHYLATION; BREAST-CANCER; RADIATION; CHEMOTHERAPY; RESISTANCE; CELLS; BETA	Improving efficacy of immune checkpoint blockade for cancer can be facilitated by combining these agents with each other and/or with other conventional or targeted therapies. Interferon and innate immune signaling pathways in immune and tumor cells have emerged as intriguing determinants of response and resistance, often in complex and seemingly paradoxical ways.	[Minn, Andy J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Minn, Andy J.; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Minn, Andy J.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	andyminn@mail.med.upenn.edu	Wherry, John/ABI-1280-2020	Minn, Andy/0000-0003-1418-0906				Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Demaria S, 2015, JAMA ONCOL, V1, P1325, DOI 10.1001/jamaoncol.2015.2756; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Minn AJ, 2015, TRENDS IMMUNOL, V36, P725, DOI 10.1016/j.it.2015.09.007; Ng CT, 2016, CELL, V164, P349, DOI 10.1016/j.cell.2015.12.027; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Pfirschke C, 2016, IMMUNITY, V44, P343, DOI 10.1016/j.immuni.2015.11.024; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Rudin CM, 2001, GENE CHROMOSOME CANC, V30, P64, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1066>3.0.CO;2-F; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Vanpouille-Box C, 2015, CANCER RES, V75, P2232, DOI 10.1158/0008-5472.CAN-14-3511; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Yu QJ, 2015, J BIOL CHEM, V290, P10191, DOI 10.1074/jbc.M114.612374; Zou Q, 2015, CELL REP, V13, P2470, DOI 10.1016/j.celrep.2015.11.046	32	173	178	4	103	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					272	275		10.1016/j.cell.2016.03.031	http://dx.doi.org/10.1016/j.cell.2016.03.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058661	Bronze			2022-12-28	WOS:000374123000007
J	Adashek, J				Adashek, Jacob			PERSONAL VIEW Patients are also people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Adashek, Jacob] Western Univ Hlth Sci, Coll Osteopath Med Pacific, 309 East Second St, Pomona, CA 91786 USA	Western University of Health Sciences	Adashek, J (corresponding author), Western Univ Hlth Sci, Coll Osteopath Med Pacific, 309 East Second St, Pomona, CA 91786 USA.	jadashek@westernu.edu						[US Department of Health and Human Services Health Resources and Services Administration Center for International Blood and Marrow Transplant], 2015, US PAT SURV REP	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2016	352								i1806	10.1136/bmj.i1806	http://dx.doi.org/10.1136/bmj.i1806			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4UH	27037087				2022-12-28	WOS:000373494400001
J	Pepling, ME				Pepling, Melissa E.			Nursing the oocyte	SCIENCE			English	Editorial Material							GERM-CELL CYSTS; PRIMORDIAL FOLLICLES; DROSOPHILA OOGENESIS; BALBIANI BODY		[Pepling, Melissa E.] Syracuse Univ, Dept Biol, 107 Coll Pl, Syracuse, NY 13244 USA	Syracuse University	Pepling, ME (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Pl, Syracuse, NY 13244 USA.	mepeplin@syr.edu						Baum JS, 2005, SEMIN CELL DEV BIOL, V16, P245, DOI 10.1016/j.semcdb.2004.12.008; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Deng W, 2001, INT REV CYTOL, V203, P93; Greenbaum MP, 2009, BIOL REPROD, V80, P449, DOI 10.1095/biolreprod.108.070649; Lei L, 2016, SCIENCE, V352, P95, DOI 10.1126/science.aad2156; Lei L, 2013, DEVELOPMENT, V140, P2075, DOI 10.1242/dev.093864; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299	10	11	11	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					35	36		10.1126/science.aaf4943	http://dx.doi.org/10.1126/science.aaf4943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034359				2022-12-28	WOS:000373039600021
J	Rodes-Cabau, J; Taramasso, M; O'Gara, PT				Rodes-Cabau, Josep; Taramasso, Maurizio; O'Gara, Patrick T.			Diagnosis and treatment of tricuspid valve disease: current and future perspectives	LANCET			English	Review							RIGHT-VENTRICULAR FUNCTION; 3-DIMENSIONAL ECHOCARDIOGRAPHY; TRANSCATHETER TREATMENT; EUROPEAN ASSOCIATION; SURGICAL-TREATMENT; EJECTION FRACTION; ANNULOPLASTY RING; INCREASED RISK; REGURGITATION; REPAIR	The assessment and management of tricuspid valve disease have evolved substantially during the past several years. Whereas tricuspid stenosis is uncommon, tricuspid regurgitation is frequently encountered and is most often secondary in nature and caused by annular dilatation and leaflet tethering from adverse right ventricular remodelling in response to any of several disease processes. Non-invasive assessment of tricuspid regurgitation must define its cause and severity; advanced three-dimensional echocardiography, MRI, and CT are gaining in clinical application. The indications for tricuspid valve surgery to treat tricuspid regurgitation are related to the cause of the disorder, the context in which it is encountered, its severity, and its effects on right ventricular function. Most operations for tricuspid regurgitation are done at the time of left-sided heart valve surgery. The threshold for restrictive ring annuloplasty repair of secondary tricuspid regurgitation at the time of left-sided valve surgery has decreased over time with recognition of the risk of progressive tricuspid regurgitation and right heart failure in patients with moderate or lesser degrees of tricuspid regurgitation and tricuspid annular dilatation, as well as with appreciation of the high risks of reoperative surgery for severe tricuspid regurgitation late after left-sided valve surgery. However, many patients with unoperated severe tricuspid regurgitation are also deemed at very high or prohibitive surgical risk. Novel transcatheter therapies have begun to emerge for the treatment of tricuspid regurgitation in such patients. Experience with such therapies is preliminary and further studies are needed to determine their role in the management of this disorder.	[Rodes-Cabau, Josep] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Taramasso, Maurizio] Univ Zurich, Univ Spital Zurich, Zurich, Switzerland; [O'Gara, Patrick T.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA	Laval University; Quebec Heart & Lung Institute; University of Zurich; University Zurich Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	O'Gara, PT (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	pogara@partners.org			Edwards Lifesciences	Edwards Lifesciences	JR-C has received research grants from Edwards Lifesciences. MT and PTO'G declare no competing interests.	Anwar AM, 2007, INT J CARDIOVAS IMAG, V23, P701, DOI 10.1007/s10554-006-9206-4; Barbanti M, 2015, CATHETER CARDIO INTE, V85, P677, DOI 10.1002/ccd.25512; Benedetto U, 2012, J THORAC CARDIOV SUR, V143, P632, DOI 10.1016/j.jtcvs.2011.12.006; Bertrand PB, 2014, J THORAC CARDIOV SUR, V147, P1256, DOI 10.1016/j.jtcvs.2013.05.007; Bevan PJW, 2014, HEART LUNG CIRC, V23, P697, DOI 10.1016/j.hlc.2014.02.011; Boudjemline Y, 2005, J AM COLL CARDIOL, V46, P360, DOI 10.1016/j.jacc.2005.01.063; Buzzatti N, 2014, EUR J CARDIO-THORAC, V46, P713, DOI 10.1093/ejcts/ezt638; Campelo-Parada F, 2015, J AM COLL CARDIOL, V66, P2475, DOI 10.1016/j.jacc.2015.09.068; Cawley PJ, 2009, CIRCULATION, V119, P468, DOI 10.1161/CIRCULATIONAHA.107.742486; Chan V, 2009, ANN THORAC SURG, V88, P1209, DOI 10.1016/j.athoracsur.2009.06.034; Chang BC, 2006, ANN THORAC SURG, V81, P1317, DOI 10.1016/j.athoracsur.2005.11.005; Chang BC, 2006, ANN THORAC SURG, V81, P23; Chikwe J, 2015, J AM COLL CARDIOL, V65, P1931, DOI 10.1016/j.jacc.2015.01.059; Cho WC, 2013, J CARDIAC SURG, V28, P212, DOI 10.1111/jocs.12093; Connolly HM, 2015, J AM COLL CARDIOL, V66, P2189, DOI 10.1016/j.jacc.2015.09.014; Dahou A, 2015, JACC-CARDIOVASC INTE, V8, P588, DOI 10.1016/j.jcin.2014.08.019; De Bonis M, 2004, EUR J CARDIO-THORAC, V25, P760, DOI 10.1016/j.ejcts.2004.01.051; De Meester P, 2014, INT J CARDIOL, V175, P333, DOI 10.1016/j.ijcard.2014.06.003; De Vega N G, 1972, Rev Esp Cardiol, V25, P555; Dreyfus GD, 2005, ANN THORAC SURG, V79, P127, DOI 10.1016/j.athoracsur.2004.06.057; Dreyfus GD, 2008, EUR J CARDIO-THORAC, V34, P908, DOI 10.1016/j.ejcts.2008.07.006; Dreyfus GD, 2015, J AM COLL CARDIOL, V65, P2331, DOI 10.1016/j.jacc.2015.04.011; Filsoufi F, 2006, ANN THORAC SURG, V81, P2273, DOI 10.1016/j.athoracsur.2005.12.044; Fukuda S, 2005, CIRCULATION, V111, P975, DOI 10.1161/01.CIR.0000156449.49998.51; Fukuda S, 2007, J AM SOC ECHOCARDIOG, V20, P1236, DOI 10.1016/j.echo.2007.03.006; Fukuda S, 2006, CIRCULATION, V114, pI582, DOI 10.1161/CIRCULATIONAHA.105.001305; GALINANES M, 1986, ANN THORAC SURG, V42, P74, DOI 10.1016/S0003-4975(10)61840-1; Godart F, 2014, ARCH CARDIOVASC DIS, V107, P583, DOI 10.1016/j.acvd.2014.07.051; Goldstone AB, 2014, J THORAC CARDIOV SUR, V148, P2802, DOI 10.1016/j.jtcvs.2014.08.001; Hammerstingl C, 2016, EUR HEART J, V37, P849, DOI 10.1093/eurheartj/ehv710; Hetzer R, 2013, EUR J CARDIO-THORAC, V43, P641, DOI 10.1093/ejcts/ezs490; Hung J, 1998, AM J CARDIOL, V82, P1301, DOI 10.1016/S0002-9149(98)00624-9; Jeganathan R, 2013, ANN THORAC SURG, V95, P119, DOI 10.1016/j.athoracsur.2012.08.058; Kaplan M, 2002, ANN THORAC SURG, V73, P467, DOI 10.1016/S0003-4975(01)03128-9; KAY JH, 1965, ANN SURG, V162, P53, DOI 10.1097/00000658-196507000-00009; Kim HK, 2005, CIRCULATION, V112, pI14, DOI 10.1161/CIRCULATIONAHA.104.524496; Kim JB, 2008, J AM SOC ECHOCARDIOG, V21, P284, DOI 10.1016/j.echo.2007.05.022; Kim YJ, 2009, CIRCULATION, V120, P1672, DOI 10.1161/CIRCULATIONAHA.109.849448; KING RM, 1984, CIRCULATION, V70, P193; Koelling TM, 2002, AM HEART J, V144, P524, DOI 10.1067/mhj.2002.123575; Kwak JJ, 2008, AM HEART J, V155, P732, DOI 10.1016/j.ahj.2007.11.010; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Lapenna E, 2010, EUR J CARDIO-THORAC, V37, P1297, DOI 10.1016/j.ejcts.2009.12.020; Latib A, 2015, JACC-CARDIOVASC INTE, V8, pE211, DOI 10.1016/j.jcin.2015.06.028; Laule M, 2013, J AM COLL CARDIOL, V61, P1929, DOI 10.1016/j.jacc.2013.01.070; Lauten A, 2014, CIRC-CARDIOVASC INTE, V7, P268, DOI 10.1161/CIRCINTERVENTIONS.113.001033; Lauten A, 2011, EUR HEART J, V32, P1207, DOI 10.1093/eurheartj/ehr028; Lee JW, 2010, CIRC J, V74, P375, DOI 10.1253/circj.CJ-09-0679; Ling LF, 2012, JACC-CARDIOVASC IMAG, V5, P747, DOI 10.1016/j.jcmg.2011.08.026; McCarthy PM, 2007, SEMIN THORAC CARDIOV, V19, P121, DOI 10.1053/j.semtcvs.2007.06.002; McCarthy PM, 2004, J THORAC CARDIOV SUR, V127, P674, DOI 10.1016/j.jtcvs.2003.11.019; Milla F, 2012, J THORAC CARDIOV SUR, V143, pS71, DOI 10.1016/j.jtcvs.2011.11.015; Min SY, 2010, EUR HEART J, V31, P2871, DOI 10.1093/eurheartj/ehq227; Minol JP, 2017, THORAC CARDIOV SURG, V65, P606, DOI 10.1055/s-0035-1546428; Nath J, 2004, J AM COLL CARDIOL, V43, P405, DOI 10.1016/j.jacc.2003.09.036; Navia JL, 2010, J THORAC CARDIOV SUR, V139, P1473, DOI 10.1016/j.jtcvs.2010.02.046; Nesser HJ, 2006, ECHOCARDIOGR-J CARD, V23, P666, DOI 10.1111/j.1540-8175.2006.00286.x; Neuhold S, 2013, EUR HEART J, V34, P844, DOI 10.1093/eurheartj/ehs465; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Northrup WE, 2010, J HEART VALVE DIS, V19, P193; Paradis JM, 2015, J AM COLL CARDIOL, V66, P2019, DOI 10.1016/j.jacc.2015.09.015; Parolari A, 2014, ANN THORAC SURG, V98, P2255, DOI 10.1016/j.athoracsur.2014.06.100; Pfannmuller B, 2012, ANN THORAC SURG, V94, P2005, DOI 10.1016/j.athoracsur.2012.06.064; Pfannmuller B, 2012, J THORAC CARDIOV SUR, V143, P1050, DOI 10.1016/j.jtcvs.2011.06.019; Raja Shahzad G, 2009, Expert Rev Cardiovasc Ther, V7, P73, DOI 10.1586/14779072.7.1.73; Ratschiller T, 2014, ANN THORAC SURG, V98, P2039, DOI 10.1016/j.athoracsur.2014.07.023; Roberts PA, 2011, J AM COLL CARDIOL, V58, P117, DOI 10.1016/j.jacc.2011.01.044; Rodes-Cabau J, J AM COLL C IN PRESS; Rogers JH, 2009, CIRCULATION, V119, P2718, DOI 10.1161/CIRCULATIONAHA.108.842773; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sagie A, 1997, J AM SOC ECHOCARDIOG, V10, P141, DOI 10.1016/S0894-7317(97)70086-5; Saremi F, 2015, AM J ROENTGENOL, V204, pW531, DOI 10.2214/AJR.14.13551; Schofer J, 2016, J AM COLL CARDIOL, V67, P889, DOI 10.1016/j.jacc.2015.11.047; Schofer J, 2015, J AM COLL CARDIOL, V65, P1190, DOI 10.1016/j.jacc.2015.01.025; Songur CM, 2014, HEART LUNG CIRC, V23, P1175, DOI 10.1016/j.hlc.2014.05.015; Starck CT, 2015, EUROINTERVENTION, V11, pW128, DOI 10.4244/EIJV11SWA36; Sugeng L, 2010, JACC-CARDIOVASC IMAG, V3, P10, DOI 10.1016/j.jcmg.2009.09.017; Tang GHL, 2006, CIRCULATION, V114, pI577, DOI 10.1161/CIRCULATIONAHA.105.001263; Taramasso M, 2017, EUR HEART J, V38, P639, DOI 10.1093/eurheartj/ehv766; Taramasso M, 2012, J AM COLL CARDIOL, V59, P703, DOI 10.1016/j.jacc.2011.09.069; Topilsky Y, 2011, CIRCULATION, V123, P1929, DOI 10.1161/CIRCULATIONAHA.110.991018; Urbandt P, 2014, J HEART VALVE DIS, V23, P783; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Van de Veire NR, 2011, J THORAC CARDIOV SUR, V141, P1431, DOI 10.1016/j.jtcvs.2010.05.050; van der Zwaan HB, 2011, EUR J ECHOCARDIOGR, V12, P656, DOI 10.1093/ejechocard/jer107; van Rosendael PJ, 2016, EUR HEART J-CARD IMG, V17, P96, DOI 10.1093/ehjci/jev140; Xanthos Theodoros, 2011, Italian Journal of Anatomy and Embryology, V116, P111; Zhu TY, 2013, INTERACT CARDIOV TH, V17, P1009, DOI 10.1093/icvts/ivt363; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	89	136	148	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 12	2016	388	10058					2431	2442		10.1016/S0140-6736(16)00740-6	http://dx.doi.org/10.1016/S0140-6736(16)00740-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB5RB	27048553				2022-12-28	WOS:000387436900030
J	Dehmer, SP; Maciosek, MV; Flottemesch, TJ; LaFrance, AB; Whitlock, EP				Dehmer, Steven P.; Maciosek, Michael V.; Flottemesch, Thomas J.; LaFrance, Amy B.; Whitlock, Evelyn P.			Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-DOSE ASPIRIN; HEALTH OUTCOMES; ALTERNATE-DAY; EVENTS; RISK; POPULATION; MORTALITY; SCORES; TRIAL; METAANALYSIS	Background: Evidence indicates that aspirin is effective for the primary prevention of cardiovascular disease (CVD) and colorectal cancer (CRC) but also increases the risk for gastrointestinal (GI) and cerebral hemorrhages. Objective: To assess the net balance of benefits and harms from routine aspirin use across clinically relevant age, sex, and CVD risk groups. Design: Decision analysis using a microsimulation model. Data Sources: 3 systematic evidence reviews. Target Population: Men and women aged 40 to 79 years with a 10-year CVD risk of 20% or less, and no history of CVD and without elevated risk for GI or cerebral hemorrhages that would contraindicate aspirin use. Time Horizon: Lifetime, 20 years, and 10 years. Perspective: Clinical. Intervention: Low-dose aspirin (<= 100 mg/d). Outcome Measures: Primary outcomes are length and quality of life measured in net life-years and quality-adjusted life-years. Benefits include reduced nonfatal myocardial infarction, nonfatal ischemic stroke, fatal CVD, CRC incidence, and CRC mortality. Harms include increased fatal and nonfatal GI bleeding and hemorrhagic stroke. Results of Base-Case Analysis: Lifetime net quality-adjusted life-years are positive for most adults initiating aspirin at ages 40 to 69 years, and life expectancy gains are expected for most men and women initiating aspirin at ages 40 to 59 years and 60 to 69 years with higher CVD risk. Harms may exceed benefits for persons starting aspirin in their 70s and for many during the first 10 to 20 years of use. Results of Sensitivity Analysis: Results are most sensitive to the relative risk for hemorrhagic stroke and CVD mortality but are affected by all relative risk estimates, baseline GI bleeding incidence and case-fatality rates, and disutilities associated with aspirin use. Limitations: Aspirin effects by age are uncertain. Stroke benefits are conservatively estimated. Gastrointestinal bleeding incidence and case-fatality rates account only for age and sex. Conclusion: Lifetime aspirin use for primary prevention initiated at younger ages (40 to 69 years) and in persons with higher CVD risk shows the greatest potential for positive net benefit.	[Dehmer, Steven P.; Maciosek, Michael V.; LaFrance, Amy B.] HealthPartners Inst, Mailstop 21111R,POB 1524, Minneapolis, MN 55440 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Flottemesch, Thomas J.] Truven Hlth Analyt, 777 East Eisenhower Pkwy, Ann Arbor, MI 48108 USA; [Whitlock, Evelyn P.] Patient Ctr Outcomes Res Inst, 1828 L St Northwest,Suite 900, Washington, DC 20036 USA	Kaiser Permanente	Dehmer, SP (corresponding author), HealthPartners Inst, Mailstop 21111R,POB 1524, Minneapolis, MN 55440 USA.	steven.p.dehmer@healthpartners.com		Maciosek, Michael/0000-0002-8164-8858; Dehmer, Steven/0000-0003-3508-9239	AHRQ [HHSA-290-2012-00015-EPC4]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract HHSA-290-2012-00015-EPC4, Task Order 4, from AHRQ.	[Anonymous], 2011, ANN EST RES POP SEX; [Anonymous], [No title captured]; [Anonymous], 2014, SURV RES PROGR SEER; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Calonge N, 2009, ANN INTERN MED, V150, P396; Centers for Disease Control and Prevention, 2007, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2005, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC), 2004, NAT HLTH NUTR EX SUR; Chubak J, 2016, ANN INTERN MED, V164, P814, DOI 10.7326/M15-2117; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Congressional Budget Office, 2012, RAIS EXC TAX CIG EFF; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; Cuzick J, 2015, ANN ONCOL, V26, P47, DOI 10.1093/annonc/mdu225; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; Dehmer SP, 2015, AHRQ PUBLICATION, V15-05229-EF-1; Djalalov S, 2014, MED DECIS MAKING, V34, P809, DOI 10.1177/0272989X14536779; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gaziano JM, 2014, JAMA-J AM MED ASSOC, V312, P2503, DOI 10.1001/jama.2014.16047; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Gold MR, 1996, COST EFFECTIVENESS H; Guirguis-Blake JM, 2016, ANN INTERN MED, V164, P804, DOI 10.7326/M15-2113; Guirguis-Blake JM, 2015, AHRQ PUBLICATION, V13-05195-EF-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; Ko CY, 2003, J SURG RES, V114, P1, DOI 10.1016/S0022-4804(03)00167-7; Krantz MJ, 2010, PHARMACOTHERAPY, V30, P115, DOI 10.1592/phco.30.2.115; Lee HY, 2010, STROKE, V41, P739, DOI 10.1161/STROKEAHA.109.573543; Meade TW, 1998, LANCET, V351, P233; Mittmann N, 1999, PHARMACOECONOMICS, V15, P369, DOI 10.2165/00019053-199915040-00004; *NAT CTR HLTH STAT, 2008, NAT HLTH INT SURV 20; National Center for Health Statistics, 2018, NAT HLTH NUTR EX SUR; Nelson MR, 2003, DRUG AGING, V20, P897, DOI 10.2165/00002512-200320120-00004; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Pignone M, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001254; Pignone M, 2013, J GEN INTERN MED, V28, P1483, DOI 10.1007/s11606-013-2465-6; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; [Smoking-Attributable Mortality Morbidity Economic Costs (SAMMEC) Centers for Disease Control and Prevention], 2007, SMOK ATTR MORT MORB; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Sullivan PW, 2005, MED CARE, V43, P736, DOI 10.1097/01.mlr.0000172050.67085.4f; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; US Preventive Services Task Force, 2007, ANN INTERN MED, V146, P361, DOI 10.7326/0003-4819-146-5-200703060-00008; van Kruijsdijk RCM, 2015, HEART, V101, P369, DOI 10.1136/heartjnl-2014-306342; Whitlock EP, 2015, AHRQ PUBLICATION, V13-05193-EF-1; Whitlock EP, 2016, ANN INTERN MED, V164, P826, DOI 10.7326/M15-2112; Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009	55	72	73	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					777	+		10.7326/M15-2129	http://dx.doi.org/10.7326/M15-2129			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27064573				2022-12-28	WOS:000379343000011
J	Kelbaek, H; Hofsten, DE; Kober, L; Helqvist, S; Klovgaard, L; Holmvang, L; Jorgensen, E; Pedersen, F; Saunamaki, K; De Backer, O; Bang, LE; Kofoed, KF; Lonborg, J; Ahtarovski, K; Vejlstrup, N; Botker, HE; Terkelsen, CJ; Christiansen, EH; Ravkilde, J; Tilsted, HH; Villadsen, AB; Aaroe, J; Jensen, SE; Raungaard, B; Jensen, LO; Clemmensen, P; Grande, P; Madsen, JK; Torp-Pedersen, C; Engstrom, T				Kelbaek, Henning; Hofsten, Dan Eik; Kober, Lars; Helqvist, Steffen; Klovgaard, Lene; Holmvang, Lene; Jorgensen, Erik; Pedersen, Frants; Saunamaki, Kari; De Backer, Ole; Bang, Lia E.; Kofoed, Klaus F.; Lonborg, Jacob; Ahtarovski, Kiril; Vejlstrup, Niels; Botker, Hans E.; Terkelsen, Christian J.; Christiansen, Evald H.; Ravkilde, Jan; Tilsted, Hans-Henrik; Villadsen, Anton B.; Aaroe, Jens; Jensen, Svend E.; Raungaard, Bent; Jensen, Lisette O.; Clemmensen, Peter; Grande, Peer; Madsen, Jan K.; Torp-Pedersen, Christian; Engstrom, Thomas			Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; NO-REFLOW PHENOMENON; DISTAL EMBOLIZATION; THROMBUS ASPIRATION; BALLOON ANGIOPLASTY; IMMEDIATE; THROMBECTOMY; PROTECTION	Background Despite successful treatment of the culprit artery lesion by primary percutaneous coronary intervention (PCI) with stent implantation, thrombotic embolisation occurs in some cases, which impairs the prognosis of patients with ST-segment elevation myocardial infarction (STEMI). We aimed to assess the clinical outcomes of deferred stent implantation versus standard PCI in patients with STEMI. Methods We did this open-label, randomised controlled trial at four primary PCI centres in Denmark. Eligible patients (aged >18 years) had acute onset symptoms lasting 12 h or less, and ST-segment elevation of 0.1 mV or more in at least two or more contiguous electrocardiographic leads or newly developed left bundle branch block. Patients were randomly assigned (1: 1), via an electronic web-based system with permuted block sizes of two to six, to receive either standard primary PCI with immediate stent implantation or deferred stent implantation 48 h after the index procedure if a stabilised flow could be obtained in the infarct-related artery. The primary endpoint was a composite of all-cause mortality, hospital admission for heart failure, recurrent infarction, and any unplanned revascularisation of the target vessel within 2 years' follow-up. Patients, investigators, and treating clinicians were not masked to treatment allocation. We did analysis by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01435408. Findings Between March 1, 2011, and Feb 28, 2014, we randomly assigned 1215 patients to receive either standard PCI (n=612) or deferred stent implantation (n=603). Median follow-up time was 42 months (IQR 33-49). Events comprising the primary endpoint occurred in 109 (18%) patients who had standard PCI and in 105 (17%) patients who had deferred stent implantation (hazard ratio 0.99, 95% CI 0.76-1.29; p=0.92). Procedure-related myocardial infarction, bleeding requiring transfusion or surgery, contrast-induced nephopathy, or stroke occurred in 28 (5%) patients in the conventional PCI group versus 27 (4%) patients in the deferred stent implantation group, with no significant differences between groups. Interpretation In patients with STEMI, routine deferred stent implantation did not reduce the occurrence of death, heart failure, myocardial infarction, or repeat revascularisation compared with conventional PCI. Results from ongoing randomised trials might shed further light on the concept of deferred stenting in this patient population.	[Kelbaek, Henning] Roskilde Hosp, Dept Cardiol, DK-4000 Roskilde, Denmark; [Hofsten, Dan Eik; Kober, Lars; Helqvist, Steffen; Klovgaard, Lene; Holmvang, Lene; Jorgensen, Erik; Pedersen, Frants; Saunamaki, Kari; De Backer, Ole; Bang, Lia E.; Kofoed, Klaus F.; Lonborg, Jacob; Ahtarovski, Kiril; Vejlstrup, Niels; Engstrom, Thomas] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Madsen, Jan K.; Torp-Pedersen, Christian] Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Copenhagen, Denmark; [Botker, Hans E.; Terkelsen, Christian J.; Christiansen, Evald H.] Univ Aarhus, Dept Cardiol, Skejby Hosp, Aarhus, Denmark; [Ravkilde, Jan; Tilsted, Hans-Henrik; Villadsen, Anton B.; Aaroe, Jens; Jensen, Svend E.; Raungaard, Bent] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Jensen, Lisette O.] Odense Univ, Dept Cardiol, Odense Hosp, Odense, Denmark; [Clemmensen, Peter; Grande, Peer] Nykobing Falster Hosp, Dept Cardiol, Nykobing Falste, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital	Kelbaek, H (corresponding author), Roskilde Hosp, Dept Cardiol, DK-4000 Roskilde, Denmark.	hkelbaek@dadlnet.dk	terkelsen, christian/ABD-6294-2021; De Backer, Ole/AAQ-2369-2020	De Backer, Ole/0000-0002-9674-0278; terkelsen, christian juhl/0000-0003-0205-9551; Botker, Hans Erik/0000-0001-6358-8962; Kofoed, Klaus Fuglsang/0000-0001-9742-1554; Jensen, Lisette Okkels/0000-0002-4838-2429; Kober, Lars/0000-0002-6635-1466	Danish Agency for Science, Technology and Innovation; Danish Council for Strategic Research	Danish Agency for Science, Technology and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	Danish Agency for Science, Technology and Innovation, and Danish Council for Strategic Research.	Cafri Carlos, 2004, J Invasive Cardiol, V16, P69; Carrick D, 2014, J AM COLL CARDIOL, V63, P2088, DOI 10.1016/j.jacc.2014.02.530; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Fokkema ML, 2009, EUR HEART J, V30, P908, DOI 10.1093/eurheartj/ehp033; Freixa X, 2013, EUROINTERVENTION, V8, P1207, DOI 10.4244/EIJV8I10A185; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Harrison RW, 2013, AM J CARDIOL, V111, P178, DOI 10.1016/j.amjcard.2012.09.015; Henriques JPS, 2002, EUR HEART J, V23, P1112, DOI 10.1053/euhj.2001.3035; Hofsten DE, 2015, AM HEART J, V169, P613, DOI 10.1016/j.ahj.2015.02.004; Isaaz K, 2006, CORONARY ARTERY DIS, V17, P261, DOI 10.1097/00019501-200605000-00010; Jaffe R, 2008, CIRCULATION, V117, P3152, DOI 10.1161/CIRCULATIONAHA.107.742312; Jolly SS, 2015, NEW ENGL J MED, V372, P1389, DOI 10.1056/NEJMoa1415098; Kaltoft A, 2006, CIRCULATION, V114, P40, DOI 10.1161/CIRCULATIONAHA.105.595660; Ke D, 2012, CORONARY ARTERY DIS, V23, P497, DOI 10.1097/MCA.0b013e328358a5ad; Kelbaek H, 2008, J AM COLL CARDIOL, V51, P899, DOI 10.1016/j.jacc.2007.10.047; Kelbaek H, 2013, EUROINTERVENTION, V8, P1126, DOI 10.4244/EIJV8I10A175; Lonborg J, 2015, EUR HEART J-ACUTE CA, V4, P180, DOI 10.1177/2048872614543780; Mehta RH, 2005, AM J CARDIOL, V96, P901, DOI 10.1016/j.amjcard.2005.05.044; Meneveau N, 2009, CLIN RES CARDIOL, V98, P257, DOI 10.1007/s00392-009-0756-z; Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Perkins GD, 2015, LANCET, V385, P947, DOI 10.1016/S0140-6736(14)61886-9; Sianos G, 2007, J AM COLL CARDIOL, V50, P573, DOI 10.1016/j.jacc.2007.04.059; Stone GW, 2012, JAMA-J AM MED ASSOC, V307, P1817, DOI 10.1001/jama.2012.421; Suryapranata H, 2005, HEART, V91, P641, DOI 10.1136/hrt.2004.056705; Tang L, 2011, CAN J CARDIOL, V27, P541, DOI 10.1016/j.cjca.2011.03.001; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	29	117	127	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2199	2206		10.1016/S0140-6736(16)30072-1	http://dx.doi.org/10.1016/S0140-6736(16)30072-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27053444				2022-12-28	WOS:000376820800029
J	Rasmussen, SA; Jamieson, DJ; Honein, MA; Petersen, LR				Rasmussen, Sonja A.; Jamieson, Denise J.; Honein, Margaret A.; Petersen, Lyle R.			Zika Virus and Birth Defects - Reviewing the Evidence for Causality	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TERATOGEN UPDATE; INFECTION; BRAZIL; BRAIN; ASSOCIATION; OUTBREAK; STATES		[Rasmussen, Sonja A.] Ctr Dis Control & Prevent, Ctr Surveillance Epidemiol & Lab Serv, Div Publ Hlth Informat Disseminat, Atlanta, GA USA; [Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA; [Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disorders, Atlanta, GA USA; [Petersen, Lyle R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Rasmussen, SA (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-33, Atlanta, GA 30329 USA.	skr9@cdc.gov		Jamieson, Denise/0000-0003-2597-1201				Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003; Associated Press-NORC Center for Public Affairs Research, 2016, ZIK VIR AM AW OP US; Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005; BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Byrd AL, 2016, SCIENCE, V351, P224, DOI 10.1126/science.aad6753; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Carey JC, 2009, BIRTH DEFECTS RES A, V85, P63, DOI 10.1002/bdra.20533; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011; Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006; Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813; Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332; de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7; Instituto Nacional de Salud, 2016, B EP SEM; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; JONES KL, 1973, LANCET, V2, P999; LAMMER EJ, 1987, TERATOLOGY, V35, P465, DOI 10.1002/tera.1420350319; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115; Mitchell AA, 2010, NEW ENGL J MED, V363, P2161, DOI 10.1056/NEJMe1009631; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; National Birth Defects Prevention Network, 2013, MAJ BIRTH DEF DAT PO; O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024; Palacios R, 2016, VACCINE, DOI [10.1056/NEJMsr1604338, DOI 10.1056/NEJMSR1604338]; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Reefhuis J, EMERG INFEC IN PRESS; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Scialli AR, 2005, BIRTH DEFECTS RES A, V73, P421, DOI 10.1002/bdra.21039; SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Webster WS, 1998, TERATOLOGY, V58, P13; Williams JV, 2010, J INFECT DIS, V201, P1611, DOI 10.1086/652406	44	1241	1286	6	356	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2016	374	20					1981	1987		10.1056/NEJMsr1604338	http://dx.doi.org/10.1056/NEJMsr1604338			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM1OX	27074377	Bronze			2022-12-28	WOS:000376116600014
J	Qiu, JZ; Sheedlo, MJ; Yu, KW; Tan, YH; Nakayasu, ES; Das, C; Liu, XY; Luo, ZQ				Qiu, Jiazhang; Sheedlo, Michael J.; Yu, Kaiwen; Tan, Yunhao; Nakayasu, Ernesto S.; Das, Chittaranjan; Liu, Xiaoyun; Luo, Zhao-Qing			Ubiquitination independent of E1 and E2 enzymes by bacterial effectors	NATURE			English	Article							LEGIONELLA-PNEUMOPHILA; ENDOPLASMIC-RETICULUM; SUBSTRATE RECOGNITION; STRUCTURAL BASIS; CELL BIOLOGY; PROTEIN; SYSTEM; FAMILY; PHAGOSOME; REPLICATION	Signalling by ubiquitination regulates virtually every cellular process in eukaryotes. Covalent attachment of ubiquitin to a substrate is catalysed by the E1, E2 and E3 three-enzyme cascade(1), which links the carboxy terminus of ubiquitin to the e-amino group of, in most cases, a lysine of the substrate via an isopeptide bond. Given the essential roles of ubiquitination in the regulation of the immune system, it is not surprising that the ubiquitination network is a common target for diverse infectious agents(2). For example, many bacterial pathogens exploit ubiquitin signalling using virulence factors that function as E3 ligases, deubiquitinases3 or as enzymes that directly attack ubiquitin(4). The bacterial pathogen Legionella pneumophila utilizes approximately 300 effectors that modulate diverse host processes to create a permissive niche for its replication in phagocytes(5). Here we demonstrate that members of the SidE effector family of L. pneumophila ubiquitinate multiple Rab small GTPases associated with the endoplasmic reticulum. Moreover, we show that these proteins are capable of catalysing ubiquitination without the need for the E1 and E2 enzymes. A putative mono-ADP-ribosyltransferase motif critical for the ubiquitination activity is also essential for the role of the SidE family in intracellular bacterial replication in a protozoan host. The E1/E2-independent ubiquitination catalysed by these enzymes is energized by nicotinamide adenine dinucleotide, which activates ubiquitin by the formation of ADP-ribosylated ubiquitin. These results establish that ubiquitination can be catalysed by a single enzyme, the activity of which does not require ATP.	[Qiu, Jiazhang; Tan, Yunhao; Luo, Zhao-Qing] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA; [Qiu, Jiazhang; Tan, Yunhao; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Sheedlo, Michael J.; Das, Chittaranjan] Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA; [Yu, Kaiwen; Liu, Xiaoyun] Peking Univ, Inst Analyt Chem, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Yu, Kaiwen; Liu, Xiaoyun] Peking Univ, Synthet & Funct Biomol Ctr, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Nakayasu, Ernesto S.] Pacific NW Natl Lab, Biol Sci Div, Richland, WA 99352 USA; [Tan, Yunhao] Harvard Univ, Sch Med, Div Gastroenterol, Boston Childrens Hosp, Boston, MA 02115 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Peking University; Peking University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Harvard University; Boston Children's Hospital; Harvard Medical School	Luo, ZQ (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.; Luo, ZQ (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	luoz@purdue.edu	Nakayasu, Ernesto S./AAJ-8374-2020; Das, Chittaranjan/AAM-1686-2020; Tan, Yunhao/K-7442-2016	Nakayasu, Ernesto S./0000-0002-4056-2695; Tan, Yunhao/0000-0002-5516-4980; Yu, Kaiwen/0000-0002-6050-8477; Luo, Zhao-Qing/0000-0001-8890-6621	National Institutes of Health [R56AI103168, K02AI085403, R21AI105714, 2R01GM103401]; National Natural Science Foundation of China [21305006, 21475005]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105714, R56AI103168, K02AI085403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Hollenbeck (Purdue University) for critical reading of the manuscript. J. Barbieri (Medical College of Wisconsin) for plasmids. This work was supported by National Institutes of Health grants R56AI103168, K02AI085403 and R21AI105714 (Z.-Q.L.), 2R01GM103401 (C.D.) and National Natural Science Foundation of China grants 21305006 and 21475005 (X.L.).	Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Dumenil G, 2001, MOL MICROBIOL, V40, P1113, DOI 10.1046/j.1365-2958.2001.02454.x; Fan HY, 1996, GENETICS, V142, P749; Fazzio TG, 2003, MOL CELL, V12, P1333, DOI 10.1016/S1097-2765(03)00436-2; Fontana MF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001289; Ganesan AK, 1998, J BIOL CHEM, V273, P7332, DOI 10.1074/jbc.273.13.7332; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Glowacki G, 2002, PROTEIN SCI, V11, P1657, DOI 10.1110/ps.0200602; Havey JC, 2015, INFECT IMMUN, V83, P3506, DOI 10.1128/IAI.00497-15; Herhaus L, 2015, EMBO REP, V16, P1071, DOI 10.15252/embr.201540891; Hsu FS, 2012, P NATL ACAD SCI USA, V109, P13567, DOI 10.1073/pnas.1207903109; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Jeong KC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004695; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Li ZR, 2005, CELL MICROBIOL, V7, P431, DOI 10.1111/j.1462-5822.2004.00472.x; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Liu YC, 2007, INFECT IMMUN, V75, P592, DOI 10.1128/IAI.01278-06; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Rolando M, 2013, CELL HOST MICROBE, V13, P395, DOI 10.1016/j.chom.2013.03.004; Sakurai J, 2009, TOXINS, V1, P208, DOI 10.3390/toxins1020208; Sandoval CO, 2012, BIOCHEM SOC T, V40, P1426, DOI 10.1042/BST20120158; Sheedlo MJ, 2015, P NATL ACAD SCI USA, V112, P15090, DOI 10.1073/pnas.1514568112; Sherwood RK, 2013, CELL HOST MICROBE, V14, P256, DOI 10.1016/j.chom.2013.08.010; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Simon S, 2014, CELL MICROBIOL, V16, P977, DOI 10.1111/cmi.12258; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tan YH, 2011, P NATL ACAD SCI USA, V108, P21212, DOI 10.1073/pnas.1114023109; Tilney LG, 2001, J CELL SCI, V114, P4637; Wilde C, 2001, TOXICON, V39, P1647, DOI 10.1016/S0041-0101(01)00152-0; Xu L, 2013, MICROBES INFECT, V15, P157, DOI 10.1016/j.micinf.2012.11.001; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Zhou Y, 2015, CELL MICROBIOL, V17, P26, DOI 10.1111/cmi.12384; Zhu WH, 2016, SCI CHINA LIFE SCI, V59, P3, DOI 10.1007/s11427-015-4945-x; Zinngrebe J, 2014, EMBO REP, V15, P28, DOI 10.1002/embr.201338025	40	199	208	8	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					120	+		10.1038/nature17657	http://dx.doi.org/10.1038/nature17657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27049943	Green Accepted			2022-12-28	WOS:000375473900051
J	Singhvi, A; Liu, BQ; Friedman, CJ; Fong, J; Lu, Y; Huang, XY; Shaham, S				Singhvi, Aakanksha; Liu, Bingqian; Friedman, Christine J.; Fong, Jennifer; Lu, Yun; Huang, Xin-Yun; Shaham, Shai			A Glial K/Cl Transporter Controls Neuronal Receptive Ending Shape by Chloride Inhibition of an rGC	CELL			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; NEMATODE CAENORHABDITIS-ELEGANS; CYCLASE-A RECEPTOR; GUANYLYL CYCLASE; C-ELEGANS; DENDRITIC SPINE; HUNTINGTONS-DISEASE; NEURAL CIRCUITS; BINDING-SITE; THERMOTAXIS	Neurons receive input from the outside world or from other neurons through neuronal receptive endings (NREs). Glia envelop NREs to create specialized microenvironments; however, glial functions at these sites are poorly understood. Here, we report a molecular mechanism by which glia control NRE shape and associated animal behavior. The C. elegans AMsh glial cell ensheathes the NREs of 12 neurons, including the thermosensory neuron AFD. KCC-3, a K/Cl transporter, localizes specifically to a glial microdomain surrounding AFD receptive ending microvilli, where it regulates K+ and Cl- levels. We find that Cl- ions function as direct inhibitors of an NRE-localized receptor-guanylyl-cyclase, GCY-8, which synthesizes cyclic guanosine monophosphate (cGMP). High cGMP mediates the effects of glial KCC-3 on AFD shape by antagonizing the actin regulator WSP-1/NWASP. Components of this pathway are broadly expressed throughout the nervous system, suggesting that ionic regulation of the NRE microenvironment may be a conserved mechanism by which glia control neuron shape and function.	[Singhvi, Aakanksha; Friedman, Christine J.; Fong, Jennifer; Lu, Yun; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10065 USA; [Liu, Bingqian; Huang, Xin-Yun] Cornell Univ, Dept Physiol, Weill Med Coll, 1300 York Ave, New York, NY 10065 USA; [Friedman, Christine J.] St Georges Univ, Sch Med, True Blue, Grenada; [Fong, Jennifer] Suny Downstate Med Ctr, Coll Med, 450 Clarkson Ave, Brooklyn, NY 11203 USA	Rockefeller University; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10065 USA.	shaham@rockefeller.edu			NIH [NS081490, HD078703]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD078703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073121, R01NS081490, R01NS064273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Cori Bargmann, Menachem Katz, Michael Koelle, and Piali Sengupta for reagents, Tarakhovsky lab members for help with cell culture, and Cori Bargmann and the S.S. lab for comments. William J. Rice at the Simons Electron Microscopy Center (NYSBC) helped with FIB/SEM imaging. A.S. was an American Cancer Society postdoctoral fellow (PF-13-083-01-DDC), NIH-T32 institutional postdoctoral fellow (5T32CA967334), and Murray Foundation fellow. This work was supported in part by grants from the NIH (NS081490 and HD078703) to S.S.	Acher FC, 2011, NEUROPHARMACOLOGY, V60, P102, DOI 10.1016/j.neuropharm.2010.07.002; Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; BRENNER S, 1974, GENETICS, V77, P71; Chao YC, 2015, EMBO J, V34, P294, DOI 10.15252/embj.201489652; Cho SW, 2004, BIOCHEM BIOPH RES CO, V325, P525, DOI 10.1016/j.bbrc.2004.10.060; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; DiRaddo JO, 2015, MOL PHARMACOL, V88, P450, DOI 10.1124/mol.114.096420; Doroquez DB, 2014, ELIFE, V3, DOI 10.7554/eLife.01948; Duda T, 1996, BIOCHEMISTRY-US, V35, P8478, DOI 10.1021/bi960752z; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Gallemore RP, 1997, PROG RETIN EYE RES, V16, P509, DOI 10.1016/S1350-9462(96)00037-7; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Guo DG, 2009, BIOCHEMISTRY-US, V48, P4417, DOI 10.1021/bi900441v; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Inglis PN., 2007, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.126.2, 10.1895/wormbook.1.126.2]; Kahle KT, 2015, TRENDS MOL MED, V21, P513, DOI 10.1016/j.molmed.2015.05.008; Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; KOLLER KJ, 1992, CIRCULATION, V86, P1081, DOI 10.1161/01.CIR.86.4.1081; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Mello C, 1995, METHOD CELL BIOL, V48, P451; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murmu RP, 2015, J NEUROSCI, V35, P287, DOI 10.1523/JNEUROSCI.0244-14.2015; Ogawa H, 2010, PROTEIN SCI, V19, P544, DOI 10.1002/pro.332; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Perrault I, 2000, EUR J HUM GENET, V8, P578, DOI 10.1038/sj.ejhg.5200503; Potter LR, 2011, PHARMACOL THERAPEUT, V130, P71, DOI 10.1016/j.pharmthera.2010.12.005; Procko C, 2011, DEVELOPMENT, V138, P1371, DOI 10.1242/dev.058305; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Satoh AK, 1997, J CELL SCI, V110, P2943; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Shaham S, 2010, NAT REV NEUROSCI, V11, P212, DOI 10.1038/nrn2740; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; Smith BA, 2013, ELIFE, V2, DOI 10.7554/eLife.01008; Smith HK, 2013, GENETICS, V194, P885, DOI 10.1534/genetics.113.152660; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tan PL, 2007, P NATL ACAD SCI USA, V104, P17524, DOI 10.1073/pnas.0706618104; Tanis JE, 2009, J NEUROSCI, V29, P9943, DOI 10.1523/JNEUROSCI.1989-09.2009; THOMPSON DK, 1995, J BIOL CHEM, V270, P425, DOI 10.1074/jbc.270.1.425; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tora AS, 2015, FASEB J, V29, P4174, DOI 10.1096/fj.14-269746; Wang D, 2013, J GEN PHYSIOL, V142, P437, DOI 10.1085/jgp.201310959; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Wasserman SM, 2011, CURR BIOL, V21, P353, DOI 10.1016/j.cub.2011.01.053; Wedel BJ, 1997, P NATL ACAD SCI USA, V94, P459, DOI 10.1073/pnas.94.2.459; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	56	48	57	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					936	948		10.1016/j.cell.2016.03.026	http://dx.doi.org/10.1016/j.cell.2016.03.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27062922	Green Accepted, Bronze			2022-12-28	WOS:000375800300020
J	Yeh, RW; Secemsky, EA; Kereiakes, DJ; Normand, SLT; Gershlick, AH; Cohen, DJ; Spertus, JA; Steg, PG; Cutlip, DE; Rinaldi, MJ; Camenzind, E; Wijns, W; Apruzzese, PK; Song, Y; Massaro, JM; Mauri, L				Yeh, Robert W.; Secemsky, Eric A.; Kereiakes, Dean J.; Normand, Sharon-Lise T.; Gershlick, Anthony H.; Cohen, David J.; Spertus, John A.; Steg, Philippe Gabriel; Cutlip, Donald E.; Rinaldi, Michael J.; Camenzind, Edoardo; Wijns, William; Apruzzese, Patricia K.; Song, Yang; Massaro, Joseph M.; Mauri, Laura		DAPT Study Investigators	Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG-ELUTING STENT; BARE-METAL; MYOCARDIAL-INFARCTION; RISK SCORE; IMPLANTATION; THROMBOSIS; DURATION; MULTICENTER; EVENTS; ANTICOAGULATION	IMPORTANCE Dual antiplatelet therapy after percutaneous coronary intervention (PCI) reduces ischemia but increases bleeding. OBJECTIVE To develop a clinical decision tool to identify patients expected to derive benefit vs harm from continuing thienopyridine beyond 1 year after PCI. DESIGN, SETTING, AND PARTICIPANTS Among 11 648 randomized DAPT Study patients from 11 countries (August 2009-May 2014), a prediction rule was derived stratifying patients into groups to distinguish ischemic and bleeding risk 12 to 30 months after PCI. Validation was internal via bootstrap resampling and external among 8136 patients from 36 countries randomized in the PROTECT trial (June 2007-July 2014). EXPOSURES Twelve months of open-label thienopyridine plus aspirin, then randomized to 18 months of continued thienopyridine plus aspirin vs placebo plus aspirin. MAIN OUTCOMES AND MEASURES Ischemia (myocardial infarction or stent thrombosis) and bleeding (moderate or severe) 12 to 30 months after PCI. RESULTS Among DAPT Study patients (derivation cohort; mean age, 61.3 years; women, 25.1%), ischemia occurred in 348 patients (3.0%) and bleeding in 215 (1.8%). Derivation cohort models predicting ischemia and bleeding had c statistics of 0.70 and 0.68, respectively. The prediction rule assigned 1 point each for myocardial infarction at presentation, priormyocardial infarction or PCI, diabetes, stent diameter less than 3 mm, smoking, and paclitaxel-eluting stent; 2 points each for history of congestive heart failure/low ejection fraction and vein graft intervention; -1 point for age 65 to younger than 75 years; and -2 points for age 75 years or older. Among the high score group (score >= 2, n = 5917), continued thienopyridine vs placebo was associated with reduced ischemic events (2.7% vs 5.7%; risk difference [RD], -3.0%[95% CI, -4.1% to -2.0%], P<.001) compared with the low score group (score <2, n = 5731; 1.7% vs 2.3%; RD, -0.7%[95% CI, -1.4% to 0.09%], P=.07; interaction P<.001). Conversely, continued thienopyridine was associated with smaller increases in bleeding among the high score group (1.8% vs 1.4%; RD, 0.4%[95% CI, -0.3% to 1.0%], P=.26) compared with the low score group (3.0% vs 1.4%; RD, 1.5%[95% CI, 0.8% to 2.3%], P<.001; interaction P=.02). Among PROTECT patients (validation cohort; mean age, 62 years; women, 23.7%), ischemia occurred in 79 patients (1.0%) and bleeding in 37 (0.5%), with a c statistic of 0.64 for ischemia and 0.64 for bleeding. In this cohort, the high-score patients (n = 2848) had increased ischemic events compared with the low-score patients and no significant difference in bleeding. CONCLUSION AND RELEVANCE Among patients not sustaining major bleeding or ischemic events 1 year after PCI, a prediction rule assessing late ischemic and bleeding risks to inform dual antiplatelet therapy duration showed modest accuracy in derivation and validation cohorts. This rule requires further prospective evaluation to assess potential effects on patient care, as well as validation in other cohorts.	[Yeh, Robert W.] Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, 185 Pilgrim Rd, Boston, MA 02215 USA; [Yeh, Robert W.; Secemsky, Eric A.; Normand, Sharon-Lise T.; Cutlip, Donald E.; Mauri, Laura] Harvard Univ, Sch Med, Boston, MA USA; [Yeh, Robert W.; Secemsky, Eric A.; Cutlip, Donald E.; Apruzzese, Patricia K.; Song, Yang; Massaro, Joseph M.; Mauri, Laura] Harvard Clin Res Inst, Boston, MA USA; [Secemsky, Eric A.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Kereiakes, Dean J.] Christ Hosp, Heart & Vasc Ctr, Cincinnati, OH 45219 USA; [Kereiakes, Dean J.] Lindner Ctr Res & Educ, Cincinnati, OH USA; [Normand, Sharon-Lise T.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Gershlick, Anthony H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Gershlick, Anthony H.] Univ Hosp Leicester NHS Trust, Glenfield Hosp, Natl Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Cohen, David J.; Spertus, John A.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Cohen, David J.; Spertus, John A.] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA; [Spertus, John A.] Washington Univ, Sch Med, St Louis, MO USA; [Steg, Philippe Gabriel] Univ Paris Diderot, Hop Bichat, INSERM, U1148, Paris, France; [Steg, Philippe Gabriel] Dept Hosp Univ Fibrosis Inflammat & Remodeling, AP HP, Paris, France; [Steg, Philippe Gabriel] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Inst Cardiovasc Med & Sci, Natl Heart & Lung Inst, London, England; [Cutlip, Donald E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Rinaldi, Michael J.] Carolinas HealthCare Syst, Sanger Heart & Vasc Inst, Charlotte, NC USA; [Camenzind, Edoardo] Univ Hosp Nancy Brabois, Inst Loraine Coeur & Vaisseaux, Vandoeuvre Les Nancy, France; [Wijns, William] Onze Lieve Vrouwziekenhuis Hosp, Ctr Cardiovasc, Aalst, Belgium; [Massaro, Joseph M.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Mauri, Laura] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Christ Hospital - Ohio; Harvard University; Harvard T.H. Chan School of Public Health; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Imperial College London; Royal Brompton Hospital; Harvard University; Beth Israel Deaconess Medical Center; Carolinas HealthCare System; CHU de Nancy; Cardiovascular Center Aalst; Boston University; Harvard University; Brigham & Women's Hospital	Yeh, RW (corresponding author), Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, 185 Pilgrim Rd, Boston, MA 02215 USA.; Mauri, L (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	ryeh@bidmc.harvard.edu; lmauril@partners.org	Spertus, John/ABD-3075-2021; mauri, laura/GPS-4868-2022; Yeh, Robert/AAJ-3463-2020; Song, Yang/HGU-4953-2022; STEG, Philippe Gabriel/Z-1567-2019	TEIGER, emmanuel/0000-0001-7515-4344; Wijns, William/0000-0002-7267-4376; STEG, Philippe Gabriel/0000-0001-6896-2941; Mansouri, Vahid/0000-0001-8472-9058; Normand, Sharon-Lise/0000-0001-7027-4769	Harvard Clinical Research Institute; National Heart, Lung, and Blood Institute [K23 HL 118138]; US Department of Health and Human Services [1RO1FD003870-01]; Abbott Vascular; Boston Scientific; Cordis; Medtronic; Bristol-Myers Squibb; Sanofi; Eli Lilly; Daiichi Sankyo; FOOD AND DRUG ADMINISTRATION [R01FD003870] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL118138] Funding Source: NIH RePORTER	Harvard Clinical Research Institute; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Health and Human Services; Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Cordis; Medtronic(Medtronic); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi; Eli Lilly(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This article was sponsored by Harvard Clinical Research Institute, grant K23 HL 118138 from the National Heart, Lung, and Blood Institute (Dr Yeh); grant 1RO1FD003870-01 from the US Department of Health and Human Services. The 8 stent and pharmaceutical manufacturers who contributed to the funding of the DAPT study included Abbott Vascular (Xience everolimus-eluting stent), Boston Scientific (TAXUS paclitaxel-eluting and PROMUS everolimus-eluting stents), Cordis (Cypher sirolimus-eluting stent), Medtronic (Endeavor zotarolimus-eluting stent), Bristol-Myers Squibb, Sanofi, Eli Lilly, and Daiichi Sankyo.	Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1; Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dangas GD, 2012, JACC-CARDIOVASC INTE, V5, P1097, DOI 10.1016/j.jcin.2012.07.012; Dangas GD, 2011, CIRCULATION, V123, P1745, DOI 10.1161/CIRCULATIONAHA.110.981688; Demler OV, 2015, STAT MED, V34, P1659, DOI 10.1002/sim.6428; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Joyner CD, 2009, AM HEART J, V157, P502, DOI 10.1016/j.ahj.2008.10.028; Kereiakes DJ, 2015, JAMA-J AM MED ASSOC, V313, P1113, DOI 10.1001/jama.2015.1671; Matteau A, 2015, AM J CARDIOL, V116, P686, DOI 10.1016/j.amjcard.2015.05.036; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Nam BH, 2002, STAT IND TECHNOL, P267; Oudot A, 2006, HEART, V92, P1077, DOI 10.1136/hrt.2005.074070; Palmerini T, 2015, LANCET, V385, P2371, DOI 10.1016/S0140-6736(15)60263-X; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Rao SV, 2013, JACC-CARDIOVASC INTE, V6, P897, DOI 10.1016/j.jcin.2013.04.016; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Udell JA, 2016, EUR HEART J, V37, P390, DOI 10.1093/eurheartj/ehv443; US Food and Drug Administration, FDA DRUG SAF COMM FD; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Wang TY, 2008, AM HEART J, V155, P361, DOI 10.1016/j.ahj.2007.09.003; Yeh RW, 2015, J AM COLL CARDIOL, V65, P2211, DOI 10.1016/j.jacc.2015.03.003	32	591	612	2	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1735	1749		10.1001/jama.2016.3775	http://dx.doi.org/10.1001/jama.2016.3775			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27022822	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000374759300021
J	Romere, C; Duerrschmid, C; Bournat, J; Constable, P; Jain, M; Xia, F; Saha, PK; Del Solar, M; Zhu, BK; York, B; Sarkar, P; Rendon, DA; Gaber, MW; LeMaire, SA; Coselli, JS; Milewicz, DM; Sutton, VR; Butte, NF; Moore, DD; Chopra, AR				Romere, Chase; Duerrschmid, Clemens; Bournat, Juan; Constable, Petra; Jain, Mahim; Xia, Fan; Saha, Pradip K.; Del Solar, Maria; Zhu, Bokai; York, Brian; Sarkar, Poonam; Rendon, David A.; Gaber, M. Waleed; LeMaire, Scott A.; Coselli, Joseph S.; Milewicz, Dianna M.; Sutton, V. Reid; Butte, Nancy F.; Moore, David D.; Chopra, Atul R.			Asprosin, a Fasting-Induced Glucogenic Protein Hormone	CELL			English	Article							CONGENITAL LIPODYSTROPHY; MARFAN-SYNDROME; 3' END; MUTATION; FEATURES; MICE; SECRETION	Hepatic glucose release into the circulation is vital for brain function and survival during periods of fasting and is modulated by an array of hormones that precisely regulate plasma glucose levels. We have identified a fasting-induced protein hormone that modulates hepatic glucose release. It is the C-terminal cleavage product of profibrillin, and we name it Asprosin. Asprosin is secreted by white adipose, circulates at nanomolar levels, and is recruited to the liver, where it activates the G protein-cAMP-PKA pathway, resulting in rapid glucose release into the circulation. Humans and mice with insulin resistance show pathologically elevated plasma asprosin, and its loss of function via immunologic or genetic means has a profound glucose- and insulin-lowering effect secondary to reduced hepatic glucose release. Asprosin represents a glucogenic protein hormone, and therapeutically targeting it may be beneficial in type II diabetes and metabolic syndrome.	[Romere, Chase; Duerrschmid, Clemens; Bournat, Juan; Constable, Petra; Saha, Pradip K.; Zhu, Bokai; York, Brian; Moore, David D.; Chopra, Atul R.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Jain, Mahim; Xia, Fan; Sutton, V. Reid; Chopra, Atul R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sarkar, Poonam; Rendon, David A.; Gaber, M. Waleed] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [LeMaire, Scott A.; Coselli, Joseph S.] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Cardiothorac Surg, Houston, TX 77030 USA; [Milewicz, Dianna M.] Univ Texas Med Sch Houston, Dept Internal Med, Houston, TX 77030 USA; [Del Solar, Maria] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Icahn School of Medicine at Mount Sinai	Chopra, AR (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Chopra, AR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	chopra@bcm.edu	Zhu, Bokai/AAF-7502-2020; Duerrschmid, Clemens/D-9933-2013	Zhu, Bokai/0000-0003-0827-5757; Duerrschmid, Clemens/0000-0001-7718-5152; gaber, Mostafa/0000-0002-6192-0367; Chopra, Atul/0000-0002-1304-3777; LeMaire, Scott/0000-0002-8736-4266	Baylor-Johns Hopkins Center for Mendelian Genomics [U54HG006542]; NHGRI [U54HG006542]; Mouse Metabolic Core at BCM; NIH [P30 DK079638, P50 HL083794, DK059637, DK020593]; Thoracic Aortic Disease Tissue Bank at BCM; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; NIDDK [1K08DK102529]; Chao Physician-Scientist Award; Caroline Weiss Law scholar award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083794] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, K08DK102529, P30DK079638, P60DK020593, P30DK020593] Funding Source: NIH RePORTER	Baylor-Johns Hopkins Center for Mendelian Genomics; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Mouse Metabolic Core at BCM; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thoracic Aortic Disease Tissue Bank at BCM; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chao Physician-Scientist Award; Caroline Weiss Law scholar award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the Baylor-Johns Hopkins Center for Mendelian Genomics, funded by the NHGRI (U54HG006542), supported by the Mouse Metabolic Core at BCM, funded by the NIH (P30 DK079638), supported by the Thoracic Aortic Disease Tissue Bank at BCM, and funded by the NIH (P50 HL083794). The Vanderbilt University Hormone Assay Core is supported by NIH grants (DK059637 and DK020593). The Genotype-Tissue Expression (GTEx) Project is supported by the Common Fund of the Office of the Director of the NIH (additional funds were provided by the NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS). Wethank Texas Children's Hospital for the use of the Small Animal Imaging facility. The laboratory of Francesco Ramirez at the Mt. Sinai School of Medicine originally generated MgR (Fbn1 hypomorphic) mice. Fbn1-null and WT mouse embryonic fibroblasts were a kind gift from Dan Rifkin. Plasma from Bscl2-null and WT mice was a kind gift from Xavier Prieur and Weiqin Chen. A.R.C. is supported by the NIDDK (1K08DK102529), the Chao Physician-Scientist Award, the Caroline Weiss Law scholar award, and a departmental laboratory start-up package.	Aronoff S.L, 2004, DIABETES SPECTR, V17, P183, DOI [DOI 10.2337/DIASPECT.17.3.183, 10.2337/diaspect.17.3.183]; BEHRENS OK, 1958, ANNU REV BIOCHEM, V27, P57, DOI 10.1146/annurev.bi.27.070158.000421; Bindlish S, 2015, POSTGRAD MED, V127, P511, DOI 10.1080/00325481.2015.1015927; Campbell JE, 2015, NAT REV ENDOCRINOL, V11, P329, DOI 10.1038/nrendo.2015.51; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; DUMOULIN G, 1995, AM J NEPHROL, V15, P238, DOI 10.1159/000168838; Goldblatt J, 2011, AM J MED GENET A, V155A, P717, DOI 10.1002/ajmg.a.33906; Graul-Neumann LM, 2010, AM J MED GENET A, V152A, P2749, DOI 10.1002/ajmg.a.33690; Horn D, 2011, AM J MED GENET A, V155A, P721, DOI 10.1002/ajmg.a.33905; Jacquinet A, 2014, EUR J MED GENET, V57, P230, DOI 10.1016/j.ejmg.2014.02.012; Lonnqvist L, 1998, HUM MOL GENET, V7, P2039, DOI 10.1093/hmg/7.13.2039; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; MILEWICZ DM, 1995, J CLIN INVEST, V95, P2373, DOI 10.1172/JCI117930; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; O'Neill B, 2007, AM J MED GENET A, V143A, P1421, DOI 10.1002/ajmg.a.31840; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Takenouchi T, 2013, AM J MED GENET A, V161, P3057, DOI 10.1002/ajmg.a.36157; Trayhurn P, 2006, J NUTR, V136, p1935S, DOI 10.1093/jn/136.7.1935S	19	209	235	4	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					566	579		10.1016/j.cell.2016.02.063	http://dx.doi.org/10.1016/j.cell.2016.02.063			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27087445	Green Accepted, Bronze			2022-12-28	WOS:000374636800016
J	Thomas, J; Ma, CP; McConnell, NJ; Greene, JE; Blakeslee, JP; Janish, R				Thomas, Jens; Ma, Chung-Pei; McConnell, Nicholas J.; Greene, Jenny E.; Blakeslee, John P.; Janish, Ryan			A 17-billion-solar-mass black hole in a group galaxy with a diffuse core	NATURE			English	Article							INITIAL MASS FUNCTION; TO-LIGHT RATIO; SIGHT VELOCITY DISTRIBUTIONS; ELLIPTIC GALAXIES; FUNDAMENTAL PLANE; SPACE-TELESCOPE; SURVEY. I.; DARK HALO; CLUSTER; CENTERS	Quasars are associated with and powered by the accretion of material onto massive black holes; the detection of highly luminous quasars with redshifts greater than z = 6 suggests that black holes of up to ten billion solar masses already existed 13 billion years ago(1). Two possible present-day 'dormant' descendants of this population of 'active' black holes have been found(2) in the galaxies NGC 3842 and NGC 4889 at the centres of the Leo and Coma galaxy clusters, which together form the central region of the Great Wall(3)-the largest local structure of galaxies. The most luminous quasars, however, are not confined to such high-density regions of the early Universe(4,5); yet dormant black holes of this high mass have not yet been found outside of modern-day rich clusters. Here we report observations of the stellar velocity distribution in the galaxy NGC 1600-a relatively isolated elliptical galaxy near the centre of a galaxy group at a distance of 64 megaparsecs from Earth. We use orbit superposition models to determine that the black hole at the centre of NGC 1600 has a mass of 17 billion solar masses. The spatial distribution of stars near the centre of NGC 1600 is rather diffuse. We find that the region of depleted stellar density in the cores of massive elliptical galaxies extends over the same radius as the gravitational sphere of influence of the central black holes, and interpret this as the dynamical imprint of the black holes.	[Thomas, Jens] Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85741 Garching, Germany; [Thomas, Jens] Univ Sternwarte Munchen, Scheinerstr 1, D-81679 Munich, Germany; [Ma, Chung-Pei] Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA; [McConnell, Nicholas J.; Blakeslee, John P.] NRC Herzberg Inst Astrophys, Domin Astrophys Observ, Victoria, BC V9E 2E7, Canada; [Greene, Jenny E.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Janish, Ryan] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Max Planck Society; University of Munich; University of California System; University of California Berkeley; National Research Council Canada; Princeton University; University of California System; University of California Berkeley	Thomas, J (corresponding author), Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85741 Garching, Germany.; Thomas, J (corresponding author), Univ Sternwarte Munchen, Scheinerstr 1, D-81679 Munich, Germany.; Ma, CP (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	jthomas@mpe.mpg.de; cpma@berkeley.edu		McConnell, Nicholas/0000-0001-5344-2062	National Science Foundation (NSF); Miller Institute for Basic Research in Science, University of California, Berkeley; Beatrice Watson Parrent Fellowship; Plaskett Fellowship	National Science Foundation (NSF)(National Science Foundation (NSF)); Miller Institute for Basic Research in Science, University of California, Berkeley(University of California System); Beatrice Watson Parrent Fellowship; Plaskett Fellowship	C.-P.M., J.E.G. and R.J. are supported by the National Science Foundation (NSF). J.E.G. is supported by the Miller Institute for Basic Research in Science, University of California, Berkeley. N.J.M. is supported by the Beatrice Watson Parrent Fellowship and Plaskett Fellowship. The spectroscopic data presented here were obtained from the Gemini Observatory and the McDonald Observatory. Gemini is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the NSF on behalf of the Gemini partnership. The McDonald Observatory is operated by the University of Texas at Austin. The photometric data presented here are based partly on observations made with the NASA/ESA Hubble Space Telescope, and obtained from the Hubble Legacy Archive, which is a collaboration between the Space Telescope Science Institute (STScI/NASA), the Space Telescope European Coordinating Facility (ST-ECF/ESA) and the Canadian Astronomy Data Centre (CADC/NRC/CSA).	Barth AJ, 2002, ASTRON J, V124, P2607, DOI 10.1086/343840; BEGELMAN MC, 1980, NATURE, V287, P307, DOI 10.1038/287307a0; BENDER R, 1987, ASTRON ASTROPHYS, V177, P71; BENDER R, 1994, MON NOT R ASTRON SOC, V269, P785, DOI 10.1093/mnras/269.3.785; Boylan-Kolchin M, 2006, MON NOT R ASTRON SOC, V369, P1081, DOI 10.1111/j.1365-2966.2006.10379.x; Cappellari M, 2004, PUBL ASTRON SOC PAC, V116, P138, DOI 10.1086/381875; Cappellari M, 2003, MON NOT R ASTRON SOC, V342, P345, DOI 10.1046/j.1365-8711.2003.06541.x; Cappellari M, 2013, MON NOT R ASTRON SOC, V432, P1862, DOI 10.1093/mnras/stt644; Carollo CM, 1997, ASTROPHYS J, V481, P710, DOI 10.1086/304060; Conroy C, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/71; Crook AC, 2007, ASTROPHYS J, V655, P790, DOI 10.1086/510201; Doeleman SS, 2012, SCIENCE, V338, P355, DOI 10.1126/science.1224768; Dullo BT, 2014, MON NOT R ASTRON SOC, V444, P2700, DOI 10.1093/mnras/stu1590; Faber SM, 1997, ASTRON J, V114, P1771, DOI 10.1086/118606; Fanidakis N, 2013, MON NOT R ASTRON SOC, V436, P315, DOI 10.1093/mnras/stt1567; Gebhardt K, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/119; Gebhardt K, 2009, ASTROPHYS J, V700, P1690, DOI 10.1088/0004-637X/700/2/1690; GELLER MJ, 1989, SCIENCE, V246, P897, DOI 10.1126/science.246.4932.897; GERHARD OE, 1993, MON NOT R ASTRON SOC, V265, P213, DOI 10.1093/mnras/265.1.213; Graham AW, 2003, ASTRON J, V125, P2951, DOI 10.1086/375320; Hill GJ, 2008, PROC SPIE, V7014, DOI 10.1117/12.788225; Ikebe Y, 2002, ASTRON ASTROPHYS, V383, P773, DOI 10.1051/0004-6361:20011769; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Kormendy J, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/1/L5; Kormendy J, 2009, ASTROPHYS J LETT, V691, pL142, DOI 10.1088/0004-637X/691/2/L142; Kubo JM, 2007, ASTROPHYS J, V671, P1466, DOI 10.1086/523101; La Barbera F, 2013, MON NOT R ASTRON SOC, V433, P3017, DOI 10.1093/mnras/stt943; Lauer TR, 2007, ASTROPHYS J, V664, P226, DOI 10.1086/519229; Lauer TR, 1995, ASTRON J, V110, P2622, DOI 10.1086/117719; Ma CP, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/158; Magorrian J, 1999, MON NOT R ASTRON SOC, V302, P530, DOI 10.1046/j.1365-8711.1999.02135.x; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Martin-Navarro I, 2015, MON NOT R ASTRON SOC, V447, P1033, DOI 10.1093/mnras/stu2480; Matthias M, 1999, MON NOT R ASTRON SOC, V310, P879, DOI 10.1046/j.1365-8711.1999.03022.x; McConnell NJ, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/184; McConnell NJ, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/179; McConnell NJ, 2011, NATURE, V480, P215, DOI 10.1038/nature10636; McConnell NJ, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/100; Merritt D, 2006, ASTROPHYS J, V648, P976, DOI 10.1086/506139; Milosavljevic M, 2001, ASTROPHYS J, V563, P34, DOI 10.1086/323830; PELETIER RF, 1990, ASTRON J, V100, P1091, DOI 10.1086/115582; Pu SB, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/201014395; Quinlan GD, 1997, NEW ASTRON, V2, P533, DOI 10.1016/S1384-1076(97)00039-0; RICHSTONE DO, 1988, ASTROPHYS J, V327, P82, DOI 10.1086/166171; Rines K, 2003, ASTRON J, V126, P2152, DOI 10.1086/378599; Saglia RP, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/1/47; Sanchez-Blazquez P, 2006, MON NOT R ASTRON SOC, V371, P703, DOI 10.1111/j.1365-2966.2006.10699.x; SCHWARZSCHILD M, 1979, ASTROPHYS J, V232, P236, DOI 10.1086/157282; Sivakoff GR, 2004, ASTROPHYS J, V617, P262, DOI 10.1086/425244; Smith RM, 2008, ASTROPHYS J, V679, P420, DOI 10.1086/587454; Smith RJ, 2015, MON NOT R ASTRON SOC, V449, P3441, DOI 10.1093/mnras/stv518; Thomas J, 2005, MON NOT R ASTRON SOC, V360, P1355, DOI 10.1111/j.1365-2966.2005.09139.x; Thomas J, 2004, MON NOT R ASTRON SOC, V353, P391, DOI 10.1111/j.1365-2966.2004.08072.x; Thomas J, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/39; Thomas J, 2011, MON NOT R ASTRON SOC, V415, P545, DOI 10.1111/j.1365-2966.2011.18725.x; Trainor RF, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/39; Treu T, 2010, ASTROPHYS J, V709, P1195, DOI 10.1088/0004-637X/709/2/1195; Trujillo I, 2004, ASTRON J, V127, P1917, DOI 10.1086/382712; VANDERMAREL RP, 1993, ASTROPHYS J, V407, P525, DOI 10.1086/172534; VANDERMAREL RP, 1991, MON NOT R ASTRON SOC, V253, P710, DOI 10.1093/mnras/253.4.710; Walsh JL, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/86; Wu XB, 2015, NATURE, V518, P512, DOI 10.1038/nature14241	64	88	88	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					340	+		10.1038/nature17197	http://dx.doi.org/10.1038/nature17197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27049949	Green Submitted			2022-12-28	WOS:000374424700027
J	Wu, TP; Wang, T; Seetin, MG; Lai, YQ; Zhu, SJ; Lin, KX; Liu, YF; Byrum, SD; Mackintosh, SG; Zhong, M; Tackett, A; Wang, GL; Hon, LS; Fang, G; Swenberg, JA; Xiao, AZ				Wu, Tao P.; Wang, Tao; Seetin, Matthew G.; Lai, Yongquan; Zhu, Shijia; Lin, Kaixuan; Liu, Yifei; Byrum, Stephanie D.; Mackintosh, Samuel G.; Zhong, Mei; Tackett, Alan; Wang, Guilin; Hon, Lawrence S.; Fang, Gang; Swenberg, James A.; Xiao, Andrew Z.			DNA methylation on N-6-adenine in mammalian embryonic stem cellse	NATURE			English	Article							X-CHROMOSOME INACTIVATION; CHIP-SEQ DATA; SINGLE-MOLECULE; REPEAT HYPOTHESIS; HISTONE VARIANTS; RNA-SEQ; ADENINE; LINE-1; MOUSE; DIFFERENTIATION	It has been widely accepted that 5-methylcytosine is the only form of DNA methylation in mammalian genomes. Here we identify N-6-methyladenine as another form of DNA modification in mouse embryonic stem cells. Alkbh1 encodes a demethylase for N-6-methyladenine. An increase of N-6-methyladenine levels in Alkbh1-deficient cells leads to transcriptional silencing. N-6-methyladenine deposition is inversely correlated with the evolutionary age of LINE-1 transposons; its deposition is strongly enriched at young (<1.5 million years old) but not old (>6 million years old) L1 elements. The deposition of N-6-methyladenine correlates with epigenetic silencing of such LINE-1 transposons, together with their neighbouring enhancers and genes, thereby resisting the gene activation signals during embryonic stem cell differentiation. As young full-length LINE-1 transposons are strongly enriched on the X chromosome, genes located on the X chromosome are also silenced. Thus, N-6-methyladenine developed a new role in epigenetic silencing in mammalian evolution distinct from its role in gene activation in other organisms. Our results demonstrate that N-6-methyladenine constitutes a crucial component of the epigenetic regulation repertoire in mammalian genomes.	[Wu, Tao P.; Wang, Tao; Lin, Kaixuan; Liu, Yifei; Xiao, Andrew Z.] Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA; [Wu, Tao P.; Wang, Tao; Lin, Kaixuan; Liu, Yifei; Zhong, Mei; Xiao, Andrew Z.] Yale Univ, Sch Med, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06520 USA; [Seetin, Matthew G.; Hon, Lawrence S.] Pacific Biosci, 1380 Willow Rd, Menlo Pk, CA 94025 USA; [Lai, Yongquan; Swenberg, James A.] Univ N Carolina, Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Zhu, Shijia; Fang, Gang] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Zhu, Shijia; Fang, Gang] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Byrum, Stephanie D.; Mackintosh, Samuel G.; Tackett, Alan] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Zhong, Mei] Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA; [Wang, Guilin] Yale Univ, Sch Med, Yale Ctr Genome Anal, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Arkansas System; University of Arkansas Medical Sciences; Yale University; Yale University	Xiao, AZ (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.; Xiao, AZ (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06520 USA.	Andrew.Xiao@Yale.edu	Wu, Tao/AAH-4501-2021; Liu, Yifei/H-1730-2014; Zhu, Shijia/K-7404-2019; Wu, Tao/A-1063-2013	Wu, Tao/0000-0002-9859-4534	CT Stem Cell Foundation [11SCA34]; National Institutes of Environmental Health Sciences (NIEHS) Superfund Basic Research Program [P42 ES005948]; NIEHS Center for Environmental Health and Susceptibility [P30 ES010126];  [R01GM114205-01];  [R01 GM114472-01]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114472, R01GM114205, P20GM103429, R01GM106024] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018445] Funding Source: NIH RePORTER	CT Stem Cell Foundation; National Institutes of Environmental Health Sciences (NIEHS) Superfund Basic Research Program; NIEHS Center for Environmental Health and Susceptibility; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Z. Li, K. Hwang and A. Leung for critical reading of the manuscript and the members of the Xiao laboratory for critical discussion. Thanks to L. Geng for helping Hiseq2000 sequencing. This work is funded by R01GM114205-01 (A.X.). T.P.W. is partially supported by CT Stem Cell Foundation (11SCA34). The Fang lab is partially supported by R01 GM114472-01 (G.F.). Mass spectrometry was supported by R01GM106024, S10OD018445 and P20GM103429. The UNC Mass Spectrometry Facility Core was supported by the National Institutes of Environmental Health Sciences (NIEHS) Superfund Basic Research Program (P42 ES005948), and NIEHS Center for Environmental Health and Susceptibility (P30 ES010126).	Abrusan G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000172; ACHWAL CW, 1983, FEBS LETT, V158, P353, DOI 10.1016/0014-5793(83)80612-7; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Byrum SD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt822; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Davis BM, 2013, CURR OPIN MICROBIOL, V16, P192, DOI 10.1016/j.mib.2013.01.011; Delatte B, 2016, SCIENCE, V351, P282, DOI 10.1126/science.aac5253; Erickson IK, 2011, J VIROL, V85, P12315, DOI 10.1128/JVI.05180-11; Fadloun A, 2013, NAT STRUCT MOL BIOL, V20, P332, DOI 10.1038/nsmb.2495; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fu Y, 2015, CELL, V161, P879, DOI 10.1016/j.cell.2015.04.010; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Heyn H, 2015, CELL, V161, P710, DOI 10.1016/j.cell.2015.04.021; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Koziol MJ, 2016, NAT STRUCT MOL BIOL, V23, P24, DOI 10.1038/nsmb.3145; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu C, 2011, INT J DEV BIOL, V55, P909, DOI 10.1387/ijdb.113342cl; Lu K, 2010, TOXICOL SCI, V116, P441, DOI 10.1093/toxsci/kfq061; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Muller TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067403; Nordstrand LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013827; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Ratel D, 2006, FEBS LETT, V580, P3179, DOI 10.1016/j.febslet.2006.04.074; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Shen L, 2014, ANNU REV BIOCHEM, V83, P585, DOI 10.1146/annurev-biochem-060713-035513; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Tomomori-Sato Chieri, 2013, Methods Mol Biol, V977, P273, DOI 10.1007/978-1-62703-284-1_22; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wu T, 2014, CELL STEM CELL, V15, P281, DOI 10.1016/j.stem.2014.06.004; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018	41	372	392	1	149	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					329	+		10.1038/nature17640	http://dx.doi.org/10.1038/nature17640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27027282	Green Submitted, Green Accepted			2022-12-28	WOS:000374424700025
J	Almario, CV				Almario, Christopher V.			Split-dose preparation for colonoscopy increased adenoma detection rates	ANNALS OF INTERNAL MEDICINE			English	Editorial Material														Almario, Christopher/0000-0003-0664-9479				Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Martel M, 2015, GASTROENTEROLOGY, V149, P79, DOI 10.1053/j.gastro.2015.04.004	2	1	1	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					JC40	JC40		10.7326/ACPJC-2016-164-8-040	http://dx.doi.org/10.7326/ACPJC-2016-164-8-040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	27089088				2022-12-28	WOS:000374257900002
J	O'Donoghue, ML; Glaser, R; Cavender, MA; Aylward, PE; Bonaca, MP; Budaj, A; Davies, RY; Dellborg, M; Fox, KAA; Gutierrez, JAT; Hamm, C; Kiss, RG; Kovar, F; Kuder, JF; Im, KA; Lepore, JJ; Lopez-Sendon, JL; Ophuis, TO; Parkhomenko, A; Shannon, JB; Spinar, J; Tanguay, JF; Ruda, M; Steg, PG; Theroux, P; Wiviott, SD; Laws, I; Sabatine, MS; Morrow, DA				O'Donoghue, Michelle L.; Glaser, Ruchira; Cavender, Matthew A.; Aylward, Philip E.; Bonaca, Marc P.; Budaj, Andrzej; Davies, Richard Y.; Dellborg, Mikael; Fox, Keith A. A.; Gutierrez, Jorge Antonio T.; Hamm, Christian; Kiss, Robert G.; Kovar, Frantisek; Kuder, Julia F.; Im, Kyung Ah; Lepore, John J.; Lopez-Sendon, Jose L.; Ophuis, Ton Oude; Parkhomenko, Alexandr; Shannon, Jennifer B.; Spinar, Jindrich; Tanguay, Jean-Francois; Ruda, Mikhail; Steg, P. Gabriel; Theroux, Pierre; Wiviott, Stephen D.; Laws, Ian; Sabatine, Marc S.; Morrow, David A.		LATITUDE-TIMI 60 Investigators	Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVATED PROTEIN-KINASE; ACUTE CORONARY SYNDROME; HEART-FAILURE; INHIBITION; APOPTOSIS; PATHWAY; EVENTS; MAPK	IMPORTANCE p38 Mitogen-activated protein kinase (MAPK)-stimulated inflammation is implicated in atherogenesis, plaque destabilization, and maladaptive processes inmyocardial infarction (MI). Pilot data in a phase 2 trial in non-ST elevation MI indicated that the p38 MAPK inhibitor losmapimod attenuates inflammation and may improve outcomes. OBJECTIVE To evaluate the efficacy and safety of losmapimod on cardiovascular outcomes in patients hospitalized with an acutemyocardial infarction. DESIGN, SETTING, AND PATIENTS LATITUDE-TIMI 60, a randomized, placebo-controlled, double-blind, parallel-group trial conducted at 322 sites in 34 countries from June 3, 2014, until December 8, 2015. Part A consisted of a leading cohort (n = 3503) to provide an initial assessment of safety and exploratory efficacy before considering progression to part B (approximately 22 000 patients). Patients were considered potentially eligible for enrollment if they had been hospitalized with an acute MI and had at least 1 additional predictor of cardiovascular risk. INTERVENTIONS Patients were randomized to either twice-daily losmapimod (7.5mg; n = 1738) or matching placebo (n = 1765) on a background of guideline-recommended therapy. Patients were treated for 12 weeks and followed up for an additional 12 weeks. MAIN OUTCOMES AND MEASURES The primary end pointwas the composite of cardiovascular death, MI, or severe recurrent ischemia requiring urgent coronary revascularization with the principal analysis specified at week 12. RESULTS In part A, among the 3503 patients randomized (median age, 66 years; 1036 [ 29.6%] were women), 99.1% had complete ascertainment for the primary outcome. The primary end point occurred by 12 weeks in 123 patients treated with placebo (7.0%) and 139 patients treated with losmapimod (8.1%; hazard ratio, 1.16; 95% CI, 0.91-1.47; P =.24). The on-treatment rates of serious adverse events were 16.0% with losmapimod and 14.2% with placebo. CONCLUSIONS AND RELEVANCE Among patients with acute MI, use of losmapimod compared with placebo did not reduce the risk of major ischemic cardiovascular events. The results of this exploratory efficacy study did not justify proceeding to a larger efficacy trial in the existing patient population.	[O'Donoghue, Michelle L.; Cavender, Matthew A.; Bonaca, Marc P.; Gutierrez, Jorge Antonio T.; Kuder, Julia F.; Im, Kyung Ah; Wiviott, Stephen D.; Sabatine, Marc S.; Morrow, David A.] Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, 350 Longwood Ave,First Floor, Boston, MA 02115 USA; [Glaser, Ruchira; Davies, Richard Y.; Lepore, John J.; Laws, Ian] GlaxoSmithKline, Res & Dev, Metab Pathways & Cardiovasc Unit, Collegeville, PA USA; [Aylward, Philip E.] Flinders Univ S Australia, Med Ctr, South Australian Hlth & Med Res Inst, Adelaide, SA 5001, Australia; [Budaj, Andrzej] Grochowski Hosp, Postgrad Med Sch, Warsaw, Poland; [Dellborg, Mikael] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Dellborg, Mikael] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Hamm, Christian] Kerckhoff Heart Ctr, Bad Nauheim, Germany; [Hamm, Christian] Univ Giessen, D-35390 Giessen, Germany; [Kiss, Robert G.] Mil Hosp, Dept Cardiol, Budapest, Hungary; [Kovar, Frantisek] Comenius Univ, Jessenius Fac Med Martin, Dept Internal Med 1, Martin, Slovakia; [Lopez-Sendon, Jose L.] Univ Hosp La Paz, Cardiovasc Div, Madrid, Spain; [Ophuis, Ton Oude] Canisius Wilhelmina Hosp, Nijmegen, Netherlands; [Parkhomenko, Alexandr] Ukranian Strazhesko Inst Cardiol, Kiev, Ukraine; [Shannon, Jennifer B.] PAREXEL Int, Durham, NC USA; [Spinar, Jindrich] Univ Hosp, Brno, Czech Republic; [Tanguay, Jean-Francois; Theroux, Pierre] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Tanguay, Jean-Francois; Theroux, Pierre] Univ Montreal, Montreal, PQ, Canada; [Ruda, Mikhail] Cardiol Res Ctr, Moscow 121552, Russia; [Steg, P. Gabriel] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, F-75877 Paris, France; [Steg, P. Gabriel] Univ Paris Diderot, Paris, France	Harvard University; Brigham & Women's Hospital; GlaxoSmithKline; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); Centre of Postgraduate Medical Education - Poland; Sahlgrenska University Hospital; University of Gothenburg; University of Edinburgh; Kerckhoff Clinic; Justus Liebig University Giessen; Comenius University Bratislava; Hospital Universitario La Paz; Canisius-Wilhelmina Hospital; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Parexel International; University Hospital Brno; Universite de Montreal; Universite de Montreal; National Medical Research Center of Cardiology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	O'Donoghue, ML (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, 350 Longwood Ave,First Floor, Boston, MA 02115 USA.	modonoghue@partners.org	Hamm, Christian W./I-3155-2017; Sabatine, Marc/AAJ-6751-2020; Mangner, Norman/AAN-4673-2020; Wiviott, Stephen/HIK-2534-2022; Bonaca, Marc/AAJ-2397-2021; Zirlik, Andreas/A-6400-2011; Kubica, Jacek/D-6906-2014; Apartsin, Konstantin/ABC-5678-2020; Nicolau, Jose C/E-1487-2012; Apartsin, Konstantin/ACA-8088-2022; Malynovsky, Yaroslav/T-1898-2017; STEG, Philippe Gabriel/Z-1567-2019; Apartsin, Konstantin A/B-9179-2017; Fox, keith A A/I-3742-2013	Hamm, Christian W./0000-0001-6763-4161; Sabatine, Marc/0000-0002-0691-3359; Mangner, Norman/0000-0003-0793-7923; Bonaca, Marc/0000-0002-9860-3584; Zirlik, Andreas/0000-0001-6290-3297; Kubica, Jacek/0000-0001-8250-754X; Apartsin, Konstantin/0000-0003-0577-9001; Nicolau, Jose C/0000-0002-9680-3689; Apartsin, Konstantin/0000-0003-0577-9001; Malynovsky, Yaroslav/0000-0002-9118-1104; Apartsin, Konstantin A/0000-0003-0577-9001; Wlodarczak, Adrian/0000-0003-3104-7728; Barrabes, Jose A./0000-0001-7062-6277; Mansouri, Vahid/0000-0001-8472-9058; STEG, Philippe Gabriel/0000-0001-6896-2941; Aylward, Philip/0000-0002-5358-8552; Budaj, Andrzej/0000-0002-6395-2098; Sinnaeve, Peter/0000-0003-4716-5892	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The LATITUDE-TIMI 60 trial was funded by GlaxoSmithKline.	Ding CH, 2006, CURR OPIN INVEST DR, V7, P1020; Kerkela R, 2006, J AM COLL CARDIOL, V48, P556, DOI 10.1016/j.jacc.2006.05.005; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Ma XL, 1999, CIRCULATION, V99, P1685, DOI 10.1161/01.CIR.99.13.1685; Marber MS, 2011, J MOL CELL CARDIOL, V51, P485, DOI 10.1016/j.yjmcc.2010.10.021; Martin ED, 2012, CIRCULATION, V126, P357, DOI 10.1161/CIRCULATIONAHA.111.071886; Newby LK, 2014, LANCET, V384, P1187, DOI 10.1016/S0140-6736(14)60417-7; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; O'Donoghue ML, 2015, AM HEART J, V169, P622, DOI 10.1016/j.ahj.2015.02.012; O'Donoghue ML, 2014, JAMA-J AM MED ASSOC, V312, P1006, DOI 10.1001/jama.2014.11061; Petrich BG, 2004, TRENDS CARDIOVAS MED, V14, P50, DOI 10.1016/j.tcm.2003.11.002; Ren J, 2005, J MOL CELL CARDIOL, V38, P617, DOI 10.1016/j.yjmcc.2005.01.012; Ridker PM, 2014, EUR HEART J, V35, P1782, DOI 10.1093/eurheartj/ehu203; Sarov-Blat L, 2010, ARTERIOSCL THROM VAS, V30, P2256, DOI 10.1161/ATVBAHA.110.209205; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Seeger FH, 2010, BASIC RES CARDIOL, V105, P389, DOI 10.1007/s00395-009-0072-9; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9	17	155	162	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1591	1599		10.1001/jama.2016.3609	http://dx.doi.org/10.1001/jama.2016.3609			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	27043082	Bronze			2022-12-28	WOS:000374289300019
J	[Anonymous]				[Anonymous]			The Harrison Antinarcotic Law (Reprinted from JAMA., vol 64, pg 911-912, 1915)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1915, JAMA, V64, P911	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15								10.1001/jama.2014.11632	http://dx.doi.org/10.1001/jama.2014.11632			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9ZT	27092844				2022-12-28	WOS:000394979300001
J	Perera, D; Poulos, RC; Shah, A; Beck, D; Pimanda, JE; Wong, JWH				Perera, Dilmi; Poulos, Rebecca C.; Shah, Anushi; Beck, Dominik; Pimanda, John E.; Wong, Jason W. H.			Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes	NATURE			English	Article							SOMATIC MUTATIONS; CHROMATIN ORGANIZATION; REGULATORY MUTATIONS; EXCISION-REPAIR; WIDE ANALYSIS; GENE; MELANOMA; DAMAGE; IDENTIFICATION; FOOTPRINTS	Promoters are DNA sequences that have an essential role in controlling gene expression. While recent whole cancer genome analyses have identified numerous hotspots of somatic point mutations within promoters, many have not yet been shown to perturb gene expression or drive cancer development(1-4). As such, positive selection alone may not adequately explain the frequency of promoter point mutations in cancer genomes. Here we show that increased mutation density at gene promoters can be linked to promoter activity and differential nucleotide excision repair (NER). By analysing 1,161 human cancer genomes across 14 cancer types, we find evidence for increased local density of somatic point mutations within the centres of DNase I-hypersensitive sites (DHSs) in gene promoters. Mutated DHSs were strongly associated with transcription initiation activity, in which active promoters but not enhancers of equal DNase I hypersensitivity were most mutated relative to their flanking regions. Notably, analysis of genome-wide maps of NER5 shows that NER is impaired within the DHS centre of active gene promoters, while XPC-deficient skin cancers do not show increased promoter mutation density, pinpointing differential NER as the underlying cause of these mutation hotspots. Consistent with this finding, we observe that melanomas with an ultraviolet-induced DNA damage mutation signature show greatest enrichment of promoter mutations, whereas cancers that are not highly dependent on NER, such as colon cancer, show no sign of such enrichment. Taken together, our analysis has uncovered the presence of a previously unknown mechanism linking transcription initiation and NER as a major contributor of somatic point mutation hotspots at active gene promoters in cancer genomes.	[Perera, Dilmi; Poulos, Rebecca C.; Shah, Anushi; Beck, Dominik; Pimanda, John E.; Wong, Jason W. H.] UNSW Australia, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [Perera, Dilmi; Poulos, Rebecca C.; Shah, Anushi; Beck, Dominik; Pimanda, John E.; Wong, Jason W. H.] UNSW Australia, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Pimanda, John E.] Prince Wales Hosp, Dept Haematol, Sydney, NSW 2031, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Wong, JWH (corresponding author), UNSW Australia, Prince Wales Clin Sch, Sydney, NSW 2052, Australia.; Wong, JWH (corresponding author), UNSW Australia, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia.	jason.wong@unsw.edu.au	; Wong, Jason/A-9466-2008	Poulos, Rebecca/0000-0002-8419-7028; Perera, Dilmi/0000-0002-6437-4744; Wong, Jason/0000-0003-2953-7728	Cancer Institute NSW [13/DATA/1-02]; Cure Cancer Foundation Australia; Cancer Australia, through the Priority-driven Collaborative Cancer Research Scheme [APP1057921]; UNSW Australia; Australian Postgraduate Award; National Health and Medical Research Council [APP1073768]; National Health and Medical Research Council (Australia); Australian Research Council [FT130100096]	Cancer Institute NSW; Cure Cancer Foundation Australia; Cancer Australia, through the Priority-driven Collaborative Cancer Research Scheme; UNSW Australia; Australian Postgraduate Award(Australian Government); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	The authors thank TCGA, ICGC as well as numerous other groups who have made their data available for public analysis. The authors additionally thank members of Intersect Pty Ltd for providing high-performance computing resources and data storage used in this study. This work was funded by Cancer Institute NSW (13/DATA/1-02) and the Cure Cancer Foundation Australia with the assistance of Cancer Australia, through the Priority-driven Collaborative Cancer Research Scheme (APP1057921) to J.W.H.W. D.P. is supported by a UNSW Australia post-graduate scholarship, R.C.P is supported by an Australian Postgraduate Award, D.B. is supported by a National Health and Medical Research Council Early Career Fellowship (APP1073768), J.E.P. is funded by the National Health and Medical Research Council (Australia) and J.W.H.W. is supported by an Australian Research Council Future Fellowship (FT130100096).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Berezikov E, 2004, GENOME RES, V14, P170; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cannistraro VJ, 2015, J BIOL CHEM, V290, P26597, DOI 10.1074/jbc.M115.673301; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2502; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Melton C, 2015, NAT GENET, V47, P710, DOI 10.1038/ng.3332; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778; Poulos RC, 2015, MOL CANCER RES, V13, P1218, DOI 10.1158/1541-7786.MCR-15-0146; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rochette PJ, 2009, MUTAT RES-FUND MOL M, V665, P7, DOI 10.1016/j.mrfmmm.2009.02.008; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Tommasi S, 2000, NUCLEIC ACIDS RES, V28, P3991, DOI 10.1093/nar/28.20.3991; TORNALETTI S, 1995, J MOL BIOL, V249, P714, DOI 10.1006/jmbi.1995.0331; Tu YQ, 1996, EMBO J, V15, P675, DOI 10.1002/j.1460-2075.1996.tb00400.x; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Wilks C, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau093; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Zheng CL, 2014, CELL REP, V9, P1228, DOI 10.1016/j.celrep.2014.10.031; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772	45	124	124	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					259	+		10.1038/nature17437	http://dx.doi.org/10.1038/nature17437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075100				2022-12-28	WOS:000374415100045
J	Johnson, TL; Ares, M				Johnson, Tracy L.; Ares, Manuel, Jr.			SMITten by the Speed of Splicing	CELL			English	Editorial Material							NUCLEOTIDE RESOLUTION; IN-VIVO; TRANSCRIPTION; YEAST	Splicing occurs co-transcriptionally, but relative rates of splicing and transcription that might reveal mechanisms of their coordinated control have remained mysterious. Now, Carrillo Oesterreich et al. show that the fastest introns are gone nearly as soon as the 3' splice site is transcribed and that introns have distinct splicing kinetics with respect to polymerase progression along the gene.	[Johnson, Tracy L.] Univ Calif Los Angeles, Mol Cell & Dev Biol, Terasaki Life Sci Bldg Room 5159, Los Angeles, CA 90095 USA; [Ares, Manuel, Jr.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Ctr Mol Biol RNA, Sinsheimer Labs, 1156 High St, Santa Cruz, CA 95064 USA	University of California System; University of California Los Angeles; University of California System; University of California Santa Cruz	Johnson, TL (corresponding author), Univ Calif Los Angeles, Mol Cell & Dev Biol, Terasaki Life Sci Bldg Room 5159, Los Angeles, CA 90095 USA.; Ares, M (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Ctr Mol Biol RNA, Sinsheimer Labs, 1156 High St, Santa Cruz, CA 95064 USA.	tljohnson@ucla.edu; ares@ucsc.edu		Ares, Manny/0000-0002-2552-9168	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040478] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Chathoth KT, 2014, MOL CELL, V53, P779, DOI 10.1016/j.molcel.2014.01.017; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Lacadie SA, 2006, GENE DEV, V20, P2055, DOI 10.1101/gad.1434706; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Oesterreich FC, 2016, CELL, V165, P372, DOI 10.1016/j.cell.2016.02.045; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682	10	1	1	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					265	267		10.1016/j.cell.2016.03.035	http://dx.doi.org/10.1016/j.cell.2016.03.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058658	Bronze			2022-12-28	WOS:000374123000004
J	Chou, MY; Amo, R; Kinoshita, M; Cherng, BW; Shimazaki, H; Agetsuma, M; Shiraki, T; Aoki, T; Takahoko, M; Yamazaki, M; Higashijima, S; Okamoto, H				Chou, Ming-Yi; Amo, Ryunosuke; Kinoshita, Masae; Cherng, Bor-Wei; Shimazaki, Hideaki; Agetsuma, Masakazu; Shiraki, Toshiyuki; Aoki, Tazu; Takahoko, Mikako; Yamazaki, Masako; Higashijima, Shin-ichi; Okamoto, Hitoshi			Social conflict resolution regulated by two dorsal habenular subregions in zebrafish	SCIENCE			English	Article							AGGRESSION; ANXIETY	When animals encounter conflict they initiate and escalate aggression to establish and maintain a social hierarchy. The neural mechanisms by which animals resolve fighting behaviors to determine such social hierarchies remain unknown. We identified two subregions of the dorsal habenula (dHb) in zebrafish that antagonistically regulate the outcome of conflict. The losing experience reduced neural transmission in the lateral subregion of dHb (dHbL)-dorsal/intermediate interpeduncular nucleus (d/iIPN) circuit. Silencing of the dHbL or medial subregion of dHb (dHbM) caused a stronger predisposition to lose or win a fight, respectively. These results demonstrate that the dHbL and dHbM comprise a dual control system for conflict resolution of social aggression.	[Chou, Ming-Yi; Amo, Ryunosuke; Kinoshita, Masae; Cherng, Bor-Wei; Agetsuma, Masakazu; Shiraki, Toshiyuki; Aoki, Tazu; Takahoko, Mikako; Yamazaki, Masako; Okamoto, Hitoshi] RIKEN Brain Sci Inst, Lab Dev Gene Regulat, Wako, Saitama 3510198, Japan; [Cherng, Bor-Wei; Okamoto, Hitoshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Shimazaki, Hideaki] RIKEN Brain Sci Inst, Lab Neural Computat & Adaptat, Wako, Saitama 3510198, Japan; [Higashijima, Shin-ichi] Natl Inst Physiol Sci, Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Okamoto, Hitoshi] Waseda Univ, Dept Life Sci & Med Biosci, Lab Mol Brain Sci, Tokyo 1628430, Japan; [Amo, Ryunosuke] Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Agetsuma, Masakazu] Osaka Univ, Inst Sci Res & Ind Res, Osaka 5670047, Japan; [Yamazaki, Masako] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo 1538902, Japan	RIKEN; University of Tokyo; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Waseda University; Harvard University; Osaka University; University of Tokyo	Okamoto, H (corresponding author), RIKEN Brain Sci Inst, Lab Dev Gene Regulat, Wako, Saitama 3510198, Japan.; Okamoto, H (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan.; Okamoto, H (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Lab Mol Brain Sci, Tokyo 1628430, Japan.	hitoshi@brain.riken.jp	Okamoto, Hitoshi/P-9767-2015; Agetsuma, Masakazu/AAD-1654-2019; Shimazaki, Hideaki/C-8606-2009	Okamoto, Hitoshi/0000-0002-7512-8549; Agetsuma, Masakazu/0000-0002-8606-4886; Shimazaki, Hideaki/0000-0001-7794-3064; Amo, Ryunosuke/0000-0001-8644-2296; Higashijima, Shin-ichi/0000-0001-6350-4992	Ministry of Education, Culture, Sports, Science and Technology of Japan [23120008]; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	We thank K. Kawakami for providing the Tol2 and pT2MUASTeTxLC constructs, RIKEN Advanced Science Institute's advanced technology support division for production of experimental chambers, C. Yokoyama for advice in preparing the manuscript, and R. Nakayama for assistance in the identification of transgenic fish line. We thank all members of the Okamoto laboratory for support and advice, the Research Resource Center of RIKEN Brain Science Institute for animal care, and the National BioResource Project of Japan for fish strains. All requests for the materials ( strains and plasmids) should be made to H. O. They are made available upon exchange of a materials transfer agreement. This work was supported by a Grant in Aid for Scientific Research ( 23120008) and Strategic Research Program for Brain Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Japan. The supplementary materials contain additional data.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Amo R, 2014, NEURON, V84, P1034, DOI 10.1016/j.neuron.2014.10.035; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Chase ID, 2011, ADV GENET, V75, P51, DOI 10.1016/B978-0-12-380858-5.00001-0; Facchin L, 2015, J NEUROSCI, V35, P15847, DOI 10.1523/JNEUROSCI.2593-15.2015; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Lindenfors P, 2011, ADV GENET, V75, P7, DOI 10.1016/B978-0-12-380858-5.00009-5; Oliveira RF, 2011, ZEBRAFISH, V8, P73, DOI 10.1089/zeb.2011.0690; Paul ED, 2013, J PSYCHOPHARMACOL, V27, P1090, DOI 10.1177/0269881113490328; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Satou C, 2012, J NEUROSCI, V32, P1771, DOI 10.1523/JNEUROSCI.5500-11.2012; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6	13	96	98	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					87	90		10.1126/science.aac9508	http://dx.doi.org/10.1126/science.aac9508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034372				2022-12-28	WOS:000373039600041
J	Lo, B; Barnes, M				Lo, Bernard; Barnes, Mark			Federal Research Regulations for the 21st Century	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lo, Bernard] Greenwall Fdn, New York, NY USA; [Barnes, Mark] Ropes & Gray LLP, Boston, MA USA; [Barnes, Mark] Brigham & Womens Hosp, Multireg Clin Trials Ctr, 75 Francis St, Boston, MA 02115 USA; [Barnes, Mark] Harvard, Boston, MA USA	Harvard University; Brigham & Women's Hospital	Lo, B (corresponding author), Greenwall Fdn, New York, NY USA.							Bayefsky MJ, 2015, JAMA-J AM MED ASSOC, V314, P21, DOI 10.1001/jama.2015.6175; Department of Homeland Security, 2015, FED REGISTER, V80, P53942; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; Tomlinson T, 2015, JAMA-J AM MED ASSOC, V313, P417, DOI 10.1001/jama.2014.16363	5	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1205	1207		10.1056/NEJMp1600511	http://dx.doi.org/10.1056/NEJMp1600511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DH8ZM	27028910				2022-12-28	WOS:000373085500003
J	Schull, G				Schull, Guillaume			A close-up view of coupled molecules	NATURE			English	Editorial Material							RESOLUTION		[Schull, Guillaume] Univ Strasbourg, CNRS, UMR 7504, Inst Phys & Chim Mat Strasbourg, F-67034 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schull, G (corresponding author), Univ Strasbourg, CNRS, UMR 7504, Inst Phys & Chim Mat Strasbourg, F-67034 Strasbourg, France.	schull@unistra.fr	Schull, Guillaume/B-6256-2016					BERNDT R, 1993, SCIENCE, V262, P1425, DOI 10.1126/science.262.5138.1425; Chong MC, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.036802; Hettich C, 2002, SCIENCE, V298, P385, DOI 10.1126/science.1075606; Merino P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9461; Qiu XH, 2003, SCIENCE, V299, P542, DOI 10.1126/science.1078675; Yang B, 2015, NAT PHOTONICS, V9, P658, DOI [10.1038/nphoton.2015.152, 10.1038/NPHOTON.2015.152]; Zhang Y, 2016, NATURE, V531, P623, DOI 10.1038/nature17428; Zhu SE, 2013, J AM CHEM SOC, V135, P15794, DOI 10.1021/ja4048569	8	0	1	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					587	588		10.1038/531587a	http://dx.doi.org/10.1038/531587a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27029273				2022-12-28	WOS:000373027400027
J	Wise, J				Wise, Jacqui			EXPERT WITNESSES "Shaken baby" expert with unconventional views struck off	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						[Anonymous], 2005, GUARDIAN; Dyer C, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1989; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Kennedy H, 2004, SUDDEN UNEXPECTED DE; Mansfield M, 2016, GUARDIAN; Royal College of Pathologists, 2009, NON HEAD INJ CAS NAH	6	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2016	352								i1726	10.1136/bmj.i1726	http://dx.doi.org/10.1136/bmj.i1726			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TW	27032811				2022-12-28	WOS:000373493300008
J	Black, RE; Levin, C; Walker, N; Chou, D; Liu, L; Temmerman, M				Black, Robert E.; Levin, Carol; Walker, Neff; Chou, Doris; Liu, Li; Temmerman, Marleen		DCP RMNCH Authors Grp	Reproductive, maternal, newborn, and child health: key messages from Disease Control Priorities 3rd Edition	LANCET			English	Review							COMMUNITY CASE-MANAGEMENT; DEVELOPING-COUNTRIES; GESTATIONAL-AGE; PUBLIC-HEALTH; INTERVENTIONS; UNDERNUTRITION; WORLDWIDE; SERVICES; INCOME; RISK	As part of Disease Control Priorities 3rd Edition, the World Bank will publish a volume on Reproductive, Maternal, Newborn, and Child Health that identifies essential cost-effective health interventions that can be scaled up to reduce maternal, newborn, and child deaths, and stillbirths. This Review summarises the volume's key findings and estimates the effect and cost of expanded implementation of these interventions. Recognising that a continuum of care from the adolescent girl, woman, or mother to child is needed, the volume includes details of preventive and therapeutic health interventions in integrated packages: Maternal and Newborn Health and Child Health ( along with folic acid supplementation, a key reproductive health intervention). Scaling up all interventions in these packages from coverage in 2015 to hypothetically immediately achieve 90% coverage would avert 149 000 maternal deaths, 849 000 stillbirths, 1 498 000 neonatal deaths, and 1 515 000 additional child deaths. In alternative calculations that consider only the effects of reducing the number of pregnancies by provision of contraceptive services as part of a Reproductive Health package, meeting 90% of the unmet need for contraception would reduce global births by almost 28 million and consequently avert deaths that could have occurred at 2015 rates of fertility and mortality. Thus, 67 000 maternal deaths, 440 000 neonatal deaths, 473 000 child deaths, and 564 000 stillbirths could be averted from avoided pregnancies. Particularly effective interventions in the Maternal and Newborn Health and Child Health packages would be management of labour and delivery, care of preterm births, and treatment of serious infectious diseases and acute malnutrition. Nearly all of these essential interventions can be delivered by health workers in the community or in primary health centres, which can increase population access to needed services. The annual incremental cost of immediately scaling up these essential interventions would be US$ 6.2 billion in low-income countries, $ 12.4 billion in lower-middle-income countries, and $ 8.0 billion in upper-middle-income countries. With the additional funding, greater focus on high-effect integrated interventions and innovations in service delivery, such as task shifting to other groups of health workers and supply and demand incentives, can help rectify major gaps in accessibility and quality of care. In recent decades, reduction of avoidable maternal and child deaths has been a global priority. With continued priority and expansion of essential reproductive, maternal, newborn, and child health interventions to high coverage, equity, and quality, as well as interventions to address underlying problems such as women's low status in society and violence against women, these deaths and substantial morbidity can be largely eliminated in another generation.	[Black, Robert E.; Walker, Neff; Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Levin, Carol] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Chou, Doris; Temmerman, Marleen] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; World Health Organization	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD 21205 USA.	rblack1@jhu.edu	liu, li/HGC-0900-2022; Johansson, Kjell Arne/ABE-3628-2020; Bhutta, Zulfiqar/L-7822-2015	Johansson, Kjell Arne/0000-0001-8912-8710; Bhutta, Zulfiqar/0000-0003-0637-599X; Das, Jai/0000-0002-2966-7162; Ziraba, Abdhalah/0000-0002-3417-6536	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The Bill & Melinda Gates Foundation provides financial support for the Disease Control Priorities Network project, of which this volume is part. We thank the following individuals for valuable assistance and comments on this volume: Brianne Adderley, Kristen Danforth, Alex Ergo, Victoria Fan, Glenda Gray, Rajat Khosla, Rachel Nugent, Lale Say, and Gavin Yamey.	Aboud FE, DIS CONTROL IN PRESS, V2; Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; Bartlett L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098550; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bellows B, 2013, HEALTH POLICY PLANN, V28, P134, DOI 10.1093/heapol/czs030; Bellows NM, 2011, TROP MED INT HEALTH, V16, P84, DOI 10.1111/j.1365-3156.2010.02667.x; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Bosch-Capblanch X, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006413.pub2; Boschi-Pinto C, 2010, INT J EPIDEMIOL, V39, P3, DOI 10.1093/ije/dyq018; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Chachamovich JR, 2010, J PSYCHOSOM OBST GYN, V31, P101, DOI 10.3109/0167482X.2010.481337; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Cui WY, 2010, B WORLD HEALTH ORGAN, V88, P881, DOI 10.2471/BLT.10.011210; Das JK, DIS CONTROL IN PRESS, V2; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; Filippi V, DIS CONTROL IN PRESS, V2; Fox MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-I1; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Grantham-McGregor S, 2007, LANCET, V369, P824, DOI 10.1016/S0140-6736(07)60404-8; Hamer DH, 2012, PATHOG GLOB HEALTH, V106, P32, DOI 10.1179/1364859411Y.0000000042; Horton S, DIS CONTROL IN PRESS, V2; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kozuki N, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.1438; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lenters L, DIS CONTROL IN PRESS, V2; Liu L, DIS CONTROL IN PRESS, V2; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; PMNCH, 2013, PMNCH PROGR REP 2013; PMNCH, 2010, GLOB STRAT WOM CHILD; PMNCH, 2014, PMNCH 2014 ACC REP; Ponsar F, 2011, HEALTH POLICY PLANN, V26, pII72, DOI 10.1093/heapol/czr068; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Sabin LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035560; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schmidt H, 2015, LANCET, V386, P928, DOI 10.1016/S0140-6736(15)60244-6; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Singh S, 2014, ADDINT IT UP COSTS B; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; SINGH Susheela, 2009, ABORTION WORLDWIDE D; Singla DR, 2015, LANCET GLOB HEALTH, V3, pE458, DOI 10.1016/S2214-109X(15)00099-6; Stenberg K, DIS CONTROL IN PRESS, V2; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Stevens GA, DIS CONTROL IN PRESS, V2; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; United Nations, 2015, 17 GOALS; Venis S, 2003, LANCET, V361, P2172, DOI 10.1016/S0140-6736(03)13787-7; Verguet Stephane, 2015, Lancet Glob Health, V3, pe288, DOI 10.1016/S2214-109X(14)70346-8; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO, 2012, WHO REC OP HLTH WORK; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2; World Health Organization, 2021, VIOL WOM PREV EST 20; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8; Young M, 2012, AM J TROP MED HYG, V87, P6, DOI 10.4269/ajtmh.2012.12-0221	65	136	135	2	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2811	2824		10.1016/S0140-6736(16)00738-8	http://dx.doi.org/10.1016/S0140-6736(16)00738-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FB	27072119				2022-12-28	WOS:000389629800032
J	Dua, KS; Hogan, WJ; Aadam, AA; Gasparri, M				Dua, Kulwinder S.; Hogan, Walter J.; Aadam, Abdul A.; Gasparri, Mario			In-vivo oesophageal regeneration in a human being by use of a non-biological scaffold and extracellular matrix	LANCET			English	Article							BIODEGRADABLE STENT PLACEMENT; PLATELET-RICH PLASMA; STRICTURE FORMATION; MUCOSAL RESECTION; ANASTOMOTIC LEAK; TISSUE; PREVENTION; CANCER; OUTCOMES; RECONSTRUCTION	Background Tissue-engineered extracellular matrix populated with autologous pluripotent cells can result in de-novo organogenesis, but the technique is complex, not widely available, and has not yet been used to repair large oesophageal defects in human beings. We aimed to use readily available stents and extracellular matrix to regenerate the oesophagus in vivo in a human being to re-establish swallowing function. Methods In a patient aged 24 years, we endoscopically placed a readily available, fully covered, self-expanding, metal stent (diameter 18 mm, length 120 mm) to bridge a 5 cm full-thickness oesophageal segment destroyed by a mediastinal abscess and leading to direct communication between the hypopharynx and the mediastinum. A commercially available extracellular matrix was used to cover the stent and was sprayed with autologous plateletrich plasma adhesive gel. The sternocleidomastoid muscle was placed over the matrix. After 4 weeks, stent removal was needed due to stent migration, and was replaced with three stents telescopically aligned to improve anchoring. The stents were removed after 3.5 years and the oesophagus was assessed by endoscopy, biopsy, endoscopic ultrasonography, and high-resolution impedance manometry. Findings After stent removal we saw full-thickness regeneration of the oesophagus with stratified squamous epithelium, a normal five-layer wall, and peristaltic motility with bolus transit. 4 years after stent removal, the patient was eating a normal diet and maintaining a steady weight. Interpretation Maintenance of the structural morphology of the oesophagus with off-the-shelf non-biological scaffold and stimulation of regeneration with commercially available extracellular matrix led to de-novo structural and functional regeneration of the oesophagus.	[Dua, Kulwinder S.; Hogan, Walter J.] Med Coll Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Milwaukee, WI 53226 USA; [Gasparri, Mario] Med Coll Wisconsin, Dept Surg, Div Cardiothorac Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Aadam, Abdul A.] Northwestern Univ, Div Gastroenterol & Hepatol, Evanston, IL USA	Medical College of Wisconsin; Medical College of Wisconsin; Northwestern University	Dua, KS (corresponding author), Med Coll Wisconsin, Div Gastroenterol & Hepatol, Milwaukee, WI 53226 USA.	kdua@mcw.edu						Aly A, 2004, BRIT J SURG, V91, P137, DOI 10.1002/bjs.4508; Amirlak B, 2014, INT J SURG CASE REP, V5, P294, DOI 10.1016/j.ijscr.2014.02.015; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Babor Richard, 2009, Surg Laparosc Endosc Percutan Tech, V19, pe1, DOI 10.1097/SLE.0b013e318196c706; Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834; Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002; Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI 10.1089/ten.tea.2010.0739; Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7; Badylak Stephen F., 2005, Anatomical Record Part B:The New Anatomist, V287, P36, DOI 10.1002/ar.b.20081; Beckstead BL, 2005, BIOMATERIALS, V26, P6217, DOI 10.1016/j.biomaterials.2005.04.010; Bee YS, 2015, OPHTHAL PLAST RECONS, V31, P348, DOI 10.1097/IOP.0000000000000339; Biere SSAY, 2011, DIGEST SURG, V28, P29, DOI 10.1159/000322014; Bozuk Michael I, 2006, JSLS, V10, P83; Briel JW, 2004, J AM COLL SURGEONS, V198, P536, DOI 10.1016/j.jamcollsurg.2003.11.026; Castro C, 2014, ANN ONCOL, V25, P283, DOI 10.1093/annonc/mdt486; Chang AC, 2008, ANN THORAC SURG, V85, P424, DOI 10.1016/j.athoracsur.2007.10.007; de Boer AGEM, 2000, BRIT J SURG, V87, P1716, DOI 10.1046/j.1365-2168.2000.01600.x; Diana M, 2015, SURG ENDOSC, V29, P3367, DOI 10.1007/s00464-015-4078-0; Donington Jessica Scott, 2006, Thorac Surg Clin, V16, P53, DOI 10.1016/j.thorsurg.2006.01.002; Dua KS, 2014, GASTROINTEST ENDOSC, V80, P577, DOI 10.1016/j.gie.2014.02.005; Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5; Gobbi A, 2015, KNEE SURG SPORT TR A, V23, P2170, DOI 10.1007/s00167-014-2987-4; Honda M, 2011, GASTROINTEST ENDOSC, V73, P777, DOI 10.1016/j.gie.2010.11.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kanai N, 2012, GASTROINTEST ENDOSC, V76, P873, DOI 10.1016/j.gie.2012.06.017; Keane TJ, 2013, BIOMATERIALS, V34, P6729, DOI 10.1016/j.biomaterials.2013.05.052; Kim RH, 2010, J SURG ONCOL, V101, P527, DOI 10.1002/jso.21510; Lewis JJ, 2011, GASTROINTEST ENDOSC, V74, P753, DOI 10.1016/j.gie.2011.05.031; Macarios D, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000387; Martin JT, 2009, ANN THORAC SURG, V87, P1708, DOI 10.1016/j.athoracsur.2009.01.075; Marx R E, 2001, Implant Dent, V10, P225; Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Nieponice A, 2009, GASTROINTEST ENDOSC, V69, P289, DOI 10.1016/j.gie.2008.04.022; Nieponice A, 2014, ANN THORAC SURG, V97, P283, DOI 10.1016/j.athoracsur.2013.08.011; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Okata Y, 2014, CLIN J GASTROENTEROL, V7, P496, DOI 10.1007/s12328-014-0537-8; Orringer MB, 2000, J THORAC CARDIOV SUR, V119, P277, DOI 10.1016/S0022-5223(00)70183-8; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Pauli EM, 2012, SURG ENDOSC, V26, P3500, DOI 10.1007/s00464-012-2373-6; Price TN, 2013, ANN THORAC SURG, V95, P1154, DOI 10.1016/j.athoracsur.2012.11.045; Saito Y, 2007, WORLD J GASTROENTERO, V13, P3977, DOI 10.3748/wjg.v13.i29.3977; Sakurai T, 2007, GASTROINTEST ENDOSC, V66, P167, DOI 10.1016/j.gie.2006.12.062; Saluja SS, 2012, J GASTROINTEST SURG, V16, P1287, DOI 10.1007/s11605-012-1885-7; Sepesi B, 2012, J THORAC CARDIOV SUR, V144, P1146, DOI 10.1016/j.jtcvs.2012.07.085; van Boeckel PGA, 2011, ALIMENT PHARM THER, V33, P1292, DOI 10.1111/j.1365-2036.2011.04663.x; van Boeckel PGA, 2013, EXPERT REV MED DEVIC, V10, P37, DOI [10.1586/erd.12.45, 10.1586/ERD.12.45]; van den Berg MW, 2014, GASTROINTEST ENDOSC, V80, P908, DOI 10.1016/j.gie.2014.06.004; Wilcox VT, 2015, SURG ENDOSC, V29, P24, DOI 10.1007/s00464-014-3640-5; Yamamoto Y, 1999, ASAIO J, V45, P311, DOI 10.1097/00002480-199907000-00011	50	41	43	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					55	61		10.1016/S0140-6736(15)01036-3	http://dx.doi.org/10.1016/S0140-6736(15)01036-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP9PM	27068836				2022-12-28	WOS:000378828400028
J	Chubak, J; Whitlock, EP; Williams, SB; Kamineni, A; Burda, BU; Buist, DSM; Anderson, ML				Chubak, Jessica; Whitlock, Evelyn P.; Williams, Selvi B.; Kamineni, Aruna; Burda, Brittany U.; Buist, Diana S. M.; Anderson, Melissa L.			Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							LOW-DOSE ASPIRIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLORECTAL-CANCER; CONTROLLED-TRIAL; CARDIOVASCULAR EVENTS; SECONDARY PREVENTION; FOLLOW-UP; MYOCARDIAL-INFARCTION; ACETYLSALICYLIC-ACID; ARTERIAL-DISEASE	Background: Cancer is the second leading cause of death in the United States. Purpose: To conduct systematic reviews of aspirin and 1) total cancer mortality and incidence in persons eligible for primary prevention of cardiovascular disease (CVD) and 2) colorectal cancer (CRC) mortality and incidence in persons at average CRC risk. Data Sources: MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials through January 2015 and relevant references from other reviews. Study Selection: Trials comparing oral aspirin versus placebo or no treatment in adults aged 40 years or older were included. Two investigators independently reviewed abstracts and articles against inclusion and quality criteria. Data Extraction: Data from 20 good-or fair-quality trials were abstracted by one reviewer and checked by another. Data Synthesis: In CVD primary prevention trials, cancer mortality (relative risk [RR], 0.96 [95% CI, 0.87 to 1.06]) (10 trials; n = 103 787) and incidence (RR, 0.98 [CI, 0.93 to 1.04]) (6 trials; n = 72 926) were similar in aspirin and control groups over 3.6 to 10.1 years. In CVD primary and secondary prevention trials, 20-year CRC mortality was reduced among persons assigned to aspirin therapy (RR, 0.67 [CI, 0.52 to 0.86]) (4 trials; n = 14 033). Aspirin appeared to reduce CRC incidence beginning 10 to 19 years after initiation (RR, 0.60 [CI, 0.47 to 0.76]) (3 trials; n = 47 464). Limitations: Most data were from clinically and methodologically heterogeneous CVD prevention trials. Outcome assessment and follow-up length varied across studies. Data on non-CRC cancer types and subgroups were limited. Conclusion: In CVD primary prevention populations, aspirin's effect on total cancer mortality and incidence was not clearly established. Evidence from CVD primary and secondary prevention studies suggested that aspirin therapy reduces CRC incidence and perhaps mortality approximately 10 years after initiation.	[Chubak, Jessica] Kaiser Permanente Res Affiliates Evidence Based P, Grp Hlth Res Inst, Seattle, WA USA; Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, Portland, OR USA; [Chubak, Jessica; Kamineni, Aruna; Buist, Diana S. M.; Anderson, Melissa L.] Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA; [Whitlock, Evelyn P.] Patient Centered Outcomes Res Inst, 1828 L St NW,Suite 900, Washington, DC 20036 USA; [Williams, Selvi B.; Burda, Brittany U.] Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente	Chubak, J (corresponding author), Kaiser Permanente Res Affiliates Evidence Based P, Grp Hlth Res Inst, Seattle, WA USA.				AHRQ [HHSA-290-2012-00151-I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract HHSA-290-2012-00151-I from the AHRQ.	AD2000 Collaborative Grp, 2008, LANCET NEUROL, V7, P41, DOI 10.1016/S1474-4422(07)70293-4; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; American Cancer Society, 2016, CANC FACTS FIGURES 2; American Cancer Society, 2014, LIF RISK DEV DYING C; Andersen V, 2014, ALIMENT PHARM THER, V40, P147, DOI 10.1111/apt.12807; [Anonymous], 1980, JAMA, V243, P661; [Anonymous], [No title captured]; BAUDOIN C, 1989, DIABETES, V38, P491; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; BOUSSER MG, 1983, STROKE, V14, P5, DOI 10.1161/01.STR.14.1.5; BREDDIN K, 1980, HAEMOSTASIS, V9, P325; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Canadian Cooperative Study Group, 1978, N Engl J Med, V299, P53; Chan AT, 2005, JNCI-J NATL CANCER I, V97, P457, DOI 10.1093/jnci/dji066; Choi CK, 2008, GUT LIVER, V2, P99, DOI 10.5009/gnl.2008.2.2.99; Cleland JGF, 2004, AM HEART J, V148, P157, DOI 10.1016/j.ahj.2004.03.010; Cleland JGF, 1999, EUR J HEART FAIL, V1, P95; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Cuzick J, 2015, ANN ONCOL, V26, P47, DOI 10.1093/annonc/mdu225; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; De Berardis G, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-21; Dehmer SP, 2015, AHRQ PUBLICATION, V15-05229-EF-1; Diener HC, 1997, J NEUROL SCI, V151, pS1, DOI 10.1016/S0022-510X(97)86566-5; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; ELWOOD PC, 1974, BRIT MED J, V1, P436, DOI 10.1136/bmj.1.5905.436; ELWOOD PC, 1979, LANCET, V2, P1313; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; FIELDS WS, 1977, STROKE, V8, P301, DOI 10.1161/01.STR.8.3.301; FIELDS WS, 1978, STROKE, V9, P309, DOI 10.1161/01.STR.9.4.309; Fink SP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008481; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; GENT M, 1980, CIRCULATION, V62, P97; Germano G, 2012, EUR HEART J, V33, P137; Gray J, 2007, CHEST, V132, p56S, DOI 10.1378/chest.07-1348; Guirguis-Blake JM, 2016, ANN INTERN MED, V164, P804, DOI 10.7326/M15-2113; Guirguis-Blake JM, 2015, AHRQ PUBLICATION, V13-05195-EF-1; GUSTAFSSON C, 1987, STROKE, V18, P299; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Henderson N, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.300; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HESS H, 1985, LANCET, V1, P415; Hirata Y, 2011, SCAND J GASTROENTERO, V46, P803, DOI 10.3109/00365521.2011.568522; Hoffmeister M, 2007, INT J CANCER, V121, P1325, DOI 10.1002/ijc.22796; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; KRETSCHMER G, 1990, ANN SURG, V211, P317, DOI 10.1097/00000658-199003000-00002; KROL WF, 1980, CIRCULATION, V62, P449; Lee I, 1995, AM J EPIDEMIOL, P141; Meade TW, 1998, LANCET, V351, P233; Nan HM, 2015, JAMA-J AM MED ASSOC, V313, P1133, DOI 10.1001/jama.2015.1815; Nelson MR, 2008, MED J AUSTRALIA, V189, P105, DOI 10.5694/j.1326-5377.2008.tb01932.x; NORRVING B, 1991, LANCET, V338, P1345; Office of Disease Prevention and Health Promotion, 2016, CANCER; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; Posada IS, 1999, AM HEART J, V138, P137, DOI 10.1016/S0002-8703(99)70259-0; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; SORENSEN PS, 1983, STROKE, V14, P15, DOI 10.1161/01.STR.14.1.15; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Steward WP, 2013, BRIT J CANCER, V109, P1, DOI 10.1038/bjc.2013.280; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; Sutcliffe P, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17430; The Coronary Drug Project Research Group, 1980, CIRCULATION, V62, pV59; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; U.S. Preventive Services Task Force, 2013, FIN RES PLAN ASP PRE; United Nations Development Programme (UNDP), 2013, HUM DEV REP 2013 RIS; US Preventive Services Task Force, 2007, ANN INTERN MED, V146, P361, DOI 10.7326/0003-4819-146-5-200703060-00008; Whitlock EP, 2015, AHRQ PUBLICATION, V132, P217; Whitlock EP, 2016, ANN INTERN MED, V164, P826, DOI 10.7326/M15-2112; Wolff T, 2009, ASPIRIN PRIMARY PREV; Ye XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057578	83	115	118	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					814	U80		10.7326/M15-2117	http://dx.doi.org/10.7326/M15-2117			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27064482				2022-12-28	WOS:000379343000015
J	Dieleman, JL; Templin, T; Sadat, NS; Reidy, P; Chapin, A; Foreman, K; Haakenstad, A; Evans, T; Murray, CJL; Kurowski, C				Dieleman, Joseph L.; Templin, Tara; Sadat, Nafi S.; Reidy, Patrick; Chapin, Abigail; Foreman, Kyle; Haakenstad, Annie; Evans, Tim; Murray, Christopher J. L.; Kurowski, Christoph			National spending on health by source for 184 countries between 2013 and 2040	LANCET			English	Article							DEVELOPMENT ASSISTANCE; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; ENSEMBLE; TRANSITION; FRAMEWORK; MORTALITY; WEATHER; DISEASE; DEATH	Background A general consensus exists that as a country develops economically, health spending per capita rises and the share of that spending that is prepaid through government or private mechanisms also rises. However, the speed and magnitude of these changes vary substantially across countries, even at similar levels of development. In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected. Methods We extracted data from WHO's Health Spending Observatory and the Institute for Health Metrics and Evaluation's Financing Global Health 2015 report. We converted these data to a common purchasing power-adjusted and inflation-adjusted currency. We used a series of ensemble models and observed empirical norms to estimate future government out-of-pocket private prepaid health spending and development assistance for health. We aggregated each country's estimates to generate total health spending from 2013 to 2040 for 184 countries. We compared these estimates with each other and internationally recognised benchmarks. Findings Global spending on health is expected to increase from US$7.83 trillion in 2013 to $18.28 (uncertainty interval 14.42-22.24) trillion in 2040 (in 2010 purchasing power parity-adjusted dollars). We expect per-capita health spending to increase annually by 2.7% (1.9-3.4) in high-income countries, 3.4% (2.4-4.2) in upper-middle-income countries, 3.0% (2.3-3.6) in lower-middle-income countries, and 2.4% (1.6-3.1) in low-income countries. Given the gaps in current health spending, these rates provide no evidence of increasing parity in health spending. In 1995 and 2015, low-income countries spent $0.03 for every dollar spent in high-income countries, even after adjusting for purchasing power, and the same is projected for 2040. Most importantly, health spending in many low-income countries is expected to remain low. Estimates suggest that, by 2040, only one (3%) of 34 low-income countries and 36 (37%) of 98 middle-income countries will reach the Chatham House goal of 5% of gross domestic product consisting of government health spending. Interpretation Despite remarkable health gains, past health financing trends and relationships suggest that many low-income and lower-middle-income countries will not meet internationally set health spending targets and that spending gaps between low-income and high-income countries are unlikely to narrow unless substantive policy interventions occur. Although gains in health system efficiency can be used to make progress, current trends suggest that meaningful increases in health system resources will require concerted action.	[Dieleman, Joseph L.; Templin, Tara; Sadat, Nafi S.; Reidy, Patrick; Chapin, Abigail; Foreman, Kyle; Murray, Christopher J. L.] Inst Heath Metr & Evaluat, Seattle, WA 98121 USA; [Haakenstad, Annie] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Evans, Tim; Kurowski, Christoph] World Bank Grp, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health; The World Bank	Dieleman, JL (corresponding author), Inst Heath Metr & Evaluat, Seattle, WA 98121 USA.	dieleman@uw.edu			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We would also like to thank the remainder of the Institute for Health Metrics and Evaluation's Financial Resources for Health research team, including Maxwell Birger, Hannah Hamavid, Cody Horst, Jonathan Joseph, Liya Lomsadze, Matthew Schneider, and Lavanya Singh. We are grateful to the Bill & Melinda Gates Foundation for financial support.	Astolfi R, 2012, OECD HLTH WORKING PA, V59, P1; BerthUlemy J.-C., 2004, INT REV ECON FINANC, V13, P253, DOI DOI 10.1016/J.IREF.2003.11.004; Chatham House, 2014, SHAR RESP HLTH COH G; Chen YH, 2007, NEUROCOMPUTING, V70, P697, DOI 10.1016/j.neucom.2006.10.005; de la Maisonneuve C., 2013, PUBLIC SPENDING HLTH; Dieleman JL, 2016, LANCET; Dieleman JL, 2015, JAMA-J AM MED ASSOC, V313, P2359, DOI 10.1001/jama.2015.5825; Duan QY, 2007, ADV WATER RESOUR, V30, P1371, DOI 10.1016/j.advwatres.2006.11.014; Evans T, 2016, LANCET; Fan VY, 2014, SOC SCI MED, V105, P112, DOI 10.1016/j.socscimed.2014.01.014; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Getzen TE, 2016, N AM ACTUAR J, V20, P101, DOI 10.1080/10920277.2015.1110490; Gneiting T, 2005, SCIENCE, V310, P248, DOI 10.1126/science.1115255; Haakenstad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128389; Hanlon M, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-8; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Honaker J, 2011, J STAT SOFTW, V45, P1; Institute for Health Metrics and Evaluation, 2016, FIN GLOB HLTH 2015 D; International Monetary Fund, 2015, FISC MON NOW IS TIM; International Monetary Fund, 2015, WORLD EC OUTL UN GRO; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Krishnamurti TN, 2000, J CLIMATE, V13, P4196, DOI 10.1175/1520-0442(2000)013<4196:MEFFWA>2.0.CO;2; McIntyre, 2014, FISCAL SPACE DOMESTI; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Oxley H, OECD EC DEP WORKING, V149, P1; Saksena P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001701; United Nations (UN), WORLD POP PROSP; Wagstaff A, 2004, HEALTH ECON, V13, P297, DOI 10.1002/hec.822; Wall H.J, 2006, DETERMINANTS AID POS; Xu K, EXPLORING THRESHOLDS	33	112	114	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2521	2535		10.1016/S0140-6736(16)30167-2	http://dx.doi.org/10.1016/S0140-6736(16)30167-2			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27086174				2022-12-28	WOS:000377947200029
J	Maruthur, NM; Tseng, E; Hutfless, S; Wilson, LM; Suarez-Cuervo, C; Berger, Z; Chu, Y; Iyoha, E; Segal, JB; Bolen, S				Maruthur, Nisa M.; Tseng, Eva; Hutfless, Susan; Wilson, Lisa M.; Suarez-Cuervo, Catalina; Berger, Zackary; Chu, Yue; Iyoha, Emmanuel; Segal, Jodi B.; Bolen, Shari			Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							CARDIOVASCULAR OUTCOMES; HEART-FAILURE; DOUBLE-BLIND; GLUCOSE CONTROL; ADD-ON; MORTALITY; RISK; GLIMEPIRIDE; SAFETY; SULFONYLUREAS	Background: Clinicians and patients need updated evidence on the comparative effectiveness and safety of diabetes medications to make informed treatment choices. Purpose: To evaluate the comparative effectiveness and safety of monotherapy (thiazolidinediones, metformin, sulfonylureas, dipeptidyl peptidase-4 [DPP-4] inhibitors, sodium-glucose cotransporter 2 [SGLT-2] inhibitors, and glucagon-like peptide-1 [GLP-1] receptor agonists) and selected metformin-based combinations in adults with type 2 diabetes. Data Sources: English-language studies from MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials, indexed from inception through March 2015 (MEDLINE search updated through December 2015). Study Selection: Paired reviewers independently identified 179 trials and 25 observational studies of head-to-head monotherapy or metformin-based combinations. Data Extraction: Two reviewers independently assessed study quality and serially extracted data and graded the strength of evidence. Data Synthesis: Cardiovascular mortality was lower for metformin versus sulfonylureas; the evidence on all-cause mortality, cardiovascular morbidity, and microvascular complications was insufficient or of low strength. Reductions in hemoglobin A1c values were similar across monotherapies and metformin-based combinations, except that DPP-4 inhibitors had smaller effects. Body weight was reduced or maintained with metformin, DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT-2 inhibitors and increased with sulfonylureas, thiazolidinediones, and insulin (between-group differences up to 5 kg). Hypoglycemia was more frequent with sulfonylureas. Gastrointestinal adverse events were highest with metformin and GLP-1 receptor agonists. Genital mycotic infections were increased with SGLT-2 inhibitors. Limitation: Most studies were short, with limited ability to assess rare safety and long-term clinical outcomes. Conclusion: The evidence supports metformin as first-line therapy for type 2 diabetes, given its relative safety and beneficial effects on hemoglobin A1c, weight, and cardiovascular mortality (compared with sulfonylureas). On the basis of less evidence, results for add-on therapies to metformin were similar to those for monotherapies.	[Maruthur, Nisa M.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Wilson, Lisa M.; Suarez-Cuervo, Catalina; Iyoha, Emmanuel] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 North Broadway,Room 680, Baltimore, MD 21205 USA; [Maruthur, Nisa M.] Welch Ctr Prevent Epidemiol & Clin Res, 2024 East Monument St,Room 2-601, Baltimore, MD 21287 USA; [Tseng, Eva] Welch Ctr Prevent Epidemiol & Clin Res, 2024 East Monument St,Room 2-617, Baltimore, MD 21287 USA; Case Western Reserve Univ, MetroHlth, Ctr Hlth Care Res & Policy, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; [Hutfless, Susan] Johns Hopkins Sch Med, Dept Med, Div Gastroenterol & Hepatol, 600 North Wolfe St,Blalock 449, Baltimore, MD 21287 USA; [Berger, Zackary; Segal, Jodi B.] Johns Hopkins Outpatient Ctr, 601 North Caroline St 7143, Baltimore, MD 21287 USA; [Chu, Yue] Johns Hopkins Univ, 615 North Wolfe St,Room W5508, Baltimore, MD 21205 USA; [Bolen, Shari] MetroHlth Med Ctr, 2500 MetroHlth Dr, Cleveland, OH 44109 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Case Western Reserve University; MetroHealth System; Case Western Reserve University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; MetroHealth System	Maruthur, NM (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	maruthur@jhmi.edu	Berger, Zackary/AAW-5761-2020; Berger, Zackary/I-7032-2013	Berger, Zackary/0000-0002-5871-0342	AHRQ, U.S. Department of Health and Human Services [290-2012-00007-I]	AHRQ, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded under contract 290-2012-00007-I from AHRQ, U.S. Department of Health and Human Services.	Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS52, DOI 10.2337/dc16-S010; Andersson C, 2010, DIABETOLOGIA, V53, P2546, DOI 10.1007/s00125-010-1906-6; Bailey CJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-43; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bennett WL, 2011, 290020018 AG HEALTHC; Bolen S, 2016, 2902012000071 AG HEA; Bolen S, 2007, 290020018 AG HEALTHC; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Bolen SD, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i801; Bolinder J, 2014, DIABETES OBES METAB, V16, P159, DOI 10.1111/dom.12189; Centers for Disease Control, 2020, NATL DIABETES STAT R; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Corrao G, 2011, EUR J CLIN PHARMACOL, V67, P289, DOI 10.1007/s00228-010-0939-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Gu SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126704; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hong J, 2013, DIABETES CARE, V36, P1304, DOI 10.2337/dc12-0719; Horsdal HT, 2011, PHARMACOEPIDEM DR S, V20, P331, DOI 10.1002/pds.2097; Hung YC, 2013, DIABETES-METAB RES, V29, P673, DOI 10.1002/dmrr.2444; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnson JA, 2005, DIABETIC MED, V22, P497, DOI 10.1111/j.1464-5491.2005.01448.x; Kahler KH, 2007, DIABETES CARE, V30, P1689, DOI 10.2337/dc06-2272; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Li L, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i610; Monami M, 2013, DIABETES OBES METAB, V15, P938, DOI 10.1111/dom.12116; Nauck MA, 2014, DIABETES OBES METAB, V16, P1111, DOI 10.1111/dom.12327; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pantalone KM, 2012, DIABETES OBES METAB, V14, P803, DOI 10.1111/j.1463-1326.2012.01604.x; Pantalone KM, 2009, ACTA DIABETOL, V46, P145, DOI 10.1007/s00592-008-0090-3; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Patorno E, 2014, DIABETOLOGIA, V57, P2237, DOI 10.1007/s00125-014-3364-z; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Phung OJ, 2013, DIABETIC MED, V30, P1160, DOI 10.1111/dme.12232; Purnell TS, 2014, DIABETES CARE, V37, P2055, DOI 10.2337/dc13-2527; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Ridderstrale M, 2014, LANCET DIABETES ENDO, V2, P691, DOI 10.1016/S2213-8587(14)70120-2; Rosenstock J, 2015, DIABETES CARE, V38, P376, DOI 10.2337/dc14-1142; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Salpeter SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub3; Schramm TK, 2011, EUR HEART J, V32, P1900, DOI 10.1093/eurheartj/ehr077; Schumm-Draeger PM, 2015, DIABETES OBES METAB, V17, P42, DOI 10.1111/dom.12387; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Shyangdan DS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006423.pub2; Tanner M, 2013, ANN INTERN MED, V158, DOI 10.7326/0003-4819-158-8-201304160-02004; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; TURNER RC, 1985, DIABETES, V34, P793; U.S. Food and Drug Administration, 2015, FDA PAN WANTS NEW DP; U.S. Food and Drug Administration, 2013, INCR MIM DRUGS TYP 2; U.S. Food and Drug Administration, 2013, REQ REV PRESCR LAB M; U.S. Food and Drug Administration, 2014, HIGHL PRESCR INF TAN; U.S. Food and Drug Administration, 2011, VICT LIR RDNA OR INJ; U.S. Food and Drug Administration, 2013, EL BOX WARN REG LACT; U.S. Food and Drug Administration, 2015, HIGHL PRESCR INF INV; U.S. Food and Drug Administration, 2011, HIGHL PRESCR INF VIC; U.S. Food and Drug Administration, 2015, HIGHL PRESCR INF BYD; United Kingdom Prospective Diabetes Study (UKPDS), 1995, BMJ-BRIT MED J, V310, P83, DOI DOI 10.1136/BMJ.310.6972.83; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Wang Chen-Pin, 2014, J Endocrinol Diabetes Obes, V2; Wheeler S, 2013, DIABETOLOGIA, V56, P1934, DOI 10.1007/s00125-013-2958-1; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001; Yang WY, 2016, J DIABETES, V8, P796, DOI 10.1111/1753-0407.12357; Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X	76	382	395	1	96	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2016	164	11					740	+		10.7326/M15-2650	http://dx.doi.org/10.7326/M15-2650			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1AI	27088241				2022-12-28	WOS:000377510100006
J	Haug, CJ; Kieny, MP; Murgue, B				Haug, Charlotte J.; Kieny, Marie Paule; Murgue, Bernadette			The Zika Challenge	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		[Haug, Charlotte J.] WHO, Geneva, Switzerland; [Kieny, Marie Paule] WHO, Hlth Syst & Innovat, Geneva, Switzerland; [Murgue, Bernadette] WHO, WHO R&D Blueprint, Geneva, Switzerland	World Health Organization; World Health Organization; World Health Organization	Haug, CJ (corresponding author), WHO, Geneva, Switzerland.		Kieny, Marie-Paule/Q-1238-2019; Kieny, Marie-Paule/N-3914-2017	Kieny, Marie-Paule/0000-0002-5943-6488; Haug, Charlotte Johanne/0000-0001-8217-7376	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9	5	62	64	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1801	1803		10.1056/NEJMp1603734	http://dx.doi.org/10.1056/NEJMp1603734			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	27028782	Bronze			2022-12-28	WOS:000375746100001
J	Hamidian, MH; Edkins, SD; Joo, SH; Kostin, A; Eisaki, H; Uchida, S; Lawler, MJ; Kim, EA; Mackenzie, AP; Fujita, K; Lee, J; Davis, JCS				Hamidian, M. H.; Edkins, S. D.; Joo, Sang Hyun; Kostin, A.; Eisaki, H.; Uchida, S.; Lawler, M. J.; Kim, E. -A.; Mackenzie, A. P. .; Fujita, K.; Lee, Jinho; Davis, J. C. Seamus			Detection of a Cooper-pair density wave in Bi2Sr2CaCu2O8+x	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; ELECTROMAGNETIC ENVIRONMENT; CUPRATE SUPERCONDUCTORS; JOSEPHSON-JUNCTIONS; CHARGE ORDER; SYMMETRY	The quantum condensate of Cooper pairs forming a superconductor was originally conceived as being translationally invariant. In theory, however, pairs can exist with finite momentum Q, thus generating a state with a spatially modulated Cooper-pair density(1,2). Such a state has been created in ultracold Li-6 gas(3) but never observed directly in any superconductor. It is now widely hypothesized that the pseudogap phase(4) of the copper oxide superconductors contains such a 'pair density wave' state(5-21). Here we report the use of nanometre-resolution scanned Josephson tunnelling microscopy(22-24) to image Cooper pair tunnelling from a d-wave superconducting microscope tip to the condensate of the superconductor Bi2Sr2CaCu2O8+x. We demonstrate condensate visualization capabilities directly by using the Cooper-pair density variations surrounding zinc impurity atoms(25) and at the Bi2Sr2CaCu2O8+x crystal supermodulation(26). Then, by using Fourier analysis of scanned Josephson tunnelling images, we discover the direct signature of a Cooper-pair density modulation at wavevectors Q(P) approximate to (0.25, 0)2 pi/a(0) and (0, 0.25)2 pi/a(0) in Bi2Sr2CaCu2O8+x. The amplitude of these modulations is about five per cent of the background condensate density and their form factor exhibits primarily s or s' symmetry. This phenomenology is consistent with Ginzburg-Landau theory(5,13,14) when a charge density wave(5,27) with d-symmetry form factor(28-30) and wavevector Q(C) = Q(P) coexists with a d-symmetry superconductor; it is also predicted by several contemporary microscopic theories for the pseudogap phase(18-21).	[Hamidian, M. H.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Edkins, S. D.; Kostin, A.; Lawler, M. J.; Kim, E. -A.; Davis, J. C. Seamus] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Edkins, S. D.; Mackenzie, A. P. .; Davis, J. C. Seamus] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Joo, Sang Hyun; Lee, Jinho] Seoul Natl Univ, Inst Appl Phys, Dept Phys & Astron, Seoul 151747, South Korea; [Joo, Sang Hyun; Lee, Jinho] Inst for Basic Sci Korea, Ctr Correlated Electron Syst, Seoul 151742, South Korea; [Eisaki, H.; Uchida, S.] Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Uchida, S.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130011, Japan; [Lawler, M. J.] SUNY Binghamton, Dept Phys, Binghamton, NY 13902 USA; [Mackenzie, A. P. .] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Fujita, K.; Davis, J. C. Seamus] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Davis, J. C. Seamus] Cornell Univ, Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA	Harvard University; Cornell University; University of St Andrews; Seoul National University (SNU); Institute for Basic Science - Korea (IBS); National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Max Planck Society; United States Department of Energy (DOE); Brookhaven National Laboratory; Cornell University	Davis, JCS (corresponding author), Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.; Davis, JCS (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.; Lee, J (corresponding author), Seoul Natl Univ, Inst Appl Phys, Dept Phys & Astron, Seoul 151747, South Korea.; Lee, J (corresponding author), Inst for Basic Sci Korea, Ctr Correlated Electron Syst, Seoul 151742, South Korea.; Davis, JCS (corresponding author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA.; Davis, JCS (corresponding author), Cornell Univ, Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA.	jinholee@snu.ac.kr; jcseamusdavis@gmail.com	Mackenzie, Andrew P/K-6742-2015; Eisaki, Hiroshi/F-6317-2018; Lawler, Michael/K-6770-2012	Mackenzie, Andrew P/0000-0001-8000-4949; Eisaki, Hiroshi/0000-0002-8299-6416; Lawler, Michael/0000-0002-2319-2274	EPSRC [EP/I031014/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I031014/1, 1265368] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Agterberg DF, 2008, NAT PHYS, V4, P639, DOI 10.1038/nphys999; AMBEGAOKAR V, 1969, PHYS REV LETT, V23, P274, DOI 10.1103/PhysRevLett.23.274.4; Berg E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.127003; Berg E, 2009, NAT PHYS, V5, P830, DOI 10.1038/NPHYS1389; Chen HD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.187002; Comin R, 2015, NAT MATER, V14, P796, DOI [10.1038/NMAT4295, 10.1038/nmat4295]; Comin R, 2016, ANNU REV CONDEN MA P, V7, P369, DOI 10.1146/annurev-conmatphys-031115-011401; Corboz P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.046402; DEVORET MH, 1990, PHYS REV LETT, V64, P1824, DOI 10.1103/PhysRevLett.64.1824; FALCI G, 1991, EUROPHYS LETT, V16, P109, DOI 10.1209/0295-5075/16/1/019; Forgan EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10064; Fradkin E, 2015, REV MOD PHYS, V87, P457, DOI 10.1103/RevModPhys.87.457; Freire H, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.045132; Fujita K, 2014, SCIENCE, V344, P612, DOI 10.1126/science.1248783; Fujita K, 2014, P NATL ACAD SCI USA, V111, pE3026, DOI 10.1073/pnas.1406297111; Fujita K, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.011005; FULDE P, 1964, PHYS REV, V135, pA550, DOI 10.1103/PhysRev.135.A550; Hamidian MH, 2016, NAT PHYS, V12, P150, DOI [10.1038/nphys3519, 10.1038/NPHYS3519]; Hamidian MH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053017; Himeda A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117001; Iansiti M., 1989, PHYS REV B A, V39, P6465; IVANCHEN.YM, 1969, SOV PHYS JETP-USSR, V28, P1272; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Larkin A I, 1964, ZH EKSP TEOR FIZ, V47, P1136; LARKIN AI, 1965, SOV PHYS JETP-USSR, V20, P762; Lee PA, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031017; Liao YA, 2010, NATURE, V467, P567, DOI 10.1038/nature09393; Loder F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.187001; MARTINIS JM, 1989, PHYS REV LETT, V63, P1507, DOI 10.1103/PhysRevLett.63.1507; Naaman O, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.097004; Nachumi B, 1996, PHYS REV LETT, V77, P5421, DOI 10.1103/PhysRevLett.77.5421; Norman MR, 2003, REP PROG PHYS, V66, P1547, DOI 10.1088/0034-4885/66/10/R01; Pepin C, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.195207; Proslier T, 2006, EUROPHYS LETT, V73, P962, DOI 10.1209/epl/i2005-10488-0; Raczkowski M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.140505; Rodrigo JG, 2004, EUR PHYS J B, V40, P483, DOI 10.1140/epjb/e2004-00273-y; Sachdev S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.027202; Seo K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094510; Slezak JA, 2008, P NATL ACAD SCI USA, V105, P3203, DOI 10.1073/pnas.0706795105; Smakov J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.212506; Wang YX, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.197001; Wang YX, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.115103; Yang KY, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055053; Zelli M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.104507	44	160	160	7	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					343	+		10.1038/nature17411	http://dx.doi.org/10.1038/nature17411			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9WR	27074504	Green Submitted			2022-12-28	WOS:000386232400001
J	Goodman, CD; Siregar, JE; Mollard, V; Vega-Rodriguez, J; Syafruddin, D; Matsuoka, H; Matsuzaki, M; Toyama, T; Sturm, A; Cozijnsen, A; Jacobs-Lorena, M; Kita, K; Marzuki, S; McFadden, GI				Goodman, Christopher D.; Siregar, Josephine E.; Mollard, Vanessa; Vega-Rodriguez, Joel; Syafruddin, Din; Matsuoka, Hiroyuki; Matsuzaki, Motomichi; Toyama, Tomoko; Sturm, Angelika; Cozijnsen, Anton; Jacobs-Lorena, Marcelo; Kita, Kiyoshi; Marzuki, Sangkot; McFadden, Geoffrey I.			Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes	SCIENCE			English	Article							FALCIPARUM CYTOCHROME-B; PLASMODIUM-BERGHEI; RODENT MALARIA; BC(1); INHERITANCE; METABOLISM; MUTATIONS; PROGUANIL; EMERGENCE; GENE	Drug resistance compromises control of malaria. Here, we show that resistance to a commonly used antimalarial medication, atovaquone, is apparently unable to spread. Atovaquone pressure selects parasites with mutations in cytochrome b, a respiratory protein with low but essential activity in the mammalian blood phase of the parasite life cycle. Resistance mutations rescue parasites from the drug but later prove lethal in the mosquito phase, where parasites require full respiration. Unable to respire efficiently, resistant parasites fail to complete mosquito development, arresting their life cycle. Because cytochrome b is encoded by the maternally inherited parasite mitochondrion, even outcrossing with wild-type strains cannot facilitate spread of resistance. Lack of transmission suggests that resistance will be unable to spread in the field, greatly enhancing the utility of atovaquone in malaria control.	[Goodman, Christopher D.; Siregar, Josephine E.; Mollard, Vanessa; Toyama, Tomoko; Sturm, Angelika; Cozijnsen, Anton; McFadden, Geoffrey I.] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Siregar, Josephine E.; Syafruddin, Din; Marzuki, Sangkot] Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia; [Vega-Rodriguez, Joel; Jacobs-Lorena, Marcelo] Johns Hopkins Univ, Malaria Res Inst, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Syafruddin, Din] Hasanuddin Univ, Dept Parasitol, Fac Med, Jalan Perintis Kemerdekaan Km10, Makassar 90245, Indonesia; [Matsuoka, Hiroyuki] Jichi Med Univ, Div Med Zool, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan; [Siregar, Josephine E.; Matsuzaki, Motomichi; Kita, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Kita, Kiyoshi] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 8528523, Japan	University of Melbourne; Eijkman Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universitas Hasanuddin; Jichi Medical University; University of Tokyo; Nagasaki University	Goodman, CD; McFadden, GI (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia.	deang@unimelb.edu.au; gim@unimelb.edu.au	Matsuzaki, Motomichi/D-4043-2016; McFadden, Geoffrey McFadden I/F-7667-2014	Matsuzaki, Motomichi/0000-0001-5811-798X; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Goodman, Christopher/0000-0002-8923-7594; Matsuoka, Hiroyuki/0000-0001-8839-0012; Syafruddin, din/0000-0001-7141-2545	National Health and Medical Research Council (Australia); Australian Research Council; Indonesian Ministry of Research, Technology, and Higher Education; U.S. National Institutes of Health [AI031478, RR00052]; Japanese Society for Promotion of Science (JSPS) KAKENHI [23117004, 26253025]; Japanese Science and Technology Agency/Japan International Cooperation Agency Science and Technology Research Partnership for Sustainable Development (SATREPS) [10000284]; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI031478, R01AI031478] Funding Source: NIH RePORTER	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Indonesian Ministry of Research, Technology, and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Society for Promotion of Science (JSPS) KAKENHI; Japanese Science and Technology Agency/Japan International Cooperation Agency Science and Technology Research Partnership for Sustainable Development (SATREPS); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Health and Medical Research Council (Australia); the Australian Research Council; the Indonesian Ministry of Research, Technology, and Higher Education; the U.S. National Institutes of Health (grants AI031478 and RR00052); the Japanese Society for Promotion of Science (JSPS) KAKENHI (grant 23117004 to M. M. and 26253025 to K. K.); and Japanese Science and Technology Agency/Japan International Cooperation Agency Science and Technology Research Partnership for Sustainable Development (SATREPS; no. 10000284 to K. K.). We acknowledge support of the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) and the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry. J.E.S. was a JSPS Ph.D. fellow (RONPAKU program) and an Endeavor Fellow from Scope Global, Australia. A.S. is affiliated with TropIQ Health Sciences (http://tropiq.nl). We thank the Johns Hopkins Malaria Research Institute mosquito and parasite core facilities for help with mosquito rearing and P. falciparum cultures, S. Narulitha of the Eijkman Institute for Molecular Biology for the novel P. berghei PbM133I atovaquone resistance mutant, and Walter Reed Army Institute of Research for the P. falciparum NF54e parasites. Data are archived at figshare (https://figshare.com) under doi 10.4225/49/56DE29B278684.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Birth D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5029; Boysen KE, 2011, J BIOL CHEM, V286, P32661, DOI 10.1074/jbc.M111.269399; Cottrell G, 2014, ANTIMICROB AGENTS CH, V58, P4504, DOI 10.1128/AAC.02550-13; CREASEY A, 1994, MOL BIOCHEM PARASIT, V65, P95, DOI 10.1016/0166-6851(94)90118-X; CREASEY AM, 1993, CURR GENET, V23, P360, DOI 10.1007/BF00310900; Dong CK, 2011, CHEM BIOL, V18, P1602, DOI 10.1016/j.chembiol.2011.09.016; Fisher N, 2012, J BIOL CHEM, V287, P9731, DOI 10.1074/jbc.M111.324319; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Hino A, 2012, J BIOCHEM, V152, P259, DOI 10.1093/jb/mvs058; Jacot D, 2016, TRENDS PARASITOL, V32, P56, DOI 10.1016/j.pt.2015.09.001; Ke HJ, 2015, CELL REP, V11, P164, DOI 10.1016/j.celrep.2015.03.011; Klein EY, 2013, INT J ANTIMICROB AG, V41, P311, DOI 10.1016/j.ijantimicag.2012.12.007; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-380; Nam TG, 2011, ACS CHEM BIOL, V6, P1214, DOI 10.1021/cb200105d; Nixon GL, 2013, J ANTIMICROB CHEMOTH, V68, P977, DOI 10.1093/jac/dks504; Okamoto N, 2009, EUKARYOT CELL, V8, P128, DOI 10.1128/EC.00267-08; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Preston MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5052; Reininger L, 2005, J BIOL CHEM, V280, P31957, DOI 10.1074/jbc.M504523200; Siregar JE, 2008, PARASITOL INT, V57, P229, DOI 10.1016/j.parint.2007.12.002; Siregar JE, 2015, PARASITOL INT, V64, P295, DOI 10.1016/j.parint.2014.09.011; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Stickles AM, 2015, AM J TROP MED HYG, V92, P1195, DOI 10.4269/ajtmh.14-0553; Sturm A, 2015, P NATL ACAD SCI USA, V112, P10216, DOI 10.1073/pnas.1423959112; Syafruddin D, 1999, MOL BIOCHEM PARASIT, V104, P185, DOI 10.1016/S0166-6851(99)00148-6; Tanaka TQ, 2012, PARASITOL INT, V61, P726, DOI 10.1016/j.parint.2012.06.002; VAIDYA AB, 1993, MOL CELL BIOL, V13, P7349, DOI 10.1128/MCB.13.12.7349; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4	32	79	79	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					349	353		10.1126/science.aad9279	http://dx.doi.org/10.1126/science.aad9279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081071	Green Accepted			2022-12-28	WOS:000373990100042
J	van der Heijden, MGA				van der Heijden, Marcel G. A.			ECOLOGY Underground networking	SCIENCE			English	Editorial Material							CARBON; GROWTH; TREES		[van der Heijden, Marcel G. A.] Inst Sustainabil Sci, Plant Soil Interact, Agroscope, CH-8046 Zurich, Switzerland; [van der Heijden, Marcel G. A.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [van der Heijden, Marcel G. A.] Univ Utrecht, Fac Sci, Inst Environm Biol, Plant Microbe Interact, NL-3584 CH Utrecht, Netherlands	Swiss Federal Research Station Agroscope; University of Zurich; Utrecht University	van der Heijden, MGA (corresponding author), Inst Sustainabil Sci, Plant Soil Interact, Agroscope, CH-8046 Zurich, Switzerland.	marcel.vanderheijden@agroscope.admin.ch	van der Heijden, Marcel G.A./H-5243-2011; van der Heijden, Marcel/AAY-1593-2021	van der Heijden, Marcel/0000-0001-7040-1924				de Vries FT, 2013, P NATL ACAD SCI USA, V110, P14296, DOI 10.1073/pnas.1305198110; Fitter AH, 1998, FUNCT ECOL, V12, P406, DOI 10.1046/j.1365-2435.1998.00206.x; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Klein T, 2016, SCIENCE, V352, P342, DOI 10.1126/science.aad6188; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; van der Heijden MGA, 2015, NEW PHYTOL, V205, P1406, DOI 10.1111/nph.13288; Walder F, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.159, 10.1038/NPLANTS.2015.159]; Wallander H, 2001, NEW PHYTOL, V151, P753, DOI 10.1046/j.0028-646x.2001.00199.x	12	6	9	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					290	291		10.1126/science.aaf4694	http://dx.doi.org/10.1126/science.aaf4694			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081054				2022-12-28	WOS:000373990100019
J	Chi, KR				Chi, Kelly Rae			THE TUMOUR TRAIL LEFT IN BLOOD	NATURE			English	Editorial Material							BREAST-CANCER; DNA; CELLS											Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chang GA, 2016, MOL ONCOL, V10, P157, DOI 10.1016/j.molonc.2015.09.005; Garcia-Murillas I., 2015, SCI TRANSL MED, V7; Im H, 2014, NAT BIOTECHNOL, V32, P490, DOI 10.1038/nbt.2886; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Olsson E, 2015, EMBO MOL MED, V7, P1034, DOI 10.15252/emmm.201404913; Smerage JB, 2014, J CLIN ONCOL, V32, P3483, DOI 10.1200/JCO.2014.56.2561; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050	8	68	72	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					269	271		10.1038/532269a	http://dx.doi.org/10.1038/532269a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075102	Bronze			2022-12-28	WOS:000374415100050
J	Maniscalco, S				Maniscalco, Sabrina			PHYSICS Quantum problems solved through games	NATURE			English	Editorial Material									[Maniscalco, Sabrina] Univ Turku, Dept Phys & Astron, Turku Ctr Quantum Phys, Turku 20014, Finland	University of Turku	Maniscalco, S (corresponding author), Univ Turku, Dept Phys & Astron, Turku Ctr Quantum Phys, Turku 20014, Finland.	sabrina.maniscalco@utu.fi	Maniscalco, Sabrina/Q-1043-2015	Maniscalco, Sabrina/0000-0001-8559-0828				Bloch I, 2005, NAT PHYS, V1, P23, DOI 10.1038/nphys138; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Lee J, 2014, P NATL ACAD SCI USA, V111, P2122, DOI 10.1073/pnas.1313039111; Sorensen JJWH, 2016, NATURE, V532, P210, DOI 10.1038/nature17620; von Ahn L, 2008, COMMUN ACM, V51, P58, DOI 10.1145/1378704.1378719; Weitenberg C, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.032322	8	3	3	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					184	185		10.1038/532184a	http://dx.doi.org/10.1038/532184a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075093				2022-12-28	WOS:000374415100027
J	Seifert, L; Werba, G; Tiwari, S; Ly, NNG; Alothman, S; Alqunaibit, D; Avanzi, A; Barilla, R; Daley, D; Greco, SH; Torres-Hernandez, A; Pergamo, M; Ochi, A; Zambirinis, CP; Pansari, M; Rendon, M; Tippens, D; Hundeyin, M; Mani, VR; Hajdu, C; Engle, D; Miller, G				Seifert, Lena; Werba, Gregor; Tiwari, Shaun; Nancy Ngoc Giao Ly; Alothman, Sara; Alqunaibit, Dalia; Avanzi, Antonina; Barilla, Rocky; Daley, Donnele; Greco, Stephanie H.; Torres-Hernandez, Alejandro; Pergamo, Matthew; Ochi, Atsuo; Zambirinis, Constantinos P.; Pansari, Mridul; Rendon, Mauricio; Tippens, Daniel; Hundeyin, Mautin; Mani, Vishnu R.; Hajdu, Cristina; Engle, Dannielle; Miller, George			The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression	NATURE			English	Article							CELLS; CANCER; APOPTOSIS; MICE; RECEPTOR; TUMOR; CARCINOGENESIS; CHEMOTHERAPY; NEOPLASIA	Neoplastic pancreatic epithelial cells are believed to die through caspase 8-dependent apoptotic cell death, and chemotherapy is thought to promote tumour apoptosis(1). Conversely, cancer cells often disrupt apoptosis to survive(2,3). Another type of programmed cell death is necroptosis (programmed necrosis), but its role in pancreatic ductal adenocarcinoma (PDA) is unclear. There are many potential inducers of necroptosis in PDA, including ligation of tumour necrosis factor receptor 1 (TNFR1), CD95, TNF-related apoptosis-inducing ligand (TRAIL) receptors, Toll-like receptors, reactive oxygen species, and chemotherapeutic drugs(4,5). Here we report that the principal components of the necrosome, receptor-interacting protein (RIP) 1 and RIP3, are highly expressed in PDA and are further upregulated by the chemotherapy drug gemcitabine. Blockade of the necrosome in vitro promoted cancer cell proliferation and induced an aggressive oncogenic phenotype. By contrast, in vivo deletion of RIP3 or inhibition of RIP1 protected against oncogenic progression in mice and was associated with the development of a highly immunogenic myeloid and T cell infiltrate. The immune-suppressive tumour microenvironment associated with intact RIP1/RIP3 signalling depended in part on necroptosis-induced expression of the chemokine attractant CXCL1, and CXCL1 blockade protected against PDA. Moreover, cytoplasmic SAP130 (a subunit of the histone deacetylase complex) was expressed in PDA in a RIP1/RIP3-dependent manner, and Mincle-its cognate receptor-was upregulated in tumour-infiltrating myeloid cells. Ligation of Mincle by SAP130 promoted oncogenesis, whereas deletion of Mincle protected against oncogenesis and phenocopied the immunogenic reprogramming of the tumour microenvironment that was induced by RIP3 deletion. Cellular depletion suggested that whereas inhibitory macrophages promote tumorigenesis in PDA, they lose their immune-suppressive effects when RIP3 or Mincle is deleted. Accordingly, T cells, which are not protective against PDA progression in mice with intact RIP3 or Mincle signalling, are reprogrammed into indispensable mediators of anti-tumour immunity in the absence of RIP3 or Mincle. Our work describes parallel networks of necroptosis-induced CXCL1 and Mincle signalling that promote macrophage-induced adaptive immune suppression and thereby enable PDA progression.	[Seifert, Lena; Werba, Gregor; Tiwari, Shaun; Nancy Ngoc Giao Ly; Alothman, Sara; Alqunaibit, Dalia; Avanzi, Antonina; Barilla, Rocky; Daley, Donnele; Greco, Stephanie H.; Torres-Hernandez, Alejandro; Ochi, Atsuo; Zambirinis, Constantinos P.; Pansari, Mridul; Rendon, Mauricio; Tippens, Daniel; Hundeyin, Mautin; Mani, Vishnu R.; Miller, George] NYU, Sch Med, Dept Surg, S Arthur Localio Lab, 550 First Ave, New York, NY 10016 USA; [Pergamo, Matthew; Miller, George] NYU, Sch Med, Dept Cell Biol, 550 First Ave, New York, NY 10016 USA; [Hajdu, Cristina] NYU, Sch Med, Dept Pathol, 550 First Ave, New York, NY 10016 USA; [Engle, Dannielle] Cold Spring Harbor Labs, Cold Spring Harbor, NY 11724 USA	New York University; New York University; New York University; Cold Spring Harbor Laboratory	Miller, G (corresponding author), NYU, Sch Med, Dept Surg, S Arthur Localio Lab, 550 First Ave, New York, NY 10016 USA.; Miller, G (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 First Ave, New York, NY 10016 USA.	george.miller@nyumc.org	Hundeyin, Mautin/AAU-6792-2020; Mani, Vishnu/AAF-1916-2020	Mani, Vishnu/0000-0003-3121-9497; Alothman, Sarah/0000-0001-5509-2115; Barilla, Rocky/0000-0002-8062-7246; Ochi, Atsuo/0000-0003-2374-7249; Engle, Dannielle/0000-0003-1876-7675; Seifert, Lena/0000-0003-4763-8127; Werba, Gregor/0000-0003-1464-9065; Alqunaibit, Dalia/0000-0002-8410-4143; Alothman, Sara/0000-0003-2375-5572; Zambirinis, Constantinos/0000-0003-2740-3259	German Research Foundation; National Pancreas Foundation; Pancreatic Cancer Action Network; Lustgarten Foundation; National Institute of Health [CA155649, CA168611, CA193111]; Cancer Center Support Grant [P30CA016087]; National Center for the Advancement of Translational Science (NCATS) [UL1 TR000038]; NATIONAL CANCER INSTITUTE [R01CA168611, T32CA148056, P30CA016087, R21CA155649, T32CA193111] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); National Pancreas Foundation; Pancreatic Cancer Action Network; Lustgarten Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; National Center for the Advancement of Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the German Research Foundation (L.S.), the National Pancreas Foundation (C.P.Z.), the Pancreatic Cancer Action Network (G.M.), the Lustgarten Foundation (G.M.), and National Institute of Health Awards CA155649 (G.M.), CA168611 (G.M.), and CA193111 (G.M., A.T.-H.). We thank the New York University Langone Medical Center (NYU LMC) Histopathology Core Facility, the NYU LMC Flow Cytometry Core Facility, the NYU LMC Microscopy Core Facility, and the NYU LMC BioRepository Center, each supported in part by the Cancer Center Support Grant P30CA016087 and by grant UL1 TR000038 from the National Center for the Advancement of Translational Science (NCATS).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Bedrosian AS, 2011, GASTROENTEROLOGY, V141, P1915, DOI 10.1053/j.gastro.2011.07.033; Connolly MK, 2010, J LEUKOCYTE BIOL, V87, P713, DOI 10.1189/jlb.0909607; Fernald K, 2013, TRENDS CELL BIOL, V23, P620, DOI 10.1016/j.tcb.2013.07.006; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Nagy A, 2001, ANTICANCER RES, V21, P1321; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Ochi A, 2012, J CLIN INVEST, V122, P4118, DOI 10.1172/JCI63606; Ochi A, 2012, J EXP MED, V209, P1671, DOI 10.1084/jem.20111706; Plath T, 2002, J NATL CANCER I, V94, P129, DOI 10.1093/jnci/94.2.129; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rosty C, 2003, AM J SURG PATHOL, V27, P1495, DOI 10.1097/00000478-200312000-00001; Takahashi H, 2013, BBA-MOL CELL RES, V1833, P2980, DOI 10.1016/j.bbamcr.2013.08.006; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P135, DOI DOI 10.1038/NRM3737; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Zambirinis CP, 2015, J EXP MED, V212, P2077, DOI 10.1084/jem.20142162	26	328	337	5	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					245	+		10.1038/nature17403	http://dx.doi.org/10.1038/nature17403			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27049944	Green Accepted			2022-12-28	WOS:000374415100042
J	Sherkow, JS				Sherkow, Jacob S.			Pursuit of profit poisons collaboration	NATURE			English	Editorial Material							CRISPR		[Sherkow, Jacob S.] New York Law Sch, Innovat Ctr Law & Technol, Law, New York, NY USA		Sherkow, JS (corresponding author), New York Law Sch, Innovat Ctr Law & Technol, Law, New York, NY USA.	jacob.sherkow@nyls.edu		Sherkow, Jacob/0000-0002-9724-9261				Abrams I., 2009, RES MGMT REV, V17, P18; Association of University Technology Managers, 2014, AUTM US LIC ACT SURV; Association of University Technology Managers, 1999, AUTM US LIC SURV FY1; Eisenberg Rebecca S., 2008, HOUS L REV, V45, P1059; Feldman R., 2014, STAN TECH L REV, V17, P773; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Sherkow JS, 2015, NAT BIOTECHNOL, V33, P256, DOI 10.1038/nbt.3160	7	17	17	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					172	173		10.1038/532172a	http://dx.doi.org/10.1038/532172a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ7TJ	27075081	Bronze, Green Published			2022-12-28	WOS:000374415100014
J	Melott, AL				Melott, Adrian L.			STELLAR ASTROPHYSICS Supernovae in the neighbourhood	NATURE			English	Editorial Material							NEARBY SUPERNOVAE; EARTH		[Melott, Adrian L.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA	University of Kansas	Melott, AL (corresponding author), Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA.	melott@ku.edu						Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Breitschwerdt D, 2016, NATURE, V532, P73, DOI 10.1038/nature17424; Ellis J, 1996, ASTROPHYS J, V470, P1227, DOI 10.1086/177945; Erlykin AD, 2010, SURV GEOPHYS, V31, P383, DOI 10.1007/s10712-010-9097-8; Fry BJ, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/71; Gehrels N, 2003, ASTROPHYS J, V585, P1169, DOI 10.1086/346127; Kachelriess M, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.181103; Knie K, 1999, PHYS REV LETT, V83, P18, DOI 10.1103/PhysRevLett.83.18; Melott AL, 2014, PALEOBIOLOGY, V40, P177, DOI 10.1666/13047; Schindewolf O. H., 1954, Neues Jahrbuch fuer Geologie und Palaeontologie, VB. 10, P457; Wallner A, 2016, NATURE, V532, P69, DOI 10.1038/nature17196	11	7	7	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					40	41		10.1038/532040a	http://dx.doi.org/10.1038/532040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27078562				2022-12-28	WOS:000373555500025
J	Yu, R; Moazed, D				Yu, Ruby; Moazed, Danesh			CSR-1 Slices a Balance	CELL			English	Editorial Material							GERMLINE GENE-EXPRESSION; C. ELEGANS; EPIGENETIC MEMORY; ARGONAUTE CSR-1; PATHWAY; PIRNAS; RNAS	CSR-1 is a germline-expressed C. elegans Argonaute protein essential for viability. In this issue of Cell, Gerson-Gurwitz et al. now demonstrate a role for CSR-1 and its slicer activity in downregulating the levels of maternally deposited mRNAs to fine-tune the expression of proteins with critical roles in embryonic cell divisions.	[Yu, Ruby; Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Cecere G, 2014, NAT STRUCT MOL BIOL, V21, P358, DOI 10.1038/nsmb.2801; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Gerson-Gurwitz A, 2016, CELL, V165, P396, DOI 10.1016/j.cell.2016.02.040; Grishok A, 2013, ADV GENET, V83, P1, DOI 10.1016/B978-0-12-407675-4.00001-8; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Wedeles CJ, 2013, DEV CELL, V27, P664, DOI 10.1016/j.devcel.2013.11.016	10	0	0	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					267	269		10.1016/j.cell.2016.03.019	http://dx.doi.org/10.1016/j.cell.2016.03.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058659	Bronze			2022-12-28	WOS:000374123000005
J	Tuccori, M; Filion, KB; Yin, H; Yu, OH; Platt, RW; Azoulay, L				Tuccori, Marco; Filion, Kristian B.; Yin, Hui; Yu, Oriana H.; Platt, Robert W.; Azoulay, Laurent			Pioglitazone use and risk of bladder cancer: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; URINARY-BLADDER; PPAR-GAMMA; THIAZOLIDINEDIONES; ALPHA; ASSOCIATION; ADJUSTMENT; TIME	OBJECTIVE To determine whether pioglitazone compared with other antidiabetic drugs is associated with an increased risk of bladder cancer in people with type 2 diabetes. DESIGN Population based cohort study. SETTING General practices contributing data to the United Kingdom Clinical Practice Research Datalink. PARTICIPANTS A cohort of 145 806 patients newly treated with antidiabetic drugs between 1 January 2000 and 31 July 2013, with follow-up until 31 July 2014. MAIN OUTCOME MEASURES The use of pioglitazone was treated as a time varying variable, with use lagged by one year for latency purposes. Cox proportional hazards models were used to estimate adjusted hazard ratios with 95% confidence intervals of incident bladder cancer associated with pioglitazone overall and by both cumulative duration of use and cumulative dose. Similar analyses were conducted for rosiglitazone, a thiazolidinedione not previously associated with an increased risk of bladder cancer. RESULTS The cohort generated 689 616 person years of follow-up, during which 622 patients were newly diagnosed as having bladder cancer (crude incidence 90.2 per 100 000 person years). Compared with other antidiabetic drugs, pioglitazone was associated with an increased risk of bladder cancer (121.0 v 88.9 per 100 000 person years; hazard ratio 1.63, 95% confidence interval 1.22 to 2.19). Conversely, rosiglitazone was not associated with an increased risk of bladder cancer (86.2 v 88.9 per 100 000 person years; 1.10, 0.83 to 1.47). Duration-response and dose-response relations were observed for pioglitazone but not for rosiglitazone. CONCLUSION The results of this large population based study indicate that pioglitazone is associated with an increased risk of bladder cancer. The absence of an association with rosiglitazone suggests that the increased risk is drug specific and not a class effect.	[Tuccori, Marco; Filion, Kristian B.; Yin, Hui; Yu, Oriana H.; Platt, Robert W.; Azoulay, Laurent] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada; [Tuccori, Marco; Filion, Kristian B.; Platt, Robert W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Filion, Kristian B.] McGill Univ, Div Clin Epidemiol, Montreal, PQ H3A 2T5, Canada; [Yu, Oriana H.] McGill Univ, Jewish Gen Hosp, Div Endocrinol, Montreal, PQ H3T 1E2, Canada; [Platt, Robert W.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Platt, Robert W.] McGill Univ, Dept Pediat, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ H3A 2T5, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Azoulay, L (corresponding author), Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada.; Azoulay, L (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ H3A 2T5, Canada.	laurent.azoulay@mcgill.ca	Azoulay, Laurent/Z-4421-2019; Tuccori, Marco/B-2113-2012	Filion, Kristian/0000-0001-6055-0088; Azoulay, Laurent/0000-0001-5162-3556	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study is funded by the Canadian Institutes of Health Research.	Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Balaji V, 2014, Indian J Endocrinol Metab, V18, P425, DOI 10.4103/2230-8210.131223; Boggon R, 2013, PHARMACOEPIDEM DR S, V22, P168, DOI 10.1002/pds.3374; Chang CH, 2012, HEPATOLOGY, V55, P1462, DOI 10.1002/hep.25509; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Egerod FL, 2010, J APPL TOXICOL, V30, P151, DOI 10.1002/jat.1481; Egerod FL, 2009, TOXICOL PATHOL, V37, P947, DOI 10.1177/0192623309351723; EMA, 2011, EUR MED AG REC NEW C; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fujimoto K, 2013, DIABETES RES CLIN PR, V99, pE21, DOI 10.1016/j.diabres.2012.11.013; Gale EAM, 2015, DIABETIC MED, V32, P431, DOI 10.1111/dme.12708; Heinzl H, 1996, STAT MED, V15, P2589, DOI 10.1002/(SICI)1097-0258(19961215)15:23<2589::AID-SIM373>3.0.CO;2-O; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Hillaire-Buys D, 2012, EUR J CLIN PHARMACOL, V68, P1681, DOI 10.1007/s00228-012-1299-1; Hsiao FY, 2013, DRUG SAFETY, V36, P643, DOI 10.1007/s40264-013-0080-4; Iles Andrew, 2003, BMJ, V327, P520, DOI 10.1136/bmj.327.7414.520-d; Jin SM, 2014, J KOREAN MED SCI, V29, P238, DOI 10.3346/jkms.2014.29.2.238; Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kung J, 2012, EXPERT OPIN DRUG SAF, V11, P565, DOI 10.1517/14740338.2012.691963; Kuo HW, 2014, KAOHSIUNG J MED SCI, V30, P94, DOI 10.1016/j.kjms.2013.09.011; Lee MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085479; Levin D, 2015, DIABETOLOGIA, V58, P493, DOI 10.1007/s00125-014-3456-9; Lewis JD, 2015, JAMA-J AM MED ASSOC, V314, P265, DOI 10.1001/jama.2015.7996; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Mamtani R, 2012, JNCI-J NATL CANCER I, V104, P1411, DOI 10.1093/jnci/djs328; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Oleksiewicz MB, 2008, PPAR RES, V2008, DOI 10.1155/2008/103167; Orasanu G, 2008, J AM COLL CARDIOL, V52, P869, DOI 10.1016/j.jacc.2008.04.055; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1085, DOI 10.1016/0895-4356(93)90106-B; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Ryder REJ, 2015, DIABETIC MED, V32, pe9, DOI 10.1111/dme.12736; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Song SO, 2012, DIABETES METAB J, V36, P371, DOI 10.4093/dmj.2012.36.5.371; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Tseng CH, 2012, DIABETES CARE, V35, P278, DOI 10.2337/dc11-1449; Turner RM, 2014, BRIT J CLIN PHARMACO, V78, P258, DOI 10.1111/bcp.12306; Vallarino C, 2013, CLIN DRUG INVEST, V33, P621, DOI 10.1007/s40261-013-0106-9; Viscoli CM, 2014, AM HEART J, V168, P823, DOI 10.1016/j.ahj.2014.07.016; Wei L, 2013, BRIT J CLIN PHARMACO, V75, P254, DOI 10.1111/j.1365-2125.2012.04325.x; Williams T, 2012, THER ADV DRUG SAF, V3, P89, DOI 10.1177/2042098611435911	44	135	138	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2016	352								i1541	10.1136/bmj.i1541	http://dx.doi.org/10.1136/bmj.i1541			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TO	27029385	Green Published, hybrid			2022-12-28	WOS:000373492400003
J	Barnett, R				Barnett, Richard			Ovarian cancer	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	18	19	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1265	1265		10.1016/S0140-6736(16)30024-1	http://dx.doi.org/10.1016/S0140-6736(16)30024-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	27035016				2022-12-28	WOS:000372697500012
J	Zhang, XL; Zhu, L; Wei, ZH; Zhu, QQ; Qiao, JZ; Dai, Q; Huang, W; Li, XH; Xie, J; Kang, LN; Wang, L; Xu, B				Zhang, Xin-Lin; Zhu, Li; Wei, Zhong-Hai; Zhu, Qing-Qing; Qiao, Jian-Zhong; Dai, Qing; Huang, Wei; Li, Xiao-Hong; Xie, Jun; Kang, Li-Na; Wang, Lian; Xu, Biao			Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-ARTERY-DISEASE; ELEVATION MYOCARDIAL-INFARCTION; MIDTERM CLINICAL-OUTCOMES; VASCULAR SCAFFOLD; FOLLOW-UP; INTRAVASCULAR ULTRASOUND; PATIENT-YEARS; IMPLANTATION; THROMBOSIS; 2ND-GENERATION	Background: Theoretically, the everolimus-eluting bioresorbable vascular scaffold (BVS) could eliminate stent thrombosis and improve outcomes in patients having percutaneous coronary intervention. Purpose: To estimate the incidence of stent thrombosis after BVS implantation and to compare the efficacy and safety of BVSs versus everolimus-eluting metallic stents (EESs) in adults having percutaneous coronary intervention. Data Sources: PubMed, EMBASE, Cochrane Central Register of Controlled Trials, conference proceedings, and relevant Web sites from inception through 20 January 2016. Study Selection: 6 randomized, controlled trials and 38 observational studies, each involving at least 40 patients with BVS implantation. Data Extraction: Two reviewers independently extracted study data and evaluated study risk of bias. Data Synthesis: The pooled incidence of definite or probable stent thrombosis after BVS implantation was 1.5 events per 100 patient-years (PYs) (95% CI, 1.2 to 2.0 events per 100 PYs) (126 events during 8508 PYs). Six randomized trials that directly compared BVSs with EESs showed a non-statistically significant increased risk for stent thrombosis (odds ratio [OR], 2.05 [CI, 0.95 to 4.43]; P = 0.067) and myocardial infarction (OR, 1.38 [CI, 0.98 to 1.95]; P = 0.064) with BVSs. The 6 observational studies that compared BVSs with EESs showed increased risk for stent thrombosis (OR, 2.32 [CI, 1.06 to 5.07]; P = 0.035) and myocardial infarction (OR, 2.09 [CI, 1.23 to 3.55]; P = 0.007) with BVSs. The relative rates of all-cause and cardiac death, revascularization, and target lesion failure were similar for BVSs and EESs. Limitation: Scarce comparative data, no published data from large trials with long-term follow-up, and limited quality and incomplete reporting of observational studies. Conclusion: Compared with EESs, BVSs do not eliminate and might increase risks for stent thrombosis and myocardial infarction in adults having percutaneous coronary intervention. Results of large trials with long-term follow-up are critically needed to establish the safety or at least the noninferiority of BVSs compared with EESs.	[Zhang, Xin-Lin; Wei, Zhong-Hai; Qiao, Jian-Zhong; Dai, Qing; Huang, Wei; Li, Xiao-Hong; Xie, Jun; Kang, Li-Na; Wang, Lian; Xu, Biao] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Li] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Radiol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Qing-Qing] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Xu, B (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	xinlzhang0807@gmail.com; wanglian@medmail.com.cn; xubiao@medmail.com.cn	祝, 清清/AHD-0460-2022; Xie, Jun/C-2193-2017	Xu, Biao/0000-0001-5351-2630; Xie, Jun/0000-0002-9385-3242				Abizaid A., 2015, EUROPCR PAR FRANC 19; Azzalini L, 2015, J INVASIVE CARDIOL, V27, P85; Bangalore S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6625; Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Bittl JA, 2010, CIRCULATION, V122, P2236, DOI 10.1161/CIRCULATIONAHA.110.988469; Brugaletta S, 2015, JACC-CARDIOVASC INTE, V8, P189, DOI 10.1016/j.jcin.2014.10.005; Camacho FSJ, 2015, EUROPCR PAR FRANC 19; Capodanno D, 2015, EUROINTERVENTION, V10, P1144, DOI 10.4244/EIJY14M07_11; Cassese S, 2016, LANCET, V387, P537, DOI 10.1016/S0140-6736(15)00979-4; Chevalier B, 2015, TRANSC CARD THER TCT; Claessen BE, 2009, CIRC-CARDIOVASC INTE, V2, P339, DOI 10.1161/CIRCINTERVENTIONS.108.831800.108.831800; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Cortese B, 2015, AM J CARDIOL, V116, P705, DOI 10.1016/j.amjcard.2015.05.049; Costopoulos C, 2015, CARDIOVASC REVASCULA, V16, P461, DOI 10.1016/j.carrev.2015.08.003; Costopoulos C, 2015, CATHETER CARDIO INTE, V85, pE10, DOI 10.1002/ccd.25569; Cuculi F., 2015, EUROPCR PAR FRANC 19; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dalos D, 2015, EUROPCR PAR FRANC 19; Di Mario C, 2015, LANCET, V385, P10, DOI 10.1016/S0140-6736(14)61636-6; Diletti R, 2014, EUR HEART J, V35, P777, DOI 10.1093/eurheartj/eht546; Dudek D., 2014, EUROPCR PAR FRANC 20; Dudek D, 2012, EUROINTERVENTION, V7, P1060, DOI 10.4244/EIJV7I9A168; Eeckhout E., 2015, EUROPCR PAR FRANC 19; El Khoury R, 2014, J AM COLL CARDIOL, V64, pB185, DOI 10.1016/j.jacc.2014.07.699; El-Mawardy M, 2015, EUROPCR PAR FRANC 19; Elabbassi W., 2014, EUROPCR PAR FRANC 20; Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Gao RL, 2015, J AM COLL CARDIOL, V66, P2298, DOI 10.1016/j.jacc.2015.09.054; Gogas BD, 2012, JACC-CARDIOVASC INTE, V5, P656, DOI 10.1016/j.jcin.2012.02.017; Gori T, 2015, EUROPCR PAR FRANC 21; Gori T, 2015, JACC-CARDIOVASC INTE, V8, P770, DOI 10.1016/j.jcin.2014.12.244; Haji K, 2015, HEART LUNG CIRC, V24, pS264; Hamm C., 2015, EUROPCR PAR FRANC 19; Hernandez FH, 2015, EUROPCR PAR FRANC 19; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoppmann P, 2016, CATHETER CARDIO INTE, V87, P822, DOI 10.1002/ccd.26346; Jaguszewski M, 2015, CLIN RES CARDIOL, V104, P124, DOI 10.1007/s00392-014-0757-4; Kabir CMS, 2015, INDIAN HEART J, V67, pS49, DOI [10.1016/j.ihj.2015.10.118, DOI 10.1016/J.IHJ.2015.10.118]; Kang SH, 2014, EUR HEART J, V35, P1147, DOI 10.1093/eurheartj/eht570; Khripun A, 2015, EUROPCR PAR FRANC 19; Kimura T, 2015, EUR HEART J, V36, P3332, DOI 10.1093/eurheartj/ehv435; Kraak RP, 2015, EUROINTERVENTION, V10, P1160, DOI 10.4244/EIJY14M08_08; Lipinski MJ, 2016, JACC-CARDIOVASC INTE, V9, P12, DOI 10.1016/j.jcin.2015.09.024; Markovic S, 2015, EUROPCR PAR FRANC 20; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moscarella E, 2015, INT J CARDIOL, V199, P366, DOI 10.1016/j.ijcard.2015.07.002; Muramatsu T, 2014, JACC-CARDIOVASC INTE, V7, P482, DOI 10.1016/j.jcin.2014.01.155; Muramatsu T, 2013, REV ESP CARDIOL, V66, P483, DOI 10.1016/j.rec.2012.12.009; Nakatani S, 2015, EUROINTERVENTION, V10, P1288, DOI 10.4244/EIJV10I11A218; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Onuma Y, 2014, EUR HEART J, V35, P982; Ormiston JA, 2012, CIRC-CARDIOVASC INTE, V5, P620, DOI 10.1161/CIRCINTERVENTIONS.112.971549; Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061; Palmerini T, 2011, CIRC-CARDIOVASC INTE, V4, P577, DOI 10.1161/CIRCINTERVENTIONS.111.963884; Puricel S, 2015, J AM COLL CARDIOL, V65, P791, DOI 10.1016/j.jacc.2014.12.017; Robaei D, 2015, J INVASIVE CARDIOL; Romero M, 2015, EUR HEART J, V36, P649; Sabate M, 2016, EUR HEART J, V37, P229, DOI 10.1093/eurheartj/ehv500; Sainsous J, 2015, ARCH CARDIOVASC DIS, V7, P134, DOI [10.1016/S1878-6480(15)30011-2, DOI 10.1016/S1878-6480(15)30011-2]; Seeger J, 2015, J AM COLL CARDIOL, V66, pB208, DOI 10.1016/j.jacc.2015.08.526; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Serruys PW, 2014, EUROINTERVENTION, V9, P1271, DOI 10.4244/EIJV9I11A217; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Serruys PW, 2011, J AM COLL CARDIOL, V58, P1578, DOI 10.1016/j.jacc.2011.05.050; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; Suarez De Lezo J, 2015, EUROPCR PAR FRANC 19; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Teeuwen K, 2015, CLIN TRIALS REGUL SC, V10, P1, DOI [10.1016/j.ctrsc.2015.09.004, DOI 10.1016/J.CTRSC.2015.09.004]; Van Geuns RJ, 2014, EUROPCR PAR FRANC 20; Vlachojannis GJ, 2015, EUROPCR PAR FRANC 19; Wells G., 2013, OTTAWA HOSP RES I; Whitbourn RJ, 2013, J AM COLL CARDIOL, V62, pB11, DOI 10.1016/j.jacc.2013.08.761; Widimsky P, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002933; Wiebe J, 2014, J AM COLL CARDIOL, V64, P2541, DOI 10.1016/j.jacc.2014.09.041; Wohrle J, 2015, EUROINTERVENTION, V11, P149, DOI 10.4244/EIJY14M12_10; Wojcik J, 2015, J AM COLL CARDIOL, V66, pB206, DOI 10.1016/j.jacc.2015.08.521; Zhang YJ, 2015, HEART, V101, P271, DOI 10.1136/heartjnl-2014-306359	81	22	22	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2016	164	11					752	+		10.7326/M16-0006	http://dx.doi.org/10.7326/M16-0006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1AI	27042809				2022-12-28	WOS:000377510100007
J	van Houte, S; Ekroth, AKE; Broniewski, JM; Chabas, H; Ashby, B; Bondy-Denomy, J; Gandon, S; Boots, M; Paterson, S; Buckling, A; Westra, ER				van Houte, Stineke; Ekroth, Alice K. E.; Broniewski, Jenny M.; Chabas, Helene; Ashby, Ben; Bondy-Denomy, Joseph; Gandon, Sylvain; Boots, Mike; Paterson, Steve; Buckling, Angus; Westra, Edze R.			The diversity-generating benefits of a prokaryotic adaptive immune system	NATURE			English	Article							HOST-PARASITE COEVOLUTION; GENETIC DIVERSITY; CRISPR-CAS; RED QUEEN; RESISTANCE; EVOLUTION; DYNAMICS; VIRUSES; DRIVES	Prokaryotic CRISPR-Cas adaptive immune systems insert spacers derived from viruses and other parasitic DNA elements into CRISPR loci to provide sequence-specific immunity(1,2). This frequently results in high within-population spacer diversity(3-6), but it is unclear if and why this is important. Here we show that, as a result of this spacer diversity, viruses can no longer evolve to overcome CRISPR-Cas by point mutation, which results in rapid virus extinction. This effect arises from synergy between spacer diversity and the high specificity of infection, which greatly increases overall population resistance. We propose that the resulting short-lived nature of CRISPR-dependent bacteria-virus coevolution has provided strong selection for the evolution of sophisticated virus-encoded anti-CRISPR mechanisms(7).	[van Houte, Stineke; Ekroth, Alice K. E.; Broniewski, Jenny M.; Chabas, Helene; Buckling, Angus; Westra, Edze R.] Univ Exeter, Biosci, ESI, Cornwall Campus, Penryn TR10 9EZ, England; [van Houte, Stineke; Ekroth, Alice K. E.; Broniewski, Jenny M.; Chabas, Helene; Ashby, Ben; Boots, Mike; Buckling, Angus; Westra, Edze R.] Univ Exeter, Biosci, CEC, Cornwall Campus, Penryn TR10 9EZ, England; [Chabas, Helene; Gandon, Sylvain] Univ Montpellier, Univ Paul Valery Montpellier, CEFE,UMR 5175, CNRS,EPHE, 1919 Route de Mende, F-34293 Montpellier 5, France; [Ashby, Ben; Boots, Mike] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Bondy-Denomy, Joseph] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Paterson, Steve] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	University of Exeter; University of Exeter; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of Liverpool	van Houte, S; Buckling, A; Westra, ER (corresponding author), Univ Exeter, Biosci, ESI, Cornwall Campus, Penryn TR10 9EZ, England.; van Houte, S; Buckling, A; Westra, ER (corresponding author), Univ Exeter, Biosci, CEC, Cornwall Campus, Penryn TR10 9EZ, England.	vanhoute.stineke@gmail.com; A.J.Buckling@exeter.ac.uk; westra.edze@gmail.com	van Houte, Stineke/AAA-4955-2022; GANDON, Sylvain/AHC-0976-2022; Chabas, Hélène/O-6350-2019; Ashby, Ben/H-7690-2019; Paterson, Steve/D-2154-2009	GANDON, Sylvain/0000-0003-2624-7856; Chabas, Helene/0000-0001-9792-3589; Buckling, Angus/0000-0003-1170-4604; Paterson, Steve/0000-0002-1307-2981; Broniewski, Jenny/0000-0003-1447-092X; Ashby, Ben/0000-0001-5588-7081	European Union [660039, 327606]; Natural Environment Research Council; Biotechnology and Biological Sciences Research Council; Royal Society; Leverhulme Trust; Wellcome Trust; AXA; University of California San Francisco Program for Breakthrough in Biomedical Research; Sandler Foundation; National Institutes of Health Director's Early Independence Award [DP5-OD021344]; Erasmus+ programme (European Union); Explora'Sup programme (Region Rhone-Alpes); Centre Regional des OEuvres Universitaires et Scolaires (CROUS; French State); Biotechnology and Biological Sciences Research Council [1622146] Funding Source: researchfish; Natural Environment Research Council [NE/K014617/1, NE/M018350/1, NE/J021806/1, NBAF010002] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021344] Funding Source: NIH RePORTER; BBSRC [1622146] Funding Source: UKRI; NERC [NE/J021806/1, NE/M018350/1, NE/K014617/1, NBAF010002] Funding Source: UKRI	European Union(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); Wellcome Trust(Wellcome Trust); AXA; University of California San Francisco Program for Breakthrough in Biomedical Research; Sandler Foundation; National Institutes of Health Director's Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Erasmus+ programme (European Union); Explora'Sup programme (Region Rhone-Alpes)(Region Auvergne-Rhone-Alpes); Centre Regional des OEuvres Universitaires et Scolaires (CROUS; French State); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank D. Morley and S. Kay for experimental contributions and A. Gardner for comments on the manuscript. S.v.H. has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement number 660039. E.R.W. received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under Research Executive Agency grant agreement number 327606. E.R.W., A.B. and M.B. also acknowledge the Natural Environment Research Council, the Biotechnology and Biological Sciences Research Council, the Royal Society, the Leverhulme Trust, the Wellcome Trust and the AXA research fund for funding. J.M.B.-D. was supported by the University of California San Francisco Program for Breakthrough in Biomedical Research, the Sandler Foundation, and a National Institutes of Health Director's Early Independence Award (DP5-OD021344). H.C. was funded by the Erasmus+ programme (European Union), the Explora'Sup programme (Region Rhone-Alpes) and the Centre Regional des OEuvres Universitaires et Scolaires (CROUS; French State).	Altermatt F, 2008, ECOL LETT, V11, P918, DOI 10.1111/j.1461-0248.2008.01203.x; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Ashby B, 2015, J EVOLUTION BIOL, V28, P511, DOI 10.1111/jeb.12590; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Childs LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101710; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Iranzo J, 2013, J BACTERIOL, V195, P3834, DOI 10.1128/JB.00412-13; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; King KC, 2012, HEREDITY, V109, P199, DOI 10.1038/hdy.2012.33; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Lively CM, 2010, J EVOLUTION BIOL, V23, P1490, DOI 10.1111/j.1420-9101.2010.02017.x; Lively CM, 2010, AM NAT, V175, pE149, DOI 10.1086/652430; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Peters AD, 1999, AM NAT, V154, P393, DOI 10.1086/303247; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Schmid-Hempel P, 1999, PHILOS T R SOC B, V354, P507, DOI 10.1098/rstb.1999.0401; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Vale PF, 2015, P ROY SOC B-BIOL SCI, V282, P41, DOI 10.1098/rspb.2015.1270; van Baalen M, 2006, AM NAT, V167, P568, DOI 10.1086/501169; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westra ER, 2015, CURR BIOL, V25, P1043, DOI 10.1016/j.cub.2015.01.065	30	148	149	6	81	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					385	+		10.1038/nature17436	http://dx.doi.org/10.1038/nature17436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27074511	Green Submitted, Green Accepted			2022-12-28	WOS:000374424700035
J	Xiong, HZ; Keith, JW; Samilo, DW; Carter, RA; Leiner, IM; Pamer, EG				Xiong, Huizhong; Keith, James W.; Samilo, Dane W.; Carter, Rebecca A.; Leiner, Ingrid M.; Pamer, Eric G.			Innate Lymphocyte/Ly6C(hi) Monocyte Crosstalk Promotes Klebsiella Pneumoniae Clearance	CELL			English	Article							TUMOR-NECROSIS-FACTOR; LYMPHOID-CELLS; HOST-DEFENSE; TH17 CELLS; RHEUMATOID-ARTHRITIS; CCR2(+) MONOCYTES; PROTECTIVE ROLE; IMMUNE DEFENSE; LIVER-ABSCESS; IL-17	Increasing antibiotic resistance among bacterial pathogens has rendered some infections untreatable with available antibiotics. Klebsiella pneumoniae, a bacterial pathogen that has acquired high-level antibiotic resistance, is a common cause of pulmonary infections. Optimal clearance of K. pneumoniae from the host lung requires TNF and IL-17A. Herein, we demonstrate that inflammatory monocytes are rapidly recruited to the lungs of K. pneumoniae-infected mice and produce TNF, which markedly increases the frequency of IL-17-producing innate lymphoid cells. While pulmonary clearance of K. pneumoniae is preserved in neutrophil-depleted mice, monocyte depletion or TNF deficiency impairs IL-17A-dependent resolution of pneumonia. Monocyte- mediated bacterial uptake and killing is enhanced by ILC production of IL-17A, indicating that innate lymphocytes engage in a positive-feedback loop with monocytes that promotes clearance of pneumonia. Innate immune defense against a highly antibiotic-resistant bacterial pathogen depends on crosstalk between inflammatory monocytes and innate lymphocytes that is mediated by TNF and IL-17A.	[Xiong, Huizhong; Keith, James W.; Samilo, Dane W.; Carter, Rebecca A.; Leiner, Ingrid M.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA; [Xiong, Huizhong; Keith, James W.; Carter, Rebecca A.; Leiner, Ingrid M.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10065 USA; [Keith, James W.] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA; [Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Clin Microbiol Serv, New York, NY 10065 USA; [Samilo, Dane W.] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA.; Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10065 USA.; Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Microbiol Serv, New York, NY 10065 USA.	pamere@mskcc.org			Memorial Sloan Kettering Flow Cytometry and Cell Sorting Core at Memorial Sloan Kettering Cancer Center [P30 CA008748]; NIH [R37AI039031, A023766]; NATIONAL CANCER INSTITUTE [P01CA023766, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039031] Funding Source: NIH RePORTER	Memorial Sloan Kettering Flow Cytometry and Cell Sorting Core at Memorial Sloan Kettering Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the members of the E.G.P. laboratory for their helpful discussions. We thank the Memorial Sloan Kettering Flow Cytometry and Cell Sorting Core at Memorial Sloan Kettering Cancer Center (core grant P30 CA008748) for their services and advice. This study was supported by grants from the NIH (R37AI039031) and P01 (A023766) (to E.G.P.).	Abt MC, 2015, CELL HOST MICROBE, V18, P27, DOI 10.1016/j.chom.2015.06.011; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Cai SS, 2009, J IMMUNOL, V183, P6629, DOI 10.4049/jimmunol.0901033; Chen K, 2011, IMMUNITY, V35, P997, DOI 10.1016/j.immuni.2011.10.018; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Ge SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085461; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Hu Y, 2011, ANN NY ACAD SCI, V1217, P60, DOI 10.1111/j.1749-6632.2010.05825.x; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Laichalk LL, 1996, INFECT IMMUN, V64, P5211, DOI 10.1128/IAI.64.12.5211-5218.1996; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Moore TA, 2005, CLIN INFECT DIS, V41, pS213, DOI 10.1086/430126; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sedgwick JD, 2000, IMMUNOL TODAY, V21, P110, DOI 10.1016/S0167-5699(99)01573-X; Seo SU, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9010; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Starner TD, 2003, AM J RESP CELL MOL, V29, P627, DOI 10.1165/rcmb.2002-0272OC; Steichen AL, 2013, J LEUKOCYTE BIOL, V94, P393, DOI 10.1189/jlb.1212622; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Sugita S, 2002, J IMMUNOL, V168, P5621, DOI 10.4049/jimmunol.168.11.5621; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Van Maele L, 2014, J INFECT DIS, V210, P493, DOI 10.1093/infdis/jiu106; Xiong HZ, 2015, INFECT IMMUN, V83, P3418, DOI 10.1128/IAI.00678-15; Xu X, 2014, J IMMUNOL, V192, P1778, DOI 10.4049/jimmunol.1300039; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	47	109	118	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					679	689		10.1016/j.cell.2016.03.017	http://dx.doi.org/10.1016/j.cell.2016.03.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27040495	Green Accepted, Bronze			2022-12-28	WOS:000374636800025
J	Farmakiotis, D; Zeluff, B				Farmakiotis, Dimitrios; Zeluff, Barry			Metronidazole-Associated Encephalopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Farmakiotis, Dimitrios] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Zeluff, Barry] St Lukes Hosp, Houston, TX USA	Harvard University; Brigham & Women's Hospital	Farmakiotis, D (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	dfarmakiotis@windowslive.com							0	10	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1465	1465		10.1056/NEJMicm1505174	http://dx.doi.org/10.1056/NEJMicm1505174			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27074069				2022-12-28	WOS:000374128400010
J	Frank, J				Frank, John			Origins of the obesity pandemic can be analysed	NATURE			English	Editorial Material									[Frank, John] Univ Edinburgh, Publ Hlth Res, Edinburgh EH8 9YL, Midlothian, Scotland; [Frank, John] Univ Toronto, Toronto, ON M5S 1A1, Canada	University of Edinburgh; University of Toronto	Frank, J (corresponding author), Univ Edinburgh, Publ Hlth Res, Edinburgh EH8 9YL, Midlothian, Scotland.; Frank, J (corresponding author), Univ Toronto, Toronto, ON M5S 1A1, Canada.	john.frank@ed.ac.uk	Frank, John/AAZ-1169-2020	Frank, John/0000-0003-3912-4214	MRC [MR/K007017/1, MR/K023209/1] Funding Source: UKRI; Medical Research Council [MR/K023209/1, MR/K007017/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	13	13	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					149	149		10.1038/532149a	http://dx.doi.org/10.1038/532149a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ7TJ	27075060	Bronze			2022-12-28	WOS:000374415100004
J	Clarke, JM				Clarke, Jonathan M.			PERSONAL VIEW Stop denying migrants their fundamental right to healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Clarke, Jonathan M.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Clarke, JM (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	jclarke@mail.harvard.edu	Clarke, Jonathan/S-8958-2019	Clarke, Jonathan/0000-0003-1495-7746				Chauvin P, 2015, ACCESS HEALTHCARE PE; Dawar A., 2015, EXPRESS         0721; Doctors of the World, 2016, BRIEF DEP HLTH CONS; Escritt T., 2016, REUTERS; European Parliament, 2014, UND WOM MIGR EU 2013; European Union, 2012, CHART FUND RIGHTS EU; Kalt A, 2013, AM J PUBLIC HEALTH, V103, pE30, DOI 10.2105/AJPH.2012.301136; Lowe J., 2016, NEWSWEEK; Slack J., 2016, MAIL ONLINE     0209; UN High Commissioner for Refugees (UNHCR), 2016, DAFNI; Unicef, 2016, NEW EU TURK AGR REF	11	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2016	353								i1971	10.1136/bmj.i1971	http://dx.doi.org/10.1136/bmj.i1971			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ7ER	27072121	Green Published			2022-12-28	WOS:000374375200005
J	Zitvogel, L; Ayyoub, M; Routy, B; Kroemer, G				Zitvogel, Laurence; Ayyoub, Maha; Routy, Bertrand; Kroemer, Guido			Microbiome and Anticancer Immunosurveillance	CELL			English	Review							REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; ANTIGEN-PRESENTING CELLS; NATURAL-KILLER-CELLS; GUT MICROBIOTA; IMMUNE-SYSTEM; INTESTINAL MICROBIOTA; EPITHELIAL BARRIERS; ANTITUMOR IMMUNITY; AUTOIMMUNE-DISEASE	Anticancer immune responses can be considered a desirable form of autoimmunity that may be profoundly shaped by the microbiome. Here, we discuss evidence for the microbiome's influence on anti-tumor immunosurveillance, including those that are indirect and can act at a distance, and we put forward hypotheses regarding mechanisms of how these effects are implemented. These may involve cross-reactivity between microbial and tumor antigens shaping T cell repertoires and/or microbial products stimulating pattern recognition receptors that influence the type and intensity of immune responses. Understanding how the microbiome impacts natural cancer immunosurveillance as well as treatment-induced immune responses will pave the way for more effective therapies and prophylactics.	[Zitvogel, Laurence; Ayyoub, Maha; Routy, Bertrand] INSERM, Equipe Labellisee Ligue Natl Canc, U1015, Gustave Roussy Canc Campus, F-95800 Villejuif, France; [Zitvogel, Laurence; Ayyoub, Maha; Routy, Bertrand] Univ Paris 11, F-94270 Le Kremlin Bicetre, France; [Zitvogel, Laurence; Ayyoub, Maha; Routy, Bertrand] Ctr Clin Invest Biotherapies Canc, F-95800 Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellise Ligue Canc 11, F-75006 Paris, France; [Kroemer, Guido] Gustave Roussy Comprehens Canc Ctr, Cell Biol & Metabol Platforms, F-95800 Villejuif, France; [Kroemer, Guido] INSERM, U1138, F-75006 Paris, France; [Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Kroemer, Guido] Univ Paris 06, F-75006 Paris, France; [Kroemer, Guido] Hop Europe Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France; [Kroemer, Guido] Karolinska Inst, Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Zitvogel, L (corresponding author), INSERM, Equipe Labellisee Ligue Natl Canc, U1015, Gustave Roussy Canc Campus, F-95800 Villejuif, France.; Zitvogel, L (corresponding author), Univ Paris 11, F-94270 Le Kremlin Bicetre, France.; Zitvogel, L (corresponding author), Ctr Clin Invest Biotherapies Canc, F-95800 Villejuif, France.; Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Labellise Ligue Canc 11, F-75006 Paris, France.; Kroemer, G (corresponding author), Gustave Roussy Comprehens Canc Ctr, Cell Biol & Metabol Platforms, F-95800 Villejuif, France.; Kroemer, G (corresponding author), INSERM, U1138, F-75006 Paris, France.; Kroemer, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France.; Kroemer, G (corresponding author), Univ Paris 06, F-75006 Paris, France.; Kroemer, G (corresponding author), Hop Europe Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France.; Kroemer, G (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden.	laurence.zitvogel@gustaveroussy.fr; kroemer@orange.fr	Ayyoub, Maha/A-2074-2017; Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	Ayyoub, Maha/0000-0003-2022-0898; KROEMER, Guido/0000-0002-9334-4405; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR)-Projets blancs; ANR; ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); LeDucq Foundation; LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); Cancer Research Institute (CRI); Ludwig Institute for Cancer Research (LICR)	Ligue contre le Cancer (equipe labelisee)(Ligue nationale contre le cancer); Agence National de la Recherche (ANR)-Projets blancs(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)); LeDucq Foundation(Leducq Foundation); LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); Cancer Research Institute (CRI); Ludwig Institute for Cancer Research (LICR)	L.Z. and G.K. are supported by the Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR)-Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the LeDucq Foundation; the LabEx Immuno-Oncology; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI). M.A. is supported by the Cancer Research Institute (CRI) and the Ludwig Institute for Cancer Research (LICR).	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409; Boursi B, 2015, EUR J CANCER, V51, P2655, DOI 10.1016/j.ejca.2015.08.015; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Burgener A, 2015, CURR OPIN IMMUNOL, V36, P22, DOI 10.1016/j.coi.2015.06.004; Burrows MP, 2015, P NATL ACAD SCI USA, V112, P9973, DOI 10.1073/pnas.1508740112; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Cheng M, 2014, CANCER RES, V74, P4030, DOI 10.1158/0008-5472.CAN-13-2462; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Deshmukh US, 2011, J AUTOIMMUN, V37, P254, DOI 10.1016/j.jaut.2011.07.002; Dominianni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124599; Dutoit V, 2002, J EXP MED, V196, P207, DOI 10.1084/jem.20020242; Floreani A., 2015, CLIN REV ALLERGY IMM; Friedman GD, 2006, CANCER EPIDEM BIOMAR, V15, P2102, DOI 10.1158/1055-9965.EPI-06-0401; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gagliani N, 2014, CELL, V157, P776, DOI 10.1016/j.cell.2014.03.006; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Green SI, 2015, INFECT IMMUN, V83, P3243, DOI 10.1128/IAI.00684-15; Greig SL, 2015, DRUGS, V75, P1687, DOI 10.1007/s40265-015-0462-2; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; GUTENSOHN N, 1981, NEW ENGL J MED, V304, P135, DOI 10.1056/NEJM198101153040302; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Jacquelot N, 2016, J CLIN INVEST, V126, P921, DOI 10.1172/JCI80071; Kiselyov A, 2015, BBA CLIN, V4, P27, DOI 10.1016/j.bbacli.2015.06.002; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; KROEMER G, 1993, ADV IMMUNOL, V53, P157, DOI 10.1016/S0065-2776(08)60500-3; Kroemer G, 2015, NAT MED, V21, P1128, DOI 10.1038/nm.3944; Kunisawa J, 2008, TRENDS IMMUNOL, V29, P505, DOI 10.1016/j.it.2008.07.008; Le DT, 2015, J CLIN ONCOL, V33, P1325, DOI 10.1200/JCO.2014.57.4244; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; Longman RS, 2015, CURR OPIN RHEUMATOL, V27, P381, DOI 10.1097/BOR.0000000000000190; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Matsumura S, 2002, HEPATOLOGY, V35, P14, DOI 10.1053/jhep.2002.30280; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Meier C, 2007, NAT CLIN PRACT RHEUM, V3, P667, DOI 10.1038/ncprheum0625; Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377; Misko IS, 1999, P NATL ACAD SCI USA, V96, P2279, DOI 10.1073/pnas.96.5.2279; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342; Oikonomopoulou K, 2013, CLIN CANCER RES, V19, P2834, DOI 10.1158/1078-0432.CCR-12-3661; Parodi S, 2013, INT J CANCER, V133, P1892, DOI 10.1002/ijc.28205; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Perez-Chanona E, 2016, CURR OPIN IMMUNOL, V39, P75, DOI 10.1016/j.coi.2016.01.003; Raffin C, 2013, J IMMUNOL, V191, P4619, DOI 10.4049/jimmunol.1301378; Rojo D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08310; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosadi F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv105; Rossini A, 2006, CANCER RES, V66, P6219, DOI 10.1158/0008-5472.CAN-05-4592; Rubio-Godoy V, 2002, J IMMUNOL, V169, P5696, DOI 10.4049/jimmunol.169.10.5696; Ruff WE, 2015, TRENDS MOL MED, V21, P233, DOI 10.1016/j.molmed.2015.02.006; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Saito K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145788; Sanchez B, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00594; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Souza DG, 2004, J IMMUNOL, V173, P4137, DOI 10.4049/jimmunol.173.6.4137; Spadoni I, 2015, SCIENCE, V350, P830, DOI 10.1126/science.aad0135; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Szymula A, 2014, CLIN IMMUNOL, V152, P1, DOI 10.1016/j.clim.2014.02.004; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Vacchelli E, 2015, SCIENCE, V350, P972, DOI 10.1126/science.aad0779; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vujanovic L, 2007, CLIN CANCER RES, V13, P6796, DOI 10.1158/1078-0432.CCR-07-1909; Wheeler R, 2014, CELL MICROBIOL, V16, P1014, DOI 10.1111/cmi.12304; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Wilson HL, 2015, MOL IMMUNOL, V66, P22, DOI 10.1016/j.molimm.2014.09.004; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xu XF, 2015, MICROBIOL RES, V171, P97, DOI 10.1016/j.micres.2014.11.002; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599; Yurkovetskiy LA, 2015, CELL HOST MICROBE, V17, P548, DOI 10.1016/j.chom.2015.04.010; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	107	250	267	1	112	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					276	287		10.1016/j.cell.2016.03.001	http://dx.doi.org/10.1016/j.cell.2016.03.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058662	Bronze			2022-12-28	WOS:000374123000008
J	Metcalf, CJE; Farrar, J; Cutts, FT; Basta, NE; Graham, AL; Lessler, J; Ferguson, NM; Burke, DS; Grenfell, BT				Metcalf, C. Jessica E.; Farrar, Jeremy; Cutts, Felicity T.; Basta, Nicole E.; Graham, Andrea L.; Lessler, Justin; Ferguson, Neil M.; Burke, Donald S.; Grenfell, Bryan T.			Use of serological surveys to generate key insights into the changing global landscape of infectious disease	LANCET			English	Editorial Material							TRANSMISSION; DYNAMICS; ANTIBODY		[Metcalf, C. Jessica E.; Graham, Andrea L.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Metcalf, C. Jessica E.; Basta, Nicole E.; Graham, Andrea L.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Farrar, Jeremy] Wellcome Trust Res Labs, Gibbs Bldg, London, England; [Cutts, Felicity T.] London Sch Hyg & Trop Med, London, England; [Basta, Nicole E.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ferguson, Neil M.] Imperial Coll London, Dept Med, Sch Publ Hlth, London, England; [Burke, Donald S.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of London; London School of Hygiene & Tropical Medicine; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Imperial College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Metcalf, CJE (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	cmetcalf@princeton.edu	Graham, Andrea/GON-8450-2022; Graham, Andrea L./A-8808-2010; Ferguson, Neil/B-8578-2008; Graham, Andrea L./P-7296-2019	Graham, Andrea L./0000-0002-6580-2755; Ferguson, Neil/0000-0002-1154-8093; Graham, Andrea L./0000-0002-6580-2755; Lessler, Justin/0000-0002-9741-8109; /0000-0002-5704-8094	Medical Research Council [MR/K010174/1] Funding Source: Medline; NICHD NIH HHS [P2C HD047879] Funding Source: Medline; NIH HHS [DP5 OD009162] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009162] Funding Source: NIH RePORTER; MRC [MR/K010174/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Boni MF, 2013, J INFECT DIS, V208, P554, DOI 10.1093/infdis/jit224; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; Cutts FT, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001404; Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Lammie PJ, 2012, INT J PARASITOL, V42, P797, DOI 10.1016/j.ijpara.2012.07.002; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; National Oceanic and Atmospheric Administration, 2014, ARGO PROF CTD FLOATS; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Uttenthal A, 2010, EXPERT REV VACCINES, V9, P73, DOI 10.1586/ERV.09.130; Van Kerkhove MD, 2012, B WORLD HEALTH ORGAN, V90, P306, DOI 10.2471/BLT.11.097949	14	129	130	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					728	730		10.1016/S0140-6736(16)30164-7	http://dx.doi.org/10.1016/S0140-6736(16)30164-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	27059886	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000381268700033
J	Hobbs, FDR; Bankhead, C; Mukhtar, T; Stevens, S; Perera-Salazar, R; Holt, T; Salisbury, C				Hobbs, F. D. Richard; Bankhead, Clare; Mukhtar, Toqir; Stevens, Sarah; Perera-Salazar, Rafael; Holt, Tim; Salisbury, Chris		Natl Inst Hlth Res	Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007-14	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; TELEPHONE TRIAGE; GENERAL-PRACTICE	Background Primary care is the main source of health care in many health systems, including the UK National Health Service (NHS), but few objective data exist for the volume and nature of primary care activity. With rising concerns that NHS primary care workload has increased substantially, we aimed to assess the direct clinical workload of general practitioners (GPs) and practice nurses in primary care in the UK. Methods We did a retrospective analysis of GP and nurse consultations of non-temporary patients registered at 398 English general practices between April, 2007, and March, 2014. We used data from electronic health records routinely entered in the Clinical Practice Research Datalink, and linked CPRD data to national datasets. Trends in age-standardised and sex-standardised consultation rates were modelled with joinpoint regression analysis. Findings The dataset comprised 101 818 352 consultations and 20 626 297 person-years of observation. The crude annual consultation rate per person increased by 10.51%, from 4.67 in 2007-08, to 5.16 in 2013-14. Consultation rates were highest in infants (age 0-4 years) and elderly people (>= 85 years), and were higher for female patients than for male patients of all ages. The greatest increases in age-standardised and sex-standardised rates were in GPs, with a rise of 12.36% per 10 000 person-years, compared with 0.9% for practice nurses. GP telephone consultation rates doubled, compared with a 5.20% rise in surgery consultations, which accounted for 90% of all consultations. The mean duration of GP surgery consultations increased by 6.7%, from 8.65 min (95% CI 8.64-8.65) to 9.22 min (9.22-9.23), and overall workload increased by 16%. Interpretation Our findings show a substantial increase in practice consultation rates, average consultation duration, and total patient-facing clinical workload in English general practice. These results suggest that English primary care as currently delivered could be reaching saturation point. Notably, our data only explore direct clinical workload and not indirect activities and professional duties, which have probably also increased. This and additional research questions, including the outcomes of workload changes on other sectors of health care, need urgent answers for primary care provision internationally. Copyright (C) Hobbs et al. Open Access article distributed under the terms of CC BY.	[Hobbs, F. D. Richard; Bankhead, Clare; Mukhtar, Toqir; Stevens, Sarah; Perera-Salazar, Rafael; Holt, Tim] Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Radcliffe Primary Care Bldg, Oxford OX2 6GG, England; [Salisbury, Chris] Ctr Acad Primary Care, Sch Social & Community Med, Canynge Hall, Bristol, Avon, England	University of Bristol	Hobbs, FDR (corresponding author), Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Radcliffe Primary Care Bldg, Oxford OX2 6GG, England.	richard.hobbs@phc.ox.ac.uk	Salisbury, Chris/C-6724-2008	Salisbury, Chris/0000-0002-4378-3960; Perera, Rafael/0000-0003-2418-2091; hobbs, richard/0000-0001-7976-7172; Lay-Flurrie, Sarah/0000-0003-1094-8455	Department of Health Policy Research Programme; National Institute for Health Research [IS-SPC-0514-10043, NF-SI-0611-10273, NF-SI-0515-10043] Funding Source: researchfish	Department of Health Policy Research Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	Department of Health Policy Research Programme.	[Anonymous], 2016, GP PAT SURV SURV RES; Campbell JL, 2014, LANCET, V384, P1859, DOI 10.1016/S0140-6736(14)61058-8; Doran N, 2016, BRIT J GEN PRACT, V66, pE128, DOI 10.3399/bjgp16X683425; Gibson J, 8 NATL GP WORKLIFE S; Health & Social Care Information Centre, 2015, GEN PERS MED SERV; Health & Social Care Information Centre, 2011, RUR URB DEF GP PRACT; Health & Social Care Information Centre, 2014, QUAL OUTC FRAM QOF S; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Holt TA, 2016, BRIT J GEN PRACT, V66, pE214, DOI 10.3399/bjgp16X684001; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; MCCORMICK A, 1995, MORBIDITY STAT GEN P; Mukhtar TK, 2013, J ROY SOC MED, V106, P234, DOI 10.1177/0141076813486779; National Cancer Institute, 2015, STAT METH APPL BRANC; NHS England, 2013, IMPR GEN PRACT CALL; Office for National Statistics, 2014, POP EST UK ENGL WAL; Office for National Statistics, 2009, GEN HOUS SURV 2007; Office for National Statistics, 2015, POP EST UK ENGL WAL; Vinogradova Y., 2009, TRENDS CONSULTATION; Williams T, 2012, THER ADV DRUG SAF, V3, P89, DOI 10.1177/2042098611435911	19	324	326	2	54	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2323	2330		10.1016/S0140-6736(16)00620-6	http://dx.doi.org/10.1016/S0140-6736(16)00620-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27059888	Green Published, hybrid			2022-12-28	WOS:000376969100035
J	Lonn, EM; Bosch, J; Lopez-Jaramillo, P; Zhu, J; Liu, LS; Pais, P; Diaz, R; Xavier, D; Sliwa, K; Dans, A; Avezum, A; Piegas, LS; Keltai, K; Keltai, M; Chazova, I; Peters, RJG; Held, C; Yusoff, K; Lewis, BS; Jansky, P; Parkhomenko, A; Khunti, K; Toff, WD; Reid, CM; Varigos, J; Leiter, LA; Molina, DI; McKelvie, R; Pogue, J; Wilkinson, J; Jung, HJ; Dagenais, G; Yusuf, S				Lonn, Eva M.; Bosch, Jackie; Lopez-Jaramillo, Patricio; Zhu, Jun; Liu, Lisheng; Pais, Prem; Diaz, Rafael; Xavier, Denis; Sliwa, Karen; Dans, Antonio; Avezum, Alvaro; Piegas, Leopoldo S.; Keltai, Katalin; Keltai, Matyas; Chazova, Irina; Peters, Ron J. G.; Held, Claes; Yusoff, Khalid; Lewis, Basil S.; Jansky, Petr; Parkhomenko, Alexander; Khunti, Kamlesh; Toff, William D.; Reid, Christopher M.; Varigos, John; Leiter, Lawrence A.; Molina, Dora I.; McKelvie, Robert; Pogue, Janice; Wilkinson, Joanne; Jung, Hyejung; Dagenais, Gilles; Yusuf, Salim		HOPE-3 Investigators	Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REDUCTION; REGIMENS; REGIONS; EVENTS; TRIAL	BACKGROUND Antihypertensive therapy reduces the risk of cardiovascular events among high-risk persons and among those with a systolic blood pressure of 160 mm Hg or higher, but its role in persons at intermediate risk and with lower blood pressure is unclear. METHODS In one comparison from a 2-by-2 factorial trial, we randomly assigned 12,705 participants at intermediate risk who did not have cardiovascular disease to receive either candesartan at a dose of 16 mg per day plus hydrochlorothiazide at a dose of 12.5 mg per day or placebo. The first coprimary outcome was the composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke; the second coprimary outcome additionally included resuscitated cardiac arrest, heart failure, and revascularization. The median follow-up was 5.6 years. RESULTS The mean blood pressure of the participants at baseline was 138.1/81.9 mm Hg; the decrease in blood pressure was 6.0/3.0 mm Hg greater in the active-treatment group than in the placebo group. The first coprimary outcome occurred in 260 participants (4.1%) in the active-treatment group and in 279 (4.4%) in the placebo group (hazard ratio, 0.93; 95% confidence interval [CI], 0.79 to 1.10; P = 0.40); the second coprimary outcome occurred in 312 participants (4.9%) and 328 participants (5.2%), respectively (hazard ratio, 0.95; 95% CI, 0.81 to 1.11; P = 0.51). In one of the three prespecified hypothesis-based subgroups, participants in the subgroup for the upper third of systolic blood pressure (>143.5 mm Hg) who were in the active-treatment group had significantly lower rates of the first and second coprimary outcomes than those in the placebo group; effects were neutral in the middle and lower thirds (P = 0.02 and P = 0.009, respectively, for trend in the two outcomes). CONCLUSIONS Therapy with candesartan at a dose of 16 mg per day plus hydrochlorothiazide at a dose of 12.5 mg per day was not associated with a lower rate of major cardiovascular events than placebo among persons at intermediate risk who did not have cardiovascular disease. (Funded by the Canadian Institutes of Health Research and AstraZeneca; ClinicalTrials. gov number, NCT00468923.)	[Lonn, Eva M.; Bosch, Jackie; McKelvie, Robert; Pogue, Janice; Wilkinson, Joanne; Jung, Hyejung; Yusuf, Salim] McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Lonn, Eva M.; McKelvie, Robert; Yusuf, Salim] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Bosch, Jackie] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Pogue, Janice] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Dagenais, Gilles] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Lopez-Jaramillo, Patricio] Univ Santander, Fdn Oftalmol Santander, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander, Sch Med, Inst Masira, Bucaramanga, Colombia; [Molina, Dora I.] Univ Caldas, Manizales, Colombia; [Molina, Dora I.] Inst Prestadora Salud Internistas Caldas, Manizales, Colombia; [Zhu, Jun; Liu, Lisheng] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100730, Peoples R China; [Zhu, Jun; Liu, Lisheng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Pais, Prem; Xavier, Denis] St Johns Res Inst, Bangalore, Karnataka, India; [Xavier, Denis] St Johns Med Coll, Bangalore, Karnataka, India; [Diaz, Rafael] Inst Cardiovasc Rosario, Rosario, Santa Fe, Argentina; [Sliwa, Karen] Univ Cape Town, Soweto Cardiovasc Res Grp, Dept Med, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa; [Dans, Antonio] Univ Philippines, Coll Med, Manila, Philippines; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Piegas, Leopoldo S.] HCor Heart Hosp, Sao Paulo, Brazil; [Keltai, Katalin; Keltai, Matyas] Semmelweis Univ, Hungarian Inst Cardiol, H-1085 Budapest, Hungary; [Chazova, Irina] Inst Clin Cardiol, Russian Cardiol Res Complex, Moscow, Russia; [Peters, Ron J. G.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Held, Claes] Uppsala Univ, Clin Res Ctr, Dept Med Sci, Cardiol, Uppsala, Sweden; [Yusoff, Khalid] Univ Teknol Majlis Amansh Rakyat, Selayang, Malaysia; [Yusoff, Khalid] Univ Coll Sedaya Int Univ, Kuala Lumpur, Malaysia; [Lewis, Basil S.] Technion Israel Inst Technol, Lady Davis Carmel Med Ctr, Ruth & Bruce Rappaport Sch Med, Haifa, Israel; [Jansky, Petr] Univ Hosp Motol, Prague, Czech Republic; [Parkhomenko, Alexander] Inst Cardiol, Kiev, Ukraine; [Khunti, Kamlesh] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Toff, William D.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Toff, William D.] Glenfield Hosp, Leicester Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, Leicester, Leics, England; [Reid, Christopher M.] Monash Univ, Monash Ctr Cardiovasc Res & Educ Therapeut, Primary Care Diabet & Vasc Med, Melbourne, Vic 3004, Australia; [Varigos, John] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Reid, Christopher M.] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Laval University; Universidad Industrial de Santander; Universidad Industrial de Santander; Universidad de Caldas; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College; University of Cape Town; University of the Philippines System; University of the Philippines Manila; Instituto Dante Pazzanese de Cardiologia; Semmelweis University; National Medical Research Center of Cardiology; University of Amsterdam; Uppsala University; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Motol University Hospital; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Monash University; Monash University; Curtin University	Lonn, EM (corresponding author), Populat Hlth Res Inst, 237 Barton St, Hamilton, ON L8L 2X2, Canada.; Lonn, EM (corresponding author), Hamilton Hlth Sci, 237 Barton St, Hamilton, ON L8L 2X2, Canada.	eva.lonn@phri.ca	Chazova, Irina/B-8688-2017; MOLINA, DORA INES/K-2117-2019; Petrella, Robert J/G-6557-2018; Avezum, Alvaro/AAP-7687-2020; Söderberg, Stefan/AAG-3881-2019; Vasilyeva, Larisa/AAZ-3708-2021; Keltai, Katalin/V-4350-2019; Urina-Triana, Miguel A/H-2605-2016; Bosch, Jacqueline/AAP-6910-2021; Aroca, Gustavo/P-9173-2016; Cífková, Renata/O-5731-2017; Avezum, Alvaro AA/K-6137-2016; Reid, Christopher M/AAP-8135-2021; Nedogoda, Sergey V/O-4656-2014; /ABC-9527-2021; Leiter, Lawrence/AAG-4059-2020; Held, Claes/AAA-3973-2021; Yusoff, Khalid/I-7029-2019; Chazova, Irina/AAK-6581-2021; Valle, Adriana/F-9897-2014	Chazova, Irina/0000-0002-9822-4357; MOLINA, DORA INES/0000-0002-8006-915X; Söderberg, Stefan/0000-0001-9225-1306; Vasilyeva, Larisa/0000-0003-0889-7898; Keltai, Katalin/0000-0002-8294-9062; Urina-Triana, Miguel A/0000-0001-6003-4622; Bosch, Jacqueline/0000-0001-6292-4207; Aroca, Gustavo/0000-0002-9222-3257; Cífková, Renata/0000-0003-2765-3821; Avezum, Alvaro AA/0000-0002-3073-6890; Nedogoda, Sergey V/0000-0001-5981-1754; Held, Claes/0000-0001-9402-7404; Yusoff, Khalid/0000-0001-5669-5188; Chazova, Irina/0000-0002-9822-4357; CELEMIN FLOREZ, CARLOS AUGUSTO/0000-0003-1147-5979; Ivchyna, Nadiia/0000-0001-9650-8818; Md Aris, Mohd Aznan/0000-0002-9967-1327; Valle, Adriana/0000-0002-0090-8524; Reid, Christopher/0000-0001-9173-3944; da Silva Franco, Roberto Jorge/0000-0001-9787-4393; Varigos, John/0000-0001-6722-3135; Abhayaratna, Walter/0000-0002-4908-0641; Yusuf, Salim/0000-0003-4776-5601; Chazova, Irina E./0000-0002-1576-4877; Lopez-Jaramillo, Patricio/0000-0002-9122-8742	Canadian Institutes of Health Research; AstraZeneca	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca(AstraZeneca)	Funded by the Canadian Institutes of Health Research and AstraZeneca	[Anonymous], 1980, LANCET, V1, P1261; [Anonymous], 1982, JAMA-J AM MED ASSOC, V247, P633; Brunstrom M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i717; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Czernichow S, 2011, J HYPERTENS, V29, P4, DOI 10.1097/HJH.0b013e32834000be; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Liu LS, 2005, J HYPERTENS, V23, P2157, DOI 10.1097/01.hjh.0000194120.42722.ac; Lonn E, 2016, CAN J CARDIOL, V32, P311, DOI 10.1016/j.cjca.2015.07.001; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Sackett DL, 2000, CAN MED ASSOC J, V162, P1311; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Sundstrom J, 2015, ANN INTERN MED, V162, P184, DOI 10.7326/M14-0773; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Turnbull F, 2003, LANCET, V362, P1527; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176; Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177; Zanchetti A, 2009, J HYPERTENS, V27, P923, DOI 10.1097/HJH.0b013e32832aa6b5	28	432	458	1	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2009	2020		10.1056/NEJMoa1600175	http://dx.doi.org/10.1056/NEJMoa1600175			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27041480	Green Published, Bronze			2022-12-28	WOS:000376443500004
J	Wang, J; Kubes, P				Wang, Jing; Kubes, Paul			A Reservoir of Mature Cavity Macrophages that Can Rapidly Invade Visceral Organs to Affect Tissue Repair	CELL			English	Article							NEUTROPHIL RECRUITMENT; PERITONEAL-MACROPHAGES; APOPTOTIC CELLS; INNATE RESPONSE; NECROTIC CELLS; KUPFFER CELLS; T-CELLS; INFLAMMATION; EXPRESSION; CLEARANCE	A key feature of inflammation is the timely recruitment of leukocytes, including monocytes, from blood into tissues, the latter maturing into macrophages over a period of 2-3 days. Using multi-channel spinning disk microscopy, we identified a rapid pathway of macrophage recruitment into an injured organ via a non-vascular route requiring no maturation from monocytes. In response to a sterile injury in liver, a reservoir of fully mature F4/80(hi)GATA6(+) peritoneal cavity macrophages rapidly invaded into afflicted tissue via direct recruitment across the mesothelium. The invasion was dependent on CD44 and DAMP molecule ATP and resulted in rapid replication and switching of macrophage toward an alternatively activated phenotype. These macrophages dismantled the nuclei of necrotic cells releasing DNA and forming a cover across the injury site. Rapid invasion of mature macrophages from body cavity with capacity for induction of reparative phenotype may impact altered tissues ranging from trauma to infections to cancer.	[Wang, Jing; Kubes, Paul] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Wang, Jing; Kubes, Paul] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Immunol Res Grp, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada.; Kubes, P (corresponding author), Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Immunol Res Grp, Calgary, AB T2N 4N1, Canada.	pkubes@ucalgary.ca		Wang, Jing/0000-0001-8758-1693	Banting Postdoctoral Fellowships Program; Canadian Institute of Health Research; Alberta Innovates Health Solutions	Banting Postdoctoral Fellowships Program; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	We thank all members of P.K.'s laboratory and the Live Cell Imaging Facility for training and assistance related to SD-IVM. We thank the University of Calgary Flow Cytometry Facility for assistance with the flow cytometry. We thank the Snyder Institute Bioinstrumentation Labs for assistance with the qRT-PCR. J.W. is supported by Banting Postdoctoral Fellowships Program. The P.K. lab is supported by Canadian Institute of Health Research and Alberta Innovates Health Solutions.	Avraham-Chakim L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060965; Bleriot C., 2015, IMMUNITY, V42, P145; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; de Meijer VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011256; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Faust N, 2000, BLOOD, V96, P719; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Herter J, 2013, J IMMUNOL, V190, P4451, DOI 10.4049/jimmunol.1203179; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Isfort K, 2011, J BIOL CHEM, V286, P44776, DOI 10.1074/jbc.M111.289793; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kim ND, 2015, TRENDS IMMUNOL, V36, P547, DOI 10.1016/j.it.2015.07.007; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; NAKATANI T, 1988, ANAT REC, V220, P132, DOI 10.1002/ar.1092200204; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Rayahin JE, 2015, ACS BIOMATER SCI ENG, V1, P481, DOI 10.1021/acsbiomaterials.5b00181; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shi C, 2010, J IMMUNOL, V184, P6266, DOI 10.4049/jimmunol.0904160; Shimotakahara A, 2007, PEDIATR SURG INT, V23, P447, DOI 10.1007/s00383-006-1851-0; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Weber GF, 2014, J EXP MED, V211, P1243, DOI 10.1084/jem.20131471; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Yu CD, 2002, AM J PATHOL, V161, P2003, DOI 10.1016/S0002-9440(10)64478-1	41	302	305	3	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					668	678		10.1016/j.cell.2016.03.009	http://dx.doi.org/10.1016/j.cell.2016.03.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27062926	Bronze			2022-12-28	WOS:000374636800024
J	McMahon, B; Kamath, S				McMahon, Brandon; Kamath, Suneel			Pancytopenia in a Patient With Hypothyroidism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COBALAMIN; DIAGNOSIS		[McMahon, Brandon] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Canc Ctr, Dept Med,Div Hematol & Oncol, 645 N Michigan Ave,Ste 1020, Chicago, IL 60611 USA; [Kamath, Suneel] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine	McMahon, B (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Canc Ctr, Dept Med,Div Hematol & Oncol, 645 N Michigan Ave,Ste 1020, Chicago, IL 60611 USA.	bmcmahon@nm.org	Kamath, Suneel/AAW-8168-2020					Bizzaro N, 2014, AUTOIMMUN REV, V13, P565, DOI 10.1016/j.autrev.2014.01.042; Carmel R, 2012, NEW ENGL J MED, V367, P385, DOI 10.1056/NEJMc1204070; Carmel R, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013441; Oberley MJ, 2013, AM J HEMATOL, V88, P522, DOI 10.1002/ajh.23421; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; Stabler SP, 2004, ANNU REV NUTR, V24, P299, DOI 10.1146/annurev.nutr.24.012003.132440; Toh BH, 2004, AUTOIMMUNITY, V37, P357, DOI 10.1080/08916930410001705439; Vidal-Alaball J, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004655.pub2, 10.1002/14651858.CD004775.pub2]; Weinzierl EP, 2013, AM J CLIN PATHOL, V139, P9, DOI 10.1309/AJCP50AEEYGREWUZ	9	3	3	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1648	1649		10.1001/jama.2016.2155	http://dx.doi.org/10.1001/jama.2016.2155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	27092833				2022-12-28	WOS:000374289300024
J	Milligan, ID; Gibani, MM; Sewell, R; Clutterbuck, EA; Campbell, D; Plested, E; Nuthall, E; Voysey, M; Silva-Reyes, L; McElrath, MJ; De Rosa, SC; Frahm, N; Cohen, KW; Shukarev, G; Orzabal, N; van Duijnhoven, W; Truyers, C; Bachmayer, N; Splinter, D; Samy, N; Pau, MG; Schuitemaker, H; Luhn, K; Callendret, B; Van Hoof, J; Douoguih, M; Ewer, K; Angus, B; Pollard, AJ; Snape, MD				Milligan, Iain D.; Gibani, Malick M.; Sewell, Richard; Clutterbuck, Elizabeth A.; Campbell, Danielle; Plested, Emma; Nuthall, Elizabeth; Voysey, Merryn; Silva-Reyes, Laura; McElrath, M. Juliana; De Rosa, Stephen C.; Frahm, Nicole; Cohen, Kristen W.; Shukarev, Georgi; Orzabal, Nicola; van Duijnhoven, Wilbert; Truyers, Carla; Bachmayer, Nora; Splinter, Daniel; Samy, Nathaly; Pau, Maria Grazia; Schuitemaker, Hanneke; Luhn, Kerstin; Callendret, Benoit; Van Hoof, Johan; Douoguih, Macaya; Ewer, Katie; Angus, Brian; Pollard, Andrew J.; Snape, Matthew D.			Safety and Immunogenicity of Novel Adenovirus Type 26-and Modified Vaccinia Ankara-Vectored Ebola Vaccines A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; RESPONSES; VIRUS; VACCINATION; PROTECTION; ANTIBODIES; CHALLENGE; IMMUNITY	IMPORTANCE Developing effective vaccines against Ebola virus is a global priority. OBJECTIVE To evaluate an adenovirus type 26 vector vaccine encoding Ebola glycoprotein (Ad26.ZEBOV) and a modified vaccinia Ankara vector vaccine, encoding glycoproteins from Ebola virus, Sudan virus, Marburg virus, and Tai Forest virus nucleoprotein (MVA-BN-Filo). DESIGN, SETTING, AND PARTICIPANTS Single-center, randomized, placebo-controlled, observer-blind, phase 1 trial performed in Oxford, United Kingdom, enrolling healthy 18- to 50-year-olds from December 2014; 8-month follow-up was completed October 2015. INTERVENTIONS Participants were randomized into 4 groups, within which they were simultaneously randomized 5:1 to receive study vaccines or placebo. Those receiving active vaccines were primed with Ad26.ZEBOV (5 x 1010 viral particles) or MVA-BN-Filo (1 x 108 median tissue culture infective dose) and boosted with the alternative vaccine 28 or 56 days later. A fifth, open-label group received Ad26.ZEBOV boosted by MVA-BN-Filo 14 days later. MAIN OUTCOMES AND MEASURES The primary outcomes were safety and tolerability. All adverse events were recorded until 21 days after each immunization; serious adverse events were recorded throughout the trial. Secondary outcomes were humoral and cellular immune responses to immunization, as assessed by enzyme-linked immunosorbent assay and enzyme-linked immunospot performed at baseline and from 7 days after each immunization until 8 months after priming immunizations. RESULTS Among 87 study participants (median age, 38.5 years; 66.7% female), 72were randomized into 4 groups of 18, and 15 were included in the open-label group. Four participants did not receive a booster dose; 67 of 75 study vaccine recipients were followed up at 8 months. Novaccine-related serious adverse events occurred. No participant became febrile after MVA-BN-Filo, compared with 3 of 60 participants (5%; 95% CI, 1%-14%) receiving Ad26.ZEBOV in the randomized groups. In the open-label group, 4 of 15 Ad26.ZEBOV recipients (27%; 95% CI, 8%-55%) experienced fever. In the randomized groups, 28 of 29 Ad26. ZEBOV recipients (97%; 95% CI, 82%-99.9%) and 7 of 30 MVA-BN-Filo recipients (23%; 95% CI, 10%-42%) had detectable Ebola glycoprotein-specific IgG 28 days after primary immunization. All vaccine recipients had specific IgG detectable 21 days postboost and at 8-month follow-up. Within randomized groups, at 7 days postboost, at least 86% of vaccine recipients showed Ebola-specific T-cell responses. CONCLUSIONS AND RELEVANCE In this phase 1 study of healthy volunteers, immunization with Ad26. ZEBOV or MVA-BN-Filo did not result in any vaccine-related serious adverse events. An immune response was observed after primary immunization with Ad26. ZEBOV; boosting by MVA-BN-Filo resulted in sustained elevation of specific immunity. These vaccines are being further assessed in phase 2 and 3 studies.	[Milligan, Iain D.; Gibani, Malick M.; Sewell, Richard; Clutterbuck, Elizabeth A.; Campbell, Danielle; Plested, Emma; Nuthall, Elizabeth; Voysey, Merryn; Silva-Reyes, Laura; Pollard, Andrew J.; Snape, Matthew D.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Voysey, Merryn] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [McElrath, M. Juliana; De Rosa, Stephen C.; Frahm, Nicole; Cohen, Kristen W.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Shukarev, Georgi; Orzabal, Nicola; van Duijnhoven, Wilbert; Truyers, Carla; Bachmayer, Nora; Splinter, Daniel; Pau, Maria Grazia; Schuitemaker, Hanneke; Luhn, Kerstin; Callendret, Benoit; Van Hoof, Johan; Douoguih, Macaya] Pharmaceut Co Johnson & Johnson, Janssen, Leiden, Netherlands; [Samy, Nathaly] Bavarian Nord, Martinsried, Germany; [Ewer, Katie] Univ Oxford, Jenner Inst Ctr Clin Vaccinol & Trop Med, Oxford, England; [Ewer, Katie; Pollard, Andrew J.; Snape, Matthew D.] Oxford Biomed Res Ctr, NIHR, Oxford, England; [Angus, Brian] Univ Oxford, Nuffield Dept Med, Oxford, England	University of Oxford; University of Oxford; Fred Hutchinson Cancer Center; Johnson & Johnson; Janssen Pharmaceuticals; Bavarian Nordic; University of Oxford; University of Oxford; University of Oxford	Snape, MD (corresponding author), Univ Oxford, Oxford Vaccine Grp, Ctr Clin Vaccinol & Trop Med, Dept Paediat,Churchill Hosp, Headington OX3 7LE, England.	matthew.snape@paediatrics.ox.ac.uk	callendret, benoit/U-4193-2019; Ewer, Katie J/B-4328-2011; Angus, Brian/L-9246-2019	Ewer, Katie J/0000-0001-9827-9836; Angus, Brian/0000-0003-3598-7784; Voysey, Merryn/0000-0001-6324-6559; Snape, Matthew/0000-0003-0531-5426; Silva-Reyes, Laura/0000-0002-3678-1836; Milligan, Iain D/0000-0002-6501-5524; Gibani, Malick/0000-0003-1781-0053	European Union's Innovative Medicines Initiative as part of the EBOVAC1 consortium [115854]; European Union; European Federation of Pharmaceutical Industries and Associations; Crucell Holland	European Union's Innovative Medicines Initiative as part of the EBOVAC1 consortium; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations; Crucell Holland	This trial was funded by the European Union's Innovative Medicines Initiative, as part of the EBOVAC1 consortium, under grant agreement 115854. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation program and the European Federation of Pharmaceutical Industries and Associations. The study sponsor was Crucell Holland, who also provided funding for the nonrandomized group immunized at a 14-day interval.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; [Anonymous], SAF IMM STUD HET HOM; Baden LR, 2015, J INFECT DIS, V211, P518, DOI 10.1093/infdis/jiu485; Baden LR, 2013, J INFECT DIS, V207, P240, DOI 10.1093/infdis/jis670; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Biswas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107903; Callendret B., PUBL WORKSH IMM PROT; Coltart CEM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0477-2; De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7; Deen GF, 2015, N ENGL J MED, DOI 10.1056/NEJMoa1511410; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; National Institute of Allergy and Infectious Diseases, DIV MICR INF DIS DMI; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Rampling T, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1411627, DOI 10.1056/NEJMOA1411627, 10.1056/NEJMoa1411627.]; Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Tapia MD, 2016, LANCET INFECT DIS, V16, P16; Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306; World Health Organization, 2016, EB SIT REP 17 FEBR 2; Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0	33	196	204	2	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1610	1623		10.1001/jama.2016.4218	http://dx.doi.org/10.1001/jama.2016.4218			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	27092831	Bronze			2022-12-28	WOS:000374289300021
J	Burke, B				Burke, Brian			CELL BIOLOGY When cells push the envelope	SCIENCE			English	Editorial Material							NUCLEAR; MIGRATION; RUPTURE		[Burke, Brian] Inst Med Biol, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore	Agency for Science Technology & Research (ASTAR); A*STAR - Institute of Medical Biology (IMB)	Burke, B (corresponding author), Inst Med Biol, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore.	brian.burke@imb.a-star.edu.sg						Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Olmos Y, 2015, NATURE, V522, P236, DOI 10.1038/nature14503; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Rowat AC, 2013, J BIOL CHEM, V288, P8610, DOI 10.1074/jbc.M112.441535; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tamiello C, 2013, NUCLEUS-AUSTIN, V4, P61, DOI 10.4161/nucl.23388; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; Vietri M, 2015, NATURE, V522, P231, DOI 10.1038/nature14408; Wilson KL, 2011, J CELL BIOL, V195, P171, DOI 10.1083/jcb.201103171	14	4	4	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					295	296		10.1126/science.aaf7735	http://dx.doi.org/10.1126/science.aaf7735			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081057				2022-12-28	WOS:000373990100022
J	Kosinski, J; Mosalaganti, S; von Appen, A; Teimer, R; DiGuilio, AL; Wan, W; Bui, KH; Hagen, WJH; Briggs, JAG; Glavy, JS; Hurt, E; Beck, M				Kosinski, Jan; Mosalaganti, Shyamal; von Appen, Alexander; Teimer, Roman; DiGuilio, Amanda L.; Wan, William; Bui, Khanh Huy; Hagen, Wim J. H.; Briggs, John A. G.; Glavy, Joseph S.; Hurt, Ed; Beck, Martin			Molecular architecture of the inner ring scaffold of the human nuclear pore complex	SCIENCE			English	Article							STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; DOMAIN	Nuclear pore complexes (NPCs) are 110-megadalton assemblies that mediate nucleocytoplasmic transport. NPCs are built from multiple copies of similar to 30 different nucleoporins, and understanding how these nucleoporins assemble into the NPC scaffold imposes a formidable challenge. Recently, it has been shown how the Y complex, a prominent NPC module, forms the outer rings of the nuclear pore. However, the organization of the inner ring has remained unknown until now. We used molecular modeling combined with cross-linking mass spectrometry and cryo-electron tomography to obtain a composite structure of the inner ring. This architectural map explains the vast majority of the electron density of the scaffold. We conclude that despite obvious differences in morphology and composition, the higher-order structure of the inner and outer rings is unexpectedly similar.	[Kosinski, Jan; Mosalaganti, Shyamal; von Appen, Alexander; Wan, William; Hagen, Wim J. H.; Briggs, John A. G.; Beck, Martin] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Teimer, Roman; Hurt, Ed] Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany; [DiGuilio, Amanda L.; Glavy, Joseph S.] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, 507 River St, Hoboken, NJ 07030 USA; [Bui, Khanh Huy] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Briggs, John A. G.; Beck, Martin] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Stevens Institute of Technology; McGill University; European Molecular Biology Laboratory (EMBL)	Beck, M (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.; Beck, M (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany.	martin.beck@embl.de	Beck, Martin/B-5589-2011; Ed Hurt, Dr./AAE-8874-2019; Kosinski, Jan/V-8540-2019	Beck, Martin/0000-0002-7397-1321; Ed Hurt, Dr./0000-0002-4535-8255; Kosinski, Jan/0000-0002-3641-0322; Wan, William/0000-0003-2497-3010; Hagen, Wim/0000-0001-6229-2692; Briggs, John/0000-0003-3990-6910; Glavy, Joseph/0000-0003-3716-3965; Bui, Khanh Huy/0000-0003-2814-9889; Mosalaganti, Shyamal/0000-0002-5934-687X; von Appen, Alexander/0000-0001-6528-2123	EMBL's Electron Microscopy and Proteomics Core Facilities; EMBL Interdisciplinary Postdoc Programme under Marie Curie COFUND actions; Robert Crooks Stanley Fellowship at the Stevens Institute of Technology and National Institute on Aging (NIA) [1R21AG047433-01]; Ignition Grant Initiative from Stevens Institute of Technology; NIA [1R21AG047433-01]; EMBL; European Research Council [309271-NPCAtlas]; NATIONAL INSTITUTE ON AGING [R21AG047433] Funding Source: NIH RePORTER	EMBL's Electron Microscopy and Proteomics Core Facilities; EMBL Interdisciplinary Postdoc Programme under Marie Curie COFUND actions; Robert Crooks Stanley Fellowship at the Stevens Institute of Technology and National Institute on Aging (NIA); Ignition Grant Initiative from Stevens Institute of Technology; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EMBL; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Andres-Pons for technical support and critical reading of the manuscript. We acknowledge support from EMBL's Electron Microscopy and Proteomics Core Facilities. W.W. and J.A.G.B. thank N. Grigorieff for sharing data before publication. J.K. was supported by the EMBL Interdisciplinary Postdoc Programme under Marie Curie COFUND actions. A.L.D. was supported by the Robert Crooks Stanley Fellowship at the Stevens Institute of Technology and National Institute on Aging (NIA) grant 1R21AG047433-01. J.S.G. was supported by an Ignition Grant Initiative from Stevens Institute of Technology and NIA grant 1R21AG047433-01. M.B. acknowledges funding by EMBL and the European Research Council (grant 309271-NPCAtlas). The density maps have been deposited in the Electron Microscopy Data Bank with accession numbers 8085, 8086, and 8087. The composite structure and the top-scoring automated models have been deposited in the Protein Data Bank with accession numbers 5IJN and 5IJO.	Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Chug H, 2015, SCIENCE, V350, P106, DOI 10.1126/science.aac7420; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Fischer J, 2015, NAT STRUCT MOL BIOL, V22, P774, DOI 10.1038/nsmb.3084; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hurt E, 2015, CURR OPIN CELL BIOL, V34, P31, DOI 10.1016/j.ceb.2015.04.009; Jeudy S, 2007, J BIOL CHEM, V282, P34904, DOI 10.1074/jbc.M705479200; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Mor A, 2014, CURR OPIN CELL BIOL, V28, P28, DOI 10.1016/j.ceb.2014.01.007; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Raices M., 2013, NAT REV MOL CELL BIO, V13, P687; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Sachdev R, 2012, MOL BIOL CELL, V23, P740, DOI 10.1091/mbc.E11-09-0761; Stuwe T, 2015, SCIENCE, V350, P56, DOI 10.1126/science.aac9176; Stuwe T, 2015, SCIENCE, V347, P1148, DOI 10.1126/science.aaa4136; Vollmer B, 2014, BIOL CHEM, V395, P515, DOI 10.1515/hsz-2013-0285; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Whittle JRR, 2009, J BIOL CHEM, V284, P28442, DOI 10.1074/jbc.M109.023580	21	193	196	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					363	365		10.1126/science.aaf0643	http://dx.doi.org/10.1126/science.aaf0643			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27081072	Green Accepted			2022-12-28	WOS:000373990100045
J	Demory, BO; Gillon, M; de Wit, J; Madhusudhan, N; Bolmont, E; Heng, K; Kataria, T; Lewis, N; Hu, RY; Krick, J; Stamenkovic, V; Benneke, B; Kane, S; Queloz, D				Demory, Brice-Olivier; Gillon, Michael; de Wit, Julien; Madhusudhan, Nikku; Bolmont, Emeline; Heng, Kevin; Kataria, Tiffany; Lewis, Nikole; Hu, Renyu; Krick, Jessica; Stamenkovic, Vlada; Benneke, Bjorn; Kane, Stephen; Queloz, Didier			A map of the large day-night temperature gradient of a super-Earth exoplanet	NATURE			English	Article							55 CANCRI; PLANET; TRANSIT; ECLIPSES; SPITZER; VARIABILITY; ATMOSPHERES; INFERENCE; RADIUS	Over the past decade, observations of giant exoplanets (Jupiter-size) have provided key insights into their atmospheres(1,2), but the properties of lower-mass exoplanets (sub-Neptune) remain largely unconstrained because of the challenges of observing small planets. Numerous efforts to observe the spectra of super-Earths-exoplanets with masses of one to ten times that of Earth-have so far revealed only featureless spectra(3). Here we report a longitudinal thermal brightness map of the nearby transiting super-Earth 55 Cancri e (refs 4, 5) revealing highly asymmetric dayside thermal emission and a strong day-night temperature contrast. Dedicated space-based monitoring of the planet in the infrared revealed a modulation of the thermal flux as 55 Cancri e revolves around its star in a tidally locked configuration. These observations reveal a hot spot that is located 41 +/- 12 degrees east of the substellar point (the point at which incident light from the star is perpendicular to the surface of the planet). From the orbital phase curve, we also constrain the nightside brightness temperature of the planet to 1,380 +/- 400 kelvin and the temperature of the warmest hemisphere (centred on the hot spot) to be about 1,300 kelvin hotter (2,700 +/- 270 kelvin) at a wavelength of 4.5 micrometres, which indicates inefficient heat redistribution from the dayside to the nightside. Our observations are consistent with either an optically thick atmosphere with heat recirculation confined to the planetary dayside, or a planet devoid of atmosphere with low-viscosity magma flows at the surface(6).	[Demory, Brice-Olivier; Queloz, Didier] Univ Cambridge, Cavendish Lab, Astrophys Grp, JJ Thomson Ave, Cambridge CB3 0HE, England; [Gillon, Michael] Univ Liege, Inst Astrophys & Geophys, Allee 6 Aout 17, B-4000 Liege, Belgium; [de Wit, Julien] MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Madhusudhan, Nikku] Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England; [Bolmont, Emeline] Univ Namur, Dept Math, NaXys, 8 Rempart Vierge, B-5000 Namur, Belgium; [Heng, Kevin] Univ Bern, Ctr Space & Habitabil, Sidlerstr 5, CH-3012 Bern, Switzerland; [Kataria, Tiffany] Univ Exeter, Sch Phys, Astrophys Grp, Stocker Rd, Exeter EX4 4QL, Devon, England; [Lewis, Nikole] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Hu, Renyu; Stamenkovic, Vlada] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Hu, Renyu; Stamenkovic, Vlada; Benneke, Bjorn] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Krick, Jessica] CALTECH, Jet Prop Lab, Spitzer Sci Ctr, MS 220-6, Pasadena, CA 91125 USA; [Kane, Stephen] San Francisco State Univ, Dept Phys & Astron, 1600 Holloway Ave, San Francisco, CA 94132 USA	University of Cambridge; University of Liege; Massachusetts Institute of Technology (MIT); University of Cambridge; University of Namur; University of Bern; University of Exeter; Space Telescope Science Institute; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California State University System; San Francisco State University	Demory, BO (corresponding author), Univ Cambridge, Cavendish Lab, Astrophys Grp, JJ Thomson Ave, Cambridge CB3 0HE, England.	bod21@cam.ac.uk	Demory, Brice-Olivier/ABG-1063-2020	Demory, Brice-Olivier/0000-0002-9355-5165; Hu, Renyu/0000-0003-2215-8485; Queloz, Didier/0000-0002-3012-0316; Bolmont, Emeline/0000-0001-5657-4503; Gillon, Michael/0000-0003-1462-7739; Krick, Jessica/0000-0002-2413-5976; Stamenkovic, Vlada/0000-0003-2416-3683	NASA; Simons Foundation [338555]	NASA(National Aeronautics & Space Administration (NASA)); Simons Foundation	We thank D. Deming, D. Apai and A. Showman for discussions as well as the Spitzer Science Center staff for their assistance in the planning and executing of these observations. This work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. Support for this work was provided by NASA through an award issued by JPL/Caltech. M.G. is a Research Associate at the Belgian Funds for Scientific Research (FRS-FNRS). V.S. was supported by the Simons Foundation (award number 338555, VS).	Agol E, 2010, ASTROPHYS J, V721, P1861, DOI 10.1088/0004-637X/721/2/1861; Ballard S, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/12; Beerer IM, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/23; Berta ZK, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/12; Bolmont E, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525909; Budaj J, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/59; Burrows AS, 2014, NATURE, V513, P345, DOI 10.1038/nature13782; Claret A, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116451; Cowan NB, 2008, ASTROPHYS J LETT, V678, pL129, DOI 10.1086/588553; Cowan NB, 2009, ASTROPHYS J, V700, P915, DOI 10.1088/0004-637X/700/2/915; Crossfield IJM, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219826; de Wit J, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219060; Deming D, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/2/132; Demory BO, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117178; Demory BO, 2016, MON NOT R ASTRON SOC, V455, P2018, DOI 10.1093/mnras/stv2239; Demory BO, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L25; Ehrenreich D, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219981; Gillon M, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218817; Gillon M, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118309; Heng K, 2015, ANNU REV EARTH PL SC, V43, P509, DOI 10.1146/annurev-earth-060614-105146; Heng K, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/60; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Knutson HA, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/155; Landsman W. B, 1993, P ASP C, V52, P246; Lanotte AA, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201424373; Lutgens F. K., 2000, ESSENTIALS GEOLOGY; Madhusudhan N, 2010, ASTROPHYS J, V725, P261, DOI 10.1088/0004-637X/725/1/261; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Mazeh T, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015550; Menou K, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/138; Miguel Y, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L19; Miller BP, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/163; Nelson BE, 2014, MON NOT R ASTRON SOC, V441, P442, DOI 10.1093/mnras/stu450; Pont F, 2006, MON NOT R ASTRON SOC, V373, P231, DOI 10.1111/j.1365-2966.2006.11012.x; Schaefer L, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/6; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shkolnik E, 2008, ASTROPHYS J, V676, P628, DOI 10.1086/527351; Showman AP, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/24; Sobolev V. V., 1975, INT SERIES MONOGRAPH, V76; Solomatov V. S., 2007, TREATISE GEOPHYS, V9, P91, DOI DOI 10.1016/B978-044452748-6.00141-3); Stevenson KB, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/136; von Braun K, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/49; Winn JN, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/1/L18	46	159	160	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					207	+		10.1038/nature17169	http://dx.doi.org/10.1038/nature17169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27027283	Green Submitted, Green Accepted			2022-12-28	WOS:000374415100033
J	Maryanovich, M; Frenette, PS				Maryanovich, Maria; Frenette, Paul S.			A Time Bomb for Leukemia	CELL			English	Editorial Material							CIRCADIAN CLOCK; CANCER	Alterations of the circadian clock have been linked to cancer development. Puram et al. (in this issue) now uncover differential requirements between healthy hematopoietic and diseased leukemic stem cells for core circadian transcription factors, wherein leukemic cells depend on the clock machinery for survival and growth.	[Maryanovich, Maria; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Maryanovich, Maria; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922	NHLBI NIH HHS [R01 HL116340, R01 HL069438, HL069438, HL116340] Funding Source: Medline; NIDDK NIH HHS [DK056638] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116340, R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antoch MP, 2013, CELL CYCLE, V12, P3673, DOI 10.4161/cc.26614; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Hanoun M, 2015, NEURON, V86, P360, DOI 10.1016/j.neuron.2015.01.026; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Masri S, 2015, CURR OPIN ONCOL, V27, P50, DOI 10.1097/CCO.0000000000000153; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Puram RV, 2016, CELL, V165, P303, DOI 10.1016/j.cell.2016.03.015; Taniguchi H, 2009, CANCER RES, V69, P8447, DOI 10.1158/0008-5472.CAN-09-0551	10	1	2	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					262	263		10.1016/j.cell.2016.03.024	http://dx.doi.org/10.1016/j.cell.2016.03.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058656	Bronze			2022-12-28	WOS:000374123000003
J	Andersen, LW; Kurth, T; Chase, M; Berg, KM; Cocchi, MN; Callaway, C; Donnino, MW				Andersen, Lars W.; Kurth, Tobias; Chase, Maureen; Berg, Katherine M.; Cocchi, Michael N.; Callaway, Clifton; Donnino, Michael W.		Amer Heart Assoc Get Guidelines-Re	Early administration of epinephrine (adrenaline) in patients with cardiac arrest with initial shockable rhythm in hospital: propensity score matched analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EUROPEAN RESUSCITATION COUNCIL; AMERICAN-HEART-ASSOCIATION; CORONARY PERFUSION-PRESSURE; HEALTH-CARE PROFESSIONALS; CARDIOPULMONARY-RESUSCITATION; PREHOSPITAL EPINEPHRINE; MULTIPLE IMPUTATION; STROKE FOUNDATION; TIME; SURVIVAL	OBJECTIVES To evaluate whether patients who experience cardiac arrest in hospital receive epinephrine (adrenaline) within the two minutes after the first defibrillation (contrary to American Heart Association guidelines) and to evaluate the association between early administration of epinephrine and outcomes in this population. DESIGN Prospective observational cohort study. SETTING Analysis of data from the Get With The Guidelines-Resuscitation registry, which includes data from more than 300 hospitals in the United States. PARTICIPANTS Adults in hospital who experienced cardiac arrest with an initial shockable rhythm, including patients who had a first defibrillation within two minutes of the cardiac arrest and who remained in a shockable rhythm after defibrillation. INTERVENTION Epinephrine given within two minutes after the first defibrillation. MAIN OUTCOME MEASURES Survival to hospital discharge. Secondary outcomes included return of spontaneous circulation and survival to hospital discharge with a good functional outcome. A propensity score was calculated for the receipt of epinephrine within two minutes after the first defibrillation, based on multiple characteristics of patients, events, and hospitals. Patients who received epinephrine at either zero, one, or two minutes after the first defibrillation were then matched on the propensity score with patients who were "at risk" of receiving epinephrine within the same minute but who did not receive it. RESULTS 2978 patients were matched on the propensity score, and the groups were well balanced. 1510 (51%) patients received epinephrine within two minutes after the first defibrillation, which is contrary to current American Heart Association guidelines. Epinephrine given within the first two minutes after the first defibrillation was associated with decreased odds of survival in the propensity score matched analysis (odds ratio 0.70, 95% confidence interval 0.59 to 0.82; P<0.001). Early epinephrine administration was also associated with a decreased odds of return of spontaneous circulation (0.71, 0.60 to 0.83; P<0.001) and good functional outcome (0.69, 0.58 to 0.83; P<0.001). CONCLUSION Half of patients with a persistent shockable rhythm received epinephrine within two minutes after the first defibrillation, contrary to current American Heart Association guidelines. The receipt of epinephrine within two minutes after the first defibrillation was associated with decreased odds of survival to hospital discharge as well as decreased odds of return of spontaneous circulation and survival to hospital discharge with a good functional outcome.	[Andersen, Lars W.; Chase, Maureen; Cocchi, Michael N.; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Rosenberg Bldg,One Deaconess Rd, Boston, MA 02215 USA; [Andersen, Lars W.] Aarhus Univ Hosp, Dept Anesthesiol, Norrebrogade 44,Bygn 21 1, DK-8000 Aarhus, Denmark; [Andersen, Lars W.] Aarhus Univ Hosp, Res Ctr Emergency Med, Trojborgvej 72-74,Bygn 30, DK-8200 Aarhus, Denmark; [Kurth, Tobias] Charite, Inst Publ Hlth, Seestr 73, D-13347 Berlin, Germany; [Berg, Katherine M.; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm & Crit Care Med, 330 Brookline Ave, Boston, MA 02215 USA; [Cocchi, Michael N.] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care, Div Crit Care, 330 Brookline Ave, Boston, MA 02215 USA; [Callaway, Clifton] Dept Emergency Med, 400A Iroquois,3600 Forbes Ave, Pittsburgh, PA 15260 USA	Harvard University; Beth Israel Deaconess Medical Center; Aarhus University; Aarhus University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Donnino, MW (corresponding author), Beth Israel Deaconess Med Ctr, One Deaconess Rd,W-CC 2, Boston, MA 02215 USA.	mdonnino@bidmc.harvard.edu	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620; Andersen, Lars Wiuff/0000-0001-5752-8082; Churpek, Matthew/0000-0002-4030-5250	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM101463] Funding Source: NIH RePORTER; NIGMS NIH HHS [K23 GM101463] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		American Hospital Association, AHA ANN SURV DAT FIS; Andersen LW, 2015, RESUSCITATION, V94, P49, DOI 10.1016/j.resuscitation.2015.05.015; Andersen L, 2015, JAMA-J AM MED ASSOC, V314, P802, DOI 10.1001/jama.2015.9678; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; [Anonymous], 1974, JAMA-J AM MED ASSOC; Arrich J, 2012, RESUSCITATION, V83, P333, DOI 10.1016/j.resuscitation.2011.10.027; Atiksawedparit P, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0463-7; Becker LB, 2011, CIRCULATION, V124, P2158, DOI 10.1161/CIR.0b013e3182340239; Behringer W, 1998, ANN INTERN MED, V129, P450, DOI 10.7326/0003-4819-129-6-199809150-00004; Berdowski J, 2009, RESUSCITATION, V80, P1336, DOI 10.1016/j.resuscitation.2009.08.011; Callaway CW, 2013, CURR OPIN CARDIOL, V28, P36, DOI 10.1097/HCO.0b013e32835b0979; Callaway CW, 2012, JAMA-J AM MED ASSOC, V307, P1198, DOI 10.1001/jama.2012.313; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Chan PS, 2013, NEW ENGL J MED, V368, P1019, DOI 10.1056/NEJMoa1200657; Chan PS, 2012, ARCH INTERN MED, V172, P947, DOI 10.1001/archinternmed.2012.2050; Chan PS, 2009, ARCH INTERN MED, V169, P1265, DOI 10.1001/archinternmed.2009.196; Cummins RO, 1997, RESUSCITATION, V34, P151, DOI 10.1016/S0300-9572(97)01112-X; Deakin CD, 2010, RESUSCITATION, V81, pE93, DOI 10.1016/j.resuscitation.2010.08.027; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; DITCHEY RV, 1988, CIRCULATION, V78, P382, DOI 10.1161/01.CIR.78.2.382; Donnino MW, 2012, CIRCULATION, V126, P1478, DOI 10.1161/CIRCULATIONAHA.111.067256; Dumas F, 2014, J AM COLL CARDIOL, V64, P2360, DOI 10.1016/j.jacc.2014.09.036; Fredriksson M, 2010, AM HEART J, V159, P749, DOI 10.1016/j.ahj.2010.01.015; Fries M, 2006, CRIT CARE MED, V34, pS454, DOI 10.1097/01.CCM.0000247717.81480.B2; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Goto Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12872; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; JENNETT B, 1975, LANCET, V1, P480; Kaye W, 2005, RESUSCITATION, V65, P285, DOI 10.1016/j.resuscitation.2004.12.020; Kim WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112779; Kim WY, 2014, RESUSCITATION, V85, P1042, DOI 10.1016/j.resuscitation.2014.04.005; Krishnamoorthy V, 2014, ANESTHESIOLOGY, V120, P792, DOI 10.1097/ALN.0000000000000032; Li YFP, 2001, J AM STAT ASSOC, V96, P870, DOI 10.1198/016214501753208573; Lin S, 2014, RESUSCITATION, V85, P732, DOI 10.1016/j.resuscitation.2014.03.008; Lindberg L, 2000, RESUSCITATION, V43, P129, DOI 10.1016/S0300-9572(99)00129-X; MCCARTNEY M, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G5258; Meaney PA, 2010, CRIT CARE MED, V38, P101, DOI 10.1097/CCM.0b013e3181b43282; MICHAEL JR, 1984, CIRCULATION, V69, P822, DOI 10.1161/01.CIR.69.4.822; Nakahara S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6829; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Nielsen N, 2014, NEW ENGL J MED, V370, P1360, DOI 10.1056/NEJMc1401250; NIEMANN JT, 1985, ANN EMERG MED, V14, P521, DOI 10.1016/S0196-0644(85)80774-5; Nolan JP, 2014, RESUSCITATION, V85, P987, DOI 10.1016/j.resuscitation.2014.04.002; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; OTTO CW, 1985, AM J EMERG MED, V3, P285, DOI 10.1016/0735-6757(85)90048-8; OTTO CW, 1981, CRIT CARE MED, V9, P321, DOI 10.1097/00003246-198104000-00008; Overgaard CB, 2008, CIRCULATION, V118, P1047, DOI 10.1161/CIRCULATIONAHA.107.728840; Pahel BT, 2011, J PUBLIC HEALTH DENT, V71, P71, DOI 10.1111/j.1752-7325.2010.00197.x; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; Peace JM, 2014, RESUSCITATION, V85, P266, DOI 10.1016/j.resuscitation.2013.10.013; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Peng TJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0867-z; Perkins GD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3245; Perkins GD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2435; REDDING JS, 1962, JAMA-J AM MED ASSOC, V182, P283; REDDING JS, 1968, J AMER MED ASSOC, V203, P255; Ristagno G, 2009, CRIT CARE MED, V37, P1408, DOI 10.1097/CCM.0b013e31819cedc9; TANG WC, 1995, CIRCULATION, V92, P3089, DOI 10.1161/01.CIR.92.10.3089; Terman SW, 2014, CRIT CARE MED, V42, P2225, DOI 10.1097/CCM.0000000000000506; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Warwick Medical School, 2015, PARAMEDIC2 SEC PARAM; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035	65	58	64	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	2016	353								i1577	10.1136/bmj.i1577	http://dx.doi.org/10.1136/bmj.i1577			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LQ	27053638	hybrid, Green Published			2022-12-28	WOS:000373895500002
J	Pace, CA; Samet, JH				Pace, Christine A.; Samet, Jeffrey H.			Substance Use Disorders	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE SETTINGS; DRUG-USE; ALCOHOL DEPENDENCE; BRIEF INTERVENTION; CLINICAL-TRIAL; SCREENING-TEST; HIV-INFECTION; DOUBLE-BLIND; METHADONE							Samet, Jeffrey/0000-0002-0897-3400				Abdul-Quader AS, 2013, AIDS BEHAV, V17, P2878, DOI 10.1007/s10461-013-0593-y; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Batalla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055821; Blondell RD, 2005, AM FAM PHYSICIAN, V71, P495; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Caplehorn J, 2002, AUST NZ J PUBL HEAL, V26, P363, DOI 10.1111/j.1467-842X.2002.tb00187.x; Caplehorn JRM, 2002, AUST NZ J PUBL HEAL, V26, P358, DOI 10.1111/j.1467-842X.2002.tb00185.x; Carmen B, 2004, ADDICTION, V99, P811, DOI 10.1111/j.1360-0443.2004.00763.x; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Chou R, 2014, J PAIN, V15, P321, DOI 10.1016/j.jpain.2014.01.494; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Elder RW, 2010, AM J PREV MED, V38, P217, DOI 10.1016/j.amepre.2009.11.005; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Friedmann PD, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-10; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Grant KM, 2012, J NEUROIMMUNE PHARM, V7, P113, DOI 10.1007/s11481-011-9288-1; Hingson R, 2014, J STUD ALCOHOL DRUGS, V75, P158, DOI 10.15288/jsad.2014.75.158; Johnson JA, 2013, ALCOHOL CLIN EXP RES, V37, pE253, DOI 10.1111/j.1530-0277.2012.01898.x; Jones T, 2012, CLIN J PAIN, V28, P93, DOI 10.1097/AJP.0b013e318225da9e; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; Kharasch ED, 2013, DRUG METAB DISPOS, V41, P2166, DOI 10.1124/dmd.113.053991; Krupitsky E, 2011, LANCET, V377, P1506, DOI 10.1016/S0140-6736(11)60358-9; Leshner AI, 1999, JAMA-J AM MED ASSOC, V282, P1314, DOI 10.1001/jama.282.14.1314; Martin JA, 2011, J ADDICT DIS, V30, P283, DOI 10.1080/10550887.2011.610710; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; McKinney CM, 2010, ALCOHOL CLIN EXP RES, V34, P655, DOI 10.1111/j.1530-0277.2009.01134.x; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Qureshi AI, 2001, CIRCULATION, V103, P502, DOI 10.1161/01.CIR.103.4.502; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001867.pub3; Roy-Byrne P, 2014, JAMA-J AM MED ASSOC, V312, P492, DOI 10.1001/jama.2014.7860; Rutkow L, 2015, JAMA INTERN MED, V175, P1642, DOI 10.1001/jamainternmed.2015.3931; Saitz R, 2014, JAMA-J AM MED ASSOC, V312, P502, DOI 10.1001/jama.2014.7862; SAMET JH, 1990, AM J MED, V89, P53, DOI 10.1016/0002-9343(90)90098-X; Smedslund G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008063.pub2; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; Thakker KD, 1998, ALCOHOL CLIN EXP RES, V22, p285S, DOI 10.1111/j.1530-0277.1998.tb04381.x; Tonigan JS, 1996, J STUD ALCOHOL, V57, P65, DOI 10.15288/jsa.1996.57.65; Tracqui A, 1998, J ANAL TOXICOL, V22, P430, DOI 10.1093/jat/22.6.430; van den Bree MBM, 1998, DRUG ALCOHOL DEPEN, V52, P231, DOI 10.1016/S0376-8716(98)00101-X; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Voshaar RCO, 2006, BRIT J PSYCHIAT, V189, P213, DOI 10.1192/bjp.189.3.213; Walley AY, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f174; Weaver MF, 2015, ADDICT SCI CLIN PRAC, V10, DOI 10.1186/s13722-015-0024-7; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Zalesky A, 2012, BRAIN, V135, P2245, DOI 10.1093/brain/aws136; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	55	13	13	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2016	164	7					ITC49	ITC62		10.7326/AITC201604050	http://dx.doi.org/10.7326/AITC201604050			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV7LE	27043992				2022-12-28	WOS:000383116600001
J	Davidoff, AM; Nathwani, AC				Davidoff, Andrew M.; Nathwani, Amit C.			Genetic Targeting of the Albumin Locus to Treat Hemophilia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IN-VIVO; THERAPY		[Davidoff, Andrew M.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, St Jude Childrens Res Hosp, Memphis, TN USA; [Davidoff, Andrew M.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN USA; [Nathwani, Amit C.] UCL, Inst Canc, Dept Hematol, London WC1E 6BT, England	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of London; University College London	Davidoff, AM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Surg, St Jude Childrens Res Hosp, Memphis, TN USA.; Davidoff, AM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN USA.				Medical Research Council [MR/L013185/1, G0502121, G0902219] Funding Source: Medline; National Institute for Health Research [NF-SI-0513-10071] Funding Source: researchfish; Rosetrees Trust [M196] Funding Source: researchfish; MRC [G0502121, G0902219, MR/L013185/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Cesana D, 2014, MOL THER, V22, P774, DOI 10.1038/mt.2014.3; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492	5	8	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1288	1290		10.1056/NEJMcibr1600347	http://dx.doi.org/10.1056/NEJMcibr1600347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8ZM	27028920				2022-12-28	WOS:000373085500015
J	McKinlay, R				McKinlay, Roger			Use or lose our navigation skills	NATURE			English	Editorial Material									[McKinlay, Roger] Royal Inst Nav, London, England; [McKinlay, Roger] Thales UK, Engn, London, England	Thales Group		roger.mckinlay@ntlworld.com						Brown M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006102; Hart V, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-38; Jeffery K., 2015, P COGNAV 2015; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; Wiener J., 2015, P COGNAV 2015; WILTSCHKO W, 1993, J NAVIGATION, V46, P174, DOI 10.1017/S0373463300011528	6	21	21	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					573	575		10.1038/531573a	http://dx.doi.org/10.1038/531573a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH8EX	27029262	Bronze			2022-12-28	WOS:000373027400013
J	Birchall, M; De Coppi, P				Birchall, Martin; De Coppi, Paolo			Novel approach to in-vivo oesophageal regeneration	LANCET			English	Editorial Material							MODEL		[Birchall, Martin] Royal Natl Throat Nose & Ear Hosp, Grays Inn Rd, London WC1X 8DA, England; [Birchall, Martin] UCL, UCL Ear Inst, London WC1X 8DA, England; [De Coppi, Paolo] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [De Coppi, Paolo] UCL, Inst Child Hlth, London WC1X 8DA, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Birchall, M (corresponding author), Royal Natl Throat Nose & Ear Hosp, Grays Inn Rd, London WC1X 8DA, England.; Birchall, M (corresponding author), UCL, UCL Ear Inst, London WC1X 8DA, England.	m.birchall@uclac.uk		De Coppi, Paolo/0000-0002-1659-0207	Medical Research Council [MR/K026453/1, G1001539] Funding Source: Medline; Department of Health [PB-PG-1013-32058, RP_2014-04-046] Funding Source: Medline; MRC [G1001539, MR/K026453/1] Funding Source: UKRI; National Institute for Health Research [RP_2014-04-046, NF-SI-0513-10089] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Dua KS, 2016, LANCET; Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110; Laituri CA, 2010, EUR J PEDIATR SURG, V20, P363, DOI 10.1055/s-0030-1261939; Lowdell MW, 2012, LANCET, V379, P2341, DOI 10.1016/S0140-6736(12)61018-6; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Schwartz JAT, 2014, J PEDIATR SURG, V49, P639, DOI 10.1016/j.jpedsurg.2013.12.016; Vogel G, 2013, SCIENCE, V340, P266, DOI 10.1126/science.340.6130.266	7	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					6	7		10.1016/S0140-6736(16)00649-8	http://dx.doi.org/10.1016/S0140-6736(16)00649-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP9PM	27068835	Green Submitted			2022-12-28	WOS:000378828400006
J	Dale, SB; Ghosh, A; Peikes, DN; Day, TJ; Yoon, FB; Taylor, EF; Swankoski, K; O'Malley, AS; Conway, PH; Rajkumar, R; Press, MJ; Sessums, L; Brown, R				Dale, Stacy B.; Ghosh, Arkadipta; Peikes, Deborah N.; Day, Timothy J.; Yoon, Frank B.; Taylor, Erin Fries; Swankoski, Kaylyn; O'Malley, Ann S.; Conway, Patrick H.; Rajkumar, Rahul; Press, Matthew J.; Sessums, Laura; Brown, Randall			Two-Year Costs and Quality in the Comprehensive Primary Care Initiative	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTERED MEDICAL HOME; PATIENT EXPERIENCE; PAYMENT REFORM; HEALTH-CARE; TRANSFORMATION; PROVIDERS; LESSONS	BACKGROUND The 4-year, multipayer Comprehensive Primary Care Initiative was started in October 2012 to determine whether several forms of support would produce changes in care delivery that would improve the quality and reduce the costs of care at 497 primary care practices in seven regions across the United States. Support included the provision of care-management fees, the opportunity to earn shared savings, and the provision of data feedback and learning support. METHODS We tracked changes in the delivery of care by practices participating in the initiative and used difference-in-differences regressions to compare changes over the first 2 years of the initiative in Medicare expenditures, health care utilization, claims-based measures of quality, and patient experience for Medicare fee-for-service beneficiaries attributed to initiative practices and a group of matched comparison practices. RESULTS During the first 2 years, initiative practices received a median of $115,000 per clinician in care-management fees. The practices reported improvements in approaches to the delivery of primary care in areas such as management of the care of high-risk patients and enhanced access to care. Changes in average monthly Medicare expenditures per beneficiary did not differ significantly between initiative and comparison practices when care-management fees were not taken into account (-$11; 95% confidence interval [CI] -$23 to $1; P=0.07; negative values indicate less growth in spending at initiative practices) or when these fees were taken into account ($7; 95% CI, -$5 to $19; P=0.27). The only significant differences in other measures were a 3% reduction in primary care visits for initiative practices relative to comparison practices (P<0.001) and changes in two of the six domains of patient experience discussion of decisions regarding medication with patients and the provision of support for patients taking care of their own health both of which showed a small improvement in initiative practices relative to comparison practices (P=0.006 and P<0.001, respectively). CONCLUSIONS Midway through this 4-year intervention, practices participating in the initiative have reported progress in transforming the delivery of primary care. However, at this point these practices have not yet shown savings in expenditures for Medicare Parts A and B after accounting for care-management fees, nor have they shown an appreciable improvement in the quality of care or patient experience.	[Dale, Stacy B.] Math Policy Res, 111 E Upper Wacker Dr, Chicago, IL 60601 USA; [Ghosh, Arkadipta; Peikes, Deborah N.; Yoon, Frank B.; Swankoski, Kaylyn; Brown, Randall] Math Policy Res, Princeton, NJ USA; [Taylor, Erin Fries; O'Malley, Ann S.] Math Policy Res, Washington, DC USA; [Day, Timothy J.; Conway, Patrick H.; Rajkumar, Rahul; Press, Matthew J.; Sessums, Laura] Ctr Medicare & Medicaid Serv, Baltimore, MD USA	Mathematica; Mathematica; Mathematica; Centers for Medicare & Medicaid Services	Dale, SB (corresponding author), Math Policy Res, 111 E Upper Wacker Dr, Chicago, IL 60601 USA.	sdale@mathematica-mpr.com		Taylor, Erin/0000-0003-1129-6655	Department of Health and Human Services, Centers for Medicare and Medicaid Services	Department of Health and Human Services, Centers for Medicare and Medicaid Services	Funded by the Department of Health and Human Services, Centers for Medicare and Medicaid Services; ClinicalTrials.gov number, NCT02320591.	American Academy of Family Physicians, 2007, JOINT PRINC PAT CTR; Berenson RA, 2010, J GEN INTERN MED, V25, P619, DOI 10.1007/s11606-010-1290-4; Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Centers for Medicare & Medicaid Services, COMPR PRIM CAR IN; Centers for Medicare & Medicaid Services, COMPR PRIM CAR CPC I; Dentzer S, 2010, HEALTH AFFAIR, V29, P757, DOI 10.1377/hlthaff.2010.0410; Edwards ST, 2014, HEALTH AFFAIR, V33, P1823, DOI 10.1377/hlthaff.2014.0351; Friedberg MW, 2015, JAMA INTERN MED, V175, P1362, DOI 10.1001/jamainternmed.2015.2047; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Heyworth L, 2014, AM J MANAG CARE, V20, P26; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Kahn KL, 2015, EVALUATION CMSS FEDE; Katerndabl DA, 2010, ANN FAM MED, V8, P341, DOI [10.1370/afm.1108, 10.1370/afm.1157]; Kern LM, 2013, AM J MANAG CARE, V19, P403; McCall N, 2015, EVALUATION MULTIPAYE; McNellis RJ, 2013, ANN FAM MED, V11, pS1, DOI 10.1370/afm.1548; Nutting PA, 2011, HEALTH AFFAIR, V30, P439, DOI 10.1377/hlthaff.2010.0159; Peikes D, 2016, EVALUATION COMPREHEN; Peikes D, 2014, EVALUATION COMPREHEN; Peikes D, 2012, AM J MANAG CARE, V18, P105; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Procopio KM, 2013, POPUL HLTH MANAG, V16, P157; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703; Reddy A, 2015, AM J MANAG CARE, V21, P413; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Reid RJ, 2009, AM J MANAG CARE, V15, pE71; Rosenthal MB, 2013, JAMA INTERN MED, V173, P1907, DOI 10.1001/jamainternmed.2013.10063; Safety Net Medical Home Initiative, 2014, PAT CTR MED HOM ASS; Scholle SH, 2012, MED CARE, V50, pS2, DOI 10.1097/MLR.0b013e3182610aba; Shapiro R, 2013, AC HLTH 2013 ANN RES; Taylor E. F., 2015, EVALUATION COMPREHEN; Werner RM, 2014, HEALTH SERV RES, V49, P1329, DOI 10.1111/1475-6773.12155; Werner RM, 2013, MED CARE, V51, P487, DOI 10.1097/MLR.0b013e31828d4d29	34	80	81	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2016	374	24					2345	2356		10.1056/NEJMsa1414953	http://dx.doi.org/10.1056/NEJMsa1414953			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DO5WW	27074035	Bronze			2022-12-28	WOS:000377854600008
J	Campanile, A; Tavazzi, G; Alam, MH; Paul, R; Price, S				Campanile, Alfonso; Tavazzi, Guido; Alam, Mohammed Harith; Paul, Richard; Price, Susanna			An unexpected finding in an asymptomatic patient with atrial fibrillation: cardiac angiosarcoma	LANCET			English	Editorial Material									[Campanile, Alfonso] dellAngelo Hosp, Dept Cardiol, Mestre Venice, Italy; [Tavazzi, Guido] Univ Pavia, Fdn Policlin San Matteo IRCCS, Dept Anaesthesia Intens Care & Pain Therapy, Via Palestro 3, I-27100 Pavia, Italy; [Tavazzi, Guido] Univ Pavia, Fdn Policlin San Matteo IRCCS, Dept Anaesthesia & Intens Care, Emergency Dept, Via Palestro 3, I-27100 Pavia, Italy; [Alam, Mohammed Harith; Paul, Richard; Price, Susanna] Royal Brompton & Harefield NHS Fdn Trust, Royal Brompton Hosp, Adult Intens Care Unit, London, England; [Alam, Mohammed Harith] Univ London Imperial Coll Sci Technol & Med, London, England; [Paul, Richard] Natl Inst Hlth Res, London, England	IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London	Tavazzi, G (corresponding author), Fdn Policlin San Matteo IRCCS, Dept Anaesthesia Intens Care & Pain Therapy, Pavia, Italy.	gtavazzi@yahoo.it	Tavazzi, Guido/AAC-3830-2022; Price, Susanna/AAH-7515-2021; Campanile, Alfonso/Q-6941-2019	Tavazzi, Guido/0000-0002-9560-5138; Campanile, Alfonso/0000-0001-7002-3556					0	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2016	387	10036					E29	E29		10.1016/S0140-6736(16)00086-6	http://dx.doi.org/10.1016/S0140-6736(16)00086-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1ST	27063640				2022-12-28	WOS:000377560100001
J	Reuben, A; Tillman, H; Fontana, RJ; Davern, T; McGuire, B; Stravitz, RT; Durkalski, V; Larson, AM; Liou, I; Fix, O; Schilsky, M; McCashland, T; Hay, JE; Murray, N; Shaikh, OS; Ganger, D; Zaman, A; Han, SB; Chung, RT; Smith, A; Brown, R; Crippin, J; Harrison, ME; Koch, D; Munoz, S; Reddy, KR; Rossaro, L; Satyanarayana, R; Hassanein, T; Hanje, AJ; Olson, J; Subramanian, R; Karvellas, C; Hameed, B; Sherker, AH; Robuck, P; Lee, WM				Reuben, Adrian; Tillman, Holly; Fontana, Robert J.; Davern, Timothy; McGuire, Brendan; Stravitz, R. Todd; Durkalski, Valerie; Larson, Anne M.; Liou, Iris; Fix, Oren; Schilsky, Michael; McCashland, Timothy; Hay, J. Eileen; Murray, Natalie; Shaikh, Obaid S.; Ganger, Daniel; Zaman, Atif; Han, Steven B.; Chung, Raymond T.; Smith, Alastair; Brown, Robert; Crippin, Jeffrey; Harrison, M. Edwyn; Koch, David; Munoz, Santiago; Reddy, K. Rajender; Rossaro, Lorenzo; Satyanarayana, Raj; Hassanein, Tarek; Hanje, A. James; Olson, Jody; Subramanian, Ram; Karvellas, Constantine; Hameed, Bilal; Sherker, Averell H.; Robuck, Patricia; Lee, William M.			Outcomes in Adults With Acute Liver Failure Between 1998 and 2013 An Observational Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							RETROSPECTIVE COHORT; INTENSIVE-CARE; CLINICAL-TRIAL; UNITED-STATES; ENCEPHALOPATHY; COMPLICATIONS; MULTICENTER	Background: Acute liver failure (ALF) is a rare syndrome of severe, rapid-onset hepatic dysfunction-without prior advanced liver disease-that is associated with high morbidity and mortality. Intensive care and liver transplantation provide support and rescue, respectively. Objective: To determine whether changes in causes, disease severity, treatment, or 21-day outcomes have occurred in recent years among adult patients with ALF referred to U.S. tertiary care centers. Design: Prospective observational cohort study. (ClinicalTrials.gov: NCT00518440) Setting: 31 liver disease and transplant centers in the United States. Patients: Consecutively enrolled patients-without prior advanced liver disease-with ALF (n = 2070). Measurements: Clinical features, treatment, and 21-day outcomes were compared over time annually for trends and were also stratified into two 8-year periods (1998 to 2005 and 2006 to 2013). Results: Overall clinical characteristics, disease severity, and distribution of causes remained similar throughout the study period. The 21-day survival rates increased between the two 8-year periods (overall, 67.1% vs. 75.3%; transplant-free survival [TFS], 45.1% vs. 56.2%; posttransplantation survival, 88.3% vs. 96.3% [P < 0.010 for each]). Reductions in red blood cell infusions (44.3% vs. 27.6%), plasma infusions (65.2% vs. 47.1%), mechanical ventilation (65.7% vs. 56.1%), and vasopressors (34.9% vs. 27.8%) were observed, as well as increased use of N-acetylcysteine (48.9% vs. 69.3% overall; 15.8% vs. 49.4% [P < 0.001] in patients with ALF not due to acetaminophen toxicity). When examined longitudinally, overall survival and TFS increased throughout the 16-year period. Limitations: The duration of enrollment, the number of patients enrolled, and possibly the approaches to care varied among participating sites. The results may not be generalizable beyond such specialized centers. Conclusion: Although characteristics and severity of ALF changed little over 16 years, overall survival and TFS improved significantly. The effects of specific changes in intensive care practice on survival warrant further study.	[Lee, William M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Baylor Univ, Med Ctr, Dallas, TX USA; Med Univ S Carolina, Charleston, SC 29425 USA; Univ Washington, Seattle, WA 98195 USA; Washington Univ, St Louis, MO USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Calif Pacific Med Ctr, San Francisco, CA USA; Univ Nebraska, Omaha, NE 68182 USA; Mt Sinai Med Ctr, New York, NY 10029 USA; Columbia Univ, Med Ctr, New York, NY USA; Mayo Clin, Rochester, MN USA; Univ Pittsburgh, Pittsburgh, PA USA; Northwestern Univ, Chicago, IL 60611 USA; Oregon Hlth & Sci Univ, Portland, OR USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Michigan, Ann Arbor, MI 48109 USA; Yale Univ, New Haven, CT USA; Univ Alabama Birmingham, Birmingham, AL USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Duke Univ, Durham, NC USA; Mayo Clin, Scottsdale, AZ USA; Albert Einstein Med Ctr, Philadelphia, PA 19141 USA; Univ Penn, Philadelphia, PA 19104 USA; Virginia Commonwealth Univ, Richmond, VA USA; Univ Calif Davis, Davis, CA 95616 USA; Mayo Clin, Jacksonville, FL 32224 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Ohio State Univ, Columbus, OH 43210 USA; Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; Emory Univ, Atlanta, GA 30322 USA; Univ Alberta, Edmonton, AB, Canada; NIDDK, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center; Medical University of South Carolina; University of Washington; University of Washington Seattle; Washington University (WUSTL); University of California System; University of California San Francisco; California Pacific Medical Center; University of Nebraska System; Icahn School of Medicine at Mount Sinai; Columbia University; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Oregon Health & Science University; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; Yale University; University of Alabama System; University of Alabama Birmingham; Harvard University; Massachusetts General Hospital; Duke University; Mayo Clinic; Mayo Clinic Phoenix; Yeshiva University; University of Pennsylvania; Virginia Commonwealth University; University of California System; University of California Davis; Mayo Clinic; University of California System; University of California San Diego; University System of Ohio; Ohio State University; University of Kansas; University of Kansas Medical Center; Emory University; University of Alberta; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Lee, WM (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.	william.lee@utsouthwestern.edu	Shaikh, Obaid/AAL-5339-2021; Larson, Anne/I-2087-2019; Sherker, Averell H/A-2889-2013; Ganger, Daniel/H-7905-2019	Shaikh, Obaid/0000-0002-4955-9222; Sherker, Averell H/0000-0003-0409-6938; Karvellas, Constantine/0000-0002-1555-1089	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [DK-U-01-58369]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK058369, R01DK058369] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (DK-U-01-58369).	ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Bernal W, 2008, SEMIN LIVER DIS, V28, P188, DOI 10.1055/s-2008-1073118; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Ichai P, 2008, LIVER TRANSPLANT, V14, pS67, DOI 10.1002/lt.21612; Karvellas CJ, 2014, CLIN GASTROENTEROL H, V12, P1942, DOI 10.1016/j.cgh.2014.03.011; Karvellas CJ, 2014, CRIT CARE MED, V42, P1157, DOI 10.1097/CCM.0000000000000144; Kim W R, 2015, Am J Transplant, V15 Suppl 2, P1, DOI 10.1111/ajt.13197; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Lee WM, 2009, GASTROENTEROLOGY, V137, P856, DOI 10.1053/j.gastro.2009.06.006; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Schiodt FV, 1997, NEW ENGL J MED, V337, P1112, DOI 10.1056/NEJM199710163371602; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Stravitz RT, 2012, J HEPATOL, V56, P129, DOI 10.1016/j.jhep.2011.04.020; Vaquero J, 2005, LIVER TRANSPLANT, V11, P1581, DOI 10.1002/lt.20625	19	188	192	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2016	164	11					724	+		10.7326/M15-2211	http://dx.doi.org/10.7326/M15-2211			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1AI	27043883	Green Accepted			2022-12-28	WOS:000377510100004
J	Hijazi, Z; Oldgren, J; Lindback, J; Alexander, JH; Connolly, SJ; Eikelboom, JW; Ezekowitz, MD; Held, C; Hylek, EM; Lopes, RD; Siegbahn, A; Yusuf, S; Granger, CB; Wallentin, L				Hijazi, Ziad; Oldgren, Jonas; Lindback, Johan; Alexander, John H.; Connolly, Stuart J.; Eikelboom, John W.; Ezekowitz, Michael D.; Held, Claes; Hylek, Elaine M.; Lopes, Renato D.; Siegbahn, Agneta; Yusuf, Salim; Granger, Christopher B.; Wallentin, Lars		ARISTOTLE RE-LY Investigators	The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study	LANCET			English	Article							LY RANDOMIZED EVALUATION; THROMBOEMBOLIC EVENTS; CARDIOVASCULAR EVENTS; PREDICTION MODELS; RENAL-FUNCTION; APIXABAN; WARFARIN; STROKE; INSIGHTS; REDUCTION	Background The benefit of oral anticoagulation in atrial fibrillation is based on a balance between reduction in ischaemic stroke and increase in major bleeding. We aimed to develop and validate a new biomarker-based risk score to improve the prognostication of major bleeding in patients with atrial fibrillation. Methods We developed and internally validated a new biomarker-based risk score for major bleeding in 14 537 patients with atrial fibrillation randomised to apixaban versus warfarin in the ARISTOTLE trial and externally validated it in 8468 patients with atrial fibrillation randomised to dabigatran versus warfarin in the RE-LY trial. Plasma samples for determination of candidate biomarker concentrations were obtained at randomisation. Major bleeding events were centrally adjudicated. The predictive values of biomarkers and clinical variables were assessed with Cox regression models. The most important variables were included in the score with weights proportional to the model coefficients. The ARISTOTLE and RE-LY trials are registered with ClinicalTrials.gov, numbers NCT00412984 and NCT00262600, respectively. Findings The most important predictors for major bleeding were the concentrations of the biomarkers growth differentiation factor-15 (GDF-15), high-sensitivity cardiac troponin T (cTnT-hs) and haemoglobin, age, and previous bleeding. The ABC-bleeding score (age, biomarkers [GDF-15, cTnT-hs, and haemoglobin], and clinical history [previous bleeding]) score yielded a higher c-index than the conventional HAS-BLED and the newer ORBIT scores for major bleeding in both the derivation cohort (0.68 [95% CI 0.66-0.70] vs 0.61 [0.59-0.63] vs 0.65 [0.62-0.67], respectively; ABC-bleeding vs HAS-BLED p< 0.0001 and ABC-bleeding vs ORBIT p= 0.0008). ABC-bleeding score also yielded a higher c-index score in the the external validation cohort (0.71 [95% CI 0.68-0.73] vs 0.62 [0.59-0.64] for HAS-BLED vs 0.68 [0.65-0.70] for ORBIT; ABC-bleeding vs HAS-BLED p< 0.0001 and ABC-bleeding vs ORBIT p= 0.0016). A modified ABC-bleeding score using alternative biomarkers (haematocrit, cTnI-hs, cystatin C, or creatinine clearance) also outperformed the HAS-BLED and ORBIT scores. Interpretation The ABC-bleeding score, using age, history of bleeding, and three biomarkers (haemoglobin, cTn-hs, and GDF-15 or cystatin C/CKD-EPI) was internally and externally validated and calibrated in large cohorts of patients with atrial fibrillation receiving anticoagulation therapy. The ABC-bleeding score performed better than HAS-BLED and ORBIT scores and should be useful as decision support on anticoagulation treatment in patients with atrial fibrillation.	[Hijazi, Ziad; Oldgren, Jonas; Held, Claes; Wallentin, Lars] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [Hijazi, Ziad; Oldgren, Jonas; Lindback, Johan; Held, Claes; Siegbahn, Agneta; Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala Sci Pk, SE-75237 Uppsala, Sweden; [Siegbahn, Agneta] Uppsala Univ, Dept Med Sci, Clin Chem, Uppsala, Sweden; [Alexander, John H.; Lopes, Renato D.; Granger, Christopher B.] Duke Med, Duke Clin Res Inst, Durham, NC USA; [Connolly, Stuart J.; Eikelboom, John W.; Yusuf, Salim] Populat Hlth Res Inst, Hamilton, ON, Canada; [Ezekowitz, Michael D.] Thomas Jefferson Med Coll & Heart Ctr, Wynnewood, PA USA; [Hylek, Elaine M.] Boston Univ, Med Ctr, Boston, MA USA	Uppsala University; Uppsala University; Uppsala University; Duke University; Population Health Research Institute; Jefferson University; Boston University	Hijazi, Z (corresponding author), Uppsala Univ, Uppsala Clin Res Ctr, Uppsala Sci Pk, SE-75237 Uppsala, Sweden.	Ziad.Hijazi@ucr.uu.se	Eikelboom, John/AAG-6117-2019; Lindbäck, Johan/R-2900-2017; Held, Claes/AAA-3973-2021; Alexander, John/GVS-7271-2022; Ezekowitz, Michael/AAJ-2543-2021	Eikelboom, John/0000-0003-4126-1285; Lindbäck, Johan/0000-0002-6473-8798; Held, Claes/0000-0001-9402-7404; Hijazi, Ziad/0000-0002-7420-743X; Alexander, John/0000-0002-1444-2462; Yusuf, Salim/0000-0003-4776-5601	BMS; Pfizer; Boehringer Ingelheim; Roche Diagnostics	BMS(Bristol-Myers Squibb); Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Roche Diagnostics	BMS, Pfizer, Boehringer Ingelheim, Roche Diagnostics.	Aulin J, 2015, AM HEART J, V170, P1151, DOI 10.1016/j.ahj.2015.09.018; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Christersson C, 2014, J THROMB HAEMOST, V12, P1401, DOI 10.1111/jth.12638; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eckman MH, 2011, CIRC-CARDIOVASC QUAL, V4, P14, DOI 10.1161/CIRCOUTCOMES.110.958108; Ezekowitz MD, 2009, AM HEART J, V157, P805, DOI 10.1016/j.ahj.2009.02.005; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hagstrom E, 2015, EUR HEART J; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Held C, 2015, EUR HEART J, V36, P1264, DOI 10.1093/eurheartj/ehu463; Hijazi Z, 2016, EUR HEART J; Hijazi Z, 2016, HEART, V102, P508, DOI 10.1136/heartjnl-2015-308887; Hijazi Z, 2014, HEART, V100, P1193, DOI 10.1136/heartjnl-2013-304872; Hijazi Z, 2014, CIRCULATION, V129, P961, DOI 10.1161/CIRCULATIONAHA.113.003628; Hijazi Z, 2014, CIRCULATION, V129, P625, DOI 10.1161/CIRCULATIONAHA.113.006286; Hijazi Z, 2014, J AM COLL CARDIOL, V63, P52, DOI 10.1016/j.jacc.2013.07.093; Hijazi Z, 2013, J AM COLL CARDIOL, V61, P2274, DOI 10.1016/j.jacc.2012.11.082; Hijazi Z, 2013, EUR HEART J, V34, P1475, DOI 10.1093/eurheartj/eht024; Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274; Hylek EM, 2014, J AM COLL CARDIOL, V63, P2141, DOI 10.1016/j.jacc.2014.02.549; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; KANNEL WB, 1998, AM J CARDIOL, V0082; Kirchhof P, 2013, EUROPACE, V15, P1540, DOI 10.1093/europace/eut232; Lopes RD, 2010, AM HEART J, V159, P331, DOI 10.1016/j.ahj.2009.07.035; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; O'Brien EC, 2015, EUR HEART J, V36, P3258, DOI 10.1093/eurheartj/ehv476; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Wallentin L, 2014, CIRCULATION, V130, P1847, DOI 10.1161/CIRCULATIONAHA.114.011204; Wallentin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078797	34	321	340	3	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2302	2311		10.1016/S0140-6736(16)00741-8	http://dx.doi.org/10.1016/S0140-6736(16)00741-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27056738				2022-12-28	WOS:000376969100033
J	Bouton, CE; Shaikhouni, A; Annetta, NV; Bockbrader, MA; Friedenberg, DA; Nielson, DM; Sharma, G; Sederberg, PB; Glenn, BC; Mysiw, WJ; Morgan, AG; Deogaonkar, M; Rezai, AR				Bouton, Chad E.; Shaikhouni, Ammar; Annetta, Nicholas V.; Bockbrader, Marcia A.; Friedenberg, David A.; Nielson, Dylan M.; Sharma, Gaurav; Sederberg, Per B.; Glenn, Bradley C.; Mysiw, W. Jerry; Morgan, Austin G.; Deogaonkar, Milind; Rezai, Ali R.			Restoring cortical control of functional movement in a human with quadriplegia	NATURE			English	Article							MOTOR CORTEX; TETRAPLEGIA; GRASP; HAND; ARM; RESTORATION; NEURONS; NEUROPROSTHESIS; STIMULATION; PERFORMANCE	Millions of people worldwide suffer from diseases that lead to paralysis through disruption of signal pathways between the brain and the muscles. Neuroprosthetic devices are designed to restore lost function and could be used to form an electronic 'neural bypass' to circumvent disconnected pathways in the nervous system. It has previously been shown that intracortically recorded signals can be decoded to extract information related to motion, allowing non-human primates and paralysed humans to control computers and robotic arms through imagined movements(1-11). In non-human primates, these types of signal have also been used to drive activation of chemically paralysed arm muscles(12,13). Here we show that intracortically recorded signals can be linked in real-time to muscle activation to restore movement in a paralysed human. We used a chronically implanted intracortical microelectrode array to record multiunit activity from the motor cortex in a study participant with quadriplegia from cervical spinal cord injury. We applied machine-learning algorithms to decode the neuronal activity and control activation of the participant's forearm muscles through a custom-built high-resolution neuromuscular electrical stimulation system. The system provided isolated finger movements and the participant achieved continuous cortical control of six different wrist and hand motions. Furthermore, he was able to use the system to complete functional tasks relevant to daily living. Clinical assessment showed that, when using the system, his motor impairment improved from the fifth to the sixth cervical (C5-C6) to the seventh cervical to first thoracic (C7-T1) level unilaterally, conferring on him the critical abilities to grasp, manipulate, and release objects. This is the first demonstration to our knowledge of successful control of muscle activation using intracortically recorded signals in a paralysed human. These results have significant implications in advancing neuroprosthetic technology for people worldwide living with the effects of paralysis.	[Bouton, Chad E.; Annetta, Nicholas V.; Sharma, Gaurav; Morgan, Austin G.] Battelle Mem Inst, Med Devices & Neuromodulat, 505 King Ave, Columbus, OH 43201 USA; [Shaikhouni, Ammar; Bockbrader, Marcia A.; Nielson, Dylan M.; Sederberg, Per B.; Mysiw, W. Jerry; Deogaonkar, Milind; Rezai, Ali R.] Ohio State Univ, Ctr Neuromodulat, Columbus, OH 43210 USA; [Shaikhouni, Ammar; Nielson, Dylan M.; Deogaonkar, Milind; Rezai, Ali R.] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Bockbrader, Marcia A.; Mysiw, W. Jerry] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Friedenberg, David A.] Battelle Mem Inst, Adv Analyt & Hlth Res, 505 King Ave, Columbus, OH 43201 USA; [Sederberg, Per B.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Glenn, Bradley C.] Battelle Mem Inst, Energy Syst, 505 King Ave, Columbus, OH 43201 USA; [Bouton, Chad E.] Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA	Battelle Memorial Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Battelle Memorial Institute; University System of Ohio; Ohio State University; Battelle Memorial Institute; Northwell Health	Bouton, CE; Sharma, G (corresponding author), Battelle Mem Inst, Med Devices & Neuromodulat, 505 King Ave, Columbus, OH 43201 USA.; Bouton, CE (corresponding author), Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.	boutonce@gmail.com; sharmag@battelle.org	Bockbrader, Marcia/J-6203-2013; Bockbrader, Marcia/U-7844-2019; Nielson, Dylan/ABD-1615-2021	Bockbrader, Marcia/0000-0001-6419-0630; Bockbrader, Marcia/0000-0001-6419-0630; Nielson, Dylan/0000-0003-4613-6643; Shaikhouni, Ammar/0000-0002-3527-4920; Friedenberg, David/0000-0002-4404-8941	Battelle Memorial Institute; Ohio State University Center for Neuromodulation	Battelle Memorial Institute; Ohio State University Center for Neuromodulation	We thank the study participant for his dedication and his family for their support. We also thank the development team and management at Battelle Memorial Institute for their support, the surgical support team, C. Majstorovic for assistance with data analysis and equipment during sessions, S. Preston for stereo camera coding and troubleshooting, the clinical study support staff, W. Pease for performing the electromyogram and nerve conduction studies, and M. Zhang for assistance with figure preparation. Financial support for this study came from Battelle Memorial Institute and The Ohio State University Center for Neuromodulation.	Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; [Anonymous], 1999, WAVELET TOUR SIGNAL, DOI DOI 10.1016/B978-012466606-1/50016-7; Bansal AK, 2012, J NEUROPHYSIOL, V107, P1337, DOI 10.1152/jn.00781.2011; Bradski G, 2000, DR DOBBS J, V25, P120; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; FETZ EE, 1980, J NEUROPHYSIOL, V43, P1070, DOI 10.1152/jn.1980.43.4.1070; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Humber C, 2010, NONSMOOTH FORMULATIO; Kalsi-Ryan S, 2012, J NEUROSURG-SPINE, V17, P65, DOI 10.3171/2012.6.AOSPINE1258; Kennedy P, 2011, NEUROCASE, V17, P381, DOI 10.1080/13554794.2010.532137; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Kilgore KL, 2008, J HAND SURG-AM, V33A, P539, DOI 10.1016/j.jhsa.2008.01.007; Kirshblum SC, 2014, J SPINAL CORD MED, V37, P120, DOI 10.1179/2045772314Y.0000000196; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Scholkopf B, 1997, IEEE T SIGNAL PROCES, V45, P2758, DOI 10.1109/78.650102; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shaikhouni A, 2013, J NEUROPHYSIOL, V109, P2192, DOI 10.1152/jn.00368.2012; Sharma G., 2015, BIOELECTRON MED, V2, P63, DOI [10.15424/bioelectronmed.2015.00010, DOI 10.15424/BIOELECTRONMED.2015.00010]; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	30	437	456	28	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					247	+		10.1038/nature17435	http://dx.doi.org/10.1038/nature17435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27074513				2022-12-28	WOS:000376007200050
J	Ye, CX; Zhou, XL; Pu, D; Stutz, J; Festa, J; Spolaor, M; Tsai, C; Cantrell, C; Mauldin, RL; Campos, T; Weinheimer, A; Hornbrook, RS; Apel, EC; Guenther, A; Kaser, L; Yuan, B; Karl, T; Haggerty, J; Hall, S; Ullmann, K; Smith, JN; Ortega, J; Knote, C				Ye, Chunxiang; Zhou, Xianliang; Pu, Dennis; Stutz, Jochen; Festa, James; Spolaor, Max; Tsai, Catalina; Cantrell, Christopher; Mauldin, Roy L., III; Campos, Teresa; Weinheimer, Andrew; Hornbrook, Rebecca S.; Apel, Eric C.; Guenther, Alex; Kaser, Lisa; Yuan, Bin; Karl, Thomas; Haggerty, Julie; Hall, Samuel; Ullmann, Kirk; Smith, James N.; Ortega, John; Knote, Christoph			Rapid cycling of reactive nitrogen in the marine boundary layer	NATURE			English	Article							MASTER CHEMICAL MECHANISM; NITRIC-ACID PHOTOLYSIS; MCM V3 PART; TROPOSPHERIC DEGRADATION; PHOTOCHEMICAL PRODUCTION; AIR-QUALITY; DUST STORM; GAS-PHASE; HONO; SURFACE	Nitrogen oxides are essential for the formation of secondary atmospheric aerosols and of atmospheric oxidants such as ozone and the hydroxyl radical, which controls the self-cleansing capacity of the atmosphere(1). Nitric acid, a major oxidation product of nitrogen oxides, has traditionally been considered to be a permanent sink of nitrogen oxides(1). However, model studies predict higher ratios of nitric acid to nitrogen oxides in the troposphere than are observed(2,3). A 'renoxification' process that recycles nitric acid into nitrogen oxides has been proposed to reconcile observations with model studies(2-4), but the mechanisms responsible for this process remain uncertain(5-9). Here we present data from an aircraft measurement campaign over the North Atlantic Ocean and find evidence for rapid recycling of nitric acid to nitrous acid and nitrogen oxides in the clean marine boundary layer via particulate nitrate photolysis. Laboratory experiments further demonstrate the photolysis of particulate nitrate collected on filters at a rate more than two orders of magnitude greater than that of gaseous nitric acid, with nitrous acid as the main product. Box model calculations based on the Master Chemical Mechanism(10,11) suggest that particulate nitrate photolysis mainly sustains the observed levels of nitrous acid and nitrogen oxides at midday under typical marine boundary layer conditions. Given that oceans account for more than 70 per cent of Earth's surface, we propose that particulate nitrate photolysis could be a substantial tropospheric nitrogen oxide source. Recycling of nitrogen oxides in remote oceanic regions with minimal direct nitrogen oxide emissions could increase the formation of tropospheric oxidants and secondary atmospheric aerosols on a global scale.	[Ye, Chunxiang; Zhou, Xianliang] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Zhou, Xianliang; Pu, Dennis] SUNY Albany, Dept Environm Hlth Sci, Albany, NY 12222 USA; [Stutz, Jochen; Festa, James; Spolaor, Max; Tsai, Catalina] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90024 USA; [Cantrell, Christopher; Mauldin, Roy L., III] Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; [Mauldin, Roy L., III] Univ Helsinki, Dept Phys, Helsinki, Finland; [Campos, Teresa; Weinheimer, Andrew; Hornbrook, Rebecca S.; Apel, Eric C.; Kaser, Lisa; Haggerty, Julie; Hall, Samuel; Ullmann, Kirk; Smith, James N.; Ortega, John; Knote, Christoph] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Guenther, Alex] Pacific NW Natl Lab, Richland, WA 99352 USA; [Yuan, Bin] NOAA, Earth Syst Res Lab, Div Chem Sci, Boulder, CO USA; [Yuan, Bin] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Karl, Thomas] Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria; [Smith, James N.] Univ Eastern Finland, Kuopio, Finland; [Knote, Christoph] Univ Munich, Inst Meteorol, Marchioninistr 15, D-81377 Munich, Germany	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Boulder; University of Helsinki; National Center Atmospheric Research (NCAR) - USA; United States Department of Energy (DOE); Pacific Northwest National Laboratory; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Innsbruck; University of Eastern Finland; University of Munich	Zhou, XL (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.; Zhou, XL (corresponding author), SUNY Albany, Dept Environm Hlth Sci, Albany, NY 12222 USA.	xianliang.zhou@health.ny.gov	Hornbrook, Rebecca/AAA-3520-2021; Cantrell, Christopher/GXH-7594-2022; Yuan, Bin/A-1223-2012; Hall, Samuel/AAG-9516-2020; Smith, James/C-5614-2008; YE, CHUNXIANG/J-6973-2013; Stutz, Jochen/K-7159-2014; Karl, Thomas/D-1891-2009; Knote, Christoph/A-9809-2010; Guenther, Alex B/B-1617-2008	Yuan, Bin/0000-0003-3041-0329; Hall, Samuel/0000-0002-2060-7112; Smith, James/0000-0003-4677-8224; YE, CHUNXIANG/0000-0002-5417-2671; Karl, Thomas/0000-0003-2869-9426; Knote, Christoph/0000-0001-9105-9179; Guenther, Alex B/0000-0001-6283-8288	National Science Foundation (NSF) [AGS-1216166, AGS-1215712, AGS-1216743]; National Science Foundation; Directorate For Geosciences [1216166, 1216743, 1215712] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research is funded by National Science Foundation (NSF) grants (AGS-1216166, AGS-1215712, and AGS-1216743). We would like to acknowledge operational, technical and scientific support provided by NCAR's Earth Observing Laboratory, sponsored by the National Science Foundation. Any opinions, findings, conclusions or recommendations expressed in this paper are those of the authors and do not necessarily reflect the views of NSF.	Baergen AM, 2013, ENVIRON SCI TECHNOL, V47, P815, DOI 10.1021/es3037862; Browne EC, 2013, ATMOS CHEM PHYS, V13, P4543, DOI 10.5194/acp-13-4543-2013; Cantrell CA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002198; Carr S, 2009, SCIENCE, V324, DOI 10.1126/science.1166669; Czader BH, 2012, ATMOS CHEM PHYS, V12, P6939, DOI 10.5194/acp-12-6939-2012; de Gouw J, 2007, MASS SPECTROM REV, V26, P223, DOI 10.1002/mas.20119; Deng JJ, 2010, PARTICUOLOGY, V8, P308, DOI 10.1016/j.partic.2009.12.003; Dix B, 2013, P NATL ACAD SCI USA, V110, P2035, DOI 10.1073/pnas.1212386110; Du J, 2011, CHEM PHYS LETT, V511, P213, DOI 10.1016/j.cplett.2011.06.062; Flagan R.C., 2011, AEROSOL MEASUREMENT, P339; Gierczak T, 2005, J PHYS CHEM A, V109, P586, DOI 10.1021/jp046632f; HELAS G, 1981, J GEOPHYS RES-OCEANS, V86, P7283, DOI 10.1029/JC086iC08p07283; Hornbrook RS, 2011, ATMOS CHEM PHYS, V11, P11103, DOI 10.5194/acp-11-11103-2011; Hornbrook RS, 2011, ATMOS MEAS TECH, V4, P735, DOI 10.5194/amt-4-735-2011; Huang G, 2002, ATMOS ENVIRON, V36, P2225, DOI 10.1016/S1352-2310(02)00170-X; Jankowski JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P431, DOI 10.1562/0031-8655(2000)071<0431:DAIOUS>2.0.CO;2; Jenkin ME, 2003, ATMOS CHEM PHYS, V3, P181, DOI 10.5194/acp-3-181-2003; Joseph DM, 2007, PHYS CHEM CHEM PHYS, V9, P5599, DOI 10.1039/b709465e; Kleffmann J, 2007, CHEMPHYSCHEM, V8, P1137, DOI 10.1002/cphc.200700016; Kumar R, 2014, ATMOS CHEM PHYS, V14, P6813, DOI 10.5194/acp-14-6813-2014; Lee JD, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011878; Li SP, 2008, SCIENCE, V319, P1657, DOI 10.1126/science.1151443; Li X, 2014, SCIENCE, V344, P292, DOI 10.1126/science.1248999; Martin MV, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009688; Mauldin R, 2010, ATMOS ENVIRON, V44, P572, DOI 10.1016/j.atmosenv.2009.07.058; McFiggans G, 2000, J GEOPHYS RES-ATMOS, V105, P14371, DOI 10.1029/1999JD901187; Nissenson P, 2006, PHYS CHEM CHEM PHYS, V8, P4700, DOI 10.1039/b609219e; Pitts Jr J. N., 2000, CHEM UPPER LOWER ATM; Platt U, 2008, PHYS EARTH SPACE ENV, P1, DOI 10.1007/978-3-540-75776-4_1; Ramazan KA, 2004, PHYS CHEM CHEM PHYS, V6, P3836, DOI 10.1039/b402195a; Ren XR, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006126; Richards NK, 2011, J PHYS CHEM A, V115, P5810, DOI 10.1021/jp109560j; Ridley B, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004769; Sander S. P., 2011, JPL PUBL, V10-6, P17; Saunders SM, 2003, ATMOS CHEM PHYS, V3, P161, DOI 10.5194/acp-3-161-2003; Savarino J, 2013, P NATL ACAD SCI USA, V110, P17668, DOI 10.1073/pnas.1216639110; Shetter RE, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001320; Stohl A, 2005, ATMOS CHEM PHYS, V5, P2461, DOI 10.5194/acp-5-2461-2005; Stohl A, 2002, ATMOS ENVIRON, V36, P4635, DOI 10.1016/S1352-2310(02)00416-8; Turekian VC, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002053; Wang K, 2012, ATMOS CHEM PHYS, V12, P10209, DOI 10.5194/acp-12-10209-2012; Weis DD, 1999, J PHYS CHEM A, V103, P4865, DOI 10.1021/jp984488q; Ye C., 2015, SCIENCE, V326, P1657; Zhang JY, 2004, J PHYS CHEM A, V108, P9082, DOI 10.1021/jp048096x; Zhang N, 2012, ATMOS CHEM PHYS, V12, P8285, DOI 10.5194/acp-12-8285-2012; Zhang N, 2011, THESIS; Zhang N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038999; Zhou XL, 2011, NAT GEOSCI, V4, P440, DOI [10.1038/ngeo1164, 10.1038/NGEO1164]; Zhou XL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018620; Zhou XL, 2001, GEOPHYS RES LETT, V28, P4087, DOI 10.1029/2001GL013531; Zhu CZ, 2010, J PHYS CHEM A, V114, P2561, DOI 10.1021/jp909867a	51	100	101	26	388	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					489	491		10.1038/nature17195	http://dx.doi.org/10.1038/nature17195			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27064904	Green Submitted			2022-12-28	WOS:000374815900044
J	Zhu, SJ; Stein, RA; Yoshioka, C; Lee, CH; Goehring, A; Mchaourab, HS; Gouaux, E				Zhu, Shujia; Stein, Richard A.; Yoshioka, Craig; Lee, Chia-Hsueh; Goehring, April; Mchaourab, Hassane S.; Gouaux, Eric			Mechanism of NMDA Receptor Inhibition and Activation	CELL			English	Article							AMINO-TERMINAL DOMAIN; LIGAND-BINDING DOMAIN; IONOTROPIC GLUTAMATE-RECEPTOR; EM STRUCTURE DETERMINATION; D-ASPARTATE RECEPTORS; SUBUNIT ARRANGEMENT; CRYO-EM; QUATERNARY STRUCTURE; EXCITATORY SYNAPSES; NR2B SUBUNIT	N-methyl-D-aspartate receptors (NMDARs) are gluta-mate-gated, calcium-permeable ion channels that mediate synaptic transmission and underpin learning and memory. NMDAR dysfunction is directly implicated in diseases ranging from seizure to ischemia. Despite its fundamental importance, little is known about how the NMDAR transitions between inactive and active states and how small molecules inhibit or activate ion channel gating. Here, we report electron cryo-microscopy structures of the GluN1-GluN2B NMDA receptor in an ensemble of competitive antagonist-bound states, an agonist-bound form, and a state bound with agonists and the allosteric inhibitor Ro25-6981. Together with double electron-electron resonance experiments, we show how competitive antagonists rupture the ligand binding domain (LBD) gating "ring,'' how agonists retain the ring in a dimer-of- dimers configuration, and how allosteric inhibitors, acting within the amino terminal domain, further stabilize the LBD layer. These studies illuminate how the LBD gating ring is fundamental to signal transduction and gating in NMDARs.	[Zhu, Shujia; Lee, Chia-Hsueh; Goehring, April; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Stein, Richard A.; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Yoshioka, Craig] Oregon Hlth & Sci Univ, Dept Biomed Engn, 2730 SW Moody Ave, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Lee, Chia-Hsueh] Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA	Oregon Health & Science University; Vanderbilt University; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Rockefeller University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Yoshioka, Craig/ABH-3720-2020	Gouaux, Eric/0000-0002-8549-2360; 	National Institutes of Health [5R37NS038631];  [U54-GM087519];  [S10 RR027091]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038631, R01NS038631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Z.H. Yu, R. Huang, C. Hong (Janelia Campus), Z. Hong Zhou, and I. Atanasov (UCLA) for assistance with data collection and to R. Stites, M. Hakanson, and A. Trzynka (OHSU) for computational support. Microscopy at Oregon Health & Science University (OHSU) was performed at the Multiscale Microscopy Core (MMC) with technical support from the OHSU-FEI Living Lab, Intel, and the OHSU Center for Spatial Systems Biomedicine (OCSSB). We thank L. Vaskalis for help with illustrations, K.L. Durr, and H. Owen for proofreading; W. Lu for help with data processing; and to all the Gouaux lab members for helpful discussions. H.S.M. and R.A.S. were supported by grants U54-GM087519, and pulsed EPR instrumentation was acquired through a shared instrumentation grant S10 RR027091. This work was supported by the National Institutes of Health (5R37NS038631). E.G. is an Investigator with the Howard Hughes Medical Institute.	Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Attwell D, 2005, NAT REV NEUROSCI, V6, P841, DOI 10.1038/nrn1784; Baron B.M., 1991, EUR J PHARMACOL, P149; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Chaudhry C, 2009, EMBO J, V28, P1518, DOI 10.1038/emboj.2009.86; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Cheriyan J, 2015, BIOCHEMISTRY-US, V54, P787, DOI 10.1021/bi501437s; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Dzubay JA, 1996, J NEUROSCI, V16, P4129; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; EVANS RH, 1982, BRIT J PHARMACOL, V75, P65, DOI 10.1111/j.1476-5381.1982.tb08758.x; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Jeschke G, 2002, J MAGN RESON, V155, P72, DOI 10.1006/jmre.2001.2498; Jespersen A, 2014, NEURON, V81, P366, DOI 10.1016/j.neuron.2013.11.033; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kew JNC, 1996, J PHYSIOL-LONDON, V497, P761, DOI 10.1113/jphysiol.1996.sp021807; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stein RA, 2015, METHOD ENZYMOL, V563, P531, DOI 10.1016/bs.mie.2015.07.031; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vergnano AM, 2014, NEURON, V82, P1101, DOI 10.1016/j.neuron.2014.04.034; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; Zhu SJ, 2014, P NATL ACAD SCI USA, V111, P6081, DOI 10.1073/pnas.1318808111; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	56	128	131	2	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					704	714		10.1016/j.cell.2016.03.028	http://dx.doi.org/10.1016/j.cell.2016.03.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27062927	Green Accepted, Bronze			2022-12-28	WOS:000374636800027
J	Fourgeaud, L; Traves, PG; Tufail, Y; Leal-Bailey, H; Lew, ED; Burrola, PG; Callaway, P; Zagorska, A; Rothlin, CV; Nimmerjahn, A; Lemke, G				Fourgeaud, Lawrence; Traves, Paqui G.; Tufail, Yusuf; Leal-Bailey, Humberto; Lew, Erin D.; Burrola, Patrick G.; Callaway, Perri; Zagorska, Anna; Rothlin, Carla V.; Nimmerjahn, Axel; Lemke, Greg			TAM receptors regulate multiple features of microglial physiology	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; APOPTOTIC CELLS; FRACTALKINE RECEPTOR; TYROSINE KINASES; GENE-EXPRESSION; TYRO-3 FAMILY; PHAGOCYTOSIS; PROTEIN; NEUROGENESIS; MACROPHAGES	Microglia are damage sensors for the central nervous system (CNS), and the phagocytes responsible for routine non-inflammatory clearance of dead brain cells(1). Here we show that the TAM receptor tyrosine kinases Mer and Axl(2) regulate these microglial functions. We find that adult mice deficient in microglial Mer and Axl exhibit a marked accumulation of apoptotic cells specifically in neurogenic regions of the CNS, and that microglial phagocytosis of the apoptotic cells generated during adult neurogenesis(3,4) is normally driven by both TAM receptor ligands Gas6 and protein S-5. Using live two-photon imaging, we demonstrate that the microglial response to brain damage is also TAM-regulated, as TAM-deficient microglia display reduced process motility and delayed convergence to sites of injury. Finally, we show that microglial expression of Axl is prominently upregulated in the inflammatory environment that develops in a mouse model of Parkinson's disease(6). Together, these results establish TAM receptors as both controllers of microglial physiology and potential targets for therapeutic intervention in CNS disease.	[Fourgeaud, Lawrence; Traves, Paqui G.; Leal-Bailey, Humberto; Lew, Erin D.; Burrola, Patrick G.; Callaway, Perri; Zagorska, Anna; Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Traves, Paqui G.] Inst Invest Biomed Alberto Sols CSIC UAM, Madrid 28029, Spain; [Tufail, Yusuf; Nimmerjahn, Axel] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Leal-Bailey, Humberto] Univ Strasbourg, Joint Master Neurosci Program, F-67081 Strasbourg, France; [Rothlin, Carla V.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Lemke, Greg] Salk Inst Biol Studies, Immunobiol & Microbial Pathogenesis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Salk Institute; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yale University; Salk Institute	Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.; Rothlin, CV (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.; Lemke, G (corresponding author), Salk Inst Biol Studies, Immunobiol & Microbial Pathogenesis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	carla.rothlin@yale.edu; lemke@salk.edu		Callaway, Perri/0000-0002-5135-0698	US National Institutes of Health [R01 NS085296, R01 AI101400, DP2 NS083038, R01 NS085938, R01 AI089824, P30CA014195]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Nomis Foundation; H.N. and Frances C. Berger Foundation; Fritz B. Burns Foundation; HKT Foundation; Waitt Foundation; Rita Allen and Hearst Foundation; Marie Curie International Outgoing Fellowship Program; Howard Hughes Medical Institute Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089824, R01AI101400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085938, R01NS085296, DP2NS083038] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Nomis Foundation; H.N. and Frances C. Berger Foundation; Fritz B. Burns Foundation; HKT Foundation; Waitt Foundation; Rita Allen and Hearst Foundation; Marie Curie International Outgoing Fellowship Program; Howard Hughes Medical Institute Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health (R01 NS085296 and R01 AI101400 to G.L., DP2 NS083038 and R01 NS085938 to A.N., R01 AI089824 to C.V.R., and P30CA014195 to the Salk Institute), the Leona M. and Harry B. Helmsley Charitable Trust (#2012-PG-MED002 to the Salk Institute), the Nomis, H.N. and Frances C. Berger, Fritz B. Burns, and HKT Foundations (to G.L.), and the Waitt, Rita Allen and Hearst Foundations (to A.N.); and by postdoctoral fellowships from the Marie Curie International Outgoing Fellowship Program (to P.G.T.), the Nomis Foundation (to A.Z. and E.D.L.), and the Howard Hughes Medical Institute Life Sciences Research Foundation (to Y.T.). We thank J. Hash for excellent technical assistance and J. Flynn for help with the CLARITY method.	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Dransfield I, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.18; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mattsson N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.69; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Tang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117787; Vives V, 2003, J COMP NEUROL, V457, P404, DOI 10.1002/cne.10552; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	39	303	307	6	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					240	+		10.1038/nature17630	http://dx.doi.org/10.1038/nature17630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27049947	Green Accepted			2022-12-28	WOS:000374415100041
J	Jiang, L; Shestov, AA; Swain, P; Yang, CD; Parker, SJ; Wang, QA; Terada, LS; Adams, ND; McCabe, MT; Pietrak, B; Schmidt, S; Metallo, CM; Dranka, BP; Schwartz, B; DeBerardinis, RJ				Jiang, Lei; Shestov, Alexander A.; Swain, Pamela; Yang, Chendong; Parker, Seth J.; Wang, Qiong A.; Terada, Lance S.; Adams, Nicholas D.; McCabe, Michael T.; Pietrak, Beth; Schmidt, Stan; Metallo, Christian M.; Dranka, Brian P.; Schwartz, Benjamin; DeBerardinis, Ralph J.			Reductive carboxylation supports redox homeostasis during anchorage-independent growth	NATURE			English	Article							CELL-SURVIVAL; FLUX ANALYSIS; TUMOR-CELLS; MITOCHONDRIA; STRESS; CANCER; ANTIOXIDANT; CONTRIBUTES; METABOLISM; MAINTAINS	Cells receive growth and survival stimuli through their attachment to an extracellular matrix (ECM)(1). Overcoming the addiction to ECM-induced signals is required for anchorage-independent growth, a property of most malignant cells(2). Detachment from ECM is associated with enhanced production of reactive oxygen species (ROS) owing to altered glucose metabolism(2). Here we identify an unconventional pathway that supports redox homeostasis and growth during adaptation to anchorage independence. We observed that detachment from monolayer culture and growth as anchorage-independent tumour spheroids was accompanied by changes in both glucose and glutamine metabolism. Specifically, oxidation of both nutrients was suppressed in spheroids, whereas reductive formation of citrate from glutamine was enhanced. Reductive glutamine metabolism was highly dependent on cytosolic isocitrate dehydrogenase-1 (IDH1), because the activity was suppressed in cells homozygous null for IDH1 or treated with an IDH1 inhibitor. This activity occurred in absence of hypoxia, a well-known inducer of reductive metabolism. Rather, IDH1 mitigated mitochondrial ROS in spheroids, and suppressing IDH1 reduced spheroid growth through a mechanism requiring mitochondrial ROS. Isotope tracing revealed that in spheroids, isocitrate/citrate produced reductively in the cytosol could enter the mitochondria and participate in oxidative metabolism, including oxidation by IDH2. This generates NADPH in the mitochondria, enabling cells to mitigate mitochondrial ROS and maximize growth. Neither IDH1 nor IDH2 was necessary for monolayer growth, but deleting either one enhanced mitochondrial ROS and reduced spheroid size, as did deletion of the mitochondrial citrate transporter protein. Together, the data indicate that adaptation to anchorage independence requires a fundamental change in citrate metabolism, initiated by IDH1-dependent reductive carboxylation and culminating in suppression of mitochondrial ROS.	[Jiang, Lei; Yang, Chendong; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Shestov, Alexander A.] Univ Penn, Sch Med, Dept Radiol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA; [Swain, Pamela; Dranka, Brian P.] Seahorse Biosci, 16 Esquire Rd, North Billerica, MA 01862 USA; [Parker, Seth J.; Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Wang, Qiong A.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Terada, Lance S.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Adams, Nicholas D.; McCabe, Michael T.; Pietrak, Beth; Schmidt, Stan; Schwartz, Benjamin] GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; GlaxoSmithKline; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBerardinis, RJ (corresponding author), Univ Texas SW Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA.; DeBerardinis, RJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.; DeBerardinis, RJ (corresponding author), Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	Ralph.Deberardinis@UTSouthwestern.edu	Metallo, Christian/HCH-3476-2022; damiani, chiara/R-4256-2016	Metallo, Christian/0000-0003-2404-3040; Wang, Qiong/0000-0003-2224-4287; Parker, Seth/0000-0001-7971-8848; Terada, Lance/0000-0001-7441-9734	N.I.H [R01CA157996]; Cancer Prevention and Research Institute of Texas [RP130272]; Robert A. Welch Foundation [I1733]; N.I.H. [R01CA188652]; NATIONAL CANCER INSTITUTE [R01CA188652, R01CA157996] Funding Source: NIH RePORTER	N.I.H(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Robert A. Welch Foundation(The Welch Foundation); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Mitsche for help with analysis of lipogenic acetyl-CoA enrichment, A. Grassian for advice about IDH1, J. Garcia for hypoxia/hyperoxia experiments and C. Frezza for discussion of mitochondrial isolation. J. Kozlitina assisted with statistical analysis and R. Egnatchik provided advice about metabolic flux analysis. R.J.D. is supported by grants from the N.I.H (R01CA157996), Cancer Prevention and Research Institute of Texas (RP130272) and Robert A. Welch Foundation (I1733). C.M.M. is supported by N.I.H. grant R01CA188652.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Garrett R. H., 2004, BIOCHEMISTRY-US, P618; Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Hunnewell MG, 2010, BIOTECHNOL PROGR, V26, P789, DOI 10.1002/btpr.360; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; KAPLAN RS, 1982, CANCER RES, V42, P4399; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Okoye-Okafor UC, 2015, NAT CHEM BIOL, V11, P878, DOI 10.1038/nchembio.1930; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Rajagopalan KN, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0134-4; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; WALEH NS, 1995, CANCER RES, V55, P6222; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632	30	339	346	8	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					255	+		10.1038/nature17393	http://dx.doi.org/10.1038/nature17393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27049945	Green Accepted, Green Published			2022-12-28	WOS:000374415100044
J	Murphy, BP; Johnson, JPL; Gasparini, NM; Sklar, LS				Murphy, Brendan P.; Johnson, Joel P. L.; Gasparini, Nicole M.; Sklar, Leonard S.			Chemical weathering as a mechanism for the climatic control of bedrock river incision	NATURE			English	Article							PROFILE EVOLUTION; KOHALA VOLCANO; SCHMIDT HAMMER; BIG ISLAND; EROSION; PRECIPITATION; LANDSCAPE; RATES; ERODIBILITY; GRADIENTS	Feedbacks between climate, erosion and tectonics influence the rates of chemical weathering reactions(1,2), which can consume atmospheric CO2 and modulate global climate(3,4). However, quantitative predictions for the coupling of these feedbacks are limited because the specific mechanisms by which climate controls erosion are poorly understood. Here we show that climate-dependent chemical weathering controls the erodibility of bedrock-floored rivers across a rainfall gradient on the Big Island of Hawai'i. Field data demonstrate that the physical strength of bedrock in streambeds varies with the degree of chemical weathering, which increases systematically with local rainfall rate. We find that incorporating the quantified relationships between local rainfall and erodibility into a commonly used river incision model is necessary to predict the rates and patterns of downcutting of these rivers. In contrast to using only precipitation-dependent river discharge to explain the climatic control of bedrock river incision(5,6), the mechanism of chemical weathering can explain strong coupling between local climate and river incision.	[Murphy, Brendan P.; Johnson, Joel P. L.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Gasparini, Nicole M.] Tulane Univ, Dept Earth & Environm Sci, New Orleans, LA 70118 USA; [Sklar, Leonard S.] San Francisco State Univ, Dept Earth & Climate Sci, San Francisco, CA 94132 USA	University of Texas System; University of Texas Austin; Tulane University; California State University System; San Francisco State University	Murphy, BP (corresponding author), Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA.	bpmurphy@utexas.edu	Gasparini, Nicole/E-2125-2016	Gasparini, Nicole/0000-0002-0803-3697; Murphy, Brendan/0000-0001-8025-1253	NSF [EAR-1024982, EAR-1025055]; Tulane Research Enhancement grant; NSF; NCALM; Division Of Earth Sciences [1339015] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Tulane Research Enhancement grant; NSF(National Science Foundation (NSF)); NCALM; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF grant EAR-1024982 to J.P.L.J., NSF grant EAR-1025055 and a Tulane Research Enhancement grant to N.M.G., and an NSF Graduate Research Fellowship to B.P.M. Airborne LiDAR was acquired by NCALM through a Seed grant to B.P.M. We thank J. Pipan for his work, H. Rowe for his XRF equipment, and landowners (Kohala Institute at 'Iole, Ponoholo Ranch, and Parker Ranch) for access, support and assistance. We also thank D. Mohrig and D. Breecker for reviews, and L. Olinde, J. Han, G. Fischer, J. Adams, I. Yokelson, and K. Kirchner for assistance in the field.	Aydin A, 2005, ENG GEOL, V81, P1, DOI 10.1016/j.enggeo.2005.06.006; Basu A, 2012, INT J ROCK MECH MIN, V49, P148, DOI 10.1016/j.ijrmms.2011.11.012; Beaumont C., 1992, THRUST TECTONICS, P1, DOI DOI 10.1007/978-94-011-3066-0_1; BIENIAWSKI ZT, 1978, INT J ROCK MECH MIN, V15, P99; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; Caruso BS, 2014, J AM WATER RESOUR AS, V50, P1304, DOI 10.1111/jawr.12189; Chadwick OA, 2003, CHEM GEOL, V202, P195, DOI 10.1016/j.chemgeo.2002.09.001; Day M. J., 1980, BRIT GEOMORPHOLOGICA, V18, P19; Dixon JL, 2012, EARTH PLANET SC LETT, V323, P40, DOI 10.1016/j.epsl.2012.01.010; Ferrier KL, 2013, NATURE, V496, P206, DOI 10.1038/nature11982; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Galewsky J, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001085; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Han JW, 2014, J GEOPHYS RES-EARTH, V119, P1418, DOI 10.1002/2013JF002961; HOWARD AD, 1994, J GEOPHYS RES-SOL EA, V99, P13971, DOI 10.1029/94JB00744; KOONS PO, 1989, AM J SCI, V289, P1041, DOI 10.2475/ajs.289.9.1041; Kurtz AC, 2000, GEOLOGY, V28, P683, DOI 10.1130/0091-7613(2000)28<683:REMIVS>2.0.CO;2; Lamb MP, 2007, GEOL SOC AM BULL, V119, P805, DOI 10.1130/B25986.1; Mackey BH, 2014, GEOL SOC AM BULL, V126, P925, DOI 10.1130/B30930.1; MCDOUGALL I, 1972, GEOL SOC AM BULL, V83, P3731, DOI 10.1130/0016-7606(1972)83[3731:PAOLFT]2.0.CO;2; Menking JA, 2013, GEOL SOC AM BULL, V125, P594, DOI 10.1130/B30625.1; Montgomery DR, 2004, AM J SCI, V304, P454, DOI 10.2475/ajs.304.5.454; Moon S, 2011, NAT GEOSCI, V4, P469, DOI [10.1038/NGEO1159, 10.1038/ngeo1159]; Moon V, 2004, ENG GEOL, V74, P57, DOI 10.1016/j.enggeo.2004.02.002; Niedzielski T, 2009, EARTH SURF PROC LAND, V34, P1713, DOI 10.1002/esp.1851; Oki D. S., 1997, 974176 US GEOL SURV; Porder S, 2007, EARTH PLANET SC LETT, V258, P414, DOI 10.1016/j.epsl.2007.03.047; Reiners PW, 2003, NATURE, V426, P645, DOI 10.1038/nature02111; Riebe CS, 2015, P NATL ACAD SCI USA, V112, P15574, DOI 10.1073/pnas.1503567112; Riebe CS, 2004, EARTH PLANET SC LETT, V224, P547, DOI 10.1016/j.epsl.2004.05.019; Rocco C, 1999, ACI MATER J, V96, P52; Roe GH, 2002, GEOLOGY, V30, P143, DOI 10.1130/0091-7613(2002)030<0143:EOOPVO>2.0.CO;2; Rowe H, 2012, CHEM GEOL, V324, P122, DOI 10.1016/j.chemgeo.2011.12.023; Schopka HH, 2012, EARTH PLANET SC LETT, V339, P67, DOI 10.1016/j.epsl.2012.05.028; SEIDL MA, 1994, J GEOL, V102, P457, DOI 10.1086/629686; Sklar LS, 2001, GEOLOGY, V29, P1087, DOI 10.1130/0091-7613(2001)029<1087:SARSCO>2.0.CO;2; Small EE, 2015, J GEOPHYS RES-EARTH, V120, P1455, DOI 10.1002/2015JF003506; SPENGLER SR, 1988, CONTRIB MINERAL PETR, V99, P90, DOI 10.1007/BF00399369; Stewart BW, 2001, GEOCHIM COSMOCHIM AC, V65, P1087, DOI 10.1016/S0016-7037(00)00614-1; Thiede RC, 2004, EARTH PLANET SC LETT, V222, P791, DOI 10.1016/j.epsl.2004.03.015; VANCE LK, 2009, GEOGRAPHICALLY ISOLA; Wallmann K, 2001, GEOCHIM COSMOCHIM AC, V65, P3005, DOI 10.1016/S0016-7037(01)00638-X; Whipple KX, 2009, NAT GEOSCI, V2, P97, DOI 10.1038/ngeo413; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Whipple KX, 2000, GEOL SOC AM BULL, V112, P490, DOI 10.1130/0016-7606(2000)112<0490:RIIBMA>2.3.CO;2; Willett SD, 1999, J GEOPHYS RES-SOL EA, V104, P28957, DOI 10.1029/1999JB900248	46	68	71	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					223	+		10.1038/nature17449	http://dx.doi.org/10.1038/nature17449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075099	Green Submitted			2022-12-28	WOS:000374415100037
J	Sabarinathan, R; Mularoni, L; Deu-Pons, J; Gonzalez-Perez, A; Lopez-Bigas, N				Sabarinathan, Radhakrishnan; Mularoni, Loris; Deu-Pons, Jordi; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria			Nucleotide excision repair is impaired by binding of transcription factors to DNA	NATURE			English	Article							CHROMATIN ORGANIZATION; MUTATIONAL LANDSCAPE; SOMATIC MUTATIONS; NUCLEOSOME CORE; UV DAMAGE; CANCER; MECHANISMS; DISCOVERY; SHAPES; RATES	Somatic mutations are the driving force of cancer genome evolution(1). The rate of somatic mutations appears to be greatly variable across the genome due to variations in chromatin organization, DNA accessibility and replication timing(2-5). However, other variables that may influence the mutation rate locally are unknown, such as a role for DNA-binding proteins, for example. Here we demonstrate that the rate of somatic mutations in melanomas is highly increased at active transcription factor binding sites and nucleosome embedded DNA, compared to their flanking regions. Using recently available excision-repair sequencing (XR-seq) data(6), we show that the higher mutation rate at these sites is caused by a decrease of the levels of nucleotide excision repair (NER) activity. Our work demonstrates that DNA-bound proteins interfere with the NER machinery, which results in an increased rate of DNA mutations at the protein binding sites. This finding has important implications for our understanding of mutational and DNA repair processes and in the identification of cancer driver mutations.	[Sabarinathan, Radhakrishnan; Mularoni, Loris; Deu-Pons, Jordi; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria] IMIM Hosp del Mar Med Res Inst, Res Program Biomed Informat, Doctor Aiguader 88, Barcelona 08003, Spain; [Sabarinathan, Radhakrishnan; Mularoni, Loris; Deu-Pons, Jordi; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Doctor Aiguader 88, Barcelona 08003, Spain; [Lopez-Bigas, Nuria] ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; ICREA	Lopez-Bigas, N (corresponding author), IMIM Hosp del Mar Med Res Inst, Res Program Biomed Informat, Doctor Aiguader 88, Barcelona 08003, Spain.; Lopez-Bigas, N (corresponding author), Univ Pompeu Fabra, Doctor Aiguader 88, Barcelona 08003, Spain.; Lopez-Bigas, N (corresponding author), ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain.	nuria.lopez@upf.edu	Lopez-Bigas, Nuria/F-6193-2011; Mularoni, Loris/B-3777-2017; Gasull, Martina/J-4076-2019	Lopez-Bigas, Nuria/0000-0003-4925-8988; Mularoni, Loris/0000-0001-7053-7717; Gonzalez-Perez, Abel/0000-0002-8582-4660	Spanish Ministry of Economy and Competitiveness [SAF2012-36199]; Marato de TV3 Foundation; Spanish National Institute of Bioinformatics (INB); EMBO - European Commission (EMBOCOFUND) from Marie Curie Actions [ALTF 568-2014, GA-2012-600394]; Ramon y Cajal contract [RYC-2013-14554]; ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness(Spanish Government); Marato de TV3 Foundation; Spanish National Institute of Bioinformatics (INB); EMBO - European Commission (EMBOCOFUND) from Marie Curie Actions; Ramon y Cajal contract(Spanish Government); ICREA(ICREA)	We acknowledge funding from the Spanish Ministry of Economy and Competitiveness (grant number SAF2012-36199), the Marato de TV3 Foundation, and the Spanish National Institute of Bioinformatics (INB). R.S. is supported by an EMBO Long-Term Fellowship (ALTF 568-2014) co-funded by the European Commission (EMBOCOFUND2012, GA-2012-600394) support from Marie Curie Actions. A.G.-P. is supported by a Ramon y Cajal contract (RYC-2013-14554).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2014, R LANG ENV STAT COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Conconi A, 1999, EMBO J, V18, P1387, DOI 10.1093/emboj/18.5.1387; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; GAO SW, 1994, SCIENCE, V263, P1438, DOI 10.1126/science.8128226; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012; Tornaletti S, 1996, BIOESSAYS, V18, P221, DOI 10.1002/bies.950180309; TORNALETTI S, 1995, J MOL BIOL, V249, P714, DOI 10.1006/jmbi.1995.0331; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wyrick JJ, 2015, DNA REPAIR, V36, P146, DOI 10.1016/j.dnarep.2015.09.018; Yazdi PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136574	35	167	167	0	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2016	532	7598					264	+		10.1038/nature17661	http://dx.doi.org/10.1038/nature17661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7TJ	27075101	Green Submitted, Green Accepted			2022-12-28	WOS:000374415100046
J	Clark, J				Clark, Jocalyn			First Liberal budget good for Canadian science, but what about global health?	LANCET			English	Editorial Material									[Clark, Jocalyn] The Lancet, London EC2Y 5AS, England		Clark, J (corresponding author), The Lancet, London EC2Y 5AS, England.			Clark, Jocalyn/0000-0002-8014-3989				Belluz J, 2015, VOX 1109; Department for Business Innovation and Skills, 2015, ENS SUC UK RES END R; Government of Canada, 2016, BUDG 2016; Kondro W, 2016, SCIENCE, DOI [10.1126/science.aaf4028, DOI 10.1126/SCIENCE.AAF4028]; Mackrael K, 2012, GLOBE MAIL TORO 1123; Payne E, 2015, OTTAWA CITIZEN OTTAW; Semeniuk I, 2016, GLOBE MAIL TORO 0323; Sibbald B, 2016, CAN MED ASSOC J, V188, P493, DOI 10.1503/cmaj.109-5258; The Lancet, 2015, LANCET, V386, P1708; Turner C, 2015, THE STAR TORONT 0916; Webster PC, 2014, LANCET, V383, P1621, DOI 10.1016/S0140-6736(14)60774-1	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1496	1497		10.1016/S0140-6736(16)30124-6	http://dx.doi.org/10.1016/S0140-6736(16)30124-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI8HH	27056736				2022-12-28	WOS:000373741600010
J	Cramer, S				Cramer, Shirley			PERSONAL VIEW Food should be labelled with the exercise needed to expend its calories	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cramer, Shirley] Royal Soc Publ Hlth, London E1 8AN, England		Cramer, S (corresponding author), Royal Soc Publ Hlth, London E1 8AN, England.	scramer@rsph.org.uk						Academy of Medical Royal Colleges, 2015, EX MIR CUR; Bleich SN, 2012, AM J PUBLIC HEALTH, V102, P329, DOI 10.2105/AJPH.2011.300350; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI 10.1079/PHN2004666; Hersey JC, 2013, NUTR REV, V71, P1, DOI 10.1111/nure.12000; NHS Choices, 2015, BEN OF EX; Nutrition Society, 2015, AV TIM MAK FOOD PURC; Public Health England, 2014, UK IR PREV TRENDS; Viera AJ, 2015, PEDIATRICS, V135, pE376, DOI 10.1542/peds.2014-2902	8	12	12	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	2016	353								i1856	10.1136/bmj.i1856	http://dx.doi.org/10.1136/bmj.i1856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0LQ	27052519				2022-12-28	WOS:000373895500004
J	Siu, AL; Bibbins-Domingo, K; Grossman, DC; Davidson, KW; Epling, JW; Garcia, FAR; Gillman, M; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Harper, DM; Phillips, WR; Phipps, MG; Pignone, MP				Siu, Albert L.; Bibbins-Domingo, Kirsten; Grossman, David C.; Davidson, Karina W.; Epling, John W., Jr.; Garcia, Francisco A. R.; Gillman, Matthew; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Harper, Diane M.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.		USPSTF	Screening for Chronic Obstructive Pulmonary Disease US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; SMOKING-CESSATION; COPD; QUESTIONNAIRE; SPIROMETRY; SMOKERS	IMPORTANCE About 14% of US adults aged 40 to 79 years have chronic obstructive pulmonary disease (COPD), and it is the third leading cause of death in the United States. Persons with severe COPD are often unable to participate in normal physical activity due to deterioration of lung function. OBJECTIVE To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for COPD in asymptomatic adults. EVIDENCE REVIEW The USPSTF reviewed the evidence on whether screening for COPD in asymptomatic adults (those who do not recognize or report respiratory symptoms) improves health outcomes. The USPSTF reviewed the diagnostic accuracy of screening tools (including prescreening questionnaires and spirometry); whether screening for COPD improves the delivery and uptake of targeted preventive services, such as smoking cessation or relevant immunizations; and the possible harms of screening for and treatment of mild to moderate COPD. FINDINGS Similar to 2008, the USPSTF did not find evidence that screening for COPD in asymptomatic persons improves health-related quality of life, morbidity, or mortality. The USPSTF determined that early detection of COPD, before the development of symptoms, does not alter the course of the disease or improve patient outcomes. The USPSTF concludes with moderate certainty that screening for COPD in asymptomatic persons has no net benefit. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends against screening for COPD in asymptomatic adults. (D recommendation)	[Siu, Albert L.] Mt Sinai Sch Med, New York, NY USA; [Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Epling, John W., Jr.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Gillman, Matthew] Harvard Univ, Sch Med, Boston, MA USA; [Gillman, Matthew] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, Sch Nursing, West Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Harper, Diane M.] Univ Louisville, Louisville, KY 40292 USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ N Carolina, Chapel Hill, NC USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of California System; University of California San Francisco; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Louisville; University of Washington; University of Washington Seattle; Brown University; University of North Carolina; University of North Carolina Chapel Hill	Siu, AL (corresponding author), Mt Sinai Sch Med, New York, NY USA.		Davidson, Karina/AAG-2388-2019; Phillips, William R./V-1065-2017; Harper, Diane M./I-2180-2014; Epling, John W/J-1097-2019; Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Phillips, William R./0000-0003-2802-4349; Harper, Diane M./0000-0001-7648-883X; Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Kemper, Alex/0000-0001-5491-3997				Ford ES, 2013, CHEST, V144, P284, DOI 10.1378/chest.13-0809; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Guirguis-Blake JM, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2016.2654, DOI 10.1001/JAMA.2016, 10.1001/jama.2016.12819]; Guirguis-Blake JM, 2016, AHRQ PUBLICATION; Kochanek Kenneth D, 2014, NCHS Data Brief, P1; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; Kotz D, 2009, EUR RESPIR J, V33, P754, DOI 10.1183/09031936.00116308; Martinez FJ, 2008, COPD, V5, P85, DOI 10.1080/15412550801940721; McClure JB, 2009, AM J PREV MED, V37, P116, DOI 10.1016/j.amepre.2009.03.018; National Institute of Health and Care Excellence, CHRON OBSTR PULM DIS; Parkes G, 2008, BMJ-BRIT MED J, V336, P598, DOI 10.1136/bmj.39503.582396.25; Price DB, 2006, CHEST, V129, P1531, DOI 10.1378/chest.129.6.1531; Price DB, 2006, RESPIRATION, V73, P285, DOI 10.1159/000090142; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; RISSER NL, 1990, J GEN INTERN MED, V5, P16, DOI 10.1007/BF02602303; Sippel JM, 1999, J GEN INTERN MED, V14, P670, DOI 10.1046/j.1525-1497.1999.11088.x; Tilert T, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-103; Yawn Barbara P, 2010, Int J Chron Obstruct Pulmon Dis, V5, P1	18	125	132	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1372	1377		10.1001/jama.2016.2638	http://dx.doi.org/10.1001/jama.2016.2638			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	27046365	Bronze			2022-12-28	WOS:000373381500021
J	Escudero-Escribano, M; Malacrida, P; Hansen, MH; Vej-Hansen, UG; Velazquez-Palenzuela, A; Tripkovic, V; Schiotz, J; Rossmeisl, J; Stephens, IEL; Chorkendorff, I				Escudero-Escribano, Maria; Malacrida, Paolo; Hansen, Martin H.; Vej-Hansen, Ulrik G.; Velazquez-Palenzuela, Amado; Tripkovic, Vladimir; Schiotz, Jakob; Rossmeisl, Jan; Stephens, Ifan E. L.; Chorkendorff, Ib			Tuning the activity of Pt alloy electrocatalysts by means of the lanthanide contraction	SCIENCE			English	Article							OXYGEN REDUCTION; CATALYSTS; PLATINUM; ENERGY; STRAIN	The high platinum loadings required to compensate for the slow kinetics of the oxygen reduction reaction (ORR) impede the widespread uptake of low-temperature fuel cells in automotive vehicles. We have studied the ORR on eight platinum (Pt)-lanthanide and Pt-alkaline earth electrodes, Pt5M, where M is lanthanum, cerium, samarium, gadolinium, terbium, dysprosium, thulium, or calcium. The materials are among the most active polycrystalline Pt-based catalysts reported, presenting activity enhancement by a factor of 3 to 6 over Pt. The active phase consists of a Pt overlayer formed by acid leaching. The ORR activity versus the bulk lattice parameter follows a high peaked "volcano" relation. We demonstrate how the lanthanide contraction can be used to control strain effects and tune the activity, stability, and reactivity of these materials.	[Escudero-Escribano, Maria; Malacrida, Paolo; Vej-Hansen, Ulrik G.; Velazquez-Palenzuela, Amado; Schiotz, Jakob; Stephens, Ifan E. L.; Chorkendorff, Ib] Tech Univ Denmark, Dept Phys, CINF, DK-2800 Lyngby, Denmark; [Escudero-Escribano, Maria] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Hansen, Martin H.; Vej-Hansen, Ulrik G.; Tripkovic, Vladimir; Schiotz, Jakob; Rossmeisl, Jan] Tech Univ Denmark, Dept Phys, Ctr Atom Scale Mat Design CAMD, DK-2800 Lyngby, Denmark; [Hansen, Martin H.; Rossmeisl, Jan] Univ Copenhagen, Dept Chem, Nanosci Ctr, DK-2100 Copenhagen, Denmark; [Tripkovic, Vladimir] Tech Univ Denmark, Dept Energy Convers & Storage, DK-4000 Roskilde, Denmark; [Stephens, Ifan E. L.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Technical University of Denmark; Stanford University; Technical University of Denmark; University of Copenhagen; Technical University of Denmark; Massachusetts Institute of Technology (MIT)	Escudero-Escribano, M; Stephens, IEL; Chorkendorff, I (corresponding author), Tech Univ Denmark, Dept Phys, CINF, DK-2800 Lyngby, Denmark.; Escudero-Escribano, M (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Stephens, IEL (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	maria.escudero@fysik.dtu.dk; ifan@fysik.dtu.dk; ibchork@fysik.dtu.dk	Chorkendorff, Ib/C-7282-2008; Schiøtz, Jakob/A-5692-2011; Hansen, Martin Hangaard/P-3000-2019; Tripkovic, Vladimir/C-3571-2015; Rossmeisl, Jan/A-5714-2011; Escudero-Escribano, Maria/D-1408-2011; Vej-Hansen, Ulrik Grønbjerg/D-7256-2011; Stephens, Ifan Erfyl Lester/B-7191-2013	Chorkendorff, Ib/0000-0003-2738-0325; Schiøtz, Jakob/0000-0002-0670-8013; Hansen, Martin Hangaard/0000-0003-0818-1515; Tripkovic, Vladimir/0000-0003-4629-043X; Rossmeisl, Jan/0000-0001-7749-6567; Escudero-Escribano, Maria/0000-0002-6432-3015; Vej-Hansen, Ulrik Grønbjerg/0000-0002-1114-9930; Stephens, Ifan Erfyl Lester/0000-0003-2157-492X; Velazquez-Palenzuela, Amado/0000-0003-2556-0656	Danish National Research Foundation [DNRF54]; EU [GA 303492]; Danish Strategic Research's project NACORR [12-133817]; Danish Council for Independent Research; Department of Mechanical Engineering at Massachusetts Institute of Technology	Danish National Research Foundation(Danmarks Grundforskningsfond); EU(European Commission); Danish Strategic Research's project NACORR; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Department of Mechanical Engineering at Massachusetts Institute of Technology	The Center for Individual Nanoparticle Functionality is sponsored by the Danish National Research Foundation (DNRF54). We gratefully acknowledge EU FP7's initiative Fuel Cell and Hydrogen Joint Undertaking's project CathCat (GA 303492), as well as Danish Strategic Research's project NACORR (12-133817), for funding this work. M.E.-E. is the recipient of a Sapere Aude: DFF-Research Talent grant from the Danish Council for Independent Research. I.E.L.S. is the recipient of the Peabody Visiting Associate Professorship from the Department of Mechanical Engineering at Massachusetts Institute of Technology. We thank C. D. Damsgaard for assistance setting up the XRD measurements and O. Hansen for critically reading the manuscript. The authors declare competing financial interests: Intellectual property pertaining to the materials presented in this Report is protected by three patents (CA2877617-A1, WO2014079462-A1, and CA2767793-A1).	Calle-Vallejo F, 2015, SCIENCE, V350, P185, DOI 10.1126/science.aab3501; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Cordero B, 2008, DALTON T, P2832, DOI 10.1039/b801115j; Dubau L, 2013, APPL CATAL B-ENVIRON, V142, P801, DOI 10.1016/j.apcatb.2013.06.011; Erlebacher J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.155505; Escudero-Escribano M, 2012, J AM CHEM SOC, V134, P16476, DOI 10.1021/ja306348d; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Greeley J, 2009, NAT CHEM, V1, P552, DOI [10.1038/NCHEM.367, 10.1038/nchem.367]; Han BH, 2015, ENERG ENVIRON SCI, V8, P258, DOI 10.1039/c4ee02144d; Hernandez-Fernandez P, 2014, NAT CHEM, V6, P732, DOI [10.1038/NCHEM.2001, 10.1038/nchem.2001]; Holby EF, 2009, ENERG ENVIRON SCI, V2, P865, DOI 10.1039/b821622n; Huang XQ, 2015, SCIENCE, V348, P1230, DOI 10.1126/science.aaa8765; Mavrikakis M, 1998, PHYS REV LETT, V81, P2819, DOI 10.1103/PhysRevLett.81.2819; Mayrhofer KJJ, 2009, J AM CHEM SOC, V131, P16348, DOI 10.1021/ja9074216; MUKERJEE S, 1995, J ELECTROCHEM SOC, V142, P1409, DOI 10.1149/1.2048590; Norskov JK, 2004, J PHYS CHEM B, V108, P17886, DOI 10.1021/jp047349j; Ohm V, 1996, J ALLOY COMPD, V238, P95, DOI 10.1016/0925-8388(96)02247-5; Pedersen CM, 2015, ELECTROCHIM ACTA, V179, P647, DOI 10.1016/j.electacta.2015.03.176; Stamenkovic V, 2006, ANGEW CHEM INT EDIT, V45, P2897, DOI 10.1002/anie.200504386; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Stamenkovic VR, 2006, J AM CHEM SOC, V128, P8813, DOI 10.1021/ja0600476; Stephens IEL, 2012, ENERG ENVIRON SCI, V5, P6744, DOI 10.1039/c2ee03590a; Stephens IEL, 2011, J AM CHEM SOC, V133, P5485, DOI 10.1021/ja111690g; Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/NCHEM.623, 10.1038/nchem.623]; Suntivich J, 2011, SCIENCE, V334, P1383, DOI 10.1126/science.1212858; Tang L, 2010, J AM CHEM SOC, V132, P596, DOI 10.1021/ja9071496; Vej-Hansen UG, 2016, PHYS CHEM CHEM PHYS, V18, P3302, DOI 10.1039/c5cp04694g; Velazquez-Palenzuela A, 2015, J CATAL, V328, P297, DOI 10.1016/j.jcat.2014.12.012; Vitos L, 1998, SURF SCI, V411, P186, DOI 10.1016/S0039-6028(98)00363-X; Wan LJ, 2002, CHEM COMMUN, P58, DOI 10.1039/b107037a; Wang DL, 2013, NAT MATER, V12, P81, DOI [10.1038/NMAT3458, 10.1038/nmat3458]	31	582	591	60	1069	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					73	76		10.1126/science.aad8892	http://dx.doi.org/10.1126/science.aad8892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034369				2022-12-28	WOS:000373039600037
J	Hicks, CC; Levine, A; Agrawal, A; Basurto, X; Breslow, SJ; Carothers, C; Charnley, S; Coulthard, S; Dolsak, N; Donatuto, J; Garcia-Quijano, C; Mascia, MB; Norman, K; Poe, MR; Satterfield, T; Martin, KS; Levin, PS				Hicks, Christina C.; Levine, Arielle; Agrawal, Arun; Basurto, Xavier; Breslow, Sara J.; Carothers, Courtney; Charnley, Susan; Coulthard, Sarah; Dolsak, Nives; Donatuto, Jamie; Garcia-Quijano, Carlos; Mascia, Michael B.; Norman, Karma; Poe, Melissa R.; Satterfield, Terre; Martin, Kevin St.; Levin, Phillip S.			Engage key social concepts for sustainability	SCIENCE			English	Editorial Material									[Hicks, Christina C.] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Hicks, Christina C.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Sydney, NSW, Australia; [Hicks, Christina C.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YW, England; [Levine, Arielle] San Diego State Univ, Geog, San Diego, CA 92182 USA; [Agrawal, Arun] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Basurto, Xavier] Duke Univ, Nicholas Sch Environm, Durham, NC 27706 USA; [Breslow, Sara J.; Norman, Karma; Poe, Melissa R.; Levin, Phillip S.] NOAA, Northwest Fisheries Sci Ctr, Tacoma, WA USA; [Carothers, Courtney] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Charnley, Susan] US Forest Serv, USDA, Washington, DC USA; [Coulthard, Sarah] Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Dolsak, Nives] Univ Washington, Sch Marine & Environm airs, Seattle, WA 98195 USA; [Donatuto, Jamie] Swinomish Indian Tribal Community, Tacoma, WA USA; [Garcia-Quijano, Carlos] Univ Rhode Isl, Anthropol & Marine Affairs, Kingston, RI 02881 USA; [Mascia, Michael B.] Conservat Int, Moore Ctr Sci, Arlington, VA USA; [Poe, Melissa R.] Univ Washington, Washington Sea Grant, Seattle, WA 98195 USA; [Satterfield, Terre] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada; [Martin, Kevin St.] Rutgers State Univ, Dept Geog, Piscataway, NJ 08855 USA	Stanford University; James Cook University; Lancaster University; California State University System; San Diego State University; University of Michigan System; University of Michigan; Duke University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; United States Department of Agriculture (USDA); United States Forest Service; Northumbria University; University of Washington; University of Washington Seattle; University of Rhode Island; Conservation International; University of Washington; University of Washington Seattle; University of British Columbia; Rutgers State University New Brunswick	Hicks, CC (corresponding author), Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA.; Hicks, CC (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Sydney, NSW, Australia.; Hicks, CC (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YW, England.	christina.hicks@lancaster.ac.uk	Levine, Arielle/AAA-4817-2021; Hicks, Christina/M-6182-2015; Mascia, Michael B./X-5516-2018; Agrawal, Arun/A-4257-2009	Levine, Arielle/0000-0002-3556-4143; Hicks, Christina/0000-0002-7399-4603; Mascia, Michael B./0000-0002-9874-9778; Dolsak, Nives/0000-0002-8325-3155; Carothers, Courtney/0000-0002-1513-9078; Basurto, Xavier/0000-0002-5321-3654; Breslow, Sara/0000-0001-8842-4884; Agrawal, Arun/0000-0001-6796-2958	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 1998, SEEING STATE; Brosch T, 2016, HDB VALUE PERSPECTIV; Castree N, 2014, NAT CLIM CHANGE, V4, P763, DOI 10.1038/NCLIMATE2339; Ibrahim S, 2007, OXF DEV STUD, V35, P379, DOI 10.1080/13600810701701897; Kabeer N, 1999, DEV CHANGE, V30, P435, DOI 10.1111/1467-7660.00125; Kelley JG, 2015, AM J POLIT SCI, V59, P55, DOI 10.1111/ajps.12119; Kroeber L., 1952, CULTURE CRITICAL REV; Lukes S, 2004, POWER RADICAL VIEW; McGregor A., 2015, 04 OV DEV I; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Organization for Economic Cooperation and Development, 2013, GUID MEAS SUBJ WELLB; Piketty T., 2014, CAPITAL SIGLO 21; SEN A, 1985, J PHILOS, V82, P169, DOI 10.2307/2026184; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Walker G., 2012, ENV JUSTICE CONCEPTS	15	151	153	0	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					38	40		10.1126/science.aad4977	http://dx.doi.org/10.1126/science.aad4977			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH8JP	27034361				2022-12-28	WOS:000373039600023
J	Volkow, ND; McLellan, AT				Volkow, Nora D.; McLellan, A. Thomas			Opioid Abuse in Chronic Pain - Misconceptions and Mitigation Strategies	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DRUG-MONITORING PROGRAMS; UNITED-STATES; NEUROPATHIC PAIN; HEROIN-ADDICTION; OVERDOSE DEATHS; BACK-PAIN; PRESCRIPTION; THERAPY; DEPENDENCE; MORPHINE		[Volkow, Nora D.] NIDA, NIH, 6001 Execut Blvd, Bethesda, MD 20892 USA; [McLellan, A. Thomas] Treatment Res Inst, Philadelphia, PA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Volkow, ND (corresponding author), NIDA, NIH, 6001 Execut Blvd, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			Indivior Pharmaceuticals; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	Indivior Pharmaceuticals; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Dr. McLellan reports receiving fees for serving on the board of directors of Indivior Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; American Pain Society American Academy of Pain Medicine Opioids Guidelines Panel, GUID US CHRON OP THE; [Anonymous], 2010, VA DOD CLIN PRACT GU; [Anonymous], 2015, COMM EL GUID PRESCR; [Anonymous], 2005, PUBL POL STAT RAP UL; [Anonymous], OP MORPH EQ CONV FAC; [Anonymous], 2014, NSDUH SER H, VH-48; Argoff C, 2008, MAJOR OPIOIDS CHRONI; Arout CA, 2015, CNS DRUGS, V29, P465, DOI 10.1007/s40263-015-0255-x; Banta-Green CJ, 2009, DRUG ALCOHOL DEPEN, V104, P34, DOI 10.1016/j.drugalcdep.2009.03.021; Baumblatt JAG, 2014, JAMA INTERN MED, V174, P796, DOI 10.1001/jamainternmed.2013.12711; Beaudoin FL, 2015, ANN EMERG MED, V65, P423, DOI 10.1016/j.annemergmed.2014.11.016; Boccard SGJ, 2015, J CLIN NEUROSCI, V22, P1537, DOI 10.1016/j.jocn.2015.04.005; Boscarino JA, 2010, ADDICTION, V105, P1776, DOI 10.1111/j.1360-0443.2010.03052.x; Bosilkovska M, 2012, DRUGS, V72, P1645, DOI 10.2165/11635500-000000000-00000; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Buntin-Mushock C, 2005, ANESTH ANALG, V100, P1740, DOI 10.1213/01.ANE.0000152191.29311.9B; Busch A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003786.pub2; Butler SF, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-29; Calcaterra S, 2013, DRUG ALCOHOL DEPEN, V131, P263, DOI 10.1016/j.drugalcdep.2012.11.018; Callop N, 2002, SLEEP MED; Centers for Disease Control and Prevention, 2014, FASTST THER DRUG US; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Cheatle MD, 2015, PAIN MED, V16, pS22, DOI 10.1111/pme.12910; Cheatle MD, 2011, PAIN MED, V12, pS43, DOI 10.1111/j.1526-4637.2011.01131.x; Chen Lucy, 2014, J Opioid Manag, V10, P383, DOI 10.5055/jom.2014.0235; Chou R, 2014, AHRQ PUBLICATION; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Compton WM, 2015, PREV MED, V80, P5, DOI 10.1016/j.ypmed.2015.04.003; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Delcher C, 2015, DRUG ALCOHOL DEPEN, V150, P63, DOI 10.1016/j.drugalcdep.2015.02.010; Department of Health and Human Services, 2015, GUID IND AB DET OP E; Deyo RA, 2014, CLIN J PAIN; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Eder H, 2005, ADDICTION, V100, P1101, DOI 10.1111/j.1360-0443.2005.001128.x; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Ewan EE, 2013, NEUROSCI LETT, V557, P60, DOI 10.1016/j.neulet.2013.08.018; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Fransen M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007912; Fransen M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub3; Glombiewski JA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/962741; Guan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123675; Hagemeier NE, 2013, SUBST USE MISUSE, V48, P761, DOI 10.3109/10826084.2013.787101; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Hall FS, 2013, PHARMACOL THERAPEUT, V140, P267, DOI 10.1016/j.pharmthera.2013.07.006; Hasegawa K, 2014, MAYO CLIN PROC, V89, P462, DOI 10.1016/j.mayocp.2013.12.008; Hildebran C, 2014, PAIN MED, V15, P1179, DOI 10.1111/pme.12469; Hill R, 2016, NEUROPSYCHOPHARMACOL, V41, P762, DOI 10.1038/npp.2015.201; Hou YY, 2015, J NEUROSCI, V35, P3689, DOI 10.1523/JNEUROSCI.3453-14.2015; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Irvine JM, 2014, J PAIN, V15, P747, DOI 10.1016/j.jpain.2014.04.003; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Jones CM, 2014, MMWR-MORBID MORTAL W, V63, P881; Jones T, 2012, CLIN J PAIN, V28, P93, DOI 10.1097/AJP.0b013e318225da9e; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kamper SJ, 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000335.PUB2; Keller CE, 2012, SUBST ABUS, V33, P103, DOI 10.1080/08897077.2011.630944; Kim SH, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00108; Knowlton A, 2013, PREHOSP EMERG CARE, V17, P317, DOI 10.3109/10903127.2013.792888; KORNETSKY C, 1968, SCIENCE, V162, P1011, DOI 10.1126/science.162.3857.1011; Krames ES, 2015, NEUROMODULATION, V18, P24, DOI 10.1111/ner.12247; Kreek MJ, 2000, ANN NY ACAD SCI, V909, P186; Lee M, 2011, PAIN PHYSICIAN, V14, P145; Lev R, 2015, FORENSIC SCI INT, V257, P347, DOI 10.1016/j.forsciint.2015.09.021; Levy B, 2015, AM J PREV MED, V49, P409, DOI 10.1016/j.amepre.2015.02.020; LING GSF, 1989, LIFE SCI, V45, P1627, DOI 10.1016/0024-3205(89)90272-5; Madadi P, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0460-1; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pES9; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Mastropietro DJ, 2015, EXPERT OPIN PHARMACO, V16, P305, DOI 10.1517/14656566.2014.970175; McCabe SE, 2007, ADDICT BEHAV, V32, P562, DOI 10.1016/j.addbeh.2006.05.022; McDonald DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069241; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; Mercadante S, 2004, J PAIN, V5, P2, DOI 10.1016/j.jpain.2003.09.007; Miguez G, 2014, ACTA PSYCHOL, V145, P10, DOI 10.1016/j.actpsy.2013.10.009; Miller M, 2015, JAMA INTERN MED, V175, P608, DOI 10.1001/jamainternmed.2014.8071; Mistry CJ, 2014, CURR PSYCHIATRY REV, V10, P156, DOI 10.2174/1573400510666140320000928; Moreno-Duarte I, 2014, NEUROIMAGE, V85, P1003, DOI 10.1016/j.neuroimage.2013.05.097; National Institute on Drug Abuse, 2015, LAT PRESCR TRENDS CO; Nuckols TK, 2014, ANN INTERN MED, V160, P38, DOI 10.7326/0003-4819-160-1-201401070-00732; Nutt DJ, 2015, J PSYCHOPHARMACOL, V29, P43, DOI 10.1177/0269881114555248; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Office of the Assistant Secretary Planning and Evaluation, 2015, OP AB US HHS ACT ADD; Pattinson KTS, 2008, BRIT J ANAESTH, V100, P747, DOI 10.1093/bja/aen094; Paulozzi LJ, 2014, J AM BOARD FAM MED, V27, P329, DOI 10.3122/jabfm.2014.03.130290; Paulozzi LJ, 2011, PAIN MED, V12, P747, DOI 10.1111/j.1526-4637.2011.01062.x; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Perrone J, 2012, NEW ENGL J MED, V366, P2341, DOI 10.1056/NEJMp1204493; Prescription Drug Monitoring Program Training and Technical Assistance Center, STAT PROF REP; Raffa RB, 2010, DRUGS, V70, P1657, DOI 10.2165/11537940-000000000-00000; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Seaman SR, 1998, BRIT MED J, V316, P426, DOI 10.1136/bmj.316.7129.426; Shei A, 2015, CURR MED RES OPIN, V31, P779, DOI 10.1185/03007995.2015.1016607; Simpson CA, 2015, PHYS MED REH CLIN N, V26, P321, DOI 10.1016/j.pmr.2014.12.005; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Starrels Joanna L, 2014, J Opioid Manag, V10, P95, DOI 10.5055/jom.2014.0198; Sullivan MD, 2008, PAIN, V138, P440, DOI 10.1016/j.pain.2008.04.027; Surratt HL, 2014, PHARMACOEPIDEM DR S, V23, P314, DOI 10.1002/pds.3553; Treister R, 2013, RAMBAM MAIMONIDES ME, V4, DOI 10.5041/RMMJ.10130; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Uhl GR, 2012, DRUG ABUSE ADDICTION, P95; Verbeeck RK, 2008, EUR J CLIN PHARMACOL, V64, P1147, DOI 10.1007/s00228-008-0553-z; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1346, DOI 10.1001/jama.2011.369; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Vowles KE, 2015, PAIN, V156, P569, DOI 10.1097/01.j.pain.0000460357.01998.f1; Wang J, 2009, PAIN PHYSICIAN, V12, P507; Wax P, 2003, ITWIN RIPPES INTENSI; Weiss RD, 2015, DRUG ALCOHOL DEPEN, V150, P112, DOI 10.1016/j.drugalcdep.2015.02.030; Wheeler E, 2015, MMWR-MORBID MORTAL W, V64, P631; Williams ACD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub3; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Wines JD, 2007, DRUG ALCOHOL DEPEN, V89, P161, DOI 10.1016/j.drugalcdep.2006.12.019; Xian H, 2000, DRUG ALCOHOL DEPEN, V61, P95, DOI 10.1016/S0376-8716(00)00127-7; Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886; Zhang Z, 2014, NEUROPSYCHOPHARMACOL, V39, P2263, DOI 10.1038/npp.2014.77	120	731	742	9	132	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1253	1263		10.1056/NEJMra1507771	http://dx.doi.org/10.1056/NEJMra1507771			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8ZM	27028915	Bronze			2022-12-28	WOS:000373085500008
J	Patel, V; Saxena, S; Frankish, H; Boyce, N				Patel, Vikram; Saxena, Shekhar; Frankish, Helen; Boyce, Niall			Sustainable development and global mental health-a Lancet Commission	LANCET			English	Editorial Material									[Patel, Vikram] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England; [Patel, Vikram] Publ Hlth Fdn India, Ctr Control Chron Condit, New Delhi 22002, India; [Patel, Vikram] Sangath, Bardez, Goa, India; [Saxena, Shekhar] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland; [Boyce, Niall] Lancet Psychiat, London, England	University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; World Health Organization	Patel, V (corresponding author), London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England.; Patel, V (corresponding author), Publ Hlth Fdn India, Ctr Control Chron Condit, New Delhi 22002, India.; Patel, V (corresponding author), Sangath, Bardez, Goa, India.	vikram.patel@lshtm.ac.uk			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Gilbert BJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001834; Kleinman A, 2009, LANCET, V374, P603, DOI 10.1016/S0140-6736(09)61510-5; Patel V, 2012, MENTAL HLTH HUMAN RI; Patel V, 2016, LANCET, V387, P1672, DOI 10.1016/S0140-6736(15)00390-6; Patel V, 2014, NEW ENGL J MED, V370, P498, DOI 10.1056/NEJMp1315214; Saxena S, 2013, LANCET, V381, P1970, DOI 10.1016/S0140-6736(13)61139-3; WHO, 2015, 2014 MENTAL HLTH ATL; World Health Organization (WHO), 2010, MENT HLTH DEV TARG P	10	31	32	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1143	1145		10.1016/S0140-6736(16)00208-7	http://dx.doi.org/10.1016/S0140-6736(16)00208-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG9OB	27025320	Bronze			2022-12-28	WOS:000372412000008
J	Jaffe, S				Jaffe, Susan			Judith Bradford: a pioneer of research on LGBT health	LANCET			English	Biographical-Item																		BRADFORD J, PUBLICATION LIST	1	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1048	1048		10.1016/S0140-6736(16)00666-8	http://dx.doi.org/10.1016/S0140-6736(16)00666-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	27025179				2022-12-28	WOS:000371775000015
J	Brown, KA; Jones, M; Daneman, N; Adler, FR; Stevens, V; Nechodom, KE; Goetz, MB; Samore, MH; Mayer, J				Brown, Kevin A.; Jones, Makoto; Daneman, Nick; Adler, Frederick R.; Stevens, Vanessa; Nechodom, Kevin E.; Goetz, Matthew B.; Samore, Matthew H.; Mayer, Jeanmarie			Importation, Antibiotics, and Clostridium difficile Infection in Veteran Long-Term Care	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICAL-CENTERS; RISK-FACTORS; FACILITIES; DIARRHEA; TRANSMISSION; METAANALYSIS	Background: Although clinical factors affecting a person's susceptibility to Clostridium difficile infection are well-understood, little is known about what drives differences in incidence across long-term care settings. Objective: To obtain a comprehensive picture of individual and regional factors that affect C difficile incidence. Design: Multilevel longitudinal nested case-control study. Setting: Veterans Health Administration health care regions, from 2006 through 2012. Participants: Long-term care residents. Measurements: Individual-level risk factors included age, number of comorbid conditions, and antibiotic exposure. Regional risk factors included importation of cases of acute care C difficile infection per 10 000 resident-days and antibiotic use per 1000 resident-days. The outcome was defined as a positive result on a long-term care C difficile test without a positive result in the prior 8 weeks. Results: 6012 cases (incidence, 3.7 cases per 10 000 resident-days) were identified in 86 regions. Long-term care C difficile incidence (minimum, 0.6 case per 10 000 resident-days; maximum, 31.0 cases per 10 000 resident-days), antibiotic use (minimum, 61.0 days with therapy per 1000 resident-days; maximum, 370.2 days with therapy per 1000 resident-days), and importation (minimum, 2.9 cases per 10 000 resident-days; maximum, 341.3 cases per 10 000 resident-days) varied substantially across regions. Together, antibiotic use and importation accounted for 75% of the regional variation in C difficile incidence (R-2 = 0.75). Multilevel analyses showed that regional factors affected risk together with individual-level exposures (relative risk of regional antibiotic use, 1.36 per doubling [95% CI, 1.15 to 1.60]; relative risk of importation, 1.23 per doubling [CI, 1.14 to 1.33]). Limitations: Case identification was based on laboratory criteria. Admission of residents with recent C difficile infection from non-Veterans Health Administration acute care sources was not considered. Conclusion: Only 25% of the variation in regional C difficile incidence in long-term care remained unexplained after importation from acute care facilities and antibiotic use were accounted for, which suggests that improved infection control and antimicrobial stewardship may help reduce the incidence of C difficile in long-term care settings.	Univ Utah, Salt Lake City, UT USA; [Jones, Makoto] Vet Affairs Salt Lake City Hlth Care Syst, 500 Foothill Dr,Mailstop 182, Salt Lake City, UT 84148 USA; [Daneman, Nick] Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave,G Wing Room 106, Toronto, ON M4N 3M5, Canada; [Goetz, Matthew B.] Vet Affairs Greater Los Angeles Healthcare Syst, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA; [Brown, Kevin A.] Publ Hlth Ontario, 480 Univ Ave, Toronto, ON M5G1V2, Canada; [Adler, Frederick R.] Univ Utah, Dept Math, 155 South 1400 East, Salt Lake City, UT 84112 USA; [Stevens, Vanessa] Univ Utah, Coll Pharm, Dept Pharmacotherapy, 30 South 2000 East,Room 4410, Salt Lake City, UT 84112 USA; [Nechodom, Kevin E.; Samore, Matthew H.; Mayer, Jeanmarie] Univ Utah, Sch Med, Dept Internal Med, Div Epidemiol, 295 Chipeta Way, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Brown, KA (corresponding author), Publ Hlth Ontario, 480 Univ Ave, Toronto, ON M5G1V2, Canada.	kevin.brown@oahpp.ca	Goetz, Matthew Bidwell/GPX-4090-2022	Goetz, Matthew/0000-0003-4542-992X; Stevens, Vanessa/0000-0001-8933-5453; Brown, Kevin Antoine/0000-0002-1483-2188	Centers for Disease Control and Prevention [11FED1106563]; Veterans Health Administration (Centers of Innovation) [13-414]; Veterans Affairs [IK2HX001165] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Veterans Health Administration (Centers of Innovation); Veterans Affairs(US Department of Veterans Affairs)	By the Centers for Disease Control and Prevention (Intra-agency agreement 11FED1106563) and the Veterans Health Administration (Centers of Innovation grant 13-414; Advanced Fellowship in Informatics [Dr. Brown]).	Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; Brown K, 2015, JAMA INTERN MED, V175, P626, DOI 10.1001/jamainternmed.2014.8273; Brown KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105454; Brown KA, 2013, ANTIMICROB AGENTS CH, V57, P2326, DOI 10.1128/AAC.02176-12; Centers for Disease Control and Prevention, 2016, MULT RES ORG CLOSTR; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Christiansen CL, 1997, ANN INTERN MED, V127, P764, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00065; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Daneman N, 2011, J ANTIMICROB CHEMOTH, V66, P2856, DOI 10.1093/jac/dkr395; Dubberke ER, 2007, ARCH INTERN MED, V167, P1092, DOI 10.1001/archinte.167.10.1092; Evans ME, 2014, INFECT CONT HOSP EP, V35, P1037, DOI 10.1086/677151; Guerrero DM, 2011, INFECT CONT HOSP EP, V32, P513, DOI 10.1086/659765; Jones M, 2014, CLIN INFECT DIS, V58, P32, DOI 10.1093/cid/cit668; Jones M, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-34; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Laffan AM, 2006, J AM GERIATR SOC, V54, P1068, DOI 10.1111/j.1532-5415.2006.00768.x; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mylotte JM, 2008, INFECT CONT HOSP EP, V29, P760, DOI 10.1086/589812; Nicolle LE, 2000, INFECT CONT HOSP EP, V21, P537, DOI 10.1086/501798; Pakyz AL, 2014, J ANTIMICROB CHEMOTH, V69, P1127, DOI 10.1093/jac/dkt489; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ren SQ, 2010, J APPL STAT, V37, P1487, DOI 10.1080/02664760903046102; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Roux AVD, 2005, J INFECT DIS, V191, pS25, DOI 10.1086/425288; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Starr JM, 1997, LANCET, V349, P426, DOI 10.1016/S0140-6736(97)80053-0; Trivedi KK, 2014, CLIN INFECT DIS, V59, pS170, DOI 10.1093/cid/ciu538	31	19	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					787	U39		10.7326/M15-1754	http://dx.doi.org/10.7326/M15-1754			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27088642				2022-12-28	WOS:000379343000012
J	Guirguis-Blake, JM; Evans, CV; Senger, CA; O'Connor, EA; Whitlock, EP				Guirguis-Blake, Janelle M.; Evans, Corinne V.; Senger, Caitlyn A.; O'Connor, Elizabeth A.; Whitlock, Evelyn P.			Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							LOW-DOSE ASPIRIN; DIABETES-MELLITUS; HEART-ASSOCIATION; AMERICAN-COLLEGE; RANDOMIZED-TRIAL; DISEASE; RISK; METAANALYSIS; GUIDELINES; CANCER	Background: Cardiovascular disease (CVD) is the leading cause of death in the United States. Purpose: To update a systematic review about the benefits of aspirin for the primary prevention of cardiovascular events in adults aged 40 years or older and to evaluate effect modification in subpopulations. Data Sources: MEDLINE, PubMed, Cochrane Central Register of Controlled Trials (January 2008 to January 2015), and Cochrane Database of Systematic Reviews. Study Selection: Two investigators independently reviewed 3396 abstracts and 65 articles according to prespecified criteria. All included trials evaluated aspirin for the primary prevention of cardiovascular events. Data Extraction: Two investigators assessed study quality; data were abstracted by 1 reviewer and checked by a second. Data Synthesis: Two good-quality and 9 fair-quality randomized, controlled trials were identified. In analyses of all doses, aspirin reduced the risk for nonfatal myocardial infarction (MI) (relative risk [RR], 0.78 [95% CI, 0.71 to 0.87]) but not nonfatal stroke; aspirin showed little or no benefit for all-cause or cardio-vascular mortality. Benefits began within the first 5 years. Older adults achieved greater relative MI reduction, but no other effect modifications were found in analyzed subpopulations. In trials with aspirin doses of 100 mg or less per day, the reduction in nonfatal MI benefit persisted (absolute risk reduction, 0.15 to 1.43 events per 1000 person-years) and a 14% reduction in non-fatal stroke benefit was noted, but no benefit was found for all-cause mortality (RR, 0.95 [CI, 0.89 to 1.01]) or cardiovascular mortality (RR, 0.97 [CI, 0.85 to 1.10]). Limitation: Evidence for aspirin in primary prevention is heterogeneous and limited by rare events and few credible subgroup analyses. Conclusion: The beneficial effect of aspirin for the primary prevention of CVD is modest and occurs at doses of 100 mg or less per day. Older adults seem to achieve a greater relative MI benefit.	[Guirguis-Blake, Janelle M.] Univ Washington, Seattle, WA 98195 USA; Kaiser Permanente Res Affiliates Evidence Based P, Portland, OR USA; [Evans, Corinne V.; Senger, Caitlyn A.; O'Connor, Elizabeth A.] Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA; [Guirguis-Blake, Janelle M.] Univ Washington, Dept Family Med, Tacoma Family Med Residency Program, 521 Martin Luther King Jr Way, Tacoma, WA 98405 USA; [Whitlock, Evelyn P.] Patient Ctr Outcomes Res Inst, 1828 L St Northwest,Suite 900, Washington, DC 20036 USA	University of Washington; University of Washington Seattle; Kaiser Permanente; Kaiser Permanente; University of Washington; University of Washington Tacoma	Guirguis-Blake, JM (corresponding author), Univ Washington, Seattle, WA 98195 USA.				AHRQ [HHSA-290-2012-00015-EPC4]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract HHSA-290-2012-00015-EPC4, Task Order 2, from AHRQ.	[Anonymous], 2008, US PREV SERV TASK FO; [Anonymous], [No title captured]; Bartolucci AA, 2011, AM J CARDIOL, V107, P1796, DOI 10.1016/j.amjcard.2011.02.325; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Berger JS, 2011, AM HEART J, V162, P115, DOI 10.1016/j.ahj.2011.04.006; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Butalia S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-25; Calonge N, 2009, ANN INTERN MED, V150, P396; Chubak J, 2016, ANN INTERN MED, V164, P814, DOI 10.7326/M15-2117; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; De Berardis G, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-21; De Berardis Giorgia, 2009, BMJ, V339, pb4531, DOI 10.1136/bmj.b4531; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; Dehmer SP, 2015, AHRQ PUBLICATION, V15-05229-EF-1; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Green S., 2009, COCHRANE HDB SYSTEMA; Guidelines and Protocols Advisory Committee, 2014, CARD DIS PRIM PREV; Guidelines and Protocols Advisory Committee Medical Services Commission of British Columbia, 2015, DIABETES CARE; Guirguis-Blake JM, 2015, AHRQ PUBLICATION, V13-05195-EF-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kjeldsen SE, 2000, J HYPERTENS, V18, P629, DOI 10.1097/00004872-200018050-00017; Matthys F, 2014, EUR J PREV CARDIOL, V21, P354, DOI 10.1177/2047487312472077; Meade TW, 1998, LANCET, V351, P233; Meade TW, 2000, BMJ-BRIT MED J, V321, P13, DOI 10.1136/bmj.321.7252.13; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; National Institute for Health and Care Excellence, 2012, GUID MAN; National Institute for Health and Care Excellence, 2013, SEC PREV PRIM SEC CA; Nelson MR, 2003, DRUG AGING, V20, P897, DOI 10.2165/00002512-200320120-00004; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pignone M, 2010, DIABETES CARE, V33, P1395, DOI 10.2337/dc10-0555; Pursnani A, 2015, JAMA-J AM MED ASSOC, V314, P134, DOI 10.1001/jama.2015.7515; Raju N, 2011, AM J MED, V124, P621, DOI 10.1016/j.amjmed.2011.01.018; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; Scottish Intercollegiate Guidelines Network, 2013, SIGN 129 ANT IND MAN; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Stavrakis S, 2011, AM J MED SCI, V341, P1, DOI 10.1097/MAJ.0b013e3181f1fba8; Sun X, 2012, BMJ-BRIT MED J, V344, pe1553, DOI 10.1136/bmj.e1553; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Vandvik O, 2012, CHEST, V141, pE637S, DOI 10.1378/chest.11-2306; VanWormer JJ, 2014, CLIN EPIDEMIOL, V6, P433, DOI 10.2147/CLEP.S72032; Whitlock EP, 2015, AHRQ PUBLICATION, V13-05193-EF-1; Whitlock EP, 2016, ANN INTERN MED, V164, P826, DOI 10.7326/M15-2112; World Health Organization, 2007, CARD DIS PREV CARD D; Younis N, 2010, EXPERT OPIN PHARMACO, V11, P1459, DOI 10.1517/14656561003792538; Zanchetti A., 2007, PHARMACOTHERAPY DIAB, P211, DOI [10.1007/978-0-387-69737-6_19, DOI 10.1007/978-0-387-69737-6_19]; Zhang CY, 2010, DIABETES RES CLIN PR, V87, P211, DOI 10.1016/j.diabres.2009.09.029	66	172	180	0	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2016	164	12					804	U62		10.7326/M15-2113	http://dx.doi.org/10.7326/M15-2113			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ6VG	27064410				2022-12-28	WOS:000379343000014
J	Yusuf, S; Lonn, E; Pais, P; Bosch, J; Lopez-Jaramillo, P; Zhu, J; Xavier, D; Avezum, A; Leiter, LA; Piegas, LS; Parkhomenko, A; Keltai, M; Keltai, K; Sliwa, K; Chazova, I; Peters, RJG; Held, C; Yusoff, K; Lewis, BS; Jansky, P; Khunti, K; Toff, WD; Reid, CM; Varigos, J; Accini, JL; McKelvie, R; Pogue, J; Jung, HJ; Liu, LS; Diaz, R; Dans, A; Dagenais, G				Yusuf, Salim; Lonn, Eva; Pais, Prem; Bosch, Jackie; Lopez-Jaramillo, Patricio; Zhu, Jun; Xavier, Denis; Avezum, Alvaro; Leiter, Lawrence A.; Piegas, Leopoldo S.; Parkhomenko, Alexander; Keltai, Matyas; Keltai, Katalin; Sliwa, Karen; Chazova, Irina; Peters, Ron J. G.; Held, Claes; Yusoff, Khalid; Lewis, Basil S.; Jansky, Petr; Khunti, Kamlesh; Toff, William D.; Reid, Christopher M.; Varigos, John; Accini, Jose L.; McKelvie, Robert; Pogue, Janice; Jung, Hyejung; Liu, Lisheng; Diaz, Rafael; Dans, Antonio; Dagenais, Gilles		HOPE-3 Investigators	Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; PREVENTION; INTERHEART; COUNTRIES; MORTALITY; STRATEGY; STROKE; ADULTS	BACKGROUND Elevated blood pressure and elevated low-density lipoprotein (LDL) cholesterol increase the risk of cardiovascular disease. Lowering both should reduce the risk of cardiovascular events substantially. METHODS In a trial with 2-by-2 factorial design, we randomly assigned 12,705 participants at intermediate risk who did not have cardiovascular disease to rosuvastatin (10 mg per day) or placebo and to candesartan (16 mg per day) plus hydrochlorothiazide (12.5 mg per day) or placebo. In the analyses reported here, we compared the 3180 participants assigned to combined therapy (with rosuvastatin and the two antihypertensive agents) with the 3168 participants assigned to dual placebo. The first coprimary outcome was the composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, and the second coprimary outcome additionally included heart failure, cardiac arrest, or revascularization. The median follow-up was 5.6 years. RESULTS The decrease in the LDL cholesterol level was 33.7 mg per deciliter (0.87 mmol per liter) greater in the combined-therapy group than in the dual-placebo group, and the decrease in systolic blood pressure was 6.2 mm Hg greater with combined therapy than with dual placebo. The first coprimary outcome occurred in 113 participants (3.6%) in the combined-therapy group and in 157 (5.0%) in the dual-placebo group (hazard ratio, 0.71; 95% confidence interval [CI], 0.56 to 0.90; P=0.005). The second coprimary outcome occurred in 136 participants (4.3%) and 187 participants (5.9%), respectively (hazard ratio, 0.72; 95% CI, 0.57 to 0.89; P=0.003). Muscle weakness and dizziness were more common in the combined-therapy group than in the dual-placebo group, but the overall rate of discontinuation of the trial regimen was similar in the two groups. CONCLUSIONS The combination of rosuvastatin (10 mg per day), candesartan (16 mg per day), and hydrochlorothiazide (12.5 mg per day) was associated with a significantly lower rate of cardiovascular events than dual placebo among persons at intermediate risk who did not have cardiovascular disease. (Funded by the Canadian Institutes of Health Research and AstraZeneca; ClinicalTrials.gov number, NCT00468923.)	[Yusuf, Salim; Lonn, Eva; Bosch, Jackie; McKelvie, Robert; Pogue, Janice; Jung, Hyejung] McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Yusuf, Salim; Lonn, Eva; McKelvie, Robert] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Bosch, Jackie] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Pogue, Janice] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Dagenais, Gilles] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Pais, Prem; Xavier, Denis] St Johns Res Inst, Bangalore, Karnataka, India; [Xavier, Denis] St Johns Med Coll, Bangalore, Karnataka, India; [Lopez-Jaramillo, Patricio] Univ Santander, Fdn Oftalmol Santander, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander, Inst Masira, Sch Med, Bucaramanga, Colombia; [Accini, Jose L.] Univ Norte, Barranquilla, Colombia; [Zhu, Jun; Liu, Lisheng] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100730, Peoples R China; [Zhu, Jun; Liu, Lisheng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Piegas, Leopoldo S.] HCor Heart Hosp, Sao Paulo, Brazil; [Parkhomenko, Alexander] Inst Cardiol, Kiev, Ukraine; [Keltai, Matyas; Keltai, Katalin] Semmelweis Univ, Hungarian Inst Cardiol, H-1085 Budapest, Hungary; [Sliwa, Karen] Univ Cape Town, Hatter Inst Cardiovasc Res Africa, Dept Med, Soweto Cardiovasc Res Grp, ZA-7925 Cape Town, South Africa; [Chazova, Irina] Inst Clin Cardiol, Russian Cardiol Res Complex, Moscow, Russia; [Peters, Ron J. G.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Held, Claes] Uppsala Univ, Clin Res Ctr, Dept Med Sci, Cardiol, Uppsala, Sweden; [Yusoff, Khalid] Univ Teknologi Majlis Amansh Rakyat, Selayang, Malaysia; [Yusoff, Khalid] Univ Coll Sedaya Int Univ, Kuala Lumpur, Malaysia; [Lewis, Basil S.] Technion Israel Inst Technol, Ruth & Bruce Rappaport Sch Med, Lady Davis Carmel Med Ctr, Haifa, Israel; [Jansky, Petr] Univ Hosp Motol, Prague, Czech Republic; [Khunti, Kamlesh] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Toff, William D.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Toff, William D.] Glenfield Hosp, Natl Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Reid, Christopher M.] Monash Ctr Cardiovasc Res & Educ Therapeut, Primary Care Diabet & Vasc Med, Melbourne, Vic, Australia; [Varigos, John] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Reid, Christopher M.] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Diaz, Rafael] Inst Cardiovasc Rosario, Rosario, Santa Fe, Argentina; [Dans, Antonio] Univ Philippines, Coll Med, Manila, Philippines	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Laval University; St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College; Universidad Industrial de Santander; Universidad Industrial de Santander; Universidad del Norte; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Instituto Dante Pazzanese de Cardiologia; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Semmelweis University; University of Cape Town; National Medical Research Center of Cardiology; University of Amsterdam; Uppsala University; Universiti Teknologi MARA; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Motol University Hospital; University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Monash University; Curtin University; University of the Philippines System; University of the Philippines Manila	Yusuf, S (corresponding author), Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Cífková, Renata/O-5731-2017; Keltai, Katalin/V-4350-2019; Yusoff, Khalid/I-7029-2019; Petrella, Robert J/G-6557-2018; Avezum, Alvaro AA/K-6137-2016; /ABC-9527-2021; Bosch, Jacqueline/AAP-6910-2021; Söderberg, Stefan/AAG-3881-2019; Chazova, Irina/AAK-6581-2021; Held, Claes/AAA-3973-2021; Urina-Triana, Miguel A/H-2605-2016; Nedogoda, Sergey V/O-4656-2014; Leiter, Lawrence/AAG-4059-2020; Vasilyeva, Larisa/AAZ-3708-2021; Reid, Christopher M/AAP-8135-2021; Chazova, Irina/B-8688-2017; Aroca, Gustavo/P-9173-2016; Avezum, Alvaro/AAP-7687-2020; Valle, Adriana/F-9897-2014	Cífková, Renata/0000-0003-2765-3821; Keltai, Katalin/0000-0002-8294-9062; Yusoff, Khalid/0000-0001-5669-5188; Avezum, Alvaro AA/0000-0002-3073-6890; Bosch, Jacqueline/0000-0001-6292-4207; Söderberg, Stefan/0000-0001-9225-1306; Chazova, Irina/0000-0002-9822-4357; Held, Claes/0000-0001-9402-7404; Urina-Triana, Miguel A/0000-0001-6003-4622; Nedogoda, Sergey V/0000-0001-5981-1754; Vasilyeva, Larisa/0000-0003-0889-7898; Chazova, Irina/0000-0002-9822-4357; Aroca, Gustavo/0000-0002-9222-3257; DUARTE VERA, YAN CARLOS/0000-0003-4685-6907; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Varigos, John/0000-0001-6722-3135; Chazova, Irina E./0000-0002-1576-4877; Abhayaratna, Walter/0000-0002-4908-0641; Ivchyna, Nadiia/0000-0001-9650-8818; da Silva Franco, Roberto Jorge/0000-0001-9787-4393; Md Aris, Mohd Aznan/0000-0002-9967-1327; Yusuf, Salim/0000-0003-4776-5601; Valle, Adriana/0000-0002-0090-8524; Reid, Christopher/0000-0001-9173-3944; CELEMIN FLOREZ, CARLOS AUGUSTO/0000-0003-1147-5979	Canadian Institutes of Health Research; AstraZeneca	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca(AstraZeneca)	Funded by the Canadian Institutes of Health Research and AstraZeneca	[Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Brunstrom M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i717; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Huo Y, 2015, JAMA-J AM MED ASSOC, V313, P1325, DOI 10.1001/jama.2015.2274; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Lonn E, 2016, CAN J CARDIOL, V32, P311, DOI 10.1016/j.cjca.2015.07.001; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Roth GA, 2015, NEW ENGL J MED, V372, P1333, DOI 10.1056/NEJMoa1406656; Sackett DL, 2000, CAN MED ASSOC J, V162, P1311; Sever P, 2006, EUR HEART J, V27, P2982, DOI 10.1093/eurheartj/ehl403; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	21	313	351	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2016	374	21					2032	2043		10.1056/NEJMoa1600177	http://dx.doi.org/10.1056/NEJMoa1600177			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6EN	27039945	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000376443500006
J	Ren, HR; Li, XP; Zhang, QM; Gu, M				Ren, Haoran; Li, Xiangping; Zhang, Qiming; Gu, Min			On-chip noninterference angular momentum multiplexing of broadband light	SCIENCE			English	Article							COLOR	Angular momentum division has emerged as a physically orthogonal multiplexing method in high-capacity optical information technologies. However, the typical bulky elements used for information retrieval from the overall diffracted field, based on the interference method, impose a fundamental limit toward realizing on-chip multiplexing. We demonstrate noninterference angular momentum multiplexing by using a mode-sorting nanoring aperture with a chip-scale footprint as small as 4.2 micrometers by 4.2 micrometers, where nanoring slits exhibit a distinctive outcoupling efficiency on tightly confined plasmonic modes. The nonresonant mode-sorting sensitivity and scalability of our approach enable on-chip parallel multiplexing over a bandwidth of 150 nanometers in the visible wavelength range. The results offer the possibility of ultrahigh-capacity and miniaturized nanophotonic devices harnessing angular momentum division.	[Ren, Haoran; Li, Xiangping; Zhang, Qiming; Gu, Min] Swinburne Univ Technol, Ctr Microphoton, Hawthorn, Vic 3122, Australia; [Ren, Haoran; Li, Xiangping; Zhang, Qiming; Gu, Min] Swinburne Univ Technol, Ctr Ultrahigh Bandwidth Devices Opt Syst CUDOS, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia; [Li, Xiangping] Jinan Univ, Inst Photon Technol, Guangzhou, Guangdong, Peoples R China; [Zhang, Qiming; Gu, Min] RMIT Univ, Sch Sci, Artificial Intelligence Nanophoton Lab, Melbourne, Vic 3001, Australia	Swinburne University of Technology; Swinburne University of Technology; Jinan University; Royal Melbourne Institute of Technology (RMIT)	Gu, M (corresponding author), Swinburne Univ Technol, Ctr Microphoton, Hawthorn, Vic 3122, Australia.; Gu, M (corresponding author), Swinburne Univ Technol, Ctr Ultrahigh Bandwidth Devices Opt Syst CUDOS, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.; Gu, M (corresponding author), RMIT Univ, Sch Sci, Artificial Intelligence Nanophoton Lab, Melbourne, Vic 3001, Australia.	min.gu@rmit.edu.au	Ren, Haoran/AAR-9523-2020; li, xiangping/X-3996-2019; li, xiangping/GRR-4678-2022; li, xiangping/W-4096-2018	Ren, Haoran/0000-0002-2885-875X; li, xiangping/0000-0003-0955-2613; li, xiangping/0000-0003-0955-2613; li, xiangping/0000-0003-0955-2613	Australian Research Council Laureate Fellowship program [FL100100099]; Australian Research Council Centre for Ultrahigh Bandwidth Devices for Optical Systems (CUDOS) [CE110001018]; Australian Research Council [DE150101665]	Australian Research Council Laureate Fellowship program(Australian Research Council); Australian Research Council Centre for Ultrahigh Bandwidth Devices for Optical Systems (CUDOS)(Australian Research Council); Australian Research Council(Australian Research Council)	We thank X. Li for help with the ion beam lithography, G. Gervinskas and F. Eftekhari from the Melbourne Centre for Nanofabrication for their fabrication efforts, H. Lu for technical assistance with the waveguide calculation, and J. Storteboom for assistance with using the Spectra-Physics Inspire laser system. This work was supported under the Australian Research Council Laureate Fellowship program (grant FL100100099). M.G. acknowledges support from the Australian Research Council Centre for Ultrahigh Bandwidth Devices for Optical Systems (CUDOS) (project CE110001018). X.L. acknowledges support from the Australian Research Council (grant DE150101665). All data related to the experiments described in this manuscript are archived on a lab computer at Swinburne University of Technology.	Berkhout GCG, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.153601; Bozinovic N, 2013, SCIENCE, V340, P1545, DOI 10.1126/science.1237861; Cai XL, 2012, SCIENCE, V338, P363, DOI 10.1126/science.1226528; Deng RR, 2015, NAT NANOTECHNOL, V10, P237, DOI [10.1038/nnano.2014.317, 10.1038/NNANO.2014.317]; Fernandez-Corbaton I, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.060401; Fernandez-Corbaton I, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.042103; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Genevet P, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2293; Gorodetski Y, 2009, NANO LETT, V9, P3016, DOI 10.1021/nl901437d; Karl NJ, 2015, NAT PHOTONICS, V9, P717, DOI [10.1038/nphoton.2015.176, 10.1038/NPHOTON.2015.176]; Li XP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7984; Li XP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2006; Lin J, 2013, SCIENCE, V340, P331, DOI 10.1126/science.1233746; Lu YQ, 2014, NAT PHOTONICS, V8, P33, DOI [10.1038/NPHOTON.2013.322, 10.1038/nphoton.2013.322]; Luo LW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4069; Mirhosseini M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3781; O'Neil AT, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.053601; Pu MB, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500396; Wang J, 2012, NAT PHOTONICS, V6, P488, DOI [10.1038/nphoton.2012.138, 10.1038/NPHOTON.2012.138]; Yin XB, 2013, SCIENCE, V339, P1405, DOI 10.1126/science.1231758; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Yun H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8133; Zambrana-Puyalto X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5922; Zhao NB, 2015, NAT PHOTONICS, V9, P822, DOI [10.1038/NPHOTON.2015.214, 10.1038/nphoton.2015.214]; Zijlstra P, 2009, NATURE, V459, P410, DOI 10.1038/nature08053	25	193	198	20	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					805	809		10.1126/science.aaf1112	http://dx.doi.org/10.1126/science.aaf1112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27056843				2022-12-28	WOS:000375663000035
J	Kudenchuk, PJ; Brown, SP; Daya, M; Rea, T; Nichol, G; Morrison, LJ; Leroux, B; Vaillancourt, C; Wittwer, L; Callaway, CW; Christenson, J; Egan, D; Ornato, JP; Weisfeldt, ML; Stiell, IG; Idris, AH; Aufderheide, TP; Dunford, JV; Colella, MR; Vilke, GM; Brienza, AM; Desvigne-Nickens, P; Gray, PC; Gray, R; Seals, N; Straight, R; Dorian, P				Kudenchuk, P. J.; Brown, S. P.; Daya, M.; Rea, T.; Nichol, G.; Morrison, L. J.; Leroux, B.; Vaillancourt, C.; Wittwer, L.; Callaway, C. W.; Christenson, J.; Egan, D.; Ornato, J. P.; Weisfeldt, M. L.; Stiell, I. G.; Idris, A. H.; Aufderheide, T. P.; Dunford, J. V.; Colella, M. R.; Vilke, G. M.; Brienza, A. M.; Desvigne-Nickens, P.; Gray, P. C.; Gray, R.; Seals, N.; Straight, R.; Dorian, P.		Resuscitation Outcomes Consortium	Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; RESUSCITATION; CARDIOPULMONARY; DURATION; RHYTHM; TRIAL; TIME	BACKGROUND Antiarrhythmic drugs are used commonly in out-of-hospital cardiac arrest for shock-refractory ventricular fibrillation or pulseless ventricular tachycardia, but without proven survival benefit. METHODS In this randomized, double-blind trial, we compared parenteral amiodarone, lidocaine, and saline placebo, along with standard care, in adults who had nontraumatic out-of-hospital cardiac arrest, shock-refractory ventricular fibrillation or pulseless ventricular tachycardia after at least one shock, and vascular access. Paramedics enrolled patients at 10 North American sites. The primary outcome was survival to hospital discharge; the secondary outcome was favorable neurologic function at discharge. The per-protocol (primary analysis) population included all randomly assigned participants who met eligibility criteria and received any dose of a trial drug and whose initial cardiac-arrest rhythm of ventricular fibrillation or pulseless ventricular tachycardia was refractory to shock. RESULTS In the per-protocol population, 3026 patients were randomly assigned to amiodarone (974), lidocaine (993), or placebo (1059); of those, 24.4%, 23.7%, and 21.0%, respectively, survived to hospital discharge. The difference in survival rate for amiodarone versus placebo was 3.2 percentage points (95% confidence interval [CI], -0.4 to 7.0; P = 0.08); for lidocaine versus placebo, 2.6 percentage points (95% CI, -1.0 to 6.3; P = 0.16); and for amiodarone versus lidocaine, 0.7 percentage points (95% CI, -3.2 to 4.7; P = 0.70). Neurologic outcome at discharge was similar in the three groups. There was heterogeneity of treatment effect with respect to whether the arrest was witnessed (P = 0.05); active drugs were associated with a survival rate that was significantly higher than the rate with placebo among patients with bystander-witnessed arrest but not among those with unwitnessed arrest. More amiodarone recipients required temporary cardiac pacing than did recipients of lidocaine or placebo. CONCLUSIONS Overall, neither amiodarone nor lidocaine resulted in a significantly higher rate of survival or favorable neurologic outcome than the rate with placebo among patients with out-of-hospital cardiac arrest due to initial shock-refractory ventricular fibrillation or pulseless ventricular tachycardia.	[Kudenchuk, P. J.] Univ Washington, Div Cardiol, 1959 N E Pacific St,Box 356422, Seattle, WA 98166 USA; [Kudenchuk, P. J.] Univ Washington, Dept Med, Seattle, WA 98166 USA; [Kudenchuk, P. J.; Rea, T.] King Cty Emergency Med Serv, Seattle, WA USA; [Brown, S. P.; Nichol, G.; Leroux, B.] Univ Washington, Dept Biostat, Clin Trial Ctr, Seattle, WA 98195 USA; [Nichol, G.] Univ Washington, Harborview Ctr Prehosp Emergency Care, Seattle, WA 98195 USA; [Wittwer, L.] Clark Cty Emergency Med Serv, Vancouver, WA USA; [Daya, M.] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Morrison, L. J.; Dorian, P.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Rescu, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Morrison, L. J.] Univ Toronto, Div Emergency Med, Dept Med, Toronto, ON, Canada; [Dorian, P.] Univ Toronto, Dept Med, Div Cardiol, Toronto, ON, Canada; [Vaillancourt, C.; Stiell, I. G.] Univ Ottawa, Ottawa Hosp Res Inst, Dept Emergency Med, Ottawa, ON, Canada; [Christenson, J.] Univ British Columbia, Providence Hlth Care Res Inst, Fac Med, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Straight, R.] Providence Hlth Care Res Inst, Vancouver, BC, Canada; [Straight, R.] British Columbia Emergency Hlth Serv, Vancouver, BC, Canada; [Callaway, C. W.; Brienza, A. M.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Egan, D.; Desvigne-Nickens, P.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Weisfeldt, M. L.] Johns Hopkins Univ, Baltimore, MD USA; [Ornato, J. P.] Virginia Commonwealth Univ, Dept Emergency Med, Richmond, VA 23284 USA; [Idris, A. H.] Univ Texas SW Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA; [Idris, A. H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Seals, N.] Dallas Fire Rescue Dept, Dallas, TX USA; [Aufderheide, T. P.] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Colella, M. R.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Dunford, J. V.; Vilke, G. M.] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Dunford, J. V.] San Diego Fire Rescue Dept, San Diego, CA USA; Univ Alabama Birmingham, Birmingham, AL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Oregon Health & Science University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Virginia Commonwealth University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical College of Wisconsin; Medical College of Wisconsin; University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham	Kudenchuk, PJ (corresponding author), Univ Washington, Div Cardiol, 1959 N E Pacific St,Box 356422, Seattle, WA 98166 USA.		Daya, Mohamud R/A-9322-2012; Christian, Mike/AAO-6338-2020; Cheskes, Sheldon/I-4456-2015; Christian, Michael/AAZ-4452-2020; Nichol, Graham/Z-4996-2019; McLeod, Shelley/AAE-9636-2019; Ferguson, Niall/D-7619-2019; Welsford, Michelle/H-5535-2017	Christian, Mike/0000-0001-9644-9950; Cheskes, Sheldon/0000-0001-7835-3074; Christian, Michael/0000-0001-9644-9950; McLeod, Shelley/0000-0003-2686-6307; Brienza, Ashley/0000-0003-2371-6338; Ferguson, Niall/0000-0002-6213-5264; Zelnick, Leila/0000-0002-8461-5111; Welsford, Michelle/0000-0003-2682-641X	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077873, U01HL077866, U01HL077885, U01HL077887, U01HL077867, U01HL077872, U01HL077871, U01HL077908, U01HL077863, U01HL077881] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute and others	American Society of Health-System Pharmacists, 2001, AHFS DRUG INFORM, P1614; Aufderheide TP, 2011, NEW ENGL J MED, V365, P798, DOI 10.1056/NEJMoa1010821; Berdowski J, 2010, CIRCULATION, V122, P1101, DOI 10.1161/CIRCULATIONAHA.110.958173; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; COLLINSWORTH KA, 1974, CIRCULATION, V50, P1217, DOI 10.1161/01.CIR.50.6.1217; Cushing DJ, 2009, EUR J PHARMACOL, V607, P167, DOI 10.1016/j.ejphar.2009.02.009; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Dorian P, 2002, NEW ENGL J MED, V346, P884, DOI 10.1056/NEJMoa013029; Eilevstjonn J, 2007, RESUSCITATION, V75, P60, DOI 10.1016/j.resuscitation.2007.02.014; Food and Drug Administration,, 2016, WHAT IS SER ADV EV; Glover BM, 2012, RESUSCITATION, V83, P1324, DOI 10.1016/j.resuscitation.2012.07.008; Kreutziger J, 2009, RESUSCITATION, V80, P723, DOI 10.1016/j.resuscitation.2009.04.028; Kudenchuk PJ, 2006, CIRCULATION, V114, P2010, DOI 10.1161/CIRCULATIONAHA.106.636506; Kudenchuk PJ, 2014, AM HEART J, V167, P653, DOI 10.1016/j.ahj.2014.02.010; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Marinelli A, 2012, EXPERT OPIN PHARMACO, V13, P573, DOI 10.1517/14656566.2012.656589; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nichol G, 2015, NEW ENGL J MED, V373, P2203, DOI 10.1056/NEJMoa1509139; Reynolds JC, 2013, CIRCULATION, V128, P2488, DOI 10.1161/CIRCULATIONAHA.113.002408; Souney PF, 2010, EXPERT OPIN DRUG SAF, V9, P319, DOI 10.1517/14740331003586811; Stiell IG, 2011, NEW ENGL J MED, V365, P787, DOI 10.1056/NEJMoa1010076; van Alem AP, 2003, RESUSCITATION, V59, P181, DOI 10.1016/S0300-9572(03)00208-9; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035	25	63	63	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1711	1722		10.1056/NEJMoa1514204	http://dx.doi.org/10.1056/NEJMoa1514204			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL0RY	27043165	Green Published, Bronze			2022-12-28	WOS:000375341500004
J	Landig, R; Hruby, L; Dogra, N; Landini, M; Mottl, R; Donner, T; Esslinger, T				Landig, Renate; Hruby, Lorenz; Dogra, Nishant; Landini, Manuele; Mottl, Rafael; Donner, Tobias; Esslinger, Tilman			Quantum phases from competing short- and long-range interactions in an optical lattice	NATURE			English	Article							POLAR-MOLECULES; ULTRACOLD ATOMS; MOTT INSULATOR; COLD ATOMS; GAS; TRANSITION; SUPERFLUID; CAVITY; BOSONS	Insights into complex phenomena in quantum matter can be gained from simulation experiments with ultracold atoms, especially in cases where theoretical characterization is challenging. However, these experiments are mostly limited to short-range collisional interactions; recently observed perturbative effects of long-range interactions were too weak to reach new quantum phases(1,2). Here we experimentally realize a bosonic lattice model with competing short-and long-range interactions, and observe the appearance of four distinct quantum phases-a superfluid, a supersolid, a Mott insulator and a charge density wave. Our system is based on an atomic quantum gas trapped in an optical lattice inside a high-finesse optical cavity. The strength of the short-range on-site interactions is controlled by means of the optical lattice depth. The long (infinite)-range interaction potential is mediated by a vacuum mode of the cavity(3,4) and is independently controlled by tuning the cavity resonance. When probing the phase transition between the Mott insulator and the charge density wave in real time, we observed a behaviour characteristic of a first-order phase transition. Our measurements have accessed a regime for quantum simulation of many-body systems where the physics is determined by the intricate competition between two different types of interactions and the zero point motion of the particles.	[Landig, Renate; Hruby, Lorenz; Dogra, Nishant; Landini, Manuele; Mottl, Rafael; Donner, Tobias; Esslinger, Tilman] Swiss Fed Inst Technol, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Donner, T (corresponding author), Swiss Fed Inst Technol, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	donner@phys.ethz.ch	Esslinger, Tilman/M-9022-2016; Donner, Tobias/A-2845-2011	Esslinger, Tilman/0000-0002-8333-107X; Donner, Tobias/0000-0001-7016-587X	Synthetic Quantum Many-Body Systems (European Research Council); EU Collaborative Project TherMiQ [618074]; SBFI; SNF	Synthetic Quantum Many-Body Systems (European Research Council)(European Research Council (ERC)); EU Collaborative Project TherMiQ; SBFI; SNF	We thank U. Bissbort, G. Graf, S. Huber, G. Morigi, L. Pollet and H. Ritsch for discussions and F. Brennecke for contributions in the early design phase of the experiment. We acknowledge funding from Synthetic Quantum Many-Body Systems (a European Research Council advanced grant) and the EU Collaborative Project TherMiQ (Grant Agreement 618074), and also SBFI support for Horizon2020 project QUIC and SNF support for NCCR QSIT and DACH project 'Quantum Crystals of Matter and Light'.	Baier S., 2015, EXTENDED BOSE HUBBAR; Baumann K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.140402; Baumann K, 2010, NATURE, V464, P1301, DOI 10.1038/nature09009; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Caballero-Benitez SF, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.243604; Dalla Torre EG, 2006, PHYS REV LETT, V97; Dutta O, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/6/066001; Goral K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.170406; Habibian H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.075304; Heidemann R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.033601; Jimenez-Garcia K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.110401; Klinder J, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.230403; Kohl M, 2005, J LOW TEMP PHYS, V138, P635, DOI 10.1007/s10909-005-2273-4; Kovrizhin DL, 2005, EUROPHYS LETT, V72, P162, DOI 10.1209/epl/i2005-10231-y; KRAUTH W, 1991, EUROPHYS LETT, V14, P627, DOI 10.1209/0295-5075/14/7/003; Landig R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8046; Li YQ, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.051604; Maschler C, 2008, EUR PHYS J D, V46, P545, DOI 10.1140/epjd/e2008-00016-4; MICNAS R, 1990, REV MOD PHYS, V62, P113, DOI 10.1103/RevModPhys.62.113; Morsch O, 2006, REV MOD PHYS, V78, P179, DOI 10.1103/RevModPhys.78.179; Mottl R, 2012, SCIENCE, V336, P1570, DOI 10.1126/science.1220314; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Petrov DS, 2000, PHYS REV LETT, V84, P2551, DOI 10.1103/PhysRevLett.84.2551; Rigol M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.053605; Ritsch H, 2013, REV MOD PHYS, V85, P553, DOI 10.1103/RevModPhys.85.553; Scarola VW, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033003; Spielman IB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120402; Stoferle T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130403; Stuhler J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.150406; vanOtterlo A, 1995, PHYS REV B, V52, P16176, DOI 10.1103/PhysRevB.52.16176; Weiner J, 1999, REV MOD PHYS, V71, P1, DOI 10.1103/RevModPhys.71.1; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483	34	248	249	4	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					476	+		10.1038/nature17409	http://dx.doi.org/10.1038/nature17409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27064902	Green Submitted			2022-12-28	WOS:000374815900041
J	Chouchani, ET; Kazak, L; Jedrychowski, MP; Lu, GNZ; Erickson, BK; Szpyt, J; Pierce, KA; Laznik-Bogoslavski, D; Vetrivelan, R; Clish, CB; Robinson, AJ; Gygi, SP; Spiegelman, BM				Chouchani, Edward T.; Kazak, Lawrence; Jedrychowski, Mark P.; Lu, Gina Z.; Erickson, Brian K.; Szpyt, John; Pierce, Kerry A.; Laznik-Bogoslavski, Dina; Vetrivelan, Ramalingam; Clish, Clary B.; Robinson, Alan J.; Gygi, Steve P.; Spiegelman, Bruce M.			Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BROWN ADIPOSE-TISSUE; UNCOUPLING PROTEIN-1; MASS-SPECTROMETRY; CHEMICAL PROBES; REDOX STATE; ADIPOCYTES; EXPRESSION; DIMEDONE; FAT	Brown and beige adipose tissues can dissipate chemical energy as heat through thermogenic respiration, which requires uncoupling protein 1 (UCP1)(1,2). Thermogenesis from these adipocytes can combat obesity and diabetes(3), encouraging investigation of factors that control UCP1-dependent respiration in vivo. Here we show that acutely activated thermogenesis in brown adipose tissue is defined by a substantial increase in levels of mitochondrial reactive oxygen species (ROS). Remarkably, this process supports in vivo thermogenesis, as pharmacological depletion of mitochondrial ROS results in hypothermia upon cold exposure, and inhibits UCP1-dependent increases in whole-body energy expenditure. We further establish that thermogenic ROS alter the redox status of cysteine thiols in brown adipose tissue to drive increased respiration, and that Cys253 of UCP1 is a key target. UCP1 Cys253 is sulfenylated during thermogenesis, while mutation of this site desensitizes the purine-nucleotide-inhibited state of the carrier to adrenergic activation and uncoupling. These studies identify mitochondrial ROS induction in brown adipose tissue as a mechanism that supports UCP1-dependent thermogenesis and whole-body energy expenditure, which opens the way to improved therapeutic strategies for combating metabolic disorders.	[Chouchani, Edward T.; Kazak, Lawrence; Lu, Gina Z.; Laznik-Bogoslavski, Dina; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA; [Chouchani, Edward T.; Kazak, Lawrence; Jedrychowski, Mark P.; Lu, Gina Z.; Erickson, Brian K.; Szpyt, John; Gygi, Steve P.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Pierce, Kerry A.; Clish, Clary B.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Vetrivelan, Ramalingam] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Robinson, Alan J.] MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.; Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Clish, Clary B/ABB-9374-2021; Chouchani, Edward T./HCH-3775-2022; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; Erickson, Brian/0000-0002-1150-5042	JPB Foundation; National Institutes of Health [DK31405]; Human Frontiers Science Program; Canadian Institutes for Health Research; MRC [MC_U105674181] Funding Source: UKRI; Medical Research Council [MC_U105674181] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031405, R37DK031405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	JPB Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the JPB Foundation and National Institutes of Health (DK31405) to B.M.S. and by grants from Human Frontiers Science Program (to E.T.C.) and the Canadian Institutes for Health Research (to L.K.). We acknowledge M. Murphy, Y. Kirichok, and A. Bertholet for many discussions. We also thank M. Murphy for providing MitoQ.	ARECHAGA I, 1993, BIOCHEM J, V296, P693, DOI 10.1042/bj2960693; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Crichton PG, 2015, J BIOL CHEM, V290, P8206, DOI 10.1074/jbc.M114.616607; Davidson Sean M, 2007, Methods Mol Biol, V372, P421, DOI 10.1007/978-1-59745-365-3_30; Divakaruni AS, 2012, J BIOL CHEM, V287, P36845, DOI 10.1074/jbc.M112.381780; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Finkel T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002943; Gospodarska E, 2015, J BIOL CHEM, V290, P8243, DOI 10.1074/jbc.M115.637785; Held JM, 2010, MOL CELL PROTEOMICS, V9, P1400, DOI 10.1074/mcp.M900643-MCP200; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurd TR, 2012, J BIOL CHEM, V287, P35153, DOI 10.1074/jbc.M112.400002; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Lee Y, 2015, P NATL ACAD SCI USA, V112, P6973, DOI 10.1073/pnas.1503833112; Li YG, 2014, EMBO REP, V15, P1069, DOI 10.15252/embr.201438775; Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639; Malingriaux EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077786; Martinez-Acedo P, 2014, J MASS SPECTROM, V49, P257, DOI 10.1002/jms.3336; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Modriansky M, 1997, J BIOL CHEM, V272, P24759, DOI 10.1074/jbc.272.40.24759; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Requejo R, 2010, METHOD ENZYMOL, V474, P123, DOI 10.1016/S0076-6879(10)74008-8; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; SRERE PA, 1974, LIFE SCI, V15, P1695, DOI 10.1016/0024-3205(74)90172-6; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; Townsend MK, 2013, CLIN CHEM, V59, P1657, DOI 10.1373/clinchem.2012.199133; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	50	257	266	9	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					112	+		10.1038/nature17399	http://dx.doi.org/10.1038/nature17399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27027295	Green Submitted, Green Accepted			2022-12-28	WOS:000373555500044
J	Liberman, LM; Benfey, PN				Liberman, Louisa M.; Benfey, Philip N.			A Friend in Need (of Nutrients) Is a...	CELL			English	Editorial Material							MICROBIOME; SYMBIOSIS	Endophytic fungi are found within the roots of healthy plants, but their function is poorly understood. In this issue, Hiruma et al. demonstrate that, under phosphate-limiting conditions, the endophytic fungus, Colletotrichum tofieldiae, provides growth-promoting and fitness benefits to Arabidopsis, but the plant must restrict fungal growth or risk pathogenesis.	[Liberman, Louisa M.; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Benfey, Philip N.] Duke Univ, Howard Hughes Med Inst, Durham, NC 27708 USA	Duke University; Duke University; Howard Hughes Medical Institute	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.; Benfey, PN (corresponding author), Duke Univ, Howard Hughes Med Inst, Durham, NC 27708 USA.	philip.benfey@duke.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Hentschel U, 2000, TRENDS MICROBIOL, V8, P226, DOI 10.1016/S0966-842X(00)01758-3; Hirsch AM, 2004, SYMBIOSIS, V37, P345; Hiruma K, 2016, CELL, V165, P464, DOI 10.1016/j.cell.2016.02.028; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x	9	2	3	3	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					269	271		10.1016/j.cell.2016.03.036	http://dx.doi.org/10.1016/j.cell.2016.03.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058660	Bronze			2022-12-28	WOS:000374123000006
J	Lin, X; Duan, XY; Liang, YY; Su, Y; Wrighton, KH; Long, JY; Hu, M; Davis, CM; Wang, JR; Brunicardi, FC; Shi, YG; Chen, YG; Meng, AM; Feng, XH				Lin, Xia; Duan, Xueyan; Liang, Yao-Yun; Su, Ying; Wrighton, Katharine H.; Long, Jianyin; Hu, Min; Davis, Candi M.; Wang, Jinrong; Brunicardi, F. Charles; Shi, Yigong; Chen, Ye-Guang; Meng, Anming; Feng, Xin-Hua			PPM1A Functions as a Smad Phosphatase to Terminate TGF beta Signaling (vol 125, pg 915, 2006) (Expression of Concern of Vol 125, Pg 915, 2006)	CELL			English	Expression of Concern													Chen, Ye-Guang/L-6998-2019; Meng, Anming/A-4785-2012	Shi, Yigong/0000-0003-2030-168X; Wrighton, Katharine/0000-0001-7075-3399				Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044	1	2	2	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					498	498		10.1016/j.cell.2016.03.038	http://dx.doi.org/10.1016/j.cell.2016.03.038			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058669	Bronze, Green Accepted			2022-12-28	WOS:000374123000027
J	Shen, HJ; Xu, WQ; Guo, R; Rong, BW; Gu, L; Wang, ZT; He, CX; Zheng, LJ; Hu, X; Hu, Z; Shao, ZM; Yang, PY; Wu, FZ; Shi, YG; Shi, Y; Lan, F				Shen, Hongjie; Xu, Wenqi; Guo, Rui; Rong, Bowen; Gu, Lei; Wang, Zhentian; He, Chenxi; Zheng, Lijuan; Hu, Xin; Hu, Zhen; Shao, Zhi-Ming; Yang, Pengyuan; Wu, Feizhen; Shi, Yujiang Geno; Shi, Yang; Lan, Fei			Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex	CELL			English	Article							TUMOR-SUPPRESSOR; SUPER-ENHANCERS; TRANSCRIPTION ELONGATION; HISTONE DEMETHYLASES; SOMATIC MUTATIONS; GENE-EXPRESSION; CELL IDENTITY; S100 PROTEINS; CHROMATIN; CANCER	Regulation of enhancer activity is important for controlling gene expression programs. Here, we report that a biochemical complex containing a potential chromatin reader, RACK7, and the histone lysine 4 tri-methyl (H3K4me3)-specific demethylase KDM5C occupies many active enhancers, including almost all super-enhancers. Loss of RACK7 or KDM5C results in overactivation of enhancers, characterized by the deposition of H3K4me3 and H3K27Ac, together with increased transcription of eRNAs and nearby genes. Furthermore, loss of RACK7 or KDM5C leads to de-repression of S100A oncogenes and various cancer-related phenotypes. Our findings reveal a RACK7/KDM5C-regulated, dynamic interchange between histone H3K4me1 and H3K4me3 at active enhancers, representing an additional layer of regulation of enhancer activity. We propose that RACK7/KDM5C functions as an enhancer "brake'' to ensure appropriate enhancer activity, which, when compromised, could contribute to tumorigenesis.	[Shen, Hongjie; Xu, Wenqi; Guo, Rui; Rong, Bowen; Wang, Zhentian; He, Chenxi; Zheng, Lijuan; Wu, Feizhen; Shi, Yujiang Geno; Shi, Yang; Lan, Fei] Fudan Univ, Minist Educ, Key Lab Metab & Mol Med, Shanghai 200032, Peoples R China; [Shen, Hongjie; Xu, Wenqi; Guo, Rui; Rong, Bowen; Wang, Zhentian; He, Chenxi; Zheng, Lijuan; Wu, Feizhen; Shi, Yujiang Geno; Shi, Yang; Lan, Fei] Fudan Univ, Dept Cellular & Genet Med, Sch Basic Med Sci, Key Lab Epigenet, Shanghai 200032, Peoples R China; [Shen, Hongjie; Xu, Wenqi; Guo, Rui; Rong, Bowen; Wang, Zhentian; He, Chenxi; Zheng, Lijuan; Wu, Feizhen; Shi, Yujiang Geno; Shi, Yang; Lan, Fei] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Shen, Hongjie; Xu, Wenqi; Shi, Yujiang Geno; Shi, Yang; Lan, Fei] Fudan Univ, Childrens Hosp, Key Lab Birth Defect, Shanghai 201102, Peoples R China; [Gu, Lei; Shi, Yang] Harvard Univ, Sch Med, Boston Childrens Hosp, Newborn Med Div, Boston, MA 02115 USA; [Gu, Lei; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Hu, Xin; Hu, Zhen; Shao, Zhi-Ming; Lan, Fei] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai 200032, Peoples R China; [Yang, Pengyuan] Fudan Univ, Inst Biomed Sci, Dept Syst Biol, 138 Yixue Yuan Rd, Shanghai 200032, Peoples R China; [Shi, Yujiang Geno] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol, Boston, MA 02115 USA	Fudan University; Fudan University; Fudan University; Fudan University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Fudan University; Fudan University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Shi, YG; Lan, F (corresponding author), Fudan Univ, Minist Educ, Key Lab Metab & Mol Med, Shanghai 200032, Peoples R China.; Shi, YG; Lan, F (corresponding author), Fudan Univ, Dept Cellular & Genet Med, Sch Basic Med Sci, Key Lab Epigenet, Shanghai 200032, Peoples R China.; Shi, YG; Lan, F (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Shi, YG; Lan, F (corresponding author), Fudan Univ, Childrens Hosp, Key Lab Birth Defect, Shanghai 201102, Peoples R China.; Lan, F (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai 200032, Peoples R China.; Shi, YG (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol, Boston, MA 02115 USA.	yshi@hms.harvard.edu; fei_lan@fudan.edu.cn	Wu, Feizhen/R-6415-2019; Wu, Feizhen/AGR-5215-2022; Gu, Lei/GWQ-6785-2022	Wu, Feizhen/0000-0002-1265-9887; Shen, Hongjie/0000-0001-9771-7988	China "Thousand Youth Talents'' [KHH1340001]; NSFC [91419306]; "973'' State Key Development Program [2014CB943103]; ISTC [2014DFB30020]; NIH grant [CA118487]; Boston Children's Hospital funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA118487] Funding Source: NIH RePORTER	China "Thousand Youth Talents''; NSFC(National Natural Science Foundation of China (NSFC)); "973'' State Key Development Program; ISTC; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Xiangdong Fu (UCSD), Maite Huarte (University of Navarra), Robert Liefke, and Aimee Badeaux (Boston Children's Hospital) for critical reading of the manuscript and for their valuable suggestions. We thank Ting Ni (Fudan University), Yong Zhang (Tongji University), and Feng Yue (Penn. State University) for advices on the RNA-seq methods and bioinformatics analyses. F.L. was supported in part by China "Thousand Youth Talents'' (KHH1340001), NSFC (91419306), "973'' State Key Development Program (2014CB943103), and ISTC (2014DFB30020). This work was also supported in part by a NIH grant (CA118487) and Boston Children's Hospital funds to Y.S., who is an American Cancer Society Research Professor. F.L. is a shareholder of Constellation Pharmaceuticals, Inc. Y.S. is a co-founder of Constellation Pharmaceuticals, Inc., as well as a member of its scientific advisory board. F.L. and Y.S. are consultants of Active Motif, Inc.	Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Blair Lauren P, 2011, Cancers (Basel), V3, P1383, DOI 10.3390/cancers3011383; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chen KF, 2015, NAT GENET, V47, P1149, DOI 10.1038/ng.3385; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Ford DJ, 2015, CANCER GENET-NY, V208, P178, DOI 10.1016/j.cancergen.2015.01.005; Fossey SC, 2000, MAMM GENOME, V11, P919, DOI 10.1007/s003350010174; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Goncalves TF, 2014, EUR J MED GENET, V57, P138, DOI 10.1016/j.ejmg.2014.02.011; Guo R, 2014, MOL CELL, V56, P298, DOI 10.1016/j.molcel.2014.08.022; Hakimi AA, 2013, EUR UROL, V63, P848, DOI 10.1016/j.eururo.2012.09.005; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kloet SL, 2015, FEBS J, V282, P1774, DOI 10.1111/febs.12972; Koch F, 2011, TRANSCR-AUSTIN, V2, P263, DOI 10.4161/trns.2.6.18747; Koues OI, 2015, IMMUNITY, V42, P186, DOI 10.1016/j.immuni.2014.12.021; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Melton C, 2015, NAT GENET, V47, P710, DOI 10.1038/ng.3332; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Mueller A, 1999, HISTOCHEM CELL BIOL, V111, P453, DOI 10.1007/s004180050381; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Outchkourov NS, 2013, CELL REP, V3, P1071, DOI 10.1016/j.celrep.2013.02.030; Park J, 2002, CANCER RES, V62, P1284; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Rasmussen PB, 2014, EPIGENOMICS-UK, V6, P277, DOI [10.2217/epi.14.14, 10.2217/EPI.14.14]; Sack U, 2011, MOL BIOL CELL, V22, P3344, DOI 10.1091/mbc.E10-09-0739; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994	55	107	113	3	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					331	342		10.1016/j.cell.2016.02.064	http://dx.doi.org/10.1016/j.cell.2016.02.064			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	27058665	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000374123000012
J	Nielsen, AAK; Der, BS; Shin, J; Vaidyanathan, P; Paralanov, V; Strychalski, EA; Ross, D; Densmore, D; Voigt, CA				Nielsen, Alec A. K.; Der, Bryan S.; Shin, Jonghyeon; Vaidyanathan, Prashant; Paralanov, Vanya; Strychalski, Elizabeth A.; Ross, David; Densmore, Douglas; Voigt, Christopher A.			Genetic circuit design automation	SCIENCE			English	Article							SYNTHETIC BIOLOGY; ESCHERICHIA-COLI; LOGIC GATES; COMPUTATIONAL DESIGN; REGULATORY NETWORKS; LIVING CELLS; EXPRESSION; TRANSCRIPTION; SYSTEM; PARTS	Computation can be performed in living cells by DNA-encoded circuits that process sensory information and control biological functions. Their construction is time-intensive, requiring manual part assembly and balancing of regulator expression. We describe a design environment, Cello, in which a user writes Verilog code that is automatically transformed into a DNA sequence. Algorithms build a circuit diagram, assign and connect gates, and simulate performance. Reliable circuit design requires the insulation of gates from genetic context, so that they function identically when used in different circuits. We used Cello to design 60 circuits for Escherichia coli (880,000 base pairs of DNA), for which each DNA sequence was built as predicted by the software with no additional tuning. Of these, 45 circuits performed correctly in every output state (up to 10 regulators and 55 parts), and across all circuits 92% of the output states functioned as predicted. Design automation simplifies the incorporation of genetic circuits into biotechnology projects that require decision-making, control, sensing, or spatial organization.	[Nielsen, Alec A. K.; Der, Bryan S.; Shin, Jonghyeon; Voigt, Christopher A.] MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Der, Bryan S.; Vaidyanathan, Prashant; Densmore, Douglas] Boston Univ, Dept Biomed Engn, Biol Design Ctr, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Paralanov, Vanya; Strychalski, Elizabeth A.; Ross, David] NIST, Biosyst & Biomat Div, Mat Measurement Lab, Gaithersburg, MD 20817 USA	Massachusetts Institute of Technology (MIT); Boston University; National Institute of Standards & Technology (NIST) - USA	Voigt, CA (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cavoigt@gmail.com	Vaidyanathan, Prashant/AAO-3682-2020; Densmore, Douglas/AAC-7059-2020	Vaidyanathan, Prashant/0000-0002-9722-7089; 	Office of Naval Research, Multidisciplinary University Research Initiative [N00014-13-1-0074]; Siebel Scholarship; Air Force Office of Scientific Research; National Defense Science and Engineering Graduate fellowship [FA9550-11-C-0028]; National Institute of General Medical Sciences [P50 GMO98792]; NSF Synthetic Biology Engineering Research Center [SynBERC EEC0540879]; NSF [1147158]; NIST Strategic and Emerging Research Initiative; National Research Council postdoctoral program; AWS in Education Grant; Thermo Fischer (Life Technologies) [A114510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; Direct For Biological Sciences [1147158] Funding Source: National Science Foundation	Office of Naval Research, Multidisciplinary University Research Initiative(MURIOffice of Naval Research); Siebel Scholarship; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Defense Science and Engineering Graduate fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF Synthetic Biology Engineering Research Center; NSF(National Science Foundation (NSF)); NIST Strategic and Emerging Research Initiative; National Research Council postdoctoral program; AWS in Education Grant; Thermo Fischer (Life Technologies); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	All data described in this paper are presented in the supplementary materials. Cello can be accessed at www.cellocad.org; the code is open source and maintained via the Nona Research Foundation (www.nonasoftware.org). The insulated gates, circuits, and plasmids defined in the UCF can be obtained via Addgene (www.addgene.org). The E. coli strain used in this UCF is available from New England Biolabs (C3019). D.D. is president and part owner of Lattice Automation, which works on software for synthetic biology. Supported by Office of Naval Research, Multidisciplinary University Research Initiative grant N00014-13-1-0074 (C.A.V. and A.A.K.N.); a Siebel Scholarship (Class of 2015) and Air Force Office of Scientific Research, National Defense Science and Engineering Graduate fellowship FA9550-11-C-0028 (A.A.K.N.); National Institute of General Medical Sciences grant P50 GMO98792 and NSF Synthetic Biology Engineering Research Center grant SynBERC EEC0540879 (C.A.V. and J.S.); NSF grant 1147158 (D.D. and P.V.); the NIST Strategic and Emerging Research Initiative (V.P., E.A.S., and D.R.); the National Research Council postdoctoral program (V.P.); an AWS in Education Grant; and Thermo Fischer (Life Technologies, A114510). We thank S. Bhatia (Boston University) for his work to enumerate the three-input, one-output logic motifs; R. Ghamari (Boston University) for early work on the Cello software foundation and design approach; N. Roehner for technical assistance with SBOL; and E. Oberortner for technical assistance with Eugene. The National Institute of Standards and Technology notes that certain commercial equipment, instruments, and materials are identified in this paper to specify an experimental procedure as completely as possible. In no case does the identification of particular equipment or materials imply a recommendation or endorsement by NIST, nor does it imply that the materials, instruments, or equipment are necessarily the best available for the purpose. The University of California, San Francisco, holds a patent application associated with this work (US20130005590 A1). The set of insulated gates, the plasmid backbones for the circuit and output plasmids (Fig. 1), and the standard RPU plasmid are available via Addgene (www.addgene.org/Christopher_Voigt/). Cello can be accessed as a web-based application (www.cellocad.org), the code for which will be open source and provided on Github (https://github.com/CIDARLAB/cello).	Alon U, 2007, INTRO SYSTEMS BIOL D; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Arkin AP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-114; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Beal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022490; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Blanchard AE, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-23; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Boyle PM, 2012, METAB ENG, V14, P223, DOI 10.1016/j.ymben.2011.10.003; Brayton R, 2010, LECT NOTES COMPUT SC, V6174, P24, DOI 10.1007/978-3-642-14295-6_5; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cardinale S, 2013, CELL REP, V4, P231, DOI 10.1016/j.celrep.2013.06.023; Chandran Deepak, 2009, J Biol Eng, V3, P19, DOI 10.1186/1754-1611-3-19; Chappell J, 2015, NAT CHEM BIOL, V11, P214, DOI 10.1038/nchembio.1737; Chen D, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.52; Chen YJ, 2013, NAT METHODS, V10, P659, DOI [10.1038/NMETH.2515, 10.1038/nmeth.2515]; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Crockford D., APPL JSON MEDIA TYPE; Czar MJ, 2009, NUCLEIC ACIDS RES, V37, pW40, DOI 10.1093/nar/gkp361; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Drubin DA, 2007, GENE DEV, V21, P242, DOI 10.1101/gad.1507207; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D., 2011, NY TIMES; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Galdzicki M, 2014, NAT BIOTECHNOL, V32, P545, DOI 10.1038/nbt.2891; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghamari R., 2011, THESIS BOSTON U; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Huynh L, 2014, ACS SYNTH BIOL, V3, P556, DOI 10.1021/sb400139h; Jang SS, 2012, ACS SYNTH BIOL, V1, P365, DOI 10.1021/sb300034m; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Lo TM, 2013, CHEM ENG SCI, V103, P29, DOI 10.1016/j.ces.2013.03.021; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Moser F, 2012, ACS SYNTH BIOL, V1, P555, DOI 10.1021/sb3000832; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Myers CJ, 2009, BIOINFORMATICS, V25, P2848, DOI 10.1093/bioinformatics/btp457; Nielsen AA, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145735; Oberortner E., 2014, J EMERG TECHNOL COMP, V11, P25, DOI [10.1021/sb400139h;pmid:24933033, DOI 10.1021/SB400139H]; Ptashne M., 1986, A GENETIC SWITCH; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quinn JY, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002310; Rhodius VA, 2012, NUCLEIC ACIDS RES, V40, P2907, DOI 10.1093/nar/gkr1190; Rodrigo G, 2013, ACS SYNTH BIOL, V2, P230, DOI 10.1021/sb300084h; Roehner N, 2014, ACS SYNTH BIOL, V3, P543, DOI 10.1021/sb400135t; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Rudge TJ, 2012, ACS SYNTH BIOL, V1, P345, DOI 10.1021/sb300031n; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; Segall-Shapiro TH, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145299; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Sleight SC, 2013, ACS SYNTH BIOL, V2, P519, DOI 10.1021/sb400055h; Smanski MJ, 2014, NAT BIOTECHNOL, V32, P1241, DOI 10.1038/nbt.3063; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stanton BC, 2014, NAT CHEM BIOL, V10, P99, DOI 10.1038/nchembio.1411; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Teo WS, 2014, BIOTECHNOL BIOENG, V111, P144, DOI 10.1002/bit.25001; Thomas D., 2002, VERILOG HARDWARE DES; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; WEISS R, 2001, THESIS MIT; Whitaker WR, 2012, P NATL ACAD SCI USA, V109, P18090, DOI 10.1073/pnas.1209230109; Wolfram S., 2002, NEW KIND SCI, V5; Yaman F, 2012, ACS SYNTH BIOL, V1, P332, DOI 10.1021/sb300032y; Yang L, 2014, NAT METHODS, V11, P1261, DOI [10.1038/nmeth.3147, 10.1038/NMETH.3147]; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; Yordanov B, 2014, ACS SYNTH BIOL, V3, P578, DOI 10.1021/sb400152n; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149	98	526	547	24	353	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281							aac7341	10.1126/science.aac7341	http://dx.doi.org/10.1126/science.aac7341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	27034378				2022-12-28	WOS:000373039600032
J	Govindaraju, R; Narayanan, P				Govindaraju, Revadi; Narayanan, Prepageran			Carotid-Cavernous Sinus Fistula	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Govindaraju, Revadi] Univ Malaya, Kuala Lumpur 50603, Malaysia; [Narayanan, Prepageran] Univ Malaya, Med Ctr, Petaling Jaya 47530, Selangor, Malaysia	Universiti Malaya; Universiti Malaya	Govindaraju, R (corresponding author), Univ Malaya, Kuala Lumpur 50603, Malaysia.	grevadi@gmail.com	GOVINDARAJU, REVADI/AAB-9047-2020; GOVINDARAJU, REVADI/GSD-3936-2022; Prepageran, Narayanan/ABC-7933-2021; Narayanan, Prepageran A/L/P-2359-2014	GOVINDARAJU, REVADI/0000-0003-3615-7168; 					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					E15	E15		10.1056/NEJMicm1509943	http://dx.doi.org/10.1056/NEJMicm1509943			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8ZM	27028934				2022-12-28	WOS:000373085500010
J	Sobolev, AV; Asafov, EV; Gurenko, AA; Arndt, NT; Batanova, VG; Portnyagin, MV; Garbe-Schonberg, D; Krasheninnikov, SP				Sobolev, Alexander V.; Asafov, Evgeny V.; Gurenko, Andrey A.; Arndt, Nicholas T.; Batanova, Valentina G.; Portnyagin, Maxim V.; Garbe-Schoenberg, Dieter; Krasheninnikov, Stepan P.			Komatiites reveal a hydrous Archaean deep-mantle reservoir	NATURE			English	Article							BORON ISOTOPIC COMPOSITION; ABITIBI GREENSTONE-BELT; MELT INCLUSIONS; TRANSITION-ZONE; OLIVINE CRYSTALLIZATION; REFRACTORY MANTLE; CA BONINITES; ORIGIN; PLUME; H2O	Archaean komatiites (ultramafic lavas) result from melting under extreme conditions of the Earth's mantle. Their chemical compositions evoke very high eruption temperatures, up to 1,600 degrees Celsius, which suggests even higher temperatures in their mantle source(1,2). This message is clouded, however, by uncertainty about the water content in komatiite magmas. One school of thought holds that komatiites were essentially dry and originated in mantle plumes(3-6) while another argues that these magmas contained several per cent water, which drastically reduced their eruption temperature and links them to subduction processes(7-9). Here we report measurements of the content of water and other volatile components, and of major and trace elements in melt inclusions in exceptionally magnesian olivine (up to 94.5 mole per cent forsterite). This information provides direct estimates of the composition and crystallization temperature of the parental melts of Archaean komatiites. We show that the parental melt for 2.7-billion-year-old komatiites from the Abitibi greenstone belt in Canada contained 30 per cent magnesium oxide and 0.6 per cent water by weight, and was depleted in highly incompatible elements. This melt began to crystallize at around 1,530 degrees Celsius at shallow depth and under reducing conditions, and it evolved via fractional crystallization of olivine, accompanied by minor crustal assimilation. As its major-and trace-element composition and low oxygen fugacities are inconsistent with a subduction setting, we propose that its high H2O/Ce ratio (over 6,000) resulted from entrainment into the komatiite source of hydrous material from the mantle transition zone(10). These results confirm a plume origin for komatiites and high Archaean mantle temperatures, and evoke a hydrous reservoir in the deep mantle early in Earth's history.	[Sobolev, Alexander V.; Arndt, Nicholas T.; Batanova, Valentina G.] Univ Grenoble Alpes, Inst Sci Terre ISTerre, CNRS, F-38041 Grenoble, France; [Sobolev, Alexander V.; Asafov, Evgeny V.; Batanova, Valentina G.; Portnyagin, Maxim V.; Krasheninnikov, Stepan P.] Russian Acad Sci, Vernadsky Inst Geochem & Analyt Chem, 19 Ul Kosygina, Moscow 119991, Russia; [Gurenko, Andrey A.] Univ Lorraine, CRPG, UMR 7358, F-54501 Vandoeuvre Les Nancy, France; [Portnyagin, Maxim V.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Wischhofstr 1-3, D-24148 Kiel, Germany; [Garbe-Schoenberg, Dieter] Univ Kiel, Inst Geosci, Ludewig Meyn Str 10, D-24118 Kiel, Germany	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Sobolev, AV (corresponding author), Univ Grenoble Alpes, Inst Sci Terre ISTerre, CNRS, F-38041 Grenoble, France.; Sobolev, AV (corresponding author), Russian Acad Sci, Vernadsky Inst Geochem & Analyt Chem, 19 Ul Kosygina, Moscow 119991, Russia.	alexander.sobolev@ujf-grenoble.fr	Sobolev, Alexander/E-6367-2010; Garbe-Schönberg, Dieter/AAO-3827-2020; Krasheninnikov, Stepan P/F-9161-2016; Sobolev, Alexander/AAB-4269-2021; Sobolev, Alexander/AAQ-6001-2021; Asafov, Evgeny/AAB-5273-2019; Portnyagin, Maxim V/G-9280-2011	Sobolev, Alexander/0000-0002-1997-2032; Krasheninnikov, Stepan P/0000-0003-0887-2711; Portnyagin, Maxim V/0000-0001-5197-6562; Asafov, Evgeny/0000-0002-7761-7661	Russian Science Foundation [14-17-00491]; Agence Nationale de la Recherche, France; Chair of Excellence grant [ANR-09-CEXC-003-01]; CNRS; Labex OSUG (Investissements d'avenir) [ANR10 LABX56]; Institut Universitaire de France; Deep Carbon Observatory; CRPG (A.A.G.'s internal funds)	Russian Science Foundation(Russian Science Foundation (RSF)); Agence Nationale de la Recherche, France(French National Research Agency (ANR)); Chair of Excellence grant; CNRS(Centre National de la Recherche Scientifique (CNRS)); Labex OSUG (Investissements d'avenir)(French National Research Agency (ANR)); Institut Universitaire de France; Deep Carbon Observatory; CRPG (A.A.G.'s internal funds)	We thank A. Kadik, A. Borisov and A. Kargal'tsev for their assistance in high-temperature experiments, V. Magnin for assistance in maintenance of the EPMA laboratory, U. Westernstroer for help with laser-ablation ICP-MS measurements, and V. Kamenetsky for providing sample 41F of the Cape Vogel boninites. The paper benefited greatly from the constructive reviews of C. Herzberg and I. Puchtel and the comments of S. Sobolev. This study was funded by the Russian Science Foundation grant number 14-17-00491 (to A.V.S.). The EPMA facility in ISTerre was established and maintained by funds of the Agence Nationale de la Recherche, France, the Chair of Excellence grant ANR-09-CEXC-003-01 and partly by CNRS and Labex OSUG@2020 (Investissements d'avenir-ANR10 LABX56). A.V.S. acknowledges the support of Institut Universitaire de France and the Deep Carbon Observatory. The costs of SIMS analyses were covered by CRPG (A.A.G.'s internal funds). This is CRPG contribution number 2430.	Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; ALLEGRE CJ, 1982, KOMATIITES, P495; Almeev RR, 2007, AM MINERAL, V92, P670, DOI 10.2138/am.2007.2484; Arndt N, 1998, GEOLOGY, V26, P739, DOI 10.1130/0091-7613(1998)026<0739:WKW>2.3.CO;2; Batanova VG, 2011, J PETROL, V52, P2483, DOI 10.1093/petrology/egr053; Batanova VG, 2015, CHEM GEOL, V419, P149, DOI 10.1016/j.chemgeo.2015.10.042; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; BROWN PE, 1989, AM MINERAL, V74, P1390; CAMPBELL IH, 1989, NATURE, V339, P697, DOI 10.1038/339697a0; Coogan LA, 2014, CHEM GEOL, V368, P1, DOI 10.1016/j.chemgeo.2014.01.004; Danyushevsky LV, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003516; Danyushevsky LV, 2002, J PETROL, V43, P1651, DOI 10.1093/petrology/43.9.1651; Dixon JE, 2002, NATURE, V420, P385, DOI 10.1038/nature01215; Evans KA, 2012, GEOLOGY, V40, P783, DOI 10.1130/G33037.1; Falloon TJ, 2000, J PETROL, V41, P257, DOI 10.1093/petrology/41.2.257; Fan J, 1997, GEOCHIM COSMOCHIM AC, V61, P4723, DOI 10.1016/S0016-7037(97)00269-X; FORD CE, 1983, J PETROL, V24, P256, DOI 10.1093/petrology/24.3.256; Grove TL, 2004, EARTH PLANET SC LETT, V219, P173, DOI 10.1016/S0012-821X(04)00002-0; Gurenko AA, 2011, EARTH PLANET SC LETT, V312, P201, DOI 10.1016/j.epsl.2011.09.033; Herzberg C, 2002, J PETROL, V43, P1857, DOI 10.1093/petrology/43.10.1857; Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; Herzberg C, 2015, GEOCHEM GEOPHY GEOSY, V16, P563, DOI 10.1002/2014GC005631; HERZBERG C, 1992, J GEOPHYS RES-SOL EA, V97, P4521, DOI 10.1029/91JB03066; Herzberg C, 2010, EARTH PLANET SC LETT, V292, P79, DOI 10.1016/j.epsl.2010.01.022; Herzberg C, 2009, NATURE, V458, P619, DOI 10.1038/nature07857; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; Jochum KP, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001060; Kamenetsky VS, 2002, CHEM GEOL, V183, P287, DOI 10.1016/S0009-2541(01)00380-1; Kent AJR, 1999, CHEM GEOL, V156, P299, DOI 10.1016/S0009-2541(98)00188-0; Lahaye Y, 1996, J PETROL, V37, P1261, DOI 10.1093/petrology/37.6.1261; Lahaye Y, 2001, CAN MINERAL, V39, P473, DOI 10.2113/gscanmin.39.2.473; Mallmann G, 2013, J PETROL, V54, P933, DOI 10.1093/petrology/egt001; Mallmann G, 2009, J PETROL, V50, P1765, DOI 10.1093/petrology/egp053; MCDONOUGH WF, 1993, NATURE, V365, P432, DOI 10.1038/365432a0; Medard E, 2008, CONTRIB MINERAL PETR, V155, P417, DOI 10.1007/s00410-007-0250-4; Mibe K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026999; Mironov N, 2015, EARTH PLANET SC LETT, V425, P1, DOI 10.1016/j.epsl.2015.05.043; Newman S, 2002, COMPUT GEOSCI-UK, V28, P597, DOI 10.1016/S0098-3004(01)00081-4; NISBET EG, 1993, LITHOS, V30, P291, DOI 10.1016/0024-4937(93)90042-B; Parman SW, 2004, S AFR J GEOL, V107, P107, DOI 10.2113/107.1-2.107; Pearson DG, 2014, NATURE, V507, P221, DOI 10.1038/nature13080; Portnyagin M, 2008, EARTH PLANET SC LETT, V272, P541, DOI 10.1016/j.epsl.2008.05.020; Puchtel IS, 2009, GEOCHIM COSMOCHIM AC, V73, P6367, DOI 10.1016/j.gca.2009.07.022; PYKE DR, 1973, GEOL SOC AM BULL, V84, P955, DOI 10.1130/0016-7606(1973)84<955:AUFIMT>2.0.CO;2; Ribeiro JM, 2015, EARTH PLANET SC LETT, V418, P136, DOI 10.1016/j.epsl.2015.02.018; Roberge M, 2015, EARTH PLANET SC LETT, V429, P25, DOI 10.1016/j.epsl.2015.07.051; Rosner M, 2004, GEOSTAND GEOANAL RES, V28, P431, DOI 10.1111/j.1751-908X.2004.tb00761.x; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; SOBOLEV AV, 1994, J PETROL, V35, P1183, DOI 10.1093/petrology/35.5.1183; SPIVACK AJ, 1986, ANAL CHEM, V58, P31, DOI 10.1021/ac00292a010; Wallace PJ, 2015, AM MINERAL, V100, P787, DOI 10.2138/am-2015-5029; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29	52	111	121	0	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					628	632		10.1038/nature17152	http://dx.doi.org/10.1038/nature17152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27029278				2022-12-28	WOS:000373027400036
J	Bravenboer, B; Debels, L				Bravenboer, Bert; Debels, Lynn			CASE REVIEW A patient with muscle weakness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DERMATOMYOSITIS; PREDICTORS		[Bravenboer, Bert; Debels, Lynn] UZ Brussels, Laarbeeklaan 101, B-1000 Brussels, Belgium		Debels, L (corresponding author), UZ Brussels, Laarbeeklaan 101, B-1000 Brussels, Belgium.	ldebels@vub.ac.be						Aggarwal R, 2014, ARTHRITIS RHEUMATOL, V66, P740, DOI 10.1002/art.38270; Chinoy H, 2007, ANN RHEUM DIS, V66, P1345, DOI 10.1136/ard.2006.068502; Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225; DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704; Drake LA, 1996, J AM ACAD DERMATOL, V34, P824; Ghirardello A, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0335-1; Hill CL, 2001, LANCET, V357, P96, DOI 10.1016/S0140-6736(00)03540-6; JOFFE MM, 1993, AM J MED, V94, P379, DOI 10.1016/0002-9343(93)90148-I; Mimori T, 2007, CURR OPIN RHEUMATOL, V19, P523, DOI 10.1097/BOR.0b013e3282f01a8c	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2016	352								i1502	10.1136/bmj.i1502	http://dx.doi.org/10.1136/bmj.i1502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TO	27029483				2022-12-28	WOS:000373492400002
J	Ledermann, JA; Embleton, AC; Raja, F; Perren, TJ; Jayson, GC; Rustin, GJS; Kaye, SB; Hirte, H; Eisenhauer, E; Vaughan, M; Friedlander, M; Gonzalez-Martin, A; Stark, D; Clark, E; Farrelly, L; Swart, AM; Cook, A; Kaplan, RS; Parmar, MKB				Ledermann, Jonathan A.; Embleton, Andrew C.; Raja, Fharat; Perren, Timothy J.; Jayson, Gordon C.; Rustin, Gordon J. S.; Kaye, Stan B.; Hirte, Hal; Eisenhauer, Elizabeth; Vaughan, Michelle; Friedlander, Michael; Gonzalez-Martin, Antonio; Stark, Daniel; Clark, Elizabeth; Farrelly, Laura; Swart, Ann Marie; Cook, Adrian; Kaplan, Richard S.; Parmar, Mahesh K. B.		ICON6 Collaborators	Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial	LANCET			English	Article							RECURRENT OVARIAN; CHEMOTHERAPY; BEVACIZUMAB; CARBOPLATIN; COMBINATION; PACLITAXEL; MONOTHERAPY; PERITONEAL; GROWTH	Background Angiogenesis is a validated clinical target in advanced epithelial ovarian cancer. Cediranib is an oral antiangiogenic vascular endothelial growth factor receptor 1-3 inhibitor that has shown antitumour activity in recurrent ovarian cancer. We assessed efficacy and safety of cediranib in combination with platinum-based chemotherapy and as continued maintenance treatment in patients with first relapse of platinum-sensitive ovarian cancer. Methods In this randomised, three-arm, double-blind, placebo-controlled phase 3 trial, we randomly assigned patients aged 18 years or older with relapsed platinum-sensitive ovarian cancer at 63 centres in Australia, Canada, New Zealand, Spain, and the UK. Participants received up to six cycles of platinum-based chemotherapy (once every 3 weeks) then entered a maintenance phase. Participants were randomly allocated (2: 3: 3), with five stratification factors and in alternating blocks, to receive placebo alongside chemotherapy and then placebo only maintenance (arm A; reference), cediranib 20 mg once-daily alongside chemotherapy then placebo only maintenance (arm B; concurrent), or cediranib 20 mg once-daily alongside chemotherapy then cediranib 20 mg once-daily maintenance (arm C; maintenance). Patients continued treatment to progression or excessive toxic effects. The primary efficacy endpoint was progression-free survival between arms A and C. Efficacy analysis was by intention to treat. Safety was assessed in all patients who received the allocated study drug. This trial is registered with ClinicalTrials.gov, number NCT00532194; the ISRCTN registry, number ISRCTN68510403; and ANZ Clinical Trials Registry, number ACTRN1261000016003. Findings We randomly assigned 456 women between Nov 13, 2007, and Dec 23, 2011; results presented are for 456 patients randomly assigned subsequent to the 30mg safety phase. During a median of 19.5 months (IQR 14-26) follow-up, 113 (96%) of 118 women assigned to arm A and 141 (86%) of 164 assigned to arm C had disease progression. Median progression-free survival was 11.0 months (95% CI 10.4-11.7) in arm C and 8.7 months (7.7-9.z4) in arm A (hazard ratio 0.56, 0.44-0.72, p< 0.0001). 156 (90%) of 174 patients in arm B had disease progression, and median progression-free survival was 9.9 months (95% CI 9.4-10.5). Diarrhoea, neutropenia, hypertension, and voice changes were significantly more common, during chemotherapy with cediranib, and diarrhoea, hypothyroidism and voice changes were more common during maintenance. Poor compliance with cediranib was noted during maintenance treatment with toxic effects being the most common cause for discontinuation. Interpretation Cediranib, when given orally with chemotherapy and continued as maintenance, yielded a meaningful in progression-free survival in women with recurrent platinum-sensitive ovarian cancer, albeit with added toxic effects. The positive results in ICON6 could provide women with a new therapeutic option for recurrent ovarian cancer. Assessment of the secondary endpoint of overall survival will need longer follow-up. Copyright (c) Ledermann et al. Open Access article distributed under the terms of CC BY.	[Ledermann, Jonathan A.] UCL, Canc Res UK, London W1T 4TJ, England; [Ledermann, Jonathan A.] UCL, UCL Canc Trials Ctr, London W1T 4TJ, England; [Ledermann, Jonathan A.] UCL Hosp, London, England; [Embleton, Andrew C.; Clark, Elizabeth; Farrelly, Laura; Cook, Adrian; Kaplan, Richard S.; Parmar, Mahesh K. B.] UCL, MRC, Clin Trials Unit UCL, London W1T 4TJ, England; [Raja, Fharat] Univ Coll London Hosp, London, England; [Perren, Timothy J.] St Jamess Inst Oncol, Leeds, W Yorkshire, England; [Perren, Timothy J.] Leeds Inst Canc Med & Pathol, Leeds, W Yorkshire, England; [Jayson, Gordon C.] Christie Hosp, Manchester, Lancs, England; [Jayson, Gordon C.] Univ Manchester, Manchester, Lancs, England; [Rustin, Gordon J. S.] Mt Vernon Canc Ctr, Northwood, Middx, England; [Kaye, Stan B.] Royal Marsden Hosp, London SW3 6JJ, England; [Hirte, Hal] Juravinski Canc Ctr, Hamilton, ON, Canada; [Hirte, Hal] McMaster Univ, Hamilton, ON, Canada; [Eisenhauer, Elizabeth] Canadian Canc Trials Grp CCTG, Kingston, ON, Canada; [Eisenhauer, Elizabeth] Queens Univ, Kingston, ON, Canada; [Vaughan, Michelle] Christchurch Hosp, Christchurch, New Zealand; [Friedlander, Michael] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Gonzalez-Martin, Antonio] Spanish Grp Invest Ovarian Canc GEICO, Madrid, Spain; [Gonzalez-Martin, Antonio] MD Anderson Canc Ctr Madrid, Madrid, Spain; [Stark, Daniel] Univ Leeds, Leeds, W Yorkshire, England; [Swart, Ann Marie] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England	Cancer Research UK; University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Medical Research Council Clinical Trials Unit; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Saint James's University Hospital; Christie NHS Foundation Trust; Christie Hospital; University of Manchester; Mount Vernon Cancer Centre; Royal Marsden NHS Foundation Trust; McMaster University; McMaster University; Queens University - Canada; Christchurch Hospital New Zealand; University of New South Wales Sydney; University of Texas System; UTMD Anderson Cancer Center; University of Leeds; University of East Anglia	Ledermann, JA (corresponding author), UCL, Inst Canc, Canc Res UK, London W1T 4TJ, England.; Ledermann, JA (corresponding author), UCL, Inst Canc, UCL Canc Trials Ctr, London W1T 4TJ, England.	j.ledermann@ucl.ac.uk	Rustin, Gordon J. S./J-9763-2019; Martín, Antonio González/AAC-5935-2020; Perren, Timothy J/D-5387-2013; Jayson, Gordon/O-8224-2015	Martín, Antonio González/0000-0001-8376-9576; Perren, Timothy J/0000-0001-8472-8856; Embleton-Thirsk, Andrew/0000-0001-9402-8132; friedlander, michael/0000-0003-3090-795X; Earl, Helena/0000-0003-1549-8094; Kaplan, Richard S./0000-0002-0189-8348; Jayson, Gordon/0000-0002-8515-8944	Medical Research Council; Cancer Research UK; Canadian Cancer Society Research Institute; Cancer Australia; National Gynecological Cancer Centre; AstraZeneca; Cancer Research UK [CRUK/07/025]; Canadian Cancer Society Research Institute [015469, 021039]; Cancer Australia [APP1006602]; MRC [MC_U122861379, MC_UU_12023/9, MC_UU_12023/28] Funding Source: UKRI; Cancer Research UK [6862] Funding Source: researchfish; Medical Research Council [MR/K006584/1, MC_U122861379, MC_UU_12023/28, MC_UU_12023/9] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Australia; National Gynecological Cancer Centre; AstraZeneca(AstraZeneca); Cancer Research UK(Cancer Research UK); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Australia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council, Cancer Research UK, Canadian Cancer Society Research Institute, Cancer Australia, National Gynecological Cancer Centre, and AstraZeneca.; The trial was funded by the Medical Research Council, Cancer Research UK (CRUK/07/025), Canadian Cancer Society Research Institute (015469 and 021039), Cancer Australia (APP1006602) and National Gynecological Cancer Centre, and AstraZeneca. The trial is registered with the ISRCTN registry, number ISRCTN68510403; ClinicalTrials.gov, number NCT00532194; and ANZ Clinical Trials Registry, number ACTRN1261000016003. ICON6 was managed by the Medical Research Council Clinical Trials Unit at University College London and employees were central to the completion of the trial and the development of this manuscript. I Tannock (Princess Margaret Cancer Centre, Toronto, ON, Canada) provided a critical review of the manuscript. See appendix for a full list of collaborators.	Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Batchelor TT, 2013, J CLIN ONCOL, V31, P3212, DOI 10.1200/JCO.2012.47.2464; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Coleman RL, 2015, GYNECOL ONCOL, V137, P3, DOI 10.1016/j.ygyno.2015.01.005; du Bois A, 2013, INT J GYNECOL CANCER, V23; du Bois A, 2014, J CLIN ONCOL, V32, P3374, DOI 10.1200/JCO.2014.55.7348; Goss GD, 2010, J CLIN ONCOL, V28, P49, DOI 10.1200/JCO.2009.22.9427; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hoff PM, 2012, J CLIN ONCOL, V30, P3596, DOI 10.1200/JCO.2012.42.6031; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Kummar S, 2013, J CLIN ONCOL, V31, P2296, DOI 10.1200/JCO.2012.47.4288; Laurie SA, 2014, EUR J CANCER, V50, P706, DOI 10.1016/j.ejca.2013.11.032; Ledermann JA, 2013, EUR J CANCER, V49, pS5; Matulonis UA, 2009, J CLIN ONCOL, V27, P5601, DOI 10.1200/JCO.2009.23.2777; Mulders P, 2012, EUR J CANCER, V48, P527, DOI 10.1016/j.ejca.2011.12.022; Parmar MKB, 2003, LANCET, V361, P2099; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pfisterer J, 2006, J CLIN ONCOL, V24, P4699, DOI 10.1200/JCO.2006.06.0913; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Raja FA, 2011, BRIT J CANCER, V105, P884, DOI 10.1038/bjc.2011.334; Royston P, 2011, STAT MED, V30, P2409, DOI 10.1002/sim.4274; Schmidinger Manuela, 2013, EJC Suppl, V11, P172, DOI 10.1016/j.ejcsup.2013.07.016; Symonds RP, 2015, LANCET ONCOL, V16, P1515, DOI 10.1016/S1470-2045(15)00220-X; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Valle JW, 2015, LANCET ONCOL, V16, P967, DOI 10.1016/S1470-2045(15)00139-4; Wagner U, 2012, BRIT J CANCER, V107, P588, DOI 10.1038/bjc.2012.307; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409	30	166	177	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1066	1074		10.1016/S0140-6736(15)01167-8	http://dx.doi.org/10.1016/S0140-6736(15)01167-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	27025186	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000371775000026
J	Petropoulos, S; Edsgard, D; Reinius, B; Deng, QL; Panula, SP; Codeluppi, S; Reyes, AP; Linnarsson, S; Sandberg, R; Lanner, F				Petropoulos, Sophie; Edsgard, Daniel; Reinius, Bjorn; Deng, Qiaolin; Panula, Sarita Pauliina; Codeluppi, Simone; Reyes, Alvaro Plaza; Linnarsson, Sten; Sandberg, Rickard; Lanner, Fredrik			Single-Cell RNA-Seq Reveals Lineage and X Chromosome Dynamics in Human Preimplantation Embryos	CELL			English	Article							GENE-EXPRESSION; INACTIVATION; MOUSE; FGF; DIFFERENTIATION; BLASTOCYST; SEGREGATION; EVOLUTION; ENDODERM; PATTERNS	Mouse studies have been instrumental in forming our current understanding of early cell-lineage decisions; however, similar insights into the early human development are severely limited. Here, we present a comprehensive transcriptional map of human embryo development, including the sequenced transcriptomes of 1,529 individual cells from 88 human preimplantation embryos. These data show that cells undergo an intermediate state of co-expression of lineage-specific genes, followed by a concurrent establishment of the trophectoderm, epiblast, and primitive endoderm lineages, which coincide with blastocyst formation. Female cells of all three lineages achieve dosage compensation of X chromosome RNA levels prior to implantation. However, in contrast to the mouse, XIST is transcribed from both alleles throughout the progression of this expression dampening, and X chromosome genes maintain biallelic expression while dosage compensation proceeds. We envision broad utility of this transcriptional atlas in future studies on human development as well as in stem cell research.	[Petropoulos, Sophie; Panula, Sarita Pauliina; Reyes, Alvaro Plaza; Lanner, Fredrik] Karolinska Inst, Dept Clin Sci Intervent & Technol, S-14186 Stockholm, Sweden; [Petropoulos, Sophie; Panula, Sarita Pauliina; Reyes, Alvaro Plaza; Lanner, Fredrik] Karolinska Univ Sjukhuset, Div Obstet & Gynecol, S-14186 Stockholm, Sweden; [Petropoulos, Sophie; Edsgard, Daniel; Reinius, Bjorn; Deng, Qiaolin; Sandberg, Rickard] Ludwig Inst Canc Res, Box 240, S-17177 Stockholm, Sweden; [Edsgard, Daniel; Reinius, Bjorn; Deng, Qiaolin; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Codeluppi, Simone] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Codeluppi, Simone; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Lanner, F (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, S-14186 Stockholm, Sweden.; Lanner, F (corresponding author), Karolinska Univ Sjukhuset, Div Obstet & Gynecol, S-14186 Stockholm, Sweden.; Sandberg, R (corresponding author), Ludwig Inst Canc Res, Box 240, S-17177 Stockholm, Sweden.; Sandberg, R (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	rickard.sandberg@ki.se; fredrik.lanner@ki.se	Petropoulos, Sophie/M-3090-2017; Petropoulos, Sophie/D-6861-2016; Plaza Reyes, Alvaro/AAC-1723-2022; Deng, Qiaolin/AAD-6905-2020; Linnarsson, Sten/HCH-3909-2022; Reyes, Alvaro Plaza/AAX-7992-2020; codeluppi, simone/I-4143-2012	Petropoulos, Sophie/0000-0003-2293-8238; Reyes, Alvaro Plaza/0000-0003-1167-6316; codeluppi, simone/0000-0002-7053-0520; Sandberg, Rickard/0000-0001-6473-1740; Reinius, Bjorn/0000-0002-7021-5248; Lanner, Fredrik/0000-0002-2771-7445; Deng, Qiaolin/0000-0001-5934-7816	Knut and Alice Wallenberg Foundation; Swedish Research Council; Centre for Innovative Medicine; Jonasson donation to the School of Technology and Health, Royal Institute of Technology, Sweden; Swedish Research Council [2013-2570, D0782401]; Ragnar Soderberg Foundation; Swedish Foundation for Strategic Research [ICA-5, FFL4]; European Research Council [CoG 648842]; Ake Wibergs Foundation; Mats Sundin Fellowship in Developmental Health; European Research Council [648842] Funding Source: Medline	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Innovative Medicine; Jonasson donation to the School of Technology and Health, Royal Institute of Technology, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council(European Research Council (ERC)European Commission); Ake Wibergs Foundation; Mats Sundin Fellowship in Developmental Health; European Research Council(European Research Council (ERC)European Commission)	The imaging was performed at the Live Cell Imaging facility/Nikon Center of Excellence, Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden, supported by grants from the Knut and Alice Wallenberg Foundation, the Swedish Research Council, the Centre for Innovative Medicine and the Jonasson donation to the School of Technology and Health, Royal Institute of Technology, Sweden. This work was supported by grants from the Swedish Research Council (2013-2570, D0782401), Ragnar Soderberg Foundation, Swedish Foundation for Strategic Research (ICA-5, FFL4), European Research Council (CoG 648842), and Ake Wibergs Foundation. S.P. is supported by the Mats Sundin Fellowship in Developmental Health. We thank all couples donating embryos to this study.	Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Clemson CM, 1998, J CELL BIOL, V142, P13, DOI 10.1083/jcb.142.1.13; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Deng XX, 2014, NAT REV GENET, V15, P367, DOI 10.1038/nrg3687; Drake PM, 2004, DEV DYNAM, V229, P877, DOI 10.1002/dvdy.10477; Escamilla-Del-Arenal M, 2011, HUM GENET, V130, P307, DOI 10.1007/s00439-011-1029-2; Goto Y, 2000, CHROMOSOME RES, V8, P101, DOI 10.1023/A:1009234217981; Goto Y, 1998, DEVELOPMENT, V125, P3353; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; HASTIE T, 1989, J AM STAT ASSOC, V84, P502, DOI 10.2307/2289936; Heard E, 2004, COLD SPRING HARB SYM, V69, P89, DOI 10.1101/sqb.2004.69.89; Jiang W, 2015, CELL REP, V11, P137, DOI 10.1016/j.celrep.2015.03.008; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Kumar P, 2013, MOL CELL BIOL, V33, P1782, DOI 10.1128/MCB.01228-12; Kunath T, 2014, PLACENTA, V35, P1079, DOI 10.1016/j.placenta.2014.09.008; Lessing D, 2013, ANNU REV GENOM HUM G, V14, P85, DOI 10.1146/annurev-genom-091212-153530; Li GA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-182; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mank JE, 2009, GENET RES, V91, P355, DOI 10.1017/S0016672309990255; Marchand M, 2011, BIOL REPROD, V84, P1258, DOI 10.1095/biolreprod.110.086413; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; de Mello JCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010947; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Nikas G, 1996, BIOL REPROD, V55, P32, DOI 10.1095/biolreprod55.1.32; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Reinius B, 2015, NAT REV GENET, V16, P653, DOI 10.1038/nrg3888; Renaud SJ, 2015, P NATL ACAD SCI USA, V112, pE6175, DOI 10.1073/pnas.1507397112; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sudheer S, 2012, STEM CELLS DEV, V21, P2987, DOI 10.1089/scd.2012.0099; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Vallot C, 2015, CELL STEM CELL, V16, P533, DOI 10.1016/j.stem.2015.03.016; van den Berg IM, 2011, HUM GENET, V130, P203, DOI 10.1007/s00439-011-1014-9; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660	46	556	561	5	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					1012	1026		10.1016/j.cell.2016.03.023	http://dx.doi.org/10.1016/j.cell.2016.03.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27662094	Green Published, hybrid			2022-12-28	WOS:000375800300026
J	Petropoulos, S; Edsgard, D; Reinius, B; Deng, QL; Panula, SP; Codeluppi, S; Reyes, AP; Linnarsson, S; Sandberg, R; Lanner, F				Petropoulos, Sophie; Edsgard, Daniel; Reinius, Bjorn; Deng, Qiaolin; Panula, Sarita Pauliina; Codeluppi, Simone; Reyes, Alvaro Plaza; Linnarsson, Sten; Sandberg, Rickard; Lanner, Fredrik			Single-Cell RNA-Seq Reveals Lineage and X Chromosome Dynamics in Human Preimplantation Embryos (vol 165, pg 1012, 2016)	CELL			English	Correction												rickard.sandberg@ki.se; fredrik.lanner@ki.se	Petropoulos, Sophie/M-3090-2017; Petropoulos, Sophie/D-6861-2016; Plaza Reyes, Alvaro/AAC-1723-2022; Deng, Qiaolin/AAD-6905-2020; Linnarsson, Sten/HCH-3909-2022; Reyes, Alvaro Plaza/AAX-7992-2020; codeluppi, simone/I-4143-2012	Petropoulos, Sophie/0000-0003-2293-8238; Reyes, Alvaro Plaza/0000-0003-1167-6316; codeluppi, simone/0000-0002-7053-0520; Sandberg, Rickard/0000-0001-6473-1740; Reinius, Bjorn/0000-0002-7021-5248; Lanner, Fredrik/0000-0002-2771-7445; Deng, Qiaolin/0000-0001-5934-7816	European Research Council [648842] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]	1	556	561	5	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 22	2016	167	1					285	285		10.1016/j.cell.2016.08.009	http://dx.doi.org/10.1016/j.cell.2016.08.009			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EA1GW	27662094	Green Published, hybrid			2022-12-28	WOS:000386341500031
J	Tape, CJ; Ling, S; Dimitriadi, M; McMahon, KM; Worboys, JD; Leong, HS; Norrie, IC; Miller, CJ; Poulogiannis, G; Lauffenburger, DA; Jorgensen, C				Tape, Christopher J.; Ling, Stephanie; Dimitriadi, Maria; McMahon, Kelly M.; Worboys, Jonathan D.; Leong, Hui Sun; Norrie, Ida C.; Miller, Crispin J.; Poulogiannis, George; Lauffenburger, Douglas A.; Jorgensen, Claus			Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation (vol 165, pg 910, 2016)	CELL			English	Correction												claus.jorgensen@cruk.manchester.ac.uk	Poulogiannis, George/AAY-2210-2021; Poulogiannis, George/AAE-1966-2019	Poulogiannis, George/0000-0002-0529-8614; Tape, Christopher/0000-0003-4712-2737; Worboys, Jonathan/0000-0002-8242-4901; Jorgensen, Claus/0000-0002-7841-943X; Miller, Crispin/0000-0003-4341-1283	Medical Research Council [1102929] Funding Source: researchfish; Cancer Research UK [12905] Funding Source: Medline; NCI NIH HHS [U54 CA112967, R01 CA096504, P30 CA014051] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029	1	113	118	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2016	165	7					1818	1818		10.1016/j.cell.2016.05.079	http://dx.doi.org/10.1016/j.cell.2016.05.079			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DO8VD	27087446	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000378062000029
